PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Showalter, LE; Oechsle, C; Ghimirey, N; Steele, C; Czerniecki, BJ; Koski, GK				Showalter, Loral E.; Oechsle, Crystal; Ghimirey, Nirmala; Steele, Chase; Czerniecki, Brian J.; Koski, Gary K.			Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITORS; CRYSTAL-STRUCTURE; EXTRACELLULAR REGION; SUPPRESSIVE FUNCTION; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; OPEN-LABEL; RECEPTOR; RESISTANCE	The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferation for multiple types of cancer. Members have therefore become thefocus of many drug and immune-based therapy innovations. The targeted anti-cancer agent, lapatinib, is a small molecule inhibitor that directly interferes with EGFR (HER-1) and HER-2 signaling, and indirectly reduces HER-3 signaling, thus suppressing important downstream events. A recently-developed dendritic cell-based vaccine against early breast cancer (ductal carcinoma in situ; DCIS) that generates strong Th1-dominated immunity against HER-2 has induced pathologic complete response in about one-third of immunized individuals. In vitro studies suggested cytokines secreted by Th1 cells could be major contributors to the vaccine effects including induction of apoptosis and suppression of HER expression. With a view toward improving complete response rates, we investigated whether the principle Th1 cytokines (IFN-gamma and TNF-alpha) could act in concert with lapatinib to suppress activity of breast cancer lines in vitro. Lapatinib-sensitive SKBR3, MDA-MB-468 and BT474 cells were incubated with Th1 cytokines, lapatinib, or both. It was found that combined treatment maximized metabolic suppression(Alamar Blue assay), as well as cell death (Trypan Blue) and apoptosis(Annexin V/Propidium Iodide and TMRE staining). Combined drug plus cytokine treatment also maximized suppression of both total and phosphorylated forms of HER-2 and HER-3. Interestingly, when lapatinib resistant lines MDA-MB-453 and JIMT-1 were tested, it was found that the presence of Th1 cytokines appeared to enhance sensitivity for lapatinib-induced metabolic suppression and induction of apoptotic cell death, nearly abrogating drug resistance. These studies provide pre-clinical data suggesting the possibility that targeted drug therapy may be combined with vaccination to enhance anti-cancer effects, and furthermore that robust immunity in the form of secreted Th1 cytokines may have the capacity to mitigate resistance to targeted drugs.	[Showalter, Loral E.; Oechsle, Crystal; Ghimirey, Nirmala; Steele, Chase; Koski, Gary K.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Czerniecki, Brian J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Breast Oncol, Tampa, FL USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; H Lee Moffitt Cancer Center & Research Institute	Koski, GK (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	dendritic_cell@hotmail.com			US Department of Defense [W81XH-16-110385]; Pennies in Action Foundation; Werner and Gertrude Henle Charitable Trust	US Department of Defense(United States Department of Defense); Pennies in Action Foundation; Werner and Gertrude Henle Charitable Trust	This work was supported by a grant from the US Department of Defense (http://cdmrp.army.mil/; Grant number W81XH-16-110385: BJC, GKK) and by support from Pennies in Action Foundation (GKK) and the Werner and Gertrude Henle Charitable Trust (GKK and LS).	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Azim H, 2009, CANCER TREAT REV, V35, P633, DOI 10.1016/j.ctrv.2009.06.007; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Canonici A, 2013, ONCOTARGET, V4, P1592, DOI 10.18632/oncotarget.1148; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crown JP, 2008, BREAST CANCER RES TR, V112, P317, DOI 10.1007/s10549-007-9860-9; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; de Azambuja E, 2014, LANCET ONCOL, V15, P1137, DOI 10.1016/S1470-2045(14)70320-1; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Guan ZZ, 2013, J CLIN ONCOL, V31, P1947, DOI 10.1200/JCO.2011.40.5241; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Koski GK, 2012, J IMMUNOTHER, V35, P54, DOI 10.1097/CJI.0b013e318235f512; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Liu S, 2016, ONCOTARGET, V7, P11310, DOI 10.18632/oncotarget.7023; Lowenfeld L, 2017, CLIN CANCER RES, V23, P2961, DOI 10.1158/1078-0432.CCR-16-1924; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Namjoshi P., 2016, ONCOTARGET; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rusnak DW, 2001, CANCER RES, V61, P7196; Saleem A, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0103-5; Segovia-Mendoza M, 2015, AM J CANCER RES, V5, P2531; Sendur MAN, 2013, CURR MED RES OPIN, V29, P1015, DOI 10.1185/03007995.2013.807232; Sharma A, 2012, CANCER-AM CANCER SOC, V118, P4354, DOI 10.1002/cncr.26734; Siwak DR, 2010, J ONCOL, V2010, P1, DOI DOI 10.1155/2010/568938; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang SH, 2016, J BIOL CHEM, V291, P21085, DOI 10.1074/jbc.M116.717892; Wetterskog D, 2014, ONCOGENE, V33, P966, DOI 10.1038/onc.2013.41; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	44	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210209	10.1371/journal.pone.0210209	http://dx.doi.org/10.1371/journal.pone.0210209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657766	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000007
J	Ingram, LA; Butler, AA; Gandevia, SC; Walsh, LD				Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.; Walsh, Lee D.			Proprioceptive measurements of perceived hand position using pointing and verbal localisation tasks	PLOS ONE			English	Article							IMPLICIT BODY REPRESENTATIONS; ANESTHESIA; DISTORTIONS; MOVEMENTS; POSTURE; BIASES; MODEL	Previous studies revealed that healthy individuals consistently misjudge the size and shape of their hidden hand during a localisation task. Specifically, they overestimate the width of their hand and underestimate the length of their fingers. This would also imply that the same individuals misjudge the actual location of at least some parts of their hand during the task. Therefore, the primary aim of the current study was to determine whether healthy individuals could accurately locate the actual position of their hand when hidden from view, and whether accuracy depends on the type of localisation task used, the orientation of the hidden hand, and whether the left or right hand is tested. Sixteen healthy right-handed participants performed a hand localisation task that involved both pointing to and verbally indicating the perceived position of landmarks on their hidden hand. Hand position was consistently misjudged as closer to the wrist (proximal bias) and, to a lesser extent, away from the thumb (ulnar bias). The magnitude of these biases depended on the localisation task (pointing vs. verbal), the orientation of the hand (straight vs. rotated), and the hand tested (left vs. right). Furthermore, the proximal location bias increased in size as the duration of the experiment increased, while the magnitude of ulnar bias remained stable through the experiment. Finally, the resultant maps of perceived hand location appear to replicate the previously reported overestimation of hand width and underestimation of finger length. Once again, the magnitude of these distortions is dependent on the task, orientation, and hand tested. These findings underscore the need to control and standardise each component of the hand localisation task in future studies.	[Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.] Neurosci Res Australia, Sydney, NSW, Australia; [Ingram, Lewis A.; Butler, Annie A.; Gandevia, Simon C.] Univ New South Wales, Sydney, NSW, Australia; [Walsh, Lee D.] Platypus Tech Consultants Pty Ltd, Canberra, ACT, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Gandevia, SC (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	s.gandevia@neura.edu.au	Walsh, Lee/D-6184-2011; Butler, Annie/O-5645-2014; Gandevia, Simon/D-5009-2011	Walsh, Lee/0000-0002-1405-1031; Ingram, Lewis/0000-0003-2741-1574; Butler, Annie/0000-0002-3678-1297; Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council (NHMRC) [1055084]; NHMRC; Platypus Technical Consultants	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Platypus Technical Consultants	This study was supported by the Motor Impairment Program grant from the National Health and Medical Research Council (NHMRC), #1055084. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Lee Walsh is currently the director of Platypus Technical Consultants Pty Ltd (Australia). The company had no role in any aspect of the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided some support in the form of salaries for authors (from NHMRC for SG, AB; from Platypus Technical Consultants for LW), but did not have role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author contributions' section.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bellan V, 2015, EXP BRAIN RES, V233, P1689, DOI 10.1007/s00221-015-4242-8; BURGESS PR, 1982, ANNU REV NEUROSCI, V5, P171, DOI 10.1146/annurev.ne.05.030182.001131; CRASKE B, 1984, J EXP PSYCHOL HUMAN, V10, P307, DOI 10.1037/0096-1523.10.2.307; CRASKE B, 1975, PERCEPT MOTOR SKILL, V40, P755, DOI 10.2466/pms.1975.40.3.755; CROWE A, 1987, PERCEPT MOTOR SKILL, V64, P831, DOI 10.2466/pms.1987.64.3.831; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; Ferre ER, 2013, NEUROPSYCHOLOGIA, V51, P1445, DOI 10.1016/j.neuropsychologia.2013.04.006; FISK JD, 1985, EXP BRAIN RES, V60, P159; Fuentes CT, 2013, ACTA PSYCHOL, V144, P344, DOI 10.1016/j.actpsy.2013.06.012; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; Gurfinkel VS, 1991, BRAIN, V34, P102; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Hoang PD, 2016, MULT SCLER J EXP TRA, V2, P1; Hodges P., 2013, SPINAL CONTROL REHAB; Hoseini N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135757; Inui N, 2011, J PHYSIOL-LONDON, V589, P5775, DOI 10.1113/jphysiol.2011.219949; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Jull G.A., 2008, WHIPLASH HEADACHE NE; Kaya D, 2018, PROPRIOCEPTION ORTHO; Longo MR, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00656; Longo MR, 2015, CONSCIOUS COGN, V36, P96, DOI 10.1016/j.concog.2015.06.009; Longo MR, 2015, ACTA PSYCHOL, V160, P77, DOI 10.1016/j.actpsy.2015.07.002; Longo MR, 2014, EXP BRAIN RES, V232, P1241, DOI 10.1007/s00221-014-3840-1; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, PSYCHOL SCI, V23, P740, DOI 10.1177/0956797612441219; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Lopez C, 2012, NEUROPSYCHOLOGIA, V50, P1830, DOI 10.1016/j.neuropsychologia.2012.04.008; Margolis AN, 2015, EXP BRAIN RES, V233, P351, DOI 10.1007/s00221-014-4118-3; Mattioni S, 2014, ACTA PSYCHOL, V153, P60, DOI 10.1016/j.actpsy.2014.09.009; Medina J, 2017, J EXP PSYCHOL HUMAN, V43, P1430, DOI 10.1037/xhp0000397; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P645, DOI 10.1016/j.neuropsychologia.2009.08.017; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J, NEUROPSYCHOLOGY SPAT; Proske U, 2018, COMPR PHYSIOL, V8, P1157, DOI 10.1002/cphy.c170036; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Sherrington C, 1906, INTEGRATIVE ACTION N; Twisk JW, 2013, APPL LONGITUDINAL DA; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Walsh LD, 2015, EXP BRAIN RES, V233, P1761, DOI 10.1007/s00221-015-4249-1; Walsh LD, 2010, J PHYSIOL-LONDON, V588, P1269, DOI 10.1113/jphysiol.2009.183038; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210911	10.1371/journal.pone.0210911	http://dx.doi.org/10.1371/journal.pone.0210911			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653568	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000456015500088
J	Masomi-Bornwasser, J; Winter, P; Neulen, A; Kantelhardt, SR; Konig, J; Kempski, O; Ringel, F; Keric, N				Masomi-Bornwasser, Julia; Winter, Philipp; Neulen, Axel; Kantelhardt, Sven R.; Koenig, Jochem; Kempski, Oliver; Ringel, Florian; Keric, Naureen			Doppler sonography enhances rtPA-induced fibrinolysis in an in vitro clot model of spontaneous intracerebral hemorrhages	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INITIAL CONSERVATIVE TREATMENT; INDEPENDENT ULTRASOUND DEVICE; MINIMALLY INVASIVE EVACUATION; EARLY SURGERY; THROMBOLYSIS; SAFETY; SONOTHROMBOLYSIS; ASPIRATION; HEMATOMA	Background Transcranial Doppler (TCD) was shown to enhance intravascular fibrinolysis by rtPA in ischemic stroke. Studies revealed that catheter- based administration of rtPA induces lysis of intracerebral hemorrhages (ICH). However, it is unknown whether TCD would be suitable to enhance rtPA-induced fibrinolysis in patients with ICH. The aim of this study was to assess the potential of TCD to enhance rtPA-induced fibrinolysis in an in vitro clot system. Methods Reproducible human blood clots of 25 ml were incubated in a water bath at 37 degrees C during treatments. They were weighed before and after 6 different treatments: (I) control (incubation only), (II) rtPA only, (III) one Doppler probe, (IV) two Doppler probes placed vis-a-vis, (V) one probe and rtPA and (VI) two probes and rtPA. To quantify lysis of the blood clots and attenuation of the Doppler through a temporal squama acoustic peak rarefaction pressure (APRP) was measured in the field of the probes. Temperature was assessed to evaluate possible side effects. Results Clot weight was reduced in all groups. The control group had the highest relative end weight of 70.2%+/- 7.2% compared to all other groups (p<0,0001). Most efficient lysis was achieved using (VI) 2 probes and rtPA 36.3%+/- 4.4% compared to (II, III, IV) (p<0.0001; p = 0.0002; p = 0.048). APRP was above lysis threshold (535.5 +/- 7.2 kPa) using 2 probes even through the temporal squama (731.6 +/- 32.5 kPa) (p = 0.0043). There was a maximal temperature elevation of 0.17 +/- 0.07 degrees C using both probes. Conclusions TCD significantly enhances rtPA-induced lysis of blood clots, and the effect is amplified by using multiple probes. Our results indicate that bitemporal TCD insonation of hematomas could be a new and safe approach to enhance fibrinolysis of ICH's treated with intralesional catheter and rtPA.	[Masomi-Bornwasser, Julia; Winter, Philipp; Neulen, Axel; Kantelhardt, Sven R.; Ringel, Florian; Keric, Naureen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Germany; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany; [Kempski, Oliver] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Masomi-Bornwasser, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Germany.	Julia.Masomi@unimedizin-mainz.de	Ringel, Florian/E-4933-2014; König, Jochem/T-3500-2019	König, Jochem/0000-0003-4683-0360; Masomi-Bornwasser, Julia/0000-0003-1955-9827; Neulen, Axel/0000-0003-3547-1630				Abdu E, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11362; Alexandrov AV, 2000, STROKE, V31, P610, DOI 10.1161/01.STR.31.3.610; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Ammi AY, 2008, ULTRASOUND MED BIOL, V34, P1578, DOI 10.1016/j.ultrasmedbio.2008.02.012; Bardon P, 2014, BIOMED PAP, V158, P233, DOI 10.5507/bp.2012.064; Barlinn K, 2013, STROKE, V44, P1641, DOI 10.1161/STROKEAHA.113.001122; Barlinn K, 2013, J CLIN ULTRASOUND, V41, P354, DOI 10.1002/jcu.21978; Barreto AD, 2013, STROKE, V44, P3376, DOI 10.1161/STROKEAHA.113.002713; Braaten JV, 1997, THROMB HAEMOSTASIS, V78, P1063; Cintas P, 2002, STROKE, V33, P626, DOI 10.1161/hs0202.103073; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Eggers J, 2003, ANN NEUROL, V53, P797, DOI 10.1002/ana.10590; Fernandes HM, 2000, ACT NEUR S, V76, P463; Fiorella D, 2015, J NEUROINTERV SURG, V7, P752, DOI 10.1136/neurintsurg-2014-011358; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Gregson BA, 2012, STROKE, V43, P1496, DOI 10.1161/STROKEAHA.111.640284; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Heit JJ, 2017, J STROKE, V19, P11, DOI 10.5853/jos.2016.00563; Huda W, 2010, REV RADIOLOGIC PHYS; Keric N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5472936; LIPPITZ BE, 1994, ACTA NEUROCHIR, V127, P157, DOI 10.1007/BF01808759; Masomi-Bornwasser J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188131; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Meunier JM, 2011, CURR NEUROVASC RES, V8, P305; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P147; Nedelmann M, 2008, ULTRASOUND MED BIOL, V34, P2019, DOI 10.1016/j.ultrasmedbio.2008.06.003; Neulen A, 2016, CLIN NEUROL NEUROSUR, V145, P14, DOI 10.1016/j.clineuro.2016.03.012; Newell DW, 2011, J NEUROSURG, V115, P592, DOI 10.3171/2011.5.JNS10505; Pfaffenberger S, 2005, STROKE, V36, P124, DOI 10.1161/01.STR.0000150503.10480.a7; Pieters M, 2004, ULTRASOUND MED BIOL, V30, P1545, DOI 10.1016/j.ultrasmedbio.2004.08.028; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rohde V, 2002, J NEUROSURG, V97, P954, DOI 10.3171/jns.2002.97.4.0954; Soltani A, 2011, J THROMB THROMBOLYS, V31, P71, DOI 10.1007/s11239-010-0483-3; Thiex R, 2004, J NEUROL, V251, P1443, DOI 10.1007/s00415-004-0554-5; Wagner KR, 1999, J NEUROSURG, V90, P491, DOI 10.3171/jns.1999.90.3.0491; Wilhelm-Schwenkmezger T, 2007, STROKE, V38, P1031, DOI 10.1161/01.STR.0000257966.32242.0b; Xiao Fang, 2015, Zhonghua Yi Xue Za Zhi, V95, P1135	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210810	10.1371/journal.pone.0210810	http://dx.doi.org/10.1371/journal.pone.0210810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653589	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500075
J	Barker, SE; Bricknell, IR; Covello, J; Purcell, S; Fast, MD; Wolters, W; Bouchard, DA				Barker, Sarah E.; Bricknell, Ian R.; Covello, Julia; Purcell, Sarah; Fast, Mark D.; Wolters, William; Bouchard, Deborah A.			Sea lice, Lepeophtheirus salmonis (Kroyer 1837), infected Atlantic salmon (Salmo salar L.) are more susceptible to infectious salmon anemia virus	PLOS ONE			English	Article							ORTHOMYXO-LIKE VIRUS; SINGLE-STEP METHOD; IMMUNE-RESPONSES; NEW-BRUNSWICK; RISK-FACTORS; LOUSE; INTERFERON; RNA; CALIGIDAE; COPEPODA	The role of parasitic sea lice (Siphonostomatoida; Caligidae), especially Lepeophtheirus salmonis, in the epidemiology of Infectious Salmon Anemia Virus (ISAv) has long been suspected. The epidemiological studies conducted during the 1998 major Infectious Salmon Anaemia (ISA) outbreak in Scotland demonstrated a strong correlation between sea lice presence and ISAv positive sites or subsequent clinical outbreaks of ISA. The question posed from this observation was "do sea lice infestations on Atlantic salmon make them more susceptible to viral infections?" This study investigated the role that sea lice infestations have on the severity of ISAv infections and disease mortality in experimental populations of farmed Atlantic salmon (Salmo salar). A series of experiments was carried out that investigated the potential of sea lice to modify the outcome of an ISAv infection. Experimental populations of Atlantic salmon were established that had: no lice and no ISAv, a single infection with either ISAv or lice and a co-infection with lice then ISAV. The results were quite clear, the process of infestation by the parasite prior to ISAv exposure significantly increased the mortality and death rates of Atlantic salmon, when compared to uninfected controls and ISAv infected groups only. This was consistent over two source strains of Atlantic salmon (Pennobscot and Saint John River), but the severity and timing was altered. Immunological responses were also consistent in that pro-inflammatory genes were induced in lice only and co-infected fish, whereas the anti-viral response, Mx, MH class I beta, Galectin 9 and TRIM 16, 25 genes were down-regulated by lice infection prior to and shortly after co-infection with ISAv. It is concluded that the sea lice settlement on Atlantic salmon and the parasite's subsequent manipulation of the host's immune system, which increases parasite settlement success, also increased susceptibility to ISAv.	[Barker, Sarah E.; Bricknell, Ian R.; Bouchard, Deborah A.] Univ Maine, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA; [Bricknell, Ian R.] Univ Maine, Sch Marine Sci, Hitchner Hall, Orono, ME USA; [Covello, Julia; Purcell, Sarah; Fast, Mark D.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Hoplite Lab, Charlottetown, PE, Canada; [Wolters, William] ARS, USDA, Natl Cold Water Marine Aquaculture Ctr, Franklin, ME USA; [Barker, Sarah E.] Benchmark Anim Hlth Ltd, Edinburgh Technopole, Penicuik, Midlothian, Scotland	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Prince Edward Island; United States Department of Agriculture (USDA)	Bouchard, DA (corresponding author), Univ Maine, Aquaculture Res Inst, Hitchner Hall, Orono, ME 04469 USA.	deborah.bouchard@maine.edu		Bouchard, Deborah/0000-0001-9552-4576	Northeastern Regional Aquaculture Center [2010-38580-21074]; Maine Agricultural and Forest Experiment Station (US), NIFA MAFES [ME21501]	Northeastern Regional Aquaculture Center; Maine Agricultural and Forest Experiment Station (US), NIFA MAFES	The authors would like to thank the Northeastern Regional Aquaculture Center for award #2010-38580-21074, https://www.ncrac.org, and the Maine Agricultural and Forest Experiment Station (US), https://umaine.edu/mafes/, NIFA MAFES for award #ME21501, for their support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolofia J, 2017, MAR RESOUR ECON, V32, P329, DOI 10.1086/691981; Barker DE, 2009, PARASITOL RES, V105, P1173, DOI 10.1007/s00436-009-1523-9; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Bjorn PA, 2011, AQUACULTURE ENV INTE, V1; Blake S, 1999, DIS AQUAT ORGAN, V36, P238; Bouchard D, 1999, DIS AQUAT ORGAN, V36, P238; Braden LM, 2015, DEV COMP IMMUNOL, V48, P178, DOI 10.1016/j.dci.2014.09.015; Braden LM, 2012, COMP BIOCHEM PHYS D, V7, P100, DOI 10.1016/j.cbd.2011.12.002; Braden LM, 2016, 11 INT SEA LIC C 201; BRON JE, 1991, J ZOOL, V224, P201, DOI 10.1111/j.1469-7998.1991.tb04799.x; Brown ABJ, 2017, 42 ANN E FISH HLTH W; Butler R.G., 2001, THESIS; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collet B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137767; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; EVENSEN O, 1991, RES VET SCI, V51, P215, DOI 10.1016/0034-5288(91)90017-I; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fast MD, 2007, PARASITE IMMUNOL, V29, P179, DOI 10.1111/j.1365-3024.2007.00932.x; Fast MD, 2014, DEV COMP IMMUNOL, V43, P300, DOI 10.1016/j.dci.2013.08.019; Fast MD, 2004, EXP PARASITOL, V107, P5, DOI 10.1016/j.exppara.2004.04.001; Hammell KL, 2005, J FISH DIS, V28, P651, DOI 10.1111/j.1365-2761.2005.00668.x; Hammell KL, 2005, J FISH DIS, V28, P639, DOI 10.1111/j.1365-2761.2005.00667.x; Hammell KL, 2005, RISK FACTORS ASS MOR; Hastings T, 1999, BULL EUR ASSN FISH P, V19, P286; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Holm H, 2015, FISH SHELLFISH IMMUN, V42, P384, DOI 10.1016/j.fsi.2014.10.038; Jackson D, 2012, AQUACULTURE, V364, P118, DOI 10.1016/j.aquaculture.2012.08.003; Jakob E, 2011, DIS AQUAT ORGAN, V97, P155, DOI 10.3354/dao02414; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Jones SRM, 2006, J PARASITOL, V92, P473, DOI 10.1645/GE-685R1.1; Jorgensen SM, 2007, FISH SHELLFISH IMMUN, V23, P576, DOI 10.1016/j.fsi.2007.01.005; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Kileng O, 2008, FISH SHELLFISH IMMUN, V24, P514, DOI 10.1016/j.fsi.2007.10.005; Kileng O, 2007, FISH SHELLFISH IMMUN, V23, P378, DOI 10.1016/j.fsi.2006.11.011; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Krossoy B, 1999, J VIROL, V73, P2136; Kvello AR, 2007, CELLS; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; LeBlanc F, 2012, MOL IMMUNOL, V51, P197, DOI 10.1016/j.molimm.2012.03.021; LeBlanc F, 2010, FISH SHELLFISH IMMUN, V29, P217, DOI 10.1016/j.fsi.2010.03.007; Lewis DL, 2014, FISH SHELLFISH IMMUN, V38, P175, DOI 10.1016/j.fsi.2014.03.014; McClure CA, 2005, PREV VET MED, V72, P263, DOI 10.1016/j.prevetmed.2005.07.010; McClure CA, 2005, DIS AQUAT ORGAN, V63, P119, DOI 10.3354/dao063119; Mishra A, 2017, INT REV IMMUNOL, V36, P89, DOI 10.1080/08830185.2017.1291640; Mjaaland S, 1997, J VIROL, V71, P7681, DOI 10.1128/JVI.71.10.7681-7686.1997; Molloy SD, 2013, J FISH DIS, V36, P35, DOI 10.1111/j.1365-2761.2012.01412.x; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Murray AG, 2010, DIS AQUAT ORGAN, V91, P189, DOI 10.3354/dao02262; NESE L, 1993, DIS AQUAT ORGAN, V16, P79, DOI 10.3354/dao016079; Nylund A., 1991, Bulletin of the European Association of Fish Pathologists, V11, P213; Oelckers K, 2015, LAT AM J AQUAT RES, V43, P380, DOI 10.3856/vol43-issue2-fulltext-15; Pert CC, 2014, AQUACULT ENV INTERAC, V5, P49, DOI 10.3354/aei00094; Pino-Marambio J, 2007, AQUACULTURE, V271, P70, DOI 10.1016/j.aquaculture.2007.05.025; Purcell SL, 2013, J FISH DIS, V36, P229, DOI 10.1111/jfd.12024; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimstad E, 2002, APMIS, V110, P273, DOI 10.1034/j.1600-0463.2002.100401.x; Rodger HD, 2016, BIRKHAUSER ADV INFEC, P1, DOI 10.1007/978-3-0348-0980-1_1; Schiotz BL, 2008, VIRUS RES, V136, P65, DOI 10.1016/j.virusres.2008.04.019; Shi WK, 2018, ACTA TROP, V177, P97, DOI 10.1016/j.actatropica.2017.09.027; Skugor S, 2008, BMC GENOMICS, V9, P18, DOI [10.1186/1471-2164-9-18, DOI 10.1186/1471-2164-9-18]; Skugor S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1921-7; Snow M, NEW DIAGNOSTIC TECHN, P133; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Valdes-Donoso P, 2013, J FISH DIS, V36, P353, DOI 10.1111/jfd.12070; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	72	32	32	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209178	10.1371/journal.pone.0209178	http://dx.doi.org/10.1371/journal.pone.0209178			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650077	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300009
J	Cavazos-Rehg, PA; Krauss, MJ; Costello, SJ; Kaiser, N; Cahn, ES; Fitzsimmons-Craft, EE; Wilfley, DE				Cavazos-Rehg, Patricia A.; Krauss, Melissa J.; Costello, Shaina J.; Kaiser, Nina; Cahn, Elizabeth S.; Fitzsimmons-Craft, Ellen E.; Wilfley, Denise E.			"I just want to be skinny.": A content analysis of tweets expressing eating disorder symptoms	PLOS ONE			English	Article							EXAMINATION-QUESTIONNAIRE; NUMBER-THINSPIRATION; FITSPIRATION; PREVALENCE; COMMUNITY	There is increasing concern about online communities that promote eating disorder (ED) behaviors through messages and/or images that encourage a "thin ideal" (i.e., promotion of thinness as attractive) and harmful weight loss/weight control practices. The purpose of this paper is to assess the content of body image and ED-related content on Twitter and provide a deeper understanding of EDs that may be used for future studies and online-based interventions. Tweets containing ED or body image-related keywords were collected from January 1-January 31, 2015 (N = 28,642). A random sample (n = 3000) was assessed for expressions of behaviors that align with subscales of the Eating Disorder Examination (EDE) 16.0. Demographic characteristics were inferred using a social media analytics company. The comprehensive research that we conducted indicated that 2,584 of the 3,000 tweets were ED-related; 65% expressed a preoccupation with body shape, 13% displayed issues related to food/eating/calories, and 4% expressed placing a high level of importance on body weight. Most tweets were sent by girls (90%) who were <= 19 years old (77%). Our findings stress a need to better understand if and how ED-related content on social media can be used for targeting prevention and intervention messages towards those who are inneed and could potentially benefit from these efforts.	[Cavazos-Rehg, Patricia A.; Krauss, Melissa J.; Costello, Shaina J.; Kaiser, Nina; Cahn, Elizabeth S.; Fitzsimmons-Craft, Ellen E.; Wilfley, Denise E.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL)	Cavazos-Rehg, PA (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	pcavazos@wustl.edu		Cavazos-Rehg, Patricia/0000-0003-3352-1198	National Institutes of Health [R01DA032843, R01DA039455]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health [grant numbers R01DA032843 (PCR), R01DA039455 (PCR)] and the Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [grant number UL1 TR000448]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2015, MEDIA IS BRAINWASHIN; [Anonymous], 2012, CBS NEW YORK    0717; Arseniev-Koehler A, 2016, J ADOLESCENT HEALTH, V58, P659, DOI 10.1016/j.jadohealth.2016.02.012; Beevolve, 2012, EXH STUD TWITT US WO; Berg KC, 2012, INT J EAT DISORDER, V45, P428, DOI 10.1002/eat.20931; Brown A., 2015, TEX REV ENT SPORTS L, V16, P87; Carrotte ER, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6368; Cavazos-Rehg PA, 2016, COMPUT HUM BEHAV, V54, P351, DOI 10.1016/j.chb.2015.08.023; COOPER PJ, 1993, INT J EAT DISORDER, V13, P385, DOI 10.1002/1098-108X(199305)13:4<385::AID-EAT2260130406>3.0.CO;2-W; Cornelius T, 2016, EAT DISORD, V24, P138, DOI 10.1080/10640266.2014.1000102; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; FAIRBURN CG, 1986, INT J EAT DISORDER, V5, P403, DOI 10.1002/1098-108X(198603)5:3<403::AID-EAT2260050302>3.0.CO;2-Z; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fiesler C, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P567, DOI 10.1145/2998181.2998223; Ghaznavi J, 2015, BODY IMAGE, V14, P54, DOI 10.1016/j.bodyim.2015.03.006; Holland G, 2017, INT J EAT DISORDER, V50, P76, DOI 10.1002/eat.22559; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Krippendorff K., 2007, COMPUTING KRIPPENDOR; Livingstone S., 2010, RISKS SAFETY INTERNE; Mishra R, 2012, CAMB Q HEALTHC ETHIC, V21, P396, DOI 10.1017/S0963180112000138; Mislove A, 2011, P 5 INT C WEBL SOC M, P554; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Pater JA, 2016, ACM CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW 2016), P1185, DOI 10.1145/2818048.2820030; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Qian Jie, 2013, Shanghai Arch Psychiatry, V25, P212, DOI 10.3969/j.issn.1002-0829.2013.04.003; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Sowles SJ, 2018, BODY IMAGE, V24, P137, DOI 10.1016/j.bodyim.2018.01.001; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Talbot CV, 2017, J EAT DISORD, V5, DOI 10.1186/s40337-017-0170-2; Tiggemann M, 2018, BODY IMAGE, V25, P133, DOI 10.1016/j.bodyim.2018.03.002; Tiggemann M, 2018, J HEALTH PSYCHOL, V23, P1003, DOI 10.1177/1359105316639436	32	26	26	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0207506	10.1371/journal.pone.0207506	http://dx.doi.org/10.1371/journal.pone.0207506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650072	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300004
J	Cespedes, V; Valdecasas, AG; Green, AJ; Sanchez, MI				Cespedes, Vanessa; Valdecasas, Antonio G.; Green, Andy J.; Sanchez, Marta I.			Water boatman survival and fecundity are related to ectoparasitism and salinity stress	PLOS ONE			English	Article							NATIONAL-PARK SW; TEMPORARY PONDS; CLIMATE-CHANGE; PARASITISM; CORIXIDAE; HEMIPTERA; DONANA; LARVAE; MITES; DISEASES	Salinity is increasing in aquatic ecosystems in the Mediterranean region due to global change, and this is likely to have an important impact on host-parasite interactions. Here we studied the relationships between infection by ectoparasitic water mites and salinity variation, on survival and fecundity of water boatmen Corixidae in the laboratory. Larvae of Sigara lateralis parasitised by larval mites (Hydrachna skorikowi) had lower survivorship, and failed to moult to the adult stage. In adult corixids (S. lateralis and Corixa affinis) fitness was reduced at high salinities and in individuals infected by H. skorikowi, both in terms of survival and fecundity. We also found evidence for parasitism-salinity interactions. Our results suggest that ongoing increases in salinity in Mediterranean ponds due to climate change and water abstraction for agriculture or urban use have a strong impact on water bugs, and that their interactions with ectoparasites may modify salinity effects.	[Cespedes, Vanessa; Green, Andy J.; Sanchez, Marta I.] CSIC, Dept Ecol Humedales, Estn Biol Donana, Seville, Spain; [Valdecasas, Antonio G.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, Madrid, Spain; [Sanchez, Marta I.] Univ Cadiz, Inst Univ Invest Marina INMAR, Campus Excelencia Int Global Mar CEI MAR, Puerto Real, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Cadiz	Cespedes, V (corresponding author), CSIC, Dept Ecol Humedales, Estn Biol Donana, Seville, Spain.	vanessa.cespedes@ebd.csic.es	Sánchez, Marta I/E-9723-2010; Céspedes, Vanessa/AAF-6316-2019; Valdecasas, Antonio G/H-6696-2015; Green, Andy J/A-5189-2008	Sánchez, Marta I/0000-0002-8349-5410; Céspedes, Vanessa/0000-0002-9399-8791; Valdecasas, Antonio G/0000-0002-5665-4906; Green, Andy J/0000-0002-1268-4951	Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia [P10-RNM-6262]; MICINN [EEBB-I-17-12675, SVP-2013-067595]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [RYC-2011-09382]	Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ministerio de Economia, Industria y Competitividad, Gobierno de Espana(Spanish Government)	This work was funded by project P10-RNM-6262 (Consejeria de Innovacion, Ciencia y empresa, Junta de Andalucia). The first author (VC) was supported by a predoctoral Severo Ochoa grant SVP-2013-067595 from the MICINN and mobility grant EEBB-I-17-12675 from the MICINN. Funding was also provided by Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (grant RYC-2011-09382) to MIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRO A, 1982, J INVERTEBR PATHOL, V39, P373, DOI 10.1016/0022-2011(82)90062-3; APPLEGATE RL, 1977, AM MIDL NAT, V97, P198, DOI 10.2307/2424695; Aykut M, 2018, ZOOKEYS, P89, DOI 10.3897/zookeys.738.21021; Blanar CA, 2009, AQUAT TOXICOL, V93, P18, DOI 10.1016/j.aquatox.2009.03.002; BOTTGER K, 1976, FRESHWATER BIOL, V6, P497, DOI 10.1111/j.1365-2427.1976.tb01641.x; Bradley T. J., 2008, Aquatic insects: challenges to populations, P20, DOI 10.1079/9781845933968.0020; CAMPBELL BC, 1979, CAN ENTOMOL, V111, P1005, DOI 10.4039/Ent1111005-9; Carbonell JA, 2016, HYDROBIOLOGIA, V768, P273, DOI 10.1007/s10750-015-2556-y; Carbonell JA, 2012, FRESHWATER BIOL, V57, P2580, DOI 10.1111/fwb.12029; Carbonell JA, 2017, FUNCT ECOL, V31, P1957, DOI 10.1111/1365-2435.12884; Cespedes V, 2019, HYDROBIOLOGIA, V827, P309, DOI [10.1007/s10750-018-3782-x, 10.100]; Cespedes V, 2017, PEERJ, V5, DOI 10.7717/peerj.3554; Coccia C, 2016, AQUAT SCI, V78, P779, DOI 10.1007/s00027-016-0469-0; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Crisp D. T., 1959, Irish Naturalists' Journal, V13, P88; DAVIDS C, 1973, Netherlands Journal of Zoology, V23, P363; Davids C., 2006, GREEN INFRASTRUCTURE, P241, DOI [10.1007/978- 3-662- 55958-1_7, 10.1007/978-3-662-55958-1_7]; Davids C, 1975, VERHANDLUNGEN INT VE, V19, P3079; Di Sabatino A, 2000, FRESHWATER BIOL, V44, P47, DOI 10.1046/j.1365-2427.2000.00591.x; Diaz-Paniagua C, 2015, LIMNETICA, V34, P407; Fairn ER, 2008, ECOSCIENCE, V15, P327, DOI 10.2980/15-3-3134; Florencio M, 2009, HYDROBIOLOGIA, V634, P167, DOI 10.1007/s10750-009-9897-3; Frisch D, 2006, HYDROBIOLOGIA, V556, P327, DOI 10.1007/s10750-005-1305-z; Gledhill T., 1985, Freshwater Biological Association Annual Report, V53, P45; Green AJ, 2017, FRONT ECOL ENVIRON, V15, P99, DOI 10.1002/fee.1459; Hall MD, 2013, OECOLOGIA, V171, P789, DOI 10.1007/s00442-012-2452-3; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heine-Fuster I, 2010, J PLANKTON RES, V32, P1405, DOI 10.1093/plankt/fbq055; Jeppesen E, 2015, HYDROBIOLOGIA, V750, P201, DOI 10.1007/s10750-014-2169-x; Kefford BJ, 2004, HYDROBIOLOGIA, V517, P179, DOI 10.1023/B:HYDR.0000027346.06304.bc; Kelly DW, 2010, J APPL ECOL, V47, P498, DOI 10.1111/j.1365-2664.2010.01791.x; KELTS LJ, 1979, HYDROBIOLOGIA, V64, P37, DOI 10.1007/BF00015451; Kortegaard Leo, 1974, Wildfowl, V25, P134; LANCIANI CA, 1975, ECOLOGY, V56, P689, DOI 10.2307/1935503; LANCIANI CA, 1982, PARASITOLOGY, V85, P1, DOI 10.1017/S0031182000054081; LANCIANI CA, 1969, T AM MICROSC SOC, V88, P356, DOI 10.2307/3224702; LOPEZ T, 1991, ARCH HYDROBIOL, V120, P357; Lorenzo-Carballa MO, 2011, EXP APPL ACAROL, V54, P225, DOI 10.1007/s10493-011-9437-5; Marcogliese DJ, 2008, REV SCI TECH OIE, V27, P467, DOI 10.20506/rst.27.2.1820; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2001, CAN J ZOOL, V79, P1331, DOI 10.1139/cjz-79-8-1331; Muhling BA, 2018, ESTUAR COAST, V41, P349, DOI 10.1007/s12237-017-0280-8; MURILLO J, 1986, Miscellania Zoologica (Barcelona), V10, P135; Nielsen GJ, 1976, ACAROLOGIA; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; OVERSTREET RM, 1993, ADV FISH SC, P111; POULIN R, 1992, PARASITOL TODAY, V8, P58, DOI 10.1016/0169-4758(92)90090-O; Proctor HC, 2015, THORP COVICHS FRESHW, P599, DOI DOI 10.1016/B978-0-12-385026-3.00025-5; Proctor HC, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P599, DOI 10.1016/B978-0-12-385026-3.00025-5; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Sanchez MI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005459; Sanchez MI, 2015, J INSECT CONSERV, V19, P433, DOI 10.1007/s10841-015-9764-7; Scudder G.G.E., 1976, P263; SERRANO L, 1995, ARCH HYDROBIOL, V133, P497; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Simonis JL, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00019.1; SMITH BP, 1988, ANNU REV ENTOMOL, V33, P487, DOI 10.1146/annurev.en.33.010188.002415; Smith BP, 1977, THESIS; Smith IM, 2010, AQUAT ECOL-SAN DIEGO, P485, DOI 10.1016/B978-0-12-374855-3.00015-7; Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010; Stevens M., 1999, ECOLOGY EVOLUTION AC, P381, DOI DOI 10.1007/978-94-017-1343-6_; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Sures B., 2008, ENV PARASITOLOGY INT, P434; Sures B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2001-3; TONES PI, 1975, CAN J ZOOL, V53, P1207, DOI 10.1139/z75-144; Van de Meutter F, 2010, FUND APPL LIMNOL, V177, P283, DOI 10.1127/1863-9135/2010/0177-0283; WURTSBAUGH WA, 1992, OECOLOGIA, V89, P168, DOI 10.1007/BF00317215; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	69	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209828	10.1371/journal.pone.0209828	http://dx.doi.org/10.1371/journal.pone.0209828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650162	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300029
J	Ferreira, SM; le Roex, N; Greaver, C				Ferreira, Sam M.; le Roex, Nikki; Greaver, Cathy			Species-specific drought impacts on black and white rhinoceroses	PLOS ONE			English	Article							LARGE HERBIVORES; NATIONAL-PARK; MEGA-GRAZER; POPULATION; DENSITY; VULNERABILITY; VARIABILITY; PERFORMANCE; COEXISTENCE; RESILIENCE	Unrelenting poaching to feed the illegal trafficking of rhinoceros (rhino) horn remains the principle threat to the persistence of south-central black and southern white rhino that live in the Kruger National Park (Kruger), South Africa. Other global environmental change drivers, such as unpredictable climatic conditions, impose additional uncertainties on the management and persistence of these species. The drought experienced in Kruger over the 2015/2016 rainy season may have affected rhino population growth and thus added an additional population pressure to the poaching pressure already occurring. Under drought conditions, reduced grass biomass predicts increased natural deaths and a subsequent decrease in birth rate for the grazing white rhino. Such variance in natural death and birth rates for the browsing black rhino are not expected under these conditions. We evaluated these predictions using rhino population survey data from 2013 to 2017. Comparisons of natural deaths and birth rates between pre-(2013/2014 and 2014/15), during(2015/2016) and post-drought (2016/2017) periods in Kruger showed increased natural mortality and decreased births for white rhino, but no significant changes for black rhino, supporting our predictions. As a result, despite reduced poaching rates, the total mortality rate of white rhino remains significantly higher than the birth rate. Decreased poaching, decreased natural deaths and no apparent drought effects in black rhino resulted in a lower total mortality rate than the estimated birth rate in 2017. Active biological management and traditional anti-poaching initiatives together therefore represent the most likely way to buffer the impacts of decreased population growth through climate change and wildlife crime on the persistence of rhinos.	[Ferreira, Sam M.; le Roex, Nikki; Greaver, Cathy] South African Natl Pk, Sci Serv, Skukuza, South Africa; [le Roex, Nikki] Univ Cape Town, Dept Biol Sci, Inst Commun & Wildlife Africa iCWild, Cape Town, South Africa	University of Cape Town	Ferreira, SM (corresponding author), South African Natl Pk, Sci Serv, Skukuza, South Africa.	sam.ferreira@sanparks.org			SANParks Park Development Fund; SANParks	SANParks Park Development Fund; SANParks	SANParks Park Development Fund provide internal budget for rhino surveys.; SANParks provided financial and logistical support. We thank Cathy Dreyer, Adolf Manganyi, Marius Renke, Marius Snyders and Pauli Viljoen for the census observations. Chenay Simms assisted with GIS requirements. We are also grateful to the pilot John Bassi for his assistance.	Aryal A, 2017, CONSERV BIOL, V31, P1494, DOI 10.1111/cobi.12894; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Clauss M, 2006, J ANIM PHYSIOL AN N, V90, P325, DOI 10.1111/j.1439-0396.2006.00606.x; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Emslie R.H., 2016, 16 COP17; Emslie RH, 1995, FINE TUNING RHINO MA; Ferreira SM, 2018, AFR J WILDL RES, V48, DOI 10.3957/056.048.013001; Ferreira SM, 2011, S AFR J WILDL RES, V41, P192, DOI 10.3957/056.041.0206; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Greaver C, 2014, AUSTRAL ECOL, V39, P437, DOI 10.1111/aec.12101; Guisoni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115187; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Janssen MA, 2006, GLOBAL ENVIRON CHANG, V16, P240, DOI 10.1016/j.gloenvcha.2006.04.001; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Knight M., 2013, GOV GAZ S AFR, V36096, P5; Knight M.H., 2015, BIODIVERSITY MANAGEM; Knight MH, 1995, AFR J ECOL, V33, P377, DOI 10.1111/j.1365-2028.1995.tb01047.x; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; Linklater WL, 2008, J WILDLIFE MANAGE, V72, P1059, DOI 10.2193/2007-398; Maron M, 2015, DIVERS DISTRIB, V21, P731, DOI 10.1111/ddi.12339; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Plotz R.D., 2014, THESIS; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Smalman N., 2016, DEVASTATING EFFECTS; Smit IPJ, 2013, PACHYDERM, P91; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; Vetter S, 2009, S AFR J SCI, V105, P29, DOI 10.1590/s0038-23532009000100017; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wilson Clevo, 2003, Human Dimensions of Wildlife, V8, P49, DOI 10.1080/10871200390180145; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	45	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209678	10.1371/journal.pone.0209678	http://dx.doi.org/10.1371/journal.pone.0209678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650097	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300023
J	Wen, HJ; Wang, SL; Chen, PC; Guo, YL				Wen, Hui-Ju; Wang, Shu-Li; Chen, Pau-Chung; Guo, Yue Leon			Prenatal perfluorooctanoic acid exposure and glutathione s-transferase T1/M1 genotypes and their association with atopic dermatitis at 2 years of age	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PERFLUORINATED CHEMICALS; AIRWAY INFLAMMATION; ALLERGIC DISEASES; LUNG-FUNCTION; ASTHMA; PERFLUOROALKYL; POLYMORPHISMS; PREVALENCE; CHILDREN	Background Perfluoroalkyl substance (PFAS) exposure was found associated with atopic diseases. Atopic dermatitis (AD) is a childhood skin disorder. However, the effect of interaction between PFASs and glutathione S-transferase (GST) T1/M1 genotype on AD remains unclear. Objective To investigate the association between gene-environmental interaction and childhood AD using a birth cohort study. Methods From 2001 to 2005, 1,264 mother-newborn pairs were recruited from eight Taiwanese maternity hospitals. PFAS levels and Genotypes were analysed from cord blood. Information on children's health status including AD occurrence was obtained via phone interviews at 6 months and 2 years. Cord plasma concentrations of nine PFASs were measured via ultra-high performance liquid chromatography/tandem mass spectrometry. GSTT1/M1 was genotyped (null/present) via polymerase chain reaction. Environment-gene interaction effects on AD were assessed using multiple logistic regression analysis. Results Overall, 839 mother-newborn pairs completed all measurements. The prevalence of ever having physician-diagnosed AD by 2 years of age was 5.4%. Among PFASs, perfluorooctanoic acid (PFOA) was positively associated with AD adjusted for potential confounders. After grouping PFOA levels into three groups: undetected, below and above the median in those with detected, children in above the median group who had the GSTT1-null, or GSTM1-null genotype exhibited a higher odds ratio for AD (OR [95%CI] = 3.45 [1.26-9.99] and 2.92 [1.12-7.91], respectively) as compared to the undetected group. Conclusions Our data demonstrated that in-utero PFOA exposure with GSTT1/M1 null genotype were associated with AD. Minimizing early-life PFAS exposure may help against AD development, especially in genetically susceptible individuals.	[Wen, Hui-Ju; Wang, Shu-Li; Guo, Yue Leon] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Wang, Shu-Li] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] NTU, Dept Environm & Occupat Med, Coll Med, Taipei, Taiwan; [Chen, Pau-Chung; Guo, Yue Leon] NTU Hosp, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Guo, YL (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.; Guo, YL (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.; Guo, YL (corresponding author), NTU, Dept Environm & Occupat Med, Coll Med, Taipei, Taiwan.; Guo, YL (corresponding author), NTU Hosp, Taipei, Taiwan.	leonguo@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; Guo, Yue-Liang Leon/ABF-2314-2020	Chen, Pau-Chung/0000-0002-6242-5974; GUO, Yue Leon/0000-0002-8530-4809; Wang, Shu-Li/0000-0002-0686-4729; Wen, Hui-Ju/0000-0003-1268-3120	Ministry of Science and Technology, Taiwan [NSC101-2621-M-002-002-, MOST106-3114-B-400-002-, MOST 107-2321-B-400-010-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology, Taiwan, grant numbers NSC101-2621-M-002-002-, MOST106-3114-B-400-002-, and MOST 107-2321-B-400-010-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Mahoney P, 2008, NEW SOLUT, V18, P129, DOI 10.2190/NS.18.2.d; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Carlsten C, 2016, THORAX, V71, P35, DOI 10.1136/thoraxjnl-2015-207399; Chang HY, 2016, J ALLERGY CLIN IMMUN, V138, P468, DOI 10.1016/j.jaci.2016.01.020; Chen BY, 2016, ENVIRON RES, V149, P145, DOI 10.1016/j.envres.2016.05.007; Chen Q, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0352-7; Cho HR, 2011, INT J IMMUNOGENET, V38, P145, DOI 10.1111/j.1744-313X.2010.00987.x; Chung J, 2015, NUTRIENTS, V7, P9440, DOI 10.3390/nu7115473; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; Dong GH, 2013, ENVIRON HEALTH PERSP, V121, P507, DOI 10.1289/ehp.1205351; Dong GH, 2011, ARCH TOXICOL, V85, P1235, DOI 10.1007/s00204-011-0661-x; Fairley KJ, 2007, TOXICOL SCI, V97, P375, DOI 10.1093/toxsci/kfm053; Fernandez-Sanjuan M, 2013, ENVIRON SCI POLLUT R, V20, P2661, DOI 10.1007/s11356-012-1158-8; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Huang CC, 2018, PEDIAT ALLERG IMM-UK, V29, P159, DOI 10.1111/pai.12835; Humblet O, 2014, ENV HLTH PERSPECT, V122; Jang HJ, 2016, ASIA PAC ALLERGY, V6, P213, DOI 10.5415/apallergy.2016.6.4.213; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773; Lee YL, 2005, CHEST, V128, P1156, DOI 10.1378/chest.128.3.1156; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Lien GW, 2011, J CHROMATOGR B, V879, P641, DOI 10.1016/j.jchromb.2011.01.037; Lin CY, 2011, ENVIRON SCI TECHNOL, V45, P10691, DOI 10.1021/es201964x; Liu CS, 2007, AQUAT TOXICOL, V82, P135, DOI 10.1016/j.aquatox.2007.02.006; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Okada E, 2014, ENVIRON INT, V65, P127, DOI 10.1016/j.envint.2014.01.007; Patelarou E, 2011, NUTR REV, V69, P627, DOI 10.1111/j.1753-4887.2011.00445.x; Qin XD, 2017, ENVIRON RES, V155, P15, DOI 10.1016/j.envres.2017.01.025; Singh TSK, 2012, TOXICOL LETT, V210, P64, DOI 10.1016/j.toxlet.2012.01.014; Somanunt S, 2017, ASIAN PAC J ALLERGY, V35, P137, DOI 10.12932/AP0825; Stein CR, 2016, PEDIATR RES, V79, P348, DOI 10.1038/pr.2015.213; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; Wang IJ, 2011, EUR RESPIR J, V37, P1371, DOI 10.1183/09031936.00137210; Wang IJ, 2011, ENVIRON RES, V111, P785, DOI 10.1016/j.envres.2011.04.006; Wang IJ, 2010, ANN ALLERG ASTHMA IM, V105, P124, DOI 10.1016/j.anai.2010.04.017; Wen HJ, 2009, BRIT J DERMATOL, V161, P1166, DOI 10.1111/j.1365-2133.2009.09412.x; Wen HJ, 2011, PEDIAT ALLERG IMM-UK, V22, P695, DOI 10.1111/j.1399-3038.2011.01177.x; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210708	10.1371/journal.pone.0210708	http://dx.doi.org/10.1371/journal.pone.0210708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650146	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300071
J	Donkor, GY; Dontoh, E; Owusu-Ofori, A				Donkor, Gracious Yoofi; Dontoh, Ebenezer; Owusu-Ofori, Alex			A cross-sectional study on the prevalence of antibiotic use prior to laboratory tests at two Ghanaian hospitals	PLOS ONE			English	Article							SELF-MEDICATION; BACTEREMIA; RESISTANCE; CULTURE	There has been a significant rise in global antibiotic use in recent years. Development of resistance has been linked to easy accessibility, lack of regulation of sale, increased tendency to self-medicate and the lack of public knowledge. The increase in antibiotic misuse, including self-medication, has not been well documented in developing countries. Antibiotic use prior to visiting health facilities has been found to be prevalent in developing countries. It has been identified by some studies to increase the likelihood of missed diagnoses and influence the outcome of bacteriological tests. This study is aimed at determining the prevalence of prior antibiotic use through a cross-sectional survey of patients undergoing laboratory tests at two health facilities in Ghana. Face-to-face questionnaires were used to interview 261 individuals chosen by random sampling of patients visiting the bacteriology laboratory of the hospitals within a two-month period. The questionnaire investigated participant demographic characteristics, knowledge about antibiotics and the nature of antibiotic use. Antibiotic property detection bioassay was performed on patient's urine sample using a disk diffusion method to accurately determine antibiotic use within 72 hours. Culture results were used as an index to evaluate the effect of prior antibiotic use on bacteriological tests. Out of a 261 participants enrolled, 19.9% (95% CI, 14.9-24.9) acknowledged using antibiotics prior to their visit to the laboratory during the study period. On the contrary, 31.4% (95% CI, 25.7-37.5) of participants' urine samples were positive for antimicrobial activity. Participants within the age ranges of 20-30, 31-40 and 41-50 years had significantly lower odds of urine antimicrobial activity. Participants who had urine antimicrobial activity were more likely to have no growth on their culture plates than participants who had no urine antimicrobial activity [OR 2.39(1.37-4.18), p = 0.002]. The most commonly used antibiotics were the penicillins, fluoroquinolones and metronidazole. Although, majority of the participant (54.8%) had knowledge of antibiotics, most of them had inadequate information on their proper use. The commonest indications for antibiotic use were aches and pains (30.3%), diarrhoea (43.3%) and urinary tract infections (28.0%). Prior antibiotic use was found to increase the likelihood of obtaining a culture negative result and can affect the outcome of bacteriological tests.	[Donkor, Gracious Yoofi; Dontoh, Ebenezer] Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana; [Owusu-Ofori, Alex] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Clin Microbiol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Donkor, GY (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana.	roknod19@hotmail.com	Dontoh, Ebenezer/AAC-5980-2021; Owusu-Ofori, Alex/AAU-9071-2020	Dontoh, Ebenezer/0000-0001-9047-3570; Donkor, Gracious/0000-0001-8871-8970; Owusu-Ofori, Alex Kwame/0000-0002-2172-8645				AduSarkodie YA, 1997, INT J STD AIDS, V8, P456, DOI 10.1258/0956462971920343; Ahiabu MA, 2016, HEALTH POLICY PLANN, V31, P250, DOI 10.1093/heapol/czv048; [Anonymous], 2016, J ANTIMICROB AGENTS, V2, P1; Arya SC, 2011, J INFECT DEV COUNTR, V5, P677, DOI 10.3855/jidc.2100; Behzadi Payam, 2010, Maedica (Bucur), V5, P111; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Center for Disease Dynamics and Policy, 2015, STAT WORLDS ANT 2015; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Dougherty TJ, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P1, DOI 10.1007/978-1-4614-1400-1; Driscoll AJ, 2012, CLIN INFECT DIS, V54, pS159, DOI 10.1093/cid/cir1061; European Centre for Disease Prevention and Control (ECDC), 2012, SUMM LAT DAT ANT RES, P1; Khennavong M, 2011, AM J TROP MED HYG, V85, P295, DOI 10.4269/ajtmh.2011.11-0076; Kimanga AN, 2012, ETHIOP J HEALTH SCI, V22, P135; Kotwani A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-99; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Lerbech A., 2014, PLOS ONE, V9, P1; Liu YC, 1999, LANCET, V354, P1360, DOI 10.1016/S0140-6736(99)07446-2; Micek S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-56; Newman MJ, 2011, RESISTANCE ANTIMICRO, P215; Ocan M, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0027-8; Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Opintan JA, 2015, INFECT DRUG RESIST, V8, P379, DOI 10.2147/IDR.S88725; Paz Z, 2015, THE IMPACT OF PRIOR, P5; Radyowijati A, IMPROVING ANTIBIOTIC; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Seiter A, 2009, POLICY NOTE PHARM SE, V2009, P1; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Vila J., 2010, J OPEN INFECT DIS, V4, P38, DOI [10.2174/1874279301004020 038, DOI 10.2174/1874279301004020038]; Yevutsey SK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4910-7	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210716	10.1371/journal.pone.0210716	http://dx.doi.org/10.1371/journal.pone.0210716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645626	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200047
J	Karger, A; Bettin, B; Gethmann, JM; Klaus, C				Karger, Axel; Bettin, Barbara; Gethmann, Joern M.; Klaus, Christine			Whole animal matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry of ticks - Are spectra of Ixodes ricinus nymphs influenced by environmental, spatial, and temporal factors?	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; IDENTIFICATION	In the recent years matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) has become a useful tool to characterize arthropod species and their different stages of development. It was reported for sand flies and mosquitoes at immature stages and also assumed for ticks that geographic location can have a subtle influence on MALDI-TOF mass spectra which allows the discrimination of animals with specific local variations of the MALDI-TOF MS phenotype. It is so far uncertain, however, if these mass-spectrometric differences are based on genetic variation or on spectral features which depend on environmental or temporal features. The aim of this study was to analyze the influence of the geographic location, environmental factors and the season of the year on the MALDI-TOF mass spectra of Ixodes (I.) ricinus nymphs and if spectral variation would allow to draw conclusions with respect to the tick's provenience or conditions that influence the tick life cycle. Application of multivariate statistical models on spectra of ticks collected in different seasons and different habitats and locations within Germany showed that the impact of the location seemed to be small while season and habitat seemed to have stronger impact on the MALDI-TOF mass spectra. Possibilities and limitations of MALDI-TOF mass spectra to draw conclusions on the tick life cycle are discussed.	[Karger, Axel; Bettin, Barbara] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Gethmann, Joern M.] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Klaus, Christine] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Klaus, C (corresponding author), Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany.	christine.klaus@fli.de	Karger, Axel/AAA-9102-2020	Karger, Axel/0000-0002-0054-7394; Gethmann, Jorn/0000-0001-7455-803X	German Federal Environmental Agency [UFOPLAN 3708 49 400]	German Federal Environmental Agency	The authors wish to thank the German Federal Environmental Agency for travel expenses (connected with UFOPLAN 3708 49 400) that allowed us to collect ticks at different places and at different seasons. Besides travel expenses no further funding for this study occurred, neither from the German Federal Environmental Agency nor from any other intern or extern funders. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB BRIEF VECT BORN; Beati L, 2012, VECTOR-BORNE ZOONOT, V12, P514, DOI 10.1089/vbz.2011.0859; Brown RN, 2005, TICK-BORNE DISEASES OF HUMANS, P363; Dieme C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0544-0; Dvorak V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-21; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Estrada-Pena A, 2009, FRONT BIOSCI-LANDMRK, V14, P2674, DOI 10.2741/3405; Josten M, 2013, J CLIN MICROBIOL, V51, P1809, DOI 10.1128/JCM.00518-13; Karger A, 2016, PROTEOMICS CLIN APPL; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kumsa B, 2016, PARASITOL RES, V115, P4199, DOI 10.1007/s00436-016-5197-9; Pineda FJ, 2003, ANAL CHEM, V75, P3817, DOI 10.1021/ac034069b; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Swei A, 2017, ISME J, V11, P813, DOI 10.1038/ismej.2016.152; Yssouf A, 2015, TICKS TICK-BORNE DIS, V6, P579, DOI 10.1016/j.ttbdis.2015.04.013; Yssouf A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003473; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	17	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210590	10.1371/journal.pone.0210590	http://dx.doi.org/10.1371/journal.pone.0210590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645604	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200038
J	Aguilera, VM; Escribano, R; Vargas, CA; Gonzalez, MT				Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.; Teresa Gonzalez, M.			Upwelling modulation of functional traits of a dominant planktonic grazer during "warm-acid" El Nino 2015 in a year-round upwelling area of Humboldt Current	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CALANUS-CHILENSIS; HATCHING SUCCESS; NORTHERN CHILE; EGG-PRODUCTION; ACARTIA-TONSA; CO2-INDUCED ACIDIFICATION; SPATIAL-DISTRIBUTION; SECONDARY PRODUCTION; CLIMATE-CHANGE	Climate change is expected to exacerbate upwelling intensity and natural acidification in Eastern Boundaries Upwelling Systems (EBUS). Conducted between January-September 2015 in a nearshore site of the northern Humboldt Current System directly exposed to year-round upwelling episodes, this study was aimed at assessing the relationship between upwelling mediated pH-changes and functional traits of the numerically dominant planktonic copepod-grazer Acartia tonsa (Copepoda). Environmental temperature, salinity, oxygen, pH, alkalinity, chlorophyll-a (Chl), copepod adult size, egg production (EP), and egg size and growth were assessed through 28 random oceanographic surveys. Agglomerative clustering and multidimensional scaling identified three main di-similitude nodes within temporal variability of abiotic and biotic variables: A) "upwelling", B) "non-upwelling", and C) "warm-acid" conditions. Nodes A and B represented typical features within the upwelling phenology, characterized by the transition from low temperature, oxygen, pH and Chl during upwelling to higher levels during non-upwelling conditions. However, well-oxygenated, saline and "warm-acid" node C seemed to be atypical for local climatology, suggesting the occurrence of a low frequency oceanographic perturbation. Multivariate (LDA and ANCOVA) analyses revealed upwelling through temperature, oxygen and pH were the main factors affecting variations in adult size and EP, and highlighted growth rates were significantly lower under node C. Likely buffering upwelling pH-reductions, phytoplankton biomass maintained copepod reproduction despite prevailing low temperature, oxygen and pH levels in the upwelling setting. Helping to better explain why this species is among the most recurrent ones in these variable yet productive upwelling areas, current findings also provide opportune cues on plankton responses under warm-acid conditions, which are expected to occur in productive EBUS as a consequence of climate perturbations.	[Aguilera, Victor M.] CEAZA, Coquimbo, Chile; [Aguilera, Victor M.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Inst Milenio Oceanog, Concepcion, Chile; [Aguilera, Victor M.; Escribano, Ruben; Vargas, Cristian A.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Fac Environm Sci, Dept Aquat Syst, Aquat Ecosyst Functioning Lab LAFE, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Environm Sci Ctr EULA Chile, Concepcion, Chile; [Vargas, Cristian A.] Univ Concepcion, Ctr Study Multiple Drivers Marine Socioecol Syst, Concepcion, Chile; [Teresa Gonzalez, M.] Univ Antofagasta, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile	Universidad Catolica del Norte; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Universidad de Antofagasta	Aguilera, VM (corresponding author), CEAZA, Coquimbo, Chile.; Aguilera, VM (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile.; Aguilera, VM (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Inst Milenio Oceanog, Concepcion, Chile.; Aguilera, VM (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile.	victor.aguilera@ceaza.cl	Aguilera, Victor M/AAH-4460-2020	Aguilera, Victor M/0000-0001-5791-5250; Vargas, Cristian A./0000-0002-1486-3611; Escribano, Ruben/0000-0002-9843-7723	VAR - FONDECYT [11130495 VAR]; Millennium Scientific Initiative [IC120019]	VAR - FONDECYT; Millennium Scientific Initiative	This work was supported by VAR was funding by FONDECYT Grant No. 11130495 VAR, RE & CVG were funded by Millennium Scientific Initiative Grant IC120019.	Aguilera VM, 2013, ESTUAR COAST, V36, P1084, DOI 10.1007/s12237-013-9615-2; Aguilera VM, 2011, MAR BIOL RES, V7, P235, DOI 10.1080/17451000.2010.499437; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bailey A, 2017, ICES J MAR SCI, V74, P996, DOI 10.1093/icesjms/fsw066; Bednarsek N, 2015, MAR ECOL PROG SER, V523, P93, DOI 10.3354/meps11199; Blanco JL, 2001, J GEOPHYS RES-OCEANS, V106, P11451, DOI 10.1029/2000JC000540; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; DAGG M, 1977, LIMNOL OCEANOGR, V22, P99, DOI 10.4319/lo.1977.22.1.0099; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dickson A., 2007, PICES SPEC PUBL; Escribano R, 2004, DEEP-SEA RES PT II, V51, P2389, DOI 10.1016/j.dsr2.2004.08.011; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; Escribano R, 1999, MAR ECOL PROG SER, V177, P147, DOI 10.3354/meps177147; Escribano R, 2012, PROG OCEANOGR, V97, P174, DOI 10.1016/j.pocean.2011.11.006; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Giraldo A, 2002, MAR ECOL PROG SER, V230, P225, DOI 10.3354/meps230225; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; Hauri C, 2013, BIOGEOSCIENCES, V10, P193, DOI 10.5194/bg-10-193-2013; Hidalgo P, 2012, PROG OCEANOGR, V92-95, P134, DOI 10.1016/j.pocean.2011.07.012; Hidalgo P, 2010, DEEP-SEA RES PT II, V57, P2089, DOI 10.1016/j.dsr2.2010.09.012; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hirst AG, 1998, MAR BIOL, V132, P247, DOI 10.1007/s002270050390; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jacox MG, 2016, GEOPHYS RES LETT, V43, P7072, DOI 10.1002/2016GL069716; Kapsenberg L, 2016, LIMNOL OCEANOGR, V61, P953, DOI 10.1002/lno.10264; KIORBOE T, 1994, LIMNOL OCEANOGR, V39, P493, DOI 10.4319/lo.1994.39.3.0493; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lefevre N, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000395; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Marin VH, 2003, INVEST           MAR, P31; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McElhany P, 2017, ICES J MAR SCI, V74, P926, DOI 10.1093/icesjms/fsw085; MCLAREN IA, 1966, BIOL BULL, V131, P457, DOI 10.2307/1539985; PARRISH KK, 1978, MAR BIOL, V46, P65, DOI 10.1007/BF00393822; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; PETERSON WT, 1988, PROG OCEANOGR, V20, P1, DOI 10.1016/0079-6611(88)90052-3; POULET SA, 1995, ICES J MAR SCI, V52, P359, DOI 10.1016/1054-3139(95)80051-4; Reum JCP, 2016, ICES J MAR SCI, V73, P582, DOI 10.1093/icesjms/fsu231; Ruz PM, 2015, J MARINE SYST, V148, P200, DOI 10.1016/j.jmarsys.2015.03.007; Sobarzo M, DEEPSEA RES 1, V48, P2699; Strickland JD, 1962, B FISH RES BD CAN, P167; Strub P, 1998, COASTAL OCEAN CIRCUL, V11; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Takeshita Y, 2015, BIOGEOSCIENCES, V12, P5853, DOI 10.5194/bg-12-5853-2015; TESTER PA, 1990, J EXP MAR BIOL ECOL, V141, P169, DOI 10.1016/0022-0981(90)90222-X; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Torres R, 2002, DEEP-SEA RES PT I, V49, P1413, DOI 10.1016/S0967-0637(02)00034-1; Torres R, 1997, J GEOPHYS RES OCEANS, V108; Ulloa O, 2001, GEOPHYS RES LETT, V28, P1591, DOI 10.1029/2000GL011548; UYE S-I, 1982, Journal of the Oceanographical Society of Japan, V38, P149, DOI 10.1007/BF02110286; Vargas CA, 2004, AQUAT MICROB ECOL, V34, P151, DOI 10.3354/ame034151; Vargas CA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0084; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	63	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209823	10.1371/journal.pone.0209823	http://dx.doi.org/10.1371/journal.pone.0209823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640913	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000014
J	Bahemuka, UM; Abaasa, A; Ruzagira, E; Lindan, C; Price, MA; Kamali, A; Fast, P				Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Ruzagira, Eugene; Lindan, Christina; Price, Matt A.; Kamali, Anatoli; Fast, Pat			Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda	PLOS ONE			English	Article							LAKE VICTORIA; OBSERVATIONAL COHORT; POPULATION	Introduction People living in fishing communities around Lake Victoria may be suitable for enrolment in HIV prevention trials because of high HIV incidence. We assessed the ability to recruit and retain individuals from fishing communities into an HIV vaccine preparedness cohort study in Masaka, Uganda. Methods HIV high risk, sero-negative adults (18-49 years) were identified from four fishing villages bordering Lake Victoria through door-to-door HIV counselling and testing (HCT). Interested persons were referred for screening, enrolment, and quarterly follow-up visits at a study clinic located approximately 30-40 kilometres away. Repeat HCT, HIV risk assessment, and evaluation and treatment for sexually transmitted infections were provided. Rates of and factors associated with study dropout were assessed using Poisson regression models. Results A total of 940 participants were screened between January 2012 and February 2015, of whom 654 were considered for the analysis. Over a two-year follow-up period, 197 (30.1%) participants dropped out of the study over 778.9 person-years, a dropout rate of 25.3 / 100 person-years of observation. Dropout was associated with being female (aRR = 1.56, 95% confidence interval [CI] 1.12-2.18), being 18-24 years (aRR = 1.64; 95% CI 1.03-2.60) or being 25-34 years (aRR = 1.63; 95% CI 1.04-2.55) compared to being 35+ years; having no education (aRR = 2.02; 95% CI: 1.23-3.31); living in the community for less than one year (aRR = 2.22; 95% CI: 1.46-3.38), or 1-5 years (aRR = 1.68; 95% CI: 1.16-2.45), compared to more than five years. Conclusions Our results suggest that individuals from fishing communities can be recruited and retained in longitudinal studies; however, intensified participant tracing may be necessary for women, younger volunteers, those who are less educated and new residents.	[Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Ruzagira, Eugene] UVRI, MRC, Entebbe, Uganda; [Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Ruzagira, Eugene] London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda; [Lindan, Christina; Price, Matt A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Price, Matt A.; Kamali, Anatoli; Fast, Pat] Int AIDS Vaccine Initiat, New York, NY USA	University of California System; University of California San Francisco; International AIDS Vaccine Initiative	Bahemuka, UM (corresponding author), UVRI, MRC, Entebbe, Uganda.; Bahemuka, UM (corresponding author), London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda.	Ubaldo.Bahemuka@lshtm.ac.uk	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Bahemuka, Ubaldo/0000-0003-1092-4832; Ruzagira, Eugene/0000-0002-7291-1693; Fast, Patricia/0000-0001-9991-0351	International AIDS Vaccine Initiative(IAVI); USAID; IAVI; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH [R25MH064712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative(IAVI); USAID(United States Agency for International Development (USAID)); IAVI; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Open cohort observational study is fully funded by the International AIDS Vaccine Initiative(IAVI) with generous support of the USAID and other donors. A full list of the donors can be accessed on their website at www.iavi.org.The sponsor supported the design of the study.; This work was funded by IAVI with the generous support of USAID and other donors; a full list of IAVI donors is available at www.iavi.org.The contents of this manuscript are the responsibility of IAVI and co-authors and do not necessarily reflect the views of USAID or the US Government. We also wish to acknowledge support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH, R25MH064712. As part of the ITAPS we thank the helpful reviews of Professor Rhoderick Machekano, and peer reviews of Drs Huub Gulderblom, Carol Camlin and Mi Suk. We recognise the logistical support of the Administration team at UCSF-ITAPS Dr Jeffery Mendel, Dr Debbie Brickley and Ritu Sehgal.	Abaasa A, 2016, VACCINE, V34, P1778, DOI 10.1016/j.vaccine.2016.02.048; Abaasa Andrew, 2015, BMC Res Notes, V8, P815, DOI 10.1186/s13104-015-1804-6; Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Conley NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043138; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kamali A, 2016, SEX TRANSM INFECT, V92, P447, DOI 10.1136/sextrans-2015-052179; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; KIWANUKA N, 2014, PLOS ONE, V9; Kiwanuka N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-986; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Max, 2002, AIDS AFRICA, P1; Mwau M, 2003, J GENE MED, V5, P3, DOI 10.1002/jgm.343; Nunan F, 2010, GEOFORUM, V41, P776, DOI 10.1016/j.geoforum.2010.04.009; Ondondo RO, 2014, WORLD J AIDS, V04; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d	17	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0198460	10.1371/journal.pone.0198460	http://dx.doi.org/10.1371/journal.pone.0198460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640918	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000455808000001
J	Holldobler, B; Kwapich, CL				Holldobler, Bert; Kwapich, Christina L.			Behavior and exocrine glands in the myrmecophilous beetle Dinarda dentata (Gravenhorst, 1806) (Coleoptera: Staphylinidae: Aleocharinae)	PLOS ONE			English	Article							CHEMICAL MIMICRY; LOMECHUSA; ATEMELES; BIOLOGY; HOST; ANTS	The nests of advanced eusocial ant species can be considered ecological islands with a diversity of ecological niches inhabited by not only the ants and their brood, but also a multitude of other organisms adapted to particular niches. In the current paper, we describe the myrmecophilous behavior and the exocrine glands that enable the staphylinid beetle Dinarda dentata to live closely with its host ants Formica sanguinea. We confirm previous anecdotal descriptions of the beetle's ability to snatch regurgitated food from ants that arrive with a full crop in the peripheral nest chambers, and describe how the beetle is able to appease its host ants and dull initial aggression in the ants.	[Holldobler, Bert; Kwapich, Christina L.] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA; [Holldobler, Bert] Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B; Kwapich, CL (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA.; Holldobler, B (corresponding author), Univ Wurzburg, Zool 2, Biozentrum, Bavaria, Germany.	bert.hoelldobler@asu.edu; ckwapich@asu.edu		Kwapich, Christina/0000-0001-5141-7605	Arizona State University	Arizona State University	This work was funded by B.H. and Arizona State University. The funders had no role in study design, data collection, decision to publish or preparation on the manuscript.	Akino Toshiharu, 2008, Myrmecological News, V11, P173; Bernhauer M., 1917, STAPHILINIDEN MADAGA; BLACKWELDER RICHARD E., 1936, SMITHSONIAN MISC COLL, V94, P1; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Donisthorpe H, 1927, GUESTS BRIT ANTS; HENDERSON G, 1986, J KANSAS ENTOMOL SOC, V59, P454; Hlavac P, 2011, ZOOTAXA, P1; Holldobler B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200309; HOLLDOBL.B, 1967, Z VERGL PHYSIOL, V56, P1, DOI 10.1007/BF00333561; HOLLDOBLER B, 1970, Z VERGL PHYSIOL, V66, P215, DOI 10.1007/BF00297780; Holldobler B., 1990, pi; HOLLDOBLER B, 1971, SCI AM, V224, P86; HOLLDOLBER B, 1981, Psyche (Cambridge), V88, P347, DOI 10.1155/1981/75317; HOWARD RW, 1980, SCIENCE, V210, P431, DOI 10.1126/science.210.4468.431; Jordan KHC, 1913, Z WISS ZOOL ABT A, V107, P346; Kloft W., 1960, ZOOL BEITR, V5, P519; Lenoir Alain, 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/840860; Lobl D, 2015, CATALOGUE PALAEARCTI; Mizuno T, 2018, CHEMOECOLOGY, P1; Paivinen J, 2003, OECOLOGIA, V134, P587, DOI 10.1007/s00442-002-1141-z; Parker J, 2016, MYRMECOL NEWS, V22, P65; Parmentier T, 2017, J CHEM ECOL, V43, P644, DOI 10.1007/s10886-017-0868-2; Parmentier T, 2016, OIKOS, V125, P1182, DOI 10.1111/oik.02991; Parmentier T, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0583-6; PASTEELS J M, 1968, Archives de Biologie, V79, P381; Phillips ZI, 2017, INSECT SOC, V64, P277, DOI 10.1007/s00040-016-0535-6; RATHMAYER W, 1962, EXPERIENTIA, V18, P47, DOI 10.1007/BF02136658; ROMEIS B, 1948, MIKROSKOPISCHE TECHN; Stoeffler M, 2007, J CHEM ECOL, V33, P1382, DOI 10.1007/s10886-007-9315-0; Stoeffler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1605, DOI 10.1007/s00265-011-1171-9; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; TRANIELLO JFA, 1980, NATURWISSENSCHAFTEN, V67, P361, DOI 10.1007/BF01106597; Tschinkel WR, 2006, FIRE ANTS; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; von Beeren Christoph, 2011, BMC Ecology, V11, P30, DOI 10.1186/1472-6785-11-30; Wasmann E., 1889, Wiener Entomologische Zeitung, Vviii, P153; Wasmann E., 1920, GASTPFLEGE AMEISEN; Wheeler W. M, 1910, ANTS	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210524	10.1371/journal.pone.0210524	http://dx.doi.org/10.1371/journal.pone.0210524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633774	Green Submitted, gold, Green Published			2022-12-27	WOS:000455485100027
J	DiNapoli, RJ; Lipo, CP; Brosnan, T; Hunt, TL; Hixon, S; Morrison, AE; Becker, M				DiNapoli, Robert J.; Lipo, Carl P.; Brosnan, Tanya; Hunt, Terry L.; Hixon, Sean; Morrison, Alex E.; Becker, Matthew			Rapa Nui (Easter Island) monument (ahu) locations explained by freshwater sources	PLOS ONE			English	Article							PREHISTORIC AGRICULTURAL PRODUCTION; MULTIMODEL INFERENCE; GRAND CHALLENGES; POINT PROCESS; LAND-USE; MODEL; SETTLEMENT; COLONIZATION; STONE; DIET	Explaining the processes underlying the emergence of monument construction is a major theme in contemporary anthropological archaeology, and recent studies have employed spatially-explicit modeling to explain these patterns. Rapa Nui (Easter Island, Chile) is famous for its elaborate ritual architecture, particularly numerous monumental platforms (ahu) and statuary (moai). To date, however, we lack explicit modeling to explain spatial and temporal aspects of monument construction. Here, we use spatially-explicit point-process modeling to explore the potential relations between ahu construction locations and subsistence resources, namely, rock mulch agricultural gardens, marine resources, and freshwater sources-the three most critical resources on Rapa Nui. Through these analyses, we demonstrate the central importance of coastal freshwater seeps for precontact populations. Our results suggest that ahu locations are most parsimoniously explained by distance from freshwater sources, in particular coastal seeps, with important implications for community formation and inter-community competition in precontact times.	[DiNapoli, Robert J.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Lipo, Carl P.] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Lipo, Carl P.] SUNY Binghamton, Environm Studies Program, Binghamton, NY USA; [Brosnan, Tanya; Becker, Matthew] Calif State Univ Long Beach, Dept Geol Sci, Long Beach, CA 90840 USA; [Hunt, Terry L.] Univ Arizona, Honors Coll, Tucson, AZ USA; [Hunt, Terry L.] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Hixon, Sean] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Morrison, Alex E.] Int Archaeol Res Inst Inc, Honolulu, HI USA; [Morrison, Alex E.] Univ Auckland, Dept Anthropol, Auckland, New Zealand	University of Oregon; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; California State University System; California State University Long Beach; University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Auckland	DiNapoli, RJ (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	rdinapol@uoregon.edu	Lipo, Carl/C-9154-2013; Becker, Matthew W/J-2711-2012; DiNapoli, Robert/AAE-9807-2020	Lipo, Carl/0000-0003-4391-3590; Hixon, Sean/0000-0001-6147-7118	National Science Foundation [1005258]; Center for Asian and Pacific Studies, Global Education Oregon, and Department of Anthropology at the University of Oregon; American Philosophical Society's Lewis and Clark Fund for Exploration and Field Research; Explorers Club Exploration Fund Grant; Conrey Endowed Chair in Hydrogeology at California State University, Long Beach	National Science Foundation(National Science Foundation (NSF)); Center for Asian and Pacific Studies, Global Education Oregon, and Department of Anthropology at the University of Oregon; American Philosophical Society's Lewis and Clark Fund for Exploration and Field Research; Explorers Club Exploration Fund Grant; Conrey Endowed Chair in Hydrogeology at California State University, Long Beach	Funding for this research was provided by National Science Foundation award #1005258 "Geospatial Research and Mapping on Easter Island". RJD was supported by the Center for Asian and Pacific Studies, Global Education Oregon, and Department of Anthropology at the University of Oregon, The American Philosophical Society's Lewis and Clark Fund for Exploration and Field Research, and the Explorers Club Exploration Fund Grant. MB and TB were supported by the Conrey Endowed Chair in Hydrogeology at California State University, Long Beach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen MS, 2014, J PAC ARCHAEOL, V5, P21; Allen MS, 2017, OXFORD HDB ZOOARCHAE, P737, DOI DOI 10.1093/OXFORDHB/9780199686476.013.51; [Anonymous], 2011, STATUES WALKED UNRAV, DOI DOI 10.1016/j.jtbi.2008.02.039; [Anonymous], 1995, EVOLUTIONARY ARCHAEO; [Anonymous], 2018, K MUMIN MULTIMODEL I; Arana PM, 2014, LAT AM J AQUAT RES, V42, P673, DOI 10.3856/vol42-issue4-fulltext-2; AYALABRADFORD I, 2005, 6 INT C RAP NUI PAC, P113; Ayres W., 1985, J SOC OCEANISTES, V41, P103, DOI [10.3406/jso.1985.2805, DOI 10.3406/JSO.1985.2805]; Ayres W.S., 1979, ASIAN PERSPECT, V22, P61; Ayres W.S., 2000, EASTER ISLAND ARCHAE, P173; Ayres WS, 2000, EASTER ISLAND ARCHAE, P191; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Baddeley AJ, 2000, STAT NEERL, V54, P329, DOI 10.1111/1467-9574.00144; Bahn P, 2017, EASTER ISLAND EARTH; Barber IG, 1996, CURR ANTHROPOL, V37, P868, DOI 10.1086/204572; Beardsley FR, 1996, B INDOPAC PREHISTORY, V15, P23; Beheim BA, 2011, P ROY SOC B-BIOL SCI, V278, P3089, DOI 10.1098/rspb.2011.0060; Bell AV, 2015, AM ANTIQUITY, V80, P397, DOI 10.7183/0002-7316.80.2.397; BERMAN M, 1986, J R STAT SOC C-APPL, V35, P54; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bevan A, 2013, J ARCHAEOL SCI, V40, P2415, DOI 10.1016/j.jas.2012.12.025; Brosnan T, 2018, HYDROGEOL J; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Canellas-Bolta N, 2013, QUATERNARY SCI REV, V72, P36, DOI 10.1016/j.quascirev.2013.04.004; Carrero-Pazos M, MEGALITHS SOC LANDSC, P1; Church F, 1996, RAPA NUI J, V10, P81; Church F, 1994, RAPA NUI J, V8, P101; Ciszewski A., 2009, CAVES EASTER ISLAND; Cochrane EE, 2015, J POLYNESIAN SOC, V124, P7; COCQUYT C., 1991, BIOL JB DODONAEA, V59, P109; Cole M, 2015, COASTAL GROUNDWATER; Commendador AS, 2014, RADIOCARBON, V56, P277, DOI 10.2458/56.16923; Commendador AS, 2013, AM J PHYS ANTHROPOL, V152, P173, DOI 10.1002/ajpa.22339; Cressey J., 1998, RAPA NUI J, V12, P75; Diamond J., 1995, DISCOVER, V9, P62; Diamond J., 2011, COLLAPSE SOC CHOOSE, V4th ed; DiNapoli RJ, 2018, J ISL COAST ARCHAEOL, V13, P202, DOI 10.1080/15564894.2016.1276490; Dinapoli RJ, 2017, ARCHAEOL OCEAN, V52, P1, DOI 10.1002/arco.5124; Dos Pasos J., 1971, EASTER ISLAND ISLAND; Dudgeon JV, 2014, INT J OSTEOARCHAEOL, V24, P634, DOI 10.1002/oa.2249; DYSONHUDSON R, 1978, AM ANTHROPOL, V80, P21, DOI 10.1525/aa.1978.80.1.02a00020; Englert S., 1948, TIERRA HOTU MATU HIS; Eve SJ, 2014, J ARCHAEOL SCI, V43, P267, DOI 10.1016/j.jas.2013.12.019; FLENLEY JR, 1984, NATURE, V307, P47, DOI 10.1038/307047a0; FLENLEY JR, 1991, J QUATERNARY SCI, V6, P85, DOI 10.1002/jqs.3390060202; Forster G, 1968, G FORSTERS WERKE; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; GEYER CJ, 1994, SCAND J STAT, V21, P359; Graves Michael W., 1993, EVOLUTION SOCIAL ORG, P106; Green R.C., 2000, RAPA NUI J, V14, P71; Hamilton S, 2008, HDB LANDSCAPE ARCHAE, P176; Harwood T., 2005, SWEET POTATO OCEANIA, P85; Hem J.D, 1985, US GEOLOGICAL SURVEY, Vthird; Herrera C, 2008, HYDROGEOL J, V16, P1329, DOI 10.1007/s10040-008-0316-z; Heyerdahl T, 1961, ARCHAEOLOGY EASTER I; Hixon SW, 2018, J ARCHAEOL SCI, V100, P148, DOI 10.1016/j.jas.2018.04.011; Hixon SW, 2018, ADV ARCHAEOL PRACT, V6, P42, DOI 10.1017/aap.2017.28; Hoffocks M, 2008, J ARCHAEOL SCI, V35, P126, DOI 10.1016/j.jas.2007.02.014; Horrocks M, 2017, PALYNOLOGY, V41, P339, DOI 10.1080/01916122.2016.1204566; Howey MCL, 2018, J ARCHAEOL SCI-REP, V19, P886, DOI 10.1016/j.jasrep.2017.05.033; Howey MCL, 2016, P NATL ACAD SCI USA, V113, P7443, DOI 10.1073/pnas.1603450113; Hunt T.L., 2018, OXFORD HDB PREHISTOR, P416, DOI [DOI 10.1093/OXFORDHB/9780199925070.001.0001/OXFORDHB-9780199925070-E-026, 10.1093/oxfordhb/9780199925070.001.0001/oxfordhb-9780199925070-e-026]; Hunt TL, 2007, J ARCHAEOL SCI, V34, P485, DOI 10.1016/j.jas.2006.10.003; Hunt TL, 2009, PAC SCI, V63, P601, DOI 10.2984/049.063.0407; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; Hunt TL, 2001, PACIFIC 2000: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON EASTER ISLAND AND THE PACIFIC, P103; Hunt TL, 2007, RAPA NUI J, V21, P85; Jarman CL, 2017, AM J PHYS ANTHROPOL, V164, P343, DOI 10.1002/ajpa.23273; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Kirch Patrick, 1994, WET DRY IRRIGATION A; Kirch PV, 2007, EARTH ENV SCI T R SO, V98, P85, DOI 10.1017/S1755691007000011; Kirch PV, 2007, AM ANTHROPOL, V109, P8, DOI 10.1525/AA.2007.109.1.8; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kolb M. J., 2012, COMP ARCHAEOLOGY COM, P138; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Ladefoged TN, 2013, J ARCHAEOL SCI, V40, P1203, DOI 10.1016/j.jas.2012.09.006; Ladefoged TN, 2010, ARCHAEOL OCEAN, V45, P80, DOI 10.1002/j.1834-4453.2010.tb00082.x; Lambrides ABJ, 2016, J ARCHAEOL RES, V24, P275, DOI 10.1007/s10814-016-9090-y; LIPO C. P., 2009, ASIAN PERSPECT, V48, P309, DOI DOI 10.1353/ASI.2009.0001; Lipo CP, 2016, ANTIQUITY, V90, P172, DOI 10.15184/aqy.2015.189; Lipo CP, 2013, J ARCHAEOL SCI, V40, P2859, DOI 10.1016/j.jas.2012.09.029; Lipo CP, 2005, ANTIQUITY, V79, P158, DOI 10.1017/S0003598X00113778; Lipo CP, SKELETAL BIOL ANCIEN; Louwagie G, 2006, J ANTHROPOL ARCHAEOL, V25, P290, DOI 10.1016/j.jaa.2005.11.008; Mann D, 2008, QUATERNARY RES, V69, P16, DOI 10.1016/j.yqres.2007.10.009; Martinsson-Wallin H., 1994, AHU THE CEREMONIAL S; Martinsson-Wallin H, 2002, ASIAN PERSPECT, V40, P243; Martinsson-Wallin H, 2013, J ISL COAST ARCHAEOL, V8, P405, DOI 10.1080/15564894.2013.834009; McCoy Patrick C., 1976, EASTER ISLAND SETTLE; McMichael CH, 2014, J BIOGEOGR, V41, P1733, DOI 10.1111/jbi.12325; Metraux A., 1957, EASTER ISLAND STONE; Metraux A, 1940, ETHNOLOGY EASTER ISL; Mieth A, CULTURAL ENV CHANGE; Mieth Andreas, 2004, RAPA NUI J, V18, P10; Montgomery & Associates Inc, 2011, COND HIDR ISL PASC; Morrison A., 2012, THESIS U HAWAII MANO, DOI DOI 10.1017/aap.2017.13; Mulrooney MA, 2009, RAPA NUI J, V23, P94, DOI DOI 10.1017/S0003598X00065546; Mulrooney MA, 2014, J POLYNESIAN SOC, V123, P301, DOI 10.15286/jps.123.3.301-338; Mulrooney MA, 2013, J ARCHAEOL SCI, V40, P4377, DOI 10.1016/j.jas.2013.06.020; OSullivan D, 2013, SPATIAL SIMULATION: EXPLORING PATTERN AND PROCESS, P1; Owsley D. W., 2016, SKELETAL BIOL ANCIEN, P222; Polet C, 2016, J ARCHAEOL SCI-REP, V6, P709, DOI 10.1016/j.jasrep.2015.09.013; Puleston CO, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00069; R Development Core Team, 2009, R LANG ENV STAT COMP; Richards C, 2011, WORLD ARCHAEOL, V43, P191, DOI 10.1080/00438243.2011.579483; Richards R., 2008, EASTER ISLAND 1793 1; Rorrer K, 1998, EAS ISL FDN, V4, P193; Routledge K., 1919, MYSTERY EASTER ISLAN; Ruiz-Tagle E., 2007, EASTER ISLAND 1 3 EX; Rull V, 2018, QUATERNARY, V1, DOI 10.3390/quat1020010; Rull V, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00032; Rull V, 2016, QUATERNARY SCI REV, V150, P31, DOI 10.1016/j.quascirev.2016.08.015; Sahlins M. D., 1955, AM ANTHROPOL, V57, P1045; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shepardson BL, 2005, ANTIQUITY, V79, P169, DOI 10.1017/S0003598X0011378X; Shepardson BL, 2006, THESIS; Shepardson BL, 2013, MOAI NEW LOOK OLD FA; Simpson DF, 2018, J PAC ARCHAEOL, V9, P12; Simpson DF, 2018, J ARCHAEOL SCI-REP, V18, P370, DOI 10.1016/j.jasrep.2018.01.038; Simpson Jr D.F., 2009, RAPA NUI J, V23, P131; Spencer C, 2018, J ANTHROPOL ARCHAEOL, V52, P71, DOI 10.1016/j.jaa.2018.09.001; Steadman David W., 1994, Asian Perspectives, V33, P79; Stevenson C. M., 1984, THESIS; Stevenson C. M., 2002, PACIFIC LANDSCAPES A, P211; Stevenson C.M., 2010, GOTLAND PAPERS, P141; Stevenson CM, 2006, ANTIQUITY, V80, P919, DOI 10.1017/S0003598X00094515; Stevenson CM, 2018, ARCHAEOL OCEAN, V53, P92, DOI 10.1002/arco.5145; Stevenson CM, 2015, P NATL ACAD SCI USA, V112, P1025, DOI 10.1073/pnas.1420712112; Stevenson CM, 2013, J ISL COAST ARCHAEOL, V8, P108, DOI 10.1080/15564894.2012.745457; Stevenson CM, 1999, ANTIQUITY, V73, P801, DOI 10.1017/S0003598X00065546; Stevenson CM, 1986, ISLAND SOC ARCHAEOLO, P69; Stevenson CM, 2002, RAPA NUI J, V16, P17; Thomas MS, 2014, ARCHAEOL OCEAN, V49, P95, DOI 10.1002/arco.5031; THOMSON W. J., 1891, PITO HENUA EASTER IS; Tromp M, 2015, J ARCHAEOL SCI, V54, P54, DOI 10.1016/j.jas.2014.11.024; Van Tilburg Jo Anne, 1994, EER ISLAND ARCHAEOLO; Vezzoli L, 2009, GEOL SOC AM BULL, V121, P869, DOI 10.1130/B26470.1; Vitousek PM, 2014, J PAC ARCHAEOL, V5, P51; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Vogt B, 2010, RAPA NUI J, V24, P18; Vogt B, CULTURAL ENV CHANGE; von Saher H., 1994, RAPA NUI J, V8, P95; Wallin P., 2010, GOTLAND PAPERS, P37; Wallin P, 2011, TIME MIND, V4, P43, DOI 10.2752/175169711X12893985693630; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Wozniak J.A., 2018, CULTURAL ENV CHANGE, P87; Wozniak Joan A., 1999, RAPA NUI J, V13, P95; Zeferjahn T L., 2016, THESIS	151	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210409	10.1371/journal.pone.0210409	http://dx.doi.org/10.1371/journal.pone.0210409			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629645	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000083
J	Lin, JP; Lin, PW; Lai, IC; Tsai, JC				Lin, Jih-Pin; Lin, Pei-Wen; Lai, Ing-Chou; Tsai, Jen-Chia			Segmental inner macular layer analysis with spectral-domain optical coherence tomography for early detection of normal tension glaucoma	PLOS ONE			English	Article							RETINAL NERVE-FIBER; OPEN-ANGLE GLAUCOMA; GANGLION-CELL COMPLEX; DIAGNOSTIC-ACCURACY; PLEXIFORM LAYER; THICKNESS; PARAMETERS; ABILITY; ONSET; OCT	Purpose To segment the inner macular layers (IML) and compare the discriminating abilities of the macular and peripapillary retinal nerve fiber layer (mRNFL and pRNFL, respectively) thicknesses in patients with early-stage normal tension glaucoma (NTG). Design Cross-sectional study Methods Forty-nine normal subjects and 69 preperimetric glaucoma (PPG) and 60 NTG patients were enrolled. Spectral-domain optical coherence tomography (SD-OCT) was used to obtain pRNFL and macular thickness parameters and segment the IML in all subjects. Area under the receiver operating characteristic (AUROC) curves were used to compare the diagnostic capabilities of different parameters. Results The pRNFL, total macular layer (TML), mRNFL, and macular ganglion cell layer (mGCL) were significantly thinner in the NTG group than in the PPG and normal groups. The global and superotemporal pRNFL and the mGCL in the superior outer area were the three best parameters for detecting early NTG. The discriminating capabilities of the superior and inferior mGCL were comparable to those of the corresponding pRNFL (p = 0.573, 0.841). Concerning location, the mGCL had higher AUROCs in the outer sectors (0.863, 0.837) than in the inner sectors (0.747, 0.747). Pearson's correlation coefficients also revealed significant correlations between the mGCL and pRNFL (superior: r = 0.499, inferior: r = 0.624). The strongest correlation was between the mGCL and mean deviation (MD) (superior: r = 0.434 and inferior: r = 0.402). Conclusions The diagnostic value of mGCL thickness is comparable to that of pRNFL thickness. IMLs in the outer sectors had better diagnostic capabilities than those in the inner sector for detecting early NTG.	[Lin, Jih-Pin; Lin, Pei-Wen; Lai, Ing-Chou; Tsai, Jen-Chia] Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lin, Pei-Wen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lin, PW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Lin, PW (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	lpw324@gmail.com		Lin, Jih-Pin/0000-0002-4085-9392				Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Edlinger FSM, 2018, GRAEF ARCH CLIN EXP, V256, P1245, DOI 10.1007/s00417-018-3944-6; Fan N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/308505; Firat PG, 2013, GRAEF ARCH CLIN EXP, V251, P831, DOI 10.1007/s00417-012-2114-5; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182404; Kim HJ, 2017, JPN J OPHTHALMOL, V61, P324, DOI 10.1007/s10384-017-0511-3; Kim HJ, 2016, INVEST OPHTH VIS SCI, V57, P4799, DOI 10.1167/iovs.16-19214; Kim NR, 2013, J GLAUCOMA, V22, P133, DOI 10.1097/IJG.0b013e3182254cde; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kiriyama N, 2003, GRAEF ARCH CLIN EXP, V241, P541, DOI 10.1007/s00417-003-0702-0; Martinez-De-La-Casa JM, 2014, INVEST OPHTH VIS SCI, V55, P8343, DOI 10.1167/iovs.14-15501; Michelessi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008803.pub2; Munemasa Y, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00060; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Oddone F, 2016, OPHTHALMOLOGY, V123, P939, DOI 10.1016/j.ophtha.2015.12.041; Pazos M, 2017, OPHTHALMOLOGY, V124, P1218, DOI 10.1016/j.ophtha.2017.03.044; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Thonginnetra O, 2010, J GLAUCOMA, V19, P151, DOI 10.1097/IJG.0b013e318193c45c; Van Ginderdeuren R, 2016, J GLAUCOMA, V25, pE546, DOI 10.1097/IJG.0000000000000388; Yamada H, 2014, AM J OPHTHALMOL, V158, P1318, DOI 10.1016/j.ajo.2014.08.040; Zangalli CS, 2016, J GLAUCOMA, V25, pE401, DOI 10.1097/IJG.0000000000000336	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210215	10.1371/journal.pone.0210215	http://dx.doi.org/10.1371/journal.pone.0210215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629663	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000062
J	Minakova, E; Lang, J; Medel-Matus, JS; Gould, GG; Reynolds, A; Shin, D; Mazarati, A; Sankar, R				Minakova, Elena; Lang, Jordan; Medel-Matus, Jesus-Servando; Gould, Georgianna G.; Reynolds, Ashley; Shin, Don; Mazarati, Andrey; Sankar, Raman			Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; SOCIAL-BEHAVIOR; OXYTOCIN TREATMENT; RECEPTOR 4; MICE; PREFERENCE; DEFICITS; AGONIST; FEMALE; RATS	Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by impaired social interactions, difficulty with communication, and repetitive behavior patterns. In humans affected by ASD, there is a male pre-disposition towards the condition with a male to female ratio of 4:1. In part due to the complex etiology of ASD including genetic and environmental interplay, there are currently no available medical therapies to improve the social deficits of ASD. Studies in rodent models and humans have shown promising therapeutic effects of oxytocin in modulating social adaptation. One pharmacological approach to stimulating oxytocinergic activity is the melanocortin receptor 4 agonist Melanotan-II (MT-II). Notably the effects of oxytocin on environmental rodent autism models has not been investigated to date. We used a maternal immune activation (MIA) mouse model of autism to assess the therapeutic potential of MT-II on autism-like features in adult male mice. The male MIA mice exhibited autism-like features including impaired social behavioral metrics, diminished vocal communication, and increased repetitive behaviors. Continuous administration of MT-II to male MIA mice over a seven-day course resulted in rescue of social behavioral metrics. Normal background C57 male mice treated with MT-II showed no significant alteration in social behavioral metrics. Additionally, there was no change in anxiety-like or repetitive behaviors following MT-II treatment of normal C57 mice, though there was significant weight loss following subacute treatment. These data demonstrate MT-II as an effective agent for improving autism-like behavioral deficits in the adult male MIA mouse model of autism.	[Minakova, Elena] UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [Lang, Jordan] Huntington Mem Hosp, Dept Internal Med, Pasadena, CA USA; [Medel-Matus, Jesus-Servando; Reynolds, Ashley; Shin, Don; Mazarati, Andrey; Sankar, Raman] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Gould, Georgianna G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Mazarati, Andrey; Sankar, Raman] UCLA, Childrens Discovery & Innovat Inst, Los Angeles, CA USA; [Minakova, Elena] Washington Univ, Sch Med, Dept Pediat, Div Neonatol, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Huntington Memorial Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; Washington University (WUSTL)	Minakova, E (corresponding author), UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA.; Minakova, E (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Neonatol, St Louis, MO 63110 USA.	eminakova@email.wustl.edu		Medel-Matus, Jesus Servando/0000-0003-1103-468X; Sankar, Raman/0000-0002-5609-0362	UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant	UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant	EM received funding from the UCLA Children's Discovery and innovation Institute William F. Friedman Fellowship Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altadottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI [10.1007/s10803-010-1006-y, DOI 10.1007/S10803-010-1006-Y]; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; ARTYMYSHYN R, 1990, J NEUROSCI METH, V32, P185, DOI 10.1016/0165-0270(90)90139-7; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Barrett CE, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.73; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Campbell-Smith EJ, 2015, LEARN MEMORY, V22, P247, DOI 10.1101/lm.036962.114; Canetta S, 2016, MOL PSYCHIATR, V21, P956, DOI 10.1038/mp.2015.222; Caruso V, 2014, NAT REV NEUROSCI, V15, P98, DOI 10.1038/nrn3657; Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V63, P88, DOI 10.1016/j.bbi.2016.09.028; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; Giuliano F, 2006, NEUROSCIENCE, V138, P293, DOI 10.1016/j.neuroscience.2005.11.008; Grabrucker S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00037; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hagen E, 2015, NEUROTHERAPEUTICS, V12, P657, DOI 10.1007/s13311-015-0357-7; Harony-Nicolas H, 2017, ELIFE, V6, DOI 10.7554/eLife.18904; INSEL TR, 1990, J NEUROENDOCRINOL, V2, P539, DOI 10.1111/j.1365-2826.1990.tb00445.x; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kim Gilbert W, 2011, Expert Rev Clin Pharmacol, V4, P243, DOI 10.1586/ecp.11.3; Klenerova V, 2008, NEUROSCI LETT, V432, P202, DOI 10.1016/j.neulet.2007.12.020; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Li K, 2016, CELL, V167, P60, DOI 10.1016/j.cell.2016.08.067; Li Y, 2018, J NEUROSCI, V38, P3358, DOI 10.1523/JNEUROSCI.3642-17.2018; Liu J, 2013, INT J NEUROPSYCHOPH, V16, P105, DOI 10.1017/S146114571100174X; Lu XY, 2003, J NEUROSCI, V23, P7863; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Meltzer A, 2017, NEUROPSYCHOPHARMACOL, V42, P284, DOI 10.1038/npp.2016.158; Meyer-Lindenberg A, 2012, NATURE REV, P524; Meziane H, 2015, BIOL PSYCHIAT, V78, P85, DOI 10.1016/j.biopsych.2014.11.010; Miller JL, 2017, AM J MED GENET A, V173, P1243, DOI 10.1002/ajmg.a.38160; Modi ME, 2015, NEUROPSYCHOPHARMACOL, V40, P1856, DOI 10.1038/npp.2015.35; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Neunuebel JP, 2015, ELIFE, V4, DOI 10.7554/eLife.06203; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penagarikano O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010257; Pineda E, 2013, ANN NEUROL, V74, P11, DOI 10.1002/ana.23898; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Prager EM, 2016, J NEUROSCI RES, V94, P548, DOI 10.1002/jnr.23690; Rauk PN, 2001, AM J REPROD IMMUNOL, V45, P148, DOI 10.1111/j.8755-8920.2001.450305.x; Sabihi S, 2014, PSYCHONEUROENDOCRINO, V45, P31, DOI 10.1016/j.psyneuen.2014.03.009; Sala M, 2013, J NEUROENDOCRINOL, V25, P107, DOI 10.1111/j.1365-2826.2012.02385.x; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Schmid B, 2001, ENDOCRINOLOGY, V142, P1380, DOI 10.1210/en.142.4.1380; Serova LI, 2014, J NEUROCHEM, V131, P825, DOI 10.1111/jnc.12847; Shamay-Tsoory SG, 2016, BIOL PSYCHIAT, V79, P194, DOI 10.1016/j.biopsych.2015.07.020; Smith CJW, 2017, BRAIN STRUCT FUNCT, V222, P981, DOI 10.1007/s00429-016-1260-7; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Walum H, 2016, BIOL PSYCHIAT, V79, P251, DOI 10.1016/j.biopsych.2015.06.016; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x	61	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210389	10.1371/journal.pone.0210389	http://dx.doi.org/10.1371/journal.pone.0210389			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629642	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000078
J	Petrovic, SM; Radunovic, M; Barac, M; Pficer, JK; Pavlica, D; Arsenijevic, VA; Pucar, A				Petrovic, Sanja Matic; Radunovic, Milena; Barac, Milena; Pficer, Jovana Kuzmanovic; Pavlica, Dusan; Arsenijevic, Valentina Arsic; Pucar, Ana			Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects	PLOS ONE			English	Article							PERIODONTAL-DISEASE; FLUCONAZOLE RESISTANCE; AMPHOTERICIN-B; PREVALENCE; COLONIZATION; ALBICANS; SUSCEPTIBILITY; DUBLINIENSIS; DIVERSITY; INFECTION	Objectives The aim of this cross-sectional observational study was to compare the prevalence of different oral Candida spp. in patients with Type 2 Diabetes and chronic periodontitis in two oral sites: dorsal surface of the tongue and subgingival area. In order to determine subgingival areas as potential reservoirs of yeasts, this study aimed to find differences in the yeasts' detection between the dorsum of the tongue, as the oral site most commonly inhabited with microorganisms, and subgingival samples. Additionally, potential predictors for the yeasts prevalence were determined. Material and methods Subjects (N = 146) were divided into four groups: group A-healthy individuals without periodontitis, group B-healthy individuals with chronic periodontitis, group C-Type 2 Diabetes patients with good glycoregulation and Chronic periodontitis and group D-Type 2 Diabetes patients with poor glycoregulation and Chronic periodontitis. Samples were obtained from the tongue by swabbing. Subgingival plaque samples were taken by paper points and periodontal curette. Isolation and identification of different Candida spp. was done using ChromAgar medium. In addition, germ-tube production and carbohydrate assimilation tests were performed. Results The prevalence of Candida spp. was higher in diabetics with poor glycoregulation. The most frequently isolated species was Candida albicans followed by Candida glabrata and Candida tropicalis. In 15.6% of cases, Candida spp. was present in the subgingival area while absent on the tongue. Multivariate regression model showed that HbA1c was Candida spp. predictor for both locations. Conclusions Our results confirmed that there are Candida spp. carriers among subjects with clinically healthy oral mucosa. Also, this study identified subgingival areas as potential reservoirs of these pathogenic species. Glycoregulation has been recognized as a positive predictor factor of Candida spp.	[Petrovic, Sanja Matic; Barac, Milena; Pucar, Ana] Univ Belgrade, Sch Dent Med, Dept Oral Med & Periodontol, Belgrade, Serbia; [Radunovic, Milena; Pavlica, Dusan] Univ Belgrade, Sch Dent Med, Dept Microbiol, Belgrade, Serbia; [Pficer, Jovana Kuzmanovic] Univ Belgrade, Sch Dent Med, Dept Med Stat & Informat, Belgrade, Serbia; [Arsenijevic, Valentina Arsic] Univ Belgrade, Sch Med, Dept Microbiol & Immunol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Pucar, A (corresponding author), Univ Belgrade, Sch Dent Med, Dept Oral Med & Periodontol, Belgrade, Serbia.; Radunovic, M (corresponding author), Univ Belgrade, Sch Dent Med, Dept Microbiol, Belgrade, Serbia.	milena.radunovic@stomf.bg.ac.rs; anapucar@gmail.com		Matic Petrovic, Sanja/0000-0002-4847-0891; Radunovic, Milena/0000-0003-3507-1186	Ministry of Education, Science and Technological Development of Serbia [41008, 41027]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work has been financed by the Grants No 41008 and 41027 of the Ministry of Education, Science and Technological Development of Serbia.	Al Mubarak S, 2013, J INFECT PUBLIC HEAL, V6, P296, DOI 10.1016/j.jiph.2012.12.007; Al-Attas SA, 2010, ANN SAUDI MED, V30, P101, DOI 10.4103/0256-4947.60514; [Anonymous], 1999, ANN PERIODONTOL; ARENDORF TM, 1980, ARCH ORAL BIOL, V25, P1, DOI 10.1016/0003-9969(80)90147-8; Bader MS, 2005, DIABETIC MED, V22, P1252, DOI 10.1111/j.1464-5491.2005.01626.x; Bokor-Bratic M, 2013, EUR J ORAL SCI, V121, P427, DOI 10.1111/eos.12073; Budtz-Jorgensen E, 2000, COMMUNITY DENT ORAL, V28, P141, DOI 10.1034/j.1600-0528.2000.028002141.x; BURFORDMASON AP, 1988, J MED VET MYCOL, V26, P49; Cankovic M, 2011, HEALTHMED, V5, P1695; Colombo AL, 2003, EUR J CLIN MICROBIOL, V22, P470, DOI 10.1007/s10096-003-0973-8; Colombo AL, 2007, INFECT CONT HOSP EP, V28, P570, DOI 10.1086/513615; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; Darwazeh AMG, 2010, INT J DENT HYG, V8, P128, DOI 10.1111/j.1601-5037.2009.00407.x; Darwazeh Azmi Mohammad-Ghaleb, 2010, J Contemp Dent Pract, V11, P017; Oliveira Luciana Fernandes de, 2006, Braz. oral res., V20, P202, DOI 10.1590/S1806-83242006000300004; Gonzalez GM, 2008, J CLIN MICROBIOL, V46, P2902, DOI 10.1128/JCM.00937-08; Grenier G, 2009, ORAL MICROBIOL IMMUN, V24, P506, DOI 10.1111/j.1399-302X.2009.00542.x; Guggenheimer J, 2000, ORAL SURG ORAL MED O, V89, P570, DOI 10.1067/moe.2000.104477; Hammad MM, 2013, OR SURG OR MED OR PA, V116, P321, DOI 10.1016/j.oooo.2013.05.013; Hintao J, 2007, ORAL MICROBIOL IMMUN, V22, P175, DOI 10.1111/j.1399-302X.2007.00341.x; HITCHCOCK CA, 1993, ANTIMICROB AGENTS CH, V37, P1962, DOI 10.1128/AAC.37.9.1962; Jarvensivu A, 2004, ORAL DIS, V10, P106, DOI 10.1046/j.1354-523X.2003.00978.x; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Mallick EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003661; Marinho SA, 2010, BRAZ J MICROBIOL, V41, P286, DOI 10.1590/S1517-83822010000200004; Melton JJ, 2010, SPEC CARE DENT, V30, P230, DOI 10.1111/j.1754-4505.2010.00159.x; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Murray P A, 1994, Periodontol 2000, V6, P50, DOI 10.1111/j.1600-0757.1994.tb00026.x; Sardi JCO, 2011, ARCH ORAL BIOL, V56, P951, DOI 10.1016/j.archoralbio.2011.03.007; Papon N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003550; Peric M, 2018, OR SURG OR MED OR PA, V126, P41, DOI 10.1016/j.oooo.2018.03.003; Petrovic SM, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0077; Rasool S, 2005, J Coll Physicians Surg Pak, V15, P679; */* S  11, 2013, DIABETES CARE S1, V36, pS1, DOI DOI 10.2337/DC13-S011; Sanchez-Vargas Luis Octavio, 2005, Revista Iberoamericana de Micologia, V22, P83; SINNOTT JT, 1987, INFECT CONT HOSP EP, V8, P334, DOI 10.1017/S0195941700066443; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005; Urzua B, 2008, MED MYCOL, V46, P783, DOI 10.1080/13693780802060899; Colombo APV, 2016, MICROB PATHOGENESIS, V94, P27, DOI 10.1016/j.micpath.2015.09.009; Yang YL, 2004, INFECT CONT HOSP EP, V25, P60, DOI 10.1086/502294; Yuan K, 2001, J PERIODONTAL RES, V36, P18, DOI 10.1034/j.1600-0765.2001.90613.x; Zomorodian K, 2016, J MYCOL MED, V26, P103, DOI 10.1016/j.mycmed.2015.12.008	42	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210527	10.1371/journal.pone.0210527	http://dx.doi.org/10.1371/journal.pone.0210527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629672	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000102
J	Amberbir, A; Banda, V; Singano, V; Matengeni, A; Pfaff, C; Ismail, Z; Allain, TJ; Chan, AK; Sodhi, SK; van Oosterhout, JJ				Amberbir, Alemayehu; Banda, Victor; Singano, Victor; Matengeni, Alfred; Pfaff, Colin; Ismail, Zahra; Allain, Theresa J.; Chan, Adrienne K.; Sodhi, Sumeet K.; van Oosterhout, Joep J.			Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HYPERTENSION; CARE; PREVALENCE; BURDEN; ART	Background Cardiovascular disease (CVD) risk among people living with HIV is elevated due to persistent inflammation, hypertension and diabetes comorbidity, lifestyle factors and exposure to antiretroviral therapy (ART). Data from Africa on how CVD risk affects morbidity and mortality among ART patients are lacking. We explored the effect of CVD risk factors and the Framingham Risk Score (FRS) on medium-term ART outcomes. Methods A prospective cohort study of standardized ART outcomes (Dead, Alive on ART, stopped ART, Defaulted and Transferred out) was conducted from July 2014-December 2016 among patients on ART at a rural and an urban HIV clinic in Zomba district, Malawi. The primary outcome was Dead. Active defaulter tracing was not done and patients who transferred out and defaulted were excluded from the analysis. At enrolment, hypertension, diabetes and dyslipidemia were diagnosed, lifestyle data collected and the FRS was determined. Cox-regression analysis was used to determine independent risk factors for the outcome Dead. Results Of 933 patients enrolled, median age was 42 years (IQR: 35-50), 72% were female, 24% had hypertension, 4% had diabetes and 15.8% had elevated total cholesterol. The median follow up time was 2.4 years. Twenty (2.1%) patients died, 50 (5.4%) defaulted, 63 (6.8%) transferred out and 800 (85.7%) were alive on ART care (81.7% urban vs. 89.9% rural). In multivariable survival analysis, male gender (aHR = 3.28; 95% CI: 1.33-8.07, p = 0.01) and total/HDL cholesterol ratio (aHR = 5.77, 95% CI: 1.21-27.32; p = 0.03) were significantly associated with mortality. There was no significant association between mortality and hypertension, body mass index, central obesity, diabetes, FRS, physical inactivity, smoking at enrolment, ART regimen and WHO disease stage. Conclusions Medium-term all-cause mortality among ART patients was associated with male gender and elevated total/HDL cholesterol ratio.	[Amberbir, Alemayehu; Banda, Victor; Singano, Victor; Matengeni, Alfred; Pfaff, Colin; Chan, Adrienne K.; Sodhi, Sumeet K.; van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [Ismail, Zahra] Pirimiti Rural Hosp, Pirimiti, Malawi; [Allain, Theresa J.; van Oosterhout, Joep J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [Chan, Adrienne K.] Univ Toronto, Div Infect Dis, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Sodhi, Sumeet K.] Univ Hlth Network, Toronto Western Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of Malawi; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Amberbir, A (corresponding author), Dignitas Int, Zomba, Malawi.	a.amberbir@dignitasinternational.org	Amberbir, Alemayehu/HGC-2647-2022					Amberbir A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197728; Benjamin LA, 2016, NEUROLOGY, V86, P324, DOI 10.1212/WNL.0000000000002278; Chihana M, 2012, TROP MED INT HEALTH, V17, pe74, DOI 10.1111/j.1365-3156.2012.02929.x; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Divala OH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3916-x; Gunda Daniel Wilfred, 2017, J Sex Transm Dis, V2017, P7075601, DOI 10.1155/2017/7075601; Harries AD, 2015, TROP MED INT HEALTH, V20, P961, DOI 10.1111/tmi.12506; Jahn A, 2016, B WORLD HEALTH ORGAN, V94, P772, DOI 10.2471/BLT.15.166074; Jamieson L, 2017, HIV MED MAR, V23; Mageda K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/843598; Malawi Ministry of Health, 2014, INT HIV PROGR REP OC; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Mbanya JC, 2011, LANCET, V377, P536, DOI 10.1016/S0140-6736(10)61891-0; Msyamboza KP, 2012, INT HEALTH, V4, P246, DOI 10.1016/j.inhe.2012.09.005; Muyanja D, 2016, AIDS PATIENT CARE ST, V30, P4, DOI 10.1089/apc.2015.0213; Nou E, 2016, AIDS, V30; Rucker SCM, 2018, AIDS, V32, P253, DOI 10.1097/QAD.0000000000001700; Setegn T, 2015, AIDS RES TREAT, V2015, DOI 10.1155/2015/148769; Seyoum D, 2017, INT J ENV RES PUB HE, V14, P1; World Health Organization, 2003, STEPS Q Q GUID CHRON	23	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210629	10.1371/journal.pone.0210629	http://dx.doi.org/10.1371/journal.pone.0210629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653539	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500056
J	Fu, Y; Zorman, B; Sumazin, P; Sanna, PP; Repunte-Canonigo, V				Fu, Yu; Zorman, Barry; Sumazin, Pavel; Sanna, Pietro Paolo; Repunte-Canonigo, Vez			Epitranscriptomics: Correlation of N-6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats	PLOS ONE			English	Article							MESSENGER-RNA; M(6)A RNA; GENE FTO; EXPRESSION; N6-METHYLADENOSINE; INJURY; CELL; ASSOCIATION; ENRICHMENT; METHYLOMES	Internal RNA modifications have been known for decades, however their roles in mRNA regulation have only recently started to be elucidated. Here we investigated the most abundant mRNA modification, N-6-methyladenosine (m(6)A) in transcripts from the hippocampus of HIV transgenic (Tg) rats. The distribution of m(6)A peaks within HIV transcripts in HIV Tg rats largely corresponded to the ones observed for HIV transcripts in cell lines and T cells. Host transcripts were found to be differentially m(6)A methylated in HIV Tg rats. The functional roles of the differentially m(6)A methylated pathways in HIV Tg rats is consistent with a key role of RNA methylation in the regulation of the brain transcriptome in chronic HIV disease. In particular, host transcripts show significant differential m(6)A methylation of genes involved in several pathways related to neural function, suggestive of synaptodendritic injury and neurodegeneration, inflammation and immune response, as well as RNA processing and metabolism, such as splicing. Changes in m(6)A methylation were usually positively correlated with differential expression, while differential m(6)A methylation of pathways involved in RNA processing were more likely to be negatively correlated with gene expression changes. Thus, sets of differentially m(6)A methylated, functionally-related transcripts appear to be involved in coordinated transcriptional responses in the context of chronic HIV. Altogether, our results support that m(6)A methylation represents an additional layer of regulation of HIV and host gene expression in vivo that contributes significantly to the transcriptional effects of chronic HIV.	[Fu, Yu; Sanna, Pietro Paolo; Repunte-Canonigo, Vez] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Fu, Yu; Sanna, Pietro Paolo; Repunte-Canonigo, Vez] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA; [Zorman, Barry; Sumazin, Pavel] Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Fu, Yu] European Bioinformat Inst EMBL EBI, Hinxton, England	Scripps Research Institute; Scripps Research Institute; Baylor College of Medicine; European Molecular Biology Laboratory (EMBL)	Sanna, PP; Repunte-Canonigo, V (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Sanna, PP; Repunte-Canonigo, V (corresponding author), Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA.	psanna@scripps.edu; canonigo@scripps.edu	Sumazin, Pavel/AAE-6607-2020	Sumazin, Pavel/0000-0002-1215-4977	National Institutes of Health/National Institute on Drug Abuse [DA041750, DA043268]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA025012, R01AA021667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041750, R01DA046204, R01DA043268, R01DA046170] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health/National Institute on Drug Abuse grants DA041750 and DA043268, https://www.drugabuse.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Choudhry Z, 2013, OBESITY, V21, pE738, DOI 10.1002/oby.20444; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Festa L, 2015, J NEUROSCI, V35, P10550, DOI 10.1523/JNEUROSCI.4403-14.2015; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Iles MM, 2013, NAT GENET, V45, P428, DOI 10.1038/ng.2571; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kok YL, 2017, TRENDS MICROBIOL, V25, P932, DOI 10.1016/j.tim.2017.06.002; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; LE PT, 1986, J IMMUNOL, V136, P2526; Leng SX, 2015, CURR HIV-AIDS REP, V12, P25, DOI 10.1007/s11904-014-0247-3; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Meyer KD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0874-7; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; PEREIRAMONTECINOS, 2017, BIOCHIM BIOPHYS ACTA, V1860, P460, DOI DOI 10.1016/J.BBAGRM.2017.02.002; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reitz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050354; Repunte-Canonigo V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-26; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Sacktor N, 2014, CURR OPIN HIV AIDS, V9, P517, DOI 10.1097/COH.0000000000000102; Sanna PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175316; Satterlee JS, 2014, J NEUROSCI, V34, P15170, DOI 10.1523/JNEUROSCI.3236-14.2014; Shen F, 2015, J CLIN ENDOCR METAB, V100, pE148, DOI 10.1210/jc.2014-1893; SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; STOLTZFUS CM, 1983, J GEN VIROL, V64, P2191, DOI 10.1099/0022-1317-64-10-2191; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Wei WQ, 2017, J CELL BIOCHEM, V118, P2534, DOI 10.1002/jcb.25967; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24345; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115	63	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0203566	10.1371/journal.pone.0203566	http://dx.doi.org/10.1371/journal.pone.0203566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653517	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500005
J	Lichtblau, D; Stoean, C				Lichtblau, Daniel; Stoean, Catalin			Cancer diagnosis through a tandem of classifiers for digitized histopathological slides	PLOS ONE			English	Article							IMAGE-ANALYSIS; CLASSIFICATION; OPTIMIZATION; MODEL	The current research study is concerned with the automated differentiation between histopathological slides from colon tissues with respect to four classes (healthy tissue and cancerous of grades 1, 2 or 3) through an optimized ensemble of predictors. Six distinct classifiers with prediction accuracies ranging from 87% to 95% are considered for the task. The proposed method of combining them takes into account the probabilities of the individual classifiers for each sample to be assigned to any of the four classes, optimizes weights for each technique by differential evolution and attains an accuracy that is significantly better than the individual results. Moreover, a degree of confidence is defined that would allow the pathologists to separate the data into two distinct sets, one that is correctly classified with a high level of confidence and the rest that would need their further attention. The tandem is also validated on other benchmark data sets. The proposed methodology proves to be efficient in improving the classification accuracy of each algorithm taken separately and performs reasonably well on other data sets, even with default weights. In addition, by establishing a degree of confidence the method becomes more viable for use by actual practitioners.	[Lichtblau, Daniel] Wolfram Res, Champaign, IL USA; [Stoean, Catalin] Univ Craiova, Fac Sci, Craiova, Romania	University of Craiova	Stoean, C (corresponding author), Univ Craiova, Fac Sci, Craiova, Romania.	catalin.stoean@inf.ucv.ro	Stoean, Catalin/C-7242-2008	Stoean, Catalin/0000-0001-5917-1857	Romanian Ministry of National Education (MEN) - Research [26/2014, PN-II-PT-PCCA-2013-4-1153]; Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI) [26/2014, PN-II-PT-PCCA-2013-4-1153]	Romanian Ministry of National Education (MEN) - Research; Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	Wolfram Research, Inc. provided support in the form of salary to DL but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CS acknowledges the support of the research grant no. 26/2014, code PN-II-PT-PCCA-2013-4-1153, entitled "Intelligent Medical Information System for the Diagnosis and Monitoring of the Treatment of Patients with Colorectal Neoplasm"; financed by the Romanian Ministry of National Education (MEN) - Research, and the Executive Agency for Higher Education Research Development and Innovation Funding (UEFISCDI). CS received support in the form of salaries and research materials from the UEFISCDI. The grant was led by CS and made possible in collaboration with physicians. The specific roles of these authors are articulated in the 'author contributions' section.	Ahammer H, 2008, PATTERN RECOGN LETT, V29, P2189, DOI 10.1016/j.patrec.2008.08.008; Arik S, 2017, LECT NOTES COMPUT SC, V10636, P903, DOI 10.1007/978-3-319-70090-8_92; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRUNYE P, 2017, JOURNAL OF BIOMEDICA, V66, P171; CAICEDO JC, 2009, BERLIN, P126; cancer org, 2016, AMERICAN CANCER SOCI; CHAM, 2013, SPRINGER, V2013, P411; CHAM, SPRINGER; COELHO LP, 2010, BERLIN, P23; Das S., 2016, SWARM EVOL COMPUT, V27, P1, DOI [DOI 10.1016/J.SWEV0.2016.01.004, 10.1016/j.swevo.2016.01.004, DOI 10.1016/J.SWEVO.2016.01.004]; DC, HISTOLOGY; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Dubitzky W, 2006, INC; DUBITZKY W, 2006, FUNDAMENTALS OF DATA; DUBITZKY W, 2009, FUNDAMENTALS OF DATA; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; FREEDMAN DA, 2009, PRESS; Freedman DA, 2009, MEDICAL IMAGE COMPUT; Gorunescu F, 2011, SPRINGER, V12; Gorunescu F, 2011, INTEL SYST REF LIBR, P1, DOI 10.1007/978-3-642-19721-5; Gorunescu F, 2010, INT J GEN SYST, V39, P471, DOI 10.1080/03081079.2010.484282; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kearney N, 2006, ELSEVIER HEALTH SCIE; Kolter JZ, 2007, J MACH LEARN RES, V8, P2755; Krizhevsky A., P 25 INT C NEUR INF, P1097; LICHTBLAU D, 2012, INT J SWARM INTELLIG, V1, P1; Lichtblau D, 2016, INT SYMP SYMB NUMERI, P105, DOI [10.1109/SYNASC.2016.22, 10.1109/SYNASC.2016.028]; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Mitchell TM, 1997, SCI REPORTS; MITCHELL TM, 1997, INC, P1; Mittal S, 2018, P NATL ACAD SCI USA, V115, pE5651, DOI 10.1073/pnas.1719551115; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OJANSIVU V, 2008, BERLIN, V8, P236; Onder D, 2013, MICRON, V47, P33, DOI 10.1016/j.micron.2013.01.003; PAJA W, 2015, FEDCSIS, V2015, P281; POSTAVARU S, 2017, SPRINGER, P38; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Sertel O, 2009, J SIGNAL PROCESS SYS, V55, P169, DOI 10.1007/s11265-008-0201-y; SIRINUKUNWATTAN.K, 2016, CORR, V1603, P275; Sirinukunwattana K, 2016, COLORECTAL CANCER HI; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; STOEAN C, INTELLIGENT INTERACT; Stoean C, 2016, SPRINGER; Stoean C, 2009, EVOLUTION OF COOPERA, P47, DOI 10.1007/978-3-642-01885-5_3; Stoean C, 2017, INT SYMP SYMB NUMERI, P419, DOI 10.1109/SYNASC.2017.00076; Stoean C, 2016, INT SYMP SYMB NUMERI, P449, DOI [10.1109/SYNASC.2016.074, 10.1109/SYNASC.2016.68]; Stoean C, 2010, IEEE T EVOLUT COMPUT, V14, P842, DOI 10.1109/TEVC.2010.2041668; STOEAN R, 2018, NEURAL COMPUTING APP; Stoean R, 2018, MATHEMATICA 11 2, DOI 10.1007/s00521-018-3709-5; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Thon A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185995; Vapnik V.N., 1998, STAT LEARNING THEORY; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Wang CW, 2010, APPL INTELL, V33, P357, DOI 10.1007/s10489-009-0172-0; Wang YS, 2018, J BIOMED INFORM, V77, P34, DOI 10.1016/j.jbi.2017.11.011; Xu Y, 2014, MED IMAGE ANAL, V18, P591, DOI 10.1016/j.media.2014.01.010; Zheng YS, 2017, PATTERN RECOGN, V71, P14, DOI 10.1016/j.patcog.2017.05.010	64	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209274	10.1371/journal.pone.0209274	http://dx.doi.org/10.1371/journal.pone.0209274			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650087	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300011
J	Pena, AE; Rincon-Gonzalez, L; Abbas, JJ; Jung, R				Pena, Andres E.; Rincon-Gonzalez, Liliana; Abbas, James J.; Jung, Ranu			Effects of vibrotactile feedback and grasp interface compliance on perception and control of a sensorized myoelectric hand	PLOS ONE			English	Article							PROSTHETIC HAND; LIMB; DISCRIMINATION; ROBOTICS; AMPUTEES; TIME	Current myoelectric prosthetic limbs are limited in their ability to provide direct sensory feedback to users, which increases attentional demands and reliance on visual cues. Vibrotactile sensory substitution (VSS), which can be used to provide sensory feedback in a non-invasive manner has demonstrated some improvement in myoelectric hand control. In this work, we developed and tested two VSS configurations: one with a single burst-rate modulated actuator and another with a spatially distributed array of five coin tactors. We performed a direct comparative assessment of these two VSS configurations with able-bodied subjects to investigate sensory perception, myoelectric control of grasp force and hand aperture with a prosthesis, and the effects of interface compliance. Six subjects completed a sensory perception experiment under a stimulation only paradigm; sixteen subjects completed experiments to compare VSS performance on perception and graded myoelectric control during grasp force and hand aperture tasks; and ten subjects completed experiments to investigate the effect of mechanical compliance of the myoelectric hand on the ability to control grasp force. Results indicated that sensory perception of vibrotactile feedback was not different for the two VSS configurations in the absence of active myoelectric control, but it was better with feedback from the coin tactor array than with the single actuator during myoelectric control of grasp force. Graded myoelectric control of grasp force and hand aperture was better with feedback from the coin tactor array than with the single actuator, and myoelectric control of grasp force was improved with a compliant grasp interface. Further investigations with VSS should focus on the use of coin tactor arrays by subjects with amputation in real-world settings and on improving control of grasp force by increasing the mechanical compliance of the hand.	[Pena, Andres E.; Rincon-Gonzalez, Liliana; Jung, Ranu] Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA; [Abbas, James J.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	State University System of Florida; Florida International University; Arizona State University; Arizona State University-Tempe	Jung, R (corresponding author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA.	rjung@fiu.edu	Pena, Andres/ABB-7878-2020; Jung, Ranu/AAA-5112-2019	Pena, Andres/0000-0002-1473-0173; Jung, Ranu/0000-0003-2042-0638; Abbas, James/0000-0002-3647-7041; Rincon-Gonzalez, Liliana/0000-0002-5565-9609	National Institutes of Health through National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, NIH [R01-EB008578]; Defense Advanced Research Projects Agency (DARPA); Army Research Office (ARO) [W911NF-17-1-0022]	National Institutes of Health through National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office (ARO)	This work was supported by the National Institutes of Health through a grant from the National Institute of Biomedical Imaging and Bioengineering and the National Institute of Child Health and Human Development, NIH-R01-EB008578 to RJ. This work was also supported in part by the Defense Advanced Research Projects Agency (DARPA) and Army Research Office (ARO) and was accomplished under Grant Number W911NF-17-1-0022 to RJ. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Defense Advanced Research Projects Agency, Army Research Office or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein.	Ajoudani A, 2014, IEEE T HAPTICS, V7, P203, DOI 10.1109/TOH.2014.2309142; Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979; Antfolk C, 2013, IEEE T NEUR SYS REH, V21, P112, DOI 10.1109/TNSRE.2012.2217989; Antfolk C, 2013, EXPERT REV MED DEVIC, V10, P45, DOI [10.1586/erd.12.68, 10.1586/ERD.12.68]; Antfolk C, 2012, J REHABIL MED, V44, P702, DOI 10.2340/16501977-1001; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Brown JD, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0098-1; Carey SL, 2015, J REHABIL RES DEV, V52, P247, DOI 10.1682/JRRD.2014.08.0192; Catalano MG, 2012, IEEE-RAS INT C HUMAN, P7, DOI 10.1109/HUMANOIDS.2012.6651492; Chai GH, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066002; Chatterjee A, 2008, 2008 IEEE REGION 5 CONFERENCE, P75; Chaubey P., 2014, J PROSTHETICS ORTHOT, V26, P120, DOI DOI 10.1097/JPO.0000000000000030; Christiansen R, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P531, DOI 10.1109/WHC.2013.6548464; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Cipriani C, 2014, EXP BRAIN RES, V232, P3421, DOI 10.1007/s00221-014-4024-8; Cipriani C, 2012, IEEE T BIO-MED ENG, V59, P400, DOI 10.1109/TBME.2011.2173342; Clemente F, 2016, IEEE T NEUR SYS REH, V24, P1314, DOI 10.1109/TNSRE.2015.2500586; Cohen J., 2005, CHI 05 EXTENDED ABST, P1296; Cordella F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00209; D'Alonzo M, 2015, IEEE T NEUR SYS REH, V23, P450, DOI 10.1109/TNSRE.2014.2337952; D'Alonzo M, 2011, INT C REHAB ROBOT; Davis TS, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036001; Della Santina C, 2015, IEEE-RAS INT C HUMAN, P497, DOI 10.1109/HUMANOIDS.2015.7363595; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Durand DM, 2013, J NEURAL ENG, P657; Erwin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134095; Gabiccini M, 2013, IEEE INT C INT ROBOT, P3738, DOI 10.1109/IROS.2013.6696890; Germany EI, 2016, IEEE ENG MED BIO, P5046, DOI 10.1109/EMBC.2016.7591861; Gustus A, 2012, BIOL CYBERN, V106, P741, DOI 10.1007/s00422-012-0532-4; Horch K, 2011, IEEE T NEUR SYS REH, V19, P483, DOI 10.1109/TNSRE.2011.2162635; Howard CL, 2017, GAIT POSTURE, V51, P91, DOI 10.1016/j.gaitpost.2016.09.025; Husman MAB, 2016, IEEE ENG MED BIO, P2120, DOI 10.1109/EMBC.2016.7591147; Jorgovanovic N, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/120357; Kim K, 2012, IEEE T NEUR SYS REH, V20, P798, DOI 10.1109/TNSRE.2012.2206080; Kundu A, 2014, IEEE T NEUR SYS REH, V22, P400, DOI 10.1109/TNSRE.2013.2267936; Luchetti M, 2015, J REHABIL RES DEV, V52, P605, DOI 10.1682/JRRD.2014.11.0283; Mahns DA, 2006, J NEUROPHYSIOL, V95, P1442, DOI 10.1152/jn.00483.2005; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; Ninu A, 2014, IEEE T NEUR SYS REH, V22, P1041, DOI 10.1109/TNSRE.2014.2318431; Novich SD, 2015, EXP BRAIN RES, V233, P2777, DOI 10.1007/s00221-015-4346-1; Oddo CM, 2016, ELIFE, V5, DOI 10.7554/eLife.09148; Oskoei MA, 2007, BIOMED SIGNAL PROCES, V2, P275, DOI 10.1016/j.bspc.2007.07.009; Resnik L, 2017, PROSTHET ORTHOT INT; Rombokas E, 2013, IEEE T BIO-MED ENG, V60, P2226, DOI 10.1109/TBME.2013.2252174; Saal H. P., 2015, NEUROPSYCHOLOGIA; Santello M, 2016, PHYS LIFE REV, V17, P1, DOI 10.1016/j.plrev.2016.02.001; Schiefer M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016001; Sergi F, 2008, P IEEE RAS-EMBS INT, P433, DOI 10.1109/BIOROB.2008.4762827; Sornkarn N, 2017, IEEE T HAPTICS, V10, P183, DOI 10.1109/TOH.2016.2615924; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Stepp CE, 2012, IEEE T NEUR SYS REH, V20, P31, DOI 10.1109/TNSRE.2011.2170856; Stronks HC, 2017, ARTIF ORGANS, V41, P1059, DOI 10.1111/aor.12882; Tavakoli M, 2017, BIOSYST BIOROBOT, V17, P5, DOI 10.1007/978-3-319-46460-2_2; Thota AK, 2015, J NEUROSCI METH, V244, P78, DOI 10.1016/j.jneumeth.2014.07.020; van der Niet O, 2013, J REHABIL RES DEV, V50, P1123, DOI 10.1682/JRRD.2012.08.0140; Walker JM, 2015, IEEE T HAPTICS, V8, P454, DOI 10.1109/TOH.2015.2420096; Wentink EC, 2011, IEEE ENG MED BIO, P1668, DOI 10.1109/IEMBS.2011.6090480; Wheeler J, 2010, IEEE T NEUR SYS REH, V18, P58, DOI 10.1109/TNSRE.2009.2039602; Williams TW, 2011, J REHABIL RES DEV, V48, pIX, DOI 10.1682/JRRD.2011.04.0078; Witteveen HJB, 2014, IEEE T NEUR SYS REH, V22, P53, DOI 10.1109/TNSRE.2013.2267394; Witteveen HJB, 2012, IEEE T BIO-MED ENG, V59, P2219, DOI 10.1109/TBME.2012.2200678	61	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210956	10.1371/journal.pone.0210956	http://dx.doi.org/10.1371/journal.pone.0210956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650161	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300081
J	Shepherd, LD; Whitehead, P; Whitehead, A				Shepherd, Lara D.; Whitehead, Peter; Whitehead, Anna			Genetic analysis identifies the missing parchment of New Zealand's founding document, the Treaty of Waitangi	PLOS ONE			English	Article							DNA	Genetic analyses provide a powerful tool with which to identify the biological components of historical objects. Te Tiriti o Waitangi vertical bar The Treaty of Waitangi is New Zealand's founding document, intended to be a partnership between the indigenous Maori and the British Crown. Here we focus on an archived piece of blank parchment that has been proposed to be the missing portion of the lower parchment of the Waitangi Sheet of the Treaty. However, its physical dimensions and characteristics are not consistent with this hypothesis. We perform genetic analyses on the parchment membranes of the Treaty, plus the blank piece of parchment. We find that all three parchments were made from ewes and that the blank parchment is highly likely to be a portion cut from the lower membrane of the Waitangi Sheet because they share identical whole mitochondrial genomes, including an unusual hetero-plasmic site. We suggest that the differences in size and characteristics between the two pieces of parchment may have resulted from the Treaty's exposure to water in the early 20th century and the subsequent repair work, light exposure during exhibition or the later conservation treatments in the 1970s and 80s. The blank piece of parchment will be valuable for comparison tests to study the effects of earlier treatments and to monitor the effects of long-term display on the Treaty.	[Shepherd, Lara D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Whitehead, Peter] Alexander Turnbull Lib, Wellington, New Zealand; [Whitehead, Anna] Arch New Zealand Te Rua Mahara Kawanatanga, Wellington, New Zealand		Shepherd, LD (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.	lara.shepherd@tepapa.govt.nz		Shepherd, Lara/0000-0002-7136-0017	Rutherford Discovery Fellowship from the Royal Society of New Zealand [RDF-MNZ1201]	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand)	This study was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (contract number RDF-MNZ1201) to LDS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Cai DW, 2007, J ARCHAEOL SCI, V34, P1347, DOI 10.1016/j.jas.2006.10.020; Campana MG, 2010, J ARCHAEOL SCI, V37, P1317, DOI 10.1016/j.jas.2009.12.036; Fiddyment S, 2015, P NATL ACAD SCI USA, V112, P15066, DOI 10.1073/pnas.1512264112; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henderson ErnestF., 1910, SELECT HIST DOCUMENT; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Lech T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161591; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; ORANGE Claudia, 2011, TREATY WAITANGI; Pangallo D, 2010, J ARCHAEOL SCI, V37, P1202, DOI 10.1016/j.jas.2009.12.018; Peng MS, 2015, MOL ECOL RESOUR, V15, P1238, DOI 10.1111/1755-0998.12386; Rambaut A, 2009, TRACER V1 5; Shepherd LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183555; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; State Services Commission, 2005, JOURN TREATY; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Teasdale MD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0379; Teasdale MD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170988; Vai S, 2016, TOPICS CURR CHEM, V374, DOI 10.1007/s41061-015-0009-8	24	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210528	10.1371/journal.pone.0210528	http://dx.doi.org/10.1371/journal.pone.0210528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650155	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300059
J	Williams-Godwin, L; Brown, D; Livingston, R; Webb, T; Karriem, L; Graugnard, E; Estrada, D				Williams-Godwin, Lizandra; Brown, Dale; Livingston, Richard; Webb, Tyler; Karriem, Lynn; Graugnard, Elton; Estrada, David			Open-source automated chemical vapor deposition system for the production of two- dimensional nanomaterials	PLOS ONE			English	Article							ELECTRONICS; GROWTH	The study of two- dimensional (2D) materials is a rapidly growing area within nanomaterials research. However, the high equipment costs, which include the processing systems necessary for creating these materials, can be a barrier to entry for some researchers interested in studying these novel materials. Such process systems include those used for chemical vapor deposition, a preferred method for making these materials. To address this challenge, this article presents the first open-source design for an automated chemical vapor deposition system that can be built for less than a third of the cost for a comparable commercial system. The materials and directions for the system are divided by subsystems, which allows the system to be easily built, customized and upgraded, depending upon the needs of the user. We include the details for the specific hardware that will be needed, instructions for completing the build, and the software needed to automate the system. With a chemical vapor deposition system built as described, a variety of 2D nanomaterials and their heterostructures can be grown. Specifically, the experimental results clearly demonstrate the capability of this open-source design in producing high quality, 2D nanomaterials such as graphene and tungsten disulfide, which are at the forefront of research in emerging semi-conductor devices, sensors, and energy storage applications.	[Williams-Godwin, Lizandra; Brown, Dale; Webb, Tyler; Karriem, Lynn; Graugnard, Elton; Estrada, David] Boise State Univ, Micron Sch Mat Sci & Engn, Boise, ID 83725 USA; [Livingston, Richard] Boise State Univ, Dept Mech & Biomed Engn, Boise, ID 83725 USA; [Estrada, David] Boise State Univ, Ctr Adv Energy Studies, Boise, ID 83725 USA	Idaho; Boise State University; Idaho; Boise State University; Idaho; Boise State University	Estrada, D (corresponding author), Boise State Univ, Micron Sch Mat Sci & Engn, Boise, ID 83725 USA.; Estrada, D (corresponding author), Boise State Univ, Ctr Adv Energy Studies, Boise, ID 83725 USA.	daveestrada@boisestate.edu		Graugnard, Elton/0000-0002-0497-9821; Livingston, Richard/0000-0001-5059-8731; Estrada, David/0000-0001-5894-0773; Godwin, Lizandra/0000-0002-0898-8338; Webb, Tyler/0000-0001-6625-4140	Micron School of Materials Science and Engineering at Boise State University; Idaho Space Grant Consortium; Nuclear Regulatory Commission	Micron School of Materials Science and Engineering at Boise State University; Idaho Space Grant Consortium; Nuclear Regulatory Commission	This work was funded through startup funds provided by the Micron School of Materials Science and Engineering at Boise State University and a gift from the Micron Foundation, http://coen.boisestate.edu/mse/.D.B.acknowledges additional support through fellowships provided by the Idaho Space Grant Consortium and the Nuclear Regulatory Commission, https://www.idahospacegrant.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported through startup funds provided by the Micron School of Materials Science and Engineering at Boise State University and a gift from the Micron Foundation. D.B. acknowledges additional support through fellowships provided by the Idaho Space Grant Consortium and the Nuclear Regulatory Commission. The authors would also like to acknowledge Corey Efaw and Mike Hurley of the Applied Electrochemistry and Corrosion research lab for their assistance with the electrochemical transfer of graphene films. Atomic force micrographs were obtained through the Boise State University Surface Science Laboratory.	Berkdemir A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01755; Brown D D, 2015, THESIS; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Campbell S.A., 1996, SCI ENG MICROELECTRO; Cong WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09361; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Deek FP, 2008, OPEN SOURCE: TECHNOLOGY AND POLICY, P1; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Fiori G, 2014, NAT NANOTECHNOL, V9, P768, DOI [10.1038/nnano.2014.207, 10.1038/NNANO.2014.207]; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; He G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11647-6; Henck H, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.155421; Koski KJ, 2013, ACS NANO, V7, P3739, DOI 10.1021/nn4022422; Krueger E, 2016, ACS BIOMATER SCI ENG, V2, P1234, DOI 10.1021/acsbiomaterials.6b00139; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Rosenegger DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110475; Salehi-Khojin A, 2012, ADV MATER, V24, P53, DOI 10.1002/adma.201102663; Shi YM, 2015, MRS BULL, V40, P566, DOI 10.1557/mrs.2015.121; Tan CL, 2017, CHEM REV, V117, P6225, DOI 10.1021/acs.chemrev.6b00558; Vogel EM, 2015, MRS BULL, V40, P558, DOI 10.1557/mrs.2015.120; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang SS, 2015, ACS NANO, V9, P5246, DOI 10.1021/acsnano.5b00655; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Wittbrodt BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134989; Wu MX, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606039; Yocham KM, 2018, ADV ENG MATER, V20, DOI 10.1002/adem.201800166; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840; Zhang Y, 2013, ACS NANO, V7, P8963, DOI 10.1021/nn403454e	30	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210817	10.1371/journal.pone.0210817	http://dx.doi.org/10.1371/journal.pone.0210817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650151	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300079
J	Hwang, JK; Gwag, HB; Park, KM; On, YK; Kim, JS; Park, SJ				Hwang, Jin Kyung; Gwag, Hye Bin; Park, Kyoung-min; On, Young Keun; Kim, June Soo; Park, Seung-Jung			Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response	PLOS ONE			English	Article							PACED HEART-RATE; FAILURE; MORTALITY; INCREASE; RHYTHM	It remains unclear as to whether cardiac resynchronization therapy (CRT) would be as effective in patients with atrial fibrillation (AF) accompanied by slow ventricular response (AFSVR, < 60 beats/min) as in those with sinus rhythm (SR). Echocardiographic reverse remodeling was compared between AF-SVR patients (n = 17) and those with SR (n = 88) at six months and 12 months after CRT treatment. We also evaluated the changes in QRS duration; New York Heart Association (NYHA) functional class; and long-term composite clinical outcomes including cardiac death, heart transplantation, and heart failure (HF)-related hospitalization. Left ventricular pacing sites and biventricular pacing percentages were not significantly different between the AF-SVR and SR groups. However, heart rate increase after CRT was significantly greater in the AF-SVR group than in the SR group (P < 0.001). At six and 12 months postoperation, both groups showed a comparable improvement in NYHA class; QRS narrowing; and echocardiographic variables including left ventricular end-systolic volume, left ventricular ejection fraction, and left atrial volume index. Over the median follow-up duration of 1.6 (interquartile range: 0.8-2.2) years, no significant between-group differences were observed regarding the rates of long-term composite clinical events (35% versus 24%; hazard ratio: 1.71; 95% confidence interval: 0.23-12.48; P = 0.60). CRT implantation provided comparable beneficial effects for patients with AF-SVR as compared with those with SR, by correcting electrical dyssynchrony and increasing biventricular pacing rate, in terms of QRS narrowing, symptom improvement, ventricular reverse remodeling, and long-term clinical outcomes.	[Hwang, Jin Kyung] Vet Hlth Serv Med Ctr, Div Cardiol, Dept Med, Seoul, South Korea; [Gwag, Hye Bin; Park, Kyoung-min; On, Young Keun; Kim, June Soo; Park, Seung-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea	Veterans Health Service Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.	orthovics@skku.edu		Park, Seung-Jung/0000-0003-3288-0594				Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Delnoy PPHM, 2007, AM J CARDIOL, V99, P1252, DOI 10.1016/j.amjcard.2006.12.040; Gasparini M, 2006, J AM COLL CARDIOL, V48, P734, DOI 10.1016/j.jacc.2006.03.056; Gasparini M, 2013, JACC-HEART FAIL, V1, P500, DOI 10.1016/j.jchf.2013.06.003; Gwag HB, 2017, YONSEI MED J, V58, P703, DOI 10.3349/ymj.2017.58.4.703; Jeon DS, 2017, KOREAN CIRC J, V47, P523, DOI 10.4070/kcj.2016.0361; Khand AU, 2000, EUR HEART J, V21, P614, DOI 10.1053/euhj.1999.1767; Lim K, 2017, KOREAN CIRC J, V47, P132, DOI 10.4070/kcj.2016.0176; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; MUKHARJI J, 1990, CLIN CARDIOL, V13, P639, DOI 10.1002/clc.4960130910; NISHIMURA RA, 1995, J AM COLL CARDIOL, V25, P281, DOI 10.1016/0735-1097(94)00419-Q; Stahlberg M, 2015, EUROPACE, V17, P439, DOI 10.1093/europace/euu289; Stahlberg M, 2011, EUROPACE, V13, P237, DOI 10.1093/europace/euq354; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wilton SB, 2011, HEART RHYTHM, V8, P1088, DOI 10.1016/j.hrthm.2011.02.014	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210603	10.1371/journal.pone.0210603	http://dx.doi.org/10.1371/journal.pone.0210603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633768	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100031
J	Cheng, G; Zhou, SH; Zhang, J; Huang, XY; Bai, XJ; Xie, TL; Guo, RR; Liu, JB; Yu, H; Xie, LJ				Cheng, Guo; Zhou, Sihong; Zhang, Jin; Huang, Xiaoyun; Bai, Xianjin; Xie, Taili; Guo, Rongrong; Liu, Jinbiao; Yu, Huan; Xie, Linjun			Comparison of transcriptional expression patterns of phenols and carotenoids in 'Kyoho' grapes under a two-crop-a-year cultivation system	PLOS ONE			English	Article							CABERNET-SAUVIGNON GRAPES; VITIS-VINIFERA; BERRY SKIN; BIOSYNTHESIS; L.; ANTHOCYANINS; ACCUMULATION; PARAMETERS; IMPACTS; CLIMATE	To fully utilize the characteristic climatic conditions in the southern region of China, a two-crop-a-year cultivation system technique for 'Kyoho' grape was developed during the past decade. After summer harvest in June, appropriate pruning and chemical treatments promote flowering and fruiting, which enables a second harvest in late December. Due to climatic differences between the two crop growing seasons, grape phenol and carotenoid metabolism differ greatly. The reported study analyzed the transcriptome of the carotenoid and phenylpropanoid/flavonoid pathways in grapes at four different stages during the two growing seasons. Compared with those in summer grapes, expression levels of the majority of genes involved in the carotenoid metabolic pathway in winter grapes were generally upregulated. This result was associated with lower rainfall and much more abundant sunlight during the second growing season. On the other hand, summer cropping strongly triggered the expression of upstream genes in the phenylpropanoid/flavonoid pathway at E-L33 and E-L35. Transcript levels of flavonoid 3',5'-hydroxylase (F3'5'H), flavonoid 3'-hydroxylase (F3'H), flavonoid 3-hydroxylase (F3H) and glutathione S-transferase (GST) were upregulated in winter grapes at the mature stage. Together, these results might indicate that more flavonoids would be synthesized in ripe winter grapes during the mature stage of the second crop under much drier conditions, longer sunlight hours and lower temperature. These data provide a theoretical foundation for the secondary metabolism of berries grown under two-crop-a-year cultivation systems.	[Cheng, Guo; Zhou, Sihong; Zhang, Jin; Huang, Xiaoyun; Bai, Xianjin; Xie, Taili; Guo, Rongrong; Liu, Jinbiao; Yu, Huan; Xie, Linjun] Guangxi Acad Agr Sci, Grape & Wine Res Inst, Nanning, Guangxi, Peoples R China; [Zhou, Sihong] Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning, Peoples R China	Guangxi Academy of Agricultural Sciences	Zhou, SH; Xie, TL (corresponding author), Guangxi Acad Agr Sci, Grape & Wine Res Inst, Nanning, Guangxi, Peoples R China.; Zhou, SH (corresponding author), Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning, Peoples R China.	bear824@126.com; xietaili@gxaas.net			Basal Research Fund of Guangxi Academy of Agricultural Sciences [2015YT82, 2015YT85]; Natural Science Foundation of Guangxi [2017GXNSFBA198156]; Guinongke Grant [2015YT82, 2015YT85, 2017GXNSFBA198156]	Basal Research Fund of Guangxi Academy of Agricultural Sciences; Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Guinongke Grant	This work was supported by the Basal Research Fund of Guangxi Academy of Agricultural Sciences (Guinongke Grant Nos. 2015YT82 and 2015YT85), and the Natural Science Foundation of Guangxi (Grant No. 2017GXNSFBA198156). Guinongke Grant Nos. 2015YT82 and 2015YT85 have roles in data collection and analysis; Grant No. 2017GXNSFBA198156 has a role in the study design and preparation of the manuscript.	Bai XianJin, 2008, Southwest China Journal of Agricultural Sciences, V21, P953; Bai XJ, 2015, S CHINA FRUITS, V45, P167; Balic I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190087; Bindon KA, 2007, J AGR FOOD CHEM, V55, P4493, DOI 10.1021/jf063331p; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Brantley P. M., 2013, MOL BIOL BIOCH FRUIT, P76; Cao XiongJun, 2014, Southwest China Journal of Agricultural Sciences, V27, P1228; Carvalho LC, 2011, MOL PLANT, V4, P1038, DOI 10.1093/mp/ssr027; Carvalho LJCB, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0826-0; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen WK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01912; Chen WK, 2017, J PLANT PHYSIOL, V213, P75, DOI 10.1016/j.jplph.2017.03.001; Cheng Guo, 2017, Journal of Fruit Science, V34, P1125; Cheng G, 2014, MOLECULES, V19, P13683, DOI 10.3390/molecules190913683; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Crupi P, 2010, J AGR FOOD CHEM, V58, P9647, DOI 10.1021/jf100564v; de Rosas I, 2017, PLANT SCI, V258, P137, DOI 10.1016/j.plantsci.2017.01.015; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Dunlevy J. D., 2009, GRAPEVINE MOL PHYSL, P293, DOI DOI 10.1007/978-90-481-2305-6_11; Fraga H, 2012, FOOD ENERGY SECUR, V1, P94, DOI 10.1002/fes3.14; Goto-Yamamoto N, 2009, J INT SCI VIGNE VIN, P75; Guan L, 2016, PLANTA, V243, P23, DOI 10.1007/s00425-015-2391-4; Jeandet P, 1995, INT J BIOCHEM CELL B, V26, P165; Li Q, 2014, PLANT PHYSIOL BIOCH, V84, P45, DOI 10.1016/j.plaphy.2014.08.026; Liang ZC, 2008, FOOD CHEM, V111, P837, DOI 10.1016/j.foodchem.2008.04.069; Liu XM, 2016, SINOOVERSEAS GRAPEVI, V05, P131; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; Montealegre RR, 2006, J FOOD COMPOS ANAL, V19, P687, DOI 10.1016/j.jfca.2005.05.003; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Oliveira C, 2004, J AGR FOOD CHEM, V52, P4178, DOI 10.1021/jf0498766; Pan QH, 2009, PLANT SCI, V176, P360, DOI 10.1016/j.plantsci.2008.12.004; Poni S, 2009, AUST J GRAPE WINE R, V15, P185, DOI 10.1111/j.1755-0238.2008.00044.x; Savoi S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0760-1; Storchi P, 2005, ACTA HORTIC, P333, DOI 10.17660/ActaHortic.2005.689.39; Sun LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-257; Sun RZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00547; Sun RZ, 2015, J PLANT PHYSIOL, V178, P43, DOI 10.1016/j.jplph.2015.01.012; Waffo-Teguo P., 2008, P25, DOI 10.1007/978-3-540-74603-4_2; Wang B, 2012, SCI HORTIC-AMSTERDAM, V137, P20, DOI 10.1016/j.scienta.2011.10.006; Xu CM, 2011, J AGR FOOD CHEM, V59, P1078, DOI 10.1021/jf104157z; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zhou YM, 2015, SO HORTIC, V26, P22	45	4	4	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210322	10.1371/journal.pone.0210322	http://dx.doi.org/10.1371/journal.pone.0210322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629640	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000074
J	Toro-Sazo, M; Brea, J; Loza, MI; Cimadevila, M; Cassels, BK				Toro-Sazo, Miguel; Brea, Jose; Loza, Maria I.; Cimadevila, Marta; Cassels, Bruce K.			5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines	PLOS ONE			English	Article							INTERACTION PROFILES; STRUCTURAL BASIS; SEROTONIN; AGONISTS; DERIVATIVES; PHENETHYLAMINES; LORCASERIN; EFFICACY; SERIES	The last fifteen years have seen the emergence and overflow into the drug scene of "super-potent" N-benzylated phenethylamines belonging to the "NBOMe" series, accompanied by numerous research articles. Although N-benzyl substitution of 5-methoxytryptamine is known to increase its affinity and potency at 5-HT2 receptors associated with psychedelic activity, N-benzylated tryptamines have been studied much less than their phenethylamine analogs. To further our knowledge of the activity of N-benzyltryptamines, we have synthesized a family of tryptamine derivatives and, for comparison, a few 5-methoxytryptamine analogs with many different substitution patterns on the benzyl moiety, and subjected them to in vitro affinity and functional activity assays vs. the human 5-HT2 receptor subtypes. In the binding (radioligand displacement) studies some of these compounds exhibited only modest selectivity for either 5-HT2A or 5-HT2C receptors suggesting that a few of them, with affinities in the 10-100 nanomolar range for 5-HT2A receptors, might presumably be psychedelic. Unexpectedly, their functional (calcium mobilization) assays reflected very different trends. All of these compounds proved to be 5-HT2C receptor full agonists while most of them showed low efficacy at the 5-HT2A subtype. Furthermore, several showed moderateto-strong preferences for activation of the 5-HT2C subtype at nanomolar concentrations. Thus, although some N-benzyltryptamines might be abuse-liable, others might represent new leads for the development of therapeutics for weight loss, erectile dysfunction, drug abuse, or schizophrenia.	[Toro-Sazo, Miguel; Cassels, Bruce K.] Univ Chile, Fac Sci, Dept Chem, Santiago, Chile; [Brea, Jose; Loza, Maria I.; Cimadevila, Marta] Univ Santiago De Compostela, CIMUS, BioFarma Res Grp, Santiago De Compostela, Spain	Universidad de Chile; Universidade de Santiago de Compostela	Cassels, BK (corresponding author), Univ Chile, Fac Sci, Dept Chem, Santiago, Chile.	bcassels@uchile.cl	Brea, Jose/ABH-3260-2020; Cassels Niven, Bruce Kennedy/H-6937-2013	Loza Garcia, Maria Isabel/0000-0003-4730-0863; Cassels Niven, Bruce Kennedy/0000-0002-0082-0661; Cimadevila, Marta/0000-0002-5090-8311; Brea, Jose/0000-0002-5523-1979	FONDECYT (Chile) [1110146, 1150868]; CONICYT [21140358]	FONDECYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT (Chile) regular research grants 1110146 and 1150868 to BKC and CONICYT doctoral grant 21140358 to MT-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Castillo C, 2002, BRIT J PHARMACOL, V136, P510, DOI 10.1038/sj.bjp.0704747; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Eshleman AJ, 2018, BIOCHEM PHARMACOL, V158, P27, DOI 10.1016/j.bcp.2018.09.024; Garcia-Carceles J, 2017, J MED CHEM, V60, P9575, DOI 10.1021/acs.jmedchem.7b00994; Glennon RA, J MED CHEM; Halberstadt AL, 2017, CURR TOP BEHAV NEURO, V32, P283, DOI 10.1007/7854_2016_64; Hansen M, 2015, BIOORGAN MED CHEM, V23, P3933, DOI 10.1016/j.bmc.2014.12.011; Hansen M, 2014, ACS CHEM NEUROSCI, V5, P243, DOI 10.1021/cn400216u; Heim R., 2003, THESIS; Higgins GA, 2015, ACS CHEM NEUROSCI, V6, P1071, DOI 10.1021/acschemneuro.5b00025; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hutcheson JD, 2011, PHARMACOL THERAPEUT, V132, P146, DOI 10.1016/j.pharmthera.2011.03.008; Jensen N., 2004, THESIS; Juncosa JI, 2013, ACS CHEM NEUROSCI, V4, P96, DOI 10.1021/cn3000668; Luethi D, 2018, INT J NEUROPSYCHOPH, V21, P926, DOI 10.1093/ijnp/pyy047; Marti-Solano M, 2015, MOL PHARMACOL, V87, P740, DOI 10.1124/mol.114.097022; Moya PR, 2007, J PHARMACOL EXP THER, V321, P1054, DOI 10.1124/jpet.106.117507; Nichols DE, 2016, PHARMACOL REV, V68, P264, DOI 10.1124/pr.115.011478; Nichols DE, 2015, ACS CHEM NEUROSCI, V6, P1165, DOI 10.1021/cn500292d; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Pogorelov VM, 2017, NEUROPSYCHOPHARMACOL, V42, P2163, DOI 10.1038/npp.2017.52; Preller KH, 2017, CURR BIOL, V27, P451, DOI 10.1016/j.cub.2016.12.030; Rickli A, 2016, EUR NEUROPSYCHOPHARM, V26, P1327, DOI 10.1016/j.euroneuro.2016.05.001; Rickli A, 2015, NEUROPHARMACOLOGY, V99, P546, DOI 10.1016/j.neuropharm.2015.08.034; Roth BL, 1997, J PHARMACOL EXP THER, V280, P576; Shimada I, 2008, BIOORGAN MED CHEM, V16, P3309, DOI 10.1016/j.bmc.2007.12.009; Silva ME, 2011, J COMPUT AID MOL DES, V25, P51, DOI 10.1007/s10822-010-9400-2; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Tan L, 2018, J MED CHEM, V61, P9841, DOI 10.1021/acs.jmedchem.8b00435; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Tirapegui C, 2014, J CHIL CHEM SOC, V59, P2625, DOI 10.4067/S0717-97072014000300022; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807	34	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209804	10.1371/journal.pone.0209804	http://dx.doi.org/10.1371/journal.pone.0209804			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629611	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000033
J	da Silva, DA; Tsai, SM; Chiorato, AF; Andrade, SCD; Esteves, JAD; Recchia, GH; Carbonell, SAM				da Silva, Daiana Alves; Tsai, Siu Mui; Chiorato, Alisson Fernando; da Silva Andrade, Sonia Cristina; de Fatima Esteves, Jose Antonio; Recchia, Gustavo Henrique; Morais Carbonell, Sergio Augusto			Analysis of the common bean (Phaseolus vulgaris L.) transcriptome regarding efficiency of phosphorus use	PLOS ONE			English	Article							PHOSPHATE STARVATION; ALIGNMENT; PLANT	Common bean is a highly important food in tropical regions, where most production occurs on small farms with limited use of technology and, consequently, greater vulnerability to abiotic stresses such as nutritional stress. Usually phosphorus (P) is the most limiting nutrient for crop growth in these regions. The aim of this study was to characterize the gene expression profiles of the genotypes of common bean IAC Imperador (P-responsive) and DOR 364 (P-unresponsive) under different P concentrations using RNA-seq transcriptome sequencing technology. Plants were grown hydroponically, with application of two P concentrations (4.00 mg L-1 restrictive level and 8.00 mg L-1 control level). Differential expression analyses, annotation, and functional classification were performed comparing genotypes within each P rate administered and comparing each genotype response to the different P levels. Considering differential expression analyses within genotypes, IAC Imperador exhibited 1538 up-regulated genes under P restriction and 1679 up-regulated genes in the control, while DOR 364 exhibited 13 up-regulated genes in the control and only 2 up-regulated genes under P restriction, strongly corroborating P-unresponsiveness of this genotype. Genes related to phosphorus restriction were identified among the differentially expressed genes, including transcription factors such as WRKY, ERF, and MYB families, phosphatase related genes such as pyrophosphatase, acid phosphatase, and purple acid phosphatase, and phosphate transporters. The enrichment test for the P restriction treatment showed 123 enriched gene ontologies (GO) for IAC Imperador, while DOR 364 enriched only 24. Also, the enriched GO correlated with P metabolism, compound metabolic processes containing phosphate, nucleoside phosphate binding, phosphorylation, and also response to stresses. Thus, this study proved to be informative to phosphorus limitation in common bean showing global changes at transcript level.	[da Silva, Daiana Alves; Chiorato, Alisson Fernando; de Fatima Esteves, Jose Antonio; Morais Carbonell, Sergio Augusto] Ctr Graos & Fibras, Inst Agron IAC, Campinas, SP, Brazil; [Tsai, Siu Mui; Recchia, Gustavo Henrique] Ctr Energia Nucl Agr CENA, Av Centenario, Piracicaba, SP, Brazil; [da Silva Andrade, Sonia Cristina] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao, Sao Paulo, SP, Brazil	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo	da Silva, DA (corresponding author), Ctr Graos & Fibras, Inst Agron IAC, Campinas, SP, Brazil.	daiagrouel2002@hotmail.com	Tsai, Siu Mui/C-2793-2012; Andrade, Sonia/GLS-1234-2022; Andrade, Sonia CS/F-8267-2014; Recchia, Gustavo Henrique/F-6162-2016	Tsai, Siu Mui/0000-0002-3733-6312; Andrade, Sonia/0000-0002-1302-5261; Andrade, Sonia CS/0000-0002-1302-5261; Recchia, Gustavo Henrique/0000-0002-5054-9806	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1992, MAXIMIZING CROP YIEL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Da Silva DA, 2014, SCI AGR, V71, P232, DOI 10.1590/S0103-90162014000300008; Dalla Via V, 2015, PLANT PHYSIOL, V169, P1356, DOI 10.1104/pp.15.00508; FAGERIA NK, 2015, PHOSPHORUS NUTR UPLA, V46, P9, DOI DOI 10.1080/00103624.2015.1018526; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George Timothy S., 2008, V7, P247; Glass K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04191; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Hernandez-Domiguez EE, 2012, PLANT SCI, V187, P39, DOI 10.1016/j.plantsci.2012.01.009; Hiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092598; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liang C, 2012, PLOS ONE, V7, P5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch Jonathan P., 2008, V7, P83; Malavolta E., 1989, Avaliacao de estado nutricional das plantas: principios e aplicacoes., ppp; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Moura WM, 1999, GENTICA LINHAGENS C, V34, P2, DOI [10.11.1/002832, DOI 10.1101/002832]; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Patel SS, 2014, LEGUME GENOMICS GENE, V5, P1, DOI DOI 10.5376/LGG.2014.05.0007; Poirier Y, 2015, ANN PLANT REV, V48, DOI [10.1002/978118958841.ch5, DOI 10.1002/978118958841.CH5]; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramirez M, 2013, INT J MOL SCI, V14, P8328, DOI 10.3390/ijms14048328; Scheible WR, 2015, ANNU PLANT REV, V48, P25, DOI 10.1002/9781118958841.ch2; SIDDIQI MY, 1981, J PLANT NUTR, V4, P289, DOI 10.1080/01904168109362919; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tryphone G.M, 2012, INT SCHOLARLY RES NE, V2012, P1, DOI DOI 10.5402/2012/309614; Westermann DT, 2011, CAN J PLANT SCI, V91, P1089, DOI [10.4141/cjps10114, 10.4141/CJPS10114]; White Philip J., 2008, V7, P51; Zhang DH, 2014, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE AND ENGINEERING (ACSE 2014), P1, DOI 10.1109/JSYST.2014.2346625	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210428	10.1371/journal.pone.0210428	http://dx.doi.org/10.1371/journal.pone.0210428			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657755	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000010
J	Winking, J; Hopkins, AL; Yeoman, M; Arcak, C				Winking, Jeffrey; Hopkins, Allison L.; Yeoman, Michelle; Arcak, Cory			M-AAA-nsplaining: Gender bias in questions asked at the American Anthropological Association's Annual Meetings	PLOS ONE			English	Article							WOMEN	A large body of research has revealed the challenges that disproportionately affect women as they climb the academic ladder. One area that has received relatively little attention is women's experiences at academic conferences, which are often integral to academics' professional development. As conferences are attended by professional colleagues and influential players in specific fields, the professional consequences of any gender bias in criticism are likely to be amplified at such venues. Here, we explore the degree to which the likelihood of audience members asking a question and offering criticism is associated with the gender of a presenter. Audience questions were tabulated during the authors' visits to the three American Anthropological Association Annual Meetings. The results suggested that men were indeed marginally more likely to ask a question, both when considering all types of questions and when considering only critical questions. However, there was no evidence that they differentially targeted women for these questions. Future research might explore what motivates assertive and critical speech in men and women and how their experiences in receiving it might differ, particularly in academic settings in which critical speech might be considered more acceptable.	[Winking, Jeffrey; Hopkins, Allison L.; Yeoman, Michelle] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Yeoman, Michelle] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Arcak, Cory] Texas A&M Univ, MSC LT Jordan Inst Int Awareness, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Winking, J (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	jwinking@tamu.edu		Winking, Jeffrey/0000-0002-2298-3680	Diversity Matters Seed Grant; University Libraries; Office of the Vice President for Research	Diversity Matters Seed Grant; University Libraries; Office of the Vice President for Research	This research was funded by the Diversity Matters Seed Grant administered by the Texas A&M University Office of Diversity. The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STAT MED R; American Anthropological Association, 2013, 2013 ANN REP FUT PUB; Anderson KJ, 1998, SEX ROLES, V39, P225, DOI 10.1023/A:1018802521676; Aries E., 1997, WOMEN MEN GENDER ONG, P91; Cameron Deborah, 2008, MYTH MARS VENUS DO M; Dowdall C., 2014, GRADUATES 2012 REPOR; Dubois Betty L., 1975, LANG SOC, V4, P289, DOI DOI 10.1017/S0047404500006680; El Emam K., 1999, Empirical Software Engineering, V4, P113, DOI 10.1023/A:1009820201126; Ginsberg D, 2016, 1 AM ANTHR ASS; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Hochschild A., 2012, 2 SHIFT WORKING FAMI; Hopkins AL, 2013, SCIENTOMETRICS, V96, P515, DOI 10.1007/s11192-012-0893-4; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682; James D, 1993, UNDERSTANDING GENDER; Jesperson Otto, 1922, LANGUAGE ITS NATURE; Jones TM, 2014, PEERJ, V2, DOI 10.7717/peerj.627; Karpowitz CF, 2012, AM POLIT SCI REV, V106, P533, DOI 10.1017/S0003055412000329; Lakoff Robin, 1975, LANGUAGE WOMANS PLAC; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leaper C, 2007, PERS SOC PSYCHOL REV, V11, P328, DOI 10.1177/1088868307302221; MacNell L, 2015, INNOV HIGH EDUC, V40, P291, DOI 10.1007/s10755-014-9313-4; McElhinny B., 2003, HDB LANGUAGE GENDER, P21; MCMILLAN JR, 1977, SEX ROLES, V3, P545, DOI 10.1007/BF00287838; Monroe K, 2008, PERSPECT POLIT, V6, P215, DOI 10.1017/S1537592708080572; Pell AN, 1996, J ANIM SCI, V74, P2843; Reeves A., 2015, NEXTIONS YELLOW PAPE; Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198; Settles IH, 2014, SEX ROLES, V71, P71, DOI 10.1007/s11199-014-0355-y; Shen H., 2015, NATURE NEWS; Solnit Rebecca, 2014, MEN EXPLAIN THINGS M; Tannen Deborah, 1991, YOU JUST DONT UNDERS; Valian V., 2005, HYPATIA, V20, P198, DOI DOI 10.1111/J.1527-2001.2005.TB00495.X; WASSON C, 2008, WEVE COME LONG WAY M; Weatherall Ann, 2002, GENDER LANGUAGE DISC; Young L. J., 2003, NEURAL BASIS PAIR BO	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0207691	10.1371/journal.pone.0207691	http://dx.doi.org/10.1371/journal.pone.0207691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657759	Green Submitted, gold, Green Published			2022-12-27	WOS:000456017000003
J	Jiang, LB; Tian, XX; Peng, DZ; Zhang, LR; Xie, FX; Bi, CR; Wang, R; Wang, JJ; Qi, DB				Jiang, Lingbo; Tian, Xinxin; Peng, Dezhi; Zhang, Liran; Xie, Fengxiang; Bi, Chunrui; Wang, Rui; Wang, Jiajia; Qi, Debo			HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS PREVALENCE; INVASIVE CERVICAL-CANCER; INTRAEPITHELIAL NEOPLASIA; CONSENSUS GUIDELINES; GLOBAL BURDEN; INFECTION; RISK; DNA; PERFORMANCE; MANAGEMENT	Background Data regarding human papillomavirus (HPV) prevalence and genotype distribution are limited in Shandong Province, China. Therefore, we investigated the recent HPV prevalence and genotype distribution among females in Shandong and aimed to provide comprehensive data to guide HPV-based cervical cancer screening and HPV vaccination for this population of Chinese women. Methods HPV testing results of 94,489 females were retrospectively reviewed and extracted from the database of Jinan KingMed Diagnostics, the largest independent pathology laboratory in Shandong Province, China. HPV was detected by a HPV genotyping panel from January 2011 to June 2017. The overall prevalence, age-specific prevalence, and genotype distribution were analyzed. Results A total of 26,839 cases (28.4%) were HPV-positive, with 4.3% positive for low- or undetermined-risk HPV (lr-/urHPV)-only, 18.1% positive for high-risk HPV (hrHPV)-only, and 6.1% positive for mixed lr-/urHPV and hrHPV infections. Single HPV infections accounted for 62.8%, while the rest were multiple HPV infections of two or more genotypes. HPV16 (5.8%), HPV52 (5.1%), HPV58 (3.5%), HPV51 (2.6%), and HPV56 (2.3%) were the five most common hrHPV genotypes; while HPV81 (2.8%), HPV53 (2.8%), and HPV6 (2.3%) were the three most common lr-/urHPV genotypes. HPV18 (1.7%) was only the ninth most common hrHPV genotype. HPV16 but not HPV52 was more common in single infections than in multiple infections. The distribution of both mixed lr-/urHPV and hrHPV as well as overall HPV infections demonstrated a bimodal pattern across age groups, of which the first peak appeared in the younger group and the second peak was found in older women. A similar age-specific distribution was observed in multiple infections of three or more subtypes as well. Moreover, the proportion of mixed lr-/urHPV and hrHPV infection significantly increased, while those of lr-/urHPV-only and hrHPV-only infections declined as the number of co-infections increased during the study period. Conclusion This large daily clinical practice report shows that HPV prevalence and genotype distribution are different in this population, who had limited cervical cancer screening service, compared to those in developed countries. Therefore, different strategies should be developed for HPV-based cervical cancer screening and vaccine-based HPV prevention in Shandong Province.	[Jiang, Lingbo; Tian, Xinxin; Peng, Dezhi; Bi, Chunrui; Wang, Rui; Wang, Jiajia] Jinan KingMed Diagnost, Dept Lab Med, Jinan, Shandong, Peoples R China; [Zhang, Liran; Xie, Fengxiang; Qi, Debo] Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China		Qi, DB (corresponding author), Jinan KingMed Diagnost, Dept Pathol, Jinan, Shandong, Peoples R China.	bobo8369@163.com						Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bi QQ, 2015, J MED VIROL, V87, P2114, DOI 10.1002/jmv.24281; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chan PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107573; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Feldman S, 2011, NEW ENGL J MED, V365, P2145, DOI 10.1056/NEJMp1112532; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gonzalez P, 2010, CANCER EPIDEM BIOMAR, V19, P3044, DOI 10.1158/1055-9965.EPI-10-0645; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Jing LP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-388; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Lee SA, 2003, CANCER LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Li J, 2013, ASIAN PAC J CANCER P, V14, P4015, DOI 10.7314/APJCP.2013.14.7.4015; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Li YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118391; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schmitt M, 2013, J CLIN MICROBIOL, V51, P1458, DOI 10.1128/JCM.00087-13; Serrano B, 2014, CANCER EPIDEMIOL, V38, P748, DOI 10.1016/j.canep.2014.09.003; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Wang LQ, 2015, J MED VIROL, V87, P516, DOI 10.1002/jmv.24094; Wang R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0998-5; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Wu EQ, 2013, CANCER CAUSE CONTROL, V24, P795, DOI 10.1007/s10552-013-0162-8; Yang L, 2015, EUR J GYNAECOL ONCOL, V36, P73; Yuan XY, 2011, ARCH GYNECOL OBSTET, V283, P1385, DOI 10.1007/s00404-010-1584-0; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971; Zeng ZY, 2016, AM J CLIN PATHOL, V145, P622, DOI [10.1093/ajcp/aqw010, 10.1093/AJCP/AQW010]; Zhang L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2223-1; Zhang LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180618; Zhao FH, 2010, LANCET ONCOL, V11, P1160, DOI 10.1016/S1470-2045(10)70256-4; Zhu XX, 2015, J MED VIROL, V87, P2106, DOI 10.1002/jmv.24280	52	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210311	10.1371/journal.pone.0210311	http://dx.doi.org/10.1371/journal.pone.0210311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653566	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500033
J	Latek, D; Rutkowska, E; Niewieczerzal, S; Cielecka-Piontek, J				Latek, Dorota; Rutkowska, Ewelina; Niewieczerzal, Szymon; Cielecka-Piontek, Judyta			Drug-induced diabetes type 2: In silico study involving class B GPCRs	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; GUI MEMBRANE-BUILDER; GLP-1 RECEPTOR; CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; GLUCOSE; MELLITUS; RISK; DATABASE; INSULIN	A disturbance of glucose homeostasis leading to type 2 diabetes mellitus (T2DM) is one of the severe side effects that may occur during a prolonged use of many drugs currently available on the market. In this manuscript we describe the most common cases of drug-induced T2DM, discuss available pharmacotherapies and propose new ones. Among various pharmacotherapies of T2DM, incretin therapies have recently focused attention due to the newly determined crystal structure of incretin hormone receptor GLP1R. Incretin hormone receptors: GLP1R and GIPR together with the glucagon receptor GCGR regulate food intake and insulin and glucose secretion. Our study showed that incretin hormone receptors, named also gut hormone receptors as they are expressed in the gastrointestinal tract, could potentially act as unintended targets (off-targets) for orally administrated drugs. Such off-target interactions, depending on their effect on the receptor (stimulation or inhibition), could be beneficial, like in the case of incretin mimetics, or unwanted if they cause, e.g., decreased insulin secretion. In this in silico study we examined which well-known pharmaceuticals could potentially interact with gut hormone receptors in the off-target way. We observed that drugs with the strongest binding affinity for gut hormone receptors were also reported in the medical information resources as the least disturbing the glucose homeostasis among all drugs in their class. We suggested that those strongly binding molecules could potentially stimulate GIPR and GLP1R and/or inhibit GCGR which could lead to increased insulin secretion and decreased hepatic glucose production. Such positive effect on the glucose homeostasis could compensate for other, adverse effects of pharmacotherapy which lead to drug-induced T2DM. In addition, we also described several top hits as potential substitutes of peptidic incretin mimetics which were discovered in the drug repositioning screen using gut hormone receptors structures against the ZINC15 compounds subset.	[Latek, Dorota; Rutkowska, Ewelina; Niewieczerzal, Szymon] Univ Warsaw, Fac Chem, Warsaw, Poland; [Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Dept Pharmacognosy, Fac Pharm, Poznan, Poland	University of Warsaw; Poznan University of Medical Sciences	Latek, D (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	dlatek@chem.uw.edu.pl		Cielecka-Piontek, Judyta/0000-0003-0891-5419; Latek, Dorota/0000-0002-0429-0637	National Science Centre in Poland [DEC-2012/07/D/NZ1/04244]	National Science Centre in Poland(National Science Centre, Poland)	DL acknowledges National Science Centre in Poland (https://www.ncn.gov.pl) for financing (Grant No. DEC-2012/07/D/NZ1/04244) and Faculty of Chemistry (http://www.chem.uw.edu.pl), Biological and Chemical Research Centre (http://cnbch.uw.edu.pl) of University of Warsaw for providing the infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2017, P NATL ACAD SCI USA, V114, P1708, DOI 10.1073/pnas.1620645114; Aiman U, 2014, J PHARMACOL PHARMACO, V5, P181, DOI 10.4103/0976-500X.136097; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2015, SCHRODINGER RELEASE; Anyanwagu U, 2016, CLIN PHARMACOL THER, V99, P390, DOI 10.1002/cpt.274; Arumugam S, 2014, EXP MOL PATHOL, V97, P137, DOI 10.1016/j.yexmp.2014.06.007; Bell DSH, 2014, DIABETES OBES METAB, V16, P689, DOI 10.1111/dom.12254; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Blackburn DF, 2006, CAN J CARDIOL, V22, P229, DOI 10.1016/S0828-282X(06)70902-3; Boulin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162951; Bozkurt O, 2009, AM J HYPERTENS, V22, P545, DOI 10.1038/ajh.2009.38; Brown MJ, 2016, LANCET DIABETES ENDO, V4, P136, DOI 10.1016/S2213-8587(15)00377-0; BRUNO A, 1987, ARCH INTERN MED, V147, P679, DOI 10.1001/archinte.147.4.679; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chatterjee A, 2014, BIOORGAN MED CHEM, V22, P6409, DOI 10.1016/j.bmc.2014.09.043; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Cheng FX, 2013, J CHEM INF MODEL, V53, P744, DOI 10.1021/ci4000079; Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cooper-DeHoff RM, 2014, CIRCULATION CARDIOVA; Cordomi A, 2016, CURR OPIN PHARMACOL, V31, P63, DOI 10.1016/j.coph.2016.09.001; Cutler JA, 2006, HYPERTENSION, V48, P198, DOI 10.1161/01.HYP.0000231339.51310.b3; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/525093; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Esteva-Font C, 2015, NAT REV NEPHROL, V11, P113, DOI 10.1038/nrneph.2014.219; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Gerthoffer WT, 2013, CURR OPIN PHARMACOL, V13, P324, DOI 10.1016/j.coph.2013.04.002; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Glover M, 2011, CARDIOVASC THER, V29, P68, DOI 10.1111/j.1755-5922.2010.00180.x; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hirst JA, 2015, BRIT J CLIN PHARMACO, V79, P733, DOI 10.1111/bcp.12543; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hwang JL, 2014, DIABETES-METAB RES, V30, P96, DOI 10.1002/dmrr.2486; Imatoh T, 2017, J CLIN PHARM THER, V42, P215, DOI 10.1111/jcpt.12499; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Izzedine Hassane, 2005, Expert Opin Drug Saf, V4, P1097, DOI 10.1517/14740338.4.6.1097; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Ji YL, 2016, CANCER PREV RES, V9, P379, DOI 10.1158/1940-6207.CAPR-15-0300; Jiao MK, 2015, CURR TOP MED CHEM, V15, P767, DOI 10.2174/1568026615666150302105831; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kim D, 2016, BIOCHEM BIOPH RES CO, V469, P399, DOI 10.1016/j.bbrc.2015.11.095; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Konstantopoulos N, 2012, DIABETES, V61, P2146, DOI 10.2337/db11-0578; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Latek D, 2017, BMC STRUCT BIOL, V17, DOI 10.1186/s12900-017-0078-8; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Latek D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056742; Latek D, 2011, J MOL MODEL, V17, P2353, DOI 10.1007/s00894-011-0986-7; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li YY, 2012, GENOME MED, V4, DOI 10.1186/gm326; Lim VJY, 2018, PROTEINS, V86, P978, DOI 10.1002/prot.25533; Lohinai Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144797; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mandal AK, 2012, J DIABETES RES CLIN, V1, P4; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Manrique C, 2010, HYPERTENSION, V55, P15, DOI 10.1161/HYPERTENSIONAHA.109.142620; McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9; McLaughlin JT, 2016, CURR OPIN PHARMACOL, V31, P8, DOI 10.1016/j.coph.2016.08.006; Messerli FH, 2011, AM J MED, V124, P896, DOI 10.1016/j.amjmed.2011.05.009; Mills E, 2015, LONDON J PRIM CARE, V7, P103, DOI 10.1080/17571472.2015.1082344; Miszta P, 2018, NUCLEIC ACIDS RES, V46, pW387, DOI 10.1093/nar/gky429; Moran BM, 2016, CURR OPIN PHARMACOL, V31, P57, DOI 10.1016/j.coph.2016.08.009; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Okuyama H, 2016, PHARMACOLOGY, V98, P134, DOI 10.1159/000446704; OMOTE M, 1994, ARZNEIMITTELFORSCH, V44-1, P149; Ong KL, 2014, AM HEART J, V167, P421, DOI 10.1016/j.ahj.2013.12.025; Oprea Tudor I, 2011, Drug Discov Today Ther Strateg, V8, P61; Orgaard A, 2017, DIABETOLOGIA, V60, P1731, DOI 10.1007/s00125-017-4315-2; Paoletta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097858; Pasznik P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210705; Pearson MJ, 2016, DIABETES CARE, V39, P1075, DOI 10.2337/dci15-0033; Petrillo MG, 2017, FASEB J S, V31; Preiss D, 2012, EUR J HEART FAIL, V14, P909, DOI 10.1093/eurjhf/hfs067; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; Rajeev SP, 2016, CURR OPIN PHARMACOL, V31, P44, DOI 10.1016/j.coph.2016.08.005; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Rehman A, 2011, DIABETES SPECTR, V24, P234, DOI DOI 10.2337/DIASPECT.24.4.234; Roglic G., 2016, GLOBAL REPORT DIABET; Rognan D, 2017, PHARMACOL THERAPEUT, V175, P47, DOI 10.1016/j.pharmthera.2017.02.034; Sander GE, 2011, J CLIN HYPERTENS, V13, P296, DOI 10.1111/j.1751-7176.2011.00454.x; Sandhu K, 2017, WORLD J CARDIOL, V9, P1, DOI 10.4330/wjc.v9.i1.1; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Sica Doemnic A, 2004, J Clin Hypertens (Greenwich), V6, P532, DOI 10.1111/j.1524-6175.2004.03789.x; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Sowers JR, 2010, J HYPERTENS, V28, P1761, DOI 10.1097/HJH.0b013e32833af380; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Suh S, 2017, ENDOCRINOL METAB, V32, P180, DOI 10.3803/EnM.2017.32.2.180; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Thakker D, 2016, PHARMACOEPIDEM DR S, V25, P1131, DOI 10.1002/pds.4020; Thanawala VJ, 2014, CURR OPIN PHARMACOL, V16, P50, DOI 10.1016/j.coph.2014.03.002; Troke RC, 2014, THER ADV CHRONIC DIS, V5, P4, DOI 10.1177/2040622313506730; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Van den Driessche G, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0202-6; van der Goes MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4686; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Vue MH., 2011, DIABETES SPECTR, V24, P171, DOI DOI 10.2337/DIASPECT.24.3.171; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; WHEELER MB, 1993, ENDOCRINOLOGY, V133, P57, DOI 10.1210/en.133.1.57; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; YOON D, 2016, MEDICINE, V95; Yuan SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047114; ZHANG DQ, 2013, BIOMED RES INT, P36053, DOI DOI 10.1155/2013/; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang WW, 2013, CLIN DRUG INVEST, V33, P263, DOI 10.1007/s40261-013-0063-3; Zhang Y, 2002, DIABETES CARE, V25, P500, DOI 10.2337/diacare.25.3.500; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhou J, 2017, EUR J MED CHEM, V138, P1158, DOI 10.1016/j.ejmech.2017.07.046; Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b	129	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0208892	10.1371/journal.pone.0208892	http://dx.doi.org/10.1371/journal.pone.0208892			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650080	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300007
J	Nagaraju, M; Kumar, SA; Reddy, PS; Kumar, A; Rao, DM; Kishor, PBK				Nagaraju, M.; Kumar, S. Anil; Reddy, Palakolanu Sudhakar; Kumar, Anuj; Rao, D. Manohar; Kishor, P. B. Kavi			Genome-scale identification, classification, and tissue specific expression analysis of late embryogenesis abundant (LEA) genes under abiotic stress conditions in Sorghum bicolor L.	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PROTEIN GENE; WIDE IDENTIFICATION; DNA-BINDING; FUNCTIONAL-ANALYSIS; CITRUS DEHYDRIN; ABSCISIC-ACID; METAL-BINDING; FAMILY; TOLERANCE	Late embryogenesis abundant (LEA) proteins, the space fillers or molecular shields, are the hydrophilic protective proteins which play an important role during plant development and abiotic stress. The systematic survey and characterization revealed a total of 68 LEA genes, belonging to 8 families in Sorghum bicolor. The LEA-2, a typical hydrophobic family is the most abundant family. All of them are evenly distributed on all 10 chromosomes and chromosomes 1, 2, and 3 appear to be the hot spots. Majority of the S. bicolor LEA (SbLEA) genes are intron less or have fewer introns. A total of 22 paralogous events were observed and majority of them appear to be segmental duplications. Segmental duplication played an important role in SbLEA-2 family expansion. A total of 12 orthologs were observed with Arabidopsis and 13 with Oryza sativa. Majority of them are basic in nature, and targeted by chloroplast subcellular localization. Fifteen miRNAs targeted to 25 SbLEAs appear to participate in development, as well as in abiotic stress tolerance. Promoter analysis revealed the presence of abiotic stress-responsive DRE, MYB, MYC, and GT1, biotic stress-responsive W-Box, hormone-responsive ABA, ERE, and TGA, and development-responsive SKn cis-elements. This reveals that LEA proteins play a vital role during stress tolerance and developmental processes. Using microarray data, 65 SbLEA genes were analyzed in different tissues (roots, pith, rind, internode, shoot, and leaf) which show clear tissue specific expression. qRT-PCR analysis of 23 SbLEA genes revealed their abundant expression in various tissues like roots, stems and leaves. Higher expression was noticed in stems compared to roots and leaves. Majority of the SbLEA family members were up-regulated at least in one tissue under different stress conditions. The SbLEA3-2 is the regulator, which showed abundant expression under diverse stress conditions. Present study provides new insights into the formation of LEAs in S. bicolor and to understand their role in developmental processes under stress conditions, which may be a valuable source for future research.	[Nagaraju, M.; Rao, D. Manohar; Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad, India; [Kumar, S. Anil] Vignans Fdn Sci Technol & Res, Dept Biotechnol, Guntur, Andhra Pradesh, India; [Reddy, Palakolanu Sudhakar] Int Crops Res Inst Semi Arid Trop, Hyderabad, India; [Kumar, Anuj] Uttarakhand Council Biotechnol, Adv Ctr Computat & Appl Biotechnol, Silk Pk, Dehra Dun, Uttar Pradesh, India	Osmania University; Vignan's Foundation for Science, Technology & Research (VFSTR); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Kishor, PBK (corresponding author), Osmania Univ, Dept Genet, Hyderabad, India.	pbkavi@yahoo.com	Kumar, Anuj/AAE-8773-2021; MARKA, NAGARAJU/Y-7001-2019; Kumar, Anuj/J-7067-2019	Kumar, Anuj/0000-0002-5023-7618; Marka, Nagaraju/0000-0002-9170-8543; Kavi Kishor, Polavarapu/0000-0002-9587-7547	UGC, New Delhi; CSIR, New Delhi	UGC, New Delhi(University Grants Commission, India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	MN is thankful to the UGC, New Delhi, for providing fellowship. PBK is thankful to the CSIR, New Delhi, for providing CSIR-Emeritus Scientist Fellowship.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Almodares A, 2008, AFR J BIOTECHNOL, V7, P4051; Almodares A., 2008, Research Journal of Environmental Sciences, V2, P298; Alsheikh MK, 2003, J BIOL CHEM, V278, P40882, DOI 10.1074/jbc.M307151200; Altunoglu YC, 2017, PHYSIOL MOL BIOL PLA, V23, P5, DOI 10.1007/s12298-016-0405-8; Altunoglu YC, 2016, PLANT GROWTH REGUL, V80, P225, DOI 10.1007/s10725-016-0160-4; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chen YZ, 2014, J INTEGR PLANT BIOL, V56, P133, DOI 10.1111/jipb.12127; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Eriksson SK, 2011, DEHYDRINS MOL BIOL S; ESPELUND M, 1992, PLANT J, V2, P241; Filiz E, 2013, PLANT OMICS, V6, P433; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gai YP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010363; Gao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19467; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2009, PLANT CELL ENVIRON, V32, P532, DOI 10.1111/j.1365-3040.2009.01947.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165953; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kamisugi Y, 2005, PLANT MOL BIOL, V59, P723, DOI 10.1007/s11103-005-0909-z; Katiyar A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00506; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Li Le, 2011, Scientia Agricultura Sinica, V44, P3945; Li X, 2016, PLANT MOL BIOL REP, V34, P15, DOI 10.1007/s11105-015-0901-y; Liang Y., 2016, SCI REP UK, V6; Lin CH, 2012, PLANT CELL PHYSIOL, V53, P930, DOI 10.1093/pcp/pcs040; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu HJ, 2015, MOL PLANT, V8, P871, DOI 10.1016/j.molp.2015.01.016; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Magwanga RO, 2018, BMC GENET, V19, DOI 10.1186/s12863-017-0596-1; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nagaraju M, 2018, PLANT GENE, V13, P64, DOI DOI 10.1016/J.PLGENE.2018.01.004; Nekrutenko A, 2003, GENE, V306, P99, DOI 10.1016/S0378-1119(03)00427-X; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Opitz N, 2016, J EXP BOT, V67, P1095, DOI 10.1093/jxb/erv453; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Pedrosa AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145785; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Promkhambut A., 2010, Asian Journal of Plant Sciences, V9, P183; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Salih H, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0436-8; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Steduto P, 1997, FIELD CROP RES, V54, P221, DOI 10.1016/S0378-4290(97)00050-6; SUNKAR R, 2008, BMC PLANT BIOL, V8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian T, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw099; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Xie FL, 2015, J EXP BOT, V66, P789, DOI 10.1093/jxb/eru437; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu JN, 2005, J INTEGR PLANT BIOL, V47, P1372, DOI 10.1111/j.1744-7909.2005.00126.x; [张林生 Zhang Lin Sheng], 2003, [植物生理学通讯, Plant Physiology Communications], V39, P61; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702	113	36	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209980	10.1371/journal.pone.0209980	http://dx.doi.org/10.1371/journal.pone.0209980			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650107	Green Accepted, Green Published, gold			2022-12-27	WOS:000455813300036
J	Sanchez-Gonzalez, MC; Perez-Cabezas, V; Gutierrez-Sanchez, E; Ruiz-Molinero, C; Rebollo-Salas, M; Jimenez-Rejano, JJ				Carmen Sanchez-Gonzalez, Maria; Perez-Cabezas, Veronica; Gutierrez-Sanchez, Estanislao; Ruiz-Molinero, Carmen; Rebollo-Salas, Manuel; Jesus Jimenez-Rejano, Jose			Nonstrabismic binocular dysfunctions and cervical complaints: The possibility of a cross-dysfunction	PLOS ONE			English	Article							CILIARY MUSCLE-CONTRACTION; NECK PAIN; HEAD; EYE; ADAPTATION; VISION; MUSCULOSKELETAL; STABILIZATION; ACCOMMODATION; REPEATABILITY	The aim of this study is to establish a relationship between non-strabismic binocular dysfunction and neck pain. One hundred twelve participants underwent binocular vision assessment by evaluating horizontal heterophoria, horizontal and vertical fusional vergence ranges and vergence facility. The subjects were classified into two groups: binocular anomalies and normal binocular function. Neck complaints were measured with the Neck Disability Index, visual analogue scale, cervical range of motion, deep-flexor muscle activation score (AS) and performance index (PI). Our results showed that participants with low AS had significantly altered values of lateral phoria (near) (mean = -6.99 SD +/- 6.96 PD) and PFV (near) blur (mean = 9.49 SD +/- 5.45 PD) against those who presented normal AS (lateral phoria (near) mean = -3.64 SD +/- 6.37 PD; PFV (near) blur mean = 12.84 SD +/- 6.20 PD). In addition, participants with NFV (near) recovery outside the norm had a significantly lower right side-bending (mean = 35.63 SD +/- 8.35 PD) than those within the standard (mean = 39.64 SD +/- 9 PD). The subjects with binocular vision impairment showed a diminished response to the deep cervical musculature, with low AS and PI, as well as a tendency to suffer from cervicalgia of more than three months' evolution and a lower range of motion.	[Carmen Sanchez-Gonzalez, Maria] Univ Seville, Opt Area, Dept Condensed Matter Phys, Seville, Spain; [Perez-Cabezas, Veronica; Ruiz-Molinero, Carmen] Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz, Spain; [Gutierrez-Sanchez, Estanislao] Univ Seville, Dept Surg, Ophthalmol Area, Seville, Spain; [Rebollo-Salas, Manuel; Jesus Jimenez-Rejano, Jose] Univ Seville, Dept Physiotherapy, Seville, Spain	University of Sevilla; Universidad de Cadiz; University of Sevilla; University of Sevilla	Ruiz-Molinero, C (corresponding author), Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz, Spain.	carmen.ruizmolinero@uca.es	Sanchez, Estanislao Gutierrez/P-7776-2018; del Carmen Sánchez, María/AAR-9887-2020; Jiménez-Rejano, José-Jesús/E-4955-2018; Rebollo Salas, M./N-4288-2018; Perez-Cabezas, Veronica/AAB-4137-2020	Sanchez, Estanislao Gutierrez/0000-0003-4851-680X; Jiménez-Rejano, José-Jesús/0000-0003-3358-3305; Rebollo Salas, M./0000-0003-2788-0725; Sanchez-Gonzalez, Maria Carmen/0000-0002-9453-8615; Ruiz Molinero, Maria del Carmen/0000-0002-6208-0208; Perez-Cabezas, Veronica/0000-0002-3896-357X				Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Bade A, 2013, OPTOMETRY VISION SCI, V90, P988, DOI 10.1097/OPX.0000000000000012; Cacho-Mart inez P, 2010, J OPTOM, V3, P185, DOI [DOI 10.1016/S1888-4296(10)70028-5, 10.1016/s1888-4296(10)70028-5]; Cacho-Martinez P, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/895803; Cacho-Martinez Pilar, 2014, J Optom, V7, P2, DOI 10.1016/j.optom.2013.01.004; Cacho-Martinez P, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/549435; Charman WN, 2008, CLIN EXP OPTOM, V91, P207, DOI 10.1111/j.1444-0938.2008.00256.x; Chiu TTW, 2005, J ORTHOP SPORT PHYS, V35, P567; Cooper Jeffrey, 2012, Optometry, V83, P137; Dagi LR, 2017, J PEDIAT OPHTH STRAB, V54, P134, DOI 10.3928/01913913-20170417-01; Domkin D, 2016, J ELECTROMYOGR KINES, V28, P193, DOI 10.1016/j.jelekin.2015.11.008; Fu T, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/987048; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Gall Ronald, 2003, Optometry, V74, P309; Garcia-munoz A, 2016, CLIN EXP OPTOM, V99, P313, DOI 10.1111/cxo.12376; GRISSOM RJ, 1994, J CONSULT CLIN PSYCH, V62, P281, DOI 10.1037/0022-006X.62.2.281; Grissom RJ, 2001, PSYCHOL METHODS, V6, P135, DOI 10.1037//1082-989X.6.2.135; GRISSOM RJ, 1994, J APPL PSYCHOL, V79, P314, DOI 10.1037/0021-9010.79.2.314; Hrynchak PK, 2010, OPHTHAL PHYSL OPT, V30, P304, DOI 10.1111/j.1475-1313.2010.00723.x; Hussaindeen JR, 2018, J OPTOM, V11, P40, DOI 10.1016/j.optom.2017.02.002; Irsch K, 2013, INVEST OPHTH VIS SCI, V54, P3108, DOI 10.1167/iovs.12-11368; Jang Jung Un, 2016, Taiwan J Ophthalmol, V6, P187, DOI 10.1016/j.tjo.2016.07.001; Jimenez R, 2004, OPHTHAL PHYSL OPT, V24, P528, DOI 10.1111/j.1475-1313.2004.00234.x; Johns HA, 2004, OPTOMETRY VISION SCI, V81, P939; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Lanca CC, 2016, STRABISMUS, V24, P63, DOI 10.3109/09273972.2016.1159234; Lim Z, 2011, J AAPOS, V15, P468, DOI 10.1016/j.jaapos.2011.05.011; Lundqvist LO, 2016, OPTOMETRY VISION SCI, V93, P1147, DOI 10.1097/OPX.0000000000000902; Maducdoc MM, 2017, INT OPHTHALMOL, V37, P433, DOI 10.1007/s10792-016-0281-9; Maxwell JS, 1997, VISION RES, V37, P441, DOI 10.1016/S0042-6989(96)00115-0; Maxwell JS, 1996, VISION RES, V36, P1195, DOI 10.1016/0042-6989(95)00222-7; Montfoort I, 2006, INVEST OPHTH VIS SCI, V47, P2881, DOI 10.1167/iovs.05-1561; Mowatt L, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13035; Nucci P, 2005, AM J OPHTHALMOL, V140, P65; Ortega JAA, 2008, MED CLIN-BARCELONA, V130, P85; Ostadimoghaddam H, 2017, CLIN EXP OPTOM, V100, P255, DOI 10.1111/cxo.12471; Parihar J K S, 2016, Med J Armed Forces India, V72, P270, DOI 10.1016/j.mjafi.2016.03.016; Radulovic B, 2012, ARH HIG RADA TOKSIKO, V63, P215, DOI 10.2478/10004-1254-63-2012-2197; Randolph SA, 2017, WORKPLACE HEALTH SAF, V65, P328, DOI 10.1177/2165079917712727; Richter HO, 2015, EUR J APPL PHYSIOL, V115, P1501, DOI 10.1007/s00421-015-3125-9; Richter HO, 2011, EUR J APPL PHYSIOL, V111, P29, DOI 10.1007/s00421-010-1629-x; Richter HO, 2010, VISION RES, V50, P2559, DOI 10.1016/j.visres.2010.08.021; Richter HO, 2014, WORK, V47, P413, DOI 10.3233/WOR-131776; Roper-Hall G, 2009, STRABISMUS, V17, P3, DOI 10.1080/09273970802678784; Rowe FJ, 2010, STRABISMUS, V18, P48, DOI 10.3109/09273971003758412; Sheard C., 1930, AM J OPTOM, V7, P9, DOI [10.1097/00006324-193001000-00001, DOI 10.1097/00006324-193001000-00001]; Taimela S, 2000, SPINE, V25, P1021, DOI 10.1097/00007632-200004150-00018; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zetterberg C, 2013, J ELECTROMYOGR KINES, V23, P1190, DOI 10.1016/j.jelekin.2013.06.003; Zetterberg C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182439; Zetterberg C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126578; Zhang D, 2016, INT J OPHTHALMOL-CHI, V9, P746, DOI 10.18240/ijo.2016.05.20	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209710	10.1371/journal.pone.0209710	http://dx.doi.org/10.1371/journal.pone.0209710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645581	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200012
J	Lee, YH; Kung, PT; Wang, YH; Kuo, WY; Kao, SL; Tsai, WC				Lee, Yung-Heng; Kung, Pei-Tseng; Wang, Yueh-Hsin; Kuo, Wei-Yin; Kao, Su-Ling; Tsai, Wen-Chen			Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study	PLOS ONE			English	Article							THERAPEUTIC DELAY; BREAST-CANCER; RECTAL-CANCER; YOUNGER; SURGERY; PATIENT; STAGE; SYMPTOMS; VOLUME; COLON	Evidence is limited regarding the effect of diagnosis-to-treatment interval (DTI) on the survival of colorectal cancer (CRC) patients. In addition, previous studies on treatment delay and CRC survival have largely grouped patients from all stages (I-IV) into one cohort. Our study provides analysis on each stage individually. We conducted a retrospective cohort study with 39,000 newly diagnosed CRC patients obtained from the Taiwan Cancer Registry Database from 2004-2010 to examine the effect of DTIs on overall survival. DTIs were divided into 3 groups: <= 30 days (36,115 patients, 90.5% of study patients), 31-150 days (2,533, 6.4%), and >= 151 days (1,252, 3.15%). Risk of death was increased for DTI 31-150 days (hazard ratio 1.51; 95% confidence interval 1.43-1.59) and DTI >= 151 days (1.64; 1.54-1.76) compared to DTI <= 30. This risk was consistent across all cancer stages. Additional factors that increased risk of death include male gender, age > 75, Charlson Comorbidity Index >= 7, other catastrophic illnesses, lack of multidisciplinary team involvement, and treatment in a low volume center. From these results, we advise that the DTI for all CRC patients, regardless of cancer staging, should be 30 days or less.	[Lee, Yung-Heng; Wang, Yueh-Hsin; Kuo, Wei-Yin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Lee, Yung-Heng] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lee, Yung-Heng] Miaoli Gen Hosp, Dept Orthoped, Miaoli, Taiwan; [Lee, Yung-Heng; Kao, Su-Ling] Jen Teh Jr Coll Med Nursing & Management, Dept Nursing Adm, Miaoli, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kung, Pei-Tseng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kao, Su-Ling] Cishan Gen Hosp, Dept Human Resource, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789; Wang, Yueh-Hsin/0000-0002-1282-5945	Ministry of Science and Technology [MOST 104-2410-H-039 -002, ASIA104-CMUH-17]; China Medical University; Asia University, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University(China Medical University); Asia University, Taiwan	This study was supported by grants (MOST 104-2410-H-039 -002 to WCT; ASIA104-CMUH-17 to PTK) from the Ministry of Science and Technology (https://www.most.gov.tw/) and China Medical University (http://www.cmu.edu.tw/) and Asia University (http://www.asia.edu.tw/EN/), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MJ, 2010, EUR J CANCER, V46, P2681, DOI 10.1016/j.ejca.2010.04.026; Abu-Helalah Munir Ahmad, 2016, J Gastrointest Cancer, V47, P36, DOI 10.1007/s12029-015-9783-3; AFZELIUS P, 1994, ACTA ONCOL, V33, P345, DOI 10.3109/02841869409098427; Alok Kumar D., 2012, HEALTH, V4, DOI [10.4236/health.2012.42012, DOI 10.4236/HEALTH.2012.42012]; [Anonymous], 2000, NHS CANC PLAN PLAN I; Bhandari A, 2017, J INVEST MED, V65, P311, DOI 10.1136/jim-2016-000229; Bilimoria KY, 2011, ANN SURG, V253, P779, DOI 10.1097/SLA.0b013e318211cc0f; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Chiang JM, 2003, DIS COLON RECTUM, V46, P904, DOI 10.1007/s10350-004-6683-1; Chou CL, 2011, AM J SURG, V202, P574, DOI 10.1016/j.amjsurg.2010.10.014; Chu YT, 2010, TAIWAN J PUBLIC HLTH, V29, P8; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; FISHER ER, 1977, CANCER-AM CANCER SOC, V40, P3160, DOI 10.1002/1097-0142(197712)40:6<3160::AID-CNCR2820400661>3.0.CO;2-P; Helewa RM, 2013, J SURG ONCOL, V108, P378, DOI 10.1002/jso.23412; Hsu YH, 2016, HEALTH POLICY, V120, P674, DOI 10.1016/j.healthpol.2016.04.001; Huang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101731; Iversen LH, 2009, BRIT J SURG, V96, P1183, DOI 10.1002/bjs.6700; Keating J, 2006, NZ MED J, V119, P2238; Liu CY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-446; Liu CY, 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lordan JT, 2009, EJSO-EUR J SURG ONC, V35, P302, DOI 10.1016/j.ejso.2008.01.028; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Ministry of Health and Welfare and Statistics Department, TAIW LEAD CAUS DEATH; Montella M, 2002, CANCER, V95, P2254, DOI 10.1002/cncr.10961; Murchie P, 2014, BRIT J CANCER, V111, P461, DOI 10.1038/bjc.2014.352; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Parikh-Patel A, 2006, CANCER-AM CANCER SOC, V107, P1189, DOI 10.1002/cncr.22016; Pruitt SL, 2013, CANCER CAUSE CONTROL, V24, P961, DOI 10.1007/s10552-013-0172-6; Ramos M, 2007, EUR J CANCER, V43, P2467, DOI 10.1016/j.ejca.2007.08.023; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Taiwan Health Promotion Administration, 2008, TAIW CANC REG CANC S; van de Velde CJH, 2014, EJSO-EUR J SURG ONC, V40, P454, DOI 10.1016/j.ejso.2013.10.013; Visser MRM, 2006, J SURG ONCOL, V93, P571, DOI 10.1002/jso.20552; Wattacheril J, 2008, ALIMENT PHARM THER, V28, P1166, DOI 10.1111/j.1365-2036.2008.03826.x; Yun YH, 2012, ANN ONCOL, V23, P2731, DOI 10.1093/annonc/mds101; Zarcos-Pedrinaci I, 2017, ONCOTARGET, V8, P36728, DOI 10.18632/oncotarget.13574	40	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210465	10.1371/journal.pone.0210465	http://dx.doi.org/10.1371/journal.pone.0210465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640932	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000030
J	Li, YJ; Wu, HH; Liu, SH; Tu, KH; Lee, CC; Hsu, HH; Chang, MY; Yu, KH; Chen, W; Tian, YC				Li, Yi-Jung; Wu, Hsin-Hsu; Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Yu, Kuang-Hui; Chen, Wei; Tian, Ya-Chung			Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-ANTIGEN; INFECTION; ERYTHEMATOSUS; REPLICATION; JC; PREVALENCE; EXPRESSION; ANTIBODIES; RECIPIENTS	Objective Lupus nephritis (LN) frequently progresses to end-stage renal disease. Finding a biomarker for LN and a predictor for the development of chronic kidney disease (CKD) is important for patients with systemic lupus erythematosus (SLE). Methods Ninety patients with SLE were divided into biopsy-proven LN (n = 54) and no kidney involvement (non-LN) (n = 36) groups and followed up for 54 months. Results Of 36 patients with LN, 3 (5.6%) had class II disease, 3 (5.6%) had class III, 35 (64.8%) had class IV, 10 (18.5%) had class V, and 3 (5.6%) had class VI (advanced sclerosis). Compared to the non-LN group, patients in the LN group had higher autoimmunity evidenced by a higher proportion of low C3 and C4 levels, positive anti-double-stranded DNA antibody levels, and lower estimated glomerular filtration rates (eGFR). Urinary neutrophil gelatinaseassociated lipocalin (uNGAL) levels were significantly higher in the LN group (LN vs nonLN, 670 vs 33 ng/mL, respectively). The patients with LN had a higher urinary polyomavirus BK (BKV) load (3.6 vs 3.0 log copies/mL) and a lower urinary BKV miRNA (miR-B1) 5p level (0.29 vs 0.55 log copies/mL, p = 0.025), while there was no significant difference in the level of miR-B1-3p. Urinary miR-B1-5p level but not urinary BKV load was negatively correlated with uNGAL level (r =-0.22, p = 0.004). At the cutoff value of 80 ng/mL, the receiver operating characteristic curve analysis showed that uNGAL level as a predictor of the presence of LN had a high sensitivity (98%) and specificity (100%) (area under the curve [AUC], 0.997; p < 0.001). During the 54-month follow-up period, 14 (7%) patients with LN and none of the non-LN patients developed CKD. Multivariate Cox regression analysis revealed that baseline uNGAL level was the only predictive factor for CKD development, while baseline serum creatinine level and eGFR were not. Conclusion An elevated urinary BKV viral load with a decreased level of miR-B1 implies the presence of LN. In addition, an increased uNGAL level is a good biomarker not only in predicting the presence of LN but also for prediction of CKD development in patients with SLE.	[Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia; Hsu, Hsiang-Hao; Chang, Ming-Yang; Tian, Ya-Chung] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Liu, Shou-Hsuan; Tu, Kun-Hua; Lee, Cheng-Chia] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Yu, Kuang-Hui] Linkou Chang Gung Mem Hosp, Dept Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Chen, Wei] Xiamen Chang Gung Hosp, Dept Nephrol, Xiamen, Fujian, Peoples R China	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Tian, YC (corresponding author), Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan.; Tian, YC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan.; Tian, YC (corresponding author), Chang Gung Univ, Dept Med, Taoyuan, Taiwan.	dryctian@cgmh.org.tw	Chang, Ming-Yang/AGH-5397-2022; Tu, Kun-Hua/ABD-1751-2021	Chang, Ming-Yang/0000-0001-8899-0376; Tu, Kun-Hua/0000-0002-7146-4481; Lee, Cheng-Chia/0000-0002-6973-5908; Tian, Ya-Chung/0000-0002-0314-5876; Wu, Hsin Hsu/0000-0002-0028-7836	Chung Gang Medical Research Project [CORPG3F0191, CMRPG3A1201-1similar to3, CMRP3E1581-2]	Chung Gang Medical Research Project	This study was supported by grants from the Chung Gang Medical Research Project to Ya-Chung Tian and Yi-Jung Li (CORPG3F0191, CMRPG3A1201-1 similar to 3, CMRPG3E1581-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Deepa Tolani for English editing. This study was supported by grants from the Chung Gang Medical Research Project to Ya-Chung Tian and Yi-Jung Li (CORPG3F0191, CMRPG3A1201-1 similar to 3, CMRP3E1581-2).	ARTHUR RR, 1986, NEW ENGL J MED, V315, P230, DOI 10.1056/NEJM198607243150405; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Colla L, 2007, LUPUS, V16, P881, DOI 10.1177/0961203307084169; Cubukcu-Dimopulo O, 2000, AM J SURG PATHOL, V24, P145, DOI 10.1097/00000478-200001000-00019; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Faurschou M, 2010, ARTHRIT CARE RES, V62, P873, DOI 10.1002/acr.20116; Fenton KA, 2008, MOL IMMUNOL, V45, P3117, DOI 10.1016/j.molimm.2008.03.001; Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8; Fogazzi GB, 2001, NEPHROL DIAL TRANSPL, V16, P1496, DOI 10.1093/ndt/16.7.1496; FREDRIKSEN K, 1993, SCAND J IMMUNOL, V38, P401, DOI 10.1111/j.1365-3083.1993.tb01744.x; GARDNER SD, 1971, LANCET, V1, P1253; Hinze CH, 2009, ARTHRITIS RHEUM-US, V60, P2772, DOI 10.1002/art.24751; Kawano Y, 2013, J INFECT DIS, V208, P771, DOI 10.1093/infdis/jit222; Li JYZ, 2014, AM J TRANSPLANT, V14, P1183, DOI 10.1111/ajt.12694; Li YJ, 2009, CLIN TRANSPLANT, V23, P505, DOI 10.1111/j.1399-0012.2009.00982.x; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Lu MC, 2009, AUTOIMMUNITY, V42, P216, DOI 10.1080/08916930802709125; Martelli F, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1927; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nukuzuma S, 2014, J MED VIROL, V86, P2026, DOI 10.1002/jmv.23886; Pawar RD, 2012, ARTHRITIS RHEUM-US, V64, P1620, DOI 10.1002/art.33485; Perez-Mercado AE, 2010, JCR-J CLIN RHEUMATOL, V16, P335, DOI 10.1097/RHU.0b013e3181f4cf52; Rekvig OP, 2006, ADV EXP MED BIOL, V577, P117; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; Rubinstein T, 2010, RHEUMATOLOGY, V49, P960, DOI 10.1093/rheumatology/kep468; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Torres-Salido MT, 2014, NEPHROL DIAL TRANSPL, V29, P1740, DOI 10.1093/ndt/gfu062; Tesar V, 2011, NAT REV NEPHROL, V7, P96, DOI 10.1038/nrneph.2010.170; Tian YC, 2014, BIOCHEM BIOPH RES CO, V447, P543, DOI 10.1016/j.bbrc.2014.04.030; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Yen CL, 2016, J FORMOS MED ASSOC, V115, P539, DOI 10.1016/j.jfma.2016.01.008	36	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210633	10.1371/journal.pone.0210633	http://dx.doi.org/10.1371/journal.pone.0210633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640964	gold, Green Submitted, Green Published			2022-12-27	WOS:000455808000036
J	Pardo, FOC; Wayne, S; Culhane, MR; Perez, A; Allerson, M; Torremorell, M				Pardo, Fabian Orlando Chamba; Wayne, Spencer; Culhane, Marie Rene; Perez, Andres; Allerson, Matthew; Torremorell, Montserrat			Effect of strain-specific maternally-derived antibodies on influenza A virus infection dynamics in nursery pigs	PLOS ONE			English	Article							SWINE-INFLUENZA; UNITED-STATES; ANTIGENIC SITES; POPULATION-DYNAMICS; IMMUNE-RESPONSES; H3N2 VIRUSES; TRANSMISSION; EVOLUTION; VACCINES; PIGLETS	Reducing the number of influenza A virus (IAV) infected pigs at weaning is critical to minimize IAV spread to other farms. Sow vaccination is a common measure to reduce influenza levels at weaning. However, the impact of maternally-derived antibodies on IAV infection dynamics in growing pigs is poorly understood. We evaluated the effect of maternallyderived antibodies at weaning on IAV prevalence at weaning, time of influenza infection, number of weeks that pigs tested IAV positive, and estimated quantity of IAV in nursery pigs. We evaluated 301 pigs within 10 cohorts for their influenza serological (seroprevalence estimated by hemagglutination inhibition (HI) test) and virological (prevalence) status. Nasal swabs were collected weekly and pigs were bled 3 times throughout the nursery period. There was significant variability in influenza seroprevalence, HI titers and influenza prevalence after weaning. Increase in influenza seroprevalence at weaning was associated with low influenza prevalence at weaning and delayed time to IAV infection throughout the nursery. Piglets with IAV HI titers of 40 or higher at weaning were also less likely to test IAV positive at weaning, took longer to become infected, tested IAV RT-PCR positive for fewer weeks, and had higher IAV RT-PCR cycle threshold values compared to piglets with HI titers less than 40. Our findings suggest that sow vaccination or infection status that results in high levels of IAV strain-specific maternally-derived antibodies may help to reduce IAV circulation in both suckling and nursery pigs.	[Pardo, Fabian Orlando Chamba; Culhane, Marie Rene; Perez, Andres; Torremorell, Montserrat] Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA; [Wayne, Spencer] Pipestone Vet Serv, Hlth Serv, Pipestone, MN USA; [Allerson, Matthew] Holden Farms Inc, Hlth & Res Div, Northfield, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA.	torr0033@umn.edu	Chamba Pardo, Fabian O/A-8202-2015; Perez, Andres/HGD-8377-2022	Chamba Pardo, Fabian O/0000-0002-3093-9719; Culhane, Marie/0000-0002-3547-7576	National Pork Board [15-026]	National Pork Board	The author(s) received funding for this work from the National Pork Board (grant number: 15-026 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2017, VIROLOGY, V511, P56, DOI 10.1016/j.virol.2017.08.021; Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; Allerson MW, 2013, THESIS; Alvarez J, 2015, PREV VET MED, V121, P240, DOI 10.1016/j.prevetmed.2015.07.003; Anderson TK, 2015, VIRUS RES, V201, P24, DOI 10.1016/j.virusres.2015.02.009; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bao Y, 2007, NUCLEIC ACIDS RES, V35, pW280, DOI 10.1093/nar/gkm354; BLASKOVIC D, 1970, B WORLD HEALTH ORGAN, V42, P767; Bolton MJ, 2019, INFLUENZA OTHER RESP, V13, P83, DOI 10.1111/irv.12610; Brown VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088817; Cador C, 2016, VET RES, V47, DOI 10.1186/s13567-016-0365-6; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Choi YK, 2004, AM J VET RES, V65, P303, DOI 10.2460/ajvr.2004.65.303; Ciacci Zanella Janice R, 2012, Influenza Res Treat, V2012, P329029, DOI 10.1155/2012/329029; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Corzo CA, 2012, J SWINE HEALTH PROD, V20, P283; Deblanc C, 2018, VET MICROBIOL, V216, P142, DOI 10.1016/j.vetmic.2018.01.019; Diaz A, 2017, J VIROL, V91, DOI 10.1128/JVI.00745-17; Diaz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129213; Er C, 2016, J ANIM SCI, V94, P751, DOI 10.2527/jas.2015-9251; Er C, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0284-6; Ferreira JB, 2018, TRANSBOUND EMERG DIS, V65, pe145, DOI 10.1111/tbed.12701; Ferreira JB, 2017, VET RES, V48, DOI 10.1186/s13567-017-0466-x; Gao SB, 2017, J GEN VIROL, V98, P2001, DOI 10.1099/jgv.0.000885; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gracia JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175267; Harris KA, 2017, ECOHEALTH, V14, P342, DOI 10.1007/s10393-017-1244-y; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Kaplan BS, 2015, EMERG INFECT DIS, V21, P1834, DOI 10.3201/eid2110.140633; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Kitikoon P, 2014, METHODS MOL BIOL, V1161, P295, DOI 10.1007/978-1-4939-0758-8_24; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Kyriakis CS, 2017, VET MICROBIOL, V211, P174, DOI 10.1016/j.vetmic.2017.10.016; Laurie KL, 2015, J INFECT DIS, V212, P1701, DOI 10.1093/infdis/jiv260; Lewis NS, 2016, ELIFE, V5, DOI 10.7554/eLife.12217; Lewis NS, 2014, J VIROL, V88, P4752, DOI 10.1128/JVI.03805-13; Loeffen WLA, 2009, VET MICROBIOL, V137, P45, DOI 10.1016/j.vetmic.2009.01.004; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Loeffen WLA, 2003, VET MICROBIOL, V91, P295, DOI 10.1016/S0378-1135(02)00306-1; Lorusso A, 2014, J GEN VIROL, V95, P2618, DOI 10.1099/vir.0.067926-0; Lorusso A, 2013, CURR TOP MICROBIOL, V370, P113, DOI 10.1007/82_2011_196; LUBECK MD, 1981, VIROLOGY, V113, P64, DOI 10.1016/0042-6822(81)90136-7; Lugar DW, 2017, J SWINE HEALTH PROD, V25, P303; Mughini-Gras Lapo, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.4211b8d6cedd8c870db723455409c0f8; Na W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0343-z; Nelson MI, 2015, J VIROL, V89, P6218, DOI 10.1128/JVI.00459-15; Nelson MI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7696; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Obadan AO, 2015, J GEN VIROL, V96, P2511, DOI 10.1099/vir.0.000190; Pardo FOC, 2018, PREV VET MED, V161, P33, DOI 10.1016/j.prevetmed.2018.10.008; Pileri E, 2017, PREV VET MED, V138, P147, DOI 10.1016/j.prevetmed.2017.01.008; R Core Team, 2020, R LANG ENV STAT COMP; Rajao DS, 2018, VIROLOGY, V518, P45, DOI 10.1016/j.virol.2018.02.006; Rajao DS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00123; Rajao DS, 2017, J VIROL, V91, DOI 10.1128/JVI.01763-16; Rajao DS, 2015, J VIROL, V89, P11213, DOI 10.1128/JVI.01675-15; Reeth VK, 2012, DIS SWINE, V10th, P557; RENSHAW HW, 1975, AM J VET RES, V36, P5; Rose N, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-72; Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001; Sandbulte MR, 2015, VACCINES-BASEL, V3, P22, DOI 10.3390/vaccines3010022; Sandbulte MR, 2014, VIROLOGY, V464, P45, DOI 10.1016/j.virol.2014.06.027; Shahmoradian SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05587-4; Simon-Grife M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-24; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Sriwilaijaroen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016302; United States Department of Agriculture, 2017, INFLUENZA A VIRUS IN; USDA, 2015, REF SWIN HLTH HLTH 2; Vincent AL, 2017, VET MICROBIOL, V206, P35, DOI 10.1016/j.vetmic.2016.11.026; Walia RR, 2019, INFLUENZA OTHER RESP, V13, P262, DOI 10.1111/irv.12559; Xu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20239; Zhang JQ, 2014, METHODS MOL BIOL, V1161, P277, DOI 10.1007/978-1-4939-0758-8_23; Zhang JQ, 2014, METHODS MOL BIOL, V1161, P265, DOI 10.1007/978-1-4939-0758-8_22; Zhang Y, 2017, NUCLEIC ACIDS RES, V45, pD466, DOI 10.1093/nar/gkw857	83	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210700	10.1371/journal.pone.0210700	http://dx.doi.org/10.1371/journal.pone.0210700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640929	gold, Green Submitted, Green Published			2022-12-27	WOS:000455808000040
J	Taskova, K; Fontaine, JF; Mrowka, R; Andrade-Navarro, MA				Taskova, Katerina; Fontaine, Jean-Fred; Mrowka, Ralf; Andrade-Navarro, Miguel A.			Literature optimized integration of gene expression for organ-specific evaluation of toxicogenomics datasets	PLOS ONE			English	Article							IN-VITRO; RANK AGGREGATION; INDUCED LIVER; DRUG; MECHANISMS; OVEREXPRESSION; IDENTIFICATION; TOXICOLOGY; DISCOVERY; DATABASE	The study of drug toxicity in human organs is complicated by their complex inter-relations and by the obvious difficulty to testing drug effects on biologically relevant material. Animal models and human cell cultures offer alternatives for systematic and large-scale profiling of drug effects on gene expression level, as typically found in the so-called toxicogenomics datasets. However, the complexity of these data, which includes variable drug doses, time points, and experimental setups, makes it difficult to choose and integrate the data, and to evaluate the appropriateness of one or another model system to study drug toxicity (of particular drugs) of particular human organs. Here, we define a protocol to integrate drug-wise rankings of gene expression changes in toxicogenomics data, which we apply to the TG-GATEs dataset, to prioritize genes for association to drug toxicity in liver or kidney. Contrast of the results with sets of known human genes associated to drug toxicity in the literature allows to compare different rank aggregation approaches for the task at hand. Collectively, ranks from multiple models point to genes not previously associated to toxicity, notably, the PCNA clamp associated factor (PCLAF), and genes regulated by the master regulator of the antioxidant response NFE2L2, such as NQO1 and SRXN1. In addition, comparing gene ranks from different models allowed us to evaluate striking differences in terms of toxicity-associated genes between human and rat hepatocytes or between rat liver and rat hepatocytes. We interpret these results to point to the different molecular functions associated to organ toxicity that are best described by each model. We conclude that the expected production of toxicogenomics panels with larger numbers of drugs and models, in combination with the ongoing increase of the experimental literature in organ toxicity, will lead to increasingly better associations of genes for organism toxicity.	[Taskova, Katerina; Fontaine, Jean-Fred; Andrade-Navarro, Miguel A.] Biozentrum I, Fac Biol, Mainz, Germany; [Mrowka, Ralf] KIM III, Univ Klinikum Jena, Expt Nephrol, Jena, Germany	Friedrich Schiller University of Jena	Andrade-Navarro, MA (corresponding author), Biozentrum I, Fac Biol, Mainz, Germany.	andrade@uni-mainz.de	Fontaine, Jean-Fred/GNP-2904-2022; Mrowka, Ralf/AAW-1480-2021; Andrade, Miguel/B-6565-2008	Fontaine, Jean-Fred/0000-0002-1101-4091; Mrowka, Ralf/0000-0002-0991-3418; Taskova, Katerina/0000-0002-3217-7877; Andrade, Miguel/0000-0001-6650-1711	BMBF grant program SysToxChip [FKZ 031A303A, FKZ 031A303E]; Bundesministerium fur Bildung und Forschung	BMBF grant program SysToxChip; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	KT, JF, RM and MAA received funds from BMBF grant program SysToxChip (FKZ 031A303A and FKZ 031A303E), Bundesministerium fur Bildung und Forschung, https://www.bmbf.de/.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Andrade-Navarro M.A., 2016, GENOMICS COMPUTATION, V2, pe33; Attia SM, 2010, OXID MED CELL LONGEV, V3, P238, DOI 10.4161/oxim.3.4.13246; Aubrecht J, 2013, GENOME MED, V5, DOI 10.1186/gm489; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Badgeley MA, 2015, BIOINFORMATICS, V31, P209, DOI 10.1093/bioinformatics/btu518; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boullata JI, 2013, J CLIN PHARM THER, V38, P269, DOI 10.1111/jcpt.12075; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Cheng Y, 2013, LAB INVEST, V93, P1276, DOI 10.1038/labinvest.2013.124; Chikina M D, 2014, R IMPLEMENTATION BIR; Clarke JI, 2016, EXPERT OPIN DRUG SAF, V15, P625, DOI 10.1517/14740338.2016.1160057; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; El-Hachem N, 2016, ENVIRON HEALTH PERSP, V124, P313, DOI 10.1289/ehp.1409157; Fisher RA, STAT METHODS RES WOR, P1925; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Griffith O, 2012, R HEATMAP FUNCTION; Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Johansson I, 2011, TOXICOL SCI, V120, P1, DOI 10.1093/toxsci/kfq374; Kato T, 2012, LUNG CANCER, V75, P110, DOI 10.1016/j.lungcan.2011.05.024; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136698; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin SL, 2010, WILEY INTERDISCIP RE, V2, P555, DOI 10.1002/wics.111; Liu ZC, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00074; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nueda MJ, 2012, BIOSTATISTICS, V13, P553, DOI 10.1093/biostatistics/kxr042; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rueda-Zarate HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176284; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suter L, 2011, TOXICOL APPL PHARM, V252, P73, DOI 10.1016/j.taap.2010.10.008; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Te JA, 2016, J APPL TOXICOL, V36, P1137, DOI 10.1002/jat.3278; Team RC, 2015, R LANG ENV STAT COMP; Tiong HY, 2014, MOL PHARMACEUT, V11, P1933, DOI 10.1021/mp400720w; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang JD, 2014, PHARMACOGENOMICS J, V14, P208, DOI 10.1038/tpj.2013.39; Zhu K, 2013, CANCER SCI, V104, P353, DOI 10.1111/cas.12083; Zou JL, 2015, CHEM RES TOXICOL, V28, P373, DOI 10.1021/tx500333q	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210467	10.1371/journal.pone.0210467	http://dx.doi.org/10.1371/journal.pone.0210467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640953	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000031
J	Christodoulou, J; Stokes, LR; Bantjes, J; Tomlinson, M; Stewart, J; Rabie, S; Gordon, S; Mayekiso, A; Rotheram-Borus, MJ				Christodoulou, Joan; Stokes, Lynissa R.; Bantjes, Jason; Tomlinson, Mark; Stewart, Jackie; Rabie, Stephan; Gordon, Sarah; Mayekiso, Andile; Rotheram-Borus, Mary Jane			Community context and individual factors associated with arrests among young men in a South African township	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; ALCOHOL-USE DISORDERS; SOCIAL DISORGANIZATION; PRISON POPULATION; CAPE-TOWN; CRIME; RISK; BEHAVIOR; VIOLENCE; PREVALENCE	Background In high-income countries, individual-and community-level factors are associated with increased contact with the criminal justice system. However, little is known about how these factors contribute to the risk of arrest in South Africa, which has one of the highest rates of arrests globally. We examine both individual-and community-level factors associated with arrests among young men living in the townships of Cape Town. Methods Data were collected from a stratified community sample of 906 young men aged 18-29 years old living in 18 township neighborhoods. Communities with high and low rates of arrest were identified. Logistic regression models were used to assess which individual-level (such as substance use and mental health status) and community-level (such as infrastructure and presence of bars and gangs) factors predict arrests. Results Significant predictors of arrests were substance use, gang activity, being older, more stressed, and less educated. Living in communities with better infrastructure and in more recently established communities populated by recent immigrants was associated with having a history of arrests. Conclusions When considering both individual-and community-level factors, substance use and gang violence are the strongest predictors of arrests among young men in South Africa. Unexpectedly, communities with better infrastructure have higher arrest rates. Community programs are needed to combat substance use and gang activity as a pathway out of risk among South African young men.	[Christodoulou, Joan; Rotheram-Borus, Mary Jane] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90024 USA; [Stokes, Lynissa R.] Oregon State Univ, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA; [Bantjes, Jason; Tomlinson, Mark; Stewart, Jackie; Rabie, Stephan; Gordon, Sarah; Mayekiso, Andile] Stellenbosch Univ, Dept Psychol, Stellenbosch, South Africa	University of California System; University of California Los Angeles; Oregon State University; Stellenbosch University	Christodoulou, J (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90024 USA.	jchristodoulou@mednet.ucla.edu	Bantjes, Jason/T-8294-2019	Bantjes, Jason/0000-0002-3626-9883; Christodoulou, Joan/0000-0001-6997-1567; Stokes, Lynissa/0000-0002-3384-9655; Gordon, Sarah/0000-0003-0982-8763	National Institute on Drug Abuse (NIDA) [R01DA038675]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R24AA022919]; National Institute of Mental Health through the Center for HIV Identification, Prevention and Treatment Services (CHIPTS) [MH58107]; UCLA Center for AIDS Research (CFAR) [5P30AI028697]; National Center for Advancing Translational Sciences through UCLA Clinical and Translational Science Institute (CTSI) [UL1TR000124]; William T. Grant Foundation [180039]; National Research Foundation, South Africa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, T32MH109205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038675] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health through the Center for HIV Identification, Prevention and Treatment Services (CHIPTS); UCLA Center for AIDS Research (CFAR); National Center for Advancing Translational Sciences through UCLA Clinical and Translational Science Institute (CTSI); William T. Grant Foundation; National Research Foundation, South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute on Drug Abuse (NIDA; R01DA038675); National Institute on Alcohol Abuse and Alcoholism (NIAAA; R24AA022919); the National Institute of Mental Health through the Center for HIV Identification, Prevention and Treatment Services (CHIPTS; MH58107); the UCLA Center for AIDS Research (CFAR; 5P30AI028697); the National Center for Advancing Translational Sciences through UCLA Clinical and Translational Science Institute (CTSI; UL1TR000124); the William T. Grant Foundation (180039); and, the National Research Foundation, South Africa (N/A - no reference number available). Contact information for the NIDA Program Officer - Aria Crump, ScD. The content is solely the responsibility of the authors and does not represent the official views of NIH.	Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; [Anonymous], 2015, WORLD PRIS BRIEF; [Anonymous], [No title captured]; Arfer KB, 2018, INT J MENT HEALTH AD, V16, P45, DOI 10.1007/s11469-017-9769-4; Booyens K, 2015, CRIMINOLOGIE, V2, P144; Brame R, 2014, CRIME DELINQUENCY, V60, P471, DOI 10.1177/0011128713514801; Breetzke GD, 2010, S AFR J SCI, V106, P41, DOI 10.4102/sajs.v106i11/12.223; Breetzke GD, 2010, J CRIM JUST, V38, P446, DOI 10.1016/j.jcrimjus.2010.04.013; Brooks David, 2018, NY TIMES; Carli V, 2011, PSYCHIAT RES, V185, P141, DOI 10.1016/j.psychres.2009.10.001; COHEN S, 1988, CLAR SYMP, P31; Corp I, 2013, IBM SPSS STAT WIND V; CPR W.P.B, WORLD PRISON POPULAT; Crutchfield Robert D, 2009, Race Soc Probl, V1, P218; Damm AP, 2014, AM ECON REV, V104, P1806, DOI 10.1257/aer.104.6.1806; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Frias-Armenta M, 2013, INT J CRIMINAL JUSTI, V8; Jonck P, 2015, INT J EDUC DEV, V45, P141, DOI 10.1016/j.ijedudev.2015.10.002; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kingston B, 2009, YOUTH SOC, V41, P53, DOI 10.1177/0044118X09338343; Kinyanjui DWC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-53; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lupton R., 2003, 73 LOND SCH EC POL S; Males MA, 2014, J ADOLESCENT RES, V29, P3, DOI 10.1177/0743558413493004; Manaliyo J.C., 2009, TOURISM MULTILINGUAL; Matzopoulos R, 2005, S AFR CRIME Q, P29; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Naidoo S, 2012, AFR J PSYCHIATRY, V15, P30, DOI [http://dx.doi.org/10.4314/ajpsy.v15i1.4, 10.4314/ajpsy.v15i1.4]; O'Regan K., 2014, SAFER KHAYELITSHA RE; Osgood DW, 2000, CRIMINOLOGY, V38, P81, DOI 10.1111/j.1745-9125.2000.tb00884.x; Parry CDH, 2005, ADDICTION, V100, P426, DOI 10.1111/j.1360-0443.2005.01015.x; Parry CDH, 2004, J ADOLESCENCE, V27, P429, DOI 10.1016/j.adolescence.2003.11.013; Parry CDH, 2004, AM J DRUG ALCOHOL AB, V30, P167, DOI 10.1081/ADA-120029872; PELSER E, 2008, LEARNING BE LOST YOU; PRETORIUS TB, 1991, PSYCHOL REP, V69, P1179, DOI 10.2466/PR0.69.8.1179-1185; Prinsloo J, 2013, J PSYCHOL AFR, V23, P133, DOI 10.1080/14330237.2013.10820607; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Redpath J, 2015, S AFR CRIME Q, P15, DOI [10.4314/SACQ.V53IL2, 10.4314/sacq.v53i1.2]; Rotheram-Borus MJ, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2804-3; Roux AVD, 2007, REV EPIDEMIOL SANTE, V55, P13, DOI 10.1016/j.respe.2006.12.003; Roux AVD, 2004, EPIDEMIOL REV, V26, P104, DOI 10.1093/epirev/mxh006; Sampson R. J., 2001, DISORDER URBAN NEIGH; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scott-Sheldon LAJ, 2014, DRUG ALCOHOL DEPEN, V140, P198, DOI 10.1016/j.drugalcdep.2014.04.022; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Seekings J., 2013, EC SOC MUNICIPAL SER; Shaw C.R., 2014, UNDERSTANDING DEVIAN, P106; Shaw CR., 1942, JUVENILE DELINQUENCY; Shewan D, 2000, DRUG USE PRISONS DRU; Statistics South Africa, 2010, CONC DEF STAT S AFR; Steinberg J., 2015, A MAN OF GOOD HOPE; Steinberg J., 2005, PRISON OVERCROWDING; Swart LA, 2016, HOMICIDE STUD, V20, P220, DOI 10.1177/1088767915611177; Swindale A, 2006, J NUTR, V136, P1449, DOI 10.1093/jn/136.5.1449S; Thornberry TP, 2011, ADV CRIM THEOR, V17, P1; Tsai AC, 2016, SOC SCI MED, V151, P69, DOI 10.1016/j.socscimed.2015.12.042; Wandersman A, 2003, AM PSYCHOL, V58, P441, DOI 10.1037/0003-066X.58.6-7.441	62	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209073	10.1371/journal.pone.0209073	http://dx.doi.org/10.1371/journal.pone.0209073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653530	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500010
J	Sandford, AJ; Ha, A; Ngan, DA; Akhabir, L; Saferali, A; Fox, N; Allen, AJH; Warby, SC; van Eeden, SF; Ayas, NT				Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; Fox, Nurit; Allen, A. J. Hirsch; Warby, Simon C.; van Eeden, Stephan F.; Ayas, Najib T.			Adhesion molecule gene variants and plasma protein levels in patients with suspected obstructive sleep apnea	PLOS ONE			English	Article							ABO BLOOD-GROUP; FUTURE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; VON-WILLEBRAND-FACTOR; E-SELECTIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; SOLUBLE FORMS; RISK; ASSOCIATION	Study objectives Untreated obstructive sleep apnea (OSA) patients have an increased risk of cardiovascular disease (CVD). Adhesion molecules, including soluble E-selectin (sE-selectin), intercellular adhesion molecule-1 (ICAM-1), and vascular adhesion molecule-1 (VCAM-1), are associated with incident CVD. We hypothesized that specific genetic variants will be associated with plasma levels of adhesion molecules in suspected OSA patients. We also hypothesized that there may be an interaction between these variants and OSA. Methods We measured levels of sE-selectin, sICAM-1 and sVCAM-1 in 491 patients with suspected OSA and genotyped them for 20 polymorphisms. Results The most significant association was between the ABO rs579459 polymorphism and sE-selectin levels (P = 7x10(-21)), with the major allele T associated with higher levels. The direction of effect and proportion of the variance in sE-selectin levels accounted for by rs579459 (16%) was consistent with estimates from non-OSA cohorts. In a multivariate regression analysis, addition of rs579459 improved the model performance in predicting sE-selectin levels. Three polymorphisms were nominally associated with sICAM-1 levels but none with sVCAM-1 levels. The combination of severe OSA and two rs579459 T alleles identified a group of patients with high sE-selectin levels; however, the increase in sE-selectin levels associated with severe OSA was greater in patients without two T alleles (P = 0.05 test for interaction). Conclusions These genetic polymorphisms may help to identify patients at greatest risk of incident CVD and may help in developing a more precision-based approach to OSA care.	[Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; van Eeden, Stephan F.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Sandford, Andrew J.; Ha, Amanda; Ngan, David A.; Akhabir, Loubna; Saferali, Aabida; van Eeden, Stephan F.; Ayas, Najib T.] Univ British Columbia, Vancouver, BC, Canada; [Fox, Nurit; Allen, A. J. Hirsch; Ayas, Najib T.] Univ British Columbia, UBC Hosp Sleep Disorders Program, Div Resp Med, Vancouver, BC, Canada; [Warby, Simon C.] Hop Sacre Coeur Montreal, Ctr Rech, Ctr Adv Res Sleep Med, Montreal, PQ, Canada; [Warby, Simon C.] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Ayas, Najib T.] Univ British Columbia, Div Crit Care Med, Vancouver, BC, Canada; [Ayas, Najib T.] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; Universite de Montreal; Universite de Montreal; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Sandford, AJ (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada.; Sandford, AJ (corresponding author), Univ British Columbia, Vancouver, BC, Canada.	andrew.sandford@hli.ubc.ca			British Columbia Lung Association; CIHR Team grant; Canadian Sleep and Circadian Network	British Columbia Lung Association; CIHR Team grant(Canadian Institutes of Health Research (CIHR)); Canadian Sleep and Circadian Network	This study was supported by funding from the British Columbia Lung Association, a CIHR Team grant, and the Canadian Sleep and Circadian Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the participants in the Sleep Apnea Clinical Research Registry and the excellent technical assistance of Sunny Fung. This study was supported by funding from the British Columbia Lung Association, a CIHR Team grant, and the Canadian Sleep and Circadian Network.	Al Lawati N, 2009, SLEEP BREATH, V13, P391, DOI 10.1007/s11325-009-0259-1; Al Lawati NM, 2009, PROG CARDIOVASC DIS, V51, P285, DOI 10.1016/j.pcad.2008.08.001; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Blann AD, 1996, BRIT J HAEMATOL, V92, P498, DOI 10.1046/j.1365-2141.1996.d01-1486.x; Bowen DJ, 2003, J THROMB HAEMOST, V1, P33, DOI 10.1046/j.1538-7836.2003.00007.x; Bruzelius M, 2014, THROMB RES, V134, P426, DOI 10.1016/j.thromres.2014.03.054; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Dehghan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144997; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; GEARING AJH, 1992, ANN NY ACAD SCI, V667, P324, DOI 10.1111/j.1749-6632.1992.tb51633.x; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jurado-Gamez B, 2012, INTERNAL MED, V51, P363, DOI 10.2169/internalmedicine.51.6571; Kunutsor SK, 2017, J ATHEROSCLER THROMB, V24, P804, DOI 10.5551/jat.38836; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; O'Donnell JS, 2005, BLOOD, V106, P1988, DOI 10.1182/blood-2005-02-0792; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sode BF, 2013, CAN MED ASSOC J, V185, pE229, DOI 10.1503/cmaj.121636; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	38	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210732	10.1371/journal.pone.0210732	http://dx.doi.org/10.1371/journal.pone.0210732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653588	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500064
J	Arroyo, L; Valent, D; Carreras, R; Pena, R; Sabria, J; Velarde, A; Bassols, A				Arroyo, Laura; Valent, Daniel; Carreras, Ricard; Pena, Raquel; Sabria, Josefa; Velarde, Antonio; Bassols, Anna			Housing and road transport modify the brain neurotransmitter systems of pigs: Do pigs raised in different conditions cope differently with unknown environments?	PLOS ONE			English	Article							C-FOS EXPRESSION; MEAT QUALITY; DOPAMINE TRANSPORTER; STRESS INDICATORS; SOCIAL STRESS; ENRICHMENT; RESPONSES; BEHAVIOR; OUTDOOR; PROTEIN	How housing and transport conditions may affect welfare in porcine production is a leading topic in livestock research. This study investigated whether pigs present a different neurological response to management conditions and to ascertain whether pigs living partially outdoors cope differently with road transport-associated stress. Twenty-four female pigs were divided in two groups: one living indoors (ID, n = 12) and the other housed combining indoor conditions with 4 hours per day of outdoor pasture (OD, n = 12). After one month, one set of animals from each housing condition were driven in a truck to the slaughterhouse in low-stress conditions (5 min drive, no mixing groups, soft management, LS group, n = 12) or high-stress conditions (2 hours drive, mixing groups, harsh management, HS group, n = 12). At the slaughterhouse, blood was collected, and the prefrontal cortex (PFC) and the hippocampus (HC) dissected. OD pigs had lower serum haptoglobin and increased dopaminergic pathway (DA-system) in the PFC, suggesting that living outdoors increases their wellbeing. HS conditions increased serum creatine kinase (CK) and affected several brain pathways: activation of the noradrenergic (NA-system) and DA-system in the PFC and the activation of the DA-system and an increase in c-Fos as well as a decrease in brain-derived neurotrophic factor (BDNF) in the HC. The serotonergic system (5-HT-system) was mildly altered in both areas. There was an interaction between housing and transport in serum NA and the DA-system in the HC, indicating that living conditions affected the response to stress. Multivariate analysis was able to discriminate the four animal groups. In conclusion, this work indicates that housing conditions and road transport markedly modifies the neurophysiology of pigs, and suggests that animals raised partially outdoors respond differently to transport-associated stress than animals raised indoors, indicating that they cope differently with unknown environments.	[Arroyo, Laura; Valent, Daniel; Pena, Raquel; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain; [Carreras, Ricard; Velarde, Antonio] IRTA, Anim Welf Subprogram, Veinat Sies S-N, Monells, Spain; [Pena, Raquel] Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola De Valles, Spain; [Sabria, Josefa] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, Cerdanyola De Valles, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain.	anna.bassols@uab.cat	Velarde, Antonio/L-4466-2014; Bassols, Anna/K-7961-2014; Sabria, Josefa/A-2439-2010	Velarde, Antonio/0000-0002-2634-3138; Bassols, Anna/0000-0003-4213-2274; Sabria, Josefa/0000-0002-1456-4136; Pena, Raquel/0000-0002-7193-9141; Carreras, Ricard/0000-0003-1610-7630	Spanish Ministerio de Economia y Competitividad [AGL2010-21578-C03-01, AGL2011-30598-C03-02]; Generalitat de Catalunya [2014 SGR4]; FEDER program from European Union	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FEDER program from European Union	This study was supported by AGL2010-21578-C03-01, Spanish Ministerio de Economia y Competitividad, to AV; AGL2011-30598-C03-02 from the Spanish Ministerio de Economia y Competitividad, to AB; 2014 SGR4 from the Generalitat de Catalunya to AB; and part of the funding was financed by the FEDER program from the European Union (https://sede.micinn.gob.es; http://agaur.gencat.cat/en/inici/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AD, 2014, NEUROBIOL LEARN MEM, V108, P65, DOI 10.1016/j.nlm.2013.11.007; ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Arroyo L, 2016, PHYSIOL BEHAV, V167, P374, DOI 10.1016/j.physbeh.2016.10.005; Aumann TD, 2016, J CHEM NEUROANAT, V73, P21, DOI 10.1016/j.jchemneu.2015.12.009; Bangasser DA, 2007, NAT NEUROSCI, V10, P1401, DOI 10.1038/nn1973; Belujon P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2516; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; CAROLDI S, 1985, BRIT J PHARMACOL, V84, P357, DOI 10.1111/j.1476-5381.1985.tb12920.x; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; Chaouloff F, 1999, NEUROPSYCHOPHARMACOL, V21, pS28, DOI 10.1016/S0893-133X(99)00008-1; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Darna M, 2015, BRAIN RES, V1599, P115, DOI 10.1016/j.brainres.2014.12.034; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; De Jong IC, 1998, PHYSIOL BEHAV, V64, P303, DOI 10.1016/S0031-9384(98)00066-3; De Vry J, 2012, HORM BEHAV, V62, P10, DOI 10.1016/j.yhbeh.2012.04.019; Douglas AJ, 2005, STRESS, V8, P5, DOI 10.1080/10253890500044380; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Edwards SA, 2005, LIVEST PROD SCI, V94, P5, DOI 10.1016/j.livprodsci.2004.11.028; Enfalt AC, 1997, MEAT SCI, V45, P1, DOI 10.1016/S0309-1740(96)00101-5; Foury A, 2011, ANIMAL, V5, P1620, DOI 10.1017/S1751731111000784; Gade PB, 2008, ANIMAL, V2, P902, DOI 10.1017/S1751731108002000; Galani R, 2007, NEUROBIOL LEARN MEM, V88, P1, DOI 10.1016/j.nlm.2007.03.009; Garrido P, 2013, J NEURAL TRANSM, V120, P829, DOI 10.1007/s00702-012-0935-3; Girbovan C, 2013, BEHAV BRAIN RES, V253, P178, DOI 10.1016/j.bbr.2013.07.018; Grandin T., 1998, ANIMAL WELFARE MEAT; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Honeyman MS, 2005, LIVEST PROD SCI, V94, P15, DOI 10.1016/j.livprodsci.2004.11.029; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; IMAKI T, 1995, ENDOCR J, V42, P121, DOI 10.1507/endocrj.42.121; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jarvinen MK, 1998, DEV BRAIN RES, V107, P21, DOI 10.1016/S0165-3806(97)00210-1; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kang DK, 2000, MOL CELLS, V10, P546, DOI 10.1007/s100590000010; Klont RE, 2001, J ANIM SCI, V79, P2835; Kotloski RJ, 2015, EXP NEUROL, V264, P121, DOI 10.1016/j.expneurol.2014.11.012; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lebret B, 2015, ANIMAL, V9, P1404, DOI 10.1017/S1751731115000609; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; Marchant JN, 1997, APPL ANIM BEHAV SCI, V55, P67, DOI 10.1016/S0168-1591(97)00022-1; Marco-Ramell A, 2011, Vet J, V190, pe66, DOI 10.1016/j.tvjl.2011.01.003; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Millet S, 2005, J SCI FOOD AGR, V85, P709, DOI 10.1002/jsfa.2033; Mora F, 2012, BRAIN RES, V1476, P71, DOI 10.1016/j.brainres.2011.12.049; Nikulina EM, 2014, NEUROSCIENCE, V282, P122, DOI 10.1016/j.neuroscience.2014.05.028; Nilzen V, 2001, MEAT SCI, V58, P267, DOI 10.1016/S0309-1740(00)00164-9; Otten W, 2010, DOMEST ANIM ENDOCRIN, V38, P146, DOI 10.1016/j.domaniend.2009.09.002; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pena Y, 2006, BEHAV BRAIN RES, V174, P181, DOI 10.1016/j.bbr.2006.07.007; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Piekarzewska AB, 2000, J VET MED A, V47, P257, DOI 10.1046/j.1439-0442.2000.00262.x; Pineiro M, 2007, VET J, V173, P669, DOI 10.1016/j.tvjl.2006.02.006; Poletto R, 2010, J ANIM SCI, V88, P3107, DOI 10.2527/jas.2009-1876; Poletto R, 2011, BRAIN RES, V1381, P11, DOI 10.1016/j.brainres.2010.11.035; Rault JL, 2018, DOMEST ANIM ENDOCRIN, V65, P67, DOI 10.1016/j.domaniend.2018.05.007; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Rocha LM, 2016, J ANIM SCI, V94, P359, DOI 10.2527/jas.2015-9176; Rosochacki SJ, 2003, J ANIM BREED GENET, V120, P192, DOI 10.1046/j.1439-0388.2003.00380.x; Rutledge RB, 2015, J NEUROSCI, V35, P9811, DOI 10.1523/JNEUROSCI.0702-15.2015; Sabria J, 2003, ADDICT BIOL, V8, P287, DOI 10.1080/13556210310001602194; Saco Y, 2003, ANIM WELFARE, V12, P403; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Terlouw C, 2009, LIVEST SCI, V122, P199, DOI 10.1016/j.livsci.2008.08.016; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tozawa A, 2016, ASIAN AUSTRAL J ANIM, V29, P428, DOI 10.5713/ajas.15.0190; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valros A, 2015, PHYSIOL BEHAV, V143, P151, DOI 10.1016/j.physbeh.2015.02.049; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Vermetten E, 2002, DEPRESS ANXIETY, V15, P126, DOI 10.1002/da.10016; WARRISS PD, 1983, MEAT SCI, V9, P271, DOI 10.1016/0309-1740(83)90037-2; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x; Zhu J, 2004, BEHAV BRAIN RES, V148, P107, DOI 10.1016/S0166-4328(03)00190-6	78	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210406	10.1371/journal.pone.0210406	http://dx.doi.org/10.1371/journal.pone.0210406			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650149	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300057
J	Brennan, JR; Hale, JT				Brennan, Jonathan R.; Hale, John T.			Hierarchical structure guides rapid linguistic predictions during naturalistic listening	PLOS ONE			English	Article							ANTERIOR NEGATIVITY LAN; BRAIN POTENTIALS; MORPHOSYNTACTIC AGREEMENT; CONTEXT-FREE; LANGUAGE; INFORMATION; SENSITIVITY; INTEGRATION; FMRI	The grammar, or syntax, of human language is typically understood in terms of abstract hierarchical structures. However, theories of language processing that emphasize sequential information, not hierarchy, successfully model diverse phenomena. Recent work probing brain signals has shown mixed evidence for hierarchical information in some tasks. We ask whether sequential or hierarchical information guides the expectations that a human listener forms about a word's part-of-speech when simply listening to every-day language. We compare the predictions of three computational models against electroencephalography signals recorded from human participants who listen passively to an audiobook story. We find that predictions based on hierarchical structure correlate with the human brain response above-and-beyond predictions based only on sequential information. This establishes a link between hierarchical linguistic structure and neural signals that generalizes across the range of syntactic structures found in every-day language.	[Brennan, Jonathan R.] Univ Michigan, Dept Linguist, Ann Arbor, MI 48109 USA; [Hale, John T.] Cornell Univ, Dept Linguist, Ithaca, NY USA; [Hale, John T.] Univ Georgia, Dept Linguist, Athens, GA 30602 USA	University of Michigan System; University of Michigan; Cornell University; University System of Georgia; University of Georgia	Brennan, JR (corresponding author), Univ Michigan, Dept Linguist, Ann Arbor, MI 48109 USA.	jobrenn@umich.edu		Brennan, Jonathan R/0000-0002-3639-350X	National Science Foundation [1607251, 1607441]; NSF [1607251, 1607441]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported in part by grants from the National Science Foundation (Grant #1607251 to JRB, Grant #1607441 to JTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. L. Lewis for helpful comments on this manuscript. This work was supported by grants from the NSF (Grant #1607251 to JRB, Grant #1607441 to JTH).	Alday PM, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0311-16.2017; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bever TG, 1970, COGNITION AND THE DE; Blevins T, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P14; Bradley DC, 1983, COMPUTATIONAL DISTIN; Brennan JR, 2017, COGNITIVE SCI, V41, P1515, DOI 10.1111/cogs.12445; Brennan JR, 2016, BRAIN LANG, V157, P81, DOI 10.1016/j.bandl.2016.04.008; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chomsky N., 1965, ASPECTS OF THE THEOR; Christiansen MH, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X1500031X; Dikker S, 2013, BRAIN LANG, V127, P55, DOI 10.1016/j.bandl.2012.08.004; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Dikker S, 2009, COGNITION, V110, P293, DOI 10.1016/j.cognition.2008.09.008; Ding N, 2017, LANG COGN NEUROSCI, V32, P570, DOI 10.1080/23273798.2016.1215477; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Dyer Chris, 2016, P 2016 C N AM CHAPT, P199, DOI DOI 10.18653/V1/N16-1024; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Frangoulidis S, 2018, TRENDS CLASS SUPPL V, V61, P1, DOI 10.1515/9783110596182-001; Frank R, 2013, LANG ACQUIS, V20, P181, DOI 10.1080/10489223.2013.796950; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Frank SL, 2013, TOP COGN SCI, V5, P475, DOI 10.1111/tops.12025; Frank SL, 2012, P ROY SOC B-BIOL SCI, V279, P4522, DOI 10.1098/rspb.2012.1741; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gers FA, 2001, IEEE T NEURAL NETWOR, V12, P1333, DOI 10.1109/72.963769; Gulordava K, 2018, PROCEEDINGS OF NAACL; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Hale J, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2727; Hale J, 2016, LANG LINGUIST COMPAS, V10, P397, DOI 10.1111/lnc3.12196; Hale JT, 2014, AUTOMATON THEORIES O; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Henderson JM, 2016, NEUROIMAGE, V132, P293, DOI 10.1016/j.neuroimage.2016.02.050; Jelinek F., 1998, STATISTICAL METHODS; Joshi A.K., 1985, NATURAL LANGUAGE PRO, P206, DOI [10.1017/CBO9780511597855.007, DOI 10.1017/CBO9780511597855]; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Linzen Tal, 2016, T ASSOC COMPUT LING, V4, P521, DOI DOI 10.1162/TACL_A_00115; Lopopolo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177794; Luong MT, 2013, TRANSACTIONS OF THE; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000663; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; Molinaro N, 2015, CORTEX, V66, P156, DOI 10.1016/j.cortex.2014.06.009; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Nelson MJ, 2017, P NATL ACAD SCI USA, V114, pE3669, DOI 10.1073/pnas.1701590114; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Nicenboim B, 2016, LANG LINGUIST COMPAS, V10, P591, DOI 10.1111/lnc3.12207; Nieuwland MS, 2018, ELIFE, V7, DOI 10.7554/eLife.33468; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Phillips C, 2006, LANGUAGE, V82, P795, DOI 10.1353/lan.2006.0217; Roark B., 2012, P ACL 2012 SYSTEM DE, P61; Roark Brian, 2009, P 2009 C EMP METH NA, P324, DOI DOI 10.3115/1699510.1699553; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Smith NJ, 2015, PSYCHOPHYSIOLOGY, V52, P157, DOI 10.1111/psyp.12317; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; STOLCKE A, 1995, COMPUT LINGUIST, V21, P165; Sundermeyer M, 2014, PROCEEDINGS OF INTER; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tanner D, 2015, CORTEX, V66, P149, DOI 10.1016/j.cortex.2014.04.007; Townsend D.J., 2001, SENTENCE COMPREHENSI; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Willems RM, 2016, CEREB CORTEX, V26, P2506, DOI 10.1093/cercor/bhv075; WILSON WM, 1973, NATURE, V244, P522, DOI 10.1038/244522a0	74	21	22	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0207741	10.1371/journal.pone.0207741	http://dx.doi.org/10.1371/journal.pone.0207741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650078	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300005
J	Dickey, J; Perrot, V				Dickey, James; Perrot, Veronique			Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro	PLOS ONE			English	Article							BACTERIOPHAGE THERAPY; PSEUDOMONAS; RESISTANCE; INFECTIONS	Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infections as they are inherently refractory to many types of antibiotics. Treating biofilms with phage has shown promise in a handful of experimental and case studies. However, quantification of the effect of phage combined with antibiotics is needed to pave the way for larger clinical trials. Here we explore the effect of using phage in combination with a total of nine antibiotics, applied simultaneously or as a pretreatment before antibiotics are applied to in vitro biofilms of Staphylococcus aureus. Most antibiotics alone were ineffective at low concentration (2xMIC), but the addition of phage to treatment regimens led to substantial improvements in efficacy. At high concentration (10xMIC), antibiotics alone were effective, and in most cases the addition of phage to treatment regimens did not improve efficacy. Using phage with rifampin was also very effective at reducing the outgrowth of resistant strains during the course of treatment.	[Dickey, James; Perrot, Veronique] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Dickey, James] Med Coll Georgia, Augusta, GA 30912 USA	Emory University; University System of Georgia; Augusta University	Perrot, V (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vperrot@emory.edu			NIH-NIGMS grant [GM091875]; Emory College of Arts and Sciences; Emory University School of Medicine; NIH [S10 RR025679]	NIH-NIGMS grant; Emory College of Arts and Sciences; Emory University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH-NIGMS grant GM091875. The Robert P. Apkarian Integrated Electron Microscopy Core is subsidized by the Emory College of Arts and Sciences and the Emory University School of Medicine and is one of the Emory Integrated Core Facilities, and the JEOL JEM-1400 120kV TEM is supported by NIH grant S10 RR025679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2015, PHARMACEUTICALS-BASE, V8, P525, DOI 10.3390/ph8030525; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; [Anonymous], 2015, RSTUDIO INT DEV ENV; Bhattacharya M, 2015, EXPERT REV ANTI-INFE, V13, P1499, DOI 10.1586/14787210.2015.1100533; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; Chaudhry WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168615; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; D'Herelle F., 1926, NATURE, V118, P183, DOI [10.1038/118183a0, DOI 10.1038/118183A0]; Danis-Wlodarczyk K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28115; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Debarbieux L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv225; DESRANLEAU J M, 1948, Can J Public Health, V39, P317; Ferreira FA, 2012, J MICROBIOL METH, V88, P393, DOI 10.1016/j.mimet.2012.01.007; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Galtier M, 2016, ENVIRON MICROBIOL, V18, P2237, DOI 10.1111/1462-2920.13284; Gorski A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01515; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270; Hawkins C, 2010, VET MICROBIOL, V146, P309, DOI 10.1016/j.vetmic.2010.05.014; Henein Alexandra, 2013, Bacteriophage, V3, pe24872; Jennes S, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1709-y; Johnson PJT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003123; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Khan W, 2010, INT MICROBIOL, V13, P207, DOI 10.2436/20.1501.01.127; Kim S, 2012, APPL ENVIRON MICROB, V78, P6380, DOI 10.1128/AEM.00648-12; KNOUF EG, 1946, JAMA-J AM MED ASSOC, V132, P134, DOI 10.1001/jama.1946.02870380016006; Kumaran D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00127; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LANG G, 1979, REV CHIR ORTHOP, V65, P33; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; ONeill J., 2016, TACKLING DRUG RESIST; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169; Roach DR, 2017, CELL HOST MICROBE, V22, P38, DOI 10.1016/j.chom.2017.06.018; Rose T, 2014, INT J BURNS TRAUMA, V4, P66; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Shen Y, 2016, ELIFE, V5; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Torres-Barcelo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106628; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196; Waters EM, 2017, THORAX, V72, P666, DOI 10.1136/thoraxjnl-2016-209265	50	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209390	10.1371/journal.pone.0209390	http://dx.doi.org/10.1371/journal.pone.0209390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650088	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300013
J	Jajack, A; Stamper, I; Gomez, E; Brothers, M; Begtrup, G; Heikenfeld, J				Jajack, Andrew; Stamper, Isaac; Gomez, Eliot; Brothers, Michael; Begtrup, Gavi; Heikenfeld, Jason			Continuous, quantifiable, and simple osmotic preconcentration and sensing within microfluidic devices	PLOS ONE			English	Article							INTERNAL CONCENTRATION POLARIZATION; OSMOSIS; CHALLENGES; MEMBRANE; SENSORS; WATER	Insurmountable detection challenges will impede the development of many of the next-generation of lab-on-a-chip devices (e.g., point-of-care and real-time health monitors). Here we present the first membrane-based, microfluidic sample preconcentration method that is continuous, quantifiable, simple, and capable of working with any analyte. Forward osmosis rapidly concentrates analytes by removing water from a stream of sample fluid. 10-100X preconcentration is possible in mere minutes. This requires careful selection of the semipermeable membrane and draw molecule; therefore, the osmosis performance of several classes of membranes and draw molecules were systematically optimized. Proof-of-concept preconcentration devices were characterized based on their concentration ability and fouling resistance. In-silico theoretical modeling predicts the experimental findings and provides an engineering toolkit for future designs. With this toolkit, inexpensive ready-formanufacturing prototypes were also developed. These devices provide broad-spectrum detection improvements across many analytes and sensing modalities, enabling next-generation lab-on-a-chip devices.	[Jajack, Andrew; Stamper, Isaac] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45220 USA; [Gomez, Eliot; Brothers, Michael; Heikenfeld, Jason] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA; [Begtrup, Gavi; Heikenfeld, Jason] Eccrine Syst Inc, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jajack, A (corresponding author), Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45220 USA.	jajackaj@mail.uc.edu		Stamper, Isaac/0000-0001-9078-757X	Air Force Research Labs (USAF) [FA8650-16-C-6760]; National Science Foundation (EPMD) [ECCS-1608275]; Ohio Federal Research Network [PO FY16-049, WSARC-1077-700]; Eccrine Systems; Center for Advanced Design and Manufacturing of Integrated Microfluidics (NSF I/UCRC) [IIP-1738617]	Air Force Research Labs (USAF); National Science Foundation (EPMD); Ohio Federal Research Network; Eccrine Systems; Center for Advanced Design and Manufacturing of Integrated Microfluidics (NSF I/UCRC)	JCH received awards from the Air Force Research Labs (USAF contract #FA8650-16-C-6760 https://www.wpafb.af.mil/afrl/), the National Science Foundation (EPMD award #ECCS-1608275 https://www.nsf.gov), the Ohio Federal Research Network (PO FY16-049; WSARC-1077-700 https://www.ohiofrn.org), Eccrine Systems, and the industrial members of the Center for Advanced Design and Manufacturing of Integrated Microfluidics (NSF I/UCRC award #IIP-1738617 http://www.inrf.uci.edu/cadmim/).Eccrine Systems provided support in the form of salaries for author GB, and GB was involved with the study design. The specific roles of this author is articulated in the 'author contributions' section.	Alturki AA, 2013, SEP PURIF TECHNOL, V103, P258, DOI 10.1016/j.seppur.2012.10.036; [Anonymous], 2012, MEMBR TECHNOL, V7, P5; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Cai YF, 2016, DESALINATION, V391, P16, DOI 10.1016/j.desal.2016.03.021; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Cha KH, 2015, ELECTROANAL, V27, P670, DOI 10.1002/elan.201400576; Datar R, 2007, IEEE SENSOR, P5, DOI 10.1109/ICSENS.2007.4388320; de Jong J, 2006, LAB CHIP, V6, P1125, DOI 10.1039/b603275c; Do J, 2011, ROBOT CIM-INT MANUF, V27, P245, DOI 10.1016/j.rcim.2010.06.004; Eijkel JCT, 2005, LAB CHIP, V5, P1202, DOI 10.1039/b509819j; Garcia-Castello EM, 2009, J MEMBRANE SCI, V338, P61, DOI 10.1016/j.memsci.2009.04.011; Giordano BC, 2012, ANAL CHIM ACTA, V718, P11, DOI 10.1016/j.aca.2011.12.050; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gray GT, 2006, DESALINATION, V197, P1, DOI 10.1016/j.desal.2006.02.003; Heikenfeld J, 2018, LAB CHIP, V18, P217, DOI 10.1039/c7lc00914c; Heikenfeld J, 2016, ELECTROANAL, V28, P1242, DOI 10.1002/elan.201600018; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Jin X, 2012, J HAZARD MATER, V227, P55, DOI 10.1016/j.jhazmat.2012.04.077; Jun BM, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42198; Khashayar P, 2017, J BRAZ SOC MECH SCI, V39, P1469, DOI 10.1007/s40430-016-0684-6; Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17; Lin CC, 2011, MICROFLUID NANOFLUID, V10, P481, DOI 10.1007/s10404-010-0661-9; McCutcheon JR, 2006, J MEMBRANE SCI, V284, P237, DOI 10.1016/j.memsci.2006.07.049; Moldovan O, 2015, IET CIRC DEVICE SYST, V9, P446, DOI 10.1049/iet-cds.2015.0259; Nicoll P. C., 2013, INT DES ASS WORLD C, V2013, P1, DOI [10.1002/pi.2491, DOI 10.1002/PI.2491]; OLSON WC, 1989, MOL IMMUNOL, V26, P129, DOI 10.1016/0161-5890(89)90094-1; Phuntsho S, 2014, J MEMBRANE SCI, V453, P240, DOI 10.1016/j.memsci.2013.11.009; Ren J, 2014, DESALINATION, V343, P187, DOI 10.1016/j.desal.2013.11.026; Roelofs SH, 2015, LAB CHIP, V15, P3428, DOI 10.1039/c5lc00481k; Walsh DI, 2017, TRENDS BIOTECHNOL, V35, P383, DOI 10.1016/j.tibtech.2017.01.001; Wu T., 2017, HDB PHOTONICS BIOMED, P87, DOI [10.1007/978-94-007-5052-4, DOI 10.1007/978-94-007-6174-2_10-3, 10.1007/978-94-007-6174-210-3]; Yasukawa M, 2015, IND ENG CHEM RES, V54, P8239, DOI 10.1021/acs.iecr.5b01960	32	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210286	10.1371/journal.pone.0210286	http://dx.doi.org/10.1371/journal.pone.0210286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650158	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300050
J	Platten, JD; Cobb, JN; Zantua, RE				Damien Platten, John; Nathaniel Cobb, Joshua; Zantua, Rochelle E.			Criteria for evaluating molecular markers: Comprehensive quality metrics to improve marker-assisted selection	PLOS ONE			English	Article							BLAST RESISTANCE GENES; GRAIN-YIELD; MICROSATELLITE MARKERS; RICE; QTL; DROUGHT	Despite strong interest over many years, the usage of quantitative trait loci in plant breeding has often failed to live up to expectations. A key weak point in the utilisation of QTLs is the "quality" of markers used during marker-assisted selection (MAS): unreliable markers result in variable outcomes, leading to a perception that MAS products fail to achieve reliable improvement. Most reports of markers used for MAS focus on markers derived from the mapping population. There are very few studies that examine the reliability of these markers in other genetic backgrounds, and critically, no metrics exist to describe and quantify this reliability. To improve the MAS process, this work proposes five core metrics that fully describe the reliability of a marker. These metrics give a comprehensive and quantitative measure of the ability of a marker to correctly classify germplasm as QTL[+]/[-], particularly against a background of high allelic diversity. Markers that score well on these metrics will have far higher reliability in breeding, and deficiencies in specific metrics give information on circumstances under which a marker may not be reliable. The metrics are applicable across different marker types and platforms, allowing an objective comparison of the performance of different markers irrespective of the platform. Evaluating markers using these metrics demonstrates that trait-specific markers consistently out-perform markers designed for other purposes. These metrics also provide a superb set of criteria for designing superior marker systems for a target QTL, enabling the selection of an optimal marker set before committing to design.	[Damien Platten, John; Nathaniel Cobb, Joshua; Zantua, Rochelle E.] Int Rice Res Inst, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI)	Platten, JD (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	j.platten@irri.org		Platten, John/0000-0001-6137-5955	Transforming Rice Breeding grant [OPP1076488]; Bill and Melinda Gates Foundation	Transforming Rice Breeding grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	JNC and JDP were funded in part by the Transforming Rice Breeding grant (OPP1076488) of the Bill and Melinda Gates Foundation, www.gatesfoundation.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Babu R, 2004, CURR SCI INDIA, V87, P607; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bernardo R, 2013, THEOR APPL GENET, V126, P999, DOI 10.1007/s00122-012-2032-2; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Platten JD, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-32; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Ghimire KH, 2012, FIELD CROP RES, V131, P88, DOI 10.1016/j.fcr.2012.02.028; Haq TU, 2010, FUNCT PLANT BIOL, V37, P634, DOI 10.1071/FP09247; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; Mohammadi-Nejad G, 2008, AFR J BIOTECHNOL, V7, P730; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Scheuermann KK, 2016, PHYTOPATHOLOGY, V106, P871, DOI 10.1094/PHYTO-02-16-0091-R; Singh AK, 2015, PLANT PATHOLOGY J, V31, P12, DOI 10.5423/PPJ.OA.06.2014.0054; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Swamy BPM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062795; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson M. J., 2014, Plant Breeding and Biotechnology, V2, P195, DOI 10.9787/PBB.2014.2.3.195; Tian DG, 2016, RICE, V9, DOI 10.1186/s12284-016-0091-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Yadaw RB, 2013, FIELD CROP RES, V144, P281, DOI 10.1016/j.fcr.2013.01.019; Yang TF, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0520-9; 조영찬, 2007, Journal of Crop Science and Biotechnology, V10, P265	32	35	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210529	10.1371/journal.pone.0210529	http://dx.doi.org/10.1371/journal.pone.0210529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645632	gold, Green Submitted, Green Published			2022-12-27	WOS:000455810200033
J	Delgado, R; Nunez-Gonzalez, JD				Delgado, Rosario; David Nunez-Gonzalez, J.			Enhancing Confusion Entropy (CEN) for binary and multiclass classification	PLOS ONE			English	Article								Different performance measures are used to assess the behaviour, and to carry out the comparison, of classifiers in Machine Learning. Many measures have been defined on the literature, and among them, a measure inspired by Shannon's entropy named the Confusion Entropy (CEN). In this work we introduce a new measure, MCEN, by modifying CEN to avoid its unwanted behaviour in the binary case, that disables it as a suitable performance measure in classification. We compare MCEN with CEN and other performance measures, presenting analytical results in some particularly interesting cases, as well as some heuristic computational experimentation.	[Delgado, Rosario] Univ Autonoma Barcelona, Dept Math, Campus UAB, Cerdanyola Del Valles, Spain; [David Nunez-Gonzalez, J.] Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain	Autonomous University of Barcelona; University of Basque Country	Nunez-Gonzalez, JD (corresponding author), Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain.	josedavid.nunez@ehu.eus		Nunez Gonzalez, Jose David/0000-0002-5047-1033; Delgado, Rosario/0000-0003-1208-9236	Ministerio de Economia y Competitividad, Gobierno de Espana [MTM2015 67802-P]	Ministerio de Economia y Competitividad, Gobierno de Espana	This work was supported by Ministerio de Economia y Competitividad, Gobierno de Espana, MTM2015 67802-P to R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work have been supported by Ministerio de Economia y Competitividad, Gobierno de Espana, project ref. MTM2015 67802-P.	[Anonymous], [No title captured]; Antunes F, 2017, APPL SOFT COMPUT, V60, P831, DOI 10.1016/j.asoc.2017.06.043; Gonzalez D, 2019, ADV INTELLIGENT SYST, V771; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Jin H., 2013, P 2013 INT C MACH LE; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036540; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Roumani YF, 2018, ANN OPER RES, V263, P429, DOI 10.1007/s10479-016-2350-x; Roumani YF, 2013, HEALTH CARE MANAG SC, V16, P119, DOI 10.1007/s10729-012-9216-9; Sigdel Madhav, 2013, Machine Learning and Data Mining in Pattern Recognition. 9th International Conference, MLDM 2013. Proceedings: LNCS 7988, P281, DOI 10.1007/978-3-642-39712-7_22; Sublime J., 2016, INT J HYBRID INTELLI, V12, P245, DOI [DOI 10.3233/HIS-160219, 10.3233/HIS-160219]; Sublime J, 2017, PATTERN RECOGN, V72, P144, DOI 10.1016/j.patcog.2017.07.014; Sublime J, 2017, IEEE IJCNN, P4126, DOI 10.1109/IJCNN.2017.7966377; Valverde-Albacete FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084217; Wang XN, 2013, ENTROPY-SWITZ, V15, P4969, DOI 10.3390/e15114969; Wei JM, 2010, EXPERT SYST APPL, V37, P3799, DOI 10.1016/j.eswa.2009.11.040	16	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210264	10.1371/journal.pone.0210264	http://dx.doi.org/10.1371/journal.pone.0210264			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640948	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000021
J	Nemtseva, EV; Gerasimova, MA; Melnik, TN; Melnik, BS				Nemtseva, Elena V.; Gerasimova, Marina A.; Melnik, Tatiana N.; Melnik, Bogdan S.			Experimental approach to study the effect of mutations on the protein folding pathway	PLOS ONE			English	Article							FLUORESCENCE LIFETIMES ORIGIN; TRANSITION-STATE; EXCHANGE; TRYPTOPHAN; STABILITY; ELEMENTS	Is it possible to compare the physicochemical properties of a wild-type protein and its mutant form under the same conditions? Provided the mutation has destabilized the protein, it may be more correct to compare the mutant protein under native conditions to the wild-type protein destabilized with a small amount of the denaturant. In general, is it appropriate to compare the properties of proteins destabilized by different treatments: mutations, pH, temperature, and denaturants like urea? These issues have compelled us to search for methods and ways of presentation of experimental results that would allow a comparison of mutant forms of proteins under different conditions and lead to conclusions on the effect of mutations on the protein folding/unfolding pathway. We have studied equilibrium unfolding of wild-type bovine carbonic anhydrase II (BCA II) and its six mutant forms using different urea concentrations. BCA II has been already studied in detail and is a good model object for validating new techniques. In this case, time-resolved fluorescence spectroscopy was chosen as the basic research method. The main features of this experimental method allowed us to compare different stages of unfolding of studied proteins and prove experimentally that a single substitution of the amino acid in three mutant forms of BCA II affected the native state of the protein but did not change its unfolding pathway. On the contrary, the inserted disulfide bridge in three other mutant forms of BCA II affected the protein unfolding pathway. An important result of this research is that we have validated the new approach allowing investigation of the effect of mutations on the folding of globular proteins, because in this way it is possible to compare proteins in the same structural states rather than under identical conditions.	[Nemtseva, Elena V.; Gerasimova, Marina A.] Siberian Fed Univ, Krasnoyarsk, Russia; [Nemtseva, Elena V.] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk, Russia; [Melnik, Tatiana N.; Melnik, Bogdan S.] Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia	Siberian Federal University; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Russian Academy of Sciences	Melnik, BS (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Gerasimova, Marina A/L-5569-2017; Nemtseva, Elena/M-5056-2016; Melnik, Bogdan/U-1988-2017	Gerasimova, Marina A/0000-0001-8445-2714; Nemtseva, Elena/0000-0003-1725-8625; Melnik, Bogdan/0000-0002-9176-6452	Ministry of Science and Education of the Russian Federation [6.7734.2017]; Russian Science Foundation [N14-24-00157]	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	The study of time-resolved protein fluorescence was supported by the Ministry of Science and Education of the Russian Federation (Projects 6.7734.2017). The investigation of protein fluorescence and genetic engineering studies of bovine carbonic anhydrase II were supported by grant N14-24-00157 from the Russian Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study of time-resolved protein fluorescence was supported by the Ministry of Science and Education of the Russian Federation (Project 6.7734.2017). The investigation of protein fluorescence and genetic engineering studies of bovine carbonic anhydrase II were supported by grant N14-24-00157 from the Russian Science Foundation.	Albani JR, 2014, J FLUORESC, V24, P93, DOI 10.1007/s10895-013-1277-8; Albani JR, 2014, J FLUORESC, V24, P105, DOI 10.1007/s10895-013-1274-y; ARMSTRONG JM, 1966, J BIOL CHEM, V241, P5137; Beechem J M, TOPICS FLUORESCENCE, P241; Beechem JM, 1997, METHOD ENZYMOL, V278, P24; Berberan-Santos, 2013, MOL FLUORESCENCE PRI; BREMS DN, 1985, BIOCHEMISTRY-US, V24, P1689, DOI 10.1021/bi00328a018; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Choe SE, 2000, J MOL BIOL, V304, P99, DOI 10.1006/jmbi.2000.4190; DOLGIKH DA, 1984, FEBS LETT, V165, P88, DOI 10.1016/0014-5793(84)80020-4; Dyson HJ, 1996, ANNU REV PHYS CHEM, V47, P369, DOI 10.1146/annurev.physchem.47.1.369; Englander SW, 2017, P NATL ACAD SCI USA, V114, P8253, DOI 10.1073/pnas.1706196114; FERSHT AR, 1992, FARADAY DISCUSS, V93, P183, DOI 10.1039/fd9929300183; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Krishnamoorthy G, 2018, J BIOSCIENCES, V43, P555, DOI 10.1007/s12038-018-9763-4; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; Melnik BS, 2008, BIOCHEM BIOPH RES CO, V369, P701, DOI 10.1016/j.bbrc.2008.02.096; Melnik B. S., 2016, Biophysics, V61, P860, DOI 10.1134/S0006350916060178; Melnik BS, 2016, BBA-PROTEINS PROTEOM, V1864, P1809, DOI 10.1016/j.bbapap.2016.09.006; Melnik TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098645; Melnik TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048604; Nemtseva E. V., 2016, Biophysics, V61, P193, DOI 10.1134/S0006350916020111; Nemtseva EV, 2018, METHODS APPL FLUORES, V6, DOI 10.1088/2050-6120/aa994a; Pilipczuk J, 2017, J BIOL CHEM, V292, P16136, DOI 10.1074/jbc.M117.785477; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; SEMISOTNOV GV, 1990, J MOL BIOL, V213, P561, DOI 10.1016/S0022-2836(05)80215-3; Tran DT, 2012, ANAL CHEM, V84, P1653, DOI 10.1021/ac202927p; Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45; VIGUERA AR, 1995, J MOL BIOL, V247, P670, DOI 10.1016/S0022-2836(05)80146-9; Yang HJ, 1997, BIOCHEMISTRY-US, V36, P14992, DOI 10.1021/bi9717183; ZAHLER WL, 1968, J BIOL CHEM, V243, P716	38	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210361	10.1371/journal.pone.0210361	http://dx.doi.org/10.1371/journal.pone.0210361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640946	gold, Green Submitted, Green Published			2022-12-27	WOS:000455808000023
J	Gomez-Torres, MJ; Santero, JR; Flores, JG				Jose Gomez-Torres, Maria; Rodriguez Santero, Javier; Gil Flores, Javier			Job-search strategies of individuals at risk of poverty and social exclusion in Spain	PLOS ONE			English	Article							GLOBALIZATION; INTERNET; EMPLOYMENT; WEALTH	In Spain, the issue of unemployment or precarious employment worsen with globalization, leading to an expansion of the so-called working poor in the labour market. According to previous literature, the economic poverty that is characteristic of this group may accompany poverty competency. In particular, the working poor resort to informal and poorly developed job-search strategies. This study addresses the job search methods used by people at risk of poverty and social exclusion. It provides evidence on the subject and serves as a basis for the adaptation of socio-labour intermediation programmes to this group. The hypothesis of this study is that people at high risk will predominantly use informal strategies that require a low level of job-search skills. A survey-based correlational study is conducted using a questionnaire completed by 279 people participating in socio-labour intermediation programmes developed by the Action against Hunger Foundation (AaHF) in Spain. Information on poverty indicators and on job-search strategies is collected. Data are analysed through cluster analysis, which distinguish two groups of people at risk of poverty and social exclusion (high risk and low risk), followed by a comparison of means (t-test) with a subsequent calculation of effect size using Cohen's d. Results show statistically significant differences with a medium effect size (between 0.45 and 0.50) for the typology of job-search strategies used, confirming the initial hypothesis. These results offer relevant information that should be considered when developing programmes aimed at improving social and labour issues for people at risk of poverty and social exclusion.	[Jose Gomez-Torres, Maria] Univ Seville, Fac Educ Sci, Dept Didact & Educ Org, Seville, Spain; [Rodriguez Santero, Javier; Gil Flores, Javier] Univ Seville, Fac Educ Sci, Dept Res Methods & Diagnost Educ, Seville, Spain	University of Sevilla; University of Sevilla	Gomez-Torres, MJ (corresponding author), Univ Seville, Fac Educ Sci, Dept Didact & Educ Org, Seville, Spain.	gomeztor@us.es		GOMEZ-TORRES, MARIA JOSE/0000-0002-4797-3681	Ministry of Economy and Competitiveness (MINECO - Government of Spain); European Regional Development Fund (ERDF-FEDER) [DER2015-63701-C3-1-R]	Ministry of Economy and Competitiveness (MINECO - Government of Spain); European Regional Development Fund (ERDF-FEDER)	Ministry of Economy and Competitiveness (MINECO - Government of Spain) and the European Regional Development Fund (ERDF-FEDER) within the DER2015-63701-C3-1-R research project "Regulatory instruments for the improvement of the trajectories of the working poor and their social inclusion", of the 2015 Call for R+D+i Projects of the State Program for Research, Development and Innovation Oriented to the Challenges of Society. 2015 Call for R+D+i Projects of the State Program for Research, Development and Innovation Oriented to the Challenges of Society and the Action againts Hunger Fundation (AaHF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo D, 2018, REWARD WORK NOT WEAL, DOI [10.21202/2017-1350, DOI 10.21202/2017-1350]; Alguacil J., 2015, WORKING POOR CTR GRA, P9; Alonso MA, 2003, REV PSICOLOGIA GEN A, V56, P335; [Anonymous], 1998, GROWTH INEQUALITY GL; Artero JM, 2017, WORKING POOR WORKING, P159; Beard TR, 2012, TELECOMMUN POLICY, V36, P260, DOI 10.1016/j.telpol.2011.12.001; Blanch JM, 1990, OLD NEW UNEMPLOYMENT; BLAU DM, 1990, J POLIT ECON, V98, P637, DOI 10.1086/261698; Boswell WR, 2012, J MANAGE, V38, P129, DOI 10.1177/0149206311421829; Calvo FJ, 2016, REV ANDALUZA TRABAJO, V134, P63; Campos R, 2014, TELECOMMUN POLICY, V38, P1095, DOI 10.1016/j.telpol.2014.09.006; Canibano C, 2008, NUEVAS TECNOLOGIAS N, P129; Carr M, 2002, 1 INTEGRATION; CHILMAN CS, 1991, FAM RELAT, V40, P191, DOI 10.2307/585482; Christainsen GB, 2013, INTELLIGENCE, V41, P688, DOI 10.1016/j.intell.2013.07.020; Crettaz E., 2011, MAPS WORKINGS PAPERS, V3; Daniele V, 2013, J SOCIO-ECON, V46, P27, DOI 10.1016/j.socec.2013.06.005; DellaVigna S, 2005, J LABOR ECON, V23, P527, DOI 10.1086/430286; Diaz R, 2003, FORUM DE RECERCA, V9, P1; Dollar D, 2002, J ECON GROWTH, V7, P195, DOI 10.1023/A:1020139631000; Dreher A, 2008, REV INT ECON, V16, P516, DOI 10.1111/j.1467-9396.2008.00743.x; Drentea P, 1998, GENDER SOC, V12, P321, DOI 10.1177/0891243298012003005; Easterly W., 2006, ARE POOR COUNTRIES D; European Commission, 2003, JOINT REP SOC INCL S; Feldman DC, 2002, HUM RESOUR MANAGE-US, V41, P175, DOI 10.1002/hrm.10030; Frijters P, 2005, ECON J, V115, pF369; García Cabrera Antonia Mercedes, 2008, Rev. psicol. trab. organ., V24, P203, DOI 10.4321/s1576-59622008000200005; Garcia I, 2000, REV EC APLICADA, VVIII, P5; Gomez-Alvarez MR, 2017, WORKING POOR WORKING, P91; Gomez-Torres MJ, 2017, WORKING POOR WORKING, P391; Gonzalez O., 2001, B EC ICE, V2709, P20; Gottfredson L., 2002, INTELLIGENCE I UNPUB; Hellier J, 2015, WORKING PAPERS, V355; HERNANDEZ PEDRENO Manuel, 2010, REV INTERUNIV FORM P, P25; Herrnstein C, 1994, BELL CURVE RESHAPING; Hirschl T, 2011, J POVERTY, V15, P350, DOI 10.1080/10875549.2011.589680; Izquierdo T, 2011, REVISTA IBEROAMERICA, V32, P105; James H, 2008, INT AFF, V84, P421, DOI 10.1111/j.1468-2346.2008.00715.x; JONES SRG, 1989, OXFORD B ECON STAT, V51, P277; Kaplinsky Raphael., 2013, GLOBALIZATION POVERT; Kleit RG, 2010, HOUSING STUDIES, V17, P83, DOI [10.1080/0267303012105910, DOI 10.1080/0267303012105910]; Krumer-Nevo M, 2011, J SOC POLICY, V40, P313, DOI 10.1017/S004727941000053X; Kuhn P, 2000, MON LABOR REV, V123, P3; Lancee B, 2016, ETHNICITIES, V16, P349, DOI 10.1177/1468796815581426; Laparra M., 2014, EDUCACION FUTURO, V30, P81; Leana CR, 2012, ORGAN SCI, V23, P888, DOI 10.1287/orsc.1110.0672; Llano JC, 2017, STATE POVERTY MONITO; Lynn R, 2012, INTELLIGENCE, V40, P226, DOI 10.1016/j.intell.2011.11.004; Malgesini G, 2014, EAPN POVERTY DOSSIER; Martinez M. F, 2001, ANU PSICOL, V32, P51; Milanovic B., 2016, GLOBAL INEQUALITY; Oasis KT, 2014, EC RES GUARDIAN, V4, P25; Pager D, 2015, AM J SOCIOL, V120, P1005, DOI 10.1086/681072; Perez B, 2014, ZERBITZUAN REV SERVI, P137, DOI DOI 10.5569/1134-7147.57.08; Pirog D, 2016, HIGH EDUC, V71, P557, DOI 10.1007/s10734-015-9923-5; Ravallion M, 2003, INT AFF, V79, P739, DOI 10.1111/1468-2346.00334; Restrepo Plaza Lina María, 2013, Semest. Econ., V16, P67; Saks AM, 2000, J VOCAT BEHAV, V56, P277, DOI 10.1006/jvbe.1999.1714; Subirats J., 2004, POVERTY SOCIAL EXCLU; UNDP, 2000, HUMAN DEV REPORT; Vansteenkiste S, 2016, EUROPEAN J WORK ORG, V25, P1; Veira J. L., 2004, REV ESP SOCIOL, V4, P51; Wade RH, 2004, INT J HEALTH SERV, V34, P381, DOI 10.2190/G8F1-01FL-MEDW-JVG1	63	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210605	10.1371/journal.pone.0210605	http://dx.doi.org/10.1371/journal.pone.0210605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633781	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100032
J	Martinez, A; Soldevila, N; Romero-Tamarit, A; Torner, N; Godoy, P; Rius, C; Jane, M; Dominguez, A; Alseda, M; Alvarez, J; Arias, C; Balana, PJ; Barrabeig, I; Camps, N; Carol, M; Ferras, J; Ferrus, G; Follia, N; Godoy, P; Bach, P; Jane, M; Martinez, A; Minguell, S; Parron, I; Plasencia, E; Sala-Farre, MR; Torner, N; Torra, R; Torres, J; Cayla, J; Gorrindo, P; Rius, C; Marcos, MA; Mosquera, MDM; Vilella, A; Anton, A; Pumarola, T; Campins, M; Garcia, D; Espejo, E; Freixas, N; Garcia, R; Maraver, E; Mas, D; Perez, R; Rebull, J; Pou, J; Garcia-Pardo, G; Olona, M; Barcenilla, F; Castellana, D; Navarro-Rubio, G; Force, LL				Martinez, Ana; Soldevila, Nuria; Romero-Tamarit, Arantxa; Torner, Nuria; Godoy, Pere; Rius, Cristina; Jane, Mireia; Dominguez, Angela; Alseda, M.; Alvarez, J.; Arias, C.; Balana, P. J.; Barrabeig, I; Camps, N.; Carol, M.; Ferras, J.; Ferrus, G.; Follia, N.; Godoy, P.; Bach, P.; Jane, M.; Martinez, A.; Minguell, S.; Parron, I; Plasencia, E.; Sala-Farre, M. R.; Torner, N.; Torra, R.; Torres, J.; Cayla, J.; Gorrindo, P.; Rius, C.; Marcos, M. A.; Mosquera, M. D. M.; Vilella, A.; Anton, A.; Pumarola, T.; Campins, M.; Garcia, D.; Espejo, E.; Freixas, N.; Garcia M, Riera; Maraver, E.; Mas, D.; Perez, R.; Rebull, J.; Pou, J.; Garcia-Pardo, G.; Olona, M.; Barcenilla, F.; Castellana, D.; Navarro-Rubio, G.; Force, L. L.		Surveillance Hospitalized Cases	Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype	PLOS ONE			English	Article							A H1N1 PDM09; SEASONAL INFLUENZA; INFECTION; PNEUMONIA; COMPLICATIONS; MORTALITY; FEATURES; DEATH	Seasonal influenza is a cause of hospitalization, especially in people with underlying disease or extreme age, and its severity may differ depending on the types and subtypes of circulating viruses. We investigated the factors associated with ICU admission or death in hospitalized patients with severe laboratory-confirmed influenza according to the viral type and subtype. An observational epidemiological study was carried out in patients aged >= 18 years from 12 Catalan hospitals between 2010 and 2016. For each reported case we collected demographic, virological and clinical characteristics. A mixed-effects logistic regression model was used to estimate crude and adjusted ORs. 1726 hospitalized patients were included: 595 (34.5%) were admitted to the ICU and 224 (13.0%) died. Lower ICU admission was associated with age >= 75 years in all influenza types and subtypes and with age 65-74 years for type A. In contrast, the 65-74 and >= 75 years age groups were associated with an increased risk of death in all types and subtypes, especially for type B (aOR 27.42, 95% CI: 4.95-151.93 and 15.96; 95% CI: 3.01-84.68). The comorbidity most closely associated with severe outcomes was immune deficiency, which was associated with death for type B (aOR 9.02, 95% CI: 3.05-26.69) and subtype A(H1N1)pdm09 (aOR 3.16, 95% CI: 1.77-5.66). Older age was a differential factor for ICU admission and death: it was associated with lower ICU admission but a risk factor for death. The comorbidity with the closest association with death was immune deficiency, mainly in influenza type B patients.	[Martinez, Ana; Torner, Nuria; Godoy, Pere; Jane, Mireia] Generalitat Catalunya, Agencia Salut Publ Catalunya, Barcelona, Spain; [Martinez, Ana; Soldevila, Nuria; Romero-Tamarit, Arantxa; Torner, Nuria; Godoy, Pere; Rius, Cristina; Jane, Mireia; Dominguez, Angela] CIBERESP, Madrid, Spain; [Soldevila, Nuria; Torner, Nuria; Dominguez, Angela] Univ Barcelona, Dept Med, Barcelona, Spain; [Rius, Cristina] Agencia Salut Publ Barcelona, Barcelona, Spain; [Alseda, M.; Alvarez, J.; Arias, C.; Balana, P. J.; Barrabeig, I; Camps, N.; Carol, M.; Ferras, J.; Ferrus, G.; Follia, N.; Godoy, P.; Bach, P.; Jane, M.; Martinez, A.; Minguell, S.; Parron, I; Plasencia, E.; Sala-Farre, M. R.; Torner, N.; Torra, R.; Torres, J.] Publ Hlth Agcy Catalonia, Barcelona, Spain; [Cayla, J.; Gorrindo, P.; Rius, C.] Publ Hlth Agcy Barcelona, Barcelona, Spain; [Marcos, M. A.; Mosquera, M. D. M.; Vilella, A.] Hosp Clin Barcelona, Barcelona, Spain; [Anton, A.; Pumarola, T.; Campins, M.] Hosp Univ Vall dHebron, Barcelona, Spain; [Garcia, D.] Hosp Josep Trueta, Girona, Spain; [Espejo, E.] Hosp Terrassa, Terrassa, Spain; [Freixas, N.; Garcia M, Riera] Mutua Terrassa, Terrassa, Spain; [Maraver, E.; Mas, D.; Perez, R.] Hosp Altahia Manresa, Manresa, Spain; [Rebull, J.] Hosp Verge Cinta, Tortosa, Spain; [Pou, J.] Hosp St Joan de Deu, Esplugues, Spain; [Garcia-Pardo, G.; Olona, M.] Hosp Joan 23, Tarragona, Spain; [Barcenilla, F.; Castellana, D.] Hosp Arnau Vilanova, Lleida, Spain; [Navarro-Rubio, G.] Consorci Sanitari Parc Tauli, Sabadell, Spain; [Force, L. L.] Hosp Mataro, Mataro, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona; Public Health Agency of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Vall d'Hebron; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat Rovira i Virgili; University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Dominguez, A (corresponding author), CIBERESP, Madrid, Spain.; Dominguez, A (corresponding author), Univ Barcelona, Dept Med, Barcelona, Spain.	angela.dominguez@ub.edu	, Nuria/AAG-8951-2019; Bach, Pascal/E-9370-2013; Antón, Andrés/B-3308-2011	, Nuria/0000-0003-0143-5295; Bach, Pascal/0000-0003-0804-8466; Antón, Andrés/0000-0002-1476-0815; Romero Tamarit, Arantxa/0000-0003-4391-6150; Dominguez, Angela/0000-0003-0219-1907; Godoy, Pere/0000-0002-2896-7286	Programme of Surveillance, Prevention and Control of Transmissible Diseases (PREVICET); CIBER de Epidemiologia y Salud Publica (CIBERESP); Instituto de Salud Carlos III, Madrid; Catalan Agency for the Management of Grants for University Research (AGAUR) [2017/SGR 1342]	Programme of Surveillance, Prevention and Control of Transmissible Diseases (PREVICET); CIBER de Epidemiologia y Salud Publica (CIBERESP); Instituto de Salud Carlos III, Madrid(Instituto de Salud Carlos III); Catalan Agency for the Management of Grants for University Research (AGAUR)	This study was supported by the Programme of Surveillance, Prevention and Control of Transmissible Diseases (PREVICET), CIBER de Epidemiologia y Salud Publica (CIBERESP), Instituto de Salud Carlos III, Madrid and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant Number 2017/SGR 1342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia de Salut Pu blica de Catalunya, 2018, PLA ACT CAT ENFR INF; Alvarez-Lerma F, 2017, J HOSP INFECT, V95, P200, DOI 10.1016/j.jhin.2016.12.017; Blaser, 2015, PRINCIPLES PRACTICE, P2000, DOI DOI 10.1016/B978-1-4557-4801-3.00167-3; Boddington NL, 2017, EPIDEMIOL INFECT, V145, P1461, DOI 10.1017/S095026881700005X; Braun ES, 2015, INFECTION, V43, DOI 10.1007/s15010-015-0802-x; Bresee JS., 2018, PLOTKINS VACCINES, P456, DOI DOI 10.1016/B978-0-323-35761-6.00031-6; Caini S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3181-y; Chagvardieff A, 2018, MED MALADIES INFECT, V48, P180, DOI 10.1016/j.medmal.2017.11.007; Cobey S, 2018, CLIN INFECT DIS, V67, P327, DOI 10.1093/cid/ciy097; Cordero A, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12240; Dominguez A, 2018, EPIDEMIOL INFECT, V146, P799, DOI 10.1017/S0950268818000663; Dwyer DE, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx212; Fedson DS, 2018, HUM VACC IMMUNOTHER, V14, P790, DOI 10.1080/21645515.2017.1378292; Garg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1004-y; Godoy P, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.43.1700732; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Huang WT, 2015, INT HEALTH, V7, P73, DOI 10.1093/inthealth/ihu083; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Ishiguro T, 2016, INTERNAL MED, V55, P731, DOI 10.2169/internalmedicine.55.5227; Katz MH., 2011, MULTIVARIABLE ANAL; Klein Sabra L, 2010, Biol Sex Differ, V1, P5, DOI 10.1186/2042-6410-1-5; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Loubet P, 2016, J CLIN VIROL, V79, P68, DOI 10.1016/j.jcv.2016.04.005; Lynfield R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101785; Mata-Marin Luis Alberto, 2015, BMC Res Notes, V8, P432, DOI 10.1186/s13104-015-1349-8; Mostaza JM, 2011, INF TER SIST NAC SAL, V35, P46; Ramos JM, 2016, REV ESP QUIM, V29, P296; Freitas ARR, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01903; Rizzo C, 2016, J Prev Med Hyg, V57, pE23; Shah NS, 2015, INFECT CONT HOSP EP, V36, P1251, DOI 10.1017/ice.2015.170; Su S, 2014, CLIN INFECT DIS, V59, P252, DOI 10.1093/cid/ciu269; Sun Y, 2016, INFECT DIS-NOR, V48, P813, DOI 10.1080/23744235.2016.1201721; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Taylor G, 2016, EPIDEMIOL INFECT, V144, P741, DOI 10.1017/S0950268815002113; Van Kerkhove MD, 2015, VACCINE, V33, P6970, DOI 10.1016/j.vaccine.2015.09.115; World Health Organization, 2018, INFL SEAS; Wright PF., 2013, FIELDS VIROLOGY, V6th ed., P1186; Yang SQ, 2014, CLIN RESPIR J, V8, P185, DOI 10.1111/crj.12056	38	54	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210353	10.1371/journal.pone.0210353	http://dx.doi.org/10.1371/journal.pone.0210353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633778	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100020
J	Adi-Japha, E; Berke, R; Shaya, N; Julius, MS				Adi-Japha, Esther; Berke, Roni; Shaya, Nehama; Julius, Mona S.			Different post-training processes in children's and adults' motor skill learning	PLOS ONE			English	Article							SPACING PRACTICE SESSIONS; AGE-RELATED DIFFERENCES; TIME-COURSE; SLEEPS ROLE; CONSOLIDATION; PERFORMANCE; MEMORY; ACQUISITION; CORTEX; STABILIZATION	Do young children and adults share similar underlying motor skill learning mechanisms? Past studies have shown that school-aged children's speed of performance developed over wake periods of a few hours post-training. Such training-dependent gains were not found in adults. In the current study of children as young as 5-years-old and young adults who practiced a simple grapho-motor task, this finding was replicated only by the children that showed faster performance a few hours post-training. These positive gains in performance speed were retained two weeks later. Furthermore, among the children, variations in gains attained a few hours post-training were associated with initial performance level. These behavioral findings indicate different underlying post-training processes in children's and adults' motor skill learning thus, supporting differential tutoring of skills.	[Adi-Japha, Esther; Berke, Roni; Shaya, Nehama] Bar Ilan Univ, Sch Educ, Ramat Gan, Israel; [Adi-Japha, Esther] Bar Ilan Univ, Gonda Goldschmied Multidisciplinary Brain Res Ctr, Ramat Gan, Israel; [Julius, Mona S.] Levinsky Coll Educ, Special Educ Studies, Tel Aviv, Israel	Bar Ilan University; Bar Ilan University	Adi-Japha, E (corresponding author), Bar Ilan Univ, Sch Educ, Ramat Gan, Israel.; Adi-Japha, E (corresponding author), Bar Ilan Univ, Gonda Goldschmied Multidisciplinary Brain Res Ctr, Ramat Gan, Israel.	Esther.Adi-Japha@biu.ac.il	/GLU-1786-2022; Adi-Japha, Esther/O-9945-2019	/0000-0001-9757-0031; Adi-Japha, Esther/0000-0001-9757-0031	EAJ Israel Science Foundation [1632/13]; Israel Science Foundation [1632/13]	EAJ Israel Science Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by EAJ Israel Science Foundation, 1632/13 (https://www.isf.org.il/#/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Israel Science Foundation, 1632/13.	Adi-Japha E., 2013, NEUROPSYCHOLOGY CHIL, P215, DOI [10.1007/978-1-4614-6834-9_11, DOI 10.1007/978-1-4614-6834-9_11]; Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Adi-Japha E, 2014, DEVELOPMENTAL SCI, V17, P424, DOI 10.1111/desc.12132; Adi-Japha E, 2011, RES DEV DISABIL, V32, P2963, DOI 10.1016/j.ridd.2011.05.005; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Ashtamker L, 2013, NEUROBIOL LEARN MEM, V106, P26, DOI 10.1016/j.nlm.2013.07.003; Astill RG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00910; Beery K., 2010, SCORING TEACHING MAN, V6th ed; Biane JS, 2015, J NEUROSCI, V35, P4719, DOI 10.1523/JNEUROSCI.2792-14.2015; Bishop DVM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037326; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Censor N, 2012, NAT REV NEUROSCI, V13, P658, DOI 10.1038/nrn3315; Cohen MJ., 1997, CHILDRENS MEMORY SCA; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Desrochers PC, 2016, EXP BRAIN RES, V234, P763, DOI 10.1007/s00221-015-4506-3; Dorfberger S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000240; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Ferrel-Chapus C, 2002, EXP BRAIN RES, V144, P506, DOI 10.1007/s00221-002-1064-2; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Goedert KM, 2008, EXP BRAIN RES, V189, P189, DOI 10.1007/s00221-008-1414-9; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hikosaka O, 2002, EXP BRAIN RES, V147, P494, DOI 10.1007/s00221-002-1258-7; Hodel AS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00153; Holz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040963; Hotermans C, 2008, EUR J NEUROSCI, V28, P1216, DOI 10.1111/j.1460-9568.2008.06421.x; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Julius MS, 2016, LEARN INDIVID DIFFER, V51, P265, DOI 10.1016/j.lindif.2016.08.034; Julius MS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00225; Julius MS, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00083; Kaufman A. S., 2004, KAUFMAN ASSESSMENT B, V2nd; Kleim JA, 2003, NEURON, V40, P167, DOI 10.1016/S0896-6273(03)00592-0; Lejeune C, 2013, J EXP CHILD PSYCHOL, V116, P157, DOI 10.1016/j.jecp.2013.05.001; Lohse KR, 2014, NEUROPSYCHOLOGIA, V59, P130, DOI 10.1016/j.neuropsychologia.2014.05.001; Lukacs A, 2014, NEUROPSYCHOLOGY, V28, P472, DOI 10.1037/neu0000052; Magallon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158684; Manuel AL, 2018, CORTEX, V106, P237, DOI 10.1016/j.cortex.2018.06.005; McBride TJ, 2015, NEUROBIOL LEARN MEM, V121, P39, DOI 10.1016/j.nlm.2015.01.011; Nettersheim A, 2015, J NEUROSCI, V35, P6696, DOI 10.1523/JNEUROSCI.1236-14.2015; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Pan SC, 2015, PSYCHOL BULL, V141, P812, DOI 10.1037/bul0000009; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Press DZ, 2005, COGNITIVE BRAIN RES, V25, P375, DOI 10.1016/j.cogbrainres.2005.05.010; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Savion-Lemieux T, 2009, EXP BRAIN RES, V195, P293, DOI 10.1007/s00221-009-1786-5; Shea CH, 2000, HUM MOVEMENT SCI, V19, P737, DOI 10.1016/S0167-9457(00)00021-X; Soderstrom NC, 2014, J MEM LANG, V73, P99, DOI 10.1016/j.jml.2014.03.003; Starch D, 1910, PSYCHOL BULL, V7, P20, DOI 10.1037/h0063796; Taubert M, 2016, NEUROIMAGE, V133, P399, DOI 10.1016/j.neuroimage.2016.03.017; Urbain C, 2014, J SLEEP RES, V23, P44, DOI 10.1111/jsr.12082; Vandierendonck A, 2017, BEHAV RES METHODS, V49, P653, DOI 10.3758/s13428-016-0721-5; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Zinke K, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12463	57	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210658	10.1371/journal.pone.0210658	http://dx.doi.org/10.1371/journal.pone.0210658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629711	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000120
J	Lee, H; Bang, J; Kim, S; Yang, H				Lee, HyeYeon; Bang, JongHo; Kim, SooJung; Yang, HeeJun			The axillary vein and its tributaries are not in the mirror image of the axillary artery and its branches	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; VASCULAR ACCESS; CEPHALIC ARCH; COMPLICATIONS; IMPLANTATION; INSERTION; LEADS; SAFE	Introduction The axillary and cephalic veins are used for various clinical purposes but their anatomy is not fully understood. Increased knowledge and information about them as well as superficial veins in the upper arm would be useful. Objective The aim of this study is to contribute to the literature regarding the anatomy of the venous drainage of the upper extremity. Methods The veins of forty upper extremities from twenty one adult cadavers were injected and their axillary regions dissected. The course and pattern of drainage of the venous tributaries in the axillary region were identified and recorded. Results The basilic, brachial, subscapular, lateral thoracic and superior thoracic veins drained mainly into the axillary vein, in common with most textbook descriptions. However, the thoracoacromial veins were observed to drain into the cephalic vein in 70.0% of upper limbs. In addition, a venous channel connecting the distal part and proximal part of the axilla was found along the posterolateral wall of the axilla in 77.5% of the upper limbs. In 95.0% of upper limbs, we discovered a superficial vein which ran from the axillary base and drained directly into the axillary vein. Conclusion The veins from the inferomedial part of the axilla drain into the axillary vein, whereas the veins from the superolateral part of the axilla drain into the cephalic vein. The venous drainage of the axilla is variable and in common with venous drainage elsewhere, does not necessarily follow the pattern of the arterial supply.	[Lee, HyeYeon; Bang, JongHo; Kim, SooJung] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Yang, HeeJun] Gachon Univ, Coll Med, Dept Anat, Incheon, South Korea	Yonsei University; Yonsei University Health System; Gachon University	Yang, H (corresponding author), Gachon Univ, Coll Med, Dept Anat, Incheon, South Korea.	yangmdphd@gmail.com		Yang, Hee-Jun/0000-0002-4983-6365; Lee, Hye-Yeon/0000-0001-6945-1967	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2055742]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2055742), http://english.moe.go.kr/main.do?s=english.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2015, INT J CARDIOL, V199, P277, DOI 10.1016/j.ijcard.2015.07.055; Al Fagih A, 2015, J INVASIVE CARDIOL, V27, P341; Andel H, 1999, BURNS, V25, P753, DOI 10.1016/S0305-4179(99)00090-X; Askegard-Giesmann JR, 2009, SEMIN PEDIATR SURG, V18, P73, DOI 10.1053/j.sempedsurg.2009.02.003; Bennett S, 2015, J VASC ACCESS, V16, P13, DOI 10.5301/jva.5000291; Bertoglio S, 2017, J VASC ACCESS, V18, P89, DOI 10.5301/jva.5000668; Birch R, 2016, GRAYS ANATOMY ANATOM, P779; Dolister M, 2013, J VASC ACCESS, V14, P216, DOI 10.5301/jva.5000130; Grimm JC, 2014, J VASC SURG, V59, P1651, DOI 10.1016/j.jvs.2013.12.042; Hadimani S, 2013, Kathmandu Univ Med J (KUMJ), V11, P162; Hadjis A, 2017, EUROPACE, V19, P1514, DOI 10.1093/europace/euw276; Kim SY, 2015, KOREAN CIRC J, V45, P428, DOI 10.4070/kcj.2015.45.5.428; Kusztal M, 2014, J VASC ACCESS, V15, pS70, DOI 10.5301/jva.5000257; Landin L, 2015, ANN PLAS SURG, V74, P52, DOI 10.1097/SAP.0b013e31828d9983; Lewis FT, 1905, AM J ANAT, V5, P113, DOI 10.1002/aja.1000050108; Liechty JM, 2015, ANN VASC SURG, V29, P690, DOI 10.1016/j.avsg.2014.11.014; Mehrotra S, 2015, Indian Heart J, V67, P136, DOI 10.1016/j.ihj.2015.04.007; Migliore F, 2016, J CARDIOVASC MED, V17, P309, DOI 10.2459/JCM.0000000000000154; Nayak BS, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/9396.5113; Neri R, 2003, PACE, V26, P2313, DOI 10.1111/j.1540-8159.2003.00365.x; Panagiotounakou P, 2014, J PERINATOL, V34, P461, DOI 10.1038/jp.2014.36; Povoski SP, 2000, ANN SURG ONCOL, V7, P496, DOI 10.1007/s10434-000-0496-9; Seo TS, 2014, J VASC INTERV RADIOL, V25, P1439, DOI 10.1016/j.jvir.2013.12.571; Sigala F, 2014, J VASC ACCESS, V15, P272, DOI 10.5301/jva.5000195; Spahos T, 2012, EUR J VASC ENDOVASC, V43, P457, DOI 10.1016/j.ejvs.2012.01.002; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000728; SVENSSON WE, 1994, EUR J CANCER, V30A, P657, DOI 10.1016/0959-8049(94)90539-8; Takano A, 2017, J ARRYTHM, V33, P12, DOI 10.1016/j.joa.2016.04.008; Tickle C., 2016, GRAYS ANATOMY ANATOM, P795	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210464	10.1371/journal.pone.0210464	http://dx.doi.org/10.1371/journal.pone.0210464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629680	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000093
J	Nakamura, A; Morise, J; Yabuno-Nakagawa, K; Hashimoto, Y; Takematsu, H; Oka, S				Nakamura, Ayasa; Morise, Jyoji; Yabuno-Nakagawa, Keiko; Hashimoto, Yuki; Takematsu, Hiromu; Oka, Shogo			Site-specific HNK-1 epitope on alternatively spliced fibronectin type-III repeats in tenascin-C promotes neurite outgrowth of hippocampal neurons through contactin-1	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; EXPRESSION; CLONING; MICE; BIOSYNTHESIS; DEFICIENT; PROTEIN; F3/CONTACTIN; L2/HNK-1; DOMAINS	The human natural killer-1 (HNK-1) carbohydrate epitope, composed of a unique sulfated trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-R), is highly expressed during brain development and regulates higher brain function. However, it remains unclear which glycoprotein carries the HNK-1 epitope in the embryonic brain and the functional role it plays. Here, we showed that one of the major HNK-1 carrier proteins in the embryonic brain is tenascin-C (TNC), an extracellular matrix protein that regulates neurite outgrowth by interacting with the GPI-anchored protein contactin-1 (CNTN). Because the alternatively spliced fibronectin type-III (FNIII) repeats in TNC give rise to many isoforms and affect neuronal function, we evaluated neurite outgrowth of primary hippocampal neurons on purified recombinant FNIII repeats with or without the HNK-1 epitope as a substrate. We found that the presence of the HNK-1 epitope on the C domain of TNC promoted neurite outgrowth, and that this signal was mediated by CNTN, which is an HNK-1-expressing neuronal receptor. The neurite-promoting activity of the HNK-1 epitope on TNC required neuronal HNK-1 expression, which was defective in neurons lacking the glucuronyltransferases GlcAT-P and GlcAT-S. These results suggest that the HNK-1 epitope is a key modifier of TNC and CNTN in the regulation of embryonic brain development.	[Nakamura, Ayasa; Morise, Jyoji; Yabuno-Nakagawa, Keiko; Hashimoto, Yuki; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan	Kyoto University	Oka, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto, Japan.	shogo@hs.med.kyoto-u.ac.jp		Takematsu, Hiromu/0000-0003-1689-9500	Japan Society for the Promotion of Science [16K14695, 17K15090]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Challenging Exploratory Research (No. 16K14695 to S.O.) and Young Scientists (B) (No. 17K15090 to J.M.) from the Japan Society for the Promotion of Science.	Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; Fukamauchi F, 1998, NEUROPEPTIDES, V32, P461, DOI 10.1016/S0143-4179(98)90072-5; Gallego RG, 2001, J BIOL CHEM, V276, P30834, DOI 10.1074/jbc.M101013200; GENNARINI G, 1989, J NEUROSCI RES, V22, P1, DOI 10.1002/jnr.490220102; Gennarini G, 2017, MOL CELL NEUROSCI, V81, P49, DOI 10.1016/j.mcn.2016.11.006; Giblin SP, 2015, CELL ADHES MIGR, V9, P48, DOI 10.4161/19336918.2014.987587; Gurevicius K, 2009, HIPPOCAMPUS, V19, P1232, DOI 10.1002/hipo.20585; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2012, CELL MOL LIFE SCI, V69, P4135, DOI 10.1007/s00018-012-1036-z; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Meiners S, 1999, J NEUROSCI, V19, P8443; Michele M, 2009, MOL CELL NEUROSCI, V41, P397, DOI 10.1016/j.mcn.2009.04.004; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Nakic M, 1998, J NEUROBIOL, V37, P393; Nakic M, 1996, J NEUROSCI RES, V44, P355; Nishio T, 2003, BRAIN RES, V990, P129, DOI 10.1016/S0006-8993(03)03448-6; Puzzo D, 2013, HIPPOCAMPUS, V23, P1367, DOI 10.1002/hipo.22186; Rigato F, 2002, J NEUROSCI, V22, P6596; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Siddiqui S, 2008, NEURON GLIA BIOL, V4, P271, DOI 10.1017/S1740925X09990020; Sogawa Y, 2000, BRAIN RES, V881, P165, DOI 10.1016/S0006-8993(00)02838-9; Stamenkovic V, 2017, BEHAV BRAIN RES, V331, P241, DOI 10.1016/j.bbr.2017.05.047; Stamenkovic V, 2017, BRAIN STRUCT FUNCT, V222, P393, DOI 10.1007/s00429-016-1224-y; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Yabuno K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144560; Yagi H, 2010, J BIOL CHEM, V285, P37293, DOI 10.1074/jbc.M110.157081; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	44	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210193	10.1371/journal.pone.0210193	http://dx.doi.org/10.1371/journal.pone.0210193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629639	Green Published, gold			2022-12-27	WOS:000455483000060
J	Rendon, D; Taylor, PW; Wilder, SM; Whitehouse, MEA				Rendon, Dalila; Taylor, Phillip W.; Wilder, Shawn M.; Whitehouse, Mary E. A.			Does prey encounter and nutrient content affect prey selection in wolf spiders inhabiting Bt cotton fields?	PLOS ONE			English	Article							LIMITATION PROMOTE OMNIVORY; ACTIVE PREDATOR CHOICE; NITROGEN LIMITATION; SIZE SELECTION; INTRAGUILD PREDATION; AUSTRALIAN COTTON; HELICOVERPA SPP.; CONSUMPTION; ARANEAE; APHID	Wolf spiders are abundant and voracious predators at the soil-plant interface in cotton crops. Among other prey, they attack late-instar larvae of the cotton bollworm Helicoverpa spp., an economically important pest. Consequently, wolf spiders in transgenic Bt cotton could provide significant biological control of Bt-resistant Helicoverpa larvae that descend to the soil to pupate. The predator-prey interactions between wolf spiders and Helicoverpa could, however, be constrained by the presence of alternative prey and intraguild predators. This study used laboratory enclosures to analyse the effect of alternative prey on predatory selection of the wolf spider Tasmanicosa leuckartii Thorell. The prey included another wolf spider Hogna crispipes Koch (potential intraguild predator), the ground cricket Teleogryllus commodus Walker (minor pest), and Helicoverpa armigera larvae (major pest). We tested if encounter rates, prey vulnerability, and prey nutritional content influenced the likelihood that a prey was attacked. In three-way food webs, Tasmanicosa encountered and attacked Teleogryllus and Helicoverpa in similar frequencies. However, in the presence of a competing intraguild predator and potential prey (Hogna) in a four-way food web, Tasmanicosa did not always attack Teleogryllus at first encounter, but still attacked Helicoverpa at each encounter. Helicoverpa (protein-poor) and Hogna (protein-rich) were consumed by Tasmanicosa in similar proportions, suggesting that Tasmanicosa might benefit from nutrient balance as an outcome of diverse prey in this food web. As Teleogryllus (protein rich) escapes quicker than Helicoverpa and Hogna, Hogna may be an easier protein-rich option than Teleogryllus. Field surveys showed that while Teleogryllus was the most common prey, wolf spiders feed on diverse insect taxa, as well as other spiders. That Tasmanicosa readily attacked Helicoverpa larvae in the presence of alternative prey is an encouraging result that supports the potential of Tasmanicosa predation to assist in the control of Bt-resistant Helicoverpa larvae and thereby inhibit the proliferation and spread of resistance.	[Rendon, Dalila; Whitehouse, Mary E. A.] CSIRO Agr & Food, Australian Cotton Res Inst, Narrabri, NSW, Australia; [Rendon, Dalila; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Wilder, Shawn M.] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University; Oklahoma State University System; Oklahoma State University - Stillwater	Rendon, D (corresponding author), CSIRO Agr & Food, Australian Cotton Res Inst, Narrabri, NSW, Australia.; Rendon, D (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	dalila.rendon@oregonstate.edu	Taylor, Phillip W/E-4620-2011	Taylor, Phillip W/0000-0002-7574-7737; Wilder, Shawn/0000-0003-0359-7220; Whitehouse, Mary/0000-0001-9911-8356	Macquarie University Post-graduate Research fund; Endeavour Postgraduate scholarship (Australia Awards)	Macquarie University Post-graduate Research fund; Endeavour Postgraduate scholarship (Australia Awards)	This project was funded by a Macquarie University Post-graduate Research fund. D. Rendon was supported by an Endeavour Postgraduate scholarship (Australia Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell CJ, 1996, ENVIRON ENTOMOL, V25, P1083, DOI 10.1093/ee/25.5.1083; Barry KL, 2013, OIKOS, V122, P1058, DOI 10.1111/j.1600-0706.2012.00164.x; BENCE JR, 1986, ECOLOGY, V67, P324, DOI 10.2307/1938576; Brechbuehl R, 2011, ECOSPHERE, V2, DOI [10.1007/s00442-010-1811-1, DOI 10.1007/S00442-010-1811-1]; Constable GA, 1988, AGFACT; Dangles O, 2006, ANIM BEHAV, V72, P603, DOI 10.1016/j.anbehav.2005.11.018; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Downes S, 2009, J ECON ENTOMOL, V102, P733, DOI 10.1603/029.102.0234; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Downes SJ, 2002, BEHAV ECOL, V13, P551, DOI 10.1093/beheco/13.4.551; EDGAR WD, 1969, J ZOOL, V159, P405, DOI 10.1111/j.1469-7998.1969.tb03897.x; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Fagan WF, 2004, ECOL LETT, V7, P876, DOI 10.1111/j.1461-0248.2004.00641.x; Fitt Gary, 2009, P507, DOI 10.1007/978-1-4020-8990-9_17; Gavish-Regev E, 2009, BIOCONTROL, V54, P341, DOI 10.1007/s10526-008-9170-0; GREENSTONE MH, 1979, NATURE, V282, P501, DOI 10.1038/282501a0; Hagler JR, 2013, ECOL ENTOMOL, V38, P258, DOI 10.1111/een.12014; Hagler JR, 2011, BIOL CONTROL, V58, P337, DOI 10.1016/j.biocontrol.2011.05.015; Harwood JD, 2009, BIOL CONTROL, V51, P499, DOI 10.1016/j.biocontrol.2009.09.007; Harwood JD, 2004, MOL ECOL, V13, P3549, DOI 10.1111/j.1365-294X.2004.02331.x; Hawley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099165; HAYES JL, 1990, ENVIRON ENTOMOL, V19, P1512, DOI 10.1093/ee/19.5.1512; Hodge MA, 1999, J ARACHNOL, V27, P351; IBM, 2011, SPSS STAT WIND 20 0; Jensen K, 2011, OECOLOGIA, V165, P577, DOI 10.1007/s00442-010-1811-1; Johnson M-L, 2000, REV BENEFICIALS COTT; Krebs J.R., 1978, P23; Kuusk AK, 2010, BIOL CONTROL, V55, P20, DOI 10.1016/j.biocontrol.2010.06.009; Lang A, 2001, J APPL ENTOMOL, V125, P53, DOI 10.1046/j.1439-0418.2001.00511.x; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Liu X, 2014, PLOS ONE, V9; Madsen M, 2004, BIOCONTROL, V49, P483, DOI 10.1023/B:BICO.0000036442.70171.66; Matsumura M, 2004, ECOLOGY, V85, P2601, DOI 10.1890/03-0629; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; MOLLES MC, 1987, OECOLOGIA, V72, P473, DOI 10.1007/BF00377582; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; NENTWIG W, 1986, OECOLOGIA, V69, P571, DOI 10.1007/BF00410365; Oelbermann K, 2002, BASIC APPL ECOL, V3, P285, DOI 10.1078/1439-1791-00094; Okuyama Toshinori, 2008, Acta Arachnologica, V57, P47, DOI 10.2476/asjaa.57.47; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Persons MH, 1997, J INSECT BEHAV, V10, P737, DOI 10.1007/BF02765390; Provost C, 2006, BIOL CONTROL, V37, P148, DOI 10.1016/j.biocontrol.2006.01.005; Rendon D, 2018, BIOL CONTROL, V122, P51, DOI 10.1016/j.biocontrol.2018.03.019; Rendon D, 2016, ENTOMOL EXP APPL, V158, P170, DOI 10.1111/eea.12390; Rendon D, 2015, ENVIRON ENTOMOL, V44, P174, DOI 10.1093/ee/nvu025; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Teakle R.E., 1985, P313; Toft S, 1999, J ARACHNOL, V27, P301; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; Turesson H, 2002, ECOL FRESHW FISH, V11, P223, DOI 10.1034/j.1600-0633.2002.00019.x; UETZ GW, 1992, J ARACHNOL, V20, P207; Vandervoet TF, 2018, J ECON ENTOMOL, V111, P1056, DOI 10.1093/jee/toy049; Welch KD, 2016, B ENTOMOL RES, V106, P91, DOI 10.1017/S0007485315000875; Whitehouse MEA, 2014, ENVIRON ENTOMOL, V43, P218, DOI 10.1603/EN13167; Whitehouse MEA, 2005, ENVIRON ENTOMOL, V34, P1224, DOI 10.1603/0046-225X(2005)034[1224:ACOACI]2.0.CO;2; Whitehouse MEA, 2009, 3 INT S BIOL CONTR A; Whitney TD, 2018, MOL ECOL, V27, P1739, DOI 10.1111/mec.14554; Wilder SM, 2013, ECOL LETT, V16, P895, DOI 10.1111/ele.12116; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, ECOLOGY, V91, P3114, DOI 10.1890/09-2080.1; Wilson LJ, 2018, ANNU REV ENTOMOL, V63, P215, DOI 10.1146/annurev-ento-020117-043432; Wise DH, 2006, ECOL APPL, V16, P865, DOI 10.1890/1051-0761(2006)016[0865:USITRS]2.0.CO;2; Xia JY, 2018, ECOL COMPLEX, V33, P11, DOI 10.1016/j.ecocom.2017.09.003	69	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210296	10.1371/journal.pone.0210296	http://dx.doi.org/10.1371/journal.pone.0210296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629650	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000070
J	Xie, DH; Lu, M; Xie, YF; Liu, D; Li, X				Xie, Dong-heng; Lu, Ming; Xie, Yong-fang; Liu, Duan; Li, Xiong			A fast threshold segmentation method for froth image base on the pixel distribution characteristic	PLOS ONE			English	Article							BUBBLE-SIZE; PROCESSING ALGORITHM	With the increase of the camera resolution, the number of pixels contained in froth image is increased, which brings many challenges to image segmentation. Froth size and distribution are the important index in froth flotation. The segmentation of froth images is always a problem in building flotation model. In segmenting froth images, Otsu method is usually used to get a binary image for classification of froth images, this method can get a satisfactory segmentation result. However, each gray level is required to calculate each of the between-class variance, it takes a longer time in froth images with a large number of pixels. To solve this problem, an improved method is proposed in this paper. Most froth images have the pixel distribution characteristic that the gray histogram curve is a sawtooth shape. The proposed method uses polynomial to fit the curve of gray histogram and takes the characteristic of gray histogram's valley into consideration in Otsu method. Two performance comparison methods are introduced and used. Experimental comparison between Otsu method and the proposed method shows that the proposed method has a satisfactory image segmentation with a low computing time.	[Xie, Dong-heng; Lu, Ming; Liu, Duan] Hunan Univ Sci & Technol, Sch Informat Elect & Engn, Xiangtan, Peoples R China; [Xie, Yong-fang] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Li, Xiong] Hunan Univ Sci & Technol, Sch Comp Sci & Engn, Xiangtan, Peoples R China	Hunan University of Science & Technology; Central South University; Hunan University of Science & Technology	Lu, M (corresponding author), Hunan Univ Sci & Technol, Sch Informat Elect & Engn, Xiangtan, Peoples R China.	543635035@qq.com	Li, Xiong/K-7233-2012	Li, Xiong/0000-0001-6619-554X	Science National Natural Science Foundation of China [61672226, 61503133]	Science National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Science National Natural Science Foundation of China under Grants 61672226, 61503133. URL: http://www.nsfc.gov.cn/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Science National Natural Science Foundation of China under Grants 61672226, 61503133.	Aldrich C, 2010, INT J MINER PROCESS, V96, P1, DOI 10.1016/j.minpro.2010.04.005; Beucher S., 1979, INT WORKSHOP IMAGE P, V2, P391; Dong ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186553; Dou WB, 2005, LECT NOTES ARTIF INT, V3613, P189; Fan JL, 2012, PATTERN RECOGN LETT, V33, P703, DOI 10.1016/j.patrec.2011.12.009; Hang L., 2012, STAT LEARNING METHOD; Jahedsaravani A, 2017, MEASUREMENT, V111, P29, DOI 10.1016/j.measurement.2017.07.023; Jahedsaravani A, 2014, MINER METALL PROC, V31, P66, DOI 10.1007/BF03402350; JiaQuan C, 2017, IEEE ACCESS, P1; LEVINE MD, 1985, IEEE T PATTERN ANAL, V7, P155, DOI 10.1109/TPAMI.1985.4767640; Lu M, 2018, CHEM ENG SCI, V175, P220, DOI 10.1016/j.ces.2017.09.048; Mehrshad N, 2011, MINER METALL PROC, V28, P146, DOI 10.1007/BF03402247; Morar SH, 2012, MINER ENG, V36-38, P152, DOI 10.1016/j.mineng.2012.03.018; Mu-ling Tian, 2014, Journal of Multimedia, V9, P325, DOI 10.4304/jmm.9.2.325-332; Ng HF, 2006, PATTERN RECOGN LETT, V27, P1644, DOI 10.1016/j.patrec.2006.03.009; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; SadrKazemi N, 1997, MINER ENG, V10, P1075, DOI 10.1016/S0892-6875(97)00094-0; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; Wang WX, MINERALS ENG, V16, P1183; Weixing W, 2016, RECENT ADV IMAGE VID; [阳春华 Yang Chunhua], 2008, [电子与信息学报, Journal of Electronics & Information Technology], V30, P1286	22	13	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210411	10.1371/journal.pone.0210411	http://dx.doi.org/10.1371/journal.pone.0210411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629638	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000084
J	Yokoyama, A; Yokoyama, T; Omori, T; Maesato, H; Takimura, T; Iwahara, C; Kimura, M; Matsui, T; Mizukami, T; Maruyama, K				Yokoyama, Akira; Yokoyama, Tetsuji; Omori, Tai; Maesato, Hitoshi; Takimura, Tsuyoshi; Iwahara, Chie; Kimura, Mitsuru; Matsui, Toshifumi; Mizukami, Takeshi; Maruyama, Katsuya			Endoscopic screening using esophageal iodine staining and genotypes of ADH1B and ALDH2 in Japanese alcohol-dependent women	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE GENOTYPES; SALIVARY ACETALDEHYDE-LEVELS; LUGOL-VOIDING LESIONS; GENETIC POLYMORPHISMS; NECK-CANCER; RISK; MEN; CONSUMPTION	Background The presence of large or multiple esophageal distinct iodine-unstained lesions (DIULs) is a strong predictor of field cancerization in the upper aerodigestive tract. Several risk factors for DIULs, including genetic polymorphisms of alcohol and aldehyde dehydrogenases (ADH1B, rs1229984; ALDH2, rs671), have been demonstrated in Japanese alcohol-dependent men. However, few evaluations of alcohol-dependent women have been conducted in this field. Methods Using multiple logistic regression models, we investigated the results of screening using esophageal iodine staining and the identification of determinants for esophageal DIULs in 472 Japanese alcohol-dependent women. Results DIULs >= 5 mm, multiple DILUs, and both characteristics were observed in 35 (7.4%), 31 (6.6%), and 16 (3.4%) patients, respectively. DIULs >= 5 mm were histologically diagnosed as low-grade intraepithelial neoplasia in 26 patients and superficial squamous cell carcinoma in 9 patients. Although the inactive heterozygous ALDH2(*) 1/(*)2 genotype was more common (33.3% vs. 11.4%, p = 0.002) in the group with DIULs >= 5 mm than in the group without DIULs. 5 mm, no significant differences in the results of a questionnaire asking about current and past facial flushing after a glass of beer were seen between the groups with and without DIULs >= 5 mm. When individuals with current or former flushing were assumed to have inactive ALDH2, the sensitivity and specificity of current or former flushing to identify the presence of inactive ALDH2 were 50.0% and 93.5%, respectively; these values were previously reported to be 88% and 92%, respectively, in a Japanese general female population. The low sensitivity in the present study suggests that a lack of alcohol flushing may play a crucial role in the development of alcohol dependence in women with inactive ALDH2. No significant differences in age, usual alcohol consumption, or smoking habits were observed according to ADH1B and ALDH2 genotypes. Multiple logistic regression analyses showed that the slow-metabolizing ADH1B(*)1/(*)1 genotype (odds ratio [95% confidence interval], 12.5 [4.82-32.4] and 9.89 [3.50-27.9]), the inactive heterozygous ALDH2(*)1/(*)2 genotype (2.94 [1.18-7.38] and 3.79 [1.40-10.3]), a lower body mass index per -1 kg/m2 (1.17 [1.02-1.35] and 1.38 [1.14-1.67]), and a mean corpuscular volume > 106 fl (3.70 [1.56-8.81] and 3.27 [1.24-8.64]) increased the risk of DIULs >= 5 mm and multiple DIULs, respectively. The combination of ADH1B(*) 1/(*) 1 and ALDH2(*)1/(*)2 markedly increased the risk of esophageal DIULs >= 5 mm (39.3 [10.6-146]). Conclusions Japanese alcohol-dependent women shared several common risk factors for esophageal squamous cell neoplasia with alcohol-dependent men, but with considerably different magnitudes.	[Yokoyama, Akira; Maesato, Hitoshi; Takimura, Tsuyoshi; Iwahara, Chie; Kimura, Mitsuru; Matsui, Toshifumi; Mizukami, Takeshi; Maruyama, Katsuya] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama, Japan; [Omori, Tai] Kawasaki Municipal Ida Hosp, Endoscopy Ctr, Kawasaki, Kanagawa, Japan	National Institute of Public Health - Japan	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan.	a_yokoyama@kurihama1.hosp.go.jp		Matsui, Toshifumi/0000-0002-8478-2809				Abiko S, 2018, J GASTROENTEROL, V53, P1120, DOI 10.1007/s00535-018-1441-7; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; Chiang CP, 2016, PHARMACOGENET GENOM, V26, P184, DOI 10.1097/FPC.0000000000000205; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154; GARRO AJ, 1986, ALCOHOL CLIN EXP RES, V10, pS73, DOI 10.1111/j.1530-0277.1986.tb05184.x; Health and Welfare Statistics Association, 2015, KOKUMIN EISEI DOKO 2, V61; Homann N, 2000, CARCINOGENESIS, V21, P663, DOI 10.1093/carcin/21.4.663; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, ALC CONS ETH CARB; International Agency for Research on Cancer World Health Organization, 2010, IARC MON EV CARC RIS, V96; Japanese Society for Esophageal Disease, 2001, GUID CLIN PATH STUD; Katada C, 2014, DIS ESOPHAGUS, V27, P457, DOI 10.1111/j.1442-2050.2012.01429.x; Katada C, 2016, GASTROENTEROLOGY, V15, pe7; Katada C, 2016, GASTROENTEROLOGY, V151, P860, DOI 10.1053/j.gastro.2016.07.040; Kimura M, 2011, ALCOHOL CLIN EXP RES, V35, P1923, DOI 10.1111/j.1530-0277.2011.01543.x; Lee CH, 2009, INT J CANCER, V125, P1134, DOI 10.1002/ijc.24357; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Matejcic M, 2017, CARCINOGENESIS, V38, P859, DOI 10.1093/carcin/bgx067; Ministry of Health Labor and Welfare, 2014, KOK EIYO GENJ 2014; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Onochi K, 2019, J CLIN GASTROENTEROL, V53, pE164, DOI 10.1097/MCG.0000000000001019; Osaki Y, 2016, ALCOHOL ALCOHOLISM, V51, P465, DOI 10.1093/alcalc/agw002; Polimanti R, 2018, AM J MED GENET B, V177, P113, DOI 10.1002/ajmg.b.32523; Polimanti R, 2016, NEUROPSYCHOPHARMACOL, V41, P2688, DOI 10.1038/npp.2016.72; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Shimizu Y, 2003, ENDOSCOPY, V35, P322, DOI 10.1055/s-2003-38151; Song H, 2017, BRIT J CANCER, V117, P1715, DOI 10.1038/bjc.2017.332; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Wang YL, 2011, ASIAN PAC J CANCER P, V12, P2065; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; Yokoyama A, 2006, ALCOHOL CLIN EXP RES, V30, P491, DOI 10.1111/j.1530-0277.2006.00053.x; Yokoyama A, 2003, CARCINOGENESIS, V24, P1773, DOI 10.1093/carcin/bgg142; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2002, CANCER EPIDEM BIOMAR, V11, P895; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Yokoyama A, 2008, CANCER SCI, V99, P1164, DOI 10.1111/j.1349-7006.2008.00807.x; Yokoyama A, 2007, INT J CANCER, V121, P1047, DOI 10.1002/ijc.22792; Yokoyama A, 2006, CANCER EPIDEM BIOMAR, V15, P2209, DOI 10.1158/1055-9965.EPI-06-0435; Yokoyama A, 2016, ALCOHOL CLIN EXP RES, V40, P1241, DOI 10.1111/acer.13073; Yokoyama A, 2014, ALCOHOL CLIN EXP RES, V38, P1237, DOI 10.1111/acer.12372; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1123, DOI 10.1111/acer.12069; Yokoyama A, 2013, ALCOHOL ALCOHOLISM, V48, P146, DOI 10.1093/alcalc/ags135; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2010, CANCER SCI, V101, P2497, DOI 10.1111/j.1349-7006.2010.01709.x; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Zhao TT, 2015, ONCOTARGETS THER, V8, P649, DOI 10.2147/OTT.S76526	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210546	10.1371/journal.pone.0210546	http://dx.doi.org/10.1371/journal.pone.0210546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629674	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000106
J	Yao, S; Tuo, TB; Gao, X; Han, CY; Yan, NN; Liu, AJ; Gao, HL; Gao, YL; Cui, HY; Liu, CJ; Zhang, YP; Qi, XL; Hussain, A; Wang, YQ; Wang, XM				Yao, Shuai; Tuo, Tianbei; Gao, Xiang; Han, Chunyan; Yan, Nana; Liu, Aijing; Gao, Honglei; Gao, Yulong; Cui, Hongyu; Liu, Changjun; Zhang, Yanping; Qi, Xiaole; Hussain, Altaf; Wang, Yongqiang; Wang, Xiaomei			Molecular epidemiology of chicken anaemia virus in sick chickens in China from 2014 to 2015	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; PHYLOGENETIC ANALYSIS; AGENT CAA; PROTEIN; CLEAVAGE; PATHOGENICITY; IDENTIFICATION; REPLICATION; INFECTION; APOPTIN	Chicken anaemia virus (CAV), a member of the genus Gyrovirus, is the etiological agent of chicken infectious anaemia. CAV infects bone marrow-derived cells, resulting in severe anaemia and immunosuppression in young chickens and a compromised immune response in older birds. We investigated the molecular epidemiology of CAV in sick chickens in China from 2014 to 2015 and showed that the CAV-positive rate was 13.30%, in which mixed infection (55.56%) was the main type of infection. We isolated and identified 15 new CAV strains using different methods including indirect immunofluorescence assay and Western Blotting. We used overlapping polymerase chain reaction to map the whole genome of the strains. Phylogenetic analyses of the obtained sequences and related sequences available in GenBank generated four distinct groups (A-D). We built phylogenetic trees using predicted viral protein (VP) sequences. Unlike CAV VP2s and VP3s that were well conserved, the diversity of VP1s indicated that the new strains were virulent. Our epidemiological study provided new insights into the prevalence of CAV in clinical settings in recent years in China.	[Yao, Shuai; Tuo, Tianbei; Wang, Xiaomei] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Yao, Shuai; Tuo, Tianbei; Gao, Xiang; Han, Chunyan; Yan, Nana; Liu, Aijing; Gao, Honglei; Gao, Yulong; Cui, Hongyu; Liu, Changjun; Zhang, Yanping; Qi, Xiaole; Hussain, Altaf; Wang, Yongqiang; Wang, Xiaomei] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Heilongjiang, Peoples R China; [Han, Chunyan] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Forestry University - China	Wang, XM (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China.; Wang, YQ; Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Heilongjiang, Peoples R China.	yqw@hvri.ac.cn; xmw@hvri.ac.cn	Gao, Yulong/HGE-6271-2022; yan, na/HDM-3747-2022	Gao, Yulong/0000-0002-0448-8467; 	China Agriculture Research System [CARS-41-G15]; Chinese Ministry of Agriculture	China Agriculture Research System; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This research was supported by China Agriculture Research System (CARS-41-G15), http://www.zgrj.org/expert.asp?smallclassname=%B9%A6%C4%DC%D1% D0%BE%BF%CA%D2&SpecialName=%BC%B2%B2%A1%BF%D8%D6%C6%D1%D0%BE%BF%CA%D2, the funding institution was Chinese Ministry of Agriculture, and XMW was the recipient of the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best SM, 2003, J VIROL, V77, P5305, DOI 10.1128/JVI.77.9.5305-5312.2003; Cheung AK, 2012, VIRUS RES, V164, P46, DOI 10.1016/j.virusres.2011.10.012; Chowdhury SMZH, 2003, ARCH VIROL, V148, P2437, DOI 10.1007/s00705-003-0189-3; CLOUD SS, 1992, VET IMMUNOL IMMUNOP, V34, P337, DOI 10.1016/0165-2427(92)90174-O; Diemer C, 2008, J MOL BIOL, V376, P23, DOI 10.1016/j.jmb.2007.11.081; Ducatez MF, 2008, AVIAN DIS, V52, P68, DOI 10.1637/8049-070407-Reg; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Eltahir YM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-145; ENGSTROM BE, 1988, AVIAN PATHOL, V17, P33, DOI 10.1080/03079458808436426; Gao Q, 2014, J CLIN MICROBIOL, V52, P37, DOI 10.1128/JCM.02200-13; Grand RJA, 2002, VIROLOGY, V301, P255, DOI 10.1006/viro.2002.1586; Hailemariam Z, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-128; Haridy M, 2009, AVIAN PATHOL, V38, P469, DOI 10.1080/03079450903349162; Heilman DW, 2006, J VIROL, V80, P7535, DOI 10.1128/JVI.02741-05; Jiang LL, 2013, VET MICROBIOL, V166, P68, DOI 10.1016/j.vetmic.2013.05.008; Kaffashi A, 2015, ARCH VIROL, V160, P2557, DOI 10.1007/s00705-015-2542-8; Kucharski TJ, 2016, J VIROL, V90; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Los M, 2009, BBA-MOL CELL RES, V1793, P1335, DOI 10.1016/j.bbamcr.2009.04.002; MCCONNELL CDG, 1993, AVIAN DIS, V37, P358, DOI 10.2307/1591659; McNulty MS, 2008, LAB MANUAL ISOLATION, P3; Munger J, 2003, VIROLOGY, V305, P364, DOI 10.1006/viro.2002.1728; Varela APM, 2014, BIOLOGICALS, V42, P346, DOI 10.1016/j.biologicals.2014.08.002; Natesan S, 2006, VIRUS RES, V118, P78, DOI 10.1016/j.virusres.2005.11.017; Niagro FD, 1998, ARCH VIROL, V143, P1723, DOI 10.1007/s007050050412; Nogueira EO, 2007, COMP IMMUNOL MICROB, V30, P81, DOI 10.1016/j.cimid.2006.11.001; NOTEBORN MHM, 1994, J VIROL, V68, P346, DOI 10.1128/JVI.68.1.346-351.1994; NOTEBORN MHM, 1991, J VIROL, V65, P3131, DOI 10.1128/JVI.65.6.3131-3139.1991; Noteborn MHM, 1998, J GEN VIROL, V79, P3073, DOI 10.1099/0022-1317-79-12-3073; Oluwayelu DO, 2008, ONDERSTEPOORT J VET, V75, P353, DOI 10.4102/ojvr.v75i4.111; OTAKI Y, 1989, JPN J VET SCI, V51, P849; Peters MA, 2002, J BIOL CHEM, V277, P39566, DOI 10.1074/jbc.M201752200; Prasetyo AA, 2009, VIROLOGY, V385, P85, DOI 10.1016/j.virol.2008.10.043; Renshaw RW, 1996, J VIROL, V70, P8872, DOI 10.1128/JVI.70.12.8872-8878.1996; ROSENBERGER JK, 1989, AVIAN DIS, V33, P753, DOI 10.2307/1591156; ROSENBERGER JK, 1989, AVIAN DIS, V33, P707, DOI 10.2307/1591148; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh S, 2000, VIROLOGY, V270, P476, DOI 10.1006/viro.2000.0287; Sauvage V, 2011, J VIROL, V85, P7948, DOI 10.1128/JVI.00639-11; Schat KA, 2009, CURR TOP MICROBIOL, V331, P151; Sommer F, 2003, AVIAN DIS, V47, P1466, DOI 10.1637/7048; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; TODD D, 1990, J GEN VIROL, V71, P819, DOI 10.1099/0022-1317-71-4-819; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Toro H, 2006, AVIAN PATHOL, V35, P455, DOI 10.1080/03079450601028811; van Santen VL, 2007, AVIAN DIS, V51, P66, DOI 10.1637/0005-2086(2007)051[0066:BCOCAV]2.0.CO;2; von Bulow V, 1986, Zentralbl Veterinarmed B, V33, P717; Wang D, 2009, VIRUS GENES, V38, P259, DOI 10.1007/s11262-008-0316-z; Wang Xiaoyan, 2007, EPITOPES IDENTIFICAT; Wang Xiurong, 10 AC S CHIN AN HUSB; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yamaguchi S, 2001, J GEN VIROL, V82, P1233, DOI 10.1099/0022-1317-82-5-1233; YUASA N, 1979, AVIAN DIS, V23, P366, DOI 10.2307/1589567; YUASA N, 1985, AVIAN PATHOL, V14, P521, DOI 10.1080/03079458508436254; Zanella A, 2001, INTERACTION MAREKS D; Zhong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35271; Zhou WP, 1997, AVIAN DIS, V41, P361, DOI 10.2307/1592190; Zhou WP, 1996, AVIAN DIS, V40, P358, DOI 10.2307/1592232	59	13	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210696	10.1371/journal.pone.0210696	http://dx.doi.org/10.1371/journal.pone.0210696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657774	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000017
J	Chard, AN; Trinies, V; Edmonds, CJ; Sogore, A; Freeman, MC				Chard, Anna N.; Trinies, Victoria; Edmonds, Caroline J.; Sogore, Assitan; Freeman, Matthew C.			The impact of water consumption on hydration and cognition among schoolchildren: Methods and results from a crossover trial in rural Mali	PLOS ONE			English	Article							HEAT-STRESS; VOLUNTARY DEHYDRATION; SANITATION PROGRAM; URINARY INDEXES; SCHOOL; EXERCISE; HYGIENE; PERFORMANCE	Adequate provision of safe water, basic sanitation, and hygiene (WASH) facilities and behavior change can reduce pupil absence and infectious disease. Increased drinking water quantity may also improve educational outcomes through the effect of hydration on attention, concentration, and short-term memory. A pilot study was conducted to adapt field measures of short-term cognitive performance and hydration, to evaluate levels of hydration, and to investigate the impact of providing supplementary drinking water on the cognitive performance of pupils attending water-scarce schools in rural Mali. Using a cross-over trial design, data were collected under normal school conditions (control condition) on one visit day; on the other, participants were given a bottle of water that was refilled throughout the day (water condition). Morning and afternoon hydration was assessed using specific gravity and urine color. Cognitive performance was evaluated using six paper-based tests. Three percent of pupils were dehydrated on the morning of each visit. The prevalence of dehydration increased in the afternoon, but was lower under the water condition. Although there was a trend indicating drinking water may improve cognitive test performance, as has been shown in studies in other settings, results were not statistically significant and were masked by a "practice effect."	[Chard, Anna N.; Trinies, Victoria; Freeman, Matthew C.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Edmonds, Caroline J.] Univ East London, Sch Psychol, London, England; [Sogore, Assitan] Save Children Mali, Monitoring Evaluat & Learning Sect, Bamako, Mali	Emory University; Rollins School Public Health; University of East London; Save the Children	Freeman, MC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	matthew.freeman@emory.edu	Freeman, Matthew/ABE-6245-2020	Freeman, Matthew/0000-0002-1517-2572; Trinies, Victoria/0000-0002-7863-7509; Edmonds, Caroline/0000-0001-7971-0918	Emory University Research Committee; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER	Emory University Research Committee; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the Emory University Research Committee (http://www.urc.emory.edu/grants/urc/index.html). MCF received funding (grant number N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Baker LB, 2007, MED SCI SPORT EXER, V39, P976, DOI 10.1097/mss.0b013e3180471ff2; Bar-David Y, 2005, ACTA PAEDIATR, V94, P1667, DOI 10.1080/08035250500254670; Bar-David Y, 2009, J HUM NUTR DIET, V22, P455, DOI 10.1111/j.1365-277X.2009.00960.x; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Bowen A, 2007, AM J TROP MED HYG, V76, P1166, DOI 10.4269/ajtmh.2007.76.1166; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Cian C, 2000, J PSYCHOPHYSIOL, V14, P29, DOI 10.1027//0269-8803.14.1.29; Edmonds CJ, 2009, APPETITE, V53, P469, DOI 10.1016/j.appet.2009.10.002; Edmonds CJ, 2009, APPETITE, V52, P776, DOI 10.1016/j.appet.2009.02.010; Fadda R, 2012, APPETITE, V59, P730, DOI 10.1016/j.appet.2012.07.005; Freeman MC, 2014, EPIDEMIOL INFECT, V142, P340, DOI 10.1017/S0950268813001118; Freeman MC, 2013, AM J TROP MED HYG, V89, P875, DOI 10.4269/ajtmh.13-0237; Freeman MC, 2012, TROP MED INT HEALTH, V17, P380, DOI 10.1111/j.1365-3156.2011.02927.x; GOPINATHAN PM, 1988, ARCH ENVIRON HEALTH, V43, P15, DOI 10.1080/00039896.1988.9934367; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010; Rogers PJ, 2001, APPETITE, V36, P57, DOI 10.1006/appe.2000.0374; SHARMA VM, 1983, INT ARCH OCC ENV HEA, V52, P315, DOI 10.1007/BF02226897; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; Trinies V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150071; UNICEF, 2013, UNICEF WATER SANITAT; Wong D L, 1988, Pediatr Nurs, V14, P9; WYON DP, 1979, SCAND J WORK ENV HEA, V5, P352, DOI 10.5271/sjweh.2646	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210568	10.1371/journal.pone.0210568	http://dx.doi.org/10.1371/journal.pone.0210568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653554	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000456015500052
J	Jaekel, N; Jaekel, J; Willard, J; Leyendecker, B				Jaekel, Nils; Jaekel, Julia; Willard, Jessica; Leyendecker, Birgit			No evidence for effects of Turkish immigrant children's bilingualism on executive functions	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; COGNITIVE CONTROL; INDIVIDUAL-DIFFERENCES; SOCIOECONOMIC-STATUS; INHIBITORY CONTROL; WORKING-MEMORY; ADVANTAGES; INTERFERENCE; PRESCHOOLERS; ORGANIZATION	Recent research has increasingly questioned the bilingual advantage for executive functions (EF). We used structural equation modeling in a large sample of Turkish immigrant and German monolingual children (N = 337; aged 5-15 years) to test associations between bilingualism and EF. Our data showed no significant group differences between Turkish immigrant and German children's EF skills while taking into account maternal education, child gender, age, and working memory (i.e., digit span backwards). Moreover, neither Turkish immigrant children's proficiency in either language nor their home language environment predicted EF. Our findings offer important new evidence in light of the ongoing debate about the existence of a bilingual advantage for EF.	[Jaekel, Nils] Univ Tennessee, Theory & Practice Teacher Educ, Knoxville, TN 37996 USA; [Jaekel, Julia] Univ Tennessee, Dept Child & Family Studies, Knoxville, TN USA; [Willard, Jessica; Leyendecker, Birgit] Ruhr Univ Bochum, Dept Dev Psychol, Bochum, Germany	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Ruhr University Bochum	Jaekel, N (corresponding author), Univ Tennessee, Theory & Practice Teacher Educ, Knoxville, TN 37996 USA.	njaekel@utk.edu	Jaekel, Julia/AAB-5795-2021; Jaekel, Nils/GQA-8059-2022; Jaekel, Julia/AAC-4459-2021; Jaekel, Nils/I-5681-2019	Jaekel, Julia/0000-0001-6123-3375; Jaekel, Julia/0000-0001-6123-3375; Jaekel, Nils/0000-0003-1562-9189; Willard, Jessica/0000-0002-2170-7684	New Opportunities for Research Funding Agency Cooperation in Europe (NORFACE); University of Tennessee's Open Publishing Support Fund;  [NORFACE 292]	New Opportunities for Research Funding Agency Cooperation in Europe (NORFACE); University of Tennessee's Open Publishing Support Fund; 	The data was collected in the Social Integration of Migrant Children: Uncovering Family and School Factors Promoting Resilience (SIMCUR) project which was funded by the New Opportunities for Research Funding Agency Cooperation in Europe (NORFACE) (http://www.norface-migration.org/currentprojectdetail.php?proj=9).Funding for open access to this research was provided by University of Tennessee's Open Publishing Support Fund. The grant was awarded to B.L (NORFACE 292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton Eneko, 2014, Front Psychol, V5, P398, DOI 10.3389/fpsyg.2014.00398; Ashcraft M., 2009, COGNITION; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 1999, CHILD DEV, V70, P636, DOI 10.1111/1467-8624.00046; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bialystok E, 2015, CHILD DEV PERSPECT, V9, P117, DOI 10.1111/cdep.12116; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2011, BRIT J PSYCHOL, V102, P303, DOI 10.1111/j.2044-8295.2011.02008.x; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Blair C, 2015, ANNU REV PSYCHOL, V66, P711, DOI 10.1146/annurev-psych-010814-015221; Blom E, 2014, J EXP CHILD PSYCHOL, V128, P105, DOI 10.1016/j.jecp.2014.06.007; Bornstein MH, 2012, CHILD DEV, V83, P16, DOI [10.1111/j.1467-8624.2011.01671.x, 10.1111/j.1467-8624.2012.01849.x]; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Brownell R., 2000, EXPRESSIVE ONE WOR P; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Chen SH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01069; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; CUMMINS J, 1979, REV EDUC RES, V49, P222, DOI 10.3102/00346543049002222; Cummins J., 2000, BILINGUAL ED BILINGU, V23; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Abreu PMJE, 2012, PSYCHOL SCI, V23, P1364, DOI 10.1177/0956797612443836; de Bruin A, 2015, CORTEX, V73, P375, DOI 10.1016/j.cortex.2015.05.025; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Filippi R, 2015, BILING-LANG COGN, V18, P490, DOI 10.1017/S1366728914000686; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gagne JR, 2010, BEHAV GENET, V40, P327, DOI 10.1007/s10519-009-9316-6; Garcia Coll C., 2002, HDB PARENTING, V4; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gluck CW, 2009, RECEPTIVE VOCABULARY; Green D.W., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Hartanto Andree, 2019, Child Dev, V90, P1215, DOI 10.1111/cdev.13032; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Hilchey M.D., 2015, CAMBRIDGE HDB BILING, P586, DOI [10.1017/CBO9781107447257.026, DOI 10.1017/CBO9781107447257.026]; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hornberger N. H., 2002, LANG POLICY-NETH, V1, P27, DOI [DOI 10.1023/A:1014548611951, 10.1023/A:1014548611951]; Hughes C, 2011, INFANT CHILD DEV, V20, P251, DOI 10.1002/icd.736; Jakel J, 2008, Z GESUNDHEITSPSYCHOL, V16, P12, DOI 10.1026/0943-8149.16.1.12; Jakel J, 2015, J CHILD FAM STUD, V24, P1097, DOI 10.1007/s10826-014-9918-3; Jaekel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065219; Jaekel N, 2017, LANG LEARN, V67, P631, DOI 10.1111/lang.12242; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Kirk NW, 2014, J COGN PSYCHOL, V26, P640, DOI 10.1080/20445911.2014.929580; Klein RM, 2015, CORTEX, V73, P340, DOI 10.1016/j.cortex.2015.07.020; Kousaie S, 2012, Q J EXP PSYCHOL, V65, P356, DOI 10.1080/17470218.2011.604788; Ladas AI, 2015, CHILD DEV, V86, P557, DOI 10.1111/cdev.12332; Leyendecker B., 2003, HDB KLEINKINDFORSCHU, P381; Leyendecker B, 2006, MON PARENT, P297; Luk G, 2011, BILING-LANG COGN, V14, P588, DOI 10.1017/S1366728911000010; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; Martin N.A., 2010, EXPRESSIVE ONE WORD, V4th ed.; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Morton JB, 2015, CORTEX, V73, P352, DOI 10.1016/j.cortex.2015.07.010; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Paap K., 2019, HDB NEUROSCIENCE MUL, P701; Paap KR, 2015, CORTEX, V69, P265, DOI 10.1016/j.cortex.2015.04.014; Paap KR, 2014, J COGN PSYCHOL, V26, P242, DOI 10.1080/20445911.2014.891597; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pelham SD, 2014, J EXP PSYCHOL LEARN, V40, P313, DOI 10.1037/a0035224; Poarch GJ, 2012, J EXP CHILD PSYCHOL, V113, P535, DOI 10.1016/j.jecp.2012.06.013; Polderman TJC, 2011, J CAN ACAD CHILD ADO, V20, P22; Poulin-Dubois D, 2011, J EXP CHILD PSYCHOL, V108, P567, DOI 10.1016/j.jecp.2010.10.009; Rauch DP, 2012, INT J BILINGUAL, V16, P402, DOI 10.1177/1367006911425819; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; UNESCO, 2006, INT STAND CLASS ED I; van Heuven WJB, 2008, CEREB CORTEX, V18, P2706, DOI 10.1093/cercor/bhn030; Verhagen J, 2017, BILING-LANG COGN, V20, P114, DOI 10.1017/S1366728915000590; von Bastian CC, 2016, J EXP PSYCHOL GEN, V145, P246, DOI 10.1037/xge0000120; Wiebe SA, 2014, MONOGR SOC RES CHILD, V79, P1, DOI [10.1002/mono.12095, 10.1002/mono.12096]; Willard JA, 2015, APPL PSYCHOLINGUIST, V36, P875, DOI 10.1017/S0142716413000544; Wright A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00213; Zelazo PD, 2015, DEV REV, V38, P55, DOI 10.1016/j.dr.2015.07.001; Zelazo Philip David, 2016, EXECUTIVE FUNCTION I	82	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209981	10.1371/journal.pone.0209981	http://dx.doi.org/10.1371/journal.pone.0209981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653525	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500020
J	Mohammad, SF; Feng, Y; Yang, GY				Mohammad, Shah Faisal; Feng, Yan; Yang, Guangyu			Optimization of cell culture and cell disruption processes to enhance the production of thermophilic cellulase FnCel5A in E.coli using response surface methodology	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; SOLID-STATE FERMENTATION; XYLANASE PRODUCTION; EXPRESSION; PROTEIN; IMPROVEMENT; RELEASE; OXIDASE	FnCel5A from Fervidobacterium nodosum is one of the most thermostable endoglucanases that have phenomenal characteristics, such as high activity, pH stability, and multi-specificity towards various substrates. However, large-scale thermophilic enzyme production is still a challenge. Herein, we focus on an optimization approach based on response surface methodology to improve the production of this enzyme. First, a Box-Behnken design was used to examine physiochemical parameters such as induction temperatures, isopropyl beta-D-1-thiogalactopyranoside concentrations and induction times on the heterogeneous expression of FnCel5A gene in E. coli. The best culture was collected after adding 0.56 mM IPTG and incubating it for 29.5 h at 24 degrees C. The highest enzymatic activity observed was 3.31 IU/ mL. Second, an economical " thermolysis" cell lysis method for the liberation of the enzymes was also optimized using Box-Behnken design. The optimal levels of the variables were temperature 77 degrees C, pH 7.71, and incubation time of 20 min, which gave about 74.3% higher activity than the well-established bead-milling cell disruption method. The maximum productivity of FnCel5A achieved (5772 IU/L) illustrated that its production increased significantly after combining both optimal models. This strategy can be scaled-up readily for overproduction of FnCel5A from recombinant E. coli to facilitate its usage in biomass energy production.	[Mohammad, Shah Faisal; Feng, Yan; Yang, Guangyu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China.	yanggy@sjtu.edu.cn			National Natural Science Foundation of China [31670791]; Ministry of Science and Technology of the People's Republic of China [2017YFE0103300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (Grant No. 31670791) to GY, and Ministry of Science and Technology of the People's Republic of China (CN) (2017YFE0103300) to FY.	Alshaibani AM, 2014, BRAZ J CHEM ENG, V31, P69, DOI 10.1590/S0104-66322014000100008; Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; Bhalla A, 2013, BIORESOURCE TECHNOL, V128, P751, DOI 10.1016/j.biortech.2012.10.145; Brijwani K, 2010, PROCESS BIOCHEM, V45, P120, DOI 10.1016/j.procbio.2009.08.015; BUNGE F, 1992, CHEM ENG SCI, V47, P225, DOI 10.1016/0009-2509(92)80216-Y; Cao Y, 2008, AFR J BIOTECHNOL, V7, P631; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003; ESTERBAUER H, 1991, BIORESOURCE TECHNOL, V36, P51, DOI 10.1016/0960-8524(91)90099-6; Falconer RJ, 1998, BIOTECHNOL BIOENG, V57, P381, DOI 10.1002/(SICI)1097-0290(19980220)57:4<381::AID-BIT1>3.3.CO;2-D; FELIU JX, 1994, BIOTECHNOL TECH, V8, P509, DOI 10.1007/BF00222845; FISH NM, 1984, BIO-TECHNOL, V2, P623, DOI 10.1038/nbt0784-623; Gawande PV, 1999, J APPL MICROBIOL, V87, P511, DOI 10.1046/j.1365-2672.1999.00843.x; Geciova J, 2002, MILCHWISSENSCHAFT, V57, P509; Geciova J, 2002, INT DAIRY J, V12, P541, DOI 10.1016/S0958-6946(02)00038-9; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Haltrich D, 1996, BIORESOURCE TECHNOL, V58, P137, DOI 10.1016/S0960-8524(96)00094-6; Hsiung M. A, 1989, BIOTECHNOLOGY, P267; Huber R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-42; Hughes DE, 1971, METHOD MICROBIOL, P1; Iandolo J J, 1996, J BACTERIOL, P134; Kaili Zhao, 2005, INT J CHEM REACT ENG, V1281, P1542; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; KATO C, 1987, GENE, V54, P197, DOI 10.1016/0378-1119(87)90487-2; Maciel GM, 2008, FOOD TECHNOL BIOTECH, V46, P183; Marco de A, 2007, BMC BIOTECHNOL, P7; Middleberg A. P. J, 1995, BIOTECHNOL ADV, P491; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller P. S, 2010, ENVIRON TECHNOL, P8; Moradpour Z, 2014, MINERVA BIOTECNOL, V26, P281; MOREIN S, 1994, ANAL BIOCHEM, V216, P47, DOI 10.1006/abio.1994.1006; Oberoi HS, 2012, FOOD BIOPROD PROCESS, V90, P257, DOI 10.1016/j.fbp.2011.05.002; OH S, 1995, APPL ENVIRON MICROB, V61, P3809, DOI 10.1128/AEM.61.11.3809-3814.1995; Paes G, 2006, J BIOTECHNOL, V125, P338, DOI 10.1016/j.jbiotec.2006.03.025; Park YS, 2002, APPL MICROBIOL BIOT, V58, P761, DOI 10.1007/s00253-002-0965-0; Ren XD, 2007, BIOCHEM ENG J, V33, P94, DOI 10.1016/j.bej.2006.09.017; Romano D, 2009, PROTEIN EXPRES PURIF, V68, P72, DOI 10.1016/j.pep.2009.05.013; SCHMITT B, 1976, BIOCHIMIE, V58, P1405; Schutte H, 1990, BEAD MILL DISRUPTION, P108; Shibasaki I, 1973, ACTA ALIMENT HUNG, P327; Szijarto N, 2011, BIOTECHNOL BIOFUELS, P1754; Viikari L, 2012, BIOMASS BIOENERG, V46, P13, DOI 10.1016/j.biombioe.2012.05.008; Virgilio C. D. E, 1991, FEBS LETT, P355; Wang HL, 2011, BIORESOURCE TECHNOL, V102, P6082, DOI 10.1016/j.biortech.2011.01.040; Wang K, 2014, APPL MICROBIOL BIOT, V98, P7051, DOI 10.1007/s00253-014-5680-0; Wang YH, 2005, PROCESS BIOCHEM, V40, P2721, DOI 10.1016/j.procbio.2004.12.024; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; YU P, 1992, BIOTECHNOL PROGR, V8, P25, DOI 10.1021/bp00013a005; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zheng BS, 2009, ACTA CRYSTALLOGR F, V65, P219, DOI 10.1107/S1744309109001316	50	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210595	10.1371/journal.pone.0210595	http://dx.doi.org/10.1371/journal.pone.0210595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653549	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500054
J	Simpson, DA; Quigley, MA; Kurinczuk, JJ; Carson, C				Simpson, Deon A.; Quigley, Maria A.; Kurinczuk, Jennifer J.; Carson, Claire			Twenty-five-year trends in breastfeeding initiation: The effects of sociodemographic changes in Great Britain, 1985-2010	PLOS ONE			English	Article							MATERNAL SMOKING; DURATION; EXPERIENCES; EMPLOYMENT; EDUCATION; BEHAVIOR; CONTEXT; LEVEL; CHILD	Background Data from the UK Infant Feeding Surveys indicate that breastfeeding initiation increased between 1985 and 2010. During this period, societal changes in GB also influenced the sociodemographic characteristics of women in the childbearing population. As breastfeeding behaviour is highly socially patterned in GB, the increasing trend in breastfeeding initiation may have hidden inequalities in breastfeeding practices. This study examines the sociodemographic inequalities in breastfeeding initiation in GB between 1985 and 2010, exploring whether and how this may have been influenced by social and policy changes. Methods Data drawn from the nationally representative 1985, 1990, 1995, 2000, 2005 and 2010 Infant Feeding Surveys were used to estimate changes in the proportion of mothers in selected sociodemographic groups over time. Logistic regression models estimated the independent associations between breastfeeding initiation in each survey year and maternal sociodemographic characteristics. Associations were adjusted for maternal sociodemographic, pregnancy-related and support factors. Evidence of a change in the association between breastfeeding initiation and each sociodemographic characteristic over time was assessed using a test for statistical heterogeneity. Results The sociodemographic characteristics of mothers in GB changed substantially between 1985 and 2010. Mothers were increasingly more likely to be 30 or over; have higher education and socioeconomic status; and be single or cohabiting. An increasing proportion of mothers in GB identified as being of black or minority ethnic origin. Reported smoking in pregnancy declined. These same characteristics independently predicted higher odds of breastfeeding initiation; the associations between these characteristics and breastfeeding initiation did not vary significantly over time. Conclusions Marked inequalities in breastfeeding initiation persisted over the study period, hidden among the increasing initiation rate at the population level. The increasing overall rate of initiation was most likely driven by the rising prevalence of those groups of mothers who were, and remain, characteristically most likely to breastfeed.	[Simpson, Deon A.; Quigley, Maria A.; Kurinczuk, Jennifer J.; Carson, Claire] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford	Simpson, DA (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	deon.simpson@npeu.ox.ac.uk		Simpson, Deon/0000-0002-3421-2437; Quigley, Maria/0000-0002-8058-6181	Nuffield Department of Population Health, University of Oxford	Nuffield Department of Population Health, University of Oxford	This study was conducted as part of DAS' Doctor of Philosophy in Population Health at the University of Oxford. DAS received a fully funded doctoral research studentship from the Nuffield Department of Population Health, University of Oxford. URL: https://www.ndph.ox.ac.uk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda J, 2017, J POLIT ECON, V125, P293, DOI 10.1086/690952; Amir LH, 2001, EARLY HUM DEV, V64, P45, DOI 10.1016/S0378-3782(01)00170-0; [Anonymous], 2017, AD FOST SURR; Bar-Yam N B, 1997, J Hum Lact, V13, P45, DOI 10.1177/089033449701300116; Becares L, 2015, SOC SCI MED, V142, P128, DOI 10.1016/j.socscimed.2015.08.025; Becares L, 2009, HEALTH PLACE, V15, P700, DOI 10.1016/j.healthplace.2008.10.008; Blanden J, 2004, SCOT J POLIT ECON, V51, P230, DOI 10.1111/j.0036-9292.2004.00304.x; Colodro-Conde L, 2011, J HUM LACT, V27, P272, DOI 10.1177/0890334411403929; Dennis CL, 2002, JOGNN-J OBST GYN NEO, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; Dex S, 1998, OXFORD B ECON STAT, V60, P79, DOI 10.1111/1468-0084.00087; European Statistics, 2015, PEOPL EU WHO AR WE D; Fitzpatrick KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153447; Griffiths LJ, 2005, INT J EPIDEMIOL, V34, P1378, DOI 10.1093/ije/dyi162; Hawkins SS, 2007, PAEDIATR PERINAT EP, V21, P242, DOI 10.1111/j.1365-3016.2007.00812.x; HENDERSHOT GE, 1984, PEDIATRICS, V74, P591; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Ingram J, 2008, MATERN CHILD NUTR, V4, P171, DOI 10.1111/j.1740-8709.2007.00129.x; Johns HM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-212; Kelly YJ, 2006, PEDIATRICS, V118, pE1428, DOI 10.1542/peds.2006-0714; Kent K., 2009, EC LABOUR MARKET REV, V3, P30; Kiernan K, 2006, SOC SCI MED, V63, P335, DOI 10.1016/j.socscimed.2006.01.006; Kiernan KE, 1989, FAMILY FORMATION FIS, P27; Law C., 2009, UNDERSTANDING HLTH I, P37; LIESTOL K, 1988, J BIOSOC SCI, V20, P45, DOI 10.1017/S0021932000017247; Magnusson M, 2016, CHILD CARE HLTH DEV, V42, P415, DOI 10.1111/cch.12327; McAndrew F, 2012, INFANT FEEDING SURVE; McFadden A, 2013, HEALTH EXPECT, V16, pE124, DOI 10.1111/j.1369-7625.2012.00770.x; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Napierala M, 2016, ENVIRON RES, V151, P321, DOI 10.1016/j.envres.2016.08.002; Oakley LL, 2016, MATERN CHILD NUTR, V12, P440, DOI 10.1111/mcn.12159; Oakley LL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002765; Office for National Statistics, 2016, FAM HOUS UK 2016; Organisation for Economic Co-operation and Development, 2009, OECD FAM DAT CHILD O; Public Health England, PUBL HLTH PROF CHILD; Public Health England, PUBL HLTH OUTC FRAM; Rempel LA, 2004, J SOC PERS RELAT, V21, P92, DOI 10.1177/0265407504039841; Rempel LA, 2011, J HUM LACT, V27, P115, DOI 10.1177/0890334410390045; Schafer Ellen J, 2017, Matern Child Health J, V21, P1288, DOI 10.1007/s10995-016-2228-1; Simpson D., 2017, THESIS; Skafida V, 2012, MATERN CHILD HLTH J, V16, P519, DOI 10.1007/s10995-011-0743-7; Skafida V, 2009, PUBLIC HEALTH NUTR, V12, P2285, DOI 10.1017/S1368980009004947; StataCorp, 2013, STATA STAT SOFTW REL; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; TRUSSELL J, 1992, POP STUD-J DEMOG, V46, P285, DOI 10.1080/0032472031000146246; Wambach K A, 2000, J Obstet Gynecol Neonatal Nurs, V29, P282, DOI 10.1111/j.1552-6909.2000.tb02050.x; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wright CM, 2006, PUBLIC HEALTH NUTR, V9, P686, DOI 10.1079/PHN2005888	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210838	10.1371/journal.pone.0210838	http://dx.doi.org/10.1371/journal.pone.0210838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653579	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500079
J	Iwasawa, T; Takahashi, K; Goto, M; Anzai, M; Shirasawa, H; Sato, W; Kumazawa, Y; Terada, Y				Iwasawa, Takuya; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro			Human frozen-thawed blastocyst morphokinetics observed using time-lapse cinematography reflects the number of trophectoderm cells	PLOS ONE			English	Article							LIVE BIRTH; HUMAN EMBRYOS; VITRIFICATION; OOCYTES; ANEUPLOIDY; COLLAPSE; REVEALS	Recent studies reported morphokinetic indices for optimal selection of embryos in assisted reproductive technology (ART). The morphokinetics in blastocyst stage include the collapse and re-expansion rates after thawing. However, evaluation methods using these morphokinetics have not been established, mainly because the underlying molecular mechanisms remain unclarified. In this study, we focused on the relationship between these morphokinetic observation of the blastocyst behaviour and the number of cells constituting the blastocyst. We evaluated 38 surplus human frozen-thawed blastocysts using time-lapse cinematography and recorded their expansion, contraction, and hatching. A total of 28 blastocysts expanded in culture (cross-sectional area >= 5,000 Pi mu m(2)). In comparison to the ones that did not, the expanded group presented significantly more number of inner cell mass (ICM) and trophectoderm (TE) cells, which eventually develop into the fetus and placenta, respectively (ICM: Expanded 10.2 +/- 6.3 vs. Non-Expanded 6.0 +/- 12.3, p<0.05; TE: Expanded 165.7 +/- 74.8 vs. Non-Expanded 57.0 +/- 29.4, p<0.05). Moreover, a positive correlation was found between the expansion rate (up to 4 h) and the number of TE cells (r=0.558, p=0.0021). Additionally, blastocysts that hatched had a significantly higher number of TE cells than those that did not (hatching 225.2 +/- 61.2 vs. no hatching 121.1 +/- 48.6, p<0.0001). The number of TE cells per unit of cross-sectional area correlated negatively with the contraction time (r=-0.601, p=0.0007). No correlation between the number of ICM cells and these morphokinetics was detected. In conclusion, our study demonstrates that different morphokinetics of frozen-thawed blastocysts reflect the number of TE cells. The differentiation of blastocysts containing sufficient TE cells would be beneficial for implantation and prognosis of a subsequent pregnancy. Thus, evaluation of these morphokinetics can be an effective method to screen good embryos for ART.	[Iwasawa, Takuya; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Shirasawa, Hiromitsu; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan	Akita University	Iwasawa, T (corresponding author), Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan.	iwasawat@med.akita-u.ac.jp			JSPS KAKENHI [17K11215]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html), Grant Number 17K11215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson E, 2018, J BRAS REPROD ASSIST, V22, P228, DOI 10.5935/1518-0557.20180042; Alikani M, 2005, HUM REPROD, V20, P3369, DOI 10.1093/humrep/dei242; Antinori M, 2007, REPROD BIOMED ONLINE, V14, P72, DOI 10.1016/S1472-6483(10)60766-3; Armstrong S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011320.pub3; Bell CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059528; Bodri D, 2016, FERTIL STERIL, V105, P1476, DOI 10.1016/j.fertnstert.2016.02.014; Campbell A, 2013, REPROD BIOMED ONLINE, V26, P477, DOI 10.1016/j.rbmo.2013.02.006; De Paepe C, 2013, HUM REPROD, V28, P740, DOI 10.1093/humrep/des432; Desai N, 2005, REPROD BIOMED ONLINE, V11, P349, DOI 10.1016/S1472-6483(10)60843-7; Desai N, 2018, FERTIL STERIL, V109, P665, DOI 10.1016/j.fertnstert.2017.12.025; Du QY, 2016, FERTIL STERIL, V105, P910, DOI 10.1016/j.fertnstert.2015.12.014; Ebner T, 2016, J ASSIST REPROD GEN, V33, P49, DOI 10.1007/s10815-015-0609-9; Fleming TP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1000, DOI 10.2741/Fleming; Gardner DK, 2016, MOL HUM REPROD, V22, P704, DOI 10.1093/molehr/gaw057; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; HARDY K, 1989, DEVELOPMENT, V107, P597; Huang TTF, 2016, REPROD BIOMED ONLINE, V33, P659, DOI 10.1016/j.rbmo.2016.08.020; Jurisicova A, 1996, MOL HUM REPROD, V2, P93, DOI 10.1093/molehr/2.2.93; Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678; Marcos J, 2015, HUM REPROD, V30, P2501, DOI 10.1093/humrep/dev216; Martinez-Burgos M, 2011, FERTIL STERIL, V95, P374, DOI 10.1016/j.fertnstert.2010.07.1089; Mio Y, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.023; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Niimura S, 2003, J REPROD DEVELOP, V49, P413, DOI 10.1262/jrd.49.413; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Onodera Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175150; Sathananthan Henry, 2003, Reprod Biomed Online, V7, P228; Shimoda Y, 2016, J REPROD DEVELOP, V62, P187, DOI 10.1262/jrd.2015-150; Shu Y, 2009, FERTIL STERIL, V91, P401, DOI 10.1016/j.fertnstert.2007.11.083; Toyooka Y, 2016, DEV BIOL, V411, P50, DOI 10.1016/j.ydbio.2016.01.011; Vialard F, 2011, CYTOGENET GENOME RES, V133, P127, DOI 10.1159/000324231; Watson AJ, 2004, ANIM REPROD SCI, V82-3, P583, DOI 10.1016/j.anireprosci.2004.04.004; Yamagata K, 2010, DEV BIOL, V346, P90, DOI 10.1016/j.ydbio.2010.07.021; Ziebe S, 2001, ACTA OBSTET GYN SCAN, V80, P169, DOI 10.1034/j.1600-0412.2001.080002169.x	35	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210992	10.1371/journal.pone.0210992	http://dx.doi.org/10.1371/journal.pone.0210992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650134	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300083
J	Vongxay, V; Albers, F; Thongmixay, S; Thongsombath, M; Broerse, JEW; Sychareun, V; Essink, DR				Vongxay, Viengnakhone; Albers, Femke; Thongmixay, Souksamone; Thongsombath, Maliphone; Broerse, Jacqueline E. W.; Sychareun, Vanphanom; Essink, Dirk Rombout			Sexual and reproductive health literacy of school adolescents in Lao PDR	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; YOUNG-PEOPLE; VIENTIANE; YOUTH; RISK; VALIDATION; STRATEGIES; PREGNANCY; ATTITUDES; BEHAVIOR	Rationale Adolescent pregnancy in Lao PDR is the highest in Southeast Asia. It leads to negative health and social consequences in young people. It is anticipated that this problem is partly caused by limited sexual and reproductive health literacy (SRHL), leading to poor sexual and reproductive health (SRH) decisions. Based on the concept of health literacy, SRHL goes beyond knowledge and behavior and is the self-perceived ability of an individual to access the needed information, understand the information, appraise and apply the information into informed decision making for a good way to contribute to sexual and reproductive health. It is not only knowing (knowledge) and doing (behavior), but it is the process of individual's thought on an SRH problem before taking an action. The aim of this study was to measure SRHL among school-going adolescents aged 15-19 and to determine factors associated with SRHL. Method We conducted a cross-sectional study in rural and urban areas of Lao PDR in 2017. Respondents completed a self-administered questionnaire with five parts: socio-demographic, personal health, SRH knowledge and behavior, SRHL, and functional literacy. We calculated the SRHL score based on the HL-EU index and used descriptive statistics to determine the score and levels. Then we used bivariate statistics and multiple linear regression to identify factors associated with SRHL in these adolescents. Result Among 461 respondents, 65.5% had inadequate SRHL. Scores were positively and significantly associated with several factors, including: school location (beta: 3.218; p<0.001), knowledge on SRH and attending SR class in school (p:0.010-p<0.001), and functional literacy on condoms, which reflected how respondents understood the use of condoms (beta: 0.871; p<0.001). Conclusion Because most school adolescents had inadequate SRHL, comprehensive sexual education and enabling information as well as service access for adolescents are essential to ensure that adolescents can access, understand, appraise and apply good SRH knowledge in decision-making to benefit their own health.	[Vongxay, Viengnakhone; Thongmixay, Souksamone; Sychareun, Vanphanom] Univ Hlth Sci, Viangchan, Laos; [Albers, Femke; Broerse, Jacqueline E. W.; Essink, Dirk Rombout] Vrije Univ Amsterdam, De Boelelaan, Amsterdam, Netherlands; [Thongsombath, Maliphone] Prov Hlth Dept, Sam Neua, Huaphan Provinc, Laos	Vrije Universiteit Amsterdam	Vongxay, V (corresponding author), Univ Hlth Sci, Viangchan, Laos.	viengnakhone_poom@yahoo.com		vongxay, viengnakhone/0000-0003-0014-5800	European Union [DCI/SANTI/2014/342-306]; EU [DCI/SANTI/2014/342-306]	European Union(European Commission); EU(European Commission)	The research was conducted under the support of European Union funded LEARN Project (Number: DCI/SANTI/2014/342-306) and the Medical Committee of Netherland-Vietnam (MCNV) in Lao PDR. The first author is the principal investigator.; The authors highly appreciate the support from the EU funded LEARN Project (Number: DCI/SANTI/2014/342-306) and MCNV Lao PDR, and the kind assistance of the University of Health Sciences of Lao PDR, and the contributions from everyone in the research team. Special acknowledgment extended to Prof. Pamela Wright, who contributed a lot on editing and knowledge of scientific writing.	[Anonymous], 2012, EARL MARR AD YOUNG P; Beatty P, 1998, MEMORY, V6, P407; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Champion JD, 2013, APPL NURS RES, V26, P204, DOI 10.1016/j.apnr.2013.06.003; CHANDRAMOULI V, 2014, REPROD HLTH, V11; Christiansen CS, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/257546; Davis TC, 2006, PEDIATRICS, V118, pE1707, DOI 10.1542/peds.2006-1139; Denno DM, 2015, J ADOLESCENT HEALTH, V56, pS22, DOI 10.1016/j.jadohealth.2014.09.012; Devine S, 2014, J ADOLESCENT HEALTH, V54, pS78, DOI 10.1016/j.jadohealth.2013.12.005; Duong TV, 2017, J EPIDEMIOL, V27, P80, DOI 10.1016/j.je.2016.09.005; Ganchimeg T, 2013, BJOG-INT J OBSTET GY, V120, P1622, DOI 10.1111/1471-0528.12391; Garfield CF, 2016, J ADOLESCENT HEALTH, V58, P497, DOI 10.1016/j.jadohealth.2015.12.010; Guria Madhumita, 2009, Journal of Human Ecology, V27, P101; Hindin MJ, 2016, J ADOLESCENT HEALTH, V59, pS8, DOI 10.1016/j.jadohealth.2016.04.021; Hulton LJ, 2001, ONLINE J KNOWL SYN N, V8, part. no.; Kirby DB, 2007, J ADOLESCENT HEALTH, V40, P206, DOI 10.1016/j.jadohealth.2006.11.143; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Lao People's Revolutionary Youth Union United Nations Population Fund, 2014, AD YOUTH SIT AN LAO; Levin-Zamir D, 2016, J HEALTH COMMUN, V21, P61, DOI 10.1080/10810730.2016.1207115; Magnani RJ, 2002, J ADOLESCENT HEALTH, V30, P76, DOI 10.1016/S1054-139X(01)00328-7; Manganello Jennifer A, 2015, J Commun Healthc, V8, P172, DOI 10.1179/1753807615Y.0000000016; Martin LT, 2009, J GEN INTERN MED, V24, P1211, DOI 10.1007/s11606-009-1105-7; Ministry of Health & Lao Statistics Bureau, 2012, LAO PDR LAO SOC IND; Naigaga MDAS, 2015, J CLIN NURS, V24, P2402, DOI 10.1111/jocn.12796; Needham HE, 2010, J ADOLESCENT HEALTH, V46, P506, DOI 10.1016/j.jadohealth.2009.11.195; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Pelikan J.M., COMP REPORT HLTH LIT; Runk L, 2017, HEALTH PROMOT INT, V32, P360, DOI 10.1093/heapro/daw087; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS11, DOI 10.1016/j.jadohealth.2016.05.022; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Svanemyr J, 2015, J ADOLESCENT HEALTH, V56, pS7, DOI 10.1016/j.jadohealth.2014.09.011; Sychareun V, 2004, REPROD HEALTH MATTER, V12, P155, DOI 10.1016/S0968-8080(04)23117-2; Sychareun V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1126; Sychareun V, 2013, GLOB PUBLIC HEALTH, V8, P958, DOI 10.1080/17441692.2013.830755; Sychareun V, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-212; Thanavanh B, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17387; Thato R, 2008, J ADV NURS, V62, P457, DOI 10.1111/j.1365-2648.2008.04609.x; United Nations Population Fund, 2016, STAT WORLD POP 2016; Zahnd WE, 2009, AM J HEALTH BEHAV, V33, P550	39	20	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209675	10.1371/journal.pone.0209675	http://dx.doi.org/10.1371/journal.pone.0209675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650100	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300022
J	Wang, ID; Chien, WC; Chung, CH; Tsai, PY; Chang, SY; Meng, FC; Peng, CK				Wang, I-Duo; Chien, Wu-Chien; Chung, Chi-Hsiang; Tsai, Pei-Yi; Chang, Shan-Yueh; Meng, Fan-Chun; Peng, Chung-Kan			Non-Apnea Sleep Disorder associates with increased risk of incident heart failure-A nationwide population-based cohort study	PLOS ONE			English	Article							INSOMNIA	Purpose Non-apnea sleep disorder (NASD) increases the risk of cardiovascular events, such as hypertension and ischemic heart disease (IHD). Patients with heart failure (HF) are at higher risk for sleep disorder; however, there is no documentation on NASD's association with HF to date. Therefore, our study aimed to determine whether NASD increases the risk of incident HF. Materials and methods Using the outpatient and inpatient data from Taiwan's Longitudinal Health Insurance Database, we conducted a nationwide cohort study of patients with a first-time diagnosis of NASD in the year 2000 and followed up the risk of incident heart failure until December 31, 2013. We calculated risks and incidence ratios of HF for patients with NASD compared with the general population. The cumulative incidence of NASD and the subsequent risk of HF are assessed by the Kaplan-Meier method and Cox regression using a matched comparison cohort of HF patients without NASD. Results The NASD cohort had an adjusted hazard ratio (HR) of incident HF 19.7% higher than that of the cohort without NASD (95% CI = 1.130-1.270; p<0.001). In the NASD population, the mean interval to HF in males and females were 5.00 +/- 3.69 years and 5.00 +/- 3.66 years, respectively. The Kaplan-Meier analysis indicated that after the seventh year, the incidence of HF was higher in the NASD cohort than in the control cohort till the end of the follow up. Conclusions Our study demonstrates that NASD patients are associated with a higher risk of incident HF.	[Wang, I-Duo; Chang, Shan-Yueh; Meng, Fan-Chun; Peng, Chung-Kan] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tsai, Pei-Yi] Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan, Taiwan; [Peng, Chung-Kan] Natl Def Med Ctr, Triserv Gen Hosp, Sleep Med Ctr, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Defense Medical Center; Tri-Service General Hospital	Peng, CK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan.; Peng, CK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Sleep Med Ctr, Taipei, Taiwan.	kanpeng@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	I DUO, WANG/0000-0002-3395-7728; Chang, Shan-Yueh/0000-0001-8944-174X	Tri-Service General Hospital [TSGH-C106-002]; National Defense Medical Center	Tri-Service General Hospital; National Defense Medical Center	The study was supported by National Defense Medical Center and Tri-Service General Hospital (TSGH-C106-002) to WCC https://wwwv.tsgh.ndmctsgh.edu.tw/Unit/102362/25530.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by National Defense Medical Center and Tri-Service General Hospital (TSGH-C106-002).	Portela PC, 2009, CEREBROVASC DIS, V27, P104, DOI 10.1159/000200447; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM., 2012, 6 COUNTRIES 6 REFORM, P171; Chung WS, 2013, SLEEP, V36, P1963, DOI 10.5665/sleep.3240; Erickson Virginia S, 2003, AACN Clin Issues, V14, P477, DOI 10.1097/00044067-200311000-00009; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017; Ingelsson E, 2007, EUR J HEART FAIL, V9, P184, DOI 10.1016/j.ejheart.2006.05.012; Lai YJ, 2013, SLEEP MED, V14, P913, DOI 10.1016/j.sleep.2013.03.024; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Lin CL, 2017, J HUM HYPERTENS, V31, P220, DOI 10.1038/jhh.2016.55; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Niiranen TJ, 2016, SLEEP BREATH, V20, P589, DOI 10.1007/s11325-015-1253-4; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Redeker NS, 2006, HEART LUNG, V35, P252, DOI 10.1016/j.hrtlng.2005.10.007; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Su TP, 2004, AUST NZ J PSYCHIAT, V38, P706, DOI 10.1111/j.1440-1614.2004.01444.x; Taiwan's National Health Insurance System, 2009, 6 COUNTRIES 6 REFORM, P171; Thorpy MJ, 2012, NEUROTHERAPEUTICS, V9, P687, DOI 10.1007/s13311-012-0145-6; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209673	10.1371/journal.pone.0209673	http://dx.doi.org/10.1371/journal.pone.0209673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650103	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300021
J	Hsu, WH; Shen, YC; Shiao, YJ; Kuo, CH; Lu, CK; Lin, TY; Ku, WC; Lin, YL				Hsu, Wei-Hsiang; Shen, Yuh-Chiang; Shiao, Young-Ji; Kuo, Ching-Hua; Lu, Chung-Kuang; Lin, Tai-Yuan; Ku, Wei-Chi; Lin, Yun-Lian			Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; BIOMARKER; PROTEIN; CSF; HYPOXANTHINE; MECHANISMS; XANTHINE; DEMENTIA; PLASMA	Ischemic stroke is one of the most common causes of death worldwide and is a major cause of acquired disability in adults. However, there is still a need for an effective drug for its treatment. Buyang Huanwu decoction (BHD), a traditional Chinese medicine (TCM) prescription, has long been used clinically to aid neurological recovery after stroke. To establish potential clinical indicators of BHD efficacy in stroke treatment and prognosis, we conducted a combined proteomic and metabolomic analysis of cerebrospinal fluid (CSF) samples in a mouse stroke model. CSF samples were obtained from male mice with acute ischemic stroke induced by middle cerebral ischemic/reperfusion (CI/R) injury, some of which were then treated with BHD. Label-free quantitative proteomics was conducted using nano-LC-MS/MS on an LTQ Orbitrap mass and metabolomic analysis was performed using nanoprobe NMR and UHPLC-QTOF-MS. The results showed that several proteins and metabolites were present at significantly different concentrations in the CSF samples from mice with CI/R alone and those treated with BHD. These belonged to pathways related to energy demand, inflammatory signaling, cytoskeletal regulation, Wnt signaling, and neuroprotection against neurodegenerative diseases. In conclusion, our in silico data suggest that BHD treatment is not only protective but can also ameliorate defects in pathways affected by neurological disorders. These data shed light on the mechanism whereby BHD may be effective in the treatment and prevention of stroke-related neurodegenerative disease.	[Hsu, Wei-Hsiang; Lin, Yun-Lian] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Shen, Yuh-Chiang; Shiao, Young-Ji; Lu, Chung-Kuang] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan; [Kuo, Ching-Hua; Lin, Yun-Lian] Natl Taiwan Univ, Dept Pharm, Taipei, Taiwan; [Lin, Tai-Yuan; Ku, Wei-Chi] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan	China Medical University Taiwan; National Research Institute of Chinese Medicine; National Taiwan University; Fu Jen Catholic University	Lin, YL (corresponding author), China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan.; Lin, YL (corresponding author), Natl Taiwan Univ, Dept Pharm, Taipei, Taiwan.; Ku, WC (corresponding author), Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan.	089052@mail.fju.edu.tw; yllin5212@gmail.com	Shiao, Young-Ji/AAA-9647-2022; Ku, Wei-Chi/F-1031-2010	Ku, Wei-Chi/0000-0001-8438-3210; Lin, Tai-Yuan/0000-0002-9958-5234	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, 104-2320-B-039-055-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from Ministry of Science and Technology of Taiwan (MOST 102-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, and 103-2320-B-039-055-MY3).; This work was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2320-B-039-055-MY3, 102-2320-B-030-012-MY2, and 104-2320-B-039-055-MY3). We thank the Mass Spectrometry Laboratory of Tzong Jwo Jang, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan, for the assistance on proteomics analyses. We are also grateful for Mr. Yen-Ming Chao assisting in <SUP>1</SUP>H-NMR analysis, Dr. Yu-Lun Kuo for the IPA analysis, and Professor Kuo-Tong Liu, Department of Chinese Martial Arts and Graduate Institute of Sport Coaching Science, Chinese Culture University, Taiwan, for his kindly providing BHD materials.	ALOM J, 1991, ANN NEUROL, V30, P735, DOI 10.1002/ana.410300518; [Anonymous], [No title captured]; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bruggink KA, 2015, J NEUROCHEM, V134, P1152, DOI 10.1111/jnc.13216; Chen HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140823; Chen HJ, 2012, METABOLOMICS, V8, P974, DOI 10.1007/s11306-011-0394-0; Chen LH, 2011, CHINESE J ETHNOMEDIC, V15, P102; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cruz T, 2014, METABOLITES, V4, P115, DOI 10.3390/metabo4010115; Cunningham R, 2013, J PROTEOME RES, V12, P719, DOI 10.1021/pr300785h; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; DEGRELL I, 1988, ARCH GERONTOL GERIAT, V7, P173, DOI 10.1016/0167-4943(88)90029-5; Dieks JK, 2013, J ALZHEIMERS DIS, V34, P387, DOI 10.3233/JAD-121810; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Hao CZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/630124; Jellinger K, 2006, EUR J NEUROL, V13, pE1, DOI 10.1111/j.1468-1331.2006.00926.x; Kelly-Spratt KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019721; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Kimberly WT, 2013, STROKE, V44, P1389, DOI 10.1161/STROKEAHA.111.000397; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Liu Chuanzhen, 2003, J Tradit Chin Med, V23, P243; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Llano DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182098; Luo L, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4072658; MARTINEZ M, 1993, J NEURAL TRANSM-PARK, V6, P1, DOI 10.1007/BF02252617; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Menzie J, 2014, AMINO ACIDS, V46, P31, DOI 10.1007/s00726-012-1382-z; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morimoto K., 1987, NO SHINKEI GEKA, V15, P25; NIKLASSON F, 1988, UPSALA J MED SCI, V93, P225, DOI 10.3109/03009738809178548; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Pla V, 2013, BRAIN PATHOL, V23, P274, DOI 10.1111/j.1750-3639.2012.00644.x; Pluta R, 2004, FOLIA NEUROPATHOL, V42, P181; Prestwich EG, 2013, CHEM RES TOXICOL, V26, P538, DOI 10.1021/tx300473n; Regeniter A, 2009, CLIN NEUROL NEUROSUR, V111, P313, DOI 10.1016/j.clineuro.2008.12.004; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Sjodin S, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0160-z; Smith JS, 2014, PROTEOMICS, V14, P1102, DOI 10.1002/pmic.201300241; Srivastava K, 2013, J CEREBR BLOOD F MET, V33, P1928, DOI 10.1038/jcbfm.2013.151; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Talelli P, 2004, ARCH NEUROL-CHICAGO, V61, P983, DOI 10.1001/archneur.61.6.983-b; THOMPSON EJ, 2005, CSF PROTEINS BIOCH A; Voevodskaya O, 2016, NEUROLOGY, V86, P1754, DOI 10.1212/WNL.0000000000002672; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Wang WR, 2011, J ETHNOPHARMACOL, V137, P214, DOI 10.1016/j.jep.2011.05.008; Wang Y, 2013, MOL BIOSYST, V9, P431, DOI 10.1039/c2mb25224d; Watabe-Rudolph M, 2012, NEUROLOGY, V78, P569, DOI 10.1212/WNL.0b013e318247caa1; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zenzmaier C, 2009, J NEUROCHEM, V110, P653, DOI 10.1111/j.1471-4159.2009.06158.x; Zhang QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033722; Zhou JY, 2009, J PROTEOME RES, V8, P5387, DOI 10.1021/pr900564f	60	11	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209184	10.1371/journal.pone.0209184	http://dx.doi.org/10.1371/journal.pone.0209184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645580	gold, Green Submitted, Green Published			2022-12-27	WOS:000455810200007
J	Pang, YY; Zhang, C; Xu, MJ; Huang, GY; Cheng, YX; Yang, XZ				Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen			The transcriptome sequencing and functional analysis of eyestalk ganglions in Chinese mitten crab (Eriocheir sinensis) treated with different photoperiods	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; POPULATION-GROWTH; CIRCADIAN-RHYTHM; PYRUVATE-KINASE; DAILY TORPOR; METABOLISM; PHOTOTRANSDUCTION; IDENTIFICATION; INHIBITION; EXPRESSION	Photoperiod plays an important role in individual growth, development, and metabolism in crustaceans. The growth and reproduction of crabs are closely related to the photoperiod. However, as of yet, there are still no transcriptomic reports of eyestalk ganglions treated under different photoperiods in the Chinese mitten crab (Eriocheir sinensis), which is a benthonic crab with high commercial value in Asia. In this study, we collected the eyestalk ganglions of crabs that were reared under different photoperiods, including a control group (L: D = 12 h: 12 h, named CC), a constant light group (L: D = 24 h: 0 h, named LL) and a constant darkness group (L: D = 0 h: 24 h, named DD). RNA sequencing was performed on these tissues in order to examine the effects of different photoperiods. The total numbers of clean reads from the CC, LL and DD groups were 48,772,584 bp, 53,943,281 bp and 53,815,178 bp, respectively. After de novo assembly, 161,380 unigenes were obtained and were matched with different databases. The DEGs were significantly enriched in phototransduction and energy metabolism pathways. Results from RT-qPCR showed that TRP channel protein (TRP) in the phototransduction pathway had a significantly higher level of expression in LL and DD groups than in the CC group. We found that the downregulation of the pyruvate dehydrogenase complex (PDC) gene and the upregulation phosphoenolpyruvate carboxykinase (PPC) gene were involved in energy metabolism processes in LL or DD. In addition, we also found that the upregulation of the expression level of the genes G alpha q, pyruvate kinase (PK), NADH peroxidase (NADH) and ATPase is involved in phototransduction and energy metabolism. These results may shed some light on the molecular mechanism underlying the effect of photoperiod in physiological activity of E. sinensis.	[Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China; [Pang, Yang-yang; Zhang, Cong; Xu, Min-jie; Huang, Gen-yong; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China	Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.	Chengyongxucrab@163.com; zny119@163.com			National Natural Science Foundation of China [41876190]; Fishery Science and Technology Projects in Jiangsu Province [d2018_4]; Shandong Joint Fund [NSFC: U1706209]; Aquaculture Engineering Research Platform in Shanghai [16DZ2281200]; China Agriculture Research System [CARS-48]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fishery Science and Technology Projects in Jiangsu Province; Shandong Joint Fund; Aquaculture Engineering Research Platform in Shanghai; China Agriculture Research System	This work was supported by National Natural Science Foundation of China (grant no. (No41876190)), Fishery Science and Technology Projects in Jiangsu Province(d2018_4), Shandong Joint Fund (NSFC: U1706209), the Aquaculture Engineering Research Platform in Shanghai Established by Shanghai Science and Technology Commission [grant number 16DZ2281200], and the China Agriculture Research System [grant number CARS-48].	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Ban M, 2006, FISHERIES SCI, V72, P128, DOI 10.1111/j.1444-2906.2006.01126.x; Barriga-Montoya C, 2017, COMP BIOCHEM PHYS A, V203, P297, DOI 10.1016/j.cbpa.2016.10.008; Bebas P, 2002, J EXP BIOL, V205, P37; Bellono NW, 2013, CHANNELS, V7, P243, DOI 10.4161/chan.25322; Bernardi P, 2015, CIRC RES, V116, P1850, DOI 10.1161/CIRCRESAHA.115.306557; Biasibetti-Brendler H, 2018, MOL NEUROBIOL, V55, P4098, DOI 10.1007/s12035-017-0634-z; Brown JCL, 2007, AM J PHYSIOL-REG I, V293, pR1833, DOI 10.1152/ajpregu.00310.2007; Cui L., 2017, B ENVIRON CONTAM TOX, V2017, P1, DOI DOI 10.1007/S00128-016-2015-0; Ding ZL, 2017, AQUACULT NUTR, V23, P1136, DOI 10.1111/anu.12482; Drezon-Tepler M., 1995, MARINE ECOLOGY PROGR, V40, DOI [10.1016/j.aquaculture.2011.11.027, DOI 10.1016/J.AQUACULTURE.2011.11.027]; Espinosa-Chaurand D, 2017, AQUACULTURE, V479, P225, DOI 10.1016/j.aquaculture.2017.05.029; Farhadi A, 2016, AQUAC RES, V47, P2518, DOI 10.1111/are.12700; Fitzgibbon QP, 2012, AQUACULTURE, V368, P48, DOI 10.1016/j.aquaculture.2012.09.018; Forward RB, 2016, BIOL BULL-US, V230, P15, DOI 10.1086/BBLv230n1p15; Gao XL, 2016, AQUACULTURE, V452, P52, DOI 10.1016/j.aquaculture.2015.09.005; Glantz RM, 2000, J NEUROSCI, V20, P1780; Groeneveld J, 2015, ECOL MODEL, V303, P78, DOI 10.1016/j.ecolmodel.2015.02.009; Guo L, 2018, BIOTECHNOL BIOENG, V115, P1571, DOI 10.1002/bit.26580; Hamasaki K, 2016, AQUAC RES, V47, P2506, DOI 10.1111/are.12699; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hardie DG, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0774; Heldmaier G, 1999, AM J PHYSIOL-ENDOC M, V276, pE896, DOI 10.1152/ajpendo.1999.276.5.E896; Hoelters L, 2016, GEN COMP ENDOCR, V237, P43, DOI 10.1016/j.ygcen.2016.07.024; Huang XS, 2014, ANIM REPROD SCI, V150, P139, DOI 10.1016/j.anireprosci.2014.09.004; Hui M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178417; Jia ZH, 2018, DEV COMP IMMUNOL, V82, P94, DOI 10.1016/j.dci.2017.12.030; Dutra BK, 2008, COMP BIOCHEM PHYS C, V147, P179, DOI 10.1016/j.cbpc.2007.09.004; Keirsse-Haquin J, 2017, EUROPEAN BIOPHYSICS, V47, P205, DOI [10.2983/35.033.0220, DOI 10.2983/35.033.0220]; Le M, 2018, ENVIRON RES, V163, P80, DOI 10.1016/j.envres.2018.01.027; Lee CH, 2018, FOOD CHEM, V258, P359, DOI 10.1016/j.foodchem.2018.03.088; Li SJ, 2017, GENETICA, V145, P175, DOI 10.1007/s10709-017-9956-z; Liu Y, 2017, LETT APPL MICROBIOL, V65, P395, DOI 10.1111/lam.12784; Loredo-Ranjel R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175046; Fanjul-Moles ML, 2009, PHOTOCHEM PHOTOBIOL, V85, P78, DOI 10.1111/j.1751-1097.2008.00399.x; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Matsuda H, 2012, AQUACULTURE, V326, P136, DOI 10.1016/j.aquaculture.2011.11.027; Maurer CM, 2010, J NEUROSCI, V30, P11962, DOI 10.1523/JNEUROSCI.2848-10.2010; Mendoza-Vargas L, 2017, INVERTEBR NEUROSCI, V17, DOI 10.1007/s10158-017-0199-6; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Mitchell J, 1998, BIOCHEMISTRY-US, V37, P9064, DOI 10.1021/bi972768a; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Moraes MN, 2017, BBA-MOL CELL RES, V1864, P324, DOI 10.1016/j.bbamcr.2016.11.010; Morata N, 2015, POLAR BIOL, V38, P67, DOI 10.1007/s00300-013-1417-2; Moreno A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45744; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nelson-Mora J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083937; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nogueira N, 2018, AQUAC RES, V49, P93, DOI 10.1111/are.13437; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Olguin-Leon P, 2017, AQUAC RES, V48, P5587, DOI 10.1111/are.13380; Patil YN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P106, DOI 10.1086/667808; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; PICONES A, 1990, J EXP BIOL, V150, P111; Suagee JK, 2010, COMP BIOCHEM PHYS B, V155, P322, DOI 10.1016/j.cbpb.2009.11.019; Taylor MR, 2004, P NATL ACAD SCI USA, V101, P4584, DOI 10.1073/pnas.0307074101; Tian Y, 2012, SCI CHINA LIFE SCI, V55, P27, DOI 10.1007/s11427-012-4272-4; Trivedi AK, 2015, COMP BIOCHEM PHYS A, V184, P34, DOI 10.1016/j.cbpa.2015.01.011; Wadsworth T, 2014, J INSECT PHYSIOL, V71, P68, DOI 10.1016/j.jinsphys.2014.10.003; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang XD, 2014, J SHELLFISH RES, V33, P511, DOI 10.2983/35.033.0220; Wang ZQ, 2017, AQUACULTURE, V477, P6, DOI 10.1016/j.aquaculture.2017.04.026; Wei BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182087; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Xie XX, 2017, CHRONOBIOL INT, V34, P1094, DOI 10.1080/07420528.2017.1341906; Yang XZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193999; Yufera M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13514-w; Zhai YF, 2016, J PEST SCI, V89, P679, DOI 10.1007/s10340-016-0760-9; Zhou YY, 2018, P NATL ACAD SCI USA, V115, pE11864, DOI 10.1073/pnas.1813162115	70	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210414	10.1371/journal.pone.0210414	http://dx.doi.org/10.1371/journal.pone.0210414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645610	Green Submitted, gold, Green Published			2022-12-27	WOS:000455810200027
J	Sukiennicki, GM; Marciniak, W; Muszynska, M; Baszuk, P; Gupta, S; Bialkowska, K; Jaworska-Bieniek, K; Durda, K; Lener, M; Pietrzak, S; Gromowski, T; Prajzendanc, K; Lukomska, A; Waloszczyk, P; Wojcik, JZ; Scott, R; Lubinski, J; Jakubowska, A				Sukiennicki, Grzegorz Mariusz; Marciniak, Wojciech; Muszynska, Magdalena; Baszuk, Piotr; Gupta, Satish; Bialkowska, Katarzyna; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Lener, Marcin; Pietrzak, Sandra; Gromowski, Tomasz; Prajzendanc, Karolina; Lukomska, Alicja; Waloszczyk, Piotr; Wojcik, Janusz Zenon; Scott, Rodney; Lubinski, Jan; Jakubowska, Anna			Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence	PLOS ONE			English	Article							SERUM FERRITIN LEVELS; SUPEROXIDE-DISMUTASE; TRACE-ELEMENT; DIETARY IRON; HEME IRON; RISK; POLYMORPHISM; VARIANTS; CHINESE; STORES	Background Lung cancer is the most common adult malignancy accounting for the largest proportion of cancer related deaths. Iron (Fe) is an essential trace element and is a component of several major metabolic pathways playing an important role in many physiological processes. In this study we evaluated the association between Fe concentration in serum, iron metabolism parameters and genetic variaton in 7 genes involved in iron metabolism and anti-oxidative processes with the incidence of lung cancer in Poland. Materials and methods The study included 200 lung cancer patients and 200 matched healthy control subjects. We analyzed serum iron concentration and iron metabolism parameters (TIBC, UIBC, serum ferritin and transferrin saturation), and genotyped seven variants in seven genes: HFE, TFR1, HAMP, TF, SOD2, CAT and GPX1. Results Lung cancer patients compared to their matched controls had significantly higher mean serum iron level (p = 0.01), ferritin level (p = 0.007) and TIBC (p = 0.006). Analysis revealed that higher concentration of iron and ferritin (IVth quartile) compared to the lower concentration (Ist quartile) was associated with over 2-fold increased lung cancer incidence. We also found that higher transferrin saturation (p = 0.01) and lower TIBC (p<0.01) are associated with better survival of lung cancer patients. The analysis of polymorphisms in iron related genes did not reveal a significant difference between lung cancer patients and controls. However, rs10421768 in HAMP showed a borderline statistically significant correlation with lung cancer risk (OR = 2.83, p = 0.05). Conclusions The results of this case control study indicate that higher body iron represented by higher Fe and ferritin levels may be associated with lung cancer incidence. Rs10421768 in HAMP may be associated with about 3-times higher lung cancer risk. Higher Fe body content may be associated with better survival of lung cancer patients.	[Sukiennicki, Grzegorz Mariusz; Baszuk, Piotr; Bialkowska, Katarzyna; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Lener, Marcin; Pietrzak, Sandra; Gromowski, Tomasz; Prajzendanc, Karolina; Lukomska, Alicja; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Marciniak, Wojciech; Muszynska, Magdalena; Lubinski, Jan] Read Gene SA, Grzepnica, Dobra Szczecins, Poland; [Gupta, Satish] Strand Life Sci, Bangalore, Karnataka, India; [Waloszczyk, Piotr] Independent Lab Pathol, Szczecin, Poland; [Wojcik, Janusz Zenon] Pomeranian Med Univ, Dept Gen Thorac Surg & Transplantat, Szczecin, Poland; [Scott, Rodney] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW, Australia; [Scott, Rodney] NSW Hlth Pathol Newcastle, Div Mol Med, Newcastle, NSW, Australia; [Jakubowska, Anna] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University; University of Newcastle; Pomeranian Medical University	Sukiennicki, GM (corresponding author), Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland.	gsukiennicki@wp.pl	Jakubowska, Anna/O-8050-2014; Lubinski, Jan/C-4420-2017; Scott, Rodney/B-2827-2013	Jakubowska, Anna/0000-0002-5650-0501; Lubinski, Jan/0000-0003-2931-3003; Bialkowska, Katarzyna/0000-0001-8489-6665; Scott, Rodney/0000-0001-7724-3404; Pietrzak, Sandra/0000-0001-8024-5013; Marciniak, Wojciech/0000-0001-7270-0063	National Science Centre [DEC-2013/11/N/NZ4/02250]; Read-Gene S.A.; Strand Life Sciences; Zdunomed	National Science Centre(National Science Centre, Poland); Read-Gene S.A.; Strand Life Sciences; Zdunomed	This work was supported by National Science Centre, grant no. DEC-2013/11/N/NZ4/02250. The funder Read-Gene S.A. provided support in the form of salaries for authors WM, MM and JL. The funder Strand Life Sciences provided support in the form of salaries for author SG. The funder Zdunomed provided support in the form of salaries for author PW. The specific roles of these authors are stated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S, 2008, CLIN CHEM LAB MED, V46, P1450, DOI 10.1515/CCLM.2008.304; Bravo IDB, 2007, J TRACE ELEM MED BIO, V21, P14, DOI 10.1016/j.jtemb.2007.09.017; Bruno F, 2010, HAEMATOL-HEMATOL J, V95, P849, DOI 10.3324/haematol.2009.018986; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.3.CO;2-G; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Cobanoglu U, 2010, ASIAN PAC J CANCER P, V11, P1383; COX R, 1986, EUR J CANCER CLIN ON, V22, P831, DOI 10.1016/0277-5379(86)90370-6; Ho JC, 2006, J THORAC ONCOL, V1, P648; Howlader N., 2021, SEER CANC STAT REV, P1975; Jafarian-Dehkordi A, 2008, DARU, V16, P160; Ji M, 2014, TUMOR BIOL, V35, P10195, DOI 10.1007/s13277-014-2317-y; KAKARI S, 1991, ANTICANCER RES, V11, P2107; Kang SW, 2015, INT J CLIN EXP MED, V8, P14647; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; KNEKT P, 1994, INT J CANCER, V56, P379, DOI 10.1002/ijc.2910560315; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Lee DH, 2005, NUTR CANCER, V52, P130, DOI 10.1207/s15327914nc5202_3; Li SX, 2016, BIOMED PHARMACOTHER, V80, P127, DOI 10.1016/j.biopha.2016.03.010; Lipinski P, 2014, KOSMOS, V63, P299; Lorenzi M, 2006, INT J BIOL MARKER, V21, P235, DOI 10.1177/172460080602100407; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; MILMAN N, 1991, BRIT J CANCER, V64, P895, DOI 10.1038/bjc.1991.421; Muka T, 2017, EUR J NUTR, V56, P1637, DOI 10.1007/s00394-016-1210-4; Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006; Radio FC, 2015, BLOOD CELL MOL DIS, V55, P71, DOI 10.1016/j.bcmd.2015.04.001; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Sawayama H, 2018, INT J CLIN ONCOL, V23, P671, DOI 10.1007/s10147-018-1274-7; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shi HB, 2014, J CANCER RES THER, V10, P681, DOI 10.4103/0973-1482.139156; Shi ZM, 2017, BRIT J NUTR, V117, P572, DOI [10.1017/S000711451700040X, 10.1017/s000711451700040x]; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; STEVENS RG, 1988, NEW ENGL J MED, V319, P1047, DOI 10.1056/NEJM198810203191603; Tasevska N, 2009, AM J CLIN NUTR, V89, P1884, DOI 10.3945/ajcn.2008.27272; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; VANASPEREN IA, 1995, INT J EPIDEMIOL, V24, P665; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05661-x; Wen CP, 2014, CANCER RES, V74, P6589, DOI 10.1158/0008-5472.CAN-14-0360; Zhang L, 2017, ANN ONCOL, V28, P1124, DOI 10.1093/annonc/mdx046; Zhang Meng, 2015, Asian Pac J Cancer Prev, V16, P4633; Zhou W, 2005, EPIDEMIOLOGY, V16, P772, DOI 10.1097/01.ede.0000181311.11585.59	40	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208610	10.1371/journal.pone.0208610	http://dx.doi.org/10.1371/journal.pone.0208610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640897	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000006
J	Algan, Y; Murtin, F; Beasley, E; Higa, K; Senik, C				Algan, Yann; Murtin, Fabrice; Beasley, Elizabeth; Higa, Kazuhito; Senik, Claudia			Well-being through the lens of the internet	PLOS ONE			English	Article							BIG DATA; LIFE; SATISFACTION; INCOME	We build models to estimate well-being in the United States based on changes in the volume of internet searches for different words, obtained from the Google Trends website. The estimated well-being series are weighted combinations of word groups that are endogenously identified to fit the weekly subjective well-being measures collected by Gallup Analytics for the United States or the biannual measures for the 50 states. Our approach combines theoretical underpinnings and statistical analysis, and the model we construct successfully estimates the out-of-sample evolution of most subjective well-being measures at a one-year horizon. Our analysis suggests that internet search data can be a complement to traditional survey data to measure and analyze the well-being of a population at high frequency and local geographic levels. We highlight some factors that are important for well-being, as we find that internet searches associated with job search, civic participation, and healthy habits consistently predict well-being across several models, datasets and use cases during the period studied.	[Algan, Yann; Murtin, Fabrice] Sci Po, Paris, France; [Murtin, Fabrice] OECD Stat & Data Directorate, Paris, France; [Beasley, Elizabeth; Senik, Claudia] CEPREMAP, Paris, France; [Higa, Kazuhito] Hitotsubashi Univ, Tokyo, Japan; [Senik, Claudia] Paris Sch Econ, Paris, France	Institut d'Etudes Politiques Paris (Sciences Po); Organisation for Economic Co-operation & Development (OECD); Hitotsubashi University; Paris School of Economics	Murtin, F (corresponding author), Sci Po, Paris, France.; Murtin, F (corresponding author), OECD Stat & Data Directorate, Paris, France.	Fabrice.Murtin@oecd.org		MURTIN, FABRICE/0000-0002-5479-9191	CEPREMAP; European Research Council	CEPREMAP; European Research Council(European Research Council (ERC)European Commission)	This research was funded by CEPREMAP and the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, APPL EC Q, DOI DOI 10.3790/AEQ.55.2.107; Baker S. R., 2014, WORKING PAPER; Benjamin DJ, 2014, AM ECON REV, V104, P2698, DOI 10.1257/aer.104.9.2698; Biddle S. J., 2005, SCI WELL BEING; Buddelmeyer H, 2015, STRESS COST CHILDREN; Choi H., 2009, TECHNICAL REPORT; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; CLARK AE, 1994, ECON J, V104, P648, DOI 10.2307/2234639; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; DAmuri F., 2010, FEEM WORKING PAPER S; Deaton A, 2013, WORKING PAPER; Deaton A., 2012, INVESTIGATION EC AGI; Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53; Durlauf SN, 2012, J APPL ECONOMET, V27, P1059, DOI 10.1002/jae.1245; Ettredge M, 2005, COMMUN ACM, V48, P87, DOI 10.1145/1096000.1096010; George D., 2016, SPSS WINDOWS STEP ST; Helliwell J., 2015, WORLD HAPPINESS REPO, P12; Helliwell J. F., 2010, INT DIFFERENCES WELL; Helliwell J. F., 2011, INT J WELL BEING, V1, P42, DOI [DOI 10.5502/IJW.V1I1.9, 10.1057/9780230306738_7]; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Krueger A. B., 2009, MEASURING SUBJECTIVE; Krueger AB, 2014, SCIENCE, V346, P42, DOI 10.1126/science.1256392; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lelkes Orsolya., 2006, J SOCIO-ECON, V35, P285, DOI [DOI 10.1016/J.SOCEC.2005.11.002, 10.1016/j.socec.2005.11.002]; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Monroe BL, 2015, PS-POLIT SCI POLIT, V48, P71, DOI 10.1017/S1049096514001760; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; OECD, 2017, HOWS LIF MEAS WELL B; Penna ND, 2009, TECHNICAL REPORT; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Radinsky K., 2009, P 2008 IEEE WIC ACM; Schwartz HA, 2016, BIOCOMPUT-PAC SYM, P516; Stephens-Davidowitz S., 2015, HANDS ON GUIDE GOOGL; Stephens-Davidowitz S, 2014, J PUBLIC ECON, V118, P26, DOI 10.1016/j.jpubeco.2014.04.010; Stone AA, 2014, SUBJECTIVE WELL BEIN; Suhoy T., 2009, TECHNICAL REPORT; van Praag B.M.S., 2008, HAPPINESS QUANTIFIED; Vitaro Frank, 2016, WORKING PAPER	41	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209562	10.1371/journal.pone.0209562	http://dx.doi.org/10.1371/journal.pone.0209562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633759	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100005
J	Kompotiatis, P; Wiley, BM; Jentzer, JC; Kashani, KB				Kompotiatis, Panagiotis; Wiley, Brandon M.; Jentzer, Jacob C.; Kashani, Kianoush B.			Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy	PLOS ONE			English	Article							ELECTRONIC SEARCH STRATEGIES; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; PULMONARY-HYPERTENSION; AMERICAN-SOCIETY; TRICUSPID REGURGITATION; EUROPEAN-ASSOCIATION; HEART-FAILURE; RECOMMENDATIONS; AKI	Main objectives Echocardiographic parameters have been used to predict outcomes for specific intensive care unit (ICU) populations. We sought to define echocardiographic parameters for ICU patients receiving continuous renal replacement therapy (CRRT). Design, setting, participants, and measurements This is a historical cohort study of consecutive ICU patients at Mayo Clinic (Rochester, Minnesota) who received CRRT from December 9, 2006, through November 13, 2015. Only patients with an echocardiographic examination within 7 days of CRRT initiation were considered. Results The study included 1,276 patients. Decreased left ventricular ejection fraction (LVEF; <= 45%) was noted in 361/1,120 (32%) and increased right ventricular systolic pressure (RVSP; >= 40 mm Hg) was noted in 529/798 (66%). Right ventricular systolic dysfunction was observed in 320/820 (39%). The most common valvular abnormality was tricuspid regurgitation (244/1,276 [19%]). Stratification of these parameters by ICU type (medical, surgical, cardiothoracic, cardiac) showed that most echocardiographic abnormalities were significantly more prevalent among cardiac ICU patients: LVEF <= 45% (67/105 [64%]), RVSP >= 40 mm Hg (63/79 [80%]) and tricuspid regurgitation (50/130 [38%]). We compared patients with acute kidney injury (AKI) vs end-stage renal disease and showed that decreased LVEF (284/921 [31%] vs 78/201 [39%]), was significantly less prevalent among patients with AKI, but increased RVSP was more prevalent (445/651 [68%] vs 84/147 [57%]) with AKI. Conclusions ICU patients who required CRRT had increased prevalence of pulmonary hypertension and right and left ventricular systolic dysfunction. Prediction of adverse outcomes with echocardiographic parameters in this patient population can lead to identification of modifiable risk factors.	[Kompotiatis, Panagiotis; Kashani, Kianoush B.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Wiley, Brandon M.; Jentzer, Jacob C.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA; [Kashani, Kianoush B.] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kashani, KB (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, KB (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	kashani.kianoush@mayo.edu	Wiley, Brandon/Z-5879-2019; Wiley, Brandon M./AAG-6306-2020	Kashani, Kianoush/0000-0003-2184-3683; Wiley, Brandon/0000-0003-3651-7231	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) [UL1 TR002377]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002377] Funding Source: NIH RePORTER	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). This study was not funded, and the grant is for the first author's training as part of the Clinical and Translational Science certificate program.	Alsara A, 2011, MAYO CLIN PROC, V86, P382, DOI 10.4065/mcp.2010.0802; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bellomo R, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0260-y; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Chen KP, 2016, CLIN J AM SOC NEPHRO, V11, P602, DOI 10.2215/CJN.08080715; Etchecopar-Chevreuil C, 2008, INTENS CARE MED, V34, P250, DOI 10.1007/s00134-007-0929-z; Haji K, 2018, J CARDIOTHOR VASC AN, V32, P354, DOI 10.1053/j.jvca.2017.08.026; HARNETT JD, 1995, KIDNEY INT, V47, P884, DOI 10.1038/ki.1995.132; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Hickson LJ, 2016, J AM COLL CARDIOL, V67, P1173, DOI 10.1016/j.jacc.2015.12.052; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Husain-Syed F, 2015, J AM COLL CARDIOL, V65, P2433, DOI 10.1016/j.jacc.2015.04.024; Jentzer JC, 2016, J INTENSIVE CARE MED, V31, P369, DOI 10.1177/0885066615583652; Jue J, 1992, J Am Soc Echocardiogr, V5, P613; Kanji HD, 2014, J CRIT CARE, V29, P700, DOI 10.1016/j.jcrc.2014.04.008; Kellum JA, 2015, J AM SOC NEPHROL, V26, P2231, DOI 10.1681/ASN.2014070724; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Klein AL, 2013, J AM SOC ECHOCARDIOG, V26, P965, DOI 10.1016/j.echo.2013.06.023; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Metcalfe W, 2002, QJM-INT J MED, V95, P579, DOI 10.1093/qjmed/95.9.579; Mutlak D, 2007, J AM SOC ECHOCARDIOG, V20, P405, DOI 10.1016/j.echo.2006.09.013; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ostermann M, 2016, BLOOD PURIFICAT, V42, P224, DOI 10.1159/000448506; Pulido JN, 2012, MAYO CLIN PROC, V87, P620, DOI 10.1016/j.mayocp.2012.01.018; Rabindranath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003773.pub3; Roberts MA, 2011, AM J KIDNEY DIS, V58, P64, DOI 10.1053/j.ajkd.2011.01.024; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Ronco C, 2008, INTENS CARE MED, V34, P2139, DOI 10.1007/s00134-008-1258-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SAGIE A, 1994, J AM COLL CARDIOL, V24, P446, DOI 10.1016/0735-1097(94)90302-6; Sanfilippo F, 2015, INTENS CARE MED, V41, P1004, DOI 10.1007/s00134-015-3748-7; Santosh S, 2019, NEPHROLOGY, V24, P74, DOI 10.1111/nep.13183; Schrier RW, 2008, CLIN J AM SOC NEPHRO, V3, P1232, DOI 10.2215/CJN.01960408; See KC, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0343-9; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Stamm Jason A, 2011, Pulm Circ, V1, P95, DOI 10.4103/2045-8932.78104; Sturgess DJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8931; Tang MY, 2018, AM J KIDNEY DIS, V72, P75, DOI 10.1053/j.ajkd.2017.11.018; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vallabhajosyula S, 2018, J INTENSIVE CARE MED, V33, P680, DOI 10.1177/0885066616684774; Vallabhajosyula S, 2018, SHOCK, V49, P144, DOI 10.1097/SHK.0000000000000952; Vallabhajosyula S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0319-9; Villa G, 2015, CRIT CARE CLIN, V31, P839, DOI 10.1016/j.ccc.2015.06.015; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Wong BT, 2015, J CRIT CARE, V30, P975, DOI 10.1016/j.jcrc.2015.05.003; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209994	10.1371/journal.pone.0209994	http://dx.doi.org/10.1371/journal.pone.0209994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633756	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100011
J	Nam, H; Guo, MH; Yu, HY; Lee, K; Li, RJ; Han, B; Xing, L; Lee, R; Gao, H				Nam, Haewon; Guo, Minghao; Yu, Hengyong; Lee, Keumsil; Li, Ruijiang; Han, Bin; Xing, Lei; Lee, Rena; Gao, Hao			Tensor framelet based iterative image reconstruction algorithm for low-dose multislice helical CT	PLOS ONE			English	Article							CONE-BEAM CT; FILTERED BACKPROJECTION; INVERSION ALGORITHM; PI-LINES; IMPLEMENTATION; FORMULA; QUALITY; SCANNER; ART	In this study, we investigate the feasibility of improving the imaging quality for low-dose multislice helical computed tomography (CT) via iterative reconstruction with tensor framelet (TF) regularization. TF based algorithm is a high-order generalization of isotropic total variation regularization. It is implemented on a GPU platform for a fast parallel algorithm of X-ray forward band backward projections, with the flying focal spot into account. The solution algorithm for image reconstruction is based on the alternating direction method of multipliers or the so-called split Bregman method. The proposed method is validated using the experimental data from a Siemens SOMATOM Definition 64-slice helical CT scanner, in comparison with FDK, the Katsevich and the total variation (TV) algorithm. To test the algorithm performance with low-dose data, ACR and Rando phantoms were scanned with different dosages and the data was equally undersampled with various factors. The proposed method is robust for the low-dose data with 25% undersampling factor. Quantitative metrics have demonstrated that the proposed algorithm achieves superior results over other existing methods.	[Nam, Haewon] Hongik Univ, Dept Liberal Arts, Sejong, South Korea; [Guo, Minghao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China; [Yu, Hengyong] Univ Massachusetts, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Lee, Keumsil] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Li, Ruijiang; Han, Bin; Xing, Lei] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Lee, Rena] Ewha Womans Univ, Dept Radiat Oncol, Seoul, South Korea; [Gao, Hao] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA	Hongik University; Shanghai Jiao Tong University; University of Massachusetts System; University of Massachusetts Lowell; Stanford University; Stanford University; Ewha Womans University; Emory University	Gao, H (corresponding author), Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA.	hao.gao.2012@gmail.com	Yu, Hengyong/AAH-5726-2019; lee, rena/AAQ-8558-2020	Yu, Hengyong/0000-0002-5852-0813; Li, Ruijiang/0000-0002-0232-5998; Xing, Lei/0000-0003-2536-5359	Basic Science Research program through NRF of Korea - ministry of Education Science and Technology [2015R1C1A2A01054731]; NIH/NIBIB [1R01 EB-016777]; Korea Institute for Advancement of Technology (KIAT) - Korea government (Ministry of Trade, Industry and Energy) [0001723]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016777] Funding Source: NIH RePORTER	Basic Science Research program through NRF of Korea - ministry of Education Science and Technology; NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Korea Institute for Advancement of Technology (KIAT) - Korea government (Ministry of Trade, Industry and Energy); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	H. Nam was supported by the Basic Science Research program through NRF (#2015R1C1A2A01054731) of Korea funded by the ministry of Education Science and Technology. L. Xing is supported partially by NIH/NIBIB 1R01 EB-016777. R. Lee was supported by the Korea Institute for Advancement of Technology (KIAT) grant funded by the Korea government (Ministry of Trade, Industry and Energy, No. 0001723).	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chen GH, 2003, MED PHYS, V30, P3217, DOI 10.1118/1.1628413; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Cho S, 2008, MED PHYS, V35, P3030, DOI 10.1118/1.2936219; Dong B, 2010, IAS LECT NOTES SERIE, P19; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Flohr TG, 2005, MED PHYS, V32, P2536, DOI 10.1118/1.1949787; Gao H, 2013, MED PHYS, V40, DOI 10.1118/1.4816303; Gao H, 2012, MED PHYS, V39, P7110, DOI 10.1118/1.4761867; Gao H, 2012, MED PHYS, V39, P6943, DOI 10.1118/1.4762288; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Gao Y, 2014, OPT EXPRESS, V22, P15190, DOI 10.1364/OE.22.015190; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hein I, 2003, MED PHYS, V30, P3233, DOI 10.1118/1.1625443; Hounsfield G, 1972, US. Patent No, Patent No. [1283925, 1283925US]; Jia X, 2011, PHYS MED BIOL, V56, P3787, DOI 10.1088/0031-9155/56/13/004; JUDY P F, 1976, Medical Physics (Woodbury), V3, P233, DOI 10.1118/1.594283; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Katsevich A, 2004, ADV APPL MATH, V32, P681, DOI 10.1016/S0196-8858(03)00099-X; Katsevich A, 2002, SIAM J APPL MATH, V62, P2012, DOI 10.1137/S0036139901387186; Katsevich A, 2002, PHYS MED BIOL, V47, P2583, DOI 10.1088/0031-9155/47/15/302; Mori I, 1986, US Patent No, Patent No. [4630202, 4630202US]; Noo F, 2003, PHYS MED BIOL, V48, P3787, DOI 10.1088/0031-9155/48/23/001; Nuyts J, 1998, PHYS MED BIOL, V43, P729, DOI 10.1088/0031-9155/43/4/003; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sunnegardh J, 2008, IEEE NUCL SCI S, V43, P5090; Taguchi K, 1998, MED PHYS, V25, P550, DOI 10.1118/1.598230; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; WANG G, 1993, IEEE T MED IMAGING, V12, P486, DOI 10.1109/42.241876; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Ye YB, 2011, MED PHYS, V38, pS69, DOI 10.1118/1.3577765; Ye YB, 2005, IEEE T MED IMAGING, V24, P1190, DOI 10.1109/TMI.2005.853626; Ye YB, 2005, MED PHYS, V32, P42, DOI 10.1118/1.1828673; Yu HY, 2004, J X-RAY SCI TECHNOL, V12, P97; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu W, 2016, SCANNING, V38, P4, DOI 10.1002/sca.21235; Zhao J, 2007, J X-RAY SCI TECHNOL, V15, P177; Zou Y, 2004, PHYS MED BIOL, V49, P941, DOI 10.1088/0031-9155/49/6/006; Zou Y, 2004, PHYS MED BIOL, V49, P2717, DOI 10.1088/0031-9155/49/12/017	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210410	10.1371/journal.pone.0210410	http://dx.doi.org/10.1371/journal.pone.0210410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633760	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100023
J	Oh, G; Abner, EL; Fardo, DW; Freeman, PR; Moga, DC				Oh, Gyeon; Abner, Erin L.; Fardo, David W.; Freeman, Patricia R.; Moga, Daniela C.			Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study	PLOS ONE			English	Article							CENTER NACC DATABASE; UNITED-STATES; CHRONIC PAIN; PRESCRIBING OPIOIDS; OVERDOSE DEATHS; CDC GUIDELINE; SAS PROCEDURE; POPULATION; DEMENTIA; RISK	Background Given the controversy around the effectiveness of opioid treatment for chronic pain and the lack of detailed guidance for prescribing opioids in older adults, the objectives of this study were to estimate the trajectories and predictors of opioid use in older adults. Methods Data were extracted from the National Alzheimer's Coordinating Center (2005-2017). Group-based trajectory modeling was used to identify the patterns of opioid use (any or strong) among participants age 65+. We used multivariable logistic regression with backward selection to evaluate demographics and comorbidities as potential predictors of trajectory membership. Results Among 13,059 participants, four trajectories were identified for the use of both any opioids and strong opioids (minimal-users, incident chronic-users, discontinuing-users, and prevalent chronic-users). For any opioids, female sex (adjusted odds ratio = 1.23; 95% confidence interval = 1.03-1.46), black vs. white (1.47; 1.18-1.82), year of education (0.96; 0.94-0.99), type of residence (independent group vs. private: 1.77; 1.38-2.26, care facility vs. private: 1.89; 1.20-2.97), hypertension (1.44; 1.20-1.72), cardiovascular disease (1.30; 1.09-1.55), urinary incontinence (1.45; 1.19-1.78), dementia (0.73; 0.57-0.92), number of medications (1 to 4 vs. none: 0.48; 0.36-0.64, 5 or more vs. none: 0.67; 0.50-0.88), and antidepressant agent (1.38; 1.14-1.67) were associated with incident chronic-use vs. non-use. For strong opioids, female sex (1.27; 1.04-1.56), type of residence (independent group vs. private: 1.90; 1.43-2.53, care facility vs. private: 2.37; 1.44-3.90), current smoking (1.68; 1.09-2.60), hypertension (1.49; 1.21-1.83), urinary incontinence (1.45; 1.14-1.84), dementia (0.73; 0.55-0.97), number of medications (1 to 4 vs. none: 0.46; 0.32-0.65, 5 or more vs. none: 0.59; 0.42-0.83), and antidepressant agent (1.55; 1.24-1.93) were associated with incident chronic-use vs. non-use. Conclusion Given that chronic opioid use was more prevalent in participants who were more vulnerable (i.e., older age, with multiple comorbidities, and polypharmacy), further studies should evaluate the safety and efficacy of using opioids in this population.	[Oh, Gyeon; Abner, Erin L.; Moga, Daniela C.] Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA; [Abner, Erin L.; Fardo, David W.; Moga, Daniela C.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Abner, Erin L.; Fardo, David W.] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Freeman, Patricia R.; Moga, Daniela C.] Univ Kentucky, Dept Pharm Practice & Sci, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Moga, DC (corresponding author), Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA.; Moga, DC (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Moga, DC (corresponding author), Univ Kentucky, Dept Pharm Practice & Sci, Lexington, KY 40506 USA.	daniela.moga@uky.edu	Freeman, Patricia/W-2473-2019; Freeman, Patricia R./L-3752-2019	Freeman, Patricia/0000-0002-4749-6563; Fardo, David/0000-0002-7207-4696; Moga, Daniela/0000-0002-3648-8197; Oh, GYeon/0000-0001-7203-8460	National Institute on Aging [R01AG054130]; NIA/NIH [U01 AG016976]; NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854];  [P30 AG008017];  [P30 AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGING [U01AG016976, P50AG016573, P50AG008702, P30AG013854, P50AG005681, P30AG010133, R01AG054130, P30AG013846, P30AG028383, P50AG047366, P50AG005142, P50AG005138, P30AG010161, P30AG035982, P30AG008017, P30AG049638, P30AG010124, P50AG033514, P50AG005131, P50AG047270, P30AG053760, P50AG005134, P50AG005146, P30AG019610, P50AG005136, P50AG047266, P50AG005133, P50AG023501, P30AG012300, P30AG008051, P50AG025688, P50AG016574, P30AG010129] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by grant R01AG054130 to DCM from the National Institute on Aging. There was no additional external funding received for this study. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded. ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Bell JS, 2011, PAIN, V152, P543, DOI 10.1016/j.pain.2010.11.003; Berecki-Gisolf J, 2017, AUST NZ J PUBL HEAL, V41, P85, DOI 10.1111/1753-6405.12568; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Horgas AL, 2018, PAIN MED; Hunnicutt JN, 2017, J AM GERIATR SOC; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Kunik ME, 2010, J CLIN PSYCHIAT, V71, P1145, DOI 10.4088/JCP.08m04703oli; Kuo YF, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.002; Lalic S, 2018, BR J CLIN PHARM; Lalic S, 2018, BRIT J CLIN PHARMACO, V84, P1267, DOI 10.1111/bcp.13556; Mantyselka P, 2004, AGE AGEING, V33, P496, DOI 10.1093/ageing/afh165; McAuliffe L, 2012, INT J OLDER PEOPLE N, V7, P219, DOI 10.1111/j.1748-3743.2012.00331.x; McCaffery Margo, 2010, PAIN ASSESSMENT PHAR; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Mojtabai R., 2017, PHARMACOEPIDEMIOL DR; Molton IR, 2014, AM PSYCHOL, V69, P197, DOI 10.1037/a0035794; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Nagin D., 2005, GROUP BASED MODELING, Vx; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Rolita L, 2013, J AM GERIATR SOC, V61, P335, DOI 10.1111/jgs.12148; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Scherder E, 2009, PAIN, V145, P276, DOI 10.1016/j.pain.2009.04.007; Shega J, 2007, J PAIN, V8, P373, DOI 10.1016/j.jpain.2007.03.003; Shield KD, 2013, PAIN RES MANAG, V18, P69, DOI 10.1155/2013/651649; Sutradhar R, 2017, CANCER-AM CANCER SOC, V123, P4286, DOI 10.1002/cncr.30839; Thielke SM, 2017, CLIN J PAIN, V33, P198, DOI 10.1097/AJP.0000000000000409; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Wilder-Smith OHG, 2005, EUR J PAIN, V9, P137, DOI 10.1016/j.ejpain.2004.07.011	41	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210341	10.1371/journal.pone.0210341	http://dx.doi.org/10.1371/journal.pone.0210341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633773	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100018
J	Gu, Y; Lu, XQ; Zhang, BH; Zhao, Y; Yu, DH; Gao, LX; Cui, GM; Wu, L; Zhou, T				Gu, Yu; Lu, Xiaoqi; Zhang, Baohua; Zhao, Ying; Yu, Dahua; Gao, Lixin; Cui, Guimei; Wu, Liang; Zhou, Tao			Automatic lung nodule detection using multi-scale dot nodule-enhancement filter and weighted support vector machines in chest computed tomography	PLOS ONE			English	Article							FALSE-POSITIVE REDUCTION; CT IMAGES; ACTIVE CONTOUR; SEGMENTATION; VESSELS; SYSTEM; CAD	A novel CAD scheme for automated lung nodule detection is proposed to assist radiologists with the detection of lung cancer on CT scans. The proposed scheme is composed of four major steps: (1) lung volume segmentation, (2) nodule candidate extraction and grouping, (3) false positives reduction for the non-vessel tree group, and (4) classification for the vessel tree group. Lung segmentation is performed first. Then, 3D labeling technology is used to divide nodule candidates into two groups. For the non-vessel tree group, nodule candidates are classified as true nodules at the false positive reduction stage if the candidates survive the rule-based classifier and are not screened out by the dot filter. For the vessel tree group, nodule candidates are extracted using dot filter. Next, RSFS feature selection is used to select the most discriminating features for classification. Finally, WSVM with an undersampling approach is adopted to discriminate true nodules from vessel bifurcations in vessel tree group. The proposed method was evaluated on 154 thin-slice scans with 204 nodules in the LIDC database. The performance of the proposed CAD scheme yielded a high sensitivity (87.81%) while maintaining a low false rate (1.057 FPs/scan). The experimental results indicate the performance of our method may be better than the existing methods.	[Gu, Yu; Lu, Xiaoqi; Zhang, Baohua] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Gu, Yu; Lu, Xiaoqi; Zhang, Baohua; Zhao, Ying; Yu, Dahua; Gao, Lixin; Cui, Guimei; Wu, Liang; Zhou, Tao] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Inner Mongolia Key Lab Pattern Recognit & Intelli, Baotou, Inner Mongolia, Peoples R China; [Gao, Lixin] Inner Mongolia Univ Sci & Technol, Sch Foreign Languages, Baotou, Inner Mongolia, Peoples R China	Shanghai University; Inner Mongolia University of Science & Technology; Inner Mongolia University of Science & Technology	Lu, XQ (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.; Lu, XQ; Cui, GM (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Inner Mongolia Key Lab Pattern Recognit & Intelli, Baotou, Inner Mongolia, Peoples R China.	lxiaoqi@imut.edu.cn; cguimei1@163.com	, 谷宇/ABW-8361-2022; Yu, Dahua/N-7242-2013	, 谷宇/0000-0003-4345-6932; Yu, Dahua/0000-0001-7850-7512	National Natural Science Foundation of China [61841204, 81460279, 61771266, 61763039, 61663036, 81571753, 81301281, 61261028, 61179019]; Natural Science Foundation of Inner Mongolia [2018LH08066, 2015MS0604, 2014MS0828]; Inner Mongolia College Science and Technology Research Project [NJZY145, NJZZ14161]; Inner Mongolia University of Science and Technology Innovation Fund [2016QDW-S04, 2015QNGG03, 2014QNGG08, 2014QNG07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Inner Mongolia College Science and Technology Research Project; Inner Mongolia University of Science and Technology Innovation Fund	This work was funded by the National Natural Science Foundation of China (grant numbers. 61841204 to YG, 81460279 to YZ, 61771266 to XL, 61763039 to GC, 61663036 to BZ, 81571753 to DY, 81301281 to DY, 61261028 to BZ, and 61179019 to XL); Natural Science Foundation of Inner Mongolia (grant numbers 2018LH08066 to YZ, 2015MS0604 to YG and 2014MS0828 to YZ), Inner Mongolia College Science and Technology Research Project (grant numbers NJZY145 to YG and NJZZ14161 to YZ), and Inner Mongolia University of Science and Technology Innovation Fund (grant numbers 2016QDW-S04 to LG, 2015QNGG03 to DY, 2014QNGG08 to YZ, and 2014QNG07 to BZ).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Anand A, 2010, AMINO ACIDS, V39, P1385, DOI 10.1007/s00726-010-0595-2; [Anonymous], 2017, MEDICAL IMAGE COMPUT, DOI DOI 10.1007/978-3-319-66179-7_72; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Armato SG, 2001, MED PHYS, V28, P1552, DOI 10.1118/1.1387272; Austin JHM, 1996, RADIOLOGY, V200, P327, DOI 10.1148/radiology.200.2.8685321; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen B, 2012, INT J COMPUT ASS RAD, V7, P465, DOI 10.1007/s11548-011-0638-5; Chumerin N, 2006, COMP 2 FEATURE EXTRA; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; de Carvalho AO, 2014, ARTIF INTELL MED, V60, P165, DOI 10.1016/j.artmed.2013.11.002; El-Baz A., 2013, INT J BIOMEDICAL IMA, V2013; Firmino M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-41; Ge ZY, 2005, MED PHYS, V32, P2443, DOI 10.1118/1.1944667; Gong J, 2018, PHYS MEDICA, V46, P124, DOI 10.1016/j.ejmp.2018.01.019; Gu Y, 2018, COMPUT BIOL MED, V103, P220, DOI 10.1016/j.compbiomed.2018.10.011; Hosseini-Asl E, 2016, IEEE T BIO-MED ENG, V63, P952, DOI 10.1109/TBME.2015.2482387; Janecek A., 2008, NEW CHALLENGES FEATU; Javaid M, 2016, COMPUT METH PROG BIO, V135, P125, DOI 10.1016/j.cmpb.2016.07.031; Jodas DS, 2016, EXPERT SYST APPL, V46, P1, DOI 10.1016/j.eswa.2015.10.016; Khalid S, 2014, SCI INF C SAI 2014; Li B, 2012, INT J COMPUTATIONAL, V4, P960; Li CF, 2018, IEEE ACCESS, V6, P16060, DOI 10.1109/ACCESS.2018.2817023; Li Q, 2003, MED PHYS, V30, P2040, DOI 10.1118/1.1581411; Li Q, 2008, ACAD RADIOL, V15, P165, DOI 10.1016/j.acra.2007.09.018; Li Z., 2015, IEEE T SERV COMPUT, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0124949; Li ZC, 2015, IEEE T IMAGE PROCESS, V24, P5343, DOI 10.1109/TIP.2015.2479560; Torres EL, 2015, MED PHYS, V42, P1477, DOI 10.1118/1.4907970; Lu L, 2015, MED PHYS, V42, P5042, DOI 10.1118/1.4927573; Lu X, 2015, OPTIK INT J LIGHT EL, V127, P1893; Pohjalainen J., 2013, COMPUTER SPEECH LANG, V29, P145; Reboucas PP, 2019, NEURAL COMPUT APPL, V31, P901, DOI 10.1007/s00521-017-3048-y; Reboucas PP, 2017, MED IMAGE ANAL, V35, P503, DOI 10.1016/j.media.2016.09.002; Riccardi A, 2011, MED PHYS, V38, P1962, DOI 10.1118/1.3560427; Setio AAA, 2016, IEEE T MED IMAGING, V35, P1160, DOI 10.1109/TMI.2016.2536809; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sivakumar S, 2013, INT J ENG TECHNOL, V5, P179; Soliman A, 2017, IEEE T MED IMAGING, V36, P263, DOI 10.1109/TMI.2016.2606370; Sun T, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054726, 10.1371/journal.pone.0063559]; Tan M, 2011, MED PHYS, V38, P5630, DOI 10.1118/1.3633941; Teramoto A, 2013, INT J COMPUT ASS RAD, V8, P193, DOI 10.1007/s11548-012-0767-5; Wang B, 2015, MED PHYS, V42, P1241, DOI 10.1118/1.4907961; Wu S, 2012, 2012 3 GLOB C INT SY; Xie HT, 2019, PATTERN RECOGN, V85, P109, DOI 10.1016/j.patcog.2018.07.031; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227; Zhang F, 2014, OPTIK, V125, P2383, DOI 10.1016/j.ijleo.2013.10.111; Zhang W, 2016, J MED IMAG HEALTH IN, V6, P1345, DOI 10.1166/jmihi.2016.1924; Zhang WH, 2017, COMPUT BIOL MED, V91, P168, DOI 10.1016/j.compbiomed.2017.10.005; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003; Zhou SJ, 2014, BIOMED SIGNAL PROCES, V13, P62, DOI 10.1016/j.bspc.2014.03.010; Zhu WT, 2018, IEEE WINT CONF APPL, P673, DOI 10.1109/WACV.2018.00079	51	24	25	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210551	10.1371/journal.pone.0210551	http://dx.doi.org/10.1371/journal.pone.0210551			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629724	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000108
J	Spettel, K; Barousch, W; Makristathis, A; Zeller, I; Nehr, M; Selitsch, B; Lackner, M; Rath, PM; Steinmann, J; Willinger, B				Spettel, Kathrin; Barousch, Wolfgang; Makristathis, Athanasios; Zeller, Iris; Nehr, Marion; Selitsch, Brigitte; Lackner, Michaela; Rath, Peter-Michael; Steinmann, Joerg; Willinger, Birgit			Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; AZOLE RESISTANCE; ECHINOCANDIN RESISTANCE; SACCHAROMYCES-CEREVISIAE; FKS MUTATIONS; CASPOFUNGIN; FLUCONAZOLE; SUSCEPTIBILITY; ERG11; MECHANISMS	Introduction/Objectives An increase in antifungal resistant Candida strains has been reported in recent years. The aim of this study was to detect mutations in resistance genes of azole-resistant, echinocandin-resistant or multi-resistant strains using next generation sequencing technology, which allows the analysis of multiple resistance mechanisms in a high throughput setting. Methods Forty clinical Candida isolates (16 C. albicans and 24 C. glabrata strains) with MICs for azoles and echinocandins above the clinical EUCAST breakpoint were examined. The genes ERG11, ERG3, TAC1 and GSC1 (FKS1) in C. albicans, as well as ERG11, CgPDR1, FKS1 and FKS2 in C. glabrata were sequenced. Results Fifty-four different missense mutations were identified, 13 of which have not been reported before. All nine echinocandin-resistant Candida isolates showed mutations in the hot spot (HS) regions of FKS1, FKS2 or GSC1. In ERG3 two homozygous premature stop codons were identified in two highly azole-resistant and moderately echinocandin-resistant C. albicans strains. Seven point mutations in ERG11 were determined in azole-resistant C. albicans whereas in azole-resistant C. glabrata, no ERG11 mutations were detected. In 10 out of 13 azole-resistant C. glabrata, 12 different potential gain-of-function mutations in the transcription factor CgPDR1 were verified, which are associated with an overexpression of the efflux pumps CDR1/2. Conclusion This study showed that next generation sequencing allows the thorough investigation of a large number of isolates more cost efficient and faster than conventional Sanger sequencing. Targeting different resistance genes and a large sample size of highly resistant strains allows a better determination of the relevance of the different mutations, and to differentiate between causal mutations and polymorphisms.	[Spettel, Kathrin; Barousch, Wolfgang; Makristathis, Athanasios; Zeller, Iris; Nehr, Marion; Selitsch, Brigitte; Willinger, Birgit] Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria; [Lackner, Michaela] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria; [Rath, Peter-Michael; Steinmann, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Steinmann, Joerg] Paracelsus Med Univ, Inst Clin Hyg Med Microbiol & Infectiol, Nurnberg, Germany	Medical University of Vienna; Medical University of Innsbruck; University of Duisburg Essen	Willinger, B (corresponding author), Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria.	birgit.willinger@meduniwien.ac.at	Lackner, Michaela/Q-9471-2018	Spettel, Kathrin/0000-0002-8901-8770; Willinger, Birgit/0000-0001-7921-5749	Pfizer Austria; Pfizer	Pfizer Austria(Pfizer); Pfizer(Pfizer)	This work was supported by a grant from Pfizer Austria. The funder had no role in study design, data analysis and preparation of the manuscript and in the decision to publish. Pure substance of micafungin was provided by Astellas GmbH, Austria. BW has received a grant by Pfizer and served on the speaker's bureau of Pfizer, Merck Sharpe & Dohme, Basilea, Gilead and Astellas.	Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Andrews S., 2010, FASTQC QUALITY CONTR; Arendrup M. C., EDUCAST DEFINITIVE D; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste AT, 2009, EUKARYOT CELL, V8, P1250, DOI 10.1128/EC.00069-09; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08; Silva DBD, 2016, MEM I OSWALDO CRUZ, V111, P192, DOI 10.1590/0074-02760150400; Dudiuk C, 2015, J CLIN MICROBIOL, V53, P2037, DOI 10.1128/JCM.00398-15; European Committee on Antimicrobial Susceptibility Testing, 2013, AN RAT CLIN BREAKP V, V2013; Favre B, 1999, MICROBIOL-SGM, V145, P2715, DOI 10.1099/00221287-145-10-2715; Ferrari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017589; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Flowers SA, 2015, ANTIMICROB AGENTS CH, V59, P450, DOI 10.1128/AAC.03470-14; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09; Garnaud C, 2015, J ANTIMICROB CHEMOTH, V70, P2556, DOI 10.1093/jac/dkv139; Healey KR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11128; Illumina, 2013, 16S METAGENOMIC SEQU; Johnson ME, 2012, EUKARYOT CELL, V11, P952, DOI 10.1128/EC.00082-12; Johnson ME, 2011, ANTIMICROB AGENTS CH, V55, P3774, DOI 10.1128/AAC.01811-10; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Katiyar SK, 2012, ANTIMICROB AGENTS CH, V56, P6304, DOI 10.1128/AAC.00813-12; Klotz U, 2016, MYCOSES, V59, P312, DOI 10.1111/myc.12472; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lamb DC, 1997, J BIOL CHEM, V272, P5682, DOI 10.1074/jbc.272.9.5682; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P2131, DOI 10.1093/jac/dks186; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3185, DOI 10.1128/JCM.00946-09; Pfaller MA, 2014, J CLIN MICROBIOL, V52, P3223, DOI 10.1128/JCM.00782-14; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rybak JM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00651-17; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Saraya T, 2014, J CLIN MICROBIOL, V52, P2709, DOI 10.1128/JCM.03593-13; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Umesha S, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0436-4; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-167; Wiederhold NP, 2011, ANTIMICROB AGENTS CH, V55, P3254, DOI 10.1128/AAC.01750-10; Xu YH, 2015, ARCH MICROBIOL, V197, P1087, DOI 10.1007/s00203-015-1146-8; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Zimbeck AJ, 2010, ANTIMICROB AGENTS CH, V54, P5042, DOI 10.1128/AAC.00836-10	52	38	41	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210397	10.1371/journal.pone.0210397	http://dx.doi.org/10.1371/journal.pone.0210397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629653	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000079
J	Wilkinson, CM; Fedor, BA; Aziz, JR; Nadeau, CA; Brar, PS; Clark, JJA; Colbourne, F				Wilkinson, Cassandra M.; Fedor, Brittany A.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick			Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHLORIDE HOMEOSTASIS; SEIZURE ACTIVITY; INJURY; COLLAGENASE; FUROSEMIDE; STROKE; HYPERTENSION; FREQUENCY; HEMATOMA	After intracerebral hemorrhage (ICH), brain edema commonly occurs and can cause death. Along with edema, there are significant alterations in the concentrations of key ions such as sodium, potassium, and chloride, which are essential to brain function. NKCC1, a cation-chloride cotransporter, is upregulated after brain damage, such as traumatic injury and ischemic stroke. NKCC1 brings sodium and chloride into the cell, possibly worsening ion dyshomeostasis. Bumetanide, a specific NKCC1 antagonist, blocks the transport of chloride into cells, and thus should attenuate the increases in chloride, which should lessen brain edema and improve neuronal functioning post-ICH, as with other injuries. We used the collagenase model of ICH to test whether bumetanide treatment for three days (vs. vehicle) would improve outcome. We gave bumetanide beginning at two hours or seven days post-ICH and measured behavioural outcome, edema, and brain ion content after treatment. There was some evidence for a minor reduction in edema after early dosing, but this did not improve behaviour or lessen injury. Contrary to our hypothesis, bumetanide did not normalize ion concentrations after late dosing. Bumetanide did not improve behavioural outcome or affect lesion volume. After ICH, bumetanide is safe to use in rats but does not improve functional outcome in the majority of animals.	[Wilkinson, Cassandra M.; Aziz, Jasmine R.; Nadeau, Colby A.; Brar, Paul S.; Clark, Julia J. A.; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Fedor, Brittany A.; Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082	Canada Research Chair award; Undergraduate Research Initiative award; Alberta Innovates Health Solutions award; Heart and Stroke Foundation of Canada [G-16-00014065]	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Undergraduate Research Initiative award; Alberta Innovates Health Solutions award; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	FC is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). CMW is supported by an Undergraduate Research Initiative award (https://www.ualberta.ca/undergraduate-research-initiative/). JRA was supported by an Alberta Innovates Health Solutions award (http://albertain.com/companies/alberta-innovates-health-solutions/). This research was supported by the Heart and Stroke Foundation of Canada to FC (G-16-00014065, http://www.heartandstroke.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2008, VASC HEALTH RISK MAN, V4, P715; Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Biffi A, 2016, BRAIN, V139, P2694, DOI 10.1093/brain/aww199; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; BRATER DC, 1983, CLIN PHARMACOL THER, V34, P207, DOI 10.1038/clpt.1983.154; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; DIXON DW, 1981, J CLIN PHARMACOL, V21, P680, DOI 10.1002/j.1552-4604.1981.tb05683.x; Eftekhari S, 2013, EPILEPSIA, V54, pe9, DOI 10.1111/j.1528-1167.2012.03654.x; Fernandez-Bouzas A, 2002, CLIN ELECTROENCEPHAL, V33, P70, DOI 10.1177/155005940203300205; Hiploylee C, 2014, EXP NEUROL, V255, P49, DOI 10.1016/j.expneurol.2014.02.017; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kaila K, 2010, EPILEPSIA, V51, P52, DOI 10.1111/j.1528-1167.2010.02838.x; Keep RF, 2008, ACT NEUR S, V105, P73; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI [10.1186/2045-8118-11-11, DOI 10.1186/2045-8118-11-11]; Klahr AC, 2016, THER HYPOTHERMIA TEM, V6, P40, DOI 10.1089/ther.2015.0028; Klahr AC, 2015, TRANSL STROKE RES, V6, P29, DOI 10.1007/s12975-014-0361-y; KONECKE LL, 1981, J CLIN PHARMACOL, V21, P688, DOI 10.1002/j.1552-4604.1981.tb05684.x; LEE SH, 1994, J PHARMACOKINET BIOP, V22, P1, DOI 10.1007/BF02353407; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Merkler AE, 2018, STROKE, V49, P1319, DOI 10.1161/STROKEAHA.117.020178; Mesko MF, 2011, INT J MASS SPECTROM, V307, P137, DOI 10.1016/j.ijms.2011.04.009; Nadeau CA, 2018, TRANSL STROKE RES, DOI [10.1007/s12975-018-0636-910.1007/s12975-018-0636-9, DOI 10.1007/S12975-018-0636-910.1007/S12975-018-0636-9]; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Portbury SD, 2018, METALLOMICS, V10, P846, DOI 10.1039/c8mt00068a; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Romermann K, 2017, NEUROPHARMACOLOGY, V117, P182, DOI 10.1016/j.neuropharm.2017.02.006; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rubenstein JLR, 2013, CELLULAR MIGRATION F, DOI [10.1016/C2011-0-07731-1, DOI 10.1016/C2011-0-07731-1]; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah QA, 2007, J NEUROL SCI, V261, P74, DOI 10.1016/j.jns.2007.04.036; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sun D, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P501; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Tollner K, 2015, EUR J PHARMACOL, V746, P167, DOI 10.1016/j.ejphar.2014.11.019; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; van der Heijden M, 1998, J CLIN PHARMACOL, V38, P630, DOI 10.1002/j.1552-4604.1998.tb04470.x; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang F, 2016, BRAIN STRUCT FUNCT, V222, P1, DOI [10.1007/s00429-016-1218-9, DOI 10.1007/S00429-016-1218-9]; Wang GB, 2014, INT J CLIN EXP PATHO, V7, P1487; Williamson MR, 2017, TRANSL STROKE RES, V8, P386, DOI 10.1007/s12975-017-0530-x; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Xu WS, 2017, MOL NEUROBIOL, V54, P2406, DOI 10.1007/s12035-016-9819-0; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	52	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210660	10.1371/journal.pone.0210660	http://dx.doi.org/10.1371/journal.pone.0210660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629699	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000121
J	Yuen, KCP; Qiu, XY; Mou, HY; Xi, X				Yuen, Kevin Chi Pun; Qiu, Xin Yue; Mou, Hong Yu; Xi, Xin			The MAndarin spoken word-Picture IDentification test in noise-Adaptive (MAPID-A) measures subtle speech-recognition-in-noise changes and spatial release from masking in very young children	PLOS ONE			English	Article							NORMAL-HEARING; NORMATIVE DATA; OLIVOCOCHLEAR BUNDLE; AGE; INTELLIGIBILITY; ANTIMASKING; INVOLVEMENT; GROWTH; QUIET; SOUND	Background Spatial release of masking (SRM) is a measure of an individual's ability to perform speech-noise segregation, which is usually quantified by the extent of improvement of the individual's speech recognition performance when the noise is switched from a spatially co-located position (e.g., speech and noise both presented from the front) to a spatially separated position (e.g., speech presented from the front and noise presented from the right side) with reference to the target speech. SRM is a combined measure of head shadow and binaural unmasking benefits. SRM has only been investigated in young children at group level but not at individual participant level in the international literature due to the lack of reliable speech recognition test materials able to detect subtle statistically significant within-participant changes in speech-recognition-in-noise thresholds. Method The performance to signal-to-noise ratio (P-SNR) functions of twenty-four disyllabic words were obtained from 40 native Mandarin-speaking children aged 3.6-6.2 years with reported normal speech, language and hearing. The test items' difficulty levels were homogenized by adjusting the speech intensity level of each item so that the adjusted signal-to-noise ratio for 50% correct score (SNR-50%) point of each item would overlap at the mean SNR-50% point of all test items. In the MAPID-A, the homogenized test items were randomly presented in an adaptive testing procedure at a fixed noise intensity level, but the speech intensity level of the upcoming test item varied in 2-dB SNR steps depending on the recognition result of the previous test item. The SNR reversal point is marked by a change from a decrease to an increase in the SNR or vice versa. Two successive SNR reversal points marked the boundaries of an excursion. The mid-points from 12 excursions (in dB SNR) were averaged to produce the adaptive SNR-50% measure (aSNR-50%). Results The aSNR-50% results were obtained from another 12 children aged 4.8-5.3 years with reported normal speech, language and hearing. The average 99% confidence interval (CI) of all participants' mean aSNR-50% values was +/- 1.61 dB SNR; therefore, 3.22 dB SNR was the average critical difference required to confirm a significant difference in the scores obtained from the same participant between two test conditions. Statistically significant within-participant SRM was identified in 95% of the participants; in other words, aSNR-50% obtained from the spatially separated condition outperformed aSNR-50% obtained from the spatially co-located condition. The adaptive testing procedure was highly reliable, with an within-participant test-retest reliability of 90.6%. and significantly limited testing time to an average of 4.2 min. This research study has fulfilled its aim on detecting subtle within-participant SRM in very young children starting from 4 years of age with a reliable statistical procedure. MAPID-A offers a reliable and efficient clinical tool to investigate speech-recognition-in- noise and SRM performances in young Mandarin-speaking children. Conclusions The narrow CIs, high test-retest reliability, and short testing time has proven that the MAPID-A is a promising sensitive, reliable and time-efficient clinical tool to detect subtle within-participant speech-recognition-in-noise changes in children as young as 4-5 years. The MAPID-A offers a clinical tool to behaviorally track young children's development in speech-recognition-in-noise and SRM, and to potentially review the development of the auditory neural pathway and the cerebral dominance for speech-recognition-in-noise in young children.	[Yuen, Kevin Chi Pun; Qiu, Xin Yue] Educ Univ Hong Kong, Dept Special Educ & Counselling, Tai Po, Hong Kong, Peoples R China; [Yuen, Kevin Chi Pun; Qiu, Xin Yue] Educ Univ Hong Kong, Integrated Ctr Wellbeing I WELL, Tai Po, Hong Kong, Peoples R China; [Mou, Hong Yu] Chinese Acad Sci, Shanghai Acoust Lab, Bion Ear & Sound Technol Lab, Shanghai, Peoples R China; [Xi, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); Chinese Academy of Sciences; Chinese People's Liberation Army General Hospital	Yuen, KCP (corresponding author), Educ Univ Hong Kong, Dept Special Educ & Counselling, Tai Po, Hong Kong, Peoples R China.; Yuen, KCP (corresponding author), Educ Univ Hong Kong, Integrated Ctr Wellbeing I WELL, Tai Po, Hong Kong, Peoples R China.	cpyuen@eduhk.hk		Xi, Xin/0000-0001-7806-8396	General Research Fund, University Grants Committee, Research Grant Council, Hong Kong [18100415]	General Research Fund, University Grants Committee, Research Grant Council, Hong Kong	This study was supported by General Research Fund, University Grants Committee, Research Grant Council, Hong Kong, https://www.ugc.edu.hk/eng/rgc/index.html (Project number: 18100415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Ambrose SE, 2014, EAR HEARING, V35, P139, DOI 10.1097/AUD.0b013e3182a76768; American Speech-Language-Hearing Association, 2005, AC ED SEETT POS STAT; Anderson J., 2007, HDB CENTRAL AUDITORY, V1, P207; Anzo M, 2002, ANN HUM BIOL, V29, P373, DOI 10.1080/03014460110089526; Barker BA, 2004, COGNITION, V94, pB45, DOI 10.1016/j.cognition.2004.06.001; Bhagat SP, 2010, NEUROSCI LETT, V485, P94, DOI 10.1016/j.neulet.2010.08.069; Bidelman GM, 2015, NEUROREPORT, V26, P483, DOI 10.1097/WNR.0000000000000376; Bregman A.S., 1990, AUDITORY SCENE ANAL; Breznitz Z., 2006, FLUENCY READING SYNC; Cameron S, 2006, INT J AUDIOL, V45, P99, DOI 10.1080/14992020500377931; Ching TYC, 2011, J ACOUST SOC AM, V129, P368, DOI 10.1121/1.3523295; CLIFTON RK, 1988, DEV PSYCHOL, V24, P477, DOI 10.1037/0012-1649.24.4.477; Crandell CC, 2000, LANG SPEECH HEAR SER, V31, P362, DOI 10.1044/0161-1461.3104.362; EGAN JP, 1948, LARYNGOSCOPE, V58, P955, DOI 10.1288/00005537-194809000-00002; ELLIOTT LL, 1979, J ACOUST SOC AM, V66, P12, DOI 10.1121/1.383065; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Fels J, 2004, ACTA ACUST UNITED AC, V90, P918; Garadat SN, 2007, J ACOUST SOC AM, V121, P1047, DOI 10.1121/1.2409863; Giraud AL, 1995, BRAIN RES, V705, P15, DOI 10.1016/0006-8993(95)01091-2; Hall JW, 2002, EAR HEARING, V23, P159, DOI 10.1097/00003446-200204000-00008; HYND GW, 1979, J EXP CHILD PSYCHOL, V28, P445, DOI 10.1016/0022-0965(79)90074-2; Ihlefeld A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045296; Jamieson Donald G, 2004, J Am Acad Audiol, V15, P508, DOI 10.3766/jaaa.15.7.5; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Lapierre MA, 2012, PEDIATRICS, V130, P839, DOI 10.1542/peds.2011-2581; Litovsky Ruth, 2015, Handb Clin Neurol, V129, P55, DOI 10.1016/B978-0-444-62630-1.00003-2; Litovsky RY, 2005, J ACOUST SOC AM, V117, P3091, DOI 10.1121/1.1873913; Lovett RES, 2012, J SPEECH LANG HEAR R, V55, P865, DOI 10.1044/1092-4388(2011/11-0096); MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; MILLER GA, 1947, PSYCHOL BULL, V44, P105, DOI 10.1037/h0055960; Misurelli SM, 2012, J ACOUST SOC AM, V132, P380, DOI 10.1121/1.4725760; MOORE DR, 1991, AUDIOLOGY, V30, P125; Moore DR, 2004, SPRINGER HDB AUDITOR; Muchnik C, 2004, AUDIOL NEURO-OTOL, V9, P107, DOI 10.1159/000076001; Murphy J, 2011, INT J PEDIATR OTORHI, V75, P489, DOI 10.1016/j.ijporl.2011.01.002; Myhrum M, 2016, EAR HEARING, V37, P80, DOI 10.1097/AUD.0000000000000224; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Nishi K, 2010, J ACOUST SOC AM, V127, P3177, DOI 10.1121/1.3377080; Nissen SL, 2005, INT J AUDIOL, V44, P379, DOI 10.1080/14992020500147615; NOZZA RJ, 1988, J SPEECH HEAR RES, V31, P212, DOI 10.1044/jshr.3102.212; Picard M, 2001, AUDIOLOGY, V40, P221; PLOMP R, 1977, ACUSTICA, V38, P186; PLOMP R, 1976, ACUSTICA, V34, P201; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Schienkiewitz A, 2011, ACTA PAEDIATR, V100, pe28, DOI 10.1111/j.1651-2227.2011.02173.x; Stollman MHP, 2003, INT J AUDIOL, V42, P303, DOI 10.3109/14992020309101322; Stuart A, 2005, EAR HEARING, V26, P78, DOI 10.1097/00003446-200502000-00007; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Vaillancourt V, 2008, EAR HEARING, V29, P453, DOI 10.1097/01.aud.0000310792.55221.0c; Van Deun L, 2010, EAR HEARING, V31, P702, DOI 10.1097/AUD.0b013e3181e40dfe; Vitevitch MS, 1999, BRAIN LANG, V68, P306, DOI 10.1006/brln.1999.2116; Wightman FL, 2005, J ACOUST SOC AM, V118, P3164, DOI 10.1121/1.2082567; Wilson RH, 2010, J SPEECH LANG HEAR R, V53, P1111, DOI 10.1044/1092-4388(2010/09-0270); Yuen KCP, 2014, J SPEECH LANG HEAR R, V57, P2005, DOI 10.1044/2014_JSLHR-H-13-0060; Yuen Kevin C P, 2009, Cochlear Implants Int, V10 Suppl 1, P138, DOI 10.1179/cim.2009.10.Supplement-1.138	59	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209768	10.1371/journal.pone.0209768	http://dx.doi.org/10.1371/journal.pone.0209768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629627	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000032
J	Zegeye, A; Dessie, G; Wagnew, F; Gebrie, A; Islam, SMS; Tesfaye, B; Kiross, D				Zegeye, Abriham; Dessie, Getnet; Wagnew, Fasil; Gebrie, Alemu; Islam, Sheikh Mohammed Shariful; Tesfaye, Bekele; Kiross, Dessalegn			Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis	PLOS ONE			English	Review							PULMONARY TUBERCULOSIS PATIENTS; ADHERENCE; DOTS; DEFAULT; ZONE; CARE	Background Tuberculosis is a global public health problem. One of the overarching dilemmas and challenges facing most tuberculosis program is non-adherence to treatment. However, in Ethiopia there are few studies with variable and inconsistent findings regarding non-adherence to treatment for tuberculosis. Methods This systematic review and meta-analysis was conducted to determine the prevalence of non-adherence to tuberculosis treatment and its determinants in Ethiopia. Biomedical databases including PubMed, Google Scholar, Science Direct, HINARI, EMBASE and Cochrane Library were systematically and comprehensively searched. To estimate the pooled prevalence, studies reporting the prevalence of adherence or non-adherence to tuberculosis treatment and its determinants were included. Data were extracted using a standardized data extraction tool prepared in Microsoft Excel and transferred to STATA/se version-14 statistical software for further analyses. To assess heterogeneity, the Cochrane Q test statistics and I 2 test were performed. Since the included studies exhibited high heterogeneity, a random effects model meta-analysis was used to estimate the pooled prevalence of nonadherence to tuberculosis treatment. Finally, the association between determinant factors and non-adherence to tuberculosis treatment was assessed. Results The result of 13 studies revealed that the pooled prevalence of non-adherence to tuberculosis treatment in Ethiopia was found to be 21.29% (95% CI: 15.75, 26.68). In the subgroup analysis, the highest prevalence was observed in Southern Nations and Nationalities of Ethiopia, 23.61% (95% CI: 21.05, 26.17) whereas the lowest prevalence was observed in Amhara region, 10.0% (95% CI: 6.48, 13.17.0;). Forgetfulness (OR = 3.22, 95% CI = 2.28, 4.53), fear side effect of the drugs (OR = 1.93, 95% CI = 1.37, 2.74), waiting time >= 1 hour during service (OR = 4.88, 95% CI = 3.44, 6.91) and feeling distance to health institution is long (OR = 5.35, 95% CI = 4.00, 7.16) were found to be determinants of non-adherence to tuberculosis treatment. Conclusion In this meta-analysis, the pooled prevalence of non-adherence to tuberculosis treatment in Ethiopia was high. Forgetfulness, fear of side effect of the drugs, long waiting time (>= 1 hour) during service and feeling distance to health institution is long were the main risk factors for non-adherence to tuberculosis treatment in Ethiopia. Early monitoring of the side effects and other reasons which account for missing medication may increase medication adherence in patients with tuberculosis in Ethiopia.	[Zegeye, Abriham; Gebrie, Alemu] Debre Markos Univ, Sch Med, Dept Biomed Sci, Debre Markos, Ethiopia; [Dessie, Getnet] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Nursing, Nursing, Bahir Dar, Ethiopia; [Wagnew, Fasil; Tesfaye, Bekele] Debre Markos Univ, Coll Hlth Sci, Dept Nursing, Debre Markos, Ethiopia; [Islam, Sheikh Mohammed Shariful] Deakin Univ, IPAN, Geeland, Australia; [Islam, Sheikh Mohammed Shariful] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Kiross, Dessalegn] Adigrat Univ, Coll Med & Hlth Sci, Dept Psychiat, Adigrat, Tigray, Ethiopia	Bahir Dar University; Deakin University; University of Sydney	Zegeye, A (corresponding author), Debre Markos Univ, Sch Med, Dept Biomed Sci, Debre Markos, Ethiopia.	abrish189@gmail.com	Gebrie, Alemu/AAD-3275-2020; Islam, Mohammed Shariful/B-1219-2011	Gebrie, Alemu/0000-0001-5575-6823; Islam, Mohammed Shariful/0000-0001-7926-9368; Dessie, Getenet/0000-0001-7276-0891; Wagnew, Fasil/0000-0003-3087-2312				Abula T., 2001, Ethiopian Journal of Health Development, V15, P185; Adane AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078791; Adane K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1933-9; Ahlburg DA, 2000, EC IMPACTS TUBERCULO; [Anonymous], 2014, AM J PUBLIC HLTH RES, V2, P239, DOI DOI 10.12691/AJPHR-2-6-4; [Anonymous], 2012, GLOB TUB REP 2012; Awofeso Niyi, 2008, Bull World Health Organ, V86, pB; Bagchi S, 2010, INT J PREVENTIVE MED, V1, P223; Chani K., 2010, FACTORS AFFECTING CO; Culqui DR, 2012, ARCH BRONCONEUMOL, V48, P150, DOI 10.1016/j.arbres.2011.12.008; Daksa MD, 2016, EUR J THER, V22, P55, DOI 10.5578/GMJ.32149; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eticha T, 2014, J BIOANALYSIS BIOMED, V6, P61, DOI DOI 10.4172/1948-593X.1000113; Floyd K, 2018, LANCET RESP MED, V6, P299, DOI 10.1016/S2213-2600(18)30057-2; FMoH E, 2008, TUB LEPR TB HIV PREV, P207; FOX W, 1983, BMJ-BRIT MED J, V287, P101, DOI 10.1136/bmj.287.6385.101; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Gele Abdi A, 2010, BMC Res Notes, V3, P86, DOI 10.1186/1756-0500-3-86; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; GUBE AA, ASSESSMENT ANTITB DR; Harries AD, 2004, TB HIV CLIN MANUAL; Haynes RB, 2002, COCHRANE DB SYST REV, V2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kebede A, 2012, N AM J MED SCI, V4, P67, DOI 10.4103/1947-2714.93376; Kifle MW, 2004, ETHIOPIAN MED J, V42, P247; Kiros YK, 2014, PUBLIC HEALTH ACTION, V4, pS31, DOI 10.5588/pha.14.0054; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Medhin G. G., 2015, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V4, P166; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nezenega ZS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-110; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Organization WH, 2011, WHO TUB CONTR REP 20; RIEDER HL, 2002, INTERVENTIONS TUBERC; SabatU E., 2003, ADHERENCE LONG TERM; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tesfahuneygn Gebrehiwet, 2015, BMC Res Notes, V8, P503, DOI 10.1186/s13104-015-1452-x; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Ubajaka CF, 2015, INT J CLIN MED, V6, P399, DOI DOI 10.4236/IJCM.2015.66052; WHO, 2008, WHO REP 2008 GLOB TU; Woimo TT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4188-9; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yin XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050328; Yusuf KO, 2007, PLOS MED, V4, pe37, DOI [10.1371/journal.pmed.0040037, DOI 10.1371/JOURNAL.PMED.0040037]	48	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210422	10.1371/journal.pone.0210422	http://dx.doi.org/10.1371/journal.pone.0210422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629684	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000087
J	Perez-Lachaud, G; Rocha, FH; Valle-Mora, J; Henaut, Y; Lachaud, JP				Perez-Lachaud, Gabriela; Rocha, Franklin H.; Valle-Mora, Javier; Henaut, Yann; Lachaud, Jean-Paul			Fine-tuned intruder discrimination favors ant parasitoidism	PLOS ONE			English	Article							ECTATOMMA-TUBERCULATUM; PONERINE ANT; NESTMATE RECOGNITION; CHEMICAL MIMICRY; CUTICULAR HYDROCARBONS; CORPSE REMOVAL; HYMENOPTERA; FORMICIDAE; BEHAVIOR; HOST	A diversity of arthropods (myrmecophiles) thrives within ant nests, many of them unmolested though some, such as the specialized Eucharitidae parasitoids, may cause direct damage to their hosts. Ants are known to discriminate between nestmates and non-nest-mates, but whether they recognize the strength of a threat and their capacity to adjust their behavior accordingly have not been fully explored. We aimed to determine whether Ectatomma tuberculatum ants exhibited specific behavioral responses to potential or actual intruders posing different threats to the host colony and to contribute to an understanding of complex ant-eucharitid interactions. Behavioral responses differed significantly according to intruder type. Ants evicted intruders that represented a threat to the colony's health (dead ants) or were not suitable as prey items (filter paper, eucharitid parasitoid wasps, non myrmecophilous adult weevils), but killed potential prey (weevil larvae, termites). The timing of detection was in accordance with the nature and size of the intruder: corpses (a potential source of contamination) were detected faster than any other intruder and transported to the refuse piles within 15 min. The structure and complexity of behavioral sequences differed among those intruders that were discarded. Workers not only recognized and discriminated between several distinct intruders but also adjusted their behavior to the type of intruder encountered. Our results confirm the previously documented recognition capabilities of E. tuberculatum workers and reveal a very fine-tuned intruder discrimination response. Colony-level prophylactic and hygienic behavioral responses through effective removal of inedible intruders appears to be the most general and flexible form of defense in ants against a diverse array of intruders. However, this generalized response to both potentially lethal and harmless intruders might have driven the evolution of ant-eucharitid interactions, opening a window for parasitoid attack and allowing adult parasitoid wasps to quickly leave the natal nest unharmed.	[Perez-Lachaud, Gabriela; Rocha, Franklin H.; Henaut, Yann; Lachaud, Jean-Paul] Colegio Frontera Sur, Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Valle-Mora, Javier] Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Lachaud, Jean-Paul] Univ Toulouse, CBI, CRCA, Toulouse, France; [Lachaud, Jean-Paul] UPS, CNRS, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Perez-Lachaud, G (corresponding author), Colegio Frontera Sur, Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	igperez@ecosur.mx	LACHAUD, Jean-Paul/ABG-3831-2021	LACHAUD, Jean-Paul/0000-0002-5082-8987; Henaut, Yann/0000-0002-8805-1739; Perez-Lachaud, Gabriela/0000-0002-8924-1606	Consejo Nacional de Ciencia y Tecnologia, Mexico [415149]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was partially funded by Consejo Nacional de Ciencia y Tecnologia, Mexico (scholarship grant no. 415149 to FHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akino T, 1996, JPN J APPL ENTOMOL Z, V40, P265, DOI 10.1303/jjaez.40.265; [Anonymous], [No title captured]; Atkinson EB, 2011, PHYSIOL ENTOMOL, V36, P282, DOI 10.1111/j.1365-3032.2010.00774.x; AYRE GL, 1962, CAN J ZOOLOG, V40, P157, DOI 10.1139/z62-020; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Bengston SE, 2014, P ROY SOC LOND B BIO, V281; Boomsma JJ, P ROYAL ENT SOC 22 S; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Breed MD, 1999, INSECT SOC, V46, P327, DOI 10.1007/s000400050153; Bruckner A, 2017, PEERJ, V5, DOI 10.7717/peerj.3870; Cerda X, PREDATION HYMENOPTER; CHAMPALBERT A, 1990, ANIM BEHAV, V39, P850, DOI 10.1016/S0003-3472(05)80949-2; Clausen C. P., 1923, Annals of the Entomological Society of America, V16, P195, DOI 10.1093/aesa/16.3.195; CLAUSEN C. P., 1941, PSYCHE, V48, P57, DOI 10.1155/1941/21539; CLAUSEN CURTIS P., 1940, JOUR WASHINGTON ACAD SCI, V30, P504; Cook OF, 1905, USDA TECHNICAL SERIE, V10, P1; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer Sylvia, 2018, Annual Review of Entomology, V63, P105, DOI 10.1146/annurev-ento-020117-043110; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; De la Mora A, 2008, BEHAV PROCESS, V78, P64, DOI 10.1016/j.beproc.2008.01.011; DEJEAN A, 1985, INSECT SOC, V32, P241, DOI 10.1007/BF02224914; DEJEAN A, 1992, INSECT SOC, V39, P129, DOI 10.1007/BF01249289; Dejean A., 1980, B SFECA, P43; Di Giulio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130541; Diez L, 2015, BEHAV PROCESS, V116, P80, DOI 10.1016/j.beproc.2015.04.016; Diez L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0306; Diez L, 2013, J CHEM ECOL, V39, P1424, DOI 10.1007/s10886-013-0365-1; Diez L, 2012, NATURWISSENSCHAFTEN, V99, P833, DOI 10.1007/s00114-012-0965-6; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Feneron R, 1996, INSECT SOC, V43, P131, DOI 10.1007/BF01242565; Feneron R, 2012, PSYCHE, DOI [10.1155/2012/573541, DOI 10.1155/2012/573541]; Franz NM, 2003, J INSECT BEHAV, V16, P381, DOI 10.1023/A:1024880110189; Fresneau D, 1984, PROCESSUS ACQUISITIO, P437; Galwey NW, 2006, INTRO MIXED MODELING; Halcroft M, 2011, INSECT SOC, V58, P245, DOI 10.1007/s00040-010-0142-x; Henaut Y, 2014, ANIM COGN, V17, P185, DOI 10.1007/s10071-013-0651-x; Heraty J. M, 2002, MEM AM ENTOMOL I, V68, P1; Heraty JM, 2015, ANN ENTOMOL SOC AM, V108, P865, DOI 10.1093/aesa/sav062; Hora RR, 2005, BEHAV ECOL SOCIOBIOL, V59, P285, DOI 10.1007/s00265-005-0040-9; Howard RW, 2002, ARCH INSECT BIOCHEM, V50, P75, DOI 10.1002/arch.10034; Howard RW, 2001, ANN ENTOMOL SOC AM, V94, P707, DOI 10.1603/0013-8746(2001)094[0707:CHOKSH]2.0.CO;2; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hughes DP, 2008, SOCIOBIOLOGY COMMUNI, P171; Ibarra-Nunez G, 2001, SOCIOBIOLOGY, V37, P723; JAFFE K, 1990, INSECT SOC, V37, P101, DOI 10.1007/BF02224024; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Kistner D. H., 1982, Social insects. Vol. III, P1; Krantz GW, 2007, ACAROLOGY, P29; Lachaud J-P, 2013, PSYCHE SPECIAL ISSUE; Lachaud J-P, 2012, ANTS THEIR PARASITES; Lachaud JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep29995; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Lachaud JP, 1998, FLA ENTOMOL, V81, P570, DOI 10.2307/3495962; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022; Murray EA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0495; Ostwald MM, 2018, J INSECT BEHAV, V31, P503, DOI 10.1007/s10905-018-9694-9; Parmentier T, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0583-6; Payne CM, 2004, ANN ZOOL FENN, V41, P843; Perez-Lachaud G, 2001, BIOL CONTROL, V22, P265, DOI 10.1006/bcon.2001.0976; Perez-Lachaud G, 2006, ANN ENTOMOL SOC AM, V99, P567, DOI 10.1603/0013-8746(2006)99[567:BABOKH]2.0.CO;2; Perez-Lachaud G, 2015, J INSECT PHYSIOL, V75, P63, DOI 10.1016/j.jinsphys.2015.03.003; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2010, BIOL CONTROL, V52, P131, DOI 10.1016/j.biocontrol.2009.10.016; PERFECTO I, 1993, INSECT SOC, V40, P295, DOI 10.1007/BF01242365; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richard FJ, 2004, CR BIOL, V327, P509, DOI 10.1016/j.crvi.2004.03.002; ROBERTSON PL, 1971, J INSECT PHYSIOL, V17, P691, DOI 10.1016/0022-1910(71)90117-X; Rocha FH, 2014, ETHOLOGY, V120, P1185, DOI 10.1111/eth.12291; Roche-Labarbe Nadege, 2004, Actes des Colloques Insectes Sociaux, V16, P52; Scharf I, 2011, ETHOLOGY, V117, P731, DOI 10.1111/j.1439-0310.2011.01926.x; SCHATZ B, 1994, ANIM BEHAV, V48, P236, DOI 10.1006/anbe.1994.1232; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; Simone-Finstrom M., 2017, Bee World, V94, P21, DOI 10.1080/0005772X.2017.1307800; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; Torrens J, 2016, SYST ENTOMOL, V41, P596, DOI 10.1111/syen.12176; Tranter C, 2015, BEHAV ECOL, V26, P396, DOI 10.1093/beheco/aru203; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2247, DOI 10.1007/BF01014113; Venables WN., 2002, MODERN APPL STAT S; von Beeren C, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0249-x; von Beeren C, 2012, J CHEM ECOL, V38, P262, DOI 10.1007/s10886-012-0083-0; von Beeren C, 2011, EVOL ECOL, V25, P259, DOI 10.1007/s10682-010-9420-3; Wheeler W, 1910, AM NAT, V91, P5927; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P1; Wickham H, 2007, J STAT SOFTW, V21, P1; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	94	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210739	10.1371/journal.pone.0210739	http://dx.doi.org/10.1371/journal.pone.0210739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653595	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500065
J	Versluis, D; Gonzalez, TDB; Zoetendal, EG; van Passel, MWJ; Smidt, H				Versluis, Dennis; Gonzalez, Teresita de J. Bello; Zoetendal, Erwin G.; van Passel, Mark W. J.; Smidt, Hauke			High throughput cultivation-based screening on porous aluminum oxide chips allows targeted isolation of antibiotic resistant human gut bacteria	PLOS ONE			English	Article							SELECTIVE DECONTAMINATION; DIGESTIVE-TRACT; INTENSIVE-CARE; FUNCTIONAL-CHARACTERIZATION; MICROBIOTA REVEALS; DIVERSITY; GROWTH; RESERVOIR; GENES	The emergence of bacterial pathogens that are resistant to clinical antibiotics poses an increasing risk to human health. An important reservoir from which bacterial pathogens can acquire resistance is the human gut microbiota. However, thus far, a substantial fraction of the gut microbiota remains uncultivated and has been little-studied with respect to its resistance reservoir-function. Here, we aimed to isolate yet uncultivated resistant gut bacteria by a targeted approach. Therefore, faecal samples from 20 intensive care patients who had received the prophylactic antibiotic treatment selective digestive decontamination (SDD), i.e. tobramycin, polymyxin E, amphotericin B and cefotaxime, were inoculated anaerobically on porous aluminium oxide chips placed on top of poor and rich agar media, including media supplemented with the SDD antibiotics. Biomass growing on the chips was analysed by 16S rRNA gene amplicon sequencing, showing large inter-individual differences in bacterial cultivability, and enrichment of a range of taxonomically diverse operational taxonomic units (OTUs). Furthermore, growth of Ruminococcaceae (2 OTUs), Enterobacteriaceae (6 OTUs) and Lachnospiraceae (4 OTUs) was significantly inhibited by the SDD antibiotics. Strains belonging to 16 OTUs were candidates for cultivation to pure culture as they shared <= 95% sequence identity with the closest type strain and had a relative abundance of >= 2%. Six of these OTUs were detected on media containing SDD antibiotics, and as such were prime candidates to be studied regarding antibiotic resistance. One of these six OTUs was obtained in pure culture using targeted isolation. This novel strain was resistant to the antibiotics metrodinazole and imipenem. It was initially classified as member of the Ruminococcaceae, though later it was found to share 99% nucleotide identity with the recently published Sellimonas intestinalis BR72(T). In conclusion, we show that high-throughput cultivation-based screening of microbial communities can guide targeted isolation of bacteria that serve as reservoirs of antibiotic resistance.	[Versluis, Dennis; Gonzalez, Teresita de J. Bello; Zoetendal, Erwin G.; van Passel, Mark W. J.; Smidt, Hauke] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [van Passel, Mark W. J.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Versluis, Dennis] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany; [Gonzalez, Teresita de J. Bello] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Carl von Ossietzky Universitat Oldenburg; University of Glasgow	Versluis, D (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.; Versluis, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany.	dversluis@hotmail.com	Smidt, Hauke/D-7054-2014	Smidt, Hauke/0000-0002-6138-5026; Bello Gonzalez, Teresita de Jesus/0000-0001-5655-9370; Versluis, Dennis/0000-0001-8430-4500	European Union [282004]	European Union(European Commission)	This work was supported by the European Union through the EvoTAR project (Grant agreement no. 282004) to HS.	Al Naiemi N, 2006, J ANTIMICROB CHEMOTH, V58, P853, DOI 10.1093/jac/dkl316; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; Baek SH, 2011, J FRESHWATER ECOL, V26, P547, DOI 10.1080/02705060.2011.582696; BLECHSCHMIDT B, 1992, J GEN MICROBIOL, V138, P1197, DOI 10.1099/00221287-138-6-1197; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Buelow E, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0309-z; Buelow E, 2014, J ANTIMICROB CHEMOTH, V69, P2215, DOI 10.1093/jac/dku092; Bulow E., 2015, THESIS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng G, 2012, FEMS MICROBIOL LETT, V336, P11, DOI 10.1111/j.1574-6968.2012.02647.x; Clinical and Laboratory Standards Institute (CLSI), 2014, CLSI DOCUMENT M100 S; CLSI, 2012, CLSI DOCUMENT M11 A8; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2012, CURR OPIN INFECT DIS, V25, P211, DOI 10.1097/QCO.0b013e3283507f8c; Deak E, 1998, MICROBIOL-SGM, V144, P2169, DOI 10.1099/00221287-144-8-2169; EUCAST, 2015, BREAKP TABL INT MICS, DOI [10.1016/j.tibtech.2012.05.007, DOI 10.1016/J.TIBTECH.2012.05.007]; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Gutleben J, 2018, CRIT REV MICROBIOL, V44, P212, DOI 10.1080/1040841X.2017.1332003; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Jiang HC, 2006, APPL ENVIRON MICROB, V72, P3832, DOI 10.1128/AEM.02869-05; Kim BS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/838040; Ma L, 2014, P NATL ACAD SCI USA, V111, P9768, DOI 10.1073/pnas.1404753111; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R development Core Team, 2010, R LANGUAGE AND ENVIR; Raes J, 2016, GUT, V65, P896, DOI 10.1136/gutjnl-2015-311015; Ramiro-Garcia Javier, 2016, F1000Res, V5, P1791, DOI 10.12688/f1000research.9227.2; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Seo B, 2016, INT J SYST EVOL MICR, V66, P951, DOI 10.1099/ijsem.0.000817; Smilauer P, 2014, MULTIVARIATE ANALYSI, V5; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2015, CURR OPIN MICROBIOL, V27, P127, DOI 10.1016/j.mib.2015.08.004; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; Steinert G, 2014, MAR BIOTECHNOL, V16, P594, DOI 10.1007/s10126-014-9575-y; Tian LM, 2016, MOL NUTR FOOD RES, V60, P2256, DOI 10.1002/mnfr.201600149; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Lingen HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00425; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Versluis D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11981; Wolf M, 2004, INT J SYST EVOL MICR, V54, P871, DOI 10.1099/ijs.0.02868-0; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	58	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210970	10.1371/journal.pone.0210970	http://dx.doi.org/10.1371/journal.pone.0210970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653573	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000456015500093
J	Carlos, S; Lopez-del Burgo, C; Ndarabu, A; Osorio, A; Rico-Campa, A; Reina, G; Burgueno, E; de Irala, J				Carlos, Silvia; Lopez-del Burgo, Cristina; Ndarabu, Adolphe; Osorio, Alfonso; Rico-Campa, Anais; Reina, Gabriel; Burgueno, Eduardo; de Irala, Jokin			Heterosexual oral and anal sex in Kinshasa (D. R.Congo): Data from OKAPI prospective cohort	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-INFECTION; HUMAN-PAPILLOMAVIRUS; RISK BEHAVIORS; FORCED SEX; CONDOM USE; PREVALENCE; ADOLESCENTS; INTERCOURSE; WOMEN	Background Sexually transmitted infections can be spread through oral and anal heterosexual sex. There are few data on these practices in Sub-Saharan Africa. We analyzed the prevalence of heterosexual oral and anal sex among HIV Voluntary Counseling and Testing (VCT) attendees in Kinshasa and the associated sociodemographics, perceptions and behavioral factors. Methods OKAPI (Observational Kinshasa AIDS Prevention Initiative) prospective cohort study. It evaluates the VCT impact on HIV-related knowledge and behaviors at 6 and 12-month follow-up. Since April 2016 until April 2018, 797 persons aged 15-59 years were HIV tested and replied to a baseline interview, including information about anal and oral sex. Descriptive, bi- and multivariate analyses were performed using baseline data. Results Among 718 sexually active participants reporting heterosexual sex, 59% had had oral sex, 22% anal sex and 18% both practices. Among participants reporting "not" having had sex, 6% reported oral sex, 3% anal sex and 1% both. Oral sex was associated with a daily use of the Internet/mobile phone, perceiving low community HIV risk, reporting HIV-related behaviors (multiple partners, inconsistent condom use, anal, paid and forced sex) and having been pregnant. Being married-monogamous was inversely associated with oral sex. Anal sex was directly associated with having other risk sexual behaviors. Conclusions Oral and anal sex were common among people reporting heterosexual sex in Kinshasa. Perceiving a low community HIV risk and having other sexual risk behaviors are associated with these practices, which are commonly not considered as risky despite their strong association with HIV/STIs. They need to be considered when designing preventive strategies in Kinshasa.	[Carlos, Silvia; Lopez-del Burgo, Cristina; Rico-Campa, Anais; de Irala, Jokin] Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain; [Carlos, Silvia; Lopez-del Burgo, Cristina; Osorio, Alfonso; Rico-Campa, Anais; Reina, Gabriel; de Irala, Jokin] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Carlos, Silvia; Lopez-del Burgo, Cristina; Osorio, Alfonso; de Irala, Jokin] Univ Navarra, ICS, Educ Affect & Human Sexual, Pamplona, Spain; [Ndarabu, Adolphe; Burgueno, Eduardo] Monkole Hosp, Kinshasa, DEM REP CONGO; [Osorio, Alfonso] Univ Navarra, Sch Educ & Psychol, Pamplona, Spain; [Rico-Campa, Anais] Biomed Res Ctr Network Obes & Nutr CIBERobn, Inst Hlth Carlos III, Madrid, Spain; [Reina, Gabriel] Clin Univ Navarra, Microbiol Serv, Pamplona, Spain; [Burgueno, Eduardo] Univ Mwene Ditu, Sch Med, Mwene Ditu, DEM REP CONGO	University of Navarra; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Carlos, S (corresponding author), Univ Navarra, Prevent Med & Publ Hlth Dept, Pamplona, Spain.; Carlos, S (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.; Carlos, S (corresponding author), Univ Navarra, ICS, Educ Affect & Human Sexual, Pamplona, Spain.	scarlos@unav.es	Osorio, Alfonso/B-4644-2011; Martinez-Gonzalez, Miguel A./AAE-7669-2019; de Irala, Jokin/H-2936-2017; Burgo, Cristina Lopez-del/I-1963-2017; Reina, Gabriel/F-2709-2017; CARLOS, SILVIA/L-9123-2014	Osorio, Alfonso/0000-0003-4337-5382; de Irala, Jokin/0000-0002-7249-6581; Reina, Gabriel/0000-0003-4079-9753; CARLOS, SILVIA/0000-0002-4968-7080	Government of Spain (Fondo de Investigacion en Salud-FIS) [PI16/01908]; Government of Navarre [045-2015]; Institute for Culture and Society of the University of Navarra	Government of Spain (Fondo de Investigacion en Salud-FIS); Government of Navarre; Institute for Culture and Society of the University of Navarra	Funding was provided by the Government of Spain (Fondo de Investigacion en Salud-FIS) (PI16/01908 to GR/SC), the Government of Navarre (045-2015 to SC), and the Institute for Culture and Society of the University of Navarra (EASH to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaro LE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-54; Abdool Karim S. S., 2010, HIV AIDS S AFRICA; Abdul R, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3138-1; [Anonymous], 2014, ENQ DEM SANT REP DEM; Arulogun OS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.261.2630; Baggaley RF, 2013, AM J REPROD IMMUNOL, V69, P95, DOI 10.1111/aji.12064; Barnabas SL, 2018, INT J STD AIDS, V29, P531, DOI 10.1177/0956462417740487; Bavoil PM, 2017, J INFECT DIS, V216, P932, DOI 10.1093/infdis/jix419; Bruni L, 2017, SUMMARY REPORT, P27; Carlos S, 2015, SEX TRANSM INFECT, V91, P334, DOI 10.1136/sextrans-2014-051734; Carter-Wicker K, 2016, SAGE OPEN MED CASE R, V4, DOI 10.1177/2050313X16682132; CDC, 2017, FACT SHEETS; Chancellor JA, 2017, COMMUNITY DENT ORAL, V45, P20, DOI 10.1111/cdoe.12255; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Cherie A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-5; Chow EPF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016779; Clutterbuck DJ, 2012, INT J STD AIDS, V23, P381, DOI 10.1258/ijsa.2012.200312; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192982; Davidson CL, 2014, SAMJ S AFR MED J, V104, P358, DOI [10.7196/SAMJ.7542, 10.7196/samj.7542]; De Vries H, 2014, ARCH SEX BEHAV, V43, P1087, DOI 10.1007/s10508-014-0280-8; Dietrich JJ, 2018, AIDS BEHAV, V22, P2312, DOI 10.1007/s10461-018-2080-y; Duby Z, 2014, J SEX RES, V51, P863, DOI 10.1080/00224499.2013.871624; Folayan MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155210; Folayan MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129106; Gaffoor Zakir, 2013, BMC Res Notes, V6, P532, DOI 10.1186/1756-0500-6-532; Githuka G, 2014, JAIDS-J ACQ IMM DEF, V66, pS46, DOI 10.1097/QAI.0000000000000137; Goldberg SK, 2017, PERSPECT SEX REPRO H, V49, P55, DOI 10.1363/psrh.12020; Goldstein R, 2018, J ADOLESCENT HEALTH, V62, P363, DOI 10.1016/j.jadohealth.2018.01.002; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Green EC, 2011, AIDS BEHAVIOR AND CU; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Harling G, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0403-8; Herbenick D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181198; Hoffman S, 2017, AJAR-AFR J AIDS RES, V16, P1, DOI 10.2989/16085906.2016.1259171; Holway GV, 2018, J ADOLESCENT HEALTH, V62, P402, DOI 10.1016/j.jadohealth.2017.08.022; Holway GV, 2017, J FAM ISSUES, V38, P1675, DOI 10.1177/0192513X15613826; Hurley EA, 2017, J ADOLESCENT HEALTH, V60, P79, DOI 10.1016/j.jadohealth.2016.08.023; IACOBUCCI G, 2018, BMJ BRIT MED J, V361; Kakoko DCV, 2013, CULT HEALTH SEX, V15, P235, DOI 10.1080/13691058.2012.738829; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalichman SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-807; Kapiga S, 2009, SEX TRANSM DIS, V36, P199, DOI 10.1097/OLQ.0b013e318191ba01; Lewis R, 2017, J ADOLESCENT HEALTH, V61, P694, DOI 10.1016/j.jadohealth.2017.07.004; Longo JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187654; Maheu-Giroux M, 2018, AM J EPIDEMIOL, V187, P287, DOI 10.1093/aje/kwx244; Maswanya Edward S, 2012, East Afr J Public Health, V9, P39; Mazeingia Yohannes Teka, 2017, Glob Health Res Policy, V2, P27, DOI 10.1186/s41256-017-0047-6; Meque I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089705; Mmbaga EJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4245-4; Morris BJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0073-5; Moscicki AB, 2014, CLIN INFECT DIS, V58, P804, DOI 10.1093/cid/cit947; Mtenga S, 2015, SEX TRANSM INFECT, V91, P576, DOI 10.1136/sextrans-2015-052055; Muanda FM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0517-4; Ndongmo Therese Ntigwa, 2017, Pan Afr Med J, V26, P71, DOI 10.11604/pamj.2017.26.71.11312; NGUYEN NP, 2016, MEDICINE, V95; Nsakala GV, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-21; O'Leary A, 2017, AIDS BEHAV, V21, P2895, DOI 10.1007/s10461-016-1635-z; Odimegwu C, 2018, J BIOSOC SCI, V10, P1; Owen BN, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21162; Parker L, 2013, EVAL PROGRAM PLANN, V36, P124, DOI 10.1016/j.evalprogplan.2012.09.002; Peltzer K, 2012, AFR HEALTH SCI, V12, P8; Peterman TA, 2018, SEX TRANSM DIS, V45, pE7, DOI [10.1097/OLQ.0000000000000737, 10.1097/olq.0000000000000737]; Le PT, 2017, J INFECT CHEMOTHER, V23, P668, DOI 10.1016/j.jiac.2017.06.011; Rice E, 2018, CHILD DEV, V89, P110, DOI 10.1111/cdev.12837; Rohde RL, 2018, VACCINE, V36, P3629, DOI 10.1016/j.vaccine.2018.05.022; Shayo Elizabeth H, 2017, BMC Res Notes, V10, P140, DOI 10.1186/s13104-017-2452-9; Shigeishi Hideo, 2016, J Clin Med Res, V8, P721, DOI 10.14740/jocmr2545w; Taberna M, 2017, CANCER-AM CANCER SOC, V123, P1156, DOI 10.1002/cncr.30564; Teasdale CA, 2017, ARCH SEX BEHAV, V46, P539, DOI 10.1007/s10508-016-0818-z; Torrone EA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002511; Toska E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178106; UNAIDS, 2018, FAST TRACK COMM AIDS; UNAIDS, 2018, IND MON 2016 POL DEC; UNAIDS, 2017, UNAIDS DATA 2017; UNAIDS, 2018, RESP HIV W CENTR AFR; UNAIDS, 2015, INV HIV PREV; Vogt SL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00303; Watt MH, 2015, J INTERPERS VIOLENCE, V30, P1533, DOI 10.1177/0886260514540807; Wiebe ER, 2012, INT J GYNECOL OBSTET, V117, P185, DOI 10.1016/j.ijgo.2011.12.018; Woto-Gaye G, 2016, Bull Soc Pathol Exot, V109, P160, DOI 10.1007/s13149-016-0500-7; Ybarra M, 2018, AIDS CARE, V30, P821, DOI 10.1080/09540121.2018.1426824	81	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210398	10.1371/journal.pone.0210398	http://dx.doi.org/10.1371/journal.pone.0210398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650137	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300056
J	Kuhl, M; Binner, C; Jozwiak, J; Fischer, J; Hahn, J; Addas, A; Dinov, B; Garbade, J; Hindricks, G; Borger, M				Kuehl, Michael; Binner, Christian; Jozwiak, Joanna; Fischer, Julia; Hahn, Jochen; Addas, Alaeldin; Dinov, Boris; Garbade, Jens; Hindricks, Gerhard; Borger, Michael			Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation	PLOS ONE			English	Article							GRAFT VESSEL DISEASE; HEART-TRANSPLANTATION; INTERNATIONAL SOCIETY; KAPPA-B; CYCLOSPORINE; EVOLOCUMAB; EFFICACY; SAFETY; TACROLIMUS; THERAPY	Background Hypercholesterolaemia is common in patients after cardiac transplantation. Monoclonal antibodies that inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9) reduce low-density lipoprotein (LDL) cholesterol levels and subsequently the risk of cardiovascular events in patients with dyslipidaemia. There are no published data on the effect of this medication class on cholesterol levels in patients after cardiac transplantation. Methods In this retrospective study we investigated patients who were treated with PCSK9 inhibitors either because of intolerance of statins or residual hypercholesterolaemia with evidence of cardiac allograft vasculopathy. We compared the data of patients prior to the start with these medications with their most recent dataset. Results Ten patients (nine men; mean age 58 +/- 6 years) underwent cardiac transplantation 8.3 +/- 4.5 (range 3-15) years ago. The treatment duration of Evolocumab or Alirocumab was on average 296 +/- 125 days and lead to a reduction of total Cholesterol (281 +/- 52 mg/dl to 197 +/- 36 mg/dl; p = 0.002) and LDL Cholesterol (170 +/- 22 mg/dl to 101 +/- 39 mg/dl; p = 0.001). No significant effects on HDL Cholesterol, BNP, Creatin Kinase or hepatic enzymes were noticed. There were no unplanned hospitalisations, episodes of rejections, change of ejection fraction or opportunistic infections. Both patients on Alirocumab developed liver pathologies: One patient died of hepatocellular carcinoma and the other developed hepatitis E. Conclusions Our study demonstrates that the PCSK9 inhibitors Evolocumab and Alirocumab lead to a significant reduction of LDL Cholesterol in heart transplantation recipients. No effect on cardiac function or episodes of rejections were noticed. Larger and long-term studies are needed to establish safety and efficacy of PCSK9 inhibitors after cardiac transplantation.	[Kuehl, Michael; Binner, Christian; Jozwiak, Joanna; Fischer, Julia; Hahn, Jochen; Addas, Alaeldin; Garbade, Jens; Borger, Michael] Univ Leipzig, Leipzig Heart Ctr, Dept Cardiac Surg, Leipzig, Germany; [Kuehl, Michael; Dinov, Boris; Hindricks, Gerhard] Univ Leipzig, Leipzig Heart Ctr, Dept Cardiol Rhythmol, Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH; Leipzig University	Kuhl, M (corresponding author), Univ Leipzig, Leipzig Heart Ctr, Dept Cardiac Surg, Leipzig, Germany.; Kuhl, M (corresponding author), Univ Leipzig, Leipzig Heart Ctr, Dept Cardiol Rhythmol, Leipzig, Germany.	Michaelkuhl@doctors.org.uk	Borger, Michael/AAX-1514-2020; Addas, Alaeldin/AAH-8149-2021; Kuehl, Michael/T-4417-2019	Borger, Michael/0000-0003-1046-1364; Addas, Alaeldin/0000-0001-7708-7296; Kuehl, Michael/0000-0002-4284-782X				Agarwal Arnav, 2016, World J Transplant, V6, P125, DOI 10.5500/wjt.v6.i1.125; Alba AC, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13206; Asleh R, 2018, J AM COLL CARDIOL, V71, P636, DOI 10.1016/j.jacc.2017.12.005; Bayes-Genis A, 2017, J AM COLL CARDIOL, V70, P2128, DOI 10.1016/j.jacc.2017.08.057; Bhat M, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0371-6; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Ding ZF, 2015, CARDIOVASC RES, V107, P556, DOI 10.1093/cvr/cvv178; Esper E, 1997, J HEART LUNG TRANSPL, V16, P420; Karatasakis A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006910; Kobashigawa JA, 2006, J HEART LUNG TRANSPL, V25, P434, DOI 10.1016/j.healun.2005.11.452; Kockx M, 2016, ARTERIOSCL THROM VAS, V36, P1338, DOI 10.1161/ATVBAHA.115.307030; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Kramer BK, 2005, NEPHROL DIAL TRANSPL, V20, P968, DOI 10.1093/ndt/gfh739; Leander K, 2016, CIRCULATION, V133, P1230, DOI 10.1161/CIRCULATIONAHA.115.018531; Lee S, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177703; Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003; Merola J, 2017, CURR OPIN ORGAN TRAN, V22, P1, DOI 10.1097/MOT.0000000000000370; Moens SJB, 2017, EUR HEART J, V38, P1584, DOI 10.1093/eurheartj/ehx002; Nagashima S, 2016, J CLIN LIPIDOL, V10, P1045, DOI 10.1016/j.jacl.2016.05.004; Nayarese EP, 2017, INT J CARDIOL, V227, P644, DOI 10.1016/j.ijcard.2016.10.084; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; ORTHNER CL, 1995, BLOOD, V86, P436, DOI 10.1182/blood.V86.2.436.bloodjournal862436; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Ramzy D, 2005, CAN J SURG, V48, P319; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Ruscica M, 2016, ANN MED, V48, P384, DOI 10.1080/07853890.2016.1188328; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; See VY, 2003, AM J CARDIOL, V92, P11, DOI 10.1016/S0002-9149(03)00456-9; Simha V, 2017, J CARDIOVASC TRANSL, V10, P9, DOI 10.1007/s12265-016-9719-8; Som R, 2014, WORLD J SURG, V38, P2324, DOI 10.1007/s00268-014-2543-x; Spinelli GA, 2011, TRANSPL P, V43, P3730, DOI 10.1016/j.transproceed.2011.08.074; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Tang ZH, 2012, INT J MOL MED, V30, P931, DOI 10.3892/ijmm.2012.1072; Taylor DO, 1999, J HEART LUNG TRANSPL, V18, P336, DOI 10.1016/S1053-2498(98)00060-6; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; Wenke K, 2003, CIRCULATION, V107, P93, DOI 10.1161/01.CIR.0000043241.32523.EE; Wenke K, 1997, CIRCULATION, V96, P1398, DOI 10.1161/01.CIR.96.5.1398; Zhang XL, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0358-8	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210373	10.1371/journal.pone.0210373	http://dx.doi.org/10.1371/journal.pone.0210373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650126	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300054
J	Newbronner, E; Glendinning, C; Atkin, K; Wadman, R				Newbronner, Elizabeth; Glendinning, Caroline; Atkin, Karl; Wadman, Ruth			The health and quality of life of Thalidomide survivors as they age - Evidence from a UK survey	PLOS ONE			English	Article							PHYSICAL-DISABILITY; INDIVIDUALS; EPIDEMIOLOGY; EMBRYOPATHY; ADULTS	Background In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the drug and the birth defects it caused but evidence about the health of Thalidomide survivors as they age is limited. Aim The aim of this study was to: explore the health and wellbeing UK Thalidomide survivors; document the health problems experienced by them as they reach their mid-50s; and examine the impacts on their health-related quality of life and employment. Methods A health and wellbeing survey of 351 UK Thalidomide survivors, which gathered information about home and employment circumstances, recent health problems, and health related quality of life (using SF12 Health Survey). Overall analysis focused on descriptive statistics; the association between respondents' health related quality of life and original impairment was examined using Pearson Correlation; and a three step Hierarchical Regression was used to explore the influence of five factors which narrative responses suggested might be important. Results As Thalidomide survivors reach their mid-50' s they are experiencing a wide range of secondary health problems, in particular musculoskeletal problems, and depression and anxiety, with multimorbidity a growing issue. These health problems are having a negative impact on their employment (two fifths are unable to work) and their physical health related quality of life, which is significantly poorer than the general population. Discussion Having lived relatively independent lives, many Thalidomide survivors are now having to adjust to growing disability. The study provides further evidence of the accumulative impact of disability over peoples' lifetimes and highlights the value of a life course perspective in understanding the complex experience of growing older with a disability.	[Newbronner, Elizabeth; Atkin, Karl; Wadman, Ruth] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Glendinning, Caroline] Univ York, Social Policy Res Unit, York, N Yorkshire, England	University of York - UK; University of York - UK	Newbronner, E (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	liz.newbronner@york.ac.uk		Wadman, Ruth/0000-0003-4205-0631; Newbronner, Elizabeth/0000-0003-2366-9981	UK Thalidomide Trust	UK Thalidomide Trust	The survey was funded by the UK Thalidomide Trust who also gave permission for the data to be used in an independent (self-funded) doctoral study. The Thalidomide Trust did assist in the study design and data collection stages, as as the involvement of Thalidomide survivors was important for the acceptability of the study. However, the Trust had no role in analysis, decision to publish or preparation of the manuscript.; We would like to thank the UK Thalidomide Trust and its beneficiaries for all their support and assistance with this study.	[Anonymous], 2011, WORLD REP DIS; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Berghs Maria, 2016, PUBLIC HLTH RES, V4; Department for Work and Pensions, 2015, EMPL STAT WORK AG 50; Ekfeldt A, 2008, ACTA ODONTOL SCAND, V66, P300, DOI 10.1080/00016350802307638; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; Ferber Sarah, 2013, BIOETHICS HIST PERSP, P7; Grassman EJ, 2013, AGEING LIFECOURSE, P1, DOI 10.1332/policypress/9781447305224.001.0001; Hoy D, ANN RHEUMATIC DIS; Jahani SAG, 2016, J CHILD ORTHOP, V10, P691, DOI 10.1007/s11832-016-0797-6; Jahani SAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155493; Jenkinson C, 1993, QUALITY LIFE MEASURE; Jensen MP, 2013, SPINAL CORD, V51, P882, DOI 10.1038/sc.2013.112; Kayamori R., 2013, JPN J REHABILIT MED, V50, P957; Kemp BJ, 2004, AGEING DISABILITY; Klingbeil H, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2004.03.014; Kruse A., 2013, REGULAR SURVEYS PROB; LaPlante MP, 2014, DISABIL HEALTH J, V7, pS44, DOI 10.1016/j.dhjo.2013.08.005; Meltzer H, 2012, DISABIL HEALTH J, V5, P102, DOI 10.1016/j.dhjo.2012.02.001; Mental Health Foundation, 2007, FUND FACTS; Molton IR, 2017, J GERONTOL B-PSYCHOL, V72, P290, DOI 10.1093/geronb/gbw122; Naidoo V, 2012, INT J INTEGR CARE, V12; Newbronner E, 2015, HLTH QUALITY LIFE EM; Newbronner E, 2018, DISABIL HEALTH J, V11, P184, DOI 10.1016/j.dhjo.2017.09.004; Office for National Statistics, 2013, HOM OWN RENT ENGL WA; Office for National Statistics, 2007, GEN HOUS SURV; Office for National Statistics, 2011, HIGH LEV QUAL ENGL W; Office for National Statistics Office for National Statistics, 2012, LAB FORC SURV; Office of National Statistics, 2014, LIV AL ENGL WASL; Papworth Trust, 2014, DIS UK 2014 FACTS FI; Peters K.M., 2015, NRW CTR HLTH; Power A, 2019, SOC SCI MED, V231, P55, DOI 10.1016/j.socscimed.2018.03.028; Priestley M., 2001, DISABILITY AND THE L; Scott C., 2015, SUNDAY TIMES; Shiga T, 2015, BIRTH DEFECTS RES A, V103, P787, DOI 10.1002/bdra.23363; SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716; Stephens T, 2001, DARK REMEDY; Turner RJ, 2006, REHABIL PSYCHOL, V51, P214, DOI 10.1037/0090-5550.51.3.214; Uppal S, 2006, SOC SCI MED, V63, P525, DOI 10.1016/j.socscimed.2006.01.016; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Verbrugge L.M., 2002, J DISABIL POLICY STU, V12, P253, DOI [10.1177/104420730201200405, DOI 10.1177/104420730201200405]; Vermette N, 2013, STUDY CURRENT LIVING	42	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210222	10.1371/journal.pone.0210222	http://dx.doi.org/10.1371/journal.pone.0210222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650111	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000455813300046
J	Ollinger, J; Kumar, A; Roberts, DM; Bailey, MA; Casey, A; Parish, T				Ollinger, Juliane; Kumar, Anuradha; Roberts, David M.; Bailey, Mai A.; Casey, Allen; Parish, Tanya			A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis	PLOS ONE			English	Article							MOTILIN AGONIST; SMALL-MOLECULE; IDENTIFICATION; ASSAY; PHENOXYALKYLBENZIMIDAZOLES; HOMEOSTASIS; DISCOVERY; GSK962040	Tuberculosis is a disease of global importance for which novel drugs are urgently required. We developed a whole-cell phenotypic screen which can be used to identify inhibitors of Mycobacterium tuberculosis growth. We used recombinant strains of virulent M. tuberculosis which express far-red fluorescent reporters and used fluorescence to monitor growth in vitro. We optimized our high throughput assays using both 96-well and 384-well plates; both formats gave assays which met stringent reproducibility and robustness tests. We screened a compound set of 1105 chemically diverse compounds previously shown to be active against M. tuberculosis and identified primary hits which showed >= 90% growth inhibition. We ranked hits and identified three chemical classes of interest-the phenoxyalkylbenzamidazoles, the benzothiophene 1-1 dioxides, and the piperidinamines. These new compound classes may serve as starting points for the development of new series of inhibitors that prevent the growth of M. tuberculosis. This assay can be used for further screening, or could easily be adapted to other strains of M. tuberculosis.	[Ollinger, Juliane; Kumar, Anuradha; Roberts, David M.; Bailey, Mai A.; Casey, Allen; Parish, Tanya] Infect Dis Res Inst, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, Seattle, WA 98102 USA.	Tanya.Parish@idri.org	Parish, Tanya/A-8912-2014	Parish, Tanya/0000-0001-7507-0423	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	The work at IDRI was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by Eli Lilly and Company in support of the mission of the Lilly TB Drug Discovery Initiative. There was no additional external funding received for this study.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Anthony KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020374; Bhat J, 2006, J BIOMOL SCREEN, V11, P968, DOI 10.1177/1087057106291978; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Carroll P, 2018, BIORXIV, DOI [10.1101/383836, DOI 10.1101/383836]; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chandrasekera NS, 2017, ACS INFECT DIS, V3, P898, DOI 10.1021/acsinfecdis.7b00112; Chandrasekera NS, 2015, J MED CHEM, V58, P7273, DOI 10.1021/acs.jmedchem.5b00546; Chandrasekera NS, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0024-x; Chandrasekera NS, 2014, PEERJ, V2, DOI 10.7717/peerj.612; Chapman MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1420-4; Cheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096348; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Christophe T, 2010, FUTURE MED CHEM, V2, P1283, DOI 10.4155/FMC.10.223; CHUNG GAC, 1995, ANTIMICROB AGENTS CH, V39, P2235, DOI 10.1128/AAC.39.10.2235; Darby CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068942; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Geist JG, 2010, CHEMMEDCHEM, V5, P1092, DOI 10.1002/cmdc.201000083; Gholap S, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700294; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Goldman RC, 2009, TUBERCULOSIS, V89, P331, DOI 10.1016/j.tube.2009.07.007; Gong YL, 2014, EUR J MED CHEM, V75, P336, DOI 10.1016/j.ejmech.2014.01.039; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; He Y, 2003, BIOORG MED CHEM LETT, V13, P3253, DOI 10.1016/S0960-894X(03)00661-9; Hellstrom PM, 2016, BRIT J PHARMACOL, V173, P1768, DOI 10.1111/bph.13475; Humnabadkar V, 2011, J BIOMOL SCREEN, V16, P303, DOI 10.1177/1087057110394845; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Iversen PW, 2012, ASSAY GUIDANCE MANUA, P1; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072786; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Mann S, 2013, ANAL BIOCHEM, V432, P90, DOI 10.1016/j.ab.2012.09.038; Maria JPS, 2017, ACS CHEM BIOL, V12, P2448, DOI 10.1021/acschembio.7b00468; Ojima I, 2014, BIOORGAN MED CHEM, V22, P5060, DOI 10.1016/j.bmc.2014.02.036; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Ozkay Y, 2010, EUR J MED CHEM, V45, P3293, DOI 10.1016/j.ejmech.2010.04.012; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Sha SS, 2012, J BIOMOL SCREEN, V17, P252, DOI 10.1177/1087057111421373; Simithy J, 2014, TUBERCULOSIS, V94, P152, DOI 10.1016/j.tube.2013.12.004; Singh U, 2006, J BIOMOL SCREEN, V11, P1035, DOI 10.1177/1087057106292798; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Westaway SM, 2009, J MED CHEM, V52, P1180, DOI 10.1021/jm801332q; White EL, 2007, J BIOMOL SCREEN, V12, P100, DOI 10.1177/1087057106296484; WHO, 2017, GLOB TUB REP 2017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao N, 2015, ACS CHEM BIOL, V10, P364, DOI 10.1021/cb500746z	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0205479	10.1371/journal.pone.0205479	http://dx.doi.org/10.1371/journal.pone.0205479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650074	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300003
J	Wado, YD; Gurmu, E; Tilahun, T; Bangha, M				Wado, Yohannes Dibaba; Gurmu, Eshetu; Tilahun, Tizta; Bangha, Martin			Contextual influences on the choice of long-acting reversible and permanent contraception in Ethiopia: A multilevel analysis	PLOS ONE			English	Article							BARRIERS; TRENDS; WOMEN	Background Long acting reversible and permanent contraception (LARPs) offer promising opportunities for addressing the high and growing unmet need for modern contraception and helps to reduce unintended pregnancies and abortion rates in sub-Saharan Africa (SSA). This study examines the contextual factors that influence the use of long acting reversible and permanent contraception among married and fecund women in Ethiopia. Method We use data from the 2016 Ethiopian Demographic and Health Survey to examine the contextual factors that influence choice of long acting reversible and permanent contraception among married, non-pregnant and fecund women. The DHS collects detailed information on individual and household characteristics, contraception, and related reproductive behaviors from women of reproductive age. In addition, we created cluster level variables by aggregating individual level data to the cluster level. Analysis was done using a two-level multilevel logistic regression with data from 6994 married (weighted = 7352) women residing in 642 clusters (communities). Results In 2016, 12% of married, non-pregnant and 'fecund' women were using long-acting reversible and permanent methods of contraception in Ethiopia. A higher proportion of women with secondary and above education (17.6%), urban residents (19.7%), in the richest wealth quintile (18.3%) and in paid employment (18.3%) were using LARP methods compared to their counterparts. Regression analysis showed that community level variables such as women's empowerment, access to family planning information and services, region of residence and knowledge of methods were significantly associated with use of LARP methods. Age, wealth status, employment status and women's fertility preferences were among the individual and household level variables associated with choice of LARP methods. With regards to age, the odds of using LARP methods was significantly lower among adolescents OR, 0.53; 95% CI, 0.32-0.85) and women over the age of 40 ( OR, 0.63; 95% CI, 0.44-0.90) compared to women in their 20's. Conclusion The findings of this study indicate that the demand for long-acting reversible and permanent contraception is influenced not only by women's individual and household characteristics but also by the community's level of women's empowerment, socio-economic development, as well as access and exposure to family planning information and services. Thus, improving knowledge of long-acting reversible and permanent methods, improving women's decision making autonomy and upgrading the capacity and skills of health workers particularly the midlevel providers and community health extension workers on the provision of LARP methods and rights-based approach is important to improve the uptake of LARP methods.	[Wado, Yohannes Dibaba; Tilahun, Tizta; Bangha, Martin] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Gurmu, Eshetu] Addis Ababa Univ, Ctr Populat Studies, Addis Ababa, Ethiopia; [Gurmu, Eshetu] Addis Ababa Univ, Inst Dev & Policy Res, Addis Ababa, Ethiopia	African Population & Health Research Centre; Addis Ababa University; Addis Ababa University	Wado, YD (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	ywado@aphrc.org		Wado, Yohannes Dibaba/0000-0002-7200-6116; Bangha, Martin/0000-0002-2201-8004				Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Anguzu Ronald, 2014, BMC Res Notes, V7, P153, DOI 10.1186/1756-0500-7-153; [Anonymous], 2017, WORLD FAM PLANN; [Anonymous], 2017, WORLD POP DAT SHEET; [Anonymous], 2001, ETH DEM HLTH SURV 20; [Anonymous], 2018, IMPL GUID PROV COMPR; [Anonymous], 2017, WOMEN HLTH, P1; Asare O, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0286-5; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Etana D, E AFRICAN SOCIAL SCI, V34; Ethiopia CSA (CSA) [Ethiopia], 2017, ETH DEM HLTH SURV 20; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Hardee K, 2014, STUD FAMILY PLANN, V45, P1, DOI 10.1111/j.1728-4465.2014.00373.x; Health Mo, 2016, NAT REPR HLTH STRAT; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Joshi R, 2015, INT J GYNECOL OBSTET, V131, pS60, DOI 10.1016/j.ijgo.2015.04.024; Kaggwa EB, 2008, INT FAM PLAN PERSPEC, V34, P79, DOI 10.1363/ifpp.34.079.08; Kumar N, 2016, J ADOLESCENT HEALTH, V59, P248, DOI 10.1016/j.jadohealth.2016.03.039; Magadi MA, 2003, STUD FAMILY PLANN, V34, P149, DOI 10.1111/j.1728-4465.2003.00149.x; Mangham-Jefferies L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-61; Mekonnen G, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.98.3421; Minister OotP, 1993, NAT POP POL ETH; MOH, 2016, COST IMPL PLAN FAM P; MOH, 2015, ETH HLTH SECT TRANST; Newman Karen., 2015, FAMILY PLANNING HUMA; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Puntscher S., 2017, WORKING PAPERS 2017; Robinson N, 2016, HEALTH CARE WOMEN IN, V37, P197, DOI 10.1080/07399332.2014.946511; Ross J, 2002, INT FAM PLAN PERSPEC, V28, P32, DOI 10.2307/3088273; Sedgh G., 2016, UNMET NEED CONTRACEP; Snijders T, 2014, MULTILEVEL ANAL INTR; Staveteig S., 2015, DHS ANAL STUDIES; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Taye A, 2015, J WOMENS HLTH CARE, V4, P217; USAID, 2012, 3 SUCC SUBS AFR FAM; Vasa P, 2013, 2013 CONFERENCE ON LASERS AND ELECTRO-OPTICS EUROPE AND INTERNATIONAL QUANTUM ELECTRONICS CONFERENCE (CLEO EUROPE/IQEC)	41	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209602	10.1371/journal.pone.0209602	http://dx.doi.org/10.1371/journal.pone.0209602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650085	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300019
J	Park, J; Yang, Y; Kim, J				Park, Jaeyoung; Yang, Yusik; Kim, Jaekwon			Unequal error protection technique for video streaming over MIMO-OFDM systems	PLOS ONE			English	Article							HIERARCHICAL QAM; H.264/AVC VIDEO; TRANSMISSION; SCHEME; ALLOCATION	In this paper, a novel unequal error protection (UEP) technique is proposed for video streaming over multiple-input multiple-output orthogonal frequency-division multiplexing (MIMO-OFDM) systems. Based on the concept of hierarchical quadrature amplitude modulation (HQAM) UEP and multi-antenna UEP, the proposed technique combines the relative protection levels (PLs) of constellation symbols and the differentiated PLs of the transmit antennas. In the proposed technique, standard square quadrature amplitude modulation (QAM) constellations are used instead of HQAM so that the QAM mapper at the transmitter side and the soft decision calculation at the receiver side remain unchanged, but the UEP benefit of HQAM is retained. The superior performance of the proposed technique is explained by the improved connections between data with various priorities and data paths with various PLs. The assumed video compression method is H.264/AVC, which is known to be commercially successful. The IEEE802.16m system is adopted as a data transmission system. With the aid of realistic simulations in strict accordance with the standards of IEEE802.16m systems and H.264/AVC video compression systems, the proposed technique HQAM-multi-antenna UEP is shown to improve the video quality significantly for a given average bit error rate when compared with previous techniques.	[Park, Jaeyoung; Yang, Yusik; Kim, Jaekwon] Yonsei Univ, Div Comp & Telecommun Engn, Wonju, Gangwon Do, South Korea	Yonsei University	Kim, J (corresponding author), Yonsei Univ, Div Comp & Telecommun Engn, Wonju, Gangwon Do, South Korea.	jaekwon@yonsei.ac.kr			National Research Foundation of Korea - Ministry of Education through the Global [NRF-2013H1A2A1032531]; BK21PLUS Program	National Research Foundation of Korea - Ministry of Education through the Global; BK21PLUS Program	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education through the Global Ph.D. Fellowship Program under Grant NRF-2013H1A2A1032531 and through the BK21PLUS Program (URL: https://www.nrf.re.kr/index) (JP). There was no additional external funding received for this study.	3rd Generation Partnership Project, 2021, 36101 3GPP TS; Abot J, 2012, SIGNAL PROCESS-IMAGE, V27, P1066, DOI 10.1016/j.image.2012.08.003; [Anonymous], 80216D6 IEEE; Bahng S, 2008, IEICE T COMMUN, VE91B, P3383, DOI 10.1093/ietcom/e91-b.10.3383; Barmada B, 2006, SIGNAL PROCESS-IMAGE, V21, P390, DOI 10.1016/j.image.2006.01.001; Chang YC, 2009, IEEE T CONSUM ELECTR, V55, P1089, DOI 10.1109/TCE.2009.5277961; Ha H, 2008, IEEE T CONSUM ELECTR, V54, P736, DOI 10.1109/TCE.2008.4560155; Hammerschmidt JS, 2006, IEEE T SIGNAL PROCES, V54, P3555, DOI 10.1109/TSP.2006.879333; Jubran MK, 2009, IEEE T IMAGE PROCESS, V18, P106, DOI 10.1109/TIP.2008.2006600; Li P, 2010, IEEE T CONSUM ELECTR, V56, P2741, DOI 10.1109/TCE.2010.5681164; Marx F, 2004, SIGNAL PROCESS-IMAGE, V19, P313, DOI 10.1016/j.image.2003.11.002; Naguib AF, 2000, IEEE SIGNAL PROC MAG, V17, P76, DOI 10.1109/79.841731; Nightingale J, 2010, IEEE T CONSUM ELECTR, V56, P2161, DOI 10.1109/TCE.2010.5681086; Park J, 2014, I SYMP CONSUM ELECTR, P205; Pyun JY, 2011, IEEE T CONSUM ELECTR, V57, P68, DOI 10.1109/TCE.2011.5735483; Song D, 2007, IEEE T CIRC SYST VID, V17, P1218, DOI 10.1109/TCSVT.2007.905531; Stockhammer T, 2003, IEEE T CIRC SYST VID, V13, P657, DOI 10.1109/TCSVT.2003.815167; Tham ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148625; Xu W, 2003, SIGNAL PROCESS-IMAGE, V18, P981, DOI 10.1016/j.image.2003.08.013; Yap CW, 1999, SIGNAL PROCESS-IMAGE, V14, P559, DOI 10.1016/S0923-5965(98)00058-7; Yun J, 2013, IEEE T CONSUM ELECTR, V59, P175, DOI 10.1109/TCE.2013.6490257; Yun J, 2012, IEEE T CONSUM ELECTR, V58, P746, DOI 10.1109/TCE.2012.6311313	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210112	10.1371/journal.pone.0210112	http://dx.doi.org/10.1371/journal.pone.0210112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645602	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200018
J	Rooney, NJ; Guest, CM; Swanson, LCM; Morant, SV				Rooney, Nicola J.; Guest, Claire M.; Swanson, Lydia C. M.; Morant, Steve V.			How effective are trained dogs at alerting their owners to changes in blood glycaemic levels?: Variations in performance of glycaemia alert dogs	PLOS ONE			English	Article							SPECIALIST SEARCH DOGS; QUESTIONNAIRE SURVEY; HYPOGLYCEMIA; EXTINCTION; ATTRIBUTES; BEHAVIOR	Aims Domestic dogs are trained to a wide variety of roles including an increasing number of medical assistance tasks. Glycaemia alert dogs are reported to greatly improve the quality of life of owners living with Type 1 diabetes. Research into their value is currently sparse, on small numbers of dogs and provides conflicting results. In this study we assess the reliability of a large number of trained glycaemic alert dogs at responding to hypo- and hyper-glycaemic (referred to as out-of-range, OOR) episodes, and explore factors associated with variations in their performance. Methods Routine owner records were used to assess the sensitivity and specificity of each of 27 dogs, trained by a single UK charity during almost 4000 out-of-range episodes. Sensitivity and positive predictive values are compared to demographic factors and instructors' ratings of the dog, owner and partnership. Results Dogs varied in their performance, with median sensitivity to out-of-range episodes at 70% (25th percentile = 50, 75th percentile = 95). To hypoglycaemic episodes the median sensitivity was 83% (66-94%) while to hyperglyaemic episodes it was 67% (17-91%). The median positive predictive value (PPV) was 81% (68-94%), i.e. on average 81% of alerts occurred when glucose levels were out of target range. For four dogs, PPV was 100%. Individual characteristics of the dog, the partnership and the household were significantly associated with performance (e.g., whether the dog was previously a pet, when it was trained, whether its partner was an adult or child). Conclusions The large sample shows that the individual performance of dogs is variable, but overall their sensitivity and specificity to OOR episodes are better than previous studies suggest. Results show that optimal performance of glycaemic alert dogs depends not only on good initial and ongoing training, but also careful selection of dogs for the conditions in which they will be working.	[Rooney, Nicola J.] Univ Bristol, Bristol Vet Sch, Anim Welf & Behav Grp, Bristol, Avon, England; [Rooney, Nicola J.; Guest, Claire M.; Swanson, Lydia C. M.] Med Detect Dogs, Greenway Business Pk, Milton Keynes, Bucks, England; [Morant, Steve V.] Univ Dundee, Medicines Monitoring Unit, Dundee, Scotland	University of Bristol; University of Dundee	Rooney, NJ (corresponding author), Univ Bristol, Bristol Vet Sch, Anim Welf & Behav Grp, Bristol, Avon, England.; Rooney, NJ (corresponding author), Med Detect Dogs, Greenway Business Pk, Milton Keynes, Bucks, England.	Nicola.Rooney@bristol.ac.uk	Rooney, Nicola/AAE-8131-2022	Guest BSc (Hons) MSc HonDSc. DHP BCAh FRSA, Claire/0000-0002-1169-9246; rooney, nicola/0000-0001-9629-1700; Morant, Steven/0000-0001-5674-3784				Barnard S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25224-y; Bentosela M, 2008, BEHAV PROCESS, V78, P464, DOI 10.1016/j.beproc.2008.03.004; Bilous R, 2010, HANDBOOK OF DIABETES, P96; Dehlinger K, 2013, DIABETES CARE, V36, pE98, DOI 10.2337/dc12-2342; Facchinetti A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122093; Gonder-Frederick L, 2013, DIABETES CARE, V36, pE47, DOI 10.2337/dc12-1998; Hardin DS, 2015, DIABETES THER, V6, P509, DOI 10.1007/s13300-015-0135-x; Hardin DS, 2012, DIABETES, V61, pA99; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Kaufmann P, WIENER KLIN WOCHENSC, V106, P119; Los Evan A, 2017, J Diabetes Sci Technol, V11, P506, DOI 10.1177/1932296816666537; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Petry NM, 2015, DIABETES RES CLIN PR, V109, P389, DOI 10.1016/j.diabres.2015.05.023; Rooney N., 2016, INTERNATIONAL ANIMAL, V3; Rooney NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069921; Rooney NJ, 2004, APPL ANIM BEHAV SCI, V86, P123, DOI 10.1016/j.applanim.2003.12.007; Rooney NJ, 2004, J FORENSIC SCI, V49, P300; Shepard J, 2014, DIABETES CONFERENCE; Tenzer-Iglesias T, 2012, J OF FAM PRACTICE SU, V61, pS1; Thrailkill EA, 2016, BEHAV PROCESS, V129, P44, DOI 10.1016/j.beproc.2016.05.009; Weber KS, 2016, DIABETIC MED, V33, P934, DOI 10.1111/dme.12975; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288; Weston PJ, 1999, THE DEAD IN BED SYND, V16, P6626	23	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210092	10.1371/journal.pone.0210092	http://dx.doi.org/10.1371/journal.pone.0210092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645613	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200017
J	Kokesova, A; Coufal, S; Frybova, B; Kverka, M; Rygl, M				Kokesova, Alena; Coufal, Stepan; Frybova, Barbora; Kverka, Miloslav; Rygl, Michal			The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis	PLOS ONE			English	Article							POSTNATAL COURSE; I-FABP; ISCHEMIA; DISEASE	Background/Purpose We analyzed the capacity of urinary Intestinal fatty acid-binding protein (I-FABP) to quantify the degree of mucosal injury in neonates with gastroschisis (GS) and to predict the speed of their clinical recovery after surgery. Methods In this prospective study, we collected urine during the first 48h after surgery from neonates operated between 2012 and 2015 for GS. Neonates with surgery that did not include gut mucosa served as controls for simple GS and neonates with surgery for intestinal atresia served as control for complex GS patients. The I-FABP levels were analyzed by ELISA. Results Urinary I-FABP after the surgery is significantly higher in GS newborns than in control group; I-FABP in complex GS is higher than in simple GS. I-FABP can predict subsequent operation for ileus in patients with complex GS. Both ways of abdominal wall closure (i.e. primary closure and stepwise reconstruction) led to similar levels of I-FABP. None of the static I-FABP values was useful for the outcome prediction. The steep decrease in I-FABP after the surgery is associated with faster recovery, but it cannot predict early start of minimal enteral feeding, full enteral feeding or length of hospitalization. Conclusion Urinary I-FABP reflects the mucosal damage in gastroschisis but it has only a limited predictive value for patients' outcome.	[Kokesova, Alena; Frybova, Barbora; Rygl, Michal] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic; [Kokesova, Alena; Coufal, Stepan; Kverka, Miloslav] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic; [Kverka, Miloslav] Czech Acad Sci, Inst Expt Med, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Kokesova, A (corresponding author), Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic.; Kokesova, A (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	alenakokes@yahoo.com	Coufal, Stepan/S-6152-2017; Frybova, Barbora/AAW-2792-2020; Kverka, Miloslav/H-2507-2014	Coufal, Stepan/0000-0001-6950-1813; Kverka, Miloslav/0000-0002-1335-5252	Charles University Grant Agency [159115, 326815]; Ministry of Health of the Czech Republic [15-28064A]; Institutional Research Concept (Inst. Microbiol. Academy of Sciences) [RVO: 61388971]	Charles University Grant Agency; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Institutional Research Concept (Inst. Microbiol. Academy of Sciences)	This project was supported by The Charles University Grant Agency: Grant No. 159115 (BF), and Grant No. 326815 (SC), Ministry of Health of the Czech Republic: Grant No 15-28064A (MK) and by Institutional Research Concept RVO: 61388971 (Inst. Microbiol. Academy of Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaanse MPM, 2013, ALIMENT PHARM THER, V37, P482, DOI 10.1111/apt.12194; Aina-Mumuney AJ, 2004, AM J OBSTET GYNECOL, V190, P1326, DOI 10.1016/j.ajog.2003.11.003; Bingold TM, 2015, SURG INFECT, V16, P247, DOI 10.1089/sur.2014.073; Caglar M, 2014, J PEDIATR SURG, V49, P1577, DOI 10.1016/j.jpedsurg.2014.06.019; Christison-Lagay ER, 2011, SEMIN FETAL NEONAT M, V16, P164, DOI 10.1016/j.siny.2011.02.003; Coufal S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5727312; Derikx JPM, 2007, GUT, V56, P1473, DOI 10.1136/gut.2007.128934; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; Frybova B, 2015, PEDIATR SURG INT, V31, P381, DOI 10.1007/s00383-015-3675-2; GOLLIN G, 1993, J PEDIATR SURG, V28, P367, DOI 10.1016/0022-3468(93)90233-B; Gollin G, 1993, J PEDIATR SURG, V28, P70; Grootjans J, 2016, WORLD J GASTROENTERO, V22, P2760, DOI 10.3748/wjg.v22.i9.2760; Huh NG, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.888; Janoo Jabin, 2013, W V Med J, V109, P22; Jones AM, 2016, MMWR-MORBID MORTAL W, V65, P23, DOI 10.15585/mmwr.mm6502a2; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Kuleva M, 2012, BJOG-INT J OBSTET GY, V119, P102, DOI 10.1111/j.1471-0528.2011.03183.x; Kunz SN, 2013, J PEDIATR SURG, V48, P845, DOI 10.1016/j.jpedsurg.2013.01.020; LANGER JC, 1989, J PEDIATR SURG, V24, P992, DOI 10.1016/S0022-3468(89)80200-3; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Molik KA, 2001, J PEDIATR SURG, V36, P51, DOI 10.1053/jpsu.2001.20004; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Olesevich M, 2005, J PEDIATR SURG, V40, P789, DOI 10.1016/j.jpedsurg.2005.01.043; Sarikaya M, 2015, CLIN LAB, V61, P87, DOI 10.7754/Clin.Lab.2014.140518; Skarsgard ED, 2016, CURR OPIN PEDIATR, V28, P363, DOI 10.1097/MOP.0000000000000336; Stuber TN, 2016, ARCH GYNECOL OBSTET, V293, P1001, DOI 10.1007/s00404-015-3936-2; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210797	10.1371/journal.pone.0210797	http://dx.doi.org/10.1371/journal.pone.0210797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640955	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000049
J	Maurer, M; Bogner, FX				Maurer, Michaela; Bogner, Franz Xaver			How freshmen perceive Environmental Education (EE) and Education for Sustainable Development (ESD)	PLOS ONE			English	Article							STUDENTS CONCEPTIONS; KNOWLEDGE; SCIENCE; ATTITUDES; CLASSIFICATION; BEHAVIOR; GROWTH; WATER; AGE	Concepts of 464 university freshmen towards Environmental Education (EE) and Education for Sustainable Development (ESD) were analyzed. Responses were classified into seven main categories: 'ecological aspects', 'ecological problems', 'economical aspects', 'social aspects', 'environmental attitudes', 'environmental behavior' and 'education'. Analyses of sustainability concepts show a large discrepancy between EE and ESD, whereby the latter includes an additional sub-group: 'the next generation aspect'. Labeling individual sources of EE in a retrospective assessment identified the family as the most important source of knowledge, followed by media, school and outreach. Further differences were detected between students' self-perception and their ideal conception of environmental behavior, by using the scale Inclusion of Nature in Self (INS). Only some EE statements produced higher (unfulfilled) expectations 'economic aspects', 'environmental behavior' and 'ecological problems'. In contrast fewer (unfulfilled) expectations were observed in the categories of 'education' and 'ecological aspects'.	[Maurer, Michaela; Bogner, Franz Xaver] Univ Bayreuth, Dept Biol Educ, Ctr Math & Sci Educ, Bayreuth, Germany	University of Bayreuth	Maurer, M (corresponding author), Univ Bayreuth, Dept Biol Educ, Ctr Math & Sci Educ, Bayreuth, Germany.	Michaela.Maurer@uni-bayreuth.de		Maurer, Michala/0000-0002-1692-1758	Federal Ministry of Education and Research [01JA160]; European Union's Horizon 2020 [741572]; German Research Foundation (DFG); University of Bayreuth	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union's Horizon 2020; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	This project is a part of the "Qualitatsoffensive Lehrerbildung", a joint initiative of the Federal Government and the Lander which aims to improve the quality of teacher training. The programme is funded by the Federal Ministry of Education and Research (Grant: 01JA160, https://www.qualitaetsoffensive-lehrerbildung.de/to MM). This project is furthermore a part of the 'OSOS - Open School For Open Society' project, funded by the European Union's Horizon 2020 (grant agreement No. 741572, https://www.openschools.eu/to MM). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The authors are responsible for the content of this publication.	Andresen L, 1999, UNDERSTANDING ADULT, P225; [Anonymous], 1977, THEORY ED; Banerjee SB, 2003, ORGAN STUD, V24, P143, DOI 10.1177/0170840603024001341; Boeve-de Pauw J, 2015, SUSTAINABILITY-BASEL, V7, P15693, DOI 10.3390/su71115693; Brody M.J., 1991, J ENVIRON EDUC, V22, P24, DOI [10.1080/00958964.1991.9943051, DOI 10.1080/00958964.1991.9943051]; Carson Rachel, 1994, SILENT SPRING; Chi MT., 1994, LEARN INSTR, V4, P27, DOI [DOI 10.1016/0959-4752(94)90017-5, 10.1016/0959-4752(94)90017-5]; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crate S.M., 2007, ANTHR CLIMATE CHANGE; Czech B, 2008, CONSERV BIOL, V22, P1389, DOI 10.1111/j.1523-1739.2008.01089.x; de Kock A, 2004, REV EDUC RES, V74, P141, DOI 10.3102/00346543074002141; Doran RL, 1972, J RES SCI TEACH, V9, P127, DOI [DOI 10.1002/TEA.3660090204, 10.1002/tea.3660090204]; Downs CA, 2016, ARCH ENVIRON CON TOX, V70, P265, DOI 10.1007/s00244-015-0227-7; DRIVER R, 1989, INT J SCI EDUC, V11, P481, DOI 10.1080/0950069890110501; Driver R., 1978, STUDIES SCI ED, V5, P61, DOI [DOI 10.1080/03057267808559857, 10.1080/03057267808559857]; Eagles P. F. J., 1999, J ENVIRON EDUC, V30, P33, DOI DOI 10.1080/00958969909601882; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Floden RE, DETACHMENT CONCERN C; Franke G., 2013, ISRN ED, V2013, P741807, DOI [10.1155/2013/741807, DOI 10.1155/2013/741807]; Frantz CM, 2014, STUD EDUC EVAL, V41, P85, DOI 10.1016/j.stueduc.2013.10.001; Fremerey C, 2014, EDUC SCI, V4, P213, DOI 10.3390/educsci4040213; Frohlich G, 2013, STUD AGRIC ECON, V115, P61, DOI 10.7896/j.1301; Gadotti M., 2008, GREEN THEORY PRAXIS, V4, P50, DOI DOI 10.3903/gtp.2008.1.3; GEORGE J. L., 1966, Pesticides in the Antarctic., P155, DOI 10.2307/2401454; Gibson HL, 2002, SCI EDUC, V86, P693, DOI 10.1002/sce.10039; HALLOUN IA, 1985, AM J PHYS, V53, P1043, DOI 10.1119/1.14030; Hansen PJK, 2010, INT J SCI EDUC, V32, P397, DOI 10.1080/09500690802600787; IUCN, 1970, INT WORKING M ENV ED; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Kaiser F. G., 2008, UMWELTPSYCHOLOGIE, V12, P56, DOI DOI 10.5167/UZH-9249; Kaiser FG, 2007, J ENVIRON PSYCHOL, V27, P242, DOI 10.1016/j.jenvp.2007.06.004; Kilinc A, 2013, RES SCI EDUC, V43, P2277, DOI 10.1007/s11165-013-9355-0; KMK, 2003, RICHTL UMW BAYER SCH; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kopnina H, 2014, SUSTAIN DEV, V22, P73, DOI 10.1002/sd.529; Kopnina H, 2012, ENVIRON EDUC RES, V18, P699, DOI 10.1080/13504622.2012.658028; LEDERMAN NG, 1992, J RES SCI TEACH, V29, P331, DOI 10.1002/tea.3660290404; Lehtonen M, 2004, ECOL ECON, V49, P199, DOI 10.1016/j.ecolecon.2004.03.019; Lieflander AK, 2013, ENVIRON EDUC RES, V19, P370, DOI 10.1080/13504622.2012.697545; Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511; Manni A., 2013, INT ELECT J ENV ED, V3, P17, DOI [https://doi.org/10.18497/iejee-green.35921, DOI 10.18497/IEJEE-GREEN.35921]; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; McComas WF, 2002, AM BIOL TEACH, V64, P665, DOI 10.1662/0002-7685(2002)064[0665:TIESCI]2.0.CO;2; McCormick J, 2009, GLOBAL THREAT ACID P; McCormick J., 1991, RECLAIMING PARADISE, V660; McKeown R., 2002, ED SUSTAINABLE DEV T; Palmer JA, 1998, 21 CENTURY THEORY PR; Parson E.A., 2003, PROTECTING OZONE LAY; Pe'er S, 2007, J ENVIRON EDUC, V39, P45, DOI 10.3200/JOEE.39.1.45-59; Prince MJ, 2006, J ENG EDUC, V95, P123, DOI 10.1002/j.2168-9830.2006.tb00884.x; REES WE, 1995, ALTERN-P SOC TEC, V21, P24; Reilly S, 2008, INT RESOUR MANAG; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rosaleen J., 2012, OUTDOOR LEARNING PRE; Rost J., 2002, Z INT BILDUNGSFORSCH, V25, P7; Schmid S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200928; Schonfelder ML, 2017, INT J SCI EDUC, V39, P723, DOI 10.1080/09500693.2017.1304670; Schonfelder ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180168; Schultz, DEV T PSYCHOL SUSTAI, P61; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Sellmann D., 2012, CLIMATE CHANGE SUSTA, P779; Thorn CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147802; TROWBRIDGE JE, 1988, J RES SCI TEACH, V25, P547, DOI 10.1002/tea.3660250704; UN, 1992, RIO DECL ENV DEV PRE; UNESCO, 2005, UN DEC ED SUST DEV 2; UNESCO, 1972, STOCKH DECL; UNESCO, 2007, UN DEC ED SUST DEV D; UNESCO UNEP, 1978, TBIL DECL FIN INT C, P1; UNESCO-IEEP, 1985, UNESCO IEEP ENV ED S, P123; UNESCO-UNEP, 1976, CONNECT UNESCO UNEP, V1, P1; United Nations, 2017, SUSTAINABLE DEV GOAL; Ursava N, 2011, ED RES REV, V6, P592; Von Carlowitz H.C., 1732, SYLVICULTURA OECONOM; Walshe N, 2008, ENVIRON EDUC RES, V14, P537, DOI 10.1080/13504620802345958; Woolcock M, 2000, CONTRIBUTION HUMAN S	75	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208910	10.1371/journal.pone.0208910	http://dx.doi.org/10.1371/journal.pone.0208910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640908	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000009
J	Asigbaase, M; Sjogersten, S; Lomax, BH; Dawoe, E				Asigbaase, Michael; Sjogersten, Sofie; Lomax, Barry H.; Dawoe, Evans			Tree diversity and its ecological importance value in organic and conventional cocoa agroforests in Ghana	PLOS ONE			English	Article							SYSTEMS; AGRICULTURE; MANAGEMENT; LANDSCAPE; SERVICES; COVER; LAND	Cocoa agroforestry systems have the potential to conserve biodiversity and provide environmental or ecological benefits at various nested scales ranging from the plot to ecoregion. While integrating organic practices into cocoa agroforestry may further enhance these potentials, empirical and robust data to support this claim is lacking, and mechanisms for biodiversity conservation and the provision of environmental and ecological benefits are poorly understood. A field study was conducted in the Eastern Region of Ghana to evaluate the potential of organic cocoa agroforests to conserve native floristic diversity in comparison with conventional cocoa agroforests. Shade tree species richness, Shannon, Simpson's reciprocal and Margalef diversity indices were estimated from 84 organic and conventional cocoa agroforestry plots. Species importance value index, a measure of how dominant a species is in a given ecosystem, and conservation status were used to evaluate the conservation potential of shade trees on studied cocoa farms. Organic farms recorded higher mean shade tree species richness (5.10 +/- 0.38) compared to conventional farms (3.48 +/- 0.39). Similarly, mean Shannon diversity index, Simpson's reciprocal diversity index and Margalef diversity index were significantly higher on organic farms compared to conventional farms. According to the importance value index, fruit and native shade tree species were the most important on both organic and conventional farms for all the cocoa age groups but more so on organic farms. Organic farms maintained 14 native tree species facing a conservation issue compared to 10 on conventional cocoa farms. The results suggest that diversified organic cocoa farms can serve as reservoirs of native tree species, including those currently facing conservation concerns thereby providing support and contributing to the conservation of tree species in the landscape.	[Asigbaase, Michael; Sjogersten, Sofie; Lomax, Barry H.] Univ Nottingham, Sch Biosci, Dept Agr & Environm Sci, Nottingham, England; [Dawoe, Evans] Kwame Nkrumah Univ Sci & Technol, Fac Renewable Nat Resources, Dept Agroforestry, Kumasi, Ghana	University of Nottingham; Kwame Nkrumah University Science & Technology	Asigbaase, M (corresponding author), Univ Nottingham, Sch Biosci, Dept Agr & Environm Sci, Nottingham, England.	mbxma18@nottingham.ac.uk	Asigbaase, Michael/AAX-2322-2021; Lomax, Barry/P-5609-2019	Asigbaase, Michael/0000-0002-9162-1149; Lomax, Barry/0000-0003-0475-7839	Ghana Education Trust Fund (GET Fund)	Ghana Education Trust Fund (GET Fund)	The study was fully funded by Ghana Education Trust Fund (GET Fund, http://www.getfund.gov.gh/) as part of a doctoral program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Rajab Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149949; African Cocoa Initiative, 2012, ASS AGR INP DEL COC; Alemagi D., 2014, INT J AGR SUSTAIN, V183, P19; Altieri M.A., 2012, SUSTAINABLE AGR REV, DOI [10.1007/978-94-007-5449-2_1, DOI 10.1007/978-94-007-5449-2_1]; Anglaaere LCN, 2011, AGROFOREST SYST, V81, P249, DOI 10.1007/s10457-010-9366-z; Anim-Kwapong GJ, 2009, AGROFOREST SYST, V76, P533, DOI 10.1007/s10457-008-9196-4; Asare R, 2014, AGROFOREST SYST, V88, P1143, DOI 10.1007/s10457-014-9688-3; Asase A, 2010, AFR J ECOL, V48, P338, DOI 10.1111/j.1365-2028.2009.01112.x; Bandanaa J, 2014, AGR FOOD SECURITY, V5, P29, DOI [10.1186/s40066-016-0077-1, DOI 10.1186/S40066-016-0077-1]; Barrientos S., 2008, MAPPING SUSTAINABLE; Barrios E., 2015, P FAO INT S 18 19 SE; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; CHAO A, 1984, SCAND J STAT, V11, P265; Chauhan H.K., 2021, NARDOSTACHYS JATAMAN, V2021, pe.T50126627A50131395, DOI [10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.en., DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN]; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dawoe E, 2016, CARBON BAL MANAGE, V11, DOI 10.1186/s13021-016-0061-x; FAO, 1991, 66 FAO; FAO, 2011, ORG AGR CLIM CHANG M; Gbetoho AJ, 2017, BOIS FOR TROP, P43; Ghana Statistical Services, 2014, 2010 POP HOUS CENS D; Gockowski J, 2013, INT J AGR SUSTAIN, V11, P331, DOI 10.1080/14735903.2013.772714; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Haggar J., 2015, BIODIVERS CONSERV, DOI [10.1007/s10531-015-0859-y, DOI 10.1007/S10531-015-0859-Y]; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hawthorne WD, 1995, FOREST PROTECTION GH; Hooper E, 2005, J APPL ECOL, V42, P1165, DOI 10.1111/j.1365-2664.2005.01106.x; HUNTER JM, 1963, T I BRIT GEOGR, V33, P61; ICCO, 2014, WORLD COC EC CURR ST; Jacobi J, 2015, AGROECOL SUST FOOD, V39, P798, DOI 10.1080/21683565.2015.1039158; Jastrzebska Magdalena, 2013, Acta Agrobotanica, V66, P113, DOI 10.5586/aa.2013.045; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kremen C., 2015, REFRAMING LAND SPARI, V1355, P52; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mbolo MMA, 2016, AGROFOREST SYST, V90, P577, DOI 10.1007/s10457-016-9945-8; Niggli U., 2008, ORGANIC FARMING CLIM; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Philpott SM, 2007, CONSERV BIOL, V21, P975, DOI 10.1111/j.1523-1739.2007.00728.x; Richard A, 2016, NEW FOREST, V47, P287, DOI 10.1007/s11056-015-9515-3; Saj S, 2017, INT J AGR SUSTAIN, V15, P282, DOI 10.1080/14735903.2017.1311764; Scialabba NEH, 2010, RENEW AGR FOOD SYST, V25, P158, DOI 10.1017/S1742170510000116; Snowdon P, 2002, 31 AUSTR GREENH OFF, P66; Solomou AD, 2013, COMMUN SOIL SCI PLAN, V44, P312, DOI 10.1080/00103624.2013.741914; Tondoh JE, 2015, GLOB ECOL CONSERV, V3, P575, DOI 10.1016/j.gecco.2015.02.007; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Vaast P, 2014, AGROFOREST SYST, V88, P947, DOI 10.1007/s10457-014-9762-x; Vanhove W, 2016, AGR ECOSYST ENVIRON, V219, P14, DOI 10.1016/j.agee.2015.12.005; Wade ASI, 2010, AGR ECOSYST ENVIRON, V138, P324, DOI 10.1016/j.agee.2010.06.007; Wessel M, 2015, NJAS-WAGEN J LIFE SC, V74-75, P1, DOI 10.1016/j.njas.2015.09.001	48	25	26	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210557	10.1371/journal.pone.0210557	http://dx.doi.org/10.1371/journal.pone.0210557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633763	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100030
J	Barnaud, ML; Schwartz, JL; Bessiere, P; Diard, J				Barnaud, Marie-Lou; Schwartz, Jean-Luc; Bessiere, Pierre; Diard, Julien			Computer simulations of coupled idiosyncrasies in speech perception and speech production with COSMO, a perceptuo-motor Bayesian model of speech communication	PLOS ONE			English	Article							MOTOR SYSTEM; SELF-ORGANIZATION; VOICE; FAMILIAR; LANGUAGE; COMPENSATION; ACQUISITION; EMERGENCE; ROLES; AREAS	The existence of a functional relationship between speech perception and production systems is now widely accepted, but the exact nature and role of this relationship remains quite unclear. The existence of idiosyncrasies in production and in perception sheds interesting light on the nature of the link. Indeed, a number of studies explore inter-individual variability in auditory and motor prototypes within a given language, and provide evidence for a link between both sets. In this paper, we attempt to simulate one study on coupled idiosyncrasies in the perception and production of French oral vowels, within COSMO, a Bayesian computational model of speech communication. First, we show that if the learning process in COSMO includes a communicative mechanism between a Learning Agent and a Master Agent, vowel production does display idiosyncrasies. Second, we implement within COSMO three models for speech perception that are, respectively, auditory, motor and perceptuo-motor. We show that no idiosyncrasy in perception can be obtained in the auditory model, since it is optimally tuned to the learning environment, which does not include the motor variability of the Learning Agent. On the contrary, motor and perceptuo-motor models provide perception idiosyncrasies correlated with idiosyncrasies in production. We draw conclusions about the role and importance of motor processes in speech perception, and propose a perceptuo-motor model in which auditory processing would enable optimal processing of learned sounds and motor processing would be helpful in unlearned adverse conditions.	[Barnaud, Marie-Lou; Schwartz, Jean-Luc] Univ Grenoble Alpes, Gipsa Lab, Grenoble, France; [Barnaud, Marie-Lou; Schwartz, Jean-Luc] CNRS, Gipsa Lab, Grenoble, France; [Barnaud, Marie-Lou; Diard, Julien] Univ Grenoble Alpes, LPNC, Grenoble, France; [Barnaud, Marie-Lou; Diard, Julien] CNRS, LPNC, Grenoble, France; [Bessiere, Pierre] Sorbonne Univ, CNRS, ISIR, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Schwartz, JL (corresponding author), Univ Grenoble Alpes, Gipsa Lab, Grenoble, France.; Schwartz, JL (corresponding author), CNRS, Gipsa Lab, Grenoble, France.	Jean-Luc.Schwartz@gipsa-lab.grenoble-inp.fr		Diard, Julien/0000-0003-0673-477X; Bessiere, Pierre/0000-0002-8620-2505	European Research Council [339152]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a grant from the European Research Council (FP7/2007-2013 Grant Agreement no. 339152 to JLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly G, 1997, SPEECH COMMUN, V22, P251, DOI 10.1016/S0167-6393(97)00025-3; Barnaud  M.-L., 2017, BRAIN LANGUAGE; Barnaud ML, 2015, 5TH INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING AND ON EPIGENETIC ROBOTICS (ICDL-EPIROB), P248, DOI 10.1109/DEVLRN.2015.7346149; Barnaud ML, 2016, INTERSPEECH 2016; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BELLBERTI F, 1979, PHONETICA, V36, P373, DOI 10.1159/000259974; Bessiere P, 2013, BAYESIAN PROGRAMMING; Browman C., 1990, PAPERS LAB PHONOLOGY, P340, DOI [10.1017/CBO9780511627736.019, DOI 10.1017/CBO9780511627736.019]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Canevari C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00364; Castellini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024055; Cristia A, 2019, CHILD DEV, V90, P759, DOI 10.1111/cdev.12974; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; de Boer B, 2000, J PHONETICS, V28, P441, DOI 10.1006/jpho.2000.0125; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; FOWLER CA, 1986, J PHONETICS, V14, P3, DOI 10.1016/S0095-4470(19)30607-2; Fowler CA, 2016, SPEECH MOTOR CONTROL; FOX RA, 1982, PHONETICA, V39, P1, DOI 10.1159/000261647; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Goldstein L., 2003, PHONETICS PHONOLOGY, P159; Graux J, 2015, SOC COGN AFFECT NEUR, V10, P101, DOI 10.1093/scan/nsu031; Graux J, 2013, BRAIN TOPOGR, V26, P72, DOI 10.1007/s10548-012-0233-2; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Holt LL, 2008, CURR DIR PSYCHOL SCI, V17, P42, DOI 10.1111/j.1467-8721.2008.00545.x; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Kaplan JT, 2008, SOC COGN AFFECT NEUR, V3, P218, DOI 10.1093/scan/nsn014; Kerzel D, 2000, J EXP PSYCHOL HUMAN, V26, P634, DOI 10.1037//0096-1523.26.2.634; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Krakauer J., 2006, PLOS BIOL, V4, P1; Kroeger BJ, 2015, J PHONETICS, V53, P88, DOI 10.1016/j.wocn.2015.09.006; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lametti DR, 2014, J NEUROSCI, V34, P10339, DOI 10.1523/JNEUROSCI.0108-14.2014; Laurent R, 2017, PSYCHOL REV, V124, P572, DOI 10.1037/rev0000069; Laurent R, 2013, INTERSPEECH, P2796; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Loakes D., 2006, FORENSIC PHONETIC IN; MAEDA S, 1990, NATO ADV SCI I D-BEH, V55, P131; Massaro DW, 1987, CATEGORICAL PARTITIO; McGettigan C, 2017, OXFORD HDB PSYCHOLIN, DOI [10.1523/JNEUROSCI.0108-14.2014, DOI 10.1523/JNEUROSCI.0108-14.2014]; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Menard L, 2014, ACTA ACUST UNITED AC, V100, P676, DOI 10.3813/AAA.918747; Meunier C., 2007, DYSARTHRIES, P164; Mottonen R, 2012, APHASIOLOGY, V26, P1103, DOI 10.1080/02687038.2011.619515; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Moulin-Frier C, 2012, LANG COGNITIVE PROC, V27, P1240, DOI 10.1080/01690965.2011.645313; Moulin-Frier C, 2015, J PHONETICS, V53, P5, DOI 10.1016/j.wocn.2015.06.001; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nearey TM, 1997, J ACOUST SOC AM, V101, P3241, DOI 10.1121/1.418290; Newman R., 1997, J ACOUST SOC AM, V102, P3114, DOI [10.1121/1, DOI 10.1121/1]; Nolan F., 2013, FORENSIC LINGUIST, V3, P39, DOI [10.1558/ijsll.v3i1.39, DOI 10.1558/IJSLL.V3I1.39]; Oudeyer PY, 2005, CONNECT SCI, V17, P325, DOI 10.1080/09540090500217145; Oudeyer PY, 2001, LECT NOTES COMPUT SC, V2130, P1171; Patri JF, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005942; Patri JF, 2015, PROGR MOTOR CONTROL; Perkell J.S., 1986, INVARIANCE VARIABILI; Perkell JS, 2012, J NEUROLINGUIST, V25, P382, DOI 10.1016/j.jneuroling.2010.02.011; Perrier P., 2005, ZAS PAPERS LINGUISTI, V40, P109; Poeppel D, 2011, LANG COGNITIVE PROC, V26, P935, DOI 10.1080/01690965.2010.493301; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Rapin L, 2017, J ACOUST SOC AM, V141, P3582, DOI [10.1121/1.4987639, DOI 10.1121/1.4987639]; Rogers JC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00754; Roon KD, 2015, PSYCHON B REV, V22, P242, DOI 10.3758/s13423-014-0666-6; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Sato M, 2011, CORTEX, V47, P1001, DOI 10.1016/j.cortex.2011.03.009; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; SAVARIAUX C, 1995, J ACOUST SOC AM, V98, P2428, DOI 10.1121/1.413277; Scarbel L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00568; Schroeder M.R., 1979, FRONTIERS SPEECH COM, P217; Schwartz J.-L., 2002, PHONETICS PHONOLOGY, P244; Schwartz JL, 2012, J NEUROLINGUIST, V25, P336, DOI 10.1016/j.jneuroling.2009.12.004; Schwartz JL, 1997, J PHONETICS, V25, P255, DOI 10.1006/jpho.1997.0043; Schwartz JL, EXPT APPROACHES PHON, DOI [10.1016/j.jneuroling.2009.12.004, DOI 10.1016/J.JNEUROLING.2009.12.004]; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2017, BRAIN LANG, V164, P77, DOI 10.1016/j.bandl.2016.10.004; Steels L, 1998, ARTIF INTELL, V103, P133, DOI 10.1016/S0004-3702(98)00066-6; Stevens KN, 1967, MODELS PERCEPTION SP, P88; Treille A., 2017, PERCEVOIR AGIR NATUR; Tye-Murray N, 2014, J SPEECH LANG HEAR R, V57, P556, DOI 10.1044/2013_JSLHR-H-12-0273; Tye-Murray N, 2013, PSYCHON B REV, V20, P115, DOI 10.3758/s13423-012-0328-5; Weiping Cai, 2010, Proceedings of the 2010 International Conference on Electrical and Control Engineering (ICECE 2010), P1246, DOI 10.1109/iCECE.2010.310; Weirich M, 2013, J ACOUST SOC AM, V134, P3766, DOI 10.1121/1.4822480; Wilson SM, 2006, NEUROIMAGING STUDIES	93	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210302	10.1371/journal.pone.0210302	http://dx.doi.org/10.1371/journal.pone.0210302			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633745	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100016
J	Boutigny, AL; Gautier, A; Basler, R; Dauthieux, F; Leite, S; Valade, R; Aguayo, J; Ioos, R; Laval, V				Boutigny, Anne-Laure; Gautier, Angelique; Basler, Ryan; Dauthieux, Florian; Leite, Stephen; Valade, Romain; Aguayo, Jaime; Ioos, Renaud; Laval, Valerie			Metabarcoding targeting the EF1 alpha region to assess Fusarium diversity on cereals	PLOS ONE			English	Article							REAL-TIME PCR; GRAMINEARUM SPECIES COMPLEX; SMALL-GRAIN CEREALS; FUNGAL COMMUNITIES; HEAD BLIGHT; MICRODOCHIUM-NIVALE; EAR BLIGHT; SP-NOV; WHEAT; SEQUENCE	Fusarium head blight (FHB) is a major cereal disease caused by a complex of Fusarium species. These species vary in importance depending on climatic conditions, agronomic factors or host genotype. In addition, Fusarium species can release toxic secondary metabolites. These mycotoxins constitute a significant food safety concern as they have health implications in both humans and animals. The Fusarium species involved in FHB differ in their pathogenicity, ability to produce mycotoxins, and fungicide sensitivity. Accurate and exhaustive identification of Fusarium species in planta is therefore of great importance. In this study, using a new set of primers targeting the EF1 alpha gene, the diversity of Fusarium species on cereals was evaluated using Illumina high-throughput sequencing. The PCR amplification parameters and bioinformatic pipeline were optimized with mock and artificially infected grain communities and further tested on 65 field samples. Fusarium species were retrieved from mock communities and good reproducibility between different runs or PCR cycle numbers was be observed. The method enabled the detection of as few as one single Fusarium-infected grain in 10,000. Up to 17 different Fusarium species were detected in field samples of barley, durum and soft wheat harvested in France. This new set of primers enables the assessment of Fusarium diversity by high-throughput sequencing on cereal samples. It provides a more exhaustive picture of the Fusarium community than the currently used techniques based on isolation or species-specific PCR detection. This new experimental approach may be used to show changes in the composition of the Fusarium complex or to detect the emergence of new Fusarium species as far as the EF1 alpha sequence of these species show a sufficient amount of polymorphism in the portion of sequence analyzed. Information on the distribution and prevalence of the different Fusarium species in a given geographical area, and in response to various environmental factors, is of great interest for managing the disease and predicting mycotoxin contamination risks.	[Boutigny, Anne-Laure; Aguayo, Jaime; Ioos, Renaud] ANSES Lab Sante Vegetaux, Unite Mycol, Malzeville, France; [Gautier, Angelique; Basler, Ryan; Dauthieux, Florian; Leite, Stephen; Laval, Valerie] INRA, BIOGER CPP UMR1290, Thiverval Grignon, France; [Valade, Romain] ARVALIS Inst Vegetal, Thiverval Grignon, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Laval, V (corresponding author), INRA, BIOGER CPP UMR1290, Thiverval Grignon, France.	valerie.laval@inra.fr		Ioos, Renaud/0000-0001-9359-5098; Laval, Valerie/0000-0002-3667-3878; Boutigny, Anne-Laure/0000-0001-8999-2314; Aguayo, Jaime/0000-0002-7552-0655	AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012)	AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012)	This work was supported by AAP PSPE 2012 (Appel a proposition Pour et Sur le Plan Ecophytro de Juin 2012) www.onema.fr.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andrews S., 2010, FASTQC QUALITY CONTR; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Audenaert K, 2009, EUR J PLANT PATHOL, V125, P445, DOI 10.1007/s10658-009-9494-3; Bluhm BH, 2004, J FOOD PROTECT, V67, P536, DOI 10.4315/0362-028X-67.3.536; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; Boutigny AL, 2014, EUR J PLANT PATHOL, V138, P133, DOI 10.1007/s10658-013-0312-6; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chandelier A, 2011, EUR J PLANT PATHOL, V130, P403, DOI 10.1007/s10658-011-9762-x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crous PW, 2004, STUD MYCOL, P19; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doohan FM, 1998, PLANT PATHOL, V47, P197, DOI 10.1046/j.1365-3059.1998.00218.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbelt S, BIORIX, DOI [10.1101/272534, DOI 10.1101/272534]; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Hietaniemi V, 2016, FOOD ADDIT CONTAM A, V33, P831, DOI 10.1080/19440049.2016.1162112; Ioos R, 2005, CROP PROT, V24, P894, DOI 10.1016/j.cropro.2005.01.014; Ioos R, 2004, MYCOPATHOLOGIA, V158, P351, DOI 10.1007/s11046-004-2228-3; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Karlsson I, 2016, APPL ENVIRON MICROB, V82, P491, DOI 10.1128/AEM.02748-15; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LeBlanc N, 2015, MICROB ECOL, V70, P188, DOI 10.1007/s00248-014-0531-1; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nicolaisen M, 2009, J MICROBIOL METH, V76, P234, DOI 10.1016/j.mimet.2008.10.016; Nielsen LK, 2011, PHYTOPATHOLOGY, V101, P960, DOI 10.1094/PHYTO-07-10-0188; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sapkota R, 2015, NEW PHYTOL, V207, P1134, DOI 10.1111/nph.13418; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Torp M, 2004, INT J FOOD MICROBIOL, V95, P247, DOI 10.1016/j.ijfoodmicro.2003.12.014; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Waalwijk C, 2003, EUR J PLANT PATHOL, V109, P743, DOI 10.1023/A:1026086510156; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu XM, 2008, PHYTOPATHOLOGY, V98, P69, DOI 10.1094/PHYTO-98-1-0069; Xu XM, 2005, EUR J PLANT PATHOL, V112, P143, DOI 10.1007/s10658-005-2446-7; Yli-Mattila T., 2008, Archives of Phytopathology and Plant Protection, V41, P243, DOI 10.1080/03235400600680659; Yli-Mattila T, 2011, INT J FOOD MICROBIOL, V147, P58, DOI 10.1016/j.ijfoodmicro.2011.03.007	50	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0207988	10.1371/journal.pone.0207988	http://dx.doi.org/10.1371/journal.pone.0207988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633747	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100002
J	Hsieh, WY; Chang, TH; Chang, HF; Chuang, WH; Lu, LC; Yang, CW; Lin, CS; Chang, CC				Hsieh, Wen-Yeh; Chang, Teng-Hsiang; Chang, Hui-Fang; Chuang, Wan-Hsuan; Lu, Li-Che; Yang, Chung-Wei; Lin, Chih-Sheng; Chang, Chia-Chu			Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; OXIDATIVE STRESS; ACTIVATION; FIBROSIS; INHIBITION; PROGRESSION; DISEASE; CELLS; INFLAMMATION; EXPRESSION	Angiotensin-converting enzyme (ACE) is the primary enzyme that converts angiotensin I (Ang I) to angiotensin II (Ang II) in the renin-angiotensin system (RAS). However, chymase hydrates Ang I to Ang II independently of ACE in some kidney diseases, and it may play an important role. The present study investigated whether chymase played a crucial role in aristolochic acid I (AAI)-induced nephropathy. C57BL/6 mice were treated with AAI via intraperitoneal injection for an accumulated AAI dosage of 45 mg/kg body weight (BW) (15 mg/kg BW per day for 3 days). The animals were sacrificed after acute kidney injury development, and blood, urine and kidneys were harvested for biochemical and molecular assays. Mice exhibited increased serum creatinine, BUN and urinary protein after the AAI challenge. Significant infiltrating inflammatory cells and tubular atrophy were observed in the kidneys, and high immunocytokine levels were detected. Renal RAS-related enzyme activities were measured, and a significantly increased chymase activity and slightly decreased ACE activity were observed in the AAI-treated mice. The renal Ang II level reflected the altered profile of RAS enzymes and was significantly increased in AAI-treated mice. Treatment of AAI-induced nephropathic mice with an ACE inhibitor (ACEI) or chymase inhibitor (CI; chymostatin) reduced renal Ang II levels. The combination of ACEI and CI (ACEI+CI) treatment significantly reversed the AAI-induced changes of Ang II levels and kidney inflammation and injuries. AAI treatment significantly increased renal p-MEK without increasing p-STAT3 and p-Smad3 levels, and p-MEK/p-ERK1/2 signalling pathway was significantly activated. CI and ACEI+CI treatments reduced this AAI-activated signaling pathway. AAI-induced nephropathy progression was significantly mitigated with CI and ACEI+CI treatment. This study elucidates the role of RAS in the pathogenesis of AAI-induced nephropathy.	[Hsieh, Wen-Yeh] Hsinchu Mackay Mem Hosp, Div Pulm Med, Dept Internal Med, Hsinchu, Taiwan; [Chang, Teng-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Chang, Hui-Fang; Chuang, Wan-Hsuan; Lin, Chih-Sheng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Hui-Fang] Hsinchu Mackay Mem Hosp, Div Endocrinol, Dept Internal Med, Hsinchu, Taiwan; [Lu, Li-Che] Shin Kong Wu Ho Su Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Yang, Chung-Wei] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Hsinchu Branch, Hsinchu, Taiwan; [Lin, Chih-Sheng] Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan; [Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Environm & Precis Med Lab, Changhua, Taiwan; [Chang, Chia-Chu] Hungkuang Univ, Dept Nutr, Taichung, Taiwan; [Chang, Chia-Chu] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan	Mackay Memorial Hospital; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Changhua Christian Hospital; Hungkuang University	Chang, CC (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Lin, CS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Lin, CS (corresponding author), Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices IDS2, Hsinchu, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Dept Environm & Precis Med Lab, Changhua, Taiwan.; Chang, CC (corresponding author), Hungkuang Univ, Dept Nutr, Taichung, Taiwan.; Chang, CC (corresponding author), Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan.	lincs@mail.nctu.edu.tw; chiachuchang0312@gmail.com		YANG, CHUNG-WEI/0000-0002-8613-3597	Ministry of Science and Technology (MOST), Taiwan [MOST 104-2313-B-009-001-MY3, MOST 107-2313-B-009-002-MY3]; "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program; Ministry of Education (MOE), Taiwan	Ministry of Science and Technology (MOST), Taiwan; "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program; Ministry of Education (MOE), Taiwan	This work was supported by the grants of MOST 104-2313-B-009-001-MY3 and MOST 107-2313-B-009-002-MY3 from the Ministry of Science and Technology (MOST), Taiwan. This work was also financially supported by the "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project of the National Chiao Tung University and Ministry of Education (MOE), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grants of MOST 104-2313-B-009-001-MY3 and MOST 107-2313-B-009-002-MY3 from the Ministry of Science and Technology (MOST), Taiwan. This work was also financially supported by the "Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B)" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project of the National Chiao Tung University and Ministry of Education (MOE), Taiwan.	Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chang HF, 2018, RSC ADV, V8, P29013, DOI 10.1039/c8ra04322a; Cheungpasitporn W, 2015, NEPHROL DIAL TRANSPL, V30, P978, DOI 10.1093/ndt/gfv023; Cristovam PC, 2012, EXP BIOL MED, V237, P985, DOI 10.1258/ebm.2012.011356; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Fan YY, 2009, J PHARMACOL SCI, V111, P82, DOI 10.1254/jphs.09152FP; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Hollenberg NK, 1998, HYPERTENSION, V32, P387, DOI 10.1161/01.HYP.32.3.387; Huang LH, 2013, NEPHRON EXTRA, V3, P12, DOI 10.1159/000346180; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Hung YH, 2016, INT J BIOL SCI, V12, P454, DOI 10.7150/ijbs.13379; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Lim Beom Jin, 2014, Drug Discov Today Dis Models, V11, P45; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Liu XC, 2015, MOL MED REP, V12, P4340, DOI 10.3892/mmr.2015.3911; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; MENGS U, 1987, ARCH TOXICOL, V59, P328, DOI 10.1007/BF00295084; Mezzano S, 2003, KIDNEY INT, V64, pS64, DOI 10.1046/j.1523-1755.64.s86.12.x; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Michl J, 2014, NAT PROD REP, V31, P676, DOI 10.1039/c3np70114j; Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P213, DOI 10.1007/s12199-011-0243-9; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Pailer M., 1955, MH CHEM, V86, P676; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Quiroga B, 2014, NEW ENGL J MED, V370, P777, DOI 10.1056/NEJMc1315504; Rabe M, 2016, NEPHRON, V133, P53, DOI 10.1159/000445171; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Solez K, 2001, AM J KIDNEY DIS, V38, P1141, DOI 10.1053/ajkd.2001.29661; Suzuki Hiromichi, 2015, World J Nephrol, V4, P118, DOI 10.5527/wjn.v4.i1.118; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Wasse H, 2012, CURR HYPERTENS REV, V8, P15, DOI 10.2174/157340212800505007; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; Wu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20556; Xiao Y, 2008, KIDNEY INT, V73, P1231, DOI 10.1038/ki.2008.103; Yang CW, 2017, RENAL FAILURE, V39, P719, DOI 10.1080/0886022X.2017.1398665; Yeh FY, 2014, RSC ADV, V4, P22266, DOI 10.1039/c4ra00258j; Zhang M, 2016, MOL MED REP, V14, P121, DOI 10.3892/mmr.2016.5234	50	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210656	10.1371/journal.pone.0210656	http://dx.doi.org/10.1371/journal.pone.0210656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633770	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100034
J	Gabitov, E; Boutin, A; Pinsard, B; Censor, N; Fogel, SM; Albouy, G; King, BR; Carrier, J; Cohen, LG; Karni, A; Doyon, J				Gabitov, Ella; Boutin, Arnaud; Pinsard, Basile; Censor, Nitzan; Fogel, Stuart M.; Albouy, Genevieve; King, Bradley R.; Carrier, Julie; Cohen, Leonardo G.; Karni, Avi; Doyon, Julien			Susceptibility of consolidated procedural memory to interference is independent of its active task-based retrieval	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; EXPERIENCE-DRIVEN CHANGES; MOTOR SEQUENCE; RETROGRADE-AMNESIA; DECLARATIVE MEMORY; PROTEIN-SYNTHESIS; RECONSOLIDATION; SLEEP; FEAR; INTEGRATION	Reconsolidation theory posits that upon retrieval, consolidated memories are destabilized and need to be restabilized in order to persist. It has been suggested that experience with a competitive task immediately after memory retrieval may interrupt these restabilization processes leading to memory loss. Indeed, using a motor sequence learning paradigm, we have recently shown that, in humans, interference training immediately after active task-based retrieval of the consolidated motor sequence knowledge may negatively affect its performance levels. Assessing changes in tapping pattern before and after interference training, we also demonstrated that this performance deficit more likely indicates a genuine memory loss rather than an initial failure of memory retrieval. Here, applying a similar approach, we tested the necessity of the hypothetical retrieval-induced destabilization of motor memory to allow its impairment. The impact of memory retrieval on performance of a new motor sequence knowledge acquired during the interference training was also evaluated. Similar to the immediate post-retrieval interference, interference training alone without the preceding active task-based memory retrieval was also associated with impairment of the pre-established motor sequence memory. Performance levels of the sequence trained during the interference training, on the other hand, were impaired only if this training was given immediately after memory retrieval. Noteworthy, an 8-hour interval between memory retrieval and interference allowed to express intact performance levels for both sequences. The current results suggest that susceptibility of the consolidated motor memory to behavioral interference is independent of its active task-based retrieval. Differential effects of memory retrieval on performance levels of the new motor sequence encoded during the interference training further suggests that memory retrieval may influence the way new information is stored by facilitating its integration within the retrieved memory trace. Thus, impairment of the pre-established motor memory may reflect interference from a competing memory trace rather than involve interruption of reconsolidation.	[Gabitov, Ella; Boutin, Arnaud; Pinsard, Basile; Carrier, Julie] CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Gabitov, Ella; Boutin, Arnaud; Pinsard, Basile; Doyon, Julien] Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Pinsard, Basile] Sorbonne Univ, CNRS, INSERM, Lab Imagerie Biomed,LIB, Paris, France; [Censor, Nitzan] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel; [Censor, Nitzan] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Fogel, Stuart M.] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Albouy, Genevieve; King, Bradley R.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Movement Sci, Leuven, Belgium; [Carrier, Julie] Sacre Coeur Hosp Montreal, Res Ctr, Montreal, PQ, Canada; [Cohen, Leonardo G.] NINDS, Human Cort Physiol & Neurorehabil Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Karni, Avi] Univ Haifa, Lab Human Brain & Learning, Sagol Dept Neurobiol, Haifa, Israel; [Karni, Avi] Univ Haifa, EJ Safra Brain Res Ctr, Haifa, Israel	Universite de Montreal; McGill University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Tel Aviv University; University of Ottawa; KU Leuven; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Haifa; University of Haifa	Gabitov, E (corresponding author), CRIUGM, Funct Neuroimaging Unit, Montreal, PQ, Canada.; Gabitov, E; Doyon, J (corresponding author), Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.	gabitovella@gmail.com; julien.doyon@mcgill.ca	Fogel, Stuart/F-7179-2017; ALBOUY, Genevieve/P-4723-2019; Censor, Nitzan/ABC-1739-2021	Fogel, Stuart/0000-0002-3227-5370; ALBOUY, Genevieve/0000-0002-5437-023X; King, Bradley/0000-0002-3010-8755; Gabitov, Ella/0000-0003-0322-0757; Carrier, Julie/0000-0001-5311-2370	CIHR [MOP 97830]; European Union [604102]; FRSQ; I-CORE program of the Planning and Budgeting Committee; ISF [51/11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002978] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); European Union(European Commission); FRSQ(Fonds de la Recherche en Sante du Quebec); I-CORE program of the Planning and Budgeting Committee; ISF(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from CIHR grant (MOP 97830) to J.D. E.G. was supported in part by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604102 (Human Brain Project) to A.K. and by postdoctoral fellowship provided by FRSQ. N.C. was supported by the I-CORE program of the Planning and Budgeting Committee and The ISF (grant 51/11).	Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059490; Amar-Halpert R, 2017, NAT NEUROSCI, V20, P1325, DOI 10.1038/nn.4629; Balderas I, 2013, NEUROSCIENCE, V253, P398, DOI 10.1016/j.neuroscience.2013.09.001; Barakat M, 2013, HUM BRAIN MAPP, V34, P2918, DOI 10.1002/hbm.22116; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Boutin A, 2018, NEUROIMAGE, V169, P419, DOI 10.1016/j.neuroimage.2017.12.066; Boutin A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00937; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Cassini LF, 2013, HIPPOCAMPUS, V23, P931, DOI 10.1002/hipo.22149; Celnik P, 2009, STROKE, V40, P1764, DOI 10.1161/STROKEAHA.108.540500; Censor N, 2016, CEREB CORTEX, V26, P3828, DOI 10.1093/cercor/bhv180; Censor N, 2014, NEURON, V81, P69, DOI 10.1016/j.neuron.2013.10.042; Censor N, 2010, CURR BIOL, V20, P1545, DOI 10.1016/j.cub.2010.07.047; Chan JCK, 2013, P NATL ACAD SCI USA, V110, P9309, DOI 10.1073/pnas.1218472110; De Beukelaar TT, 2014, CORTEX, V59, P138, DOI 10.1016/j.cortex.2014.07.008; Dijk DJ, 2005, J BIOL RHYTHM, V20, P279, DOI 10.1177/0748730405278292; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2015, NEURON, V88, P20, DOI 10.1016/j.neuron.2015.09.004; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Gabitov E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09677-1; Gabitov E, 2014, J COGNITIVE NEUROSCI, V26, P2716, DOI 10.1162/jocn_a_00675; Gershman SJ, 2013, J NEUROSCI, V33, P8590, DOI 10.1523/JNEUROSCI.0096-13.2013; Gisquet-Verrier P, 2015, J NEUROSCI, V35, P11623, DOI 10.1523/JNEUROSCI.1386-15.2015; Hardwicke TE, 2016, P NATL ACAD SCI USA, V113, P5206, DOI 10.1073/pnas.1601440113; Herszage J, 2017, CURR BIOL, V27, P1529, DOI 10.1016/j.cub.2017.04.025; Hesseg RM, 2016, LEARN MEMORY, V23, P189, DOI 10.1101/lm.041228.115; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Hupbach A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00033; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kastellakis G, 2016, CELL REP, V17, P1491, DOI 10.1016/j.celrep.2016.10.015; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POVEL DJ, 1982, ACTA PSYCHOL, V52, P107, DOI 10.1016/0001-6918(82)90029-4; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Rodriguez-Ortiz CJ, 2012, NEUROBIOL LEARN MEM, V98, P215, DOI 10.1016/j.nlm.2012.08.002; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Sajikumar S, 2014, P NATL ACAD SCI USA, V111, P12217, DOI 10.1073/pnas.1403643111; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Santoyo-Zedillo M, 2014, LEARN MEMORY, V21, P452, DOI 10.1101/lm.035428.114; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schlichting ML, 2015, CURR OPIN BEHAV SCI, V1, P1, DOI 10.1016/j.cobeha.2014.07.005; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Trent S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8897; Vahdat S, 2017, ELIFE, V6, DOI 10.7554/eUfe.249t37; VERWEY WB, 1994, ACTA PSYCHOL, V85, P245, DOI 10.1016/0001-6918(94)90038-8; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	72	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210876	10.1371/journal.pone.0210876	http://dx.doi.org/10.1371/journal.pone.0210876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653576	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500083
J	Venegas, CL; Nkangu, MN; Duffy, MC; Fergusson, DA; Spilg, EG				Venegas, Carolina Lavin; Nkangu, Miriam N.; Duffy, Melissa C.; Fergusson, Dean A.; Spilg, Edward G.			Interventions to improve resilience in physicians who have completed training: A systematic review	PLOS ONE			English	Review							HEALTH-CARE PROFESSIONALS; JOB-SATISFACTION; MINDFULNESS; PROGRAM; BURNOUT; STRESS; QUALITY; EMPATHY; SCALE	Background Resilience is a contextual phenomenon where a complex and dynamic interplay exists between individual, environmental, and socio-cultural factors. With growing interest in enhancing resilience in physicians, given their high risk for experiencing prolonged or intense stress, effective strategies are necessary to improve resilience and reduce negative outcomes including burnout. The objective of this review was to identify effective interventions to improve resilience in physicians who have completed training, working in any setting. Methods and findings We included randomized controlled trials (RCT), and observational studies (including pilot studies) published in English, French, and Spanish that included an intervention to improve resilience in physicians who have completed training. We included studies that implemented interventions to reduce burnout, anxiety, and depression or to improve empathy to ultimately enhance resilience, rather than studies designed solely to reduce stress or trauma-induced stress. We performed a systematic search of Medline, EMBASE, PsychInfo, CINAHL and Cochrane Library with no publication year limit. The last search was conducted on March 29, 2017. We used random effect models to calculate pooled standardized mean differences. Resilience was the primary outcome measure using validated resilience scores. Secondary outcome measures included proxy measures of resilience such as burnout, empathy, anxiety and depression. Our search strategy identified 7,579 records; 74 met the criteria for full-text review. Seventeen studies were included in the final review published between 1998 and 2016 of which 9 (4 RCT, 5 observational) had physician data extractable. Interventions varied greatly regarding their approach, duration, and follow-up. Two RCTs measured resilience using validated scales; both found a significant improvement. No meta-analysis for resilience was conducted due to the presence of high clinical and methodological heterogeneity. Conclusions Our systematic review demonstrates that there is weak evidence to support one intervention over another to improve resilience in physicians who have completed training. The quality of evidence for the outcomes ranged from very low to low. There is a need for a consensus on the definition of resilience and how it is measured. Longer follow-up is required to ensure any intervention effects are sustained over time.	[Venegas, Carolina Lavin; Nkangu, Miriam N.] Univ Ottawa, Sch Epidemiol, Ottawa, ON, Canada; [Duffy, Melissa C.] Univ South Carolina, Dept Educ Studies, Columbia, SC USA; [Fergusson, Dean A.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Spilg, Edward G.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Spilg, Edward G.] Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; University of South Carolina System; University of South Carolina Columbia; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Spilg, EG (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; Spilg, EG (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.	espilg@toh.ca		Spilg, Edward/0000-0002-6012-1571				Balme E, 2015, BMJ CAREERS; Bridger RS, 2013, ERGONOMICS, V56, P1629, DOI 10.1080/00140139.2013.836251; CATON DJ, 1988, AM J MENT RETARD, V93, P300; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cosco TD, 2017, J EPIDEMIOL COMMUN H, V71, P98, DOI 10.1136/jech-2015-206980; Dyrbye L, 2012, MED EDUC, V46, P343, DOI 10.1111/j.1365-2923.2011.04206.x; Dyrbye LN, 2013, J GEN INTERN MED, V28, P421, DOI 10.1007/s11606-012-2252-9; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Fortney L, 2013, ANN FAM MED, V11, P412, DOI 10.1370/afm.1511; Fox S, 2018, POSTGRAD MED J, V94, P162, DOI 10.1136/postgradmedj-2017-135212; Goodman MJ, 2012, INT J PSYCHIAT MED, V43, P119, DOI 10.2190/PM.43.2.b; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haramati A, 2017, MED TEACH, V39, P118, DOI 10.1080/0142159X.2017.1279278; Howe A, 2012, MED EDUC, V46, P349, DOI 10.1111/j.1365-2923.2011.04188.x; Jackson D, 2007, J ADV NURS, V60, P1, DOI 10.1111/j.1365-2648.2007.04412.x; Jensen PM, 2008, CAN FAM PHYSICIAN, V54, P722; Kemper KJ, 2015, J EVID-BASED INTEGR, V20, P247, DOI 10.1177/2156587215575816; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Leppin AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111420; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mache S, 2016, INT J PSYCHIAT CLIN, V20, P239, DOI 10.1080/13651501.2016.1207085; Asuero AM, 2014, J CONTIN EDUC HEALTH, V34, P4, DOI 10.1002/chp.21211; Asuero AM, 2013, GAC SANIT, V27, P521, DOI 10.1016/j.gaceta.2013.04.007; Mehta DH, 2016, J PAIN SYMPTOM MANAG, V51, P604, DOI 10.1016/j.jpainsymman.2015.10.013; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Rees CS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00073; Ro KEI, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-213; Robertson HD, 2016, BRIT J GEN PRACT, V66, pE423, DOI 10.3399/bjgp16X685261; Rogers D, 2016, MED TEACH, V38, P1236, DOI 10.1080/0142159X.2016.1210111; Santos MC, 2010, PHYSIOTHERAPY, V96, P303, DOI 10.1016/j.physio.2010.03.001; Schneider S, 2014, EXPLORE-NY, V10, P372, DOI 10.1016/j.explore.2014.08.007; Shanafelt, 2016, BURNOUT RES, V3, P69, DOI DOI 10.1016/J.BURN.2016.06.002; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Sherlock C, 2016, BRIT J MED PRACTITIO, V9; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Sood A, 2014, EXPLORE-NY, V10, P358, DOI 10.1016/j.explore.2014.08.002; Sood A, 2011, J GEN INTERN MED, V26, P858, DOI 10.1007/s11606-011-1640-x; Sterne JAC., 2014, COCHRANE RISK BIAS A; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Winefield H, 1998, PSYCHOL HEALTH MED, V3, P163, DOI DOI 10.1080/13548509808402232; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010	45	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210512	10.1371/journal.pone.0210512	http://dx.doi.org/10.1371/journal.pone.0210512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653550	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500045
J	Gomez-Armayones, S; Chimenos-Kustner, E; Mari, A; Tous, S; Penin, R; Clavero, O; Quiros, B; Pavon, MA; Taberna, M; Alemany, L; Servitje, O; Mena, M				Gomez-Armayones, Sara; Chimenos-Kustner, Eduardo; Mari, Antonio; Tous, Sara; Penin, Rosa; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Taberna, Miren; Alemany, Laia; Servitje, Octavio; Mena, Marisa			Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; SQUAMOUS-CELL CARCINOMA; LICHEN-PLANUS; MUCOSA; LEUKOPLAKIA; CAVITY; HPV; CLASSIFICATION; PREVALENCE; INFECTION	Background Human papillomavirus (HPV) is the cause of a fraction of head and neck squamous cell carcinoma. Although this relation is well-known, it is still not clear the role of HPV in premalignant oral lesions such as oral lichen planus (OLP) and dysplasia. We aimed to evaluate the HPV-DNA prevalence and type distribution in a set of oral biopsies obtained from patients diagnosed with OLP and dysplasia, as well as the role of HPV in these lesions. Methods A retrospective cohort of all premalignant oral lesions consecutively diagnosed from March 30th 1995 to May 21st 2014 at Hospital of Bellvitge and Odontological University Hospital of Bellvitge was identified and classified in four groups: OLP (groups 1 and 2) and dysplasias (groups 3 and 4) that progressed or not to invasive cancer during follow-up. A random selection targeting 25 cases was aimed to be performed for each group. All selected cases were subjected to pathological evaluation, DNA quality control and HPV-DNA detection. HPV-DNA positive samples were further subject to p16(INK4a) analysis. Results A total of 83 cases yielded a valid HPV-DNA result. From those, 7 and 34 cases were OLP that progressed or not to invasive cancer during follow-up, whereas 24 and 18 cases were displasias that progressed or not to invasive cancer during follow-up, respectively. HPV-DNA was detected in 4 samples (3 dysplastic lesions and 1 OLP). Two samples were HPV16 positive (2%), 1 sample HPV18 positive (1%) and 1 sample (1%) was HPV indeterminate. Two out of four HPV-DNA positive cases had high p16(INK4a) expression and none of the HPV positive cases progressed to invasive cancer during long-term follow-up. Conclusions We found a low HPV-DNA attributable fraction in premalignant lesions of the oral cavity, suggesting that HPV is unlikely to play a significant role in oral carcinogenesis in our setting.	[Gomez-Armayones, Sara; Servitje, Octavio] Bellvitge Univ Hosp, Dept Dermatol, Barcelona, Spain; [Gomez-Armayones, Sara; Mari, Antonio; Penin, Rosa; Servitje, Octavio] Bellvitge Univ Hosp, Dept Med, Barcelona, Spain; [Chimenos-Kustner, Eduardo] Odontol Univ Hosp Barcelona, Dept Odontostomatol, Barcelona, Spain; [Mari, Antonio] Bellvitge Univ Hosp, Dept Oral & Maxillofacial Surg, Barcelona, Spain; [Tous, Sara; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Alemany, Laia; Mena, Marisa] Catalan Inst Oncol ICO, Canc Epidemiol Res Program, IDIBELL, Barcelona, Spain; [Tous, Sara; Clavero, Omar; Quiros, Beatriz; Angel Pavon, Miguel; Mena, Marisa] CIBER Primary & Secondary Prevent Viral Induced C, Madrid, Spain; [Penin, Rosa] Bellvitge Univ Hosp, Dept Pathol, Barcelona, Spain; [Taberna, Miren] Catalan Inst Oncol ICO, Dept Med Oncol, ONCOBELL, IDIBELL, Barcelona, Spain; [Taberna, Miren] Univ Barcelona, Barcelona, Spain; [Alemany, Laia] Inst Salud Carlos III, CIBERESP, Epidemiol & Publ Hlth, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Gomez-Armayones, S (corresponding author), Bellvitge Univ Hosp, Dept Dermatol, Barcelona, Spain.; Gomez-Armayones, S (corresponding author), Bellvitge Univ Hosp, Dept Med, Barcelona, Spain.	sara.gomez.armayones@gmail.com	Chimenos-Küstner, Eduardo/AAD-1050-2019; Alemany, Laia/G-9643-2015; Tous, Sara/G-5052-2015; Pavon, Miguel Angel/N-3538-2014; Mari, Antonio/D-4499-2014	Chimenos-Küstner, Eduardo/0000-0002-0728-1808; Alemany, Laia/0000-0003-0945-6015; Taberna, Miren/0000-0002-2446-186X; Tous, Sara/0000-0002-5423-7092; Pavon, Miguel Angel/0000-0003-3677-5329; Mari, Antonio/0000-0002-7213-0862				Al-Hashimi I, 2007, ORAL SURG ORAL MED O, V103, pS25, DOI 10.1016/j.tripleo.2006.11.001; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Amagasa T, 2011, INT J CLIN ONCOL, V16, P5, DOI 10.1007/s10147-010-0157-3; Arirachakaran P, 2013, ISRN DENT, V2013, P1; Campisi G, 2004, ORAL SURG ORAL MED O, V98, P705, DOI 10.1016/j.tripleo.2004.04.012; Campisi G, 2007, INT J ONCOL, V30, P813; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, P1; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Medeiros Maia HC, 2016, EINSTEIN, V14; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Debanth S, 2009, ASIA-PAC J CLIN ONCO, V5, P111, DOI 10.1111/j.1743-7563.2009.01200.x; Epstein JB, 2003, ORAL SURG ORAL MED O, V96, P32, DOI 10.1016/S1079-2104(03)00161-6; Giovannelli L, 2006, MOL DIAGN THER, V10, P49, DOI 10.1007/BF03256442; Gorsky M, 2011, ORAL SURG ORAL MED O, V111, P461, DOI 10.1016/j.tripleo.2010.11.007; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Hirth JM, 2017, VACCINE, V35, P3446, DOI 10.1016/j.vaccine.2017.05.025; Ishibashi M, 2011, INT J CLIN ONCOL, V16, P646, DOI 10.1007/s10147-011-0236-0; Khovidhunkit SOP, 2008, ASIAN PAC J CANCER P, V9, P771; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Llamas-Martinez S, 2008, ANTICANCER RES, V28, P3733; Lodi G, 2005, ORAL SURG ORAL MED O, V100, P164, DOI 10.1016/j.tripleo.2004.06.076; Ma J, 2016, PLOS ONE, V11, P1; Mattila R, 2012, ORAL ONCOL, V48, P980, DOI 10.1016/j.oraloncology.2012.04.009; Mehanna HM, 2009, HEAD NECK-J SCI SPEC, V31, P1600, DOI 10.1002/hed.21131; Mena M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184520; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; Mirghani H, 2015, ORAL ONCOL, V51, P229, DOI 10.1016/j.oraloncology.2014.11.011; Nankivell P, 2014, J ORAL PATHOL MED, V43, P245, DOI 10.1111/jop.12128; Pol CA, 2015, INT DENT J, V65, P11, DOI 10.1111/idj.12125; Prigge ES, EUROGIN 2017; Prigge ES, 2018, 2 INT S TUM HOST INT; Radochova V, 2015, ACTA VIROL, V59, P434, DOI 10.4149/av_2015_04_434; Rautava J, 2011, J AM DENT ASSOC, V142, P905, DOI 10.14219/jada.archive.2011.0297; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Szarka K, 2009, ORAL MICROBIOL IMMUN, V24, P314, DOI 10.1111/j.1399-302X.2009.00516.x; Van der Waal I., 2014, MED ORAL PATOL ORAL, V19, P1; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004	41	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210070	10.1371/journal.pone.0210070	http://dx.doi.org/10.1371/journal.pone.0210070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650110	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300039
J	Patience, GS; Galli, F; Patience, PA; Boffito, DC				Patience, Gregory S.; Galli, Federico; Patience, Paul A.; Boffito, Daria C.			Intellectual contributions meriting authorship: Survey results from the top cited authors across all science categories	PLOS ONE			English	Article							COMMUNICATION; CREDIT	Authorship is the currency of an academic career for which the number of papers researchers publish demonstrates creativity, productivity, and impact. To discourage coercive authorship practices and inflated publication records, journals require authors to affirm and detail their intellectual contributions but this strategy has been unsuccessful as authorship lists continue to grow. Here, we surveyed close to 6000 of the top cited authors in all science categories with a list of 25 research activities that we adapted from the National Institutes of Health (NIH) authorship guidelines. Responses varied widely from individuals in the same discipline, same level of experience, and same geographic region. Most researchers agreed with the NIH criteria and grant authorship to individuals who draft the manuscript, analyze and interpret data, and propose ideas. However, thousands of the researchers also value supervision and contributing comments to the manuscript, whereas the NIH recommends discounting these activities when attributing authorship. People value the minutiae of research beyond writing and data reduction: researchers in the humanities value it less than those in pure and applied sciences; individuals from Far East Asia and Middle East and Northern Africa value these activities more than anglophones and northern Europeans. While developing national and international collaborations, researchers must recognize differences in peoples values while assigning authorship.	[Patience, Gregory S.; Galli, Federico; Boffito, Daria C.] Polytech Montreal, Dept Chem Engn, Montreal, PQ, Canada; [Patience, Paul A.] Polytech Montreal, Dept Elect Engn, Montreal, PQ, Canada; [Galli, Federico] Univ Milan, Dept Chem, Milan, Italy; [Patience, Paul A.] SITAONAIR, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; University of Milan	Patience, GS (corresponding author), Polytech Montreal, Dept Chem Engn, Montreal, PQ, Canada.	gregory-s.patience@polymtl.ca	Galli, Federico/AAQ-1525-2021; Galli, Federico/ABE-2196-2021	Galli, Federico/0000-0002-6230-4646; Patience, Gregory/0000-0001-6593-7986				Aaboud M, 2018, PHYS LETT B, V777, P91, DOI 10.1016/j.physletb.2017.12.011; Aad G, 2015, PHYS REV LETT, V114, P1; Allen L, 2014, NATURE, V508, P312, DOI 10.1038/508312a; [Anonymous], 2017, CLARIVATE ANAL; Armani A., 2017, CRITERIA AUTHORSHIP; Boffito DC, 2016, CAN J CHEM ENG, V94, P1127, DOI 10.1002/cjce.22479; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097; CRONIN B, 1993, J AM SOC INFORM SCI, V44, P406, DOI 10.1002/(SICI)1097-4571(199308)44:7<406::AID-ASI6>3.0.CO;2-8; Ecological Society of America, 2013, NTR; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Franklin S., 2010, SURVEY METHODS PRACT; Guglielmi G., 2018, NATURE, DOI [10.1038/d41586-018-05280-0, DOI 10.1038/D41586-018-05280-0]; Haley MR, 2017, APPL ECON LETT, V24, P85, DOI 10.1080/13504851.2016.1164812; Harvard Medical School, 2017, AUTH GUID; HUTH EJ, 1986, ANN INTERN MED, V104, P269, DOI 10.7326/0003-4819-104-2-269; International Committee of Medical Journal Editors, 2017, DEF ROL AUTH CONTR; Ioannidis JPA, 2018, NATURE, V561, P167, DOI 10.1038/d41586-018-06185-8; Jabbehdari S, 2017, SCI TECHNOL HUM VAL, V42, P872, DOI 10.1177/0162243917697192; Kosslyn SM, 2002, AUTHORSHIP CRITERIA; Lariviere V, 2016, SOC STUD SCI, V46, P417, DOI 10.1177/0306312716650046; Logan JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179956; Lozano GA, 2014, SCI ENG ETHICS, V20, P363, DOI 10.1007/s11948-013-9451-6; Lozano GA, 2013, CURR SCI INDIA, V105, P443; Mack C., 2013, J MICRO-NANOLITH MEM, V12, P1; MCCAIN KW, 1991, SCI TECHNOL HUM VAL, V16, P491, DOI 10.1177/016224399101600404; McDonald RJ, 2010, MAYO CLIN PROC, V85, P920, DOI 10.4065/mcp.2010.0291; McNutt MK, 2018, P NATL ACAD SCI USA, V115, P2557, DOI 10.1073/pnas.1715374115; Moffatt B, 2018, ACCOUNT RES, V25, P199, DOI 10.1080/08989621.2018.1437347; Moffatt B, 2013, ACCOUNT RES, V20, P59, DOI 10.1080/08989621.2013.767115; Newman A, 2006, J MED ETHICS, V32, P420, DOI 10.1136/jme.2005.012757; Patience GS, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00300; Paul-Hus A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185578; Penders B, 2017, ACCOUNT RES, V24, P433, DOI 10.1080/08989621.2017.1386565; Penders B, 2016, ACCOUNT RES, V23, P136, DOI 10.1080/08989621.2015.1060128; Ralston E., 2015, NATL I HLTH GEN GUID; Resnik DB, 2016, J MED ETHICS, V42, P199, DOI 10.1136/medethics-2015-103171; Sauermann H, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700404; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; Wislar JS, 2011, HONORARY GHOST AUTHO; World Association of Medical Editors, 2007, AUTH; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095	41	34	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0198117	10.1371/journal.pone.0198117	http://dx.doi.org/10.1371/journal.pone.0198117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650079	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000455813300001
J	Cui, WT; Xiao, GJ; Jiang, SW; Qian, LL; Cai, CB; Li, B; Xie, SS; Gao, T; Li, K				Cui, Wen-Tao; Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Li, Biao; Xie, Shan-Shan; Gao, Ting; Li, Kui			Effect of ZFN-edited myostatin loss-of-function mutation on gut microbiota in Meishan pigs	PLOS ONE			English	Article							GENE	Intestine contains the body's second largest genetic information, so a relatively stable micro-biota ecosystems and interactions between intestinal micro-organisms play a pivotal role in the normal growth and development in animals. The establishment of intestinal microflora is affected by a variety of factors such as species, environmental factors, developmental stage, organizational structure and physiological characteristics of various parts of the digestive tract. Gene editing technology such as ZFN has recently been used as a new approach to replace the traditional transgenic technology and to make genetic modifications in animals. However, it is not known if genetic modification by gene editing technology will have any impact on gut microbiota. In this study, by sequencing 16S rRNA collected from rectum, we investigated the effects of ZFN-mediated myostatin (MSTN) loss-of-function mutation (MSTN-/-) on gut microbiota in Meishan pigs. Our results showed that the fecal microbial composition is very similar between MSTN-/- Meishan pigs and wild type Meishan pigs. Although significant differences in certain individual strains were observed, all the dominant microorganism species are basically the same between MSTN-/- and wild type pigs. However, these differences do not adversely affect MSTN-/- Meishan pigs. Thus, it is concluded that ZFN-mediated MSTN loss-of-function mutation did not have any adverse effect on the gut microbiota in Meishan pigs.	[Cui, Wen-Tao; Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Li, Biao; Xie, Shan-Shan; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Qian, Li-Li; Cai, Chun-Bo; Gao, Ting] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	cuiwentao@caas.cn	xie, shanshan/GSM-8999-2022; 钱, 钱丽丽/GWV-8162-2022		National Transgenic Project of China [2016ZX08006-001]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05]; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China; Agricultural Science and Technology Innovation Program; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2016ZX08006-001), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05), and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11) to LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Cai CB, 2017, ONCOTARGET, V8, P34911, DOI 10.18632/oncotarget.16822; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Evans NJ, 2011, APPL ENVIRON MICROB, V77, P138, DOI 10.1128/AEM.00993-10; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Inoue R, 2005, J GEN APPL MICROBIOL, V51, P257, DOI 10.2323/jgam.51.257; Legault C, 1985, J Reprod Fertil Suppl, V33, P151; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nan Chun-yan, 2013, Chinese Journal of Parasitology and Parasitic Diseases, V31, P114; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Wang QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150937; Xiao GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165843; Yang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35692; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	25	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210619	10.1371/journal.pone.0210619	http://dx.doi.org/10.1371/journal.pone.0210619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645618	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200041
J	Stewart, JAE; Butterfield, HS; Richmond, JQ; Germano, DJ; Westphal, MF; Tennant, EN; Sinervo, B				Stewart, Joseph A. E.; Butterfield, H. Scott; Richmond, Jonathan Q.; Germano, David J.; Westphal, Michael F.; Tennant, Erin N.; Sinervo, Barry			Habitat restoration opportunities, climatic niche contraction, and conservation biogeography in California's San Joaquin Desert	PLOS ONE			English	Article							NOSED LEOPARD LIZARD; BIODIVERSITY; MANAGEMENT; FARMLAND; EXTREMES; GRASSES; ECOLOGY; MODELS; WATER; RISK	A recent global trend toward retirement of farmland presents opportunities to reclaim habitat for threatened and endangered species. We examine habitat restoration opportunities in one of the world's most converted landscapes, California's San Joaquin Desert (SJD). Despite the presence of 35 threatened and endangered species, agricultural expansion continues to drive habitat loss in the SJD, even as marginal farmland is retired. Over the next decades a combination of factors, including salinization, climate change, and historical groundwater overdraft, are projected to lead to the retirement of more than 2,000 km(2) of farmland in the SJD. To promote strategic habitat protection and restoration, we conducted a quantitative assessment of habitat loss and fragmentation, habitat suitability, climatic niche stability, climate change impacts, habitat protection, and reintroduction opportunities for an umbrella species of the SJD, the endangered blunt-nosed leopard lizard (Gambelia sila). We use our suitability models, in conjunction with modern and historical land use maps, to estimate the historical and modern rate of habitat loss to development. The estimated amount of habitat lost since the species became protected under endangered species law in 1967 is greater than the total amount of habitat currently protected through public ownership and conservation easement. We document climatic niche contraction and associated range contraction away from the more mesic margins of the species' historical distribution, driven by the anthropogenic introduction of exotic grasses and forbs. The impact of exotic species on G. sila range dynamics appears to be still unfolding. Finally, we use NASA fallowed area maps to identify 610 km(2) of fallowed or retired agricultural land with high potential to again serve as habitat. We discuss conservation strategies in light of the potential for habitat restoration and multiple drivers of ongoing and historical habitat loss.	[Stewart, Joseph A. E.; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Stewart, Joseph A. E.; Sinervo, Barry] Univ Calif Santa Cruz, Inst Study Ecol & Evolutionary Climate Impacts, Santa Cruz, CA 95064 USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA; [Richmond, Jonathan Q.] US Geol Survey, San Diego, CA USA; [Germano, David J.] Calif State Univ Bakersfield, Dept Biol, Bakersfield, CA USA; [Westphal, Michael F.] US Bur Land Management, Marina, CA USA; [Tennant, Erin N.] Calif Dept Fish & Wildlife, Lands Unit, Cent Reg, Fresno, CA USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Nature Conservancy; United States Department of the Interior; United States Geological Survey; California State University System; California State University Bakersfield	Stewart, JAE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.; Stewart, JAE (corresponding author), Univ Calif Santa Cruz, Inst Study Ecol & Evolutionary Climate Impacts, Santa Cruz, CA 95064 USA.	jaes@ucsc.edu	Stewart, Joseph/AAA-4647-2020	Stewart, Joseph/0000-0001-5915-6892	US BLM [L12AC20104]; Nature Conservancy [12112012-1361]; California Department of Fish and Wildlife; NSF [EF-1241848]; Institute for the Study of Ecological Effects of Climate Impacts	US BLM; Nature Conservancy; California Department of Fish and Wildlife; NSF(National Science Foundation (NSF)); Institute for the Study of Ecological Effects of Climate Impacts	This work was supported by a Grant from US BLM to Regents of University of California Santa Cruz Award #L12AC20104, www.grants.gov. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. This work also received support from a Grant from The Nature Conservancy to Regents of the University of California Santa Cruz #12112012-1361, www.nature.org. The funder had a role in decision to publish, and preparation of the manuscript. The California Department of Fish and Wildlife supported this project and had a role in decision to publish, and preparation of the manuscript. An NSF grant EF-1241848 to B. Sinervo supported this work. The funder did not have a role in decision to publish or preparation of the manuscript. A grant from the Institute for the Study of Ecological Effects of Climate Impacts to J. Stewart supported this work. The funder did not have a role in decision to publish or preparation of the manuscript.	AghaKouchak A, 2014, GEOPHYS RES LETT, V41, P8847, DOI 10.1002/2014GL062308; Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; ALLEN EB, 1995, USDA INTERM, V315, P7; [Anonymous], 1998, RECOVERY PLAN UPLAND; Ausubel JH, 2013, POPUL DEV REV, V38, P221, DOI 10.1111/j.1728-4457.2013.00561.x; Bailey CV, 2015, W WILD, V2, P23; Baillie J. E., 2004, 2004 IUCN RED LIST T, DOI [10.2305/IUCN.CH.2005.3.en, DOI 10.2305/IUCN.CH.2005.3.EN]; Bean WT, 2014, J APPL ECOL, V51, P1116, DOI 10.1111/1365-2664.12281; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cismowski G., 2006, SALINITY CENTRAL VAL; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Cypher Brian L., 2013, Canid News, V16, P25; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Germano DJ, 2007, SOUTHWEST NAT, V52, P318, DOI 10.1894/0038-4909(2007)52[318:FHOTBL]2.0.CO;2; Germano DJ, 2012, J WILDLIFE MANAGE, V76, P670, DOI 10.1002/jwmg.316; Germano DJ, 2011, NAT AREA J, V31, P138, DOI 10.3375/043.031.0206; Germano DJ, 2005, J HERPETOL, V39, P1, DOI 10.1670/0022-1511(2005)039[0001:PEOBLL]2.0.CO;2; GERMANO DJ, 1992, T W SEC WIL, V28, P38; Germano DJ, 2001, WILDLIFE SOC B, V29, P551; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Goldingay RL, 1997, KANGAROO RATS CALIFO, V3, P47; Gozdowski D, 2015, J SOIL SCI PLANT NUT, V15, P639; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Grimes AJ, 2014, SOUTHWEST NAT, V59, P38, DOI 10.1894/F06-GC-233.1; Hanak E, 2017, WATER STRESS CHANGIN, DOI [10.13140/RG.2.2.3179.31522, DOI 10.13140/RG.2.2.3179.31522]; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Jennings Mark R., 1995, Catalogue of American Amphibians and Reptiles, V612, P1; Kelly Patrick A., 2005, University of California Publications in Zoology, V133, P57; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Laymon S, 2010, ATWELL ISLAND RESTOR; Lortie CJ, 2018, ECOSPHERE, V9, P1, DOI [10.1093/annonc/mdy039/4835470, DOI 10.1093/ANNONC/MDY039/4835470]; Means D.B., 1975, J BIOGEOGR, V2, P253, DOI [10.2307/3037999, DOI 10.2307/3037999]; MONTANUCCI RICHARD R., 1965, HERPETOLOGICA, V21, P270; Mueller, 2015, FALLOWED AREA MAPPIN; Nelson C, 2003, CENTRAL VALLEY HIST; Olmstead A., 2003, CALIFORNIA AGR DIMEN, P1; Pearce D, 2015, THESIS; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Richmond JQ, 2017, MOL ECOL, V26, P3618, DOI 10.1111/mec.14125; Schoups G, 2005, P NATL ACAD SCI USA, V102, P15352, DOI 10.1073/pnas.0507723102; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Sinervo B, 2018, INTEGR ZOOL, V13, P450, DOI 10.1111/1749-4877.12315; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stewart JAE, 2016, CLIMATE CHANGE VULNE, DOI [10.13140/RG.2.2.13009.33124/1, DOI 10.13140/RG.2.2.13009.33124/1]; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thorne JH, 2016, CLIMATE CHANGE VULNE, DOI [10.1371/journal.pone.0029507, DOI 10.1371/JOURNAL.PONE.0029507]; United States Fish and Wildlife Service, 2010, BLUNT NOS LEOP LIZ G; USFWS (U. S. Fish and Wildlife Service), 1967, FED REGISTER, V32, P4001; Vicenzi N, 2017, BIOL CONSERV, V206, P151, DOI 10.1016/j.biocon.2016.12.030; Wang SY, 2014, GEOPHYS RES LETT, V41, P3220, DOI 10.1002/2014GL059748; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; Wester L., 1981, Madrono, V28, P231; Westphal MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154838; Williams D. F., 1992, ENDANGERED SENSITIVE, P65	64	9	9	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210766	10.1371/journal.pone.0210766	http://dx.doi.org/10.1371/journal.pone.0210766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645624	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200051
J	Xi, R; Murthy, PKL; Tung, KL; Guy, CD; Wan, J; Li, F; Wang, Z; Li, XD; Varanko, A; Rakhilin, N; Xin, YN; Liu, BT; Qian, SB; Su, LS; Han, Y; Shen, XL				Xi, Rui; Murthy, Preetish Kadur Lakshminarasimha; Tung, Kuei-Ling; Guy, Cynthia D.; Wan, Ji; Li, Feng; Wang, Zhuo; Li, Xiaodong; Varanko, Anastasia; Rakhilin, Nikolai; Xin, Yongning; Liu, Botao; Qian, Shu-Bing; Su, Lishan; Han, Yan; Shen, Xiling			SENP3-mediated host defense response contains HBV replication and restores protein synthesis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; OXIDATIVE STRESS; MOLECULAR-BIOLOGY; SUMO MODIFICATION; TUMOR-SUPPRESSOR; SENP3; SUMOYLATION; INFECTION; IQGAP2; CELLS	Certain organs are capable of containing the replication of various types of viruses. In the liver, infection of Hepatitis B virus (HBV), the etiological factor of Hepatitis B and hepatocellular carcinoma (HCC), often remains asymptomatic and leads to a chronic carrier state. Here we investigated how hepatocytes contain HBV replication and promote their own survival by orchestrating a translational defense mechanism via the stress-sensitive SUMO-2/3-specific peptidase SENP3. We found that SENP3 expression level decreased in HBV-infected hepatocytes in various models including HepG2-NTCP cell lines and a humanized mouse model. Downregulation of SENP3 reduced HBV replication and boosted host protein translation. We also discovered that IQGAP2, a Ras GTPase-activating-like protein, is a key substrate for SENP3-mediated de-SUMOylation. Downregulation of SENP3 in HBV infected cells facilitated IQGAP2 SUMOylation and degradation, which leads to suppression of HBV gene expression and restoration of global translation of host genes via modulation of AKT phosphorylation. Thus, The SENP3-IQGAP2 de-SUMOylation axis is a host defense mechanism of hepatocytes that restores host protein translation and suppresses HBV gene expression.	[Xi, Rui; Murthy, Preetish Kadur Lakshminarasimha; Rakhilin, Nikolai; Han, Yan; Shen, Xiling] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA; [Xi, Rui; Tung, Kuei-Ling; Han, Yan; Shen, Xiling] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA; [Xi, Rui; Tung, Kuei-Ling; Han, Yan; Shen, Xiling] Duke Univ, Duke Canc Inst, Durham, NC USA; [Murthy, Preetish Kadur Lakshminarasimha] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Tung, Kuei-Ling; Varanko, Anastasia] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Guy, Cynthia D.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Wan, Ji; Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Coll Human Ecol, Ithaca, NY 14853 USA; [Li, Feng; Wang, Zhuo; Li, Xiaodong; Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Li, Feng] Guangzhou Eighth Peoples Hosp, Inst Infect Dis, Guangzhou, Guangdong, Peoples R China; [Rakhilin, Nikolai] Cornell Univ, Coll Engn, Sch Elect & Comp Engn, Ithaca, NY USA; [Xin, Yongning] Qingdao Municipal Hosp, Dept Gastroenterol, Qingdao, Peoples R China; [Xin, Yongning] Digest Dis Key Lab Qingdao, Qingdao, Peoples R China; [Xin, Yongning] Qingdao Univ, Med Coll, Qingdao, Peoples R China; [Liu, Botao] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA	Duke University; Duke University; Duke University; Cornell University; Cornell University; Duke University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Cornell University; Qingdao Municipal Hospital; Qingdao University; University of Massachusetts System; University of Massachusetts Worcester	Han, Y; Shen, XL (corresponding author), Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA.; Han, Y; Shen, XL (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA.; Han, Y; Shen, XL (corresponding author), Duke Univ, Duke Canc Inst, Durham, NC USA.	yhan58@gmail.com; xiling.shen@duke.edu	li, xiaofeng/GXF-9442-2022; Murthy, Preetish Kadur Lakshminarasimha/AFK-2904-2022; li, xiao/GSN-6181-2022; Wan, Ji/K-1344-2014	Murthy, Preetish Kadur Lakshminarasimha/0000-0002-9762-8376; Varanko, Anastasia/0000-0003-2763-5842; Li, Feng/0000-0003-3169-6349; Wan, Ji/0000-0002-5279-0345	National Institutes of Health [NIH R21CA201963, R35GM122465, U01CA214300]; National Science Foundation [NSF 1350659]; Shanghai Pujiang Program [13PJ1406100]; National Natural Science Foundation of China [81302086]; Ministry of Education of China [20130073120007]; NSF [DGE 1545220]; NATIONAL CANCER INSTITUTE [R21CA201963, U01CA214300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122465, R01GM122814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the National Institutes of Health NIH R21CA201963, R35GM122465, U01CA214300, and the National Science Foundation NSF 1350659 to X.S.; Shanghai Pujiang Program (No. 13PJ1406100), National Natural Science Foundation of China (No. 81302086) Ministry of Education of China (No. 20130073120007) to Y.H.; NSF DGE 1545220 to R.X. (Integrative Bioinformatics for Investigating and Engineering Microbiomes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The co-author Dr. Yan Han performed related work when she was a postdoc at Duke University. She left Duke and joined CuraCloud in February 2017 and has not performed any work related to the manuscript since then. She is currently employed by CuraCloud. The co-author Dr. Ji Wan performed related work when he was a postdoc at Cornell University. He left Cornell and joined CuraCloud in April 2017, and has not performed any work related to the manuscript since then. He is currently employed by CuraCloud. CuraCloud did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CuraCloud has not provided any form of funding to work related to the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Balmasova I. P., 2016, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P119; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Brisac C, 2016, J HEPATOL, V65, P972, DOI 10.1016/j.jhep.2016.06.028; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Ghaleb AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129314; Gingras Ac, 1998, GENES DEV, V12; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Han Y, 2014, CELL RES, V24, P842, DOI 10.1038/cr.2014.74; Han Y, 2012, P NATL ACAD SCI USA, V109, P12467, DOI 10.1073/pnas.1208138109; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KOCK J, 1993, J VIROL, V67, P4867; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li F, 2014, SCI REPORTS, V4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Minosse C, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.28751; Murphy CM, 2016, CELL REP, V16, P2846, DOI 10.1016/j.celrep.2016.08.026; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Rawat S, 2015, J VIROL, V89, P999, DOI 10.1128/JVI.02440-14; Ren YH, 2014, ONCOTARGET, V5, P7093, DOI 10.18632/oncotarget.2197; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; Samal J, 2015, VIROLOGY, V484, P234, DOI 10.1016/j.virol.2015.06.011; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang Y, 2012, ACTA PHARMACOL SIN, V33, P953, DOI 10.1038/aps.2012.40; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Xie YY, 2012, BBA-MOL BASIS DIS, V1822, P875, DOI 10.1016/j.bbadis.2012.02.019; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209179	10.1371/journal.pone.0209179	http://dx.doi.org/10.1371/journal.pone.0209179			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640896	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000010
J	Zuo, PY; Wang, YA; Liu, J; Hu, SY; Zhao, GX; Huang, LJ; Lin, DH				Zuo, Peiying; Wang, Yinan; Liu, Jia; Hu, Siyuan; Zhao, Guoxiang; Huang, Lijie; Lin, Danhua			Effects of early adversity on the brain: Larger-volume anterior cingulate cortex in AIDS orphans	PLOS ONE			English	Article							INSTITUTIONAL DEPRIVATION; MESSENGER-RNA; CHILD-ABUSE; LIFE STRESS; HIPPOCAMPAL; AMYGDALA; PSYCHOPATHOLOGY; ABNORMALITIES; FRAMEWORK	Multiple studies have revealed that adolescent AIDS orphans have more psychosocial problems than healthy adolescents. However, little is known about whether and how the brain structures of adolescent AIDS orphans differ from those of healthy adolescents. Here, we used magnetic resonance imaging to compare adolescent AIDS orphans reared in institutions (N = 20) with a sex- and age-matched group of healthy adolescents reared in families (N = 20) in China using a voxel-based morphometry analysis. First, we found that both total gray-and white-matter volumes did not differ between groups. Second, after correcting for age, sex, and total gray-matter volume, the AIDS orphan group demonstrated smaller hippocampal volumes, larger anterior cingulate cortex (ACC) volumes, and no differences in the amygdala. Third, a whole-brain analysis identified higher gray-matter volume of the ACC in the AIDS orphan group than in the control group. The preliminary findings of this study highlight the need for future research to confirm the sensitivity of the hippocampus and ACC to early adversity.	[Zuo, Peiying; Lin, Danhua] Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China; [Wang, Yinan; Liu, Jia; Hu, Siyuan] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China; [Zhao, Guoxiang] Henan Univ, Dept Psychol, Kaifeng, Peoples R China; [Huang, Lijie] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Huang, Lijie] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Henan University; Beijing Normal University; Beijing Normal University	Lin, DH (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing, Peoples R China.	danhualin@bnu.edu.cn		Liu, Jia/0000-0003-0383-0934	National Social Science Foundation of China [15ZDB138]	National Social Science Foundation of China	This work was supported by the National Social Science Foundation of China (15ZDB138).	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avishai-Eliner S, 2001, ENDOCRINOLOGY, V142, P89, DOI 10.1210/en.142.1.89; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Brett Z., 2014, INT J BEHAV DEV; Brett ZH, 2015, DEV PSYCHOPATHOL, V27, P347, DOI 10.1017/S0954579415000036; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Carrion VG, 2009, PSYCHIAT RES-NEUROIM, V172, P226, DOI 10.1016/j.pscychresns.2008.07.008; Chi P, 2015, PSYCHOL SCI; Chi PL, 2013, AIDS BEHAV, V17, P2554, DOI 10.1007/s10461-012-0290-2; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver LD, 2008, J ADOLESCENT HEALTH, V42, P410, DOI 10.1016/j.jadohealth.2007.09.022; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fang X, 2009, J PEDIATR PSYCHOL; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Good CD, 2002, BIOMEDICAL IMAGING 2, P16; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hodel AS, 2015, NEUROIMAGE, V105, P112, DOI 10.1016/j.neuroimage.2014.10.020; Hughes V, 2012, NATURE, V490, P165, DOI 10.1038/490165a; Kong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097071; Kreppner JM, 2001, J ABNORM CHILD PSYCH, V29, P513; Li XM, 2008, J ASSOC NURSE AIDS C, V19, P147, DOI 10.1016/j.jana.2007.08.004; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; McCrory E, 2011, FRONT PSYCHIATRY, P2; McCrory E, 2012, J ROY SOC MED, V105, P151, DOI 10.1258/jrsm.2011.110222; McLaughlin KA, 2014, BIOL PSYCHIAT, V76, P629, DOI 10.1016/j.biopsych.2013.08.016; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Rametti G, 2007, SCHIZOPHR RES, V96, P62, DOI 10.1016/j.schres.2007.04.034; Richert KA, 2006, DEPRESS ANXIETY, V23, P17, DOI 10.1002/da.20131; Richter L., 2004, GENERATION RISK HIVA, V109, P9; Rutter M, 2010, MONOGR SOC RES CHILD, V75, P212, DOI 10.1111/j.1540-5834.2010.00557.x; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Tottenham N, 2009, FRONT HUM NEUROSCI, P3; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Vijayakumar N, 2014, SOCIAL COGNITIVE AFF; Wang Y, 2018, REPORT ADV PSYCHOL 2, P191; Yi S, IMPROVING ED OPPORTU; Zhao Q, 2009, J ASSOC NURSE AIDS C, V20, P122, DOI 10.1016/j.jana.2008.09.009	50	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210489	10.1371/journal.pone.0210489	http://dx.doi.org/10.1371/journal.pone.0210489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640928	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000033
J	Fotedar, S; Lukehurst, S; Jackson, G; Snow, M				Fotedar, Seema; Lukehurst, Sherralee; Jackson, Gary; Snow, Michael			Molecular tools for identification of shark species involved in depredation incidents in Western Australian fisheries	PLOS ONE			English	Article							CARCHARHINUS-TILSTONI; HAMMERHEAD SHARKS; C.-LIMBATUS; DNA; PCR; TRADE; CONSERVATION; MANAGEMENT; BYCATCH; RATIOS	Shark depredation is an issue of concern in some Western Australian recreational and commercial fisheries where it can have economic, social and ecological consequences. Knowledge of the shark species involved is fundamental to developing effective management strategies to mitigate the impacts of depredation. Identification of the species responsible is difficult as direct observation of depredation events is uncommon and evaluating bite marks on fish has a high degree of uncertainty. The use of trace DNA techniques has provided an alternative method for species identification. We demonstrate proof of concept for a targeted DNA barcoding approach to identify shark species using trace DNA found at bite marks on recovered remains of hooked fish. Following laboratory validation, forensic analysis of swabs collected from samples of bitten demersal fish, led to the definitive identification of shark species involved in 100% of the incidences of depredation (n = 16).	[Fotedar, Seema; Lukehurst, Sherralee; Jackson, Gary; Snow, Michael] Govt Western Australia, Dept Primary Ind & Reg Dev, Hillarys, WA, Australia; [Lukehurst, Sherralee] Univ Western Australia, Sch Biol Sci, Ctr Evolutionary Biol, Crawley, WA, Australia	University of Western Australia	Fotedar, S (corresponding author), Govt Western Australia, Dept Primary Ind & Reg Dev, Hillarys, WA, Australia.	seema.fotedar@dpird.wa.gov.au						Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Chuang PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147290; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Cozza K, 1996, BIOL CONSERV, V78, P329, DOI 10.1016/S0006-3207(96)00053-5; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Farley S, 2014, WILDLIFE SOC B, V38, P370, DOI 10.1002/wsb.391; Feitosa LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21683-5; Fields AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114844; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Glen AS, 2010, CONSERV GENET, V11, P1099, DOI 10.1007/s10592-009-9888-y; Green SJ, 2005, APPL ENVIRON MICROB, V71, P4721, DOI 10.1128/AEM.71.8.4721-4727.2005; Greig TW, 2005, FISH B-NOAA, V103, P516; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoey JJ, 1999, CAPTAINS REPORT MULT; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; Jauniaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108993; Johnson GJ, 2017, J FISH BIOL, V90, P39, DOI 10.1111/jfb.13102; Kagi J., 2016, ABC NEWS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kemper Catherine M., 2003, P208; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; Marlow NJ, 2015, AUST J ZOOL, V63, P18, DOI 10.1071/ZO14024; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitchell JD, 2018, REV FISH BIOL FISHER, V28, P715, DOI 10.1007/s11160-018-9528-z; Mitchell JD, 2018, MAR ECOL PROG SER, V587, P141, DOI 10.3354/meps12412; Morgan JAT, 2012, CONSERV GENET, V13, P455, DOI 10.1007/s10592-011-0298-6; Morgan JAT, 2011, MOL ECOL RESOUR, V11, P813, DOI 10.1111/j.1755-0998.2011.03023.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Rabearisoa N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202037; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remeslo AV, 2015, J NAT HIST, V49, P2483, DOI 10.1080/00222933.2015.1040477; Robinson Louise Anne, 2013, P367; Romanov E., 2007, WORKSH DEPR TUN LONG, P7; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; Shivji MS, 2005, CONSERV GENET, V6, P1035, DOI 10.1007/s10592-005-9082-9; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Tobe SS, 2010, FORENSIC SCI MED PAT, V6, P195, DOI 10.1007/s12024-010-9168-7; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148	54	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210500	10.1371/journal.pone.0210500	http://dx.doi.org/10.1371/journal.pone.0210500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633772	Green Submitted, gold, Green Published			2022-12-27	WOS:000455485100026
J	Hankerson, BR; Schierhorn, F; Prishchepov, AV; Dong, CX; Eisfelder, C; Muller, D				Hankerson, Brett R.; Schierhorn, Florian; Prishchepov, Alexander V.; Dong, Changxing; Eisfelder, Christina; Mueller, Daniel			Modeling the spatial distribution of grazing intensity in Kazakhstan	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NET PRIMARY PRODUCTIVITY; LAND-COVER DATA; LIVESTOCK DISTRIBUTIONS; CHALLENGES; BIODIVERSITY; YEAR-2000; PATTERNS; STEPPES	With increasing affluence in many developing countries, the demand for livestock products is rising and the increasing feed requirement contributes to pressure on land resources for food and energy production. However, there is currently a knowledge gap in our ability to assess the extent and intensity of the utilization of land by livestock, which is the single largest land use in the world. We developed a spatial model that combines fine-scale livestock numbers with their associated energy requirements to distribute livestock grazing demand onto a map of energy supply, with the aim of estimating where and to what degree pasture is being utilized. We applied our model to Kazakhstan, which contains large grassland areas that historically have been used for extensive livestock production but for which the current extent, and thus the potential for increasing livestock production, is unknown. We measured the grazing demand of Kazakh livestock in 2015 at 286 Petajoules, which was 25% of the estimated maximum sustainable energy supply that is available to livestock for grazing. The model resulted in a grazed area of 1.22 million km(2), or 48% of the area theoretically available for grazing in Kazakhstan, with most utilized land grazed at low intensities (average offtake rate was 13% of total biomass energy production). Under a conservative scenario, our estimations showed a production potential of 0.13 million tons of beef additional to 2015 production (31% increase), and much more with utilization of distant pastures. This model is an important step forward in evaluating pasture use and available land resources, and can be adapted at any spatial scale for any region in the world.	[Hankerson, Brett R.; Schierhorn, Florian; Dong, Changxing; Mueller, Daniel] Leibniz Inst Agr Dev Transit Econ IAMO, Halle, Saale, Germany; [Hankerson, Brett R.; Mueller, Daniel] Humboldt Univ, Dept Geog, Berlin, Germany; [Prishchepov, Alexander V.] Univ Copenhagen, Dept Geosci & Nat Resource Management IGN, Copenhagen, Denmark; [Prishchepov, Alexander V.] Kazan Fed Univ, Inst Environm Sci, Kazan, Russia; [Eisfelder, Christina] German Aerosp Ctr DLR, German Remote Sensing Data Ctr DFD, Oberpfaffenhofen, Germany; [Mueller, Daniel] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany	Leibniz Institut fur Agrarentwicklung in Transformationsokonomien (IAMO); Humboldt University of Berlin; University of Copenhagen; Kazan Federal University; Helmholtz Association; German Aerospace Centre (DLR); Humboldt University of Berlin	Hankerson, BR (corresponding author), Leibniz Inst Agr Dev Transit Econ IAMO, Halle, Saale, Germany.; Hankerson, BR (corresponding author), Humboldt Univ, Dept Geog, Berlin, Germany.	hankerson@iamo.de	, IAMO/G-2328-2012; Change, Structural/W-8306-2019; Mueller, Daniel/A-4454-2009; Müller, Daniel/AAI-4867-2021; Prishchepov, Alexander/H-6708-2012	, IAMO/0000-0001-7922-9665; Change, Structural/0000-0002-2459-4646; Mueller, Daniel/0000-0001-8988-0718; Müller, Daniel/0000-0001-8988-0718; Prishchepov, Alexander/0000-0003-2375-1651	Leibniz-Gemeinschaft [SAW-2012-IAMO-7]; Open Access Fund of the Leibniz Association	Leibniz-Gemeinschaft; Open Access Fund of the Leibniz Association	Funded by Leibniz-Gemeinschaft to DM. Grant number: SAW-2012-IAMO-7. URL: https://www.leibniz-gemeinschaft.de/start/. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimaev Illya I., 2008, P151, DOI 10.1007/978-1-4020-4906-4_7; [Anonymous], 2016, OPENSTREETMAP DAT EX; [Anonymous], R LANG ENV STAT COMP; Association for the Conservation of Biodiversity of Kazakhstan, 2018, ALT DAL CONS IN; BARET F, 1992, PLANT SOIL, V140, P137, DOI 10.1007/BF00012815; Behnke R., 2008, SOCIOECONOMIC CAUSES; Behnke R, 2016, LAND USE POLICY, V52, P103, DOI 10.1016/j.landusepol.2015.12.012; Bouwman AF, 2005, AGR SYST, V84, P121, DOI 10.1016/j.agsy.2004.05.006; Brinkert A, 2015, BIODIVERS CONSERV, P1; Chang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127554; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Coughenour M, SOCIOECONOMIC CAUSES; Eisfelder C, 2017, ECOL INDIC, V72, P13, DOI 10.1016/j.ecolind.2016.07.042; Eisfelder C, 2014, J ARID ENVIRON, V103, P17, DOI 10.1016/j.jaridenv.2013.12.005; Ellis J., 2003, Prospects for pastoralism in Kazakstan and Turkmenistan: from state farms to private flocks, P52; Erb KH, 2016, HUMAN ENVIRON INTERA, P295, DOI 10.1007/978-3-319-33326-7_13; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; Fetzel T, 2017, GLOBAL BIOGEOCHEM CY, V31, P1089, DOI 10.1002/2016GB005601; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garnett Tara, 2017, GRAZED CONFUSED RUMI; Gilbert M, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.227; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Goldewijk KK, 2007, J LAND USE SCI, V2, P167, DOI 10.1080/17474230701622940; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Grebennikov VG, 2012, PERENNIAL GRASSES PA; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hall W. B., 1998, Rangeland Journal, V20, P177, DOI 10.1071/RJ9980177; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Herrero M, 2009, CURR OPIN ENV SUST, V1, P111, DOI 10.1016/j.cosust.2009.10.003; Holechek J.L., 1988, RANGELANDS, V10, P10, DOI DOI 10.2307/4000362; Holzel N., 2002, Journal for Nature Conservation, V10, P75, DOI 10.1078/1617-1381-00009; IIASA FAO, 2012, GLOB AGR ZON GAEZ V3; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Kamp J, 2016, BIODIVERS CONSERV, V25, P2521, DOI 10.1007/s10531-016-1083-0; Kamp J, 2015, J APPL ECOL, V52, P1578, DOI 10.1111/1365-2664.12527; Kamp J, 2012, AGR ECOSYST ENVIRON, V155, P41, DOI 10.1016/j.agee.2012.03.023; Kamp J, 2009, IBIS, V151, P452, DOI 10.1111/j.1474-919X.2009.00938.x; KazStat, 2008, RES 1 NAT AGR CENS; Kerven C, 2016, LAND USE POLICY, V52, P392, DOI 10.1016/j.landusepol.2015.12.030; Klein I, 2012, APPL GEOGR, V35, P219, DOI 10.1016/j.apgeog.2012.06.016; Kock RA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao2314; Kraemer R, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/5/054012; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; Kuemmerle T, 2013, CURR OPIN ENV SUST, V5, P484, DOI 10.1016/j.cosust.2013.06.002; Low F, 2015, APPL GEOGR, V62, P377, DOI 10.1016/j.apgeog.2015.05.009; Manceron S, 2014, OCL OILS FAT CROP LI, V21, DOI 10.1051/ocl/2014020; McNaughton SJ, 1996, ECOLOGY, V77, P974, DOI 10.2307/2265518; Meyfroidt P, 2016, GLOBAL ENVIRON CHANG, V37, P1, DOI 10.1016/j.gloenvcha.2016.01.003; Milner-Gulland EJ, 2001, ORYX, V35, P340, DOI 10.1017/S0030605300032105; Mirzabaev A, 2016, J ARID LAND, V8, P93, DOI 10.1007/s40333-015-0057-5; Nasiev BN, 2014, P ORENBURG STATE AGR, P54; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; NHSS, 2015, RES CENS CONSTR BUIL; Nicolas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150424; O'Mara FP, 2011, ANIM FEED SCI TECH, V166-67, P7, DOI 10.1016/j.anifeedsci.2011.04.074; Olcott MB, 1995, KAZAKHS HOOVER I PRE; Petrick M, 2013, WORLD DEV, V43, P164, DOI 10.1016/j.worlddev.2012.09.015; Pflugmacher D, 2011, REMOTE SENS ENVIRON, V115, P3539, DOI 10.1016/j.rse.2011.08.016; Phelps LN, 2017, GLOBAL CHANGE BIOL, V23, P4457, DOI 10.1111/gcb.13732; Propastin PA, 2012, INT J REMOTE SENS, V33, P1465, DOI 10.1080/01431161.2011.577105; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robinson S, 2016, AGR SYST, V143, P169, DOI 10.1016/j.agsy.2015.12.018; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Robinson S, 2003, J ARID ENVIRON, V53, P419, DOI 10.1006/jare.2002.1047; Robinson S, 2016, HUM ECOL, P1; Robinson Sarah., 2000, PASTORALISM LAND DEG; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Safin KM, 2011, BASHKIR STATE AGRARI, P5; Schierhorn F, 2016, GLOB FOOD SECUR-AGR, V11, P84, DOI 10.1016/j.gfs.2016.08.001; Shelestov A, 2017, FRONT EARTH SC-SWITZ, V5, P1, DOI 10.3389/feart.2017.00017; Smil V, 1999, BIOSCIENCE, V49, P299, DOI 10.2307/1313613; Sommer R, 2013, AGR ECOSYST ENVIRON, V178, P78, DOI 10.1016/j.agee.2013.06.011; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; Wang D, 2005, 20 INT GRASSL C DUBL; Webber B. L., 2015, Sheep & Goat Research Journal, V30, P18; Wesche K., 2012, EURASIAN STEPPES ECO, P3, DOI [10.1007/978-94-007-3886-7_1, DOI 10.1007/978-94-007-3886-7_]; Wint W., 2007, GRIDDED LIVESTOCK WO; Wirsenius, 2000, HUMAN USE LAND ORGAN; Wisskirchen K, 2013, GEOSCI MODEL DEV, V6, P1623, DOI 10.5194/gmd-6-1623-2013; Yan L, 2014, REMOTE SENS ENVIRON, V144, P42, DOI 10.1016/j.rse.2014.01.006; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zhazylbekov NA, 2008, NUTR LIVESTOCK POULT	86	17	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210051	10.1371/journal.pone.0210051	http://dx.doi.org/10.1371/journal.pone.0210051			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633752	Green Published, Green Accepted, gold			2022-12-27	WOS:000455485100013
J	Clark, B; Panzone, LA; Stewart, GB; Kyriazakis, I; Niemi, JK; Latvala, T; Tranter, R; Jones, P; Frewer, LJ				Clark, Beth; Panzone, Luca A.; Stewart, Gavin B.; Kyriazakis, Ilias; Niemi, Jarkko K.; Latvala, Terhi; Tranter, Richard; Jones, Philip; Frewer, Lynn J.			Consumer attitudes towards production diseases in intensive production systems	PLOS ONE			English	Article							FARM-ANIMAL WELFARE; RISK-FACTORS; PIG FARMERS; FOOD; CITIZENS; QUALITY; METAANALYSIS; WILLINGNESS; PREFERENCES; CONFIDENCE	Many members of the public and important stakeholders operating at the upper end of the food chain, may be unfamiliar with how food is produced, including within modern animal production systems. The intensification of production is becoming increasingly common in modern farming. However, intensive systems are particularly susceptible to production diseases, with potentially negative consequences for farm animal welfare (FAW). Previous research has demonstrated that the public are concerned about FAW, yet there has been little research into attitudes towards production diseases, and their approval of interventions to reduce these. This research explores the public's attitudes towards, and preferences for, FAW interventions in five European countries (Finland, Germany, Poland, Spain and the UK). An online survey was conducted for broilers (n = 789), layers (n = 790) and pigs (n = 751). Data were analysed by means of Kruskal-Wallis ANOVA, exploratory factor analysis and structural equation modelling. The results suggest that the public have concerns regarding intensive production systems, in relation to FAW, naturalness and the use of antibiotics. The most preferred interventions were the most "proactive" interventions, namely improved housing and hygiene measures. The least preferred interventions were medicine-based, which raised humane animal care and food safety concerns amongst respondents. The results highlighted the influence of the identified concerns, perceived risks and benefits on attitudes and subsequent behavioural intention, and the importance of supply chain stakeholders addressing these concerns in the subsequent communications with the public.	[Clark, Beth; Panzone, Luca A.; Stewart, Gavin B.; Kyriazakis, Ilias; Frewer, Lynn J.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Niemi, Jarkko K.; Latvala, Terhi] Nat Resources Inst Finland Luke, Seinajoki, Finland; [Tranter, Richard; Jones, Philip] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	Newcastle University - UK; Natural Resources Institute Finland (Luke); University of Reading	Frewer, LJ (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	lynn.frewer@newcastle.ac.uk	Niemi, Jarkko/ABG-8512-2020; Latvala, Terhi/D-9866-2013; Panzone, Luca/I-3086-2019; Clark, Beth/A-5561-2015	Niemi, Jarkko/0000-0002-9545-3509; Panzone, Luca/0000-0003-2382-3635; Latvala, Terhi/0000-0002-8855-7377; Jones, Philip/0000-0003-3464-5424; Clark, Beth/0000-0002-9828-6806; Kyriazakis, Ilias/0000-0001-7703-3626	European Union's Seventh Framework Programme for research, technological development and demonstration [613574]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 613574 to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, INTENTIONS ACTIONS T, DOI DOI 10.1007/978-3-642-69746-3_2; Ajzen I., 2011, THEORY PLANNED BEHAV; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Asveld L, 2015, J AGR ENVIRON ETHIC, V28, P571, DOI 10.1007/s10806-015-9542-2; Bauman Z, 2014, INT POLIT SOCIOL, V8, P121, DOI 10.1111/ips.12048; Benard M, 2013, J AGR ENVIRON ETHIC, V26, P1015, DOI 10.1007/s10806-013-9438-y; Bengtsson B, 2014, UPSALA J MED SCI, V119, P96, DOI 10.3109/03009734.2014.901445; Bennett RM, 2012, VALUATION ANIMAL WEL; Bernard JC, 2009, AM J AGR ECON, V91, P826, DOI 10.1111/j.1467-8276.2009.01258.x; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; Breakwell GM, 2003, PUBLIC PERCEPTIONS A; Broom DM, 2010, J VET MED EDUC, V37, P83, DOI 10.3138/jvme.37.1.83; Byrne B. M, 2001, INT J TEST, V1, P327, DOI DOI 10.1080/15305058.2001.9669479; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Conti GO, 2015, FOOD CONTROL, V50, P937, DOI 10.1016/j.foodcont.2014.10.050; Contributors.s, 2016, SEMTOOLS US TOOLS ST; Corp I, 2011, IBM SPSS STAT WIND V; D'Eath RB, 2014, ANIMAL, V8, P1479, DOI 10.1017/S1751731114001359; Dawkins MS, 2017, ANIM PROD SCI, V57, P201, DOI 10.1071/AN15383; de Jonge J, 2008, APPETITE, V51, P311, DOI 10.1016/j.appet.2008.03.008; Department of Environment FaRA, 2017, AV INFL BIRD FLU WIN; European Commission, 2007, ATT EU CIT AN WELF; Evermann J, 2010, STRUCT EQU MODELING, V17, P677, DOI 10.1080/10705511.2010.510070; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Field A., 2013, DISCOVERING STAT USI; Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S; Fischer ARH, 2009, FOOD QUAL PREFER, V20, P576, DOI 10.1016/j.foodqual.2009.06.008; Food and Acriculture Organization of the United Nations Organization WH, 1998, APPL RISK COMM FOOD; Fraser D., 2005, ALTERNATIVE INTERPRE; Frewer L, 2004, TOXICOL LETT, V149, P391, DOI 10.1016/j.toxlet.2003.12.049; Frewer L., 2002, SCI PUBLIC POLICY, V29, P137, DOI DOI 10.3152/147154302781781092; GILBERT M, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0133381; Griffiths R., 2004, MEAT SCI, V66, P259, DOI [10.1016/S0309-1740(03)00130-X, DOI 10.1016/S0309-1740(03)00130-X]; Grunert KG, 2006, MEAT SCI, V74, P149, DOI 10.1016/j.meatsci.2006.04.016; Harper G., 2001, CONSUMER CONCERNS AN; High Level Panel of Experts on Food Security and Nutrition, 2016, SUST AGR DEV FOOD SE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson JA, 2017, TRENDS FOOD SCI TECH, V69, P131, DOI 10.1016/j.tifs.2017.09.007; Hughes P, 2002, ANTIBIOTICS ANIMAL G; Jones P, 2016, LIST STAKEHOLDER PRE; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KilBride AL, 2012, PREV VET MED, V104, P281, DOI 10.1016/j.prevetmed.2011.11.011; Kirk SFL, 2002, APPETITE, V38, P189, DOI 10.1006/appe.2001.0478; Kjaernes U, 2007, FARM ANIMAL WELFARE; Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., DOI DOI 10.1038/156278A0; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lassoued R, 2015, FOOD POLICY, V52, P99, DOI 10.1016/j.foodpol.2014.12.003; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lusk JL., 2007, CONSUMER PREFERENCES; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Miele M, 2011, ANIM WELFARE, V20, P103; Niemi J. K., 2016, Review of Agricultural, Food and Environmental Studies, V97, P215, DOI 10.1007/s41130-016-0022-5; Niemi JK, 2015, QUANTIFICATION COSTS; Nocella G, 2012, PSYCHOL MARKET, V29, P850, DOI 10.1002/mar.20569; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pandolfi F, 2017, PREV VET MED, V137, P1, DOI 10.1016/j.prevetmed.2016.12.005; Pandolfi F, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00041; Papadopoulos GA, 2010, VET J, V184, P167, DOI 10.1016/j.tvjl.2009.01.010; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poinhos R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110614; Poortinga W, 2005, RISK ANAL, V25, P199, DOI 10.1111/j.0272-4332.2005.00579.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Rosseel Y., 2011, LAVAAN R PACKAGE STR; Scudamore JM, 2007, REV SCI TECH OIE, V26, P451, DOI 10.20506/rst.26.2.1755; Spooner JM, 2014, LIVEST SCI, V163, P150, DOI 10.1016/j.livsci.2014.02.011; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Stevens J., 1996, APPL MULTIVARIATE ST, V3rd Edn.; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Dijk H, 2011, RISK ANAL, V31, P429, DOI 10.1111/j.1539-6924.2010.01505.x; Van Kleef E, 2007, RISK ANAL, V27, P1565, DOI 10.1111/j.1539-6924.2007.00989.x; Vanhonacker F, 2010, J AGR ENVIRON ETHIC, V23, P551, DOI 10.1007/s10806-010-9235-9; Velde H. te, 2002, Journal of Agricultural & Environmental Ethics, V15, P203, DOI 10.1023/A:1015012403331; Verbeke W, 2010, MEAT SCI, V84, P284, DOI 10.1016/j.meatsci.2009.05.001; Willgert KJE, 2014, PREV VET MED, V113, P268, DOI 10.1016/j.prevetmed.2013.10.004; You KG, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5163-0; Zhong YQ, 2017, FOOD CONTROL, V73, P1532, DOI 10.1016/j.foodcont.2016.11.016; Zingg A, 2012, FOOD POLICY, V37, P226, DOI 10.1016/j.foodpol.2012.02.001	85	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210432	10.1371/journal.pone.0210432	http://dx.doi.org/10.1371/journal.pone.0210432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629667	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000455483000089
J	Eshun-Wilson, I; Rohwer, A; Hendricks, L; Oliver, S; Garner, P				Eshun-Wilson, Ingrid; Rohwer, Anke; Hendricks, Lynn; Oliver, Sandy; Garner, Paul			Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model	PLOS ONE			English	Review							MIDDLE-INCOME COUNTRIES; HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICA; HEALTH-CARE; IMPROVE ADHERENCE; FOOD INSECURITY; RE-ENGAGEMENT; FOLLOW-UP; EXPERIENCES; PEOPLE	Background Adherence to antiretroviral therapy (ART) and long-term uninterrupted engagement in HIV care is difficult for HIV-positive people, and randomized trials of specific techniques to promote adherence often show small or negligible effects. Understanding what influences decision-making in HIV-positive people in Africa may help researchers and policy makers in the development of broader, more effective interventions and policies. Methods We used thematic synthesis and a grounded theory approach to generate a detailed narrative and theoretical model reflecting life with HIV in Africa, and how this influences ART adherence and engagement decisions. We included qualitative primary studies that explored perspectives, perceptions and experiences of HIV-positive people, caregivers and healthcare service providers. We searched databases from 1 January 2013 to 9 December 2016, screened all studies, and selected those for inclusion using purposeful sampling methods. Included studies were coded with Atlas.ti, and we assessed methodological quality across five domains. Results We included 59 studies from Africa in the synthesis. Nine themes emerged which we grouped under three main headings. First, people who are HIV-positive live in a complicated world where they must navigate the challenges presented by poverty, competing priorities, unpredictable life events, social identity, gender norms, stigma, and medical pluralism-these influences can make initiating and maintaining ART difficult. Second, the health system is generally seen as punishing and uninviting and this can drive HIV-positive people out of care. Third, long-term engagement and adherence requires adaptation and incorporation of ART into daily life, a process which is facilitated by: inherent self-efficacy, social responsibilities, previous HIV-related illnesses and emotional, practical or financial support. These factors together can lead to a "tipping point", a point in time when patients choose to either engage or disengage from care. HIV-positive people may cycle in and out of these care states in response to fluctuations in influences over time. Conclusion This analysis provides a practical theory, arising from thematic synthesis of research, to help understand the dynamics of adherence to ART and engagement in HIV care. This can contribute to the design of service delivery approaches, and informed thinking and action on the part of policy makers, providers, and society: to understand what it is to be HIV-positive in Africa and how attitudes and the health service need to shift to help those with HIV lead 'normal' lives.	[Eshun-Wilson, Ingrid; Rohwer, Anke; Hendricks, Lynn] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Cape Town, South Africa; [Eshun-Wilson, Ingrid] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Oliver, Sandy] UCL, UCL Inst Educ, London, England; [Oliver, Sandy] Univ Johannesburg, Africa Ctr Evidence, Johannesburg, South Africa; [Garner, Paul] Univ Liverpool Liverpool Sch Trop Med, Ctr Evidence Synth Global Hlth, Liverpool, Merseyside, England	Stellenbosch University; University of California System; University of California San Francisco; University of London; University College London; UCL Institute of Education; University of Johannesburg; Liverpool School of Tropical Medicine	Eshun-Wilson, I (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Cape Town, South Africa.; Eshun-Wilson, I (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.	wilson.ingrid@gmail.com	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019; Hendricks, Lynn/AAF-7593-2019	Garner, Paul/0000-0002-0607-6941; Oliver, Sandy/0000-0001-9571-269X; Hendricks, Lynn/0000-0003-0382-4163	UK aid from the UK government [300342-104]	UK aid from the UK government(CGIAR)	This publication is associated with the Research, Evidence and Development Initiative (READ-It) project. The READ-It (project number 300342-104 to PG) is funded by UK aid from the UK government; however, the views expressed do not necessarily reflect the UK government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonkhai AA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1137-z; [Anonymous], 2017, ADHERENCE LINKAGE RE; Asgary R, 2014, AM J TROP MED HYG, V90, P153, DOI 10.4269/ajtmh.13-0215; Assefa Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-45; Audet CM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1934-6; Axelsson JM, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0026-9; Bajunirwe F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9619684; Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181144; Barford TS, AFRICAN TIME IS TIME; Beckmann N, 2013, ANTHROPOL MED, V20, P160, DOI 10.1080/13648470.2013.800805; Belisle HA, 2015, GLOB PUBLIC HEALTH, V10, P71, DOI 10.1080/17441692.2014.967709; Benoot C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0114-6; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bhagwanjee A, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18973, DOI 10.7448/IAS.16.1.18973]; Bhagwanjee A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18021; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bogart LM, 2013, AIDS CARE, V25, P843, DOI 10.1080/09540121.2012.729808; Bourdieu P., 1986, FORMS CAPITAL; Braga B, 2013, DEATH IS DESTINY SOV; Braga CMT, 2012, DEATH IS DESTINY SOV; Buhikire K, 2018, AIDS BEHAV, V22, P2458, DOI 10.1007/s10461-018-2137-y; Burrowes S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1442-1; Busza J, 2018, AIDS CARE, V30, P903, DOI 10.1080/09540121.2018.1445826; Busza J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18839; Campbell C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1139-x; Cange CW, 2015, SEX HEALTH, V12, P315, DOI 10.1071/SH15001; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; Chop E, 2017, HEALTH CARE WOMEN IN, V38, P927, DOI 10.1080/07399332.2017.1337774; Claborn KR, 2015, PSYCHOL HEALTH MED, V20, P255, DOI 10.1080/13548506.2014.945601; Coetzee B, 2015, AIDS CARE, V27, P315, DOI 10.1080/09540121.2014.967658; Covidence, 2016, COV SYST REV SOFTW; Dahourou DL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21528; Devine PG, 1999, AM BEHAV SCI, V42, P1212, DOI 10.1177/00027649921954732; Dlamini-Simelane TTT, 2017, HEALTH POLICY PLANN, V32, P248, DOI 10.1093/heapol/czw117; Elwell K., 2015, THESIS, P210; Elwell K., 2015, SOCIAL STRUCTURAL FA; Evangeli M, 2017, AIDS BEHAV, V21, P1, DOI 10.1007/s10461-016-1453-3; Fielding-Miller R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-79; Flax VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178298; Fords GM, 2017, SAHARA J-J SOC ASP H, V14, P85, DOI 10.1080/17290376.2017.1379430; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Guise A, 2016, AIDS CARE, V28, P1595, DOI 10.1080/09540121.2016.1191606; Hatcher AM, 2016, SOC SCI MED, V168, P130, DOI 10.1016/j.socscimed.2016.09.013; Hoddinott G, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25135; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Hornschuh S, 2014, J HIV-AIDS SOC SERV, V13, P420, DOI 10.1080/15381501.2013.804472; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Hurley EA, 2018, J HEALTH COMMUN, V23, P129, DOI 10.1080/10810730.2017.1417513; Inzaule SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167492; Jones C., 2014, STATE SICKNESS SOCIA; Jones Claire, 2014, THESIS; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Katz IT, 2015, AIDS CARE, V27, P1298, DOI 10.1080/09540121.2015.1051502; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kaufman MR, 2014, JAIDS-J ACQ IMM DEF, V66, pS250, DOI 10.1097/QAI.0000000000000236; Kawuma R, 2014, AJAR-AFR J AIDS RES, V13, P189, DOI 10.2989/16085906.2014.927778; Kennedy CE, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18749; Kim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192983; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Kruk ME, 2018, HEALTH POLICY PLANN, V33, pE26, DOI 10.1093/heapol/czu079; Kulane A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070721; Kutnick AH, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00100; Larson E, 2016, HEALTH POLICY PLANN, V31, P964, DOI 10.1093/heapol/czw020; Layer EH, 2014, AIDS PATIENT CARE ST, V28, P483, DOI 10.1089/apc.2014.0077; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Lee H, 2018, STAT MED, V37, P302, DOI 10.1002/sim.7502; Leyva-Moral JM, 2018, INT J NURS STUD, V77, P207, DOI 10.1016/j.ijnurstu.2017.10.012; Li HC, 2017, AIDS BEHAV, V21, P341, DOI 10.1007/s10461-016-1545-0; Lytvyn L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019023; Maeri I, 2016, AIDS CARE, V28, P59, DOI 10.1080/09540121.2016.1168917; Masquillier C, 2015, INT J ENV RES PUB HE, V12, P3264, DOI 10.3390/ijerph120303264; Mattes D, 2014, CHILD YOUTH SERV REV, V45, P28, DOI 10.1016/j.childyouth.2014.03.035; Mbonye M, 2016, AIDS CARE, V28, P33, DOI 10.1080/09540121.2016.1164804; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; McLaren L, 2005, J EPIDEMIOL COMMUN H, V59, P6, DOI 10.1136/jech.2003.018044; McLean E, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052972; McMahon SA, 2017, AIDS BEHAV, V21, P317, DOI 10.1007/s10461-016-1505-8; Mendelsohn JB, 2014, SOC SCI MED, V120, P387, DOI 10.1016/j.socscimed.2014.06.010; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mills EJ, 2006, ADHERENCE HAART SYST, V3, DOI [10.1371/JOURNAL.PMED.0030438, DOI 10.1371/JOURNAL.PMED.0030438]; Moriarty K, 2018, J ASSOC NURSE AIDS C, V29, P231, DOI 10.1016/j.jana.2017.09.014; Moshabela M, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052974; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Mutumba M, 2015, AIDS PATIENT CARE ST, V29, P86, DOI 10.1089/apc.2014.0222; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nachega JB, 2018, CLIN INFECT DIS, V66, P1487, DOI 10.1093/cid/ciy008; Nachega JB, 2016, CURR HIV-AIDS REP, V13, P241, DOI 10.1007/s11904-016-0325-9; Naik R, 2013, LINKAGE CARE FOLLOWI; Nakanwagi S, 2016, J SEX TRANSM DIS, V2016, P1, DOI [10.1155/2016/7673014, DOI 10.1155/2016/7673014]; Nanfuka EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197979; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Niehaus I, 2014, MED ANTHROPOL, V33, P351, DOI 10.1080/01459740.2013.802319; O'Laughlin KN, 2018, CONFL HEALTH, V12, DOI 10.1186/s13031-018-0145-1; Okoror TA, 2013, AIDS PATIENT CARE ST, V27, P55, DOI 10.1089/apc.2012.0150; Ondenge K, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052973; Parsons JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127392; Patton M. Q., 1990, QUALITATIVE EVALUATI; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Rasmussen LM, 2013, CULT HEALTH SEX, V15, pS537, DOI 10.1080/13691058.2013.809606; Rees R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-188; Russell S, 2016, QUAL HEALTH RES, V26, P1447, DOI 10.1177/1049732315597654; Russell S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147896; Saleem HT, 2016, INT J DRUG POLICY, V30, P59, DOI 10.1016/j.drugpo.2015.12.009; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Scott K, 2014, HEALTH PROMOT INT, V29, P645, DOI 10.1093/heapro/dat014; Shabalala FS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25120; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Sikstrom L, 2014, CHILD YOUTH SERV REV, V45, P47, DOI 10.1016/j.childyouth.2014.03.037; Sikweyiya YM, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24631; Siu GE, 2014, SAHARA J-J SOC ASP H, V11, P211, DOI 10.1080/17290376.2014.986516; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Skodval M, 2018, J HEALTH PSYCHOL, P1, DOI [10.1177/13591053187886, DOI 10.1177/13591053187886]; Skovdal M, 2017, SEX TRANSM INFECT, V93, DOI 10.1136/sextrans-2016-052977; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; Sze L, 2016, AIDS, V30, P1639, DOI 10.1097/QAD.0000000000001101; Topp SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193641; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2018, UNAIDS FACT SHEET EN; Wanyenze RK, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0119-1; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Watt MH, 2017, AIDS BEHAV, V21, P3209, DOI 10.1007/s10461-016-1617-1; WHO, 2018, PREV HIV TEST TREAT; WHO, MAN ADV HIV DIS RAP; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0018-7; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; Wouters E, 2016, SOCIOL HEALTH ILL, V38, P521, DOI 10.1111/1467-9566.12377; Yoshida K, 2014, DISABIL REHABIL, V36, P2161, DOI 10.3109/09638288.2014.894144; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4; Zissette S, 2016, PSYCHOL MEN MASCULIN, V17, P265, DOI 10.1037/men0000025	140	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210408	10.1371/journal.pone.0210408	http://dx.doi.org/10.1371/journal.pone.0210408			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629648	Green Published, gold, Green Accepted			2022-12-27	WOS:000455483000082
J	Fan, ZY; Liao, ZJ; Zong, XN; Zhang, SM				Fan, Zhaoyang; Liao, Zijun; Zong, Xinnan; Zhang, Shuaiming			Differences in prevalence of prehypertension and hypertension in children and adolescents in the eastern, central and western regions of China from 1991-2011 and the associated risk factors	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; BODY-MASS INDEX; WAIST CIRCUMFERENCE; PREDICTS HYPERTENSION; METABOLIC SYNDROME; NATIONAL-HEART; OBESE CHILDREN; TRENDS; OVERWEIGHT; HEIGHT	The present study aimed to estimate the differences in rates of prehypertension and hypertension in children and adolescents among three regions with different socioeconomic status in China, and explore the corresponding risk factors associated with prehypertension and hypertension to guide the prevention. Blood pressure measurements of 13 762 children and adolescents aged 6-17 years were obtained from a prospective national survey (the China Health and Nutrition Survey, 1991-2011). Prehypertension and hypertension were defined by age and gender, according to China's standard criteria. Chi-square tests were used to compare the differences in the prevalence of prehypertension and hypertension among three regions. Trend chi-square tests were used to detect the trends in rates of pre-hypertension and hypertension over survey years. Logistic regression models were used to detect the potential risk factors of prehypertension and hypertension in children and adolescents. During the survey years, the overall prevalence of prehypertension and hypertension were 6.0% and 10.6%. The corresponding rates in the western region were lowest, but increased rapidly over the two decades (84.0% and 122.6% increases respectively, P<0.001). The overall hypertension rate remained high in the eastern region, despite the slower increase (24.2% increase). In the central region, although the prehypertension rate remained stable, the rate of hypertension had a 94.8% increase these years (P<0.0001). According to the results of logistic regression, age, body mass index (BMI) and waist/height ratio (WHtR) were associated with prehypertension and hypertension. Children and adolescents in the eastern region had the highest level of prehypertension and hypertension, while the rapid increase of blood pressure in the western and central regions were also supposed to concern. Improvement of the healthy lifestyle is urgent for prehypertension and hypertension prevention in children and adolescents.	[Fan, Zhaoyang; Zhang, Shuaiming] Capital Inst Pediat, Dept Early Child Dev, Beijing, Peoples R China; [Liao, Zijun] Peking Univ, Inst Reprod & Child Hlth, Key Lab Reprod Hlth, Minist Hlth,Hlth Sci Ctr, Beijing, Peoples R China; [Liao, Zijun] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Zong, Xinnan] Capital Inst Pediat, Dept Growth, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Peking University; Peking University; Capital Institute of Pediatrics (CIP)	Fan, ZY (corresponding author), Capital Inst Pediat, Dept Early Child Dev, Beijing, Peoples R China.	fanzhaoyang@126.com						[Anonymous], CHIN J EVID BASED PE; Berenson GS, 1995, AM J MED SCI, V310, pS22, DOI 10.1097/00000441-199512000-00005; BLUMENTHAL S, 1977, PEDIATRICS, V59, P797; Chen C, 2018, CANCER BIOL THER, V19, P1065, DOI 10.1080/15384047.2018.1480291; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; CHNSs, CHIN HLTH NUTR SURV; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 1996, J PEDIATR-US, V129, P208, DOI 10.1016/S0022-3476(96)70244-5; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Dong B, 2013, AM J HYPERTENS, V26, P997, DOI 10.1093/ajh/hpt050; Fu JF, 2007, INT J OBESITY, V31, P15, DOI 10.1038/sj.ijo.0803453; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hansen ML, 2007, JAMA-J AM MED ASSOC, V298, P874, DOI 10.1001/jama.298.8.874; Hu YH, 2011, J INT MED RES, V39, P23, DOI 10.1177/147323001103900103; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Leung LCK, 2011, ARCH DIS CHILD, V96, P804, DOI 10.1136/adc.2010.202770; Levine DA, 2013, STROKE, V44, P3243, DOI 10.1161/STROKEAHA.113.003051; Li YC, 2017, INT J CARDIOL, V227, P516, DOI 10.1016/j.ijcard.2016.10.110; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Lu X, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-24; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Muntner P, 2004, JAMA-J AM MED ASSOC, V291, P2107, DOI 10.1001/jama.291.17.2107; POPKIN BM, 1995, OBES RES, V3, pS135, DOI 10.1002/j.1550-8528.1995.tb00456.x; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tareque MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127954; Wan YP, 2009, WORLD J PEDIATR, V5, P269, DOI 10.1007/s12519-009-0051-0; Wen M, 2016, J BIOSOC SCI, V48, P129, DOI 10.1017/S002193201500005X; Willig AL, 2010, AM J HYPERTENS, V23, P904, DOI 10.1038/ajh.2010.82; Xu HQ, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/987159; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Yan WL, 2016, J HYPERTENS, V34, P2337, DOI 10.1097/HJH.0000000000001114; Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195; Yao SJ, 2001, J DEV STUD, V38, P167, DOI 10.1080/00220380412331322301; Yiannikouris F, 2010, CURR OPIN NEPHROL HY, V19, P195, DOI 10.1097/MNH.0b013e3283366cd0	39	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210591	10.1371/journal.pone.0210591	http://dx.doi.org/10.1371/journal.pone.0210591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629671	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000114
J	Goshu, YA; Yitayew, AE				Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu			Malaria knowledge and its associated factors among pregnant women attending antenatal clinic of Adis Zemen Hospital, North-western Ethiopia, 2018	PLOS ONE			English	Article								Introduction In Ethiopia, the burden of malaria during pregnancy remains a public health problem. Having a good malaria knowledge leads to practicing the prevention of malaria and seeking a health care. Researches regarding pregnant women's knowledge on malaria in Ethiopia is limited. So the aim of this study was to assess malaria knowledge and its associated factors among pregnant woman, 2018. Methods An institutional-basedcross-sectional study was conducted in Adis Zemen Hospital. Data were collected using pre-tested, an interviewer-administered structured questionnaire among 236 mothers. Women's knowledge on malaria was measured using six malariarelated questions (cause of malaria, mode of transmission, signs and symptoms, complication and prevention of malaria). The collected data were entered using Epidata version 3.1 and exported to SPSS version 20 for analysis. Bivariate and multivariate logistic regressions were computed to identify predictor variables at 95% confidence interval. Variables having P value of < 0.05 were considered as predictor variables of malaria knowledge. Result A total of 235 pregnant women participated which makes the response rate 99.6%. One hundred seventy two pregnant women (73.2%) of mothers had good knowledge on malaria. Women who were from urban (AOR; 2.4: CI; 1.8, 5.7), had better family monthly income (AOR; 3.4: CI; 2.7, 3.8), attended education (AOR; 1.8: CI; 1.4, 3.5) were more knowledgeable. Conclusion and recommendation Majority of participants had good knowledge on malaria. Educational status, household monthly income and residence werepredictors of malaria knowledge. Increasing women's knowledge especially for those who are from rural, have no education, and have low monthly income is still needed.	[Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu] Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre, Tabor, Ethiopia		Goshu, YA; Yitayew, AE (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Midwifery, Debre, Tabor, Ethiopia.	ayalewyitayal@gmail.com; yitayal@ymail.com	Goshu, Yitayal Ayalew/J-7479-2019	Goshu, Yitayal Ayalew/0000-0002-3760-4903				Aguzie ION, 2018, CLIN MOTHER CHILD HL, V15, P1; Akaba GO, 2013, NIGER J CLIN PRACT, V16, P201, DOI 10.4103/1119-3077.110162; Assefa Y, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000318; Ayiisi AE, 2017, SCI J PUBLIC HLTH, V5, P254, DOI [10.11648/j.sjph.20170503.24, DOI 10.11648/J.SJPH.20170503.24]; Beyene B.H., 2015, SCI J PUBLIC HLTH, V3, P303, DOI 10.11648/j.sjph.20150303.11; Central Statistical Agency, 2018, NAT SURV; Centre for Disease Prevention and Control, 2017, CDC MAL PROGR; Centre for disease prevention and control, 2018, CDC AB MAL; De Beaudrap P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-139; Dombrowski JG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199415; EDHS, 2016, EDHS ETH MIN HLTH SU; Emmanuela E.A., 2011, TANZANIA J HLTH RES, V13; Fuge TG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0755-7; Geremew M., 2016, J TROP DIS, V4, P217, DOI [10.4172/2329-891X.1000217, DOI 10.4172/2329-891X.1000217]; Hamza TAAN., 2017, AM J BIOSCIENCE, V5, P80, DOI 10.11648/j.ajbio.20170505.12; Henok A, 2015, HLTH SCI J, V10, P1; Jimee H, 2007, PLOS ONE, V5, DOI [10.1371/journal.pone.0011692, DOI 10.1371/JOURNAL.PONE.0011692]; Kimbi HK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-883; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Masaad TTM, 2017, SCI J CLIN MED, V6, P24, DOI [10.11648/j.sjcm.20170602.11, DOI 10.11648/J.SJCM.20170602.11]; Nega D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123630; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Obol James, 2011, Malar Res Treat, V2011, P107987, DOI 10.4061/2011/107987; Ojong IN, 2013, HAMDARD MED, V56; Omaka-Omari LN, 2015, RES HUMANIT SOC SCI, V5, P10; Omer SA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2028-0; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; van Eijk AM, 2015, LANCET GLOB HEALTH, V3, pE617, DOI 10.1016/S2214-109X(15)00049-2; World Health Organisation (WHO), 2017, NEED PREV MOSQ BIT U; World Health Organization, 2018, WORLD MAL FACT; World Health Organization, 2017, DEPRESSION; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180508; 2011, WORLD MAL REP 2011, P1	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210221	10.1371/journal.pone.0210221	http://dx.doi.org/10.1371/journal.pone.0210221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629651	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000063
J	Liu, M; Yang, Y; Xie, F; Guo, JG; Wang, SY; Yang, HP; Wang, S				Liu, Miao; Yang, Yang; Xie, Fei; Guo, Jiagia; Wang, Siyuan; Yang, Houpu; Wang, Shu			Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SENTINEL LYMPH-NODE; DISSECTION; ULTRASONOGRAPHY; CYTOLOGY; TRIAL; METASTASIS; MANAGEMENT; NOMOGRAM; UTILITY	Background and objectives The role of ultrasound (US) guided biopsy in selecting patients for an upfront lymph node dissection (ALND) has been controversial following the publication of the American College of Surgeons (ACOSOG) Z0011 data. The purpose of this study was to investigate if patients with positive axillary lymph nodes (LNs) proven by US guided biopsy should be recommended for ALND and to analyze the utility of preoperative US and US guided biopsy in planning axillary surgery to avoid both unnecessary ALND and unnecessary SLNB. Methods Patients with a positive preoperative LN biopsy were identified and evaluated to determine their suitability for inclusion according to the criteria proposed in the Z0011 data. The correlation of the number of suspicious nodes found using US with the number of positive nodes on ALND was studied. Results A total of 261 breast cancer patients who had a positive preoperative LN needle biopsy were identified, among them, 79 patients with cT1-2N0 breast cancer and ALND were enrolled in the study. Thirty-one patients (39.2%) had <= 2 positive nodes identified in pathology and 10 patients (12.7%) met all of the Z0011 criteria and might have been spared ALND. A significantly greater proportion of women with. 3 positive nodes during ALND had > 1 abnormal LN identified using US compared to women with <= 2 positive LNs found using ALND (66.7% vs. 6.5%, p<0.0001). Conclusion US with needle biopsy is valuable to patients with multiple suspicious nodes found using US while SLND without US guided needle biopsy is suggested if only one abnormal LN is detected on US in the post-Z0011 era.	[Liu, Miao; Yang, Yang; Xie, Fei; Guo, Jiagia; Wang, Siyuan; Yang, Houpu; Wang, Shu] Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China	Peking University	Wang, S (corresponding author), Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China.	shuwang@pkuph.edu.cn						Aigner J, 2013, ANN SURG ONCOL, V20, P1538, DOI 10.1245/s10434-012-2798-0; Baruah BP, 2010, BRIT J SURG, V97, P680, DOI 10.1002/bjs.6964; Boland MR, 2015, EJSO-EUR J SURG ONC, V41, P559, DOI 10.1016/j.ejso.2015.01.011; Bonnema J, 1997, WORLD J SURG, V21, P270, DOI 10.1007/s002689900227; Boughey JC, 2010, ANN SURG ONCOL, V17, P953, DOI 10.1245/s10434-010-0919-1; Caretta-Weyer H, 2012, AM J SURG, V204, P308, DOI 10.1016/j.amjsurg.2011.10.016; Caudle AS, 2014, ANN SURG ONCOL, V21, P3440, DOI 10.1245/s10434-014-3813-4; Choi JJ, 2011, J ULTRAS MED, V30, P429, DOI 10.7863/jum.2011.30.4.429; Delpech Y, 2013, ANN SURG ONCOL, V20, P2556, DOI 10.1245/s10434-013-2917-6; Dengel LT, 2014, ANN SURG ONCOL, V21, P22, DOI 10.1245/s10434-013-3200-6; Diepstraten SCE, 2014, ANN SURG ONCOL, V21, P51, DOI 10.1245/s10434-013-3229-6; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hieken TJ, 2013, SURGERY, V154, P831, DOI 10.1016/j.surg.2013.07.017; Houssami N, 2011, ANN SURG, V254, P243, DOI 10.1097/SLA.0b013e31821f1564; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Kwak HY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-104; Lee MC, 2011, ANN SURG ONCOL, V18, P72, DOI 10.1245/s10434-010-1171-4; Leenders MWH, 2012, BREAST, V21, P578, DOI 10.1016/j.breast.2012.05.008; Liu M, 2011, ZHONGHUA PU TONG WAI, V26, P25; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15241; Mittendorf EA, 2012, ANN SURG, V255, P109, DOI 10.1097/SLA.0b013e318238f461; National Comprehensive Cancer Network (NCCN), 2012, CLIN PRACT GUID ONC; Ngui NK, 2013, ANZ J SURG, V83, P924, DOI 10.1111/ans.12388; Pilewskie M, 2016, ANN SURG ONCOL, V23, P1123, DOI 10.1245/s10434-015-4944-y; Posther KE, 2005, ANN SURG, V242, P593, DOI 10.1097/01.sla.0000184210.68646.77; Sahoo S, 2007, AM J SURG, V194, P524, DOI 10.1016/j.amjsurg.2007.07.006; Sever A, 2009, BRIT J SURG, V96, P1295, DOI 10.1002/bjs.6725; Solon JG, 2012, J AM COLL SURGEONS, V214, P12, DOI 10.1016/j.jamcollsurg.2011.09.024; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Verbanck J, 1997, J CLIN ULTRASOUND, V25, P53, DOI 10.1002/(SICI)1097-0096(199702)25:2<53::AID-JCU1>3.0.CO;2-I; Verheuvel NC, 2015, ANN SURG ONCOL, V22, P409, DOI 10.1245/s10434-014-4071-1; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782	33	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210437	10.1371/journal.pone.0210437	http://dx.doi.org/10.1371/journal.pone.0210437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629686	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000091
J	Niazi, RK; Sun, JH; Have, CT; Hollensted, M; Linneberg, A; Pedersen, O; Nielsen, JS; Rungby, J; Grarup, N; Hansen, T; Gjesing, AP				Niazi, Robina Khan; Sun, Jihua; Have, Christian Theil; Hollensted, Mette; Linneberg, Allan; Pedersen, Oluf; Nielsen, Jens Steen; Rungby, Jorgen; Grarup, Niels; Hansen, Torben; Gjesing, Anette Prior			Increased frequency of rare missense PPP1R3B variants among Danish patients with type 2 diabetes	PLOS ONE			English	Article							GLYCOGEN-TARGETING SUBUNIT; GLYCEMIC TRAITS; POPULATION; IDENTIFICATION; ASSOCIATION; PREGNANCY; MELLITUS; LOCUS; GENE	Background PPP1R3B has been suggested as a candidate gene for monogenic forms of diabetes as well as type 2 diabetes (T2D) due to its association with glycaemic trait and its biological role in glycogen synthesis. Objectives To study if rare missense variants in PPP1R3B increase the risk of maturity onset diabetes of the young (MODY), T2D or affect measures of glucose metabolism. Method Targeted resequencing of PPP1R3B was performed in 8,710 samples; MODY patients with unknown etiology (n = 54), newly diagnosed patients with T2D (n = 2,930) and population-based control individuals (n = 5,726, of whom n = 4,569 had normal glucose tolerance). All population-based sampled individuals were examined using an oral glucose tolerance test. Results Among n = 396 carriers, we identified twenty-three PPP1R3B missense mutations, none of which segregated with MODY. The burden of likely deleterious PPP1R3B variants was significantly increased with a total of 17 carriers among patients with T2D (0.58% (95% CI: 0.36-0.93)) compared to 18 carriers among non-diabetic individuals (0.31% (95% CI: 0.20-0.49)), resulting in an increased risk of T2D (OR (95% CI) = 2.57 (1.14-5.79), p = 0.02 (age and sex adjusted)). Furthermore, carriers with diabetes had less abdominal fat and a higher serum concentration of LDL-cholesterol compared to patients with T2D without rare missense PPP1R3B variants. In addition, non-diabetic carriers had a higher birth weight compared to non-carriers. Conclusion Rare missense PPP1R3B variants may predispose to T2D.	[Niazi, Robina Khan] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan; [Sun, Jihua] BGI Europe, Copenhagen, Denmark; [Have, Christian Theil; Hollensted, Mette; Pedersen, Oluf; Grarup, Niels; Hansen, Torben; Gjesing, Anette Prior] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Linneberg, Allan] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Nielsen, Jens Steen] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Nielsen, Jens Steen; Rungby, Jorgen] Odense Univ Hosp, SDCO, DD2, Odense, Denmark; [Rungby, Jorgen] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark	International Islamic University, Pakistan; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital	Gjesing, AP (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	anette.gjesing@sund.ku.dk	Rungby, Jørgen/AAQ-4332-2021; Gjesing, Anette/ACC-7521-2022; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Nielsen, Jens Steen/N-5218-2018	Gjesing, Anette/0000-0003-4580-1576; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Hollensted, Mette/0000-0001-5572-3183; Linneberg, Allan/0000-0002-0994-0184; Nielsen, Jens Steen/0000-0003-3179-1186	European Union [667191]; Steno Diabetes Center; Danish Diabetes Academy; Danish Medical Research Council; European Novo Nordisk Foundation [NNF15CC0018486]; Danish Diabetes Association; Danish Agency for Science [09-067009, 09-075724]; BGI	European Union(European Commission); Steno Diabetes Center; Danish Diabetes Academy; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Novo Nordisk Foundation; Danish Diabetes Association; Danish Agency for Science; BGI	This project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 667191 (authors awarded: APG, NG and TH). In addition, the study was supported from the Steno Diabetes Center, the Danish Diabetes Academy, the Danish Medical Research Council, the European Novo Nordisk Foundation (Immunometabolism, NNF15CC0018486) and the Danish Diabetes Association. The DD2 cohort was funded by the Danish Agency for Science (grant no. 09-067009 and 09-075724) (authors awarded: JSN and JR). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). The BGI provided support in the form of salaries for author [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dunn JS, 2006, ANN HUM GENET, V70, P587, DOI 10.1111/j.1469-1809.2005.00248.x; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Gedebjerg A, 2018, J DIABETES COMPLICAT, V32, P34, DOI 10.1016/j.jdiacomp.2017.09.010; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hayes MG, 2013, DIABETES, V62, P3282, DOI 10.2337/db12-1692; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lau C, 2011, DIABETES METAB, V37, P546, DOI 10.1016/j.diabet.2011.06.001; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mehta MB, 2017, J BIOL CHEM, V292, P10444, DOI 10.1074/jbc.M116.766329; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Munro S, 2002, DIABETES, V51, P591, DOI 10.2337/diabetes.51.3.591; Pezzolesi MG, 2004, DIABETES, V53, P486, DOI 10.2337/diabetes.53.2.486; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang K, 2010, NUCL ACIDS RES, V38; World Health Organization, 1999, WHO DIAGN CLASS DI 1; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079; Zibrova D, 2008, BIOCHEM J, V412, P359, DOI 10.1042/BJ20071483	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210114	10.1371/journal.pone.0210114	http://dx.doi.org/10.1371/journal.pone.0210114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629617	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000051
J	Agemi, Y; Shimokawa, T; Sasaki, J; Miyazaki, K; Misumi, Y; Sato, A; Aida, S; Ishii, M; Nakamura, Y; Naoki, K; Okamoto, H				Agemi, Yoko; Shimokawa, Tsuneo; Sasaki, Jiichiro; Miyazaki, Kazuhito; Misumi, Yuki; Sato, Akira; Aida, Shinzi; Ishii, Mari; Nakamura, Yukiko; Naoki, Katsuhiko; Okamoto, Hiroaki			Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; MINI NUTRITIONAL ASSESSMENT; OLDER PATIENTS; CHEMOTHERAPY TOXICITY; IDENTIFICATION; RECOMMENDATIONS; SOCIETY; UPDATE; ADULTS; RISK	The G8 questionnaire is a quick and easy-to-use screening tool. Several studies reported that the G8 questionnaire had a high sensitivity for predicting abnormalities in the full comprehensive geriatric assessment and predicted functional decline and survival in elderly cancer patients. The present study aimed to evaluate the role of the G8 questionnaire for predicting clinical outcomes and overall survival (OS) in elderly patients with lung cancer, who received chemotherapy or chemoradiotherapy. The data of 101 lung cancer patients aged. 70 years, who were hospitalized between September 2011 and August 2014, were analyzed. Of these patients (median age, 77 years), 83 (82%) had impaired G8 scores. The proportion of patients with an impaired G8 score was significantly higher in patients aged. 80 years than those aged <80 years (p = 0.04). All 18 patients with a normal G8 score possessed an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 or 1, and none of the patients with a normal G8 score had an ECOG PS of >= 2 (p < 0.0001). An impaired G8 score tended to correlate with a relative dose intensity of <0.65 in patients who received chemotherapy or chemoradiotherapy (p = 0.05, odds ratio = 5.40). In the univariate analysis, an ECOG PS of. 2 and an impaired G8 score were significantly associated with a poor OS (p = 0.009 and p = 0.003, respectively). Moreover, in the multivariate analysis, an ECOG PS of >= 2 (HR 2.55; 95% CI, 1.23-5.30; p = 0.01) and an impaired G8 score (HR 3.86; 95% CI, 1.44-13.36; p = 0.006) were remained independent prognostic factor for OS. G8 screening tool is useful for the prognostication of elderly lung cancer patients treated with chemotherapy. These finding suggest that the G8 questionnaire could be a useful tool in treatment decision-making to predict prognosis and prevent patients from receiving inappropriate anti-cancer treatment near the end of life.	[Agemi, Yoko; Shimokawa, Tsuneo; Miyazaki, Kazuhito; Misumi, Yuki; Aida, Shinzi; Nakamura, Yukiko; Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan; [Agemi, Yoko; Sasaki, Jiichiro; Naoki, Katsuhiko] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan; [Sato, Akira] Osaka Int Canc Inst, Canc Control Ctr, Dept Canc Strategy, Osaka, Japan; [Ishii, Mari; Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Med Oncol, Yokohama, Kanagawa, Japan	Kitasato University	Agemi, Y (corresponding author), Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan.; Agemi, Y (corresponding author), Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan.	yama.yoko.c9@gmail.com		Miyazaki, Kazuhito/0000-0002-0079-2883				Aapro M, 2000, ANN ONCOL, V11, P223, DOI 10.1023/A:1011156805700; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Baitar A, 2015, J GERIATR ONCOL, V6, P401, DOI 10.1016/j.jgo.2015.07.005; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Corre R, 2016, J CLIN ONCOL, V34, P1476, DOI 10.1200/JCO.2015.63.5839; Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210; Dubruille S, 2015, J GERIATR ONCOL, V6, P362, DOI 10.1016/j.jgo.2015.07.006; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Extermann M, 2004, CRIT REV ONCOL HEMAT, V49, P69, DOI 10.1016/S1040-8428(03)00099-4; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Giannousi Z, 2012, SUPPORT CARE CANCER, V20, P1823, DOI 10.1007/s00520-011-1282-x; Hamaker ME, 2014, ANN HEMATOL, V93, P1031, DOI 10.1007/s00277-013-2001-0; Hoppe S, 2013, J CLIN ONCOL, V31, P3877, DOI 10.1200/JCO.2012.47.7430; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Kenis C, 2014, J CLIN ONCOL, V32, P19, DOI 10.1200/JCO.2013.51.1345; Liuu E, 2014, J GERIATR ONCOL, V5, P11, DOI 10.1016/j.jgo.2013.08.003; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P641, DOI 10.1093/jjco/hyn074; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Ramsdale E, 2013, J AM GERIATR SOC, V61, P2043, DOI 10.1111/jgs.12536; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Schulkes KJG, 2017, CLIN LUNG CANCER, V18, P660, DOI 10.1016/j.cllc.2017.02.006; Simmons CP, 2015, LUNG CANCER, V88, P304, DOI 10.1016/j.lungcan.2015.03.020; Soubeyran P, 2014, PLOS ONE, V9, P40, DOI [10.1007/s00277-013-2001-0Epub2014Feb2, DOI 10.1007/S00277-013-2001-0EPUB2014FEB2]; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, VIT STAT JAP; Takahashi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179694; Valentini A, 2018, CLIN INTERV AGING, V13, P1237, DOI 10.2147/CIA.S164174; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3	29	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210499	10.1371/journal.pone.0210499	http://dx.doi.org/10.1371/journal.pone.0210499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653558	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500044
J	Oudega, ML; van der Werf, YD; Dols, A; Wattjes, MP; Barkhof, F; Bouckaert, F; Vandenbulcke, M; De Winter, FL; Sienaert, P; Eikelenboom, P; Stek, ML; van den Heuvel, OA; Emsell, L; Rhebergen, D; van Exel, E				Oudega, Mardien L.; van der Werf, Ysbrand D.; Dols, Annemieke; Wattjes, Mike P.; Barkhof, Frederik; Bouckaert, Filip; Vandenbulcke, Mathieu; De Winter, Francois-Laurent; Sienaert, Pascal; Eikelenboom, Piet; Stek, Max L.; van den Heuvel, Odile A.; Emsell, Louise; Rhebergen, Didi; van Exel, Eric			Exploring resting state connectivity in patients with psychotic depression	PLOS ONE			English	Article							DELUSIONAL MAJOR DEPRESSION; LATE-LIFE; PREVALENCE; ATTENTION; NETWORKS; FEATURES; MINI	Background Severe depression is associated with high morbidity and mortality. Neural network dysfunction may contribute to disease mechanisms underlying different clinical subtypes. Here, we apply resting-state functional magnetic resonance imaging based measures of brain connectivity to investigate network dysfunction in severely depressed in-patients with and without psychotic symptoms. Methods A cohort study was performed at two sites. Older patients with major depressive disorder with or without psychotic symptoms were included (n = 23 at site one, n = 26 at site two). Resting state 3-Tesla functional MRI scans, with eyes closed, were obtained and Montgomery-Asberg Depression Rating Scales were completed. We denoised data and calculated resting state networks in the two groups separately. We selected five networks of interest (1. bilateral frontoparietal, 2. left lateralized frontoparietal, 3. right lateralized frontoparietal, 4. default mode network (DMN) and 5. bilateral basal ganglia and insula network) and performed regression analyses with severity of depression, as well as presence or absence of psychotic symptoms. Results The functional connectivity (FC) patterns did not correlate with severity of depression. Depressed patients with psychotic symptoms (n = 14, 61%) compared with patients without psychotic symptoms (n = 9, 39%) from site one showed significantly decreased FC in the right part of the bilateral frontoparietal network (p = 0.002). This result was not replicated when comparing patients with (n = 9, 35%) and without (n = 17, 65%) psychotic symptoms from site two. Conclusion Psychotic depression may be associated with decreased FC of the frontoparietal network, which is involved in cognitive control processes, such as attention and emotion regulation. These findings suggest that FC in the frontoparietal network may be related to the subtype of depression, i.e. presence of psychotic symptoms, rather than severity of depression. Since the findings could not be replicated in the 2nd sample, replication is needed before drawing definite conclusions.	[Oudega, Mardien L.; Dols, Annemieke; Eikelenboom, Piet; Stek, Max L.; van den Heuvel, Odile A.; Rhebergen, Didi; van Exel, Eric] Locat VU Univ Med Ctr VUmc, GGZ inGeest Specialized Mental Hlth Care, Dept Old Age Psychiat, Amsterdam, Netherlands; [Oudega, Mardien L.; Dols, Annemieke; Eikelenboom, Piet; Stek, Max L.; van den Heuvel, Odile A.; Rhebergen, Didi; van Exel, Eric] Locat VU Univ Med Ctr VUmc, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Oudega, Mardien L.; van der Werf, Ysbrand D.; Dols, Annemieke; Barkhof, Frederik; van den Heuvel, Odile A.; van Exel, Eric] Vu Vumc UVA AMC, Amsterdam Neurosci, Amsterdam, Netherlands; [Oudega, Mardien L.; van der Werf, Ysbrand D.; Dols, Annemieke; van den Heuvel, Odile A.] Locat VUmc, Amsterdam Univ Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Dols, Annemieke; Rhebergen, Didi; van Exel, Eric] Vrije Univ, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Psychiat, Amsterdam, Netherlands; [Wattjes, Mike P.; Barkhof, Frederik] Locat VUmc, Amsterdam Univ Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Barkhof, Frederik] UCL, Inst Neurol, London, England; [Barkhof, Frederik] UCL, Inst Healthcare Engn, London, England; [Bouckaert, Filip; Vandenbulcke, Mathieu; De Winter, Francois-Laurent; Emsell, Louise] Katholieke Univ Leuven, KU Leuven, Univ Psychiat Ctr, Dept Old Age Psychiat, Leuven, Belgium; [Sienaert, Pascal] Katholieke Univ Leuven, Univ Psychiat Ctr, Acad Ctr ECT & Neuromodulat AcCENT, Kortenberg, Belgium	Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of London; University College London; University of London; University College London; KU Leuven; KU Leuven	Oudega, ML (corresponding author), Locat VU Univ Med Ctr VUmc, GGZ inGeest Specialized Mental Hlth Care, Dept Old Age Psychiat, Amsterdam, Netherlands.; Oudega, ML (corresponding author), Locat VU Univ Med Ctr VUmc, Amsterdam Univ Med Ctr, Amsterdam, Netherlands.; Oudega, ML (corresponding author), Vu Vumc UVA AMC, Amsterdam Neurosci, Amsterdam, Netherlands.; Oudega, ML (corresponding author), Locat VUmc, Amsterdam Univ Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands.	m.oudega@ggzingeest.nl	Emsell, Louise/ABA-8107-2020; Barkhof, Frederik/AAJ-6226-2020; Eikelenboom, Piet/AAF-6359-2020	Barkhof, Frederik/0000-0003-3543-3706; De Winter, Francois-Laurent/0000-0001-7753-3575; Sienaert, Pascal/0000-0002-0650-415X; van den Heuvel, Odile/0000-0002-9804-7653; Emsell, Louise/0000-0003-0011-4158; Dols, Annemiek/0000-0003-1964-0318; van Exel, Eric/0000-0002-5737-9600; Oudega, Mardien/0000-0002-1521-1682; van der Werf, Ysbrand/0000-0003-2370-9584	department of psychiatry of GGZ inGeest; VUmc	department of psychiatry of GGZ inGeest; VUmc	This study was supported by the department of psychiatry of GGZ inGeest and VUmc.	Aizenstein HJ, 2009, AM J GERIAT PSYCHIAT, V17, P30, DOI 10.1097/JGP.0b013e31817b60af; Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Beckmann C. F., 2009, GROUP COMPARISON OF; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Caldieraro MA, 2013, J NERV MENT DIS, V201, P855, DOI 10.1097/NMD.0b013e3182a5c06e; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2010, PROG NEUROBIOL, V92, P345, DOI 10.1016/j.pneurobio.2010.06.007; Dols A, 2017, AM J GERIAT PSYCHIAT, V25, P178, DOI 10.1016/j.jagp.2016.09.005; DSM-IV-TR; Association AP, 2000, DIAGNOSTIC AND STATI; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaudiano BA, 2008, COMPR PSYCHIAT, V49, P421, DOI 10.1016/j.comppsych.2008.02.007; Gournellis R, 2001, INT J GERIATR PSYCH, V16, P1085, DOI 10.1002/gps.483; Gournellis R, 2006, CURR PSYCHIATRY REV, V2, P235, DOI 10.2174/157340006776876003; Hoyer D, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/fnhum.2014.01047, 10.3389/fnhum.2014.00948]; Hyett MP, 2015, JAMA PSYCHIAT, V72, P350, DOI 10.1001/jamapsychiatry.2014.2490; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JOHNSON J, 1991, ARCH GEN PSYCHIAT, V48, P1075; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ohayon MM, 2002, AM J PSYCHIAT, V159, P1855, DOI 10.1176/appi.ajp.159.11.1855; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Roiser Jonathan P, 2013, Front Psychiatry, V4, P176, DOI 10.3389/fpsyt.2013.00176; Roiser JP, 2013, FRONT PSYCHIATRY, P24176; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sudheimer K, 2015, NEUROPSYCHOPHARMACOL, V40, P849, DOI 10.1038/npp.2014.259; Vythilingam M, 2003, AM J PSYCHIAT, V160, P574, DOI 10.1176/appi.ajp.160.3.574; Wang LH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/343720; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209908	10.1371/journal.pone.0209908	http://dx.doi.org/10.1371/journal.pone.0209908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653516	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500017
J	Wang, P; Li, RH; Bu, GC; Zhao, R				Wang, Pei; Li, Ronghao; Bu, Guochao; Zhao, Rui			Automated low-cost terrestrial laser scanner for measuring diameters at breast height and heights of plantation trees	PLOS ONE			English	Article							AIRBORNE LIDAR; FOREST; STEM; RECONSTRUCTION; EXTRACTION; BIOMASS; METRICS; SYSTEM	A terrestrial laser scanner is a fast, high-precision data acquisition device, which has been applied more and more to the research area of forest inventory. In this study, a type of automated low-cost terrestrial laser scanner was designed and implemented based on a SICK LMS-511 two-dimensional laser scanning sensor and a stepper motor. The new scanner was named BEE(developed by the department of Electronic Engineering, Beijing Forestry University), which can scan the forest trees in three dimensions. The BEE scanner and its supporting software are specifically designed for forest inventory. The specific software was developed to smoothly control the BEE scanner and to acquire the data, including the angular data, range data, and intensity data, and the data acquired by the BEE scanner could be processed into point cloud data, a range map, and an intensity map. Based on the point cloud data, the trees were detected by a single slice of the single scan in a plot, and the local ground plane was fitted for each detected tree. Then the diameter at breast height (DBH), tree height, and tree position could be estimated automatically by using the specific software. The experiments have been performed by using the BEE scanner in an artificial ginkgo forest which was located in the Haidian District of Beijing. Four 10 m x 10 m square plots were selected for the experiments. The BEE scanner scanned in the four plots and acquired the single-scan data, respectively. The DBH, tree height, and tree position of the trees in the four plots were estimated and analyzed. For comparison, manually-measured data was also collected in the four plots. The trunk detection rate for all four plots was 92.75%; the root mean square error of the DBH estimation was 1.27 cm; the root mean square error of the tree height estimation was 0.24 m; and the tree position estimation was in line with the actual position. The scanner also was tested in more natural forest in the Jiu-Feng Forest Park. Two plots with a radius of 5 meters were scanned. Eleven trees in the plot with a flat ground were detected and DBH were estimated. But tree detection was failed in the other plot because of the undulating ground. Experimental results show that the BEE scanner can efficiently estimate the structure parameters of plantation trees and has good potential in practical applications of forest inventory.	[Wang, Pei; Li, Ronghao; Bu, Guochao; Zhao, Rui] Beijing Forestry Univ, Inst Sci, Beijing, Peoples R China	Beijing Forestry University	Wang, P (corresponding author), Beijing Forestry Univ, Inst Sci, Beijing, Peoples R China.	wangpei@bjuf.edu.cn		Wang, Pei/0000-0002-0229-4909	Fundamental Research Funds for the Central Universities [2015ZCQ-LY-02, YX2015-08]; Beijing Natural Science Foundation [6164037]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The authors gratefully acknowledge the financial support from the Fundamental Research Funds for the Central Universities (Nos. 2015ZCQ-LY-02 and YX2015-08) and the Beijing Natural Science Foundation (No. 6164037). Pei Wang received these funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OS, 2015, ISPRS J PHOTOGRAMM, V101, P89, DOI 10.1016/j.isprsjprs.2014.11.007; [Anonymous], VZ 400 OP INSTR; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Beland M, 2011, AGR FOREST METEOROL, V151, P1252, DOI 10.1016/j.agrformet.2011.05.004; Bienert A., 2006, INT ARCH PHOTOGRAMM, V36; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; Boehm HDV, 2013, IEEE J-STARS, V6, P1524, DOI 10.1109/JSTARS.2013.2258895; Bu GC, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.026040; Chernov N., 2010, CIRCULAR LINEAR REGR; Culvenor DS, 2014, SENSORS-BASEL, V14, P14994, DOI 10.3390/s140814994; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Fofi D, 2004, BBA LIB, V5303, P90, DOI 10.1117/12.525369; Hauglin M, 2013, SCAND J FOREST RES, V28, P456, DOI 10.1080/02827581.2013.777772; Hopkinson C, 2004, CAN J FOREST RES, V34, P573, DOI [10.1139/x03-225, 10.1139/X03-225]; Jaakkola A, 2010, ISPRS J PHOTOGRAMM, V65, P514, DOI 10.1016/j.isprsjprs.2010.08.002; Kato A, 2009, REMOTE SENS ENVIRON, V113, P1148, DOI 10.1016/j.rse.2009.02.010; Kelbe D., 2013, RECONSTRUCTION 3D TR; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Kong JL, 2015, SENSORS-BASEL, V15, P15661, DOI 10.3390/s150715661; Liang XL, 2014, SENSORS-BASEL, V14, P1228, DOI 10.3390/s140101228; Lindberg E, 2012, EUR J FOREST RES, V131, P1917, DOI 10.1007/s10342-012-0642-5; Lovell JL, 2011, ISPRS J PHOTOGRAMM, V66, P46, DOI 10.1016/j.isprsjprs.2010.08.006; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; Montesano PM, 2013, REMOTE SENS ENVIRON, V130, P153, DOI 10.1016/j.rse.2012.11.016; Niska H, 2010, IEEE T GEOSCI REMOTE, V48, P1076, DOI 10.1109/TGRS.2009.2029864; Olofsson K, 2014, REMOTE SENS-BASEL, V6, P4323, DOI 10.3390/rs6054323; Percoco G, 2011, PHOTOGRAMM REC, V26, P73, DOI 10.1111/j.1477-9730.2010.00605.x; Popescu SC, 2008, REMOTE SENS ENVIRON, V112, P767, DOI 10.1016/j.rse.2007.06.011; Pratt V., 1987, COMPUTER GRAPHICS AC, V21, P145, DOI DOI 10.1145/37402.37420; Pueschel P, 2013, ISPRS J PHOTOGRAMM, V78, P58, DOI 10.1016/j.isprsjprs.2013.01.005; Pueschel P, 2013, ISPRS J PHOTOGRAMM, V77, P44, DOI 10.1016/j.isprsjprs.2012.12.001; Remondino F, 2005, PROC SPIE, V5665, P216, DOI 10.1117/12.586294; TAUBIN G, 1991, IEEE T PATTERN ANAL, V13, P1115, DOI 10.1109/34.103273; Watt PJ, 2005, INT J REMOTE SENS, V26, P1437, DOI 10.1080/01431160512331337961; Weinberger K., 2006, ADV NEURAL INFORM PR, V18, P1473, DOI DOI 10.1007/978-3-319-13168-9_; Yang XY, 2013, REMOTE SENS ENVIRON, V135, P36, DOI 10.1016/j.rse.2013.03.020; [No title captured]	37	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209888	10.1371/journal.pone.0209888	http://dx.doi.org/10.1371/journal.pone.0209888			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653532	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500016
J	Pellegrino, M; Crino, A; Rosado, MM; Fierabracci, A				Pellegrino, Marsha; Crino, Antonino; Rosado, Manuela M.; Fierabracci, Alessandra			Identification and functional characterization of CD8(+) T regulatory cells in type 1 diabetes patients	PLOS ONE			English	Article							LOW-DOSE INTERLEUKIN-2; REMITTING MULTIPLE-SCLEROSIS; PRIMARY IMMUNE-RESPONSE; INCREASED SUSCEPTIBILITY; PROGRAMMED DEATH-1; MICE; PD-1; GENERATION; SUPPRESSES; POPULATION	Type 1 diabetes is an autoimmune disease where autoreactive T lymphocytes destroy pancreatic beta cells. We previously reported a defect in CD4(+) Tregs cell proliferation and reduced CD4(+) Tregs PD-1 expression in patients. Another 'memory-like' regulatory subset, CD8(+) Tregs, evaluated as CD8(+)CD25(+)FOXP3(+), has recently raised interest for their effective suppressive activity. Different CD8(+) T cell populations, their proliferation capacity and expression of PD-1 molecule were evaluated by flow-cytometer analysis in newly diagnosed, long-term Type 1 diabetes patients compared to healthy normal donors. Under basal conditions, CD8(+) Tregs and CD8(+) Teffs were seemingly represented among study groups while there was evidence of diminished expression of PD-1 in Teff subsets of long-term patients. After 3 days of PMA/ionomycin stimulation, patients CD8(+) Tregs showed decreased percentage in respect to control group. CD8(+) Teffs were instead increased in long-term diabetics versus controls. PD-1(+)CD8(+) Tregs were represented at a much lower percentage in long-term diabetic patients, in respect to controls. Importantly, patients CD8(+) Tregs and CD8(+) Teffs presented a significant proliferation defect in respect to the control group. In conclusion, our study indicates that a defect of CD8(+) Tregs is observed in diabetics. This subset could thus represent a novel target of immunotherapy in patients.	[Pellegrino, Marsha; Fierabracci, Alessandra] Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Div, Rome, Italy; [Crino, Antonino] Bambino Gesu Pediat Hosp, Endocrinol Dept, Rome, Italy; [Rosado, Manuela M.] Bambino Gesu Pediat Hosp, Res Labs, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Fierabracci, A (corresponding author), Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Div, Rome, Italy.	alessandra.fierabracci@opbg.net	Fierabracci, Alessandra/K-5930-2016; Rosado, Maria Manuela/AAX-6495-2020; Pellegrino, Marsha/K-4500-2016	Fierabracci, Alessandra/0000-0003-3078-9754; Pellegrino, Marsha/0000-0002-9002-3622; Crino, Antonino/0000-0003-3548-7114	Italian Ministry of Health Ricerca corrente RC201702P003967	Italian Ministry of Health Ricerca corrente RC201702P003967	This work was supported by Italian Ministry of Health Ricerca corrente RC201702P003967 (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Berger CT, 2016, J CLIN INVEST, V126, P1646, DOI 10.1172/JCI87429; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Churlaud G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00171; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Fenoglio D, 2008, HUM IMMUNOL, V69, P745, DOI 10.1016/j.humimm.2008.08.282; Field AC, 2003, J AUTOIMMUN, V21, P201, DOI 10.1016/S0896-8411(03)00118-5; Fierabracci A, 2011, AUTOIMMUN REV, V10, P137, DOI 10.1016/j.autrev.2010.08.019; Fierabracci A, 2011, DIABETES-METAB RES, V27, P216, DOI 10.1002/dmrr.1165; Filaci G, 2011, AUTOIMMUNITY, V44, P51, DOI 10.3109/08916931003782171; Filaci Gilberto, 2002, Autoimmunity Reviews, V1, P279, DOI 10.1016/S1568-9972(02)00065-4; Frisullo G, 2010, HUM IMMUNOL, V71, P437, DOI 10.1016/j.humimm.2010.01.024; Fujisawa R, 2015, CLIN EXP IMMUNOL, V180, P452, DOI 10.1111/cei.12603; Gianchecchi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110755; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; Hu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059545; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huo CY, 2017, MICROB PATHOGENESIS, V113, P233, DOI 10.1016/j.micpath.2017.10.026; Jebbawi F, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0218-x; Kumar V, 2001, IMMUNOL REV, V182, P113, DOI 10.1034/j.1600-065X.2001.1820109.x; Lau D, 2013, THORAX, V68, P658, DOI 10.1136/thoraxjnl-2012-203109; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nanda NK, 1996, J EXP MED, V184, P1037, DOI 10.1084/jem.184.3.1037; Nenna R, 2011, INT J IMMUNOPATH PH, V24, P651, DOI 10.1177/039463201102400311; Pauken KE, 2013, DIABETES, V62, P2859, DOI 10.2337/db12-1475; Perri V, 2015, INT J MOL SCI, V16, P22584, DOI 10.3390/ijms160922584; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Reading PC, 1998, J VIROL, V72, P6884, DOI 10.1128/JVI.72.8.6884-6887.1998; Rosenzwajg M, 2015, J AUTOIMMUN, V58, P48, DOI 10.1016/j.jaut.2015.01.001; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saresella M, 2008, FASEB J, V22, P3500, DOI 10.1096/fj.08-110650; Shameli A, 2013, EUR J IMMUNOL, V43, P394, DOI 10.1002/eji.201242845; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang XL, 2005, CELL MOL IMMUNOL, V2, P11; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Tsutsumi Y, 2006, DIABETIC MED, V23, P1145, DOI 10.1111/j.1464-5491.2006.01951.x; Wang H, 2013, TRANSPL P, V45, P1822, DOI 10.1016/j.transproceed.2012.10.061; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang YS, 2017, ONCOTARGET, V8, P60201, DOI 10.18632/oncotarget.18732; Wong MD, 2013, J IMMUNOL, V190, P5402, DOI 10.4049/jimmunol.1202382; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01578; Zimring JC, 2004, IMMUNOL RES, V29, P303, DOI 10.1385/IR:29:1-3:303	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210839	10.1371/journal.pone.0210839	http://dx.doi.org/10.1371/journal.pone.0210839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650147	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300080
J	Sin, CZ; Wang, TS; Chiu, HY; Tsai, TF				Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang			Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic	PLOS ONE			English	Article							HLA-C LOCUS; DOUBLE-BLIND; GENETIC SUSCEPTIBILITY; MONOCLONAL-ANTIBODY; USTEKINUMAB; PLACEBO; ALLELES; HLA-CW6; RISK; POLYMORPHISM	Background Correlation between severity of psoriasis and psoriatic arthritis (PsA) is inconsistent. Also, human leukocyte antigen (HLA)-Cw6 was found to be underrepresented in severe psoriasis who failed conventional systemic therapies, but the effect of HLA polymorphism on PsA severity needs to be confirmed. Objectives To describe the severity of psoriasis, demographic features and HLA polymorphism among Chinese patients with active peripheral type PsA who had inadequate response to conventional disease-modifying antirheumatic drugs. Methods We included all patients with PsA who had at least 3 tender and swollen peripheral joints despite at least two conventional non-biologic treatments in our clinic. Demographic results were compared with global pivotal studies of biologics for PsA. HLA-Cw and HLA-DRB1 genotyping was also analyzed. Results We identified 60 patients who met our inclusion criteria. The male to female ratio was 1.31:1. The majority of patients presented with psoriasis first (81.7%). The mean interval between psoriasis and PsA was 7.2 +/- 8.1 years (mean +/- SD). The baseline number of tender and swollen joints was 14.9 +/- 10.7 and 11.3 +/- 10.2, respectively. In total, 41.7% subjects had more than 3% body surface area involvement of psoriasis. Genotyping of HLA-Cw and HLA-DRB1 was performed in 47 subjects. HLA-Cw*0702 was the most frequent allele (29.8%), followed by HLA-Cw*01 (26.6%). The frequency of HLA-Cw*0602 allele was similar to normal population. The most frequent HLA-DRB1 allele was HLA-DRB1*04 (20.2%), followed by HLA-DRB1*08 (16.0%). No cases carrying HLA-DRB1*13 were detected. Conclusions Compared with Western population, our patients had less psoriasis and PsA burden. The frequencies of HLA-Cw*06, HLA-Cw*12, and HLA-DRB1*07 were not increased. In contrast, HLA-Cw*0702 and HLA-DRB1*08 allele frequencies were increased compared with psoriasis patients and normal population in Taiwan. Future studies are still needed to characterize the demographic and genetic features of high need PsA patients.	[Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sin, Chi-Zai; Wang, Ting-Shun; Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wang, Ting-Shun] Chung Shan Med Univ Hosp, Div Dermatol, Taichung, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Tsai, TF (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	tftsai@yahoo.com		Chiu, Hsien-Yi/0000-0002-0493-9707; Sin, Chi-Zai/0000-0002-0597-6964; TSAI, TSEN-FANG/0000-0002-1498-1474				Al-Heresh AM, 2002, RHEUMATOLOGY, V41, P525, DOI 10.1093/rheumatology/41.5.525; Alamanos Y, 2008, J RHEUMATOL, V35, P1354; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Baek HJ, 2000, RHEUMATOL INT, V19, P89, DOI 10.1007/s002960050109; Blanco EA, 2013, ANN RHEUMATIC DIS S3, V72, pA965, DOI [10.1136/annrheumdis-2013-eular, DOI 10.1136/ANNRHEUMDIS-2013-EULAR]; Chandran V, 2013, HUM IMMUNOL, V74, P1333, DOI 10.1016/j.humimm.2013.07.014; Chiu HY, 2014, BRIT J DERMATOL, V171, P1181, DOI 10.1111/bjd.13056; Chiu HY, 2012, BRIT J DERMATOL, V166, P288, DOI 10.1111/j.1365-2133.2011.10688.x; Christophers E, 2010, J EUR ACAD DERMATOL, V24, P548, DOI 10.1111/j.1468-3083.2009.03463.x; Dobosz AS, 2005, INT J IMMUNOGENET, V32, P389, DOI 10.1111/j.1744-313X.2005.00543.x; EASTMOND CJ, 1994, BAILLIERE CLIN RHEUM, V8, P263, DOI 10.1016/S0950-3579(94)80018-9; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Schneeberger EE, 2015, CLIN RHEUMATOL, V34, P1413, DOI 10.1007/s10067-014-2739-3; Edwards CJ, 2016, ANN RHEUM DIS, DOI [10.1136/ard.2004.032268, DOI 10.1136/ARD.2004.032268]; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; Fan X, 2007, ACTA DERM-VENEREOL, V87, P335, DOI 10.2340/00015555-0253; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Galluzzo M, 2016, DERMATOLOGY, V232, P230, DOI 10.1159/000441719; GERBER LH, 1982, J RHEUMATOL, V9, P703; Gladman DD, 1999, HUM IMMUNOL, V60, P259, DOI 10.1016/S0198-8859(98)00123-2; GLADMAN DD, 1995, ARTHRITIS RHEUM, V38, P845, DOI 10.1002/art.1780380619; GLADMAN DD, 1986, J RHEUMATOL, V13, P586; Gonzalez S, 2002, J RHEUMATOL, V29, P973; Ho PYPC, 2007, ANN RHEUM DIS, V66, P807, DOI 10.1136/ard.2006.064972; Jee SH, 1998, BRIT J DERMATOL, V139, P978, DOI 10.1046/j.1365-2133.1998.02552.x; Kavanaugh A, 2012, ARTHRITIS RHEUM-US, V64, P2504, DOI 10.1002/art.34436; Kim TG, 2000, J INVEST DERMATOL, V114, P309, DOI 10.1046/j.1523-1747.2000.00863.x; Korendowych E, 2003, J RHEUMATOL, V30, P96; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Leung YY, 2017, CLIN RHEUMATOL, V36, P125, DOI 10.1007/s10067-016-3460-1; Liao HT, 2008, J RHEUMATOL, V35, P891; Lin M, 2000, TISSUE ANTIGENS, V55, P1, DOI 10.1034/j.1399-0039.2000.550101.x; Mason KJ, 2018, JAMA DERMATOL, V154, P581, DOI 10.1001/jamadermatol.2018.0183; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease PJ, 2014, ANN RHEUM DIS, V73, P48, DOI 10.1136/annrheumdis-2013-203696; Mease PJ, 2017, ANN RHEUM DIS, V76, P1550, DOI 10.1136/annrheumdis-2016-210724; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; MURRAY C, 1980, J CLIN INVEST, V66, P670, DOI 10.1172/JCI109903; NAKAGAWA H, 1991, ARCH DERMATOL RES, V283, P281, DOI 10.1007/BF00376613; Nash P, 2017, LANCET; Ohara Y, 2015, J RHEUMATOL, V42, P1439, DOI 10.3899/jrheum.141598; Popa OM, 2011, TISSUE ANTIGENS, V77, P325, DOI 10.1111/j.1399-0039.2010.01624.x; Prasad PVS, 2007, INDIAN J DERMATOL VE, V73, P166, DOI 10.4103/0378-6323.32739; Queiro R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2097; Queiro-Silva R, 2004, SCAND J RHEUMATOL, V33, P318, DOI 10.1080/03009740410005953; Rahman P, 2005, ANN RHEUM DIS, V64, P37, DOI 10.1136/ard.2004.030775; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; Rouzaud M, 2014, J EUR ACAD DERMATOL, V28, P17, DOI 10.1111/jdv.12562; SALVARANI C, 1989, CLIN EXP RHEUMATOL, V7, P391; SCHMITTEGENOLF M, 1993, J INVEST DERMATOL, V100, P749, DOI 10.1111/1523-1747.ep12476080; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shin D, 2016, RHEUMATOL INT, V36, P207, DOI 10.1007/s00296-015-3365-3; Talamonti M, 2017, BRIT J DERMATOL, V177, P489, DOI 10.1111/bjd.15387; Talamonti M, 2013, BRIT J DERMATOL, V169, P458, DOI 10.1111/bjd.12331; Talamonti M, 2016, J AM ACAD DERMATOL, V74, P374, DOI 10.1016/j.jaad.2015.08.055; Tam LS, 2009, RHEUMATOLOGY, V48, P1473, DOI 10.1093/rheumatology/kep230; Thorarensen SM, 2017, ANN RHEUM DIS, V76, P521, DOI 10.1136/annrheumdis-2016-209334; Tsai TF, 2002, ARCH DERMATOL RES, V294, P214, DOI 10.1007/s00403-002-0324-0; Tsai YC, 2016, GIORN ITAL DERMAT V, V151, P412; Tsai Yi-Giien, 2003, Journal of Microbiology Immunology and Infection, V36, P101; Wang TS, 2016, J DERMATOL SCI, V84, P340, DOI 10.1016/j.jdermsci.2016.08.535; West J, 2017, CLIN EXP DERMATOL, V42, P651, DOI 10.1111/ced.13100; Wittkowski KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020279; Yang Q, 2011, J EUR ACAD DERMATOL, V25, P1409, DOI 10.1111/j.1468-3083.2011.03985.x	67	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210076	10.1371/journal.pone.0210076	http://dx.doi.org/10.1371/journal.pone.0210076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650098	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300041
J	Jeger, RV; Pfisterer, M; Vogt, DR; Galatius, S; Abildgaard, U; Naber, C; Alber, H; Eberli, F; Kurz, DJ; Pedrazzini, G; Vuilliomenet, A; Weilenmann, D; Rickli, H; Hansen, W; Rickenbacher, P; Conen, D; Muller, C; Osswald, S; Gilgen, N; Kaiser, C				Jeger, Raban V.; Pfisterer, Matthias; Vogt, Deborah R.; Galatius, Soren; Abildgaard, Ulrik; Naber, Christoph; Alber, Hannes; Eberli, Franz; Kurz, David J.; Pedrazzini, Giovanni; Vuilliomenet, Andre; Weilenmann, Daniel; Rickli, Hans; Hansen, Wadt; Rickenbacher, Peter; Conen, David; Muller, Christian; Osswald, Stefan; Gilgen, Nicole; Kaiser, Christoph			Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; BARE-METAL STENTS; CLINICAL-OUTCOMES; CLOPIDOGREL; IMPACT; TRIALS; SAFETY; REVASCULARIZATION; DEFINITIONS; ASSOCIATION	Background Dual antiplatelet therapy (DAPT) prevents thrombotic events after coronary stent implantation but may induce bleedings, specifically in elderly patients. However, a competitive risk analysis is lacking. Objectives To assess the determinants of major bleeding and the balance between the competing risks of major bleeding and thrombotic events during prasugrel-based DAPT after stent implantation. Methods Overall, 2,291 patients randomized to drug-eluting or bare metal stents and treated with prasugrel 10mg/day for 1 year were followed over 2 years for major bleeding (BARC 3/5) and thrombotic events (cardiac death, myocardial infarction, definitive/probable stent thrombosis). Prasugrel dose was reduced to 5mg in patients >75 years and/or <60kg. Predictors of major bleeding and competing risks of major bleeding and thrombotic events were assessed. Results Two-year rates of major bleeding and thrombotic events were 2.9% and 9.0%, respectively. The only independent predictor of major bleeding was age (hazard ratio per year increase 1.05 [1.02,1.07], p<0.001). The relationship between major bleeding and age was non-linear, with lowest hazard ratios at 57 years and an exponential increase only above 65 years. In contrast, the relationship between thrombotic events and age was linear and continuously increasing with older age. While the competing risk of thrombotic events was higher than that of major bleeding in younger patients, the two risks were similar in older patients. After discontinuation of prasugrel, bleeding events leveled off in all patients, while thrombotic events continued to increase. Conclusions In prasugrel-based DAPT, age is the strongest risk factor for major bleeding, increasing exponentially >65 years. In younger patients, thrombotic events represent a higher risk than bleeding, while thrombotic and bleeding risks were similar in older patients. Important clinical implications relate to prasugrel dose in the elderly, duration of DAPT and the competing risk balance necessitating individualized treatment decisions.	[Jeger, Raban V.; Pfisterer, Matthias; Vogt, Deborah R.; Hansen, Wadt; Conen, David; Muller, Christian; Osswald, Stefan; Gilgen, Nicole; Kaiser, Christoph] Univ Basel, Univ Basel Hosp, Cardiol, Basel, Switzerland; [Galatius, Soren; Abildgaard, Ulrik] Gentofte Univ, Hosp Copenhagen, Cardiol, Hellerup, Denmark; [Naber, Christoph] Elisabeth Hosp, Cardiol, Essen, Germany; [Alber, Hannes] Univ Hosp Innsbruck, Cardiol, Innsbruck, Austria; [Alber, Hannes] Klinikum Klagenfurt Worthersee, Klagenfurt, Austria; [Eberli, Franz; Kurz, David J.] Triemli Hosp, Cardiol, Zurich, Switzerland; [Pedrazzini, Giovanni] Cardiocentro, Cardiol, Lugano, Switzerland; [Vuilliomenet, Andre] State Hosp, Cardiol, Aarau, Switzerland; [Weilenmann, Daniel; Rickli, Hans] State Hosp, Cardiol, St Gallen, Switzerland; [Rickenbacher, Peter] State Hosp, Cardiol, Bruderholz, Switzerland; [Conen, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	University of Basel; Medical University of Innsbruck; Triemli Hospital; McMaster University; Population Health Research Institute	Jeger, RV (corresponding author), Univ Basel, Univ Basel Hosp, Cardiol, Basel, Switzerland.	raban.jeger@usb.ch	Kaiser, Christoph/AAA-9284-2022; Vogt, Deborah/AAA-6583-2020; Osswald, Stefan/A-6904-2018; Jeger, Raban/ABG-1678-2021	Vogt, Deborah/0000-0002-0668-5675; Osswald, Stefan/0000-0002-9240-6731; Jeger, Raban/0000-0003-1290-5491; Kurz, David/0000-0002-3921-6939	Basel Cardiovascular Research Foundation, Basel, Switzerland	Basel Cardiovascular Research Foundation, Basel, Switzerland	Basel Cardiovascular Research Foundation, Basel, Switzerland. Prasugrel was provided without charge by Eli Lilly Europe, Windlesham, UK, and Daiichy Sankyo Europe, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; [Anonymous], 2014, R LANG ENV STAT COMP; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chhatriwalla AK, 2013, JAMA-J AM MED ASSOC, V309, P1022, DOI 10.1001/jama.2013.1556; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jeger R, 2012, AM HEART J, V163, P136, DOI 10.1016/j.ahj.2011.08.023; Jeger RV, 2014, AM HEART J, V168, P698, DOI 10.1016/j.ahj.2014.07.019; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Lopes RD, 2009, J AM COLL CARDIOL, V53, P1021, DOI 10.1016/j.jacc.2008.12.021; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Meira-Machado L, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/745742; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Pfisterer M, 2012, CIRCULATION, V125, P471, DOI 10.1161/CIRCULATIONAHA.111.078923; Riesmeyer JS, 2012, J CLIN PHARMACOL, V52, P789, DOI 10.1177/0091270011406280; Roe MT, 2013, CIRCULATION, V128, P823, DOI 10.1161/CIRCULATIONAHA.113.002303; Steinhubl SR, 2007, AM HEART J, V154, P3, DOI 10.1016/j.ahj.2007.04.009; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	31	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210821	10.1371/journal.pone.0210821	http://dx.doi.org/10.1371/journal.pone.0210821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645635	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000455810200058
J	Morgat, C; Schollhammer, R; Macgrogan, G; Barthe, N; Velasco, V; Vimont, D; Cazeau, AL; Fernandez, P; Hindie, E				Morgat, Clement; Schollhammer, Romain; Macgrogan, Gaetan; Barthe, Nicole; Velasco, Valerie; Vimont, Delphine; Cazeau, Anne-Laure; Fernandez, Philippe; Hindie, Elif			Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist Ga-68-RM2 and F-18-FDG in breast cancer samples	PLOS ONE			English	Article							THERAPY; RELEVANCE; PET/CT	The Gastrin-Releasing Peptide Receptor (GRPR) is over-expressed in estrogen receptor (ER) positive breast tumors and related metastatic lymph nodes offering the opportunity of imaging and therapy of luminal tumors. Ga-68-RM2 binding and F-18-FDG binding in tumoral zones were measured and compared using tissue micro-imaging with a beta imager on 14 breast cancer samples (10 primaries and 4 associated metastatic lymph nodes). Results were then assessed against ER expression, progesterone receptor (PR) expression, HER2 over-expression or not and Ki-67 expression. GRPR immunohistochemistry (IHC) was also performed on all samples. We also retrospectively compared Ga-68-RM2 and F-18-FDG bindings to F-18-FDG SUVmax on the pre-therapeutic PET/CT examination, if available. Ga-68-RM2 binding was significantly higher in tumors expressing GRPR on IHC than in GRPR-negative tumors (P = 0.022). In ER+ tumors, binding of Ga-68-RM2 was significantly higher than F-18-FDG (P = 0.015). In tumors with low Ki-67, Ga-68-RM2 binding was also significantly increased compared to F-18-FDG (P = 0.029). Overall, the binding of Ga-68-RM2 and F-18-FDG displayed an opposite pattern in tumor samples and Ga-68-RM2 binding was significantly higher in tumors that had low F-18-FDG binding (P = 0.021). This inverse correlation was also documented in the few patients in whom a F-18-FDG PET/CT examination before surgery was available. Findings from this in vitro study suggest that GRPR targeting can be an alternative to F-18-FDG imaging in ER+ breast tumors. Moreover, because GRPR antagonists can also be labeled with lutetium-177 this opens new avenues for targeted radionuclide therapy in the subset of patients with progressive metastatic disease following conventional treatments.	[Morgat, Clement; Schollhammer, Romain; Fernandez, Philippe; Hindie, Elif] Univ Hosp Bordeaux, Dept Nucl Med, Bordeaux, France; [Morgat, Clement; Schollhammer, Romain; Vimont, Delphine; Fernandez, Philippe; Hindie, Elif] Univ Bordeaux, INCIA, CNRS, UMR 5287, Talence, France; [Morgat, Clement; Schollhammer, Romain; Vimont, Delphine; Fernandez, Philippe; Hindie, Elif] CNRS, INCIA, UMR 5287, Talence, France; [Macgrogan, Gaetan; Velasco, Valerie] Inst Bergonie, Dept BioPathol, Surg Pathol Unit, Bordeaux, France; [Macgrogan, Gaetan; Velasco, Valerie] INSERM, ACTION, U1218, Bordeaux, France; [Barthe, Nicole] INSERM, BioTis, U1026, Bordeaux, France; [Cazeau, Anne-Laure] Inst Bergonie, Dept Nucl Med, Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie	Morgat, C (corresponding author), Univ Hosp Bordeaux, Dept Nucl Med, Bordeaux, France.; Morgat, C (corresponding author), Univ Bordeaux, INCIA, CNRS, UMR 5287, Talence, France.; Morgat, C (corresponding author), CNRS, INCIA, UMR 5287, Talence, France.	clement.morgat@u-bordeaux.fr	Morgat, Clément/L-6911-2019	Morgat, Clément/0000-0002-9432-9223; MacGrogan, Gaetan/0000-0002-3483-9758	La ligue contre le Cancer Gironde; La Ligue contre le Cancer Gironde 2016; French Investment for the Future program within LabEx TRAIL [ANR-10-LABX-57]	La ligue contre le Cancer Gironde; La Ligue contre le Cancer Gironde 2016; French Investment for the Future program within LabEx TRAIL	This study was funded by "La ligue contre le Cancer Gironde".; Authors thank Life Molecular Imaging for the provision of the precursor RM2 and the reference compound <SUP>nat</SUP>Ga-RM2. Authors thank also CURIUM for the provision of <SUP>18</SUP>F-FDG. This work was funded by "La Ligue contre le Cancer Gironde 2016" and was performed under the context of the French Investment for the Future program within LabEx TRAIL ANR-10-LABX-57.	Dalm SU, 2015, J NUCL MED, V56, P1487, DOI 10.2967/jnumed.115.160739; Dumont RA, 2013, J NUCL MED, V54, P762, DOI 10.2967/jnumed.112.112169; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Groheux D, 2016, J NUCL MED, V57, p17S, DOI 10.2967/jnumed.115.157859; Hindie E, 2016, J NUCL MED, V57, P759, DOI 10.2967/jnumed.115.170423; Humbert O, 2014, EUR J NUCL MED MOL I, V41, P416, DOI 10.1007/s00259-013-2616-3; Maina T, 2016, EUR J NUCL MED MOL I, V43, P964, DOI 10.1007/s00259-015-3232-1; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Morgat C, 2017, J NUCL MED, V58, P1401, DOI 10.2967/jnumed.116.188011; Morgat C, 2014, J NUCL MED, V55, P1650, DOI 10.2967/jnumed.114.142000; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Muller C, 2012, J NUCL MED, V53, P1951, DOI 10.2967/jnumed.112.107540; Stoykow C, 2016, THERANOSTICS, V6, P1641, DOI 10.7150/thno.14958; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zang J, 2018, CLIN NUCL MED, V43, P663, DOI 10.1097/RLU.0000000000002209; Zhang JJ, 2018, THERANOSTICS, V8, P1121, DOI 10.7150/thno.22601	16	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210905	10.1371/journal.pone.0210905	http://dx.doi.org/10.1371/journal.pone.0210905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645633	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200061
J	Hjelmso, MH; Mollerup, S; Jensen, RH; Pietroni, C; Lukjancenko, O; Schultz, AC; Aarestrup, FM; Hansen, AJ				Hjelmso, Mathis Hjort; Mollerup, Sarah; Jensen, Randi Holm; Pietroni, Carlotta; Lukjancenko, Oksana; Schultz, Anna Charlotte; Aarestrup, Frank M.; Hansen, Anders Johannes			Metagenomic analysis of viruses in toilet waste from long distance flights-A new procedure for global infectious disease surveillance	PLOS ONE			English	Article							RESPIRATORY VIRUSES; BINDING-SITES; CHILDREN; BURDEN; EPIDEMIOLOGY; MORTALITY; HEPATITIS; IDENTIFICATION; CORONAVIRUS; MULTIPLE	Human viral pathogens are a major public health threat. Reliable information that accurately describes and characterizes the global occurrence and transmission of human viruses is essential to support national and global priority setting, public health actions, and treatment decisions. However, large areas of the globe are currently without surveillance due to limited health care infrastructure and lack of international cooperation. We propose a novel surveillance strategy, using metagenomic analysis of toilet material from international air flights as a method for worldwide viral disease surveillance. The aim of this study was to design, implement, and evaluate a method for viral analysis of airplane toilet waste enabling simultaneous detection and quantification of a wide range of human viral pathogens. Toilet waste from 19 international airplanes was analyzed for viral content, using viral capture probes followed by high-throughput sequencing. Numerous human pathogens were detected including enteric and respiratory viruses. Several geographic trends were observed with samples originating from South Asia having significantly higher viral species richness as well as higher abundances of salivirus A, aichivirus A and enterovirus B, compared to samples originating from North Asia and North America. In addition, certain city specific trends were observed, including high numbers of rotaviruses in airplanes departing from Islamabad. Based on this study we believe that central sampling and analysis at international airports could be a useful supplement for global viral surveillance, valuable for outbreak detection and for guiding public health resources.	[Hjelmso, Mathis Hjort; Lukjancenko, Oksana; Aarestrup, Frank M.] Tech Univ Denmark, Res Grp Genom Epidemiol, Lyngby, Denmark; [Mollerup, Sarah; Jensen, Randi Holm; Pietroni, Carlotta; Hansen, Anders Johannes] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Schultz, Anna Charlotte] Tech Univ Denmark, Natl Food Inst, Div Microbiol & Prod, Lyngby, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Hjelmso, MH (corresponding author), Tech Univ Denmark, Res Grp Genom Epidemiol, Lyngby, Denmark.	mathishjelmsoe@gmail.com	Hansen, Anders Johannes/A-5608-2013; Lukjancenko, Oksana/B-9049-2019; Schultz, Anna C/N-4898-2016	Hansen, Anders Johannes/0000-0002-1890-2702; Lukjancenko, Oksana/0000-0003-0102-0364; Schultz, Anna C/0000-0003-1484-9120; Aarestrup, Frank/0000-0002-7116-2723; Mollerup, Sarah/0000-0003-2429-4018; Hjelmso, Mathis Hjort/0000-0001-9716-624X	Innovation Fund Denmark [019-2011-2]; European Union [643476]; Villum Foundation [VKR023052]	Innovation Fund Denmark; European Union(European Commission); Villum Foundation(Villum Fonden)	This study has received funding from the Innovation Fund Denmark, https://innovationsfonden.dk/en, (The GenomeDenmark platform, grant no. 019-2011-2) (AHJ) and the European Union's Horizon 2020 research and innovation programme, https://ec.europa.eu/programmes/horizon2020/en/, under grant agreement no 643476 (COMPARE) (FMA), and The Villum Foundation, https://veluxfoundations.dk/en, (VKR023052) (FMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamlan FS, 2015, J INFECT DEV COUNTR, V9, P128, DOI 10.3855/jidc.6101; [Anonymous], 2014, R LANG ENV STAT COMP; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P2, DOI 10.1021/ez5003715; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Boros A, 2018, VIROLOGY, V525, P62, DOI 10.1016/j.virol.2018.09.008; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Chan PKS, 2013, J THORAC DIS, V5, pS118, DOI 10.3978/j.issn.2072-1439.2013.06.19; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Furtak V, 2016, EUROSURVEILLANCE, V21, P40, DOI 10.2807/1560-7917.ES.2016.21.15.30193; Ganesh Balasubramanian, 2014, VirusDisease, V25, P223, DOI 10.1007/s13337-014-0207-y; Gaunt ER, 2011, J CLIN VIROL, V52, P215, DOI 10.1016/j.jcv.2011.07.017; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Graf EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hjelmso MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170199; Itta KC, 2016, INT J INFECT DIS, V52, P14, DOI 10.1016/j.ijid.2016.09.015; Jensen RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122636; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Khamrin Pattara, 2014, VirusDisease, V25, P195, DOI 10.1007/s13337-014-0200-5; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Kolde R., 2018, PHEATMAP PRETTY HEAT; Krishnamurthy SR, 2018, VIROLOGY, V516, P108, DOI 10.1016/j.virol.2018.01.006; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Li H., 2013, PREPRINT, P1, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LOGRIPPO GA, 1952, J LAB CLIN MED, V39, P970; Mangili A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.IOL5-0009-2015; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mee ET, 2016, VACCINE, V34, P2035, DOI 10.1016/j.vaccine.2015.12.020; Muhlemann B, 2018, NATURE, V557, P418, DOI 10.1038/s41586-018-0097-z; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santos N, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.04.004; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Socan M, 2012, CENT EUR J PUBL HEAL, V20, P156, DOI 10.21101/cejph.a3735; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Todd S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004869; Tsiodras S, 2014, EURO SURVEILL, V19; Vinner L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13201; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang XW, 2005, WATER SCI TECHNOL, V52, P213, DOI 10.2166/wst.2005.0266; World Bank (2020a), AIR TRANSP PASS CARR; YAMASHITA T, 1995, MICROBIOL IMMUNOL, V39, P433, DOI 10.1111/j.1348-0421.1995.tb02225.x; Yu JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130977	64	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210368	10.1371/journal.pone.0210368	http://dx.doi.org/10.1371/journal.pone.0210368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640944	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000024
J	Emanuel, A; Qiu, HY; Barker, D; Takla, T; Gillum, K; Neimuth, N; Kodihalli, S				Emanuel, Andrew; Qiu, Hongyu; Barker, Douglas; Takla, Teresa; Gillum, Karen; Neimuth, Nancy; Kodihalli, Shantha			Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model	PLOS ONE			English	Article							TOXIN TYPE-A; CLOSTRIDIUM-BOTULINUM; NEUROTOXIN SEROTYPES; IDENTIFICATION; CHALLENGES; ANTIBODIES; VACCINES; STRAIN	Background Botulism is a disease caused by neurogenic toxins that block acetylcholine release, resulting in potentially life threatening neuroparalysis. Seven distinct serotypes of botulinum neurotoxins (BoNTs) have been described and are found in nature world-wide. This, combined with ease of production, make BoNTs a significant bioweapon threat. An essential countermeasure to this threat is an antitoxin to remove circulating toxin. An antitoxin, tradename BAT (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)), has been developed and its efficacy evaluated against all seven serotypes in guinea pigs. Methods and findings Studies were conducted to establish the lethal dose and clinical course of intoxication for all seven toxins, and post-exposure prophylactic efficacy of BAT product. Animals were monitored for signs of intoxication and mortality for 14 days. Guinea pig intramuscular LD50s (GPIMLD(50)) for all BoNTs ranged from 2.0 (serotype C) to 73.2 (serotype E) of mouse intraperitoneal LD50 units. A dose of 4x GPIMLD(50) was identified as the appropriate toxin dose for use in subsequent efficacy and post-exposure prophylaxis studies. The main clinical signs observed included hind limb paralysis, weak limb, change in breathing rate/pattern, and forced abdominal respiration. Mean time to onset of clinical signs ranged from 12 hours (serotype E) to 39 hours (serotype G). Twelve hours post-intoxication was selected as the appropriate time point for intervention for all serotypes apart from E where 6 hours was selected because of the rapid onset and progression of clinical signs. Post-exposure treatment with BAT product resulted in a significantly (p<0.0001) higher survival at >0.008 scaled human dose for serotypes A, B, C, F and G, at >0.2x for serotype D and >0.04x for serotype E. Conclusions These studies confirm the efficacy of BAT as a post-exposure prophylactic therapy against all seven known BoNT serotypes.	[Emanuel, Andrew; Qiu, Hongyu; Barker, Douglas; Takla, Teresa; Kodihalli, Shantha] Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada; [Gillum, Karen; Neimuth, Nancy] Battelle Biomed Res Ctr, Columbus, OH USA		Kodihalli, S (corresponding author), Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada.	skodihalli@ebsi.com			Emergent BioSolutions Canada Inc. - Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHSO100200600017C]	Emergent BioSolutions Canada Inc. - Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	The funder Emergent BioSolutions Canada Inc. provided support in the form of salaries for authors [AE, DB, TT, SK]. The specific roles of these authors are articulated in the 'author contributions' section. Additionally, this work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHSO100200600017C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. None of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleem FH, 2011, J PHARMACOL EXP THER, V338, P503, DOI 10.1124/jpet.111.180653; Anderson J, 2015, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, 2ND EDITION, P361, DOI 10.1016/B978-0-12-800159-2.00028-2; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1454; [Anonymous], 2007, AN CAR POL MAN; BALL AP, 1979, Q J MED, V48, P473; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Carlella M.A., 1964, PHS999FP1 PUBL, P113; Centers for Disease Control, 2018, NAT BOT SURV SUMM 20; Chen ZXP, 2012, TOXINS, V4, P1196, DOI 10.3390/toxins4111196; Cheng LW, 2011, TOXICON, V58, P62, DOI 10.1016/j.toxicon.2011.05.003; CICCARELLI AS, 1977, APPL ENVIRON MICROB, V34, P843, DOI 10.1128/AEM.34.6.843-848.1977; Dorner MB, 2013, CURR TOP MICROBIOL, V364, P219, DOI 10.1007/978-3-642-33570-9_11; European Centre for Disease Prevention and Control, 2018, BOT ANN EP REP 2018; Finney D.J., 1971, PROBIT ANAL; Gao W, 2018, CURR OPIN MICROBIOL, V41, P76, DOI 10.1016/j.mib.2017.11.030; Greenbaum SB, 2012, BIODEFENSE RES METHO, P415; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Hansbauer EM, 2016, ANALYST, V141, P5281, DOI [10.1039/c6an00693k, 10.1039/C6AN00693K]; Harvey SM, 2002, J CLIN MICROBIOL, V40, P2260, DOI 10.1128/JCM.40.6.2260-2262.2002; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; IIDA H, 1970, JPN J MED SCI BIOL, V23, P344; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; McCarty CL, 2015WEEKLY      0731, P20; McLellan K, 1996, TOXICON, V34, P975, DOI 10.1016/0041-0101(96)00070-0; METZGER JF, 1979, REV INFECT DIS, V1, P689; Middlebrook JL, BOTULINUM TOXINS MED, P643; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nelson W., 1982, APPL LIFE DATA ANAL, DOI [10.1021/es60130a004, DOI 10.1021/ES60130A004]; Peck MW, 2017, TOXINS, V9, DOI 10.3390/toxins9010038; Pellett S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00100-15; Pirazzini M, 2017, EXPERT OPIN DRUG DIS, V12, P497, DOI 10.1080/17460441.2017.1303476; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; Sesardic D, 2004, MOVEMENT DISORD, V19, pS85, DOI 10.1002/mds.20021; SESARDIC D, 1994, J ROY SOC MED, V87, P307; Sheridan RE, 2001, TOXICON, V39, P651, DOI 10.1016/S0041-0101(00)00189-6; Simpson LL, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P891, DOI 10.1016/B978-0-12-369408-9.00046-9; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Zhang SC, 2018, CELL HOST MICROBE, V23, P169, DOI 10.1016/j.chom.2017.12.018; Zhang SC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14130	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209019	10.1371/journal.pone.0209019	http://dx.doi.org/10.1371/journal.pone.0209019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633746	gold, Green Published, Green Submitted			2022-12-27	WOS:000455485100004
J	Goorts, K; Vandenbroeck, S; Elst, TV; Rusu, D; Du Bois, M; Decuman, S; Godderis, L				Goorts, Kaat; Vandenbroeck, Sofie; Elst, Tinne Vander; Rusu, Dorina; Du Bois, Marc; Decuman, Saskia; Godderis, Lode			Quickscan assesses risk factors of long-term sickness absence: A cross-sectional (factorial) construct validation study	PLOS ONE			English	Article							RETURN; LEAVE; WORK	Objectives The number of sick-listed employees has increased dramatically worldwide. Therefore, many countries aim to stimulate early and sustainable return to work opportunities to obtain better health outcomes and lower costs for disability pensions. To effectively orientate resources to patients with a high risk of not resuming work spontaneously, it is necessary to screen patients early in their sickness absence process. In this study, we validate "Quickscan", a new instrument to assess return-to-work needs and to predict risks of long-term sick leave. Methods As part of the Quickscan validation process, we tested and compared the reliability and construct validity of the questionnaire in two different populations. First, we conducted a cross-sectional study in which the screening instrument was sent to sick-listed individuals in healthcare insurance. In a second cross-sectional study, sick-listed workers who consulted the occupational health physician for return-to-work assessment were asked to fill out the questionnaire. We compared both samples for descriptive statistics: frequencies, means and standard deviations. Reliability of the scales was calculated using Cronbach's alpha. Confirmatory factor analysis was performed to evaluate the construct (factorial) validity of the studied scales using software package AMOS 24. Results The screening tool was shown to be an instrument with reliable scales (except for the perfectionism and health perception patient scale) in both populations. The construct validity was satisfactory: we found that the hypothesized measurement models with the theoretical factors fitted the data well in both populations. In the first sample, the model improved for scales concerning stressful life events and showed worse fit for person-related factors. Work-related factors and functioning factors both showed similar fit indices across samples. We found small differences in descriptive statistics, which we could explain by the differences in characteristics of both populations. Conclusions We can conclude that the instrument has considerable potential to function as a screening tool for disability management and follow-up of sick-leave, provided that some adaptations and validation tests are executed.	[Goorts, Kaat; Vandenbroeck, Sofie; Du Bois, Marc; Godderis, Lode] Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium; [Vandenbroeck, Sofie; Elst, Tinne Vander; Godderis, Lode] Idewe, External Serv Prevent & Protect Work, Leuven, Belgium; [Elst, Tinne Vander] Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Rusu, Dorina] Univ Liege, Dept Sci Sante Publ, Liege, Belgium; [Rusu, Dorina] SPMT ARISTA, External Serv Prevent & Protect Work, Liege, Belgium; [Decuman, Saskia] Natl Inst Hlth & Disabil Insurance, Dept Benefits, Brussels, Belgium	KU Leuven; KU Leuven; University of Liege	Goorts, K (corresponding author), Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium.	kaat.goorts@kuleuven.be	Godderis, Lode/AAE-5880-2019	Godderis, Lode/0000-0003-4764-8835; Vander Elst, Tinne/0000-0001-8709-2371; Du Bois, Marc/0000-0001-6326-4343; Goorts, Kaat/0000-0003-0793-0414	National Institute for health and disability insurance	National Institute for health and disability insurance	This was supported by National Institute for health and disability insurance http://www.riziv.fgov.be/nl/themas/arbeidsongeschiktheid/Paginas/Kenniscentrum.aspx#.WxfIb0iFNPY.The funders had a role in the data collection process (contacts with different sickness fund organizations) and in the preparation of the manuscript. They did not have a role in the study design and analysis or in the decision to publish.	Annette E, ROLE EUROPEAN PHYS A; Beemsterboer W, 2009, INT J OCCUP MED ENV, V22, P169, DOI 10.2478/v10001-009-0013-8; Brouwer S, 2011, J OCCUP REHABIL, V21, P244, DOI 10.1007/s10926-010-9262-4; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Dekkers-Sanchez PM, 2008, OCCUP ENVIRON MED, V65, P153, DOI 10.1136/oem.2007.034983; Edwards P, 2010, CONDITIONS EFFTIOLAW; Franklin GM, 2008, SPINE, V33, P199, DOI 10.1097/BRS.0b013e318160455c; Goorts K, J PUBLIC HLTH RES, V7, P81; Goorts K, 2017, TBV TIJDSCHRIFT BEDR, V25, P59, DOI [10.1007/s12498-017-0023-6, DOI 10.1007/S12498-017-0023-6]; Goorts K, 2018, J PUBLIC HEALTH RES, V7, P81, DOI 10.4081/jphr.2018.1419; Joosen M, 2017, EUR J PUBLIC HEALTH, V27; Kausto J, 2017, SCAND J WORK ENV HEA, V43, P358, DOI 10.5271/sjweh.3643; Marhold C, 2002, J OCCUP REHABIL, V12, P65, DOI 10.1023/A:1015056429505; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Reininga IHF, 2015, INJURY, V46, P308, DOI 10.1016/j.injury.2014.08.042; Roelen C, 2018, DISABIL REHABIL, V40, P168, DOI 10.1080/09638288.2016.1247471; Somville PR, 2015, ARCH MAL PROF ENVIRO, P458; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; van Amelsvoort LGPM, 2017, SCAND J WORK ENV HEA, V43, P1, DOI 10.5271/sjweh.3605; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210359	10.1371/journal.pone.0210359	http://dx.doi.org/10.1371/journal.pone.0210359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633762	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100021
J	Ara, G; Khanam, M; Rahman, AS; Islam, Z; Farhad, S; Sanin, KI; Khan, SS; Rahman, MM; Majoor, H; Ahmed, T				Ara, Gulshan; Khanam, Mansura; Rahman, Ahmed Shafiqur; Islam, Zhahirul; Farhad, Shahriar; Sanin, Kazi Istiaque; Khan, Sihan Sadat; Rahman, Mohammad Mahbobor; Majoor, Herma; Ahmed, Tahmeed			Effectiveness of micronutrient-fortified rice consumption on anaemia and zinc status among vulnerable women in Bangladesh	PLOS ONE			English	Article							IRON STATUS; SERUM ZINC; HEMOGLOBIN CONCENTRATION; SCHOOL-CHILDREN; PREVALENCE; DEFICIENCY; ABSORPTION; GROWTH; FORTIFICATION; MORBIDITY	Micronutrient deficiency is one of the biggest public health concerns in Bangladesh. As per World Health Organisation (WHO) in the 2016 report, 40% women of reproductive age suffer from anaemia. According to the National Micronutrient Survey 2011-2012, 57% women suffer from zinc deficiency. The objective of the present study was to determine the effectiveness of fortified rice (FFR in addressing anaemia and zinc deficiency among vulnerable women. Baseline and endline surveys were conducted among female Vulnerable Group Development (VDG) beneficiaries in five districts in Bangladesh before and after 12 months of FFR distribution. The intervention group received 30 kg FFR; the control group received 30 kg non-FFR for every month from January 2013 to December 2013. The sample sizes were 870 women (435/group) at baseline and 800 (400/group) at endline. Difference-in-difference (DID) was estimated to measure the effect of FFR on anaemia and serum zinc. In the baseline survey, 39% of the FFR group and 34% of the non-FFR group had anaemia. At endline, 34% of women in the FFR group were anaemic compared to 40.7% in the non-FFR group. At endline, prevalence of anaemia was reduced in the FFR group by 4.8% but increased in the non-FFR group by 6.7%. The DID estimation showed the reduction in anaemia after 12 months of FFR consumption was significant (p = 0.035). The DID in mean haemoglobin level after 12 months of FFR consumption was also statistically significant (p = 0.002). Zinc deficiency decreased by 6% in the FFR group at endline, though the DID was not significant. Most of the respondents of the FFR group reported that they received their entitled rice on a regular basis however only half of the non-FFR respondents received every month in 12 months. Anaemia was significantly associated with not consuming fortified rice, geographical region, older age and heavy menstrual bleeding (P<0.05). FFR reduced anaemia and zinc deficiency prevalence. Replacement of regular rice with FFR in the VGD programme is recommended to reduce anaemia among vulnerable groups.	[Ara, Gulshan; Khanam, Mansura; Rahman, Ahmed Shafiqur; Islam, Zhahirul; Farhad, Shahriar; Sanin, Kazi Istiaque; Khan, Sihan Sadat; Ahmed, Tahmeed] Icddr B, Dhaka, Bangladesh; [Rahman, Mohammad Mahbobor; Majoor, Herma] United Nations World Food Programme, IDB Bhaban, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Ara, G (corresponding author), Icddr B, Dhaka, Bangladesh.	gulshan.ara@icddrb.org		Islam, Dr. Zhahirul/0000-0003-0935-8079	United nations World Food Programme [1209]; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Agency; Department for International Development, UK	United nations World Food Programme; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC)(CGIAR); Swedish International Development Agency; Department for International Development, UK	This research is supported by the United nations World Food Programme Grant #1209, http://www1.wfp.org/countries/bangladesh.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted at the icddr, b Centre for Health and Population Research, Bangladesh with the support of the United Nations World Food Programme. The icddr, b thanks the WFP for its commitment to the Centre's research efforts. We also thank the VGD participants and field staff for their encouragement and support. The icddr, b also acknowledges with gratitude the commitment of the Government of Bangladesh to the Centre's research efforts, and also gratefully acknowledges the following donors who provided unrestricted support: the Government of the People's Republic of Bangladesh, Global Affairs Canada (GAC), the Swedish International Development Agency, and the Department for International Development, UK.	Ahmed F, 2016, J NUTR SCI, V5; Ahmed F, 2000, PUBLIC HEALTH NUTR, V3, P385, DOI 10.1017/S1368980000000446; Allen L, 2006, GUIDELINES FOOD FORT; Angeles-Agdeppa I, 2008, INT J VITAM NUTR RES, V78, P74, DOI 10.1024/0300-9831.78.2.74; [Anonymous], 2013, ICDDRB UNDEFINED BAN; Badii A, 2012, INT J PREVENTIVE MED, V3, pS124; Bagni UV, 2009, CAD SAUDE PUBLICA, V25, P291, DOI 10.1590/S0102-311X2009000200007; Balasubramaniam P, 1992, J Postgrad Med, V38, P8; Bhandari S, 2015, INT SCH RES NOT, V2015; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Broadley M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P191, DOI 10.1016/B978-0-12-384905-2.00007-8; Brown KH, 2007, AM J CLIN NUTR, V85, P538, DOI 10.1093/ajcn/85.2.538; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; de Pee S, 2014, ANN NY ACAD SCI, V1324, P55, DOI 10.1111/nyas.12478; de Romana DL, 2005, AM J CLIN NUTR, V81, P637; Eisenstaedt R, 2006, BLOOD REV, V20, P213, DOI 10.1016/j.blre.2005.12.002; Engle-Stone R, 2011, J NUTR, V141, P2233, DOI 10.3945/jn.111.145805; Garcia-Banuelos ML, 2014, J ELEM, V19; Hasan M, 2017, CUREUS, V9; Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94; Hotz C, 2005, J NUTR, V135, P1102, DOI 10.1093/jn/135.5.1102; Hotz C, 2008, FOOD NUTR BULL, V29, P140, DOI 10.1177/156482650802900208; Hunt JM, 2002, J NUTR, V132, p794S, DOI 10.1093/jn/132.4.794S; Hyder SMZ, 2001, PUBLIC HEALTH NUTR, V4, P79, DOI 10.1079/PHN200055; Islam MZ, 2001, EUR J CLIN NUTR, V55, P598, DOI 10.1038/sj.ejcn.1601190; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Khambalia A, 2009, J NUTR, V139, P1179, DOI 10.3945/jn.108.101022; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Lindstrom E, 2011, ACTA OBSTET GYN SCAN, V90, P47, DOI 10.1111/j.1600-0412.2010.01014.x; Makipour S, 2008, SEMIN HEMATOL, V45, P250, DOI 10.1053/j.seminhematol.2008.06.003; Malpeli A, 2013, BIOL TRACE ELEM RES, V155, P176, DOI 10.1007/s12011-013-9780-y; Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Organization WH, 2001, GUID PROGR MAN, P47; Perignon M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010029; PERRY DF, 1990, J ASSOC OFF ANA CHEM, V73, P619; Piccoli NB, 2012, FOOD NUTR BULL, V33, pS360, DOI 10.1177/15648265120334S312; Pinkaew S, 2013, J NUTR, V143, P362, DOI 10.3945/jn.112.166058; Research NI of P Training Mitra Associates International M, 2009, BANGL DEM HLTH SURV; Roy SK, 2007, J HEALTH POPUL NUTR, V25, P67; Sampath Cdr S, 2007, AM J OBSTET GYNECOL, V63, P233; Seshadri S, 2001, BRIT J NUTR, V85, pS87, DOI 10.1079/BJN2000299; Shah D, 2013, COCHRANE DATABASE SY; Shahabuddin A.K.M., 2000, Indian Journal of Pediatrics, V67, P93, DOI 10.1007/BF02726173; Stallkamp G, 2006, SIGHT LIFE, V3, P16; Strengthening Public Financial Management for Social Protection (SPFMSP), DIAGN STUD VULN GROU; Thankachan P, 2012, J NUTR, V142, P846, DOI 10.3945/jn.111.149021; Unnevehr L, 2007, ADDRESSING MICRONUTR; Whitley E, 2002, CRIT CARE, V6, P335; Winichagoon P, 2006, J NUTR, V136, P1617, DOI 10.1093/jn/136.6.1617	52	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210501	10.1371/journal.pone.0210501	http://dx.doi.org/10.1371/journal.pone.0210501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629717	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000097
J	Nava, AC; Pino, ZMS; Perez, AMH; Hernandez, MEH; Sanchez, MJD; Manzano, JMS				Cubo Nava, Ana; Soto Pino, Zandra M.; Haro Perez, Ana M.; Hernandez Hernandez, M. Estrella; Doyague Sanchez, M. Jose; Sayagues Manzano, Jose M.			Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis	PLOS ONE			English	Article							EARLY-PREGNANCY FAILURE; MISSED MISCARRIAGE; MANAGEMENT; MISOPROSTOL; EXPECTANT; CURETTAGE; TRIAL	Background Traditionally the gold-standard technique for the treatment of spontaneous abortion has been uterine evacuation by aspiration curettage. However, many studies have proposed medical treatment with misoprostol as an alternative to the conventional surgical treatment. The aim of this study was to apply cost minimization methods to compare the cost and effectiveness of the use of vaginal misoprostol as a medical treatment for first trimester spontaneous abortion with those of evacuation curettage as a surgical treatment. Methodology/Principal findings We present a longitudinal, prospective and quasi-experimental research study including a total of 547 patients diagnosed with first-trimester spontaneous abortion, in the period from January 2013 to December 2015. Patients were offered medical treatment with 800 mg vaginal misoprostol or evacuation curettage. Patients treated with misoprostol were followed-up at 7 days and a transvaginal ultrasound was performed to confirm the success of the treatment. If it failed, a second dose of 800 mg of vaginal misoprostol was prescribed and a new control ultrasound was performed. In case of failure of medical treatment after the second dose of misoprostol, evacuation curettage was indicated. The effectiveness of each of the treatment options was calculated using a decision tree. The cost minimization study was carried out by weighting each cost according to the effectiveness of each branch of the treatment. Of the 547 patients who participated in the study, 348 (64%) chose medical treatment and 199 (36%) chose surgical treatment. The overall effectiveness of medical treatment was 81% (283/348) and surgical treatment of 100%. The estimated final cost for medical treatment was (sic) 461.92 compared to (sic) 2038.72 for surgical treatment, which represents an estimated average saving per patient of (sic) 1576.8. Conclusions/Significance Medical treatment with misoprostol is a cheaper alternative to surgery: in the Spanish Public Healthcare System, it is five times more inexpensive than curettage. Given its success rates higher than 80%, mild side effects, controllable with additional medication and the high degree of overall satisfaction, it should be prioritized over the evacuation curettage in patients who meet the treatment criteria.	[Cubo Nava, Ana; Soto Pino, Zandra M.; Hernandez Hernandez, M. Estrella; Doyague Sanchez, M. Jose] Complejo Asistencial Univ Salamanca, Dept Obstet & Gynecol, Salamanca, Spain; [Haro Perez, Ana M.] Complejo Asistencial Univ Salamanca, Dept Prevent Med & Publ Hlth, Salamanca, Spain; [Sayagues Manzano, Jose M.] Complejo Asistencial Univ Salamanca, Dept Hematol, Salamanca, Spain; [Sayagues Manzano, Jose M.] Inst Biomed Res IBSAL, Salamanca, Spain		Nava, AC (corresponding author), Complejo Asistencial Univ Salamanca, Dept Obstet & Gynecol, Salamanca, Spain.	amcubo@saludcastillayleon.es	NAVA, ANA MARIA CUBO/L-4535-2019; Nava, Ana M Cubo/D-4848-2019; Nava, Ana María Cubo/AAN-3445-2020	Nava, Ana María Cubo/0000-0003-4473-4914	Institute for Biomedical Research (IBSAL), Salamanca, Spain	Institute for Biomedical Research (IBSAL), Salamanca, Spain	This work was supported by the Institute for Biomedical Research (IBSAL), Salamanca, Spain, has paid for the publication fees (Article Processing Charges) of this manuscript. There was no additional external funding received for this study. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2012, AUST NZ J OBSTET GYN, V52, P39, DOI 10.1111/j.1479-828X.2011.01382.x; Creinin MD, 2004, OBSTET GYNECOL, V103, P851, DOI 10.1097/01.AOG.0000124271.23499.84; Creinin MD, 2000, CONTRACEPTION, V62, P117, DOI 10.1016/S0010-7824(00)00151-7; DEJONGE ETM, 1995, BRIT MED J, V311, P662, DOI 10.1136/bmj.311.7006.662; Diop A, 2009, CONTRACEPTION, V79, P456, DOI 10.1016/j.contraception.2008.11.016; Graziosi GCM, 2005, HUM REPROD, V20, P1067, DOI 10.1093/humrep/deh709; Graziosi GCM, 2004, HUM REPROD, V19, P1894, DOI 10.1093/humrep/deh344; Ministerio de Sanidad Servicios Sociales e Igualdad, REG ALT HOSP GEN SIS; Neilson JP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007223.pub3; OMS, PROGR EPI INFO; Rausch M, 2012, FERTIL STERIL, V97, P355, DOI 10.1016/j.fertnstert.2011.11.044; Reeves MF, 2009, ULTRASOUND OBST GYN, V34, P104, DOI 10.1002/uog.6404; Rubio Cebrian S., 2012, METODOLOGI TIPO ESTU; Rubio-Terres C, 2004, MED CLIN-BARCELONA, V122, P668, DOI 10.1157/13061390; Sayagues JM, 2018, HARVARD DATAVERSE, DOI [10.7910/DVN/HNGE05, DOI 10.7910/DVN/HNGE05]; SEGO, 2011, PROGR OBST GIN, V54, P207, DOI DOI 10.1016/J.POG.2010.10.008; Shankar M, 2007, J OBSTET GYNAECOL, V27, P283, DOI 10.1080/01443610701213927; Sifakis Stavros, 2005, Archives of Gynecology and Obstetrics, V272, P183, DOI 10.1007/s00404-004-0697-8; Trinder J, 2006, BMJ-BRIT MED J, V332, P1235, DOI 10.1136/bmj.38828.593125.55; Xia W, 2011, GYNECOL OBSTET INVES, V72, P257, DOI 10.1159/000328313; You JHS, 2005, HUM REPROD, V20, P2873, DOI 10.1093/humrep/dei163; Zhang J, 2005, NEW ENGL J MED, V353, P761, DOI 10.1056/NEJMoa044064	22	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210449	10.1371/journal.pone.0210449	http://dx.doi.org/10.1371/journal.pone.0210449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629715	Green Published, gold			2022-12-27	WOS:000455483000092
J	Taba, ST; Brennan, PC; Lewis, S				Taba, Seyedamir Tavakoli; Brennan, Patrick C.; Lewis, Sarah			Dynamics of breast imaging research: A global scoping review and Sino-Australian comparison case study	PLOS ONE			English	Review							CANCER; CHINA; CENTRALITY; MORTALITY; NETWORKS	This study presents a quantitative analysis of global breast imaging research over the last eight decades. A dedicated Sino-Australian case study via a social network analysis (SNA) is included as China and Australia have a recent rapidly increasing number of research partnerships and strategic education/economic connections. Bibliographic data was extracted via Scopus and analysed for the social network parameters of degree centrality, closeness centrality, betweenness centrality and multiple cohesion measures in order to explore research collaboration networks at the organisational level. Within the last three decades there has been a tremendous increase in the publication rate within the scientific domain of breast imaging research, however, there is a significant lag in the development of this research area in China compared with Australia. Breast imaging research in China is considerably more insular, with less international collaboration and reduced variation between collaborators than Australia. The impact of national breast screening programs and novel cancer technologies upon collaboration networks is discussed alongside the ability of networks paradigm to reveal both frailties in research connections and to highlight networking strategies.	[Taba, Seyedamir Tavakoli; Brennan, Patrick C.; Lewis, Sarah] Univ Sydney, Fac Hlth Sci, Med Imaging Optimisat & Percept Grp MIOPeG, Sydney, NSW, Australia	University of Sydney	Taba, ST (corresponding author), Univ Sydney, Fac Hlth Sci, Med Imaging Optimisat & Percept Grp MIOPeG, Sydney, NSW, Australia.	amir.tavakoli@sydney.edu.au	Tavakoli Taba, Seyedamir/GON-6126-2022; Brennan, Patrick/AAC-7774-2019	Brennan, Patrick/0000-0001-8611-7258; Tavakoli Taba, Seyedamir/0000-0001-8759-0063	University of Sydney's China Studies Centre; University of Hong Kong; University of Sydney	University of Sydney's China Studies Centre; University of Hong Kong(University of Hong Kong); University of Sydney(University of Sydney)	This study was supported by funding from the University of Sydney's China Studies Centre and Priority Partnerships Collaboration Award with the University of Hong Kong and the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All-China Women's Federation, 2015, CERV BREAST CANC SCR; Australian Bureau of Statistics, 2017, ABS MIGR AUSTR 2015; Australian Institute of Health and Welfare (AIHW), 2014, AUSTR I HLTH WELF AI; Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; Borgatti, 1995, CONNECTIONS, V18, P112; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Burnside Elizabeth S, 2009, J Am Coll Radiol, V6, P851, DOI 10.1016/j.jacr.2009.07.023; Cancer Australia, 2017, BREAST CANC STAT BRE; Chen RC, 2009, J CLIN ULTRASOUND, V37, P319, DOI 10.1002/jcu.20596; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen WQ, 2016, CHINESE J CANCER RES, V28, P1, DOI 10.3978/j.issn.1000-9604.2016.02.08; Chinchilla-Rodriguez Z, 2018, SCIENTOMETRICS, V115, P1485, DOI 10.1007/s11192-018-2652-7; Chinchilla-Rodriguez Z, 2012, J AM SOC INF SCI TEC, V63, P2223, DOI 10.1002/asi.22669; Commonwealth of Australia, 2012, AUSTR AS CENT; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Glynn RW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2795; Ha R, 2014, AM J ROENTGENOL, V202, P696, DOI 10.2214/AJR.13.11993; Krackhardt David., 1994, COMPUTATIONAL ORG TH; Kuhl CK, 2015, INVEST RADIOL, V50, P615, DOI 10.1097/RLI.0000000000000166; LEAVITT HJ, 1951, J ABNORM SOC PSYCH, V46, P38, DOI 10.1037/h0057189; Li T, 2016, BREAST CANCER RES TR, V159, P395, DOI 10.1007/s10549-016-3947-0; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Moed HF, 2008, SCIENTOMETRICS, V74, P153, DOI 10.1007/s11192-008-0108-1; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Taba ST, 2015, SCIENTOMETRICS, V103, P531, DOI 10.1007/s11192-015-1560-3; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017; Wang BH, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130136; Wasserman, 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; WEGENER B, 1991, AM SOCIOL REV, V56, P60, DOI 10.2307/2095673; WOLFE JN, 1969, CANCER, V23, P791, DOI 10.1002/1097-0142(196904)23:4<791::AID-CNCR2820230408>3.0.CO;2-Y	32	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210256	10.1371/journal.pone.0210256	http://dx.doi.org/10.1371/journal.pone.0210256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629713	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000068
J	Allen, CH; Vold, K; Felsen, G; Blumenthal-Barby, JS; Aharoni, E				Allen, Corey H.; Vold, Karina; Felsen, Gidon; Blumenthal-Barby, Jennifer S.; Aharoni, Eyal			Reconciling the opposing effects of neurobiological evidence on criminal sentencing judgments	PLOS ONE			English	Article							SOCIAL DISTANCE; BRAIN IMAGES; EXPLANATIONS; PEOPLE; IMPACT	Legal theorists have characterized physical evidence of brain dysfunction as a double-edged sword, wherein the very quality that reduces the defendant's responsibility for his transgression could simultaneously increase motivations to punish him by virtue of his apparently increased dangerousness. However, empirical evidence of this pattern has been elusive, perhaps owing to a heavy reliance on singular measures that fail to distinguish between plural, often competing internal motivations for punishment. The present study employed a test of the theorized double-edge pattern using a novel approach designed to separate such motivations. We asked a large sample of participants (N = 330) to render criminal sentencing judgments under varying conditions of the defendant's mental health status (Healthy, Neurobiological Disorder, Psychological Disorder) and the disorder's treatability (Treatable, Untreatable). As predicted, neurobiological evidence simultaneously elicited shorter prison sentences (i.e., mitigating) and longer terms of involuntary hospitalization (i.e., aggravating) than equivalent psychological evidence. However, these effects were not well explained by motivations to restore treatable defendants to health or to protect society from dangerous persons but instead by deontological motivations pertaining to the defendant's level of deservingness and possible obligation to provide medical care. This is the first study of its kind to quantitatively demonstrate the paradoxical effect of neuroscientific trial evidence and raises implications for how such evidence is presented and evaluated.	[Allen, Corey H.; Aharoni, Eyal] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Vold, Karina] Univ Cambridge, Leverhulme Ctr Future Intelligence, Fac Philosophy, Cambridge, England; [Felsen, Gidon] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO USA; [Blumenthal-Barby, Jennifer S.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Aharoni, Eyal] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [Aharoni, Eyal] Georgia State Univ, Dept Philosophy, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University of Cambridge; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Aharoni, E (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.; Aharoni, E (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.; Aharoni, E (corresponding author), Georgia State Univ, Dept Philosophy, Atlanta, GA 30303 USA.	eaharoni@gsu.edu			John Templeton Foundation via the Summer Seminars on Neuroscience and Philosophy at Duke University [283-0635]	John Templeton Foundation via the Summer Seminars on Neuroscience and Philosophy at Duke University	All authors received support from a grant from the John Templeton Foundation (www.templeton.org) via the Summer Seminars on Neuroscience and Philosophy at Duke University (Subaward #: 283-0635). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Felipe De Brigard, Walter Sinnott-Armstrong, and Peter Reiner for helpful comments. This publication was made possible through the support of a grant from the John Templeton Foundation via the Summer Seminars on Neuroscience and Philosophy at Duke University. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation.	Ahn WK, 2009, COGNITIVE SCI, V33, P147, DOI 10.1111/j.1551-6709.2009.01008.x; Aspinwall LG, 2012, SCIENCE, V337, P846, DOI 10.1126/science.1219569; Bag B, 2006, INT J CLIN PRACT, V60, P289, DOI 10.1111/j.1368-5031.2006.00743.x; Baumeister R., 2010, FREE WILL CONSCIOUSN; Berryessa CM, 2017, CRIM JUSTICE BEHAV, V44, P1073, DOI 10.1177/0093854817716485; Blakey R, 2018, FRONT PSYCHOL, P8; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Capestany BH, 2014, SOC NEUROSCI-UK, V9, P265, DOI 10.1080/17470919.2014.892531; Chandler JA, 2015, J LAW BIOSCI, V2, P550, DOI 10.1093/jlb/lsv026; Clifford S, 2015, RES POLITICS, V2, DOI 10.1177/2053168015622072; Dennett DC, 2015, ELBOW ROOM: THE VARIETIES OF FREE WILL WORTH WANTING, P1; Farah MJ, 2013, PERSPECT PSYCHOL SCI, V8, P88, DOI 10.1177/1745691612469035; Farahany NA, 2015, J LAW BIOSCI, V2, P485, DOI 10.1093/jlb/lsv059; Fuss J, 2015, J MED GENET, V52, P730, DOI 10.1136/jmedgenet-2015-103284; Grausgruber A, 2007, ACTA PSYCHIAT SCAND, V115, P310, DOI 10.1111/j.1600-0447.2006.00882.x; Greene E, 2012, BEHAV SCI LAW, V30, P280, DOI 10.1002/bsl.1993; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; HAMPTON J, 1984, PHILOS PUBLIC AFF, V13, P208; Hardcastle VG, 2018, J EVAL CLIN PRACT, V24, P909, DOI 10.1111/jep.12932; Haslam N, 2015, CURR DIR PSYCHOL SCI, V24, P399, DOI 10.1177/0963721415588082; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Kaufman EA, 2016, J PSYCHOPATHOL BEHAV, V38, P443, DOI 10.1007/s10862-015-9529-3; LaDuke C, 2018, J FOREN PSYCHOL RES, V18, P114, DOI 10.1080/24732850.2018.1439142; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Marshall J, 2017, J FORENSIC PSYCHI PS, V28, P412, DOI 10.1080/14789949.2017.1291706; Martin JK, 2007, J HEALTH SOC BEHAV, V48, P50, DOI 10.1177/002214650704800104; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; McCabe DP, 2011, BEHAV SCI LAW, V29, P566, DOI 10.1002/bsl.993; Michael RB, 2013, PSYCHON B REV, V20, P720, DOI 10.3758/s13423-013-0391-6; Morse S. J., 2006, OHIO STATE J CRIMINA, V3, P397; Murphy K, 2004, STAT POWER ANAL SIMP, V2nd; Remmel RJ, 2019, J PERS DISORD, V33, P164, DOI 10.1521/pedi_2018_32_337; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Saks MJ, 2014, J EMPIR LEGAL STUD, V11, P105, DOI 10.1111/jels.12036; Schweitzer NJ, 2011, 2018114 SOC SCI RES; Shariff AF, 2014, PSYCHOL SCI, V25, P1563, DOI 10.1177/0956797614534693; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P342, DOI 10.1037/0022-0663.89.2.342; Weisberg DS, 2015, JUDGM DECIS MAK, V10, P429; West RF, 2012, J PERS SOC PSYCHOL, V103, P506, DOI 10.1037/a0028857	40	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210584	10.1371/journal.pone.0210584	http://dx.doi.org/10.1371/journal.pone.0210584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657761	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000011
J	Basile, MS; Mazzon, E; Russo, A; Mammana, S; Longo, A; Bonfiglio, V; Fallico, M; Caltabiano, R; Fagone, P; Nicoletti, F; Avitabile, T; Reibaldi, M				Basile, Maria Sofia; Mazzon, Emanuela; Russo, Andrea; Mammana, Santa; Longo, Antonio; Bonfiglio, Vincenza; Fallico, Matteo; Caltabiano, Rosario; Fagone, Paolo; Nicoletti, Ferdinando; Avitabile, Teresio; Reibaldi, Michele			Differential modulation and prognostic values of immune-escape genes in uveal melanoma	PLOS ONE			English	Article							PD-L1 EXPRESSION; IFN-GAMMA	Uveal melanoma (UM) is the most common primary intraocular cancer in adults. In the present study, we aimed to characterize the immunological features of primary UM cancer and to provide an association with prognostic markers and outcome. Also, we assessed the influence of the microenvironment on the expression of inhibitory immune checkpoints in UM. Genes of interest included MHC Class I and Class II molecules, as well as inhibitory immune-checkpoints, i.e. PDL1, PDL2, B7-H3, B7-H4, TBFRSF6B, CD47, CD155, GAL9, HVEM and CD200. We observed significant lower levels of MHC genes in UM cells as compared to normal uveal melanocytes. Unexpectedly however, the expression levels of most of the analyzed inhibitory immune-checkpoint genes were not different in cancer cells as compared to normal melanocytes, with the exception of CD200 and HVEM, that resulted significantly reduced. On the other hand, PDL1 inversely correlated with OS, PFS and thickness of the tumor. Also, PDL1, along with PDL2, expression significantly increased under inflammatory conditions. Finally, for the first time, we propose a possible role for CD47 in the immune evasive properties of UM. We show here that CD47 is significantly upregulated by UM cells following inflammatory stimuli and that it represents a good independent predictor of disease progression. The results from this study may propel advances in the development of immune-based therapies for UM patients.	[Basile, Maria Sofia; Fagone, Paolo; Nicoletti, Ferdinando] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Mazzon, Emanuela; Mammana, Santa] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Russo, Andrea; Longo, Antonio; Bonfiglio, Vincenza; Fallico, Matteo; Avitabile, Teresio; Reibaldi, Michele] Univ Catania, Dept Ophthalmol, Catania, Italy; [Caltabiano, Rosario] Univ Catania, Sect Anat Pathol, Dept GF Ingrassia, Catania, Italy	University of Catania; IRCCS Bonino Pulejo; University of Catania; University of Catania	Fagone, P (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.	paolofagone@yahoo.it	Mazzon, Emanuela/AAL-4334-2020; Nicoletti, Ferdinando/M-4428-2016; Basile, Maria Sofia/AAC-3393-2019; Avitabile, Teresio/AAC-6076-2022; Fallico, Matteo/AAC-5284-2022; Russo, Andrea/AAC-5349-2022; Reibaldi, Michele/AAL-1113-2021; Longo, Antonio/AAC-6092-2022; Fagone, Paolo/Q-4455-2016	Nicoletti, Ferdinando/0000-0002-4570-8462; Basile, Maria Sofia/0000-0002-4811-4694; Russo, Andrea/0000-0002-7725-5971; LONGO, Antonio/0000-0002-9525-1800; Caltabiano, Rosario/0000-0001-8591-8010; mazzon, emanuela/0000-0002-5073-717X; FALLICO, MATTEO/0000-0003-2639-1321; Fagone, Paolo/0000-0002-6694-1992	IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy	IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy	This study was supported by current research funds 2016 of IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazi AP, 2016, CANCER-AM CANCER SOC, V122, P3344, DOI 10.1002/cncr.30258; Bene L, 2004, BIOCHEM BIOPH RES CO, V322, P678, DOI 10.1016/j.bbrc.2004.07.171; Blom DJR, 1997, INVEST OPHTH VIS SCI, V38, P1865; Chattopadhyay C, 2016, CANCER-AM CANCER SOC, V122, P2299, DOI 10.1002/cncr.29727; Chen PW, 2007, EXP EYE RES, V85, P617, DOI 10.1016/j.exer.2007.07.014; DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112; Duval C, 2015, EXP EYE RES, V135, P146, DOI 10.1016/j.exer.2015.03.001; Fagone P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44564; Ge H, 2018, CLIN CHIM ACTA, V481, P126, DOI 10.1016/j.cca.2018.02.038; Javed A, 2017, IMMUNOTHERAPY-UK, V9, P1323, DOI 10.2217/imt-2017-0066; Jehs T, 2014, INVEST OPHTH VIS SCI, V55, P5169, DOI 10.1167/iovs.14-14394; Kaunitz GJ, 2017, LAB INVEST, V97, P1063, DOI 10.1038/labinvest.2017.64; Lagouros Evan, 2009, Trans Am Ophthalmol Soc, V107, P223; Mandai M, 2016, CLIN CANCER RES, V22, P2329, DOI 10.1158/1078-0432.CCR-16-0224; McKenna KC, 2010, OCUL IMMUNOL INFLAMM, V18, P80, DOI 10.3109/09273941003669950; McLaughlin CC, 2005, CANCER-AM CANCER SOC, V103, P1000, DOI 10.1002/cncr.20866; Niederkorn JY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00148; Oliva M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.04; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rodriguez A, 2016, MOL CLIN ONCOL, V5, P675, DOI 10.3892/mco.2016.1037; Rothermel LD, 2016, CLIN CANCER RES, V22, P2237, DOI 10.1158/1078-0432.CCR-15-2294; Tong B, 2018, FUTURE ONCOL, V14, P2179, DOI 10.2217/fon-2018-0035; van Essen TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164292; Yang J, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758834018757175; Yang WH, 2008, INVEST OPHTH VIS SCI, V49, P2518, DOI 10.1167/iovs.07-1606; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Zhou XX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00452	28	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210276	10.1371/journal.pone.0210276	http://dx.doi.org/10.1371/journal.pone.0210276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653520	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500031
J	Deshmukh, SS; Kornblatt, MJ; Kornblatt, JA				Deshmukh, Sasmit S.; Kornblatt, M. Judith; Kornblatt, Jack A.			The influence of truncating the carboxyterminal amino acid residues of streptococcal enolase on its ability to interact with canine plasminogen	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; DUAL-POLARIZATION INTERFEROMETRY; SIZE-DISTRIBUTION ANALYSIS; ALPHA-ENOLASE; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; REAL-TIME; BINDING; PROTEIN; PNEUMONIAE	The native octameric structure of streptococcal enolase from Streptococcus pyogenes increasingly dissociates as amino acid residues are removed one by one from the carboxy-terminus. These truncations gradually convert native octameric enolase into monomers and oligomers. In this work, we investigated how these truncations influence the interaction between Streptococcal enolase and canine plasminogen. We used dual polarization interferometry (DPI), localized surface plasmon resonance (LSPR), and sedimentation velocity analytical ultracentrifugation (AUC) to study the interaction. The DPI was our first technique, was performed on all the truncations and used one exclusive kind of chip. The LSRP was used to show that the DPI results were not dependent on the type of chip used. The AUC was required to show that our surface results were not the result of selecting a minority population in any given sample; the majority of the protein was responsible for the binding phenomenon we observed. By comparing results from these techniques we identified one detail that is essential for streptococcal enolase to bind plasminogen: In our hands the individual monomers bind plasminogen; dimers, trimers, tetramers may or may not bind, the fully intact, native, octamer does not bind plasminogen. We also evaluated the contribution to the equilibrium constant made by surface binding as well as in solution. On a surface, the association coefficient is about twice that in solution. The difference is probably not significant. Finally, the fully octameric form of the protein that does not contain a hexa-his N-terminal peptide does not bind to a silicon oxynitride surface, does not bind to an Au-nanoparticle surface, does not bind to a surface coated with Ni-NTA nor does it bind to a surface coated with DPgn. The likelihood is great that the enolase species on the surface of Streptococcus pyogenes is an x-mer of the native octamer.	[Deshmukh, Sasmit S.] Concordia Univ, Dept Phys, Montreal, PQ, Canada; [Kornblatt, M. Judith] Concordia Univ, Dept Chem & Biochem, Montreal, PQ, Canada; [Kornblatt, Jack A.] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [Deshmukh, Sasmit S.] Sanofi Pasteur, N York, ON, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada; Sanofi-Aventis	Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ, Canada.	jack.kornblatt@concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council of Canada [9988-2006]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (URL www.nserc-crsng.gc.ca), Grant Number 9988-2006 to JAK. The funder had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	ABAZA MSI, 1992, J PROTEIN CHEM, V11, P687, DOI 10.1007/BF01024970; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bachmann F., 1994, MOL ASPECTS PLASMINO, P525; Balhara V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088395; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Coffey PD, 2013, RSC ADV, V3, P3316, DOI 10.1039/c2ra22911k; Cork AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121764; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Daghestani HN, 2010, SENSORS-BASEL, V10, P9630, DOI 10.3390/s101109630; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Feng XY, 2013, ANAL CHEM, V85, P2370, DOI 10.1021/ac303392a; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fox D, 2001, MED MYCOL, V39, P495, DOI 10.1080/714031070; Hirst DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P503, DOI 10.1007/s00249-010-0664-1; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt JA, 2007, ANAL CHEM INSIGHTS, V2, P17; Kornblatt JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135754; Kornblatt MJ, 2013, YEAST, V30, P55, DOI 10.1002/yea.2940; Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P544, DOI 10.1016/j.bbamem.2010.01.014; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Lu Q, 2012, PROTEIN CELL, V3, P769, DOI 10.1007/s13238-012-2040-7; Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Philo JS, 2006, AAPS J, V8, pE564, DOI 10.1208/aapsj080365; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Piazza M., 2016, BIOCHEMISTRY; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2016, SEDIMENTATION VELOCI, V1, P1; Schuck P., 2015, BASIC PRINCIPLES ANA, V1, P1; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Sumitomo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20069; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Yonzon CR, 2004, J AM CHEM SOC, V126, P12669, DOI 10.1021/ja047118q; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010; Zhao J, 2006, NANOMEDICINE-UK, V1, P219, DOI 10.2217/17435889.1.2.219; Zhao J, 2006, J AM CHEM SOC, V128, P11004, DOI 10.1021/ja0636082	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0206338	10.1371/journal.pone.0206338	http://dx.doi.org/10.1371/journal.pone.0206338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653526	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000456015500007
J	Shen, KY; Vesey, DA; Ellis, RJ; Del Vecchio, SJ; Cho, Y; Teixeira-Pinto, A; McGuckin, MA; Johnson, DW; Gobe, GC				Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Cho, Yeoungjee; Teixeira-Pinto, Armando; McGuckin, Michael A.; Johnson, David W.; Gobe, Glenda C.			GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma	PLOS ONE			English	Article							QUANTIFICATION; PATHOLOGY; STRESS	Objective Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer, which is difficult to treat and lacks a reliable prognostic marker. A previous study showed that the endoplasmic reticulum stress marker, glucose-regulated-protein-78 (GRP78), is a potential prognostic marker for ccRCC. The present study aimed to: (1) examine whether GRP78 was upregulated in ccRCC compared with matched non-neoplastic renal tissue; and (2) investigate whether GRP78 expression in ccRCC tissue or perinephric adipose tissue has any association with ccRCC aggressiveness. Methods A retrospective cross-sectional study of 267 patients who underwent nephrectomy for renal tumors between June 2013 and October 2017 was conducted at Princess Alexandra Hospital, Brisbane, Australia. Software-assisted quantification of average grey value of staining intensity (staining intensity method) and proportion of positive pixels (positive pixel method) was applied to measure expression of GRP78 in archived specimens of renal tumor tissues (n = 114), adjacent non-neoplastic renal tissues (n = 68), and perinephric adipose tissues (n = 60) in participants diagnosed with ccRCC. Results GRP78 was not upregulated in renal tumor tissue compared with paired normal renal tissue. In tumor tissue, GRP78 expression did not show any association with ccRCC aggressiveness using either quantification method. In adipose tissue, downregulation of GRP78 demonstrated poor correlation with increased probability of metastasis, with one unit increase in average grey value of GRP78 staining weakly correlating with a 17% increase in the odds ratio of metastasis (95% confidence interval: 0.99 to 1.38, p = 0.07). Conclusion GRP78 is not valuable as a risk stratification marker for ccRCC.	[Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Johnson, David W.; Gobe, Glenda C.] Univ Queensland, Ctr Kidney Dis Res, Brisbane, Qld, Australia; [Shen, Kunyu; Vesey, David A.; Ellis, Robert J.; Del Vecchio, Sharon Juliet; Johnson, David W.; Gobe, Glenda C.] Translat Res Inst, Brisbane, Qld, Australia; [Vesey, David A.; Ellis, Robert J.; Cho, Yeoungjee; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Teixeira-Pinto, Armando] Childrens Hosp Westmead, Ctr Kidney Res, Kids Res, Westmead, NSW, Australia; [Teixeira-Pinto, Armando] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [McGuckin, Michael A.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia	University of Queensland; University of Sydney; University of Sydney; University of Melbourne	Gobe, GC (corresponding author), Univ Queensland, Ctr Kidney Dis Res, Brisbane, Qld, Australia.; Gobe, GC (corresponding author), Translat Res Inst, Brisbane, Qld, Australia.	g.gobe@uq.edu.au	McGuckin, Michael/G-2310-2010; Vesey, David A/C-2253-2011; Cho, Yeoungjee/G-6176-2013; Teixeira-Pinto, Armando/H-7947-2013; Ellis, Robert/C-7335-2016; Johnson, David/F-2897-2011	McGuckin, Michael/0000-0002-8375-2675; Vesey, David A/0000-0002-2856-6650; Cho, Yeoungjee/0000-0002-3502-9837; Teixeira-Pinto, Armando/0000-0002-9389-2516; Ellis, Robert/0000-0002-9755-9913; Johnson, David/0000-0001-5491-3460	China Scholarship Council [2016008440278]; Australian Government; Australian National Health and Medical Research Council	China Scholarship Council(China Scholarship Council); Australian Government(Australian GovernmentCGIAR); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge that the China Scholarship Council provides a PhD stipend for Kunyu Shen (File No. 2016008440278). An Australian Government Research Training Stipend was provided for Robert Ellis. An Australian National Health and Medical Research Council Practitioner Fellowship was provided for David Johnson".	Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Clapp WL, 2012, HISTOLOGY PATHOLOGIS, P893; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Ellis Robert J, 2017, Asian Pac J Cancer Prev, V18, P3281; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fowler C, 2001, IMAGING, V13, P27; Fu WJ, 2010, UROLOGY, V75, P603, DOI 10.1016/j.urology.2009.05.007; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Labno, 2018, BAS INT QUANT IMAGEJ; Li T, 2016, CLIN GENITOURIN CANC, V14, pE553, DOI 10.1016/j.clgc.2016.03.017; Matsuo K, 2012, GYNECOL ONCOL; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Muglia Valdair F., 2015, Radiol Bras, V48, P166, DOI 10.1590/0100-3984.2013.1927; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Patel HD, 2016, J UROLOGY, V195, P1340, DOI 10.1016/j.juro.2015.11.029; Pereira ER, 2014, J BIO CHEM; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Samali A, 2010, INT J CELL BIOL, V2010, P11; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shu J, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0161-6; Van Drie John H, 2011, Chin J Cancer, V30, P124; Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206; Zhong YP, 2016, ONCOL LETT, V12, P2702, DOI 10.3892/ol.2016.5005	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210246	10.1371/journal.pone.0210246	http://dx.doi.org/10.1371/journal.pone.0210246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653515	Green Published, gold			2022-12-27	WOS:000456015500030
J	Van Roie, E; Van Driessche, S; Huijben, B; Baggen, R; van Lummel, RC; Delecluse, C				Van Roie, Evelien; Van Driessche, Stijn; Huijben, Bas; Baggen, Remco; van Lummel, Rob C.; Delecluse, Christophe			A body-fixed-sensor-based analysis of stair ascent and sit-to-stand to detect age-related differences in leg-extensor power	PLOS ONE			English	Article							MUSCLE POWER; PHYSICAL PERFORMANCE; CLIMB POWER; LOWER-LIMB; RELIABILITY; VELOCITY; HEALTHY; MEN; STRENGTH; VALIDITY	Human ageing is accompanied by a progressive decline in leg-extensor power (LEP). LEP is typically measured with specialized and expensive equipment, which limits the large-scale applicability. Previously, sensor-based trunk kinematics have been used to estimate the vertical power required to elevate the body's center of mass during functional tests, but the link with LEP and age remains to be investigated. Therefore, we investigated whether a body-fixed sensor-based analysis of power during stair ascent (SA) and sit-to-stand (STS) is positively related to LEP and whether its ability to detect age-related declines is similar. In addition, the effect of load during SA and STS was investigated. 98 adults (20-70 years) performed a leg press to assess LEP, SA and 5-repetition STS tests. In SA and STS, two conditions were tested: unloaded and loaded (+10% body mass). An inertial measurement unit was used to analyze (sub)-durations and vertical power. SA and STS power were more related to LEP than duration parameters (i. e. 0.80-0.81 for power and -0.41 -0.66 for duration parameters, p < 0.05). The average annual age-related percent change was higher in SA power (-1.38%) than in LEP (-0.86%) and STS power (-0.38%) (p < 0.05). Age explained 29% in SA power (p < 0.001), as opposed to 14% in LEP (p < 0.001) and a non-significant 2% in STS power (p = 0.102). The addition of 10% load did not influence the age-related decline of SA and STS power nor the relationship with LEP. These results demonstrate the potential of SA tests to detect age-related deterioration in neuromuscular function. SA seems more sensitive to detect age-related changes than LEP, probably because of the additional balance component and plantar- and dorsiflexor activity. On the contrary, STS is less sensitive to age-related changes because of a ceiling effect in well-functioning adults.	[Van Roie, Evelien; Van Driessche, Stijn; Baggen, Remco; Delecluse, Christophe] Katholieke Univ Leuven, Dept Movement Sci, Phys Act Sports & Hlth Res Grp, Leuven, Belgium; [Huijben, Bas; van Lummel, Rob C.] McRoberts BV, The Hague, Netherlands	KU Leuven	Van Roie, E (corresponding author), Katholieke Univ Leuven, Dept Movement Sci, Phys Act Sports & Hlth Res Grp, Leuven, Belgium.	evelien.vanroie@kuleuven.be	Van Roie, Evelien/AAP-2065-2020	Van Roie, Evelien/0000-0002-4547-589X; Baggen, Remco/0000-0002-1034-8997; Delecluse, Christophe/0000-0001-7895-5665				ANDRIACCHI TP, 1980, J BONE JOINT SURG AM, V62, P749, DOI 10.2106/00004623-198062050-00008; Bean JF, 2002, J AM GERIATR SOC, V50, P461; Bean JF, 2007, ARCH PHYS MED REHAB, V88, P604, DOI 10.1016/j.apmr.2007.02.004; Bohannon RW, 1998, CLIN REHABIL, V12, P434, DOI 10.1191/026921598673062266; Cerrito A, 2015, GAIT POSTURE, V41, P409, DOI 10.1016/j.gaitpost.2014.11.001; Charlier R, 2016, AGE, V38, DOI 10.1007/s11357-016-9900-7; Corrigan D, 2001, ARCH PHYS MED REHAB, V82, P1666, DOI 10.1053/apmr.2001.26811; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; DAVIES CTM, 1986, ACTA MED SCAND, P219; Ruiz-Cardenas JD, 2018, GAIT POSTURE, V59, P261, DOI 10.1016/j.gaitpost.2017.10.029; Edwen CE, 2014, SCAND J MED SCI SPOR, V24, P717, DOI 10.1111/sms.12066; FERRETTI G, 1994, EUR J APPL PHYSIOL O, V68, P111, DOI 10.1007/BF00244022; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; Gray M, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-145; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Han YL, 2015, ACTA BIOENG BIOMECH, V17, P13, DOI 10.5277/ABB-00155-2014-06; Hardy R, 2010, AGING CLIN EXP RES, V22, P412, DOI 10.1007/BF03324942; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Izquierdo M, 1999, EUR J APPL PHYSIOL, V79, P260, DOI 10.1007/s004210050504; Kanehisa H, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-26; Kostka T, 2005, EUR J APPL PHYSIOL, V95, P140, DOI 10.1007/s00421-005-1390-8; Larsen AH, 2009, SCAND J MED SCI SPOR, V19, P678, DOI 10.1111/j.1600-0838.2008.00845.x; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; MCFADYEN BJ, 1988, J BIOMECH, V21, P733, DOI 10.1016/0021-9290(88)90282-5; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; MOFFET H, 1993, GAIT POSTURE, V1, P35; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Ni M, 2017, PHYS THER, V97, P767, DOI 10.1093/ptj/pzx039; Petrella JK, 2005, J APPL PHYSIOL, V98, P211, DOI 10.1152/japplphysiol.00294.2004; Raj IS, 2010, EXP GERONTOL, V45, P81, DOI 10.1016/j.exger.2009.10.013; Regterschot GRH, 2014, GAIT POSTURE, V39, P303, DOI 10.1016/j.gaitpost.2013.07.122; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Savelberg HHCM, 2007, CLIN BIOMECH, V22, P805, DOI 10.1016/j.clinbiomech.2007.05.002; Schwenk M, 2012, PHYSIOL MEAS, V33, P1931, DOI 10.1088/0967-3334/33/11/1931; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Van Driessche S, 2018, EXP GERONTOL, V110, P98, DOI 10.1016/j.exger.2018.05.019; Van Driessche S, 2018, EXP GERONTOL, V101, P95, DOI 10.1016/j.exger.2017.11.009; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; van Lummel RC, 2012, PHYSIOL MEAS, V33, P1855, DOI 10.1088/0967-3334/33/11/1855; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157968; Van Roie E, 2018, EXP GERONTOL, V110, P260, DOI 10.1016/j.exger.2018.06.021; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Walaszek MC, 2017, J ELECTROMYOGR KINES, V34, P102, DOI 10.1016/j.jelekin.2017.04.005; Wilken JM, 2011, GAIT POSTURE, V34, P142, DOI 10.1016/j.gaitpost.2011.03.015; WRETENBERG P, 1994, EUR J APPL PHYSIOL, V68, P413, DOI 10.1007/BF00843738; Yoshioka S, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-27; Zech A, 2011, ARCH PHYS MED REHAB, V92, P967, DOI 10.1016/j.apmr.2010.12.031; Zemkova E, 2016, EXP AGING RES, V42, P418, DOI 10.1080/0361073X.2016.1224665; Zijlstra W, 2010, GAIT POSTURE, V31, P272, DOI 10.1016/j.gaitpost.2009.11.003	50	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210653	10.1371/journal.pone.0210653	http://dx.doi.org/10.1371/journal.pone.0210653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653542	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500060
J	Kislaya, I; Rodrigues, AP; Sousa-Uva, M; Gomez, V; Goncalves, P; Froes, F; Nunes, B				Kislaya, Irina; Rodrigues, Ana Paula; Sousa-Uva, Mafalda; Gomez, Veronica; Goncalves, Paulo; Froes, Filipe; Nunes, Baltazar			Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; VACCINATION; POPULATION; ADULTS; SEROTYPES; DISEASE; BURDEN; TRENDS; IMPACT; USA	Background Pneumonia is one of the leading causes of mortality and has a high burden in morbidity. In Portugal, 7-valent pneumococcal conjugated vaccine (PCV) was used since 2001 and PCV10/13 since 2009, being the last introduced into the National Immunization Program in 2015. Methods We conducted an ecological study to evaluate the impact of PCV7 and PCV13 on pneumococcal pneumonia (PP) hospitalizations in adults aged 65 years or more in Portugal. National hospital discharge registry data from 1998/99 to 2015/16 were used, and PP hospitalization was defined as any hospitalization coded in primary diagnosis as 481 (ICD-9-CM) or J18 (ICD-10-CM). Poisson regression models adjusted for seasonality, influenza-like illness and allowing for overdispersion was used to estimate annual average change of PP hospitalization rate. To assess PP hospitalization trends before and after PCV7 and PCV13 introduction interrupted time series analysis was performed. Results In 1998/99 PP hospitalization rate was 7.0 per 10,000 inhabitants, varying between 3.2 (females, 65-74 years) to 20.7 (males, + 85 years), and annually increasing by 16% during the pre-PCV7 period. Statistically significant reduction of 14% per year in PP hospitalization rate was observed after PCV7 introduction. Between 2004/05 and 2009/10 PP hospitalization rate decreased annually by 4% and after PCV13 introduction by 11% per year. In 2015/ 16 we found an overall reduction of 2.9 (CI 95%: 2.7; 3.1) PP hospitalizations per 10,000 inhabitants (598 hospitalizations) attributable to PCV13, varying from 2.2 (CI 95%: 1.3; 3.1) (female, 65-74 years) to 5.6 (CI 95%: 3.8; 7.5) (female, + 85 years). Conclusions Our results suggest that introduction of both PCV7 and PCV13 vaccines resulted in the reduction of PP hospitalizations rates among older adults.	[Kislaya, Irina; Rodrigues, Ana Paula; Sousa-Uva, Mafalda; Gomez, Veronica; Nunes, Baltazar] Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Kislaya, Irina; Sousa-Uva, Mafalda; Nunes, Baltazar] Univ Nova Lisboa, Escola Nacl Saude Publ, Ctr Invest Saude Publ, Lisbon, Portugal; [Goncalves, Paulo] Inst Nacl Saude Doutor Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Froes, Filipe] Ctr Hosp Lisboa Norte, Thorax Dept, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade Nova de Lisboa; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Rodrigues, AP (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal.	ana.rodrigues@insa.min-saude.pt	Froes, Filipe/F-6607-2015; Kislaya, Irina/AFK-6244-2022; Kislaya, Irina/GSE-3763-2022; Kislaya, Irina/AAG-4539-2022; Kislaya, Irina/GVS-9537-2022; Gonçalves, Paulo B/G-9818-2012	Froes, Filipe/0000-0003-4135-6022; Kislaya, Irina/0000-0001-5772-2416; Kislaya, Irina/0000-0001-5772-2416; Kislaya, Irina/0000-0001-5772-2416; Gonçalves, Paulo B/0000-0002-0671-1466; Nunes, Baltazar/0000-0001-6230-7209; GONCALVES, PAULO/0000-0002-4633-6306	European Union's Horizon 2020 research and innovation programme [634446]	European Union's Horizon 2020 research and innovation programme	This work is part of I-MOVE+ (Integrated Monitoring of Vaccines in Europe) project that received funding from the European Union's Horizon 2020 research and innovation programme [grant agreement number 634446].	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Barreto M, 2016, 1O INQUERITO NACL SA; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Direcao Geral da Saude (DGS), 2015, NORM 012 2015; Direcao Geral da Saude (DGS), 2015, NORM 08 2015; Geral da Saude (DGS), 2015, 0122015 DGS; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Horacio AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103092; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Instituto Nacional de Estatistica, 2017, CAM HOSP 100000 HAB; Instituto Nacional de Estatistica (INE), 2014, POP SEX GRUP ET AN; Instituto Nacional de Estatistica (INE), 2015, CAM HOSP 100000 HAB; International Classification of Diseases, 9 REV CLIN MOD; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Menzies RI, 2015, CLIN INFECT DIS, V61, P927, DOI 10.1093/cid/civ429; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Okasha O, 2018, THORAX, V73, P262, DOI 10.1136/thoraxjnl-2017-210440; Palmu AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172690; Queiros L, 2004, ACTA MEDICA PORT, V17, P49; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rodrigues E, 2018, INFLUENZA OTHER RESP, V12, P153, DOI 10.1111/irv.12501; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Shivaji T, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.50.20991; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Smith SB, 2014, JAMA INTERN MED, V174, P1837, DOI 10.1001/jamainternmed.2014.4344; Thorrington D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1004-z; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; van Werkhoven CH, 2016, VACCINE, V34, P3275, DOI 10.1016/j.vaccine.2016.05.002; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; World Health Organization, 2008, TOP 10 CAUS DEATHS; World Health Organization, 2019, INT CLASS DIS; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209428	10.1371/journal.pone.0209428	http://dx.doi.org/10.1371/journal.pone.0209428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650091	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300015
J	Moore, W; Di Giulio, A				Moore, Wendy; Di Giulio, Andrea			Out of the burrow and into the nest: Functional anatomy of three life history stages of Ozaena lemoulti (Coleoptera: Carabidae) reveals an obligate life with ants	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BEETLES COLEOPTERA; 1ST-INSTAR LARVA; PAUSSINAE; OZAENINI	The carabid subfamily Paussinae contains many species known to be obligately associated with ants during at least one stage of their life history. Myrmecophilous larvae have been documented for members of the tribe Paussini as well as several genera in the tribes Ozaenini, including Physea and Eustra. Here we describe the first instar larva of Ozaena lemoulti, and find it to be the most highly modified ozaenine larva that we have examined to date. Many structures of the larva suggest that it is a myrmecophile. Unlike all other described ozaenine larvae, which live in burrows that they construct and seal with their terminal disk, the completely unique larval morphology suggests Ozaena has adapted to living without the protection of a burrow and therefore must have a completely different feeding strategy than the typical ambush strategy of burrow dwelling larvae. We hypothesize that Ozaena larvae live in association with ants and use their long legs for running within the nest, and modifications of the mouthparts suggest the larva feeds on soft lightly sclerotized prey, such as ant brood. Our findings support an earlier hypothesis that Ozaena is mymecophilous during the adult stage. Comparisons of the functional anatomy of the eggs, larvae and adult between Ozaena lemoulti and the closely related, non-myrmecophilous general arthropod predator, Goniotropis kuntzeni, provide complementary, yet independent, evidence suggestive of this shift in lifestyle. We also examine and molecularly identify gut contents, providing direct evidence that adult Ozaena exclusively eat Camponotus ants. We conclude that Ozaena represents an independent shift to adopting a life of myrmecophily among beetles classified within the carabid subfamily Paussinae and document the morphological changes at each life history stage associated with the shift to a nest parasite lifestyle.	[Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Di Giulio, Andrea] Univ Roma Tre, Dept Sci, Rome, Italy	University of Arizona; Italfarmaco; Roma Tre University	Moore, W (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	wmoore@email.arizona.edu		Moore, Wendy/0000-0003-4441-6203				Ball G.E., 1990, Quaestiones Entomologicae, V26, P30; BALL GE, 1990, CAN ENTOMOL, V122, P779, DOI 10.4039/Ent122779-9; BOUSQUET Y, 1986, CAN ENTOMOL, V118, P373, DOI 10.4039/Ent118373-4; BOUSQUET Y, 1984, CAN J ZOOL, V62, P573, DOI 10.1139/z84-085; Brandmayr T. Zetto, 1993, Tropical Zoology, V6, P299; CoSTA C, 1988, LARVAS COLEPTERA BRA; DARLINGTON P. J., 1950, TRANS AMER ENT SOC, V76, P47; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Di Giulio A, 2017, RAFFLES B ZOOL, V65, P49; Di Giulio A, 2004, INVERTEBR SYST, V18, P101, DOI 10.1071/IS03028; Di Giulio A, 2003, SYST ENTOMOL, V28, P509, DOI 10.1046/j.1365-3113.2003.00227.x; Di Giulio A, 2001, TROP ZOOL, V14, P157, DOI 10.1080/03946975.2001.10531149; Di Giulio A, 2008, ZOOTAXA, P37; Di Giulio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130541; Di Giulio A, 2014, EUR J ENTOMOL, V111, P692, DOI 10.14411/eje.2014.083; Di Giulio A, 2011, EUR J ENTOMOL, V108, P127, DOI 10.14411/eje.2011.016; Di Giulio A, 2009, AUST J ENTOMOL, V48, P140, DOI 10.1111/j.1440-6055.2009.00698.x; Di Giulio Andrea, 2000, P89; Erwin T.L., 1979, P479; ERWIN T L, 1981, Coleopterists Bulletin, V35, P53; Geiselhardt SF, 2007, NATURWISSENSCHAFTEN, V94, P871, DOI 10.1007/s00114-007-0271-x; Giglio A, 2008, ZOOL ANZ, V247, P209, DOI 10.1016/j.jcz.2007.12.001; Green P, 2002, PHRED VERSION 002042; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Hinton H.E., 1981, BIOL INSECT EGGS, VI; Holldobler B., 1990, pi; Kaupp Andreas, 2000, P111; Lawrence J.F., 1991, IMMATURE INSECTS, V2, P144; Luna de Carvalho E, 1992, ELYTRON, V5, P285; Luna de Carvalho E, 1989, MEMORIAS I INVESTIGA; Maddison DR, 2017, CHROMASEQ MESQUITE P; Maddison W.P., 2018, MESQUITE MODULAR SYS; Maurizi E., 2012, Psyche: A Journal of Entomology, V2012, P940315, DOI 10.1155/2012/940315; Moore W, 2006, ZOOTAXA, P1; Moore W, 2008, ANN CARNEGIE MUS, V77, P79, DOI 10.2992/0097-4463-77.1.79; Moore W, 2008, PAN-PAC ENTOMOL, V84, P33, DOI 10.3956/2007-32.1; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Moore W, 2011, ZOOKEYS, P63, DOI 10.3897/zookeys.90.1136; Nagel P., 1979, MISCELLANEOUS PAPERS LANDBOUWHOGESCHOOL WAGENINGEN, P15; Oberprieler RG, 1985, INSECTS SO AFRICA, P196; Parker J, 2016, MYRMECOL NEWS, V22, P65; Robertson JA, 2017, SYST ENTOMOL, V42, P134, DOI 10.1111/syen.12205; Song XB, 2018, ZOOKEYS, P45, DOI 10.3897/zookeys.740.20458	43	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209790	10.1371/journal.pone.0209790	http://dx.doi.org/10.1371/journal.pone.0209790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650132	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300027
J	Campderrich, I; Nazar, FN; Wichman, A; Marin, RH; Estevez, I; Keeling, LJ				Campderrich, Irene; Nicolas Nazar, Franco; Wichman, Anette; Hector Marin, Raul; Estevez, Inma; Keeling, Linda J.			Environmental complexity: A buffer against stress in the domestic chick	PLOS ONE			English	Article							TONIC IMMOBILITY DURATION; TO-LYMPHOCYTE RATIO; LAYING HENS; FLUCTUATING ASYMMETRY; PERCHING BEHAVIOR; IMMUNE-RESPONSE; HEAT-STRESS; GROUP-SIZE; PHENOTYPIC APPEARANCE; COLD STRESS	Birds kept in commercial production systems can be exposed to multiple stressors from early life and this alters the development of different morphological, immunological and behavioural indicators. We explore the hypothesis that provision of a complex environment during early life, better prepares birds to cope with stressful events as well as buffers them against future unpredictable stressful episodes. In this study, 96 one day old pullets were randomly distributed in eight pens (12 birds/pen). Half of the chicks (N = 48) were assigned to a Complex Environment (CENV: with perches, a dark brooder etc.) the others to a Simple Environment (SENV: without enrichment features). Half of the birds from each of these treatments were assigned to a No Stress (NSTR, 33 degrees C) or to an acute Cold Stress (CSTR, 18-20 degrees C) treatment during six hours on their second day of life. At four weeks of age, chicks with these four different backgrounds were exposed to an Intermittent Stressful Challenges Protocol (ISCP). In an immunological test indicative of pro-inflammatory status Phytohemagglutinin-P (PHA-P), the response of CSTR birds was ameliorated by rearing chicks in a CENV as they had a similar response to NSTR chicks and a significantly better pro-inflammatory response than those CSTR birds reared in a SENV (five days after the CSTR treatment was applied). A similar better response when coping with new challenges (the ISCP) was observed in birds reared in a CENV compared to those from a SENV. Birds reared in the CENV had a lower heterophil/lymphocyte ratio after the ISCP than birds reared in SENV, independently of whether or not they had been exposed to CSTR early in life. No effects of stress on general behaviour were detected, however, the provision of a CENV increased resting behaviour, which may have favoured stress recover. Additionally, we found that exposure to cold stress at an early age might have rendered birds more vulnerable to future stressful events. CSTR birds had lower humoral immune responses (sheep red blood cells induced antibodies) after the ISCP and started using elevated structures in the CENV later compared to their NSTR conspecifics. Our study reflects the importance of the early provision of a CENV in commercial conditions to reduce negative stress-related effects. Within the context of the theory of adaptive plasticity, our results suggest that the early experience of the birds had long lasting effects on the modulation of their phenotypes.	[Campderrich, Irene; Estevez, Inma] Neiker Tecnalia Basque Inst Agr Res & Dev, Dept Anim Hlth, Vitoria, Spain; [Campderrich, Irene; Wichman, Anette; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden; [Nicolas Nazar, Franco; Hector Marin, Raul] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol & Tecnol, Cordoba, Argentina; [Nicolas Nazar, Franco; Hector Marin, Raul] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Inst Ciencia & Tecnol Alimentos, Cordoba, Argentina; [Estevez, Inma] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Swedish University of Agricultural Sciences; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Basque Foundation for Science	Keeling, LJ (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	linda.keeling@slu.se	Nazar, Franco Nicolas/I-5464-2019; Keeling, Linda/K-6542-2012	Nazar, Franco Nicolas/0000-0002-5282-5931; Marin, Raul/0000-0001-8161-4044; Keeling, Linda/0000-0003-2629-0117	Swedish Research Council Formas [Dnr 221-2010-35]; Ministry of Science and Innovation, Spain [AGL2010-18276, BES-2011-050055, EEBB-I-14-08368, EEBB-I-15-10297]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Swedish Research Council Formas (grant to LJK, Dnr 221-2010-35) provided the financial support for the experiment. The Ministry of Science and Innovation, Spain also contributed to this research (AGL2010-18276, MODELAY), by a PhD Scholarship for I.C. (BES-2011-050055) and a grant from their program for promoting mobility of pre-doctoral students (2014 and 2015) to fund IC's stay in Sweden (EEBB-I-14-08368, EEBB-I-15-10297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen-Tennekes R, 2009, POULTRY SCI, V88, P1879, DOI 10.3382/ps.2009-00150; [Anonymous], 2006, SAS MIXED MODELS; APPLEBY MC, 1989, BIOL BEHAV, V14, P157; Appleby MC, 1992, POULTRY PRODUCTION S; Arnould U, 2003, APPL ANIM BEHAV SCI, V84, P281, DOI 10.1016/j.applanim.2003.07.003; Baarendse PJJ, 2007, WORLD POULTRY SCI J, V63, P267, DOI 10.1017/S0043933907001456; Bailie CL, 2013, ANIMAL, V7, P618, DOI 10.1017/S1751731112002108; Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P289, DOI 10.1016/0168-1591(84)90121-7; BRAKE J, 1994, POULTRY SCI, V73, P1470, DOI 10.3382/ps.0731470; Campo JL, 2008, POULTRY SCI, V87, P621, DOI 10.3382/ps.2007-00466; Campo JL, 2007, POULTRY SCI, V86, P37, DOI 10.1093/ps/86.1.37; Campo JL, 2010, ARCH GEFLUGELKD, V74, P126; Campo JL, 2005, APPL ANIM BEHAV SCI, V91, P75, DOI 10.1016/j.applanim.2004.08.028; Carere C, 2010, CURRENT ZOOLOGY, V56; Cheng HW, 2004, POULTRY SCI, V83, P707, DOI 10.1093/ps/83.5.707; Cichon M, 2002, P ROY SOC B-BIOL SCI, V269, P1493, DOI 10.1098/rspb.2002.2054; COLLIAS NE, 1967, CONDOR, V69, P360, DOI 10.2307/1366199; Cornetto T, 2002, APPL ANIM BEHAV SCI, V75, P325, DOI 10.1016/S0168-1591(01)00195-2; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; Cornetto T, 2001, POULTRY SCI, V80, P1455, DOI 10.1093/ps/80.10.1455; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Ericsson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153879; Fraser A.F., 1997, FARM ANIMAL BEHAV WE, V3rd; Garcia-Navas V, 2013, ECOSCIENCE, V20, P9, DOI 10.2980/20-1-3545; Ghazi S, 2012, BIOL TRACE ELEM RES, V146, P309, DOI 10.1007/s12011-011-9260-1; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Gunnarsson S, 2000, APPL ANIM BEHAV SCI, V67, P217, DOI 10.1016/S0168-1591(99)00125-2; Huff GR, 2005, POULTRY SCI, V84, P709, DOI 10.1093/ps/84.5.709; JONES RB, 1989, PHYSIOL BEHAV, V46, P439, DOI 10.1016/0031-9384(89)90017-6; Keeling LJ, 1997, P 31 INT C ISAE RES, P83; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Lechner O, 2001, INT IMMUNOL, V13, P769, DOI 10.1093/intimm/13.6.769; Leone EH, 2007, APPL ANIM BEHAV SCI, V102, P39, DOI 10.1016/j.applanim.2006.03.004; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Liste G, 2015, APPL ANIM BEHAV SCI, V163, P144, DOI 10.1016/j.applanim.2014.11.013; Malleau AE, 2007, APPL ANIM BEHAV SCI, V106, P52, DOI 10.1016/j.applanim.2006.06.017; Marin RH, 2001, APPL ANIM BEHAV SCI, V71, P57, DOI 10.1016/S0168-1591(00)00167-2; MOLLER AP, 1995, POULTRY SCI, V74, P1761, DOI 10.3382/ps.0741761; Mujahid A, 2009, POULTRY SCI, V88, P917, DOI 10.3382/ps.2008-00472; Munoz-Abellan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021426; Nazar FN, 2015, STRESS, V18, P710, DOI 10.3109/10253890.2015.1078306; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Nelson JR, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8100173; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, P23, DOI 10.1098/rspb.2015.1005; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Newberry RC, 1997, ANIM BEHAV, V54, P387, DOI 10.1006/anbe.1996.0421; Newberry RC, 2001, APPL ANIM BEHAV SCI, V73, P117, DOI 10.1016/S0168-1591(01)00135-6; Newberry RC, 2007, APPL ANIM BEHAV SCI, V107, P262, DOI 10.1016/j.applanim.2006.10.010; Oden K, 2002, BRIT POULTRY SCI, V43, P169, DOI 10.1080/00071660120121364; Olfati A, 2018, SPAN J AGRIC RES, V16, DOI 10.5424/sjar/2018162-12753; Quinteiro WM, 2012, J ANIM SCI, V90, P1986, DOI 10.2527/jas.2011-3949; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Rodriguez S, 2016, ECOL EVOL, V6, P4458, DOI 10.1002/ece3.2192; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; Schrader L, 2009, APPL ANIM BEHAV SCI, V121, P179, DOI 10.1016/j.applanim.2009.09.010; Server JL, 1961, J IMMUNOL, V88, P320; Shinder D, 2002, J THERM BIOL, V27, P517, DOI 10.1016/S0306-4565(02)00025-6; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Smits JE, 1999, ECOTOXICOLOGY ENV SA, V44, P324; Smits JEG, 2005, DEV COMP IMMUNOL, V29, P161, DOI 10.1016/j.dci.2004.06.007; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Struelens E, 2008, BRIT POULTRY SCI, V49, P381, DOI 10.1080/00071660802158332; SUK YO, 1995, POULTRY SCI, V74, P285, DOI 10.3382/ps.0740285; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Ventura BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029826; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wichman A, 2007, APPL ANIM BEHAV SCI, V105, P165, DOI 10.1016/j.applanim.2006.05.009; Widowski T, 2010, ANIM WELFARE SER, V9, P137, DOI 10.1007/978-90-481-3650-6_6; WOODGUSH DGM, 1959, POULTRY SCI, V38, P321, DOI 10.3382/ps.0380321; Yahav S, 1996, BRIT POULTRY SCI, V37, P43, DOI 10.1080/00071669608417835; Yngvesson J, 2001, ANIM BEHAV, V61, P609, DOI 10.1006/anbe.2000.1616; Yunianto VD, 1997, BRIT J NUTR, V77, P897, DOI 10.1079/BJN19970088; Zidar J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23545-6	81	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210270	10.1371/journal.pone.0210270	http://dx.doi.org/10.1371/journal.pone.0210270			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640921	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000022
J	Ferreira, JE; Ferreira, SC; Almeida-Neto, C; Nishiya, AS; Alencar, CS; Gouveia, GR; Caiaffa, H; Gomes, H; Santosid, RTD; Witkin, SS; Mendrone, A; Sabino, EC				Ferreira, Jerenice E.; Ferreira, Suzete C.; Almeida-Neto, Cesar; Nishiya, Anna S.; Alencar, Cecilia S.; Gouveia, Gisele R.; Caiaffa-Filho, Helio; Gomes, Helio; de Macedo Santosid, Raimunda Telma; Witkin, Steven S.; Mendrone-Junior, Alfredo; Sabino, Ester C.			Molecular characterization of viruses associated with encephalitis in Sao Paulo, Brazil	PLOS ONE			English	Article							ZIKA VIRUS; PCR ASSAYS; DENGUE; INFECTIONS; EPIDEMIOLOGY; ENTEROVIRUS; DISEASES	The objective of this study was to characterize the prevalence of viral encephalitis due to arbovirus infection of the Togaviridae and Flaviviridae families in Sao Paulo, Brazil. A total of 500 cerebrospinal fluid (CSF) samples collected between August 2012 and January 2013, from patients with symptoms of acute encephalitis were analyzed. Findings suggestive of viral encephalitis-elevations in cell concentration, glucose and total protein-were observed in 234 (46.8%) samples, designated as Group 1. The remaining 266 samples comprised Group 2. All samples were tested for Flaviviruses (dengue virus 1, 2, 3 and 4, yellow fever virus and West Nile virus), Alphavirus (NS5 region) and enterovirus by RT-PCR and for herpesviruses and enteroviruses using CLART(-)Entherpex. A presumptive viral etiological agent was detected in 26 samples (5.2%), 18 (8.0%) in Group 1 and 8 (3.0%) in Group 2. In Group 1 human herpesviruses were detected in 9 cases, enteroviruses in 7 cases, dengue viruses (DENV) in 2 CSFs and St. Louis encephalitis virus (SLEV) in one case. In Group 2 there were 3 CSFs positive for human herpesviruses, 2 for enteroviruses, 2 for DENV and 1 for SLEV. Detection of arboviruses, even though present in a minority of infected patients, identifies these viruses as a probable etiological agent of encephalitis. This is of special concern in regions where this class of viruses is endemic and has been linked to other recent epidemics.	[Ferreira, Jerenice E.; Sabino, Ester C.] Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil; [Ferreira, Jerenice E.; Caiaffa-Filho, Helio; de Macedo Santosid, Raimunda Telma] Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil; [Ferreira, Suzete C.; Almeida-Neto, Cesar; Nishiya, Anna S.; Mendrone-Junior, Alfredo] FPS HSP, Sao Paulo, Brazil; [Almeida-Neto, Cesar] Univ Sao Paulo, Fac Med, Disciplina Ciencias Med, Sao Paulo, Brazil; [Alencar, Cecilia S.; Caiaffa-Filho, Helio; Gomes, Helio] HCSP, DLC, Cent Lab Div, Sao Paulo, Brazil; [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, Clin Lab, Sao Paulo, Brazil; [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, LIM 03, Sao Paulo, Brazil; [Gouveia, Gisele R.] Univ Sao Paulo, Fac Med, FMUSP, Sao Paulo, Brazil; [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Cornell University	Ferreira, JE (corresponding author), Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil.; Ferreira, JE (corresponding author), Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil.	jerenice.ferreira@gmail.com	Witkin, Steven/AAF-3812-2019; Witkin, Steven/AAW-8602-2021; Sabino, Ester C/F-7750-2010; Nishiya, Anna/Q-8156-2016; Gouveia, Gisele/T-6376-2019; de Almeida-Neto, Cesar/O-9224-2014	Witkin, Steven/0000-0002-3502-3929; Sabino, Ester C/0000-0003-2623-5126; Gouveia, Gisele/0000-0002-1627-4490; de Almeida-Neto, Cesar/0000-0002-8490-4634; Ferreira, Jerenice/0000-0002-9729-9154	Foundation for Research Support of the State of Sao Paulo (FAPESP) [2011/52094-3]	Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Foundation for Research Support of the State of Sao Paulo for the Financial Assistance (FAPESP) (Process Number: 2011/52094-3). Principal Investigator: Ester C. Sabino.; We thank the Foundation for Research Support of the State of Sao Paulo for financial assistance (Process 2011/52094-3). The funders had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIR ASS PROT ENC; Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953; Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0; Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cerri GG., 2014, HOSP CLIN FACULDADE; Collucci C, 2016, HC FAZ ANIVERSARIO M; Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017; da Silva ANM, 2006, MEM I OSWALDO CRUZ, V101, P547, DOI 10.1590/S0074-02762006000500011; Faria JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44949; Ferreira MLB, 2005, ARQ NEURO-PSIQUIAT, V63, P488, DOI 10.1590/S0004-282X2005000300023; Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4; Fujita DM, 2018, J TRAVEL MED, V25; Gendelman HE, 2005, LANCET NEUROL, V4, P12, DOI 10.1016/S1474-4422(04)00951-2; Gilden DH, 2008, ACP MED, P1, DOI [10.1016/S1474-4422(04)00951-2, DOI 10.1016/S1474-4422(04)00951-2]; Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; Jaijakul S, 2017, INT J INFECT DIS, V59, P77, DOI 10.1016/j.ijid.2017.04.010; Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89; Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6; Kennedy PGE, 2005, J NEUROL, V252, P268, DOI 10.1007/s00415-005-0770-7; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]; Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x; LOPES ODS, 1979, AM J TROP MED HYG, V28, P583, DOI 10.4269/ajtmh.1979.28.583; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007; Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905; Pinheiro FP, 1997, DOENCAS INFECCIOSAS, P208; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008; Rodrigues SG, 2010, PAN AMAZ SAUDE, V1, P81; Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537; Silva MTT, 2013, ARQ NEURO-PSIQUIAT, V71, P703, DOI 10.1590/0004-282X20130155; Teixeira M.G., 1999, INF EPIDEMIOLOGICO S, V8, P5, DOI [10.5123/S0104-16731999000400002, DOI 10.5123/S0104-16731999000400002]; Vasconcelos PFC, 2015, REV PANAMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001; Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170; Volle R, 2012, J VIROL METHODS, V185, P142, DOI 10.1016/j.jviromet.2012.06.019; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209993	10.1371/journal.pone.0209993	http://dx.doi.org/10.1371/journal.pone.0209993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640927	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000017
J	Nielsen, T; Kristensen, SR; Gregersen, H; Teodorescu, EM; Christiansen, G; Pedersen, S				Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Christiansen, Gunna; Pedersen, Shona			Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; THROMBIN GENERATION; CIRCULATING MICROPARTICLES; COAGULATION ACTIVATION; ROUTINE TEST; CANCER; THALIDOMIDE; RISK	Multiple myeloma (MM) patients have increased risk of developing venous thromboembolism, but the underlying mechanisms and the effect on the coagulation system of the disease and the current cancer therapies are not known. It is possible that cancer-associated extracellular vesicles (EV), carrying tissue factor (TF) and procoagulant phospholipids (PPL) may play a role in thrombogenesis. The aim of this study was to perform an in-depth analysis of procoagulant activity of small and large EVs isolated from 20 MM patients at diagnosis and after receiving first-line treatment compared with 20 healthy control subjects. Differential ultracentrifugation at 20,000 x g and 100,000 x g were used to isolate EVs for quantitative and phenotypical analysis through nanoparticle tracking analysis, Western blotting and transmission electron microscopy. The isolated EVs were analyzed for procoagulant activity using the calibrated automated thrombogram technique, a factor Xa-based activity assay, and the STA Procoag-PPL assay. In general, MM patients contained more EVs, and immunoelectron microscopy confirmed the presence of CD9- and CD38-positive EVs. EVs in the 20,000 x g pellets from MM patients exerted procoagulant activity visualized by increased thrombin generation and both TF and PPL activity. This effect diminished during treatment, with the most prominent effect observed in the high-dose chemotherapy eligible patients after induction therapy with bortezomib, cyclophosphamide, and dexamethasone. In conclusion, the EVs in patients with MM carrying TF and PPL are thus capable of exerting procoagulant activity.	[Nielsen, Thoger; Kristensen, Soren Risom; Pedersen, Shona] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Pedersen, Shona] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Nielsen, Thoger; Kristensen, Soren Risom; Gregersen, Henrik; Teodorescu, Elena Manuela; Pedersen, Shona] Aalborg Univ Hosp, Fac Med, Aalborg, Denmark; [Gregersen, Henrik; Teodorescu, Elena Manuela] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University	Pedersen, S (corresponding author), Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark.; Pedersen, S (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.; Pedersen, S (corresponding author), Aalborg Univ Hosp, Fac Med, Aalborg, Denmark.	shp@rn.dk		Nielsen, Thoger/0000-0003-1698-2099; Pedersen, Shona/0000-0001-6636-0293	Danish Research Council for Independent Research [4183-00268]; Obel Family Foundation [26145]	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Obel Family Foundation	This work was funded by grants from the Danish Research Council for Independent Research, https://ufm.dk/en/research-and-innovation/councils-and-commissions/independent-research-fund-Denmark (grant no. 4183-00268), and the Obel Family Foundation, http://obel.com/english (grant no. 26145), awarded to Soren Risom Kristensen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerda JJA, 2011, THROMB HAEMOSTASIS, V105, P14, DOI 10.1160/TH10-03-0187; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Bharthuar A, 2013, THROMB RES, V132, P180, DOI 10.1016/j.thromres.2013.06.026; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Boknas N, 2014, J THROMB HAEMOST, V12, P515, DOI 10.1111/jth.12503; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Caivano A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061183; Campello E, 2014, BLOOD COAGUL FIBRIN, V25, P534, DOI 10.1097/MBC.0000000000000068; CATOVSKY D, 1970, BRIT MED J, V3, P438, DOI 10.1136/bmj.3.5720.438; Elyamany G, 2014, CLIN MED INSIGHTS-ON, V8, P129, DOI 10.4137/CMO.S18991; Esmon CT, 1999, BEST PRACT RES CL HA, V12, P343, DOI 10.1053/beha.1999.0029; Gardiner C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26901; Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hisada Y, 2016, THROMB RES, V139, P90, DOI 10.1016/j.thromres.2016.01.011; Johnsen KB, 2016, CYTOTECHNOLOGY, V68, P2125, DOI 10.1007/s10616-016-9952-7; Judicone C., 2013, J. Thromb. Haemost, V150, P137, DOI 10.1111/jth.12207; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Katsuda T, 2014, PROTEOMICS, V14, P412, DOI 10.1002/pmic.201300389; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Leebeek FWG, 2012, THROMB RES, V129, pS88, DOI 10.1016/S0049-3848(12)70024-5; Leiba M, 2017, BLOOD CELL MOL DIS, V65, P1, DOI 10.1016/j.bcmd.2017.03.010; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Marchetti M, 2014, AM J HEMATOL, V89, P68, DOI 10.1002/ajh.23590; Minnema MC, 2003, J THROMB HAEMOST, V1, P445, DOI 10.1046/j.1538-7836.2003.00083.x; Nielsen T, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1454777; Pap E, 2011, CRIT REV ONCOL HEMAT, V79, P213, DOI 10.1016/j.critrevonc.2010.07.015; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Thaler J, 2012, J THROMB HAEMOST, V10, P1363, DOI 10.1111/j.1538-7836.2012.04754.x; Tilley RE, 2008, THROMB RES, V122, P604, DOI 10.1016/j.thromres.2007.12.023; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tripisciano C, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; van Doormaal FF, 2012, THROMB HAEMOSTASIS, V108, P160, DOI 10.1160/TH12-02-0099; Vogel R, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31242; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zangari M, 2003, CLIN LYMPHOMA, V4, P32, DOI 10.3816/CLM.2003.n.011; Zangari M, 2001, BLOOD, V98, P1614, DOI 10.1182/blood.V98.5.1614	44	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210835	10.1371/journal.pone.0210835	http://dx.doi.org/10.1371/journal.pone.0210835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640949	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000051
J	Waschbusch, D; Hubel, N; Ossendorf, E; Lobbestael, E; Baekelandt, V; Lindsay, AJ; McCaffrey, MW; Khan, AR; Barnekow, A				Waschbuesch, Dieter; Huebel, Nicole; Ossendorf, Edith; Lobbestael, Evy; Baekelandt, Veerle; Lindsay, Andrew J.; McCaffrey, Mary W.; Khan, Amir R.; Barnekow, Angelika			Rab32 interacts with SNX6 and affects retromer-dependent Golgi trafficking	PLOS ONE			English	Article							EARLY/RECYCLING ENDOSOMES; EMERGING ROLE; PROTEIN; TRANSPORT; COMPLEX; GTPASES; IDENTIFICATION; RECOGNITION; SUBUNIT; LRRK2	The Rab family of small GTPases regulate various aspects of cellular dynamics in eukaryotic cells. Membrane trafficking has emerged as central to the functions of leucine-rich repeat kinase 2 (LRRK2), which is associated with inherited and sporadic forms of Parkinson's disease (PD). Rabs act as both regulators of the catalytic activity and targets for serine/threonine phosphorylation by LRRK2. Rab32, Rab38 and Rab29 have been shown to regulate LRRK2 sub-cellular localization through direct interactions. Recently, Rab29 was shown to escort LRRK2 to the Golgi apparatus and activate the phosphorylation of Rab8 and Rab10. Rab32 is linked to multiple cellular functions including endosomal trafficking, mitochondrial dynamics, and melanosome biogenesis. A missense mutation in Rab32 has also recently been linked to PD. Here, we demonstrate that Rab32 directly interacts with sorting nexin 6 (SNX6). SNX6 is a transient subunit of the retromer, an endosome-Golgi retrieval complex whose Vps35 subunit is strongly associated with PD. We could further show that localization of cation-independent mannose-6-phosphate receptors, which are recycled to the trans-Golgi network (TGN) by the retromer, was affected by both Rab32 and SNX6. These data imply that Rab32 is linked to SNX6/retromer trafficking at the Golgi, and also suggests a possible connection between the retromer and Rab32 in the trafficking and biological functions of LRRK2.	[Waschbuesch, Dieter; Huebel, Nicole; Ossendorf, Edith; Barnekow, Angelika] Westfalische Wilhelms Univ Muenster, Dept Expt Tumorbiol, Munster, Germany; [Waschbuesch, Dieter; Khan, Amir R.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Lobbestael, Evy; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Leuven, Belgium; [Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Cork, Ireland	Trinity College Dublin; KU Leuven; University College Cork	Barnekow, A (corresponding author), Westfalische Wilhelms Univ Muenster, Dept Expt Tumorbiol, Munster, Germany.; Khan, AR (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	Amir.Khan@tcd.ie; barneko@uni-muenster.de	Baekelandt, Veerle/ABB-9736-2020; Lindsay, Andrew J/P-9778-2017; Lobbestael, Evy/H-7537-2018	Baekelandt, Veerle/0000-0001-8966-2921; Lindsay, Andrew J/0000-0001-9693-7022; Lobbestael, Evy/0000-0002-6417-4670; Waschbusch, Dieter/0000-0002-8953-2585; Khan, Amir/0000-0003-1176-6952	Science Foundation Ireland [12/IA/1239]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant no. 12/IA/1239 to ARK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Gao YJ, 2018, MOVEMENT DISORD, V33, P196, DOI 10.1002/mds.27270; Gustavsson E, 2017, INTERNATIONAL CONGRE; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Kail Mark, 2008, V440, P111, DOI 10.1007/978-1-59745-178-9_9; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; McMillan KJ, 2017, CURR OPIN CELL BIOL, V47, P72, DOI 10.1016/j.ceb.2017.02.004; Mir R, 2018, BIOCHEM J, V475, P1861, DOI 10.1042/BCJ20180248; Ortiz-Sandoval C. G., 2014, CELL LOGIST, P2799, DOI [10.4161/21592799.2014.986399, DOI 10.4161/21592799.2014.986399]; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Purlyte E., 2017, EMBO J; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Simonetti B, 2017, J CELL BIOL, V216, P3695, DOI 10.1083/jcb.201703015; Solano-Collado Virtu, 2018, Small GTPases, V9, P216, DOI 10.1080/21541248.2016.1219207; Spano S, 2014, CELL MICROBIOL, V16, P1321, DOI 10.1111/cmi.12327; Steger M, 2017, ELIFE, V6, DOI 10.7554/eLife.31012; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; SU GF, 1992, INFECT IMMUN, V60, P3345, DOI 10.1128/IAI.60.8.3345-3359.1992; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096242; Waschbusch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111632; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Weide T, 2003, BIOCHEM BIOPH RES CO, V306, P79, DOI 10.1016/S0006-291X(03)00918-5; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	34	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208889	10.1371/journal.pone.0208889	http://dx.doi.org/10.1371/journal.pone.0208889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640902	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000008
J	Hertz, JT; Fu, T; Vissoci, JR; Rocha, TAH; Carvalho, E; Flanagan, B; de Andrade, L; Limkakeng, AT; Staton, CA				Hertz, Julian T.; Fu, Tommy; Vissoci, Joao Ricardo; Hernandes Rocha, Thiago Augusto; Carvalho, Elias; Flanagan, Brendan; de Andrade, Luciano; Limkakeng, Alex T.; Staton, Catherine A.			The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; UNITED-STATES; CHEST-PAIN; RISK; MORTALITY; PREVALENCE; TRENDS	Background Little is known about the utilization of cardiac diagnostic testing in Brazil and how such testing is related with local rates of acute coronary syndrome (ACS)-related mortality. Methods and results Using data from DATASUS, the public national healthcare database, absolute counts of diagnostic tests performed were calculated for each of the 5570 municipalities and mapped. Spatial error regression and geographic weighted regression models were used to describe the geographic variation in the association between ACS mortality, income, and access to diagnostic testing. From 2008 to 2014, a total of 4,653,884 cardiac diagnostic procedures were performed in Brazil, at a total cost of $271 million USD. The overall ACS mortality rate during this time period was 133.8 deaths per 100,000 inhabitants aged 20 to 79. The most commonly utilized test was the stress ECG (3,015,993), followed by catheterization (862,627), scintigraphy (669,969) and stress echocardiography (105,295). The majority of these procedures were conducted in large urban centers in more economically developed regions of the country. Increased access to testing and increased income were not uniformly associated with decreased ACS mortality, and tremendous geographic heterogeneity was observed in the relationship between these variables. Conclusions The majority of testing for ACS in Brazil is conducted at referral centers in developed urban settings. Stress ECG is the dominant testing modality in use. Increased access to diagnostic testing was not consistently associated with decreased ACS mortality across the country.	[Hertz, Julian T.; Fu, Tommy; Flanagan, Brendan; Limkakeng, Alex T.; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Vissoci, Joao Ricardo; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Vissoci, Joao Ricardo] Ctr Univ Inga, Dept Med, Maringa, Parana, Brazil; [Hernandes Rocha, Thiago Augusto] Panamer Hlth Org, Brasilia, DF, Brazil; [Carvalho, Elias] Pontifical Univ Catholic Parana, Dept Comp Sci, Curitiba, Parana, Brazil; [Carvalho, Elias] Univ Estadual Maringa, Dept Data Proc, Maringa, Parana, Brazil; [de Andrade, Luciano] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil	Duke University; Duke University; Centro Universitario Inga (UNINGA); Universidade Estadual de Maringa; Universidade Estadual de Maringa	Staton, CA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA.; Staton, CA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.	catherine.staton@duke.edu	Rocha, Thiago/AAW-3805-2020; Carvalho, Elias/J-7086-2012	Rocha, Thiago/0000-0002-6262-3276; Staton, Catherine/0000-0002-6468-2894; Hertz, Julian/0000-0002-7396-4789; Carvalho, Elias/0000-0002-2638-7202				Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; [Anonymous], 2017, CNES CAD NAC EST SAU; [Anonymous], 2017, SIA SIST INF AMB SUS; [Anonymous], 2014, POV EQ BRAZ; [Anonymous], 2017, SIM SIST INF MORT; Araujo DV, 2013, SCI WORLD J, DOI 10.1155/2013/864962; Arefalk G, 2014, CIRCULATION, V130, P325, DOI 10.1161/CIRCULATIONAHA.113.007252; Chang AM, 2018, ANN EMERG MED, V71, P464, DOI 10.1016/j.annemergmed.2017.08.048; de Andrade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103577; de Azevedo CF, 2011, JACC-CARDIOVASC IMAG, V4, P740, DOI 10.1016/j.jcmg.2011.02.017; Teixeira de Paula Josiane Aparecida, 2015, Invest. educ. enferm, V33, P325, DOI 10.17533/udea.iee.v33n2a15; Deaton C, 2011, EUR J CARDIOVASC NUR, V10, pS5, DOI 10.1016/S1474-5151(11)00111-3; Konfino J, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2012-050599; Lassen JF, 2013, NAT REV CARDIOL, V10, P41, DOI 10.1038/nrcardio.2012.156; Lotufo PA, 2015, SAO PAULO MED J, V133, P69, DOI 10.1590/1516-3180.2015.13320018; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Machado Juliana Pires, 2016, Rev. bras. epidemiol., V19, P567, DOI 10.1590/1980-5497201600030008; de Souza MDM, 2012, HEART, V98, P1207, DOI 10.1136/heartjnl-2012-301828; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; Moreira MD, 2014, NUTR HOSP, V29, P1320, DOI 10.3305/nh.2014.29.6.7303; Mudrick DW, 2012, AM HEART J, V163, P454, DOI 10.1016/j.ahj.2011.11.022; Ngui Andre Ngamini, 2011, BMC Health Serv Res, V11, P166, DOI 10.1186/1472-6963-11-166; Oliveira Joselina L M, 2007, Cardiovasc Ultrasound, V5, P38, DOI 10.1186/1476-7120-5-38; Peltzer K, 2014, INT J ENV RES PUB HE, V11, P7425, DOI 10.3390/ijerph110707425; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Reboldi G, 2014, HYPERTENSION, V63, P475, DOI 10.1161/HYPERTENSIONAHA.113.02089; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Soeiro AD, 2015, EINSTEIN-SAO PAULO, V13, P370, DOI 10.1590/S1679-45082015AO3381; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sun BC, 2018, ANN EMERG MED, V71, P465, DOI 10.1016/j.annemergmed.2017.06.004; Sun Benjamin C, 2016, Crit Pathw Cardiol, V15, P60, DOI 10.1097/HPC.0000000000000068; United Nations, 2017, WORLD POPULATION PRO; Baroncini LAV, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0030-7; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; World Bank, 2017, DOES WORLD BANK CLAS; World Bank, 2015, GROSS DOM PROD 2015; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058516; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210502	10.1371/journal.pone.0210502	http://dx.doi.org/10.1371/journal.pone.0210502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629670	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000098
J	Monsey, L; Best, LG; Zhu, JH; DeCroo, S; Anderson, MZ				Monsey, Laine; Best, Lyle G.; Zhu, Jianhui; DeCroo, Susan; Anderson, Matthew Z.			The association of mannose binding lectin genotype and immune response to Chlamydia pneumoniae: The Strong Heart Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIOVASCULAR-DISEASE; PROTEIN-LEVELS; RISK-FACTOR; AMERICAN-INDIANS; SERUM-LEVELS; MBL2; GENE; POLYMORPHISMS	Cardiovascular disease (CVD) is an important contributor to morbidity and mortality in American Indian communities. The Strong Heart Study (SHS) was initiated in response to the need for population based estimates of cardiovascular disease in American Indians. Previous studies within SHS have identified correlations between heart disease and deficiencies in mannose binding lectin (MBL), a motif recognition molecule of the innate immune system. MBL mediates the immune response to invading pathogens including Chlamydia pneumoniae (Cp), which has also been associated with the development and progression of CVD. However, a link between MBL2 genotype and Cp in contributing to heart disease has not been established. To address this, SHS collected baseline Cp antibody titers (IgA and IgG) and MBL2 genotypes for common functional variants from 553 individuals among twelve participating tribes. A single nucleotide polymorphism (SNP) in the promoter, designated X/Y, correlated significantly with increased Cp IgG titer levels, whereas another promoter SNP (H/L) did not significantly influence antibody levels to Cp. Two variants within exon 1 of MBL2, the A and B alleles, also displayed significant association with Cp antibody titers. Some MBL2 genotypes were absent from the population, suggesting linkage disequilibrium may be operating within the SHS cohort. Additional factors, such as increasing age and socioeconomic status, were also associated with increased Cp IgG antibody titers. This study demonstrates that MBL2 genotype associates with immune reactivity to C. pneumoniae in the SHS cohort. Thus, MBL2 may contribute to the progression of cardiovascular disease (CVD) among American Indians indirectly through pathogen interactions in addition to its previously defined roles.	[Monsey, Laine; Anderson, Matthew Z.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Best, Lyle G.] Missouri Breaks Ind Res Inc, Timber Lakes, SD USA; [Zhu, Jianhui; DeCroo, Susan] Medstar Res Inst, Washington, DC USA; [Anderson, Matthew Z.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Anderson, MZ (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.; Anderson, MZ (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	anderson.3196@osu.edu	Anderson, Matthew/R-4842-2019	Anderson, Matthew/0000-0003-1683-2170	National Heart, Lung, and Blood Institute, Bethesda, MD [U01-HL65520, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65521, R01HL62233]; ASC Undergraduate Research Scholarship from The Ohio State University; Missouri Breaks Industries Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109319] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ASC Undergraduate Research Scholarship from The Ohio State University; Missouri Breaks Industries Research, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by cooperative agreement grants U01-HL65520, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65521, and R01HL62233 from the National Heart, Lung, and Blood Institute, Bethesda, MD (https://www.nhlbi.nih.gov/).LM was supported by an ASC Undergraduate Research Scholarship from The Ohio State University (https://aschonors.osu.edu/opportunities/scholarships/undergrad). Missouri Breaks Industries Research, Inc, provided support in the form of salaries for author LGB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Asner SA, 2014, CLIN MICROBIOL INFEC, V20, P1246, DOI 10.1111/1469-0691.12806; Assar Omid, 2015, Glob J Health Sci, V8, P260, DOI 10.5539/gjhs.v8n4p260; Babovic-Vuksanovic D, 1999, ANN ALLERG ASTHMA IM, V82, P134, DOI 10.1016/S1081-1206(10)62586-0; Bernig T, 2005, HUM GENET, V118, P404, DOI 10.1007/s00439-005-0053-5; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Best LG, 2004, CIRCULATION, V109, P471, DOI 10.1161/01.CIR.0000109757.95461.10; Blasi F., 1998, Clin Microbiol Infect, V4 Suppl 4, pS1; Branden E, 2005, RESP MED, V99, P20, DOI 10.1016/j.rmed.2004.04.014; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Crosdale DJ, 2000, EUR J IMMUNOGENET, V27, P111, DOI 10.1046/j.1365-2370.2000.00211.x; de Waure C, 2013, AM J PREV MED, V45, P207, DOI 10.1016/j.amepre.2013.03.020; Fong IW, 2009, CURR CARDIOL REV, V5, P87, DOI 10.2174/157340309788166679; Fong IW, 1999, INFECT IMMUN, V67, P6048, DOI 10.1128/IAI.67.11.6048-6055.1999; Fong IW, 2002, J INFECT DIS, V186, P1469, DOI 10.1086/344730; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; Hegele RA, 1999, CLIN CHEM, V45, P1283; Heron Melonie, 2016, NCHS Data Brief, P1; Jakab L, 2007, CLIN IMMUNOL, V125, P230, DOI 10.1016/j.clim.2007.08.020; Keller TT, 2006, ARTERIOSCL THROM VAS, V26, P2345, DOI 10.1161/01.ATV.0000240517.69201.77; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9; Moazed TC, 1999, J INFECT DIS, V180, P238, DOI 10.1086/314855; Nagy A, 2003, J ALLERGY CLIN IMMUN, V112, P729, DOI 10.1016/S0091-6749(03)02010-4; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Paldanius M, 2005, CLIN DIAGN LAB IMMUN, V12, P654, DOI 10.1128/CDLI.12.5.654-659.2005; Pesonen E, 2009, ANN MED, V41, P591, DOI 10.1080/07853890903110994; Phoon MC, 2001, CELL BIOL INT, V25, P777, DOI 10.1006/cbir.2001.0733; Rantala A, 2011, INNATE IMMUN-LONDON, V17, P35, DOI 10.1177/1753425909349759; Rugonfalvi-Kiss S, 2002, CIRCULATION, V106, P1071, DOI 10.1161/01.CIR.0000027137.96791.6A; Sasaki K, 2000, SCAND J GASTROENTERO, V35, P960, DOI 10.1080/003655200750023039; Speletas M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/478412; Stevenson HL, 2013, TRANSPL IMMUNOL, V28, P73, DOI 10.1016/j.trim.2013.02.002; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Su CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32147; Triant VA, 2013, CURR HIV-AIDS REP, V10, P199, DOI 10.1007/s11904-013-0168-6; Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x	46	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210640	10.1371/journal.pone.0210640	http://dx.doi.org/10.1371/journal.pone.0210640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629683	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000118
J	Souza, PWM; Giannini, TC; Jaffe, R; Giulietti, AM; Santos, DC; Nascimento, WR; Guimaraes, JTF; Costa, MF; Imperatriz-Fonseca, VL; Siqueira, JO				Souza-Filho, Pedro Walfir M.; Giannini, Tereza C.; Jaffe, Rodolfo; Giulietti, Ana M.; Santos, Diogo C.; Nascimento, Wilson R., Jr.; Guimaraes, Jose Tasso F.; Costa, Marlene F.; Imperatriz-Fonseca, Vera L.; Siqueira, Jose O.			Mapping and quantification of ferruginous outcrop savannas in the Brazilian Amazon: A challenge for biodiversity conservation	PLOS ONE			English	Article							LAND-USE; FOREST; CLASSIFICATION; DEFORESTATION; ACCURACY; IMPACTS; METAL	The eastern Brazilian Amazon contains many isolated ferruginous savanna ecosystem patches (locally known as 'canga vegetation') located on ironstone rocky outcrops on the top of plateaus and ridges, surrounded by tropical rainforests. In the Caraja's Mineral Province (CMP), these outcrops contain large iron ore reserves that have been exploited by opencast mining since the 1980s. The canga vegetation is particularly impacted by mining, since the iron ores that occur are associated with this type of vegetation and currently, little is known regarding the extent of canga vegetation patches before mining activities began. This information is important for quantifying the impact of mining, in addition to helping plan conservation programmes. Here, land cover changes of the Canga area in the CMP are evaluated by estimating the pre-mining area of canga patches and comparing it to the actual extent of canga patches. We mapped canga vegetation using geographic object-based image analysis (GEOBIA) from 1973 Landsat-1 MSS, 1984 and 2001 Landsat-5 TM, and 2016 Landsat-8 OLI images, and found that canga vegetation originally occupied an area of 144.2 km(2) before mining exploitation. By 2016, 19.6% of the canga area was lost in the CMP due to conversion to other land-use types (mining areas, pasturelands). In the Caraja's National Forest (CNF), located within the CMP, the original canga vegetation covered 105.2 km(2) (2.55% of the CNF total area), and in 2016, canga vegetation occupied an area of 77.2 km(2) (1.87%). Therefore, after more than three decades of mineral exploitation, less than 20% of the total canga area was lost. Currently, 21% of the canga area in the CMP is protected by the Campos Ferruginosos National Park. By documenting the initial extent of canga vegetation in the eastern Amazon and the extent to which it has been lost due to mining operations, the results of this work are the first step towards conserving this ecosystem.	[Souza-Filho, Pedro Walfir M.; Giannini, Tereza C.; Jaffe, Rodolfo; Giulietti, Ana M.; Nascimento, Wilson R., Jr.; Guimaraes, Jose Tasso F.; Imperatriz-Fonseca, Vera L.; Siqueira, Jose O.] Inst Tecnol Vale, Belem, Para, Brazil; [Souza-Filho, Pedro Walfir M.; Santos, Diogo C.] Univ Fed Para, Geosci Inst, Belem, Para, Brazil; [Costa, Marlene F.] Vale SA Parauapebas, Gerencia Meio Ambiente Minas Carajas, Dept Ferrosos Norte, Parauapebas, Para, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal do Para	Souza, PWM (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Souza, PWM (corresponding author), Univ Fed Para, Geosci Inst, Belem, Para, Brazil.	pedro.martins.souza@itv.org	Giannini, Tereza C/F-2676-2012; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Souza-Filho, Pedro Walfir M. M./J-4958-2012; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Jaffé, Rodolfo/K-3230-2013; Giulietti, Ana Maria/T-3917-2019; Guimarães, José Tasso Felix/D-2079-2013; Souza, Pedro/GZH-1275-2022; Giannini, Tereza Cristina/AAA-2958-2019	Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Souza-Filho, Pedro Walfir M. M./0000-0003-0252-808X; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Jaffé, Rodolfo/0000-0002-2101-5282; Giulietti, Ana Maria/0000-0002-2754-0221; Guimarães, José Tasso Felix/0000-0002-5772-5104; Giannini, Tereza Cristina/0000-0001-9830-1204	Instituto Tecnologico Vale; Vale S.A.; CNPq	Instituto Tecnologico Vale; Vale S.A.; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by the Instituto Tecnologico Vale, a non-profit research institution. Vale S.A. provided support in the form of salary for author MFC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first (PWMSF), third (RJ), fourth (AMG), and seventh (JTFG) authors were supported by CNPq through research scholarships. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Vale Institute of Technology (ITV) for its management support. The authors are also grateful to the Vale Mining Company for logistical support and to the United States Geological Survey (USGS) for providing the digital elevation model (SRTM, 1 arc-second) and Landsat images. The first (PWMSF), third (RJ), fourth (AMG), and seventh (JTFG) authors were supported by CNPq through research scholarships. This project was carried out in the Carajas National Forest under permission of IBAMA (SISBIO 35594-2).	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Carmo FF, 2012, HOJE, V295, P49; Congalton R G, 2009, PHOTOGRAMM REC, V2, P183; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Desclee B, 2006, REMOTE SENS ENVIRON, V102, P1, DOI 10.1016/j.rse.2006.01.013; Dorr JohnVanN., 1964, ECON GEOL, V59, P1203, DOI DOI 10.2113/GSECONGEO.59.7.1203; Dragut L, 2010, INT J GEOGR INF SCI, V24, P859, DOI 10.1080/13658810903174803; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Fearnside Philip M., 2013, Environment Development and Sustainability, V15, P325, DOI 10.1007/s10668-012-9412-2; Fernandes GW, 2014, NAT CONSERVACAO, V12, P162, DOI 10.1016/j.ncon.2014.08.003; Gastauer M, 2019, AMBIO, V48, P74, DOI 10.1007/s13280-018-1053-8; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; Gibson N, 2010, BIODIVERS CONSERV, V19, P3951, DOI 10.1007/s10531-010-9939-1; Goncalves A.R., 2016, PLANO MANEJO FLOREST, V1; Goncalves A.R., 2016, PLANO MANEJO FLOREST, VII; Grainger CJ, 2008, ORE GEOL REV, V33, P451, DOI 10.1016/j.oregeorev.2006.10.010; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2011, AMBIO, V40, P540, DOI 10.1007/s13280-011-0151-7; Jaffe R, 2018, PEERJ, V6, DOI 10.7717/peerj.4531; Jaffe R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168348; Lanes EC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00532; Lobo FD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070579; Lowe SH, 2011, IEEE J-STARS, V4, P890, DOI 10.1109/JSTARS.2011.2157659; Lu DS, 2013, INT J REMOTE SENS, V34, P5953, DOI 10.1080/01431161.2013.802825; Madeira JA, 2015, GEOSSISTEMAS FERRUGI, P521; Martins F.D., 2014, DIVERSIDADE CABE UNI, P580; Maurity Clovis Wagner, 1995, Boletim do Museu Paraense Emilio Goeldi Serie Ciencias da Terra, V7, P331; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Mota Nara Furtado de Oliveira, 2018, Rodriguésia, V69, P1435, DOI 10.1590/2175-7860201869336; Pilo LB, 2015, WOR GEOMORPHOL LANDS, P273, DOI 10.1007/978-94-017-8023-0_25; Radoux J, 2011, INT J GEOGR INF SCI, V25, P895, DOI 10.1080/13658816.2010.498378; Rasi R, 2011, REMOTE SENS ENVIRON, V115, P3659, DOI 10.1016/j.rse.2011.09.004; Rezende NP, 1972, DISTRITO FERRI UNPUB; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Sahoo PK, 2016, AN ACAD BRAS CIENC, V88, P2211, DOI 10.1590/0001-3765201620160354; Salomao GN, 2018, GEOCHIM BRAS, V21, DOI DOI 10.21715/GB2358-2812.2018322180; Sandstrom H, 2006, GEOCHEMICAL ATLAS 1; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Sonter LJ, 2014, CONSERV BIOL, V28, P1068, DOI 10.1111/cobi.12260; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Souza CM, 2013, REMOTE SENS-BASEL, V5, P5493, DOI 10.3390/rs5115493; Souza PWM, 2015, INT ARCH PHOTOGRAMM, V47, P1491, DOI 10.5194/isprsarchives-XL-7-W3-1491-2015; Souza PWM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111683; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Takahasi A., 2015, GEOSSISTEMAS FERRUGI, P317; TARPLEY JD, 1984, J CLIM APPL METEOROL, V23, P491, DOI 10.1175/1520-0450(1984)023<0491:GVIFTN>2.0.CO;2; Tassinari CCG, 1999, EPISODES, V22, P174; TOLBERT GE, 1971, ECON GEOL, V66, P985, DOI 10.2113/gsecongeo.66.7.985; Vale, 2012, VAL NOSS HIST; Vale, 2017, SUST REP 2017; Viana Pedro Lage, 2016, Rodriguésia, V67, P1107, DOI 10.1590/2175-7860201667501; Vidrih Ferreira GLB, 2011, MEIO AMBIENTE MINERA, V11, P111, DOI [10.15600/2238-1228/cd.v11n20p111-124, DOI 10.15600/2238-1228/CD.V11N20P111-124]	53	31	31	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211095	10.1371/journal.pone.0211095	http://dx.doi.org/10.1371/journal.pone.0211095			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653607	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500099
J	Vanbutsele, G; Deliens, L; Cocquyt, V; Cohen, J; Pardon, K; Chambaere, K				Vanbutsele, Gaelle; Deliens, Luc; Cocquyt, Veronique; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth			Use and timing of referral to specialized palliative care services for people with cancer: A mortality follow-back study among treating physicians in Belgium	PLOS ONE			English	Article							OF-LIFE PRACTICES; SYMPTOM BURDEN; HEMATOLOGICAL MALIGNANCIES; PATIENT; INTEGRATION; OUTCOMES; HEALTH; EUTHANASIA; ENROLLMENT; BARRIERS	Background Referral to specialized palliative care services (SPCS) occurs often late in the illness trajectory but may differ across cancer types. We examined differences between cancer types in the use and timing of referral to specialized palliative care services (SPCS) and in the reasons for non-referral. Methods We conducted a population-based mortality follow-back survey among physicians who certified a representative sample of deaths in Flanders, Belgium. We focused only on sampled death cases of cancer (n = 2392). The questionnaire asked about the use of the existing types of SPCS and the timing of referral to these services. Results Response rate was 58% (1394/2392). Patients who died from breast, respiratory, head and neck, genitourinary or gastrointestinal cancer had higher chances of using SPCS compared to hematologic cancer patients. The most prevalent reason for non-referral was that regular care sufficiently addressed palliative and supportive care needs (51%). This differed significantly between cancer types ranging from 77,8% for breast cancer and 42.1% for hematologic cancer. A second prevalent reason for not using SPCS was that it was not meaningful (enough) (23.9%), particularly for hematologic malignancies (35,1%) and only in 5.3% for breast cancer. Conclusion Differences in referral across different types of cancer were found. Referral is more often delayed or not initiated for patients with hematologic cancer, possibly due to differences in illness trajectory. An influencing reason is that physicians perceive palliative care as not meaningful or not meaningful enough for these patients which may be linked to the uncertainty in the disease trajectory of hematologic malignancies.	[Vanbutsele, Gaelle; Deliens, Luc; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Vanbutsele, Gaelle; Deliens, Luc; Cohen, Joachim; Pardon, Koen; Chambaere, Kenneth] Univ Ghent, Brussels, Belgium; [Vanbutsele, Gaelle; Deliens, Luc; Chambaere, Kenneth] Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Cocquyt, Veronique] Ghent Univ Hosp, Dept Med Oncol, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vanbutsele, G; Pardon, K; Chambaere, K (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.; Vanbutsele, G; Pardon, K; Chambaere, K (corresponding author), Univ Ghent, Brussels, Belgium.; Vanbutsele, G; Chambaere, K (corresponding author), Univ Ghent, Dept Publ Hlth & Primary Care, Ghent, Belgium.	gaelle.vanbutsele@uzgent.be; koen.pardon@vub.be; Kenneth.chambaere@vub.be	Cohen, Joachim/B-6803-2008; Chambaere, Kenneth/ACV-2311-2022	Cohen, Joachim/0000-0002-7224-9476; Pardon, Koen/0000-0002-0571-709X; Vanbutsele, Gaelle/0000-0003-0284-8585	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT) [100036]; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO) [G018012N]; Belgian society Kom Op Tegen Kanker; scientific fund Willy Gepts (UZ Brussel)	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT); Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO)(FWO); Belgian society Kom Op Tegen Kanker; scientific fund Willy Gepts (UZ Brussel)	This study is part of the 'Flanders Study to Improve End-of-Life Care and Evaluation Tools (FLIECE) project', a collaboration between the Vrije Universiteit Brussel, Ghent University, the Katholieke Universiteit Leuven, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. This study is supported by a grant from the Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT nr. 100036). The first author, Gaelle Vanbutsele, was funded by a grant from the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek) (FWO nr. G018012N), by the Belgian society Kom Op Tegen Kanker and by the scientific fund Willy Gepts (UZ Brussel). The funding sources had no role in the design and collection, analysis, and interpretation of data and in writing the manuscript.	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Ansell P, 2007, PALLIATIVE MED, V21, P487, DOI 10.1177/0269216307082020; Auret K, 2003, INTERN MED J, V33, P566, DOI 10.1111/j.1445-5994.2003.00490.x; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bauman JR, 2014, J NATL COMPR CANC NE, V12, P1763, DOI 10.6004/jnccn.2014.0177; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Beernaert K, 2014, PALLIATIVE MED, V28, P480, DOI 10.1177/0269216314522318; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bennett MI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012576; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Brickner Leslea, 2004, J Palliat Med, V7, P411, DOI 10.1089/1096621041349518; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Burge F, 2002, PALLIATIVE MED, V16, P255, DOI 10.1191/0269216302pm550xx; Casarett D, 2006, J AM GERIATR SOC, V54, P472, DOI 10.1111/j.1532-5415.2005.00628.x; Chambaere K, 2015, NEW ENGL J MED, V372, P1179, DOI 10.1056/NEJMc1414527; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Cheung WY, 2009, SUPPORT CARE CANCER, V17, P1223, DOI 10.1007/s00520-009-0577-7; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376; Costantini M, 1999, J PAIN SYMPTOM MANAG, V18, P243, DOI 10.1016/S0885-3924(99)00084-6; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Fadul N, 2007, J PALLIAT MED, V10, P1146, DOI 10.1089/jpm.2006.0259; Fadul NA, 2008, J PALLIAT MED, V11, P422, DOI 10.1089/jpm.2007.0184; Federale Evaluatiecel Palliatieve Zorg, 2014, EV PALL ZORG; Good PD, 2004, J PAIN SYMPTOM MANAG, V27, P310, DOI 10.1016/j.jpainsymman.2003.12.011; Howell DA, 2011, PALLIATIVE MED, V25, P630, DOI 10.1177/0269216310391692; Hui D, 2015, ONCOLOGIST, V20, P77, DOI 10.1634/theoncologist.2014-0312; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Hui D, 2012, ONCOLOGIST, V17, P1574, DOI 10.1634/theoncologist.2012-0192; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Hunt RW, 2002, PALLIATIVE MED, V16, P403, DOI 10.1191/0269216302pm571oa; Johnson C, 2011, J PALLIAT MED, V14, P429, DOI 10.1089/jpm.2010.0259; Kaasa S, 2015, PALLIATIVE CARE ONCO, P299; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kwon JH, 2013, J PALLIAT MED, V16, P148, DOI 10.1089/jpm.2012.0344; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; LeBlanc TW, 2015, J ONCOL PRACT, V11, pE230, DOI 10.1200/JOP.2014.001859; Love AW, 2014, PROG PALLIAT CARE, V22, P9, DOI 10.1179/1743291X13Y.0000000055; Manitta V, 2011, J PAIN SYMPTOM MANAG, V42, P432, DOI 10.1016/j.jpainsymman.2010.12.008; Manitta VJ, 2010, J PALLIAT MED, V13, P1021, DOI 10.1089/jpm.2009.0267; McCaughan D, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0289-1; McCaughan D, 2018, BMJ SUPPORT PALLIAT, V8, P78, DOI 10.1136/bmjspcare-2016-001289; McGrath P, 2007, EUR J CANCER CARE, V16, P164, DOI 10.1111/j.1365-2354.2006.00745.x; McGrath Pam, 2002, Am J Hosp Palliat Care, V19, P103, DOI 10.1177/104990910201900208; Morita T, 2002, PALLIATIVE MED, V16, P185, DOI 10.1191/0269216302pm524oa; Pardon K, 2013, J CLIN ONCOL, V31, P1450, DOI 10.1200/JCO.2012.44.5916; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rehse B, 2003, PATIENT EDUC COUNS, V50, P179; Rosenwax LK, 2006, PALLIATIVE MED, V20, P439, DOI 10.1191/0269216306pm1146oa; Schmidt H, 2015, J PAIN SYMPTOM MANAG, V49, P118, DOI 10.1016/j.jpainsymman.2014.04.007; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Vanbutsele G, 2018, LANCET ONCOL, V19, P394, DOI 10.1016/S1470-2045(18)30060-3; Walshe C, 2008, SOC SCI MED, V67, P137, DOI 10.1016/j.socscimed.2008.03.027; Zimmermann C, 2016, LEUKEMIA RES, V48, P78, DOI 10.1016/j.leukres.2016.07.012; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	56	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210056	10.1371/journal.pone.0210056	http://dx.doi.org/10.1371/journal.pone.0210056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653508	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500025
J	Sommer, K; Jakob, H; Badjlan, F; Henrich, D; Frank, J; Marz, I; Sander, AL				Sommer, Katharina; Jakob, Heike; Badjlan, Farsin; Henrich, Dirk; Frank, Johannes; Marz, Ingo; Sander, Anna Lena			11,12 and 14,15 epoxyeicosatrienoic acid rescue deteriorated wound healing in ischemia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEOVASCULARIZATION; EPITHELIALIZATION; PROLIFERATION; MIGRATION; BETA	Introduction Epoxyeicosatrienoic acids (EETs) are able to enhance angiogenesis and regulate inflammation that is especially important in wound healing under ischemic conditions. Thus, we evaluated the effect of local EET application on ischemic wounds in mice. Methods Ischemia was induced by cautherization of two of the three supplying vessels to the mouse ear. Wounding was performed on the ear three days later. Wounds were treated either with 11,12 or 14,15 EET and compared to untreated control and normal wounds. Epithelialization was measured every second day. VEGF, TNF-alpha, TGF-beta, matrix metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP), Ki67, and SDF-1 alpha were evaluated immuno-histochemically in wounds on day 3, 6, and 9. Results Ischemia delayed wound closure (12.8 days +/- 1.9 standard deviation (SD) for ischemia and 8.0 days +/- 0.94 SD for control). 11,12 and14,15 EET application ameliorated deteriorated wound healing on ischemic ears (7.6 +/- 1.3 SD for 11,12 EET and 9.2 +/- 1.4 SD for 14,15 EET). Ischemia did not change VEGF, TNF-alpha, TGF-beta, SDF-1 alpha, TIMP, MMP7 or MMP9 level significantly compared to control. Local application of 11,12 as well as 14,15 EET induced a significant elevation of VEGF, TGF-beta, and SDF-1 alpha expression as well as proliferation during the whole phase of wound healing compared to control and ischemia alone. Conclusion In summary, EET improve impaired wound healing caused by ischemia as they enhance neovascularization and alter inflammatory response in wounds. Thus elevating lipid mediator level as 11,12 and 14,15 EET in wounds might be a successful strategy for amelioration of deranged wound healing under ischemia.	[Sommer, Katharina; Badjlan, Farsin; Henrich, Dirk; Frank, Johannes; Marz, Ingo; Sander, Anna Lena] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Jakob, Heike] Marienhausklin St Josef Kohlhof, Dept Trauma Hand & Reconstruct Surg, Neunkirchen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sommer, K (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	katharina.sommer@kgu.de						Barker John H., 1994, Wound Repair and Regeneration, V2, P138, DOI 10.1046/j.1524-475X.1994.20208.x; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2043, DOI 10.1159/000374011; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; KAMLER M, 1993, EUR SURG RES, V25, P30, DOI 10.1159/000129254; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Nissen NN, 1998, AM J PATHOL, V152, P1445; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sander AL, 2013, J SURG RES, V182, P362, DOI 10.1016/j.jss.2012.10.034; Sander AL, 2011, J SURG RES, V165, P165, DOI 10.1016/j.jss.2009.07.003; Sander AL, 2011, LANGENBECK ARCH SURG, V396, P1245, DOI 10.1007/s00423-011-0838-z; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Sommer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073992; STEENFOS HH, 1994, SCAND J PLAST RECONS, V28, P95, DOI 10.3109/02844319409071186; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Weinstein DA, 2010, J AM ACAD DERMATOL, V63, P146, DOI 10.1016/j.jaad.2009.08.004; Zhang F, 2003, BRIT J PLAST SURG, V56, P334, DOI 10.1016/S0007-1226(03)00175-9	28	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209158	10.1371/journal.pone.0209158	http://dx.doi.org/10.1371/journal.pone.0209158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650075	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300008
J	Gamba, CD; Damasceno, KA; Ferreira, IC; Rodrigues, MA; Gomes, DA; Alves, MR; Rocha, RM; Lima, AE; Ferreira, E; Cassali, GD				Gamba, Conrado de Oliveira; Damasceno, Karine Araujo; Ferreira, Izabel Cristina; Rodrigues, Michele Angela; Gomes, Dawidson Assis; Alves, Mariana Resende; Rocha, Rafael Malagoli; Lima, Alessandra Estrela; Ferreira, Enio; Cassali, Geovanni Dantas			The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; CELL-ADHESION MOLECULES; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; DOWN-REGULATION; SIP1; TUMOR; PROGRESSION; GRADE; SNAIL	The E-cadherin loss has frequently been associated with transcriptional repression mediated by transcription factors, such as the Zinc Finger E-Box Binding Homeobox-2 (ZEB2). Invasive micropapillary carcinomas (IMPCs) of the breast are aggressive neoplasms frequently related to lymph node metastasis and poor overall survival. In the canine mammary gland, IMPCs has just been reported and, based on its behavioral similarity with the human IMPCs, appears to be a good spontaneous model to this human entity. This study aimed to evaluate the relationship between E-cadherin and ZEB2 in a spontaneous canine model of invasive micropapillary carcinoma of the mammary gland. The correlation among gene expression (ZEB2 and CDH1) and clinicopathological findings was also explored. Nineteen cases of IMPC of the canine mammary gland were obtained, protein and mRNA expression were investigated through immunohistochemistry and RNA In Situ Hybridization, respectively. To better understand the relationship between E-cadherin and ZEB2, immunofluorescence was performed in canine IMPCs. Immunohistochemically, most of IMPCs showed 1+ (14/19, 73.7%) for E-cadherin; and positivity for ZEB2 was diagnosed in 47.4% of the IMPCs. Regarding the RNA In Situ Hybridization (ISH), most of IMPCs showed 4+ and 0+ for E-cadherin (CDH1) and ZEB2 respectively. Through immunofluorescence, the first and second more frequent combinatorial group were E-cadherin(+)ZEB2(-) and E-cadherin(+)ZEB2(+); neoplastic cells showing concomitantly weak expression for E-cadherin and positivity for ZEB2 were frequently observed. A negative correlation was observed between E-cadherin and progesterone receptor expression in IMPCs. Based on these results, canine mammary IMPCs show E-cadherin lost and, at times reveals nuclear positivity for the transcription factor ZEB2 that seems to exert transcriptional repression of the CDH1.	[Gamba, Conrado de Oliveira; Damasceno, Karine Araujo; Ferreira, Izabel Cristina; Rodrigues, Michele Angela; Ferreira, Enio; Cassali, Geovanni Dantas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Gamba, Conrado de Oliveira] Univ Oeste Santa Catarina, Curso Med Vet, Campus Aproximado Campos Novos, Campos Novos, SC, Brazil; [Damasceno, Karine Araujo] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil; [Gomes, Dawidson Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Alves, Mariana Resende; Rocha, Rafael Malagoli] AC Camargo Canc Ctr, Int Ctr Res Canc CIPE, Sao Paulo, SP, Brazil; [Lima, Alessandra Estrela] Univ Fed Bahia, Escola Med Vet, Dept Patol & Clin, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade do Oeste de Santa Catarina; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; A.C.Camargo Cancer Center; Universidade Federal da Bahia	Cassali, GD (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	cassalig@icb.ufmg.br	Ferreira, Enio/AAC-8167-2022; Gomes, Dawidson Assis/O-1372-2013; DAMASCENO, KARINE ARAÚJO/AAV-6002-2021; DAMASCENO, KARINE/AAO-3340-2021	Ferreira, Enio/0000-0002-1835-0303; Gomes, Dawidson Assis/0000-0001-7714-991X; DAMASCENO, KARINE ARAÚJO/0000-0003-2087-1690; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [035/98, 112/04]; Conselho Nacional de Desenvolvimento e Pesquisa (CNPq) [14/2011, 470696/2011-7]; Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG) [CBS: 838/96, 919/97, 1005/01, CDS 572/04]; Universidade do Oeste de Santa Catarina (Unoesc) (Edital - Fundo de apoio a pesquisa, FAPE) [18/UNOESC-R/2018]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade do Oeste de Santa Catarina (Unoesc) (Edital - Fundo de apoio a pesquisa, FAPE)	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br) (Projects CAPES/ICCTI, 035/98; and CAPES/GRICES, 112/04) (GDC), Conselho Nacional de Desenvolvimento e Pesquisa (CNPq) (http://www.cnpq.br) (Edital Universal 14/2011; Processo 470696/2011-7) (GDC), Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG) (http://fapemig.br/pt) (Projects CBS: 838/96, 919/97, 1005/01, CDS 572/04) (GDC) and Universidade do Oeste de Santa Catarina (Unoesc) (https://www.unoesc.edu.br) (Edital - Fundo de apoio a pesquisa, FAPE, No 18/UNOESC-R/2018) (COG).	Alves MR, 2014, VIRCHOWS ARCH, V465, P321, DOI 10.1007/s00428-014-1629-z; Badyal RK, 2016, APPL IMMUNOHISTO M M, V24, P151, DOI 10.1097/PAI.0000000000000167; Cassali G. D., 2014, BRAZILIAN J VET PATH, V7, P1; Dai YH, 2012, DIGEST DIS SCI, V57, P1253, DOI 10.1007/s10620-012-2042-6; Damasceno KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160419; De La Cruz C, 2004, PATHOL INT, V54, P90, DOI 10.1111/j.1440-1827.2004.01590.x; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Elston CW, 1998, BREAST, DOI [10.3892/ijo.2013.2059, DOI 10.3892/IJO.2013.2059]; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Galvan JA, 2015, BRIT J CANCER, V112, P1944, DOI 10.1038/bjc.2015.177; Gamba CO, 2015, J COMP PATHOL, V153, P256, DOI 10.1016/j.jcpa.2015.08.006; Gamba CO, 2014, RES VET SCI, V97, P554, DOI 10.1016/j.rvsc.2014.09.016; Gamba CO, 2013, VET J, V196, P241, DOI 10.1016/j.tvjl.2012.08.022; Gamba CD, 2017, RES VET SCI, V115, P189, DOI 10.1016/j.rvsc.2017.04.012; Geradts J, 2011, HUM PATHOL, V42, P1125, DOI 10.1016/j.humpath.2010.11.004; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Guriec N, 1995, INVAS METAST, V16, P19; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; He Y, 2017, ONCOGENE, V36, P3490, DOI 10.1038/onc.2016.492; Hegarty SV, 2015, PROG NEUROBIOL, V132, P81, DOI 10.1016/j.pneurobio.2015.07.001; Heimann R, 2000, CANCER RES, V60, P298; Hunt NCA, 1997, VIRCHOWS ARCH, V430, P285, DOI 10.1007/BF01092751; Jouppila-Matto A, 2015, HISTOL HISTOPATHOL, V30, P569, DOI 10.14670/HH-30.569; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Kong YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134045; Kurahara H, 2012, J SURG ONCOL, V105, P655, DOI 10.1002/jso.23020; Lee H, 2014, VIRCHOWS ARCH, V464, P213, DOI 10.1007/s00428-013-1518-x; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Luna-More S, 2000, PATHOL RES PRACT, V196, P35, DOI 10.1016/S0344-0338(00)80019-9; Misdorp W., 1999, HISTOLOGICAL CLASSIF; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; OKA H, 1993, CANCER RES, V53, P1696; OKA H, 1992, VIRCHOWS ARCH A, V421, P149, DOI 10.1007/BF01607048; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng Z, 2014, WORLD J GASTROENTERO, V20, P5403, DOI 10.3748/wjg.v20.i18.5403; Pettinato G, 2004, AM J CLIN PATHOL, V121, P857, DOI 10.1309/XTJ7VHB49UD78X60; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Prislei S, 2015, ROLE PROGNOSTIC SIGN, V6, DOI [10.18632/oncotarget.3943, DOI 10.18632/ONCOTARGET.3943]; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111/j.1365-2559.2005.02156.x; Rodrigues MA, 2016, PATHOL RES PRACT, V212, P340, DOI 10.1016/j.prp.2015.11.017; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; UMBAS R, 1992, CANCER RES, V52, P5104; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yan B, 2014, INT J CLIN EXP MED, V7, P4352; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Zheng X, 2015, INT J CLIN EXP MED, V8, P18689	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209497	10.1371/journal.pone.0209497	http://dx.doi.org/10.1371/journal.pone.0209497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645591	gold, Green Submitted, Green Published			2022-12-27	WOS:000455810200010
J	Kramar, MK; Tinta, T; Lucic, D; Malej, A; Turk, V				Kramar, Maja Kos; Tinta, Tinkara; Lucic, Davor; Malej, Alenka; Turk, Valentina			Bacteria associated with moon jellyfish during bloom and post-bloom periods in the Gulf of Trieste (northern Adriatic)	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CORAL DENDRONEPHTHYA SP; AURELIA-AURITA; GELATINOUS ZOOPLANKTON; ORGANIC-MATTER; SOFT CORAL; ANTIBACTERIAL ACTIVITY; POPULATION-DYNAMICS; NESTED PCR; CRUDE-OIL	Jellyfish are a prominent component of the plankton community. They frequently form conspicuous blooms which may interfere with different human enterprises. Among the aspects that remain understudied are jellyfish associations with microorganisms having potentially important implications for organic matter cycling. To the best of our knowledge, this study is the first to investigate the bacterial community associated with live moon jellyfish (Aurelia solida, Scyohozoa) in the Adriatic Sea. Using 16S rRNA clone libraries and culture-based methods, we have analyzed the bacterial community composition of different body parts: the exumbrella surface, oral arms, and gastric cavity, and investigated possible differences in medusa-associated bacterial community structure at the time of the jellyfish population peak, and during the senescent phase at the end of bloom. Microbiota associated with moon jellyfish was different from ambient seawater bacterial assemblage and varied between different body parts. Betaproteobacteria (Burkholderia, Cupriavidus and Achromobacter) dominated community in the gastral cavity of medusa, while Alphaproteobacteria (Phaeobacter, Ruegeria) and Gammaproteobacteria (Stenotrophomonas, Alteromonas, Pseudoalteromonas and Vibrio) prevailed on 'outer' body parts. Bacterial community structure changed during senescent phase, at the end of the jellyfish bloom, showing an increased abundance of Gammaproteobacteria, exclusively Vibrio. The results of cultured bacterial isolates showed the dominance of Gammaproeteobacteria, especially Vibrio and Pseudoalteromonas in all body parts. Our results suggest that jellyfish associated bacterial community might have an important role for the host, and that anthropogenic pollution in the Gulf of Trieste might affect their community structure.	[Kramar, Maja Kos; Tinta, Tinkara; Malej, Alenka; Turk, Valentina] Natl Inst Biol, Marine Biol Stn Piran, Piran, Slovenia; [Tinta, Tinkara] Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria; [Lucic, Davor] Univ Dubrovnik, Inst Marine & Coastal Res, Dubrovnik, Croatia	National Institute of Biology - Slovenia; University of Vienna; University of Dubrovnik	Turk, V (corresponding author), Natl Inst Biol, Marine Biol Stn Piran, Piran, Slovenia.	Valentina.Turk@nib.si	turk, Valentina/AAV-8033-2020; Tinta, Tinkara/L-8912-2016	Turk, Valentina/0000-0002-3932-1974; Malej, Alenka/0000-0001-6650-4795; Tinta, Tinkara/0000-0001-6740-8973	Ministry of Higher Education, Science and Technology of the R Slovenia [ARRS-34503, BI-HR/12-13-030]; Ministry of Science, Education and Sport of the Croatia [BI-HR/12-13-030]; European Union [793778]	Ministry of Higher Education, Science and Technology of the R Slovenia; Ministry of Science, Education and Sport of the Croatia; European Union(European Commission)	This work was supported by: Ministry of Higher Education, Science and Technology of the R Slovenia (ARRS-34503 Maja Kos Kramar), Bilateral cooperation with the Ministry of Science, Education and Sport of the Croatia and Ministry of Higher Education, Science and Technology of the R Slovenia (BI-HR/12-13-030 Dr. Davor Lucic and Dr. Valentina Turk; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie (grant agreement No 793778 Tinkara Tinta).	Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; ALMEDA R, 2013, PLOS ONE, V8; Apprill A., 2017, FRONTIERS MARINE SCI, V4, P9; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Ates RML, 2017, PLANKTON BENTHOS RES, V12, P71; Bacosa HP, 2012, INT BIODETER BIODEGR, V74, P109, DOI 10.1016/j.ibiod.2012.04.022; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Blanchet M, 2015, ENVIRON SCI POLLUT R, V22, P13638, DOI 10.1007/s11356-014-3848-x; Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Clarke K.R., 2006, PRIMER V6 MANUAL TUT; Cleary DW, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw159; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Daley MC, 2016, MAR BIOL RES, V12, P1088, DOI 10.1080/17451000.2016.1228974; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2016, MICROBIOL MOL BIOL R, V80, P91, DOI 10.1128/MMBR.00037-15; Daniels C, 2012, FEMS MICROBIOL ECOL, V82, P90, DOI 10.1111/j.1574-6941.2012.01409.x; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Deng MC, 2014, MAR POLLUT BULL, V83, P79, DOI 10.1016/j.marpolbul.2014.04.018; Briz LD, 2017, MAR BIOL RES, V13, P630, DOI 10.1080/17451000.2016.1274403; Dinasquet J, 2012, FRONTIERS MICROBIOLO, V3, P1; Dobretsov S, 2004, J EXP MAR BIOL ECOL, V299, P35, DOI 10.1016/j.jembe.2003.08.011; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Doyle TK, 2014, JELLYFISH BLOOMS, P1; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P706, DOI 10.4319/lo.1979.24.4.0706; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; Gemmell BJ, 2016, MAR POLLUT BULL, V113, P483, DOI 10.1016/j.marpolbul.2016.08.065; Gerdts G, 2013, HELGOLAND MAR RES, V67, P757, DOI 10.1007/s10152-013-0361-4; Giloteaux L, 2010, APPL ENVIRON MICROB, V76, P2856, DOI 10.1128/AEM.02023-09; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; Grossart HP, 2013, FRONTIERS MICROBIOLO, V4, P2012; Hagstrom A, 2018, AQUAT MICROB ECOL, V80, P15, DOI 10.3354/ame01838; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANSSON LJ, 1995, MAR BIOL, V121, P527, DOI 10.1007/BF00349462; Hao W., 2014, BACTERIAL COMMUNITIE; Harayama Shigeaki, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P63; Harder T, 2003, FEMS MICROBIOL ECOL, V43, P337, DOI 10.1111/j.1574-6941.2003.tb01074.x; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; HEEGER T, 1987, MAR BIOL, V96, P391, DOI 10.1007/BF00412523; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hocevar S, 2018, MAR ECOL PROG SER, V591, P155, DOI 10.3354/meps12387; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Holmstrom C, 2002, FEMS MICROBIOL ECOL, V41, P47, DOI 10.1111/j.1574-6941.2002.tb00965.x; Hong YH, 2017, FRONTIERS MICROBIOLO, V8, P1; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Johnston IS, 2007, CORAL REEFS, V26, P375, DOI 10.1007/s00338-007-0208-z; Juhasz AL, 1997, J APPL MICROBIOL, V83, P189, DOI 10.1046/j.1365-2672.1997.00220.x; Kittelmann S, 2005, J EXP MAR BIOL ECOL, V327, P201, DOI 10.1016/j.jembe.2005.06.020; Kogovsek T, 2018, SCI TOTAL ENVIRON, V626, P982, DOI 10.1016/j.scitotenv.2018.01.011; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Lane D., 1991, NUCL ACID TECHNIQUES, p[329, xxix]; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lucas CH, 2014, GLOBAL ECOL BIOGEOGR, V23, P701, DOI 10.1111/geb.12169; Lynam CP, 2005, MAR ECOL PROG SER, V298, P157, DOI 10.3354/meps298157; Malai V., 2001, PHYS OCEANOGRAPHY AD, P167, DOI DOI 10.1007/978-94-015-9819-4_6; Malej A, 2012, CAH BIOL MAR, V53, P337; Manzari C, 2015, BIOL INVASIONS, V17, P923, DOI 10.1007/s10530-014-0810-2; Maravic A, 2012, INT J ENVIRON HEAL R, V22, P531, DOI 10.1080/09603123.2012.667797; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Palomo S, 2013, MAR DRUGS, V11, P1071, DOI 10.3390/md11041071; Patwa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11387; Pitt Kylie A., 2014, P79; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; PRINCE RC, 1993, CRIT REV MICROBIOL, V19, P217, DOI 10.3109/10408419309113530; PURCELL JE, 1985, B MAR SCI, V37, P739; PURCELL JE, 1991, HYDROBIOLOGIA, V216, P335, DOI 10.1007/BF00026483; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Radwan M, 2010, MAR BIOTECHNOL, V12, P350, DOI 10.1007/s10126-009-9239-5; Ramsak A, 2012, HYDROBIOLOGIA, V690, P69, DOI 10.1007/s10750-012-1053-9; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Riemann L, 2006, MAR ECOL PROG SER, V325, P29, DOI 10.3354/meps325029; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Scorrano S, 2017, ZOOL J LINN SOC-LOND, V180, P243, DOI 10.1111/zoj.12494; SHANKS AL, 1988, MAR ECOL PROG SER, V45, P81, DOI 10.3354/meps045081; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Tang KW, 2010, AQUAT MICROB ECOL, V61, P261, DOI 10.3354/ame01424; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thakur NL, 2000, J CHEM ECOL, V26, P57, DOI 10.1023/A:1005485310488; Tinta T, 2015, ENVIRON MICROBIOL, V17, P3581, DOI 10.1111/1462-2920.12519; Tinta T, 2016, J EXP MAR BIOL ECOL, V475, P19, DOI 10.1016/j.jembe.2015.10.018; Tinta T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039274; Tinta T, 2010, HYDROBIOLOGIA, V645, P179, DOI 10.1007/s10750-010-0223-x; Titelman J, 2006, MAR ECOL PROG SER, V325, P43, DOI 10.3354/meps325043; Turk Valentina, 2007, Annales Series Historia Naturalis, V17, P197; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Vodopivec M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa75d9; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Webster NS, 2007, FEMS MICROBIOL ECOL, V59, P81, DOI 10.1111/j.1574-6941.2006.00195.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Weiland-Brauer N, 2015, APPL ENV MICROBIOLOG, V81; West EJ, 2009, HYDROBIOLOGIA, V616, P151, DOI 10.1007/s10750-008-9586-7; Zobell CE, 1946, CHRONICA BOT	116	25	26	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0198056	10.1371/journal.pone.0198056	http://dx.doi.org/10.1371/journal.pone.0198056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645606	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200001
J	Shteyer, E; Shekhtman, L; Zinger, T; Harari, S; Gafanovich, I; Wolf, D; Ivgi, H; Barsuk, R; Dery, I; Armoni, D; Rivkin, M; Pipalia, R; Eliav, MC; Skorochod, Y; Breuer, GS; Tur-Kaspa, R; Wiener, YW; Stern, A; Cotler, SJ; Dahari, H; Lurie, Y				Shteyer, Eyal; Shekhtman, Louis; Zinger, Tal; Harari, Sheri; Gafanovich, Inna; Wolf, Dana; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Rivkin, Mila; Pipalia, Rahul; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Tur-kaspa, Ran; Wiener, Yonit Weil; Stern, Adi; Cotler, Scott J.; Dahari, Harel; Lurie, Yoav			Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography	PLOS ONE			English	Article							VIRUS-INFECTION; CHIMPANZEES; HCV; TRANSMISSION; RESPONSES; IL28B	Background & aims Acute hepatitis C (AHC) is not frequently identified because patients are usually asymptomatic, although may be recognized after iatrogenic exposures such as needle stick injuries, medical injection, and acupuncture. We describe an outbreak of AHC among 12 patients who received IV saline flush from a single multi-dose vial after intravenous contrast administration for a computerized tomography (CT) scan. The last patient to receive IV contrast with saline flush from a multi-dose vial at the clinic on the previous day was known to have chronic HCV genotype 1b (termed potential source, PS). Here we sought to confirm (via genetic analysis) the source of infection and to predict the minimal contaminating level of IV saline flush needed to transmit infectious virus to all patients. Methods In order to confirm the source of infection, we sequenced the HCV E1E2 region in 7 CT patients, in PS, and in 2 control samples from unrelated patients also infected with HCV genotype 1b. A transmission probabilistic model was developed to predict the contamination volume of blood that would have been sufficient to transmit infectious virus to all patients. Results Viral sequencing showed close clustering of the cases with the PS. The transmission probabilistic model predicted that contamination of the multi-dose saline vial with 0.6-8.7 microliters of blood would have been sufficient to transmit infectious virus to all patients. Conclusion Analysis of this unique cohort provides a new understanding of HCV transmission with respect to contaminating volumes and viral titers.	[Shteyer, Eyal] Shaare Zedek Med Ctr, Juliet Keidan Pediat Gastroenterol Inst, Jerusalem, Israel; [Shteyer, Eyal; Gafanovich, Inna; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Wiener, Yonit Weil; Lurie, Yoav] Hebrew Univ Jerusalem, Jerusalem, Israel; [Shekhtman, Louis; Pipalia, Rahul; Cotler, Scott J.; Dahari, Harel] Loyola Univ Med Ctr, Dept Med, Program Expt & Theoret Modeling, Div Hepatol, Maywood, IL 60153 USA; [Shekhtman, Louis] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel; [Zinger, Tal; Harari, Sheri; Stern, Adi] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel; [Gafanovich, Inna; Ivgi, Hefziba; Barsuk, Rima; Dery, Ilana; Armoni, Daniela; Eliav, Michal Cohen; Skorochod, Yizhak; Breuer, Gabriel S.; Wiener, Yonit Weil; Lurie, Yoav] Shaare Zedek Med Ctr, Liver Unit, Jerusalem, Israel; [Wolf, Dana; Rivkin, Mila] Hadassah Hebrew Univ Med Ctr, Clin Virol Unit, Jerusalem, Israel; [Tur-kaspa, Ran] Bar Ilan Univ, Fac Med Galilee, Safed, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Loyola University Chicago; Bar Ilan University; Tel Aviv University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Bar Ilan University	Shteyer, E (corresponding author), Shaare Zedek Med Ctr, Juliet Keidan Pediat Gastroenterol Inst, Jerusalem, Israel.; Shteyer, E (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	eyals@szmc.org.il	Breuer, Gabriel/AAD-1349-2020	Stern, Adi/0000-0002-2919-3542; Breuer, Gabriel/0000-0003-0398-3471; Zinger, Tal/0000-0002-5580-5282	U.S. National Institute of Health (NIH) [R01-AI078881, R01GM121600]; Shaare Zedek Medical Center; Hadassah Medical Center; Tel Aviv; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121600] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaare Zedek Medical Center; Hadassah Medical Center; Tel Aviv; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the U.S. National Institute of Health (NIH) grants R01-AI078881 and R01GM121600 (H. Dahari), internal funding of Shaare Zedek Medical Center (E. Shteyer), internal funding of Hadassah Medical Center (D. Wolf) and Internal funding of Tel Aviv (A. Stern). There was no additional external funding received for this study.	Benson AA, 2018, DIGEST LIVER DIS, V50, P630, DOI 10.1016/j.dld.2018.03.011; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Canini L, 2015, ANTIVIR THER, V20, P149, DOI 10.3851/IMP2806; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; Engle RE, 2008, J MED VIROL, V80, P72, DOI 10.1002/jmv.21043; Fabrizi F, 2010, CLIN LIVER DIS, V14, P49, DOI 10.1016/j.cld; FATEH A, 2005, PUBMED; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Germain JM, 2005, INFECT CONT HOSP EP, V26, P789, DOI 10.1086/502618; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katayama K, 2004, INTERVIROLOGY, V47, P57, DOI 10.1159/000076643; Knoll A, 2001, LAB INVEST, V81, P251; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; Lazarus JV, 2017, J HEPATOL, V67, P665, DOI 10.1016/j.jhep.2017.06.033; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lurie Y, 2007, J GASTROEN HEPATOL, V22, P158, DOI 10.1111/j.1440-1746.2006.04491.x; Major M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4496; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Operskalski EA, 2003, TRANSFUSION, V43, P1433, DOI 10.1046/j.1537-2995.2003.00475.x; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; POZZETTO B, 2014, WORLD JOURNAL OF GAS, V12, P18; SCHVARCZ R, 1997, INFECTION, V3, P1; Shemer-Avni Y, 2007, CLIN INFECT DIS, V45, pE32, DOI 10.1086/520014; Shteyer E, 2017, THER ADV GASTROENTER, V10, P429, DOI 10.1177/1756283X17694808; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2005, CLIN LIVER DIS, V9, P383, DOI 10.1016/j.cld.2005.05.003; Venegas M, 2011, WORLD J GASTROENTERO, V17, P3636, DOI 10.3748/wjg.v17.i31.3636; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007; WJG, 1965, PUBMED; WJG, PUBMED	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210173	10.1371/journal.pone.0210173	http://dx.doi.org/10.1371/journal.pone.0210173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645600	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200019
J	Takagaki, M; Kinoshita, M; Kawaguchi, A; Murasawa, A; Nakao, K; Nakamura, H; Kishima, H				Takagaki, Masatoshi; Kinoshita, Manabu; Kawaguchi, Atsushi; Murasawa, Akira; Nakao, Kazutami; Nakamura, Hajime; Kishima, Haruhiko			Relationship between normalized distributional pattern and functional outcome in patients with acute cardiogenic cerebral embolism	PLOS ONE			English	Article							EARLY DECOMPRESSIVE CRANIECTOMY; IMAGING LESION VOLUME; ARTERY INFARCTION; INTRAVENOUS THROMBOLYSIS; ISCHEMIC-STROKE; DIFFUSION; PROPENSITY; PREDICTION; TRIAL	This study aimed to elucidate spatial characteristics for magnetic resonance imaging (MRI) of cardiogenic cerebral embolism, to determine imaging biomarkers predicting patient outcome and cerebral herniation in cardioembolic stroke. This retrospective study assessed 90 patients with cardiogenic cerebral embolism. All images from MRI were normalized using a voxel-based symptom lesion mapping technique. Patients were categorized into two sub-groups based on the outcome and presence of cerebral herniation. Each subgroup was assessed individually. The distribution map of all analyzed patients revealed accumulated ischemic lesions in bilateral middle cerebral artery areas. Ischemic lesions for the poor outcome group accumulated at the corona radiata on the right side and throughout the entire left hemisphere. Receiver operating characteristic (ROC) analysis suggested that a normalized ischemic volume of 62.8 mL allowed optimal differentiation between good and poor outcomes (sensitivity, 0.923; specificity, 0.923; area under the curve (AUC), 0.91) for left-side-dominant infarction. The distribution map for the cerebral herniation group revealed large ischemic areas in the left hemisphere. The analysis of differential involvement map with random permutation analysis showed that left anterior circulation infarcts were associated with midline shift. Receiver operating characteristic analysis revealed that a normalized infarction volume of 192.9 mL was highly predictive of cerebral herniation (sensitivity, 0.929; specificity, 0.750; AUC, 0.895). The medial frontal and occipital lobes, caudate head and basal ganglia were significantly involved in those patients who developed cerebral herniation. Ischemic volume contributed to outcomes and cerebral herniation. Ischemic lesions of the anterior and posterior cerebral arteries and basal ganglia in addition to middle cerebral artery area were identified as differences on MRI images between with and without cerebral herniation patients.	[Takagaki, Masatoshi; Murasawa, Akira; Nakao, Kazutami] Kawachi Gen Hosp, Dept Neurosurg, Osaka, Japan; [Takagaki, Masatoshi; Kinoshita, Manabu] Osaka Int Canc Inst, Dept Neurosurg, Osaka, Japan; [Takagaki, Masatoshi; Nakamura, Hajime; Kishima, Haruhiko] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Japan	Osaka University; Saga University	Takagaki, M (corresponding author), Kawachi Gen Hosp, Dept Neurosurg, Osaka, Japan.; Takagaki, M (corresponding author), Osaka Int Canc Inst, Dept Neurosurg, Osaka, Japan.; Takagaki, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan.	m-takagaki@nsurg.med.osaka-u.ac.jp	Nakamura, Hajime/GPK-0454-2022	Kinoshita, Manabu/0000-0001-7923-6902	Japan Society for the Promotion of Science KAKENHI [16K20032]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 16K20032 (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiha T, 2017, J STROKE CEREBROVASC, V26, P1521, DOI 10.1016/j.jstrokecerebrovasdis.2017.02.038; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Carr IA, 2013, AM J PHYSIOL-HEART C, V305, pH732, DOI 10.1152/ajpheart.00320.2013; Cheng B, 2014, STROKE, V45, P1695, DOI 10.1161/STROKEAHA.114.005152; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; Ellingson BM, 2012, NEUROIMAGE, V59, P908, DOI 10.1016/j.neuroimage.2011.09.076; Golsari A, 2015, STROKE, V46, P1004, DOI 10.1161/STROKEAHA.114.007292; Goto Y, 2016, J STROKE CEREBROVASC, V25, P1389, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.034; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kemmling A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071141; Kim HJ, 2011, STROKE, V42, P2323, DOI 10.1161/STROKEAHA.111.616573; Kinoshita M, 2014, NEURO-ONCOLOGY, V16, P728, DOI 10.1093/neuonc/not319; Kruetzelmann A, 2011, STROKE, V42, P1251, DOI 10.1161/STROKEAHA.110.600148; Meyer JS, 1971, STROKE, V2, P541, DOI 10.1161/01.STR.2.6.541; Meyer S, 2016, NEUROIMAGE-CLIN, V10, P257, DOI 10.1016/j.nicl.2015.12.005; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Park KY, 2014, SCAND CARDIOVASC J, V48, P335, DOI 10.3109/14017431.2014.983964; Payabvash S, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160869; Rastogi V, 2015, J NEUROL SCI, V353, P20, DOI 10.1016/j.jns.2015.04.036; Rovira A, 2005, EUR RADIOL, V15, P416, DOI 10.1007/s00330-004-2633-5; Slezins J, 2012, MEDICINA-LITHUANIA, V48, P521, DOI 10.3390/medicina48100076; Streib CD, 2016, NEUROL-CLIN PRACT, V6, P433, DOI 10.1212/CPJ.0000000000000272; Takano K, 2015, NEURO-ONCOLOGY, P1, DOI [10.1093/neuonc/nou334, DOI 10.1093/NEUONC/NOU334]; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Yoo AJ, 2012, STROKE, V43, P1323, DOI 10.1161/STROKEAHA.111.639401; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656; Zaidi SF, 2012, STROKE, V43, P3238, DOI 10.1161/STROKEAHA.112.671594	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210709	10.1371/journal.pone.0210709	http://dx.doi.org/10.1371/journal.pone.0210709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645646	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200044
J	Emmert, M; Schuster-Amft, C; de Bruin, ED; McCaskey, MA				Emmert, Maria; Schuster-Amft, Corina; de Bruin, Eling D.; McCaskey, Michael A.			Comparison of proprioceptive acuity of the cervical spine in healthy adults and adults with chronic non-specific low back pain: A cross-sectional study	PLOS ONE			English	Article							HEAD REPOSITIONING ACCURACY; NECK PAIN; SENSORIMOTOR FUNCTION; MOTOR CONTROL; NORMAL RANGE; POSITION; ERROR; DISABILITY; MOTION; CLASSIFICATION	Background It has been suggested that patients with chronic non-specific low back pain (CNSLBP) perform poorly in postural tasks when compared to healthy individuals. Despite its importance in posture and alignment of the trunk in relation to the head, neck proprioception has not been examined in patients with low back pain. The purpose of this study was to compare neck proprioception in patients with CNSLBP with healthy individuals. Methods Cervical joint reposition error was measured five times consecutively in the neutral head position, 30 degrees and 60 degrees left and right head rotation. The main outcome measure was the mean cervical joint repositioning error of the head. Results Forty-six participants with (n = 24, 54 +/- 16yrs SD, 14 females) and without (n = 22, 36 +/- 13yrs SD, 13 females) CNSLBP were included in the study. Comparison of mean cervical joint repositioning error between patients and healthy controls showed no statistically significant group difference in any of the applied positions. The range of deviation in CNSLBP patients was between 1.57 degrees and 3.27 degrees compared to 1.46 degrees to 2.26 degrees in healthy controls. An overshooting tendency for both groups was found in the neutral head position. Conclusion The ability to accurately position the head does not seem to be impaired in patients with CNSLBP. This may suggest that sensorimotor control is affected on other levels of the movement system and future research should focus on methods to identify the source of these aberrations.	[Emmert, Maria; Schuster-Amft, Corina; McCaskey, Michael A.] Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland; [Emmert, Maria] ZHAW Sch Hlth Profess, Winterthur, Switzerland; [Schuster-Amft, Corina] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [de Bruin, Eling D.; McCaskey, Michael A.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet	McCaskey, MA (corresponding author), Reha Rheinfelden, Res Dept, Rheinfelden, Switzerland.; McCaskey, MA (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	michael.mccaskey@alumni.ethz.ch	Schuster, Corina/B-6939-2008; de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385; Schuster-Amft, Corina/0000-0003-1120-4423	cantonal department of health and social services of the Canton of Argovia, Switzerland; ETH Zurich; Reha Rheinfelden, Switzerland	cantonal department of health and social services of the Canton of Argovia, Switzerland; ETH Zurich(ETH Zurich); Reha Rheinfelden, Switzerland	MM and CS were partially funded by a grant from the cantonal department of health and social services of the Canton of Argovia (www.ag.ch/dgs), Switzerland. Internal funding was provided by MM and CS's employer, Reha Rheinfelden, Switzerland. EdB was funded by his employer, ETH Zurich, as part of his teaching activity (student supervision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors had unrestricted access to the data. There was no additional external funding received for this study.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Artz NJ, 2015, CLIN BIOMECH, V30, P260, DOI 10.1016/j.clinbiomech.2015.01.005; Astfalck RG, 2013, MANUAL THER, V18, P410, DOI 10.1016/j.math.2013.02.005; BfS, 2012, GES SCHWEIZ 2012; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2013, SPINAL CONTROL REHAB, P219; de Vries J, 2015, MANUAL THER, V20, P736, DOI 10.1016/j.math.2015.04.015; Delitto A, 2012, J ORTHOP SPORT PHYS, V42, pA1, DOI 10.2519/jospt.2012.42.4.A1; DEYO RA, 1988, ARCH PHYS MED REHAB, V69, P1044; Dolan KJ, 2006, MANUAL THER, V11, P202, DOI 10.1016/j.math.2006.03.003; Dugailly PM, 2015, EUR SPINE J, V24, P2885, DOI 10.1007/s00586-015-4263-9; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Georgy EE, 2011, ASIAN SPINE J, V5, P201, DOI 10.4184/asj.2011.5.4.201; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hill R, 2009, MANUAL THER, V14, P110, DOI 10.1016/j.math.2008.02.008; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Humphreys BK, 2008, J MANIP PHYSIOL THER, V31, P540, DOI 10.1016/j.jmpt.2008.08.007; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Langevin HM, 2007, MED HYPOTHESES, V68, P74, DOI 10.1016/j.mehy.2006.06.033; Lansade C, 2009, SPINE, V34, P2900, DOI 10.1097/BRS.0b013e3181b4f667; Lee J, 2014, J PHYS THER SCI, V26, P595, DOI 10.1589/jpts.26.595; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Mano Hiroaki, 2018, Wellcome Open Res, V3, P19, DOI 10.12688/wellcomeopenres.14069.1; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; McCaskey MA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-382; Miekisiak G, 2013, SPINE, V38, pE237, DOI 10.1097/BRS.0b013e31827e948b; Nagai T, 2014, AVIAT SPACE ENVIR MD, V85, P529, DOI 10.3357/ASEM.3874.2014; Newcomer KL, 2000, SPINE, V25, P2488, DOI 10.1097/00007632-200010010-00011; Noh KH, 2015, J PHYS THER SCI, V27, P293, DOI 10.1589/jpts.27.293; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Pettorossi VE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00895; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Rausch Osthoff Anne-Kathrin, 2015, Spine (Phila Pa 1976), V40, pE97, DOI 10.1097/BRS.0000000000000677; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Ribeiro F, 2011, FACTORS INFLUENCING; Ribeiro F, 2007, EUR REV AGING PHYS A, V4, P71, DOI 10.1007/s11556-007-0026-x; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Stanton TR, 2016, PHYS THER, V96, P876, DOI 10.2522/ptj.20150241; Stedman TL, 2006, STEDMANS MED DICT; Strimpakos N, 2011, J BODYW MOV THER, V15, P114, DOI 10.1016/j.jbmt.2009.06.003; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zusman M, 2013, J MULTIDISCIP HEALTH, V6, P197, DOI 10.2147/JMDH.S44117	55	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209818	10.1371/journal.pone.0209818	http://dx.doi.org/10.1371/journal.pone.0209818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629608	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000034
J	Hodgins, B; Pillet, S; Landry, N; Ward, BJ				Hodgins, Breanna; Pillet, Stephane; Landry, Nathalie; Ward, Brian James			A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HEMAGGLUTININ; ANTIBODY; PROTECTION; CHALLENGE; PATHOLOGY; PATTERNS; BEARING; INDUCE; AGE	Background The elderly are at high risk from influenza, in part because immunity wanes with age and through the accumulation of comorbidities. A novel plant-derived virus-like-particle (VLP) vaccine bearing influenza hemagglutinin can induce a balanced humoral and cellular response in old mice (16-18 months) while split virion vaccines elicit mostly antibodies. Because mice also collect comorbidities and lose immune competence as they age, we wished to determine how the plant-derived VLP vaccine would perform in animals approaching the end of their life-span. Materials and methods Old (24-26 months) female BALB/c mice received two intramuscular doses of H1-VLP vaccine, an inactivated H1N1 vaccine (IIV) (both based on A/H1N1/California/07/09) (3 mu g each) or PBS. Serum was collected on day 42 and humoral responses were measured by enzyme-linked immunosorbent assay (ELISA), microneutralization (MN) and hemagglutination inhibition (HI) assays. Influenza-specific splenocyte CD4(+) & CD8(+) T cell responses were measured by flow cytometry. Full body computed tomography (CT) and structured necropsies were performed on day 42. Comorbidities including reduced lung volume (kyphosis), masses, abscesses, etc. were assessed using a standard scoring system (1-21) and mice with scores >= 5 were considered to have important comorbidities. Results Overall, 53.3% of the animals had significant comorbidities. Three weeks post-boost, HI and MN titres were mostly undetectable but ELISA titres were significantly higher in the H1-VLP animals compared to the IIV group (GMT (95% CI): 961 (427, 2163) vs 425 (200, 903): p = 0.03). Both CD4(+)(TNF alpha, IFN gamma) and CD8(+) (IFN gamma) T cell responses were also greater in the H1-VLP group than the IIV. Conclusions Even in very old mice with comorbidities, the plant-made H1-VLP vaccine elicited a stronger and more balanced immune response than IIV. Animals with fewer comorbidities tended to have the better composite (humoral and cellular) responses. These novel vaccines have the potential to address some of the limitations of the limitations of current vaccines in the elderly.	[Hodgins, Breanna] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Pillet, Stephane; Ward, Brian James] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Pillet, Stephane; Landry, Nathalie; Ward, Brian James] Medicago Inc, Quebec City, PQ, Canada	McGill University; McGill University	Ward, BJ (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.; Ward, BJ (corresponding author), Medicago Inc, Quebec City, PQ, Canada.	brian.ward@mcgill.ca		Ward, Brian/0000-0003-3251-958X; Hodgins, Breanna/0000-0002-7744-4377	Canadian Institutes of Health Research [34469]; Medicago Inc; Ministere des Finances et de l'Economie du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medicago Inc; Ministere des Finances et de l'Economie du Quebec	This work was supported in part by a Canadian Institutes of Health Research grant to BJW (#34469) and an academic-industry team award led by BJW that was co-funded by Medicago Inc and the Ministere des Finances et de l'Economie du Quebec with project oversight by Genome Quebec. The funders had no direct role in study design, data collection and analysis or decision to publish. NL is an employee at Medicago Inc. and both SP and BJW receive partial salary support from Medicago Inc. The company also provided research materials and other 'in-kind' support for the work. The specific roles of these authors are articulated in the 'author contributions' section.	BRONSON RT, 1993, AGING-CLIN EXP RES, V5, P253, DOI 10.1007/BF03324169; Cai MY, 2017, ACTA BIOCH BIOPH SIN, V49, P74, DOI 10.1093/abbs/gmw118; Centers for Disease Control and Prevention NCfIaRDN, 2017, INFL FLU WHAT YOU SH; Combadiere B, 2010, Pathol Biol (Paris), V58, pe79, DOI 10.1016/j.patbio.2010.01.010; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; DiazGranados CA, 2015, VACCINE, V33, P4565, DOI 10.1016/j.vaccine.2015.07.003; FAGIOLO U, 1993, AGING-CLIN EXP RES, V5, P451, DOI 10.1007/BF03324202; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hendin HE, 2017, VACCINE, V35, P2592, DOI 10.1016/j.vaccine.2017.03.058; Hodgins B, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00273-17; Landry N, 2014, CLIN IMMUNOL, V154, P164, DOI 10.1016/j.clim.2014.08.003; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Makarkov AI, 2017, VACCINE, V35, P4629, DOI 10.1016/j.vaccine.2017.07.012; McElhaney JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00041; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202; Piccirillo JF, 2008, CRIT REV ONCOL HEMAT, V67, P124, DOI 10.1016/j.critrevonc.2008.01.013; Pillet S, 2015, VACCINE, V33, P6282, DOI 10.1016/j.vaccine.2015.09.065; Pillet S, 2016, CLIN IMMUNOL, V168, P72, DOI 10.1016/j.clim.2016.03.008; Ren ZG, 2015, VIRUS RES, V200, P9, DOI 10.1016/j.virusres.2015.01.007; RODERICK TH, 1961, SCIENCE, V134, P48, DOI 10.1126/science.134.3471.48; Roghani T, 2017, AGING CLIN EXP RES, V29, P567, DOI 10.1007/s40520-016-0617-3; Stadlbauer D, 2017, FRONT MED-PRC, V11, P471, DOI 10.1007/s11684-017-0602-z; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sukoff Rizzo Stacey J, 2018, Curr Protoc Mouse Biol, V8, pe45, DOI 10.1002/cpmo.45; Trucchi C, 2015, J Prev Med Hyg, V56, pE37; Valkenburg SA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01479; Ward BJ, 2018, HUM VACC IMMUNOTHER, V14, P647, DOI 10.1080/21645515.2017.1413518; Weinberger B, 2012, CLIN MICROBIOL INFEC, V18, P100, DOI 10.1111/j.1469-0691.2012.03944.x; Xia SJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8426874; Yam KK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00207; Yam KK, 2013, CLIN VACCINE IMMUNOL, V20, P459, DOI 10.1128/CVI.00619-12; Young B, 2017, VACCINE, V35, P212, DOI 10.1016/j.vaccine.2016.11.013; Young KR, 2015, FASEB J, V29, P3817, DOI 10.1096/fj.15-270421	36	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210009	10.1371/journal.pone.0210009	http://dx.doi.org/10.1371/journal.pone.0210009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629622	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000040
J	Popping, S; Hullegie, SJ; Boerekamps, A; Rijnders, BJA; de Knegt, RJ; Rockstroh, JK; Verbon, A; Boucher, CAB; Nichols, BE; van de Vijver, DAMC				Popping, Stephanie; Hullegie, Sebastiaan J.; Boerekamps, Anne; Rijnders, Bart J. A.; de Knegt, Robert J.; Rockstroh, Juergen K.; Verbon, Annelies; Boucher, Charles A. B.; Nichols, Brooke E.; van de Vijver, David A. M. C.			Early treatment of acute hepatitis C infection is cost-effective in HIV-infectedmen-who-have-sex-with-men	PLOS ONE			English	Article							REAL-WORLD EFFECTIVENESS; DIRECT-ACTING ANTIVIRALS; VIRUS-INFECTION; GENOTYPE 1; HEPATOCELLULAR-CARCINOMA; PREEXPOSURE PROPHYLAXIS; REINFECTION INCIDENCE; POSITIVE MEN; INJECT DRUGS; HCV	Background Treatment of hepatitis C virus infections (HCV) with direct acting antivirals (DAA) can prevent new infections since cured individuals cannot transmit HCV. However, as DAAs are expensive, many countries defer treatment to advances stages of fibrosis, which results in ongoing transmission. We assessed the epidemiological impact and cost-effectiveness of treatment initiation in different stages of infection in the Netherlands where the epidemic is mainly concentrated among HIV-infected MSMs. Methods We calibrated a deterministic mathematical model to the Dutch HCV epidemic among HIV-infected MSM to compare three different DAA treatment scenarios: 1) immediate treatment, 2) treatment delayed to chronic infection allowing spontaneous clearance to occur, 3) treatment delayed until F2 fibrosis stage. All scenarios are simulated from 2015 onwards. Total costs, quality adjusted life years (QALY), incremental cost-effectiveness ratios (ICERs), and epidemiological impact were calculated from a providers perspective over a lifetime horizon. We used a DAA price of (sic)35,000 and 3% discounting rates for cost and QALYs. Results Immediate DAA treatment lowers the incidence from 1.2/100 person-years to 0.2/100 person-years (interquartile range 0.1-0.2) and the prevalence from 5.0/100 person-years to 0.5/100 person-years (0.4-0.6) after 20 years. Delayed treatment awaiting spontaneous clearance will result in a similar reduction. However, further delayed treatment to F2 will increases the incidence and prevalence. Earlier treatment will cost society (sic)68.3 and (sic)75.1 million over a lifetime for immediate and awaiting until the chronic stage, respectively. The cost will increase if treatment is further delayed until F2 to (sic)98.4 million. Immediate treatment will prevent 7070 new infections and gains 3419 (3019-3854) QALYs compared to F2 treatment resulting in a cost saving ICER. Treatment in the chronic stage is however dominated. Conclusions Early DAA treatment for HIV-infected MSM is an excellent and sustainable tool to meet the WHO goal of eliminating HCV in 2030.	[Popping, Stephanie; Boucher, Charles A. B.; Nichols, Brooke E.; van de Vijver, David A. M. C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Hullegie, Sebastiaan J.; Boerekamps, Anne; Rijnders, Bart J. A.; Verbon, Annelies] Erasmus MC, Dept Internal Med & Infect Dis, Rotterdam, Netherlands; [de Knegt, Robert J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Rockstroh, Juergen K.] Bonn Univ Hosp, Dept Internal Med, Bonn, Germany; [Nichols, Brooke E.] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Bonn; Boston University	Popping, S (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	s.popping@erasmusmc.nl	Nichols, Brooke E./V-5496-2019; De Knegt, Robert/X-4629-2019; rijnders, bart/AAB-2868-2019	Nichols, Brooke E./0000-0003-4682-4999; De Knegt, Robert/0000-0003-0934-6975; rijnders, bart/0000-0003-3343-9610; van de Vijver, David/0000-0001-5877-8526	Gilead Sciences [NL-2018-000171, 215001269]; Gilead [215001269, IN-NL-987-4558/4652/4653]; MSD [SDD 343462, MSD IISA11/jul/2015]; ViiV Healthcare [14-0614-ViiV]; Janssen [771290]; Boehringer [S14064/32844]	Gilead Sciences(Gilead Sciences); Gilead(Gilead Sciences); MSD; ViiV Healthcare; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer(Boehringer Ingelheim)	Stephanie Popping: reports funding in the form of a unrestricted educational grant by Gilead Sciences [NL-2018-000171] and grants from Gilead [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], and Janssen [771290]. Bart J.A. Rijnders: reports grants from MSD [MSD IISA11/jul/2015], Gilead [IN-NL-987-4558/4652/4653] and honoraria from Jansen-Cilag, BMS, Pfizer and Viiv Robert J. de Knegt: Reports honoraria for consulting or speaking (last 5 years): AbbVie, BMS, Gilead, Janssen-Cilag, Merck/MSD, and Roche. Jurgen K. Rockstroh: reports honaria for lectures and/or consultancies from Abbott, AbbVie, Bionor, BMS, Cipla, Gilead, Janssen, Merck, Roche, Viiv Charles A.B. Boucher: reports grants from Gilead sciences [NL-2018-000171] and [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], Janssen [771290], and Boehringer [S14064/32844]]. David A.M.C. van de Vijver: reports grants from Gilead sciences [NL-2018-000171] and [215001269], MSD [SDD 343462], ViiV Healthcare [14-0614-ViiV], and Janssen [771290].	AASLD- IDSA, 2017, REC TEST MAN TREAT H; Annemans L., 2008, HLTH EC NONECONOMICS; [Anonymous], 2017, J HEPATOL, V66, P153, DOI DOI 10.1016/j.jhep.2016.09.001; Ard van Sighem LG, 2014, MONITORING REPORT 20; Backus LI, 2016, HEPATOLOGY, V64, P405, DOI 10.1002/hep.28625; Berenguer J, 2018, HEPATOLOGY; Blaxhult A, 2014, INT J STD AIDS, V25, P493, DOI 10.1177/0956462413515192; Boerekamps A, 2018, CLIN INFECT DIS, V66, P1360, DOI 10.1093/cid/cix1007; Boersma C, 2010, VALUE HEALTH, V13, P853, DOI 10.1111/j.1524-4733.2010.00736.x; Bourliere M, 2017, NEW ENGL J MED, V376, P2134, DOI 10.1056/NEJMoa1613512; Bruins BJ, 2017, DEN HAAG; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Cotte L, 2018, LIVER INT; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Forns X, 2017, LANCET INFECT DIS; Gowda C, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy076; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Hoornenborg E, 2017, AIDS, V31, P1603, DOI 10.1097/QAD.0000000000001522; Hullegie SJ, 2016, J HEPATOL, V64, P807, DOI 10.1016/j.jhep.2015.12.004; Hullegie SJ, 2015, CLIN MICROBIOL INFEC; Hullegie SJ, 2015, J HEPATOL, P62; Ingiliz P, 2017, J HEPATOL, V66, P282, DOI 10.1016/j.jhep.2016.09.004; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Leyten, 2016, CLIN MICROBIOL INFEC, V22, P209; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Mantovani LG, 2016, HEPATOLOGY; Marshall AD, 2018, LANCET GASTROENTEROL, V3, P125, DOI 10.1016/S2468-1253(17)30284-4; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Martin NK, 2016, CLIN INFECT DIS; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mcgreal-bellone SC A., 2012, PHS60 HLTH RELATED Q, V15, pA528; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Midgard H, 2016, J HEPATOL, V65, pS33, DOI 10.1016/j.jhep.2016.07.012; Newsum AM, 2018, SEX TRANSM DIS; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Nichols BE, 2014, JAIDS-J ACQ IMM DEF, V66, P221, DOI 10.1097/QAI.0000000000000145; Pardo M, 2007, J VIRAL HEPATITIS, V14, P36, DOI 10.1111/j.1365-2893.2006.00783.x; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Popping BENS, 2016, INTERNSIVE HEPATITIS; ROSE KA, 1991, J FORECASTING, V10, P117, DOI 10.1002/for.3980100108; Ryom L., 2017, EACS GUID 9 0 2017; Salazar-Vizcaya L, 2016, HEPATOLOGY, V64, P1856, DOI 10.1002/hep.28769; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Scott N, 2016, J GASTROEN HEPATOL, V31, P872, DOI 10.1111/jgh.13223; Sighem A, 2014, MONITORING REPORT 20; Smith DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1807-5; Tan SS, 2012, INT J TECHNOL ASSESS, V28, P152, DOI 10.1017/S0266462312000062; Tapper EB, 2017, J VIRAL HEPATITIS, V24, P22, DOI 10.1111/jvh.12611; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Santen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163488; Van Sighem A, 2015, HIV MONITORING REPOR; van Sighemea A., 2016, HIV MONITORING REPOR; van-Sighem A, 2013, MONITORING REPORT 20; Vanhommerig JW, 2014, JAIDS-J ACQ IMM DEF, V66, pE111, DOI 10.1097/QAI.0000000000000208; Virlogeux V, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0979-1; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; WHO, 2017, WHO PUBLISHES LIST B; Zorginstituut Nederland, 2015, KOST PRAKT DIEM	67	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210179	10.1371/journal.pone.0210179	http://dx.doi.org/10.1371/journal.pone.0210179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629662	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000058
J	Bastin, L; Gorelick, N; Saura, S; Bertzky, B; Dubois, G; Fortin, MJ; Pekel, JF				Bastin, Lucy; Gorelick, Noel; Saura, Santiago; Bertzky, Bastian; Dubois, Gregoire; Fortin, Marie-Josee; Pekel, Jean-Francois			Inland surface waters in protected areas globally: Current coverage and 30-year trends	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LONG-TERM; CONSERVATION; BIODIVERSITY; THREATS; PERFORMANCE; STRATEGIES; DIVERSITY; TARGETS; WETLAND	Inland waters are unique ecosystems offering services and habitat resources upon which many species depend. Despite the importance of, and threats to, inland water, global assessments of protected area (PA) coverage and trends have focused on land habitats or have assessed land and inland waters together. We here provide the first assessment of the level of protection of inland open surface waters and their trends (1984-2015) within PAs for all countries, using a globally consistent, high-resolution (30 m) and validated dataset on permanent and seasonal surface waters based on Landsat images. Globally, 15% of inland surface waters are covered by PAs with mapped boundaries. Estimated inland water protection increases to 16.4% if PAs with reported area but delineated only as points are included as circular buffers. These coverage estimates slightly exceed the comparable figure for land but fall below the 17% goal of the Convention on Biological Diversity's Aichi Target 11 for 2020. Protection levels are very uneven across countries, half of which do not yet meet the 17% target. The lowest coverage of surface water by PAs (<5%) was found in Africa and in parts of Asia. There was a global trend of permanent water losses and seasonal water gains within PAs, concomitant with an increase of both water types outside PAs. In 38% of countries, PAs lost over 5% of permanent water. Global protection targets for inland waters may well be met by 2020, but much stronger efforts are required to ensure their effective conservation, which will depend not only on sound PA governance and management but also on the sustainable use of water resources outside PAs. Given the pressures on water in a rapidly changing world, integrated management planning of water resources involving multiple sectors and entire basins is therefore necessary.	[Bastin, Lucy; Saura, Santiago; Bertzky, Bastian; Dubois, Gregoire; Pekel, Jean-Francois] European Commiss, Joint Res Ctr, Ispra, VA, Italy; [Bastin, Lucy] Aston Univ, Dept Comp Sci, Birmingham, W Midlands, England; [Gorelick, Noel] Google Inc, Zurich, Switzerland; [Fortin, Marie-Josee] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	European Commission Joint Research Centre; EC JRC ISPRA Site; Aston University; Google Incorporated; University of Toronto	Bastin, L (corresponding author), European Commiss, Joint Res Ctr, Ispra, VA, Italy.; Bastin, L (corresponding author), Aston Univ, Dept Comp Sci, Birmingham, W Midlands, England.	lucy.bastin@ec.europa.eu	Bastin, Lucy/ABD-2663-2021; Bastin, Lucy/ABE-1099-2021; Saura, Santiago/A-9994-2008; Dubois, Gregoire/AAM-6513-2020; Bertzky, Bastian/I-6909-2013	Bastin, Lucy/0000-0003-1321-0800; Bastin, Lucy/0000-0003-1321-0800; Saura, Santiago/0000-0002-5239-0763; Dubois, Gregoire/0000-0002-0515-7168; Bertzky, Bastian/0000-0001-7025-4733; Gorelick, Noel/0000-0002-5548-2436				Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Abell R, 2017, CONSERV LETT, V10, P384, DOI 10.1111/conl.12312; Adams VM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0274; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; [Anonymous], 2016, WORLD DAT PROT AR WD; [Anonymous], 2012, GLOB ADM AR GADM VER; Barnes MD, 2018, NAT ECOL EVOL, V2, P759, DOI 10.1038/s41559-018-0501-y; Britton AW, 2017, BIOL CONSERV, V212, P120, DOI 10.1016/j.biocon.2017.06.001; Brooks EGE, 2016, GLOBAL ECOL BIOGEOGR, V25, P553, DOI 10.1111/geb.12435; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; CBD, 2010, 10 M C PART CONV BIO; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Dixon MJR, 2016, BIOL CONSERV, V193, P27, DOI 10.1016/j.biocon.2015.10.023; Dodds WK, 2013, ENVIRON SCI TECHNOL, V47, P9061, DOI 10.1021/es4021052; Dubois G, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5120242; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Harrison IJ, 2016, AQUAT CONSERV, V26, P103, DOI 10.1002/aqc.2652; Hermoso V, 2016, AQUAT CONSERV, V26, P3, DOI 10.1002/aqc.2681; IUCN WCPA, 2018, DRAFT GUID REC REP O; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Juffe-Bignoli D, 2016, AQUAT CONSERV, V26, P133, DOI 10.1002/aqc.2638; Lantz V, 2013, REG ENVIRON CHANGE, V13, P939, DOI 10.1007/s10113-012-0393-3; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; Markert KN, 2018, RESULTS PHYS, V9, P275, DOI 10.1016/j.rinp.2018.02.054; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; Moilanen A, 2014, BIOL CONSERV, V170, P188, DOI 10.1016/j.biocon.2014.01.001; Nel JL, 2007, DIVERS DISTRIB, V13, P341, DOI 10.1111/j.1472-4642.2007.00308.x; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; Pekel JF, 2014, REMOTE SENS ENVIRON, V140, P704, DOI 10.1016/j.rse.2013.10.008; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pittock J, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P569; Rayfield B, 2008, BIOL CONSERV, V141, P438, DOI 10.1016/j.biocon.2007.10.013; Saura S, 2018, BIOL CONSERV, V219, P53, DOI 10.1016/j.biocon.2017.12.020; Saura S, 2017, ECOL INDIC, V76, P144, DOI 10.1016/j.ecolind.2016.12.047; Tognelli MF, 2017, FRESHWATER KEY BIODI; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Visconti P, 2013, CONSERV BIOL, V27, P1000, DOI 10.1111/cobi.12095; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Watson JEM, 2016, CONSERV BIOL, V30, P243, DOI 10.1111/cobi.12645; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; World Wildlife Fund, 2018, PADDDTRACKER TRACK P	48	27	27	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210496	10.1371/journal.pone.0210496	http://dx.doi.org/10.1371/journal.pone.0210496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653553	Green Accepted, gold, Green Published			2022-12-27	WOS:000456015500043
J	Campolo, M; Siracusa, R; Cordaro, M; Filippone, A; Gugliandolo, E; Peritore, AF; Impellizzeri, D; Crupi, R; Paterniti, I; Cuzzocrea, S				Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Filippone, Alessia; Gugliandolo, Enrico; Peritore, Alessio F.; Impellizzeri, Daniela; Crupi, Rosalia; Paterniti, Irene; Cuzzocrea, Salvatore			The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; URINARY-BLADDER; MAST-CELL; PALMITOYLETHANOLAMIDE ANALOG; INFLAMMATORY RESPONSE; NEUROTROPHIC FACTOR; FUNCTIONAL HISTORY; UNITED-STATES; MANAGEMENT; MODEL	The disruption of coordinated control between the brain, spinal cord and peripheral nervous system caused by spinal cord injury (SCI) leads to several secondary pathological conditions, including lower urinary tract dysfunction. In fact, urinary tract dysfunction associated with SCI is urinary dysfunction could be a consequence of a lack of neuroregeneration of supraspinal pathways that control bladder function. The object of the current research was to explore the effects of adelmidrol + sodium hyaluronate, on bladder damage generated after SCI in mice. Spinal cord was exposed via laminectomy, and SCI was induced by extradural compression at T6 to T7 level, by an aneurysm clip with a closing force of 24 g. Mice were treated intravesically with adelmidrol + sodium hyaluronate daily for 48 h and 7 days after SCI. Adelmidrol + sodium hyaluronate reduced significantly mast cell degranulation and down-regulated the nuclear factor-kappa B pathway in the bladder after SCI both at 48 h and 7days. Moreover, adelmidrol + sodium hyaluronate reduced nerve growth factor expression, suggesting an association between neurotrophins and bladder pressure. At 7 days after SCI, the bladder was characterized by a marked bacterial infection and proteinuria; surprisingly, adelmidrol + sodium hyaluronate reduced significantly both parameters. These data show the protective roles of adelmidrol + sodium hyaluronate on bladder following SCI, highlighting a potential therapeutic target for the reduction of bladder changes.	[Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Filippone, Alessia; Gugliandolo, Enrico; Peritore, Alessio F.; Impellizzeri, Daniela; Crupi, Rosalia; Paterniti, Irene; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Saint Louis University	Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	salvator@unime.it	Gugliandolo, Enrico/AAB-9972-2019; Crupi, Rosalia/U-4364-2019; Campolo, Michela/K-6432-2016; Filippone, Alessia/AAC-3679-2022; Cordaro, Marika/K-7329-2016; Siracusa, Rosalba/AAC-3110-2022; Peritore, Alessio/HGB-1327-2022; Cuzzocrea, Salvatore/K-4734-2016	Gugliandolo, Enrico/0000-0001-6840-3154; Filippone, Alessia/0000-0002-9642-6844; Cordaro, Marika/0000-0002-3980-0043; Siracusa, Rosalba/0000-0001-7868-2505; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690; peritore, alessio filippo/0000-0001-8545-990X; Impellizzeri, Daniela/0000-0001-9492-3161; Crupi, Rosalia/0000-0002-7629-3132				Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; ALOE L, 1993, AGENTS ACTIONS, V39, pC145, DOI 10.1007/BF01972748; Ambrozaitis K, 2005, MED LITH, V42, P255; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bloemen-Vrencken JHA, 2005, DISABIL REHABIL, V27, P1381, DOI 10.1080/09638280500164685; Cameron AP, 2010, J UROLOGY, V184, P213, DOI 10.1016/j.juro.2010.03.008; Cerrato S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-230; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Cruz CD, 2011, THESCIENTIFICWORLDJO, V11, P214, DOI 10.1100/tsw.2011.26; De Filippis D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-3; De Filippis D, 2009, J CELL MOL MED, V13, P1086, DOI 10.1111/j.1582-4934.2008.00353.x; de Jong BWD, 2008, NEUROUROL URODYNAM, V27, P454, DOI 10.1002/nau.20567; de Jong BWD, 2007, BJU INT, V100, P846, DOI 10.1111/j.1464-410X.2007.07046.x; DEGROAT WC, 1990, CIBA F SYMP, V151, P27; Di Paola R, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1189-5; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Fehlings MG, 2005, INJURY, V36, P113, DOI 10.1016/j.injury.2005.06.022; Forner S, 2012, BRIT J PHARMACOL, V167, P1737, DOI 10.1111/j.1476-5381.2012.02127.x; Gamper M, 2015, J UROLOGY, V193, P1994, DOI 10.1016/j.juro.2015.01.036; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; Howard PS, 2004, NEUROUROL URODYNAM, V23, P374, DOI 10.1002/nau.20032; Impellizzeri D, 2016, BIOCHEM PHARMACOL, V119, P27, DOI 10.1016/j.bcp.2016.09.001; Impellizzeri D, 2015, IMMUNOBIOLOGY, V220, P1039, DOI 10.1016/j.imbio.2015.05.013; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Janzen J, 1998, NEUROUROL URODYNAM, V17, P525; Janzen J, 2001, SPINAL CORD, V39, P568, DOI 10.1038/sj.sc.3101218; Juszczak K, 2009, J PHYSIOL PHARMACOL, V60, P85; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; KRUSE MN, 1995, J AUTONOM NERV SYST, V54, P215, DOI 10.1016/0165-1838(95)00011-L; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Mastrofrancesco A, 2010, EXP DERMATOL, V19, P813, DOI 10.1111/j.1600-0625.2010.01107.x; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Ostardo E, 2018, PHARMACOL RES, V134, P16, DOI 10.1016/j.phrs.2018.05.013; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Pulvirenti N, 2007, ACTA DERMATOVENER CR, V15, P80; Rahnama'i MS, 2018, NEUROUROL URODYNAM, V37, pS99, DOI 10.1002/nau.23493; Reis LO, 2011, ACTA CIR BRAS, V26, P106, DOI 10.1590/S0102-86502011000800019; Rickard A, 2008, IN VITRO CELL DEV-AN, V44, P261, DOI 10.1007/s11626-008-9116-y; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; SANT GR, 1994, UROL CLIN N AM, V21, P41; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wada N, 2018, NEUROUROL URODYNAM, V37, P1889, DOI 10.1002/nau.23539; Wada N, 2017, NEUROUROL URODYNAM, V36, P1301, DOI 10.1002/nau.23120; Wang XC, 2000, J UROLOGY, V163, P993, DOI 10.1016/S0022-5347(05)67870-6; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0208730	10.1371/journal.pone.0208730	http://dx.doi.org/10.1371/journal.pone.0208730			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653511	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500009
J	Drak, D; Barratt, H; Templeton, DJ; O'Connor, CC; Gracey, DM				Drak, Douglas; Barratt, Hamish; Templeton, David J.; O'Connor, Catherine C.; Gracey, David M.			Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; KIDNEY-FUNCTION; MEN; EXPOSURE; ASSOCIATION; ADHERENCE	Background Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) significantly reduces the risk of HIV acquisition. TDF is a known nephrotoxin however, renal dysfunction from TDF is mostly reversible following discontinuation. Aims To describe the renal function, risk factors for renal disease and associated clinical testing practices in a cohort of PrEP patients. Methods A retrospective review was conducted of all PrEP patients commenced on TDF/FTC at an inner metropolitan sexual health clinic in Sydney, Australia between April 2016 and July 2017, with follow-up data obtained at 3-monthly intervals until 18 months. Results 525 patients met inclusion criteria. Patients were almost exclusively male and median age was 34 years (IQR: 28 to 42). At baseline, 1.5% had an estimated glomerular filtration rate (eGFR) < 70 mL/min/1.73m(2). A small significant drop in eGFR of -2.5 mL/min/1.73m(2) (p<0.05) occurred between PrEP commencement and the first follow-up period, followed by a progressive decline in eGFR of -0.38 mL/min/1.73m(2) per month (95% CI: -0.57 to -0.20; p<0.001). Renal impairment (eGFR < 70 mL/min/1.73m(2)) occurred in 6.5% of patients and persisted across consecutive follow-up periods in five (1.0%) patients. Patients aged. 40 years had a greater risk of renal impairment than younger patients (HR 3.9, 95% CI: 1.8 to 8.4; p<0.001), despite similar rates of eGFR decline (p = 0.19). PrEP was discontinued in two patients (0.4%) due to renal function concerns. Conclusion PrEP use led to an initial drop in eGFR and a more gradual progressive decline subsequently, but significant renal impairment remained uncommon up to 18 months of follow-up.	[Drak, Douglas; Barratt, Hamish] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Barratt, Hamish; Templeton, David J.; O'Connor, Catherine C.; Gracey, David M.] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia; [Templeton, David J.; O'Connor, Catherine C.] RPA Sexual Hlth, Sydney, NSW, Australia; [Templeton, David J.; O'Connor, Catherine C.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Gracey, David M.] Royal Prince Alfred Hosp, Renal Unit, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; Kirby Institute; University of Sydney	Drak, D (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	douglas.drak@sydney.edu.au		Templeton, David/0000-0003-2157-9587				Gandhi M, 2016, LANCET HIV, V3, pE521, DOI 10.1016/S2352-3018(16)30153-9; Glidden DV, 2016, CLIN INFECT DIS, V62, P1172, DOI 10.1093/cid/ciw022; Health N, 2016, PREEXP PROPH HIV ANT, P42; Kakar S, 2017, NEPHROLOGY, V22, P174, DOI 10.1111/nep.12844; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugwanya K, 2016, J INFECT DIS, V214, P1050, DOI 10.1093/infdis/jiw125; Mugwanya KK, 2016, JAIDS-J ACQ IMM DEF, V71, P374, DOI 10.1097/QAI.0000000000000868; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P1996, DOI 10.2215/CJN.00360114; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Solomon MM, 2014, AIDS, V28, P851, DOI 10.1097/QAD.0000000000000156; Suzuki S, 2017, AIDS PATIENT CARE ST, V31, P105, DOI 10.1089/apc.2016.0286; Tang EC, 2018, JAIDS-J ACQ IMM DEF, V77, P193, DOI 10.1097/QAI.0000000000001566; Wright E., 2018, J VIRUS ERAD, V2018, P143; Zablotska IB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5018-9; Zablotska IB, 2017, CURR HIV-AIDS REP, V14, P201, DOI 10.1007/s11904-017-0367-7	21	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210106	10.1371/journal.pone.0210106	http://dx.doi.org/10.1371/journal.pone.0210106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653509	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500026
J	Olivier, M; Bouaoun, L; Villar, S; Robitaille, A; Cahais, V; Heguy, A; Byrnes, G; Calvez-Kelm, F; Torres-Mejia, G; Alvarado-Cabrero, I; Imani-Razavi, FS; Sanchez, GI; Jaramillo, R; Porras, C; Rodriguez, AC; Garmendia, M; Soto, J; Romieu, I; Porter, P; Guenthoer, J; Rinaldi, S; Biessy, C; Olivier, M; Rinaldi, S; Romieu, I; Bustamante, E; Gaete, F; Garmendia, ML; Soto, J; Angel, A; Ossa, CA; Arias, WH; Bedoya, G; Borrero, M; Cock-Rada, A; Diaz-Yunez, I; Echeverri, C; Herazo, F; Hernandez, A; Jaramillo, R; Navarro, E; Cortes, YR; Sanchez, GI; Cortes, B; Gonzalez, P; Guillen, D; Loria, V; Ocampo, R; Porras, C; Rodriguez, AC; Torres-Meija, G; Angeles-Llerenas, A; Tejeda, J; Porter, P; Rodriguez, AC				Olivier, Magali; Bouaoun, Liacine; Villar, Stephanie; Robitaille, Alexis; Cahais, Vincent; Heguy, Adriana; Byrnes, Graham; Le Calvez-Kelm, Florence; Torres-Mejia, Gabriela; Alvarado-Cabrero, Isabel; Shahram Imani-Razavi, Fazlollah; Ines Sanchez, Gloria; Jaramillo, Roberto; Porras, Carolina; Cecilia Rodriguez, Ana; Luisa Garmendia, Maria; Luis Soto, Jose; Romieu, Isabelle; Porter, Peggy; Guenthoer, Jamie; Rinaldi, Sabina; Biessy, Carine; Olivier, Magali; Rinaldi, Sabina; Romieu, Isabelle; Bustamante, Eva; Gaete, Fancy; Luisa Garmendia, Maria; Soto, Jose; Angel, Alberto; Andres Ossa, Carlos; Arias, William H.; Bedoya, Gabriel; Borrero, Mauricio; Cock-Rada, Alicia; Diaz-Yunez, Israel; Echeverri, Carolina; Herazo, Fernando; Hernandez, Angel; Jaramillo, Roberto; Navarro, Edgar; Rodas Cortes, Yorlany; Sanchez, Gloria I.; Cortes, Bernal; Gonzalez, Paula; Guillen, Diego; Loria, Viviana; Ocampo, Rebecca; Porras, Carolina; Cecilia Rodriguez, Ana; Torres-Meija, Gabriela; Angeles-Llerenas, Angelica; Tejeda, Jenny; Porter, Peggy; Rodriguez, Ana Cecilia		PRECAMA Team	Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study	PLOS ONE			English	Article							MUTATIONAL PROCESSES; THERAPY; REVEALS; SIGNATURES; PORTRAITS; LANDSCAPE; EVOLUTION; DATABASE; PATTERN; GENES	Background In Latin America (LA), there is a high incidence rate of breast cancer (BC) in premenopausal women, and the genomic features of these BC remain unknown. Here, we aim to characterize the molecular features of BC in young LA women within the framework of the PRECAMA study, a multicenter population-based case-control study of BC in premenopausal women. Methods Pathological tumor tissues were collected from incident cases from four LA countries. Immunohistochemistry (IHC) was performed centrally for ER, PR, HER2, Ki67, EGFR, CK5/6, and p53 protein markers. Targeted deep sequencing was done on genomic DNA extracted from formalin-fixed, paraffin-embedded tumor tissues and their paired blood samples to screen for somatic mutations in eight genes frequently mutated in BC. A subset of samples was analyzed by exome sequencing to identify somatic mutational signatures. Results The majority of cases were positive for ER or PR (168/233; 72%), and 21% were triple-negative (TN), mainly of basal type. Most tumors were positive for Ki67 (189/233; 81%). In 126 sequenced cases, TP53 and PIK3CA were the most frequently mutated genes (32.5% and 21.4%, respectively), followed by AKT1 (9.5%). TP53 mutations were more frequent in HER2-enriched and TN IHC subtypes, whereas PIK3CA/AKT1 mutations were more frequent in ER-positive tumors, as expected. Interestingly, a higher proportion of G:C>T:A mutations was observed in TP53 in PRECAMA cases compared with TCGA and METAB-RIC BC series (27% vs 14%). Exome-wide mutational patterns in 10 TN cases revealed alterations in signal transduction pathways and major contributions of mutational signatures caused by altered DNA repair pathways. Conclusions These pilot results on PRECAMA tumors give a preview of the molecular features of premenopausal BC in LA. Although the overall mutation burden was as expected from data in other populations, mutational patterns observed in TP53 and exome-wide suggested possible differences in mutagenic processes giving rise to these tumors compared with other populations. Further-omics analyses of a larger number of cases in the near future will enable the investigation of relationships between these molecular features and risk factors.	[Olivier, Magali; Villar, Stephanie; Robitaille, Alexis; Cahais, Vincent] Int Agcy Res Canc, Sect Mech Carcinogenesis, Lyon, France; [Bouaoun, Liacine; Byrnes, Graham] Int Agcy Res Canc, Sect Environm & Radiat, Lyon, France; [Heguy, Adriana] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA; [Heguy, Adriana] NYU, Langone Med Ctr, Genome Technol Ctr, New York, NY USA; [Le Calvez-Kelm, Florence] Int Agcy Res Canc, Genet Canc Susceptibil Grp, Lyon, France; [Torres-Mejia, Gabriela] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Alvarado-Cabrero, Isabel] Hosp Oncol, Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Dept Pathol, Mexico City, DF, Mexico; [Shahram Imani-Razavi, Fazlollah] UMAE Hosp Gineco Obstetricia 4 Luis Castelazo Aya, Inst Mexicano Seguro Social, Dept Pathol, Mexico City, DF, Mexico; [Ines Sanchez, Gloria] Univ Antioquia, Sch Med, Grp Infect & Canc, Medellin, Colombia; [Jaramillo, Roberto] Hemato Oncologos, Cali, Colombia; [Porras, Carolina; Cecilia Rodriguez, Ana] Fdn INCIENSA, ACIB, San Jose, Costa Rica; [Luisa Garmendia, Maria] Inst Nutr & Tecnol Aliment, Santiago, Chile; [Luis Soto, Jose] Natl Inst Canc, Santiago, Chile; [Romieu, Isabelle; Rinaldi, Sabina] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France; [Porter, Peggy] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Guenthoer, Jamie] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Universidad de Antioquia; World Health Organization; International Agency for Research on Cancer (IARC); Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Olivier, M (corresponding author), Int Agcy Res Canc, Sect Mech Carcinogenesis, Lyon, France.	olivierm@iarc.fr	Heguy, Adriana/GPP-3907-2022; Bustamante, Eva/AAI-9717-2021; Lechuga, Edgar Navarro/ABB-2780-2021; Garmendia, Maria Luisa MLG/H-7417-2013; Sanchez, Gloria I./AAX-3080-2020; Rodríguez, Ana/GQR-0554-2022; OLIVIER, Magali/G-3728-2010	Garmendia, Maria Luisa MLG/0000-0002-0589-6091; Sanchez, Gloria Ines/0000-0001-5992-0475; Arias, William/0000-0002-2543-4855; Alvarado-Cabrero, Isabel/0000-0003-4000-9280; OLIVIER, Magali/0000-0002-8202-342X; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Byrnes, Graham/0000-0003-3893-7539	International Agency for Research on Cancer (IARC); Union for International Cancer Control (UICC); Pan American Health Organization (PAHO); Ibero-American Programme for the Development of Science and Technology (CYTED); COLCIENCIAS [1115-569-348899]; CODI-Universidad de Antioquia [CPT-1229]	International Agency for Research on Cancer (IARC)(World Health Organization); Union for International Cancer Control (UICC); Pan American Health Organization (PAHO); Ibero-American Programme for the Development of Science and Technology (CYTED); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CODI-Universidad de Antioquia	The study is funded by the International Agency for Research on Cancer (IARC), the Union for International Cancer Control (UICC), the Pan American Health Organization (PAHO), the Ibero-American Programme for the Development of Science and Technology (CYTED), COLCIENCIAS (grant no 1115-569-348899), CODI-Universidad de Antioquia (grant CPT-1229).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Amadou A, 2014, SALUD PUBLICA MEXICO, V56, P547; Ardin M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1011-z; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen B, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0522-4; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeMarini DM, 2001, CANCER RES, V61, P6679; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-654; Huo DZ, 2017, JAMA ONCOL, V3, P1654, DOI 10.1001/jamaoncol.2017.0595; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Liao S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0618-8; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Olivier Magali, 2004, IARC Sci Publ, P247; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Porter PL, 2009, SALUD PUBLICA MEXICO, V51, pS141, DOI 10.1590/s0036-36342009000800003; Regan M, 2015, BREAST CANCER RES TR, V154, P275, DOI 10.1007/s10549-015-3612-z; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rummel SK, 2017, BREAST CANCER RES TR, V164, P593, DOI 10.1007/s10549-017-4291-8; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Vaca-Paniagua F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126762; Vaught JB, 2010, CANCER EPIDEM BIOMAR, V19, P912, DOI 10.1158/1055-9965.EPI-10-0058; Viel A, 2017, EBIOMEDICINE, V20, P39, DOI 10.1016/j.ebiom.2017.04.022; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Yamashita H, 2015, WORLD J CLIN ONCOL, V6, P220, DOI 10.5306/wjco.v6.i6.220	47	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210372	10.1371/journal.pone.0210372	http://dx.doi.org/10.1371/journal.pone.0210372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653559	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500036
J	Samelko, L; Caicedo, MS; Jacobs, J; Hallab, NJ				Samelko, Lauryn; Caicedo, Marco S.; Jacobs, Joshua; Hallab, Nadim James			Transition from metal-DTH resistance to susceptibility is facilitated by NLRP3 inflammasome signaling induced Th17 reactivity: Implications for orthopedic implants	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TOTAL HIP-ARTHROPLASTY; IN-VITRO; T-CELLS; CYTOKINE PRODUCTION; MONONUCLEAR-CELLS; INTERFERON-GAMMA; ADVERSE-REACTION; IMMUNE-RESPONSE; NICKEL RELEASE	Metal hypersensitivity has been recognized as an adverse biologic reaction that can compromise total joint arthroplasty (TJA) performance. However, the etiology of metal hypersensitivity responses in TJAs remains unclear. Metal implant debris is known to act as a danger signal that drives NLRP3 inflammasome activation. It remains unknown if implant debris induced inflammasome activation regulates T cell lineage in TJA metal hypersensitivity responses. In this study, we show both in vivo and in vitro that the pathogenesis of metal hypersensitivity responses to implant debris are largely dependent on activation of the inflammasome/caspase-1 pathway and subsequent production of IL-17A/F by CD4+ T cells. Inhibiting either the inflammasome pathway or IL-17A bioactivity in vivo and in vitro (in vivo using NLRP3 and Caspase-1 deficient mice or in vitro using blocking agents such as Capase-1 inhibitor, IL-1Ra and anti-IL-17A), significantly (p<0.05) mitigated metal-DTH paw inflammation as well as lymphocyte cytokine (IFN-gamma and IL-17) and proliferation responses in metal-sensitized mice and primary human PBMCs. This study provides mechanistic insight into how in vivo exposure to orthopedic implant debris, and metals in general, elicits NLRP3 inflammasome activation that mediates the generation of IL-17A/F producing CD4+ T cells, leading to metal-delayed type hypersensitivity reactions.	[Samelko, Lauryn; Caicedo, Marco S.; Jacobs, Joshua; Hallab, Nadim James] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Rush University	Hallab, NJ (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	nhallab@rush.edu		Hallab, Nadim/0000-0001-6421-2836	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR060782]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (https://www.niams.nih.gov/), and was received by corresponding author NJH, grant number: AR060782. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroukatos P, 2010, CLIN ORTHOP RELAT R, V468, P2135, DOI 10.1007/s11999-009-1187-x; Ashrin MN, 2014, J IMMUNOL, V192, P4025, DOI 10.4049/jimmunol.1300276; Atkinson SM, 2016, DIS MODEL MECH, V9, P427, DOI 10.1242/dmm.022905; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett WP, 2012, J ARTHROPLASTY, V27, P976, DOI 10.1016/j.arth.2012.01.019; BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x; Bechara R, 2017, J INVEST DERMATOL, V137, P2140, DOI 10.1016/j.jid.2017.05.025; BENSON MKD, 1975, BRIT MED J, V4, P374, DOI 10.1136/bmj.4.5993.374; Borg L, 2000, ARCH DERMATOL RES, V292, P285, DOI 10.1007/s004030000129; BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004; Caicedo MS, 2013, J ORTHOP RES, V31, P1633, DOI 10.1002/jor.22411; Caicedo MS, 2010, J BIOMED MATER RES A, V93A, P1312, DOI 10.1002/jbm.a.32627; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; CARLSSON AS, 1980, ACTA ORTHOP SCAND, V51, P57, DOI 10.3109/17453678008990769; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245, DOI 10.3109/17453677708988763; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; DEUTMAN R, 1977, J BONE JOINT SURG AM, V59, P862, DOI 10.2106/00004623-197759070-00004; Dyring-Andersen B, 2013, CONTACT DERMATITIS, V68, P339, DOI 10.1111/cod.12043; Falsafi-Amin H, 2000, INT ARCH ALLERGY IMM, V123, P170, DOI 10.1159/000024437; Ferber IA, 1996, J IMMUNOL, V156, P5; FISCHER T, 1984, ACTA DERM-VENEREOL, V64, P121; FISHER AA, 1977, CUTIS, V19, P285; GAWKRODGER DJ, 1993, CONTACT DERMATITIS, V28, P257, DOI 10.1111/j.1600-0536.1993.tb03427.x; Hallab NJ, 2013, J ORTHOP RES, V31, P173, DOI 10.1002/jor.22214; Hallab Nadim James, 2008, J Orthop Surg Res, V3, P6, DOI 10.1186/1749-799X-3-6; Hallab NJ, 2010, J BIOMED MATER RES A, V92A, P667, DOI 10.1002/jbm.a.32368; Hallab NJ, 2004, J ARTHROPLASTY, V19, P88, DOI 10.1016/j.arth.2004.09.012; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; HAUDRECHY P, 1994, CONTACT DERMATITIS, V31, P249, DOI 10.1111/j.1600-0536.1994.tb01997.x; He D, 2006, J IMMUNOL, V177, DOI [10.1002/art.22453, DOI 10.1002/ART.22453]; Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P1171, DOI 10.2106/JBJS.F.00453; Jakobson E, 2002, BRIT J DERMATOL, V147, P442, DOI 10.1046/j.1365-2133.2002.04850.x; KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x; Kitchen CMR, 2009, AM J OPHTHALMOL, V147, P571, DOI 10.1016/j.ajo.2008.06.031; KONDO S, 1995, J INVEST DERMATOL, V105, P334, DOI 10.1111/1523-1747.ep12320329; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; KUBBA R, 1981, ARCH DERMATOL, V117, P554, DOI 10.1001/archderm.117.9.554; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Kwon YM, 2010, J ORTHOP RES, V28, P444, DOI 10.1002/jor.21015; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Lee YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176484; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; LIDEN C, 1994, ACTA DERM-VENEREOL, V74, P341; Liden C, 1995, SKIN, P447; Marshall D, 2014, J IMMUNOL, V193, P5525, DOI 10.4049/jimmunol.1402144; MAYOR MB, 1980, AM J SURG, V139, P477, DOI 10.1016/0002-9610(80)90323-2; Merritt K, 1996, CLIN ORTHOP RELAT R, P71; MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8; MERRITT K, 1981, INT J DERMATOL, V20, P89, DOI 10.1111/j.1365-4362.1981.tb00408.x; Milosev I, 2006, J BONE JOINT SURG AM, V88A, P1173, DOI 10.2106/JBJS.E.00604; Minang JT, 2006, CLIN EXP IMMUNOL, V146, P417, DOI 10.1111/j.1365-2249.2006.03226.x; Mishra PK, 2011, J IMMUNOL, V187, P6491, DOI 10.4049/jimmunol.1101392; Morwood MP, 2015, J SHOULDER ELB SURG, V24, P1156, DOI 10.1016/j.jse.2015.01.015; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Perry MJ, 1995, BRIT J RHEUMATOL, V34, P1127; PINKSTON JA, 1979, STAIN TECHNOL, V54, P233, DOI 10.3109/10520297909110677; Reito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147872; Reito A, 2014, INT ORTHOP, V38, P2251, DOI 10.1007/s00264-014-2429-4; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROOKER GD, 1980, J BONE JOINT SURG BR, V62, P502, DOI 10.1302/0301-620X.62B4.7430234; Samelko L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160141; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Shornick LP, 2001, CELL IMMUNOL, V211, P105, DOI 10.1006/cimm.2001.1834; Summer B, 2010, CONTACT DERMATITIS, V63, P15, DOI 10.1111/j.1600-0536.2010.01744.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Thomas P, 2009, ALLERGY, V64, P1157, DOI 10.1111/j.1398-9995.2009.01966.x; TORGERSEN S, 1995, EUR J ORAL SCI, V103, P46, DOI 10.1111/j.1600-0722.1995.tb00010.x; Vermeire K, 1997, J IMMUNOL, V158, P5507; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	77	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210336	10.1371/journal.pone.0210336	http://dx.doi.org/10.1371/journal.pone.0210336			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653583	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500035
J	Covy, N; Benedict, L; Keeley, WH				Covy, Nora; Benedict, Lauryn; Keeley, William H.			Rock climbing activity and physical habitat attributes impact avian community diversity in cliff environments	PLOS ONE			English	Article							BIRD COMMUNITIES; CONSERVATION VALUE; NATIONAL-PARK; VEGETATION	As the sport of outdoor rock climbing rapidly grows, there is increasing pressure to understand how it can affect communities of organisms in cliff habitats. To that end, we surveyed 32 cliff sites in Boulder, Colorado, USA, and assessed the relative roles of human recreation and natural habitat features as drivers of bird diversity and activity. We detected only native avian species during our observations. Whereas avian abundance was not affected by climbing, avian species diversity and community conservation value were higher at low-use climbing formations. Models indicated that climber presence and cliff aspect were important predictors of both avian diversity and avian cliff use within our study area, while long-term climbing use frequency has a smaller, but still negative association with conservation value and cliff use by birds in the area. In contrast, the diversity of species on the cliff itself was not affected by any of our measured factors. To assess additional community dynamics, we surveyed vegetation and arthropods at ten site pairs. Climbing negatively affected lichen communities, but did not significantly affect other vegetation metrics or arthropods. We found no correlations between avian diversity and diversity of either vegetation or arthropods. Avian cliff use rate was positively correlated with arthropod biomass. We conclude that while rock climbing is associated with lower community diversity at cliffs, some common cliff-dwelling birds, arthropods and plants appear to be tolerant of climbing activity. An abiotic factor, cliff aspect strongly affected patterns of both avian diversity and cliff use, suggesting that the negative effects of rock climbing may be mitigated by informed management of cliff habitat that considers multiple site features.	[Covy, Nora; Benedict, Lauryn] Univ Northern Colorado, Sch Biol Sci, Greeley, CO USA; [Keeley, William H.] City Boulder Open Space & Mt Pk, Boulder, CO USA	University of Northern Colorado	Covy, N (corresponding author), Univ Northern Colorado, Sch Biol Sci, Greeley, CO USA.	nora.covy@gmail.com			City of Boulder Open Space and Mountain Parks; Colorado Field Ornithologists; Boulder County Nature Association; University of Northern Colorado, School of Biological Sciences	City of Boulder Open Space and Mountain Parks; Colorado Field Ornithologists; Boulder County Nature Association; University of Northern Colorado, School of Biological Sciences	This research was funded by: City of Boulder Open Space and Mountain Parks (NC) - Boulder OSMP representative William Keeley approved study design, provided spatial information on wildlife closures and rock climbing routes as well as rock climbing usage ratings, and assisted with review of final manuscript, https://bouldercolorado.gov/osmp; Colorado Field Ornithologists (NC) - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, https://cobirds.org/; Boulder County Nature Association (NC) - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, http://www.bcna.org/; University of Northern Colorado, School of Biological Sciences (NC) - Nora Covy and Lauryn Benedict are both affiliated with this department, http://www.unco.edu/nhs/biology/.	Adams MD, 2012, BOTANY, V90, P253, DOI 10.1139/B11-109; [Anonymous], 2008, AVIAN CONSERVATION A; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Brambilla M, 2004, ARDEOLA, V51, P425; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Camp RJ, 1998, WILDLIFE SOC B, V26, P892; Camp RJ, 1998, CONSERV BIOL, V12, P1302, DOI 10.1046/j.1523-1739.1998.97363.x; Clark P, 2015, APPL VEG SCI, V18, P705, DOI 10.1111/avsc.12172; Colorado Department of Transportation, 2009, HYDR STREAMS GIS DAT; Cruz A, 2004, EFFECTS FOREST MANAG; Cseke J., 2015, OSMP TRAIHEADS GIS D; Cseke J., 2015, OSMP TRAILS GIS DATA; DOBKIN DS, 1986, CONDOR, V88, P252, DOI 10.2307/1368926; ESRI, TOP BAS BAS SCAL NOT; Evanoff E, GEOLOGY TRAILS W NCA; Farris MA, 1998, CAN J BOT, V76, P1981, DOI 10.1139/b98-178; Federal Emergency Management Agency, 2013, BOULD DEMS; Fraterrigo JM, 2005, LANDSCAPE URBAN PLAN, V71, P263, DOI 10.1016/S0169-2046(04)00080-5; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; Gruner Daniel S., 2003, Pacific Science, V57, P325, DOI 10.1353/psc.2003.0021; Gutzwiller KJ, 1998, CONDOR, V100, P519, DOI 10.2307/1369718; Haas J., 2009, CLIMBING BOULDERS FL; Heil L, 2006, AVIAN RESPONSES TOUR, P183; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hogan T., 1995, REPORT VEGETATION FL; HOLM S, 1979, SCAND J STAT, V6, P65; Holzman R., 2013, EFFECTS ROCK CLIMBER; Jones L., 2008, 10 ROCK FACES CLIMB; Jones S., 1990, MANAGING BOULDER MOU; KNIGHT S., 1964, U COLORADO MUSEUM LE, V13, P1; Krajick K, 1999, SCIENCE, V283, P1623, DOI 10.1126/science.283.5408.1623; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067304; Larson D.W., 2000, CAMBRIDGE STUDIES EC; Larson DW, 2000, J BIOGEOGR, V27, P319, DOI 10.1046/j.1365-2699.2000.00401.x; Lenth BA, 2006, CONSERV BIOL, V20, P1445, DOI 10.1111/j.1523-1739.2006.00491.x; Matheson JD, 1998, CAN J ZOOL, V76, P278, DOI 10.1139/cjz-76-2-278; McMillan MA, 2002, CONSERV BIOL, V16, P389, DOI 10.1046/j.1523-1739.2002.00377.x; Merkle WW, 2002, RECREATIONAL TRAIL U; Nicholoff SH, 2003, SPECIALIZED HABITATS; Nuttle T, 2003, AUK, V120, P541, DOI 10.1642/0004-8038(2003)120[0541:ACVOBC]2.0.CO;2; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Rossi LG, 2006, NAT AREA J, V26, P331, DOI 10.3375/0885-8608(2006)26[331:CAABCI]2.0.CO;2; The Outdoor Foundation, 2013, OUTD PART REP; United States Department of Agriculture Natural Resources Conservation Service, 2016, 274014901 NC  US DEP; Wachob DG, 1996, CONDOR, V98, P114, DOI 10.2307/1369514; WARD JP, 1988, J WILDLIFE MANAGE, V52, P673, DOI 10.2307/3800930; Warning N, 2015, WILSON J ORNITHOL, V127, P395; Warning N, 2015, AM MIDL NAT, V174, P150, DOI 10.1674/0003-0031-174.1.150; Weisberg PJ, 2014, ACTA OECOL, V59, P72, DOI 10.1016/j.actao.2014.06.002; West Virginia Department of Natural Resources, 2015, STAT WILDL ACT PLAN; Wolf ID, 2013, J ENVIRON MANAGE, V129, P224, DOI 10.1016/j.jenvman.2013.07.017; Wood KT, 2006, J PARK RECREAT ADM, V24, P86	52	11	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209557	10.1371/journal.pone.0209557	http://dx.doi.org/10.1371/journal.pone.0209557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650086	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300017
J	Gejo, NG; Weldearegay, HG; Tinsaie, KTW; Mekango, DE; Woldemichael, ES; Buda, AS; Dinsa, LH; Alemayehu, M; Goba, G				Gejo, Negeso Gebeyehu; Weldearegay, Haftom Gebrehiwot; Tinsaie, Kidisti Tesfay W.; Mekango, Dejene Ermias; Woldemichael, Ermias Sahile; Buda, Alula Seyum; Dinsa, Leta Hinkosa; Alemayehu, Mussie; Goba, Gelila			Exclusive breastfeeding and associated factors among HIV positive mothers in Northern Ethiopia	PLOS ONE			English	Article								Background It is estimated that sub-optimal feeding, especially non-exclusive breastfeeding in the first 6months of life, results in 1.4million deaths and 10% of disease burden in children younger than five years. Worldwide, it is estimated that only 34.8% of infants are exclusively breastfed for the first 6months of life, the majority receiving some other food or fluid in the early months. Besides, the Ethiopian demographic and health survey (2016) stated that the median duration of exclusive breastfeeding in Tigray region was 3.8 months which is shorter than the recommended duration. The main purpose of this study was to determine the magnitude of exclusive breastfeeding practice and associated factors among HIV positive mothers in public hospitals of Tigray region, Northern Ethiopia. Methods A facility based cross-sectional study was conducted from July 9 to October 11, 2016, in public hospitals of Tigray region. Data was collected by using structured questionnaire using face-to-face interview among 304 eligible women through a systematic sampling technique. Data was analyzed using SPSS version 20.0. Binary and multiple variable logistic regressions ("odds ratio") analyses were calculated with 95% CI and p value <= 0.05 as significance were used. Result Two hundred seventy (88.8%) of mothers practiced exclusive breastfeeding for the first six months of life. Infant feeding counseling during antenatal care of last pregnancy [AOR = 6.9, 95% CI; 2.63, 17.99], knowledge on exclusive breastfeeding (AOR = 5.5, 95% CI; (2.12, 14.02] and attitude towards exclusive breastfeeding [AOR = 7.9; 95% CI; 2.96, 21.21] had significant association with exclusive breastfeeding practice. Conclusions A high proportion of mothers practiced exclusive breastfeeding for the first six months of life. Infant feeding counseling, knowledge and attitude towards exclusive breastfeeding practice were the predictors of exclusive breastfeeding among HIV positive mothers. Strengthening infant feeding counseling during antenatal care and improving mothers' knowledge and attitude on exclusive breastfeeding is essential.	[Gejo, Negeso Gebeyehu] Wachemo Univ, Dept Midwifery, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Weldearegay, Haftom Gebrehiwot; Tinsaie, Kidisti Tesfay W.] Mekelle Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia; [Mekango, Dejene Ermias] Wachemo Univ Hosanna, Dept Publ Hlth, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Woldemichael, Ermias Sahile] Mizan Tepi Univ, Dept Midwifery, Coll Med & Hlth Sci, Mizan, Ethiopia; [Buda, Alula Seyum] Wachemo Univ, Dept Nursing, Coll Med & Hlth Sci, Hosanna, Ethiopia; [Dinsa, Leta Hinkosa] Wollega Univ, Dept Midwifery, Coll Med & Hlth Sci, Nekemte, Ethiopia; [Alemayehu, Mussie] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Goba, Gelila] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	Mekelle University; Mekelle University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gejo, NG (corresponding author), Wachemo Univ, Dept Midwifery, Coll Med & Hlth Sci, Hosanna, Ethiopia.	negiyeman@gmail.com	Alemayehu, Mussie/AAH-3016-2019	Alemayehu, Mussie/0000-0002-0035-631X; Dinsa, Leta Hinkosa Dinsa/0000-0003-2691-7071; Woldemichael, Ermias/0000-0001-9200-7098				Aishat U, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.309.6498; Bekere A, 2014, J NUTR FOOD SCI, V4, P6, DOI DOI 10.4172/2155-9600.1000319; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Federal ministry of health Ethiopia (FMOH) and ICF,, 2016, ETH DEM HLTH SURV 20; Fletcher FE, 2008, THEOR MED BIOETH, V29, P307, DOI 10.1007/s11017-008-9083-z; Girma Y A, 2014, J HIV AIDS INFECT DI, V2; Hiwot A H, 2014, INT J PHARMA SCI RES, V5; Hunt DP, 2003, J INTELLECTUAL CAPIT, V4; Maru Y H., 2009, ETHIOP J HLTH DEV, V23; Modjo KE, 2015, AM J HLTH RES, V3, P105, DOI DOI 10.11648/J.AJHR.20150302.18; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Onono MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-390; UNAIDS, 2020, GLOB HIV AIDS STAT F; UNICEF data, 2006, PROGR CHILDR REP CAR; World Health Organization, 2008, IND ASS INF YOUNG CH; Yalcin SS, 2016, PAEDIATR PERINAT EP, V30, P439, DOI 10.1111/ppe.12305; Zewdu MD A., 2014, AFRICAN J MIDWIFERY, V8	17	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210782	10.1371/journal.pone.0210782	http://dx.doi.org/10.1371/journal.pone.0210782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650156	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300077
J	Kadir, A; Shenoda, S; Goldhagen, J				Kadir, Ayesha; Shenoda, Sherry; Goldhagen, Jeffrey			Effects of armed conflict on child health and development: A systematic review	PLOS ONE			English	Review							INCOME COUNTRIES RISK; REFUGEE CHILDREN; PEDIATRIC TRAUMA; MORTALITY-RATES; MENTAL-HEALTH; GULF-WAR; UNEXPLODED ORDNANCE; CIVIL-WAR; PSYCHOSOCIAL ADJUSTMENT; MILITARY DEPLOYMENT	Background Armed conflicts affect more than one in 10 children globally. While there is a large literature on mental health, the effects of armed conflict on children's physical health and development are not well understood. This systematic review summarizes the current and past knowledge on the effects of armed conflict on child health and development. Methods A systematic review was performed with searches in major and regional databases for papers published 1 January 1945 to 25 April 2017. Included studies provided data on physical and/or developmental outcomes associated with armed conflict in children under 18 years. Data were extracted on health outcomes, displacement, social isolation, experience of violence, orphan status, and access to basic needs. The review is registered with PROSPERO: CRD42017036425. Findings Among 17,679 publications screened, 155 were eligible for inclusion. Nearly half of the 131 quantitative studies were case reports, chart or registry reviews, and one-third were cross-sectional studies. Additionally, 18 qualitative and 6 mixed-methods studies were included. The papers describe mortality, injuries, illnesses, environmental exposures, limitations in access to health care and education, and the experience of violence, including torture and sexual violence. Studies also described conflict-related social changes affecting child health. The geographical coverage of the literature is limited. Data on the effects of conflict on child development are scarce. Interpretation The available data document the pervasive effect of conflict as a form of violence against children and a negative social determinant of child health. There is an urgent need for research on the mechanisms by which conflict affects child health and development and the relationship between physical health, mental health, and social conditions. Particular priority should be given to studies on child development, the long term effects of exposure to conflict, and protective and mitigating factors against the harmful effects of armed conflict on children.	[Kadir, Ayesha] Malmo Univ, Malmo Inst Studies Migrat Divers & Welf, Malmo, Sweden; [Kadir, Ayesha] Med Sans Frontieres, Geneva, Switzerland; [Shenoda, Sherry; Goldhagen, Jeffrey] Univ Florida, Coll Med, Div Community & Societal Pediat, Jacksonville, FL USA	Malmo University; Doctors Without Borders; State University System of Florida; University of Florida	Kadir, A (corresponding author), Malmo Univ, Malmo Inst Studies Migrat Divers & Welf, Malmo, Sweden.; Kadir, A (corresponding author), Med Sans Frontieres, Geneva, Switzerland.	kadira@gmail.com	Kadir, Ayesha/AGB-1054-2022		University of Florida-Jacksonville College of Medicine; University of Florida-Jacksonville	University of Florida-Jacksonville College of Medicine; University of Florida-Jacksonville(University of Florida)	The University of Florida-Jacksonville College of Medicine provided partial funding for the study. There was no additional external funding received for this study.; The University of Florida-Jacksonville provided partial funding for this work. The authors are indebted to Gretchen Kuntz for her assistance in developing and refining the searches, using Covidence, and obtaining full text papers. Several others also assisted in location of papers, including Jeremy Nagle (Science 2 Enquiry Desk, The British Library), Khalid Kadir, and Gonca Yilmaz, for which we are very grateful. Several individuals assisted in translation of papers to English, including Birte Kadir, Saadoon Kadir, Natalya Ustinova, Krzyzstof Karski, Raul Mercer, Vanya Petrovic, and Giuseppe Annunziata. Without their assistance, such a thorough review would not have been possible. Finally, we wish to thank Sham Lal and Michael Fahmi for support in the critical appraisal of two papers with complex methodological design.	Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; Abushaban L, 2004, INT J CARDIOL, V93, P157, DOI 10.1016/S0167-5273(03)00193-1; AMITAI Y, 1992, JAMA-J AM MED ASSOC, V268, P630, DOI 10.1001/jama.268.5.630; [Anonymous], 1995, Lancet, V345, P339; [Anonymous], 2016, UPPS CONFL DAT PROGR; [Anonymous], 2016, REP ATT HLTH CAR EM; Araneta MRG, 2003, BIRTH DEFECTS RES A, V67, P246, DOI 10.1002/bdra.10033; ASCHERIO A, 1992, NEW ENGL J MED, V327, P931, DOI 10.1056/NEJM199209243271306; Attanayake Vindya, 2009, Med Confl Surviv, V25, P4, DOI 10.1080/13623690802568913; Avogo WA, 2010, SOC SCI MED, V70, P53, DOI 10.1016/j.socscimed.2009.09.057; Barisic N, 1999, PEDIATR NEUROL, V21, P450, DOI 10.1016/S0887-8994(99)00027-2; Barnes VA, 2007, MIL MED, V172, P40, DOI 10.7205/MILMED.172.1.40; Barry MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-835; Battersby A, 2018, CHILD CARE HLTH DEV, V44, P161, DOI 10.1111/cch.12485; Bayarogullari H, 2016, CHILD NERV SYST, V32, P2233, DOI 10.1007/s00381-016-3075-5; Bertani A, 2015, ORTHOP TRAUMATOL-SUR, V101, P365, DOI 10.1016/j.otsr.2015.02.003; Betancourt TS, 2008, COMP EDUC REV, V52, P565, DOI 10.1086/591298; Betancourt TS, 2013, J CHILD PSYCHOL PSYC, V54, P17, DOI 10.1111/j.1469-7610.2012.02620.x; Betancourt TS, 2010, CHILD DEV, V81, P1077, DOI 10.1111/j.1467-8624.2010.01455.x; Bilukha OO, 2008, PREHOSP DISASTER MED, V23, P493, DOI 10.1017/S1049023X00006300; Bilukha OO, 2006, JAMA-J AM MED ASSOC, V296, P516, DOI 10.1001/jama.296.5.516-b; Bilukha OO, 2011, INJURY PREV, V17, P326, DOI 10.1136/ip.2010.030312; Bilukha OO, 2005, BMJ-BRIT MED J, V330, P127, DOI 10.1136/bmj.38337.361782.82; Bilukha OO, 2003, JAMA-J AM MED ASSOC, V290, P650, DOI 10.1001/jama.290.5.650; Bodalal Z, 2014, E MEDITERR HEALTH J, V20, P175, DOI 10.26719/2014.20.3.175; Bogdanovich U, 1946, VRACHEBNOYE DIELO, V3-4, P166; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Borgman MA, 2015, PEDIATR CRIT CARE ME, V16, pE23, DOI 10.1097/PCC.0000000000000307; Bosnjak J, 2002, EPILEPSY BEHAV, V3, P502, DOI 10.1016/S1525-5050(02)00602-9; Bronstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056156; Bronstein I, 2011, CLIN CHILD FAM PSYCH, V14, P44, DOI 10.1007/s10567-010-0081-0; Busby C, 2010, INT J ENV RES PUB HE, V7, P2828, DOI 10.3390/ijerph7072828; Celikel A, 2015, J FORENSIC LEG MED, V34, P1, DOI 10.1016/j.jflm.2015.04.021; Ceri V, 2016, NEUROPSYCHIATRIE, V30, P145, DOI 10.1007/s40211-016-0195-9; Charchuk R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1479-z; Chi PC, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0045-z; Chironna M, 2001, Int J Infect Dis, V5, P209, DOI 10.1016/S1201-9712(01)90073-6; Chironna M, 2003, INFECTION, V31, P70, DOI 10.1007/s15010-002-3100-3; Choonara Imti, 2013, Med Confl Surviv, V29, P93; Cliff J, 1997, TROP MED INT HEALTH, V2, P1068, DOI 10.1046/j.1365-3156.1997.d01-178.x; Cohn J, 1979, Ugeskr Laeger, V141, P3431; Cook TL, 2015, BMC INT HEALTH HUM R, P1, DOI [10.1186/s12914-015-0041-3, DOI 10.1186/S12914-015-0041-3]; Coppola CP, 2006, ARCH PEDIAT ADOL MED, V160, P972, DOI 10.1001/archpedi.160.9.972; Cowan DN, 1997, NEW ENGL J MED, V336, P1650, DOI 10.1056/NEJM199706053362306; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; CURLIN GT, 1976, POP STUD-J DEMOG, V30, P87, DOI 10.1080/00324728.1976.10412722; de Smedt J, 1998, AFRICA, V68, P211, DOI 10.2307/1161279; Deeb M, 1997, INT J EPIDEMIOL, V26, P110, DOI 10.1093/ije/26.1.110; Denov M, 2017, CHILD ABUSE NEGLECT, V65, P255, DOI 10.1016/j.chiabu.2017.02.014; Denov M, 2010, INT SOC WORK, V53, P791, DOI 10.1177/0020872809358400; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Devanarayana NM, 2010, J TROP PEDIATRICS, V56, P144, DOI 10.1093/tropej/fmp077; Di Maio M, 2013, J DEV ECON, V100, P107, DOI 10.1016/j.jdeveco.2012.08.007; Dickson-Gomez J, 2002, ETHOS, V30, P327, DOI 10.1525/eth.2002.30.4.327; Dupuy K., 2017, TRENDS ARMED CONFLIC; Duque V, 2017, SSM-POPUL HLTH, V3, P121, DOI 10.1016/j.ssmph.2016.09.012; Edwards MJ, 2014, J TRAUMA ACUTE CARE, V76, P854, DOI 10.1097/TA.0b013e3182aa2e66; Edwards MJ, 2012, J TRAUMA ACUTE CARE, V73, P1278, DOI 10.1097/TA.0b013e318270d3ee; Eide M, 2010, PEDIATRICS, V126, P22, DOI 10.1542/peds.2009-2704; Elbert T, 2009, CHILD ABUSE NEGLECT, V33, P238, DOI 10.1016/j.chiabu.2008.02.008; Erjavec K, 2010, J ADOLESCENT RES, V25, P359, DOI 10.1177/0743558410361373; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Feldman R, 2013, DEV PSYCHOPATHOL, V25, P943, DOI 10.1017/S0954579413000291; Fouad FM, 2017, LANCET, V390, P2516, DOI 10.1016/S0140-6736(17)30741-9; Garfield R, 2000, INT J EPIDEMIOL, V29, P510, DOI 10.1093/ije/29.3.510; Gasparovic H, 2004, ANN THORAC SURG, V77, P1083, DOI 10.1016/S0003-4975(03)01221-9; Gataa IS, 2011, INT J ORAL MAX SURG, V40, P65, DOI 10.1016/j.ijom.2010.07.005; Geltman PL, 2005, ARCH PEDIAT ADOL MED, V159, P585, DOI 10.1001/archpedi.159.6.585; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; Ghobarah HA, 2004, SOC SCI MED, V59, P869, DOI 10.1016/j.socscimed.2003.11.043; Global Coalition to Protect Education from Attack (GCPEA), 2021, SAF SCH DECL INTG PO; Green Crystal, 2007, Pediatr Nurs, V33, P267; Greene JM, 2014, ANN THORAC SURG, V97, P1788, DOI 10.1016/j.athoracsur.2013.07.115; Grein T, 2003, BRIT MED J, V327, P650, DOI 10.1136/bmj.327.7416.650; Guha-Sapir D, 2004, DISASTERS, V28, P418, DOI 10.1111/j.0361-3666.2004.00267.x; Guha-Sapir D, 2003, LANCET, V361, P2126, DOI 10.1016/S0140-6736(03)13691-4; Guha-Sapir D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4736; Guy Kitwe Mulunda, 2009, Torture, V19, P137; Hagopian A, 2010, AM J PUBLIC HEALTH, V100, P1081, DOI 10.2105/AJPH.2009.164236; Halileh S, 2006, J TROP PEDIATRICS, V52, P12, DOI 10.1093/tropej/fmi045; HALLORAN ME, 1989, AM J PUBLIC HEALTH, V79, P424, DOI 10.2105/AJPH.79.4.424; Hanevik K, 2000, BRIT MED J, V321, P1189, DOI 10.1136/bmj.321.7270.1189; Helweg-Larsen K, 2004, SCAND J PUBLIC HEALT, V32, P17, DOI 10.1080/14034940310018048; Hemat H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165270; Henrich CC, 2013, J AM ACAD CHILD PSY, V52, P619, DOI 10.1016/j.jaac.2013.02.016; Hicks MHR, 2011, LANCET, V378, P906, DOI 10.1016/S0140-6736(11)61023-4; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hisle-Gorman E, 2015, J AM ACAD CHILD PSY, V54, P294, DOI 10.1016/j.jaac.2014.12.017; HOFFER MM, 1992, J BONE JOINT SURG AM, V74A, P766, DOI 10.2106/00004623-199274050-00016; Inwald DP, 2014, J ROY ARMY MED CORPS, V160, P236, DOI 10.1136/jramc-2013-000177; Kandala NB, 2009, SOC SCI MED, V68, P1728, DOI 10.1016/j.socscimed.2009.02.004; Khamaysi I, 2015, ENDOSCOPY, V47, pE426, DOI 10.1055/s-0034-1392656; Kinra S, 2003, J EPIDEMIOL COMMUN H, V57, P264, DOI 10.1136/jech.57.4.264; Klimo P, 2015, NEUROSURGERY, V77, P1, DOI 10.1227/NEU.0000000000000743; Klimo P, 2010, J NEUROSURG-PEDIATR, V6, P107, DOI 10.3171/2010.3.PEDS109; Kvaskoff M, 2013, EPIDEMIOLOGY, V24, P261, DOI 10.1097/EDE.0b013e3182806445; Lawn JE, 2016, BEST PRACT RES CL OB, V36, P169, DOI 10.1016/j.bpobgyn.2016.07.004; Lee TJ, 2006, TROP MED INT HEALTH, V11, P1119, DOI 10.1111/j.1365-3156.2006.01651.x; Lindskog EE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3685-6; Liu C, 2014, EUR J EPIDEMIOL, V29, P141, DOI 10.1007/s10654-013-9877-9; Longombe AO, 2008, REPROD HEALTH MATTER, V16, P132, DOI 10.1016/S0968-8080(08)31350-0; Maclure R, 2006, TERROR POLIT VIOLENC, V18, P119, DOI 10.1080/09546550500384801; Mann G, 2010, CHILD SOC, V24, P261, DOI 10.1111/j.1099-0860.2010.00310.x; MANONCOURT S, 1992, LANCET, V340, P176, DOI 10.1016/0140-6736(92)93252-I; Marquardt L, 2016, TROP MED INT HEALTH, V21, P210, DOI 10.1111/tmi.12649; Martin JE, 2010, J NEUROSURG-PEDIATR, V6, P250, DOI 10.3171/2010.6.PEDS1031; Masterson AR, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-25; Mathieu L, 2015, J PEDIATR ORTHOP B, V24, P238, DOI 10.1097/BPB.0000000000000166; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; McGuigan R, 2007, J PEDIATR SURG, V42, P207, DOI 10.1016/j.jpedsurg.2006.09.020; Meiqari L, 2017, EUROPEAN J PEDIAT; Metreveli I T, 1994, Prehosp Disaster Med, V9, P71; Miller LC, 1996, JAMA-J AM MED ASSOC, V276, P370; MOMENI AZ, 1994, INT J DERMATOL, V33, P184, DOI 10.1111/j.1365-4362.1994.tb04977.x; Montgomery E, 2001, EUR J PUBLIC HEALTH, V11, P18, DOI 10.1093/eurpub/11.1.18; Morof Diane F, 2014, Confl Health, V8, P8, DOI 10.1186/1752-1505-8-8; Mujkic A, 2008, ARCH PEDIAT ADOL MED, V162, P140, DOI 10.1001/archpediatrics.2007.31; Murray CJL, 2002, BRIT MED J, V324, P346, DOI 10.1136/bmj.324.7333.346; Nelson Brett D, 2011, Med Confl Surviv, V27, P211, DOI 10.1080/13623699.2011.645148; Nielsen J, 2006, INT J EPIDEMIOL, V35, P438, DOI 10.1093/ije/dyi246; Nnadi C, 2017, MMWR-MORBID MORTAL W, V66, P190, DOI 10.15585/mmwr.mm6607a2; Novo A, 2009, EURO SURVEILL, V14; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Pannell Dylan, 2015, Can J Surg, V58, pS141; Patel SH, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-38; Pearn J, 2003, J PAEDIATR CHILD H, V39, P166, DOI 10.1046/j.1440-1754.2003.00124.x; Pesonen AK, 2008, AM J HUM BIOL, V20, P345, DOI 10.1002/ajhb.20735; Pesonen AK, 2011, INTELLIGENCE, V39, P335, DOI 10.1016/j.intell.2011.06.003; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; Poirier T, 2012, INT J EDUC DEV, V32, P341, DOI 10.1016/j.ijedudev.2011.06.001; Qouta S, 2008, AGGRESSIVE BEHAV, V34, P231, DOI 10.1002/ab.20236; Rabenhorst MM, 2015, CHILD MALTREATMENT, V20, P61, DOI 10.1177/1077559514560625; Radoncic F, 2008, J MATERN-FETAL NEO M, V21, P567, DOI 10.1080/14767050802165935; Radonic V, 2004, MIL MED, V169, P313, DOI 10.7205/MILMED.169.4.313; Rashid J, 2012, INT SOC WORK, V55, P629, DOI 10.1177/0020872812447640; Reed RV, 2012, LANCET, V379, P250, DOI 10.1016/S0140-6736(11)60050-0; Rees S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069207; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; REYNA TM, 1993, J PEDIATR SURG, V28, P209, DOI 10.1016/S0022-3468(05)80277-5; Rieder M, 2012, ARCH DIS CHILD, V97, P59, DOI 10.1136/adc.2009.178186; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Rodriguez C, 2012, DEFENCE PEACE ECON, V23, P161, DOI 10.1080/10242694.2011.597239; Rouhani SA, 2015, PEDIATRICS, V136, pE1195, DOI 10.1542/peds.2014-3373; Saile R, 2014, CHILD ABUSE NEGLECT, V38, P135, DOI 10.1016/j.chiabu.2013.10.007; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Salignon P, 2002, Med Trop (Mars), V62, P433; Samms S, 2010, MIL MED, V175, P926, DOI 10.7205/MILMED-D-09-00221; Santavirta T, 2014, AM J PUBLIC HEALTH, V104, P1759, DOI 10.2105/AJPH.2014.301939; Schiff M, 2006, AM J ADDICTION, V15, P220, DOI 10.1080/10550490600626200; Schiff M, 2007, AM J PUBLIC HEALTH, V97, P1852, DOI 10.2105/AJPH.2006.090514; Schiff M, 2012, SOC SCI MED, V75, P1321, DOI 10.1016/j.socscimed.2012.05.010; Schlecht J, 2013, REPROD HEALTH MATTER, V21, P234, DOI 10.1016/S0968-8080(13)41710-X; Shemyakina O, 2011, J DEV ECON, V95, P186, DOI 10.1016/j.jdeveco.2010.05.002; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; SHUKER S, 1985, J MAXILLOFAC SURG, V13, P70, DOI 10.1016/S0301-0503(85)80019-9; Skokic F, 2006, CROAT MED J, V47, P714; SLIM MS, 1990, PEDIATR SURG INT, V5, P188; Slone M, 2016, CHILD PSYCHIAT HUM D; Soroush AR, 2010, IRAN RED CRESCENT ME, V12, P384; Sphere Project, 2011, SPHER HDB; Spiegel Paul B., 2011, Morbidity and Mortality Weekly Report, V60, P1133; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Stark L, 2015, SOC SCI MED, V146, P173, DOI 10.1016/j.socscimed.2015.10.045; STERN SCM, 1995, LANCET, V346, P183, DOI 10.1016/S0140-6736(95)91241-X; Sullivan K, 2015, JAMA PEDIATR, V169, P922, DOI 10.1001/jamapediatrics.2015.1413; Terzic J, 2001, CROAT MED J, V42, P156; Trenholm J, 2013, MEN MASC, V16, P203, DOI 10.1177/1097184X12470113; UNICEF, 2016, UPR GROW CRIS REF MI; UNICEF, 2015, MOR 1 10 CHILDR LIV; Uppsala Conflict Data Program, 2018, DEF; Valente F, 2000, B WORLD HEALTH ORGAN, V78, P339; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; VAN LEENT J P, 1951, Med J Aust, V1, P673; Veale A, 2003, CHILD ABUSE NEGLECT, V27, P253, DOI 10.1016/S0145-2134(03)00005-X; Verelst A, 2014, CHILD ABUSE NEGLECT, V38, P1139, DOI 10.1016/j.chiabu.2014.04.003; Villamaria CY, 2014, J PEDIATR SURG, V49, P428, DOI 10.1016/j.jpedsurg.2013.10.002; Vrankovic D, 1997, UNFALLCHIRURG, V100, P13, DOI 10.1007/s001130050089; Wagner Z, 2018, LANCET, V392, P857, DOI 10.1016/S0140-6736(18)31437-5; WEILE B, 1990, J DEV BEHAV PEDIATR, V11, P79; Weishut DJN, 2015, REPROD HEALTH MATTER, V23, P71, DOI 10.1016/j.rhm.2015.11.019; Wen WQ, 2000, AM J EPIDEMIOL, V151, P231, DOI 10.1093/oxfordjournals.aje.a010198; Wilson KL, 2013, AM SURGEON, V79, P257; Woods KL, 2012, J ROY ARMY MED CORPS, V158, P34, DOI 10.1136/jramc-158-01-08	183	51	52	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210071	10.1371/journal.pone.0210071	http://dx.doi.org/10.1371/journal.pone.0210071			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650095	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300040
J	Prukop, T; Stenzel, J; Wernick, S; Kungl, T; Mroczek, M; Adam, J; Ewers, D; Nabirotchkin, S; Nave, KA; Hajj, R; Cohen, D; Sereda, MW				Prukop, Thomas; Stenzel, Jan; Wernick, Stephanie; Kungl, Theresa; Mroczek, Magdalena; Adam, Julia; Ewers, David; Nabirotchkin, Serguei; Nave, Klaus-Armin; Hajj, Rodolphe; Cohen, Daniel; Sereda, Michael W.			Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)	PLOS ONE			English	Article							AXONAL LOSS; GENE; NEUROPATHIES; MYELINATION; VARIABILITY; EXPRESSION; SUBTYPES	The most common type of Charcot-Marie-Tooth disease is caused by a duplication of PMP22 leading to dysmyelination, axonal loss and progressive muscle weakness ( CMT1A). Currently, no approved therapy is available for CMT1A patients. A novel polytherapeutic proof-of-principle approach using PXT3003, a low-dose combination of baclofen, naltrexone and sorbitol, slowed disease progression after long-term dosing in adult Pmp22 transgenic rats, a known animal model of CMT1A. Here, we report an early postnatal, short-term treatment with PXT3003 in CMT1A rats that delays disease onset into adulthood. CMT1A rats were treated from postnatal day 6 to 18 with PXT3003. Behavioural, electrophysiological, histological and molecular analyses were performed until 12 weeks of age. Daily oral treatment for approximately 2 weeks ameliorated motor deficits of CMT1A rats reaching wildtype levels. Histologically, PXT3003 corrected the disturbed axon calibre distribution with a shift towards large motor axons. Despite dramatic clinical amelioration, only distal motor latencies were improved and correlated with phenotype performance. On the molecular level, PXT3003 reduced Pmp22 mRNA overexpression and improved the misbalanced downstream PI3K-AKT / MEK-ERK signalling pathway. The improved differentiation status of Schwann cells may have enabled better long-term axonal support function. We conclude that short-term treatment with PXT3003 during early development may partially prevent the clinical and molecular manifestations of CMT1A. Since PXT3003 has a strong safety profile and is currently undergoing a phase III trial in CMT1A patients, our results suggest that PXT3003 therapy may be a bona fide translatable therapy option for children and young adolescent patients suffering from CMT1A.	[Prukop, Thomas; Stenzel, Jan; Wernick, Stephanie; Kungl, Theresa; Mroczek, Magdalena; Adam, Julia; Ewers, David; Nave, Klaus-Armin; Sereda, Michael W.] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Prukop, Thomas] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany; [Nabirotchkin, Serguei; Hajj, Rodolphe; Cohen, Daniel] Pharnext, Issy Les Moulineaux, France; [Sereda, Michael W.] Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen	Sereda, MW (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany.; Sereda, MW (corresponding author), Univ Med Ctr Gottingen, Dept Clin Neurophysiol, Gottingen, Germany.	sereda@em.mpg.de	Mroczek, Magdalena/GNM-7358-2022; Ewers, David/AAG-8478-2021	Mroczek, Magdalena/0000-0002-8731-0540; Ewers, David/0000-0003-1037-1027	German Ministry of Education and Research (BMBF) [FKZ: 01ES0812, FKZ: 01GM1511C, FKZ: 01GM1605]; European Leukodystrophie Society [ELA 2014-020I1]; DFG [SPP1757]; DFG (CNMPB); Pharnext	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Leukodystrophie Society; DFG(German Research Foundation (DFG)); DFG (CNMPB)(German Research Foundation (DFG)); Pharnext	MWS was supported by the German Ministry of Education and Research (BMBF, CMT-BIO, FKZ: 01ES0812, CMT-NET, FKZ: 01GM1511C, CMT-NRG, ERA-NET 'ERARE3', FKZ: 01GM1605). MWS holds a DFG Heisenberg Professorship (SE 1944/1-1). TP was supported by the European Leukodystrophie Society (ELA 2014-020I1 to MWS). KAN is supported by the DFG (SPP1757 and CNMPB) and holds an ERC Advanced Grant. This trial was financially supported by Pharnext who provided support in the form of salaries for authors SN, RH and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Attarian S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0463-6; Attarian S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0199-0; Berciano J, 2009, ADV EXP MED BIOL, V652, P183, DOI 10.1007/978-90-481-2813-6_12; Braathen GJ, 2011, EUR J NEUROL, V18, P39, DOI 10.1111/j.1468-1331.2010.03037.x; Burns J, 2009, NEUROMUSCULAR DISORD, V19, P818, DOI 10.1016/j.nmd.2009.09.007; Chumakov I, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0201-x; Cornett KMD, 2016, JAMA NEUROL, V73, P645, DOI 10.1001/jamaneurol.2016.0171; Fledrich R, 2014, NAT MED, V20, P1055, DOI 10.1038/nm.3664; Fledrich R, 2012, BRIT MED BULL, V102, P89, DOI 10.1093/bmb/lds010; Fledrich R, 2012, BRAIN, V135, P72, DOI 10.1093/brain/awr322; Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x; Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026; Micallef J, 2009, LANCET NEUROL, V8, P1103, DOI 10.1016/S1474-4422(09)70260-1; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Pareyson D, 2014, CURR MOL MED, V14, P1009, DOI 10.2174/1566524014666141010154205; Pareyson D, 2011, LANCET NEUROL, V10, P320, DOI 10.1016/S1474-4422(11)70025-4; PATEL PI, 1990, AM J HUM GENET, V47, P926; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rossor AM, 2016, CURR OPIN NEUROL, V29, P537, DOI 10.1097/WCO.0000000000000373; Rossor Alexander M, 2015, Pract Neurol, V15, P187, DOI 10.1136/practneurol-2015-001095; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Rudnik-Schoneborn S, 2016, CLIN GENET, V89, P34, DOI 10.1111/cge.12594; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Shy ME, 2018, J CLIN INVEST, V128, P110, DOI 10.1172/JCI98617; SKRE H, 1974, CLIN GENET, V6, P98; Sociali G, 2016, NEUROBIOL DIS, V95, P145, DOI 10.1016/j.nbd.2016.07.017; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Verhamme C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-70; Visigalli D, 2016, HUM MUTAT, V37, P98, DOI 10.1002/humu.22921; Yiu EM, 2008, J PERIPHER NERV SYST, V13, P236, DOI 10.1111/j.1529-8027.2008.00182.x; Young P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006052.pub2; Zhao H, 2017, TREE PHYSIOL, V22, P1, DOI DOI 10.1172/JCI96499	40	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209752	10.1371/journal.pone.0209752	http://dx.doi.org/10.1371/journal.pone.0209752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650121	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300025
J	Schweiger, S; Cress, U				Schweiger, Stefan; Cress, Ulrike			Attitude confidence and source credibility in information foraging with social tags	PLOS ONE			English	Article							COLLECTIVE KNOWLEDGE; EPISTEMIC BELIEFS; PUBLIC-ATTITUDES; WEB SEARCH; PSYCHOTHERAPY; METAANALYSIS; INTERNET; PHARMACOTHERAPY; DISORDERS; EFFICACY	There is growing concern that online information searchers are overconfident and therefore largely search for information which reinforces their prior attitudes, blinded by confirmation bias. This study tests if this effect can be reduced in content aggregation platforms, when social tag clouds show popular topics among experts. We manipulated (1) confidence in prior attitudes, and (2) the credibility of the expert community that tagged the content. We found that both factors influence navigation in different ways. First, attitude confidence moderated the influence of prior attitudes when choosing how much attitude-consistent content in blog posts to read. When attitude confidence was high, prior attitudes were positively associated with selection of blog posts, when low, not positively associated. After navigation, when confidence was high, the content of attitude-consistent blog posts was more favourably evaluated, whereas when confidence was low, attitude inconsistent blog posts were more favourably evaluated. Second, source credibility moderated the influence of prior attitudes on tag selection. When source credibility was low, prior attitudes did guide tag selection, when high, they did not. With low source credibility, people selected more attitude-consistent content. The findings advance social tagging theories by showing that not only semantic associations, but also attitudes play a role when people select and process tags and related content. The findings also show that credibility and confidence have a different impact on different stages of information selection and evaluation. Whereas credibility is more important when switching among pages, attitude confidence is more important when reading and evaluating the content of one page.	[Schweiger, Stefan; Cress, Ulrike] Leibniz Inst Wissensmedien, Knowledge Construct Lab, Tubingen, Germany; [Cress, Ulrike] Univ Tubingen, Tubingen, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Schweiger, S (corresponding author), Leibniz Inst Wissensmedien, Knowledge Construct Lab, Tubingen, Germany.	schw.stefan@gmail.com	Cress, Ulrike/AAB-4264-2020; Cress, Ulrike/A-5615-2013	Cress, Ulrike/0000-0002-8996-8303; Cress, Ulrike/0000-0002-8996-8303	Leibniz-Institut fuer Wissensmedien	Leibniz-Institut fuer Wissensmedien	This study was funded by the Leibniz-Institut fuer Wissensmedien. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames M, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P971; Angermeyer MC, 2017, WORLD PSYCHIATRY, V16, P50, DOI 10.1002/wps.20383; Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cress U, 2013, J COMPUT ASSIST LEAR, V29, P235, DOI 10.1111/j.1365-2729.2012.00491.x; Cress U, 2013, COMPUT EDUC, V60, P59, DOI 10.1016/j.compedu.2012.06.015; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; De Maat S, 2006, PSYCHOTHER RES, V16, P562, DOI 10.1080/10503300600756402; Dunning D, 2011, PSYCHOL SCI, V5, P69; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Ferguson AM, 2015, CONSCIOUS COGN, V37, P91, DOI 10.1016/j.concog.2015.08.008; Fisher M, 2015, J EXP PSYCHOL GEN, V144, P674, DOI 10.1037/xge0000070; Fu W, 2013, P SIGCHI C HUM FACT, P2359, DOI [10.1145/2470654.2481326, DOI 10.1145/2470654.2481326]; Fu WT, 2010, ACM T COMPUT-HUM INT, V17, DOI 10.1145/1806923.1806926; Gawronski B, 2011, ADV EXP SOC PSYCHOL, V44, P59, DOI 10.1016/B978-0-12-385522-0.00002-0; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; Heckner M, 2008, P 2008 ACM WORKSH SE, P3, DOI [10.1145/1458583.1458589, DOI 10.1145/1458583.1458589]; Held C, 2012, COMPUT HUM BEHAV, V28, P34, DOI 10.1016/j.chb.2011.08.008; Hosanagar K, 2014, MANAGE SCI, V60, P805, DOI 10.1287/mnsc.2013.1808; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Kammerer Y, 2015, COMPUT HUM BEHAV, V48, P297, DOI 10.1016/j.chb.2015.01.045; Kammerer Y, 2014, INT J HUM-COMPUT INT, V30, P177, DOI 10.1080/10447318.2013.846790; Kammerer Y, 2013, COMPUT HUM BEHAV, V29, P1193, DOI 10.1016/j.chb.2012.10.012; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Knobloch-Westerwick S, 2005, J BROADCAST ELECTRON, V49, P296, DOI 10.1207/s15506878jobem4903_3; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Liao QV, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1439, DOI 10.1145/2702123.2702570; Ma T, 2017, TELEMAT INFORM, V34, P472, DOI 10.1016/j.tele.2016.09.009; Magezi DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00002; Medin D.L., 1995, PSYCHOL LEARN MOTIV, V32, P385, DOI [DOI 10.1016/S0079-7421(08)60315-1, 10.1016/S0079-7421(08)60315-1]; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Neville Kathleen L, 2003, Orthop Nurs, V22, P206, DOI 10.1097/00006416-200305000-00009; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; O'Grady L, 2012, INT J MED INFORM, V81, P36, DOI 10.1016/j.ijmedinf.2011.10.001; Petty RE, 2002, J PERS SOC PSYCHOL, V82, P722, DOI 10.1037//0022-3514.82.5.722; Pirolli P, 1999, PSYCHOL REV, V106, P643, DOI 10.1037/0033-295X.106.4.643; R Development Core Team, 2009, R LANG ENV STAT COMP; Rowland F., 2011, FILTER BUBBLE WHAT I, DOI [10.1353/pla.2011.0036, DOI 10.1353/PLA.2011.0036]; Schweiger S, 2014, J MED INTERNET RES, V16, P369, DOI 10.2196/jmir.3044; Schwind C, 2012, COMPUT EDUC, V58, P787, DOI 10.1016/j.compedu.2011.10.003; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Skaug AH, 2018, PACKAGE GLMMADMB; Van der Auwera S, 2017, EPIDEMIOL PSYCH SCI, V26, P61, DOI 10.1017/S2045796015001134; Vydiswaran V, 2012, P 21 ACM INT C INF K, P1905; West S. G, 1991, MULTIPLE REGRESSION, DOI [10.1080/00031305.1972.10478934, DOI 10.1080/00031305.1972.10478934]; White RW, 2015, ACM T INFORM SYST, V33, DOI 10.1145/2746229; Winter S, 2014, COMMUNICATIONS-GER, V39, P435, DOI 10.1515/commun-2014-0020; Winter S, 2012, J COMPUT-MEDIAT COMM, V18, P80, DOI 10.1111/j.1083-6101.2012.01596.x; Zell E, 2014, PERSPECT PSYCHOL SCI, V9, P111, DOI 10.1177/1745691613518075	55	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210423	10.1371/journal.pone.0210423	http://dx.doi.org/10.1371/journal.pone.0210423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645619	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200028
J	Wu, TC; Chang, CC; Leu, HB; Huang, PH; Lin, SJ; Chen, JW				Wu, Tao-Cheng; Chang, Chia-Chi; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen			Phorbol ester-induced angiogenesis of endothelial progenitor cells: The role of NADPH oxidase-mediated, redox-related matrix metalloproteinase pathways	PLOS ONE			English	Article							PROTEIN-KINASE-C; ISCHEMIA-INDUCED NEOVASCULARIZATION; PKC-ALPHA; INHIBITION; MATRIX-METALLOPROTEINASE-9; MECHANISMS; MONOCYTES; TARGET; MMP-9	Endothelial progenitor cells (EPCs) may contribute to ischemia-induced angiogenesis in atherosclerotic diseases. The protein kinase C (PKC) family is involved in the regulation of angiogenesis, however the role of PKC alpha in EPCs during angiogenesis is unclear. The aim of this study was to evaluate the role of PKC alpha in EPCs during angiogenesis. Phorbol-12-myristate-13-acetate (PMA), a PKC alpha activator, significantly increased the activity and expression of matrix metalloproteinases (MMP) -2 and -9 in human (late outgrowth) EPCs in vitro. The MMPs promoted the migratory function and vascular formation of EPCs, which then contributed to neovascularization in a mouse hindlimb-ischemia model. Reactive oxygen species derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enhanced the expression of MMPs to increase the bioactivity of EPCs during angiogenesis. The mitogen-activated protein kinase (MAPK) signal pathway was associated with the activation of NADPH oxidase. PMA extensively activated the extracellular signal-regulated kinase (Erk) signal pathway to increase the expression of MMP-9. PMA also activated the p38, Erk, and c-Jun N-terminal kinase signal pathways to increase the expression of MMP-2. PMA-stimulated EPCs enhanced neovascularization in a mouse model of hindlimb ischemia via nuclear factor-kappa B translocation to up-regulation of the expression of MMP-2 and MMP-9. PMA could activate PKCa and promote the angiogenesis capacity of human EPCs via NADPH oxidase-mediated, redox-related, MMP-2 and MMP-9 pathways. The PKC alpha activated, NADPH oxidase-mediated, redox-related MMP pathways could contribute to the function of human EPCs for ischemia-induced neovascularization, which may provide novel insights into the potential modification of EPCs for therapeutic angiogenesis.	[Wu, Tao-Cheng; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Wu, Tao-Cheng; Chang, Chia-Chi; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Chang, Chia-Chi; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Chen, JW (corresponding author), Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.; Chen, JW (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan.; Chen, JW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	jwchen@vghtpe.gov.tw			Taipei Veterans General Hospital [V102E1-006, V103E1-005]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by the funding from Taipei Veterans General Hospital (V102E1-006 and V103E1-005 to JW Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Corti F, 2013, J BIOL CHEM, V288, P12712, DOI 10.1074/jbc.M113.452383; de la Rosa CM, 2013, J PHARMACOL EXP THER, V345, P15, DOI 10.1124/jpet.112.200881; Diebold I, 2012, J CELL SCI, V125, P956, DOI 10.1242/jcs.094060; Dopheide JF, 2016, ANGIOGENESIS, V19, P67, DOI 10.1007/s10456-015-9489-y; Haidari M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-105; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; MONTESANO R, 1987, J CELL PHYSIOL, V130, P284, DOI 10.1002/jcp.1041300215; Moriya J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0180-9; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Scoditti E, 2014, ATHEROSCLEROSIS, V232, P17, DOI 10.1016/j.atherosclerosis.2013.10.017; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shahin R, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0010; Shin Y, 2007, EXP MOL MED, V39, P97, DOI 10.1038/emm.2007.11; Singh RM, 2017, HEART FAIL REV, V22, P843, DOI 10.1007/s10741-017-9634-3; Singh Rishi Kant, 2017, BioMolecular Concepts, V8, P143, DOI 10.1515/bmc-2017-0005; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wu TC, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0243-y; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zhi KK, 2016, ANGIOGENESIS, V19, P311, DOI 10.1007/s10456-016-9504-y	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209426	10.1371/journal.pone.0209426	http://dx.doi.org/10.1371/journal.pone.0209426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645596	Green Submitted, gold, Green Published			2022-12-27	WOS:000455810200009
J	Motta, D; Santos, AAB; Winkler, I; Machado, BAS; Pereira, DADI; Cavalcanti, AM; Fonseca, EOL; Kirchner, F; Badaro, R				Motta, Daniel; Bandeira Santos, Alex Alisson; Winkler, Ingrid; Souza Machado, Bruna Aparecida; Dias Imperial Pereira, Daniel Andre; Cavalcanti, Alexandre Morais; Lins Fonseca, Eduardo Oyama; Kirchner, Frank; Badaro, Roberto			Application of convolutional neural networks for classification of adult mosquitoes in the field	PLOS ONE			English	Article							AEDES-AEGYPTI; SPATIAL-DISTRIBUTION; CHIKUNGUNYA VIRUS; ZIKA; DIPTERA; SYSTEM	Dengue, chikungunya and Zika are arboviruses transmitted by mosquitos of the genus Aedes and have caused several outbreaks in world over the past ten years. Morphological identification of mosquitos is currently restricted due to the small number of adequately trained professionals. We implemented a computational model based on a convolutional neural network (CNN) to extract features from mosquito images to identify adult mosquitoes from the species Aedes aegypti, Aedes albopictus and Culex quinquefasciatus. To train the CNN to perform automatic morphological classification of mosquitoes, we used a dataset that included 4,056 mosquito images. Three neural networks, including LeNet, AlexNet and GoogleNet, were used. During the validation phase, the accuracy of the mosquito classification was 57.5% using LeNet, 74.7% using AlexNet and 83.9% using GoogleNet. During the testing phase, the best result (76.2%) was obtained using GoogleNet; results of 52.4% and 51.2% were obtained using LeNet and AlexNet, respectively. Significantly, accuracies of 100% and 90% were achieved for the classification of Aedes and Culex, respectively. A classification accuracy of 82% was achieved for Aedes females. Our results provide information that is fundamental for the automatic morphological classification of adult mosquito species in field. The use of CNN's is an important method for autonomous identification and is a valuable and accessible resource for health workers and taxonomists for the identification of some insects that can transmit infectious agents to humans.	[Motta, Daniel; Bandeira Santos, Alex Alisson; Winkler, Ingrid; Souza Machado, Bruna Aparecida; Dias Imperial Pereira, Daniel Andre; Cavalcanti, Alexandre Morais; Badaro, Roberto] Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida; Lins Fonseca, Eduardo Oyama; Badaro, Roberto] Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil; [Kirchner, Frank] DFKI, Res Ctr Artificial Intelligence, Bremen, Germany	German Research Center for Artificial Intelligence (DFKI)	Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.; Machado, BAS (corresponding author), Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.	brunam@fieb.org.br	Winkler, Ingrid/AAU-9884-2020; Santos, Alex A.B./J-4829-2012; Machado, Bruna Aparecida Souza/C-3130-2016; Motta, Daniel/AAW-1869-2021; Machado, Bruna/AAP-6877-2021; Kirchner, Frank/P-6503-2016	Winkler, Ingrid/0000-0001-6505-6636; Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Kirchner, Frank/0000-0002-1713-9784				Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233; Batista G. E. A. P. A., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P364, DOI 10.1109/ICMLA.2011.145; Bova J, 2016, J AM MOSQUITO CONTR, V32, P244, DOI 10.2987/15-6535.1; Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; CDC C for DC and P, 2016, SURV CONTR AED AEG A, P1, DOI [10.1371/journal.pntd.0004043, DOI 10.1371/JOURNAL.PNTD.0004043]; Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029; de Souza VMA, 2013, 2013 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P76, DOI 10.1109/BRACIS.2013.21; del Carpio-Orantes L, 2018, J ASIA-PAC BIODIVERS, V11, P317, DOI 10.1016/j.japb.2018.01.002; Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020; Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933; Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006; Kesavaraju B, 2012, J AM MOSQUITO CONTR, V28, P330, DOI 10.2987/12-6254R.1; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Lorenz C, 2015, ACTA TROP, V152, P165, DOI 10.1016/j.actatropica.2015.09.011; Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524; Mewara A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2854-0; Mundada R., 2013, IOSR J ELECT COMMUN, V5, P57, DOI DOI 10.9790/2834-565763; Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/S1473-3099(18)30269-X, 10.1016/s1473-3099(18)30269-x]; Ouyang TH, 2015, COMPUT ELECTRON AGR, V118, P47, DOI 10.1016/j.compag.2015.08.021; Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Sanchez AH, 2017, P REL MAINT S; Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015; Schaper S, 2006, REV BIOL TROP, V54, P847; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493; Shin JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161015; Sifferlin Alexandra, 2018, TIME; Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448; van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020; Wang JN, 2012, KNOWL-BASED SYST, V33, P102, DOI 10.1016/j.knosys.2012.03.014; WHO, 2017, GLOBAL VECTOR CONTRO, V2030, P47; Yang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13122; Yao Q, 2012, J INTEGR AGR, V11, P978, DOI 10.1016/S2095-3119(12)60089-6; Zhong YH, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051489	48	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210829	10.1371/journal.pone.0210829	http://dx.doi.org/10.1371/journal.pone.0210829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640961	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000050
J	Shaw, TJ; Yang, S; Nash, TR; Pigg, RM; Grim, JM				Shaw, Tarren J.; Yang, Suann; Nash, Troy R.; Pigg, Rachel M.; Grim, Jeffrey M.			Knowing is half the battle: Assessments of both student perception and performance are necessary to successfully evaluate curricular transformation	PLOS ONE			English	Article							SCIENCE	Student-centered pedagogies increase learning and retention. Quantifying change in both student learning gains and student perception of their experience allows faculty to evaluate curricular transformation more fully. Student buy-in, particularly how much students value and enjoy the active learning process, has been positively associated with engagement in active learning and increased learning gains. We hypothesize that as the frequency of students who have successfully completed the course increases in the student population, current students may be more likely to buy-in to the curriculum because this common experience could create a sense of community. We measured learning gains and attitudes during the transformation of an introductory biology course at a small, liberal arts college using our novel curriculum, Integrating Biology and Inquiry Skills (IBIS). Students perceived substantial learning gains in response to this curriculum, and concept assessments confirmed these gains. Over time, buy-in increased with each successive cohort, as demonstrated by the results of multiple assessment instruments, and students increasingly attributed specific components of the curriculum to their learning. These findings support our hypothesis and should encourage the adoption of curricular transformation using IBIS or other student-centered approaches.	[Shaw, Tarren J.; Yang, Suann; Nash, Troy R.; Pigg, Rachel M.; Grim, Jeffrey M.] Presbyterian Coll, Dept Biol, Clinton, SC 29325 USA; [Shaw, Tarren J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Yang, Suann] SUNY Coll Geneseo, Dept Biol, Geneseo, NY 14454 USA; [Nash, Troy R.] Mercer Univ, Dept Biol, Macon, GA 31207 USA; [Grim, Jeffrey M.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA	University of Oklahoma System; University of Oklahoma - Norman; State University of New York (SUNY) System; SUNY Geneseo; Mercer University; University of Tampa	Shaw, TJ (corresponding author), Presbyterian Coll, Dept Biol, Clinton, SC 29325 USA.; Shaw, TJ (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	tjshaw@ou.edu		Yang, Suann/0000-0001-7985-3011; Nash, Troy/0000-0002-2509-1733	National Science Foundation [DUE-1245706]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (www.nsf.gov): DUE-1245706 to TJS, SY, and TRN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrabsheh N, 2014, TOOLS ART INT ICTAI; Anderson L. W., 2001, TAXONOMY LEARNING TE; Balan P, 2015, EDUC TRAIN, V57, P639, DOI 10.1108/ET-07-2014-0088; Bates D, 2014, ARXIV14065823; Bloom B.S., 1956, TAXONOMY ED OBJETIVE; Brazeal KR, 2017, JMBE, V18, P1, DOI DOI 10.1128/JMBE.V18I1.1235; Brewer CA, 2011, VISION CHANGE UNDERG; Brown TL, 2017, J MICROBIOL BIOL EDU, V18, DOI 10.1128/jmbe.v18i1.1241; Cavanagh AJ, 2018, CBE-LIFE SCI EDUC, V17, DOI 10.1187/cbe.17-06-0107; Cavanagh AJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-07-0212; Cleveland LM, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-06-0181; Council N R, 2000, INQUIRY NATL SCI ED; Dormann CF, 2008, INTERACTION, V1; Elliott ER, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.14-07-0112; Emmeans Lenth R., 2018, EMMEANS ESTIMATED MA; Feinerer H, 2018, 0 7 5 RPV; Feinerer I, 2008, J STAT SOFTW, V25, P1; Fox J., 2011, R COMPANION APPL REG; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Gregory E, 2011, AM BIOL TEACH, V73, P16, DOI 10.1525/abt.2011.73.1.4; Hake R. R., 2002, PHYS ED RES C; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Rybarczyk BJ, 2007, BIOCHEM MOL BIOL EDU, V35, P181, DOI 10.1002/bmb.40; Seidel SB, 2013, CBE-LIFE SCI EDUC, V12, P586, DOI 10.1187/cbe-13-09-0190; Society TR, 2011, PREP TRANSF SCH COLL; Team,R.C, 2018, R LANG ENV STAT COMP; Theobald R, 2014, CBE-LIFE SCI EDUC, V13, P41, DOI 10.1187/cbe-13-07-0136; Trujillo G, 2014, CBE-LIFE SCI EDUC, V13, P6, DOI 10.1187/cbe.13-12-0241; Uttl B, 2017, STUD EDUC EVAL, V54, P22, DOI 10.1016/j.stueduc.2016.08.007; Wyse SA, 2018, CBE-LIFE SCI EDUC, V17, DOI 10.1187/cbe.17-12-0278	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210030	10.1371/journal.pone.0210030	http://dx.doi.org/10.1371/journal.pone.0210030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633765	Green Submitted, gold, Green Published			2022-12-27	WOS:000455485100012
J	Heller, AA; Spence, DM				Heller, Andrew A.; Spence, Dana M.			A rapid method for post-antibiotic bacterial susceptibility testing	PLOS ONE			English	Article							DEVELOPMENT SUCCESS RATES; ANTIBIOTIC SUSCEPTIBILITY; DISC DIFFUSION; ATP; DECLINE	Antibiotic susceptibility testing is often performed to determine the most effective antibiotic treatment for a bacterial infection, or perhaps to determine if a particular strain of bacteria is becoming drug resistant. Such tests, and others used to determine efficacy of candidate antibiotics during the drug discovery process, have resulted in a demand for more rapid susceptibility testing methods. Here, we have developed a susceptibility test that utilizes chemiluminescent determination of ATP release from bacteria and the overall optical density (OD600) of the bacterial solution. Bacteria release ATP during a growth phase or when they are lysed in the presence of an effective antibiotic. Because optical density increases during growth phase, but does not change during bacterial lysing, an increase in the ATP: optical density ratio after the bacteria have reached the log phase of growth (which is steady) would indicate antibiotic efficacy. Specifically, after allowing a kanamycin-resistant strain of Escherichia coli (E. coli) to pass through the growth phase and reach steady state, the addition of levofloxacin, an antibiotic to which E. coli is susceptible, resulted in a significant increase in the ATP: OD600 ratio in comparison to the use of kanamycin alone (1.80 +/- 0.50 vs. 1.12 +/- 0.28). This difference could be measured 20 minutes after the addition of the antibiotic, to which the bacteria are susceptible, to the bacterial sample. Furthermore, this method also proved useful with gram positive bacteria, as the addition of kanamycin to a chloramphenicol-resistant strain of Bacillus subtilis (B. subtilis) resulted in an ATP: OD600 ratio of 2.14 +/- 0.26 in comparison to 0.62 +/- 0.05 for bacteria not subjected to the antibiotic to which the bacteria are susceptible. Collectively, these results suggest that measurement of the ATP: OD600 ratio may provide a susceptibility test for antibiotic efficacy that is more rapid and quantitative than currently accepted techniques.	[Heller, Andrew A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Heller, Andrew A.; Spence, Dana M.] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Spence, Dana M.] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Spence, DM (corresponding author), Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.; Spence, DM (corresponding author), Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA.	spenceda@msu.edu			National Institutes of Health [GM110406]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institutes of Health (GM110406 to DMS); www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti MO, 2016, J CLIN MICROBIOL, V54, P2194, DOI 10.1128/JCM.00822-16; Amodio E, 2014, J INFECT PUBLIC HEAL, V7, P92, DOI 10.1016/j.jiph.2013.09.005; Badiee P, 2011, IRAN J MICROBIOL, V3, P183; Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029; BLAIR JM, 2014, NAT REV MICROBIOL, V13, P42, DOI DOI 10.1038/NRMICR03380; Bottari B, 2015, TRENDS FOOD SCI TECH, V44, P36, DOI 10.1016/j.tifs.2015.02.012; Botts RT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01922; Buzon-Duran L, 2018, FOOD MICROBIOL, V72, P220, DOI 10.1016/j.fm.2017.11.018; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Ghafur A, 2014, J MICROBIOLOGY INFEC, V4; Gupta P, 2015, J CLIN DIAGN RES, V9, pDC4, DOI 10.7860/JCDR/2015/10467.5395; Halder S, 2017, P NATL ACAD SCI USA, V114, pE10677, DOI 10.1073/pnas.1711467114; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Hombach M, 2017, J ANTIMICROB CHEMOTH, V72, P1659, DOI 10.1093/jac/dkx026; House W., 2015, NAT ACT PLAN COMB AN; Ivancic V, 2008, J CLIN MICROBIOL, V46, P1213, DOI 10.1128/JCM.02036-07; Ivanova EP, 2006, INT MICROBIOL, V9, P37; Iwase T, 2010, J CLIN MICROBIOL, V48, P1949, DOI 10.1128/JCM.01941-09; Jooma S, 2015, J LAW BIOSCI, V2, P129, DOI 10.1093/jlb/lsv005; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Juhas M, 2015, CRIT REV MICROBIOL, V41, P101, DOI 10.3109/1040841X.2013.804031; Jutkina J, 2016, SCI TOTAL ENVIRON, V548, P131, DOI 10.1016/j.scitotenv.2016.01.044; Leong C, 2017, J CLIN MICROBIOL, V55, P1883, DOI 10.1128/JCM.00338-17; Luo JP, 2009, ANAL BIOCHEM, V394, P1, DOI 10.1016/j.ab.2009.05.021; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Meir-Gruber L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164873; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Miller JH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00263; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Obama B., 2014, EXECUTIVE ORDER COMB; Ogata SK, 2014, BRAZ J MICROBIOL, V45, P1439, DOI 10.1590/S1517-83822014000400039; Pruller S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123883; Ranque S, 2012, J CLIN MICROBIOL; Ratnayake PU, 2016, PROTEIN EXPRES PURIF, V117, P6, DOI 10.1016/j.pep.2015.08.021; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Van Duijkeren E, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0019-2017; Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Zowawi HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15082	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210534	10.1371/journal.pone.0210534	http://dx.doi.org/10.1371/journal.pone.0210534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629681	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000104
J	Kurm, V; van der Putten, WH; Hol, WHG				Kurm, Viola; van der Putten, Wim H.; Hol, W. H. Gera			Cultivation-success of rare soil bacteria is not influenced by incubation time and growth medium	PLOS ONE			English	Article							PURE CULTURE; ACTINOBACTERIA; MICROORGANISMS; CULTURABILITY; COMMUNITIES; BIOSPHERE; ABUNDANT; SIZE	Rare bacterial species have recently attracted interest due to their many potential beneficial functions. However, only little is known about their cultivability. In this study we test the hypotheses that the use of flow cell-sorting for cultivation results in a high proportion of rare soil bacterial isolates relative to bacterial taxa that are abundant in soil. Moreover, we investigate whether different oligotrophic cultivation media and a prolonged incubation time increase the number of cultivated rare species. In a cultivation study we used flow cell sorting to select for small cells and to separate single cells, and grew bacteria on different oligotrophic media with prolonged incubation times. The abundance of the isolates in the field was assessed by comparing them to a 454-sequencing dataset from the same soil. Consequentially, all bacterial isolates were classified as either rare (<0.01% relative abundance) or abundant (>0.01% relative abundance) in the field soil. We found more bacterial taxa among the isolates that were abundant in soil than would be expected by the proportion of abundant species in the field. Neither incubation time nor growth medium had an influence on the recovery of rare species. However, we did find differences in time until visible growth on the plate between different phylogenetic classes of the isolates. These results indicate that rare cultivable species are active and not more likely to be dormant than abundant species, as has been suggested as a reason for their rarity. Moreover, future studies should be aware of the influence incubation time might have on the phylogenetic composition of the isolate collection.	[Kurm, Viola; van der Putten, Wim H.; Hol, W. H. Gera] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands; [Kurm, Viola] Wageningen Plant Res Biointeract & Plant Hlth, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Kurm, V (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.; Kurm, V (corresponding author), Wageningen Plant Res Biointeract & Plant Hlth, Wageningen, Netherlands.	viola.kurm@wur.nl	van der Putten, Wim H/C-3707-2011; KNAW, NIOO-KNAW/A-4320-2012; Kurm, Viola/F-2329-2016	van der Putten, Wim H/0000-0002-9341-4442; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kurm, Viola/0000-0003-1261-9778				Aanderud ZT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00024; Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; [Anonymous], 2016, LOW ABUNDANT SOIL BA; Archer E., 2013, RFPERMUTE ESTIMATE P; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Berns AE, 2008, EUR J SOIL SCI, V59, P540, DOI 10.1111/j.1365-2389.2008.01016.x; BONNER WA, 1972, REV SCI INSTRUM, V43, P404, DOI 10.1063/1.1685647; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Dell'Anno A, 2012, ENVIRON POLLUT, V167, P85, DOI 10.1016/j.envpol.2012.03.043; Flather Curtis H., 2007, P40; Foladori P, 2007, WATER RES, V41, P235, DOI 10.1016/j.watres.2006.08.021; Fox J., 2019, R COMPANION APPL REG, V.; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Geisen S, 2014, EUR J PROTISTOL, V50, P153, DOI 10.1016/j.ejop.2014.01.007; Green P, 2002, COMPUTER PROGRAM DOC; Hamaki T, 2005, J BIOSCI BIOENG, V99, P485, DOI 10.1263/jbb.99.485; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kato S, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00807-18; Kurm V, 2017, ECOLOGY, V98, P555, DOI 10.1002/ecy.1670; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; McCaig AE, 2001, FEMS MICROBIOL ECOL, V35, P37, DOI 10.1111/j.1574-6941.2001.tb00786.x; Mitsui H, 1997, J MICROBIOL METH, V30, P103, DOI 10.1016/S0167-7012(97)00052-3; Morrissey EM, 2016, ISME J, V10, P2336, DOI 10.1038/ismej.2016.28; Portillo MC, 2013, APPL ENVIRON MICROB, V79, P7610, DOI 10.1128/AEM.02710-13; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Senechkin IV, 2010, MICROB ECOL, V60, P829, DOI 10.1007/s00248-010-9670-1; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; SRINIVASAN MC, 1991, WORLD J MICROB BIOT, V7, P171, DOI 10.1007/BF00328987; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Tanaka T, 2014, APPL ENVIRON MICROB, V80, P7659, DOI 10.1128/AEM.02741-14; Vage S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101415; van de Voorde TFJ, 2012, OIKOS, V121, P1251, DOI 10.1111/j.1600-0706.2011.19964.x; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; VanInsberghe D, 2013, APPL ENVIRON MICROB, V79, P2096, DOI 10.1128/AEM.03112-12; WHANG K, 1988, A VAN LEEUW J MICROB, V54, P19, DOI 10.1007/BF00393955; Wilhelm L, 2014, ENV MICROBIOL	46	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210073	10.1371/journal.pone.0210073	http://dx.doi.org/10.1371/journal.pone.0210073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629606	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000046
J	Myssayev, A; Myssayev, A; Ideguchi, R; Eguchi, S; Adachi, T; Sumida, Y; Tobinaga, S; Uetani, M; Kudo, T				Myssayev, Altay; Myssayev, Ayan; Ideguchi, Reiko; Eguchi, Susumu; Adachi, Tomohiko; Sumida, Yorihisa; Tobinaga, Shuichi; Uetani, Masataka; Kudo, Takashi			Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; METABOLIC TUMOR VOLUME; PROGNOSTIC-FACTORS; F-18-FDG PET/CT; COMPUTED-TOMOGRAPHY; CANCER; SURVIVAL; DIAGNOSIS; MANAGEMENT	Purpose Pancreatic cancer is the 4th most common cause of cancer death in Japan and exhibits a 5year overall survival rate of approximately 7%. The accurate diagnosis of pancreatic cancer is important for determining the optimal management strategy. Fludeoxyglucose-positron emission tomography (FDG PET) integrated with computed tomography (F-18-FDG PET/CT) has emerged as a powerful imaging tool for detecting and evaluating various cancers, and it is used for staging, detecting local recurrence and distant metastasis, measuring therapeutic effects, and predicting prognosis in pancreatic cancer patients. Lately, FDG PET/CT-derived parameters, such as standardized uptake values (SUV), the metabolic tumor volume (MTV), and total lesion glycolysis (TLG), have been suggested as prognostic factors for various types of cancer, including pancreatic cancer. However, there is no consensus regarding the best parameters for evaluating patient prognosis, operability, etc. The purpose of this study was to examine the differences between operable and non-operable pancreatic cancer using FDG PET/CT-derived parameters, and to investigate whether volumetric parameters (TLG and the MTV) are superior to SUV-based parameters for predicting infiltration status/determining operability. Materials and methods We conducted a retrospective study of the cases of 48 patients with clinically proven pancreatic adenocarcinoma, who underwent FDG PET/CT imaging before treatment. In the operable group, the surgical specimens were subjected to histopathological examinations, and the cases were separated into those exhibiting less and greater infiltration. SUVmax, SUV-peak, the tumor background ratio (TBR), TLG, and the MTV were compared between these groups as well as between the operable and non-operable groups. Results Venous infiltration showed significant associations with several metabolic parameters (SUV-max, SUVpeak, and the TBR). However, it did not display any significant associations with volumetric parameters, such as TLG or the MTV. None of the FDG PET/CT-derived parameters exhibited significant associations with lymphatic or neural infiltration. Significant differences in volumetric parameters, such as the MTV and TLG, were detected between the operable and non-operable subgroups. Conclusions Metabolic F-18-FDG PET/CT-derived parameters, such as SUVmax, SUVpeak, and the TBR, are useful for predicting venous infiltration status in patients with operable pancreatic adenocarcinoma.	[Myssayev, Altay; Ideguchi, Reiko; Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radioisotope Med, Nagasaki, Japan; [Myssayev, Ayan] Semey State Med Univ, Dept Publ Hlth, Semey City, Kazakhstan; [Ideguchi, Reiko; Kudo, Takashi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki, Japan; [Eguchi, Susumu; Adachi, Tomohiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki, Japan; [Sumida, Yorihisa; Tobinaga, Shuichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Sumida, Yorihisa] Sasebo City Gen Hosp, Dept Surg, Nagasaki, Japan; [Uetani, Masataka] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol Sci, Nagasaki, Japan	Nagasaki University; Semey State Medical University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University	Kudo, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radioisotope Med, Nagasaki, Japan.; Kudo, T (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki, Japan.	tkudo123@nagasaki-u.ac.jp	Uetani, Masataka/ABF-7525-2021; Ayan, Myssayev/AAP-7455-2020	Ayan, Myssayev/0000-0001-7332-4856; Eguchi, Susumu/0000-0002-7876-0152; Kudo, Takashi/0000-0002-8484-9209	Nihon Medi-Physics	Nihon Medi-Physics	Takashi Kudo received grant support through his institution from Nihon Medi-Physics. He also received honoraria for lectures from Nihon Medi-Physics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addeo P, 2017, SURGERY, V162, P264, DOI 10.1016/j.surg.2017.03.008; Asagi A, 2013, PANCREAS, V42, P11, DOI 10.1097/MPA.0b013e3182550d77; Bouvet M, 2000, AM J SURG, V180, P13, DOI 10.1016/S0002-9610(00)00405-0; Bruzzi JF, 2007, CANCER, V109, P125, DOI 10.1002/cncr.22397; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V129, P1232, DOI 10.1016/j.jtcvs.2004.12.042; Delbeke D, 1999, J NUCL MED, V40, P1784; Dholakia AS, 2014, INT J RADIAT ONCOL, V89, P539, DOI 10.1016/j.ijrobp.2014.02.031; Fendler WP, 2013, J NUCL MED, V54, P1202, DOI 10.2967/jnumed.112.116426; Garcea G, 2008, J PANCREAS, V9, P99; Heinrich S, 2005, ANN SURG, V242, P235, DOI 10.1097/01.sla.0000172095.97787.84; Higashi T, 2003, ANN NUCL MED, V17, P261, DOI 10.1007/BF02988521; Hirata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105682; Hyun SH, 2016, EUR J NUCL MED MOL I, V43, P1461, DOI 10.1007/s00259-016-3316-6; Japan Pancreas Society, 2009, GEN RUL STUD PANCR C; Javery O, 2013, CLIN IMAG, V37, P295, DOI 10.1016/j.clinimag.2012.07.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaida H, 2016, EUR J RADIOL, V85, P1804, DOI 10.1016/j.ejrad.2016.08.007; Kauhanen SP, 2009, ANN SURG, V250, P957, DOI 10.1097/SLA.0b013e3181b2fafa; Kim HS, 2014, NUCL MED MOLEC IMAG, V48, P180, DOI 10.1007/s13139-013-0262-0; Kim YI, 2014, EUR J RADIOL, V83, P231, DOI 10.1016/j.ejrad.2013.09.031; Konski A, 2005, INT J RADIAT ONCOL, V61, P1123, DOI 10.1016/j.ijrobp.2004.07.717; Kuhlmann KFCD, 2004, EUR J CANCER, V40, P549, DOI 10.1016/j.ejca.2003.10.026; Lemke AJ, 2004, J NUCL MED, V45, P1279; Meyer W, 2000, SURG TODAY, V30, P582, DOI 10.1007/s005950070096; Moon SY, 2013, CLIN NUCL MED, V38, P778, DOI 10.1097/RLU.0b013e31829f8c90; Nishiyama Y, 2005, ANN NUCL MED, V19, P491, DOI 10.1007/BF02985577; Ozaki H, 1999, SURG TODAY, V29, P16; Parlak C, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-37; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; Shimada K, 2006, SURGERY, V139, P288, DOI 10.1016/j.surg.2005.08.004; Sierzega M, 2006, PANCREAS, V33, P240, DOI 10.1097/01.mpa.0000235306.96486.2a; The Editorial Board of the Cancer Statistics in Japan, 2016, CANC STAT JAP 2015	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210178	10.1371/journal.pone.0210178	http://dx.doi.org/10.1371/journal.pone.0210178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629646	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000057
J	Hope, HF; Binkley, GM; Fenton, S; Kitas, GD; Verstappen, SMM; Symmons, DPM				Hope, Holly F.; Binkley, George M.; Fenton, Sally; Kitas, George D.; Verstappen, Suzanne M. M.; Symmons, Deborah P. M.			Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; HEART-DISEASE; THERAPY; RISK; NONADHERENCE; MEDICATION; METAANALYSIS; PERSPECTIVE; PROPORTION; BELIEFS	Introduction Previous research has shown that statin adherence for the primary prevention of CVD is lower compared to secondary prevention populations. Therefore the aim of this systematic review was to review predictors of statin adherence for the primary prevention of CVD. Methods A systematic search of papers published between Jan 1984 and May 2017 was conducted in PubMed, PsycINFO, EMbase and CINAHL databases. A study was eligible for inclusion if; 1) it was a study of the general population or of patients with familial hypercholesterolemia, hypertension, diabetes or arthritis; 2) statins were prescribed; 3) adherence was defined and measured as the extent to which patients followed their statin regimen during the period of prescription, and 4) it was an original trial or observational study (excluding case reports). A study was subsequently excluded if 1) results were not presented separately for primary prevention; 2) it was a trial of an intervention (for example patient education). Papers were reviewed by two researchers and consensus agreed with a third. A quality assessment (QA) tool was used to formally assess each included article. To evaluate the effect of predictors, data were quantitatively and qualitatively synthesised. Results In total 19 studies met the inclusion criteria and nine were evaluated as high quality using the QA tool. The proportion of patients classed as "adherent" ranged from 17.8% to 79.2%. Potential predictors of statin adherence included traditional risk factors for CVD such as age, being male, diabetes and hypertension. Income associated with adherence more strongly in men than women, and highly educated men were more likely and highly educated women less likely to be adherent. Alcohol misuse and high BMI associated with non-adherence. There was no association between polypharmacy and statin adherence. The evidence base for the effect of other lifestyle factors and health beliefs on statin adherence was limited. Conclusion Current evidence suggests that patients with more traditional risk factors for CVD are more likely to be adherent to statins. The implications for future research are discussed.	[Hope, Holly F.; Binkley, George M.; Verstappen, Suzanne M. M.; Symmons, Deborah P. M.] Univ Manchester, Fac Biol Med & Hlth, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res, Manchester, Lancs, England; [Fenton, Sally; Kitas, George D.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Kitas, George D.] Dudley Grp NHS Fdn Trust, Russells Hall Hosp, Rheumatol Dept, Dudley, England; [Verstappen, Suzanne M. M.] Cent Manchester Univ Hosp NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Hope, Holly F.] Univ Manchester, Sch Hlth Sci, Div Psychol & Mental Hlth, Ctr Womens Mental Hlth, Manchester, Lancs, England	University of Manchester; University of Birmingham; Russells Hall Hospital; University of Manchester; University of Manchester	Hope, HF (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res, Manchester, Lancs, England.	holly.hope@manchester.ac.uk	Kitas, George/AAO-6396-2020; Fenton, Sally/AAC-3606-2022	Fenton, Sally/0000-0002-3732-1348; Hope, Holly/0000-0002-4834-6719	British Heart Foundation [16514] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Aarnio E, 2016, CIRC-CARDIOVASC QUAL, V9, P704, DOI 10.1161/CIRCOUTCOMES.116.002728; Aarnio E, 2015, ATHEROSCLEROSIS, V239, P240, DOI 10.1016/j.atherosclerosis.2014.12.059; Al-Foraih M, 2017, MED PRIN PRACT, V26, P35, DOI 10.1159/000450644; Batal HA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-175; Braamskamp MJAM, 2015, PEDIATR DRUGS, V17, P159, DOI 10.1007/s40272-014-0116-y; Bryson CL, 2008, ANN INTERN MED, V149, P795, DOI 10.7326/0003-4819-149-11-200812020-00004; Casebeer L, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-48; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chee YJ, 2014, SINGAP MED J, V55, P416, DOI 10.11622/smedj.2014099; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Corrao G, 2010, CLIN THER, V32, P300, DOI 10.1016/j.clinthera.2010.02.004; Santos CMD, 2007, REV LAT-AM ENFERM, V15, P508, DOI 10.1590/S0104-11692007000300023; de Cates AN, 2014, COCHRANE DB SYST REV, V4; Degli Esposti L, 2012, CLIN THER, V34, P190, DOI 10.1016/j.clinthera.2011.12.011; Deshpande S, 2017, CURR MED RES OPIN, V33, P769, DOI 10.1080/03007995.2017.1281109; Dragomir A, 2010, VALUE HEALTH, V13, P87, DOI 10.1111/j.1524-4733.2009.00583.x; Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Farsaei S, 2015, J RES MED SCI, V20, P109; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Guthrie RM, 2001, CLIN THER, V23, P970, DOI 10.1016/S0149-2918(01)80084-9; Halava H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130901; Halava H, 2014, CAN MED ASSOC J, V186, pE449, DOI 10.1503/cmaj.131807; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison TN, 2013, AM J MANAG CARE, V19, pE133; HIPPISLEYCOX J, 2017, BMJ BRIT MED J, V357; Hope HF, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000171; Horne R, 1999, J PSYCHOSOM RES, V47, P491, DOI 10.1016/S0022-3999(99)00058-6; Kalia NK, 2006, ATHEROSCLEROSIS, V185, P394, DOI 10.1016/j.atherosclerosis.2005.06.018; Kooy MJ, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00069; Kronish IM, 2016, CIRC-CARDIOVASC QUAL, V9, P364, DOI 10.1161/CIRCOUTCOMES.115.002418; Lavikainen P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011306; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Mann DM, 2007, CARDIOVASC DRUG THER, V21, P311, DOI 10.1007/s10557-007-6040-4; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; McNaughton RJ, 2015, J PUBLIC HEALTH-UK, V37, P218, DOI 10.1093/pubmed/fdu066; NICE, 2016, CLIN GUID CG181 CARD; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Ofori-Asenso R, 2018, J GERONTOL A-BIOL, V73, P813, DOI 10.1093/gerona/glx169; Perreault S, 2009, EUR J CLIN PHARMACOL, V65, P1013, DOI 10.1007/s00228-009-0673-0; Perreault S, 2009, AM J MED, V122, P647, DOI 10.1016/j.amjmed.2009.01.032; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Rash JA, 2016, PREV MED, V90, P155, DOI 10.1016/j.ypmed.2016.07.006; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Reese PP, 2016, J GEN INTERN MED, V31, P402, DOI 10.1007/s11606-015-3540-y; Rublee DA, 2012, AM J THER, V19, P24, DOI 10.1097/MJT.0b013e3181ee707e; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Slejko JF, 2014, J MANAGE CARE PHARM, V20, P51, DOI 10.18553/jmcp.2014.20.1.51; Stilley CS, 2004, ANN BEHAV MED, V27, P117, DOI 10.1207/s15324796abm2702_6; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Watanabe JH, 2013, CURR MED RES OPIN, V29, P175, DOI 10.1185/03007995.2013.766164; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xu T, 2017, CNS DRUGS, V31, P263, DOI 10.1007/s40263-017-0420-5; Xu WH, 2016, INT J CLIN EXP MED, V9, P9195	60	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0201196	10.1371/journal.pone.0201196	http://dx.doi.org/10.1371/journal.pone.0201196			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653535	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500001
J	Lee, TL; Kao, FC; Hsu, YC; Lo, YY; Tu, YK				Lee, Thung-Lip; Kao, Feng-Chen; Hsu, Yao-Chun; Lo, Ying-Ying; Tu, Yuan-Kun			Perioperative acute myocardial infarction rate in chronic renal disease patients undergoing orthopedic surgery: Is there any difference between dialyzed and nondialyzed patients?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ACUTE CORONARY SYNDROME; POSTOPERATIVE MORBIDITY; DIALYSIS PATIENTS; CARDIAC RISK; MORTALITY; OUTCOMES; ISCHEMIA; REINFARCTION	Background The incidence of acute myocardial infarction (AMI) in healthy patients undergoing noncardiac surgery is <1%. When patients with chronic kidney disease (CKD) undergo orthopedic surgery, AMI incidence can be expected to be relatively high. However, data on a population-wide scale is lacking. Objective To investigate AMI incidence in patients with CKD (with and without dialysis) undergoing orthopedic surgery. Design A population-based study covering the period from January 1, 1997, to December 31, 2011. Setting Data from the Taiwan National Health Insurance Research Database. Participants Participants were 219,195 patients with CKD who underwent surgery between January 1, 1997, and December 31, 2011. Results AMI occurred in 2,708 participants (1.24%). The AMI incidence rate in the dialyzed group was 1.52%, which was higher than that in the nondialyzed group after propensity score matching. Dialysis (odds ratio [OR]: 1.79; 95% confidence interval [CI]: 1.62-1.98), male (OR: 1.42; 95% CI: 1.28-1.57), diabetes mellitus (OR: 1.61; 95% CI: 1.44-1.80), hyperlipidemia (OR: 1.88; 95% CI: 1.68-2.11), old myocardial infarction (OR: 18.87; 95% CI: 16.26-1.21.90), and cerebral vascular disease (CVA) (OR: 1.29; 95% CI: 1.30-1.47) were all associated with AMI in the patients with CKD. Conclusions The AMI risk was higher in the patients with CKD undergoing orthopedic surgery than in the general population, and the dialyzed group had a higher risk of AMI than did the nondialyzed group.	[Lee, Thung-Lip] E Da Hosp, Dept Cardiovasc, Kaohsiung, Taiwan; [Lee, Thung-Lip; Kao, Feng-Chen; Tu, Yuan-Kun] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Kao, Feng-Chen; Tu, Yuan-Kun] E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Hsu, Yao-Chun] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lo, Ying-Ying] I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; Fu Jen Catholic University; E-Da Hospital; China Medical University Taiwan; I Shou University	Kao, FC (corresponding author), I Shou Univ, Sch Med, Kaohsiung, Taiwan.; Kao, FC (corresponding author), E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan.; Lo, YY (corresponding author), I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan.	ed100735@edah.org.tw; iilo991027@gmail.com		Kao, FengChen/0000-0002-6068-3144	E-Da Hospital [EDAHP103048]	E-Da Hospital	This study was funded by E-Da Hospital (EDAHP103048).; This study was based on data from the NHIRD (NHIRD-104-167, NHIRD-104-347) of the NHI Bureau, Taiwan Department of Health, which is managed by the NHRI. The interpretations and conclusions contained herein do not represent those of the NHI Bureau, the Department of Health, or the NHRI. The authors are grateful to Tzu-shan Chen for her assistance.	Ackland GL, 2011, ANESTH ANALG, V112, P1375, DOI 10.1213/ANE.0b013e3181ee8456; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Baig Sara Z, 2009, Adv Perit Dial, V25, P147; Cai QJ, 2013, CURR CARDIOL REV, V9, P331, DOI 10.2174/1573403X10666140214122234; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; French GWG, 1999, ANAESTHESIA, V54, P235, DOI 10.1046/j.1365-2044.1999.00713.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Han JH, 2006, AM J MED, V119, P248, DOI 10.1016/j.amjmed.2005.08.057; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; Knapp RB, 1962, JAMA-J AM MED ASSOC, V182, P106; Kosuge M, 2006, CIRC J, V70, P222, DOI 10.1253/circj.70.222; Lee CH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001066; Lee YC, 2015, SLEEP, V38, P213, DOI 10.5665/sleep.4400; LEPPO J, 1987, J AM COLL CARDIOL, V9, P269, DOI 10.1016/S0735-1097(87)80374-1; Mallinson T., 2010, FOCUS 1 AID, V15, P15; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MARSCH SCU, 1992, ANESTHESIOLOGY, V76, P518, DOI 10.1097/00000542-199204000-00006; Mathew A, 2008, KIDNEY INT, V73, P1069, DOI 10.1038/ki.2008.29; Mellord C, 2008, J AM COLL CARDIOL, V51, P991, DOI 10.1016/j.jacc.2007.11.045; Menendez ME, 2015, INT ORTHOP, V39, P777, DOI 10.1007/s00264-014-2502-z; RAO TLK, 1983, ANESTHESIOLOGY, V59, P499, DOI 10.1097/00000542-198312000-00003; RILES TS, 1979, SURGERY, V85, P249; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; STEEN PA, 1978, JAMA-J AM MED ASSOC, V239, P2566, DOI 10.1001/jama.239.24.2566; TARHAN S, 1972, J AMER MED ASSOC, V220, P1451, DOI 10.1001/jama.220.11.1451; US Renal Data System, 1998, USRDS 1998 ANN DAT R; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Vashistha V, 2016, INT J CARDIOL, V223, P401, DOI 10.1016/j.ijcard.2016.07.175; VONKNORRING J, 1981, SURGERY, V90, P55; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yin WH, 2016, INT J CARDIOL, V209, P103, DOI 10.1016/j.ijcard.2016.02.022	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210554	10.1371/journal.pone.0210554	http://dx.doi.org/10.1371/journal.pone.0210554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653544	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500049
J	Milic, V; Grujic, M; Barisic, J; Marinkovic-Eric, J; Duisin, D; Cirkovic, A; Damjanov, N				Milic, Vera; Grujic, Milica; Barisic, Jasmina; Marinkovic-Eric, Jelena; Duisin, Dragana; Cirkovic, Andja; Damjanov, Nemanja			Personality, depression and anxiety in primary Sjogren's syndrome - Association with sociodemographic factors and comorbidity	PLOS ONE			English	Article							QUALITY-OF-LIFE; SICCA SYMPTOMS; FATIGUE; NEUROTICISM; DISEASE; CLASSIFICATION; EXTROVERSION; FIBROMYALGIA; VALIDATION; COGNITIONS	Objective Patients with primary Sjogren's Syndrome (pSS) have diminished health quality and fatigue, arthralgia along with dryness of the mouth and eyes have major impact on their psychological and social aspects of life. The purpose of this study was to determine psychological features of patients with pSS. We analyzed personality, depression and anxiety of patients with primary Sjogren's Syndrome (pSS) in comparison with patients with rheumatoid arthritis (RA) and healthy controls (HC) and assessed their association with sociodemographic factors and comorbidity. Methods In 105 pSS patients (mean age 51.34 years, mean disease duration 5.98 years), 52 RA patients (mean age 51.37 years, mean disease duration 8.10 years) and 54 HC (mean age 51.35 years) clinical and sociodemographic characteristics were determined and results analyzed. At enrollment patients and controls completed the Revisited NEO Personality Inventory Five-Factor model (NEO-PI-R), the Zung Self-Rating Depression Scale and the Zung Self-Rating Anxiety Scale. Statistical analyses were performed using SPSS [Version 16.0]. The relative size of the effect was assessed based on standardized estimates of effect size (d). Results Patients with pSS, similarly to RA patients had higher scores of Neuroticism (d = 0.46, p = 0.007) and lower scores of Extraversion (d = 0.51, p = 0.001) and Openness for experience (d = 0.65, p = 0.013) compared to HC. There was no significant differences between pSS group and HC in the depression (d = 0.171, p>0.05). However, patients with pSS had higher anxiety in comparison to HC (p<0.0001). In multivariate models, education and satisfaction with family relationships were significant predictors for psychological characteristics of patients, independently of clinical diagnosis. Conclusions Our study is the first to show that patients with pSS scored high on neuroticism and anxiety and low on sociability. Education and satisfaction with family relationships predisposed to their psychological profile. Psychological assessment of patients with pSS may improve understanding and treatment of this clinical condition.	[Milic, Vera; Grujic, Milica; Damjanov, Nemanja] Univ Belgrade, Dept Rheumatol, Fac Med, Belgrade, Serbia; [Barisic, Jasmina; Duisin, Dragana] Clin Ctr Serbia, Dept Psychiat, Belgrade, Serbia; [Marinkovic-Eric, Jelena; Cirkovic, Andja] Univ Belgrade, Dept Med Stat, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Milic, V (corresponding author), Univ Belgrade, Dept Rheumatol, Fac Med, Belgrade, Serbia.	veramilic1409@gmail.com		Cirkovic, Andja/0000-0002-7542-5690; Milic, Vera/0000-0003-1160-9674				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Axelsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018241; Ben-Porath Y.S., 1992, PSYCHOL ASSESSMENT, V4, P14, DOI [https://doi.org/10.1037/1040-3590.4.1.14, DOI 10.1037/1040-3590.4.1.14]; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Boyle MP, 2013, J FLUENCY DISORD, V38, P368, DOI 10.1016/j.jfludis.2013.09.001; Bucourt E, 2017, JOINT BONE SPINE, V84, P203, DOI 10.1016/j.jbspin.2016.03.006; Cameron DS, 2015, HEALTH PSYCHOL REV, V9, P345, DOI 10.1080/17437199.2014.923164; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Champey J, 2006, ARTHRIT RHEUM-ARTHR, V55, P451, DOI 10.1002/art.21990; Costa PT, 2005, J AFFECT DISORDERS, V89, P45, DOI 10.1016/j.jad.2005.06.010; Costa PTJ, 1992, THE REVISITED NEO PE; Eysenc H. J., 1969, PERSONALITY STRUCTUR; Fayard JV, 2012, J PERS, V80, P1, DOI 10.1111/j.1467-6494.2011.00720.x; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Jokela M, 2014, PSYCHOL MED, V44, P2629, DOI 10.1017/S0033291714000257; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Karageorgas T, 2016, ARTHRIT CARE RES, V68, P123, DOI 10.1002/acr.22720; Karaiskos D, 2010, RHEUMATOLOGY, V49, P1762, DOI 10.1093/rheumatology/keq158; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Lackner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172056; Littlejohn G., 2012, PAIN RES TREATMENT, V2012, P730; Lodi-Smith J, 2010, PSYCHOL HEALTH, V25, P305, DOI 10.1080/08870440902736964; Lucas RE, 2011, J PERS SOC PSYCHOL, V101, P847, DOI 10.1037/a0024298; Lukkahatai N, 2013, J PSYCHOSOM RES, V74, P100, DOI 10.1016/j.jpsychores.2012.11.006; MAGNUS K, 1993, J PERS SOC PSYCHOL, V65, P1046, DOI 10.1037/0022-3514.65.5.1046; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; Meijer JM, 2009, RHEUMATOLOGY, V48, P1077, DOI 10.1093/rheumatology/kep141; Milin M, 2016, JOINT BONE SPINE, V83, P681, DOI 10.1016/j.jbspin.2015.10.005; Mirowsky J, 2007, AM J SOCIOL, V112, P1339, DOI 10.1086/511800; Morey LC, 2010, AM J PSYCHIAT, V167, P528, DOI 10.1176/appi.ajp.2009.09071023; Ode S, 2007, PERS INDIV DIFFER, V43, P2137, DOI 10.1016/j.paid.2007.06.035; Martinez MP, 2011, J CLIN PSYCHOL MED S, V18, P380, DOI 10.1007/s10880-011-9263-2; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Prins JB, 2004, PSYCHOTHER PSYCHOSOM, V73, P174, DOI 10.1159/000076455; Santiago T, 2015, CURR PHARM DESIGN, V21, P257; Savic D, 2000, PSYCHOBIOLOGY, V28, P581; Seror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615; Shen CC, 2015, J RHEUMATOL, V42, P1203, DOI 10.3899/jrheum.141361; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Valtysdottir ST, 2000, CLIN EXP RHEUMATOL, V18, P597; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322; Wouters EJM, 2012, ANN RHEUM DIS, V71, P668, DOI 10.1136/ard.2011.154245; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	55	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210466	10.1371/journal.pone.0210466	http://dx.doi.org/10.1371/journal.pone.0210466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653543	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500039
J	Raasch-Fernandes, LD; Bonaldo, SM; Rodrigues, DD; Vieira, GM; Schwan-Estrada, KRF; da Silva, CR; Vercosa, AGA; de Oliveira, DL; Debiasi, BW				Raasch-Fernandes, Livia Deice; Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus; Vieira-Junior, Gerardo Magela; Freitas Schwan-Estrada, Katia Regina; da Silva, Camila Rocco; Araujo Vercosa, Ana Gabriela; de Oliveira, Daiane Lopes; Debiasi, Bryan Wender			Induction of phytoalexins and proteins related to pathogenesis in plants treated with extracts of cutaneous secretions of southern Amazonian Bufonidae amphibians	PLOS ONE			English	Article							NATURAL-PRODUCTS; POSTHARVEST DISEASES; INDUCED RESISTANCE; ACTIVE COMPOUNDS; CHITOSAN; DEFENSE; L.; BUFADIENOLIDES; ACCUMULATION; DISCOVERY	Cutaneous secretions produced by amphibians of the family Bufonidae are rich sources of bioactive compounds that can be useful as new chemical templates for agrochemicals. In crop protection, the use of elicitors to induce responses offers the prospect of durable, broad-spectrum disease control using the plant's own resistance. Therefore, we evaluated the potential of methanolic extracts of cutaneous secretions of two species of amphibians of the family Bufonidae found in the Amazon biome-Rhaebo guttatus (species 1) and Rhinella marina (species 2)-in the synthesis of phytoalexins in soybean cotyledons, bean hypocotyls, and sorghum mesocotyls. Additionally, changes in the enzyme activity of beta-1,3-glucanase, peroxidase (POX), and polyphenol oxidase (PPO) and in the total protein content of soybean cotyledons were determined. In the soybean cultivar 'TMG 132 RR', our results indicated that the methanolic extract of R. guttatus cutaneous secretions suppressed glyceollin synthesis and beta-1,3-glucanase activity and increased POX and PPO activities at higher concentrations and total protein content at a concentration of 0.2 mg/mL. On the other hand, the methanolic extract of R. marina cutaneous secretions induced glyceollin synthesis in the soybean cultivars 'TMG 132 RR' and 'Monsoy 8372 IPRO' at 0.1-0.2 mg/mL and 0.2 mg/mL, respectively. The methanolic extract of R. marina cutaneous secretions also increased the specific activity of POX and PPO in 'Monsoy 8372 IPRO' and 'TMG 132 RR', respectively, and decreased the activity of beta-1,3-glucanases in 'Monsoy 8372 IPRO'. At 0.3 mg/mL, it stimulated phaseolin synthesis. The extracts did not express bioactivity in the synthesis of deoxyanthocyanidins in sorghum mesocotyls. The study in soybean suggests that the bioactivity in defense responses is influenced by cultivar genotypes. Therefore, these results provide evidence that extracts of cutaneous secretions of these amphibians species may contribute to the bioactivity of defense metabolites in plants.	[Raasch-Fernandes, Livia Deice] Univ Fed Mato Grosso, Postgrad Program Environm Sci, Sinop, MG, Brazil; [Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus] Univ Fed Mato Grosso, Sinop, MG, Brazil; [Bonaldo, Solange Maria; Rodrigues, Domingos de Jesus] Postgrad Program Environm Sci, Sinop, MG, Brazil; [Vieira-Junior, Gerardo Magela] Univ Fed Piaui, Ministro Petronio Portela Campus, Teresina, Piaui State, Brazil; [Freitas Schwan-Estrada, Katia Regina] Univ Estadual Maringa, Maringa, Parana, Brazil; [da Silva, Camila Rocco] Univ Estadual Maringa, Grad Program Agron, Maringa, Parana, Brazil; [Araujo Vercosa, Ana Gabriela; de Oliveira, Daiane Lopes] Univ Fed Mato Grosso, Inst Agr & Environm Sci, Sinop, MG, Brazil; [Debiasi, Bryan Wender] Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, MG, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal do Piaui; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Bonaldo, SM (corresponding author), Univ Fed Mato Grosso, Sinop, MG, Brazil.; Bonaldo, SM (corresponding author), Postgrad Program Environm Sci, Sinop, MG, Brazil.	sbonaldo@ufmt.br	Junior, Gerardo Magela Vieira/W-7465-2019; Rodrigues, Domingos/D-6039-2013; Vieira, Gerardo Magela/AAP-2228-2021; Bonaldo, Solange Maria/N-1909-2019; Debiasi, Bryan Wender/ABD-2179-2021; Debiasi, Bryan Wender/M-2140-2018	Rodrigues, Domingos/0000-0002-8360-2036; Vieira, Gerardo Magela/0000-0001-8113-8957; Bonaldo, Solange Maria/0000-0002-2240-2700; Debiasi, Bryan Wender/0000-0001-8926-2362; Schwan Estrada, Katia Regina Freitas/0000-0001-8384-8557; /0000-0002-0062-525X	Foundation for Research Support of the State of Mato Grosso (FAPEMAT) [219465/2015]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Scientific and Technological Development (CNPq); Foundation for Research Support of the State of Mato Grosso (FAPEMAT)	Foundation for Research Support of the State of Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	Foundation for Research Support of the State of Mato Grosso (FAPEMAT) for the financial support to the project (Process No. 219465/2015). URL: http://www.fapemat.mt.gov.br. Coordination for the Improvement of Higher Education Personnel (CAPES) with the provision of a scholarship during the period of the Graduate Program in Environmental Sciences (PPGCAM). URL http://www.capes.gov.br. (Author: L.D.R.F). National Council of Scientific and Technological Development (CNPq) with the concession of scientific initiation grants. URL: http://cnpq.br. (Authors: A.G.A.V and D.L.O) Foundation for Research Support of the State of Mato Grosso (FAPEMAT) for the provision of a scientific initiation grant (Author: B.W.D). URL: http://www.fapemat.mt.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeil K, 2013, FRONT PLANT SCI, V4, P1; Ahmad I, 2013, AM-EURASIAN J AGRIC, V13, P539, DOI [10.5829/idosi.aejaes.2013.13.04.1975, DOI 10.5829/idosi.aejaes.2013.13.04.1975]; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; ARRUDA R. S., 2012, BIOSCI J, V28, P164; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Baldin D, 2013, C BRASILEIRO AGROECO, V8, P1; Banfi FF, 2016, KOREAN J PARASITOL, V54, P415, DOI 10.3347/kjp.2016.54.4.415; Barcelos RA, 2015, THESIS; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennecke K, 2015, REV AGROGEOAMBIENTAL, V7, P19, DOI 10.18406/2316-1817v7n42015786; Bucar F, 2013, NAT PROD REP, V30, P525, DOI 10.1039/c3np20106f; Chen Y, 2017, J CHEM INF MODEL, V57, P2099, DOI 10.1021/acs.jcim.7b00341; Chen YH, 2015, ANNU REV ENTOMOL, V60, P35, DOI 10.1146/annurev-ento-010814-020601; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cui XY, 2010, BIOL PHARM BULL, V33, P1728, DOI 10.1248/bpb.33.1728; Cabral LD, 2013, INT J FOOD MICROBIOL, V166, P1, DOI 10.1016/j.ijfoodmicro.2013.05.026; Curvelo CRD, 2013, BRAGANTIA, V72, P41, DOI 10.1590/S0006-87052013005000017; Solino AJD, 2017, REV CAATINGA, V30, P1073, DOI 10.1590/1983-21252017v30n429rc; Melo LGD, 2016, PESQUI AGROPECU BRAS, V51, P1703, DOI [10.1590/S0100-204X2016001000001, 10.1590/s0100-204x2016001000001]; De Sousa LQ, 2017, TOXICON, V127, P63, DOI 10.1016/j.toxicon.2017.01.004; Delaunois B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00249; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; Duangmal K, 1999, FOOD CHEM, V64, P351, DOI 10.1016/S0308-8146(98)00127-7; Durango D, 2013, MOLECULES, V18, P10609, DOI 10.3390/molecules180910609; Ferreira DF., 2008, REV S, V6, P36, DOI DOI 10.1080/00103620903261577; Fesel PH, 2016, FUNGAL GENET BIOL, V90, P53, DOI 10.1016/j.fgb.2015.12.004; Filho GAC, 2005, TOXICON, V45, P777, DOI 10.1016/j.toxicon.2005.01.017; Fishal EMM, 2010, AGR SCI CHINA, V9, P1140, DOI 10.1016/S1671-2927(09)60201-7; Gao HM, 2010, J ETHNOPHARMACOL, V131, P368, DOI 10.1016/j.jep.2010.07.017; Garcia-Mier L, 2013, INT J MOL SCI, V14, P4203, DOI 10.3390/ijms14024203; Goel Navodit, 2015, Archives of Phytopathology and Plant Protection, V48, P555, DOI 10.1080/03235408.2015.1075296; Gozzo F, 2013, J AGR FOOD CHEM, V61, P12473, DOI 10.1021/jf404156x; Grant T, 2012, CHEMOECOLOGY, V22, P169, DOI 10.1007/s00049-012-0107-9; GUIMARÃES SS, 2015, Rev. bras. plantas med., V17, P143, DOI 10.1590/1983-084X/12_190; Heinrich M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P351; Jain S, 2015, ADV PLANTS AGR RES, V3, P1, DOI DOI 10.15406/apar.2015.03.00077; Jeandet P, 2015, MOLECULES, V20, P2770, DOI 10.3390/molecules20022770; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; Jeandet P, 2013, INT J MOL SCI, V14, P14136, DOI 10.3390/ijms140714136; Jiang L, 2015, PLOS ONE, V10, P1; Kamboj A., 2013, INT J PHARM PHARM SC, V5, P20; Kandasamy R, 2017, INSECT BIOCHEM MOLEC, V84, P32, DOI 10.1016/j.ibmb.2017.03.005; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Lahlou M., 2013, PHARM PHARMACOL-RUSS, V4, P17, DOI [10.4236/pp.2013.43A003, DOI 10.4236/PP.2013.43A003]; Lavanya SN, 2016, INT J LIFE SCI, V5, P46; Li BJ, 2015, FITOTERAPIA, V105, P7, DOI 10.1016/j.fitote.2015.05.013; Li YF, 2014, PROTEOMICS, V14, P1088, DOI 10.1002/pmic.201300104; Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019; Liu YC, 2014, MOLECULES, V19, P568, DOI 10.3390/molecules19010568; Llorens E, 2017, SCI AGR, V74, P90, DOI [10.1590/1678-992x-2016-0012, 10.1590/1678-992X-2016-0012]; Lo SCC, 1999, PHYSIOL MOL PLANT P, V55, P263, DOI 10.1006/pmpp.1999.0231; Loiseleur O, 2017, CHIMIA, V71, P810, DOI 10.2533/chimia.2017.810; Lusso Marcos F. G., 1999, Summa Phytopathologica, V25, P244; Matiello J., 2013, Rev. bras. plantas med., V15, P541, DOI 10.1590/S1516-05722013000400010; Matiello J, 2016, REV AGRONEGOCIO MEIO, V9, P617; Mazaro S. M., 2015, Revista Brasileira de Ciencias Agrarias (Agraria), V10, P512, DOI 10.5039/agraria.v10i4a5190; Mazaro S.M., 2013, Rev. bras. plantas med., V15, P208, DOI 10.1590/S1516-05722013000200007; Meinerz C.C, 2014, Rev. bras. plantas med., V16, P794, DOI 10.1590/1983-084X/10_091; Mishra BB., 2017, MICROBIAL BIOTECHNOL, V1, P29, DOI DOI 10.1111/1751-7915.12231; Moreira D, 2016, CURR DRUG TARGETS, V17, P942, DOI 10.2174/1389450116666150416120559; Nascimento J., 2014, AGRARIANACADEMY, V1, P234, DOI [10.18677/Agrarian_Academy_2014_021, DOI 10.18677/AGRARIAN_ACADEMY_2014_021]; Oliveira J. S. B., 2014, African Journal of Agricultural Research, V9, P971; Owen WJ, 2017, PEST MANAG SCI, V73, P2005, DOI 10.1002/ps.4588; Park HL, 2013, PHYTOCHEMISTRY, V96, P57, DOI 10.1016/j.phytochem.2013.08.012; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; PAULA C. S., 2015, Rev. bras. plantas med., V17, P577, DOI 10.1590/1983-084X/13_079; Peiter-Beninca C., 2008, Arq. Inst. Biol., V75, P285, DOI 10.1590/1808-1657v75p2852008; Cordova WHP, 2016, TOXICON, V110, P27, DOI 10.1016/j.toxicon.2015.11.015; Phitaktim S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0814-4; Ferreira PMP, 2013, TOXICON, V72, P43, DOI 10.1016/j.toxicon.2013.06.009; Poloni A, 2014, MOLECULES, V19, P9114, DOI 10.3390/molecules19079114; Purkayastha RP, 2017, HDB PHYTOALEXIN META, P1; Puschett JB, 2010, AM J KIDNEY DIS, V56, P359, DOI 10.1053/j.ajkd.2010.01.023; Qi FH, 2011, INT IMMUNOPHARMACOL, V11, P342, DOI 10.1016/j.intimp.2010.12.007; Racchi ML, 2013, ANTIOXIDANTS-BASEL, V2, P340, DOI 10.3390/antiox2040340; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodriguez C, 2017, J ETHNOPHARMACOL, V198, P235, DOI 10.1016/j.jep.2016.12.021; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Romanazzi G, 2002, J FOOD SCI, V67, P1862, DOI 10.1111/j.1365-2621.2002.tb08737.x; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saul N, 2013, CHEMOSPHERE, V93, P1005, DOI 10.1016/j.chemosphere.2013.05.069; Schmeda-Hirschmann G, 2014, J ETHNOPHARMACOL, V155, P1076, DOI 10.1016/j.jep.2014.06.025; Schmelz EA, 2014, PLANT J, V79, P659, DOI 10.1111/tpj.12436; Schwan-Estrada K.R.F., 2008, PLANT PATHOGEN INTER, P227; Shen JH, 2003, CURR MED CHEM, V10, P2327, DOI 10.2174/0929867033456729; Singh R., 2017, INT J CURR MICROBIOL, V6, P125, DOI [10.20546/ijcmas.2017.601.016, DOI 10.20546/IJCMAS.2017.601.016]; Sparks TC, 2017, PEST MANAG SCI, V73, P700, DOI 10.1002/ps.4458; Stangarlin JR., 2011, SCI AGRARIA PARANAEN, V6, P18, DOI DOI 10.1818/SAP.V10I1.5268; Sun DQ, 2013, SCI HORTIC-AMSTERDAM, V164, P484, DOI 10.1016/j.scienta.2013.10.011; Taranto F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020377; Telaxka FJ, 2014, EUCALYPTUS GLOBULUS, V9, P1; Thakur Meenakshi, 2013, ISRN Biochem, V2013, P762412, DOI 10.1155/2013/762412; Tian HY, 2013, J NAT PROD, V76, P1842, DOI 10.1021/np400174f; Usman MG, 2018, PJSRR, V4, P54; VOGELSANG R, 1993, PLANTA, V189, P60, DOI 10.1007/BF00201344; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Wang DL, 2011, CHEM BIODIVERS, V8, P559, DOI 10.1002/cbdv.201000283; Wojtasik W, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-10; Wulff N. A., 1998, Scientia Agricola, V55, P138, DOI 10.1590/S0103-90161998000100022; Xu HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658531; Yuan B, 2016, ONCOL REP, V36, P1377, DOI 10.3892/or.2016.4946; Zernova OV, 2014, MOLECULES, V19, P7480, DOI 10.3390/molecules19067480; Zhang DF, 2015, J AGR FOOD CHEM, V63, P7399, DOI 10.1021/acs.jafc.5b01566; Zhang DL, 1998, J HORTIC SCI BIOTECH, V73, P763, DOI 10.1080/14620316.1998.11511045; Zhang HY, 2014, J AGR FOOD CHEM, V62, P4214, DOI 10.1021/jf500065n; Zhu XY, 2006, TUMOR J WORLD, V5, P272; ZIEGLER E, 1982, PHYSIOL PLANT PATHOL, V20, P321, DOI 10.1016/0048-4059(82)90057-1	110	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211020	10.1371/journal.pone.0211020	http://dx.doi.org/10.1371/journal.pone.0211020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653617	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500098
J	Saberi, P; Ming, K; Legnitto, D; Neilands, TB; Gandhi, M; Johnson, MO				Saberi, Parya; Ming, Kristin; Legnitto, Dominique; Neilands, Torsten B.; Gandhi, Monica; Johnson, Mallory O.			Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study	PLOS ONE			English	Article							REFILL MEASURE; SELF-REPORT; HIV; THERAPY; HAIR; EFAVIRENZ; PATIENT; PLASMA	Due to marked reductions in morbidity and mortality, antiretroviral (ARV) adherence monitoring is of high interest. Researchers and clinicians often resort to the most feasible and cost-effective adherence methods possible, which may result in biased or inaccurate estimates and require the physical presence of a participant at a research or clinic site. The objective of our study was to evaluate the feasibility and acceptability of three objective, innovative, and remote methods to estimate ARV adherence which may be conducted with less time and financial resources in a wide range of clinic and research settings. These three methods included: (a) text-messaged photographs of pharmacy refill dates to measure refill-based adherence, (b) text-messaged photographs of ARV medications to estimate pill-count-based adherence, and (c) home-collected hair samples for the measurement of ARV concentration to determine pharmacologic-based adherence. We conducted a pilot study from March through October 2017 to examine the feasibility and acceptability of these three adherence measures and the remotely conducted study procedures in 93 adults living with HIV nationwide. From our diverse national sample of participants, 95.7% were retained until the end of the study, 89.9% sent all text messages, and 84.3% sent all hair samples. Approximately 74.2% of participants reported excellent overall experience with the study, 60.2% were very or extremely satisfied with participating in a hair collection study, and 76.3% noted extremely high likelihood of participating in a similar study including text messaging pictures of medications or refill dates. We noted high levels of feasibility and acceptability with the remote study methodology, collection of photographed and text messaged pharmacy refill dates and pill counts, and home-collected hair samples. Here we describe the feasibility and acceptability metrics, results from the exit qualitative interviews with the participants, and lessons learned. These adherence measures represent innovative approaches to expand monitoring tools for HIV treatment and prevention adherence in future research.	[Saberi, Parya; Ming, Kristin; Legnitto, Dominique; Neilands, Torsten B.; Johnson, Mallory O.] Univ Calif San Francisco, Div Prevent Sci, Dept Med, San Francisco, CA USA; [Gandhi, Monica] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Saberi, P (corresponding author), Univ Calif San Francisco, Div Prevent Sci, Dept Med, San Francisco, CA USA.	parya.saberi@ucsf.edu			National Institute of Mental Health [R21MH108414, K23MH097649, K24DA037034]; National Institute of Allergy and Infectious Diseases [R01AI098472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R21MH108414, K23MH097649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA037034] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml), R21MH108414, to PS; by the National Institute of Mental Health, K23MH097649 to PS; by the National Institute of Mental Health, K24DA037034, to MOJ; by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), R01AI098472, to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J INFECT DIS, V206, P1453, DOI [10.1093/infdis/jis508, DOI 10.1093/INFDIS/JIS508]; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bangsberg DR., 2001, AIDS BEHAV, V5, P275, DOI DOI 10.1023/A:1011396711486; Beumer JH, 2001, INT J CLIN PRACT, V55, P353; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; DiFrancesco R, 2013, CLIN PHARMACOL THER, V93, P479, DOI 10.1038/clpt.2013.62; Duong M, 2001, CLIN INFECT DIS, V33, P386, DOI 10.1086/321876; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/00126334-200207010-00009, 10.1097/01.QAI.0000014768.35851.DB]; Kalichman SC, 2008, HIV CLIN TRIALS, V9, P298, DOI 10.1310/hct0905-298; Kalichman SC, 2007, J GEN INTERN MED, V22, P1003, DOI 10.1007/s11606-007-0171-y; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Miles M., 2013, QUALITATIVE DATA ANA; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Saberi P, 2008, AIDS CARE, V20, P741, DOI 10.1080/09540120701694006; Saberi P, 2018, PATIENT PREFER ADHER, V12, P1033, DOI 10.2147/PPA.S166380; Saberi P, 2017, JAIDS-J ACQ IMM DEF, V76, pE101, DOI 10.1097/QAI.0000000000001492; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017	24	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210791	10.1371/journal.pone.0210791	http://dx.doi.org/10.1371/journal.pone.0210791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645641	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200054
J	Mukai, R; Park, DH; Okunuki, Y; Hasegawa, E; Klokman, G; Kim, CB; Krishnan, A; Gregory-Ksander, M; Husain, D; Miller, JW; Connor, KM				Mukai, Ryo; Park, Dong Ho; Okunuki, Yoko; Hasegawa, Eiichi; Klokman, Garrett; Kim, Clifford B.; Krishnan, Anitha; Gregory-Ksander, Meredith; Husain, Deeba; Miller, Joan W.; Connor, Kip M.			Mouse model of ocular hypertension with retinal ganglion cell degeneration	PLOS ONE			English	Article							AUTOMATED KINETIC PERIMETRY; ELEVATED INTRAOCULAR-PRESSURE; ANGLE-CLOSURE; EXPERIMENTAL GLAUCOMA; FIELD DEFECTS; IRIS ATROPHY; DEATH; SUSCEPTIBILITY; PROTECTION; MUTATIONS	Objectives Ocular hypertension is a primary risk factor for glaucoma and results in retinal ganglion cell (RGC) degeneration. Current animal models of glaucoma lack severe RGC cell death as seen in glaucoma, making assessment of physiological mediators of cell death difficult. We developed a modified mouse model of ocular hypertension whereby long-lasting elevation of intraocular pressure (IOP) is achieved, resulting in significant reproducible damage to RGCs. Results In this model, microbeads are mixed with hyaluronic acid and injected into the anterior chamber of C57BL/6J mice. The hyaluronic acid allows for a gradual release of microbeads, resulting in sustained blockage of Schlemm's canal. IOP elevation was bimodal during the course of the model's progression. The first peak occurred 1 hours after beads injection, with an IOP value of 44.69 +/- 6.00 mmHg, and the second peak occurred 6-12 days post-induction, with an IOP value of 34.91 +/- 5.21 mmHg. RGC damage was most severe in the peripheral retina, with a loss of 64.1% compared to that of untreated eyes, while the midperiphery exhibited a 32.4% loss, 4 weeks following disease induction. Conclusions These results suggest that sustained IOP elevation causes more RGC damage in the periphery than in the midperiphery of the retina. This model yields significant and reproducible RGC degeneration.	[Mukai, Ryo; Park, Dong Ho; Okunuki, Yoko; Klokman, Garrett; Kim, Clifford B.; Husain, Deeba; Miller, Joan W.; Connor, Kip M.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02115 USA; [Mukai, Ryo] Gunma Univ, Dept Ophthalmol, Grad Sch Med Sci, Maebashi, Gunma, Japan; [Park, Dong Ho] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Ophthalmol, Sch Med, Daegu, South Korea; [Hasegawa, Eiichi] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Krishnan, Anitha; Gregory-Ksander, Meredith] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Gunma University; Kyungpook National University; Kyungpook National University Hospital; Kyushu University; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Connor, KM (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02115 USA.	Kip_Connor@meei.harvard.edu	Gregory-Ksander, Meredith/AAG-1413-2019; Okunuki, Yoko/ABE-8090-2020	Gregory-Ksander, Meredith/0000-0002-7193-0032; Okunuki, Yoko/0000-0002-1612-7925; Mukai, Ryo/0000-0003-1796-9232; Husain, Deeba/0000-0002-8494-0950	Research to Prevent Blindness; Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary; Massachusetts Lions Eye Research Fund; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03027966]; Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1501];  [R01EY022084/S1]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary; Massachusetts Lions Eye Research Fund; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; 	This study was supported by a Special Scholar Award (to K.M.C.), Medical Student Fellowship Grant (to C.B.K.), and an unrestricted grant (to J.W.M.) from Research to Prevent Blindness; Special thanks to the Harvard Department of Ophthalmology and Massachusetts Eye and Ear Infirmary for supporting this research (K.M.C.); the Massachusetts Lions Eye Research Fund (KMC); and by Grants R01EY022084/S1 (to K.M.C.) and by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2017R1D1A1B03027966) (to D.H.P), and the Korea Health Technology R&D Project of the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C1501) (to D.H.P).	Agarwal A MD., 2012, GASS ATLAS MACULAR D, P437; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Andreatta W, 2014, J GLAUCOMA, V23, P206, DOI 10.1097/IJG.0000000000000042; ARMALY MF, 1980, ARCH OPHTHALMOL-CHIC, V98, P2163, DOI 10.1001/archopht.1980.01020041015002; Bailey Freund DS K, 2017, THE RETINAL ATLAS, P493; BALLON BJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P1730, DOI 10.1001/archopht.1992.01080240070033; Bayer AU, 2001, EXP EYE RES, V72, P667, DOI 10.1006/exer.2001.1004; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chatterjee A, 2013, EXP EYE RES, V115, P106, DOI 10.1016/j.exer.2013.06.017; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Garway-Heath DF, 2013, OPHTHALMOLOGY, V120, P68, DOI 10.1016/j.ophtha.2012.07.028; Ito YA, 2016, JOVE-J VIS EXP, DOI 10.3791/53731; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kiyota N, 2015, CLIN EXP OPHTHALMOL, V43, P841, DOI 10.1111/ceo.12562; Klatt C, 2010, OPHTHALMOLOGE, V107, P446, DOI 10.1007/s00347-009-2018-x; Krishnan A, 2016, J IMMUNOL, V197, P4626, DOI 10.4049/jimmunol.1601488; Kuroiwa S, 1998, INVEST OPHTH VIS SCI, V39, P610; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lau LI, 2003, OPHTHALMOLOGY, V110, P1890, DOI 10.1016/S0161-6420(03)00666-3; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Ma J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125695; Matsumoto Y, 2014, JPN J OPHTHALMOL, V58, P290, DOI 10.1007/s10384-014-0311-y; Michaelides M, 2010, J GLAUCOMA, V19, P643, DOI 10.1097/IJG.0b013e3181d12dea; MILLER KN, 1989, ARCH OPHTHALMOL-CHIC, V107, P1316, DOI 10.1001/archopht.1989.01070020386041; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Pease ME, 2011, INVEST OPHTH VIS SCI, V52, P858, DOI 10.1167/iovs.10-5556; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rovere G, 2016, INVEST OPHTH VIS SCI, V57, P6652, DOI 10.1167/iovs.16-20146; Samsel PA, 2011, INVEST OPHTH VIS SCI, V52, P1671, DOI 10.1167/iovs.09-3921; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Smedowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05910; SONTY S, 1981, OPHTHALMOLOGY, V88, P225; Stephen J., 2013, RETINA, P1039; STEWART WC, 1988, ARCH OPHTHALMOL-CHIC, V106, P202; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vidal-Sanz M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00235; WERNER EB, 1979, OPHTHALMOLOGY, V86, P1875; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Yokoyama Y, 2014, BIOCHEM BIOPH RES CO, V451, P510, DOI 10.1016/j.bbrc.2014.08.009; Zhu YL, 2013, MOL VIS, V19, P2360	58	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208713	10.1371/journal.pone.0208713	http://dx.doi.org/10.1371/journal.pone.0208713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640920	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000007
J	Quaglia, D; Alejaldre, L; Ouadhi, S; Rousseau, O; Pelletier, JN				Quaglia, Daniela; Alejaldre, Lorea; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.			Holistic engineering of Cal-A lipase chain-length selectivity identifies triglyceride binding hot-spot	PLOS ONE			English	Article							CANDIDA-ANTARCTICA LIPASE; DIRECTED EVOLUTION; FATTY-ACIDS; SATURATED MEDIUM; COMBINATORIAL; BIOCATALYSTS; HYDROLYSIS; STRATEGIES; ENZYMES; ASSAY	Through the application of a region-focused saturation mutagenesis and randomization approach, protein engineering of the Cal-A enzyme was undertaken with the goal of conferring new triglyceride selectivity. Little is known about the mode of triglyceride binding to Cal-A. Engineering Cal-A thus requires a systemic approach. Targeted and randomized Cal-A libraries were created, recombined using the Golden Gate approach and screened to detect variants able to discriminate between long-chain (olive oil) and short-chain (tributyrin) triglyceride substrates using a high-throughput in vivo method to visualize hydrolytic activity. Discriminative variants were analyzed using an in-house script to identify predominant substitutions. This approach allowed identification of variants that exhibit strong discrimination for the hydrolysis of short-chain triglycerides and others that discriminate towards hydrolysis of long-chain triglycerides. A clear pattern emerged from the discriminative variants, identifying the 217-245 helix-loop-helix motif as being a hot-spot for triglyceride recognition. This was the consequence of introducing the entire mutational load in selected regions, without putting a strain on distal parts of the protein. Our results improve our understanding of the Cal-A lipase mode of action and selectivity. This holistic perspective to protein engineering, where parts of the gene are individually mutated and the impact evaluated in the context of the whole protein, can be applied to any protein scaffold.	[Quaglia, Daniela; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ, Canada; [Quaglia, Daniela; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] Univ Montreal, CGCC, Montreal, PQ, Canada; [Quaglia, Daniela; Alejaldre, Lorea; Ouadhi, Sara; Rousseau, Olivier; Pelletier, Joelle N.] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Alejaldre, Lorea; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Pelletier, JN (corresponding author), Univ Montreal, Dept Chim, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, CGCC, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ, Canada.	joelle.pelletier@umontreal.ca		Quaglia, Daniela/0000-0003-3756-3782; Alejaldre, Lorea/0000-0003-3086-5446	Natural Sciences and Engineering Research Council of Canada [227853]; Canada Foundation for Innovation [11510]; CGCC; Quebec Centre for Green Chemistry and Catalysis; Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CGCC; Quebec Centre for Green Chemistry and Catalysis; Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This work was supported by Natural Sciences and Engineering Research Council of Canada grant 227853 to JNP and Canada Foundation for Innovation grant 11510 to JNP. SO received a scholarship from CGCC, the Quebec Centre for Green Chemistry and Catalysis, which is funded by les Fonds Quebecois pour la Recherche sur la Nature et les Technologies (FQRNT).	Akanbi TO, 2017, FOOD CHEM, V229, P509, DOI 10.1016/j.foodchem.2017.02.099; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Borrelli GM, 2015, INT J MOL SCI, V16, P20774, DOI 10.3390/ijms160920774; Boskou D., 2006, OLIVE OIL COMPOSITIO, DOI [10.4324/9781003040217, DOI 10.4324/9781003040217]; Brundiek H, 2012, EUR J LIPID SCI TECH, V114, P1148, DOI 10.1002/ejlt.201200106; Brundiek HB, 2012, ANGEW CHEM INT EDIT, V51, P412, DOI 10.1002/anie.201106126; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Cozens C, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky067; Damborsky J, 2009, CURR OPIN CHEM BIOL, V13, P26, DOI 10.1016/j.cbpa.2009.02.021; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; Denard CA, 2015, CURR OPIN CHEM BIOL, V25, P55, DOI 10.1016/j.cbpa.2014.12.036; Divakar K, 2014, ANAL BIOCHEM, V448, P38, DOI 10.1016/j.ab.2013.11.031; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Ericsson DJ, 2008, J MOL BIOL, V376, P109, DOI 10.1016/j.jmb.2007.10.079; Gillam EMJ, 2014, METHODS MOL BIOL, V1179, P1, DOI 10.1007/978-1-4939-1053-3; He YJ, 2017, FOOD CHEM, V219, P230, DOI 10.1016/j.foodchem.2016.09.149; JOERGER RD, 1994, LIPIDS, V29, P377, DOI 10.1007/BF02537305; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Li Y, 2014, BIOTECHNOL BIOENG, V111, P1273, DOI 10.1002/bit.25240; Miettinen H, 2013, INT DAIRY J, V32, P61, DOI 10.1016/j.idairyj.2013.05.007; Nyyssola A, 2015, INT DAIRY J, V41, P16, DOI 10.1016/j.idairyj.2014.09.003; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Porter JL, 2016, CHEMBIOCHEM, V17, P197, DOI 10.1002/cbic.201500280; Quaglia D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171741; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Scrutton NS, 2017, IUCRJ, V4, P5, DOI 10.1107/S2052252516019692; Stoytcheva M, 2012, CURR ANAL CHEM, V8, P400, DOI 10.2174/157341112801264879; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanaka S, 2018, ACS CHEM BIOL, V13, P1487, DOI 10.1021/acschembio.8b00384; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Zorn K, 2018, ADV SYNTH CATAL, V360, P4115, DOI 10.1002/adsc.201800889	38	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210100	10.1371/journal.pone.0210100	http://dx.doi.org/10.1371/journal.pone.0210100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640952	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000018
J	Conley, ZC; Carlson-Banning, KM; Carter, AG; de la Cova, A; Song, YC; Zechiedrich, L				Conley, Zachary C.; Carlson-Banning, Kimberly M.; Carter, Ashley G.; de la Cova, Alejandro; Song, Yongcheng; Zechiedrich, Lynn			Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; ACINETOBACTER-BAUMANNII; SWARMING MOTILITY; VIRULENCE FACTORS; RCS PHOSPHORELAY; GENE-REGULATION; OUTER-MEMBRANE; POLYMYXIN-B; LIPOPOLYSACCHARIDE; OLAMINE	New antibiotics are needed against antibiotic-resistant gram-negative bacteria. The repurposed antifungal drug, ciclopirox, equally blocks antibiotic-susceptible or multidrug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates, indicating that it is not affected by existing resistance mechanisms. Toward understanding how ciclopirox blocks growth, we screened E. coli mutant strains and found that disruption of genes encoding products involved in galactose salvage, enterobacterial common antigen synthesis, and transport of the iron binding siderophore, enterobactin, lowered the minimum inhibitory concentration of ciclopirox needed to block growth of the mutant compared to the isogenic parent strain. We found that ciclopirox induced enterobactin production and that this effect is strongly affected by the deletion of the galactose salvage genes encoding UDP-galactose 4-epimerase, galE, or galactose-1-phosphate uridylyltransferase, galT. As disruption of ECA synthesis activates the regulation of capsular synthesis (Rcs) phosphorelay, which inhibits bacterial swarming and promotes biofilm development, we test whether ciclopirox prevents activation of the Rcs pathway. Sub-inhibitory concentrations of ciclopirox increased swarming of the E. coli laboratory K12 strain BW25113 but had widely varying effects on swarming or surface motility of clinical isolate E. coli, A. baumannii, and K. pneumoniae. There was no effect of ciclopirox on biofilm production, suggesting it does not target Rcs. Altogether, our data suggest ciclopirox-mediated alteration of lipopolysaccharides stimulates enterobactin production and affects bacterial swarming.	[Conley, Zachary C.; Carlson-Banning, Kimberly M.; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Conley, Zachary C.; Carlson-Banning, Kimberly M.; Carter, Ashley G.; de la Cova, Alejandro; Zechiedrich, Lynn] Baylor Coll Med, Dept Virol & Microbiol, Houston, TX 77030 USA; [de la Cova, Alejandro] Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Song, Yongcheng; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Carlson-Banning, Kimberly M.] Univ Texas Southwestern, Dallas, TX USA; [Carter, Ashley G.] Alabama Coll Osteopath Med, Dothan, AL USA	Baylor College of Medicine; Baylor College of Medicine; State University System of Florida; University of Florida; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019	Zechiedrich, Lynn/0000-0003-0533-1637	National Institutes of Health [R01 GM115501]; Molecular Basis of Infectious Diseases [T32 AI55449]; CPRIT grant [RP160283]; Baylor-UT Houston CFAR [P30AI1036211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Basis of Infectious Diseases; CPRIT grant; Baylor-UT Houston CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM115501 (to L.Z.). Z.C.C. was supported, in part, by the Molecular Basis of Infectious Diseases grant T32 AI55449 (Norris S and Koehler TM, co-PIs). A.d.l.C. and A. G.C. were participants of the Baylor College of Medicine SMART program supported by the CPRIT grant RP160283 and the Baylor-UT Houston CFAR grant P30AI1036211, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; ALPERMANN HG, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1328; Armbruster CE, 2013, J BACTERIOL, V195, P1305, DOI 10.1128/JB.02136-12; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Bernier KM, 2018, ANTIVIR RES, V156, P102, DOI 10.1016/j.antiviral.2018.06.010; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Carabarin-Lima A, 2016, J MED MICROBIOL, V65, P729, DOI 10.1099/jmm.0.000291; Carlson-Banning KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069646; Castelli ME, 2011, J BACTERIOL, V193, P63, DOI 10.1128/JB.00839-10; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Conley ZC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006805; COPPI G, 1992, FARMACO, V47, P779; COPPI G, 1993, J CHEMOTHERAPY, V5, P302; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; EVANS ME, 1993, J INFECT DIS, V167, P1336, DOI 10.1093/infdis/167.6.1336; Fernandez L, 2013, ANTIMICROB AGENTS CH, V57, P110, DOI 10.1128/AAC.01583-12; Folsom JP, 2014, J BACTERIOL, V196, P2748, DOI 10.1128/JB.01606-14; Frawley ER, 2014, MOL MICROBIOL, V93, P609, DOI 10.1111/mmi.12709; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Hanauske-Abel HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074414; Harding CM, 2018, NAT REV MICROBIOL, V16, P91, DOI 10.1038/nrmicro.2017.148; Harshey RM, 2015, J MOL BIOL, V427, P3683, DOI 10.1016/j.jmb.2015.07.025; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Horiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108642; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Jayaseelan S, 2014, WORLD J MICROB BIOT, V30, P1159, DOI 10.1007/s11274-013-1552-5; Caceres CJ, 2016, ANTIVIR RES, V134, P192, DOI 10.1016/j.antiviral.2016.09.006; Jorgenson MA, 2016, MOL MICROBIOL, V100, P1, DOI 10.1111/mmi.13284; Kalynych S, 2015, PROTEIN SCI, V24, P58, DOI 10.1002/pro.2586; Kalynych S, 2014, FEMS MICROBIOL REV, V38, P1048, DOI 10.1111/1574-6976.12070; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kebouchi M, 2018, J BIOL CHEM, V293, P497, DOI 10.1074/jbc.M117.804443; KELLNER HM, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1337; Kim KS, 2015, J ANTIBIOT, V68, P395, DOI 10.1038/ja.2014.164; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Ko SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027844; Lee SJ, 2014, MBIO, V5, DOI 10.1128/mBio.00972-13; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; McQueary CN, 2012, J MICROBIOL, V50, P434, DOI 10.1007/s12275-012-1555-1; McRose DL, 2018, J BIOL INORG CHEM, V23, P983, DOI 10.1007/s00775-018-1617-x; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mihailidou C, 2017, ONCOTARGET, V9, P10360, DOI [DOI 10.18632/ONCOTARGET.23164, 10.18632/oncotarget.23164]; Mihailidou C, 2017, ANTIOXID REDOX SIGN, V27, P185, DOI 10.1089/ars.2016.6671; Mihailidou C, 2016, PFLUG ARCH EUR J PHY, V468, P1957, DOI 10.1007/s00424-016-1887-5; Minden MD, 2014, AM J HEMATOL, V89, P363, DOI 10.1002/ajh.23640; Moon K, 2009, MOL MICROBIOL, V19, P389, DOI [10.1016/j.asieco.2008.09.006.EAST, DOI 10.1016/J.ASIECO.2008.09.006.EAST]; Morgan-Linnell SK, 2009, ANTIMICROB AGENTS CH, V53, P235, DOI 10.1128/AAC.00665-08; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Morikawa M, 2000, BBA-MOL CELL BIOL L, V1488, P211, DOI 10.1016/S1388-1981(00)00124-4; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051241; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Ogasawara H, 2012, MICROBIOL-SGM, V158, P1482, DOI 10.1099/mic.0.057745-0; Organization WH, 2017, PRIOR PATH GUID DISC; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; POOLE K, 1990, J BACTERIOL, V172, P6991, DOI 10.1128/jb.172.12.6991-6996.1990; Qian JH, 2014, BIOCHEMISTRY-US, V53, P1250, DOI 10.1021/bi4015665; Rahman A, 2001, J BACTERIOL, V183, P6509, DOI 10.1128/JB.183.22.6509-6516.2001; Rangel-Vega A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00282; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Ross KL, 2004, MOL GENET METAB, V83, P103, DOI 10.1016/j.ymgme.2004.07.005; SAKURAI K, 1978, CHEMOTHERAPY, V24, P68, DOI 10.1159/000237762; Santos JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1101, DOI 10.1016/j.bbapap.2015.01.010; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Sen S, 2013, EXP HEMATOL, V41, P799, DOI 10.1016/j.exphem.2013.04.012; Shen Tao, 2018, Genes Cancer, V9, P39, DOI 10.18632/genesandcancer.166; Shen Tao, 2017, Genes Cancer, V8, P505, DOI 10.18632/genesandcancer.135; Shin J, 2018, BIOCHEM BIOPH RES CO, V500, P296, DOI 10.1016/j.bbrc.2018.04.063; Sigle HC, 2005, J ANTIMICROB CHEMOTH, V55, P663, DOI 10.1093/jac/dki089; Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Urquiza P, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7467; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Wayne P.A., 2006, M100S16 CLIN LAB STA; Welch TJ, 2005, INFECT IMMUN, V73, P5864, DOI 10.1128/IAI.73.9.5864-5872.2005; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001; Yuan BS, 2018, MOL MED REP, V17, P4291, DOI 10.3892/mmr.2018.8418; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007; Zhou H, 2017, BIOCHEM PHARMACOL, V116, P39, DOI [10.1016/j.bcp.2016.07, DOI 10.1016/J.BCP.2016.07]; Zhou HY, 2014, ONCOTARGET, V5, P10140, DOI 10.18632/oncotarget.2471; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	101	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210547	10.1371/journal.pone.0210547	http://dx.doi.org/10.1371/journal.pone.0210547			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633761	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100029
J	De Benedictis, A; Lettieri, E; Masella, C; Gastaldi, L; Macchini, G; Santu, C; Tartaglini, D				De Benedictis, Anna; Lettieri, Emanuele; Masella, Cristina; Gastaldi, Luca; Macchini, Giordana; Santu, Camilla; Tartaglini, Daniela			WhatsApp in hospital? An empirical investigation of individual and organizational determinants to use	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; PERCEIVED EASE; HEALTH-CARE; ACCEPTANCE; SMARTPHONES; COMMUNICATION; TELEMEDICINE; MESSENGER; DOCTORS; MEMBERS	The increasing use of messaging applications such as WhatsApp for both social and personal purposes has determined an increase in the widespread use of these technologies, even in healthcare. A growing number of healthcare professionals have adopted WhatsApp in their daily work in order to share information with peers and patients. Past research has highlighted the advantages and disadvantages of WhatsApp usage in healthcare settings; in particular two positions appear to coexist in the scientific debate: those that expose and underline all of the positive aspects of the phenomenon, and those which also highlight the negative aspects, linked in particular to the clinical risks for patients, data security and privacy protection. The main objective of this study was to assess if and how individual and organizational determinants can trigger or inhibit the use of WhatsApp in a hospital setting, and which variables managers can exploit to guide professionals' behaviors. Data were collected through a survey administered to physicians and nurses in an Italian University Hospital in Rome; a total of 191 high-quality responses were received. The results show that WhatsApp is widely used in the Hospital, and that its use is mainly due to the perception of numerous advantages and benefits reported in clinical practice. Moreover, an interplay exists between organizational and individual factors in determining the use of WhatsApp between healthcare professionals and with patients. In particular, individual factors play a key role as determinants of the use of WhatsApp; healthcare professionals use this technology mainly based on its perceived usefulness. Instead, organizational factors play a secondary role; they do not have a direct influence on the use of WhatsApp, but always act through individual factors. This study is the first to analyses the influence of individual and organizational determinants of WhatsApp usage in the hospital setting, and provides hospital managers with important information in order to manage this phenomenon and implement adequate strategies to exploit its potential increase.	[De Benedictis, Anna; Tartaglini, Daniela] Univ Hosp Campus Biomed, Hosp Gen Management, Dept Healthcare Profess, Rome, Italy; [De Benedictis, Anna; Macchini, Giordana; Tartaglini, Daniela] Univ Campus Biomed, Fac Med & Surg, Rome, Italy; [Lettieri, Emanuele; Masella, Cristina; Gastaldi, Luca; Santu, Camilla] Politecn Milan, Dept Econ Management & Ind Engn, Milan, Italy; [De Benedictis, Anna; Tartaglini, Daniela] Univ Hosp Campus Biomed, Dept Healthcare Profess, Rome, Italy; [Macchini, Giordana] Univ Campus Biomed, Dept Nursing, Rome, Italy	University Campus Bio-Medico - Rome Italy; Polytechnic University of Milan; University Campus Bio-Medico - Rome Italy	De Benedictis, A (corresponding author), Univ Hosp Campus Biomed, Hosp Gen Management, Dept Healthcare Profess, Rome, Italy.; De Benedictis, A (corresponding author), Univ Campus Biomed, Fac Med & Surg, Rome, Italy.; De Benedictis, A (corresponding author), Univ Hosp Campus Biomed, Dept Healthcare Profess, Rome, Italy.	a.debenedictis@unicampus.it	Gastaldi, Luca/O-8066-2019; Masella, Cristina/AHA-4620-2022	Gastaldi, Luca/0000-0003-1997-8423; De Benedictis, Anna/0000-0001-8655-0895				Agarwal R, 1999, DECISION SCI, V30, P361, DOI 10.1111/j.1540-5915.1999.tb01614.x; Astarcioglu MA, 2015, AM J EMERG MED, V33, P1382, DOI 10.1016/j.ajem.2015.07.029; Choudhari P, 2014, INT SURG J, V1, P9, DOI 10.5455/2349-2902.isj20140504; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Dhuvad JM, 2015, J CLIN DIAGN RES, V9, pZC22, DOI 10.7860/JCDR/2015/14466.6454; Dorwal P, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0384-2; Giordano V, 2017, INTERACT J MED RES, V6, DOI 10.2196/ijmr.6214; Giordano V, 2015, INT J MED INFORM, V84, P141, DOI 10.1016/j.ijmedinf.2014.11.002; Graziano F, 2015, NEUROREPORT, V26, P602, DOI 10.1097/WNR.0000000000000393; Gulacti U, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0483-8; Haffey F, 2013, DRUG SAFETY, V36, P111, DOI 10.1007/s40264-013-0015-0; Jagannathan Mukund, 2013, Indian J Plast Surg, V46, P506; Johnston MJ, 2015, AM J SURG, V209, P45, DOI 10.1016/j.amjsurg.2014.08.030; Kaliyadan F, 2016, INDIAN J DERMATOL VE, V82, P67, DOI 10.4103/0378-6323.171638; Kamel Boulos Maged N., 2016, Future Internet, V8, DOI 10.3390/fi8030037; Kelahmetoglu O, 2015, J CRANIOFAC SURG, V26, P1437, DOI 10.1097/SCS.0000000000001627; Khanna Vishesh, 2015, Eur J Orthop Surg Traumatol, V25, P821, DOI 10.1007/s00590-015-1600-y; Lee RS, 2008, EMERG MED J, V25, DOI 10.1136/emj.2007.051631; Martinez-Perez B, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0004-y; Martyn-Hemphill C, 2015, J UROLOGY, V193, pE169, DOI 10.1016/j.juro.2015.02.813; Migliore M, 2015, ANN ITAL CHIR, V86, P185; Mobasheri M.H, 2015, BMJ INNOVATION, P1, DOI [10.1136/bmj.j3266, DOI 10.1136/BMJ.J3266]; Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; O'Reilly MK, 2014, IRISH J MED SCI, V183, P573, DOI 10.1007/s11845-013-1053-4; Pandian SS, 2014, J MAXILLOFAC ORAL SU, V13, P355, DOI 10.1007/s12663-013-0497-4; Petruzzi M, 2016, OR SURG OR MED OR PA, V121, P248, DOI 10.1016/j.oooo.2015.11.005; Pinzone M, 2016, J CLEAN PROD, V122, P201, DOI 10.1016/j.jclepro.2016.02.031; Raiman L, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0855-x; Scott W.R, 1995, CINEMA J; SCOTT WR, 1987, ADMIN SCI QUART, V32, P493, DOI 10.2307/2392880; Scott WR, 2003, IND CORP CHANGE, V12, P879, DOI 10.1093/icc/12.4.879; Scott WR, 2008, ORGAN STUD, V29, P2; Suliman MT, 2014, J LOCAL GLOBAL HLTH, V2; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Venkatesh V, 2011, INFORM SYST RES, V22, P523, DOI 10.1287/isre.1110.0383; Wani Shabeer Ahmad, 2013, Indian J Plast Surg, V46, P502, DOI 10.4103/0970-0358.121990; Watson L, 2016, AM J SURG, V211, P302, DOI 10.1016/j.amjsurg.2015.04.017; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382	41	39	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209873	10.1371/journal.pone.0209873	http://dx.doi.org/10.1371/journal.pone.0209873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633754	gold, Green Published, Green Submitted			2022-12-27	WOS:000455485100007
J	Koiv, V; Arbo, K; Maivali, U; Kisand, V; Roosaare, M; Remm, M; Tenson, T				Koiv, Viia; Arbo, Kroot; Maivali, Ulo; Kisand, Veljo; Roosaare, Mart; Remm, Maido; Tenson, Tanel			Endophytic bacterial communities in peels and pulp of five root vegetables	PLOS ONE			English	Article							GUT MICROBIOTA; PLANT; IMPACT; ASSOCIATIONS; RHIZOSPHERE; PROBIOTICS; DIVERSITY; INFECTION; DYNAMICS; DEPENDS	Plants contain endophytic bacteria, whose communities both influence plant growth and can be an important source of probiotics. Here we used deep sequencing of a 16S rRNA gene fragment and bacterial cultivation to independently characterize the microbiomes of five plant species from divergent taxonomic orders-potato (Solanum tuberosum), carrot (Daucus sativus), beet (Beta vulgaris), neep (Brassica napus spp. napobrassica), and topinambur (Helianthus tuberosus). We found that both species richness and diversity tend to be higher in the peel, where Alphaproteobacteria and Actinobacteria dominate, while Gamma-proteobacteria and Firmicutes dominate in the pulp. A statistical analysis revealed that the main characteristic features of the microbiomes of plant species originate from the peel microbiomes. Topinambur pulp displayed an interesting characteristic feature: it contained up to 10(8) CFUs of lactic acid bacteria, suggesting its use as a source of probiotic bacteria. We also detected Listeria sp., in topinambur pulps, however, the 16S rRNA gene fragment is unable to distinguish between pathogenic versus non-pathogenic species, so the evaluation of this potential health risk is left to a future study.	[Koiv, Viia; Arbo, Kroot; Maivali, Ulo; Kisand, Veljo; Tenson, Tanel] Univ Tartu, Inst Technol, Tartu, Estonia; [Roosaare, Mart; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia	University of Tartu; University of Tartu	Koiv, V (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.	viia.koiv@ut.ee	Kisand, Veljo/H-2466-2012; Remm, Maido/L-9072-2019	Kisand, Veljo/0000-0002-5535-1639; Remm, Maido/0000-0003-3966-8422	Estonian Research Council [PUT-134, IUT2-22, IUT34-11]; European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering [SLTTI16143T]	Estonian Research Council(Estonian Research Council); European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering	TT, UM, VK, KA: Estonian Research Council IUT2-22. https://www.etis.ee/Portal/Projects/Display/db4a3ea8-611d-4be5-af16-a18d2d861873?lang= ENG. MR, MRo: Estonian Research Council IUT34-11. https://www.etis.ee/Portal/Projects/Display/2493d2a9-1edf-4a53-a6d1- 9cbf469758c3?lang=ENG. TT, UM: European Union from the European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering SLTTI16143T https://www.etis.ee/Portal/Projects/Display/e6209fe6-9b6a-4a8e-9ad4-89ecc5c60cc2?lang=ENG.Ki: Estonian Research Council PUT-134 https://www.etis.ee/Portal/Projects/Display/08c424fe-696c-45cb-9bc0-fdd02f9af2a2?lang=ENG.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAROUSI ZS, 2016, INT J MICROBIOL, V2016, DOI DOI 10.1155/2016/4292417; Angel R, 2016, MICROB ECOL, V72, P394, DOI 10.1007/s00248-016-0779-8; Bamberger C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020244; Bazanella M, 2017, AM J CLIN NUTR, V106, P1274, DOI 10.3945/ajcn.117.157529; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Berg G, 2014, MICROB BIOTECHNOL, V7, P487, DOI 10.1111/1751-7915.12159; Bergey DH, 2005, BERGEYS MANUAL SYSTE, DOI [10.1345/aph.1P777, DOI 10.1345/APH.1P777]; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Browne HP, 2017, NAT REV MICROBIOL, V15, P531, DOI 10.1038/nrmicro.2017.50; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dees MW, 2015, APPL ENVIRON MICROB, V81, P1530, DOI 10.1128/AEM.03470-14; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Edwards JA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003862; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Fragiadakis GK, 2019, GUT MICROBES, V10, P216, DOI 10.1080/19490976.2018.1494103; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Gharechahi J, 2017, MICROB BIOTECHNOL, V10, P1663, DOI 10.1111/1751-7915.12751; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gurry T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30783-1; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hale VL, 2018, MICROB ECOL, V75, P515, DOI 10.1007/s00248-017-1041-8; Hanchi H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01791; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartman K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0220-z; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Izquierdo E, 2009, FOOD MICROBIOL, V26, P16, DOI 10.1016/j.fm.2008.08.002; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; Kecskemeti E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160852; Koiv V, 2015, SCI REP-UK, V5, DOI 10.1038/srep11606; Lang JM, 2014, PEERJ, V2, DOI 10.7717/peerj.659; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Lehtimaki J, 2018, P NATL ACAD SCI USA, V115, P4897, DOI 10.1073/pnas.1719785115; Li F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00187; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mezzasalma V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00946; Minervini F, 2015, APPL ENVIRON MICROB, V81, P6736, DOI 10.1128/AEM.01852-15; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Moronta-Barrios F, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010014; Nithya A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0974-x; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Oksanen F.J., 2017, VEGAN COMMUNITY ECOL; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Rascovan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28084; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rosenblueth M, 2004, ARCH MICROBIOL, V181, P337, DOI 10.1007/s00203-004-0661-9; Sanders ME, 2010, GUT MICROBES, V1, P164, DOI 10.4161/gmic.1.3.12127; Santos-Medellin C, 2017, MBIO, V8, DOI [10.1128/mbio.00764-17, 10.1128/mBio.00764-17]; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Seo WT, 2010, J KOREAN SOC APPL BI, V53, P493, DOI 10.3839/jksabc.2010.075; Shortt C, 2018, EUR J NUTR, V57, P25, DOI 10.1007/s00394-017-1546-4; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Warnes G. R, 2016, COMPREHENSIVE R ARCH; Wassermann B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17949-z; World Health Organization, 2015, INCR FRUIT VEG CONS; Xu L, 2018, P NATL ACAD SCI USA, V115, pE4284, DOI 10.1073/pnas.1717308115; Yeoh YK, 2016, ENVIRON MICROBIOL, V18, P1338, DOI 10.1111/1462-2920.12925; Zhang CH, 2016, ISME J, V10, P2235, DOI 10.1038/ismej.2016.13; Zhang YZ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0304-4	79	14	14	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210542	10.1371/journal.pone.0210542	http://dx.doi.org/10.1371/journal.pone.0210542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633764	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100028
J	Liu, JY; Parrish, JR; Hines, J; Mansfield, L; Finley, RL				Liu, Jiayou; Parrish, Jodi R.; Hines, Julie; Mansfield, Linda; Finley, Russell L., Jr.			A proteome-wide screen of Campylobacter jejuni using protein microarrays identifies novel and conformational antigens	PLOS ONE			English	Article							HUMAN-ANTIBODY RESPONSE; MEMBRANE-PROTEIN; SERA; GENE; IMMUNOGENICITY; COLONIZATION; PURIFICATION; INFECTIONS; EXPRESSION; SEQUENCE	Campylobacter jejuni (C. jejuni) is a foodborne intestinal pathogen and major cause of gastroenteritis worldwide. C. jejuni proteins that are immunogenic have been sought for their potential use in the development of biomarkers, diagnostic assays, or subunit vaccines for humans or livestock. To identify new immunogenic C. jejuni proteins, we used a native protein microarray approach. A protein chip, with over 1400 individually purified GST-tagged C. jejuni proteins, representing over 86% of the proteome, was constructed to screen for antibody titers present in test sera raised against whole C. jejuni cells. Dual detection of GST signals was incorporated as a way of normalizing the variation of protein concentrations contributing to the antibody staining intensities. We detected strong signals to 102 C. jejuni antigens. In addition to antigens recognized by antiserum raised against C. jejuni, parallel experiments were conducted to identify antigens cross-reactive to antiserum raised against various serotypes of E. coli or Salmonella or to healthy human sera. This led to the identification of 34 antigens specifically recognized by the C. jejuni antiserum, only four of which were previously known. The chip approach also allowed identification of conformational antigens. We demonstrate in the case of Cj1621 that antigen signals are lost to denaturing conditions commonly used in other approaches to identify immunogens. Antigens identified in this study include those possessing sequence features indicative of cell surface localization, as well as those that do not. Together, our results indicate that the unbiased chip-based screen can help reveal the full repertoire of host antibodies against microbial proteomes.	[Liu, Jiayou; Parrish, Jodi R.; Hines, Julie; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Mansfield, Linda] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA; [Liu, Jiayou] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Wayne State University; Michigan State University; Wayne State University	Finley, RL (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.; Finley, RL (corresponding author), Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA.	rfinley@wayne.edu		Mansfield, Linda S./0000-0002-7523-7577; Finley, Russ/0000-0003-1144-6887	State of Michigan, Michigan Life Sciences Corridor; NIAID, NIH, Department of Health and Human Services [N01-AI-30058]; Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant [U19AI090872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121748] Funding Source: NIH RePORTER	State of Michigan, Michigan Life Sciences Corridor; NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JL, JRP, JH, and RLF, received support for this work from the State of Michigan, Michigan Life Sciences Corridor funding to the Michigan Proteome Consortium; LM received support for all contributions to from the NIAID, NIH, Department of Health and Human Services, under contract no. N01-AI-30058 and Enteric Research Investigational Network Cooperative Research Center (ERIN CRC) grant U19AI090872. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arai M, 2003, GENE, V304, P77, DOI 10.1016/S0378-1119(02)01181-2; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Baqar S, 2008, INFECT IMMUN, V76, P3170, DOI 10.1128/IAI.00076-08; BURNENS A, 1995, J CLIN MICROBIOL, V33, P2826, DOI 10.1128/JCM.33.11.2826-2832.1995; CDC U, 2013, ANTIBIOTIC RESISTANC; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; Chen PC, 2015, MOL CELL PROTEOMICS, V14, P510, DOI 10.1074/mcp.M114.045930; Coelho PSR, 2015, J PROTEOME RES, V14, P3924, DOI 10.1021/acs.jproteome.5b00365; Connerton PL, 1999, LETT APPL MICROBIOL, V28, P233, DOI 10.1046/j.1365-2672.1999.00491.x; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Du LF, 2008, WORLD J GASTROENTERO, V14, P6244, DOI 10.3748/wjg.14.6244; Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172; Haab BB, 2001, GENOME BIOL, V2; Hansson I, 2018, TRANSBOUND EMERG DIS, V65, P30, DOI 10.1111/tbed.12870; He YQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/297505; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; Hoppe S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-12; Hu YQ, 2014, J MICROBIOL BIOTECHN, V24, P363, DOI 10.4014/jmb.1311.11019; Hu YQ, 2013, BBA-GEN SUBJECTS, V1830, P5229, DOI 10.1016/j.bbagen.2013.06.042; Jain R, 2019, INTERDISCIP SCI, V11, P337, DOI 10.1007/s12539-017-0260-5; Kempsell KE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00747; Kuhn KG, 2012, DIAGN MICR INFEC DIS, V74, P113, DOI 10.1016/j.diagmicrobio.2012.06.004; Liang L, 2015, CURR OPIN INFECT DIS, V28, P438, DOI 10.1097/QCO.0000000000000193; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Loshaj-Shala A, 2018, J NEUROIMMUNOL, V317, P77, DOI 10.1016/j.jneuroim.2018.01.006; MacBeath G, 2000, SCIENCE, V289, P1760; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Meunier M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188472; Meunier M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5715790; Miller JC, 2003, PROTEOMICS, V3, P56, DOI 10.1002/pmic.200390009; MILLS SD, 1984, INFECT IMMUN, V43, P739, DOI 10.1128/IAI.43.2.739-743.1984; NACHAMKIN I, 1989, J CLIN MICROBIOL, V27, P2195, DOI 10.1128/JCM.27.10.2195-2198.1989; Nielsen LN, 2012, CLIN VACCINE IMMUNOL, V19, P113, DOI 10.1128/CVI.05161-11; NUIJTEN PJM, 1991, INFECT IMMUN, V59, P1100, DOI 10.1128/IAI.59.3.1100-1105.1991; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Pawelec D, 1997, FEMS IMMUNOL MED MIC, V19, P137, DOI 10.1111/j.1574-695X.1997.tb01083.x; Pawelec DP, 2000, FEMS MICROBIOL LETT, V185, P43, DOI 10.1111/j.1574-6968.2000.tb09038.x; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Riddle MS, 2016, VACCINE, V34, P2903, DOI 10.1016/j.vaccine.2016.02.080; Schmidt-Ott R, 2005, J MED MICROBIOL, V54, P761, DOI 10.1099/jmm.0.46040-0; WENMAN WM, 1985, J CLIN MICROBIOL, V21, P108, DOI 10.1128/JCM.21.1.108-112.1985; WHO OIE FAO, 2017, EARLY IMPLEMENTATION; Wyszynska A, 2008, CURR MICROBIOL, V57, P181, DOI 10.1007/s00284-008-9171-3; Wyszyznska Agnieszka, 2002, Acta Microbiol Pol, V51, P313; Yeh HY, 2015, ARCH MICROBIOL, V197, P353, DOI 10.1007/s00203-014-1062-3; Yeh HY, 2013, MICROBIOL RES, V168, P192, DOI 10.1016/j.micres.2012.11.010; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; Zeng Ximin, 2010, J Vaccines Vaccin, V1; Zeng XM, 2009, INFECT IMMUN, V77, P5437, DOI 10.1128/IAI.00666-09; Zhang QJ, 2000, INFECT IMMUN, V68, P5679, DOI 10.1128/IAI.68.10.5679-5689.2000; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	53	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210351	10.1371/journal.pone.0210351	http://dx.doi.org/10.1371/journal.pone.0210351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633767	gold, Green Submitted, Green Published			2022-12-27	WOS:000455485100019
J	Matheus, Z; Francini, RB; Pereira, GH; Moraes, FC; de Moura, RL; Brasileiro, PS; Amado, GM				Matheus, Zaira; Francini-Filho, Ronaldo Bastos; Pereira-Filho, Guilherme Henrique; Moraes, Fernando C.; de Moura, Rodrigo L.; Brasileiro, Poliana S.; Amado-Filho, Gilberto Menezes			Benthic reef assemblages of the Fernando de Noronha Archipelago, tropical South-west Atlantic: Effects of depth, wave exposure and cross-shelf positioning	PLOS ONE			English	Article							REMOTE ST PETER; CORAL-REEFS; COMMUNITY STRUCTURE; CLIMATE-CHANGE; BASE-LINES; FISH; RESILIENCE; CONSERVATION; BIOGEOGRAPHY; COMPETITION	Oceanic islands can be relatively isolated from overfishing and pollution sources, but they are often extremely vulnerable to climate and anthropogenic stress due to their small size and unique assemblages that may rely on a limited larval supply for replenishment. Vulnerability may be especially high when these islands bear permanent human populations or are subjected to regular or intermittent fishing. Since the late 1970's, Brazil has been establishing marine protected areas (MPAs) around its four oceanic island groups, which concentrate high endemism levels and are considered peripheral outposts of the Brazilian Biogeographic Province. In 2018, the Brazilian legally marine protected area increased > 10-fold, but most of the similar to 1,000,000 km(2) of MPAs around Brazil's oceanic islands are still unknown and unprotected. Here, we provide the first detailed quantitative baseline of benthic reef assemblages, including shallow and mesophotic zones, of the Fernando de Noronha Archipelago (FNA). The archipelago is partially protected as a no-take MPA and recognized by the UNESCO as a World Heritage Site, but also represents the only Brazilian oceanic island with a large permanent human population (3,000 people), mass tourism (up to 90,000 people per year) and a permanent small-scale fishing community. The influence of depth, wave exposure, and distance from the island and shelf edge on the structure of benthic assemblages was assessed from benthic photoquadrats obtained in 12 sites distributed in the lee and windward shores of the archipelago. Unique assemblages and discriminating species were identified using Multivariate Regression Trees, and environmental drivers of dominant assemblages' components were evaluated using Boosted Regression Trees. A total of 128 benthic taxa were recorded and 5 distinct assemblages were identified. Distance to the insular slope, depth and exposure were the main drivers of assemblages' differentiation. Our results represent an important baseline for evaluating changes in benthic assemblages due to increased local and global stressors.	[Matheus, Zaira; Moraes, Fernando C.; Brasileiro, Poliana S.; Amado-Filho, Gilberto Menezes] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Francini-Filho, Ronaldo Bastos] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, PB, Brazil; [Pereira-Filho, Guilherme Henrique] Univ Fed Sao Paulo, Lab Ecol & Conservacao Marinha, Inst Mar, Campus Baixada Santista, Santos, SP, Brazil; [de Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Inst Biol, Lab Sistemas Avancados Gestao Prod SAGE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Rio De Janeiro, RJ, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal da Paraiba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Amado, GM (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil.; Pereira, GH (corresponding author), Univ Fed Sao Paulo, Lab Ecol & Conservacao Marinha, Inst Mar, Campus Baixada Santista, Santos, SP, Brazil.	pereira.filho@unifesp.br; gfilho@jbrj.gov.br	Pereira-Filho, Guilherme-Henrique/I-2946-2013; Francini-Filho, Ronaldo/I-5708-2012; de Moura, Rodrigo Leao/AAL-5781-2020	Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Francini-Filho, Ronaldo/0000-0002-7678-6797; de Moura, Rodrigo Leao/0000-0002-5597-6196	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [447101/2014-5]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Grant 447101/2014-5 to GHPF - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Individual grants from CNPq (to GHPF, GMAF, RLdM and RBFF), from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio Janeiro (FAPERJ) (to GMAF), and from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to ZM and FCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2016, MAR BIODIVERS, V46, P933, DOI 10.1007/s12526-015-0441-6; Amado GM, 2012, AQUAT BOT, V101, P41, DOI 10.1016/j.aquabot.2012.03.016; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Balata D, 2011, MAR BIOL, V158, P2459, DOI 10.1007/s00227-011-1747-y; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Chaves LTC, 2013, MAR FRESHWATER RES, V64, P1101, DOI 10.1071/MF13054; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; de Eston V.R., 1986, Boletim do Instituto Oceanografico, V34, P37; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Duing W, 1980, PHYSICA1 OCEANOGRAPH; Edgar GJ, 2016, ANNU REV MAR SCI, V8, P435, DOI 10.1146/annurev-marine-122414-033921; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fonseca A. C., 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/179128; Foster MS, 1985, HDB PHYCOLOGICAL MET, P199; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Giglio VJ, 2018, MAR POLICY, V96, P13, DOI 10.1016/j.marpol.2018.07.017; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Littler DS, 2000, LITTLER MM CARIBBEAN; Longo GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127176; Magalhaes GM, 2015, B MAR SCI, V91, P377, DOI 10.5343/bms.2014.1044; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meirelles PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130084; Moraes F., 2011, ESPONJAS ILHAS OCEAN; Moraes F, 2007, J MAR BIOL ASSOC UK, V87, P1387, DOI 10.1017/S0025315407058316; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pereira-Filho GH, 2015, B MAR SCI, V91, P45, DOI 10.5343/bms.2014.1067; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pinheiro HT, 2017, NATURE, V549, P82, DOI 10.1038/nature23680; Rocha LA, 2018, SCIENCE, V361, P281, DOI 10.1126/science.aaq1614; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Zar JH., 1999, BIOSTAT ANAL, V663rd	55	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210664	10.1371/journal.pone.0210664	http://dx.doi.org/10.1371/journal.pone.0210664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629719	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000122
J	Saud, MAM; Guo, P; ul Haq, I; Pan, GQ; Khan, A				Saud, Alotaish Mohammed M.; Guo, Ping; ul Haq, Ihtisham; Pan, Guoqin; Khan, Alam			Do government expenditure and financial development impede environmental degradation in Venezuela?	PLOS ONE			English	Article							ENERGY-CONSUMPTION; ECONOMIC-GROWTH; KUZNETS CURVE; GHG EMISSIONS; CO2 EMISSIONS; POLICY; IMPACT; LINKAGES; TRADE	Environmental degradation is causing global warming, which is of the utmost concern to both physical and social scientists. A number of potential determinants of environmental degradation are analysed in the literature. This study examines the role of government expenditure and financial development in environmental degradation in the context of the environmental Kuznets curve (EKC) hypothesis for the Venezuelan economy. Time series data have been analysed for this purpose. The long-term relationship between the variables in this study is established through a bounds test in the presence of an unknown structural break. The results of this study confirm the EKC hypothesis. It is found that energy use is harming the quality of the environment not only in the long run but also in the short run. This study finds a positive impact of government expenditure on environmental degradation, which indicates that the Venezuelan government is not taking its expenditure for a sustainable environment into account. Moreover, this study finds that financial development is hindering environmental degradation. This means that financial institutions in Venezuela can help to develop the concept of sustainable energy in the country and the Venezuelan government can reduce carbon emissions through financial development.	[Saud, Alotaish Mohammed M.; Guo, Ping; Pan, Guoqin] Hunan Univ, Sch Econ & Trade, Changsha, Hunan, Peoples R China; [ul Haq, Ihtisham; Khan, Alam] Kohat Univ Sci & Technol, Dept Econ, Kohat, KP, Pakistan	Hunan University; Kohat University of Science & Technology	Saud, MAM (corresponding author), Hunan Univ, Sch Econ & Trade, Changsha, Hunan, Peoples R China.	mohdalotaish@hotmail.com	PAN, GUOQIN/HHY-7592-2022	Khan, Alam/0000-0001-8728-0516; Haq, Ihtisham ul/0000-0003-1961-6000				Adewuyi AO, 2017, RENEW SUST ENERG REV, V69, P275, DOI 10.1016/j.rser.2016.11.178; Ahmed K, 2015, ECOL INDIC, V49, P95, DOI 10.1016/j.ecolind.2014.09.040; Akbostanci E, 2009, ENERG POLICY, V37, P861, DOI 10.1016/j.enpol.2008.09.088; Al-Mulali U, 2015, NAT HAZARDS, V79, P621, DOI 10.1007/s11069-015-1865-9; Al-Mulali U, 2015, ENVIRON SCI POLLUT R, V22, P9717, DOI 10.1007/s11356-015-4142-2; [Anonymous], 29 U GOTH; Baiocchi G, 2010, J IND ECOL, V14, P50, DOI 10.1111/j.1530-9290.2009.00216.x; Bautista S, 2012, ENERG POLICY, V44, P331, DOI 10.1016/j.enpol.2012.01.060; Bernauer T, 2006, STATES PROVIDERS PUB; Bernauer T, 2013, GLOBAL ENVIRON POLIT, V13, P88, DOI 10.1162/GLEP_a_00155; Calbick KS, 2014, ENERG POLICY, V67, P895, DOI 10.1016/j.enpol.2013.12.030; Cole MA, 2003, J ENVIRON ECON MANAG, V46, P363, DOI 10.1016/S0095-0696(03)00021-4; Fullerton D, 2008, J ENVIRON ECON MANAG, V56, P141, DOI 10.1016/j.jeem.2008.02.001; Galinato GI, 2014, WORKING PAPER SERIES; Gamage SKN, 2017, ENERG SOURCE PART B, V12, P910, DOI 10.1080/15567249.2017.1324533; Grossman G, 1991, 3194 NBER; Halkos GE, 2013, ECOL ECON, V91, P48, DOI 10.1016/j.ecolecon.2013.04.002; Hang LM, 2007, ENERG POLICY, V35, P2978, DOI 10.1016/j.enpol.2006.10.022; Haq IU, 2016, ECOL INDIC, V67, P491, DOI 10.1016/j.ecolind.2016.03.019; Heyes A, 2000, ECOL ECON, V32, P1; Hossain S., 2012, LOW CARBON EC, V3, P92, DOI DOI 10.4236/LCE.2012.323013; Isik C, 2017, ENERG SOURCE PART B, V12, P665, DOI 10.1080/15567249.2016.1263251; Islam AM, 2014, INT REV ENVIRON RESO, V8, P139, DOI 10.1561/101.00000068; Jalil A, 2011, ENERG ECON, V33, P284, DOI 10.1016/j.eneco.2010.10.003; Jalil A, 2009, ENERG POLICY, V37, P5167, DOI 10.1016/j.enpol.2009.07.044; Khan MA, 2014, RENEW SUST ENERG REV, V29, P63, DOI 10.1016/j.rser.2013.08.088; Kuznets S, 1955, AM ECON REV, V45, P1; Lawn P.A., 2003, AUST ECON PAP, P118, DOI DOI 10.1111/1467-8454.00190; Lopez R, 2011, J ENVIRON ECON MANAG, V62, P180, DOI 10.1016/j.jeem.2011.03.001; Lopez RE, 2010, WORKING PAPERS, P94795; Nasir M, 2011, ENERG POLICY, V39, P1857, DOI 10.1016/j.enpol.2011.01.025; Ozturk I, 2015, ECOL INDIC, V57, P324, DOI 10.1016/j.ecolind.2015.05.018; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Sadorsky P, 2010, ENERG POLICY, V38, P2528, DOI 10.1016/j.enpol.2009.12.048; Shahbaz M, 2014, ECOL INDIC, V45, P622, DOI 10.1016/j.ecolind.2014.05.022; Shahbaz M, 2013, ECON MODEL, V35, P145, DOI 10.1016/j.econmod.2013.06.037; Sim NCS, 2006, ECOL ECON, V59, P401, DOI 10.1016/j.ecolecon.2005.11.006; Sobrino N, 2014, ENERG POLICY, V74, P486, DOI 10.1016/j.enpol.2014.07.020; Stern Nicholas, 2006, STERN REV EC CLIMATE; Tamazian A, 2009, ENERG POLICY, V37, P246, DOI 10.1016/j.enpol.2008.08.025; World Bank, WORLD DEV IND; Zhang QX, 2017, J CLEAN PROD, V161, P143, DOI 10.1016/j.jclepro.2017.05.096; Zhang YJ, 2011, ENERG POLICY, V39, P2197, DOI 10.1016/j.enpol.2011.02.026; Zhu Q, 2012, ENVIRON IMPACT ASSES, V36, P1, DOI 10.1016/j.eiar.2012.03.003; Ziaei SM, 2015, RENEW SUST ENERG REV, V42, P752, DOI 10.1016/j.rser.2014.10.085; ZIVOT E, 1992, J BUS ECON STAT, V10, P251, DOI 10.2307/1391541	46	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210255	10.1371/journal.pone.0210255	http://dx.doi.org/10.1371/journal.pone.0210255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629649	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000067
J	LaFoya, B; Munroe, JA; Albig, AR				LaFoya, Bryce; Munroe, Jordan A.; Albig, Allan R.			A comparison of resveratrol and other polyphenolic compounds on Notch activation and endothelial cell activity	PLOS ONE			English	Article							ANAPLASTIC THYROID-CARCINOMA; TUMOR-GROWTH; PROLIFERATION; ANGIOGENESIS; INHIBITION; SUPPRESSES; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; APOPTOSIS	Resveratrol is a polyphenolic compound produced by plants which makes its way into the human diet through plant-based foods. It has been shown to provide many health benefits, helping to ward of age-related diseases and promoting cardiovascular health. Additionally, resveratrol is a potent activator of the Notch signaling pathway. While resveratrol receives the most attention as a polyphenolic nutraceutical, other compounds with similar structures may be more potent regulators of specific cellular processes. Here, we compare resveratrol, apigenin, chrysin, genistein, luteolin, myricetin, piceatannol, pterostilbene, and quercetin for their ability to regulate Notch signaling. In addition, we compare the ability of these polyphenolic compounds to regulate endothelial cell viability, proliferation, and migration. Out of these compounds we found that resveratrol is the best activator of Notch signaling, however, other similar compounds are also capable of stimulating Notch. We also discovered that several of these polyphenols were able to inhibit endothelial cell proliferation. Finally, we found that many of these polyphenols are potent inhibitors of endothelial migration during wound healing assays. These findings provide the first side-by-side comparison of the regulation of Notch signaling, and endothelial cell proliferation and migration, by nine polyphenolic compounds.	[LaFoya, Bryce; Albig, Allan R.] Boise State Univ, Biomol Sci PhD Program, Boise, ID 83725 USA; [Munroe, Jordan A.; Albig, Allan R.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA	Idaho; Boise State University; Idaho; Boise State University	Albig, AR (corresponding author), Boise State Univ, Biomol Sci PhD Program, Boise, ID 83725 USA.; Albig, AR (corresponding author), Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA.	allanalbig@boisestate.edu		Albig, Allan/0000-0002-1162-0139	National Institute of General Medical Sciences [2R15GM102852-02, P20GM103408, P20GM109095]; NIGMS [P20GM109095, 1R15GM102852-01]; INBRE program (NIH Grant) [P20 RR016454, P20 GM103408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, R15GM102852, P20GM109095] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); INBRE program (NIH Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medical Sciences to A. Albig (grants 2R15GM102852-02, P20GM103408, and P20GM109095).; This work was supported by funding from the NIGMS to ARA (1R15GM102852-01) and (P20GM109095), the INBRE program (NIH Grant #P20 RR016454 (National Center for Research Resources) and #P20 GM103408 (National Institute of General Medical Sciences). Author contributions were as follows. A. Albig and B. LaFoya conceived and designed the experiments. B. LaFoya, J. Munroe, and A. Albig performed the experiments and interpreted the data. B. LaFoya designed and constructed all figures. B. LaFoya, J. Munroe, and A. Albig prepared the final manuscript.	Baczko I, 2014, BRIT J PHARMACOL, V171, P92, DOI 10.1111/bph.12409; Basli A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/805762; Belleri M, 2008, MOL CANCER THER, V7, P3761, DOI 10.1158/1535-7163.MCT-07-2351; Buhrmann C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101073; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Chen PL, 2011, CURR NEUROVASC RES, V8, P14, DOI 10.2174/156720211794520233; Chin YT, 2014, ONCOTARGET, V5, P12891, DOI 10.18632/oncotarget.2632; Chowdhury F, 2016, NANO LETT, V16, P3892, DOI 10.1021/acs.nanolett.6b01403; Deford P, 2016, EXP CELL RES, V341, P84, DOI 10.1016/j.yexcr.2016.01.011; Fang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01742-7; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Granzotto A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00095; Guo R, 2014, MED SCI MONIT BASIC, V20, P82, DOI 10.12659/MSMBR.890858; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; In Kyungmin, 2006, Cancer Res Treat, V38, P48, DOI 10.4143/crt.2006.38.1.48; Katoh M, 2007, INT J ONCOL, V31, P461; LaFoya B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33920-y; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Lin H, 2011, ONCOL REP, V26, P925, DOI 10.3892/or.2011.1380; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Ma T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/350516; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Matsumura N, 2018, CARDIOVASC RES, V114, P1350, DOI 10.1093/cvr/cvy064; Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870; Muhammad MH, 2018, J PHYSIOL SCI, V68, P681, DOI 10.1007/s12576-017-0582-4; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Norton KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep36992; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Palomero T, 2008, CELL GROWTH DIFFER, V15, P1203, DOI [10.1016/j.drugalcdep.2008.02.002.A, DOI 10.1016/J.DRUGALCDEP.2008.02.002.A]; Pinchot SN, 2011, CANCER-AM CANCER SOC, V117, P1386, DOI 10.1002/cncr.25652; Ravishankar D, 2015, EUR J MED CHEM, V97, P259, DOI 10.1016/j.ejmech.2015.04.056; Rokicki D, 2014, CENT EUR J IMMUNOL, V39, P449, DOI 10.5114/ceji.2014.47727; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Shigematsu S, 2003, FREE RADICAL BIO MED, V34, P810, DOI 10.1016/S0891-5849(02)01430-2; Song H, 2015, J NUTR BIOCHEM, V26, P1368, DOI 10.1016/j.jnutbio.2015.07.005; Sun DW, 2015, CELL PHYSIOL BIOCHEM, V37, P1693, DOI 10.1159/000438535; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; Tanriverdi G, 2016, HISTOL HISTOPATHOL, V31, P769, DOI 10.14670/HH-11-720; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Verschuren L, 2011, J NUTR, V141, P863, DOI 10.3945/jn.110.133751; Voloshyna I, 2013, EUR J PHARMACOL, V698, P299, DOI 10.1016/j.ejphar.2012.08.024; Wang Q, 2017, ONCOL LETT, V14, P3545, DOI 10.3892/ol.2017.6643; Yan FQ, 2018, EXP THER MED, V15, P1728, DOI 10.3892/etm.2017.5537; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062652; Yu XM, 2013, MOL CANCER THER, V12, P1276, DOI 10.1158/1535-7163.MCT-12-0841; Yu XM, 2013, CANCER-AM CANCER SOC, V119, P774, DOI 10.1002/cncr.27742; Zang MD, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1151-6; Zhou P, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-016-0921-2	52	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210607	10.1371/journal.pone.0210607	http://dx.doi.org/10.1371/journal.pone.0210607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653610	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500055
J	Sant'Anna, ID; Ferreira, RADC; Nascimento, M; Silva, GN; Carneiro, VQ; Cruz, CD; Oliveira, MS; Chagas, FE				Sant'Anna, Isabela de Castro; Diniz Cabral Ferreira, Ricardo Augusto; Nascimento, Moyses; Silva, Gabi Nunes; Carneiro, Vinicius Quintao; Cruz, Cosme Damiao; Oliveira, Marciane Silva; Chagas, Francyse Edith			Multigenerational prediction of genetic values using genome-enabled prediction	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SELECTION; RECOMBINATION; INFORMATION; ACCURACY; LOCUS	The identification of elite individuals is a critical component of most breeding programs. However, the achievement of this goal is limited by the high cost of phenotyping and experimental research. A significant benefit of genomic selection (GS) to plant breeding is the identification of elite individuals without the need for phenotyping. This study aimed to propose different calibration strategies using combinations between generations from different genetic backgrounds to improve the reliability of GS and to investigate the effects of LD in different types of mating systems: outcrossing (A(n)) self-pollination (S-n) and hybridization (H-n). For this purpose, we simulated a genome with 10 linkage groups. In each group, two QTL were simulated. Subsequently, an F-2 population was created, followed by four generations of inbreeding (S-1 to S-4, H-1 to H-4, A(1), to A(4),). Quantitative traits were simulated in three scenarios considering three degrees of dominance (d/a = 0, 0.5 and 1) and two broad sense heritabilities (h(2) = 0.30 and 0.70), totaling six genetic architectures. To evaluate prediction reliability, a model (RR-BLUP) was trained in one generation and used to predict the following generations of mating systems. For example, the marker effects estimated in the F-2 population were used to estimate the expected genomic breeding value (GEBV) in populations S-1 through A(4). The squared correlation between the GEBV and the true genetic value were used to measure the reliability of the predictions. Independently of the population used to estimate the marker effect, reliability showed the lowest values in the scenario where d = 1. For any scenario, the use of the multigenerational prediction methodology improved the reliability of GS.	[Sant'Anna, Isabela de Castro; Nascimento, Moyses] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil; [Diniz Cabral Ferreira, Ricardo Augusto] Syngenta Seeds Prod Res, Uberlandia, MG, Brazil; [Silva, Gabi Nunes] Fed Univ Rondonia, Dept Stat, Rondonia, Ji Parana, Brazil; [Carneiro, Vinicius Quintao; Cruz, Cosme Damiao; Oliveira, Marciane Silva; Chagas, Francyse Edith] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Syngenta; Universidade Federal de Rondonia; Universidade Federal de Vicosa	Sant'Anna, ID (corresponding author), Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil.	isabelacsantanna@gmail.com	CARNEIRO, VINICIUS QUINTAO/AAM-3006-2020; Nascimento, Moyses/Y-8767-2019	Nascimento, Moyses/0000-0001-5886-9540	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -, FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo CF, ACTA SCI; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Dekkers JCM, 2007, J ANIM SCI, V85, P2104, DOI 10.2527/jas.2006-683; Dekkers JCM, 1998, GENET RES, V71, P257, DOI 10.1017/S0016672398003267; Denis M, 2013, TREE GENET GENOMES, V9, P927, DOI [10.1007/s11295-013-0606-z, 10.1007/s11295-012-0528-1]; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Meuwissen THE, 2001, GENETICS, V157, P1819; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Nordborg M, 2000, GENETICS, V154, P923; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; RESENDE M. D. V., 2014, ESTATISTICA MATEMATI; Romay MC, HEREDITY; Santos VS, 2016, GENET MOL RES, V15; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Sorkheh K, 2008, GENET MOL BIOL, V31, P805, DOI 10.1590/S1415-47572008000500001; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; WEIR BS, 1986, AM J HUM GENET, V38, P776; Wientjes YCJ, 2013, GENETICS, V193, P621, DOI 10.1534/genetics.112.146290; Xu Y, 2018, RICE, V11, DOI 10.1186/s12284-018-0223-4; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X	31	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210531	10.1371/journal.pone.0210531	http://dx.doi.org/10.1371/journal.pone.0210531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653561	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500048
J	Stark, PB; Miller, D; Carlson, TJ; de Vasquez, KR				Stark, Philip B.; Miller, Daphne; Carlson, Thomas J.; de Vasquez, Kristen Rasmussen			Open-source food: Nutrition, toxicology, and availability of wild edible greens in the East Bay	PLOS ONE			English	Article							PLANTS; ACCUMULATION; HEALTH; RISK	Significance Foraged leafy greens are consumed around the globe, including in urban areas, and may play a larger role when food is scarce or expensive. It is thus important to assess the safety and nutritional value of wild greens foraged in urban environments. Methods Field observations, soil tests, and nutritional and toxicology tests on plant tissue were conducted for three sites, each roughly 9 square blocks, in disadvantaged neighborhoods in the East San Francisco Bay Area in 2014-2015. The sites included mixed-use areas and areas with high vehicle traffic. Results Edible wild greens were abundant, even during record droughts. Soil at some survey sites had elevated concentrations of lead and cadmium, but tissue tests suggest that rinsed greens of the tested species are safe to eat. Daily consumption of standard servings comprise less than the EPA reference doses of lead, cadmium, and other heavy metals. Pesticides, glyphosate, and PCBs were below detection limits. The nutrient density of 6 abundant species compared favorably to that of the most nutritious domesticated leafy greens. Conclusions Wild edible greens harvested in industrial, mixed-use, and high-traffic urban areas in the San Francisco East Bay area are abundant and highly nutritious. Even grown in soils with elevated levels of heavy metals, tested species were safe to eat after rinsing in tap water. This does not mean that all edible greens growing in contaminated soil are safe to eat-tests on more species, in more locations, and over a broader range of soil chemistry are needed to determine what is generally safe and what is not. But it does suggest that wild greens could contribute to nutrition, food security, and sustainability in urban ecosystems. Current laws, regulations, and public-health guidance that forbid or discourage foraging on public lands, including urban areas, should be revisited.	[Stark, Philip B.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Miller, Daphne] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Miller, Daphne] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Carlson, Thomas J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [de Vasquez, Kristen Rasmussen] Univ Calif Berkeley, Dept Nutr & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stark, PB (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	stark@stat.berkeley.edu		Miller, Daphne/0000-0002-2974-4893; Stark, Philip/0000-0002-3771-9604	Berkeley Food Institute	Berkeley Food Institute	This research was supported by the Berkeley Food Institute, Dr. Lorraine Schnurr, and from The Oxalis Prize, funded by Ms. Jenny Hammer. These funders did not play any role in the research, data collection, analysis, decision to publish, or preparation of the manuscript.	Altieri M, 2014, AGROECOLOGICAL SURVE; Bianco VV, 1998, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.1998.467.7; Ceuterick M, 2008, J ETHNOPHARMACOL, V120, P342, DOI 10.1016/j.jep.2008.09.004; Chang CY, 2014, ENVIRON MONIT ASSESS, V186, P1547, DOI 10.1007/s10661-013-3472-0; Charnley S, 2018, SOC NATUR RESOUR, V31, P1; COWAN JW, 1963, J SCI FOOD AGR, V14, P484, DOI 10.1002/jsfa.2740140707; Dabady S, 2017, URBAN FORAGING MUNIC; Dudka S, 1999, J ENVIRON SCI HEAL B, V34, P681, DOI 10.1080/03601239909373221; Farhangi MA, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0807-3; Gholizadeh F, 2018, PRIM CARE DIABETES, P1; Guil JL, 1997, PLANT FOOD HUM NUTR, V51, P99, DOI 10.1023/A:1007988815888; Guil-Guerrero JL, 1998, J SCI FOOD AGR, V76, P628, DOI [10.1002/(SICI)1097-0010(199804)76:4<628::AID-JSFA997>3.3.CO;2-L, 10.1002/(SICI)1097-0010(199804)76:4&lt;628::AID-JSFA997&gt;3.0.CO;2-U]; Holm LG., 1977, WORLDS WORST WEEDS D; James Sarah W, 2015, Public Health Nutr, V18, P2498, DOI 10.1017/S1368980015000610; Jensen DA, 2015, FOOD MICROBIOL, V46, P428, DOI 10.1016/j.fm.2014.08.025; Licata M, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-015-0074-7; Maroyi A., 2014, J ETHNOBIOL ETHNOMED, V10, P1, DOI DOI 10.1186/1746-; Maroyi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-60; Matzrafi M, 2016, PLANTA, V244, P1217, DOI 10.1007/s00425-016-2577-4; McLain RJ, 2014, LOCAL ENVIRON, V19, P220, DOI 10.1080/13549839.2013.841659; MERCADANTE AZ, 1990, INT J FOOD SCI TECH, V25, P213, DOI 10.1111/j.1365-2621.1990.tb01077.x; Milovanovic M, 2002, J SERB CHEM SOC, V67, P7, DOI 10.2298/JSC0201007M; Phillips KM, 2014, J FOOD COMPOS ANAL, V34, P136, DOI 10.1016/j.jfca.2014.02.010; Ramesh K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00095; Renna M, 2015, FOOD CHEM, V177, P29, DOI 10.1016/j.foodchem.2014.12.069; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rivera L., 2017, INDEPENDENT; Robbins P, 2008, AREA, V40, P265, DOI 10.1111/j.1475-4762.2008.00794.x; Saumel I, 2012, ENVIRON POLLUT, V165, P124, DOI 10.1016/j.envpol.2012.02.019; Sansanelli S, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-69; SENGUPTA SR, 1970, J SCI FOOD AGR, V21, P215, DOI 10.1002/jsfa.2740210412; SRIDHAR R, 1993, J AGR FOOD CHEM, V41, P61, DOI 10.1021/jf00025a013; Synk CM, 2017, GATHERING BALTIMORES, P2; Tareau MA, 2017, J ETHNOPHARMACOL, V203, P200, DOI 10.1016/j.jep.2017.03.031; U.S. Department of Agriculture, 2018, ALL VEG GROUP; Vadiveloo M, 2015, J NUTR, V145, P555, DOI 10.3945/jn.114.199067; Vorstenbosch T, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0190-7; ZENNIE TM, 1977, ECON BOT, V31, P76, DOI 10.1007/BF02860657; Zhang LL, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0113-z	39	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0202450	10.1371/journal.pone.0202450	http://dx.doi.org/10.1371/journal.pone.0202450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653545	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500003
J	Valdivia, A; Wolf, S; Suckling, K				Valdivia, Abel; Wolf, Shaye; Suckling, Kieran			Marine mammals and sea turtles listed under the US Endangered Species Act are recovering	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION RECOVERY; EXCLUDER DEVICES; EXTINCTION RISK; PACIFIC SALMON; FISHERIES; CONSERVATION; WHALES; SURVIVAL; BYCATCH	The U.S. Endangered Species Act (ESA) is a powerful environmental law protecting imperiled plants and animals, and a growing number of marine species have been protected under this law as extinction risk in the oceans has increased. Marine mammals and sea turtles comprise 38% of the 163 ESA-listed marine "species", which includes subspecies and distinct population segments, yet analyses of recovery trends after listing are lacking. Here we gathered the best available annual abundance estimates for geographically delimited populations of all 62 marine mammal and sea turtle species listed under the ESA. Of these, we chose representative populations of species that were listed before 2012, occur and reproduce in U.S. waters, and have data of sufficient quality and timespan for trend analyses. Thus, we quantitatively analyzed population trends, magnitude of population change, and recovery status for 23 and 8 representative populations of 14 marine mammal and 5 sea turtle species, respectively. Using generalized linear and non-linear models, we found that 18 marine mammal (78%) and 6 sea turtle (75%) populations significantly increased after listing; 3 marine mammal (13%) and 2 sea turtle (25%) populations showed non-significant changes; while 2 marine mammal (9%), but no sea turtle populations declined after ESA protection. Overall, the 24 populations that increased in abundance were from species listed for 20 years or more (e.g., large whales, manatees, and sea turtles). Conservation measures triggered by ESA listing such as ending exploitation, tailored species management, and fishery regulations, and other national and international measures, appear to have been largely successful in promoting species recovery, leading to the delisting of some species and to increases in most populations. These findings underscore the capacity of marine mammal and sea turtle species to recover from substantial geographical population declines when conservation actions are implemented in a timely and effective manner.	[Valdivia, Abel; Wolf, Shaye] Ctr Biol Divers, Oakland, CA 94612 USA; [Suckling, Kieran] Ctr Biol Divers, Tucson, AZ USA; [Valdivia, Abel] RARE, Arlington, VA 22201 USA		Valdivia, A (corresponding author), Ctr Biol Divers, Oakland, CA 94612 USA.; Valdivia, A (corresponding author), RARE, Arlington, VA 22201 USA.	avaldivia@rare.org						Andersson D, 2008, LECT NOTES COMPUT SC, V5028, P1, DOI 10.1007/978-3-540-69407-6_1; [Anonymous], 2016, FED REGISTER, V81, P62259; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Baker JD, 2007, MAR ECOL PROG SER, V346, P277, DOI 10.3354/meps06968; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Barton K., 2016, MUMIN MULTI MODEL IN; Bettridge S, 2015, NOAATMNMFSSWFSC540; Boersma PD, 2001, BIOSCIENCE, V51, P643; de Morais IOB, 2017, MAMMAL REV, V47, P11, DOI 10.1111/mam.12073; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Caillouet CW, 2015, HERPETOL CONSERV BIO, V10, P309; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carroll C, 2010, CONSERV BIOL, V24, P395, DOI 10.1111/j.1523-1739.2009.01435.x; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Conant TA, 2009, REP LOGGERHEAD BIOL, V222, P5; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Crowder LB, 1995, COPEIA, P773, DOI 10.2307/1447026; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Elphick CS, 2001, CONSERV BIOL, V15, P1285, DOI 10.1046/j.1523-1739.2001.00356.x; Estes JA, 2016, P NATL ACAD SCI USA, V113, P880, DOI 10.1073/pnas.1502552112; Evans D.M., 2016, ISSUES ECOL, V20, P1, DOI 10.22201/ib.20078706e.2020.91.2909; Federal Register, 2016, FED REGISTER, V81, P20057; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Finkbeiner EM, 2011, BIOL CONSERV, V144, P2719, DOI 10.1016/j.biocon.2011.07.033; Foley CM, 2017, BIOSCIENCE, V67, P627, DOI 10.1093/biosci/bix027; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Fritz L, 2008, AERIAL SHIP LAND BAS, V183, P81; Fritz LW, 2016, NMFSAFSC321 AL FISH; FWC, 2017, SEA TURT MON SNBS IN; Gerber LR, 2002, ECOL APPL, V12, P668; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; Good TP, 2007, FISHERIES, V32, P426, DOI 10.1577/1548-8446(2007)32[426:RPFESL]2.0.CO;2; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hanson B, 2014, SAL SEA EC C; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holt M.M., 2008, BIOACOUSTICS, V17, P164, DOI [10.1080/09524622.2008.9753802, DOI 10.1080/09524622.2008.9753802]; Hui TCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123786; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jenkins Lekelia D., 2012, U S National Marine Fisheries Service Marine Fisheries Review, V74, P26; Johnson A, 2005, MAR MAMMAL SCI, V21, P635, DOI 10.1111/j.1748-7692.2005.tb01256.x; Johnson DS, 2014, METHODS ECOL EVOL, V5, P1110, DOI 10.1111/2041-210X.12231; Kerkvliet J, 2007, ECOL ECON, V63, P499, DOI 10.1016/j.ecolecon.2006.12.007; Kraus SD, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00137; Laist DW, 2006, MAR MAMMAL SCI, V22, P472, DOI 10.1111/j.1748-7692.2006.00027.x; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2003, CONSERV BIOL, V17, P1089, DOI 10.1046/j.1523-1739.2003.02057.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Luther D, 2016, BIOL CONSERV, V197, P229, DOI 10.1016/j.biocon.2016.03.019; Magera AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077908; Malcom JW, 2015, P NATL ACAD SCI USA, V112, P15844, DOI 10.1073/pnas.1516938112; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Matkin CO, 2017, REV RECENT RES SO RE, DOI [10.1575/1912/8803, DOI 10.1575/1912/8803]; Mazaris AD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600730; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Moore E, 2009, MAR POLLUT BULL, V58, P1045, DOI 10.1016/j.marpolbul.2009.02.006; Muto MM, 2016, NOAATMAFSC355; National Marine Fisheries Service, 2016, MAIN HAW ISL MONK SE; National Marine Fisheries Service (DFO), 2008, REC PLAN SO RES KILL, P251; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Nester L. R., 2006, THESIS; NMFS, 2017, FED REGISTER, V82, P24944; NMFS, 2007, REC PLAN HAW MONK SE; NMFS, 1995, FED REGISTER, V60, P3775; NMFS, 2003, FED REGISTER, V68, P204; NMFS, 1995, FED REGISTER, V60, P48000; NMFS, 2001, FED REGISTER, V66, P29502; NMFS (National Marine Fisheries Service), 2017, MONK SEAL POP SIZ TH; NMFS (National Marine Fisheries Service), 2017, REC PLAN COOK INL BE; NMFS USFWS, 2013, LEATH SEA TURTL DERM; NOAA, 2011, FED REGISTER, V76, P20870; NOAA Fisheries, 2016, SPEC SPOTL SURV THRI; NOAA Fisheries, 2015, END THREAT MAR SPEC; Norman Stephanie A., 2015, U S National Marine Fisheries Service Marine Fisheries Review, V77, P89; NRC (National Research Council), 2010, ASSESSMENT SEA TURTL, DOI [10.17226/12889, DOI 10.17226/12889]; O'Neill SM, 2014, ENDANGER SPECIES RES, V25, P265, DOI 10.3354/esr00631; Pace RM, 2017, ECOL EVOL, V7, P8730, DOI 10.1002/ece3.3406; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Perry Simona A., 1999, U S National Marine Fisheries Service Marine Fisheries Review, V61, P1; Pettis H. M., 2017, N ATLANTIC RIGHT WHA; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2018, R LANG ENV STAT COMP; Rice D. W., 1973, IUCN PUBLICATIONS NE, P98; Rohlf D., 1989, ENDANGERED SPECIES A; Roman J, 2014, FRONT ECOL ENVIRON, V12, P377, DOI 10.1890/130220; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Salmon Michael, 2006, P141; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Scott JM., 2006, ENDANGERED SPECIES A; Sease JL, 2002, AERIAL LAND BASED SU; SEASE JL, 2001, NMFSAFSC122; Seminoff J.A., 2015, NOAATMNMFSSWFSC539; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Stewart KR, 2014, BIOL CONSERV, V176, P117, DOI 10.1016/j.biocon.2014.05.008; Suckling K., 2016, WILD SUCCESS SYSTEMA; Surma S, 2015, FISH OCEANOGR, V24, P291, DOI 10.1111/fog.12109; Swimmer Y, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00260; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; U.S. Fish and Wildlife Service; Marine Mammals Management Office, 2013, SW AL DIST POP SEG N; [U. S. Fish & Wildlife Service U. S. Fish and Wildlife Service], 2017, ECOS ENV CONV ONL SY; USFWS NMFS, 1996, FED REGISTER, V61, P4722; van der Hoop JM, 2015, CONSERV LETT, V8, P24, DOI 10.1111/conl.12105; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Walls SC, 2017, BIOSCIENCE, V67, P156, DOI 10.1093/biosci/biw153; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Waring Gordon T., 2015, NOAA Technical Memorandum NMFS-NE, V231, P1; Waring GT, 2016, NMFSNE238 NOAA; Wasser SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179824; Webb TJ, 2015, CURR BIOL, V25, P506, DOI 10.1016/j.cub.2014.12.023; Wickham H, 2009, GGPLOT2, DOI [10.1007/978-0-387-98141-3, DOI 10.1007/978-0-387-98141-3]; Wiley DN, 2008, CONSERV BIOL, V22, P450, DOI 10.1111/j.1523-1739.2008.00897.x; Williams T. H., 2016, NOAATMNMFSSWFSC564; Wolf S, 2015, BIOSCIENCE, V65, P200, DOI 10.1093/biosci/biu218; Zirbel K, 2011, MAR POLLUT BULL, V63, P40, DOI 10.1016/j.marpolbul.2011.03.018; Zuur Alain F., 2009, P1	129	26	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210164	10.1371/journal.pone.0210164	http://dx.doi.org/10.1371/journal.pone.0210164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650125	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300045
J	Xiao, W; Yang, JH; Fang, HY; Zhuang, JT; Ku, YD				Xiao, Wen; Yang, Jianhong; Fang, Huaiying; Zhuang, Jiangteng; Ku, Yuedong			Development of online classification system for construction waste based on industrial camera and hyperspectral camera	PLOS ONE			English	Article								Construction waste is a serious problem that should be addressed to protect environment and save resources, some of which have a high recovery value. To efficiently recover construction waste, an online classification system is developed using an industrial near-infrared hyperspectral camera. This system uses the industrial camera to capture a region of interest and a hyperspectral camera to obtain the spectral information about objects corresponding to the region of interest. The spectral information is then used to build classification models based on extreme learning machine and resemblance discriminant analysis. To further improve this system, an online particle swarm optimization extreme learning machine is developed. The results indicate that if a near-infrared hyperspectral camera is used in conjunction with an industrial camera, construction waste can be efficiently classified. Therefore, extreme learning machine and resemblance discriminant analysis can be used to classify construction waste. Particle swarm optimization can be used to further enhance the proposed system.	[Xiao, Wen; Yang, Jianhong; Fang, Huaiying; Zhuang, Jiangteng; Ku, Yuedong] Huaqiao Univ, Fujian Prov Univ, Key Lab Proc Monitoring & Syst Optimizat Mech & E, Xiamen, Fujian, Peoples R China	Fuzhou University; Huaqiao University	Yang, JH (corresponding author), Huaqiao Univ, Fujian Prov Univ, Key Lab Proc Monitoring & Syst Optimizat Mech & E, Xiamen, Fujian, Peoples R China.	yjhong@hqu.edu.cn		xiao, wen/0000-0002-7860-0087	Major Project Foundation of Science and Technology in Fujian Province [2016H6013]; Joint Innovation Project of Industrial Technology in Fujian Province [2016H6013]; Quanzhou Science and Technology Plan Project [2018C100R]	Major Project Foundation of Science and Technology in Fujian Province; Joint Innovation Project of Industrial Technology in Fujian Province; Quanzhou Science and Technology Plan Project	This work was financially supported by the Major Project Foundation of Science and Technology in Fujian Province (2016H6013), and Joint Innovation Project of Industrial Technology in Fujian Province. Jianhong Yang received the funding, grant numbers: 2016H6013, urls: http://xmgl.fjkjt.gov.cn/. This work was also supported by the Quanzhou Science and Technology Plan Project (2018C100R); Huaiying Fang received the funding, grant numbers: 2018C100R.	Arguello F, 2015, INT J REMOTE SENS, V36, P645, DOI 10.1080/01431161.2014.999882; Bi H, 2013, J ZHENGZHOU U, V45, P100, DOI [10.3969/j.issn.1671-6841.2013.01.024, DOI 10.3969/J.ISSN.1671-6841.2013.01.024]; Chen YS, 2016, IEEE T GEOSCI REMOTE, V54, P6232, DOI 10.1109/TGRS.2016.2584107; Demir B, 2010, INT GEOSCI REMOTE SE, P488, DOI 10.1109/IGARSS.2010.5652698; Dmitriev EV, 2014, IZV ATMOS OCEAN PHY+, V50, P929, DOI 10.1134/S0001433814090072; Guo C.-A., 2013, THESIS; Heras DB, 2014, INT J REMOTE SENS, V35, P401, DOI 10.1080/01431161.2013.869633; Huang G. B., 2005, P IEEE INT JOINT C N, V2, P985; Ivorra E, 2013, J FOOD ENG, V117, P342, DOI 10.1016/j.jfoodeng.2013.02.022; Kumar S, 2001, IEEE T GEOSCI REMOTE, V39, P1368, DOI 10.1109/36.934070; Le JH, 2015, LECT NOTES COMPUT SC, V9474, P682, DOI 10.1007/978-3-319-27857-5_61; Ma R., 2012, NO ENV, V4, P33; Marquetti I, 2016, COMPUT ELECTRON AGR, V121, P313, DOI 10.1016/j.compag.2015.12.018; Nakamura RYM, 2014, IEEE T GEOSCI REMOTE, V52, P2126, DOI 10.1109/TGRS.2013.2258351; Ni QianQian, 2016, Journal of Zhejiang A&F University, V33, P489; Palsson F, 2017, IEEE GEOSCI REMOTE S, V14, P639, DOI 10.1109/LGRS.2017.2668299; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Serranti S, 2012, RESOUR CONSERV RECY, V61, P52, DOI 10.1016/j.resconrec.2012.01.007	18	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0208706	10.1371/journal.pone.0208706	http://dx.doi.org/10.1371/journal.pone.0208706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650081	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300006
J	Kim, J; Pajarillo, E; Rizor, A; Son, DS; Lee, J; Aschner, M; Lee, E				Kim, Judong; Pajarillo, Edward; Rizor, Asha; Son, Deok-Soo; Lee, Jayden; Aschner, Michael; Lee, Eunsook			LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia	PLOS ONE			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; TAMOXIFEN PROTECT; OXIDATIVE DAMAGE; DAXX TRAFFICKING; GENE-EXPRESSION; ALPHA-SYNUCLEIN; MOUSE MODEL; CELL-DEATH	Long-term exposure to elevated levels of manganese (Mn) causes manganism, a neurodegenerative disorder with Parkinson's disease (PD)-like symptoms. Increasing evidence suggests that leucine-rich repeat kinase 2 (LRRK2), which is highly expressed in microglia and macrophages, contributes to the inflammation and neurotoxicity seen in autosomal dominant and sporadic PD. As gene-environment interactions have emerged as important modulators of PD-associated toxicity, LRRK2 may also mediate Mn-induced inflammation and pathogenesis. In this study, we investigated the role of LRRK2 in Mn-induced toxicity using human microglial cells (HMC3), LRRK2-wild-type (WT) and LRRK2-knockout (KO) RAW264.7 macrophage cells. Results showed that Mn activated LRRK2 kinase by phosphorylation of its serine residue at the 1292 position (S1292) as a marker of its kinase activity in macrophage and microglia, while inhibition with GSK2578215A (GSK) and MLi-2 abolished Mn-induced LRRK2 activation. LRRK2 deletion and its pharmacological inhibition attenuated Mn-induced apoptosis in macrophages and microglia, along with concomitant decreases in the pro-apoptotic Bcl-2-associated X (Bax) protein. LRRK2 deletion also attenuated Mn-induced production of reactive oxygen species (ROS) and the pro-inflammatory cytokine TNF-alpha. Mn-induced phosphorylation of mitogen-activated protein kinase (MAPK) p38 and ERK signaling proteins was significantly attenuated in LRRK2 KO cells and GSK-treated cells. Moreover, inhibition of MAPK p38 and ERK as well as LRRK2 attenuated Mn-induced oxidative stress and cytotoxicity. These findings suggest that LRRK2 kinase activity plays a critical role in Mn-induced toxicity via downstream activation of MAPK signaling in macrophage and microglia. Collectively, these results suggest that LRRK2 could be a potential molecular target for developing therapeutics to treat Mn-related neurodegenerative disorders.	[Kim, Judong; Pajarillo, Edward; Rizor, Asha; Lee, Eunsook] Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Jayden] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	State University System of Florida; Florida A&M University; Meharry Medical College; Boston University; Yeshiva University; Albert Einstein College of Medicine	Lee, E (corresponding author), Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607	National Institute of Environmental Health Sciences [R01 ES024756, R01 ES10563, 1R03 ES024849, 1R21 ES025415]; National Cancer Institute [SC1 CA200519]; NATIONAL CANCER INSTITUTE [SC1CA200519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563, R03ES024849, R21ES025415, R01ES024756] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institute of Environmental Health Sciences, grants R01 ES024756 (EL), R01 ES10563 (MA), 1R03 ES024849 (MA) and 1R21 ES025415 (MA) and the National Cancer Institute SC1 CA200519 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21931-8; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Atashrazm F, 2016, CLIN PHARMACOL-ADV A, V8, P177, DOI 10.2147/CPAA.S102191; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Brockmann K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0588-5; Caesar M, 2013, NEUROBIOL DIS, V54, P280, DOI 10.1016/j.nbd.2012.12.019; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Cao J, 2018, NEUROBIOL DIS, V119, P53, DOI 10.1016/j.nbd.2018.07.024; Chen CY, 2012, CELL DEATH DIFFER, V19, P1623, DOI 10.1038/cdd.2012.42; Chen JY, 2018, BIOCHEM BIOPH RES CO, V498, P171, DOI 10.1016/j.bbrc.2018.02.007; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; Cirnaru MD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00049; Cook DA, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0010-8; Cookson MR, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0564-y; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Dahlke C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0435-0; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Diaz-Aparicio I, 2016, NEURAL REGEN RES, V11, P1533, DOI 10.4103/1673-5374.193220; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Elmazoglu Z, 2020, DRUG CHEM TOXICOL, V43, P96, DOI 10.1080/01480545.2018.1504961; Exil V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094753; Filipov NM, 2012, J APPL TOXICOL, V32, P310, DOI 10.1002/jat.1762; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Games D, 2013, AM J PATHOL, V182, P940, DOI 10.1016/j.ajpath.2012.11.018; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Giguere N, 2018, J BIOL CHEM, V293, P9580, DOI 10.1074/jbc.RA117.000499; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hartmann Andreas, 2004, Dialogues Clin Neurosci, V6, P281; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Howlett EH, 2017, HUM MOL GENET, V26, P4340, DOI 10.1093/hmg/ddx320; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Islam MS, 2017, BIOCHEM SOC T, V45, P163, DOI 10.1042/BST20160264; Johnson J, 2018, NEUROTOXICOLOGY, V64, P230, DOI 10.1016/j.neuro.2017.06.007; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Keen CL, 1999, NEUROTOXICOLOGY, V20, P213; Kim B.H., 2012, PLOS ONE, V7; Kim T, 2017, J CEREBR BLOOD F MET, V37, P1910, DOI 10.1177/0271678X17694186; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kluss JH, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0049-1; Kwon SH, 2011, NEUROCHEM INT, V58, P533, DOI 10.1016/j.neuint.2011.01.012; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Loeffler DA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00089; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martinez M, 2000, BRAIN RES, V869, P216, DOI 10.1016/S0006-8993(00)02363-5; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Miklossy J, 2007, ACTA NEUROPATHOL, V114, P243, DOI 10.1007/s00401-007-0230-9; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Milatovic D, 2011, TOXICOL APPL PHARM, V256, P219, DOI 10.1016/j.taap.2011.06.001; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Munoz L, 2015, EUR J MED CHEM, V95, P29, DOI 10.1016/j.ejmech.2015.03.003; Niu YL, 2011, ARCH BIOCHEM BIOPHYS, V515, P89, DOI 10.1016/j.abb.2011.07.016; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pajarillo E, 2019, BBA-MOL BASIS DIS, V1865, P1992, DOI 10.1016/j.bbadis.2018.11.017; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Puccini JM, 2015, J NEUROSCI, V35, P5271, DOI 10.1523/JNEUROSCI.0650-14.2015; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Schapansky J, 2014, HUM MOL GENET, V23, P4201, DOI 10.1093/hmg/ddu138; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Streck L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070981; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8; Tsika Elpida, 2013, Small GTPases, V4, P164, DOI 10.4161/sgtp.25130; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Wang CY, 2018, CELL BIOL INT, V42, P84, DOI 10.1002/cbin.10864; Wang Jingcai, 2012, Commun Integr Biol, V5, P319, DOI 10.4161/cib.20216; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zhao Y, 2011, NEUROBIOL AGING, V32, P1990, DOI 10.1016/j.neurobiolaging.2009.11.019; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	93	31	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210248	10.1371/journal.pone.0210248	http://dx.doi.org/10.1371/journal.pone.0210248			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645642	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200023
J	Kim, SH; Kang, PA; Han, K; Lee, SW; Rhee, S				Kim, Sang-Hoon; Kang, Pyeoung-Ann; Han, Keetae; Lee, Seon-Woo; Rhee, Sangkee			Crystal structure of chloramphenicol-metabolizing enzyme EstDL136 from a metagenome	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ESTERASES; ACETYLTRANSFERASE; INSIGHTS; SERVER; CARBOXYLESTERASE; INACTIVATION; PROTEINS; SEQUENCE	Metagenomes often convey novel biological activities and therefore have gained considerable attention for use in biotechnological applications. Recently, metagenome-derived EstDL136 was found to possess chloramphenicol (Cm)-metabolizing features. Sequence analysis showed EstDL136 to be a member of the hormone-sensitive lipase (HSL) family with an Asp-His-Ser catalytic triad and a notable substrate specificity. In this study, we determined the crystal structures of EstDL136 and in a complex with Cm. Consistent with the high sequence similarity, the structure of EstDL136 is homologous to that of the HSL family. The active site of EstDL136 is a relatively shallow pocket that could accommodate Cm as a substrate as opposed to the long acyl chain substrates typical of the HSL family. Mutational analyses further suggested that several residues in the vicinity of the active site play roles in the Cm-binding of EstDL136. These results provide structural and functional insights into a metagenome-derived EstDL136.	[Kim, Sang-Hoon; Kang, Pyeoung-Ann; Han, Keetae; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Seon-Woo] Dong A Univ, Dept Appl Biol, Busan, South Korea	Seoul National University (SNU); Dong A University	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Lee, SW (corresponding author), Dong A Univ, Dept Appl Biol, Busan, South Korea.	seonlee@dau.ac.kr; srheesnu@snu.ac.kr		Rhee, Sangkee/0000-0002-8779-9737; Lee, Seon-Woo/0000-0001-6142-7612	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration of Korea [PJ01325801]; National Research Foundation of Korea from MSIP, Republic of Korea [2017R1A2B4002860]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea from MSIP, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ01325801 to SR), Rural Development Administration of Korea and by the National Research Foundation of Korea grant (2017R1A2B4002860) from MSIP, Republic of Korea (to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, CURR OPIN BIOTECH, V13, P543, DOI 10.1016/S0958-1669(02)00350-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cousin X, 1997, NUCLEIC ACIDS RES, V25, P143, DOI 10.1093/nar/25.1.143; De Simone G, 2004, J MOL BIOL, V343, P137, DOI 10.1016/j.jmb.2004.08.014; De Simone G, 2004, J BIOL CHEM, V279, P6815, DOI 10.1074/jbc.M307738200; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giuseppe M, 2012, PROTEIN PEPTIDE LETT, V19, P144, DOI 10.2174/092986612799080400; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HEMILA H, 1994, BBA-LIPID LIPID MET, V1210, P249, DOI 10.1016/0005-2760(94)90129-5; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; NAKANO H, 1977, J ANTIBIOT, V30, P76, DOI 10.7164/antibiotics.30.76; Ohara K, 2014, J BIOL CHEM, V289, P24499, DOI 10.1074/jbc.M113.521856; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Sohaskey CD, 2000, J BACTERIOL, V182, P1930, DOI 10.1128/JB.182.7.1930-1934.2000; Sohaskey CD, 2004, FEMS MICROBIOL LETT, V240, P187, DOI 10.1016/j.femsle.2004.09.028; Sohaskey CD, 1999, ANTIMICROB AGENTS CH, V43, P655, DOI 10.1128/AAC.43.3.655; Tao W, 2012, APPL ENVIRON MICROB, V78, P6295, DOI 10.1128/AEM.01154-12; Tao WX, 2011, J MICROBIOL BIOTECHN, V21, P1203, DOI 10.4014/jmb.1107.07034; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SQ, 2015, J LIPID RES, V56, P1616, DOI 10.1194/jlr.M060673	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210298	10.1371/journal.pone.0210298	http://dx.doi.org/10.1371/journal.pone.0210298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645605	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200024
J	Aslam, MA; Alemdehy, MF; Pritchard, CEJ; Song, JY; Muhaimin, FI; Wijdeven, RH; Huijbers, IJ; Neefjes, J; Jacobs, H				Aslam, Muhammad Assad; Alemdehy, Mir Farshid; Pritchard, Colin E. J.; Song, Ji-Ying; Muhaimin, Fitriari Izzatunnisa; Wijdeven, Ruud H.; Huijbers, Ivo J.; Neefjes, Jacques; Jacobs, Heinz			Towards an understanding of C9orf82 protein/CAAP1 function	PLOS ONE			English	Article							DNA-DAMAGE; PCNA UBIQUITINATION; TOPOISOMERASE-II; BREAKS; ROLES; ETA	C9orf82 protein, or conserved anti-apoptotic protein 1 or caspase activity and apoptosis inhibitor 1 (CAAP1) has been implicated as a negative regulator of the intrinsic apoptosis pathway by modulating caspase expression and activity. In contrast, an independent genome wide screen for factors capable of driving drug resistance to the topoisomerase II (Topo II) poisons doxorubicin and etoposide, implicated a role for the nuclear protein C9orf82 in delaying DSBs repair downstream of Topo II, hereby sensitizing cells to DSB induced apoptosis. To determine its function in a genetically defined setting in vivo and ex vivo, we here employed CRISPR/Cas9 technology in zygotes to generate a C9orf82 knock-out mouse model. C9orf82(ko/ko) mice were born at a Mendelian ratio and did not display any overt macroscopic or histological abnormalities. DSBs repair dependent processes like lymphocyte development and class switch recombination (CSR) appeared normal, arguing against a link between the C9orf82 encoded protein and V(D) J recombination or CSR. Most relevant, primary pre-B cell cultures and Tp53 transformed mouse embryo fibroblasts (MEFs) derived from C9orf82(ko/ko) E14.5 and wild type embryos displayed comparable sensitivity to a number of DNA lesions, including DSBs breaks induced by the topoisomerase II inhibitors, etoposide and doxorubicin. Likewise, the kinetics of.H2AX formation and resolution in response to etoposide of C9orf82 protein proficient, deficient and overexpressing MEFs were indistinguishable. These data argue against a direct role of C9orf82 protein in delaying repair of Topo II generated DSBs and regulating apoptosis. The genetically defined systems generated in this study will be of value to determine the actual function of C9orf82 protein.	[Aslam, Muhammad Assad; Alemdehy, Mir Farshid; Muhaimin, Fitriari Izzatunnisa; Jacobs, Heinz] Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands; [Pritchard, Colin E. J.; Huijbers, Ivo J.] Netherlands Canc Inst, Mouse Clin Canc & Aging Res MCCA Transgen Facil, Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Div Expt Anim Pathol, Amsterdam, Netherlands; [Wijdeven, Ruud H.; Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jacobs, H (corresponding author), Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands.	h.jacobs@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Muhaimin, Fitriari Izzatunnisa/0000-0002-7466-0947	Netherlands Organisation for Health Research and Development (ZonMw) [91213018]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This research was supported by a Top Grant from the Netherlands Organisation for Health Research and Development (ZonMw, project 91213018) to HJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2014, DNA REPAIR, V19, P169, DOI 10.1016/j.dnarep.2014.03.014; Bredemeyer AL, 2015, CURR BIOL, V25, pR45, DOI 10.1016/j.cub.2014.11.024; Buoninfante Olimpia Alessandra, 2018, Oncotarget, V9, P18832, DOI 10.18632/oncotarget.24777; De Zio D, 2013, ANTIOXID REDOX SIGN, V19, P559, DOI 10.1089/ars.2012.4938; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Izykowska K, 2017, ONCOTARGET, V8, P39627, DOI 10.18632/oncotarget.17383; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Nowsheen S., 2012, Experimental Oncology, V34, P243; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Prochazkova J, 2016, IMMUNOLOGY, V147, P11, DOI 10.1111/imm.12547; Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Wijdeven RH, 2015, CANCER RES, V75, P4176, DOI 10.1158/0008-5472.CAN-15-0380; Wit N, 2015, NUCLEIC ACIDS RES, V43, P282, DOI 10.1093/nar/gku1301; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025284	17	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210526	10.1371/journal.pone.0210526	http://dx.doi.org/10.1371/journal.pone.0210526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629682	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000101
J	Crans, RAJ; Janssens, J; Daelemans, S; Wouters, E; Raedt, R; Van Dam, D; De Deyn, PP; Van Craenenbroeck, K; Stove, CP				Crans, Rene A. J.; Janssens, Jana; Daelemans, Sofie; Wouters, Elise; Raedt, Robrecht; Van Dam, Debby; De Deyn, Peter P.; Van Craenenbroeck, Kathleen; Stove, Christophe P.			The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy	PLOS ONE			English	Article							RNA-POLYMERASE-II; KAINIC ACID; REAL-TIME; MESSENGER-RNA; REFERENCE GENES; B2 RNA; RAT MODEL; EXPRESSION; TRANSCRIPTION; SEIZURES	Background In gene expression studies via RT-qPCR many conclusions are inferred by using reference genes. However, it is generally known that also reference genes could be differentially expressed between various tissue types, experimental conditions and animal models. An increasing amount of studies have been performed to validate the stability of reference genes. In this study, two rodent-specific Short Interspersed Nuclear Elements (SINEs), which are located throughout the transcriptome, were validated and assessed against nine reference genes in a model of Temporal Lobe Epilepsy (TLE). Two different brain regions (i.e. hippocampus and cortex) and two different disease stages (i.e. acute phase and chronic phase) of the systemic kainic acid rat model for TLE were analyzed by performing expression analyses with the geNorm and NormFinder algorithms. Finally, we performed a rank aggregation analysis and validated the reference genes and the rodent-specific SINEs (i.e. B elements) individually via Gfap gene expression. Results GeNorm ranked Hprt1, Pgk1 and Ywhaz as the most stable genes in the acute phase, while Gusb and B2m were ranked as the most unstable, being significantly upregulated. The two B elements were ranked as most stable for both brain regions in the chronic phase by geNorm. In contrast, NormFinder ranked the B1 element only once as second best in cortical tissue for the chronic phase. Interestingly, using only one of the two algorithms would have led to skewed conclusions. Finally, the rank aggregation method indicated the use of the B1 element as the best option to normalize target genes, independent of the disease progression and brain region. This result was supported by the expression profile of Gfap. Conclusion In this study, we demonstrate the potential of implementing SINEs-notably the B1 element as a stable normalization factor in a rodent model of TLE, independent of brain region or disease progression.	[Crans, Rene A. J.; Wouters, Elise; Van Craenenbroeck, Kathleen; Stove, Christophe P.] Univ Ghent, L GEST, Toxicol Lab, Dept Bioanal, Ghent, Belgium; [Janssens, Jana; Van Dam, Debby; De Deyn, Peter P.] Univ Antwerp, Lab Neurochem & Behav, Dept Biomed Sci, Inst Born Bunge, Antwerp, Belgium; [Daelemans, Sofie; Raedt, Robrecht] Ghent Univ Hosp, LCEN3, Dept Internal Med, Ghent, Belgium; [Van Dam, Debby; De Deyn, Peter P.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Van Dam, Debby; De Deyn, Peter P.] Univ Med Ctr Groningen, Alzheimer Res Ctr, Groningen, Netherlands; [De Deyn, Peter P.] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, Antwerp, Belgium; [De Deyn, Peter P.] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, Antwerp, Belgium; [De Deyn, Peter P.] Univ Antwerp, Biobank, Inst Born Bunge, Antwerp, Belgium	Ghent University; University of Antwerp; Ghent University; Ghent University Hospital; University of Groningen; University of Groningen; University of Antwerp	Stove, CP (corresponding author), Univ Ghent, L GEST, Toxicol Lab, Dept Bioanal, Ghent, Belgium.	christophe.stove@ugent.be	Crans, Rene/AAX-5631-2020; Wouters, Elise/AAR-6437-2021; Stove, Christophe/B-6057-2008; Van Dam, Debby/G-1666-2018	Crans, Rene/0000-0003-2832-4405; Stove, Christophe/0000-0001-7126-348X; De Deyn, Peter Paul/0000-0002-2228-2964; Raedt, Robrecht/0000-0002-8939-0169; Van Dam, Debby/0000-0003-4739-6076	Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant [140028]; Fonds Wetenschappelijk Onderzoek grant [G021715N]; Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant [IAP7/16]; Belgian Alzheimer Research Foundation (SAO-FRA) [15002, 2017/0025]	Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant; Fonds Wetenschappelijk Onderzoek grant; Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant; Belgian Alzheimer Research Foundation (SAO-FRA)	This work was supported by the Agentschap voor Innovatie door Wetenschap en Techniek by Strategisch Basisonderzoek grant #140028 (http://www.fwo.be) (RAJC, JJ, SD, EW, RR, DVD, PPDD, KVK, CS), the Fonds Wetenschappelijk Onderzoek grant #G021715N (http://www.fwo.be) (KVK), Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office grant #IAP7/16 (http://belspo.be/iap/) (JJ, DVD) and Belgian Alzheimer Research Foundation (SAO-FRA) grant #15002 and #2017/0025 (http://www.alzh.org/) (DVD, PPDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armagan G, 2012, NEUROCHEM INT, V60, P555, DOI 10.1016/j.neuint.2012.02.015; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Bayrakdar ET, 2013, EPILEPSY RES, V105, P13, DOI 10.1016/j.eplepsyres.2012.12.008; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bojang P, 2018, MOL ONCOL, V12, P1342, DOI 10.1002/1878-0261.12329; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; Crow MK, 2010, AUTOIMMUNITY, V43, P7, DOI 10.3109/08916930903374865; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; DENDUNNEN JT, 1987, NUCLEIC ACIDS RES, V15, P2772; Dridi S, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/545328; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Gholami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176368; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gong H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38513; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hunter RG, 2015, P NATL ACAD SCI USA, V112, P6828, DOI 10.1073/pnas.1411260111; Jarvela JT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-29; Kainate Ben-Ari Y., 2012, JASPERS BASIC MECH E; Khanna P, 2017, Biotech Histochem, V92, P459, DOI 10.1080/10520295.2017.1362474; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Latham S, 2016, J CLIN PATHOL, V69, P817, DOI 10.1136/jclinpath-2015-203538; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; Mavragani CP, 2018, J AUTOIMMUN, V88, P75, DOI 10.1016/j.jaut.2017.10.004; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Odom GL, 2004, MOL BIOL EVOL, V21, P2140, DOI 10.1093/molbev/msh225; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Papasotiriou I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171466; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Rihani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071776; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Tan HP, 2012, HUM MOL GENET, V21, P57, DOI 10.1093/hmg/ddr437; Teneng I, 2007, GENES CELLS, V12, P1101, DOI 10.1111/j.1365-2443.2007.01117.x; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tsirigos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000610; Ullal G, 2005, EPILEPSIA, V46, P616, DOI 10.1111/j.1528-1167.2005.49604.x; Umylny B, 2007, J CELL BIOCHEM, V102, P110, DOI 10.1002/jcb.21278; Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011; Van Nieuwenhuyse B, 2015, BRAIN RES, V1627, P1, DOI 10.1016/j.brainres.2015.08.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Veniaminova NA, 2007, GENOMICS, V89, P678, DOI 10.1016/j.ygeno.2007.02.007; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Wongpaiboonwattana W, 2013, ASIAN PAC J CANCER P, V14, P3773, DOI 10.7314/APJCP.2013.14.6.3773; Yang JH, 2016, ONCOL LETT, V11, P2673, DOI 10.3892/ol.2016.4232; Yoo JE, 2017, J MICROBIOL BIOTECHN, V27, P816, DOI 10.4014/jmb.1612.12026; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	65	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210567	10.1371/journal.pone.0210567	http://dx.doi.org/10.1371/journal.pone.0210567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629669	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000109
J	Graefe, A; Green, KC; Armstrong, JS				Graefe, Andreas; Green, Kesten C.; Armstrong, J. Scott			Accuracy gains from conservative forecasting: Tests using variations of 19 econometric models to predict 154 elections in 10 countries	PLOS ONE			English	Article							REGRESSION; OUTCOMES	Problem Do conservative econometric models that comply with the Golden Rule of Forecasting provide more accurate forecasts? Methods To test the effects of forecast accuracy, we applied three evidence-based guidelines to 19 published regression models used for forecasting 154 elections in Australia, Canada, Italy, Japan, Netherlands, Portugal, Spain, Turkey, U. K., and the U. S. The guidelines direct forecasters using causal models to be conservative to account for uncertainty by (I) modifying effect estimates to reflect uncertainty either by damping coefficients towards no effect or equalizing coefficients, (II) combining forecasts from diverse models, and (III) incorporating more knowledge by including more variables with known important effects. Findings Modifying the econometric models to make them more conservative reduced forecast errors compared to forecasts from the original models: (I) Damping coefficients by 10% reduced error by 2% on average, although further damping generally harmed accuracy; modifying coefficients by equalizing coefficients consistently reduced errors with average error reductions between 2% and 8% depending on the level of equalizing. Averaging the original regression model forecast with an equal-weights model forecast reduced error by 7%. (II) Combining forecasts from two Australian models and from eight U.S. models reduced error by 14% and 36%, respectively. (III) Using more knowledge by including all six unique variables from the Australian models and all 24 unique variables from the U.S. models in equalweight "knowledge models" reduced error by 10% and 43%, respectively. Originality This paper provides the first test of applying guidelines for conservative forecasting to established election forecasting models. Usefulness Election forecasters can substantially improve the accuracy of forecasts from econometric models by following simple guidelines for conservative forecasting. Decision-makers can make better decisions when they are provided with models that are more realistic and forecasts that are more accurate.	[Graefe, Andreas] Macromedia Univ, Munich, Germany; [Green, Kesten C.] Univ South Australia, Sch Business, Adelaide, SA, Australia; [Green, Kesten C.; Armstrong, J. Scott] Univ South Australia, Ehrenberg Bass Inst, Adelaide, SA, Australia; [Armstrong, J. Scott] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of South Australia; University of South Australia; University of Pennsylvania	Graefe, A (corresponding author), Macromedia Univ, Munich, Germany.	graefe.andreas@gmail.com	Green, Kesten/F-3716-2013	Green, Kesten/0000-0001-9122-885X				Abramowitz A, 2012, PS-POLIT SCI POLIT, V45, P618, DOI 10.1017/S104909651200087X; Armstrong JS, 2018, J GLOB SCHOLARS MARK, V28, P103, DOI 10.1080/21639159.2018.1441735; Armstrong JS, 2015, J BUS RES, V68, P1717, DOI 10.1016/j.jbusres.2015.03.031; Armstrong JS, 2012, INT J FORECASTING, V28, P689, DOI 10.1016/j.ijforecast.2012.02.001; Armstrong JS, 2011, J BUS RES, V64, P699, DOI 10.1016/j.jbusres.2010.08.005; ARMSTRONG JS, 1992, INT J FORECASTING, V8, P69, DOI 10.1016/0169-2070(92)90008-W; Belanger E, 2010, PS-POLIT SCI POLIT, V43, P691, DOI 10.1017/S1049096510001113; Bellucci P, 2010, INT J FORECASTING, V26, P54, DOI 10.1016/j.ijforecast.2009.09.004; Cameron L, 2000, ECON REC, V76, P354, DOI 10.1111/j.1475-4932.2000.tb00032.x; Campbell JE, 2012, PS-POLIT SCI POLIT, V45, P630, DOI 10.1017/S104909651200090X; Cuzan AG, 2012, PS-POLIT SCI POLIT, V45, P648, DOI 10.1017/S1049096512000947; Cuzan AG, 2009, POLIT ANAL, V17, P333, DOI 10.1093/pan/mpp008; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Dassonneville R, 2017, RES POLITICS, V4, DOI 10.1177/2053168017720023; Erikson RS, 2012, PS-POLIT SCI POLIT, V45, P620, DOI 10.1017/S1049096512000881; Fair RC, 2009, AM J POLIT SCI, V53, P55, DOI 10.1111/j.1540-5907.2008.00357.x; Graefe A, 2015, INT J FORECASTING, V31, P943, DOI 10.1016/j.ijforecast.2014.12.001; Graefe A, 2015, J BUS RES, V68, P1792, DOI 10.1016/j.jbusres.2015.03.038; Graefe A, 2014, INT J FORECASTING, V30, P43, DOI 10.1016/j.ijforecast.2013.02.005; Graefe A, 2013, ELECT STUD, V32, P644, DOI 10.1016/j.electstud.2013.04.003; Holbrook TM, 2012, PS-POLIT SCI POLIT, V45, P640, DOI 10.1017/S1049096512000923; JACKMAN S, 1995, AUST J POLIT SCI, V30, P347, DOI 10.1080/00323269508402342; KEREN G, 1978, ORGAN BEHAV HUM PERF, V22, P143, DOI 10.1016/0030-5073(78)90010-7; Lewis-Beck M.S., 2005, BRIT J POLIT INT REL, V7, P145, DOI 10.1111/j.1467-856X.2005.00178; Lewis-Beck MS, 2012, PS-POLIT SCI POLIT, V45, P625, DOI 10.1017/S1049096512000893; Lewis-Beck MS, 2012, INT J FORECASTING, V28, P797, DOI 10.1016/j.ijforecast.2012.04.005; Lewis-Beck MS, 2004, ELECT STUD, V23, P279, DOI 10.1016/S0261-3794(02)00071-9; Lockerbie B, 2012, PS-POLIT SCI POLIT, V45, P644, DOI 10.1017/S1049096512000935; Magalhaes PC, 2012, INT J FORECASTING, V28, P769, DOI 10.1016/j.ijforecast.2012.04.007; Magalhaes PC, 2009, ELECT STUD, V28, P314, DOI 10.1016/j.electstud.2009.03.004; NADEAU R, 1993, CAN J POLIT SCI, V26, P775, DOI 10.1017/S0008423900000470; Sparks J., 1844, WORKS B FRANKLIN; Toros E, 2011, INT J FORECASTING, V27, P1248, DOI 10.1016/j.ijforecast.2011.01.002; Wilks SS, 1938, PSYCHOMETRIKA, V3, P23, DOI 10.1007/BF02287917	34	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209850	10.1371/journal.pone.0209850	http://dx.doi.org/10.1371/journal.pone.0209850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629630	Green Published, Green Accepted, gold			2022-12-27	WOS:000455483000037
J	Uphoff, CC; Pommerenke, C; Denkmann, SA; Drexler, HG				Uphoff, Cord C.; Pommerenke, Claudia; Denkmann, Sabine A.; Drexler, Hans G.			Screening human cell lines for viral infections applying RNA-Seq data analysis	PLOS ONE			English	Article							BOVINE POLYOMAVIRUS; SEQUENCE; CULTURES	Monitoring viral infections of cell cultures is largely neglected although the viruses may have an impact on the physiology of cells and may constitute a biohazard regarding laboratory safety and safety of bioactive agents produced by cell cultures. PCR, immunological assays, and enzyme activity tests represent common methods to detect virus infections. We have screened more than 300 Cancer Cell Line Encyclopedia RNA sequencing and 60 whole exome sequencing human cell lines data sets for specific viral sequences and general viral nucleotide and protein sequence assessment applying the Taxonomer bioinformatics tool developed by IDbyDNA. The results were compared with our previous findings from virus specific PCR analyses. Both, the results obtained from the direct alignment method and the Taxonomer alignment method revealed a complete concordance with the PCR results: twenty cell lines were found to be infected with five virus species. Taxonomer further uncovered a bovine polyomavirus infection in the breast cancer cell line SK-BR-3 most likely introduced by contaminated fetal bovine serum. RNA-Seq data sets were more sensitive for virus detection although a significant proportion of cell lines revealed low numbers of virus specific alignments attributable to low level nucleotide contamination during RNA preparation or sequencing procedure. Low quality reads leading to Taxonomer false positive results can be eliminated by trimming the sequence data before analysis. One further important result is that no viruses were detected that had never been shown to occur in cell cultures. The results prove that the currently applied testing of cell cultures is adequate for the detection of contamination and for the risk assessment of cell cultures. The results emphasize that next generation sequencing is an efficient tool to determine the viral infection status of human cells.	[Uphoff, Cord C.; Pommerenke, Claudia; Denkmann, Sabine A.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Uphoff, CC (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	cup@dsmz.de						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bofill-Mas S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/192089; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolin S R, 1991, J Vet Diagn Invest, V3, P199; BOLIN SR, 1994, J VIROL METHODS, V48, P211, DOI 10.1016/0166-0934(94)90120-1; Cao SB, 2015, J VIROL, V89, P713, DOI 10.1128/JVI.02570-14; Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Granata I, 2017, PEERJ PREPRINTS, V5; Hempel HA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00156; Kakisi OK, 2013, TRANSFUSION MED, V23, P142, DOI 10.1111/tme.12049; KLUINNELEMANS HC, 1991, LEUKEMIA, V5, P221; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Merten OW, 2002, CYTOTECHNOLOGY, V39, P91, DOI 10.1023/A:1022969101804; Miyazawa M, 1999, J HEPATOL, V31, P967, DOI 10.1016/S0168-8278(99)80304-3; Pamies D, 2017, ALTEX-ALTERN ANIM EX, V34, P95, DOI 10.14573/altex.1607121; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Pienkowska M, 1998, J HEPATOL, V28, P396, DOI 10.1016/S0168-8278(98)80312-7; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006; SCHUURMAN R, 1991, BIOLOGICALS, V19, P265, DOI 10.1016/S1045-1056(05)80014-4; SCHUURMAN R, 1991, J GEN VIROL, V72, P2739, DOI 10.1099/0022-1317-72-11-2739; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437; Tae H, 2014, GENOMICS, V104, P453, DOI 10.1016/j.ygeno.2014.08.009; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Uphoff CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125622; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Uryvaev LV, 2012, B EXP BIOL MED+, V153, P77, DOI 10.1007/s10517-012-1648-1; Wessman S J, 1999, Dev Biol Stand, V99, P3; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210404	10.1371/journal.pone.0210404	http://dx.doi.org/10.1371/journal.pone.0210404			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629668	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000081
J	Mayengbam, S; Virtanen, H; Hittel, DS; Elliott, C; Reimer, RA; Vogel, HJ; Shearer, J				Mayengbam, Shyamchand; Virtanen, Heidi; Hittel, Dustin S.; Elliott, Charlene; Reimer, Raylene A.; Vogel, Hans J.; Shearer, Jane			Metabolic consequences of discretionary fortified beverage consumption containing excessive vitamin B levels in adolescents	PLOS ONE			English	Article							ENERGY DRINKS; HOMOCYSTEINE CONCENTRATIONS; GLUCOSE-TOLERANCE; PUBERTAL CHANGES; SWEETENERS; ASSOCIATION; FORTIFICATION; CHILDREN; PATTERN; OBESITY	Over the past decade, there has been a substantial increase in the number of beverage products containing added vitamins and minerals. Often viewed as a healthier choice by consumers, the metabolic impacts of excessive vitamin consumption are relatively unknown, especially in children. The aim of this study was to examine the effects of a widely available, vitamin fortified beverage (5h Energy Decaffeinated) on insulin sensitivity, metabolic hormones and serum metabolomic responses in adolescents. Twenty adolescents (13-19y, 10M/10F) completed two randomized trials, consuming either coloured water as placebo (PL) or a vitamin fortified, sugar free beverage (FB, 1.5ml/kg) 40min prior to a modified oral glucose tolerance test (OGTT, 1.75g/kg glucose). Samples were collected at baseline and at 30, 45, 60, 90 and 120min during the OGTT. No differences in blood glucose response were observed between the treatments. However, compared to PL, postprandial plasma C-peptide and insulin excursion was significantly greater with FB, resulting in a 28% decline in the insulin sensitivity index. This was accompanied by elevated GLP-1, glucagon and PYY responses with FB compared to PL. Serum metabolomics (H-1-NMR) analysis also revealed perturbations to vitamin B-linked one carbon metabolism flux with FB consumption that became more pronounced over time. These included a transient reduction in homocysteine flux accompanied by increases in betaine, vitamin B6, vitamin B12, choline, folate and taurine. Although these impacts are likely short-lived, results show that beverages fortified with excessive amounts of vitamins are not metabolically inert, but likely result in greater insulin secretion, differential gut hormone secretion and elevated one-carbon flux to process the excessive vitamin loads.	[Mayengbam, Shyamchand; Virtanen, Heidi; Reimer, Raylene A.; Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Mayengbam, Shyamchand; Elliott, Charlene; Reimer, Raylene A.; Shearer, Jane] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Virtanen, Heidi] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Hittel, Dustin S.; Reimer, Raylene A.; Shearer, Jane] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Elliott, Charlene] Univ Calgary, Fac Arts, Dept Commun Media & Film, Calgary, AB, Canada; [Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Mayengbam, S (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.; Mayengbam, S (corresponding author), Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada.	shyamchandsingh.maye@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947; Elliott, Charlene/0000-0003-2615-2144; Virtanen, Heidi/0000-0002-9335-2712	Alberta Children's Hospital Research Institute; Natural Sciences and Engineering Research Council of Canada; Eyes High Postdoctoral Fellowship; Alberta Innovates Health Solutions Postdoctoral Fellowship	Alberta Children's Hospital Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Eyes High Postdoctoral Fellowship; Alberta Innovates Health Solutions Postdoctoral Fellowship	The research was funded by the Alberta Children's Hospital Research Institute and the Natural Sciences and Engineering Research Council of Canada (JS). SM is funded through an Eyes High Postdoctoral Fellowship and an Alberta Innovates Health Solutions Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NATL ACAD COLLECTION, DOI [10.1016/J.PEC.2013.09.026, DOI 10.1016/J.PEC.2013.09.026]; Atkinson W, 2008, AM J CLIN NUTR, V87, P577, DOI 10.1093/ajcn/87.3.577; Brown RJ, 2012, DIABETES CARE, V35, P959, DOI 10.2337/dc11-2424; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Connors KE, 2014, CIRC-CARDIOVASC GENE, V7, P576, DOI 10.1161/CIRCGENETICS.114.000534; Dachner N, 2015, APPL PHYSIOL NUTR ME, V40, P191, DOI 10.1139/apnm-2014-0252; Dwyer JT, 2014, NUTR REV, V72, P127, DOI 10.1111/nure.12086; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1; Gordish-Dressman H, 2010, EXERCISE GENOMICS; Harb Jennifer Nicole, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-216612; Harris JL, 2015, NUTR REV, V73, P247, DOI 10.1093/nutrit/nuu061; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Hennessy A, 2015, BRIT J NUTR, V113, P310, DOI 10.1017/S0007114514003651; Hoyte C, 2013, CLIN TOXICOL, V51, P729, DOI 10.3109/15563650.2013.825268; Jones AC, 2017, HLTH EC IMPACTS SUGA; Kumar GS, 2014, PATIENT EDUC COUNS, V94, P250, DOI 10.1016/j.pec.2013.09.026; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meni ACS, 2015, DIABETOLOGIA, V58, P2455, DOI 10.1007/s00125-015-3694-5; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Olthof MR, 2005, AM J CLIN NUTR, V82, P111, DOI 10.1093/ajcn/82.1.111; Palmnas MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109841; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Sacco JE, 2011, EUR J CLIN NUTR, V65, P313, DOI 10.1038/ejcn.2010.261; SNODGRASS SR, 1992, MOL NEUROBIOL, V6, P41, DOI 10.1007/BF02935566; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Swithers SE, 2013, TRENDS ENDOCRIN MET, V24, P431, DOI 10.1016/j.tem.2013.05.005; Sylvetsky AC, 2017, J ACAD NUTR DIET, V117, P441, DOI 10.1016/j.jand.2016.11.004; Sylvetsky AC, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0129-3; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; van der Klaauw AA, 2013, OBESITY, V21, P1602, DOI 10.1002/oby.20154; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; YEH KC, 1978, J PHARMACOKINET BIOP, V6, P79, DOI 10.1007/BF01066064; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209913	10.1371/journal.pone.0209913	http://dx.doi.org/10.1371/journal.pone.0209913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653534	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500018
J	Takahashi, Y; Konishi, T; Yamaki, K				Takahashi, Yoko; Konishi, Tomokazu; Yamaki, Kohji			Tofu and fish oil independently modulate serum lipid profiles in rats: Analyses of 10 class lipoprotein profiles and the global hepatic transcriptome	PLOS ONE			English	Article							FATTY-ACID OXIDATION; APOLIPOPROTEIN-B; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; LDL-CHOLESTEROL; PROTEIN; LIVER; METABOLISM; DISCORDANCE; ISOFLAVONE	Soy protein and fish oil are food components that decrease the risk of cardiovascular disease. Previous studies demonstrated that these food components reduced serum cholesterol levels and suppressed hepatic lipogenesis. However, the underlying mechanisms of action of these food components remain unclear. Ten classes of serum lipoprotein profiles showed that dietary tofu, a soybean curd, suppressed cholesterol absorption, while fish oil reduced most of the lipoprotein classes in rats. Tofu and fish oil both halved the level of the lipoprotein class LAC1 (LDL-anti-protease complex), a 15-nm LDL-anti-protease complex, which is speculated to be a cause of atherosclerosis. Moreover, a global transcriptome analysis revealed that tofu inhibited the mRNA expression of genes involved in hepatic lipogenesis, while fish oil stimulated that of genes related to fatty acid degradation. Therefore, tofu and fish oil independently regulate lipid metabolism. The decrease observed in LAC1 may have been due to reduced cholesterol absorption in the tofu diet group and the interference of lipogenesis via the activation of polyunsaturated fatty acid detoxification in the fish oil group.	[Takahashi, Yoko; Yamaki, Kohji] Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan; [Konishi, Tomokazu] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan	National Agriculture & Food Research Organization - Japan; Akita Prefectural University	Takahashi, Y (corresponding author), Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan.	youkot@affrc.go.jp	Stefanadis, Christodoulos/ABH-2232-2020; Konishi, Tomokazu/K-8067-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Konishi, Tomokazu/0000-0003-4826-6265	Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan	Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan	This study was supported by the Research Project on the Development of Evaluation and Management Methods for the Supply of Safe, Reliable and Functional Food and Farm produce, from the Ministry of Agriculture, Forestry and Fisheries, Japan (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BMC MED, V11, P117, DOI [10.1186/1741-7015-11-117, DOI 10.1186/1741-7015-11-117]; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; BAUM CL, 1990, J BIOL CHEM, V265, P19263; BENHIZIA F, 1994, AM J PHYSIOL-ENDOC M, V267, pE975, DOI 10.1152/ajpendo.1994.267.6.E975; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; DIETSCHY JM, 1984, KLIN WOCHENSCHR, V62, P338, DOI 10.1007/BF01716251; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; FOLCH J, 1957, J BIOL CHEM, V226, P497; Food and Agriculture Organization of United Nations, 1996, COD GEN STAND FOOD A; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; GLICKMAN RM, 1986, P NATL ACAD SCI USA, V83, P5296, DOI 10.1073/pnas.83.14.5296; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grossman A, ENDOTEXT; HUFF MW, 1980, J LIPID RES, V21, P546; IDE T, 1978, J NUTR, V108, P601, DOI 10.1093/jn/108.4.601; IDE T, 1981, J BIOL CHEM, V256, P247; Ide T, 2000, BBA-MOL CELL BIOL L, V1485, P23, DOI 10.1016/S1388-1981(00)00026-3; Iritani N, 1996, J NUTR, V126, P380, DOI 10.1093/jn/126.2.380; Klett EL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-5; Konishi T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192955; Konishi T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S7; Konishi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003555; Kromhout D, 2012, EUR HEART J, V33, P436, DOI 10.1093/eurheartj/ehr362; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Lu H, 2015, ARTERIOSCL THROM VAS, V35, P485, DOI 10.1161/ATVBAHA.115.305380; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; MYANT NB, 1977, J LIPID RES, V18, P135; Robins SJ, 1999, HEPATOLOGY, V29, P1541, DOI 10.1002/hep.510290518; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shimanaka Y, 2017, NAT MED, V23, P1287, DOI 10.1038/nm.4417; SMIT MJ, 1991, J CLIN INVEST, V88, P943, DOI 10.1172/JCI115397; Stradling Clare, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P208; Takahashi Y, 2008, J NUTR BIOCHEM, V19, P682, DOI 10.1016/j.jnutbio.2007.09.003; Takahashi Y, 2017, FOOD SCI TECHNOL RES, V23, P163, DOI 10.3136/fstr.23.163; Takahashi Y, 2011, J AGR FOOD CHEM, V59, P8976, DOI 10.1021/jf201403u; TERPSTRA AHM, 1983, ANN NUTR METAB, V27, P132, DOI 10.1159/000176632; Tousoulis D, 2003, HEART, V89, P993, DOI 10.1136/heart.89.9.993; Usui S, 2002, J LIPID RES, V43, P805; Viola J, 2015, SEMIN IMMUNOL, V27, P184, DOI 10.1016/j.smim.2015.03.013; Wilkins JT, 2016, J AM COLL CARDIOL, V67, P193, DOI 10.1016/j.jacc.2015.10.055; Yamori Yukio, 2006, Exp Clin Cardiol, V11, P94; ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210950	10.1371/journal.pone.0210950	http://dx.doi.org/10.1371/journal.pone.0210950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653569	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500091
J	Guensch, DP; Fischer, K; Jung, C; Hurni, S; Winkler, BM; Jung, B; Vogt, AP; Eberle, B				Guensch, Dominik P.; Fischer, Kady; Jung, Christof; Hurni, Samuel; Winkler, Bernhard M.; Jung, Bernd; Vogt, Andreas P.; Eberle, Balthasar			Relationship between myocardial oxygenation and blood pressure: Experimental validation using oxygenation-sensitive cardiovascular magnetic resonance	PLOS ONE			English	Article							CORONARY-ARTERY; FLOW; PERFUSION; STATE; PHENYLEPHRINE; HYPERCAPNIA; WALL	Background The relationship between mean arterial pressure (MAP) and coronary blood flow is well described. There is autoregulation within a MAP range of 60 to 140 mmHg providing near constant coronary blood flow. Outside these limits flow becomes pressure-dependent. So far, response of myocardial oxygenation to changes in pressure and flow has been more difficult to assess. While established techniques mostly require invasive approaches, Oxygenation-Sensitive (OS) Cardiovascular Magnetic Resonance (CMR) is a technique that can non-invasively assess changes in myocardial tissue oxygenation. The purpose of this study was to follow myocardial oxygenation over a wide range of blood pressure variation within and outside known coronary autoregulatory limits using OS-CMR, and to relate these data to coronary hemodynamics. Methods Ten anaesthetized swine (German Large White) underwent left-sided thoracotomy and attachment of a perivascular flow probe to the proximal left anterior descending (LAD) coronary artery for continuous measurement of blood flow (QLAD). Thereafter, animals were transferred into a 3T MRI scanner. Mean arterial pressure (MAP) was varied in 10-15 mmHg steps by administering alpha1-receptor agents phenylephrine or urapidil. For each MAP level, OS-CMR images as well as arterial and coronary sinus blood gas samples were obtained simultaneously during brief periods of apnea. Relative changes (Delta) of coronary sinus oxygen saturation (ScsO(2)), oxygen delivery (DO2) and demand (MVO2), extraction ratio (O2ER) and excess (Omega) from respective reference levels at a MAP of 70 mmHg were determined and were compared to % change in OS-signal intensity (OS-SI) in simultaneously acquired OS-CMR images. Results Q(LAD) response indicated autoregulation between MAP levels of 52 mmHg ( lower limit) and127 mmHg ( upper limit). OS-CMR revealed a global myocardial oxygenation deficit occurring below the lower autoregulation limit, with the nadir of OS-SI at -9.0%. With MAP values surpassing 70 mmHg, relative OS-SI increased to a maximum of +10.6%. Consistent with this, Delta ScsO(2), Delta DO2, Delta MVO2, Delta O2ER and Delta Omega responses indicated increasing mismatch of oxygenation balance outside the autoregulated zone. Changes in global OS-CMR were significantly correlated with all of these parameters ( p <= 0.02) except with Delta MVO2. Conclusion OS-CMR offers a novel and non-invasive route to evaluate the effects of blood pressure variations, as well as of cardiovascular drugs and interventions, on global and regional myocardial oxygenation, as demonstrated in a porcine model. OS-CMR identified mismatch of O-2 supply and demand below the lower limit of coronary autoregulation. Vasopressor induced acute hypertension did not compromise myocardial oxygenation in healthy hearts despite increased cardiac workload and O-2 demand. The clinical usefulness of OS-CMR remains to be established.	[Guensch, Dominik P.; Fischer, Kady; Jung, Christof; Vogt, Andreas P.; Eberle, Balthasar] Univ Bern, Bern Univ Hosp, Inselspital, Dept Anaesthesiol & Pain Med, Bern, Switzerland; [Guensch, Dominik P.; Fischer, Kady; Jung, Bernd] Univ Bern, Bern Univ Hosp, Inselspital, Inst Diagnost Intervent & Paediat Radiol, Bern, Switzerland; [Fischer, Kady] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Hurni, Samuel; Winkler, Bernhard M.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiovasc Surg, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; McGill University; University of Bern; University Hospital of Bern	Guensch, DP (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Anaesthesiol & Pain Med, Bern, Switzerland.; Guensch, DP (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Inst Diagnost Intervent & Paediat Radiol, Bern, Switzerland.	dominik.guensch@gmail.com		Vogt, Andreas/0000-0002-3676-7188; Fischer, Kady/0000-0002-7765-4550; Gunsch, Dominik/0000-0003-4127-4086	institutional funds of the Department of Anaesthesiology and Pain Medicine at the Bern University Hospital, Inselspital, University of Bern; Foundation for Research in Anaesthesiology and Intensive Care Medicine in Bern, Switzerland	institutional funds of the Department of Anaesthesiology and Pain Medicine at the Bern University Hospital, Inselspital, University of Bern; Foundation for Research in Anaesthesiology and Intensive Care Medicine in Bern, Switzerland	This work was supported by institutional funds of the Department of Anaesthesiology and Pain Medicine at the Bern University Hospital, Inselspital, University of Bern and the Foundation for Research in Anaesthesiology and Intensive Care Medicine in Bern, Switzerland.	ABDELLATIF M, 1992, ANESTH ANALG, V74, P870; ARDEHALI A, 1990, CHEST, V98, P699, DOI 10.1378/chest.98.3.699; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bauer WR, 1999, MAGN RESON MED, V42, P1004, DOI 10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M; Bauer WR, 1999, MAGN RESON MED, V41, P51, DOI 10.1002/(SICI)1522-2594(199901)41:1<51::AID-MRM9>3.0.CO;2-G; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Beaudin AE, 2011, AM J PHYSIOL-HEART C, V301, pH1678, DOI 10.1152/ajpheart.00281.2011; Berne R M, 1974, Adv Cardiol, V12, P303; Boehme S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060591; Bopp C, 2016, EUR J PHARMACOL, V779, P53, DOI 10.1016/j.ejphar.2016.03.012; Caille V, 2006, CRIT CARE, V10, DOI 10.1186/cc4831; COLLINS P, 1993, BRIT HEART J, V69, P279; DELAYE J, 1983, ARCH MAL COEUR VAISS, V76, P7; Dharmakumar R, 2006, MAGN RESON MED, V55, P1372, DOI 10.1002/mrm.20911; Dick GM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00580; Donato P, 2012, SURG RADIOL ANAT, V34, P805, DOI 10.1007/s00276-012-0976-1; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Fieno DS, 2004, CIRCULATION, V110, P1284, DOI 10.1161/01.CIR.0000140673.13057.34; Fischer K, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0446-y; Fischer K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164524; Fischer K, 2015, EUR HEART J-CARD IMG, V16, P395, DOI 10.1093/ehjci/jeu202; Formenti F, 2015, BRIT J ANAESTH, V114, P683, DOI 10.1093/bja/aeu407; Friedrich MG, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-43; Guensch DP, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0262-1; Guensch DP, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002928; Guensch DP, 2014, EUR HEART J-CARD IMG, V15, P409, DOI 10.1093/ehjci/jet171; Guensch DP, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.98; Iizuka K, 2017, J ARTIF ORGANS, V20, P194, DOI 10.1007/s10047-017-0960-y; KANDEL G, 1983, ARCH INTERN MED, V143, P1400, DOI 10.1001/archinte.143.7.1400; Karamat Muhammad Irfan, 2016, Critical Reviews in Biomedical Engineering, V44, P73, DOI 10.1615/CritRevBiomedEng.2016016365; Karamitsos TD, 2010, CIRC-CARDIOVASC IMAG, V3, P32, DOI 10.1161/CIRCIMAGING.109.860148; KRALIOS AC, 1975, CARDIOVASC RES, V9, P811, DOI 10.1093/cvr/9.6.811; Kurosawa H, 2014, SURG TODAY, V44, P1128, DOI 10.1007/s00595-013-0639-9; Luu JM, 2014, EUR HEART J-CARD IMG, V15, P1358, DOI 10.1093/ehjci/jeu138; MAHMOD M, 2014, J CARDIOVASC MAGN R, V16, DOI DOI 10.1186/1536-429X-16-29; McLellan SA, 2004, CONTIN ED ANESTH CRI, V4, P123, DOI DOI 10.1093/BJACEACCP/MKH033; MOSHER P, 1964, CIRC RES, V14, P250, DOI 10.1161/01.RES.14.3.250; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paslawska U, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0054-2; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; Pelaez AFV, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12806; Pries AR, 2015, EUR HEART J, V36, P3134, DOI 10.1093/eurheartj/ehv100; Ramanathan T, 2005, BJA EDUC, V5, P61, DOI 10.1093/bjaceaccp/mki012; Schelbert HR, 2010, J NUCL CARDIOL, V17, P545, DOI 10.1007/s12350-010-9255-x; van Beest P, 2011, CRIT CARE, V15, DOI 10.1186/cc10351; Varghese J, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0403-1; Vincent J- L, 2006, APPL PHYSL INTENSIVE, P337, DOI [10.1007/3-540-37363-2_48, DOI 10.1007/3-540-37363-2_48]; Vohringer M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-20; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5; Walcher T, 2012, CIRC-CARDIOVASC IMAG, V5, P580, DOI 10.1161/CIRCIMAGING.111.971507; Yang HJ, 2014, RADIOLOGY, V272, P397, DOI 10.1148/radiol.14132549; Zhang JH, 2015, BIOMED REP, V3, P379, DOI 10.3892/br.2015.446; Zhang ZH, 2011, ANN THORAC SURG, V91, P150, DOI 10.1016/j.athoracsur.2010.06.132	54	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210098	10.1371/journal.pone.0210098	http://dx.doi.org/10.1371/journal.pone.0210098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650118	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300042
J	Hong, EH; Ryu, SJ; Kang, MH; Seong, M; Cho, H; Yeom, JH; Shin, YU				Hong, Eun Hee; Ryu, So Jung; Kang, Min Ho; Seong, Mincheol; Cho, Heeyoon; Yeom, Jong Hun; Shin, Yong Un			Comparison of repeatability of swept-source and spectral-domain optical coherence tomography for measuring inner retinal thickness in retinal disease	PLOS ONE			English	Article							NERVE-FIBER LAYER; CHOROIDAL THICKNESS; EPIRETINAL MEMBRANE; REPRODUCIBILITY; AGREEMENT; EYES	Purpose To compare repeatability between SS-OCT and SD-OCT for measurement of macular, macular retinal nerve fiber (mRNFL), and ganglion cell-inner plexiform layer (GC-IPL) thickness in various retinal diseases. Methods One hundred and fourteen eyes of 114 subjects were investigated. Seventy-eight eyes with retinal disease and 36 normal eyes underwent two consecutive measurements of macular, mRNFL, and GC-IPL thickness using SS-OCT and SD-OCT. The data were obtained using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol. The eyes with retinal diseases were divided into three subgroups according to central macular thickness (CMT) for analysis. The intraclass correlation coefficient (ICC) was calculated to determine the repeatability of OCT device. Results In normal eyes, both OCT devices showed excellent repeatability of macula, mRNFL, and GC-IPL thickness measurements with high ICCs in all ETDRS subfields. In eyes with retinal disease, although SS-OCT showed better repeatability for inner retinal thickness measurements than SD-OCT, the overall ICCs were lower than those in normal eyes. In subgroup analysis, the ICCs in the low CMT group were lower than those in the normal and high CMT groups, particularly when using SD-OCT. Conclusions Both OCT devices had comparable repeatability for retinal thickness measurement in normal eyes and eyes with retinal disease. However, the possibility of measurement error should be considered in eyes with a thin and atrophic retina.	[Hong, Eun Hee; Ryu, So Jung; Kang, Min Ho; Seong, Mincheol; Cho, Heeyoon; Shin, Yong Un] Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Yeom, Jong Hun] Hanyang Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University	Shin, YU (corresponding author), Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.	syu2000@hanmail.net	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985	Hanyang University [HY-201800000000614]	Hanyang University	This work was supported by the research fund of Hanyang University (HY-201800000000614) (YUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareef RA, 2016, BRIT J OPHTHALMOL, V100, P1506, DOI 10.1136/bjophthalmol-2015-308106; Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Gao E, 2015, COMP RETINAL THICKNE, V10; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Kafieh Raheleh, 2013, J Med Signals Sens, V3, P45; Keane PA, 2009, BRIT J OPHTHALMOL, V93, P1461, DOI 10.1136/bjo.2008.155846; Krebs I, 2010, OPHTHALMOLOGY, V117, P1577, DOI 10.1016/j.ophtha.2010.04.032; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EK, 2014, OPHTHALMOLOGY, V121, P1579, DOI 10.1016/j.ophtha.2014.02.010; Lee HJ, 2015, INVEST OPHTH VIS SCI, V56, P4554, DOI 10.1167/iovs.15-16949; Lee HJ, 2015, AM J OPHTHALMOL, V160, P283, DOI 10.1016/j.ajo.2015.05.015; Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Min JK, 2017, CURR EYE RES, V42, P307, DOI 10.3109/02713683.2016.1170855; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Polito A, 2002, AM J OPHTHALMOL, V134, P240, DOI 10.1016/S0002-9394(02)01528-3; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Sabater AL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/458631; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535; Tan CS, 2015, OSLI RETINA, V46, P172, DOI 10.3928/23258160-20150213-23; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210729	10.1371/journal.pone.0210729	http://dx.doi.org/10.1371/journal.pone.0210729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650130	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300073
J	Huh, G; Yoon, H; Choi, YJ; Shin, CM; Park, YS; Kim, N; Lee, DH; Kim, JS				Huh, Gunn; Yoon, Hyuk; Choi, Yoon Jin; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho; Kim, Joo Sung			Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; NATURAL-HISTORY; EPIDEMIOLOGY; METAANALYSIS; CHILDREN; SURGERY; KOREA; TIME	Background The use of biologics in inflammatory bowel disease (IBD) has increased recently. However, studies on whether the proportion of IBD patient visits to the emergency department (ED) has decreased are scarce. We investigated the trends in IBD-related ED visits and hospitalization rates. Methods Medical records of IBD-related visits to the ambulatory department (AD) and the ED of the Seoul National University Bundang Hospital in 2007, 2009, 2012, and 2014 were reviewed. Multiple-variable logistic regression analysis was used to identify significant risk factors for hospitalization. Results The proportion of IBD patients who visited ED was 12.3% in 2007, 9.7% in 2009, 8.3% in 2012, and 6.4% in 2014 (P = 0.002). The most common chief complaints were abdominal pain (66.9%) in Crohn's disease (CD) patients and hematochezia (36.5%) in ulcerative colitis (UC) patients. The hospitalization rate following ED visits was 47.2% in CD patients and 55.6% in UC patients (P = 0.100). Multiple-variable analysis showed that significant risk factors associated with hospitalization in CD were aggressive disease behavior (odds ratio[OR] 3.54, P = 0.017) and presence of steroid exposure (OR 2.35, P = 0.047). Elevated C-reactive protein (CRP) (>0.5 mg/dL) (OR 5.40, P = 0.016) was the only risk factor associated with hospitalization in UC. Conclusions The proportion of ED visits decreased from 2007 to 2014; there was no significant change in hospitalization rates. Disease behavior/presence of steroid exposure and elevated CRP were associated with hospitalization among CD and UC patients who visited the ED, respectively.	[Huh, Gunn; Kim, Nayoung; Lee, Dong Ho; Kim, Joo Sung] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Yoon, Hyuk; Choi, Yoon Jin; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yoon, H (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	bodnsoul@hanmail.net	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Choi, Yoon Jin/0000-0002-1922-9388				Ananthakrishnan AN, 2010, AM J GASTROENTEROL, V105, P363, DOI 10.1038/ajg.2009.580; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Gajendran M, 2016, DIGEST DIS SCI, V61, P389, DOI 10.1007/s10620-015-3895-2; Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190; Jung YS, 2017, DIGEST DIS SCI, V62, P2102, DOI 10.1007/s10620-017-4640-9; Kappelman MD, 2011, INFLAMM BOWEL DIS, V17, P62, DOI 10.1002/ibd.21371; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kim HJ, 2015, INFLAMM BOWEL DIS, V21, P623, DOI 10.1097/MIB.0000000000000313; Kim JW, 2018, J GASTROEN HEPATOL, V33, P847, DOI 10.1111/jgh.14027; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; Lichtenstein GR, 2004, AM J GASTROENTEROL, V99, P91, DOI 10.1046/j.1572-0241.2003.04010.x; Mao EJ, 2017, ALIMENT PHARM THER, V45, P3, DOI 10.1111/apt.13847; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; Nugent Z, 2016, INFLAMM BOWEL DIS, V22, P2907, DOI 10.1097/MIB.0000000000000965; Park SH, 2007, INFLAMM BOWEL DIS, V13, P278, DOI 10.1002/ibd.20015; Reich KM, 2014, ALIMENT PHARM THER, V40, P629, DOI 10.1111/apt.12873; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210703	10.1371/journal.pone.0210703	http://dx.doi.org/10.1371/journal.pone.0210703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650133	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300070
J	Yen, HH; Murray, CM; Washington, EA; Kimpton, WG; Davies, HMS				Yen, Hung-Hsun; Murray, Christina M.; Washington, Elizabeth A.; Kimpton, Wayne G.; Davies, Helen M. S.			Characterisation of ovine lymphatic vessels in fresh specimens	PLOS ONE			English	Article							THORACIC-DUCT CANNULATION; AFFERENT LYMPH; COLLECTION; MODEL; SHEEP; RECIRCULATION; THORACOTOMY	Background and aim The development and use of experimental models using lymphatic cannulation techniques have been hampered by the lack of high-quality colour imaging of lymphatic vessels in situ. Most descriptions of lymphatic anatomy in sheep have historically depended on schematic diagrams due to limitations in the ability to publish colour images of the lymphatic vessels with decent resolution. The aim of this work was to encourage more widespread use of the ovine cannulation model by providing clear photographic images identifying the location and anatomical layout of some major lymphatic ducts and their in situ relationship to surrounding tissues. Methods The cadavers of the sheep were collected after they had been euthanized at the end of animal trials not associated with this study. The lymphatics were dissected and exposed to show their appearance in the surrounding tissues and their relationship to other organs. Patent Blue was used to locate lymphatic vessels in exploratory preparations. However, in order to present the natural appearance of the vessels, we used minimal dissection and dye was not used for the photographed examples. Instead, we have indicated the course of the vessels with lines where their position is less clear. Results and conclusion In this paper, we have used sheep specimens as examples to show characteristic images of lymphatic vessels. The images of in situ lymphatics and lymph nodes combined with schematic summaries provide a concise illustration of the lymphatic drainage scheme in sheep.	[Yen, Hung-Hsun; Murray, Christina M.; Washington, Elizabeth A.; Kimpton, Wayne G.; Davies, Helen M. S.] Univ Melbourne, Melbourne Vet Sch, Parkville, Vic, Australia; [Yen, Hung-Hsun] Natl Pingtung Univ Sci & Technol, Res Ctr Anim Biol, Neipu, Taiwan	University of Melbourne; National Pingtung University Science & Technology	Yen, HH (corresponding author), Univ Melbourne, Melbourne Vet Sch, Parkville, Vic, Australia.; Yen, HH (corresponding author), Natl Pingtung Univ Sci & Technol, Res Ctr Anim Biol, Neipu, Taiwan.	hyen@unimelb.edu.au	Washington, Elizabeth A/K-5185-2015; Davies, Helen/K-6343-2015	Washington, Elizabeth A/0000-0002-2905-0912; Davies, Helen/0000-0002-5110-2002; Yen, Hung-Hsun/0000-0002-1911-1646				Burke ML, 2014, INNATE IMMUN-LONDON, V20, P501, DOI 10.1177/1753425913501213; HEATH TJ, 1986, J ANAT, V144, P61; Hein WR, 2004, J IMMUNOL METHODS, V293, P153, DOI 10.1016/j.jim.2004.07.008; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; KIMPTON WG, 1989, IMMUNOLOGY, V66, P69; LANDOLT CC, 1981, J APPL PHYSIOL, V50, P1372, DOI 10.1152/jappl.1981.50.6.1372; LASCELLES A, 1961, Q J EXP PHYSIOL CMS, V46, P199, DOI 10.1113/expphysiol.1961.sp001536; PEARSON LD, 1976, J EXP MED, V143, P167, DOI 10.1084/jem.143.1.167; Saar LI, 1975, SISSON GROSSMANS ANA, V1, P1042; SALAZAR I, 1984, LYMPHOLOGY, V17, P46; Scheerlinck JPY, 2006, VACCINE, V24, P3929, DOI 10.1016/j.vaccine.2006.02.032; STAUB NC, 1975, J SURG RES, V19, P315, DOI 10.1016/0022-4804(75)90056-6; Tanudimadja K., 1973, THESIS; UHLEY H, 1963, P SOC EXP BIOL MED, V112, P684; Washington EA, 2018, J IMMUNOL METHODS, V457, P6, DOI 10.1016/j.jim.2018.03.011; Wilkens B., 1981, CIRCULATORY SYSTEM S; Yen HH, 2006, METHODS, V38, P117, DOI 10.1016/j.ymeth.2005.09.011; Yen HH, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0908-0; Yen HH, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0808-3; Yen HH, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0430-9; Yen HH, 2009, VET IMMUNOL IMMUNOP, V129, P76, DOI 10.1016/j.vetimm.2008.12.014	21	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209414	10.1371/journal.pone.0209414	http://dx.doi.org/10.1371/journal.pone.0209414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650093	Green Published, gold			2022-12-27	WOS:000455813300014
J	Seo, JH; Yoon, S; Min, SH; Row, HS; Bahk, JH				Seo, Jeong-Hwa; Yoon, Susie; Min, Se-Hee; Row, Hyung Sang; Bahk, Jae-Hyon			Augmentation of curved tip of left-sided double-lumen tubes to reduce right bronchial misplacement: A randomized controlled trial	PLOS ONE			English	Article							ENDOBRONCHIAL TUBES; ENDOTRACHEAL-TUBE; LUNG ISOLATION; INTUBATION; SIZE; PLACEMENT; BLOCKER; EXPERIENCE; INJURIES; DEVICES	Background During intubation with a blind technique, a left-sided double-lumen tube (DLT) can be misdirected into the right bronchus even though its curved tip of the bronchial lumen turns to the left. This right bronchial misplacement may be associated with the tip angle of DLTs. We thus performed a randomized trial to test the hypothesis that the DLT with an acute tip angle enters the right bronchus less frequently than the tube with an obtuse tip angle. Methods We randomized surgical patients (n = 1427) receiving a polyvinyl chloride left-sided DLT. Before intubation, the curved tip was further bent to an angle of 135 degrees and kept with a stylet inside in the curved-tip group, but not in the control group. After the tip was inserted into the glottis under direct or video laryngoscopy, the stylet was removed and the DLT was advanced into the bronchus with its tip turning to the left. We checked which bronchus was intubated, and the time and number of attempts for intubation. After surgery, we assessed airway injury, sore throat, and hoarseness. The primary outcome was the incidence of right bronchial misplacement of the DLT. Results DLTs were misdirected into the right bronchus more frequently in the control group than in the curved-tip group: 57/715 (8.0%) vs 17/712 (2.4%), risk ratio (95% CI) 3.3 (2.0-5.7), P < 0.001. The difference was significant in the use of 32 (P = 0.003), 35 (P = 0.007), and 37 (P = 0.012) Fr DLTs. Intubation required longer time (P < 0.001) and more attempts (P = 0.002) in the control group. No differences were found in postoperative airway injury, sore throat and hoarseness. Conclusions Before intubation of left-sided DLTs, augmentation of the curved DLT tip reduced the right bronchial misplacement and facilitated intubation without aggravating airway injury.	[Seo, Jeong-Hwa; Yoon, Susie; Min, Se-Hee; Row, Hyung Sang; Bahk, Jae-Hyon] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Bahk, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea.	bahkjh@snu.ac.kr	Min, Se-Hee/GLU-9925-2022	Bahk, Jae-Hyon/0000-0002-3082-5244				Baraka A, 1996, PAEDIATR ANAESTH, V6, P487, DOI 10.1046/j.1460-9592.1996.d01-13.x; BENUMOF JL, 1987, ANESTHESIOLOGY, V67, P729, DOI 10.1097/00000542-198711000-00018; Bernard L, 2017, TALANTA, V162, P604, DOI 10.1016/j.talanta.2016.10.033; Boucek CD, 1998, J CLIN ANESTH, V10, P557, DOI 10.1016/S0952-8180(98)00081-6; BRODSKY JB, 1991, ANESTH ANALG, V73, P570; Brodsky JB, 2003, J CARDIOTHOR VASC AN, V17, P289, DOI 10.1016/S1053-0770(03)00046-6; BRODSKY JB, 1985, ANESTHESIOLOGY, V62, P667, DOI 10.1097/00000542-198505000-00028; Campos JH, 2006, ANESTHESIOLOGY, V104, P261, DOI 10.1097/00000542-200602000-00010; Campos JH, 2002, ANESTHESIOLOGY, V97, P1295; Chow MYH, 1998, ANESTH ANALG, V87, P158, DOI 10.1097/00000539-199807000-00033; Chow MYH, 1999, ANESTH ANALG, V88, P302, DOI 10.1097/00000539-199902000-00014; Cohen E, 2002, J CARDIOTHOR VASC AN, V16, P249, DOI 10.1053/jcan.2002.31092; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Dumans-Nizard V, 2015, EUR J ANAESTH, V32, P418, DOI 10.1097/EJA.0000000000000201; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Hampton T, 2000, ANAESTH INTENS CARE, V28, P540, DOI 10.1177/0310057X0002800510; HANNALLAH M, 1989, ANESTHESIOLOGY, V71, P457, DOI 10.1097/00000542-198909000-00027; Hannallah M, 1997, J CARDIOTHOR VASC AN, V11, P168, DOI 10.1016/S1053-0770(97)90208-1; HANNALLAH MS, 1993, ANESTH ANALG, V77, P990; Henderson JJ, 1997, ANAESTHESIA, V52, P552, DOI 10.1111/j.1365-2222.1997.129-az0125.x; Jeon Y, 2005, ANAESTH INTENS CARE, V33, P59, DOI 10.1177/0310057X0503300109; Kabrhel Christopher, 2007, N Engl J Med, V356, pe15, DOI 10.1056/NEJMvcm063574; Kim J, 2011, KOREAN J ANESTHESIOL, V60, P285, DOI 10.4097/kjae.2011.60.4.285; Knoll H, 2006, ANESTHESIOLOGY, V105, P471, DOI 10.1097/00000542-200609000-00009; KUBOTA H, 1987, ANESTHESIOLOGY, V67, P587, DOI 10.1097/00000542-198710000-00028; KUBOTA Y, 1986, ANESTHESIOLOGY, V64, P374, DOI 10.1097/00000542-198603000-00015; Lieberman D, 1996, CAN J ANAESTH, V43, P238, DOI 10.1007/BF03011741; Lieutaud T, 2003, CAN J ANAESTH, V50, P121, DOI 10.1007/BF03017842; MANGAR D, 1994, SOUTHERN MED J, V87, P1129, DOI 10.1097/00007611-199411000-00014; Mourisse J, 2013, ANESTHESIOLOGY, V118, P550, DOI 10.1097/ALN.0b013e3182834f2d; NEUSTEIN SM, 1989, ANESTHESIOLOGY, V71, P996, DOI 10.1097/00000542-198912000-00034; Seo JH, 2013, BRIT J ANAESTH, V111, P812, DOI 10.1093/bja/aet203; Seo JH, 2016, BRIT J ANAESTH, V116, P282, DOI 10.1093/bja/aev414; Seo JH, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0138-1; Sharma Anil, 2008, Middle East Journal of Anesthesiology, V19, P909; SMITH M, 1990, CAN J ANAESTH, V37, P144, DOI 10.1007/BF03007497; ZMYSLOWSKI WP, 1989, ANESTHESIOLOGY, V70, P883, DOI 10.1097/00000542-198905000-00039	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210711	10.1371/journal.pone.0210711	http://dx.doi.org/10.1371/journal.pone.0210711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645611	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200045
J	Varkila, MRJ; Vos, AG; Barth, RE; Tempelman, HA; Deville, WLJ; Coutinho, RA; Grobbee, DE; Klipstein-Grobusch, K				Varkila, Meri R. J.; Vos, Alinda G.; Barth, Roos E.; Tempelman, Hugo A.; Deville, Walter L. J.; Coutinho, Roel A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin			The association between HIV infection and pulmonary function in a rural African population	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; LUNG-FUNCTION; ANTIRETROVIRAL THERAPY; RESPIRATORY SYMPTOMS; REFERENCE VALUES; TOBACCO USE; DISEASE; TUBERCULOSIS; RISK; EPIDEMIOLOGY	Objectives HIV infection has been associated with an impaired lung function in high-income countries, but the association between HIV infection and pulmonary function in Sub-Saharan Africa remains unclear. This study aims to investigate the relation between HIV infection and pulmonary function in a rural African population. Methods A cross-sectional study was conducted among HIV-positive and HIV-negative adults in a rural area in South Africa, as part of the Ndlovu Cohort Study. A respiratory questionnaire and post-bronchodilator spirometry were performed. Multivariable regression analysis was used to investigate whether HIV was independently associated with a decrease in post-bronchodilator FEV1/FVC ratio considering age, sex, body mass index, respiratory risk factors and a history of a pulmonary infection (tuberculosis (TB) or a pneumonia). Possible mediation by a history of pulmonary infection was tested by removing this variable from the final model. Results Two hundred and one consecutive participants were enrolled in the study in 2016, 84 (41.8%) were HIV-positive (82.1% on ART). The median age was 38 (IQR 29-51) years. Following multivariable analysis HIV was not significantly associated to a decline in post-bronchodilator FEV1/FVC ratio (beta -0.017, p 0.18). However, upon removal of a history of a pulmonary infection from the final model HIV was significantly related to post-bronchodilator FEV1/FVC ratio, beta -0.026, p 0.03. Conclusions Pulmonary function is affected by HIV infection which most likely results from co-infection with TB or other pneumonia. Further research should focus on the influence of a pulmonary infection, most notably TB, on pulmonary function, especially as the incidence of TB is high in HIV infection.	[Varkila, Meri R. J.; Vos, Alinda G.; Deville, Walter L. J.; Coutinho, Roel A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Vos, Alinda G.; Barth, Roos E.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Vos, Alinda G.] Univ Witwatersrand Johannesburg, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Tempelman, Hugo A.; Deville, Walter L. J.] Ndlovu Care Grp, Groblersdal, South Africa; [Grobbee, Diederick E.] Acad Contract Res Org, Julius Clin Res, Zeist, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Div Epidemiol & Biostat, Sch Publ Hlth, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; University of Witwatersrand	Vos, AG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Witwatersrand Johannesburg, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa.	a.g.vos-8@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Vos, Alinda/0000-0002-9551-6223; Deville, Walter/0000-0001-9854-1718; Varkila, Meri/0000-0002-2831-0292				Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Akanbi MO, 2015, J AIDS CLIN RES, V6; Amaral AFS, 2015, EUR RESPIR J, V46, P1104, DOI 10.1183/13993003.02325-2014; [Anonymous], 2012, GLOB REP UNAIDS REP; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Bigna JJ, 2018, LANCET GLOB HEALTH, V6, pE182, DOI 10.1016/S2214-109X(17)30451-5; Brandli O, 1996, THORAX, V51, P277, DOI 10.1136/thx.51.3.277; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; COTES JE, 1987, LANCET, V2, P1028; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Diaz PT, 2003, CHEST, V123, P1977, DOI 10.1378/chest.123.6.1977; DOCKERY DW, 1985, AM REV RESPIR DIS, V131, P511, DOI 10.1164/arrd.1985.131.4.511; Drummond MB, 2015, AIDS, V29, P1691, DOI 10.1097/QAD.0000000000000750; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; Gautam SS, 2016, COPD, V13, P790, DOI 10.1080/15412555.2016.1191456; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Hayden LP, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0273-8; Institute for Health Metrics and Evaluation Human Development Network The The World Bank, 2013, GLOB BURD DIS GEN EV; Isara AR, 2014, EURASIAN J MED, V46, P203, DOI 10.5152/eajm.2014.0051; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Kristoffersen US, 2012, CLIN PHYSIOL FUNCT I, V32, P288, DOI 10.1111/j.1475-097X.2012.01124.x; Kunisaki KM, 2016, LANCET RESP MED, V4, P980, DOI 10.1016/S2213-2600(16)30319-8; Lalley PM, 2013, RESP PHYSIOL NEUROBI, V187, P199, DOI 10.1016/j.resp.2013.03.012; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Mengersen K, 2011, SCI TOTAL ENVIRON, V409, P1378, DOI 10.1016/j.scitotenv.2011.01.016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; North CM, 2018, LUNG, V196, P49, DOI 10.1007/s00408-017-0080-8; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Pefura-Yone EW, 2015, RESP MED, V109, P247, DOI 10.1016/j.rmed.2014.12.003; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Petrache I, 2008, THORAX, V63, P463, DOI 10.1136/thx.2007.079111; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Risso K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169359; Ronit A, 2018, THORAX, V73, P431, DOI 10.1136/thoraxjnl-2017-211079; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sreeramareddy CT, 2018, TOB CONTROL, V27, P26, DOI 10.1136/tobaccocontrol-2016-053266; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; Twigg Homer L 3rd, 2007, Drug Discov Today Dis Mech, V4, P95, DOI 10.1016/j.ddmec.2007.11.001; UNAIDS, 2014, THE GAP REP; van Gemert F, 2015, LANCET GLOB HEALTH, V3, pE44, DOI 10.1016/S2214-109X(14)70337-7; Vos A, 2017, EUR J PREV CARDIOL, V24, P1043, DOI 10.1177/2047487317702039; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2002, WORLD HLTH SURV 2002	50	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210573	10.1371/journal.pone.0210573	http://dx.doi.org/10.1371/journal.pone.0210573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645622	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200035
J	Ajamian, M; Steer, D; Rosella, G; Gibson, PR				Ajamian, Mary; Steer, David; Rosella, Gennaro; Gibson, Peter R.			Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems	PLOS ONE			English	Article							TIGHT JUNCTIONS; HAPTOGLOBIN; DISEASE; PERMEABILITY; IDENTIFICATION; POLYMORPHISM; MODULATOR; PROTEIN; GLUTEN; C3	The protein, zonulin, has emerged as a popular serological marker to assess the integrity of the intestinal mucosal barrier. However, there is limited information on the utility of serum zonulin to indicate gastrointestinal disease and the validity of zonulin detection in widely-used commercial assays. The current study reports differences in zonulin levels across patient groups with gastrointestinal dysfunction compared with healthy individuals, though methodological inconsistencies indicated that actual zonulin protein was not detected by the commercial assays applied. The nature of the assays' detected antigen was investigated using immunoprecipitation followed by mass spectrometric analysis and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by protein staining. Top matches of the assays' detected antigen included haptoglobin and complement C3 for the assay manufactured by CUSABIO (Wuhan, China) and complement C3 for the assay manufactured by Immundiagnostik AG (Bensheim ,Germany). These findings confirm that current commercial zonulin assays are not detecting the actual protein as prehaptoglobin-2. Until assay methodology is improved, we advise the greater scientific and medical community to exercise caution in considering the measurement of serum zonulin as a marker of mucosal barrier integrity.	[Ajamian, Mary; Rosella, Gennaro; Gibson, Peter R.] Monash Univ, Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Steer, David] Monash Biomed Prote Facil, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Ajamian, M (corresponding author), Monash Univ, Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia.	Mary.Ajamian@monash.edu			Australian-American Fulbright Commission	Australian-American Fulbright Commission	MA received a Fulbright Scholarship from the Australian-American Fulbright Commission (https://www.fulbright.org.au/) to undertake research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro MR CC, 2014, UNITED EUROPEAN G S1, V2; Beswick L, 2018, J CROHNS COLITIS, V12, P289, DOI 10.1093/ecco-jcc/jjx146; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Di Pierro M, 2001, J BIOL CHEM, V276, P19160, DOI 10.1074/jbc.M009674200; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Fasano A, 2012, ANN NY ACAD SCI, V1258, P25, DOI 10.1111/j.1749-6632.2012.06538.x; Fasano A, 2012, CLIN REV ALLERG IMMU, V42, P71, DOI 10.1007/s12016-011-8291-x; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; Hollon J, 2015, NUTRIENTS, V7, P1565, DOI 10.3390/nu7031565; Khaleghi S, 2016, THER ADV GASTROENTER, V9, P37, DOI 10.1177/1756283X15616576; Koch W, 2002, CLIN CHEM, V48, P1377; Kuo SJ, 2015, J FORMOS MED ASSOC, V114, P943, DOI 10.1016/j.jfma.2014.01.016; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Newnham E, 2017, J GASTROENTEROLOGY H; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Scheffler L., 2017, BIORXIV, DOI [10.1101/157578, DOI 10.1101/157578]; Scheffler L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00022; Sina C, 2018, SEMIN IMMUNOL, V37, P66, DOI 10.1016/j.smim.2018.02.008; Sunderhauf A, 2017, MOL IMMUNOL, V90, P227, DOI 10.1016/j.molimm.2017.08.003; TOSI M, 1989, J MOL BIOL, V208, P709, DOI 10.1016/0022-2836(89)90161-7; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang WL, 2000, J CELL SCI, V113, P4435; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; Wicher KB, 2004, P NATL ACAD SCI USA, V101, P14390, DOI 10.1073/pnas.0405692101	30	74	76	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210728	10.1371/journal.pone.0210728	http://dx.doi.org/10.1371/journal.pone.0210728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640940	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000041
J	Mohamed, N; Timofeyeva, Y; Jamrozy, D; Rojas, E; Hao, L; de Monerri, NCS; Hawkins, J; Singh, G; Cai, B; Liberator, P; Sebastian, S; Donald, RGK; Scully, IL; Jones, CH; Creech, CB; Thomsen, I; Parkhill, J; Peacock, SJ; Jansen, KU; Holden, MTG; Anderson, AS				Mohamed, Naglaa; Timofeyeva, Yekaterina; Jamrozy, Dorota; Rojas, Eduardo; Hao, Li; de Monerri, Natalie C. Silmon; Hawkins, Julio; Singh, Guy; Cai, Bing; Liberator, Paul; Sebastian, Shite; Donald, Robert G. K.; Scully, Ingrid L.; Jones, C. Hal; Creech, C. Buddy; Thomsen, Isaac; Parkhill, Julian; Peacock, Sharon J.; Jansen, Kathrin U.; Holden, Matthew T. G.; Anderson, Annaliesa S.			Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States	PLOS ONE			English	Article							METHICILLIN-RESISTANT; SEROTYPE 5; IN-VITRO; BACTERIAL VIRULENCE; CONJUGATE VACCINE; CLUMPING FACTOR; PCR STRATEGY; ANTIBODIES; HEALTH; VIVO	Staphylococcus aureus capsular polysaccharides (CP) are important virulence factors under evaluation as vaccine antigens. Clinical S. aureus isolates have the biosynthetic capability to express either CP5 or CP8 and an understanding of the relationship between CP genotype/phenotype and S. aureus epidemiology is valuable. Using whole genome sequencing, the clonal relatedness and CP genotype were evaluated for disease-associated S. aureus isolates selected from the Tigecycline Evaluation and Surveillance Trial (T. E. S. T) to represent different geographic regions in the United States (US) during 2004 and 2009-10. Thirteen prominent clonal complexes (CC) were identified, with CC5, 8, 30 and 45 representing >80% of disease isolates. CC5 and CC8 isolates were CP type 5 and, CC30 and CC45 isolates were CP type 8. Representative isolates from prevalent CC were susceptible to in vitro opsonophagocytic killing elicited by anti-CP antibodies, demonstrating that susceptibility to opsonic killing is not linked to the genetic lineage. However, as not all S. aureus isolates may express CP, isolates representing the diversity of disease isolates were assessed for CP production. While approximately 35% of isolates (primarily CC8) did not express CP in vitro, CP expression could be clearly demonstrated in vivo for 77% of a subset of these isolates (n = 20) despite the presence of mutations within the capsule operon. CP expression in vivo was also confirmed indirectly by measuring an increase in CP specific antibodies in mice infected with CP5 or CP8 isolates. Detection of antigen expression in vivo in relevant disease states is important to support the inclusion of these antigens in vaccines. Our findings confirm the validity of CP as vaccine targets and the potential of CP-based vaccines to contribute to S. aureus disease prevention.	[Mohamed, Naglaa; Timofeyeva, Yekaterina; Rojas, Eduardo; Hao, Li; de Monerri, Natalie C. Silmon; Hawkins, Julio; Singh, Guy; Cai, Bing; Liberator, Paul; Sebastian, Shite; Donald, Robert G. K.; Scully, Ingrid L.; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA; [Jamrozy, Dorota; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Creech, C. Buddy; Thomsen, Isaac] Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, Dept Pediat,Div Pediat Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA; [Peacock, Sharon J.] London Sch Hyg & Trop Med, London, England; [Holden, Matthew T. G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	Pfizer; Wellcome Trust Sanger Institute; Vanderbilt University; University of London; London School of Hygiene & Tropical Medicine; University of St Andrews	Anderson, AS (corresponding author), Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA.	annaliesa.anderson@pfizer.com	Peacock, Sharon J/ABE-6331-2020; Parkhill, Julian/G-4703-2011; Holden, Matthew TG/K-6449-2014; Donald, Robert George Konrad/GNP-4958-2022	Parkhill, Julian/0000-0002-7069-5958; Holden, Matthew TG/0000-0002-4958-2166; Creech, Clarence/0000-0002-8276-9053; Peacock, Sharon/0000-0002-1718-2782	Pfizer Vaccine Research	Pfizer Vaccine Research	This study was sponsored by Pfizer Vaccine Research who provided support in the form of salaries for authors NM, YT, ER, LH, NSM, JH, GS, BC, PL, SS, RGKD, ILS, CHJ, KUJ and ASA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson AS, 2012, HUM VACC IMMUNOTHER, V8, P1585, DOI 10.4161/hv.21872; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Benjamin DK, 2006, J PERINATOL, V26, P290, DOI 10.1038/sj.jp.7211496; BLOCK SL, 2015, PEDIATR INFECT DIS J, V4, P3; BOETZER M, BIOINFORMATICS, P578; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; BOUCHILLON SK, 2005, DIAGN MICROBIOL INFE, V8, P18; BOYLEVAVRA S, 2006, LAB INVEST, V12, P6; CHAMBERS HF, NATURE REVIEWS MICRO, P629; Chaves-Moreno D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33174; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2009, J INFECT DIS, V200, P1371, DOI 10.1086/606011; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DAVID MZ, 2011, PUBMED, V5, P3; De Montalembert M, 2015, PEDIATR BLOOD CANCER, V62, P1427, DOI 10.1002/pbc.25502; Diekema DJ, 2014, INFECT CONT HOSP EP, V35, P285, DOI 10.1086/675283; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; FATTOM A, 1974, PUBMED; FATTOM A, 2014, PUBMED, V12, P9; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; FATTOM AI, 1998, PUBMED, V9, P24; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Giersing BK, 2016, VACCINE, V34, P2962, DOI 10.1016/j.vaccine.2016.03.110; GOERKE C, MOL MICROBIOL, P1439; GOETGHEBEUR M, 2008, PUBMED, V10, P17; GUIDRY AJ, 1991, J DAIRY SCI, V74, P3360, DOI 10.3168/jds.S0022-0302(91)78525-1; Gupta RK, 2013, J INFECT DIS, V208, P1841, DOI 10.1093/infdis/jit367; Hallin M, 2007, J ANTIMICROB CHEMOTH, V59, P465, DOI 10.1093/jac/dkl535; Handke LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077874; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; HARRISON LH, J INFECT DIS, P1208; HAWKINS J, 2012, A RECOMBINANT CLUMPI; Herbert S, 1997, Pneumologie, V51, P1043; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hsu LY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0643-z; Hsu LY, 2015, MBIO, V16, P81; Inouye M, 2014, PUBMED, V6, P90; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jamrozy DM, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000058; Jansen KU, 2013, VACCINE, V31, P2723, DOI 10.1016/j.vaccine.2013.04.002; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Jenkins A, 2015, MBIO, V6, DOI 10.1128/mBio.02272-14; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KOSER CU, 2012, PUBMED, V6, P15; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Lattar SM, 2009, INFECT IMMUN, V77, P1968, DOI 10.1128/IAI.01214-08; LATTAR SM, INFECT IMMUN, P83; LEE CY, 2001, INFEC AGENT, P35; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Li WJ, 2014, INT J MED MICROBIOL, V304, P958, DOI 10.1016/j.ijmm.2014.06.002; LIMBAGO B, J CLIN MICROBIOL, P1344; LINDSAY JA, 2005, PUBMED, V12, P31; Liu B, 2017, VIRULENCE, V8, P859, DOI 10.1080/21505594.2016.1270494; LUONG T, 2010, PUBMED, V12, P7; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; MA X, ANTIMICROB AGENTS CH, P1147; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; MATSON MAGD, 2001, ICAAC, P5; MCADOW M, 2011, PLOS PATHOG, V7, P10; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; McNamara Peter J., 2008, P89; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; MOHAMED N, 2017, THE BRITISH JOURNAL, V104, P2; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MURPHY E, 2011, HUM VACCINES, V1, P20; Murphy E, 2011, HUM VACCINES, V7, P51, DOI 10.4161/hv.7.0.14562; Nanra JS, 2009, VACCINE, V27, P3276, DOI 10.1016/j.vaccine.2009.01.062; NANRA JS, 2012, PUBMED, V12, P20; Nissen M, 2015, VACCINE, V33, P1846, DOI 10.1016/j.vaccine.2015.02.024; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; OUYANG S, 1999, PUBMED, V4, P10; OUYANG S, 1997, MOL MICROBIOL, V2, P1; Page AJ, 2016, MICROB GENOMICS, V2; Park S, 2014, INFECT IMMUN, V82, P5049, DOI 10.1128/IAI.02373-14; Pasquale TR, 2013, INT J INFECT DIS, V17, pE398, DOI 10.1016/j.ijid.2012.12.013; PMID, 2006, PUBMED; PMID, 2012, PUBMED, V6, P27; PMID, PUBMED; PMID, 2011, PUBMED, V11, P29; PMID, 2015, PUBMED, V2, P19; PMID, 2017, PUBMED, V3, P30; PMID, 2004, PUBMED, V1, P17; PMID, PUBMED, P144; PMID, 2012, PUBMED, V16, P7391; PMID, 2017, PUBMED, V1, P26; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RASMUSSEN G, 2013, PLOS ONE, V10, P17; ROGHMANN M, J HOSP INFECT, P27; ROZEMEIJER W, 2015, PUBMED, V2, P27; Rupp ME, 2007, ANTIMICROB AGENTS CH, V51, P4249, DOI 10.1128/AAC.00570-07; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Scully IL, 2018, HUM VACC IMMUNOTHER, V14, P81, DOI 10.1080/21645515.2017.1386360; Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109; Sharma-Kuinkel BK, 2015, BIOINFORMATICS, V2, DOI 10.1093/ofid/ofv093; SHARMAKUINKEL BK, 2015, PUBMED, V7, P28; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; SOELL M, 1995, PUBMED, V4, P1; SOMPOLINSKY D, 1985, J CLIN MICROBIOL, V22, P828, DOI 10.1128/JCM.22.5.828-834.1985; Spoor LE, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000036; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; SUN FJIQ, 2011, PUBMED, V11, P30; Sutter DE, 2011, FEMS IMMUNOL MED MIC, V63, P16, DOI 10.1111/j.1574-695X.2011.00822.x; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; TALAN DA, R J; TENOVER FC, J CLIN MICROBIOL, P108; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Timofeyeva Yekaterina, 2014, Methods Mol Biol, V1085, P85, DOI 10.1007/978-1-62703-664-1_4; TROTTER CL, VACCINE, P4434; Tuchscherr LPN, 2008, INFECT IMMUN, V76, P5738, DOI 10.1128/IAI.00874-08; VANWAMEL W, 2002, MICROB PATHOGENESIS, V8, P31; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; WYRES KL, J INFECT DIS, P439; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	130	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208356	10.1371/journal.pone.0208356	http://dx.doi.org/10.1371/journal.pone.0208356			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30641545	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000455808000004
J	Monamele, CG; Njifon, HLM; Vernet, MA; Njankouo, MR; Kenmoe, S; Yahaya, AA; Deweerdt, L; Nono, R; Mbacham, W; Anong, DN; Akoachere, JF; Njouom, R				Monamele, Chavely Gwladys; Njifon, Hermann Landry Munshili; Vernet, Marie-Astrid; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Yahaya, Ali Ahmed; Deweerdt, Louis; Nono, Raphael; Mbacham, Wilfred; Anong, Damian Nota; Akoachere, Jane Francis; Njouom, Richard			Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; VIRUSES; HEMAGGLUTININ; EPIDEMIOLOGY; A(H3N2); H1N1	In 2009, Influenza A(H1N1)pdm09 caused the first influenza pandemic of the 21st century with high mortality rates of about 284 500 deaths. This virus, however, continues to circulate as a seasonal influenza virus and to cause illness and deaths worldwide. In this study, we describe the genetic diversity of A(H1N1)pdm09 viruses collected between 2014 and 2016 in Cameroon. Three gene segments (HA, NA and M) of Cameroon strains were studied. The phylogenetic tree of the coding nucleotide sequences was generated by MEGA version 6.0 using a Maximum Likelihood method. The NA and M protein coding sequences were analyzed for the reported genetic markers of resistance against neuraminidase inhibitors and adamantanes, while predicted vaccine efficacy was estimated using the P-epitope method. Overall 39 strains were obtained. Phylogenetic analysis of the HA gene of influenza A(H1N1)pdm09 showed that Cameroon strains belonged to two major clades. The 2014 Cameroon sequences belonged to clade 6C while all sequences collected between 2015 and 2016 belonged to clade 6B. Majority of the samples had some mutations in the NA gene notably: I117M, N248D, and N369K while the amantadine-resistant M mutant, S31N, was found to be absent only in the two sequences collected in 2014. Overall, A/California/07/2009 vaccine strain showed a predicted vaccine efficacy of 24.55% to 35.77% against Cameroon A(H1N1)pdm09 strains circulating between 2014 and 2016. Our findings confirms the fast evolution of A(H1N1)pdm09 since its first introduction and highlights on the importance of influenza vaccine in reducing the burden caused by influenza in the community.	[Monamele, Chavely Gwladys; Vernet, Marie-Astrid; Njankouo, Mohamadou Ripa; Kenmoe, Sebastien; Njouom, Richard] Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon; [Monamele, Chavely Gwladys; Anong, Damian Nota; Akoachere, Jane Francis] Univ Buea, Buea, Cameroon; [Njifon, Hermann Landry Munshili; Deweerdt, Louis; Nono, Raphael] Ctr Pasteur Cameroon, Annex Of Garoua, Garoua, Cameroon; [Njifon, Hermann Landry Munshili; Mbacham, Wilfred] Univ Yaounde I, Yaounde, Cameroon; [Yahaya, Ali Ahmed] WHO, Reg Off Africa, Brazzaville, Rep Congo	University of Yaounde I; World Health Organization	Njouom, R (corresponding author), Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon.	njouom@pasteur-yaounde.org		Hermann Landry, Munshili Njifon/0000-0002-7181-9836; KENMOE, SEBASTIEN/0000-0002-5536-080X	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes [6 DESP060001-01-01]	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes	This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes.	[Anonymous], 2018, SEAS INFL VACC EFF 2; [Anonymous], 2004, PREDICTION N GLYCOSY; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Eshaghi A, 2014, INFLUENZA OTHER RESP, V8, P250, DOI 10.1111/irv.12219; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Han Y, 2016, VIRUS GENES, V52, P606, DOI 10.1007/s11262-016-1358-2; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Hurt AC, 2016, ANTIVIR RES, V132, P178, DOI 10.1016/j.antiviral.2016.06.001; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Korsun N, 2017, INFECT GENET EVOL, V49, P241, DOI 10.1016/j.meegid.2017.01.027; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Monamele GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184411; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Nelson MI, 2014, J INFECT DIS, V210, P121, DOI 10.1093/infdis/jiu047; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Potdar VA, 2014, INDIAN J MED RES, V140, P244; Sanou AM, 2018, INFLUENZA OTHER RESP, V12, P490, DOI 10.1111/irv.12539; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; Wedde M, 2015, INT J MED MICROBIOL, V305, P762, DOI 10.1016/j.ijmm.2015.08.030; WHO, 2018, INFL SEAS MED CTR; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Ogranization (WHO), 2018, LAB METH TEST ANT SU; World Health Organization, WHO REC COMP INFL VI	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210119	10.1371/journal.pone.0210119	http://dx.doi.org/10.1371/journal.pone.0210119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640922	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000019
J	Sinn, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW				Sinn, Dong Hyun; Choi, Gyu-Seong; Park, Hee Chul; Kim, Jong Man; Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Il Yu, Jeong; Ha, Sang Yun; Lee, Su Jin; Lim, Ho Yeong; Kim, Kyunga; Ahn, Joong Hyun; Kang, Wonseok; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Joh, Jae-Won; Lim, Hyo Keun; Paik, Seung Woon			Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients	PLOS ONE			English	Article							COMPLEXITY SCIENCE; MANAGEMENT; GUIDELINES; OUTCOMES; TEAM; THERAPY; CANCER; CARE	Background Given the complexity of managing hepatocellular carcinoma (HCC),a multidisciplinary approach (MDT) is recommended to optimize management of HCC patients. However, evidence suggesting that MDT improves patient outcome is limited. Methods We performed a retrospective cohort study of all patients newly-diagnosed with HCC between 2005 and 2013 (n = 6,619). The overall survival (OS) rates between the patients who were and were not managed via MDT were compared in the entire cohort (n = 6,619), and in the exactly matched cohort (n = 1,396). Results In the entire cohort, the 5-year survival rate was significantly higher in the patients who were managed via MDT compared to that of the patients who were not (71.2% vs. 49.4%, P < 0.001), with an adjusted hazard ratio (HR) of 0.47 (95% confidence interval [CI]; 0.41-0.53). In the exactly matched cohort, the 5-year survival rate was higher in patients who were managed via MDT (71.4% vs. 58.7%, P < 0.001; HR [95% CI] = 0.67 [0.56-0.80]). The survival benefit of MDT management was observed in most pre-defined subgroups, and was especially significant in patients with poor liver function (ALBI grade 2 or 3), intermediate or advanced tumor stage (BCLC stage B or C), or high alphafetoprotein levels (>= 200 ng/ml). Conclusion MDT management was associated with improved overall survival in HCC patients, indicating that MDT management can be a valuable option to improve outcome of HCC patients. This warrants prospective evaluations.	[Sinn, Dong Hyun; Lee, Su Jin; Lim, Ho Yeong; Kang, Wonseok; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Gyu-Seong; Kim, Jong Man; Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Park, Hee Chul; Il Yu, Jeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Lim, Hyo Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Honsoul; Song, Kyoung Doo; Kang, Tae Wook; Lee, Min Woo; Rhim, Hyunchul; Hyun, Dongho; Cho, Sung Ki; Shin, Sung Wook; Jeong, Woo Kyoung; Kim, Seong Hyun; Lim, Hyo Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Ha, Sang Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Kyunga; Ahn, Joong Hyun] Samsung Med Ctr, Res Inst Future Med, Stat & Data Ctr, Seoul, South Korea; [Lim, Hyo Keun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Paik, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea.; Lim, HK (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	hyokeun.lim@samsung.com; sw.paik@samsung.com	Jeong, Woo Kyoung/ABE-7025-2021; Kim, Jong Man/AAH-5295-2020	Jeong, Woo Kyoung/0000-0002-0676-2116; Park, Hee Chul/0000-0003-0385-9681; Ahn, Joong Hyun/0000-0002-5768-5990; Lee, Su Jin/0000-0003-3405-9935				Agarwal PD, 2017, J CLIN GASTROENTEROL, V51, P845, DOI 10.1097/MCG.0000000000000825; Bertuccio P, 2017, J HEPATOL, V67, P302, DOI 10.1016/j.jhep.2017.03.011; Blanc JF, 2015, CLIN RES HEPATOL GAS, V39, P180, DOI 10.1016/j.clinre.2014.10.003; Bolondi L, 2013, DIGEST LIVER DIS, V45, P712, DOI 10.1016/j.dld.2013.01.012; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Chang TT, 2008, HPB, V10, P405, DOI 10.1080/13651820802356572; Charriere B, 2017, J SURG ONCOL, V115, P330, DOI 10.1002/jso.24500; Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104; De Ieso PB, 2013, BRIT J CANCER, V109, P2295, DOI 10.1038/bjc.2013.586; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Gashin L, 2014, HPB, V16, P1009, DOI 10.1111/hpb.12280; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim KM, 2016, LIVER INT, V36, P1490, DOI 10.1111/liv.13107; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Lee HW, 2016, CLIN MOL HEPATOL, V22, P309, DOI 10.3350/cmh.2016.0042; Moon H, 2017, J CANCER RES CLIN, V143, P2327, DOI 10.1007/s00432-017-2480-9; Nathan H, 2013, ANN SURG ONCOL, V20, P448, DOI 10.1245/s10434-012-2619-5; Serper M, 2017, GASTROENTEROLOGY, V152, P1954, DOI 10.1053/j.gastro.2017.02.040; SHIN DONG HYUN, 2016, Journal of Liver Cancer, V16, P101; Soares KC, 2014, ANN SURG ONCOL, V21, P1059, DOI 10.1245/s10434-013-3419-2; Yopp AC, 2014, ANN SURG ONCOL, V21, P1287, DOI 10.1245/s10434-013-3413-8; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zaky S, 2015, TURK J GASTROENTEROL, V26, P498, DOI 10.5152/tjg.2015.0158; Zhang J, 2013, CURR ONCOL, V20, pE123, DOI 10.3747/co.20.1297; Zhu RX, 2016, GUT LIVER, V10, P332, DOI 10.5009/gnl15257	28	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210730	10.1371/journal.pone.0210730	http://dx.doi.org/10.1371/journal.pone.0210730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640924	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000042
J	Muehlemann, N; Jouaneton, B; de Leotoing, L; Chale, JJ; Fernandes, J; Kagi, G; Sarikaya, H; Arnold, M				Muehlemann, Natalia; Jouaneton, Baptiste; de Leotoing, Lucie; Chale, Jean-Jacques; Fernandes, Jerome; Kagi, Georg; Sarikaya, Hakan; Arnold, Marcel			Hospital costs impact of post ischemic stroke dysphagia: Database analyses of hospital discharges in France and Switzerland	PLOS ONE			English	Article								Introduction Oropharyngeal dysphagia is frequent in hospitalized post-stroke patients and is associated with increased mortality and comorbidities. The aim of our analysis was to evaluate the impact of dysphagia on Length of Hospital Stay (LOS) and costs. The hospital perspective was used to assess costs. Methods Hospital discharge databases comparing hospital stays for ischemic stroke associated with dysphagia vs stroke without dysphagia in France and Switzerland were analyzed. The French Medical Information System Program (PMSI) database analysis focused on 62'297 stays for stroke in the public sector. 6'037 hospital stays for stroke were analyzed from the Swiss OFS (Office federal de la statistique: Statistique des couts par cas 2012) database. Diagnosis codes and listing of procedures were used to identify dysphagia in stroke patients. Results Patients with post-stroke dysphagia accounted for 8.4% of stroke hospital stays in Switzerland, which is consistent with recently reported prevalence of dysphagia at hospital discharge (Arnold et al, 2016). The French database analysis identified 4.2% stays with post-stroke dysphagia. We hypothesize that the difference between the Swiss and French datasets may be explained by the limitations of an analysis based on diagnosis and procedure coding. Patients with post-stroke dysphagia stayed longer at hospitals (LOS of 23.7 vs. 11.8 days in France and LOS of 14.9 vs. 8.9 days in Switzerland) compared with patients without post-stroke dysphagia. Post-stroke dysphagia was associated with about (sic)3'000 and CHF14'000 cost increase in France and Switzerland respectively. Discussion In this study post-stroke dysphagia was associated with increased LOS and higher hospital costs. It is difficult to isolate the impact of dysphagia in patients with multiple symptoms and disabilities impacting rehabilitation and recovery. After adjusting for confounding factors by matching stays according to age, sex and stroke complications, post-stroke dysphagia association with increased LOS and higher hospital costs was found to be independent of sensory or motor complications. Conclusion Post-stroke dysphagia is associated with increased length of hospital stay and higher hospital costs.	[Muehlemann, Natalia] Nestle Hlth Sci, Epalinges, Switzerland; [Jouaneton, Baptiste; de Leotoing, Lucie] HEVA, Lyon, France; [Chale, Jean-Jacques] Geneva Univ Hosp, Finance Dept, Geneva, Switzerland; [Fernandes, Jerome] Grp OC Sante, Montpellier, France; [Kagi, Georg] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Sarikaya, Hakan; Arnold, Marcel] Univ Hosp Berne, Dept Neurol, Bern, Switzerland	University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern	Muehlemann, N (corresponding author), Nestle Hlth Sci, Epalinges, Switzerland.	natalia.muehlemann@nestle.com		Muehlemann, Natalia/0000-0001-5167-904X	Nestle Health Science, Nestec S.A., Vevey, Switzerland; HEVA, Lyon, France	Nestle Health Science, Nestec S.A., Vevey, Switzerland(Nestle SA); HEVA, Lyon, France	This study was sponsored by Nestle Health Science, Nestec S.A., Vevey, Switzerland, through research contracts with HEVA, Lyon, France to L.L. HEVA was commissioned by Nestle Health Science to perform databases analysis and statistical analysis. In collaboration with coauthors, the funder was involved in study design, data interpretation, decision to publish and preparation of the manuscript. The funder was not involved in databases analysis and statistical analysis. All authors had full access to the data. All authors had final responsibility for the decision to submit for publication.	Arnold M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148424; Bonilha HS, 2014, DYSPHAGIA, V29, P545, DOI 10.1007/s00455-014-9543-8; Clave P, 2015, NAT REV GASTRO HEPAT, V12, P259, DOI 10.1038/nrgastro.2015.49; De Peretti C, 2012, BEH; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; NICE, 2008, NICE NATL CLIN GUIDE	6	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210313	10.1371/journal.pone.0210313	http://dx.doi.org/10.1371/journal.pone.0210313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629665	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000073
J	Sillivan, SE; Jones, ME; Jamieson, S; Rumbaugh, G; Miller, CA				Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Rumbaugh, Gavin; Miller, Courtney A.			Bioinformatic analysis of long-lasting transcriptional and translational changes in the basolateral amygdala following acute stress	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MICRORNA; MEMORY; DISORDERS; NETWORKS; MIRBASE; SYSTEM; RATS	Stress profoundly impacts the brain and increases the risk of developing a psychiatric disorder. The brain's response to stress is mediated by a number of pathways that affect gene expression and protein function throughout the cell. Understanding how stress achieves such dramatic effects on the brain requires an understanding of the brain's stress response pathways. The majority of studies focused on molecular changes have employed repeated or chronic stress paradigms to assess the long-term consequences of stress and have not taken an integrative genomic and/or proteomic approach. Here, we determined the lasting impact of a single stressful event (restraint) on the broad molecular profile of the basolateral amygdala complex (BLC), a key brain region mediating emotion, memory and stress. Molecular profiling performed thirty days post-restraint consisted of small RNA sequencing, RNA sequencing and quantitative mass spectrometry and identified long-lasting changes in microRNA (miRNA), messenger RNA (mRNA) and proteins. Alignment of the three datasets further delineated the regulation of stress-specific pathways which were validated by qPCR and Western Blot analysis. From this analysis, mir-29a-5p was identified as a putative regulator of stress-induced adaptations in the BLC. Further, a number of predicted mir-29a-5p targets are regulated at the mRNA and protein level. The concerted and long-lasting disruption of multiple molecular pathways in the amygdala by a single stress event is expected to be sufficient to alter behavioral responses to a wide array of future experiences, including exposure to additional stressors.	[Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Miller, Courtney A.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Rumbaugh, Gavin; Miller, Courtney A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Sillivan, Stephanie E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, CA (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.; Miller, CA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	cmiller@scripps.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902	National Institute of Mental Health [MH105400]; National Institute on Drug Abuse [DA041469]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA041469, K99DA041469] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants from the National Institute of Mental Health (MH105400 to CAM) and the National Institute on Drug Abuse (DA041469 to SS). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Bagot RC, 2016, NEURON, V90, P969, DOI 10.1016/j.neuron.2016.04.015; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Cathomas F, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12475; Cohen JL, 2017, BEHAV BRAIN RES, V319, P110, DOI 10.1016/j.bbr.2016.11.015; Daskalakis NP, 2018, BIOL PSYCHIAT, V83, P849, DOI 10.1016/j.biopsych.2018.01.009; Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528; Filatova EV, 2014, DOKL BIOCHEM BIOPHYS, V456, P116, DOI 10.1134/S1607672914030107; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griggs EM, 2013, J NEUROSCI, V33, P1734, DOI 10.1523/JNEUROSCI.2873-12.2013; Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011; Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Korn CW, 2017, BIOL PSYCHIAT, V82, P522, DOI 10.1016/j.biopsych.2017.01.018; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewy R. L., 2018, SCHIZOPHR RES; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mannironi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073385; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875; Moreira PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163245; Novais A, 2017, NEUROBIOL STRESS, V6, P44, DOI 10.1016/j.ynstr.2016.11.004; Okkels N, 2017, SCHIZOPHRENIA BULL, V43, P180, DOI 10.1093/schbul/sbw082; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Pfau ML, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00144; Ranjbar H, 2017, CLIN EXP PHARMACOL P, V44, P470, DOI 10.1111/1440-1681.12727; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rumbaugh G, 2015, NEUROPSYCHOPHARMACOL, V40, P2307, DOI 10.1038/npp.2015.93; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharanova NE, 2016, B EXP BIOL MED+, V161, P355, DOI 10.1007/s10517-016-3413-3; Sillivan SE, 2017, BIOL PSYCHIAT, V82, P924, DOI 10.1016/j.biopsych.2017.06.030; Sousa N, 2016, MOL PSYCHIATR, V21, P302, DOI 10.1038/mp.2015.196; Sun JD, 2015, CELL REP, V12, P449, DOI 10.1016/j.celrep.2015.06.023; Syed S. A., 2017, EARLY LIFE STRESS MO, V1; Vaisvaser S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146236; Van't Veer A, 2013, PSYCHOPHARMACOLOGY, V229, P435, DOI 10.1007/s00213-013-3195-5; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vyas S., 2016, NEURAL PLAST, V2016, DOI [10.1155/2016/6391686, DOI 10.1155/2016/6391686]; Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Zhou M, 2018, NEUROSCIENCE, V376, P24, DOI 10.1016/j.neuroscience.2018.02.010	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209846	10.1371/journal.pone.0209846	http://dx.doi.org/10.1371/journal.pone.0209846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629705	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000036
J	Dias, A; Bernardes, JM; Coquemala, SAS; Gomez-Salgado, J; Ruiz-Frutos, C				Dias, Adriano; Bernardes, Joao Marcos; Servilha Coquemala, Sandro Augusto; Gomez-Salgado, Juan; Ruiz-Frutos, Carlos			Predictors of return to work with and without restrictions in public workers	PLOS ONE			English	Article							SICKNESS ABSENCE; MENTAL-DISORDERS; BACK-PAIN; DURATION; LEAVE; INDIVIDUALS; EMPLOYEES; ANXIETY	Background Sick leaves are important events for both the worker and the employer. Many factors are related with sick leaves and depending on the factors the worker could perform a successful return to work. In this sense, the objective of this study is to identify those factors associated with return to work after sick leaves in a group of public workers in Brazil. Methods A case-control study of return to work after sick leaves in a university campus from 2010 to 2015. Logistic regression models were adjusted for two different response variables: return to work with and without restrictions. A digital database was created and completed with data from manual sources. Results A computerised database has been created, based on manual records, which has allowed us to identify labour and non-labour factors associated with the return to work after a sick leave and the possible functional readaptation, with or without restrictions, in public workers. Age at the beginning of the process, number of sick leaves, those of more than 16 days, average duration (total time of sick leaves / number of medical records), and mid-level healthcare positions were associated with return to work without restrictions. In the model of return to work with restrictions, the age of hiring by the university, the number of sick leaves, those of more than 16 days, and mid-level healthcare positions, both rural work and operational positions, were associated to the response variable. Conclusions This study has allowed us to identify the factors associated with the return to work after a period of sick leave in a large group of public workers. However, more research is needed on the mental disorders that cause sick leaves, their evaluation and the handling of these situations.	[Dias, Adriano; Bernardes, Joao Marcos] Univ Estadual Paulista UNESP, Botucatu Med Sch, Publ Hlth Grad Program, Sao Paulo, Brazil; [Servilha Coquemala, Sandro Augusto] Univ Estadual Paulista UNESP, Botucatu Med Sch, Sao Paulo, Brazil; [Gomez-Salgado, Juan] Univ Huelva, Dept Nursing, Huelva, Spain; [Gomez-Salgado, Juan; Ruiz-Frutos, Carlos] Univ Espiritu Santo, Safety & Hlth Posgrade Program, Guayaquil, Ecuador; [Ruiz-Frutos, Carlos] Univ Huelva, Dept Prevent Med & Publ Hlth, Huelva, Spain	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidad de Huelva; Universidad de Especialidades Espiritu Santo; Universidad de Huelva	Gomez-Salgado, J (corresponding author), Univ Huelva, Dept Nursing, Huelva, Spain.; Gomez-Salgado, J (corresponding author), Univ Espiritu Santo, Safety & Hlth Posgrade Program, Guayaquil, Ecuador.	jgsalgad@gmail.com	Gómez -Salgado, Juan/G-7252-2017; Dias, Adriano/S-6683-2019; Dias, Adriano/B-1799-2010	Gómez -Salgado, Juan/0000-0001-9053-7730; Dias, Adriano/0000-0001-6895-372X; Dias, Adriano/0000-0001-6895-372X; RUIZ-FRUTOS, CARLOS/0000-0003-3715-1382; Bernardes, Joao/0000-0003-4494-9421	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [2016-23096-1]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Dr. Adriano Dias received a fund for research of the Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP), process 2016-23096-1 (http://internet.aquila.fapesp.br/agilis/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SCI MED, V18, P166, DOI [10.5271/sjweh.3379, DOI 10.5271/SJWEH.3379]; Arends I, 2014, SCAND J WORK ENV HEA, V40, P195, DOI 10.5271/sjweh.3384; Biering K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049268; Cruz CRB, 2011, REV PSIQ CLIN-BRAZIL, V38, P265; Brox JI, 2008, SPINE J, V8, P948, DOI 10.1016/j.spinee.2007.07.389; Catalina-Romero C, 2013, GAC SANIT, V27, P40, DOI 10.1016/j.gaceta.2011.12.008; Cocker F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105430; Cunha Jane Bittencourt, 2009, Rev. bras. epidemiol., V12, P226, DOI 10.1590/S1415-790X2009000200012; da Costa FM, 2009, REV BRAS ENFERM, V62, P38, DOI 10.1590/S0034-71672009000100006; de Boer WEL, 2016, EUR J PUBLIC HEALTH, V26, P306, DOI 10.1093/eurpub/ckv222; de Braga LC, 2010, CIENC SAUDE COLETIVA, V15, P1585, DOI 10.1590/S1413-81232010000700070; Declos J, 2010, ARCH PREV RIESGOS LA, V13, P180, DOI [DOI 10.1016/J.GENHOSPPSYCH.2016.09.008, 10.1016/j.genhosppsych.2016.09.008]; Demou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018085; Dewa CS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005533; Ekberg K, 2015, J OCCUP REHABIL, V25, P627, DOI 10.1007/s10926-015-9570-9; Ferdiana A, 2014, J REHABIL MED, V46, P984, DOI 10.2340/16501977-1873; Gimeno D, 2014, EUR J PUBLIC HEALTH, V24, P663, DOI 10.1093/eurpub/cku070; Hamer H, 2013, OCCUP MED-OXFORD, V63, P253, DOI 10.1093/occmed/kqt019; Hensing G, 1998, BRIT J PSYCHIAT, V172, P250, DOI 10.1192/bjp.172.3.250; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; InfanteRivard C, 1996, OCCUP ENVIRON MED, V53, P488, DOI 10.1136/oem.53.7.488; Jensen OK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-140; Leao Ana Lucia M, 2017, BMC Res Notes, V10, P773, DOI 10.1186/s13104-017-3116-5; Mehnert A, 2013, SCAND J WORK ENV HEA, V39, P76, DOI 10.5271/sjweh.3291; Munch-Hansen T, 2009, AM J IND MED, V52, P153, DOI 10.1002/ajim.20657; Nielsen MBD, 2010, SCAND J PUBLIC HEALT, V38, P864, DOI 10.1177/1403494810384424; Roelen CAM, 2012, J OCCUP REHABIL, V22, P409, DOI 10.1007/s10926-012-9363-3; Saastamoinen P, 2014, SCAND J WORK ENV HEA, V40, P82, DOI 10.5271/sjweh.3379; Shiels C, 2004, BRIT J GEN PRACT, V54, P86; Stubbs B, 2016, GEN HOSP PSYCHIAT, V43, P63, DOI 10.1016/j.genhosppsych.2016.09.008; Suoyrjo H, 2009, OCCUP ENVIRON MED, V66, P235, DOI 10.1136/oem.2007.038067; Tonetto E.S., 2011, REV U SOC, V21, P54; Tora-Rocamora I, 2015, GAC SANIT, V29, P164, DOI 10.1016/j.gaceta.2014.12.004; von Celsing AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1077; Wallman T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-104; Wynn P, 2008, OCCUP MED-OXFORD, V58, P263, DOI 10.1093/occmed/kqn033; Wynne-Jones G, 2014, OCCUP ENVIRON MED, V71, P448, DOI 10.1136/oemed-2013-101571; Zaballa E, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0152-x	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210392	10.1371/journal.pone.0210392	http://dx.doi.org/10.1371/journal.pone.0210392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653597	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500037
J	Griffioen, AM; Handgraaf, MJJ; Antonides, G				Griffioen, Anouk M.; Handgraaf, Michel J. J.; Antonides, Gerrit			Which construal level combinations generate the most effective interventions? A field experiment on energy conservation	PLOS ONE			English	Article							CLIMATE-CHANGE; PSYCHOLOGICAL DISTANCE; VALUE ORIENTATIONS; PUBLIC ENGAGEMENT; BEHAVIOR; VALUES; PERCEPTIONS; REPRESENTATION; CONSISTENCY; INTENTIONS	Many campaigns targeting pro-environmental behavior combine multiple approaches without properly understanding how these different approaches interact. Here we study the effect of such combinations. We apply construal level theory to classify different intervention approaches, which can either be at a high construal level (abstract and distant) or at a low construal level (concrete and proximal). In a field experiment we recruited 197 students living in one-person apartments in an all-inclusive student housing facility. We objectively measured their individual electricity and warm water use, and measured psychological variables through surveys. We expected that the (commonly considered superior) combination between a high and a low construal level approach would be least effective. Participants were randomly assigned to a 2(Construal Level: low vs. high) x 2(Social Distance: low vs. high) plus control condition mixed-model design targeting a reduction in warm water use. Our findings suggest that a congruent combination at a high construal level (i.e., the high construal level condition combined with the high social distance condition) has the largest effect on warm water use and that spillover to electricity use is most likely to occur when a high construal level is used (i.e., high social distance). Moreover, especially participants who valued nature and the environment less were most strongly influenced by the combination of two high construal level approaches. In sum, our study suggests that when designing interventions one should consider the construal level and when targeting pro-environmental behavior high construal levels appear most appropriate.	[Griffioen, Anouk M.; Handgraaf, Michel J. J.; Antonides, Gerrit] Wageningen Univ, Social Sci Grp, Urban Econ, Wageningen, Netherlands	Wageningen University & Research	Griffioen, AM (corresponding author), Wageningen Univ, Social Sci Grp, Urban Econ, Wageningen, Netherlands.	anouk.griffioen@wur.nl	Antonides, Gerrit/AAY-2234-2020	Antonides, Gerrit/0000-0002-9983-1263	European Climate Knowledge and Innovation Community (Climate-KIC) grant from Topsector Energie (STEM) [TESA113012]; National Science Foundation: Division of Social and Economic Sciences (NSF) [0951516]	European Climate Knowledge and Innovation Community (Climate-KIC) grant from Topsector Energie (STEM); National Science Foundation: Division of Social and Economic Sciences (NSF)	This research is funded by a grant from the European Climate Knowledge and Innovation Community (Climate-KIC; www.climate-kic.org), a grant from Topsector Energie (STEM; TESA113012; http://www.rvo.nl/onderwerpen/duurzaam-ondernemen/energie-en-milieu-innovaties/sociale-innovatie/projecten/projectsamenvattingen-stem) in collaboration with The Student Hotel and Bectro Installatietechniek and a grant from the National Science Foundation: Division of Social and Economic Sciences (NSF; 0951516; https://www.nsf.gov/awardsearch/showAward?AWD_ID=0951516).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Amit E, 2009, J EXP PSYCHOL GEN, V138, P400, DOI 10.1037/a0015835; Attari SZ, 2014, P NATL ACAD SCI USA, V111, P5129, DOI 10.1073/pnas.1316402111; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Bain PG, 2016, NAT CLIM CHANGE, V6, P154, DOI [10.1038/NCLIMATE2814, 10.1038/nclimate2814]; Bolderdijk JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083911; Brugger A, 2015, NAT CLIM CHANGE, V5, P1031, DOI 10.1038/NCLIMATE2760; Carmi N, 2015, HUM ECOL RISK ASSESS, V21, P2239, DOI 10.1080/10807039.2015.1046419; Chang H, 2015, INT J ADVERT, V34, P158, DOI 10.1080/02650487.2014.994731; Corner A, 2014, WIRES CLIM CHANGE, V5, P411, DOI 10.1002/wcc.269; Dam Y. K. van, 2016, APSTRACT: Applied Studies in Agribusiness and Commerce, V10, P51; de Groot JIM, 2008, ENVIRON BEHAV, V40, P330, DOI 10.1177/0013916506297831; de Groot JM, 2010, J ENVIRON PSYCHOL, V30, P368, DOI 10.1016/j.jenvp.2010.04.002; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Evans L, 2013, NAT CLIM CHANGE, V3, P122, DOI [10.1038/NCLIMATE1662, 10.1038/nclimate1662]; Eyal T, 2009, J EXP SOC PSYCHOL, V45, P35, DOI 10.1016/j.jesp.2008.07.023; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Freitas AL, 2004, J EXP SOC PSYCHOL, V40, P739, DOI 10.1016/j.jesp.2004.04.003; Fujita K, 2013, ENCOURAGING SUSTAINA, P81; Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005; Giacomantonio M, 2010, J EXP SOC PSYCHOL, V46, P824, DOI 10.1016/j.jesp.2010.05.001; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Goldsmith K, 2016, NAT CLIM CHANGE, V6, P847, DOI 10.1038/NCLIMATE3019; Griffioen AM, 2016, APSTRACT APPL STUD A, V10, P27; Gronhoj A, 2011, AM BEHAV SCI, P55; Handgraaf MJJ, 2013, ECOL ECON, V86, P86, DOI 10.1016/j.ecolecon.2012.11.008; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hess YD, 2018, SOC PERSONAL PSYCHOL, V12, DOI 10.1111/spc3.12409; Hunt CV, 2010, J EXP SOC PSYCHOL, V46, P1155, DOI 10.1016/j.jesp.2010.05.004; Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014; Kormos C, 2014, J ENVIRON PSYCHOL, V40, P359, DOI 10.1016/j.jenvp.2014.09.003; Ledgerwood A, 2010, J PERS SOC PSYCHOL, V99, P32, DOI 10.1037/a0019843; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Liberman N, 1998, J PERS SOC PSYCHOL, V75, P5, DOI 10.1037/0022-3514.75.1.5; MacDonnell R, 2015, J CONSUM RES, V42, P551, DOI 10.1093/jcr/ucv042; Maio GR, 2009, J PERS SOC PSYCHOL, V97, P699, DOI 10.1037/a0016420; Mullen E, 2016, ANNU REV PSYCHOL, V67, P363, DOI 10.1146/annurev-psych-010213-115120; Rabinovich A, 2009, J ENVIRON PSYCHOL, V29, P391, DOI 10.1016/j.jenvp.2009.09.004; Raven Housing Trust, 2013, SAV MON SAV EN SAV E; Schoenefeld J.J., 2016, J ENV STUD SCI, V6, P724, DOI DOI 10.1007/S13412-015-0288-Y; Schultz PW, 2016, ENVIRON BEHAV, V48, P686, DOI 10.1177/0013916514553835; Schwartz D, 2015, J EXP PSYCHOL-APPL, V21, P158, DOI 10.1037/xap0000042; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Spence A, 2014, J ENVIRON PSYCHOL, V38, P17, DOI 10.1016/j.jenvp.2013.12.006; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Steg L, 2011, SOC NATUR RESOUR, V24, P349, DOI 10.1080/08941920903214116; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; Thogersen J, 2009, J CONSUM POLICY, V32, P141, DOI 10.1007/s10603-009-9101-1; Tiefenbeck V, 2013, ENERG POLICY, V57, P160, DOI 10.1016/j.enpol.2013.01.021; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Truelove HB, 2014, GLOBAL ENVIRON CHANG, V29, P127, DOI 10.1016/j.gloenvcha.2014.09.004; VALLACHER RR, 1989, J PERS SOC PSYCHOL, V57, P660, DOI 10.1037/0022-3514.57.4.660; van der Linden S, 2015, PERSPECT PSYCHOL SCI, V10, P758, DOI 10.1177/1745691615598516; van der Werff E, 2013, J ENVIRON PSYCHOL, V34, P55, DOI 10.1016/j.jenvp.2012.12.006; Verplanken B, 2002, J PERS SOC PSYCHOL, V82, P434, DOI 10.1037/0022-3514.82.3.434; Verplanken B, 2016, J ENVIRON PSYCHOL, V45, P127, DOI 10.1016/j.jenvp.2015.11.008; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; White K, 2011, J MARKETING RES, V48, P472, DOI 10.1509/jmkr.48.3.472; Wiesenfeld BM, 2017, ANNU REV ORGAN PSYCH, V4, P367, DOI 10.1146/annurev-orgpsych-032516-113115	63	9	9	10	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209469	10.1371/journal.pone.0209469	http://dx.doi.org/10.1371/journal.pone.0209469			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653528	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500012
J	Hessl, D; Harvey, D; Sansone, S; Crestodina, C; Chin, J; Joshi, R; Hagerman, RJ; Berry-Kravis, E				Hessl, David; Harvey, Danielle; Sansone, Stephanie; Crestodina, Crystal; Chin, Jamie; Joshi, Reshma; Hagerman, Randi J.; Berry-Kravis, Elizabeth			Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; UNDERLYING FACE; YOUNG MALES; MOUSE MODEL; GAZE; BOYS; PROFILE; CHILDREN; DEFICITS; ANXIETY	Background Numerous preclinical studies have supported the theory that enhanced activation of mGluR5 signaling, due to the absence or reduction of the FMR1 protein, contributes to cognitive and behavioral deficits in patients with fragile X syndrome (FXS). However multiple phase 2 controlled trials in patients with FXS have failed to demonstrate efficacy of compounds that negatively modulate mGluR5, including two phase 2b randomized controlled trials (RCT) of mavoglurant (AFQ056, Novartis Pharma AG), when the primary measures of interest were behavioral ratings. This has cast some doubt onto the translation of the mGluR5 theory from animal models to humans with the disorder. Methods We evaluated social gaze behavior-a key phenotypic feature of the disorder-and sympathetic nervous system influence on pupil size using a previously-validated eye tracking paradigm as a biobehavioral probe, in 57 adolescent or adult patients with FXS at baseline and following three months of blinded treatment with one of three doses of mavoglurant or placebo, within the context of the AFQ056 RCTs. Results Patients with FXS treated with mavoglurant demonstrated increased total absolute looking time and number of fixations to the eye region while viewing human faces relative to baseline, and compared to those treated with placebo. In addition, patients had greater pupil reactivity to faces relative to baseline following mavoglurant treatment compared to placebo. Discussion The study shows that negative modulation of mGluR5 activity improves eye gaze behavior and alters sympathetically-driven reactivity to faces in patients with FXS, providing preliminary evidence of this drug's impact on behavior in humans with the disorder.	[Hessl, David; Sansone, Stephanie; Hagerman, Randi J.] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; [Hessl, David; Sansone, Stephanie] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Harvey, Danielle] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA 95817 USA; [Crestodina, Crystal; Chin, Jamie; Joshi, Reshma; Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Hagerman, Randi J.] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Rush University; University of California System; University of California Davis; Rush University; Rush University	Hessl, D (corresponding author), Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.; Hessl, D (corresponding author), Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.	drhessl@ucdavis.edu		Joshi, Reshma/0000-0001-7617-8890	Novartis Pharma AG, Basel, Switzerland; MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125] Funding Source: NIH RePORTER	Novartis Pharma AG, Basel, Switzerland; MIND Institute Intellectual and Developmental Disabilities Research Center; Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported by Novartis Pharma AG, Basel, Switzerland and the MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125). Novartis had a role in the original clinical trial design, but had no role in the eyetracking data collection or analysis, decision to publish, or preparation of this manuscript. The National Institute of Child Health and Human Development, funder of the Intellectual and Developmental Disabilities Research Center, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAN MG, 1985, AM J MENT DEF, V89, P485; Backes M, 2000, AM J MED GENET, V95, P150; BAUMGARDNER TL, 1995, PEDIATRICS, V95, P744; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry- Kravis E, 2010, ARBACLOFEN TREATMENT; Berry-Kravis E, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-016-9181-6; Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Bruno JL, 2014, AM J PSYCHIAT, V171, P1099, DOI 10.1176/appi.ajp.2014.13111464; Budimirovic DB, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9193-x; Codreiro L, 2010, J NEURODEV DISORD; COHEN IL, 1988, AM J MENT RETARD, V92, P436; Cornish K, 2004, BRAIN COGNITION, V54, P235, DOI 10.1016/j.bandc.2004.02.017; Cornish K, 2001, REV NEUROLOGIA, V33, pS24, DOI 10.33588/rn.33S1.2001356; Dalton KM, 2008, AUTISM RES, V1, P231, DOI 10.1002/aur.32; de Esch CEF, 2015, NEUROBIOL DIS, V75, P31, DOI 10.1016/j.nbd.2014.12.021; de Vries PJ, 2010, NEUROTHERAPEUTICS, V7, P275, DOI 10.1016/j.nurt.2010.05.001; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Erickson CA, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9186-9; Farzin F, 2011, J AUTISM DEV DISORD, V41, P1515, DOI 10.1007/s10803-011-1176-2; Farzin F, 2009, J AUTISM DEV DISORD, V39, P946, DOI 10.1007/s10803-009-0744-1; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Gantois I, 2013, BEHAV BRAIN RES, V239, P72, DOI 10.1016/j.bbr.2012.10.059; Garrett AS, 2004, ARCH GEN PSYCHIAT, V61, P281, DOI 10.1001/archpsyc.61.3.281; Gross C, 2015, NEUROTHERAPEUTICS, V12, P584, DOI 10.1007/s13311-015-0355-9; Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2; Heneghan C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1870-2; Hessl D, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e88; Hessl D, 2008, J AUTISM DEV DISORD, V38, P184, DOI 10.1007/s10803-007-0365-5; Hessl D, 2006, J CHILD PSYCHOL PSYC, V47, P602, DOI 10.1111/j.1469-7610.2005.01556.x; Hessl D, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9167-4; Holsen LM, 2008, NEUROIMAGE, V43, P592, DOI 10.1016/j.neuroimage.2008.08.009; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kau ASM, 2004, AM J MED GENET A, V126A, P9, DOI 10.1002/ajmg.a.20218; Kau ASM, 2000, AM J MENT RETARD, V105, P286, DOI 10.1352/0895-8017(2000)105<0286:EBSOPP>2.0.CO;2; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; Munir F, 2000, NEUROPSYCHOLOGIA, V38, P1261, DOI 10.1016/S0028-3932(00)00036-1; Roid G.H., 2013, LOS ANGELES W PSYCHO, V3rd ed.; Roid GH., 2003, STANFORD BINET INTEL, V5th; Sullivan K, 2007, J INTELL DISABIL RES, V51, P54, DOI 10.1111/j.1365-2788.2006.00899.x; Sullivan K, 2007, AM J MED GENET B, V144B, P517, DOI 10.1002/ajmg.b.30504; Suvrathan A, 2010, P NATL ACAD SCI USA, V107, P11591, DOI 10.1073/pnas.1002262107; Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Watson C, 2008, ARCH GEN PSYCHIAT, V65, P1315, DOI 10.1001/archpsyc.65.11.1315; Wilding J, 2002, NEUROPSYCHOLOGIA, V40, P1343, DOI 10.1016/S0028-3932(01)00212-3; Woodcock K, 2009, J INTELL DISABIL RES, V53, P265, DOI 10.1111/j.1365-2788.2008.01122.x	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209984	10.1371/journal.pone.0209984	http://dx.doi.org/10.1371/journal.pone.0209984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653533	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500021
J	Kotsias, M; Kozak, RP; Gardner, RA; Wuhrer, M; Spencer, DIR				Kotsias, Maximilianos; Kozak, Radoslaw P.; Gardner, Richard A.; Wuhrer, Manfred; Spencer, Daniel I. R.			Improved and semi-automated reductive beta-elimination workflow for higher throughput protein O-glycosylation analysis	PLOS ONE			English	Article							BIOLOGICAL ROLES; GLYCANS; EXPRESSION; GLYCOMICS; RELEASE	Protein O-glycosylation has shown to be critical for a wide range of biological processes, resulting in an increased interest in studying the alterations in O-glycosylation patterns of biological samples as disease biomarkers as well as for patient stratification and personalized medicine. Given the complexity of O-glycans, often a large number of samples have to be analysed in order to obtain conclusive results. However, most of the O-glycan analysis work done so far has been performed using glycoanalytical technologies that would not be suitable for the analysis of large sample sets, mainly due to limitations in sample throughput and affordability of the methods. Here we report a largely automated system for O-glycan analysis. We adapted reductive beta-elimination release of O-glycans to a 96-well plate system and transferred the protocol onto a liquid handling robot. The workflow includes O-glycan release, purification and derivatization through permethylation followed by MALDI-TOF-MS. The method has been validated according to the ICH Q2 (R1) guidelines for the validation of analytical procedures. The semi-automated reductive beta-elimination system enabled for the characterization and relative quantitation of O-glycans from commercially available standards. Results of the semi-automated method were in good agreement with the conventional manual in-solution method while even outperforming it in terms of repeatability. Release of O-glycans for 96 samples was achieved within 2.5 hours, and the automated data acquisition on MALDI-TOF-MS took less than 1 minute per sample. This largely automated workflow for O-glycosylation analysis showed to produce rapid, accurate and reliable data, and has the potential to be applied for O-glycan characterization of biological samples, biopharmaceuticals as well as for biomarker discovery.	[Kotsias, Maximilianos; Kozak, Radoslaw P.; Gardner, Richard A.; Spencer, Daniel I. R.] Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England; [Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands	Culham Science Centre; UK Atomic Energy Authority; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kotsias, M (corresponding author), Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England.	maximilianos.kotsias@ludger.com	Wuhrer, Manfred/ABE-9168-2020	Wuhrer, Manfred/0000-0002-0814-4995	European Commission, Horizon 2020 GlyCoCan programme [676421]; Ludger Ltd	European Commission, Horizon 2020 GlyCoCan programme; Ludger Ltd	Authors: M.K, R.P.K, R.A.G, M.W, D.I.R.S. This work was supported by the European Commission, Horizon 2020 GlyCoCan programme under grant agreement number 676421 (https://glycocan.eu/) and Ludger Ltd (https://www.ludger.com/).The funder provided support in the form of salaries for authors MK, RPK, RAG, DIRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almeida A, 2016, BBA-GEN SUBJECTS, V1860, P1583, DOI 10.1016/j.bbagen.2016.03.012; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Approach E, MALDI TARG SPOTT PRO; Biancone L, 1996, J EXP MED, V183, P581, DOI 10.1084/jem.183.2.581; Bladergroen MR, 2012, J PROTEOMICS, V77, P144, DOI 10.1016/j.jprot.2012.07.023; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chia J, 2016, BBA-GEN SUBJECTS, V1860, P1623, DOI 10.1016/j.bbagen.2016.03.008; Conference I, 2011, ACC CHANG IN QUAL AT, V29, P3; Glycoscience T Academy N, COMM ASS IMP IMP GLY; ICH, 1994, ICH TOP Q2 R1 VAL AN, P17; Kanie Y, 2017, BIOCH COMPD, V5, P3, DOI DOI 10.7243/2052-9341-5-3; Kozak RP, 2014, ANAL BIOCHEM, V453, P29, DOI 10.1016/j.ab.2014.02.030; Kozak RP, 2012, ANAL BIOCHEM, V423, P119, DOI 10.1016/j.ab.2012.01.002; Kudelka MR, 2015, ADV CANCER RES, V126, P53, DOI 10.1016/bs.acr.2014.11.002; Lan Y, 2016, AM J CANCER RES, V6, P2390; Lichtenstein RG, 2013, CELL DEATH DIFFER, V20, P976, DOI 10.1038/cdd.2013.50; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Morozov V, 2018, MOLECULES, V23, DOI 10.3390/molecules23051151; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Padler-Karavani V, 2014, CANCER LETT, V352, P102, DOI 10.1016/j.canlet.2013.10.005; Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003; Selman MHJ, 2012, PROTEOMICS, V12, P1337, DOI 10.1002/pmic.201100498; Shubhakar A, 2016, ANAL CHEM, V88, P8562, DOI 10.1021/acs.analchem.6b01639; Shubhakar A, 2015, CHROMATOGRAPHIA, V78, P321, DOI 10.1007/s10337-014-2803-9; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stockmann H, 2015, INTEGR BIOL-UK, V7, P1026, DOI 10.1039/c5ib00130g; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Ventham NT, 2015, PLOS ONE, V10, P1; Wargovich MJ, 2004, APPL IMMUNOHISTO M M, V12, P350, DOI 10.1097/00129039-200412000-00011; Wuhrer M, 2013, GLYCOCONJUGATE J, V30, P11, DOI 10.1007/s10719-012-9376-3; You X, 2018, J SEP SCI, V41, P248, DOI 10.1002/jssc.201700834; Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144; Zhang L, 2016, MABS-AUSTIN, V8, P205, DOI 10.1080/19420862.2015.1117719; Zhang PQ, 2013, PHARM BIOPROCESS, V1, P89, DOI 10.4155/PBP.13.7	38	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210759	10.1371/journal.pone.0210759	http://dx.doi.org/10.1371/journal.pone.0210759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653606	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500067
J	Montesanto, S; Smithers, NP; Bucchieri, F; Brucato, V; La Carrubba, V; Davies, DE; Conforti, F				Montesanto, Salvatore; Smithers, Natalie P.; Bucchieri, Fabio; Brucato, Valerio; La Carrubba, Vincenzo; Davies, Donna E.; Conforti, Franco			Establishment of a pulmonary epithelial barrier on biodegradable poly-L-lactic-acid membranes	PLOS ONE			English	Article							PLLA; CULTURE; CELLS; LUNG; CARTILAGE; COLLAGEN; MODELS; GROWTH	Development of biocompatible and functional scaffolds for tissue engineering is a major challenge, especially for development of polarised epithelia that are critical structures in tissue homeostasis. Different in vitro models of the lung epithelial barrier have been characterized using non-degradable polyethylene terephthalate membranes which limits their uses for tissue engineering. Although poly-L-lactic acid (PLLA) membranes are biodegradable, those prepared via conventional Diffusion Induced Phase Separation (DIPS) lack open porous geometry and show limited permeability compromising their use for epithelial barrier studies. Here we used PLLA membranes prepared via a modification of the standard DIPS protocol to control the membrane surface morphology and permeability. These were bonded to cell culture inserts for use in barrier function studies. Pulmonary epithelial cells (H441) readily attached to the PLLA membranes and formed a confluent cell layer within two days. This was accompanied by a significant increase in trans-epithelial electrical resistance and correlated with the formation of tight junctions and vectorial cytokine secretion in response to TNF alpha. Our data suggest that a structurally polarized and functional epithelial barrier can be established on PLLA membranes produced via a non-standard DIPS protocol. Therefore, PLLA membranes have potential utility in lung tissue engineering applications requiring bio-absorbable membranes.	[Montesanto, Salvatore; Smithers, Natalie P.; Davies, Donna E.; Conforti, Franco] Univ Southampton, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England; [Montesanto, Salvatore; Brucato, Valerio; La Carrubba, Vincenzo] Univ Palermo, Dept Civil Environm Aerosp Mat Engn DICAM, Palermo, Italy; [Bucchieri, Fabio] Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, Palermo, Italy; [Brucato, Valerio; La Carrubba, Vincenzo] Interuniv Consortium Mat Sci & Technol INSTM, Res Unit Palermo, Palermo, Italy; [Davies, Donna E.; Conforti, Franco] Univ Hosp Southampton, NIHR Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; University of Palermo; University of Palermo	Conforti, F (corresponding author), Univ Southampton, Fac Med, Brooke Lab Clin & Expt Sci, Southampton, Hants, England.; Conforti, F (corresponding author), Univ Hosp Southampton, NIHR Resp Biomed Res Unit, Southampton, Hants, England.	F.Conforti@soton.ac.uk		BUCCHIERI, Fabio/0000-0002-0209-8668; Conforti, Franco/0000-0001-5305-3155; Davies, Donna/0000-0002-5117-2991; La Carrubba, Vincenzo/0000-0002-3185-8398	Medical Research Foundation [MRF-091-0003-RG-CONFO]; Medical Research Council [MRC-G0900453]; British Lung Foundation [IPFPG12-2]; MRC [G0900453] Funding Source: UKRI	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Foundation (MRF-091-0003-RG-CONFO to F.C.), Medical Research Council (MRC-G0900453 to D.E.D.) and the British Lung Foundation (IPFPG12-2 to D.E.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume C, 2015, TISSUE BARRIERS, V3, DOI 10.1080/15476286.2015.1062316; Brouwer KM, 2013, AM J RESP CRIT CARE, V187, P468, DOI 10.1164/rccm.201208-1558PP; Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014; Cao Y, 1997, PLAST RECONSTR SURG, V100, P3; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Davies Donna E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS244, DOI 10.1513/AnnalsATS.201407-304AW; Francois S, 2009, ACTA BIOMATER, V5, P2418, DOI 10.1016/j.actbio.2009.03.013; Goncalves F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152412; Gordon S, 2015, ALTEX-ALTERN ANIM EX, V32, P327, DOI 10.14573/altex.1510051; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Granger DN, 2010, INFLAMMATION MICROCI, DOI DOI 10.4199/C00013ED1V01Y201006ISP008; Guillen GR, 2011, IND ENG CHEM RES, V50, P3798, DOI 10.1021/ie101928r; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; Hermanns MI, 2010, J R SOC INTERFACE, V7, pS41, DOI 10.1098/rsif.2009.0288.focus; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Higuita-Castro N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12044-9; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; KWON OJ, 1994, AM J PHYSIOL-LUNG C, V267, pL398, DOI 10.1152/ajplung.1994.267.4.L398; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Loxham M, 2017, J ALLERGY CLIN IMMUN, V139, P1736, DOI 10.1016/j.jaci.2017.04.005; Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Montesanto S, 2016, MAT SCI ENG C-MATER, V69, P841, DOI 10.1016/j.msec.2016.07.030; Montesanto S, 2015, AIP CONF PROC, V1695, DOI 10.1063/1.4937319; Montesanto S, 1695, BIOL EVALUATION PLLA, DOI [10.1063/1.4937319, DOI 10.1063/1.4937319]; Montesanto S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42151; Ostwald J, 2003, LARYNGO RHINO OTOL, V82, P693; Pavia FC, 2013, POLYM ENG SCI, V53, P431, DOI 10.1002/pen.23273; Saini P, 2016, ADV DRUG DELIVER REV, V107, P47, DOI 10.1016/j.addr.2016.06.014; Salomon JJ, 2014, MOL PHARMACEUT, V11, P995, DOI 10.1021/mp4006535; Santos AR, 2001, ARTIF ORGANS, V25, P7, DOI 10.1046/j.1525-1594.2001.025001007.x; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Selvam S, 2009, TISSUE ENG PART C-ME, V15, P463, DOI 10.1089/ten.tec.2008.0431; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xing Q, 2013, POLYMER, V54, P5965, DOI 10.1016/j.polymer.2013.08.007; Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210830	10.1371/journal.pone.0210830	http://dx.doi.org/10.1371/journal.pone.0210830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653572	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000456015500077
J	Griffiths, GO; Cowan, RA; Grigor, KM; Uscinska, BM; Sydes, M; Russell, M				Griffiths, Gareth O.; Cowan, Richard A.; Grigor, Kenneth M.; Uscinska, Barbara M.; Sydes, Matthew; Russell, Martin			BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract	PLOS ONE			English	Article							CARCINOMA; BLADDER	Background Pure squamous cell carcinoma (SCC) of the urinary tract is rare in the UK and has a poor prognosis compared with transitional cell carcinoma (TCC). Cisplatin based chemotherapy has been shown to be effective in TCC. Methods Patients with T3-T4, pelvic relapsed, nodal or metastatic SCC of the urinary tract were recruited into an open-label, single-arm, non-randomised, phase 2 trial evaluating the activity and safety of cisplatin, methotrexate and vinblastine (CMV) chemotherapy. CMV was given as three 21-day cycles of methotrexate 30mg/m(2) (day 1 & 8), vinblastine 4mg/m(2) (day 1 & 8) and cisplatin 100mg/m(2) (day 2). Results 38 patients were recruited. Overall response was 39% (95% CI 24%, 55%)-13% CR and 26% PR. Median OS was 7.8 months (95% CI 3.4, 12.6) with 39% 1-year survival. Toxicity was acceptable. Conclusion CMV is well tolerated and active in patients with pure SCC of the urinary tract.	[Griffiths, Gareth O.] Univ Southampton, Southampton Clin Trials Unit, Southampton, Hants, England; [Cowan, Richard A.] Christie Hosp, Manchester, Lancs, England; [Grigor, Kenneth M.] Western Gen Hosp, Dept Pathol, Edinburgh, Midlothian, Scotland; [Uscinska, Barbara M.; Sydes, Matthew] UCL, Med Res Council, Clin Trials Unit, London, England; [Russell, Martin] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	University of Southampton; Christie NHS Foundation Trust; Christie Hospital; University of Edinburgh; Medical Research Council Clinical Trials Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Glasgow	Griffiths, GO (corresponding author), Univ Southampton, Southampton Clin Trials Unit, Southampton, Hants, England.	G.O.Griffiths@soton.ac.uk	Sydes, Matthew/C-3373-2008; Cowan, Richard/N-7633-2015	Sydes, Matthew/0000-0002-9323-1371; Russell, John/0000-0003-4594-4155; Cowan, Richard/0000-0001-9004-8136; Griffiths, Gareth/0000-0002-9579-8021	UK Medical Research Council; MRC at the MRC Clinical Trials Unit; MRC [MC_UU_12023/28] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC at the MRC Clinical Trials Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The trial was funded by the UK Medical Research Council (www.mrc.ac.uk) which funded staff at the MRC Clinical Trial Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The BA08 trial was developed on behalf of the MRC Working Party in Bladder Cancer (now the UK National Cancer Research Institute Bladder and Renal Cancer Clinical Studies Group). The trial was sponsored by the MRC at the MRC Clinical Trials Unit (formally the MRC Cancer Trials office). We thank all the participants, the doctors, UK National Institute for Health Research Clinical Research Network Cancer research nurses, and other members of the multidisciplinary teams and research teams who supported this trial at participating centres (Beatson Oncology Centre-13 patients, Christie Hospital-5 patients, Clatterbridge Hospital-4 patients, Middlesex Hospital-4 patients, Western General-2 patients, Weston Park-2 patients, Guys Hospital-2 patients, Newcastle General-1 patient, Queen Elizabeth-1 patient, Norwegian Radium Hospital-1 patient, Walsgrave Hospital-1 patient, North Staffordshire Hospital-1 patient, Oncology centre, Warsaw-1 patient).	Bogaerts J, 2015, EUR J CANCER, V51, P271, DOI 10.1016/j.ejca.2014.10.027; COSTELLO AJ, 1984, UROLOGY, V23, P234, DOI 10.1016/S0090-4295(84)90035-9; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Guo CC, 2009, HUM PATHOL, V40, P1448, DOI 10.1016/j.humpath.2009.03.005; JOHNSON DE, 1976, J UROLOGY, V115, P542, DOI 10.1016/S0022-5347(17)59272-1; JONES MA, 1980, BRIT J UROL, V52, P511, DOI 10.1111/j.1464-410X.1980.tb03102.x; Mead GM, 1998, BRIT J CANCER, V78, P1067, DOI 10.1038/bjc.1998.629; National Institute for Health and Clinical Excellence (NICE) Guidance, 2015, BLADD CANC DIAGN MAN; QUILTY PM, 1986, INT J RADIAT ONCOL, V12, P861, DOI 10.1016/0360-3016(86)90377-9; Youssef R, 2012, BJU INT, V110, P961, DOI 10.1111/j.1464-410X.2012.10949.x	10	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210785	10.1371/journal.pone.0210785	http://dx.doi.org/10.1371/journal.pone.0210785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650143	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000455813300078
J	Guerrero-Sanchez, VM; Maldonado-Alconada, AM; Amil-Ruiz, F; Verardi, A; Jorrin-Novo, JV; Rey, MD				Guerrero-Sanchez, Victor M.; Maldonado-Alconada, Ana M.; Amil-Ruiz, Francisco; Verardi, Andrea; Jorrin-Novo, Jesus V.; Rey, Maria-Dolores			Ion Torrent and lllumina, two complementary RNA-seq platforms for constructing the holm oak (Quercus ilex) transcriptome	PLOS ONE			English	Article							BALLOTA DESF. SAMP.; PROTEIN PROFILE; DROUGHT STRESS; QUALITY; CLIMATE; TOOL	Transcriptome analysis is widely used in plant biology research to explore gene expression across a large variety of biological contexts such as those related to environmental stress and plant-pathogen interaction. Currently, next generation sequencing platforms are used to obtain a high amount of raw data to build the transcriptome of any plant. Here, we compare Illumina and Ion Torrent sequencing platforms for the construction and analysis of the holm oak (Quercus ilex) transcriptome. Genomic analysis of this forest tree species is a major challenge considering its recalcitrant character and the absence of previous molecular studies. In this study, Quercus ilex raw sequencing reads were obtained from Illumina and Ion Torrent and assembled by three different algorithms, MIRA, RAY and TRINITY. A hybrid transcriptome combining both sequencing technologies was also obtained in this study. The RAY-hybrid assembly generated the most complete transcriptome (1,116 complete sequences of which 1,085 were single copy) with a E90N50 of 1,122 bp. The MIRA-Illumina and TRINITY-Ion Torrent assemblies annotated the highest number of total transcripts (62,628 and 74,058 respectively). MIRA-Ion Torrent showed the highest number of shared sequences (84.8%) with the oak transcriptome. All the assembled transcripts from the hybrid transcriptome were annotated with gene ontology grouping them in terms of biological processes, molecular functions and cellular components. In addition, an in silico proteomic analysis was carried out using the translated assemblies as databases. Those from Ion Torrent showed more proteins compared to the Illumina and hybrid assemblies. This new generated transcriptome represents a valuable tool to conduct differential gene expression studies in response to biotic and abiotic stresses and to assist and validate the ongoing Q. ilex whole genome sequencing.	[Guerrero-Sanchez, Victor M.; Maldonado-Alconada, Ana M.; Jorrin-Novo, Jesus V.; Rey, Maria-Dolores] Univ Cordoba, Dept Biochem & Mol Biol, Agroforestry & Plant Biochem & Prote Res Grp, Cordoba, Spain; [Amil-Ruiz, Francisco] Univ Cordoba, SCAI, Bioinformat Unit, Cordoba, Spain; [Verardi, Andrea] Thermo Fisher Sci, Madrid, Spain	Universidad de Cordoba; Universidad de Cordoba; Thermo Fisher Scientific	Rey, MD (corresponding author), Univ Cordoba, Dept Biochem & Mol Biol, Agroforestry & Plant Biochem & Prote Res Grp, Cordoba, Spain.	b52resam@uco.es	Mary, Ana/AAA-2822-2019; Guerrero-Sanchez, Victor M./AAO-4745-2020; Jorrin-Novo, Jesus V./AAA-6354-2019; Rey, María-Dolores/I-3931-2018	Mary, Ana/0000-0002-9357-012X; Guerrero-Sanchez, Victor M./0000-0002-0777-0476; Jorrin-Novo, Jesus V./0000-0002-8778-3604; Rey, María-Dolores/0000-0002-6967-8536; Amil-Ruiz, Francisco/0000-0002-3470-0860	University of Cordoba; Spanish Ministry of Economy and Competitiveness [BIO2015-64737-R2]	University of Cordoba; Spanish Ministry of Economy and Competitiveness(Spanish Government)	The authors thank the staff of the Central Service for Research Support (SCAI) at the University of Cordoba (Spain) for its technical support in the bioinformatics data analysis and the Research, Technological Innovation and Supercomputing Center of Extremadura (CenitS) for allowing us to use their supercomputing facilities (LUSITANIA II). This work was supported by the University of Cordoba and the Spanish Ministry of Economy and Competitiveness (Project BIO2015-64737-R2).	Allaire J., 2016, RSTUDIO INT DEV ENV, V537, P538; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Biswas A, 2014, P 5 ACM C BIOINF COM, P653; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Romero-Rodriguez MC, 2014, J PROTEOMICS, V105, P85, DOI 10.1016/j.jprot.2014.01.027; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Echevarria-Zomeno S, 2012, ACTA PHYSIOL PLANT, V34, P793, DOI 10.1007/s11738-011-0880-z; Echevarria-Zomeno S, 2009, J PLANT PHYSIOL, V166, P233, DOI 10.1016/j.jplph.2008.05.008; El-Metwally S, 2014, NEXT GENERATION SEQU, P103; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerrero-Sanchez VM, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00070; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haas B.J., 2016, TRANSCRIPTOME CONTIG; Jorrin-Novo JV, 2009, J PROTEOMICS, V72, P285, DOI 10.1016/j.jprot.2009.01.026; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lesur I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1331-9; Li B, 2014, GENOME BIOL, V15; Lopez-Hidalgo C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00935; Lowe R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005457; Merida A, 2017, PROTEOMICS, V17; Munoz-Merida A, 2014, DNA RES, V21, P341, DOI 10.1093/dnares/dsu001; Pages H, 2009, R PACKAGE VERSION, V2, P2; Paton D, 2009, GEOCHRONOMETRIA, V34, P49, DOI 10.2478/v10003-009-0017-1; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sghaier-Hammami B, 2016, PLANTA, V243, P369, DOI 10.1007/s00425-015-2404-3; Sghaier-Hammami B, 2013, PLANT PHYSIOL BIOCH, V71, P191, DOI 10.1016/j.plaphy.2013.06.030; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simova-Stoilova LP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00627; Sleep JA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-367; Team RC, 2015, R A LANGUAGE AND ENV; Valero G. J., 2012, EUROPEAN J FOREST RE, V131, P893, DOI DOI 10.1007/S10342-011-0563-8; Galvan JV, 2011, J PROTEOMICS, V74, P1244, DOI 10.1016/j.jprot.2011.05.003; Valero-Galvan J, 2013, J PROTEOME RES, V12, P5110, DOI 10.1021/pr400591n; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319	41	19	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210356	10.1371/journal.pone.0210356	http://dx.doi.org/10.1371/journal.pone.0210356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650136	gold, Green Submitted, Green Published			2022-12-27	WOS:000455813300053
J	Monczak, A; Ji, YM; Soueidan, J; Montie, EW				Monczak, Agnieszka; Ji, Yiming; Soueidan, Jamileh; Montie, Eric W.			Automatic detection, classification, and quantification of sciaenid fish calls in an estuarine soundscape in the Southeast United States	PLOS ONE			English	Article							PASSIVE ACOUSTICS; SONIFEROUS FISH; MECHANISM; HABITATS; WEAKFISH; MODEL; RIVER; GULF	In the Southeast USA, major contributors to estuarine soundscapes are the courtship calls produced by fish species belonging to the family Sciaenidae. Long-term monitoring of sciaenid courtship sounds may be valuable in understanding reproductive phenology, but this approach produces massive acoustic datasets. With this in mind, we designed a feature-based, signal detector for sciaenid fish calls and tested the efficacy of this detector against manually reviewed data. Acoustic recorders were deployed to collect sound samples for 2 min every 20 min at four stations in the May River estuary, South Carolina, USA from February to November, 2014. Manual analysis of acoustic files revealed that four fish species, belonging to the family Sciaenidae, were the major sound producers in this estuarine soundscape, and included black drum (Pogonias cromis), silver perch (Bairdiella chrysoura), spotted seatrout (Cynoscion nebulosus), and red drum (Sciaenops ocellatus). Recorded calls served as an acoustic library of signature features that were used to create a signal detector to automatically detect, classify, and quantify the number of calls in each acoustic file. Correlation between manual and automatic detection was significant and precision varied from 61% to 100%. Automatic detection provided quantitative data on calling rates for this long-term data set. Positive temperature anomalies increased calling rates of black drum, silver perch, and spotted seatrout, while negative anomalies increased calling rates of red drum. Acoustic monitoring combined with automatic detection could be an additional or alternative method for monitoring sciaenid spawning and changes in phenology associated with climate change.	[Monczak, Agnieszka; Soueidan, Jamileh; Montie, Eric W.] Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA; [Ji, Yiming] Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC USA		Montie, EW (corresponding author), Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC 29909 USA.	emontie@uscb.edu		Montie, Eric/0000-0003-4568-4963	ASPIRE II grant from the University of South Carolina; Palmetto Bluff Conservancy; Sea Island Institute of the University of South Carolina Beaufort; Port Royal Sound Foundation	ASPIRE II grant from the University of South Carolina; Palmetto Bluff Conservancy; Sea Island Institute of the University of South Carolina Beaufort; Port Royal Sound Foundation	This work was supported primarily by an ASPIRE II grant from the University of South Carolina and the Palmetto Bluff Conservancy. The Sea Island Institute of the University of South Carolina Beaufort and the Port Royal Sound Foundation provided additional funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Bittle M., 2013, P ANN C AUSTR AC SOC, P208; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Brown JC, 2010, J ACOUST SOC AM, V3, P93; Brown JC, 2009, J ACOUST SOC AM, V125, pEL221, DOI 10.1121/1.3124659; Butler J, 2016, J EXP MAR BIOL ECOL, V479, P89, DOI 10.1016/j.jembe.2016.03.006; Connaughton MA, 2000, J EXP BIOL, V203, P1503; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Dugan PJ, APPL TECHN C LISAT 2, P1; Eggleston DB, 1998, MAR ECOL PROG SER, V174, P33, DOI 10.3354/meps174033; Erbe C, 2008, J ACOUST SOC AM, V124, P2833, DOI 10.1121/1.2982368; Frasier KE, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005823; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Jr Gilmore RG, 2003, BIOL SPOTTED SEATROU, P99; Kandia V, 2006, APPL ACOUST, V67, P1144, DOI 10.1016/j.apacoust.2006.05.007; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Ladich F., 2018, FISH FISH, V00, P1; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Lin TH, 2018, J ACOUST SOC AM, V143, pEL278, DOI 10.1121/1.5034169; Lowerre-Barbieri SK, 2008, T AM FISH SOC, V137, P562, DOI 10.1577/T04-226.1; Luczkovich JJ, 2008, T AM FISH SOC, V137, P576, DOI 10.1577/T05-290.1; Luczkovich Joseph J., 1999, Bioacoustics, V10, P143; Malfante M., 2018, J ACOUST SOC AM, V139, P2115, DOI [10.1121/1.4950295, DOI 10.1121/1.4950295]; Mann D, 2010, AQUAT BIOL, V10, P149, DOI 10.3354/ab00272; Mann David A., 1995, Bioacoustics, V6, P199; Mellinger DK, 2004, MAR MAMMAL SCI, V20, P48, DOI 10.1111/j.1748-7692.2004.tb01140.x; Monczak A, 2017, MAR ECOL PROG SER, V581, P1, DOI 10.3354/meps12322; Montie EW, 2016, J FISH BIOL, V88, P1776, DOI 10.1111/jfb.12938; Montie EW, 2017, PEERJ, V5, DOI 10.7717/peerj.2944; Montie EW, 2015, T AM FISH SOC, V144, P705, DOI 10.1080/00028487.2015.1037014; Mooney T.A., 2016, AQUAT BIOL, V24, P201; Nimon KF, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00322, 10.3389/fpsyg.2012.00102]; Pace F, 2012, P M AC 2012, V17, P70046; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Ricci SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182757; Ricci SW, 2016, MAR ECOL PROG SER, V550, P25, DOI 10.3354/meps11724; Roch MA, 2007, J ACOUST SOC AM, V121, P1737, DOI 10.1121/1.2400663; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; Smott S, 2018, MAR POLLUT BULL, V133, P246, DOI 10.1016/j.marpolbul.2018.05.016; Sprague MW, 2000, J ACOUST SOC AM, V108, P2430, DOI 10.1121/1.1315296; Sprague MW, 2004, J ACOUST SOC AM, V116, P3186, DOI 10.1121/1.1802651; Stolkin R., 2007, P OCEANS 2007, P1; Stowell D, 2013, INT CONF ACOUST SPEE, P468, DOI 10.1109/ICASSP.2013.6637691; Vieira M, 2015, J ACOUST SOC AM, V138, P3941, DOI 10.1121/1.4936858; Wall CC, 2014, J FISH BIOL, V85, P1470, DOI 10.1111/jfb.12500; Walters S, 2009, T AM FISH SOC, V138, P88, DOI 10.1577/T07-106.1	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209914	10.1371/journal.pone.0209914	http://dx.doi.org/10.1371/journal.pone.0209914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650120	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300034
J	Reithmeier, R; O'Leary, L; Zhu, XY; Dales, C; Abdulkarim, A; Aquil, A; Brouillard, L; Chang, S; Miller, S; Shi, WYZ; Vu, N; Zou, C				Reithmeier, Reinhart; O'Leary, Liam; Zhu, Xiaoyue; Dales, Corey; Abdulkarim, Abokor; Aquil, Anum; Brouillard, Lochin; Chang, Samantha; Miller, Samantha; Shi, Wenyangzi; Vu, Nancy; Zou, Chang			The 10,000 PhDs project at the University of Toronto: Using employment outcome data to inform graduate education	PLOS ONE			English	Article								The purpose of the 10,000 PhDs Project was to determine the current (2016) employment status of the 10,886 individuals who graduated from the University of Toronto with a PhD in all disciplines from 2000-2015. Using internet searches, we found that about half (51%) of the PhD graduates are employed in the post-secondary education sector, 26% as tenure-track professors, with an additional 3% as adjunct professors and 2% as full-time teaching-stream professors. Over the time-period 2000-2015 there has been a near doubling in PhD graduates with the biggest increase in graduation numbers for the Physical (2.6-fold) and Life Sciences (2.2-fold). Increasingly, these graduates are finding employment in the private and public sectors providing the highly qualified personnel needed to drive an innovation economy.	[Reithmeier, Reinhart] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Reithmeier, Reinhart; O'Leary, Liam; Zhu, Xiaoyue; Dales, Corey; Abdulkarim, Abokor; Aquil, Anum; Brouillard, Lochin; Chang, Samantha; Miller, Samantha; Shi, Wenyangzi; Vu, Nancy; Zou, Chang] Univ Toronto, Sch Grad Studies, Toronto, ON, Canada	University of Toronto; University of Toronto	Reithmeier, R (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Reithmeier, R (corresponding author), Univ Toronto, Sch Grad Studies, Toronto, ON, Canada.	r.reithmeier@utoronto.ca		Chang, Samantha/0000-0002-1306-5597; Vu, Nancy/0000-0002-2579-9854	School of Graduate Studies at the University of Toronto	School of Graduate Studies at the University of Toronto	The 10,000 PhDs Project was an initiative of the School of Graduate Studies at the University of Toronto, that provided internal funding for this project.	Allum JR, 2014, UNDERSTANDING PHD CA; [Anonymous], 2015, MCGILLS PHD OUTCOMES; Blank R, 2017, SCIENCE, V358, P1388, DOI 10.1126/science.aar4638; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Conti A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133177; Denecke D., 2017, PROFESSIONAL DEV SHA; Desjardin L., 2011, CULTURE TOURISM CTR; Edge J, 2015, INSIDE OUTSIDE ACAD; Heggeness ML, 2017, NATURE, V541, P21, DOI 10.1038/541021a; Jonker L., 2016, ONTARIOS PHD GRADUAT; Mason JL, 2016, FASEB J, V30, P2673, DOI 10.1096/fj.201500067R; Meyers FJ, 2016, FASEB J, V30, P507, DOI 10.1096/fj.15-276139; Munro D, 2013, NEED MAKE SKILLS WOR; National Academies of Sciences E, 2018, NEXT GEN BIOM BEH SC, DOI [10.17226/25008, DOI 10.17226/25008]; Pola J. K., 2015, MOL BIOL CELL, V26, P1413, DOI [10.1091/mbc.e14-10-1432, DOI 10.1091/MBC.E14-10-1432]; Porter S., 2017, UBC PHD CAREER OUTCO; Reithmeier R. A. F., 2016, MENTORSHIP MATTERS C; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Statistics Canada, 2016, STAT CAN CAT 98 400; Tilghman, 2012, BIOMEDICAL RES WORKF; Turk-Bickal Berger A., 2014, NONACADEMIC CAREERS; Wood L. Maren, 2013, MANY CAREERS HIST PH; Woolston, 2017, NATURE, V550, P549, DOI [10.1038/nj7677-549a, DOI 10.1038/NJ7677-549A]	23	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209898	10.1371/journal.pone.0209898	http://dx.doi.org/10.1371/journal.pone.0209898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650157	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300033
J	Martin-Galiano, AJ; Lopez, D				Martin-Galiano, Antonio J.; Lopez, Daniel			Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells	PLOS ONE			English	Article							CLASS-I MOLECULES; PRESENTED PEPTIDES; T-LYMPHOCYTES; DEFICIENT; REPERTOIRE; ABUNDANCE; PROTEINS; REVEALS; LIGANDS; GENE	The transporter associated with antigen processing (TAP) is a key element of the major histocompatibility complex (MHC) class I antigen processing and presentation pathway. Nonfunctional TAP complexes impair the translocation of cytosol-derived proteolytic peptides to the endoplasmic reticulum lumen. This drastic reduction in the available peptide repertoire leads to a significant decrease in MHC class I cell surface expression. Using mass spectrometry, different studies have analyzed the cellular MHC class I ligandome from TAP-deficient cells, but the analysis of the parental proteins, the source of these ligands, still deserves an in-depth analysis. In the present report, several bioinformatics protocols were applied to investigate the nature of parental proteins for the previously identified TAP-independent MHC class I ligands. Antigen processing in TAP-deficient cells mainly focused on small, abundant or highly integral transmembrane proteins of the cellular proteome. This process involved abundant proteins of the central RNA metabolism. In addition, TAP-independent ligands were preferentially cleaved from the N- and C-terminal ends with respect to the central regions of the parental proteins. The abundance of glycine, proline and aromatic residues in the C-terminal sequences from TAP-independently processed proteins allows the accessibility and specificity required for the proteolytic activities that generates the TAP-independent ligandome. This limited proteolytic activity towards a set of preferred proteins in a TAP-negative environment would therefore suffice to promote the survival of TAP-deficient individuals.	[Martin-Galiano, Antonio J.] Inst Salud Carlos III, Unidad Bioinformat, Ctr Nacl Microbiol, Madrid, Spain; [Lopez, Daniel] Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Martin-Galiano, AJ (corresponding author), Inst Salud Carlos III, Unidad Bioinformat, Ctr Nacl Microbiol, Madrid, Spain.; Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Madrid, Spain.	mgaliano@isciii.es; dlopez@isciii.es	López, Daniel/I-2632-2014	López, Daniel/0000-0003-0268-5878; Martin-Galiano, Antonio Javier/0000-0002-6662-329X	Spanish Ministry of Economy (MINECO/FEDER) [SAF2014-58052]; Accion Estrategica en Salud 2019	Spanish Ministry of Economy (MINECO/FEDER); Accion Estrategica en Salud 2019	This work was supported by the Spanish Ministry of Economy (MINECO/FEDER) grant SAF2014-58052 and Accion Estrategica en Salud 2019 to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029805; Del Val M, 2013, MOL IMMUNOL, V55, P117, DOI 10.1016/j.molimm.2012.10.018; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Dengjel J, 2006, CLIN CANCER RES, V12, P4163, DOI 10.1158/1078-0432.CCR-05-2470; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Fortier M. H., 2008, J EXP MED; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; Juncker AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007448; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Lopez D, 2013, EXPERT REV VACCINES, V12, P1077, DOI 10.1586/14760584.2013.825447; Lorente E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059118; Lorente E, 2011, J BIOL CHEM, V286, P38054, DOI 10.1074/jbc.M111.281808; Mommen GPM, 2016, MOL CELL PROTEOMICS, V15, P1412, DOI 10.1074/mcp.M115.055780; Mylonas R, 2018, MOL CELL PROTEOMICS, V17, P2347, DOI 10.1074/mcp.RA118.000877; Oliveira CC, 2010, J EXP MED, V207, P207, DOI 10.1084/jem.20091429; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Scholz E, 2016, ARTHRITIS RHEUMATOL, V68, P2412, DOI 10.1002/art.39736; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Unanue ER, 2016, ANNU REV IMMUNOL, V34, P265, DOI 10.1146/annurev-immunol-041015-055420; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; Wilkins MR, 1999, METH MOL B, V112, P531; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	43	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210583	10.1371/journal.pone.0210583	http://dx.doi.org/10.1371/journal.pone.0210583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645615	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200036
J	Alves, DFR; Greco, LSL; Barros-Alves, SD; Hirose, GL				Rodrigues Alves, Douglas Fernandes; Lopez Greco, Laura S.; Barros-Alves, Samara de Paiva; Hirose, Gustavo Luis			Sexual system, reproductive cycle and embryonic development of the red-striped shrimp Lysmata vittata, an invader in the western Atlantic Ocean	PLOS ONE			English	Article							PROTANDRIC SIMULTANEOUS HERMAPHRODITISM; CALLINECTES-SAPIDUS RATHBUN; OVARIAN DEVELOPMENT; INVASIVE CRAB; LIFE-HISTORY; ZOEAL STAGES; DECAPODA; CARIDEA; HIPPOLYTIDAE; BRACHYURA	Several decapod crustaceans are invaders, but little is known about the biological characteristics that potentiate the success of these decapods in invaded ecosystems. Here, we evaluate and describe some aspects of the reproductive biology and development of Lysmata vittata, an invasive shrimp species in the Atlantic Ocean. In addition, we intend to provide important insights into the biology of invasion by comparing the reproductive traits of this shrimp with some of the predictions about aquatic invasive species. We used experimental and laboratory observations to evaluate the functionality of protandric simultaneous hermaphroditism (PSH), the macro and microscopic development of the ovarian portion of the ovotestes, the reproductive cycle, and the embryonic development of L. vittata. We confirm the functionality of PSH in L. vittata. This shrimp has a rapid reproductive cycle; the ovarian portion of the ovotestes develops (mean +/- SD) 6.28 +/- 1.61 days after spawning. Embryonic development also occurs over a short time, with a mean (+/- SD) of 8.37 +/- 0.85 days. The larvae hatch without macroscopically visible yolk reserves. Our study provides evidence that the invasive shrimp L. vittata has reproductive and embryonic developmental characteristics (i.e., short generation time and high reproductive capacity) that may be favorable to the establishment of populations during invasive processes.	[Rodrigues Alves, Douglas Fernandes; Hirose, Gustavo Luis] Univ Fed Sergipe, Dept Biol, Sao Cristovao, Sergipe, Brazil; [Rodrigues Alves, Douglas Fernandes; Hirose, Gustavo Luis] Univ Fed Sergipe, Programa Posgrad Ecol & Conservacao, Sao Cristovao, Sergipe, Brazil; [Lopez Greco, Laura S.] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat,IBBEA, Dept Biodiversidad & Biol Expt,Lab Biol Exactas &, Buenos Aires, DF, Argentina; [Barros-Alves, Samara de Paiva] Univ Fed Uberlandia, Lab Ecol Ecossistemas Aqua, Uberlandia, MG, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Uberlandia	Alves, DFR (corresponding author), Univ Fed Sergipe, Dept Biol, Sao Cristovao, Sergipe, Brazil.; Alves, DFR (corresponding author), Univ Fed Sergipe, Programa Posgrad Ecol & Conservacao, Sao Cristovao, Sergipe, Brazil.	douglas_biologo@yahoo.com.br	Alves, Douglas Fernandes Rodrigues/AAB-8944-2021; Barros-Alves, Samara de Paiva/G-2249-2012; Hirose, Gustavo/D-9603-2012	Alves, Douglas Fernandes Rodrigues/0000-0003-4363-6511; Barros-Alves, Samara de Paiva/0000-0001-7216-3421; Hirose, Gustavo/0000-0001-7484-0393	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PROEF grants (CAPES/FAPITEC/) [88881.157451/2017-01]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PROEF grants (CAPES/FAPITEC/)	DFRA thanks CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for Research Scholarships (Programa Nacional de Pos Doutorado/Capes - PNPD). This study was supported by PROEF grants (CAPES/FAPITEC/#88881.157451/2017-01).	Ahyong ST, 2010, ZOOTAXA, P341; Baeza JA, 2013, ZOOL J LINN SOC-LOND, V168, P699, DOI 10.1111/zoj.12044; Baeza JA, 2008, J CRUSTACEAN BIOL, V28, P148, DOI 10.1651/07-2839R.1; Baeza JA, 2013, MOL PHYLOGENET EVOL, V69, P46, DOI 10.1016/j.ympev.2013.05.013; Baeza JA, 2007, BEHAV ECOL SOCIOBIOL, V61, P365, DOI 10.1007/s00265-006-0265-2; Baeza J. Antonio, 2009, Smithsonian Contributions to the Marine Sciences, P95; Baeza JA, 2007, J NAT HIST, V41, P2843, DOI 10.1080/00222930701770778; Bauer RT, 2006, INTEGR COMP BIOL, V46, P430, DOI 10.1093/icb/icj036; Bauer RT, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P277, DOI 10.1007/978-0-387-77101-4_14; Bauer RT, 2005, J MAR BIOL ASSOC UK, V85, P101, DOI 10.1017/S0025315405010891h; Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Bauer RT, 2004, J CRUSTACEAN BIOL, V24, P131, DOI 10.1651/C-2426; Bauer RT, 1991, CRUSTACEAN SEXUAL BI; Bauer RT., 2005, J CRUSTACEAN BIOL, V25, P319, DOI [10.1651/0278-0372(2005)025[0319:BR]2.0.CO;2, DOI 10.1651/0278-0372(2005)025[0319:BR]2.0.CO;2]; Bazin E, 2014, BIOL INVASIONS, V16, P875, DOI 10.1007/s10530-013-0544-6; Brillon S, 2005, MAR BIOL, V147, P895, DOI 10.1007/s00227-005-1633-6; Calado R, 2007, J EXP MAR BIOL ECOL, V351, P226, DOI 10.1016/j.jembe.2007.06.022; Calado R, 2007, AQUACULTURE, V263, P68, DOI 10.1016/j.aquaculture.2006.10.013; Crawley, 2013, STAT COMPUTING INTRO; D'Udekem C, 2002, CRUSTACEANA, V75, P1149, DOI 10.1163/156854002763270545; Dineen JF, 2001, J CRUSTACEAN BIOL, V21, P774, DOI 10.1651/0278-0372(2001)021[0774:LHLDAN]2.0.CO;2; da Silva GMF, 2009, AQUAC RES, V40, P798, DOI 10.1111/j.1365-2109.2009.02165.x; Fiedler G. Curt, 1998, Pacific Science, V52, P161; Fletcher D. J., 1995, International Zoo Yearbook, V34, P73, DOI 10.1111/j.1748-1090.1995.tb00661.x; Garcia L, 2018, BIOINVASIONS REC, V7, P191, DOI 10.3391/bir.2018.7.2.12; Garcia-Guerrero M, 2003, COMP BIOCHEM PHYS A, V135, P147, DOI 10.1016/S1095-6433(02)00354-9; Garcia-Guerrero MU, 2005, CRUSTACEANA, V78, P1089, DOI 10.1163/156854005775361089; Gonzalez-Pisani X, 2013, ZOOTAXA, V3718, P301, DOI 10.11646/zootaxa.3718.4.1; GORE R H, 1972, Crustaceana (Leiden), V22, P67, DOI 10.1163/156854072X00688; Gregati RA, 2010, AQUACULTURE, V306, P185, DOI 10.1016/j.aquaculture.2010.05.009; Gust N, 2006, BIOL INVASIONS, V8, P339, DOI 10.1007/s10530-004-8243-y; Hanson E, 2008, BIOL INVASIONS, V10, P603, DOI 10.1007/s10530-007-9156-3; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hertzler P. L., 2015, EVOLUTIONARY DEV BIO, V4, P63; Hiller A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03410-8; Keunecke KA, 2009, CRUSTACEANA, V82, P753, DOI 10.1163/156854009X423175; Klann M, 2014, ZOOMORPHOLOGY, V133, P295, DOI 10.1007/s00435-014-0224-9; Klotz W, 2013, AQUAT INVASIONS, V8, P333, DOI 10.3391/ai.2013.8.3.09; Lardies MA, 2008, EVOL ECOL RES, V10, P747; Lenz M, 2018, BIOL INVASIONS, V20, P3107, DOI 10.1007/s10530-018-1762-8; Greco LSL, 2007, ACTA ZOOL-STOCKHOLM, V88, P223, DOI 10.1111/j.1463-6395.2007.00269.x; Mantelatto F, 1999, CRUSTACEANA, V72, P39, DOI [10.1163/156854099504068, DOI 10.1163/156854099504068]; Marin IN, 2012, RUSS J MAR BIOL+, V38, P359, DOI 10.1134/S1063074012040062; Marin I, 2012, CRUSTACEANA, V85, P123, DOI 10.1163/156854012X623548; Martins J, 2007, J CRUSTACEAN BIOL, V27, P220, DOI 10.1651/C-2597.1; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Negri M, 2018, BIOL INVASIONS, V20, P1771, DOI 10.1007/s10530-018-1660-0; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Alves DFR, 2018, ZOOTAXA, V4526, P41, DOI 10.11646/zootaxa.4526.1.3; Romero-Carvajal A, 2018, BIOL BULL-US, V234, P165, DOI 10.1086/698468; Sant'Anna BS, 2012, AQUAT INVASIONS, V7, P347, DOI 10.3391/ai.2012.7.3.006; Almeida ASE, 2018, INVERTEBR REPROD DEV, V62, P257, DOI 10.1080/07924259.2018.1509903; Soledade GO, 2013, J CRUSTACEAN BIOL, V33, P66, DOI 10.1163/1937240X-00002122; Stasolla G, 2014, BIOINVASIONS REC, V3, P39, DOI 10.3391/bir.2014.3.1.07; Tavares M, 2011, INVAD NAT SPRING SER, V6, P251, DOI 10.1007/978-94-007-0591-3_7; Triay-Portella R, 2017, MAR BIOL RES, V13, P174, DOI 10.1080/17451000.2016.1239018; Tropea C, 2013, ACTA ZOOL-STOCKHOLM, V94, P462, DOI 10.1111/j.1463-6395.2012.00575.x; Turner R. L., 1979, REPROD ECOLOGY MARIN, P25; Tziouveli V, 2012, AQUACULT INT, V20, P201, DOI 10.1007/s10499-011-9496-y; Wang YR, 2018, ZOOTAXA, V4392, P28, DOI 10.11646/zootaxa.4392.1.2; Yang Hoi Jeong, 2010, Korean Journal of Systematic Zoology, V26, P261; Zar JH., 2010, BIOSTAT ANAL, V5th	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210723	10.1371/journal.pone.0210723	http://dx.doi.org/10.1371/journal.pone.0210723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645636	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200048
J	Dunk, JR; Woodbridge, B; Schumaker, N; Glenn, EM; White, B; LaPlante, DW; Anthony, RG; Davis, RJ; Halupka, K; Henson, P; Marcot, BG; Merola-Zwartjes, M; Noon, BR; Raphael, MG; Caicco, J; Hansen, DL; Mazurek, MJ; Thrailkill, J				Dunk, Jeffrey R.; Woodbridge, Brian; Schumaker, Nathan; Glenn, Elizabeth M.; White, Brendan; LaPlante, David W.; Anthony, Robert G.; Davis, Raymond J.; Halupka, Karl; Henson, Paul; Marcot, Bruce G.; Merola-Zwartjes, Michele; Noon, Barry R.; Raphael, Martin G.; Caicco, Jody; Hansen, Dan L.; Mazurek, Mary Jo; Thrailkill, James			Conservation planning for species recovery under the Endangered Species Act: A case study with the Northern Spotted Owl	PLOS ONE			English	Article							BARRED OWLS; HABITAT SELECTION; HOME-RANGE; CLIMATE-CHANGE; DEMOGRAPHIC PERFORMANCE; DISTRIBUTION MODELS; PACIFIC-NORTHWEST; CASCADE MOUNTAINS; NEST SITES; UNCERTAINTY	The northern spotted owl (Strix occidentalis caurina) was listed as threatened under the U. S. Endangered Species Act (ESA) in 1990. We applied modern spatial conservation theory and models to evaluate several candidate critical habitat networks, and sought an efficient conservation solution that encompassed the highest value lands for spotted owl recovery rather than maximizing the total area of potential critical habitat. We created a map of relative habitat suitability, which served as input to the spatial conservation prioritization program Zonation. We used the spatially-explicit individual-based population model HexSim to estimate and compare simulated spotted owl population outcomes among a suite of candidate critical habitat networks that varied in size and spatial arrangement under alternative scenarios of future habitat suitability and barred owl (S. varia) effects. We evaluated simulated spotted owl population outcomes, including total population size, and extinction and quasi-extinction likelihoods for 108 combinations of candidate critical habitat networks by habitat change by barred owl scenarios, both range-wide and within 11 distinct portions of the owl's range. Barred owl encounter rates and the amount and suitability of habitat had substantial effects on simulated spotted owl populations. When barred owl encounter rates were high, changes in the amount and suitability of habitat had minimal impacts on population performance. Under lowered barred owl encounter rates, candidate critical habitat networks that included most existing high suitability habitat supported a high likelihood of long-term population persistence. Barred owls are currently the primary driving force behind poor population performance of NSOs; however, our models demonstrated that a sufficient area of high suitability habitat remains essential for recovery when effects of barred owls can be reduced. The modeling approach we employed is sufficiently flexible to incorporate new information about spotted owls as it becomes available and could likely be applied to conservation planning for other species.	[Dunk, Jeffrey R.] Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA; [Woodbridge, Brian] US Fish & Wildlife Serv, Western Golden Eagle Conservat, Corvallis, OR USA; [Schumaker, Nathan] US EPA, Environm Res Lab, 200 SW 35Th St, Corvallis, OR 97333 USA; [Glenn, Elizabeth M.; White, Brendan; Henson, Paul; Caicco, Jody] US Fish & Wildlife Serv, Portland, OR USA; [LaPlante, David W.] Nat Resources Geospatial, Smontague, CA USA; [Anthony, Robert G.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Davis, Raymond J.] US Forest Serv, Forestry Sci Lab, Corvallis, OR USA; [Halupka, Karl] US Fish & Wildlife Serv, Wenatchee, WA USA; [Marcot, Bruce G.] US Forest Serv, USDA, Pacific Northwest Res Stn, Portland, OR USA; [Merola-Zwartjes, Michele] US Fish & Wildlife Serv, Reg Endangered Species Listing Div 1, Portland, OR USA; [Noon, Barry R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Noon, Barry R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Raphael, Martin G.] US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA USA; [Hansen, Dan L.; Mazurek, Mary Jo] Humboldt State Univ Sponsored Programs Fdn, Arcata, CA USA; [Thrailkill, James] US Fish & Wildlife Serv, USDI, Roseburg, OR USA	California State University System; California State Polytechnic University, Humboldt; United States Department of the Interior; US Fish & Wildlife Service; United States Environmental Protection Agency; United States Department of the Interior; US Fish & Wildlife Service; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service; Colorado State University; Colorado State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; US Fish & Wildlife Service	Dunk, JR (corresponding author), Humboldt State Univ, Dept Environm Sci & Management, Arcata, CA 95521 USA.	Jeffrey.Dunk@humboldt.edu		Schumaker, Nathan/0000-0002-4331-825X; Dunk, Jeffrey/0000-0002-3213-9272	USFWS [134250BJ151, F12AC01135, 81333BG035, 81333BG036, 13420]	USFWS(US Fish & Wildlife Service)	This work was supported in part by USFWS Agreements 134250BJ151 and F12AC01135 to JRD, and USFWS Agreements 81333BG035, 81333BG036, and 13420 -BJ to DL. The information in this document has been funded in part by the U.S. Environmental Protection Agency.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akcakaya HR, 1998, BIODIVERS CONSERV, V7, P875, DOI 10.1023/A:1008867602813; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anthony RG, 2006, WILDLIFE MONOGR, P1; BARROWS C, 1978, Western Birds, V9, P1; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bell DM, 2015, FOREST ECOL MANAG, V358, P154, DOI 10.1016/j.foreco.2015.09.007; Bingham BB, 1997, CONSERV BIOL, V11, P127, DOI 10.1046/j.1523-1739.1997.95331.x; Blakesley J.A., 2004, SCI EVALUATION STATU; BLAKESLEY JA, 1992, J WILDLIFE MANAGE, V56, P388, DOI 10.2307/3808840; Bodine EN, 2017, NAT RESOUR MODEL, V30, DOI 10.1111/nrm.12131; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Buchanan JB, 1998, CONSERV BIOL, V12, P238, DOI 10.1046/j.1523-1739.1998.97278.x; Burnham Kenneth P., 1996, Studies in Avian Biology, V17, P92; Camaclang Abbey, 2014, CONSERV BIOL, V29, P482, DOI DOI 10.1111/C0BI.12428; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Carroll C, 2008, CONSERV BIOL, V22, P1026, DOI 10.1111/j.1523-1739.2008.00931.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Clark D. A., 2007, THESIS; Comfort EJ, 2016, LANDSCAPE ECOL, V31, P1227, DOI 10.1007/s10980-015-0330-1; Correia RA, 2018, MITIG ADAPT STRAT GL, V23, P371, DOI 10.1007/s11027-017-9738-z; Davis R. J., 2011, PNWGTR850 USDA FOR S; Davis R.J., 2015, PNWGTR911 PAC NW RES; Diller LV, 2016, J WILDLIFE MANAGE, V80, P691, DOI 10.1002/jwmg.1046; Diller LV, 2014, WILDLIFE SOC B, V38, P211, DOI 10.1002/wsb.381; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; Dunk J. R., 2014, IDENTIFYING EVALUATI; Dunk JR, 2004, ECOL APPL, V14, P713, DOI 10.1890/02-5322; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FORSMAN E D, 1984, Wildlife Monographs, P1; Forsman ED, 2005, J RAPTOR RES, V39, P365; Forsman ED, 2002, WILDLIFE MONOGR, P1; Forsman ED, 2015, J RAPTOR RES, V49, P109, DOI 10.3356/rapt-49-02-109-128.1; Forsman ED, 2011, STUD AVIAN BIOL, P1; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRANKLIN AB, 1999, RANGE WIDE STATUS TR; Franklin J. F., 2004, SCI EVALUATION STATU; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Gabriel MW, 2018, AVIAN CONSERV ECOL, V13, DOI 10.5751/ACE-01134-130102; GANEY JL, 1993, WILSON BULL, V105, P645; Glenn EM, 2017, LANDSCAPE ECOL, V32, P563, DOI 10.1007/s10980-016-0467-6; Glenn EM, 2010, BIOL CONSERV, V143, P2543, DOI 10.1016/j.biocon.2010.06.021; Glenn EM, 2004, J WILDLIFE MANAGE, V68, P33, DOI 10.2193/0022-541X(2004)068[0033:SOHAHU]2.0.CO;2; Gremel S, 2005, THESIS; Grimm V., 2005, PRINCETON SERIES THE; Grinnell J., 1917, Auk Cambridge Mass, V34; Gutierrez RJ, 2007, BIOL INVASIONS, V9, P181, DOI 10.1007/s10530-006-9025-5; GUTIERREZ RJ, 1995, BIRDS N AM, V179; Hagmann RK, 2017, FOREST ECOL MANAG, V389, P374, DOI 10.1016/j.foreco.2016.12.029; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hamer TE, 2007, CONDOR, V109, P750, DOI 10.1650/0010-5422(2007)109[750:HRAAHS]2.0.CO;2; Heinrichs J. A., ECOLOGICAL MODELLING, V359, P449; Heinrichs JA, 2010, BIOL CONSERV, V143, P2229, DOI 10.1016/j.biocon.2010.06.009; Hershey KT, 1998, J WILDLIFE MANAGE, V62, P1398, DOI 10.2307/3802006; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Holm SR, 2016, WILDLIFE SOC B, V40, P615, DOI 10.1002/wsb.714; Huff M. H., 2006, SPATIALLY EXPLICIT E, V650; HUNTER JE, 1995, CONDOR, V97, P684, DOI 10.2307/1369177; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Irwin LL, 2018, J WILDLIFE MANAGE, V82, P202, DOI 10.1002/jwmg.21339; Kelly EG, 2003, CONDOR, V105, P45, DOI 10.1650/0010-5422(2003)105[45:ABODSO]2.0.CO;2; LaHaye WS, 1999, CONDOR, V101, P324, DOI 10.2307/1369995; Lint J., 1999, GEN TECHNICAL REPORT; Lint J. B., 1990, INT SCI COMM CONS NO; Loman ZG, 2018, LANDSCAPE ECOL, V33, P77, DOI 10.1007/s10980-017-0582-z; MARCOT B G, 1980, Western Birds, V11, P79; Marcot B. G., 1997, PNWGTR408 USDA FOR S; Marcot BG, 2015, NAT RESOUR MODEL, V28, P37, DOI 10.1111/nrm.12056; Marcot BG, 2013, NAT RESOUR MODEL, V26, P194, DOI 10.1111/j.1939-7445.2012.00134.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Meyer JS, 1998, WILDLIFE MONOGR, P5; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; MURPHY DD, 1992, ECOL APPL, V2, P3, DOI 10.2307/1941885; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Noon Barry R., 1996, P139; NOON BR, 1990, J WILDLIFE MANAGE, V54, P18, DOI 10.2307/3808895; Ohmann JL, 2014, REMOTE SENS ENVIRON, V151, P3, DOI 10.1016/j.rse.2013.08.048; Ohmann JL, 2002, CAN J FOREST RES, V32, P725, DOI [10.1139/x02-011, 10.1139/X02-011]; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peterson AT, 2003, CONSERV BIOL, V17, P1161, DOI 10.1046/j.1523-1739.2003.02206.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Raphael M. G., 2014, 0910831 JFSP; Reed J. Michael, 2006, P164; Reyers B, 2010, CONSERV BIOL, V24, P957, DOI 10.1111/j.1523-1739.2010.01497.x; RIPPLE WJ, 1991, J WILDLIFE MANAGE, V55, P316, DOI 10.2307/3809156; Schilling J.W., 2009, THESIS; Schumaker NH, 2018, LANDSCAPE ECOL, V33, P197, DOI 10.1007/s10980-017-0605-9; Schumaker NH, 2014, LANDSCAPE ECOL, V29, P579, DOI 10.1007/s10980-014-0004-4; Singleton P. H., 2013, THESIS; Smith AG, 2017, MATH BIOSCI, V291, P46, DOI 10.1016/j.mbs.2017.07.003; Solis D. M, 1983, THESIS; SOLIS DM, 1990, CONDOR, V92, P739, DOI 10.2307/1368693; Spies T., 1998, PNWGTR438 USDA FOR S; Stalberg D., 2009, LANDSCAPE URBAN PLAN, V90, P76; Thome DM, 1999, J WILDLIFE MANAGE, V63, P44, DOI 10.2307/3802486; United States Fish Wildlife Service [USFWS], 2011, REV REC PLAN NO SPOT; US Fish and Wildlife Service, 1990, FED REGISTER, V55, P26114; USDA (US Department of Agriculture) Forest Service and USDI BLM (Bureau of Land Management), 1994, REC DEC AM FOR SERV; USFWS (U. S. Fish and Wildlife Service), 1992, DRAFT FIN REC NO SPO; USFWS (US Fish and Wildlife Service), 2012, FED REGISTER, V77, P71876; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiens J. D., 2012, THESIS; Wiens JD, 2017, J RAPTOR RES, V51, P234, DOI 10.3356/JRR-16-77.1; Wiens JD, 2014, WILDLIFE MONOGR, V185, P1, DOI 10.1002/wmon.1009; Yackulic CB, 2014, ECOLOGY, V95, P265, DOI 10.1890/13-0012.1; Yaffee SL., 1994, WISDOM SPOTTED OWL P; Zabel CJ, 2003, ECOL APPL, V13, P1027, DOI 10.1890/02-5084	115	13	13	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210643	10.1371/journal.pone.0210643	http://dx.doi.org/10.1371/journal.pone.0210643			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640947	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000037
J	Fracasso, BD; Rangel, JO; Machado, AG; Curuja, FS; Lopes, A; Olsen, V; Clausell, N; Biolo, A; Rohde, LE; Andrades, M				Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Curuja, Fernanda Severo; Lopes, Amanda; Olsen, Virgilio; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael			Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction	PLOS ONE			English	Article							HEART-FAILURE; IMMUNE MATURATION; N-EPSILON-(CARBOXYMETHYL)LYSINE; DISEASE; LYSINE; AGES; RAT	Circulating advanced glycation end products (AGE) and their receptor, RAGE, are increased after a myocardial infarction (MI) episode and seem to be associated with worse prognosis in patients. Despite the increasing importance of these molecules in the course of cardiac diseases, they have never been characterized in an animal model of MI. Thus, the aim of this study was to characterize AGE formation and RAGE expression in plasma and cardiac tissue during cardiac remodeling after MI in rats. Adult male Wistar rats were randomized to receive sham surgery (n = 15) or MI induction (n = 14) by left anterior descending coronary artery ligation. The MI group was stratified into two subgroups based on postoperative left ventricular ejection fraction: low (MIlowEF) and intermediate (MIintermEF). Echocardiography findings and plasma levels of AGEs, protein carbonyl, and free amines were assessed at baseline and 2, 30, and 120 days postoperatively. At the end of follow-up, the heart was harvested for AGE and RAGE evaluation. No differences were observed in AGE formation in plasma, except for a decrease in absorbance in MIlowEF at the end of follow-up. A decrease in yellowish-brown AGEs in heart homogenate was found, which was confirmed by immunodetection of N-epsilon-carboxymethyl-lysine. No differences could be seen in plasma RAGE levels among the groups, despite an increase in MI groups over the time. However, MI animals presented an increase of 50% in heart RAGE at the end of the follow-up. Despite the inflammatory and oxidative profile of experimental MI in rats, there was no increase in plasma AGE or RAGE levels. However, AGE levels in cardiac tissue declined. Thus, we suggest that the rat MI model should be employed with caution when studying the AGE-RAGE signaling axis or anti-AGE drugs for not reflecting previous clinical findings.	[Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Curuja, Fernanda Severo; Lopes, Amanda; Olsen, Virgilio; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael] Hosp Clin Porto Alegre, Expt Res Ctr, Cardiovasc Res Lab, Porto Alegre, RS, Brazil; [Fracasso, Bianca de Moraes; Rangel, Juliana Oliveira; Machado, Alessandra Goncalves; Clausell, Nadine; Biolo, Andreia; Rohde, Luis Eduardo; Andrades, Michael] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol & Cardiovasc Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Andrades, M (corresponding author), Hosp Clin Porto Alegre, Expt Res Ctr, Cardiovasc Res Lab, Porto Alegre, RS, Brazil.; Andrades, M (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Cardiol & Cardiovasc Sci, Porto Alegre, RS, Brazil.	meandrades@hcpa.edu.br	Clausell, Nadine Oliveira/C-7813-2016; Rohde, Luis Eduardo/I-4216-2013; Andrades, Michael/S-5394-2019	Clausell, Nadine Oliveira/0000-0003-4207-3809; Andrades, Michael/0000-0003-0337-9661; Biolo, Andreia/0000-0002-8579-4158; Lopes, Amanda/0000-0002-8390-2821	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre [13-0445]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre 13-0445 (FIPE-HCPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2007, J CLIN BIOCHEM NUTR, V41, P97, DOI 10.3164/jcbn.2007014; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Almeida F, 2013, CARDIOVASC THER, V31, pE79, DOI 10.1111/1755-5922.12039; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrades ME, 2009, CHEM-BIOL INTERACT, V180, P478, DOI 10.1016/j.cbi.2009.04.005; Ashraf JM, 2015, IUBMB LIFE, V67, P897, DOI 10.1002/iub.1450; Baidoshvili A, 2006, ARTERIOSCL THROM VAS, V26, P2497, DOI 10.1161/01.ATV.0000245794.45804.ab; Boschetto P, 2013, EUR J CLIN INVEST, V43, P562, DOI 10.1111/eci.12079; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao WW, 2015, ARCH BIOCHEM BIOPHYS, V580, P112, DOI 10.1016/j.abb.2015.07.003; Cao WW, 2014, APPL BIOCHEM BIOTECH, V172, P4062, DOI 10.1007/s12010-014-0804-7; Cebe T, 2014, AGE, V36, DOI 10.1007/s11357-014-9728-y; Chang KC, 2004, BRIT J PHARMACOL, V142, P1099, DOI 10.1038/sj.bjp.0705831; Cohen MM, 2013, AM J MED GENET A, V161, P2750, DOI 10.1002/ajmg.a.36181; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Guilbaud A, 2016, FOODS, V5, DOI 10.3390/foods5040084; Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009; Hayashi CM, 2002, LAB INVEST, V82, P795, DOI 10.1097/01.LAB.0000018826.59648.07; Kilkenny C., 2013, ANIMALS, V4, P35, DOI DOI 10.3390/ani4010035; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Maneewong K, 2011, INDIAN J CLIN BIOCHE, V26, P389, DOI 10.1007/s12291-011-0118-2; McAlindon E, 2015, HEART, V101, P155, DOI 10.1136/heartjnl-2013-304289; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Peron Alessandra P. O. N., 2006, Arq. Bras. Cardiol., V86, P105, DOI 10.1590/S0066-782X2006000200005; Ramasamy Ravichandran, 2012, Curr Heart Fail Rep, V9, P107, DOI 10.1007/s11897-012-0089-5; Raposeiras-Roubin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074302; Raposeiras-Roubin S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-102; Raposeiras-Roubin S, 2011, AM J CARDIOL, V107, P938, DOI 10.1016/j.amjcard.2010.11.011; Raposeiras-Roubin S, 2010, EUR J HEART FAIL, V12, P1092, DOI 10.1093/eurjhf/hfq117; Sharma C, 2015, J FOOD SCI TECH MYS, V52, P7561, DOI 10.1007/s13197-015-1851-y; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; Vidart J, 2014, J CLIN ENDOCR METAB, V99, P4537, DOI 10.1210/jc.2014-2192; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vollenbrock CE, 2017, J DIABETES, V9, P308, DOI 10.1111/1753-0407.12498; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019; Zhang F, 2011, J SURG RES, V171, P871, DOI 10.1016/j.jss.2010.04.027	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209964	10.1371/journal.pone.0209964	http://dx.doi.org/10.1371/journal.pone.0209964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633750	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100008
J	Silva, RDS; Macedo, LA; dos Santos, GA; Aguiar, PM; de Lyra, DP				Santos Silva, Rafaella de Oliveira; Macedo, Luana Andrade; dos Santos Junior, Genival Araujo; Aguiar, Patricia Melo; de Lyra Junior, Divaldo Pereira			Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews	PLOS ONE			English	Review							CLINICAL PHARMACY; OLDER PATIENTS; HOSPITAL ADMISSIONS; COMMUNITY PHARMACY; ELDERLY-PATIENTS; MEDICINES USE; FOLLOW-UP; CARE; QUALITY; POLYPHARMACY	Introduction Medication review (MR) is a pharmacy practice conducted in different settings that has a positive impact on patient health outcomes. In this context, systematic reviews on MR have restricted the assessment of this practice using criteria such as methodological quality, practice settings, and patient outcomes. Therefore, expanding research on this subject is necessary to facilitate the understanding of the effectiveness of MR and the comparison of its results. Aim To examine the panorama of systematic reviews on pharmacist-participated MR in different practice settings. Methods A literature search was undertaken in Biblioteca Virtual em Saude (BVS), Embase, PubMed, Scopus, The Cochrane Library, and Web of Science databases through January 2018 using keywords for "medication review", "systematic review", and "pharmacist". Two independents investigators screened titles, abstracts, full texts; assessed methodological quality; and, extracted data from the included reviews. Results Seventeen systematic reviews were included, of which sixteen presented low to moderate methodological quality. Most of reviews were conducted in Europe (n = 7), included controlled primary studies (n = 16), elderly patients (n = 9), and long-term care facilities (n = 8). Seven reviews addressed MR as an intervention and thirteen reviews cited collaboration between physicians and pharmacists in the practice of MR. In addition, thirteen terminologies for MR were used and the main objective was to identify and solve drug-related problems and/or optimize the drug use (n = 11). Conclusion There is considerable heterogeneity in practice settings, population, definitions, terminologies, and approach of MR as well as poor description of patient care process in the systematic reviews. These facts may limit the comparison, summarization and understanding of the results of MR. Furthermore, the methodological quality of most systematic reviews was below ideal. Thus, international agreement on the MR process is necessary to assess, compare and optimize the quality of care provided.	[Santos Silva, Rafaella de Oliveira; Macedo, Luana Andrade; dos Santos Junior, Genival Araujo; de Lyra Junior, Divaldo Pereira] Univ Fed Sergipe, Dept Pharm, Lab Teaching & Res Social Pharm LEPFS, Sao Cristovao, Sergipe, Brazil; [Aguiar, Patricia Melo] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Sao Paulo, Brazil	Universidade Federal de Sergipe; Universidade de Sao Paulo	de Lyra, DP (corresponding author), Univ Fed Sergipe, Dept Pharm, Lab Teaching & Res Social Pharm LEPFS, Sao Cristovao, Sergipe, Brazil.	lepfs.ufs@gmail.com	Aguiar, Patricia Melo/D-7095-2013; Junior, Divaldo Lyra/AAU-9987-2020; Santos Júnior, Genival Araujo dos/HGF-0618-2022	Aguiar, Patricia Melo/0000-0002-3957-4533; Junior, Divaldo Lyra/0000-0002-0266-0702; Santos Júnior, Genival Araujo dos/0000-0002-5618-1846	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001. The authors thanks specially to the researchers of the Laboratory of Teaching and Research in Social Pharmacy (LEPFS) for their contribution to this manuscript.	Adams RP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009246; Aguiar PM, 2014, ANN PHARMACOTHER, V48, P887, DOI 10.1177/1060028014529411; Ahmed SI, 2010, AM J PHARM EDUC, V74, P193; American Pharmacists Association; National Association of Chain Drug Stores Foundation, 2008, J AM PHARM ASSOC, V48, P341, DOI DOI 10.1331/JAPHA.2008.08514; [Anonymous], 1999, WHO TECHN REP SER; [Anonymous], 2015, ACCR STAND KEY EL PR; Aslani Parisa, 2009, Pharmacy Pract (Granada), V7, P1; Australian Government, 2005, DOM MED MAN HOM MED; Blundell DB, 2015, FARM COMUNITARIOS, V7, P31, DOI 10.5672/FC.21739218.(2015/Vol7).002.05; Basheti IA, 2016, INT J CLIN PHARM-NET, V38, P404, DOI 10.1007/s11096-016-0266-9; Bedouch P, 2012, J EVAL CLIN PRACT, V18, P911, DOI 10.1111/j.1365-2753.2011.01704.x; Bell Simon, 2005, Aust New Zealand Health Policy, V2, P29, DOI 10.1186/1743-8462-2-29; Benrimoj SI, 2010, ARS PHARM, V51, P69; Bereznicki LRE, 2016, INTERN MED J, V46, P288, DOI 10.1111/imj.12964; Blenkinsopp A, 2012, BRIT J CLIN PHARMACO, V74, P573, DOI 10.1111/j.1365-2125.2012.04331.x; Brito G., 2015, THESIS, p282f; Bulajeva A, 2014, RES SOC ADMIN PHARM, V10, P731, DOI 10.1016/j.sapharm.2014.02.005; Bulow C, 2018, BASIC CLIN PHARMACOL, V122, P253, DOI 10.1111/bcpt.12901; Burda BU, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0237-1; Casserlie Lucas M., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.03.792; Ocampo CC, 2015, INT J CLIN PHARM-NET, V37, P931, DOI 10.1007/s11096-015-0145-9; Chan P., 2008, CAN PHARM J, V141, P102, DOI 10.3821/1913-701X(2008)141[102:ASRORS]2.0.CO;2; Chau SH, 2016, INT J CLIN PHARM-NET, V38, P46, DOI 10.1007/s11096-015-0199-8; Chen TF, 2016, DRUG AGING, V33, P199, DOI 10.1007/s40266-016-0357-2; Chen Y, 2014, THER CLIN RISK MANAG, V10, P437, DOI 10.2147/TCRM.S63756; Cipolla RC, 2012, PROCEEDINGS OF THE ASME PRESSURE VESSELS AND PIPING CONFERENCE, PVP 2012, VOL 1, P3; Clyne W, 2008, GUIDE MED REV; Correr CJ, 2013, ACTA FARMACEUTICA PO, V2, P21; da Costa FA, 2016, DRUGS-REAL WOR OUTC, V3, P89, DOI [10.1007/s40801-016-0061-x, DOI 10.1007/S40801-016-0061-X]; Dolovich L, 2016, CAN PHARM J, V149, P293, DOI 10.1177/1715163516662670; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Federal Council of Pharmacy (Brazil), 2016, PHARM PRESCR CLIN AT; Forsetlund L, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-16; Franklin BD, 2005, PHARM WORLD SCI, V27, P137, DOI 10.1007/s11096-005-7060-4; Gallagher J, 2016, DRUG AGING, V33, P285, DOI 10.1007/s40266-016-0348-3; Geurts MME, 2016, INT J CLIN PHARM-NET, V38, P808, DOI 10.1007/s11096-016-0281-x; Graabaek T, 2013, BASIC CLIN PHARMACOL, V112, P359, DOI 10.1111/bcpt.12062; Griffiths Rhonda, 2004, Int J Nurs Pract, V10, P166, DOI 10.1111/j.1440-172X.2004.00476.x; Hadi MA, 2014, CLIN J PAIN, V30, P1006, DOI 10.1097/AJP.0000000000000063; Hanna Mary, 2016, Journal of Pharmacy Practice and Research, V46, P112, DOI 10.1002/jppr.1173; Hatah E, 2014, BRIT J CLIN PHARMACO, V77, P102, DOI 10.1111/bcp.12140; Health and Social Care Board (United Kingdom), 2016, MED REV GUID; Hohl CM, 2015, BRIT J CLIN PHARMACO, V80, P51, DOI 10.1111/bcp.12585; Holland R, 2008, BRIT J CLIN PHARMACO, V65, P303, DOI 10.1111/j.1365-2125.2007.03071.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Huiskes VJB, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-016-0577-x; International Pharmaceutical Federation, 1993, TOK DECL STAND QUAL; Jokanovic N, 2017, RES SOC ADMIN PHARM, V13, P661, DOI 10.1016/j.sapharm.2016.08.005; Jokanovic N, 2016, RES SOC ADMIN PHARM, V12, P384, DOI 10.1016/j.sapharm.2015.06.007; Jorgenson Derek, 2013, Can Pharm J (Ott), V146, P342, DOI 10.1177/1715163513504528; Karani MV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00250; Kelly Deborah V, 2014, Can Pharm J (Ott), V147, P239, DOI 10.1177/1715163514535731; Knoer SJ, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0066-3; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Koskela T, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0245-z; KOZMA CM, 1993, CLIN THER, V15, P1121; Kwint HF, 2013, DRUG AGING, V30, P91, DOI 10.1007/s40266-012-0048-6; Leikola S, 2012, INT J CLIN PHARM-NET, V34, P510, DOI 10.1007/s11096-012-9662-y; Leikola SNS, 2012, J AM PHARM ASSOC, V52, P630, DOI 10.1331/JAPhA.2012.10163; Loganathan M, 2011, AGE AGEING, V40, P150, DOI 10.1093/ageing/afq161; Loh ZWR, 2016, J CLIN PHARM THER, V41, P621, DOI 10.1111/jcpt.12453; Malet-Larrea A, 2016, BRIT J CLIN PHARMACO, V82, P831, DOI 10.1111/bcp.13012; Marques TC, 2015, THESIS; McKean M, 2016, INTERN MED J, V46, P35, DOI 10.1111/imj.12906; Melchiors AC, 2012, INT J CLIN PHARM-NET, V34, P32, DOI 10.1007/s11096-011-9592-0; Messerli M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1384-8; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Moles Rebekah J, 2015, Can J Hosp Pharm, V68, P418; Lopez TM, 2012, ATEN PRIM, V44, P453, DOI 10.1016/j.aprim.2011.09.015; National Center for Biotechnology Information, 2016, MESH MED SUBJ HEAD; National Health System (United Kingdom), 2013, GUID MED US REV SERV; Nishtala PS, 2016, J CLIN PHARM THER, V41, P279, DOI 10.1111/jcpt.12385; Nishtala PS, 2008, AM J GERIAT PSYCHIAT, V16, P621, DOI 10.1097/JGP.0b013e31817c6abe; Nunes-da-Cunha I, 2016, AM J PHARM EDUC, V80, DOI 10.5688/ajpe80583; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Palagyi A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0181-x; Pan American Health Organization, 2013, PRIM HLTH CAR BAS PH; Pan American Health Organization, 2002, BRAZ CONS PHARM CAR; Patel CH, 2016, ANN PHARMACOTHER, V50, P534, DOI 10.1177/1060028016647067; Perraudin C, 2016, HEALTH POLICY, V120, P1350, DOI 10.1016/j.healthpol.2016.09.013; Pharmaceutical Care Network Europe, 2016, MED REV DEF APPR; Pharmaceutical Society of Australia, 2011, GUID PHARM PROV RES; Pharmaceutical Society of Australia, 2012, GUID PHARM PROV MED; Pharmaceutical Society of Australia, 2011, GUID PHARM PROV HOM; Pharmacy Council of New Zealand, 2006, MED MAN DEF LEV COMP; Pharmacy Guild of Australia and Australian Divisions of General Practice Limited, 2005, HOM MED REV INF PHAR; Pintor-Marmol A, 2012, PHARMACOEPIDEM DR S, V21, P799, DOI 10.1002/pds.3296; Ramsbottom HF, 2016, INT J CLIN PHARM-NET, V38, P208, DOI 10.1007/s11096-015-0243-8; Renaudin P, 2016, BRIT J CLIN PHARMACO, V82, P1660, DOI 10.1111/bcp.13085; Rigoni CC, 2015, BRAZ J PHARM SCI, V51, P763, DOI 10.1590/S1984-82502015000400002; Rodgers RM, 2016, PATIENT PREFER ADHER, V10, P1749, DOI 10.2147/PPA.S112931; Rodis Jennifer, 2009, Am J Pharm Educ, V73, P74; Rose O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156304; Rotta I, 2015, INT J CLIN PHARM-NET, V37, P687, DOI 10.1007/s11096-015-0137-9; Santos GA, 2015, LAT AM J PHARM, V34, P1172; Scahill SL, 2017, INTEGR PHARM RES PRA, V6, P121, DOI 10.2147/IPRP.S124866; Shaw J, 2002, ROOM REV GUIDE MED R; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sistema Sanitario Publico Andaluz (Spain), 2013, GUIA TRAB REV SIST M; Society of Hospital Pharmacists Australia Committee of Specialty Practice in Clinical Pharmacy, 2005, J PHARM PRACT RES, V35, P122, DOI DOI 10.1002/j.2055-2335.2005.tb00322.x; Stewart K, 2014, J CLIN PHARM THER, V39, P527, DOI 10.1111/jcpt.12185; Suggett Emma, 2016, Drugs Real World Outcomes, V3, P241; Tang MM, 2016, J RES PHARM PRACT, V5, P126, DOI 10.4103/2279-042X.179578; Tarn DM, 2009, J GEN INTERN MED, V24, P1296, DOI 10.1007/s11606-009-1132-4; Thiruchelvam K, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.10.004; van Mil JWF, 2016, INT J CLIN PHARM-NET, V38, P709, DOI 10.1007/s11096-016-0294-5; Vouri SM, 2015, CURR PHARM TEACH LEA, V7, P892, DOI 10.1016/j.cptl.2015.08.018; Wang JL, 2015, AM HEALTH DRUG BENEF, V8, P247; Wegewitz U, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0183-6; Weiss BD, 2016, J AM BOARD FAM MED, V29, P18, DOI 10.3122/jabfm.2016.01.150163; World Health Organization, 2011, WHO TECHN REP SER	112	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210312	10.1371/journal.pone.0210312	http://dx.doi.org/10.1371/journal.pone.0210312			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629654	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000072
J	Keil, R; Drabek, J; Lochmannova, J; Stovicek, J; Koptova, P; Wasserbauer, M; Frybova, B; Snajdauf, J; Matous, J; Kotalova, R; Rygl, M; Hlava, S				Keil, Radan; Drabek, Jiri; Lochmannova, Jindra; Stovicek, Jan; Koptova, Petra; Wasserbauer, Martin; Frybova, Barbora; Snajdauf, Jiri; Matous, Jan; Kotalova, Radana; Rygl, Michal; Hlava, Stepan			ERCP in infants, children, and adolescents-Different roles of the methods in different age groups	PLOS ONE			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; PEDIATRIC POPULATION; SAFETY; EFFICACY; BILE	Background Endoscopic retrograde cholangiopancreatography (ERCP) is seldom used in children, and published series have limited numbers of pediatric patients. The aim of this retrospective observational study was to assess the efficacy and safety of pediatric ERCP in a large group of children. Methods Data were evaluated from 626 children with biliopancreatic disorders admitted to University Hospital Motol, Prague, between January 1999 and January 2018. Clinical data were obtained by retrospective evaluation of our database of pediatric ERCP procedures and from clinical records. Results We performed 856 ERCPs on 626 pediatric patients; of these procedures, 59% were therapeutic and 41% were diagnostic. We achieved 96% technical success. Indications for ERCP and pathological findings differed in different age groups. The main role of ERCP was in excluding biliary atresia in those aged less than one year. In children aged 1 to 6 years, the most frequent diagnoses were choledochal cyst followed by choledocholithiasis. In children aged 7 to 12 years and 13 to 19 years, the most frequent diagnoses were choledocholithiasis followed by pancreatic pathology. The overall complication rate found in this study was similar to rates observed in adult populations. Conclusions Our study shows the efficacy and safety of diagnostic and therapeutic ERCP in a large series of infants and children with technical success and complication rates comparable to those in adults. Our data show that ERCP had different roles in different age groups of children.	[Keil, Radan; Drabek, Jiri; Lochmannova, Jindra; Stovicek, Jan; Koptova, Petra; Wasserbauer, Martin; Hlava, Stepan] Charles Univ Prague, Univ Hosp Motol, Fac Med 2, Dept Internal Med, Prague, Czech Republic; [Frybova, Barbora; Snajdauf, Jiri; Rygl, Michal] Charles Univ Prague, Univ Hosp Motol, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic; [Matous, Jan] Charles Univ Prague, FNKV, Fac Med 3, Dept Internal Med 2, Prague, Czech Republic; [Kotalova, Radana] Charles Univ Prague, Univ Hosp Motol, Fac Med 2, Dept Pediat, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital; Charles University Prague; University Hospital Vinohrady; Charles University Prague; Motol University Hospital	Hlava, S (corresponding author), Charles Univ Prague, Univ Hosp Motol, Fac Med 2, Dept Internal Med, Prague, Czech Republic.	stepan.hlava@fnmotol.cz	Stovicek, Jan/ABC-5518-2020; Keil, Radan/AAQ-6496-2021; Matous, Jan/S-9617-2017; Šťovíček, Jan/AAV-1175-2020; Drábek, Jiří/AAI-6723-2021; Frybova, Barbora/AAW-2792-2020	Matous, Jan/0000-0002-9873-4007; Hlava, Stepan/0000-0001-8004-844X	Ministry of Health, Czech Republic - conceptual development of research organization, Motol University Hospital, Prague, Czech Republic [00064203]	Ministry of Health, Czech Republic - conceptual development of research organization, Motol University Hospital, Prague, Czech Republic	Supported by Ministry of Health, Czech Republic - conceptual development of research organization, Motol University Hospital, Prague, Czech Republic 00064203.	Cohen S, 2002, NATL I HLTH STATE SC, P803; Drabek J, 2017, GASTROENTEROL REV, V12, P303, DOI 10.5114/pg.2017.72107; Enestvedt BK, 2012, GASTROINTEST ENDOSC, V75, P164; Felux J, 2017, UNITED EUR GASTROENT, V5, P1024, DOI 10.1177/2050640616687868; Giefer MJ, 2015, SURG ENDOSC, V29, P3543, DOI 10.1007/s00464-015-4105-1; Halpern Z, 1996, J PEDIATR GASTR NUTR, V23, P147, DOI 10.1097/00005176-199608000-00009; Halvorson L, 2013, DIGEST DIS SCI, V58, P3611, DOI 10.1007/s10620-013-2857-9; Hiramatsu T, 2015, J PEDIATR SURG, V50, P377, DOI 10.1016/j.jpedsurg.2014.08.024; Keil R, 2010, ENDOSCOPY, V42, P121, DOI 10.1055/s-0029-1215372; Keil R, 2017, SCAND J GASTROENTERO, V52, P870, DOI 10.1080/00365521.2017.1309453; Keil R, 2016, SCAND J GASTROENTERO, V51, P218, DOI 10.3109/00365521.2015.1070899; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Limketkai BN, 2013, DIGEST DIS SCI, V58, P2653, DOI 10.1007/s10620-013-2691-0; Otto AK, 2011, SURG ENDOSC, V25, P2536, DOI 10.1007/s00464-011-1582-8; Pant C, 2014, J PEDIATR GASTR NUTR, V59, P57, DOI 10.1097/MPG.0000000000000333; Paris C, 2010, J PEDIATR SURG, V45, P938, DOI 10.1016/j.jpedsurg.2010.02.009; Troendle DM, 2015, GASTROINTEST ENDOSC, V81, pAB173, DOI 10.1016/j.gie.2015.03.1924; VONBERGMANN K, 1986, EUR J CLIN INVEST, V16, P531	18	15	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210805	10.1371/journal.pone.0210805	http://dx.doi.org/10.1371/journal.pone.0210805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653580	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500073
J	Rettig, TA; Bye, BA; Nishiyama, NC; Hlavacek, S; Ward, C; Pecaut, MJ; Chapes, SK				Rettig, Trisha A.; Bye, Bailey A.; Nishiyama, Nina C.; Hlavacek, Savannah; Ward, Claire; Pecaut, Michael J.; Chapes, Stephen K.			Effects of skeletal unloading on the antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice	PLOS ONE			English	Article							PERIPHERAL-BLOOD LEUKOCYTES; IMMUNE-RESPONSES; SPACE-FLIGHT; ANTIORTHOSTATIC SUSPENSION; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN HEAVY; AFFINITY MATURATION; GENE-EXPRESSION; CELL-FUNCTION; PLASMA-CELLS	Spaceflight affects the immune system, but the effects on the antibody repertoire, responsible for humoral immunity, has not been well explored. In particular, the complex gene assembly and expression process; including mutations, might make this process vulnerable. Complementarity determining region 3 (CDR3), composed of parts of the V-(D-) J-gene segments, is very important for antigen binding and can be used as an important measure of variability. Skeletal unloading, and the physiological effects of it, parallel many impacts of space flight. Therefore, we explored the impact of skeletal unloading using the antiorthostatic suspension (AOS) model. Animals were experimentally challenged with tetanus toxoid (TT) and/or the adjuvant CpG. Blood was analyzed for anti-TT antibody and corticosterone concentrations. Whole spleen tissue was prepared for repertoire characterization. AOS animals showed higher levels of corticosterone levels, but AOS alone did not affect anti-TT serum antibody levels. Administration of CpG significantly increased the circulating anti-TT antibody concentrations. AOS did alter constant gene usage resulting in higher levels of IgM and lower levels of IgG. CpG also altered constant gene region usage increasing usage of IgA. Significant changes could be detected in multiple V-, D-, and J-gene segments in both the heavy and light chains in response to AOS, TT, and CpG treatments. Analysis of class-switched only transcripts revealed a different pattern of V-gene segment usage than detected in the whole repertoire and also showed significant alterations in gene segment usage after challenge. Alterations in V/J pairing were also detected in response to challenge. CDR3 amino acid sequence overlaps were similar among treatment groups, though the addition of CpG lowered overlap in the heavy chain. We isolated 3,045 whole repertoire and 98 potentially TT-specific CDR3 sequences for the heavy chain and 569 for the light chain. Our results demonstrate that AOS alters the repertoire response to challenge with TT and/or CpG.	[Rettig, Trisha A.; Bye, Bailey A.; Hlavacek, Savannah; Ward, Claire; Chapes, Stephen K.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Nishiyama, Nina C.; Pecaut, Michael J.] Loma Linda Univ, Div Biomed Engn Sci, Loma Linda, CA 92350 USA	Kansas State University; Loma Linda University	Chapes, SK (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	skcbiol@ksu.edu	Pecaut, Michael J/P-6481-2015	Pecaut, Michael J/0000-0002-2915-9686; Ward, Claire/0000-0002-1486-4403; Rettig, Trisha/0000-0001-7434-9182	National Aeronautics and Space Administration [NNX13AN34G, NNX15AB45G]; National Institute of Health [GM103418]; College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NNX13AN34G and NNX15AB45G from National Aeronautics and Space Administration (https://www.nasa.gov/) (SKC and MJP); GM103418 from the National Institute of Health (https://www.nih.gov/) (SKC); College of Veterinary Medicine at Kansas State University (http://www.vet.k-state.edu/); and Kansas State University Johnson Cancer - Research Center (http://cancer.k-state.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebban Z, 1996, J APPL PHYSIOL, V81, P117, DOI 10.1152/jappl.1996.81.1.117; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Atkinson W, 2012, CTR DIS CONTROL PREV, DOI [10.1126/science.1135299, DOI 10.1126/SCIENCE.1135299]; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Bauer K, 2002, J IMMUNOL, V169, P1349, DOI 10.4049/jimmunol.169.3.1349; BERRY CA, 1970, AEROSPACE MED, V41, P500; BIKLE DD, 1994, AM J PHYSIOL-ENDOC M, V267, pE822, DOI 10.1152/ajpendo.1994.267.6.E822; Blanc S, 1998, NEUROCHEM INT, V33, P375, DOI 10.1016/S0197-0186(98)00042-4; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Cao YR, 2010, J IMMUNOL METHODS, V358, P56, DOI 10.1016/j.jim.2010.03.009; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cogoli A, 1990, ESA, P89; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; de Kruif J, 2009, J MOL BIOL, V387, P548, DOI 10.1016/j.jmb.2009.02.009; Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Fitzgerald W, 2009, IN VITRO CELL DEV-AN, V45, P622, DOI 10.1007/s11626-009-9225-2; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; FUCHS BB, 1993, J LEUKOCYTE BIOL, V54, P245, DOI 10.1002/jlb.54.3.245; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Greiff V, 2017, CELL REP, V19, P1467, DOI 10.1016/j.celrep.2017.04.054; GRIGORIEV AI, 1993, ACTA ASTRONAUT, V29, P581, DOI 10.1016/0094-5765(93)90073-6; GRINDELAND RE, 1990, FASEB J, V4, P105, DOI 10.1096/fasebj.4.1.2295371; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2002, J IMMUNOLOGY, V168; HUGHESFULFORD M, 1991, EXP GERONTOL, V26, P247, DOI 10.1016/0531-5565(91)90017-G; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Jahns G, 1992, 43 CONGRESSTHE INT A; Kamgang RK, 2008, MED MICROBIOL IMMUN, V197, P369, DOI 10.1007/s00430-008-0081-6; Kimzey S.L., 1977, BIOMEDICAL RESULTS S; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Klinman DM, 2000, SPRINGER SEMIN IMMUN, V22, P173, DOI 10.1007/s002810050027; Konstantinova I.V., 1973, SPACE BIOL MED, V7, P48; KOPYDLOWSKI KM, 1992, J LEUKOCYTE BIOL, V52, P202, DOI 10.1002/jlb.52.2.202; Krieg AM, 1996, TRENDS MICROBIOL, V4, P73, DOI 10.1016/0966-842X(96)81515-0; Krohn TC, 2006, ANIM WELFARE, V15, P343; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Lesnyak A, 1996, J APPL PHYSIOL, V81, P178, DOI 10.1152/jappl.1996.81.1.178; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; Maldonado MA, 1999, J IMMUNOL, V162, P6322; MANDEL AD, 1977, AVIAT SPACE ENVIR MD, V48, P1051; MANSER T, 1984, SCIENCE, V226, P1283, DOI 10.1126/science.6334361; MANSER T, 1990, IMMUNOL TODAY, V11, P305, DOI 10.1016/0167-5699(90)90124-R; MANSER T, 1985, IMMUNOL TODAY, V6, P94, DOI 10.1016/0167-5699(85)90024-6; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; MILLER ES, 1995, J APPL PHYSIOL, V78, P810, DOI 10.1152/jappl.1995.78.3.810; MOREYHOLTON E, 1981, PHYSIOLOGIST S, V24, pS45; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; NASH PV, 1992, J APPL PHYSIOL, V73, pS186; Nasonkin IO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028355; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, DOI [10.1152/jappl.1998.85.1.279, DOI 10.1152/JAPPL.1998.85.1.279]; PERSSON MAA, 1991, P NATL ACAD SCI USA, V88, P2432, DOI 10.1073/pnas.88.6.2432; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; Rettig Trisha A, 2017, Gravit Space Res, V5, P2; Scheule RK, 2000, ADV DRUG DELIVER REV, V44, P119, DOI 10.1016/S0169-409X(00)00090-9; Serova L V, 1980, Physiologist, V23, pS22; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; SONNENFELD G, 1990, AVIAT SPACE ENVIR MD, V61, P648; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld G, 1998, J APPL PHYSIOL, V85, P1429, DOI 10.1152/jappl.1998.85.4.1429; Spielmann G, 2019, J APPL PHYSIOL, V126, P469, DOI 10.1152/japplphysiol.00789.2018; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Stowe RP, 2001, PSYCHOSOM MED, V63, P891, DOI 10.1097/00006842-200111000-00007; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tascher G, 2019, FASEB J, V33, P3772, DOI 10.1096/fj.201801463R; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TAYLOR GR, 1983, AVIAT SPACE ENVIR MD, V54, pS55; Truck J, 2015, J IMMUNOL, V194, P252, DOI 10.4049/jimmunol.1401405; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; WOLOSCHAK GE, 1987, MOL IMMUNOL, V24, P751, DOI 10.1016/0161-5890(87)90058-7; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279	97	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210284	10.1371/journal.pone.0210284	http://dx.doi.org/10.1371/journal.pone.0210284			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653556	Green Submitted, gold, Green Published			2022-12-27	WOS:000456015500032
J	Huang, J; Kinateder, M; Dunn, MJ; Jarosz, W; Yang, XD; Cooper, EA				Huang, Jonathan; Kinateder, Max; Dunn, Matt J.; Jarosz, Wojciech; Yang, Xing-Dong; Cooper, Emily A.			An augmented reality sign-reading assistant for users with reduced vision	PLOS ONE			English	Article							NAVIGATION	People typically rely heavily on visual information when finding their way to unfamiliar locations. For individuals with reduced vision, there are a variety of navigational tools available to assist with this task if needed. However, for wayfinding in unfamiliar indoor environments the applicability of existing tools is limited. One potential approach to assist with this task is to enhance visual information about the location and content of existing signage in the environment. With this aim, we developed a prototype software application, which runs on a consumer head-mounted augmented reality (AR) device, to assist visually impaired users with sign-reading. The sign-reading assistant identifies real-world text (e.g., signs and room numbers) on command, highlights the text location, converts it to high contrast AR lettering, and optionally reads the content aloud via text-to-speech. We assessed the usability of this application in a behavioral experiment. Participants with simulated visual impairment were asked to locate a particular office within a hallway, either with or without AR assistance (referred to as the AR group and control group, respectively). Subjective assessments indicated that participants in the AR group found the application helpful for this task, and an analysis of walking paths indicated that these participants took more direct routes compared to the control group. However, participants in the AR group also walked more slowly and took more time to complete the task than the control group. The results point to several specific future goals for usability and system performance in AR-based assistive tools.	[Huang, Jonathan; Jarosz, Wojciech; Yang, Xing-Dong] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Kinateder, Max; Cooper, Emily A.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Dunn, Matt J.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Kinateder, Max] Natl Res Council Canada Fire Safety, Ottawa, ON, Canada; [Cooper, Emily A.] Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	Dartmouth College; Dartmouth College; Cardiff University; National Research Council Canada; University of California System; University of California Berkeley	Huang, J (corresponding author), Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA.	jonathan.l.huang.17@dartmouth.edu	Kinateder, Max/AAC-5833-2019	Kinateder, Max/0000-0002-1669-3900; Dunn, Matt James/0000-0002-0295-2182; Cooper, Emily/0000-0003-4889-7446	Microsoft; Oculus	Microsoft(Microsoft); Oculus	This research was supported by gifts provided by Microsoft and Oculus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetovic D, 2017, W4A, V31, P1; Alghamdi S, 2013, 2013 IEEE EIGHTH INTERNATIONAL CONFERENCE ON INTELLIGENT SENSORS, SENSOR NETWORKS AND INFORMATION PROCESSING, P18, DOI 10.1109/ISSNIP.2013.6529756; Asad M, 2012, INT CONF IMAG PROC, P442, DOI 10.1109/IPTA.2012.6469553; Bochsler TM, 2012, OPTOMETRY VISION SCI, V89, pE1299, DOI 10.1097/OPX.0b013e318264f2bd; Culham LE, 2004, OPHTHAL PHYSL OPT, V24, P281, DOI 10.1111/j.1475-1313.2004.00193.x; Ehrlich JR, 2017, AM J OPHTHALMOL, V176, P26, DOI 10.1016/j.ajo.2016.12.021; Fallah N, 2012, USER SENSOR NAVIGATI, P425; Flores G, 2018, ACM CHI 2018 C HUM F, V17; Humanware, BRAILLENOTE GPS; Hwang AD, 2014, OPTOMETRY VISION SCI, V91, P1021, DOI 10.1097/OPX.0000000000000326; Kallie CS, 2012, INVEST OPHTH VIS SCI, V53, P7997, DOI 10.1167/iovs.12-10013; Kim JE, 2016, P 31 ANN ACM S APPL, P604; Legge GE, 2014, OPTOMETRY VISION SCI, V91, P696, DOI 10.1097/OPX.0000000000000310; Legge GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076783; Li B, 2016, LECT NOTES COMPUT SC, V9914, P448, DOI 10.1007/978-3-319-48881-3_31; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Manduchi R, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3113, DOI 10.1145/2556288.2557328; Microsoft, 2018, HOLOLENS HARDW DET; Perez GM, 2010, INVEST OPHTH VIS SCI, V51, P609, DOI 10.1167/iovs.09-3726; Roentgen UR, 2011, J VISUAL IMPAIR BLIN, V105, P612, DOI 10.1177/0145482X1110501008; Tian YL, 2013, MACH VISION APPL, V24, P521, DOI 10.1007/s00138-012-0431-7; Vargas-Martin F, 2002, OPTOMETRY VISION SCI, V79, P715, DOI 10.1097/00006324-200211000-00009; Varma R, 2016, JAMA OPHTHALMOL, V134, P802, DOI 10.1001/jamaophthalmol.2016.1284; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Zhang D, 2014, MACH VISION APPL, V25, P811, DOI 10.1007/s00138-013-0575-0; Zhao YQ, 2016, ADV COMPUT VIS PATT, P73, DOI 10.1007/978-3-662-49373-1_4; Zhao YH, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P4170, DOI 10.1145/3025453.3025949	27	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210630	10.1371/journal.pone.0210630	http://dx.doi.org/10.1371/journal.pone.0210630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650159	Green Published, Green Accepted, gold			2022-12-27	WOS:000455813300065
J	Krassovka, J; Borgschulze, A; Sahlender, B; Logters, T; Windolf, J; Grotheer, V				Krassovka, Julia; Borgschulze, Annika; Sahlender, Benita; Loegters, Tim; Windolf, Joachim; Grotheer, Vera			Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts	PLOS ONE			English	Article							DISEASE; GROWTH; CONTRACTURE; DIFFERENTIATION; MYOFIBROBLAST; STIMULATION; CELLS; BETA	Dupuytren's contracture is a fibroproliferative disorder affecting the palmar fascia of the hand. Most affected are the ring fingers, and little fingers of middle-aged men. Symptomatic for this disease is the increased proliferation and differentiation of fibroblasts to myofibroblasts, which is accompanied by an elevated alpha-SMA expression. The present study evaluated the therapeutic benefit of blue light (lambda = 453 nm, 38 mW/cm(2), continuous radiance, spot size 10-12 cm(2)) as well as the molecular mechanism mediating this effect. It could be determined that blue light significantly diminished the induced alpha-SMA protein expression in both normal palmar fibroblasts and Duypuytren's fibroblasts. The beneficial effect mediated by this irradiance, radiant exposure and wavelength was associated with an elevated reactive oxygen species generation. Furthermore, the data underlines the potential usefulness of blue light irradiation as a promising therapy option for Dupuytren's disease, especially for relapse prevention, and may represent a useful strategy to treat further fibrotic diseases, such as keloids, hypertrophic scarring, and scleroderma.	[Krassovka, Julia; Borgschulze, Annika; Sahlender, Benita; Loegters, Tim; Windolf, Joachim; Grotheer, Vera] Heinrich Heine Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Grotheer, V (corresponding author), Heinrich Heine Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany.	vera.grotheer@med.uni-duesseldorf.de						Adamskaya N, 2011, INJURY, V42, P917, DOI 10.1016/j.injury.2010.03.023; Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boulton M, 2004, PHOTOCH PHOTOBIO SCI, V3, P759, DOI 10.1039/b400108g; Feldman G, 2017, ISR MED ASSOC J, V19, P648; Fischer MR, 2013, EXP DERMATOL, V22, P558, DOI 10.1111/exd.12193; Gorgidze LA, 1998, BIOSCIENCE REP, V18, P215, DOI 10.1023/A:1020104914726; Gudmundsson KG, 2001, SCAND J RHEUMATOL, V30, P31; Jemec B, 1999, J HAND SURG-BRIT EUR, V24B, P511, DOI 10.1054/jhsb.1999.0251; KARU T, 1994, INT J RADIAT BIOL, V65, P691, DOI 10.1080/09553009414550811; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Krause C, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-14; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Meek RMD, 2002, J HAND SURG-BRIT EUR, V27B, P270, DOI 10.1054/jhsb.2001.0742; Niemz MH, 2007, LASER TISSUE INTERAC; Ohara M, 2003, CANCER SCI, V94, P205, DOI 10.1111/j.1349-7006.2003.tb01420.x; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; Pavelic SK, 2009, J PATHOL, V217, P524, DOI 10.1002/path.2483; Picardo NE, 2012, SURG-J R COLL SURG E, V10, P151, DOI 10.1016/j.surge.2012.01.004; Rayan GM, 2007, J BONE JOINT SURG AM, P89; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Shaw RB, 2007, PLAST RECONSTR SURG, V120, p44E, DOI 10.1097/01.prs.0000278455.63546.03; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Shnitkind Elaine, 2006, J Drugs Dermatol, V5, P605; Stromberg J, 2016, J HAND SURG-AM, V41, P873, DOI 10.1016/j.jhsa.2016.06.014; Taflinski L, 2014, EXP DERMATOL, V23, P240, DOI 10.1111/exd.12353; TOMASEK JJ, 1986, J HAND SURG-AM, V11A, P365, DOI 10.1016/S0363-5023(86)80143-5; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33719; Wilutzky B, 1998, HISTOL HISTOPATHOL, V13, P67, DOI 10.14670/HH-13.67	32	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209833	10.1371/journal.pone.0209833	http://dx.doi.org/10.1371/journal.pone.0209833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633751	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100006
J	Laffranchi, M; Elliston, ELK; Gangemi, F; Berardelli, R; Lomas, DA; Irving, JA; Fra, A				Laffranchi, Mattia; Elliston, Emma L. K.; Gangemi, Fabrizio; Berardelli, Romina; Lomas, David A.; Irving, James A.; Fra, Annamaria			Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population	PLOS ONE			English	Article							REACTIVE CENTER LOOP; SERPIN-PROTEINASE COMPLEX; Z ALPHA(1)-ANTITRYPSIN; CONFORMATIONAL-CHANGE; PROTEASE COMPLEX; HINGE REGION; ACTIVE-SITE; INHIBITOR; ANTITHROMBIN; INSERTION	Lung disease in alpha-1-antitrypsin deficiency (AATD) results from dysregulated proteolytic activity, mainly by neutrophil elastase (HNE), in the lung parenchyma. This is the result of a substantial reduction of circulating alpha-1-antitrypsin (AAT) and the presence in the plasma of inactive polymers of AAT. Moreover, some AAT mutants have reduced intrinsic activity toward HNE, as demonstrated for the common Z mutant, as well as for other rarer variants. Here we report the identification and characterisation of the novel AAT reactive centre loop variant Gly349Arg (p.G373R) present in the ExAC database. This AAT variant is secreted at normal levels in cellular models of AATD but shows a severe reduction in anti-HNE activity. Biochemical and molecular dynamics studies suggest it exhibits unfavourable RCL presentation to cognate proteases and compromised insertion of the RCL into beta-sheet A. Identification of a fully dysfunctional AAT mutant that does not show a secretory defect underlines the importance of accurate genotyping of patients with pulmonary AATD manifestations regardless of the presence of normal levels of AAT in the circulation. This subtype of disease is reminiscent of dysfunctional phenotypes in anti-thrombin and C1-inibitor deficiencies so, accordingly, we classify this variant as the first pure functionally-deficient (type II) AATD mutant.	[Laffranchi, Mattia; Gangemi, Fabrizio; Berardelli, Romina; Fra, Annamaria] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Elliston, Emma L. K.; Lomas, David A.; Irving, James A.] UCL, UCL Resp, London, England; [Elliston, Emma L. K.; Lomas, David A.; Irving, James A.] UCL, Inst Struct & Mol Biol, London, England	University of Brescia; University of London; University College London; University of London; Birkbeck University London; University College London	Fra, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.; Irving, JA (corresponding author), UCL, UCL Resp, London, England.; Irving, JA (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	j.irving@ucl.ac.uk; annamaria.fra@unibs.it	Laffranchi, Mattia/GZK-2643-2022; Laffranchi, Mattia/AAF-5731-2019; Irving, James A/I-8467-2015; Fra, Annamaria/I-5532-2012; Irving, James/P-3860-2019	Laffranchi, Mattia/0000-0002-0556-6068; Fra, Annamaria/0000-0002-4327-3004; Irving, James/0000-0003-3204-6356; Berardelli, Romina/0000-0001-5167-0504	Medical Research Council UK Programme grant [MR/N024842/1]; UCLH NIHR Biomedical Research Centre; Fondazione Cariplo [2013-0967]; Italian association Alfa1-AT; Wellcome Trust PhD studentship; MRC [MR/N024842/1] Funding Source: UKRI	Medical Research Council UK Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH NIHR Biomedical Research Centre; Fondazione Cariplo(Fondazione Cariplo); Italian association Alfa1-AT; Wellcome Trust PhD studentship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DAL acknowledges funding from a Medical Research Council UK (url: mrc.ukri.org/) Programme grant (MR/N024842/1) and the support of the UCLH NIHR Biomedical Research Centre. AF acknowledges funding from Fondazione Cariplo (2013-0967) (url: www.fondazionecariplo.it) and by the Italian association Alfa1-AT. ELKE is the recipient of a Wellcome Trust PhD studentship (url: wellcome.ac.uk). Computing resources of FG were provided by CINECA (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aguila S, 2017, J BIOL CHEM, V292, P16513, DOI 10.1074/jbc.M117.787325; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Andersen OJ, 2017, BIOCHEMISTRY-US, V56, P634, DOI 10.1021/acs.biochem.6b00839; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Caccia S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16667-w; Carugati A, 2001, MOL IMMUNOL, V38, P161, DOI 10.1016/S0161-5890(01)00040-2; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Cook L, 1996, PATHOLOGY, V28, P242, DOI 10.1080/00313029600169074; Corral J, 2018, THROMB RES, V169, P23, DOI 10.1016/j.thromres.2018.07.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Fra AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038405; Fra A, 2018, METHODS MOL BIOL, V1826, P109, DOI 10.1007/978-1-4939-8645-3_7; Fra A, 2016, EUR RESPIR J, V47, P1005, DOI 10.1183/13993003.00940-2015; Giacopuzzi E, 2018, HUM MUTAT, V39, P1203, DOI 10.1002/humu.23562; Haq I, 2016, AM J RESP CELL MOL, V54, P71, DOI 10.1165/rcmb.2015-0154OC; Haq I, 2013, BIOSCIENCE REP, V33, P499, DOI 10.1042/BSR20130038; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JORG M, 1985, THROMB RES, V39, P323, DOI 10.1016/0049-3848(85)90228-2; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; KOIDE T, 1984, P NATL ACAD SCI-BIOL, V81, P289, DOI 10.1073/pnas.81.2.289; Laffranchi M, 2018, HUM MOL GENET, V27, P1785, DOI 10.1093/hmg/ddy090; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lukacs CM, 1998, BIOCHEMISTRY-US, V37, P3297, DOI 10.1021/bi972359e; Maddur AA, 2013, J BIOL CHEM, V288, P32020, DOI 10.1074/jbc.M113.510990; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Medicina D, 2009, HUM MUTAT, V30, pE771, DOI 10.1002/humu.21043; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2017, FEBS J, V284, P2110, DOI 10.1111/febs.14111; Nyon MP, 2012, STRUCTURE, V20, P504, DOI 10.1016/j.str.2012.01.012; OKAYAMA H, 1991, AM J HUM GENET, V48, P1154; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; RAO NV, 1991, J BIOL CHEM, V266, P9540; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Tan L, 2014, EUR RESPIR J, V43, P1501, DOI 10.1183/09031936.00111213; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Tiberio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059410; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Yamasaki M, 2010, J BIOL CHEM, V285, P30752, DOI 10.1074/jbc.M110.156042; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0206955	10.1371/journal.pone.0206955	http://dx.doi.org/10.1371/journal.pone.0206955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633749	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100001
J	Tanaka, T; Nishimura, F; Kakiuchi, C; Kasai, K; Kimura, M; Haruno, M				Tanaka, Toshiko; Nishimura, Fumichika; Kakiuchi, Chihiro; Kasai, Kiyoto; Kimura, Minoru; Haruno, Masahiko			Interactive effects of OXTR and GAD1 on envy-associated behaviors and neural responses	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RECEPTOR GENE OXTR; ECONOMIC DECISION-MAKING; POLYMORPHISM OXTR; SOCIAL COGNITION; ULTIMATUM GAME; GABA LEVELS; OXYTOCIN; AMYGDALA; BRAIN	Inequity aversion (negative feelings induced by outcome differences between the self and other) plays a key role in human social behaviors. The neurotransmitters oxytocin and GABA have been implicated in neural responses to inequity. However, it remains poorly understood not only how individual genetic factors related to oxytocin and GABA affect the neural mechanisms behind inequity aversion, but also how these genes interact. To address these issues, we examined relationships between genotypes, behavioral decisions and brain activities during the ultimatum game. We identified interactive effects between the polymorphisms of the oxytocin receptor gene (OXTR) and glutamate decarboxylase 1 gene for GABA synthesis (GAD1) on envy aversion (i.e., disadvantageous inequity aversion) and on envy-induced activity in the dorsal ACC (dACC). Thus, our integrated approach suggested interactive genetic effects between OXTR and GAD1 on envy aversion and the underlying neural substrates.	[Tanaka, Toshiko; Haruno, Masahiko] NICT, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Nishimura, Fumichika; Kakiuchi, Chihiro; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Kimura, Minoru] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Nishimura, Fumichika] Univ Tokyo, Div Counseling & Support, Bunkyo Ku, Tokyo, Japan; [Kakiuchi, Chihiro] Univ Tokyo, Disabil Serv Off, Bunkyo Ku, Tokyo, Japan	National Institute of Information & Communications Technology (NICT) - Japan; University of Tokyo; University of Tokyo; University of Tokyo	Tanaka, T (corresponding author), NICT, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	toshiko_t@nict.go.jp	Kakiuchi, Chihiro/AAO-1103-2020	Kasai, Kiyoto/0000-0002-4443-4535	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Center of innovation at Osaka University [17H06314, 26242087]; JST AIP-PRISM [JPMJCR18ZR]	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Center of innovation at Osaka University; JST AIP-PRISM	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), the Center of innovation at Osaka University, Grant-in-Aid for Scientific Reserch (KAKENHI) (17H06314 and 26242087) and JST AIP-PRISM (JPMJCR18ZR). These funders had roles in data collection, analysis, and preparation of manuscripts.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Apps MAJ, 2016, NEURON, V90, P692, DOI 10.1016/j.neuron.2016.04.018; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccia ML, 2013, NEUROSCIENCE, V253, P155, DOI 10.1016/j.neuroscience.2013.08.048; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chang SW, 2015, P NATL ACAD SCI USA, V112, P15012, DOI [10.1073/pnas.1520704112, DOI 10.1073/PNAS.1520704112]; Colic L, 2018, J NEUROSCI, V38, P5067, DOI 10.1523/JNEUROSCI.1985-17.2018; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Eckstein M, 2017, NEUROIMAGE, V149, P458, DOI 10.1016/j.neuroimage.2017.01.078; Eden AS, 2015, J NEUROSCI, V35, P6020, DOI 10.1523/JNEUROSCI.3659-14.2015; Fatfouta R, 2018, SOC NEUROSCI-UK, V13, P61, DOI 10.1080/17470919.2016.1252795; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Feng CL, 2015, HUM BRAIN MAPP, V36, P591, DOI 10.1002/hbm.22649; Fliessbach K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00165; Gabay AS, 2014, NEUROSCI BIOBEHAV R, V47, P549, DOI 10.1016/j.neubiorev.2014.10.014; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haruno M, 2014, J COGNITIVE NEUROSCI, V26, P1861, DOI 10.1162/jocn_a_00589; Haruno M, 2010, NAT NEUROSCI, V13, P160, DOI 10.1038/nn.2468; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20236; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Karlsson Linner R, 2018, BIORXIV, DOI [10.1101/261081, DOI 10.1101/261081]; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klackl J, 2013, BIOL PSYCHOL, V92, P387, DOI 10.1016/j.biopsycho.2012.11.010; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kodaka F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041338; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Levar N, 2017, NEUROIMAGE, V158, P136, DOI 10.1016/j.neuroimage.2017.06.055; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lockwood PL, 2015, J NEUROSCI, V35, P13720, DOI 10.1523/JNEUROSCI.1703-15.2015; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Nihonsugi T, 2015, J NEUROSCI, V35, P3412, DOI 10.1523/JNEUROSCI.3885-14.2015; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; Ogawa T., 1998, TRH244 ATR; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Qi J, 2012, ADDICT BIOL, V17, P758, DOI 10.1111/j.1369-1600.2012.00439.x; Radke S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00193; Riem MME, 2013, EUR NEUROPSYCHOPHARM, V23, P1288, DOI 10.1016/j.euroneuro.2013.01.011; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Sabihi S, 2017, NEUROPHARMACOLOGY, V125, P1, DOI 10.1016/j.neuropharm.2017.06.024; Saito Y, 2014, SOC COGN AFFECT NEUR, V9, P1443, DOI 10.1093/scan/nst136; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sesarini CV, 2015, PSYCHIAT RES, V229, P580, DOI 10.1016/j.psychres.2015.07.077; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tsang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062322; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; Yu RJ, 2014, HUM BRAIN MAPP, V35, P3290, DOI 10.1002/hbm.22402; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	74	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210493	10.1371/journal.pone.0210493	http://dx.doi.org/10.1371/journal.pone.0210493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633779	gold, Green Published, Green Submitted			2022-12-27	WOS:000455485100025
J	Huang, WS; Chu, IM				Huang, Wei-Shun; Chu, I-Ming			Injectable polypeptide hydrogel/inorganic nanoparticle composites for bone tissue engineering	PLOS ONE			English	Article							STATIC MAGNETIC-FIELDS; MESENCHYMAL STEM-CELLS; IN-VITRO; HYDROXYAPATITE NANOPARTICLES; OSTEOGENIC DIFFERENTIATION; SECONDARY STRUCTURE; HYDROGELS; CALCIUM; SCAFFOLDS; ANTIBACTERIAL	The general concept of tissue engineering is to restore biological function by replacing defective tissues with implantable, biocompatible, and easily handleable cell-laden scaffolds. In this study, osteoinductive and osteoconductive super paramagnetic Fe3O4 nanoparticles (MNP) and hydroxyapatite (HAP) nanoparticles were incorporated into a di-block copolymer based thermo-responsive hydrogel, methoxy(polyethylene glycol)-polyalanine (mPA), at various concentrations to afford composite, injectable hydrogels. Incorporating nanoparticles into the thermo-responsive hydrogel increased the complex viscosity and decreased the gelation temperature of the starting hydrogel. Functionally, the integration of inorganic nanoparticles modulated bio-markers of bone differentiation and enhanced bone mineralization. Moreover, this study adopted the emerging method of using either a supplementary static magnetic field (SMF) or a moving magnetic field to elicit biological response. These results demonstrate that combining external (magnet) and internal (scaffold) magne-tisms is a promising approach for bone regeneration.	[Huang, Wei-Shun; Chu, I-Ming] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan	National Tsing Hua University	Chu, IM (corresponding author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan.	imchu@che.nthu.edu.tw	Chu, I-Ming/AAL-1148-2021	HUANG, WEI SHUN/0000-0001-6381-5184	Ministry of Science and Technology (Taiwan) [104-2221-E-007-126-MY3]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the grant 104-2221-E-007-126-MY3 from the Ministry of Science and Technology (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016; Chirinos JR, 2014, J ANAL ATOM SPECTROM, V29, P1292, DOI 10.1039/c4ja00066h; Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Chung HJ, 2009, NANO TODAY, V4, P429, DOI 10.1016/j.nantod.2009.08.008; Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047; Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335; Fu YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091581; Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z; Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t; Gao TJ, 1996, J BIOMED MATER RES, V32, P505, DOI 10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V; Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833; Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/anie.200200546; Haraguchi K, 2007, MACROMOLECULAR S, DOI [10.1002/masy.200750318, DOI 10.1002/MASY.200750318]; Haraguchi K, 2007, CURR OPIN SOLID ST M, V11, P47, DOI 10.1016/j.cossms.2008.05.001; Hou RX, 2013, COLLOID SURFACE B, V103, P318, DOI 10.1016/j.colsurfb.2012.10.067; Huang HM, 2006, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000203464.35561.be; Karadzic I, 2015, J BIOMED MATER RES A, V103, P350, DOI 10.1002/jbm.a.35180; Kim EC, 2015, BIOELECTROMAGNETICS, V36, P267, DOI 10.1002/bem.21903; Kim SJ, 2014, ACS APPL MATER INTER, V6, P17034, DOI 10.1021/am504652y; Kim U, 2007, P NATL ACAD SCI USA, V104, P20708, DOI 10.1073/pnas.0708760104; Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Lee H, 2007, J AM CHEM SOC, V129, P12739, DOI 10.1021/ja072210i; Lee JS, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043201; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Li DW, 2014, ACS APPL MATER INTER, V6, P9402, DOI 10.1021/am5017792; Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310; Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3; Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1; Luo F, 2012, ORTHOPEDICS, V35, pE526, DOI 10.3928/01477447-20120327-11; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; MCDONALD F, 1993, BIOELECTROMAGNETICS, V14, P187, DOI 10.1002/bem.2250140302; Meng J, 2013, SCI REPORTS, V3, DOI [10.1016/j.bone.2013.07.015, DOI 10.1016/J.BONE.2013.07.015]; Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045; Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; Panseri S, 2013, BONE, V56, P432, DOI 10.1016/j.bone.2013.07.015; Panseri S, 2012, J BIOMED MATER RES A, V100A, P2278, DOI 10.1002/jbm.a.34167; Park MH, 2014, ADV HEALTHC MATER, V3, P1782, DOI 10.1002/adhm.201400140; Peng S, 2017, MAT SCI ENG C-MATER, V76, P181, DOI 10.1016/j.msec.2017.02.130; Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Pozebon D, 2014, J ANAL ATOM SPECTROM, V29, P2204, DOI 10.1039/c4ja00250d; Rea SM, 2004, J MATER SCI-MATER M, V15, P997, DOI 10.1023/B:JMSM.0000042685.63383.86; Remya NS, 2014, COLLOID SURFACE B, V117, P389, DOI 10.1016/j.colsurfb.2014.02.004; Ren KX, 2016, BIOMACROMOLECULES, V17, P3862, DOI 10.1021/acs.biomac.6b00884; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Su DH, 2016, ACS APPL MATER INTER, V8, P9619, DOI 10.1021/acsami.6b00891; Sun C, 2008, SMALL, V4, P372, DOI 10.1002/smll.200700784; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tsutsumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086834; Uskokovic V, 2013, ACS APPL MATER INTER, V5, P2422, DOI 10.1021/am4000694; Wongwitwichot P, 2010, Open Biomed Eng J, V4, P279, DOI 10.2174/1874120701004010279; Wu ATH, 2015, BIOMACROMOLECULES, V16, P166, DOI 10.1021/bm501356c; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zhang XY, 2006, BIOELECTROMAGNETICS, V27, P1, DOI 10.1002/bem.20165; Zhang YX, 2016, POLYMER, V86, P32, DOI 10.1016/j.polymer.2016.01.030; Zhao RB, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2353-y; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	74	24	24	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210285	10.1371/journal.pone.0210285	http://dx.doi.org/10.1371/journal.pone.0210285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629660	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000069
J	Tessa, C; Toschi, N; Orsolini, S; Valenza, G; Lucetti, C; Barbieri, R; Diciotti, S				Tessa, Carlo; Toschi, Nicola; Orsolini, Stefano; Valenza, Gaetano; Lucetti, Claudio; Barbieri, Riccardo; Diciotti, Stefano			Central modulation of parasympathetic outflow is impaired in de novo Parkinson's disease patients	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SYMPATHETIC-NERVE ACTIVITY; BRAIN-STEM NUCLEI; AUTONOMIC DYSFUNCTION; ESSENTIAL TREMOR; FMRI; FLUCTUATIONS; METAANALYSIS; ASSOCIATION; PROGRESSION	Task- and stimulus-based neuroimaging studies have begun to unveil the central autonomic network which modulates autonomic nervous system activity. In the present study, we aimed to evaluate the central autonomic network without the bias constituted by the use of a task. Additionally, we assessed whether this circuitry presents signs of dysregulation in the early stages of Parkinson's disease (PD), a condition which may be associated with dysautonomia. We combined heart-rate-variability based methods for time-varying assessments of the autonomic nervous system outflow with resting-state fMRI in 14 healthy controls and 14 de novo PD patients, evaluating the correlations between fMRI time-series and the instantaneous high-frequency component of the heart-rate-variability power spectrum, a marker of parasympathetic outflow. In control subjects, the high-frequency component of the heart-rate-variability power spectrum was significantly anti-correlated with fMRI time-series in several cortical, subcortical and brainstem regions. This complex central network was not detectable in PD patients. In between-group analysis, we found that in healthy controls the brain activation related to the high-frequency component of the heart-rate-variability power spectrum was significantly less than in PD patients in the mid and anterior cingulum, sensorimotor cortex and supplementary motor area, insula and temporal lobe, prefrontal cortex, hippocampus and in a region encompassing posterior cingulum, precuneus and parieto-occipital cortex. Our results indicate that the complex central network which modulates parasympathetic outflow in the resting state is impaired in the early clinical stages of PD.	[Tessa, Carlo] Azienda USL Toscana Nord Ovest, Versilia Hosp, Dept Radiol & Nucl Med, Lido Di Camaiore, Lu, Italy; [Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, Rome, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Orsolini, Stefano; Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Cesena, Italy; [Valenza, Gaetano; Barbieri, Riccardo] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Valenza, Gaetano] Univ Pisa, Sch Engn, Res Ctr E Piaggio, Pisa, Italy; [Valenza, Gaetano] Univ Pisa, Sch Engn, Dept Informat Engn, Pisa, Italy; [Lucetti, Claudio] Azienda USL Toscana Nord Ovest, Versilia Hosp, Div Neurol, Lido Di Camaiore, Lu, Italy; [Barbieri, Riccardo] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy	Ospedale Versilia; University of Rome Tor Vergata; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Bologna; Harvard University; Massachusetts General Hospital; University of Pisa; University of Pisa; Ospedale Versilia; Polytechnic University of Milan	Tessa, C (corresponding author), Azienda USL Toscana Nord Ovest, Versilia Hosp, Dept Radiol & Nucl Med, Lido Di Camaiore, Lu, Italy.	ctessa@sirm.org	Diciotti, Stefano/C-4167-2008; Barbieri, Riccardo/AAC-5310-2022; Toschi, Nicola/J-2555-2012	Diciotti, Stefano/0000-0001-8778-7819; Barbieri, Riccardo/0000-0001-9381-3833; Toschi, Nicola/0000-0003-1929-5833; Valenza, Gaetano/0000-0001-6574-1879; Orsolini, Stefano/0000-0002-9024-314X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; ANAND BK, 1956, J NEUROPHYSIOL, V19, P393, DOI 10.1152/jn.1956.19.5.393; Andersson JLR., 2007, NONLINEAR REGISTRATI; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Barbieri R, 2014, COMP CARD C CINC; Barbieri R, 2013, COMP CARD C CINC; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beissner F, 2015, CLIN NEURORADIOL, V25, P251, DOI 10.1007/s00062-015-0404-0; Beissner F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00116; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bianciardi M, 2015, BRAIN CONNECT, V5, P597, DOI 10.1089/brain.2015.0347; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Bonuccelli U, 2003, ARCH NEUROL-CHICAGO, V60, P1400, DOI 10.1001/archneur.60.10.1400; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Brisinda D, 2014, J NEUROL SCI, V336, P197, DOI 10.1016/j.jns.2013.10.039; Brooks JCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00623; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camm AJ, 1996, CIRCULATION, V93, P1043; Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; Cechetto DF., 1990, CENTRAL REGULATION A, P208; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Citi L, 2012, IEEE T BIO-MED ENG, V59, P2828, DOI 10.1109/TBME.2012.2211356; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Coon EA, 2018, MOVEMENT DISORD, V33, P349, DOI 10.1002/mds.27186; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Danti S, 2015, EUR J NEUROL, V22, P1564, DOI 10.1111/ene.12785; De Pablo-Fernandez E, 2017, JAMA NEUROL, V74, P970, DOI 10.1001/jamaneurol.2017.1125; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; Ewing DJ, 1988, AUTONOMIC FAILURE, P667; Fahn S, RECENT DEV PARKINSOS; Friedrich C, 2010, MOVEMENT DISORD, V25, P315, DOI 10.1002/mds.22844; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; James C, 2013, NEUROIMAGE, V74, P188, DOI 10.1016/j.neuroimage.2013.02.030; James C, 2013, NEUROIMAGE, V70, P59, DOI 10.1016/j.neuroimage.2012.12.047; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kallio M, 2000, EUR J NEUROL, V7, P667, DOI 10.1046/j.1468-1331.2000.00127.x; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Lucetti C, 2006, PARKINSONISM RELAT D, V12, P279, DOI 10.1016/j.parkreldis.2005.12.005; Mascalchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089410; Menke RAL, 2014, HUM BRAIN MAPP, V35, P1681, DOI 10.1002/hbm.22282; Mumford JA, 2012, SOC COGN AFFECT NEUR, V7, P738, DOI 10.1093/scan/nss059; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; Palma JA, 2018, MOVEMENT DISORD, V33, P372, DOI 10.1002/mds.27344; PASTAKIA B, 1986, RADIOLOGY, V159, P499, DOI 10.1148/radiology.159.2.3961183; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Pazo JH, 2002, CELL MOL NEUROBIOL, V22, P645, DOI 10.1023/A:1021844605250; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Poldrack RA, 2011, HANDBOOK OF FUNCTION; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Salsone M, 2016, PARKINSONISM RELAT D, V33, P134, DOI 10.1016/j.parkreldis.2016.09.027; Sclocco R, 2016, CEREB CORTEX, V26, P485, DOI 10.1093/cercor/bhu172; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spyer KM, 1999, AUTONOMIC FAILURE TX, P45; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valenza G, 2018, J APPL PHYSIOL, V125, P19, DOI 10.1152/japplphysiol.00842.2017; Valenza G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052803; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yoon JH, 2016, J NEUROL SCI, V368, P55, DOI 10.1016/j.jns.2016.06.059	74	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210324	10.1371/journal.pone.0210324	http://dx.doi.org/10.1371/journal.pone.0210324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653564	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500034
J	Barboza, GE; Garcia, CC; Gonzalez, SL; Scaldaferro, M; Reyes, X				Barboza, Gloria E.; Carrizo Garcia, Carolina; Leiva Gonzalez, Segundo; Scaldaferro, Marisel; Reyes, Ximena			Four new species of Capsicum (Solanaceae) from the tropical Andes and an update on the phylogeny of the genus	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; DIVERSIFICATION; REGIONS	Four new species of Capsicum (Capsiceae, Solanaceae) from Andean tropical forests in South America are described. Capsicum benoistii Hunz. ex Barboza sp. nov. (incertae sedis) is endemic to a restricted area in south-central Ecuador and is most similar to the more widespread C. geminifolium (Dammer) Hunz. (Colombia, Ecuador, and Peru). Capsicum piuranum Barboza & S. Leiva sp. nov. (Andean clade) is found in northern Peru (Department Piura) and is morphologically most similar to C. caballeroi M. Nee of the Bolivian yungas (Departments Santa Cruz and Cochabamba) but closely related to C. geminifolium and C. lycianthoides Bitter. Capsicum longifolium Barboza & S. Leiva sp. nov. (Andean clade) occurs from northern Peru (Departments Amazonas, Cajamarca, and Piura) to southern Ecuador (Province Zamora-Chinchipe), and is morphologically most similar to C. dimorphum (Miers) Kuntze (Colombia, Ecuador, and Peru). Capsicum neei Barboza & X. Reyes sp. nov. (Bolivian clade) is endemic to southeastern Bolivia (Departments Chuquisaca and Santa Cruz) in the Boliviano-Tucumano Forest, is morphologically most similar to another Bolivian endemic species C. minutiflorum Rusby (Hunz.), and is closely related to C. caballeroi. Complete descriptions, illustrations, distributions and conservation assessments of all new species are given. Chromosome numbers for C. piuranum and C. longifolium are also provided. Three of the new species were included in a new phylogenetic analysis for Capsicum; their positions were strongly resolved within clades previously recognized in the genus.	[Barboza, Gloria E.; Carrizo Garcia, Carolina; Reyes, Ximena] Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina; [Barboza, Gloria E.] Univ Nacl Cordoba, Fac Ciencias Quim, Cordoba, Argentina; [Carrizo Garcia, Carolina] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Leiva Gonzalez, Segundo] Univ Privada Antenor Orrego, Museo Hist Nat, Trujillo, Peru; [Scaldaferro, Marisel] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina; [Reyes, Ximena] Ctr Invest Fitoecogenet Pairumani, Cochabamba, Bolivia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Vienna; Universidad Privada Antenor Orrego; National University of Cordoba	Barboza, GE (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina.; Barboza, GE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Cordoba, Argentina.	gbarboza@imbiv.unc.edu.ar	Gonzalez, Sophia/GWM-7305-2022	Barboza, Gloria Estela/0000-0003-1085-036X	National Science Foundation [DEB 1457366]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PID 11220170100147CO]; Joint Project CONICET-FWF, Argentina-Austria; Secretaria de Ciencia y Tecnologia, SECYT-UNC, Argentina [411/18]; Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, Argentina [PICT 2015-3022]; FWF Lise Meitner, Austria [M2282-B29]; Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Joint Project CONICET-FWF, Argentina-Austria; Secretaria de Ciencia y Tecnologia, SECYT-UNC, Argentina; Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, Argentina(FONCyT); FWF Lise Meitner, Austria; Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia	Financial assistance was provided by National Science Foundation, DEB 1457366 (GEB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PID 11220170100147CO (GEB); Joint Project CONICET-FWF, Argentina-Austria (GEB & CCG); Secretaria de Ciencia y Tecnologia, SECYT-UNC Res. 411/18, Argentina (GEB); Fondo para la Investigacion Cientifica y Tecnologica, FONCyT, PICT 2015-3022, Argentina (CCG); FWF Lise Meitner M2282-B29, Austria (CCG); Centro de Investigaciones Fitoecogeneticas de Pairumani, Cochabamba, Bolivia (XR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Barboza GE, 2013, SOLANACEAE FLORA ARG, V13, P21; Basu SK, 2003, MED AROM PLANTS, V33, P1; Garcia CC, 2016, ANN BOT-LONDON, V118, P35, DOI 10.1093/aob/mcw079; Castro L, 2011, PUEBLOS PLANTAS CHUQ, P345; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De AK., 2003, CAPSICUM GENUS CAPSI; GeoCAT, GEOSP CONS ASS TOOL; Hunziker A.T., 2001, GENERA SOLANACEAE; Hunziker Armando T., 1998, Kurtziana, V26, P23; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Libreros D, 2014, CATALOGO AJIES NATIV; Miller JS, 2009, SYST BOT, V34, P796, DOI 10.1600/036364409790139709; Moscone EA, 1996, PLANT SYST EVOL, V202, P37, DOI 10.1007/BF00985817; MOSCONE EA, 1993, PLANT SYST EVOL, V186, P213, DOI 10.1007/BF00940799; Navarro G., 2011, PUEBLOS PLANTAS CHUQ, P25; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Papoiu ADP, 2010, EXPERT OPIN PHARMACO, V11, P1359, DOI 10.1517/14656566.2010.481670; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pruthi JS, 2003, MED AROM PLANTS, V33, P25; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scaldaferro MA, 2011, BAG-J BASIC APPL GEN, V41, P31; Scaldaferro MA, 2018, BIOL J LINN SOC, V124, P466, DOI 10.1093/biolinnean/bly062; Scaldaferro MA, 2013, GENET RESOUR CROP EV, V60, P693, DOI 10.1007/s10722-012-9867-x; Schweizer D, METHODS MOL BIOL 29; Spalink D, 2018, MOL PHYLOGENET EVOL, V126, P293, DOI 10.1016/j.ympev.2018.04.030; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thampi PSS, 2003, MED AROM PLANTS, V33, P16; Thiers B., 2018, INDEX HERBARIORUM GL; Tong N., 1997, CAPSICUM EGGPLANT NE, V16, P42; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	36	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209792	10.1371/journal.pone.0209792	http://dx.doi.org/10.1371/journal.pone.0209792			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650102	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300028
J	Daniels, DR				Daniels, D. R.			Transport of solid bodies along tubular membrane tethers	PLOS ONE			English	Article							FLUCTUATING LIPID-BILAYER; FLUID MEMBRANES; NANOTUBES	We study the crucial role of membrane fluctuations in maintaining a narrow gap between a fluid membrane tube and an enclosed solid particle. Solvent flows can occur in this gap, hence giving rise to a finite particle mobility along the tube. While our study has relevance for how cells are able to transport large organelles or other cargo along connecting membrane tubes, known as tunneling nanotubes, our calculations are also framed so that they can be tested by a specific in vitro experiment: A tubular membrane tether can be pulled from a membrane reservoir, such as an aspirated Giant Unilamellar Vesicle (GUV), e.g. using a conjugated bead that binds to the membrane and is held in a laser trap. We compute the subsequent mobility of colloidal particles trapped in the tube, focusing on the case when the particle is large compared to the equilibrium tube radius. We predict that the particle mobility should scale as similar to sigma(-2/3), with sigma the membrane tension.	[Daniels, D. R.] Swansea Univ, Coll Engn, Bay Campus, Swansea, W Glam, Wales	Swansea University	Daniels, DR (corresponding author), Swansea Univ, Coll Engn, Bay Campus, Swansea, W Glam, Wales.	d.r.daniels@swansea.ac.uk						Alberts B., 2008, MOL BIOL CEL, V5th ed.; Batchelor G.K., 2000, INTRO FLUID DYNAMICS; CRICK FHC, 1950, EXP CELL RES, V1, P505, DOI 10.1016/0014-4827(50)90002-4; Cuvelier D, 2005, EUROPHYS LETT, V71, P1015, DOI 10.1209/epl/i2005-10173-4; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Daniels DR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238101; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Deserno M, 2015, CHEM PHYS LIPIDS, V185, P11, DOI 10.1016/j.chemphyslip.2014.05.001; Dommersnes PG, 2005, EUROPHYS LETT, V70, P271, DOI 10.1209/epl/i2004-10477-9; Ferrati S, 2012, SMALL, V8, P3151, DOI 10.1002/smll.201200472; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Happel J., 1983, LOW REYNOLDS NUMBER; HELFRICH W, 1978, Z NATURFORSCH A, V33, P305; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6; Lamb H, 1997, HYDRODYNAMICS; Landau L. D., 1976, MECHANICS, V1; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Marzo L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00072; Mecke KR, 2003, LANGMUIR, V19, P2080, DOI 10.1021/la026606d; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Nelson D, 1989, STAT MECH MEMBRANES; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; PODGORNIK R, 1992, LANGMUIR, V8, P557, DOI 10.1021/la00038a041; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Safran S. A., 1994, STAT THERMODYNAMICS; SEIFERT U, 1995, PHYS REV LETT, V74, P5060, DOI 10.1103/PhysRevLett.74.5060; Sigurdsson JK, 2013, J COMPUT PHYS, V252, P65, DOI 10.1016/j.jcp.2013.06.016; Sigurdsson JK, 2016, SOFT MATTER, V12, P6685, DOI 10.1039/c6sm00194g; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Zhong-can, 1989, Phys Rev A Gen Phys, V39, P5280, DOI 10.1103/PhysRevA.39.5280	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210259	10.1371/journal.pone.0210259	http://dx.doi.org/10.1371/journal.pone.0210259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650122	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300048
J	Gartner, T; Zoche-Golob, V; Redlberger, S; Reinhold, P; Donat, K				Gaertner, Tanja; Zoche-Golob, Veit; Redlberger, Stefanie; Reinhold, Petra; Donat, Karsten			Acid-base assessment of post-parturient German Holstein dairy cows from jugular venous blood and urine: A comparison of the strong ion approach and traditional blood gas analysis	PLOS ONE			English	Article							ANION GAP; SERUM-PROTEINS; EXCRETION; BALANCE; EQUILIBRIA; STEWART; UTILITY; PH	Evaluating acid-base status is important for monitoring dairy herd health. In a field study, we aimed to compare the acid-base status measured by net acid-base excretion (NABE) in urine with results of venous blood analysis in clinically healthy, but possibly metabolically burdened cows in their transition period. For this, we sampled blood from the jugular vein and urine from 145 German Holstein cows within 1 to 76 days post-partum. In blood, the metabolic parameters non-esterified fatty acids (NEFA) and beta-hydroxybutyrate (BHB), as well as numerous parameters of the acid-base status were measured. The traditional approach, based on bicarbonate concentration, base excess (BE) and anion gap (AG), was compared to the strong ion approach variables, e.g. acid total (A(tot)), measured strong ion difference (SIDm), strong ion gap (SIG), and unmeasured anions (XA), respectively. Results of both approaches were set against the outcome of urine analysis, i.e. the NABE, base-acid ratio and pH of urine, in a cluster analysis, which provided 7 moderately stable clusters. Evaluating and interpreting these 7 clusters offered novel insights into the pathophysiology of the acid-base equilibrium in fresh post-partum dairy cows. Especially in case of subclinical acid-base disorders, the parameters of the strong ion difference theory, particularly SIDm, Atot and SIG or XA, provided more in-depth information about acid-base status than the traditional parameters BE, bicarbonate or AG in blood. The acid-base status of fresh cows with protein aberrations in blood could be differentiated in a much better way using the strong ion approach than by traditional blood gas analysis or by the measurement of urinary excretion. Therefore, the strong ion approach seems to be a suitable supplement for monitoring acid-base balance in dairy cattle.	[Gaertner, Tanja; Zoche-Golob, Veit; Donat, Karsten] Thuringian Anim Hlth Fund, Cattle Hlth Serv, Jena, Thuringia, Germany; [Redlberger, Stefanie; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Thuringia, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Donat, K (corresponding author), Thuringian Anim Hlth Fund, Cattle Hlth Serv, Jena, Thuringia, Germany.	kdonat@thueringertierseuchenkasse.de	Zoche-Golob, Veit/AAD-9074-2019	Zoche-Golob, Veit/0000-0002-0164-6255; Gartner, Tanja/0000-0003-2522-8514	European Agricultural Fund for Rural Development (EAFRD) [2015 LFE 003]; EU	European Agricultural Fund for Rural Development (EAFRD); EU(European Commission)	The work was financially supported by the European Agricultural Fund for Rural Development (EAFRD), processed by "Thuringer Aufbaubank" (Grant Number 2015 LFE 003) https://www.aufbaubank.de/Foerderprogramme/LFE-Foerderung-der-Zusammenarbeit-Land-Forstund-Ernaehrung. The EAFRD is an EU funding instrument for rural development mainly provided from the EU budget (https://ec.europa.eu/agriculture/rural-development-2014-2020_en) with a contribution from the budget of the Thuringian Government (https://www.thueringen.de/th9/tmil/lawi/eler/eler20142020/index.aspx).The "Thuringer Aufbaubank" (institution by law) is the business development bank of the Thuringian government that handles the business development instrument which are in force in the federal state of Thuringia (e.g. subsidies, low-coupon credits, guarantees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN WH, 1963, J APPL PHYSIOL, V18, P301, DOI 10.1152/jappl.1963.18.2.301; Bleul U, 2007, VET REC, V161, P688, DOI 10.1136/vr.161.20.688; Christiansen T, 1981, PROC IFCC WORKSHOP; Constable PD, 1999, VET CLIN N AM-FOOD A, V15, P447, DOI 10.1016/S0749-0720(15)30158-4; Constable PD, 1997, J APPL PHYSIOL, V83, P297, DOI 10.1152/jappl.1997.83.1.297; Constable PD, 2002, AM J VET RES, V63, P482, DOI 10.2460/ajvr.2002.63.482; Constable PD, 1997, J VET INTERN MED, V11, P71, DOI 10.1111/j.1939-1676.1997.tb00076.x; Constable PD, 2014, VET CLIN N AM-FOOD A, V30, P295, DOI 10.1016/j.cvfa.2014.03.001; Constable PD, 2009, AM J VET RES, V70, P915, DOI 10.2460/ajvr.70.7.915; Constable Peter D., 2000, Veterinary Clinical Pathology, V29, P115, DOI 10.1111/j.1939-165X.2000.tb00241.x; Darrow DC, 1929, AM J DIS CHILD, V37, P51, DOI 10.1001/archpedi.1929.01930010058003; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Elisaf MS, 1996, DIABETES RES CLIN PR, V34, P23, DOI 10.1016/S0168-8227(96)01332-0; EMMETT M, 1977, MEDICINE, V56, P38, DOI 10.1097/00005792-197756010-00002; FENCL V, 1993, RESP PHYSIOL, V91, P1, DOI 10.1016/0034-5687(93)90085-O; FIGGE J, 1991, J LAB CLIN MED, V117, P453; FIGGE J, 1992, J LAB CLIN MED, V120, P713; Furll M, 2016, TIERAERZTL PRAX G N, V44, P107, DOI 10.15653/TPG-151045; Furll M., 2013, KRAFT DURR KLINISCHE; GRABER ML, 1983, ANN INTERN MED, V98, P607, DOI 10.7326/0003-4819-98-5-607; Hasselbalch K. A., 1917, BIOCHEM Z, V78, P112; HAUSSINGER D, 1990, KLIN WOCHENSCHR, V68, P175, DOI 10.1007/BF01649081; Henderson LJ, 1908, AM J PHYSIOL, V21, P427, DOI 10.1152/ajplegacy.1908.21.4.427; Hennig C, 2014, STUD CLASS DATA ANAL, P41, DOI 10.1007/978-3-319-01595-8_5; JORGENSEN K, 1957, SCAND J CLIN LAB INV, V9, P287, DOI 10.3109/00365515709079972; Kessler EC, 2014, J DAIRY SCI, V97, P5481, DOI 10.3168/jds.2014-7926; Kimura S, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118801255; Kurtz I, 2008, AM J PHYSIOL-RENAL, V294, pF1009, DOI 10.1152/ajprenal.00475.2007; KUTAS F, 1965, ACTA VET ACAD SCI H, V15, P147; LACHMANN G, 1979, MONATSH VETERINARMED, V34, P44; Lachmann G, 1985, MATH NATURWISS R, V34, P466, DOI [10.1016/j.tvjl.2017.10.017, DOI 10.1016/J.TVJL.2017.10.017]; LARSON BL, 1957, J DAIRY SCI, V40, P659, DOI 10.3168/jds.S0022-0302(57)94535-6; Meachler M, 2016, CLUSTER CLUSTER ANAL; Obitz K, 2014, TIERAERZTL PRAX G N, V42, P209; OH MS, 1977, NEW ENGL J MED, V297, P814, DOI 10.1056/NEJM197710132971507; OSTERMANN C, 2014, MULTIDISCIP RESP MED, V9; Pier AC, 1992, VET DERMATOL, V3, P131; PUTNAM RW, 1991, AM J PHYSIOL, V260, pC1113, DOI 10.1152/ajpcell.1991.260.5.C1113; Redlberger S, 2017, VET J, V229, P45, DOI 10.1016/j.tvjl.2017.10.017; RIOND JL, 1995, VET RES COMMUN, V19, P195, DOI 10.1007/BF01839298; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Siggaard-Andersen O., 1974, THE ACID BASE STATUS; SIGGAARDANDERSEN O, 1977, SCAND J CLIN LAB INV, V37, P15, DOI 10.3109/00365517709098927; SIGGAARDANDERSEN O, 1988, SCAND J CLIN LAB INV, V48, P7; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Team RC, 2016, R A LANGUAGE AND ENV; Trefz FM, 2015, J VET INTERN MED, V29, P678, DOI 10.1111/jvim.12556; Zhu LH, 2000, J DAIRY SCI, V83, P734, DOI 10.3168/jds.S0022-0302(00)74935-6	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210948	10.1371/journal.pone.0210948	http://dx.doi.org/10.1371/journal.pone.0210948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650142	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300087
J	Chung, JE; Magis, W; Vu, J; Heo, SJ; Wartiovaara, K; Walters, MC; Kurita, R; Nakamura, Y; Boffelli, D; Martin, DIK; Corn, JE; Dewitt, MA				Chung, Jennifer E.; Magis, Wendy; Vu, Jonathan; Heo, Seok-Jin; Wartiovaara, Kirmo; Walters, Mark C.; Kurita, Ryo; Nakamura, Yukio; Boffelli, Dario; Martin, David I. K.; Corn, Jacob E.; Dewitt, Mark A.			CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells	PLOS ONE			English	Article							HEMOGLOBIN; DISEASE; GENE; LIFE	Sickle Cell Disease and beta-thalassemia, which are caused by defective or deficient adult beta-globin (HBB) respectively, are the most common serious genetic blood diseases in the world. Persistent expression of the fetal beta-like globin, also known gamma-globin, can ameliorate both disorders by serving in place of the adult beta-globin as a part of the fetal hemoglobin tetramer (HbF). Here we use CRISPR-Cas9 gene editing to explore a potential gamma-globin silencer region upstream of the delta-globin gene identified by comparison of naturally-occurring deletion mutations associated with up-regulated gamma-globin. We find that deletion of a 1.7 kb consensus element or select 350 bp sub-regions from bulk populations of cells increases levels of HbF. Screening of individual sgRNAs in one sub-region revealed three single guides that caused increases gamma-globin expression. Deletion of the 1.7 kb region in HUDEP-2 clonal sublines, and in colonies derived from CD34+ hematopoietic stem/progenitor cells (HSPCs), does not cause significant up-regulation of gamma-globin. These data suggest that the 1.7 kb region is not an autonomous gamma-globin silencer, and thus by itself is not a suitable therapeutic target for gene editing treatment of beta-hemoglobinopathies.	[Chung, Jennifer E.; Vu, Jonathan; Corn, Jacob E.; Dewitt, Mark A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Magis, Wendy; Heo, Seok-Jin; Wartiovaara, Kirmo; Walters, Mark C.; Boffelli, Dario; Martin, David I. K.] UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Wartiovaara, Kirmo] Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Fac Med, Helsinki, Finland; [Wartiovaara, Kirmo] Univ Helsinki, Clin Genet, HUSLAB, Cent Hosp, Helsinki, Finland; [Walters, Mark C.] UCSF Benioff Childrens Hosp, Div Hematol, Blood & Marrow Transplant Program, Oakland, CA USA; [Kurita, Ryo; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; RIKEN; University of Tsukuba; University of California System; University of California Berkeley	Corn, JE; Dewitt, MA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Martin, DIK (corresponding author), UCSF Benioff Childrens Hosp, Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dimartin@chori.org; jcorn@berkeley.edu; dewittm@berkeley.edu	Nakamura, Yukio/A-5263-2016	Nakamura, Yukio/0000-0001-8056-4946; Vu, Jonathan/0000-0002-4950-7967; Chung, Jennifer/0000-0003-1332-6301	NIH [S10 OD018174]; Li Ka Shing Foundation; Heritage Medical Research Institute; California Institute of Regenerative Medicine; Siebel foundation; Lam foundation; Jordan Family Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Li Ka Shing Foundation; Heritage Medical Research Institute; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Siebel foundation; Lam foundation; Jordan Family Foundation	This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Synthetic RNAs for studies presented in Figure 3D were obtained from Synthego, Inc. through their 2017 Synthego Grant Program (MAD). This work was supported by the Li Ka Shing Foundation (JEC), the Heritage Medical Research Institute (JEC), the California Institute of Regenerative Medicine (MAD, JEC), the Siebel foundation (MAD), the Lam foundation (J. Chung), and the Jordan Family Foundation (DKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant. Synthetic RNAs for studies presented in Fig 3D were provided by Synthego, Inc. This work was supported by the Li Ka Shing Foundation (J.E.C.), the Heritage Medical Research Institute (J.E.C.), the California Institute of Regenerative Medicine (M.A.D., J.E.C.), the Siebel foundation (M.A.D.), the Lam foundation (J. Chung), and the Jordan Family Foundation (D.I.K.M.).	Antoniani C, 2018, BLOOD, DOI [10.1182/blood-2017-10-811505, 10.1182/blood-2003-11-4069, DOI 10.1182/BLOOD-2017-10-811505]; Appelbaum FR, 2009, THOMAS HEMATOPOIETIC, DOI [10.1002/9781444303537, DOI 10.1002/9781444303537]; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Charlesworth CT, 2018, BIORXIV, DOI [10.1101/243345, DOI 10.1101/243345]; Davis Bruce H, 2004, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0617s28; DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lingeman Emily, 2017, Curr Protoc Mol Biol, V120, DOI 10.1002/cpmb.43; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Long J, 2018, MOL THER, V26, P468, DOI 10.1016/j.ymthe.2017.11.001; McGann PT, 2017, BLOOD, V129, P155, DOI 10.1182/blood-2016-09-702324; Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Wienert B, 2017, BLOOD, V130, P803, DOI 10.1182/blood-2017-02-767400; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113	37	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0208237	10.1371/journal.pone.0208237	http://dx.doi.org/10.1371/journal.pone.0208237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645582	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200005
J	Fickler, A; Staats, S; Rimbach, G; Schulz, C				Fickler, Anna; Staats, Stefanie; Rimbach, Gerald; Schulz, Carsten			Screening dietary biochanin A, daidzein, equol and genistein for their potential to increase DHA biosynthesis in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; COA DESATURASE 1; FISH-OIL; OVARIECTOMIZED RATS; GENE-EXPRESSION; VEGETABLE-OILS; SOY; PHYTOESTROGENS; GROWTH; LIVER	Plant oil utilization in aquafeeds is still the most practical option, although it decreases the content of the nutritionally highly valuable omega-3 fatty acids eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) in fish. Phytoestrogens and their metabolites are putatively able to affect genes encoding proteins centrally involved in the biosynthesis of EPA and DHA due to their estrogenic potential. Thus, the aim of the study was to screen the potential of the phytoestrogens to stimulate the biosynthesis of EPA and DHA in rainbow trout (Oncorhynchus mykiss). Additionally, the potential effects on growth performance, nutrient composition and hepatic lipid metabolism in rainbow trout were investigated. For that, a vegetable oil based diet served as a control diet (C) and was supplemented with 15 g/kg dry matter of biochanin A (BA), daidzein (DA), genistein (G) and equol (EQ), respectively. These five diets were fed to rainbow trout (initial body weight 83.3 +/- 0.4 g) for 52 days. Growth performance and nutrient composition of whole body homogenates were not affected by the dietary treatments. Furthermore, feeding EQ to rainbow trout significantly increased DHA levels by +8% in whole body homogenates compared to samples of fish fed the diet C. A tendency towards increased DHA levels in whole body homogenates was found for fish fed the diet G. Fish fed diets BA and DA lacked these effects. Moreover, EQ and G fed fish showed significantly decreased hepatic mRNA steady state levels for fatty acyl desaturase 2a (delta-6) (fads2a(d6)). In contrast, carnitine palmitoyl transferases 1 (cpt1) hepatic mRNA steady state levels and hepatic Fads2a(d6) protein contents were not affected by the dietary treatment. In conclusion, when combined with dietary vegetable oils, equol and genistein seem to stimulate the biosynthesis of DHA and thereby increase tissue DHA levels in rainbow trout, however, only to a moderate extent.	[Fickler, Anna; Schulz, Carsten] GMA Gesell Marine Aquakultur mbH, Busum, Germany; [Fickler, Anna; Schulz, Carsten] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Staats, Stefanie; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany	University of Kiel; University of Kiel	Fickler, A (corresponding author), GMA Gesell Marine Aquakultur mbH, Busum, Germany.; Fickler, A (corresponding author), Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany.	fickler@gma-buesum.de	Schulz, Carsten/C-2127-2017; Rimbach, Gerald/A-7178-2011	Rimbach, Gerald/0000-0001-7888-4684	Federal Office for Agriculture and Food [BLE 2815NA044]; Land Schleswig-Holstein	Federal Office for Agriculture and Food; Land Schleswig-Holstein	The funder (Federal Office for Agriculture and Food - BLE 2815NA044) provided support in the form of salaries for Anna Fickler, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. Further, the Gesellschaft fur Marine Aquakultur mbH (GMA) is a non-profit company working in aquaculture research which is shared by public institutions. GMA provided research infrastructure, but were not included in conceptualisation of experimental design, data collection and analysis and MS preparation. We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds for the publication fee.; We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds. We would like to thank Dr. Mario Hasler and Jonas Schaler for their statistical advice and Dr. Hubert Wehage at the LUFA-ITL in Kiel, Germany, for the fatty acid analysis. Further, the authors would like to thank Bahne Christiansen, Julian Wessel, Sandra Nevermann and Petra Rettmann for their assistance during the experimental period and in the lab. In addition, we are grateful for the guidance given by Markus Griese, Michael Schlachter and all GMA colleagues for their help during sampling.	[Anonymous], 2015, AQUACULTURE, V448, P365, DOI DOI 10.1016/J.AQUACULTURE.2015.06.023; Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5; Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1; Bretz F., 2010, MULTIPLE COMP USING, DOI [10.1201/9781420010909-f, DOI 10.1201/9781420010909-F]; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Chacko BK, 2007, J NUTR, V137, P351, DOI 10.1093/jn/137.2.351; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; Cleveland BM, 2015, COMP BIOCHEM PHYS C, V170, P28, DOI 10.1016/j.cbpc.2015.02.001; Crespillo A, 2011, BRIT J PHARMACOL, V164, P1899, DOI 10.1111/j.1476-5381.2011.01477.x; Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Fickler A, 2018, LIPIDS, V53, P809, DOI 10.1002/lipd.12092; Food and Agriculture Organization, 2015, STAT WORLD FISH AQ 2; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Gontier-Latonnelle K, 2007, GEN COMP ENDOCR, V150, P298, DOI 10.1016/j.ygcen.2006.10.001; Gonzalez-Bengtsson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164241; Hernandez-Montes E, 2006, BIOCHEM BIOPH RES CO, V346, P851, DOI 10.1016/j.bbrc.2006.05.197; Ishak SD, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-56; Jobling M, 2011, AQUACULT INT, V20, P601, DOI [10.1007/s10499-011-9480-6, DOI 10.1007/S10499-011-9480-6, DOI 10.17226/13039]; Jourdehi AY, 2014, FISH PHYSIOL BIOCHEM, V40, P117, DOI 10.1007/s10695-013-9829-z; Karalazos V, 2007, AQUACULT NUTR, V13, P256, DOI 10.1111/j.1365-2095.2007.00471.x; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Kitson AP, 2013, PROSTAG LEUKOTR ESS, V89, P81, DOI 10.1016/j.plefa.2013.05.003; Kitson AP, 2010, LIPIDS, V45, P209, DOI 10.1007/s11745-010-3391-6; Klejdus B, 2001, ANAL CHIM ACTA, V450, P81, DOI 10.1016/S0003-2670(01)01370-8; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Latonnelle K, 2002, GEN COMP ENDOCR, V126, P39, DOI 10.1006/gcen.2001.7773; Marks KA, 2013, PROSTAG LEUKOTR ESS, V89, P89, DOI 10.1016/j.plefa.2013.05.002; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mezei O, 2003, J NUTR, V133, P1238; Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; RuizLarrea MB, 1997, FREE RADICAL RES, V26, P63, DOI 10.3109/10715769709097785; Sargent John R., 2002, P181; Schiller V.A., 2012, LIPIDS, V47, P897, DOI DOI 10.1007/S11745-012-3697-7; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Setchell KDR, 2009, AM J CLIN NUTR, V90, P1029, DOI 10.3945/ajcn.2009.27981; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Torno C, 2019, ANIMAL, V13, P933, DOI 10.1017/S1751731118002458; Torno C, 2017, MAR DRUGS, V15, DOI 10.3390/md15080252; Trattner S, 2008, LIPIDS, V43, P999, DOI 10.1007/s11745-008-3229-7; Turchini G. M., 2010, FISH OIL REPLACEMENT; Turchini GM, 2011, FOOD CHEM, V124, P609, DOI 10.1016/j.foodchem.2010.06.083; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Verbeke G., 2000, LINEAR MIXED MODELS, DOI [10.1007/978-1-4419-0300-6, DOI 10.1007/978-1-4419-0300-6]; Vestergren ALS, 2011, NEUROENDOCRINOL LETT, V32, P41; VOSS A, 1991, J BIOL CHEM, V266, P19995; Wiseman H, 2000, AM J CLIN NUTR, V72, P395; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	60	6	6	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210197	10.1371/journal.pone.0210197	http://dx.doi.org/10.1371/journal.pone.0210197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645603	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200020
J	Wormsbecker, AE; Johnson, C; Bourns, L; Harris, T; Crowcroft, NS; Deeks, SL				Wormsbecker, Anne E.; Johnson, Caitlin; Bourns, Laura; Harris, Tara; Crowcroft, Natasha S.; Deeks, Shelley L.			Demonstration of background rates of three conditions of interest for vaccine safety surveillance	PLOS ONE			English	Article							IMMUNE THROMBOCYTOPENIC PURPURA; KAWASAKI-DISEASE; MULTIPLE-SCLEROSIS; UNITED-STATES; IMMUNIZATION; EPIDEMIOLOGY; HOSPITALIZATIONS; CHILDREN; ONTARIO	Introduction Adverse events following immunization (AEFIs) are unwanted or unexpected health outcomes following vaccination, which may or may not be causally-linked to vaccines. AEFI reporting is important to post-marketing vaccine safety surveillance and has the potential to identify new or rare AEFIs, show increases in known AEFIs, and help to maintain public confidence in vaccine programs. Knowledge of the expected incidence (i.e. background rate) of a possible AEFI is essential to the investigation of vaccine safety signals. We selected three rarely reported AEFIs representing the spectrum of causal association with vaccines, from proven (immune thrombocytopenia [ITP]) to questioned (Kawasaki disease [KD]) to unsubstantiated (multiple sclerosis [MS]) and determined their background rates. Methods We extracted data on hospitalizations (CIHI Discharge Abstract Database) for ITP, KD, and MS among Ontario children for the period 2005 to 2014 from IntelliHEALTH. As ITP can be managed without hospitalization, we also extracted emergency department (ED) visits from the CIHI National Ambulatory Care Reporting System. For all conditions, we only counted the first visit and if the same child had both an ED visit and a hospitalization for ITP, only the hospitalization was included. We calculated rates by year, age group and sex using population estimates from 2005-2014, focusing on age groups within the Ontario immunization schedule around vaccine(s) of interest. Results Per 100,000 population, annual age-specific incidence of ITP in children age 1 to 7 years ranged from 8.9 to 12.2 and annual incidence of KD in children less than 5 years ranged from 19.1 to 32.1. Average annualized incidence of adolescent (11-17 years) MS across the study period was 0.8 per 100,000. Discussion Despite limitations, including lack of clinical validation, this study provides an example of how health administrative data can be used to determine background rates which may assist with interpretation of passive vaccine safety surveillance.	[Wormsbecker, Anne E.] St Josephs Hlth Ctr, Toronto, ON, Canada; [Wormsbecker, Anne E.] St Michaels Hosp, Toronto, ON, Canada; [Wormsbecker, Anne E.] Univ Toronto, Dept Pediat, Fac Med, Toronto, ON, Canada; [Johnson, Caitlin; Harris, Tara; Crowcroft, Natasha S.; Deeks, Shelley L.] Publ Hlth Ontario, Toronto, ON, Canada; [Bourns, Laura] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Crowcroft, Natasha S.; Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Ottawa; University of Toronto; University of Toronto	Wormsbecker, AE (corresponding author), St Josephs Hlth Ctr, Toronto, ON, Canada.; Wormsbecker, AE (corresponding author), St Michaels Hosp, Toronto, ON, Canada.; Wormsbecker, AE (corresponding author), Univ Toronto, Dept Pediat, Fac Med, Toronto, ON, Canada.	WormsbeckerA@smh.ca						Abrams JY, 2015, VACCINE, V33, P382, DOI 10.1016/j.vaccine.2014.10.044; [Anonymous], 2017, SCIENCE; Black C, 2003, BRIT J CLIN PHARMACO, V55, P107, DOI 10.1046/j.1365-2125.2003.01790.x; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; Esposito S, 2016, EXPERT REV VACCINES, V15, P417, DOI 10.1586/14760584.2016.1128329; France EK, 2008, PEDIATRICS, V121, pE687, DOI 10.1542/peds.2007-1578; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Hua W, 2009, PEDIATR INFECT DIS J, V28, P943, DOI 10.1097/INF.0b013e3181a66471; Lin YHT, 2010, PEDIATR INT, V52, P699, DOI 10.1111/j.1442-200X.2010.03092.x; Mailand MT, 2017, J NEUROL, V264, P1035, DOI 10.1007/s00415-016-8263-4; Makino N, 2015, J EPIDEMIOL, V25, P239, DOI 10.2188/jea.JE20140089; Manlhiot C, 2015, INT KAW DIS S FIN PR; Mantadakis E, 2010, J PEDIATR-US, V156, P623, DOI 10.1016/j.jpeds.2009.10.015; McCrindle B, 2015, INT KAW DIS S FIN PR; Meggiolaro A, 2018, HUM VACC IMMUNOTHER, V15, P1; Ministry of Health and Long-Term Care, 2016, PUBL FUND IMM SCHED; Monteyne P, 2000, VACCINE, V18, P1994, DOI 10.1016/S0264-410X(99)00533-2; Multiple Sclerosis International Federation, 2013, ATL MULTPL SCLER; Off C, 2015, CBC RADIO IT HA 0211; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2017, ANN REP VACC SAF ONT; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, ANN REP VACC SAF ONT; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, ANN REP VACC SAF ONT; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2018, IMM COV REP SCH PUP; Ontario Ministry of Health and Long Term Care, 2015, INF DIS PROT 2014 AP; Phuong LK, 2017, VACCINE, V35, P1770, DOI 10.1016/j.vaccine.2016.09.033; Rajantie J, 2007, VACCINE, V25, P1838, DOI 10.1016/j.vaccine.2006.10.054; Sauve LJ, 2010, PEDIATR INFECT DIS J, V29, P559, DOI 10.1097/INF.0b013e3181d2bb45; Scuccimarri R, 2015, KAWASAKI DIS NOVEMBE; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Statistics Canada, 2018, POP EST POP PROJ; Stratton K. R., 1994, ADVERSE EVENTS ASS C, DOI [10.17226/2138, DOI 10.17226/2138]; Terrell DR, 2010, AM J HEMATOL, V85, P174, DOI 10.1002/ajh.21616; The World Health Organization, 2002, GLOB VACC SAF GLOB A; Wang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071818; WHO, GLOB VACC SAF; Widdifield J, 2015, MULT SCLER J, V21, P1045, DOI 10.1177/1352458514556303; Wise RP, 2007, VACCINE, V25, P5717, DOI 10.1016/j.vaccine.2007.02.067; Yong M, 2010, BRIT J HAEMATOL, V149, P855, DOI 10.1111/j.1365-2141.2010.08176.x; Zeller B, 2005, ACTA PAEDIATR, V94, P178, DOI 10.1080/08035250410025294	41	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210833	10.1371/journal.pone.0210833	http://dx.doi.org/10.1371/journal.pone.0210833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645649	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200059
J	Kumar, L; Cox, CR; Sarkar, SK				Kumar, Lokender; Cox, Christopher R.; Sarkar, Susanta K.			Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BIOFILM; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; PROTEOLYTIC-ENZYMES; MEMBRANE-PROTEINS; SURFACE PROTEIN; CONGO RED; GROWTH; INFECTIONS; MECHANISMS	Enterococcus faecalis is a major opportunistic pathogen that readily forms protective biofilms leading to chronic infections. Biofilms protect bacteria from detergent solutions, antimicrobial agents, environmental stress, and effectively make bacteria 10 to 1000-fold more resistant to antibiotic treatment. Extracellular proteins and polysaccharides are primary components of biofilms and play a key role in cell survival, microbial persistence, cellular interaction, and maturation of E. faecalis biofilms. Degradation of biofilm components by mammalian proteases is an effective antibiofilm strategy because proteases are known to degrade bacterial proteins leading to bacterial cell lysis and growth inhibition. Here, we show that human matrix metalloprotease-1 inhibits and disrupts E. faecalis biofilms. MMPs are cell-secreted zinc- and calcium-dependent proteases that degrade and regulate various structural components of the extracellular matrix. Human MMP1 is known to degrade type-1 collagen and can also cleave a wide range of substrates. We found that recombinant human MMP1 significantly inhibited and disrupted biofilms of vancomycin sensitive and vancomycin resistant E. faecalis strains. The mechanism of antibiofilm activity is speculated to be linked with bacterial growth inhibition and degradation of biofilm matrix proteins by MMP1. These findings suggest that human MMP1 can potentially be used as a potent antibiofilm agent against E. faecalis biofilms.	[Kumar, Lokender; Sarkar, Susanta K.] Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA; [Cox, Christopher R.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Colorado School of Mines; Colorado School of Mines	Sarkar, SK (corresponding author), Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA.	ssarkar@mines.edu	Kumar, Lokender/AAY-6862-2020	Kumar, Lokender/0000-0002-0692-0137	Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines	Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines	We acknowledge Reuben Collins for help with SEM imaging and comments on the manuscript.The authors acknowledge a seed funding from the Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines for the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge a seed funding from the Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Baidamshina DR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46068; Baldassarri L, 2005, INT J ARTIF ORGANS, V28, P1101, DOI 10.1177/039139880502801107; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Baylan O, 2011, MIKROBIYOL BUL, V45, P430; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; BLAKE MS, 1981, INFECT IMMUN, V33, P212, DOI 10.1128/IAI.33.1.212-222.1981; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Brinckerhoff CE., 2017, MATRIX METALLOPROTEI, P65; Bulacio María de los Á, 2015, Acta odontol. latinoam., V28, P210; Cathro P, 2016, FEBS OPEN BIO, V6, P586, DOI 10.1002/2211-5463.12075; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Chen C, 2013, J BIOL CHEM, V288, P29440, DOI 10.1074/jbc.M113.502039; Chuang-Smith ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015798; Control CfD Prevention, 2013, ANT RES THREATS US 2; Cui HY, 2016, FOOD FUNCT, V7, P4030, DOI 10.1039/c6fo01201a; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; Dittmore A, 2016, P NATL ACAD SCI USA, V113, P8436, DOI 10.1073/pnas.1523228113; Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Dunavant TR, 2006, J ENDODONT, V32, P527, DOI 10.1016/j.joen.2005.09.001; Dunny G.M., 2014, ENTEROCOCCAL BIOFILM; Elchinger PH, 2014, LETT APPL MICROBIOL, V59, P507, DOI 10.1111/lam.12305; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; GIERTSEN E, 1989, SCAND J DENT RES, V97, P233; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Gouran H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31098; GRENIER D, 1994, ORAL MICROBIOL IMMUN, V9, P224, DOI 10.1111/j.1399-302X.1994.tb00062.x; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hoffman SB, 2001, COMP CONT EDUC PRACT, V23, P464, DOI 10.1128/microbiolspec.VMBF-0016-2015; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Ike Yasuyoshi, 2017, Nihon Saikingaku Zasshi, V72, P189, DOI 10.3412/jsb.72.189; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; KOMATSUZAWA H, 1994, J ANTIMICROB CHEMOTH, V34, P885, DOI 10.1093/jac/34.6.885; Kumar L, 2018, PROTEIN EXPRES PURIF, V148, P59, DOI 10.1016/j.pep.2018.04.001; Kumar L, 2013, FITOTERAPIA, V90, P73, DOI 10.1016/j.fitote.2013.06.017; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Law Edward J., 1994, Journal of Burn Care and Rehabilitation, V15, P236, DOI 10.1097/00004630-199405000-00006; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lee SF, 1996, INFECT IMMUN, V64, P1035, DOI 10.1128/IAI.64.3.1035-1038.1996; Lefevre J, 2008, J MOL BIOL, V378, P840, DOI 10.1016/j.jmb.2008.03.044; Leroy C, 2008, BIOFOULING, V24, P11, DOI 10.1080/08927010701784912; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Loughran AJ, 2014, MICROBIOLOGYOPEN, V3, P897, DOI 10.1002/mbo3.214; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Moormeier DE, 2014, MBIO, V5, DOI 10.1128/mBio.01341-14; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nguyen UT, 2014, INT J FOOD MICROBIOL, V187, P26, DOI 10.1016/j.ijfoodmicro.2014.06.025; Niazi SA, 2014, INT ENDOD J, V47, P756, DOI 10.1111/iej.12214; Nissinen L, 2014, BBA-GEN SUBJECTS, V1840, P2571, DOI 10.1016/j.bbagen.2014.03.007; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park JH, 2012, BIOTECHNOL LETT, V34, P655, DOI 10.1007/s10529-011-0825-z; Patterson T, 2007, AM J OBSTET GYNECOL, V197, pS175, DOI 10.1016/j.ajog.2007.10.634; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Ran SJ, 2015, AUST DENT J, V60, P143, DOI 10.1111/adj.12324; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Schallenberger MA, 2012, J BACTERIOL, V194, P2677, DOI 10.1128/JB.00064-12; SELAN L, 1993, ANTIMICROB AGENTS CH, V37, P2618, DOI 10.1128/AAC.37.12.2618; Shukla SK, 2013, J ANTIBIOT, V66, P55, DOI 10.1038/ja.2012.98; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Taglialegna A, 2016, J BACTERIOL, V198, P2579, DOI 10.1128/JB.00122-16; Talebi M, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.23349; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Watters CM, 2016, INFECT DRUG RESIST, V9, P71, DOI 10.2147/IDR.S103101; Zhang XH, 2016, LIVEST SCI, V188, P25, DOI 10.1016/j.livsci.2016.03.017; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	78	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210218	10.1371/journal.pone.0210218	http://dx.doi.org/10.1371/journal.pone.0210218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633757	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100014
J	Kim, S; Voss, JL				Kim, Sungshin; Voss, Joel L.			Large-scale network interactions supporting item-context memory formation	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; EPISODIC MEMORY; BRAIN NETWORKS; LONG; RECOLLECTION; SYSTEMS	Episodic memory is thought to involve functional interactions of large-scale brain networks that dynamically reconfigure depending on task demands. Although the hippocampus and closely related structures have been implicated, little is known regarding how large-scale and distributed networks support different memory formation demands. We investigated patterns of interactions among distributed networks while human individuals formed item-context memories for two stimulus categories. Subjects studied object-scene and objectlocation associations in different fMRI sessions. Stimulus-responsive brain regions were organized based on their fMRI interconnectivity into networks and modules using probabilistic module-detection algorithms to maximize measurement of individual differences in modular structure. Although there was a great deal of consistency in the modular structure between object-scene and object-location memory formation, there were also significant differences. Interactions among functional modules predicted later memory accuracy, explaining substantial portions of variability in memory formation success. Increased interactivity of modules associated with internal thought and anti-correlation of these modules with those related to stimulus-evoked processing robustly predicted object-scene memory, whereas decreased interactivity of stimulus-evoked processing modules predicted object-location memory. Assessment of individual differences in network organization therefore allowed identification of distinct patterns of functional interactions that robustly predicted memory formation. This highlights large-scale brain network interactions for memory formation and indicates that although networks are largely robust to task demands, reconfiguration nonetheless occurs to support distinct memory formation demands.	[Kim, Sungshin] IBS, Ctr Neurosci Imaging Res, Suwon, South Korea; [Kim, Sungshin] Sungkyunkwan Univ SKKU, Suwon, South Korea; [Voss, Joel L.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Dept Med Social Sci,Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Northwestern University; Feinberg School of Medicine	Kim, S (corresponding author), IBS, Ctr Neurosci Imaging Res, Suwon, South Korea.; Kim, S (corresponding author), Sungkyunkwan Univ SKKU, Suwon, South Korea.	clmnlab@gmail.com	Kim, Sungshin/AAE-5645-2019	Kim, Sungshin/0000-0001-9500-4677; Voss, Joel/0000-0003-4180-9335	National Institute of Mental Health (US) [R01-MH106512]; Department of Radiology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106512] Funding Source: NIH RePORTER	National Institute of Mental Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Radiology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health (US), R01-MH106512 to JLV; https://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Jonathan O'Neil and Robert Palumbo for data collection and technical support. Data analyses were supported in part through the computational resources and staff contributions provided for the Quest high-performance computing facility at Northwestern University. MRI was performed at the Northwestern University Center for Translational Imaging, supported by the Department of Radiology.	Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuertinger S, 2016, J COGNITIVE NEUROSCI, V28, P2030, DOI 10.1162/jocn_a_01026; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Geib BR, 2017, CEREB CORTEX, V27, P680, DOI 10.1093/cercor/bhv272; GRAF P, 1989, J EXP PSYCHOL LEARN, V15, P930, DOI 10.1037/0278-7393.15.5.930; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; Kim S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2768; King DR, 2015, J NEUROSCI, V35, P1763, DOI 10.1523/JNEUROSCI.3219-14.2015; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mohr H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13217; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newton AT, 2011, HUM BRAIN MAPP, V32, P1649, DOI 10.1002/hbm.21138; Nilakantan AS, 2017, CURR BIOL, V27, P465, DOI 10.1016/j.cub.2016.12.042; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Ritchey M, 2015, PROG BRAIN RES, V219, P45, DOI 10.1016/bs.pbr.2015.04.001; Ritchey M, 2014, J COGNITIVE NEUROSCI, V26, P1085, DOI 10.1162/jocn_a_00533; Ritchey M, 2013, CEREB CORTEX, V23, P2818, DOI 10.1093/cercor/bhs258; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Schedlbauer AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06431; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059204; Westphal AJ, 2017, J NEUROSCI, V37, P3523, DOI 10.1523/JNEUROSCI.2509-16.2017	54	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210167	10.1371/journal.pone.0210167	http://dx.doi.org/10.1371/journal.pone.0210167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629666	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000056
J	Rathore, AS; Sarker, A; Gupta, RD				Rathore, Abhishek Singh; Sarker, Animesh; Gupta, Rinkoo Devi			Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; MONOCLONAL-ANTIBODIES; FUSION-LOOP; DOMAIN-III; VIRUS; GLYCOPROTEIN; PEPTIDE; BINDING; TARGET	Dengue being one of the deadliest diseases of tropical regions, enforces to put continuous efforts for the development of vaccine and effective therapeutics. Most of the antibodies generated during dengue infection are non-neutralizing and cause antibody dependent enhancement. Hence, making a potent neutralizing antibody against all four dengue sero-types could be very effective for the treatment. However, designing a single antibody for all serotypes is difficult due to variation in protein sequences. Therefore, the objective is to identify conserved region of dengue envelope protein and then develop an antibody against that conserved region. Before advancing to the development of such an antibody, it is desirable to validate the interactions between antibody and dengue envelope protein. In silico analysis of such interactions provides a good platform to find out a suitable region to design and construct an antibody against it by analyzing antigen-antibody interaction before synthesizing the antibody. In this study, two highly conserved regions of dengue envelope protein were identified and an scFv was constructed against it. Both scFv and FuBc proteins were expressed in bacterial expression system and binding efficiency was analyzed by SPR analysis with K-D value 2.3 mu M. In order to improve binding efficiency, an in silico scFv mutant library was created which was virtually screened for higher binding efficiency. Six mutants with high binding efficiency were selected for further analysis. The binding ability of these mutants were predicted using simulation analysis which shows these mutations were stabilizing scFv-FuBc complex.	[Rathore, Abhishek Singh; Sarker, Animesh; Gupta, Rinkoo Devi] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	South Asian University (SAU)	Gupta, RD (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rdgupta@sau.ac.in	Gupta, Rinkoo Devi/AAI-9528-2021	Gupta, Rinkoo Devi/0000-0003-1156-9596	South Asian University's "Start-up Fund"; University Grants Commission; University Grants Commission (UGC), India; South Asian University	South Asian University's "Start-up Fund"; University Grants Commission(University Grants Commission, India); University Grants Commission (UGC), India(University Grants Commission, India); South Asian University	This work is financially supported by South Asian University's "Start-up Fund" to RDG and the University Grants Commission (JRF/SRF (2013-2018)) to ASR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ASR thanks University Grants Commission (UGC), India for Senior Research Fellowship. AS and RDG thanks South Asian University for financial support.	[Anonymous], LANCET, DOI 10.1016/S0140-6736(14)60572-9; Bandehpour M, 2017, J THEOR COMPUT CHEM, V16, DOI 10.1142/S0219633617500699; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chen W-H, 2017, VIROL J, P14; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386; Entzminger KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10737-9; Fahimi H, 2014, IRAN J BASIC MED SCI, V17, P836; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; Fleith RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36339; Geng SS, 2015, IMMUNOL RES, V62, P377, DOI 10.1007/s12026-015-8667-8; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Hu GD, 2011, J MOL MODEL, V17, P1919, DOI 10.1007/s00894-010-0892-4; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Ji XF, 2012, BIOINFORM BIOL INSIG, V6, P255, DOI 10.4137/BBI.S10663; Jones ML, 2017, MOL BASEL SWITZ, V22; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Karim HAA, 2015, MOL DYNAMICS SIMULAT, P24; Khor BY, 2017, J MOL GRAPH MODEL, V76, P543, DOI 10.1016/j.jmgm.2017.07.004; Lai B, 2014, INT J MOL SCI, V15, P438, DOI 10.3390/ijms15010438; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai PY, 2014, J GEN VIROL, V95, P2155, DOI 10.1099/vir.0.062562-0; Li TW, 2016, ARCH VIROL, V161, P19, DOI 10.1007/s00705-015-2625-6; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Poosarla VG, 2017, BIOTECHNOL BIOENG, V114, P1331, DOI 10.1002/bit.26244; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Tang CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125307; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; WHO, DENG SEV DENG; Yamanaka A, 2013, J VIROL, V87, P12828, DOI 10.1128/JVI.01874-13	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209576	10.1371/journal.pone.0209576	http://dx.doi.org/10.1371/journal.pone.0209576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629625	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000029
J	Solomon, T; Loha, E; Deressa, W; Gari, T; Overgaard, HJ; Lindtjorn, B				Solomon, Tarekegn; Loha, Eskindir; Deressa, Wakgari; Gari, Taye; Overgaard, Hans J.; Lindtjorn, Bernt			Low use of long-lasting insecticidal nets for malaria prevention in south-central Ethiopia: A community-based cohort study	PLOS ONE			English	Article							INTERVENTIONS; IRRIGATION; MORTALITY; COVERAGE; INDEXES	Introduction A decline in malaria morbidity and mortality has been documented in Ethiopia since 2005 following a scale-up of the distribution of long-lasting insecticidal nets (LLINs). However, universal access to LLINs ownership and use has not yet been achieved. This study aimed to determine ownership and use of LLINs over time in south-central Ethiopia. Methods A cohort of 17,142 individuals residing in 3,006 households was followed-up from October 2014 to January 2017 (121 weeks). New PermaNet2.0 LLINs were given to households in October 2014. Once per week, the LLIN use status was documented for each individual. A survey was conducted after 110 weeks of LLIN distribution to determine LLIN ownership. A multilevel negative binomial regression model was fitted to identify significant predictors of LLIN use. Results At baseline, the LLIN ownership was 100%. After 110 weeks only 233 (8%) of the house-holds owned at least one LLIN. The median proportion of LLIN use per individuals during the study period was only 14%. During the first year (week 1-52) the average LLIN use per individuals was 36% and during the second year (week 53-104) it was 4.6%. More frequent LLIN use was reported among age group [5-14 years (adjusted IRR = 1.13, 95% CI 1.04-1.22), 15-24 years (adjusted IRR = 1.33, 95% CI 1.23-1.45),. 25 years (adjusted IRR = 1.99, 95% CI 1.83-2.17)] compared to < 5 years, and household head educational status [read and write (adjusted IRR = 1.17, 95% CI 1.09-1.26), primary (adjusted IRR = 1.20, 95% CI 1.12-1.27), secondary or above (adjusted IRR = 1.20, 95% CI (1.11-1.30)] compared to illiterate. Having a family size of over five persons (adjusted IRR = 0.78, 95% CI 0.73-0.84) was associated with less frequent use of LLINs compared to a family size of <= 5 persons. Conclusions The study showed a low LLIN ownership after 110 weeks and a low LLIN use during 121 weeks of follow-up, despite 100% LLIN coverage at baseline. The study highlights the need to design strategies to increase LLIN ownership and use for setting similar to those studied here.	[Solomon, Tarekegn; Loha, Eskindir; Gari, Taye] Hawassa Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Solomon, Tarekegn; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Deressa, Wakgari] Univ Addis Ababa, Sch Publ Hlth, Dept Prevent Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Overgaard, Hans J.] Norwegian Univ Life Sci, Fac Sci & Technol, Akershus, Norway	Hawassa University; University of Bergen; Addis Ababa University; Norwegian University of Life Sciences	Solomon, T (corresponding author), Hawassa Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia.; Solomon, T (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	tarekegn2solomon@yahoo.com	Lindtjorn, Bernt/K-9465-2018; loha, eskindir/AAN-4925-2020; Overgaard, Hans/AAE-9972-2020; Shumbullo, Eskindir Loha/ABB-6422-2021	Lindtjorn, Bernt/0000-0002-6267-6984; Shumbullo, Eskindir Loha/0000-0003-0003-2734; Shanka, Tarekegn/0000-0003-0923-2740	Norwegian Research Council [220554]; Hawassa University; Addis Ababa University; University of Bergen	Norwegian Research Council(Research Council of NorwayEuropean Commission); Hawassa University; Addis Ababa University; University of Bergen	BL, EL and WD received funding by the the Norwegian Research Council (project number: 220554). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the community members in the Adami Tullu District, particularly those households that participated in the study. We wish to thank the district health office teams that helped us to coordinate and conduct the study. We would also like to thank the data collectors and supervisors for their active involvement in the study. We are also grateful to Hawassa University, Addis Ababa University and the University of Bergen for their support.	Abeku TA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0852-7; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Aregawi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106359; Baume CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-265; Bekele D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-127; Birhanu Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2677-2; Clark S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154808; Deressa W, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2048-9; Deressa W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1154-2; Deressa W, 2014, T ROY SOC TROP MED H, V108, P616, DOI 10.1093/trstmh/tru129; Deribew A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1919-4; Doda Z, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2209-5; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Ethiopian Federal Minsitry of Health, 2012, NAT MAL GUID; Ethiopian Health and Nutrition Research Institute, 2012, ETH NAT MAL IND SURV; Ethiopian National Meteorology Agency, 2016, UNPUB; Ethiopian Public Health Institute, 2016, ETH NAT MAL IND SURV; Federal Democratic Republic of Ethiopia, 2008, SUMM STAT REP 2007 P; Federal Ministry of Health, 2014, NAT STRAT PLAN MAL P; Finlay AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183936; Gari T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190983; Gari T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170898; Gari T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1199-4; Gnanguenon V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-69; Gobena T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-914; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Hailu A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1425-0; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; International Federation of Red Cross Ethiopia, 2015, DROUGHT EM PLAN ACT; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kenea O, 2016, UNPUB; Kenea O, 2011, J VECTOR DIS, V48, P85; Kibret S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-360; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y; Loha E, 2017, UNPUB; Loha E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-23; Loha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047354; Loha E, 2012, AM J TROP MED HYG, V87, P450, DOI 10.4269/ajtmh.2012.12-0155; Mboma ZM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2247-z; Newell K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1128-6; Ngondi JM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-92; Nuwamanya Simpson, 2018, Malar Res Treat, V2018, P4387506, DOI 10.1155/2018/4387506; Ouattara AF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-288; President's Malaria Initiative Ethiopia, 2017, MAL OP PLAN FY 2017; President's Malaria Initiative Ethiopia, 2015, MAL OP PLAN FY 2015; Roberts D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1290-x; Sangare LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039712; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Solomon T, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2391-5; Tan KR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1154-4; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wanzira H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191191; WHO, 2016, WORLD MALARIA REPORT; WHO, 2017, WORLD MALARIA REPORT; World Health Organization, 2015, ACHIEVING MALARIA MD; Ye Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-32	56	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210578	10.1371/journal.pone.0210578	http://dx.doi.org/10.1371/journal.pone.0210578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629675	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000112
J	Rodrigues, JPV; Marques, FA; Goncalves, AMRF; Campos, MSD; dos Reis, TM; Morelo, MRS; Fontoura, A; Girolineto, BMP; Souza, HPMD; Cazarim, MD; Maduro, LCD; Pereira, LRL				Vilela Rodrigues, Joao Paulo; Marques, Fabiana Angelo; Rosa Freato Goncalves, Ana Maria; de Almeida Campos, Marilia Silveira; dos Reis, Tiago Marques; Siani Morelo, Manuela Roque; Fontoura, Andrea; Pereira Girolineto, Beatriz Maria; Miranda de Camargo Souza, Helen Palmira; Cazarim, Maurilio de Souza; da Silva Maduro, Lauro Cesar; Leira Pereira, Leonardo Regis			Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital	PLOS ONE			English	Article							MEDICATION RECONCILIATION; CARE; IMPACT; THERAPY; DISEASE; PATIENT; SERVICE; STRATEGIES; MANAGEMENT; PROGRAM	It is estimated that around five to 10.0% of hospital admissions occur due to clinical conditions resulting from pharmacotherapy. Clinical pharmacist's activity can enhance drug therapy's effectiveness and safety through pharmacotherapy interventions (PIs), thus minimizing drug-related problems (DRPs) and optimizing the allocation of financial resources associated with health care. This study aimed to estimate the DRPs prevalence, evaluate PI which were performed by clinical pharmacists in the Neurology Unit of a Brazilian tertiary teaching hospital and to identify factors associated with the occurrence of PI-related DRP. A single-arm trial included adults admitted in the referred Unit from 2012 July to 2015 June. Patients were evaluated during their hospitalization period and PIs were performed based on trigger DRPs that were detected in medication reconciliation (admission or discharge) or during inpatient follow-up. Student's t-test, Chi-square test, Pearson and Multiple logistic regression models to analise the association among age, number of drugs, hospitalization period, and number of diagnoses with occurrence of DRPs. Analyses level of significance was 5%. In total 409 inpatients were followed up [51.1% male, mean age of 49.1 (SD 16.5)]. Patients received, on average, 11.9 (SD 5.8) drugs, ranging from two to 38 drugs per patient, and 54.3% of the sample presented at least one DRP whose most frequent description was "untreated condition". From all 516 performed PIs that resulted from DRPs, 82.8% were accepted and the majority referred to "drug introduction" (27.5%). Multiple logistic regression showed that age, length of hospital stay, number of drugs used, diagnosis of epilepsy, multiple sclerosis and myasthenia gravis would be clinical variables associated with DRP (p < 0,05). Monitoring the use of drugs allowed the clinical pharmacist to detect DRPs and to suggest interventions that promote rational pharmacotherapy.	[Vilela Rodrigues, Joao Paulo; Marques, Fabiana Angelo; Rosa Freato Goncalves, Ana Maria; de Almeida Campos, Marilia Silveira; Siani Morelo, Manuela Roque; Fontoura, Andrea; Miranda de Camargo Souza, Helen Palmira; Cazarim, Maurilio de Souza; da Silva Maduro, Lauro Cesar; Leira Pereira, Leonardo Regis] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Pharmaceut Serv & Clin Pharm Res Ctr, Ribeirao Preto, Brazil; [dos Reis, Tiago Marques] Univ Fed Alfenas, Clin Anal Dept, Alfenas, Brazil; [Pereira Girolineto, Beatriz Maria] Univ Fed Piaui, Hlth Sci Ctr, Piaui, Brazil	Universidade de Sao Paulo; Universidade Federal de Alfenas; Universidade Federal do Piaui	Campos, MSD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Pharmaceut Serv & Clin Pharm Res Ctr, Ribeirao Preto, Brazil.	mariliac@fcfrp.usp.br	Pereira, Leonardo R L/J-9322-2012; Rodrigues, João/GVU-7735-2022; Rodrigues, Ana/GYQ-6273-2022; Cazarim, Maurilio/AFT-1083-2022; Reis, Tiago Marques/ABB-9988-2020	Pereira, Leonardo R L/0000-0002-8609-1390; Cazarim, Maurilio/0000-0002-2826-5903; Reis, Tiago Marques/0000-0002-0789-0187				Abunahlah N, 2018, INT J CLIN PHARM-NET, V40, P360, DOI 10.1007/s11096-017-0585-5; Agrawal H, 2015, CURR CARDIOL REV, V11, P261, DOI 10.2174/1573403X1103150514155757; Alderman CP, 1997, J CLIN PHARM THER, V22, P27, DOI 10.1046/j.1365-2710.1997.95975959.x; Ali MAS, 2018, INT J CLIN PHARM-NET, V40, P1257, DOI 10.1007/s11096-018-0658-0; American Coll Clinical Pharm, 2008, PHARMACOTHERAPY, V28, P816, DOI 10.1592/phco.28.6.816; Andrade C, 2013, J CLIN PSYCHIAT, V74, pE744, DOI 10.4088/JCP.13f08668; [Anonymous], 2016, GLOBAL REPORT ON DIA; Bedouch P, 2008, ANN PHARMACOTHER, V42, P1095, DOI 10.1345/aph.1L045; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Cipolle R.J., 2004, PHARMACEUTICAL CARE, V2nd; Foppa AA, 2016, NEUROL THER, V5, P85, DOI 10.1007/s40120-016-0046-4; Gallagher J, 2014, INT J CLIN PHARM-NET, V36, P1101, DOI 10.1007/s11096-014-0008-9; Gardner KN, 2016, AM J HEALTH-SYST PH, V73, pE46, DOI 10.2146/ajhp150368; Gilhus NE, 2016, NEW ENGL J MED, V375, P2570, DOI 10.1056/NEJMra1602678; Harris IM, 2014, PHARMACOTHERAPY, V34, pE133, DOI 10.1002/phar.1459; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Ianiro G, 2014, EUR REV MED PHARMACO, P18; Jones Jocelyn D., 2011, Pharmacy Pract (Granada), V9, P11; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kopp BJ, 2007, AM J HEALTH-SYST PH, V64, P2483, DOI 10.2146/ajhp060674; Kraus SK, 2017, PHARM PRACT-GRANADA, V15, DOI [10.18549/PharmPract.2017.02.901, 10.18549/pharmpract.2017.02.901]; Langebrake C, 2010, PHARM WORLD SCI, V32, P194, DOI 10.1007/s11096-010-9367-z; Lazrak HH, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0596-4; Lee EH, 2017, J RES PHARM PRACT, V6, P106, DOI 10.4103/jrpp.JRPP_16_160; Lertxundi U, 2008, AM J HEALTH-SYST PH, V65, P414, DOI 10.2146/ajhp060624; Losada-Camacho M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0162-8; Luiz RR, 2006, EPIDEMIOLOGIA, P298; Mekonnen AB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010003; Mergenhagen KA, 2012, AM J GERIATR PHARMAC, V10, P242, DOI 10.1016/j.amjopharm.2012.06.001; Moore E, 2012, INT PSYCHOGERIATR, V24, P541, DOI 10.1017/S1041610211002511; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Page AT, 2016, MATURITAS, V91, P115, DOI 10.1016/j.maturitas.2016.06.006; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Reeve E, 2018, EXPERT OPIN DRUG SAF, V17, P39, DOI 10.1080/14740338.2018.1397625; Ruiz-Millo O, 2017, INT J CLIN PHARM-NET, V39, P1201, DOI 10.1007/s11096-017-0548-x; Rychlickova J, 2016, PHARMACOTHERAPY, V36, P766, DOI 10.1002/phar.1777; Salahudeen MS, 2018, DRUG TODAY, V54, P489, DOI 10.1358/dot.2018.54.8.2856495; Saokaew Surasak, 2009, Pharmacy Pract (Granada), V7, P81; Sekhar MS, 2011, SAUDI PHARM J, V19, P273, DOI 10.1016/j.jsps.2011.04.004; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; Simons SMJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0341-0; Skelin M, 2018, ENDOCRINE, V62, P432, DOI 10.1007/s12020-018-1686-1; Spalla LD, 2016, BRAZ J PHARM SCI, V52, P143, DOI 10.1590/S1984-82502016000100016; Strand LM, 2004, CURR PHARM DESIGN, V10, P3987, DOI 10.2174/1381612043382576; WEED LL, 1971, ARCH INTERN MED, V127, P101, DOI 10.1001/archinte.127.1.101; Welty TE, 2006, ANN PHARMACOTHER, V40, P2235, DOI 10.1345/aph.1H495; WHO Collaborating Center for Drug Statistics and Methodology, 2012, GUIDELINES FOR ATC C; World Health Organization, 2013, A GLOBAL BRIEF HYPER; Yi ZM, 2016, INT J CLIN PHARM-NET, V38, P30, DOI 10.1007/s11096-015-0224-y; Zaccara G, 2014, EPILEPTIC DISORD, V16, P409, DOI 10.1684/epd.2014.0714; Zierler-Brown S, 2007, AM J HEALTH-SYST PH, V64, P1851, DOI 10.2146/ajhp060682	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210779	10.1371/journal.pone.0210779	http://dx.doi.org/10.1371/journal.pone.0210779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657771	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000019
J	Mane, A; Sacks, J; Sharma, S; Singh, H; Tejada-Strop, A; Kamili, S; Kacholia, K; Gautam, R; Thakar, M; Gupta, RS; Gangakhedkar, R				Mane, Arati; Sacks, Jilian; Sharma, Sadhya; Singh, Harpreet; Tejada-Strop, Alexandra; Kamili, Saleem; Kacholia, Kartik; Gautam, Ritubhan; Thakar, Madhuri; Gupta, Radhey Shyam; Gangakhedkar, Raman			Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in India	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; INJECT DRUGS; IMPACT; TRANSMISSION; PERFORMANCE; INFECTION; PEOPLE; ASSAYS; RISK	Objectives Hepatitis C virus (HCV) infection is a major contributor to morbidity and mortality worldwide. Early detection and curative treatment of HCV can reduce the risk of liver-related mortality and serve to prevent transmission of new infections. India is estimated to have about six million HCV infected individuals, most of whom are unaware of their infection status. Rapid diagnostic test kits (RDTs) could help identify HCV infected persons more expeditiously and thus availability of high performing, quality-assured RDTs is essential to scale-up HCV screening efforts. The present study was thus undertaken to evaluate the performance characteristics of five anti-HCV RDTs. Methods Five anti-HCV RDTs (Alere Truline, Flaviscreen, Advanced Quality, SD Bioline and OraQuick) were evaluated using two panels of known anti-HCV positive and negative samples; one characterized from Indian patient samples (n = 360) and other obtained from the US Centers for Disease Control and Prevention (CDC), Atlanta (n = 100). Sensitivity, specificity, inter-observer agreement, test validity and operational characteristics of RDTs were assessed. Results The combined sensitivities across both panels for Alere Truline, Flaviscreen, Advanced Quality, SD Bioline and OraQuick RDTs were 99.4% (95% CI-96.6%-99.9%), 86.2% (95% CI-79.8%-91.1%), 96.2% (95% CI-91.9%-98.6%), 99.4% (95% CI-96.6%-99.9%) and 99.4% 95% CI-96.6%-99.9%) respectively. The overall specificities across both panels for all RDTs were 99.7%. The inter-observer agreement was 100% for Alere Truline, SD Bioline and OraQuick, while it was 99.5% and 98.6% with Advanced Quality and Flavicheck respectively. Discordant results were significantly associated with human immunodeficiency virus (HIV) positivity for both Advanced Quality and Flavicheck (p<0.001). Conclusion The present evaluation demonstrated that Alere Truline, SD Bioline and OraQuick RDTs had sensitivity and specificity in accordance with the acceptance criteria of the Drug Controller General, India, the national regulatory authority, had excellent inter-observer agreement and superior operational characteristics. Our findings suggest that certain HCV RDTs perform well and can be a useful tool in screening of HCV infections expeditiously.	[Mane, Arati; Thakar, Madhuri] ICMR Natl AIDS Res Inst, Pune, Maharashtra, India; [Sacks, Jilian; Sharma, Sadhya; Kacholia, Kartik; Gautam, Ritubhan] Clinton Hlth Access Initiat, New Delhi, India; [Singh, Harpreet] Govt Med Coll Amritsar, ART Plus Ctr, Amritsar, Punjab, India; [Tejada-Strop, Alexandra; Kamili, Saleem] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Gupta, Radhey Shyam] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Gangakhedkar, Raman] Govt India, Minist Hlth & Family Welf, Indian Council Med Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR)	Mane, A (corresponding author), ICMR Natl AIDS Res Inst, Pune, Maharashtra, India.	amane@nariindia.org		Mane, Dr. Arati/0000-0001-8064-9325	William J. Clinton Foundation, New Delhi, India	William J. Clinton Foundation, New Delhi, India	Funded by William J. Clinton Foundation, New Delhi, India.	Ayoub HH, 2017, J VIRAL HEPATITIS, V24, P486, DOI 10.1111/jvh.12671; Bonacini M, 2001, J ACQ IMMUN DEF SYND, V26, P340, DOI 10.1097/00126334-200104010-00008; Butt AS, 2018, WORLD J HEPATOL, V10, P267, DOI 10.4254/wjh.v10.i2.267; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150512; Department of Health and Family Welfare Government of Punjab, 2016, MUKH MANTR PUNJ HEP; Dhiman RK, 2016, J CLIN EXP HEPATOL, V6, P224, DOI 10.1016/j.jceh.2016.09.005; Dhiman Radha Krishan, THE PUNJAB MODEL; Doan T.Q., 2018, HEPATITIS C DEV COUN, P97, DOI [10.1016/B978-0-12-803233-6.00009-6, DOI 10.1016/B978-0-12-803233-6.00009-6]; Fraser H, 2018, J HEPATOL, V68, P402, DOI 10.1016/j.jhep.2017.10.010; Gupta V, 2017, INDIAN J MED RES, V146, P22, DOI [10.4103/ijmr.IJMR_679_15, 10.4103/ijmr.ijmr_679_15]; Khuroo MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121450; Kim MH, 2013, J VIROL METHODS, V193, P379, DOI 10.1016/j.jviromet.2013.07.005; Kosack CS, 2016, TROP MED INT HEALTH, V21, P603, DOI 10.1111/tmi.12688; MARCELLIN P, 1994, J INFECT DIS, V170, P433, DOI 10.1093/infdis/170.2.433; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Midgard H, 2016, J HEPATOL, V65, pS33, DOI 10.1016/j.jhep.2016.07.012; Mixson-Hayden T, 2015, J CLIN VIROL, V66, P15, DOI 10.1016/j.jcv.2015.02.015; National Center for Disease Control Ministry of Health and Family welfare Government of India, 2018, NAT PROGR PREV CONTR; Ringehan M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0274; Shekhar S., 2018, HEPATITIS C DEV COUN, P83, DOI [10.1016/B978-0-12-803233-6.00008-4, DOI 10.1016/B978-0-12-803233-6.00008-4]; Shivkumar S, 2012, ANN INTERN MED, V157, P558, DOI 10.7326/0003-4819-157-8-201210160-00006; Singer AW, 2018, ALIMENT PHARM THER, V47, P1278, DOI 10.1111/apt.14593; Smith BD, 2011, CLIN INFECT DIS, V53, P780, DOI 10.1093/cid/cir499; Smith BD, 2011, J INFECT DIS, V204, P825, DOI 10.1093/infdis/jir422; Tanday S, 2016, LANCET ONCOL, V17, pE484, DOI 10.1016/S1470-2045(16)30512-5; Tang WM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2773-2; Thornton AC, 2017, AIDS, V31, P2525, DOI 10.1097/QAD.0000000000001646	27	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210556	10.1371/journal.pone.0210556	http://dx.doi.org/10.1371/journal.pone.0210556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653562	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500050
J	Prufer, TL; Rohde, J; Verspohl, J; Rohde, M; de Greeff, A; Willenborg, J; Valentin-Weigand, P				Prufer, T. Louise; Rohde, Judith; Verspohl, Jutta; Rohde, Manfred; de Greeff, Astrid; Willenborg, Joerg; Valentin-Weigand, Peter			Molecular typing of Streptococcus suis strains isolated from diseased and healthy pigs between 1996-2016	PLOS ONE			English	Article							SYNTHESIS GENE LOCI; CAPSULAR TYPES; SEROTYPE; VIRULENCE; PATHOGENESIS; BACTERIN; PHAGOCYTOSIS; MENINGITIS; INFECTION; SWINE	Streptococcus suis is an economically important pathogen of pigs as well as a zoonotic cause of human disease. Serotyping is used for further characterization of isolates; some serotypes seem to be more virulent and more widely spread than others. This study characterizes a collection of German field isolates of Streptococcus suis from pigs dating from 1996 to 2016 with respect to capsular genes (cps) specific for individual serotypes and pathotype by multiplex PCR and relates results to the clinical background of these isolates. The most prominent finding was the reduction in prevalence of serotype-2/serotype-1/2 among invasive isolates during this sampling period, which might be attributed to widely implemented autogenous vaccination programs in swine against serotype 2 in Germany. In diseased pigs (systemically ill; respiratory disease) isolates of serotype-1/serotype-14, serotype-2/serotype-1/2, serotype 3 to 5 and 7 to 9 were most frequent while in carrier isolates a greater variety of cps types was found. Serotype-1/serotype-14 seemed to be preferentially located in joints, serotype 4 and serotype 3 in the central nervous system, respectively. The virulence associated extracellular protein factor was almost exclusively associated with invasive serotype-1/serotype-14 and serotype-2/serotype-1/2 isolates. In contrast, lung isolates of serotype-2/serotype-1/2 mainly harbored the gene for muramidase-released protein. Serotype 4 and serotype 9 isolates from clinically diseased pigs most frequently carried the muramidase-released protein gene and the suilysin gene. When examined by transmission electron microscopy all but one of the isolates which were non-typable by molecular and serological methods showed various amounts of capsular material indicating potentially new serotypes among these isolates. Given the variety of cps types/serotypes detected in pigs, not only veterinarians but also medical doctors should consider other serotypes than just serotype 2 when investigating potential human cases of Streptococcus suis infection.	[Prufer, T. Louise; Rohde, Judith; Verspohl, Jutta; Willenborg, Joerg; Valentin-Weigand, Peter] Univ Vet Med, Inst Microbiol, Hannover, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, Braunschweig, Germany; [de Greeff, Astrid] Wageningen Biovet Res, Lelystadt, Netherlands; [Prufer, T. Louise] Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Germany; [Willenborg, Joerg] Bayer Anim Hlth GmbH, Leverkusen, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; Wageningen University & Research; Bayer AG	Rohde, J (corresponding author), Univ Vet Med, Inst Microbiol, Hannover, Germany.	Judith.Rohde@tiho-hannover.de		Rohde, Judith/0000-0002-4671-2164				Baig A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01191; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Baums CG, 2009, CLIN VACCINE IMMUNOL, V16, P200, DOI 10.1128/CVI.00371-08; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Buttner N, 2012, VET IMMUNOL IMMUNOP, V146, P191, DOI 10.1016/j.vetimm.2012.03.012; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Dekker CNT, 2012, VACCINE, V30, P1379, DOI 10.1016/j.vaccine.2011.12.035; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1993, J CLIN MICROBIOL, V31, P2192, DOI 10.1128/JCM.31.8.2192-2194.1993; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Ishida S, 2014, J MICROBIOL METH, V107, P66, DOI 10.1016/j.mimet.2014.09.003; Kerdsin A, 2014, J MED MICROBIOL, V63, P824, DOI 10.1099/jmm.0.069757-0; Le HTT, 2013, VET MICROBIOL, V162, P842, DOI 10.1016/j.vetmic.2012.11.001; Li J, 2016, EXPERT OPIN THER TAR, V20, P7, DOI 10.1517/14728222.2016.1121236; Liu ZQ, 2013, PLASMONICS, V8, P1285, DOI 10.1007/s11468-013-9551-9; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okura M, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030045; Okura M, 2014, J CLIN MICROBIOL, V52, P1714, DOI 10.1128/JCM.03411-13; Pan ZH, 2015, APPL ENVIRON MICROB, V81, P976, DOI 10.1128/AEM.02962-14; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Segura M, 2015, EXPERT REV VACCINES, V14, P1587, DOI 10.1586/14760584.2015.1101349; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; Soares TCS, 2014, CAN J VET RES, V78, P145; Smith HE, 1999, INFECT IMMUN, V67, P1750; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Willemse N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28984; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Zheng H, 2017, VET RES, V48, DOI 10.1186/s13567-017-0417-6; Zheng H, 2015, APPL ENVIRON MICROB, V81, P4111, DOI 10.1128/AEM.00315-15; Zou G, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02590-17	41	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210801	10.1371/journal.pone.0210801	http://dx.doi.org/10.1371/journal.pone.0210801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653570	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500072
J	Althagafi, II; Ahmed, SA; El-Saidid, WA				Althagafi, Ismail I.; Ahmed, Saleh A.; El-Saidid, Waleed A.			Fabrication of gold/graphene nanostructures modified ITO electrode as highly sensitive electrochemical detection of Aflatoxin B1	PLOS ONE			English	Article							GOLD NANOPARTICLE; GRAPHENE; IMMUNOSENSOR; BIOSENSOR; ASSAY; SUBSTRATE; AU; AG	Aflatoxins (AFs) are a family of fungal toxins that produced in food and feed by two Aspergillus species (Aspergillus flavus and Aspergillus parasiticus). Several techniques have been reported for AFs detection including high-pressure liquid chromatography, enzyme-linked immunosorbent assay, surface plasmon resonance and recombinant immune blotting assay. But, these methods are disadvantaged because they consumed a long time for analysis; in addition, they required a piece of complicated and expensive equipment. Therefore, developing of inexpensive sensors with high selectivity and sensitivity for detecting of AFs levels without extensive sample preparation has received great attention. Several Ielectrochemical AFs sensors have been reported; however, there is still a need for developing a new, simple and rapid electrochemical AFs sensor. Here, we have developed a new AFs sensor based on Au nanostructures/graphene nanosheets modified ITO substrate that could enhance the Raman effect and the electrochemical conductivity. The modified electrode was prepared based on layer-by-layer electrochemical deposition method. AFs antibody was immobilized onto the Au nanostructures/graphene nanosheets; then it was used as a probe for rapid, simple and cheap detection of AFs level using Raman spectroscopy and electrochemical techniques. Our results demonstrated that the developed system showed a simple, easy and sensitive sensor for monitoring low concentrations of AFB1 with a detection limit of about 6.9 pg/mL, also it allowed the determination of AFB1 in spiked food samples.	[Althagafi, Ismail I.; Ahmed, Saleh A.] Umm Al Qura Univ, Fac Appl Sci, Chem Dept, Mecca, Saudi Arabia; [Ahmed, Saleh A.; El-Saidid, Waleed A.] Assiut Univ, Dept Chem, Fac Sci, Assiut, Egypt	Umm Al Qura University; Egyptian Knowledge Bank (EKB); Assiut University	Althagafi, II (corresponding author), Umm Al Qura Univ, Fac Appl Sci, Chem Dept, Mecca, Saudi Arabia.	iithagafi@uqu.edu.sa	El-Said, Waleed/X-9913-2018	El-Said, Waleed/0000-0002-7052-7612; Althagafi, Ismail/0000-0002-9343-2595	Deanship of the Scientific Research (DSR), Umm Al-Qura University [15-SCI-3-1-0013]	Deanship of the Scientific Research (DSR), Umm Al-Qura University	The Authors are highly indebted to the Deanship of the Scientific Research (DSR), Umm Al-Qura University for full financial support of this work through the project number 15-SCI-3-1-0013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors are highly indebted to the Deanship of the Scientific Research (DSR), Umm Al-Qura University for full financial support of this work through the project number 15-SCI-3-1-0013.	Abdallah M. I. M., 2012, EGYPTAIN J APPL SCI, V27, P40; Arati Sharma A., 2017, ELECTROCHEMICAL IMMU, DOI [10.1016/j.msec.2017.03.146, DOI 10.1016/J.MSEC.2017.03.146]; Badea M, 2016, INT J ELECTROCHEM SC, V11, P6719, DOI 10.20964/2016.08.21; Chauhan R, 2015, FOOD CONTROL, V52, P60, DOI 10.1016/j.foodcont.2014.12.009; Chen YH, 2016, ELECTROCHIM ACTA, V205, P124, DOI 10.1016/j.electacta.2016.04.111; Eaton D.L., 1994, TOXICOLOGY AFLATOXIN, P521; El-Said WA, 2014, ELECTROCHIM ACTA, V123, P51, DOI 10.1016/j.electacta.2013.12.144; El-Said WA, 2011, J NANOSCI NANOTECHNO, V11, P6539, DOI 10.1166/jnn.2011.4377; El-Said WA, 2011, J NANOSCI NANOTECHNO, V11, P768, DOI 10.1166/jnn.2011.3268; El-Said WA, 2010, ULTRAMICROSCOPY, V110, P676, DOI 10.1016/j.ultramic.2010.02.031; Evtugyn G, 2014, ELECTROANAL, V26, P2100, DOI 10.1002/elan.201400328; Gu H, 2013, ACS APPL MATER INTER, V5, P6762, DOI 10.1021/am401738k; Guermoune A, 2011, CARBON, V49, P4204, DOI 10.1016/j.carbon.2011.05.054; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Jiang Chaoyi, SCI CHINA CHEM, DOI [10.1007/s11426-016-0015-2.2, DOI 10.1007/S11426-016-0015-2.2]; Lee KM, 2014, J AGR FOOD CHEM, V62, P4466, DOI 10.1021/jf500854u; Li PW, 2009, FOOD CHEM, V115, P313, DOI 10.1016/j.foodchem.2008.11.052; Liu YD, 2017, BIOSENS BIOELECTRON, V87, P101, DOI 10.1016/j.bios.2016.08.015; Lu YH, 2007, BIOELECTROCHEMISTRY, V71, P211, DOI 10.1016/j.bioelechem.2007.05.003; Moon J, 2012, MATERIALS, V5, P634, DOI 10.3390/ma5040634; Owino JHO, 2007, ANAL BIOANAL CHEM, V388, P1069, DOI 10.1007/s00216-007-1333-9; Owino JHO, 2008, SENSORS-BASEL, V8, P8262, DOI 10.3390/s8128262; Rameshkumar P, 2015, J ELECTROANAL CHEM, V754, P118, DOI 10.1016/j.jelechem.2015.07.011; Shim WB, 2014, BIOSENS BIOELECTRON, V62, P288, DOI 10.1016/j.bios.2014.06.059; Shim WB, 2014, FOOD CONTROL, V36, P30, DOI 10.1016/j.foodcont.2013.07.042; Shin JW, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122771; Soldatkin OO, 2013, SENSOR ACTUAT B-CHEM, V188, P999, DOI 10.1016/j.snb.2013.06.107; Srivastava S, 2014, APPL BIOCHEM BIOTECH, V174, P960, DOI 10.1007/s12010-014-0965-4; Tan Y, 2009, ANAL BIOCHEM, V387, P82, DOI 10.1016/j.ab.2008.12.030; Wang D, 2015, BIOSENS BIOELECTRON, V63, P185, DOI 10.1016/j.bios.2014.06.070; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Xu X, 2013, BIOSENS BIOELECTRON, V47, P361, DOI 10.1016/j.bios.2013.03.048; Yong Zhang, RSC ADV, DOI [10.1039/x0xx00000x, DOI 10.1039/X0XX00000X]; Zhou LT, 2012, SENSOR ACTUAT B-CHEM, V174, P359, DOI 10.1016/j.snb.2012.06.051	34	23	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210652	10.1371/journal.pone.0210652	http://dx.doi.org/10.1371/journal.pone.0210652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650140	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300068
J	Apollo, A; Ortenzi, V; Scatena, C; Zavaglia, K; Aretini, P; Lessi, F; Franceschi, S; Tomei, S; Sepich, CA; Viacava, P; Mazzanti, CM; Naccarato, AG				Apollo, Alessandro; Ortenzi, Valerio; Scatena, Cristian; Zavaglia, Katia; Aretini, Paolo; Lessi, Francesca; Franceschi, Sara; Tomei, Sara; Sepich, Carlo Alberto; Viacava, Paolo; Mazzanti, Chiara Maria; Naccarato, Antonio Giuseppe			Molecular characterization of low grade and high grade bladder cancer	PLOS ONE			English	Article							E-CADHERIN; EXPRESSION; CARCINOMA; DIAGNOSIS; PROGNOSIS; SURVIVIN; MARKERS; FGFR3; TIME	Background Bladder cancer (BC) is the 9th most common cancer diagnosis worldwide. Low grade (LG) represents 70% of all BCs, characterized by recurrence and rare ability (10-15%) to progress to high grade (HG) and invade. The remaining 30% is high grade (HG), fast invasive BC, which is resistant to therapy. Identifying biomarkers for predicting those tumors able to progress is a key goal for patient outcome improvement. This study focuses on the most promising prognostic markers. Materials and methods TP53 and FGFR3 mutational status, Survivin, CK19, CK20, E-cadherin and CD44 gene expression analysis were performed on 66 BCs. Results Survivin was found associated to tumor grade (p<0.05). Moreover, Survivin correlated with CD44 in TP53 wild type (p = 0.0242) and FGFR3 wild type (p = 0.0036) tumors. In particular the Survivin-CD44 correlation was associated to HG FGFR3 wild type BCs (p = 0.0045). Unsupervised hierarchical clustering based on gene expression data identified four distinct molecular groups reflecting the patient histology (p = 0.038). Conclusion We suggest Survivin, both as a biomarker associated to G3 BCs but negatively related to TP53 mutational status, and as a potential novel therapeutic target.	[Apollo, Alessandro] Univ Pisa, Biol Dept, Genet Unit, Pisa, Italy; [Ortenzi, Valerio; Scatena, Cristian; Zavaglia, Katia; Naccarato, Antonio Giuseppe] Univ Hosp Pisa, Dept Pathol, Pisa, Italy; [Aretini, Paolo; Lessi, Francesca; Franceschi, Sara; Mazzanti, Chiara Maria] Fdn Pisana Sci, Sect Canc Gen, Pisa, Italy; [Tomei, Sara] Sidra Med, Omics Core & Biorepository, Doha, Qatar; [Sepich, Carlo Alberto] Versilia Hosp, Div Urol, Lido Di Camaiore, Italy; [Viacava, Paolo] Hosp Livorno, Div Pathol, Livorno, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sidra Medical & Research Center; Ospedale Versilia	Apollo, A (corresponding author), Univ Pisa, Biol Dept, Genet Unit, Pisa, Italy.	alessandro.apollo@hotmail.com	Mazzanti, Chiara/AAX-6539-2021; Lessi, Francesca/AAE-6812-2022; Aretini, Paolo/AAF-1205-2020	Lessi, Francesca/0000-0002-3346-4296; Aretini, Paolo/0000-0003-1075-4319; Franceschi, Sara/0000-0002-4246-4407				Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Bachir BG, 2012, EXPERT REV ANTICANC, V12, P1499, DOI [10.1586/ERA.12.140, 10.1586/era.12.140]; Bassily NH, 2000, AM J CLIN PATHOL, V113, P383, DOI 10.1309/G1RA-EU9X-X6VV-3W79; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Chen XC, 2013, ONCOL LETT, V5, P1278, DOI 10.3892/ol.2013.1150; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hussain SA, 2005, SEMIN RADIAT ONCOL, V15, P3, DOI 10.1016/j.semradonc.2004.07.007; Jeon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076719; Khorrami MH, 2012, UROL J, V9, P581; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Lamm D, 2014, J UROLOGY, V191, P20, DOI 10.1016/j.juro.2013.07.102; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; MOLL R, 1992, AM J PATHOL, V140, P427; Neuzillet Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048993; Omran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20; Omran OM, 2012, ULTRASTRUCT PATHOL, V36, P145, DOI 10.3109/01913123.2011.651522; Ramirez D, 2016, BJU INT, V117, P783, DOI 10.1111/bju.13345; Remy E, 2015, CANCER RES, V75, P4042, DOI 10.1158/0008-5472.CAN-15-0602; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Southgate J, 1999, HISTOL HISTOPATHOL, V14, P657, DOI 10.14670/HH-14.657; Sugino T, 1996, AM J PATHOL, V149, P873; Urquidi V, 2012, CURR MED CHEM, V19, P3653, DOI 10.2174/092986712801661103; Weyerer V, 2017, J CANCER, V8, P323, DOI 10.7150/jca.17482; Wu CT, 2017, J CANCER, V8, P1137, DOI 10.7150/jca.18297; Xi RC, 2013, J SURG ONCOL, V107, P550, DOI 10.1002/jso.23272; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Zhao J, 2014, INT BRAZ J UROL, V40, P179, DOI 10.1590/S1677-5538.IBJU.2014.02.07	29	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210635	10.1371/journal.pone.0210635	http://dx.doi.org/10.1371/journal.pone.0210635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650148	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300066
J	Cheung, PC; Franks, PA; Kramer, MR; Kay, CM; Drews-Botsch, CD; Welsh, JA; Gazmararian, JA				Cheung, Patricia C.; Franks, Padra A.; Kramer, Michael R.; Kay, Christi M.; Drews-Botsch, Carolyn D.; Welsh, Jean A.; Gazmararian, Julie A.			Elementary school physical activity opportunities and physical fitness of students: A statewide cross-sectional study of schools	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK; AEROBIC FITNESS; UNITED-STATES; WEIGHT STATUS; EDUCATION; OBESITY; CHILDREN; HEALTH; YOUTH	Background Using a cross-sectional design, we assessed the relationship between the time schools provide for physical activity and the proportion of students achieving a healthy aerobic capacity or body mass index. Methods In 2013-2014, physical education and grade-level teachers from 905 of 1,244 Georgia elementary schools provided survey data about the frequency and duration of physical activity opportunities offered before, during, and after school. Log-binomial models related the weekly physical activity minutes provided by schools to the proportion of children in the FitnessGram healthy fitness zone for aerobic capacity or body mass index while adjusting for school characteristics and demographics. Results During-school physical activity time was not associated with student fitness, but schools with before-school physical activity programs had a moderately higher prevalence of healthy aerobic capacity (prevalence ratio among girls: 1.06; 99% confidence interval: 1.00-1.13; prevalence ratio among boys: 1.03; 99% confidence interval: 0.99-1.08). Each additional 30 minutes of recess per week was associated with no more than a 3%-higher proportion of students with healthy body mass indexes (prevalence ratio among girls: 1.01; 99% confidence interval: 1.00-1.03; prevalence ratio among boys: 1.01; 99% confidence interval: 0.99-1.03). Conclusions The amount of physical activity time provided by schools is not strongly associated with school-aggregated student fitness. Future studies should be designed to assess the importance of school-based physical activity time on student fitness, relative to physical activity type and quality.	[Cheung, Patricia C.; Kramer, Michael R.; Drews-Botsch, Carolyn D.; Welsh, Jean A.; Gazmararian, Julie A.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Franks, Padra A.; Kay, Christi M.] HealthMPowers, Norcross, GA USA; [Welsh, Jean A.] Emory Univ, Sch Med, Atlanta, GA USA	Emory University; Emory University	Cheung, PC (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	pccheun@emory.edu; jagazma@emory.edu	Kramer, Michael R/A-3195-2013; Drews-Botsch, Carolyn/M-8560-2016	Kramer, Michael R/0000-0002-6372-6170; Cheung, Patricia C./0000-0002-2329-0413; Drews-Botsch, Carolyn/0000-0002-8763-7404	Robert Wood Johnson Foundation [71061]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [T32HD052460]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in part, by Robert Wood Johnson Foundation (JAG, award number 71061). PCC received support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health T32 Predoctoral Training Program in Reproductive, Perinatal, and Pediatric Epidemiology (award number T32HD052460). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PAF and CMK are supported by HealthMPowers which conducted the training where some of the data were collected, but HealthMPowers did not have any role in the study design, analysis, decision to publish, or finalization of the manuscript.	Alliance for a Healthier Generation, 2015, HLTH SCH PROGR; Bai Y, 2015, J PEDIATR-US, V167, P662, DOI 10.1016/j.jpeds.2015.05.035; Beam M, 2012, PREV CHRONIC DIS, V9, P9; Camhi SM, 2011, J PEDIATR-US, V159, P303, DOI 10.1016/j.jpeds.2011.01.059; Cawley J, 2013, J HEALTH ECON, V32, P743, DOI 10.1016/j.jhealeco.2013.04.006; Centers for Disease Control and Prevention, 2013, COMPR SCH PHYS ACT P; Centers for Disease Control and Prevention, 2014, SCH HLTH IND SHI SEL; Cheung P, 2019, J SCI MED SPORT, V22, P191, DOI 10.1016/j.jsams.2018.07.015; Cheung PC, 2017, EVALUATION INTERVENT; Cooper Institute, FITNESSGRAM; Dencker M, 2007, EUR J APPL PHYSIOL, V99, P19, DOI 10.1007/s00421-006-0310-x; Dietz WH, 1998, PEDIATRICS, V101, P518; Donnelly JE, 1996, OBES RES, V4, P229, DOI 10.1002/j.1550-8528.1996.tb00541.x; Efron B., 1994, MONOGRAPHS STAT APPL; Eisenmann JC, 2007, ACTA PAEDIATR, V96, P1723, DOI 10.1111/j.1651-2227.2007.00534.x; Erfle SE, 2015, J SCHOOL HEALTH, V85, P27, DOI 10.1111/josh.12217; Fakhouri THI, 2013, JAMA PEDIATR, V167, P223, DOI 10.1001/2013.jamapediatrics.122; Foltz JL, 2011, CLIN PEDIATR, V50, P424, DOI 10.1177/0009922810393499; Friedman SL, 2003, ARCH PEDIAT ADOL MED, V157, P185; Ganley KJ, 2011, PEDIATR PHYS THER, V23, P208, DOI 10.1097/PEP.0b013e318227b3fc; Guerrero AD, 2016, J ACAD NUTR DIET, V116, P439, DOI 10.1016/j.jand.2015.08.019; Hollis JL, 2016, PREV MED, V86, P34, DOI 10.1016/j.ypmed.2015.11.018; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Jelalian E, 2012, AM J LIFESTYLE MED, V6, P505, DOI 10.1177/1559827612458633; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Juonala M, 2010, EUR HEART J, V31, P1745, DOI 10.1093/eurheartj/ehq141; Kahan D, 2015, AM J PUBLIC HEALTH, V105, P653, DOI 10.2105/AJPH.2014.302355; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Kristensen PL, 2013, J SPORT SCI, V31, P188, DOI 10.1080/02640414.2012.723818; Laurson KR, 2011, AM J PREV MED, V41, pS100, DOI 10.1016/j.amepre.2011.07.004; Lounsbery MAF, 2013, J PHYS ACT HEALTH, V10, P496, DOI 10.1123/jpah.10.4.496; Madsen KA, 2009, ARCH PEDIAT ADOL MED, V163, P1014, DOI 10.1001/archpediatrics.2009.181; Martin K, 2012, AUST NZ J PUBL HEAL, V36, P469, DOI 10.1111/j.1753-6405.2012.00914.x; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miller DP, 2011, SOC SCI MED, V72, P677, DOI 10.1016/j.socscimed.2010.12.003; National Center for Education Statistics, FAST FACTS; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Plowman SA., 2013, FITNESSGRAM ACTIVITY, V3, P7; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Resaland GK, 2011, SCAND J MED SCI SPOR, V21, P302, DOI 10.1111/j.1600-0838.2009.01028.x; Richter TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115063; Roberts CK, 2010, J PEDIATR-US, V156, P711, DOI 10.1016/j.jpeds.2009.11.039; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Sallis JF, 1997, AM J PUBLIC HEALTH, V87, P1328, DOI 10.2105/AJPH.87.8.1328; Saydah S, 2013, PEDIATRICS, V131, pE679, DOI 10.1542/peds.2012-2583; Society of Health and Phys, 2016, 2016 SHAP NAT STAT P; UCLA Center to Eliminate Health Disparities, 2007, FAIL FITN PHYS ACT P; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; Zaqout M, 2016, INT J PUBLIC HEALTH, V61, P573, DOI 10.1007/s00038-016-0811-2	49	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210444	10.1371/journal.pone.0210444	http://dx.doi.org/10.1371/journal.pone.0210444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645628	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200032
J	Chu, TL; Wang, J; Monrouxe, L; Sung, YC; Kuo, CL; Ho, LH; Lin, YE				Chu, Tsung-Lan; Wang, Jeng; Monrouxe, Lynn; Sung, Yu-Chih; Kuo, Chen-li; Ho, Lun-Hui; Lin, Yueh-E			The effects of the flipped classroom in teaching evidence based nursing: A quasi-experimental study	PLOS ONE			English	Article							EDUCATION; FACULTY	Background Evidence-based nursing (EBN) has been an important training mechanism for improving the quality of clinical care. At present, the pedagogy focuses on the application of e-learning and team-based learning to enhance learners' engagement and learning effectiveness. Objectives This study applied the flipped classroom approach to conduct evidence-based nursing (EBN) teaching. The aim of this study is to elevate the learning effectiveness of the flipped classroom group to the traditional teaching group in terms of knowledge and self-efficacy in practice. Design A pretest-posttest nonequivalent control group with a quasi-experimental quantitative design. Methods The study recruited 151 nurses, of whom 75 were in the control group and 76 were in the experimental group. During the EBN course, the control group received training via traditional pedagogy while the experimental group engaged the flipped classroom approach. The learning effectiveness of EBN knowledge and self-efficacy in practice were evaluated across the three time points: pre-course, post-course, and one month after the course. Results In both group the scores of the EBN knowledge and self-efficacy in practice improved after training. The scores of the experimental group increased significantly than in the control group. However, the scores declined in both groups one month after the course. Even so, the experimental group's score of self-efficacy in practice was still higher than that of the control group. Conclusion The implementation of the flipped classroom approach and team-based learning effectively enhanced the learners EBN knowledge accumulation and self-efficacy in practice. The research results can be used as an important reference for improving clinical nursing teaching quality.	[Chu, Tsung-Lan] Chang Gung Med Fdn, Dept Qual Management, Adm Ctr, Taoyuan, Taiwan; [Chu, Tsung-Lan; Wang, Jeng; Ho, Lun-Hui; Lin, Yueh-E] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Wang, Jeng; Sung, Yu-Chih; Kuo, Chen-li; Ho, Lun-Hui; Lin, Yueh-E] Linkou Chang Gung Mem Hosp, Dept Nursing, Taoyuan, Taiwan; [Monrouxe, Lynn] Chang Gung Mem Hosp, Chang Gung Med Educ Res Ctr, Gueishan, Taiwan; [Kuo, Chen-li] Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan; [Lin, Yueh-E] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Taipei University of Nursing & Health Science (NTUNHS)	Lin, YE (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan.; Lin, YE (corresponding author), Linkou Chang Gung Mem Hosp, Dept Nursing, Taoyuan, Taiwan.; Lin, YE (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan.	amy436643@cgmh.org.tw	Monrouxe, Lynn/AAG-9817-2019; Monrouxe, Lynn Valerie/H-6770-2012	Lin, Yueh E/0000-0003-3216-2613; Monrouxe, Lynn Valerie/0000-0002-4895-1812	MOST [NMRPG3F0541]; Chang Gung Memorial Hospital	MOST(Ministry of Science & Technology (MOST), Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors who received the fund: TLC, Grant No. MOST NMRPG3F0541, The name of funder: Chang Gung Memorial Hospital, URL: www.cgmh.org.tw.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash K, 2012, ED WEEK, V32, ps6; Benner P., 2009, ED NURSES CALL RADIC; Betihavas V, 2016, NURS EDUC TODAY, V38, P15, DOI 10.1016/j.nedt.2015.12.010; Burden ML, 2015, NURS EDUC, V40, P233, DOI 10.1097/NNE.0000000000000162; Chang AM, 2011, WORLDV EVID-BASED NU, V8, P106, DOI 10.1111/j.1741-6787.2011.00215.x; Chen JL, 2015, J FAR E U GEN ED, V9, P1; Chen KS, 2018, MED EDUC, V52, P910, DOI 10.1111/medu.13616; Chen YC, 2014, LEADERSHIP NURSING, V15, P2; Chen Yu-Chih, 2013, Hu Li Za Zhi, V60, P25, DOI 10.6224/JN.60.5.25; CHIA HN, 2015, J LANGUAGE LIT STUDI, V9, DOI DOI 10.1186/S13036-015-0001-4; DeBruyn Rebecca R., 2014, Invest. educ. enferm, V32, P9, DOI 10.17533/udea.iee.v32n1a02; Dickinson S, 2012, CRIT CARE NURS Q, V35, P1, DOI 10.1097/CNQ.0b013e31823d6d3f; Eizenberg MM, 2011, J ADV NURS, V67, P33, DOI 10.1111/j.1365-2648.2010.05488.x; Fawcett J, 2012, NURS SCI QUART, V25, P199, DOI 10.1177/0894318412437967; Fulton CR, 2014, J PROF NURS, V30, P292, DOI 10.1016/j.profnurs.2014.01.004; Fulton K., 2012, LEARNING LEADING TEC, V38, P12; Geist MJ, 2015, NURS EDUC PERSPECT, V36, P114, DOI 10.5480/13-1292; Gilboy MB, 2015, J NUTR EDUC BEHAV, V47, P109, DOI 10.1016/j.jneb.2014.08.008; Herreid C. F., 2013, J COLL SCI TEACH, V42, P62, DOI DOI 10.4108/EL.1.3.E1; Hsiao HS, 2015, LIVING TECHNOLOGY ED, V38, P40; Hsu Li-Ling, 2015, Hu Li Za Zhi, V62, P30, DOI 10.6224/JN62.5.30; Ilic D, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-169; Jeffers BR, 2008, J NURSES PROF DEV, V24, pE8, DOI 10.1097/01.NND.0000320688.57308.f9; Johnston JM, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-63; Koehn ML, 2008, J ADV NURS, V62, P209, DOI 10.1111/j.1365-2648.2007.04589.x; Kuo C.-C., 2014, TAIWAN ED REV, V686, P9; Lee C.Y., 2011, NEW TAIPEI J NUR, V13, P19, DOI [10.6540/NTJN.2011.1.003, DOI 10.6540/NTJN.2011.1.003, 10.6540/ntjn.2011.1.003]; Leung JYC, 2014, MED EDUC, V48, P1127, DOI 10.1111/medu.12576; Lu HC, 2008, J IND TECHNOLOGY ED, P41; Mattis KV, 2015, TECHNOL KNOWL LEARN, V20, P231, DOI 10.1007/s10758-014-9238-0; McConnell ES, 2009, J GERONTOL NURS, V35, P26, DOI 10.3928/00989134-20090401-10; McConnell ES, 2009, J GERONTOL NURS, V35, P34; Melnyk BM, 2010, AM J NURS, V110, P51, DOI 10.1097/01.NAJ.0000366056.06605.d2; Presti CR, 2016, J NURS EDUC, V55, P252, DOI 10.3928/01484834-20160414-03; Reiber Karin, 2011, GMS Z Med Ausbild, V28, pDoc27, DOI 10.3205/zma000739; Rosas LG, 2014, PATIENT EDUC COUNS, V97, P244, DOI 10.1016/j.pec.2014.07.018; Sams A, 2013, EDUC LEADERSHIP, V70, P16; Shy ST, 2014, J GEN EDUC, V2, P177; Tsai YM, 2010, J NURSING HEALTHCARE, V6, P79, DOI DOI 10.7091/SS; von Klitzing Waltraut, 2007, Pflege, V20, P41, DOI 10.1024/1012-5302.20.1.41; Weisgram Brian, 2008, Medsurg Nurs, V17, P429	42	14	14	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210606	10.1371/journal.pone.0210606	http://dx.doi.org/10.1371/journal.pone.0210606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645609	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200040
J	Duquette, P; Yeung, M; Mouallif, S; Nakhaipour, HR; Haddad, P; Schecter, R				Duquette, Pierre; Yeung, Michael; Mouallif, Soukaina; Nakhaipour, Hamid Reza; Haddad, Paola; Schecter, Robyn			A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies	PLOS ONE			English	Article							ADHERENCE; FINGOLIMOD; PERSISTENCE; IMPACT	Background Compliance to disease modifying therapy (DMT) is associated with a reduced risk of relapse, lower healthcare resource utilization, and improved health-related quality of life in patients with multiple sclerosis (MS). Our objective was to assess the compliance and discontinuation rates of fingolimod relative to other oral, injectable, and infusible DMTs available on the market at the time of the study in Canada in patients with relapsing-remitting MS (RRMS). Methods and findings We conducted a retrospective claims analysis. Patients with RRMS with. 1 prescription for each DMT were included. Compliance (medication possession ratio of. 80%) and discontinuation (gap > 30 days from the end of the index prescription) were calculated at the 6-, 12-and 24-month time points. Compliance with fingolimod at the 6-, 12-and 24-month time points was 75%, 75% and 70%, respectively; compared with DMF [70% (P < 0.001), 68% (P < 0.001), and 56% (P < 0.001), respectively], and BRACE [53% (P < 0.001), 47% (P < 0.001), and 35% (P < 0.001), respectively]. Compliance with fingolimod was comparable to teriflunomide at each time point, but was higher compared to natalizumab [70% versus 57% (P < 0.001)] at the 24-month time point. At the 6-, 12-and 24-month time points, patients on fingolimod had the lowest discontinuation rate (26%, 24%, and 29%, respectively) compared to BRACE [49% (P < 0.001), 44% (P < 0.001), and 57% (P < 0.001)], respectively], and natalizumab [33% (P < 0.001), 29% (P < 0.001), and 45% (P < 0.001), respectively], and was similar to teriflunomide (26%, 25%, and 31%, respectively). Conclusions The compliance rate in fingolimod treated patients at the 24 month time point was higher than that observed in natalizumab treated patients. The discontinuation rate was lower with fingolimod compared to other DMTs at all time points but was similar to teriflunomide.	[Duquette, Pierre] Univ Montreal, Notre Dame Hosp, Montreal, PQ, Canada; [Yeung, Michael] Univ Calgary, Multiple Sclerosis Clin, Calgary, AB, Canada; [Mouallif, Soukaina; Nakhaipour, Hamid Reza; Haddad, Paola; Schecter, Robyn] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada	Universite de Montreal; University of Calgary; Novartis	Schecter, R (corresponding author), Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada.	robyn.schecter@novartis.com		Schecter, Robyn/0000-0002-7229-121X	Novartis Pharmaceuticals Canada Inc.	Novartis Pharmaceuticals Canada Inc.	This research was funded by Novartis Pharmaceuticals Canada Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Soukaina Mouallif, Hamid Reza Nakhaipour, Paola Haddad, and Robyn Schecter are employees of Novartis Pharmaceuticals Canada Inc. The specific roles of these authors are articulated in the 'author contributions' section.	Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; Bergvall Niklas, 2014, J Med Econ, V17, P696, DOI 10.3111/13696998.2014.940422; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Freedman MS, 2018, CAN J NEUROL SCI, V45, P489, DOI 10.1017/cjn.2018.17; Girouard N, 2011, PATIENT PREFER ADHER, V5, P101, DOI 10.2147/PPA.S10506; Johnson Kristen M, 2017, J Manag Care Spec Pharm, V23, P844, DOI 10.18553/jmcp.2017.23.8.844; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; MSIF, 2016, ATL MS 2013; Oleen-Burkey M A, 2011, J Med Econ, V14, P739, DOI 10.3111/13696998.2011.618517; Portaccio E, 2009, CNS DRUGS, V23, P453, DOI 10.2165/00023210-200923060-00001; Remington Gina, 2013, Int J MS Care, V15, P36, DOI 10.7224/1537-2073.2011-038; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Wingerchuk DM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3518; Yermakov S, 2015, J MED ECON, V18, P711, DOI 10.3111/13696998.2015.1044276	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210417	10.1371/journal.pone.0210417	http://dx.doi.org/10.1371/journal.pone.0210417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640935	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000028
J	Arhoune, B; Oumokhtar, B; Hmami, F; El Fakir, S; Moutaouakkil, K; Chami, F; Bouharrou, A				Arhoune, Btissam; Oumokhtar, Bouchra; Hmami, Fouzia; El Fakir, Samira; Moutaouakkil, Kaoutar; Chami, Fouzia; Bouharrou, Abdelhak			Intestinal carriage of antibiotic resistant Acinetobacter baumannii among newborns hospitalized in Moroccan neonatal intensive care unit	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MULTIPLEX PCR; RISK-FACTORS; COLONIZATION; GENES; CARBAPENEMASES; PREVALENCE; IMIPENEM; THREAT; SPP.	This study was conducted in order to assess the acquisition rate of Acinetobacter baumannii by newborn screening, on admission and during the discharge process of neonatal intensive care unit. (NICU). Furthermore, we investigated risk factors for potential colonization and molecular epidemiology of isolated resistant bacteria. This prospective study was conducted in the neonatal unit of Hassan II University Hospital of Fez from February 2013 to July 2015. During this period, all consecutive admitted neonates were screened for A. baumannii intestinal carriage, on admission and during the discharge process. Bacteriological and molecular tests were evaluated according to the international standards. This study examines the screening on admission of 455 newborns, 59% of whom were male. The average gestational age and birth weight were 35.2 weeks and 2612.1 g respectively. In total, 277 patients were included in the acquisition study on admission. The prevalence of multi-drug resistant (MDR) A. baumannii strain carriage was 6.5%, while the acquisition rate during the hospital recovery was 13.7%. In this study, 68 MDR A. baumannii isolates were collected. The resistance rates to different antibiotic classes including, Ceftazidime, Gentamycin and Ciprofloxacin varied between 92 and 100%. Moreover, 13% of MDR A. baumannii isolates were carbapenemase producers and 88% harbored bla(OXA-23)gene. On admission, three risk factors were significantly associated with A. baumannii colonization: age (OR, 2.803; IC95%, 1.191-6.596; P = 0.01), gender (OR, 0.382; IC95%, 0.158-0.921; P = 0.03) and the delivery birth at the Maternity of University Hospital (MUH), (OR, 0.196; IC95%, 0.071-0.540; P = 0.002). However during hospitalization, the only risk factor associated with acquisition of A. baumannii was the respiratory distress (OR, 2.270; IC95%, 1.055-4.881; P = 0.03). A high intestinal carriage rate of A. baumannii and multiple antibiotic resistance were found in our NICU. Thus, the spread of MDR A. baumannii should be monitored by an active surveillance strategy.	[Arhoune, Btissam; Oumokhtar, Bouchra; Moutaouakkil, Kaoutar] Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Microbiol & Mol Biol, Fes, Morocco; [Arhoune, Btissam; Chami, Fouzia] Sidi Mohammed Ben Abdellah Univ, Biotechnol Lab, Fac Sci Dhar El Mahraz, Fes, Morocco; [Hmami, Fouzia; Bouharrou, Abdelhak] Univ Hosp Hassan II, Neonatal Intens Care Unit, Fes, Morocco; [El Fakir, Samira] Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Epidemiol & Clin Res, Fes, Morocco	Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez	Oumokhtar, B (corresponding author), Sidi Mohammed Ben Abdellah Univ, Fac Med & Pharm, Lab Microbiol & Mol Biol, Fes, Morocco.	bouchra.oumokhtar@usmba.ac.ma		oumokhtar, bouchra/0000-0001-8186-4000	University Hospital Hassan II (Fez, Morocco)	University Hospital Hassan II (Fez, Morocco)	This study was supported by the University Hospital Hassan II (Fez, Morocco). The institution did not participate in the study design, the collection of data collection, the analysis, the decision to publish, nor the writing of the manuscript.	Aljindan R, 2015, J MED MICROBIOL, V64, P400, DOI 10.1099/jmm.0.000033; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carbapenemase O, 2010, WORLDWIDE DISSEMINAT, V16, P1; Cisneros-Herreros Jose Miguel, 2005, Enferm Infecc Microbiol Clin, V23 Suppl 3, P46; Corbella X, 1996, RELEVANCE DIGESTIVE; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Djahmi N, 2014, EPIDEMIOLOGY CARBAPE, V2014; Ehlers MM, 2012, ANTIBIOTIC RESISTANT BACTERIA - A CONTINUOUS CHALLENGE IN THE NEW MILLENNIUM, P213; el kadi MA, 2006, MED MALADIES INFECT, V36, P386, DOI 10.1016/j.medmal.2006.05.003; Elkalioubie A, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.09.01; Ertugrul S, 2016, RISK FACTORS HLTH CA, V26; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Feizabadi MM, 2008, JPN J INFECT DIS, V61, P274; Lortholary O, 2016, COLONIZATION ACINETO, V19, P188; Manchanda V, 2010, MULTIDRUG RESISTANT, V3; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Masse J, 2017, EUR J CLIN MICROBIOL, V36, P797, DOI 10.1007/s10096-016-2863-x; Moati A, 2009, PALESTINE, P623; Moghnieh R, 2016, J HOSP INFECT, V92, P47, DOI 10.1016/j.jhin.2015.10.007; Nordmann P., 2010, CARBAPENEMES CHEZ BA, V26; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x; Park SY, 2013, INFECT CHEMOTHER, V45, P325, DOI 10.3947/ic.2013.45.3.325; Playford EG, 2007, CARBAPENEM RESISTANT, P204; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Safari M, 2015, SAUDI J BIOL SCI, V22, P424, DOI 10.1016/j.sjbs.2015.01.004; Thuy DB, PLOS ONE; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Ulu-Kilic A., 2013, OA CRIT CARE, V1; Uwingabiye J, 2017, ANTIMICROB RESIST IN, V6; Wei HM, 2015, J MICROBIOL IMMUNOL, V48, P531, DOI 10.1016/j.jmii.2014.08.025; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yesilbag Z, 2014, BULLET KABUL EDIL TA; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769; Zhang De-Shuang, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P14; Zhou BIN, 2016, CLIN MICROBIOLOGICAL, P3621	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209425	10.1371/journal.pone.0209425	http://dx.doi.org/10.1371/journal.pone.0209425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629614	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000025
J	Braun, C; Alcazar-Roman, AR; Laska, A; Molleken, K; Fleig, U; Hegemann, JH				Braun, Corinna; Alcazar-Roman, Abel R.; Laska, Alexandra; Moelleken, Katja; Fleig, Ursula; Hegemann, Johannes H.			CPn0572, the C. pneumoniae ortholog of TarP, reorganizes the actin cytoskeleton via a newly identified F-actin binding domain and recruitment of vinculin	PLOS ONE			English	Article							CHLAMYDIA EFFECTOR TARP; FISSION YEAST; ARP2/3 COMPLEX; EXPRESSION; INTERACTS; PROMOTE; PROTEIN; SYSTEM; KINASE; ENTRY	Chlamydia pneumoniae is one of the two major species of the Chlamydiaceae family that have a profound effect on human health. C. pneumoniae is linked to a number of severe acute and chronic diseases of the upper and lower respiratory tract including pneumonia, asthma, bronchitis and infection by the pathogen might play a role in lung cancer. Following adhesion, Chlamydiae secrete effector proteins into the host cytoplasm that modulate the actin cytoskeleton facilitating internalization and infection. Members of the conserved TarP protein family comprise such effector proteins that polymerize actin, and in the case of the C. trachomatis TarP protein, has been shown to play a critical role in pathogenesis. In a previous study, we demonstrated that, upon bacterial invasion, the C. pneumoniae TarP family member CPn0572 is secreted into the host cytoplasm and recruits and associates with actin via an actin-binding domain conserved in TarP proteins. We have now extended our analysis of CPn0572 and found that the CPn0572 actin binding and modulating capability is more complex. With the help of the fission yeast system, a second actin modulating domain was identified independent of the actin binding domain. Microscopic analysis of HEp-2 cells expressing different CPn0572 deletion variants mapped this domain to the C-terminal part of the protein as CPn0572(536-755) binds F-actin in vitro and colocalizes with aberrantly thickened actin cables in vivo. Finally, microscopic and bioinformatic analysis revealed the existence of a vinculin binding sequence in CPn0572. Our findings contribute to the understanding of the function of the TarP family and underscore the existence of several actin binding domains and a vinculin binding site for host actin modulation.	[Braun, Corinna; Laska, Alexandra; Moelleken, Katja; Hegemann, Johannes H.] Heinrich Heine Univ, Inst Funct Microbial Genom, Dusseldorf, Germany; [Alcazar-Roman, Abel R.; Fleig, Ursula] Heinrich Heine Univ, Inst Funct Microbial Genom, Eukaryot Microbiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Heinrich Heine Univ, Inst Funct Microbial Genom, Dusseldorf, Germany.	johannes.hegemann@hhu.de		Hegemann, Johannes H./0000-0003-4733-2435; Alcazar-Roman, Abel R./0000-0003-1668-1886	Deutsche Forschungsgemeinschaft [FL 168/5-1, HE 1383/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft research grants FL 168/5-1 (UF) and HE 1383/13-1 (JHH) http://www.dfg.de.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Asadi F, 2016, G3-GENES GENOM GENET, V6, P3399, DOI 10.1534/g3.116.032664; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Blasi F., 1998, Clin Microbiol Infect, V4 Suppl 4, pS1; Blasi Francesco, 1996, Clin Microbiol Infect, V1 Suppl 1, pS14, DOI 10.1111/j.1469-0691.1996.tb00585.x; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Chang F, 2017, MOL BIOL CELL, V28, P1819, DOI 10.1091/mbc.E16-09-0671; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; DAHLEN GH, 1995, ATHEROSCLEROSIS, V114, P165, DOI 10.1016/0021-9150(94)05480-7; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Huang JQ, 2012, J CELL BIOL, V199, P831, DOI 10.1083/jcb.201209044; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Jiwani S, 2012, BIOCHEM BIOPH RES CO, V420, P816, DOI 10.1016/j.bbrc.2012.03.080; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Lamason RL, 2016, CELL, V167, P670, DOI 10.1016/j.cell.2016.09.023; Leonhardt C, 2014, NANOMED-NANOTECHNOL, V10, P679, DOI 10.1016/j.nano.2013.11.008; MARKS J, 1986, J CELL SCI, P229; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Parrett CJ, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00084; Pohlmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004586; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.3.CO;2-D; Thwaites T, 2014, J BIOL CHEM, V289, P30426, DOI 10.1074/jbc.M114.604876; Thwaites TR, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/foimb.2015.00088, 10.3389/fcimb.2015.00088]; Tolchard J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20290-8; Whitewood AJ, 2018, FEBS LETT, V592, P1751, DOI 10.1002/1873-3468.13074; Zilio N, 2012, YEAST, V29, P425, DOI 10.1002/yea.2920; Zrieq R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00511	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210403	10.1371/journal.pone.0210403	http://dx.doi.org/10.1371/journal.pone.0210403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629647	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000080
J	Chavez, RD; Sohn, P; Serra, R				Chavez, Robert Dalton; Sohn, Philip; Serra, Rosa			Prg4 prevents osteoarthritis induced by dominant-negative interference of TGF-ss signaling in mice	PLOS ONE			English	Article							MURINE KNEE-JOINT; ARTICULAR-CARTILAGE; RADIOGRAPHIC OSTEOARTHRITIS; DIFFERENTIAL REGULATION; SOX9 PROTEIN; ZONE PROTEIN; FALLS RISK; BETA; EXPRESSION; PAIN	Objective Prg4, also known as Lubricin, acts as a joint/boundary lubricant. Prg4 has been used to prevent surgically induced osteoarthritis (OA) in mice. Surgically induced OA serves as a good model for post-traumatic OA but is not ideal for recapitulating age-related OA. Reduced expression of the TGF-beta type II receptor (TGF beta R2) is associated with age-related OA in clinical samples, so we previously characterized a mouse model that exhibits OA due to expression of a mutated dominant-negative form of TGF beta R2 (DNIIR). Prg4 expression was significantly reduced in DNIIR mice. Furthermore, we showed that Prg4 was a transcriptional target of TGF-ss via activation of Smad3, the main signal transducing protein for TGF-ss. The objective of the present study was to determine whether maintenance of Prg4, a down-stream transcriptional target of TGF-ss, prevents OA associated with attenuated TGF-ss signaling in mice. Design Wild-type, DNIIR, and bitransgenic mice that express both DNIIR and Prg4, were compared. Mice were assessed with a foot misplacement behavioral test, mu CT, histology, and Western blot. Results Compared to DNIIR mice, bitransgenic DNIIR+Prg4 mice missed 1.3 (0.4, 2.1) fewer steps while walking (mean difference (95% confidence interval)), exhibited a cartilage fibrillation score that was 1.8 (0.4, 3.1) points lower, exhibited cartilage that was 28.2 (0.5, 55.9) mu m thicker, and exhibited an OARSI score that was 6.8 (-0.9, 14.5) points lower. However, maintenance of Prg4 expression did not restore levels of phosphorylated Smad3 in DNIIR mice, indicating Prg4 does not simply stimulate TGF-ss signaling. Conclusions Our results indicate that maintenance of Prg4 expression prevents OA progression associated with reduced TGF-beta signaling in mice. Since there was no evidence that Prg4 acts by stimulating the TGF-ss signaling cascade, we propose that Prg4, a transcriptional target of TGF-ss, attenuates OA progression through its joint lubrication function.	[Chavez, Robert Dalton] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Sohn, Philip; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	rserra@uab.edu			HHMI [56005705];  [R01 AR062507];  [T32 AR069516];  [P30 NS47466];  [P30 DK079626]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062507, T32AR069516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); ; ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by R01 AR062507 to RS, HHMI 56005705 (PI Patel) to RDC, and T32 AR069516 (PI Bridges) to RDC. The UAB Neuroscience Behavioral Assessment Core is funded by P30 NS47466. The UAB Small Animal Phenotyping Core is funded by P30 DK079626. The study sponsors had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript.	Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Al-Sharif A, 2015, ARTHRITIS RHEUMATOL, V67, P1503, DOI 10.1002/art.39087; Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; BROWN T D, 1984, Journal of Orthopaedic Research, V2, P190, DOI 10.1002/jor.1100020210; Chavez RD, 2017, OSTEOARTHR CARTILAGE, V25, P332, DOI 10.1016/j.joca.2016.10.007; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; DuRaine GD, 2011, OSTEOARTHR CARTILAGE, V19, P103, DOI 10.1016/j.joca.2010.10.008; EMERY IH, 1973, J ANAT, V116, P103; Falah M, 2010, INT ORTHOP, V34, P621, DOI 10.1007/s00264-010-0959-y; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Gardiner MD, 2015, OSTEOARTHR CARTILAGE, V23, P616, DOI 10.1016/j.joca.2014.12.014; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; IHCWorld, H E STAIN PROT; IHCWorld, SAFR STAIN PROT CART; Iqbal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18910; Jay GD, 2012, ARTHRITIS RHEUM-US, V64, P1162, DOI 10.1002/art.33461; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Levy AS, 1996, AM J SPORT MED, V24, P634, DOI 10.1177/036354659602400512; Neu CP, 2010, ARTHRITIS RHEUM-US, V62, P2680, DOI 10.1002/art.27577; Niikura T, 2007, ARTHRITIS RHEUM, V56, P2312, DOI 10.1002/art.22659; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Ramaswamy G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3762; ROBERTS S, 1986, J BONE JOINT SURG BR, V68, P418, DOI 10.1302/0301-620X.68B3.3733808; Roemhildt ML, 2006, J BIOMECH, V39, P2331, DOI 10.1016/j.jbiomech.2005.07.017; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Ruan MZC, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.8; RUAN MZ, 2013, SCI TRANSLATIONAL ME, V0005; Scharstuhl A, 2002, ANN RHEUM DIS, V61, P1095, DOI 10.1136/ard.61.12.1095; Schmidt TA, 2008, OSTEOARTHR CARTILAGE, V16, P90, DOI 10.1016/j.joca.2007.05.009; Scott D, 2012, ARTHRIT CARE RES, V64, P30, DOI 10.1002/acr.20545; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Stuart K, 2017, OSTEOARTHR CARTILAGE, V25, pS415, DOI 10.1016/j.joca.2017.02.717; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Tsonga T, 2015, CLIN ORTHOP SURG, V7, P449, DOI 10.4055/cios.2015.7.4.449; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Wang Q, 2017, OSTEOARTHR CARTILAGE, V25, P1868, DOI 10.1016/j.joca.2017.07.010; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210601	10.1371/journal.pone.0210601	http://dx.doi.org/10.1371/journal.pone.0210601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629676	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000116
J	Gruenstaeudl, M; Hartmaring, Y				Gruenstaeudl, Michael; Hartmaring, Yannick			EMBL2checklists: A Python package to facilitate the user-friendly submission of plant and fungal DNA barcoding sequences to ENA	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-BIOLOGY; REGION	Background The submission of DNA sequences to public sequence databases is an essential, but insufficiently automated step in the process of generating and disseminating novel DNA sequence data. Despite the centrality of database submissions to biological research, the range of available software tools that facilitate the preparation of sequence data for database submissions is low, especially for sequences generated via plant and fungal DNA bar-coding. Current submission procedures can be complex and prohibitively time expensive for any but a small number of input sequences. A user-friendly software tool is needed that streamlines the file preparation for database submissions of DNA sequences that are commonly generated in plant and fungal DNA barcoding. Methods A Python package was developed that converts DNA sequences from the common EMBL and GenBank flat file formats to submission-ready, tab-delimited spreadsheets (so-called 'checklists') for a subsequent upload to the annotated sequence section of the European Nucleotide Archive (ENA). The software tool, titled 'EMBL2checklists', automatically converts DNA sequences, their annotation features, and associated metadata into the idiosyncratic format of marker-specific ENA checklists and, thus, generates files that can be uploaded via the interactive Webin submission system of ENA. Results EMBL2checklists provides a simple, platform-independent tool that automates the conversion of common DNA barcoding sequences into easily editable spreadsheets that require no further processing but their upload to ENA via the interactive Webin submission system. The software is equipped with an intuitive graphical as well as an efficient command-line interface for its operation. The utility of the software is illustrated by its application in four recent investigations, including plant phylogenetic and fungal metagenomic studies. Discussion EMBL2checklists bridges the gap between common software suites for DNA sequence assembly and annotation and the interactive data submission process of ENA. It represents an easy-to-use solution for plant and fungal biologists without bioinformatics expertise to generate submission-ready checklists from common DNA sequence data. It allows the post-processing of checklists as well as work-sharing during the submission process and solves a critical bottleneck in the effort to increase participation in public data sharing.	[Gruenstaeudl, Michael] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hartmaring, Yannick] Free Univ Berlin, Inst Bioinformat, Berlin, Germany	Free University of Berlin; Free University of Berlin	Gruenstaeudl, M (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	m.gruenstaeudl@fu-berlin.de	Gruenstaeudl, Michael/W-6050-2019	Gruenstaeudl, Michael/0000-0002-1666-1773	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [418670221]; Freie Universitat Berlin (Initiativmittel der Forschungskommission)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Freie Universitat Berlin (Initiativmittel der Forschungskommission)	This investigation was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project number 418670221 - and by a start-up grant of the Freie Universitat Berlin (Initiativmittel der Forschungskommission), both to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; .	Amid C, 2012, NUCLEIC ACIDS RES, V40, pD43, DOI 10.1093/nar/gkr946; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Blaxter M, 2016, SCIENCE, V352, P780, DOI 10.1126/science.aaf7672; Borsch T, 2018, TAXON, V67, P944, DOI 10.12705/675.7; Buyya R, 2005, P IEEE, V93, P698, DOI 10.1109/JPROC.2004.842784; Canal D, 2018, AM J BOT, V105, P1035, DOI 10.1002/ajb2.1111; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dean GH, 2018, APPL PLANT SCI, V6, DOI 10.1002/aps3.1167; Drew Bryan T., 2013, PLoS Biology, V11, P1; Fairbairn DJ, 2011, EVOLUTION, V65, P1, DOI 10.1111/j.1558-5646.2010.01182.x; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hankeln W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024797; Harrison PW, 2019, NUCLEIC ACIDS RES, V47, pD84, DOI 10.1093/nar/gky1078; Hartmaring Y., 2018, AUSBAU SOFTWARE SCRI; Heckenhauer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185861; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang XL, 2012, CONSERV LETT, V5, P399, DOI 10.1111/j.1755-263X.2012.00259.x; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Karsch-Mizrachi I, 2018, NUCLEIC ACIDS RES, V46, pD48, DOI 10.1093/nar/gkx1097; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan S, 2017, J NETW COMPUT APPL, V88, P99, DOI 10.1016/j.jnca.2017.02.013; Kodama Y, 2018, NUCLEIC ACIDS RES, V46, pD30, DOI 10.1093/nar/gkx926; Korotkova N, 2018, J SYST EVOL, V56, P35, DOI 10.1111/jse.12276; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2017, J SYST EVOL, V55, P291, DOI 10.1111/jse.12254; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu JX, 2014, MOL ECOL RESOUR, V14, P1231, DOI 10.1111/1755-0998.12262; Mons Barend, 2017, Information Services & Use, V37, P49, DOI 10.3233/ISU-170824; Mueller J, 2010, PHYDE PHYLOGENETIC D; NEUHAUS H, 1987, CURR GENET, V11, P251, DOI 10.1007/BF00355398; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; Norling Martin, 2018, BMC Res Notes, V11, P584, DOI 10.1186/s13104-018-3686-x; Page A, 2016, J OPEN SOURCE SOFTWA, V1, P8, DOI [10.21105/joss.00080, DOI 10.21105/JOSS.00080]; Pajankar A., 2017, PYTHON UNIT TEST AUT; Pei NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15127; Pirovano W, 2017, BRIEF BIOINFORM, V18, P179, DOI 10.1093/bib/bbv104; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roche DG, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002295; Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779; Roy J, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix102; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silvester N, 2018, NUCLEIC ACIDS RES, V46, pD36, DOI 10.1093/nar/gkx1125; Soltis DE, 1997, ANN MO BOT GARD, V84, P1, DOI 10.2307/2399952; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tan SL, 2018, ECOL EVOL, V8, P7195, DOI 10.1002/ece3.4254; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wicke S, 2009, ANAL JARDIN BOT MAD, V66, P285, DOI 10.3989/ajbm.2231; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Williams J, 2018, QUBES ED RESOURCES; Xu JP, 2016, GENOME, V59, P913, DOI 10.1139/gen-2016-0046	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210347	10.1371/journal.pone.0210347	http://dx.doi.org/10.1371/journal.pone.0210347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629718	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000076
J	Ito, JT; Cervilha, DAD; Lourenco, JD; Goncalves, NG; Volpini, RA; Caldini, EG; Landman, G; Lin, CJ; Velosa, APP; Teodoro, WPR; Tiberio, IDLC; Mauad, T; Martins, MD; Macchione, M; Lopes, FDTQD				Ito, Juliana Tiyaki; de Brito Cervilha, Daniela Aparecida; Lourenco, Juliana Dias; Goncalves, Natalia Gomes; Volpini, Rildo Aparecido; Caldini, Elia Garcia; Landman, Gilles; Lin, Chin Jia; Pereira Velosa, Ana Paula; Rosolia Teodoro, Walcy Paganelli; Lopes Calvo Tiberio, Iolanda de Fatima; Mauad, Thais; Martins, Milton de Arruda; Macchione, Mariangela; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio			Th17/Treg imbalance in COPD progression: A temporal analysis using a CS-induced model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MOUSE MODEL; LUNG; CELLS; EXPRESSION; INFLAMMATION; RESPONSES; IMMUNITY; TH17; REG	Background The imbalance between pro- and anti-inflammatory immune responses plays a pivotal role in chronic obstructive pulmonary disease (COPD) development and progression. To clarify the pathophysiological mechanisms of this disease, we performed a temporal analysis of immune response-mediated inflammatory progression in a cigarette smoke (CS)-induced mouse model with a focus on the balance between Th17 and Treg responses. Methods C57BL/6 mice were exposed to CS for 1, 3 or 6 months to induce COPD, and the control groups were maintained under filtered air conditions for the same time intervals. We then performed functional (respiratory mechanics) and structural (alveolar enlargement) analyses. We also quantified the NF-kappa B, TNF-alpha, CD4, CD8, CD20, IL-17, IL-6, FOXP3, IL-10, or TGF-beta positive cells in peribronchovascular areas and assessed FOXP3 and IL-10 expression through double-label immunofluorescence. Additionally, we evaluated the gene expression of NF-kappa B and TNF in bronchiolar epithelial cells. Results Our CS-induced COPD model exhibited an increased proinflammatory immune response (increased expression of the NF-kappa B, TNF-alpha, CD4, CD8, CD20, IL-17, and IL-6 markers) with a concomitantly decreased anti-inflammatory immune response (FOXP3, IL-10, and TGF-beta markers) compared with the control mice. These changes in the immune responses were associated with increased alveolar enlargement and impaired lung function starting on the first month and third month of CS exposure, respectively, compared with the control mice. Conclusion Our results showed that the microenvironmental stimuli produced by the release of cyto-kines during COPD progression lead to a Th17/Treg imbalance.	[Ito, Juliana Tiyaki; de Brito Cervilha, Daniela Aparecida; Lourenco, Juliana Dias; Lopes Calvo Tiberio, Iolanda de Fatima; Martins, Milton de Arruda; Quirino dos Santos Lopes, Fernanda Degobbi Tenorio] Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Expt Therapeut, Sao Paulo, Brazil; [Goncalves, Natalia Gomes; Lin, Chin Jia] Univ Sao Paulo, Sch Med, Dept Pathol, Lab Mol Pathol, Sao Paulo, Brazil; [Volpini, Rildo Aparecido] Univ Sao Paulo, Sch Med, Dept Clin Med, Basic Res Lab Kidney Dis, Sao Paulo, Brazil; [Caldini, Elia Garcia] Univ Sao Paulo, Sch Med, Dept Pathol, Cell Biol Lab, Sao Paulo, Brazil; [Landman, Gilles] Univ Fed Sao Paulo, Dept Pathol, Multipurpose Lab Mol Pathol, Sao Paulo, Brazil; [Pereira Velosa, Ana Paula; Rosolia Teodoro, Walcy Paganelli] Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Extracellular Matrix, Sao Paulo, Brazil; [Mauad, Thais; Macchione, Mariangela] Univ Sao Paulo, Sch Med, Dept Pathol, Expt Air Pollut Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Ito, JT (corresponding author), Univ Sao Paulo, Sch Med, Dept Clin Med, Lab Expt Therapeut, Sao Paulo, Brazil.	jutiyakito@hotmail.com	Ito, Juliana Tiyaki/Q-8041-2019; Lin, Chin J/B-7895-2013; Lourenço, Juliana D./C-5326-2013; Martins, Milton A/L-7541-2017; Volpini, Rildo Aparecido/L-5690-2019; Goncalves, Natalia/GNP-2099-2022; Caldini, Elia Garcia/F-1105-2011; Macchione, Mariangela/C-6696-2012; Teodoro, Walcy/H-5133-2017; Tibério, Iolanda FLC/C-6461-2012; GonÃalves, Natalia/AAE-7276-2022; Volpini, Rildo A/B-7521-2013; LANDMAN, GILLES/D-5071-2012	Ito, Juliana Tiyaki/0000-0002-9438-5292; Lin, Chin J/0000-0001-7489-560X; Lourenço, Juliana D./0000-0002-9291-5237; Volpini, Rildo Aparecido/0000-0001-6611-2249; Macchione, Mariangela/0000-0003-3335-2654; Teodoro, Walcy/0000-0001-7559-4542; Tibério, Iolanda FLC/0000-0002-5662-7895; Volpini, Rildo A/0000-0001-6611-2249; DTQS Lopes, Fernanda/0000-0002-6402-3055; Gomes Goncalves, Natalia/0000-0002-5253-5483; Caldini, Elia Garcia/0000-0001-5322-3812; LANDMAN, GILLES/0000-0001-7441-3068; Pereira Velosa, Ana Paula/0000-0002-6465-0796	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/15819-8 - FDTQSL]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI); Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI); Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa	The Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant 2014/15819-8 - FDTQSL) played a role in the data collection and analysis, and in preparation of the manuscript. The Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (demanda social - JTI) provided the scholarship to the first author who played a role in the study design, data collection and analysis, and preparation of the manuscript. The Instituto dos Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo - LIM-20 played a role in the data collection. The Fundacao Faculdade de Medicina through the Programa de Fomento as Atividades de Pesquisa supported in the payment of English language review expenses and publication costs.	[Anonymous], 2018, GLOBAL STRATEGY DIAG; Baraldo S, 2008, EUR RESPIR J, V31, P486, DOI 10.1183/09031936.00000608; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; Chu SY, 2011, INT IMMUNOPHARMACOL, V11, P1780, DOI 10.1016/j.intimp.2011.06.010; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Duan MC, 2016, INFLAMMATION, V39, P1334, DOI 10.1007/s10753-016-0365-8; Eppert BL, 2013, J IMMUNOL, V190, P1331, DOI 10.4049/jimmunol.1202442; Fuke S, 2004, AM J RESP CELL MOL, V31, P405, DOI 10.1165/rcmb.2004-0131OC; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Hizume DC, 2012, RESP PHYSIOL NEUROBI, V181, P167, DOI 10.1016/j.resp.2012.03.005; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111044; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; Le Rouzic O, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02434-2016; Li HJ, 2015, AM J MED SCI, V349, P392, DOI 10.1097/MAJ.0000000000000447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Rahman MS, 2005, CLIN IMMUNOL, V115, P268, DOI 10.1016/j.clim.2005.01.014; Roos AB, 2015, AM J RESP CRIT CARE, V192, P428, DOI 10.1164/rccm.201409-1689OC; Sales DS, 2017, COPD, V14, P533, DOI 10.1080/15412555.2017.1346069; Shaykhiev R, 2013, GERONTOLOGY, V59, P481, DOI 10.1159/000354173; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Toumpanakis D, 2010, AM J RESP CRIT CARE, V182, P1129, DOI 10.1164/rccm.201001-0116OC; Tsoumakidou M, 2011, CURR DRUG TARGETS, V12, P450, DOI 10.2174/138945011794751546; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Wang HY, 2015, CLIN RESPIR J, V9, P330, DOI 10.1111/crj.12147; Wang HY, 2012, INT IMMUNOPHARMACOL, V14, P504, DOI 10.1016/j.intimp.2012.09.011; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; WEIBEL ER, 1963, LAB INVEST, V12, P131; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	43	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209351	10.1371/journal.pone.0209351	http://dx.doi.org/10.1371/journal.pone.0209351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629626	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000023
J	Jonsson, J; Stein, M; Johansson, G; Bodin, T; Stromdahl, S				Jonsson, Johanna; Stein, Mart; Johansson, Gun; Bodin, Theo; Stromdahl, Susanne			A performance assessment of web-based respondent driven sampling among workers with precarious employment in Sweden	PLOS ONE			English	Article							TEMPORARY EMPLOYMENT; HEALTH CONSEQUENCES; POPULATIONS; ONLINE	Objectives Precarious employment (PE) is a social determinant of poor health of workers. However, this population usually lack a sampling frame, making it challenging to identify the characteristics of this group. Web-based respondent driven sampling (webRDS) recruits individuals online through the social network and can provide population estimates. This study aims to assess the performance of webRDS in a population of workers with PE. Method WebRDS was used for recruitment and data collection in the PRecarious EMployment In Stockholm (PREMIS) study. Cross-sectional questionnaire data was collected between November 2016 and May 2017. Eligible participants were living and/or working in Stockholm County, 18-65 years old, had a personal identification number and were currently employed. WebRDS performance was assessed by the total sample size, length of recruitment chains, sample composition, sample proportions and estimated RDSII population proportions with confidence intervals. Results The webRDS process resulted in a sample of 358 recruits and a total sample of 415 participants, recruited over 1-15 waves. Of the participating seeds and recruits, 60% and 48%, respectively, successfully recruited at least one peer. The sample composition stabilized for all variables assessed. The sample proportions and RDSII estimates differed by 1-8% and the confidence intervals included the sample proportions for all variables except one. Conclusions WebRDS successfully recruited a sufficient sample of workers with precarious employment from which population estimates could be made. Future studies should consider implementing webRDS on a national level in order to further study this population.	[Jonsson, Johanna; Johansson, Gun; Bodin, Theo] Karolinska Inst, Unit Occupat Med, Inst Environm Med, Stockholm, Sweden; [Stein, Mart] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Stromdahl, Susanne] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden; [Stromdahl, Susanne] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; Netherlands National Institute for Public Health & the Environment; Karolinska Institutet; Uppsala University	Jonsson, J (corresponding author), Karolinska Inst, Unit Occupat Med, Inst Environm Med, Stockholm, Sweden.	Johanna.Jonsson@ki.se	Stein, Mart/U-8914-2019; Bodin, Theo/AAC-2823-2020	Bodin, Theo/0000-0002-2074-5857; Stein, Mart L./0000-0003-0502-7993; Jonsson, Johanna/0000-0002-9132-4734; Johansson, Gun/0000-0003-1877-8569	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2015-00933]	Swedish Research Council for Health, Working Life and Welfare (FORTE)	This work was supported by grant 2015-00933 from The Swedish Research Council for Health, Working Life and Welfare (FORTE). The grant was received by Theo Bodin. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.forte.se.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Benach J, 2007, J EPIDEMIOL COMMUN H, V61, P276, DOI 10.1136/jech.2005.045237; Benach J, 2014, ANNU REV PUBL HEALTH, V35, P229, DOI 10.1146/annurev-publhealth-032013-182500; Bengtsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049417; Boman J, 2014, OTRYGGHET FLEXIBILIT; Canivet C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3358-5; CSDH, 2008, CLOS GAP GEN HLTH EQ; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Hammarstrom A, 2011, SCAND J PUBLIC HEALT, V39, P187, DOI 10.1177/1403494810394906; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jacobsson B., 1987, SCANDINAVIAN J SOCIA, V16, P21; Johnston LG, 2013, INTRO HIV AIDS SEXUA; Johnston LG, 2010, AIDS CARE, V22, P784, DOI 10.1080/09540120903373557; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; Lu X., 2013, RESPONDENT DRIVEN SA; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; ostlund B., 2012, JOBBA LANGRE VAD VET; Quinlan M, 2001, INT J HEALTH SERV, V31, P507, DOI 10.2190/22BK-9XC0-AK7L-M6QH; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Scott-Marshall H, 2011, WORK, V38, P369, DOI 10.3233/WOR-2011-1140; Statistics Sweden, 2017, ARB 2016; Statistics Sweden, 2016, ARB 2015; Statistics Sweden, 2016, VALF 3 2016; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113711; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085256; Stromdahl S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138599; Swedish Tax Agency, 2014, POP REG SWED; Swedish Work Environment Auhority, 2016, WORK ENV 2015; The State of Queensland, 2017, LAB ED STAT 2017 1 A, P1; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024; Volz E, 2008, J OFF STAT, V24, P79; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; White RG, 2015, J CLIN EPIDEMIOL, V68, P1463, DOI 10.1016/j.jclinepi.2015.04.002	34	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210183	10.1371/journal.pone.0210183	http://dx.doi.org/10.1371/journal.pone.0210183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629661	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000059
J	Tota, L; Piotrowska, A; Palka, T; Morawska, M; Mikulakova, W; Mucha, D; Zmuda-Palka, M; Pilch, W				Tota, Lukasz; Piotrowska, Anna; Palka, Tomasz; Morawska, Malgorzata; Mikulakova, Wioletta; Mucha, Dariusz; Zmuda-Palka, Magdalena; Pilch, Wanda			Muscle and intestinal damage in triathletes	PLOS ONE			English	Article							ENDURANCE EXERCISE; IRONMAN TRIATHLON; BARRIER FUNCTION; SKELETAL-MUSCLE; INFLAMMATION; PLASMA; MARKERS; VOLUME; INTERLEUKIN-6; TESTOSTERONE	The aim of the paper was to assess indicators of muscle and intestinal damage in triathletes. The study involved 15 triathletes whose objective for the season was to start in the XTERRA POLAND 2017 event (1,500-m swimming, 36-km cycling, and 10-km mountain running). Before the 14-week preparatory period, the competitors' body composition was measured, aerobic capacity was tested (graded treadmill test) and blood samples were collected to determine markers showing the level of muscle and intestinal damage. Subsequent tests for body composition were carried out before and after the competition. Blood samples for biochemical indicators were collected the day before the competition, after the completed race, and 24 and 48 hours later. A significant decrease in body mass was observed after completing the race (-3.1 +/- 1.5%). The mean maximal oxygen uptake level among the studied athletes equalled 4.9 +/- 0.4 L.min(-1), 58.8 +/- 4.5 mL.kg(-1). min(-1). The significant increase in concentrations of cortisol, c-reactive protein and myoglobin after the competition, significantly correlated with the significant increase in zonulin concentration (post 1h: r = 0.88, p = 0.007, r = 0,79, p = 0.001, r = 0.78, p = 0.001, and post 12h: r = 0.75, p = 0.01, r = 0.71, p = 0.011, r = 0.83, p = 0.02). No significant changes in the concentration of tumour necrosis factor alpha among the examined competitors were noted at following stages of the study. The results of our research showed that in order to monitor overload in the training of triathletes, useful markers reflecting the degree of muscle and intestinal damage include cortisol, testosterone, testosterone to cortisol ratio, c-reactive protein, myoglobin and zonulin. Changes in muscle cell damage markers strongly correlated with changes in zonulin concentration at particular stages of the study. Thus, one can expect that the concentrations of markers depicting the level of muscle cell damage after an intense and long-lasting effort will significantly influence the level of the intestinal barrier.	[Tota, Lukasz; Palka, Tomasz] Univ Phys Educ Krakow, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland; [Piotrowska, Anna; Pilch, Wanda] Univ Phys Educ Krakow, Fac Rehabil, Dept Cosmetol, Krakow, Poland; [Morawska, Malgorzata] Univ Phys Educ Krakow, Fac Phys Educ & Sport, Dept Sports Med & Human Nutr, Krakow, Poland; [Mikulakova, Wioletta] Univ Presov, Fac Hlth Care, Dept Physiotherapy, Presov, Slovakia; [Mucha, Dariusz] Univ Phys Educ Krakow, Fac Phys Educ & Sport, Dept Biomed Sci, Krakow, Poland; [Zmuda-Palka, Magdalena] Univ Phys Educ Krakow, Fac Phys Educ & Sport, Dept Humanities, Krakow, Poland	University of Presov	Tota, L (corresponding author), Univ Phys Educ Krakow, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland.	lukasz.tota@awf.krakow.pl	Palka, Magdalena Zmuda/AAE-1082-2022; Piotrowska, Anna/ACM-3562-2022; Mikuľáková, Wioletta/AAW-1219-2021	Palka, Magdalena Zmuda/0000-0002-5344-8998; Mucha, Dariusz/0000-0001-8361-8663; Palka, Tomasz/0000-0001-5225-9397; Piotrowska, Anna/0000-0002-9535-173X; Tota, Lukasz/0000-0001-7108-0704; Pilch, Wanda/0000-0001-6689-0155				ADLERCREUTZ H, 1986, INT J SPORTS MED, V7, P27; Anderson T, 2016, EUR J APPL PHYSIOL, V116, P1503, DOI 10.1007/s00421-016-3406-y; Ashtary-Larky D., 2017, ASIAN J SPORTS MED; BHAMBHANI Y, 1985, RESPIRATION, V47, P120, DOI 10.1159/000194758; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Brownlee KK, 2005, J SPORT SCI MED, V4, P76; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Del Coso J, 2014, J SPORT SCI, V32, P1680, DOI 10.1080/02640414.2014.915425; Diaz V, 2009, J HUM SPORT EXERC, V4, P237, DOI 10.4100/jhse.2009.43.05; Doering TM, 2016, INT J SPORT NUTR EXE, V26, P168, DOI 10.1123/ijsnem.2015-0102; Drenowatz C, 2012, APPL PHYSIOL NUTR ME, V37, P199, DOI [10.1139/h11-155, 10.1139/H11-155]; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Etxebarria N, 2013, INT J SPORT PHYSIOL, V8, P502, DOI 10.1123/ijspp.8.5.502; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Fehrenbach E, 2006, SPORTS MED, V36, P373, DOI 10.2165/00007256-200636050-00001; FELLMANN N, 1992, SPORTS MED, V13, P37, DOI 10.2165/00007256-199213010-00004; Furman J, 2015, JAAPA-J AM ACAD PHYS, V28, P38, DOI 10.1097/01.JAA.0000458861.78559.3b; Gonzalez-Parra G, 2013, J HUM SPORT EXERC, V8, P342, DOI 10.4100/jhse.2012.82.03; Hackney AC, 2008, J ENDOCRINOL INVEST, V31, P932, DOI 10.1007/BF03346444; Hough J, 2015, INT J SPORT PHYSIOL, V10, P935, DOI 10.1123/ijspp.2014-0360; Hough JP, 2011, J STRENGTH COND RES, V25, P23, DOI 10.1519/JSC.0b013e3181fef8e7; Ispirlidis I, 2008, CLIN J SPORT MED, V18, P423, DOI 10.1097/JSM.0b013e3181818e0b; Jeukendrup AE, 2005, SPORTS MED, V35, P163, DOI 10.2165/00007256-200535020-00005; Johansen LB, 1998, AM J PHYSIOL-REG I, V274, pR126, DOI 10.1152/ajpregu.1998.274.1.R126; KRAEMER RR, 1986, EUR J APPL PHYSIOL O, V55, P579, DOI 10.1007/BF00423200; Lamprecht M, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-45; Mach N, 2017, J SPORT HEALTH SCI, V6, P179, DOI 10.1016/j.jshs.2016.05.001; Margeli A, 2005, J CLIN ENDOCR METAB, V90, P3914, DOI 10.1210/jc.2004-2346; Marlicz W., 2014, FORUM ZABURZEN METAB, V5, P129; Millet GP, 2009, SPORTS MED, V39, P179, DOI 10.2165/00007256-200939030-00002; Moore DR, 2015, CURR SPORT MED REP, V14, P294, DOI 10.1249/JSR.0000000000000180; Munteanu A.M., 2014, SPORT MED J, V10, P2357; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nieman DC, 2005, MED SCI SPORT EXER, V37, P57, DOI 10.1249/01.MSS.0000149808.38194.21; Obminski Z., 2016, J COMBAT SPORTS MART, V7, P117; Ogawa K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/171023; Pals KL, 1997, J APPL PHYSIOL, V82, P571, DOI 10.1152/jappl.1997.82.2.571; Pedersen BK, 2000, BRIT J SPORT MED, V34, P246, DOI 10.1136/bjsm.34.4.246; Pugh JN, 2017, APPL PHYSIOL NUTR ME, V42, P941, DOI 10.1139/apnm-2016-0646; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Ruiz JR, 2013, J PHYSIOL-LONDON, V591, P4943, DOI 10.1113/jphysiol.2013.257147; Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816; Salinero JJ, 2012, ANN C SPAN OL COMM, P3; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Sonier B, 2009, INT REV IMMUNOL, V28, P414, DOI 10.3109/08830180903208329; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Sugama K, 2015, EXERC IMMUNOL REV, V21, P130; Suzuki K, 2006, EUR J APPL PHYSIOL, V98, P525, DOI 10.1007/s00421-006-0296-4; Thorpe R, 2012, J STRENGTH COND RES, V26, P2783, DOI 10.1519/JSC.0b013e318241e174; van de Weert-van Leeuwen PB, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-32; Walter P, 2007, ANN NUTR METAB, V51, P15, DOI 10.1159/000103562; Zapico AG, 2014, REV INT MED CIENC AC, V14, P619	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210651	10.1371/journal.pone.0210651	http://dx.doi.org/10.1371/journal.pone.0210651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657773	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000015
J	Chakravarty, AB; Rangan, S; Dholakia, Y; Rai, S; Kamble, S; Raste, T; Shah, S; Shah, S; Mistry, N				Chakravarty, Aruna Bhattacharya; Rangan, Sheela; Dholakia, Yatin; Rai, Sonu; Kamble, Swaran; Raste, Tejaswi; Shah, Sanchi; Shah, Shimoni; Mistry, Nerges			Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us	PLOS ONE			English	Article							MDR-TB; INDIA; BEHAVIOR; PRACTITIONERS	Introduction The Indian Tuberculosis (TB) Programme currently faces the dual challenges of tackling increasing numbers of drug resistant (DR) TB cases and regulating practices of a pluralistic private sector catering to TB patients. A study of health seeking behaviour of DR-TB patients in such a situation, offers an opportunity to understand the problems patients face while interacting with health systems. Methodology Forty-six DR-TB patients drawn from 15 high TB burden wards in Mumbai were interviewed using an open ended interview tool. Interviews were audio recorded and transcribed. Pathway schematics developed from analysis of patient records, were linked to transcripts. Open coding was used to analyse these units and themes were derived after collating the codes. Results and discussion The paper presents themes interwoven with narratives in the discussions. These include awareness-action gap among patients, role of neighbourhood providers, responsiveness of health systems, the not-such a 'merry go round' that patients go/are made to go on while seeking care, costs of diagnostics and treatment, and how DR-TB is viewed as the 'big TB'. Conclusion The recommendations are based on a preventative ethos which is sustainable, compared to interventions with top-down approaches, which get piloted, but fail to sustain impact when scaled up.	[Chakravarty, Aruna Bhattacharya; Rangan, Sheela; Dholakia, Yatin; Rai, Sonu; Kamble, Swaran; Raste, Tejaswi; Shah, Sanchi; Shah, Shimoni; Mistry, Nerges] Fdn Med Res, Mumbai, India		Mistry, N (corresponding author), Fdn Med Res, Mumbai, India.	fmr@fmrindia.org	Dholakia, Yatin/I-7339-2019	Dholakia, Yatin/0000-0001-8482-1305; Shah, Sanchi/0000-0002-7786-2384; Shah, Shimoni/0000-0003-0991-5138; Mistry, Nerges/0000-0003-3509-4994	Bill & Melinda Gates Foundation [OPP1091874]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation via Sambodhi (OPP1091874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PROVISIONAL POPULATI; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Atre S, 2016, LANCET INFECT DIS, V16, P1328, DOI 10.1016/S1473-3099(16)30470-4; Atre SR, 2016, J PUBLIC HEALTH POL, V37, P277, DOI 10.1057/jphp.2016.14; Atre SR, 2005, J PUBLIC HEALTH POL, V26, P96, DOI 10.1057/palgrave.jphp.3200014; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bloom BR, 2016, J PUBLIC HEALTH POL, V37, P300, DOI 10.1057/jphp.2016.16; Bode Maarten, 2011, J Ayurveda Integr Med, V2, P14, DOI 10.4103/0975-9476.78186; Central TB Division GoI, RNTCP POST FEAT AM B; Central TB Division GoI, 2016, RNTCP GUID; Central TB Division GoI, 2012, TB NOT; Central TB Division GoI, 2017, TB IND NEW DELH; Central TB Division GoI, 2017, ANN STAT REP REV NAT; Central TB Division GoI, IEC BCC MAT RNTCP; Chakraborty A. K., 2001, Indian Journal of Tuberculosis, V48, P181; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; DAVIS MS, 1968, AM J PUBLIC HEALTH N, V58, P274, DOI 10.2105/AJPH.58.2.274; Dholakia Y, 2012, LUNG INDIA, V29, P30, DOI 10.4103/0970-2113.92359; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P., 1999, INFECT INEQUALITIES, pxiv; Foster G.M., 1978, MED ANTHROPOL; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; HAEFNER DP, 1970, PUBLIC HEALTH REP, V85, P478, DOI 10.2307/4593885; HORTON R, 1967, AFRICA, V37, P155, DOI 10.2307/1158253; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Jayachandran V, 2014, ANN TROP MED PUBLIC, V7, P124, DOI 10.4103/1755-6783.146402; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Kanabus A., 2017, DRUG RESISTANT TB IN; Kanabus A., 2017, TB STAT INDIA NATL T; Kaul S., 1998, OBSERVATIONAL STUDY; Kleinman A., 2011, CURARE, V34, P214; Kleinman A., 1975, NATIONAL COUNCIL INT, P159; Landy D., 1977, STUDIES MED ANTHR, P467; LAZARE A, 1975, ARCH GEN PSYCHIAT, V32, P553; LIPSITT DR, 1968, J GERIATR PSYCHIAT, V2, P51; Lobo Eunice, 2018, Gates Open Res, V2, P9, DOI 10.12688/gatesopenres.12785.2; Martensen R., 2004, BOOK REV ENCY MED AN; McDowell A, 2016, T ROY SOC TROP MED H, V110, P192, DOI 10.1093/trstmh/trw009; Mistry N, 2017, J EPIDEMIOL GLOB HEA, V7, P241, DOI 10.1016/j.jegh.2017.08.001; Mistry N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152287; Mullerpattan JB, 2018, INDIAN J TUBERCULOSI; NFHS4-Telangana, 2015, NATL FAMILY HLTH SUR; Pai Madhukar, 2013, J Lab Physicians, V5, P1, DOI 10.4103/0974-2727.115895; PATH, 2016, IMPR TUB SERV MUMB; Pradhan A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-263; Rangan S, 2003, TUBERCULOSIS, V83, P165, DOI 10.1016/S1472-9792(02)00070-7; Samal J, 2016, J CLIN DIAGN RES, V10, pLE1, DOI 10.7860/JCDR/2016/19678.8598; Satpati M, 2017, TUBERCULOSIS RES TRE, V2017; Sharma NC, 2017, LIVEMINT        1101; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Strauss A., 1998, BASICS QUALITATIVE R; TNN, 2018, TIMES INDIA; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Vijayan S, CAN PRIVATE SECTOR B; WHO, 2015, END TB STRAT GEN; WHO, 2017, GLOB TUB REP; Yellappa V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4627-7; ZOLA IK, 1972, SOC SCI MED, V6, P673, DOI 10.1016/0037-7856(72)90040-6	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209924	10.1371/journal.pone.0209924	http://dx.doi.org/10.1371/journal.pone.0209924			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653523	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500019
J	Crouse, JJ; Chitty, KM; Iorfino, F; White, D; Nichles, A; Zmicerevska, N; Guastella, AJ; Moustafa, AA; Hermens, DF; Scott, EM; Hickie, IB				Crouse, Jacob J.; Chitty, Kate M.; Iorfino, Frank; White, Django; Nichles, Alissa; Zmicerevska, Natalia; Guastella, Adam J.; Moustafa, Ahmed A.; Hermens, Daniel F.; Scott, Elizabeth M.; Hickie, Ian B.			Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service	PLOS ONE			English	Article							1ST ALCOHOL-USE; ONSET CANNABIS USE; 1ST-EPISODE PSYCHOSIS; DRUG-USE; PSYCHOLOGICAL DISTRESS; PSYCHIATRIC-DISORDER; COGNITIVE DEFICITS; ADOLESCENT TOBACCO; NICOTINE EXPOSURE; MAJOR DEPRESSION	Neuropsychiatric disorders (including substance misuse) are associated with the greatest burden of functional disability in young people, and contributory factors remain poorly understood. Early-onset substance use is one candidate risk factor which may inform functional prognosis and facilitate direction of interventions aiming to curtail impairment. Accordingly, we modelled associations between early-onset use of alcohol, tobacco, cannabis and amphetamine-type stimulants (ATSs) and longitudinal socio-occupational functioning (indexed by the Social and Occupational Functioning Assessment Scale) in an observational cohort presenting to early intervention mental health services. A clinical proforma collated demographic, clinical, and socio-occupational information for up to 60-months from presentation to services in young people aged 17-30. Of the wider cohort (n = 2398), 446 participants were selected with complete alcohol and substance use data. Latent class analysis was used to derive an 'early-onset' (n = 243) and 'later-onset' class (n = 203) based on age of first use of alcohol, tobacco, cannabis and ATSs. Maximum-likelihood multilevel analyses modelled functioning over time in care and tested associations with substance use latent class, age, gender and diagnosis. Membership in the 'early-onset' class (B = -1.64, p = 0.05), male gender (B = -3.27, p<0.001) and psychotic disorder diagnosis (B = -7.62, p<0.001) were associated with poorer functioning at presentation and at least one other time-point. To our knowledge, this is the first study to explore associations of early-onset substance use and longitudinal functioning in a cohort of young people with mental disorders. The identified factors may be useful for directing specific social (e.g. Social Recovery Therapy) or occupational (e.g. Individual Placement and Support) interventions to at-risk individuals, early in illness course.	[Crouse, Jacob J.; Iorfino, Frank; White, Django; Nichles, Alissa; Zmicerevska, Natalia; Guastella, Adam J.; Hermens, Daniel F.; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Brain & Mind Ctr, Youth Mental Hlth Team, Camperdown, NSW, Australia; [Chitty, Kate M.] Univ Sydney, Translat Australian Clin Toxicol TACT Res Grp, Discipline Pharmacol, Camperdown, NSW, Australia; [Moustafa, Ahmed A.] Western Sydney Univ, Sch Social Sci & Psychol, Milperra, NSW, Australia; [Moustafa, Ahmed A.] MARCS Inst Brain Behav & Dev, Milperra, NSW, Australia; [Moustafa, Ahmed A.] Qatar Univ, Coll Arts & Sci, Dept Social Sci, Doha, Qatar; [Hermens, Daniel F.] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia; [Scott, Elizabeth M.] Notre Dame Med Sch, Sydney, NSW, Australia	University of Sydney; University of Sydney; Western Sydney University; Qatar University; University of the Sunshine Coast	Crouse, JJ (corresponding author), Univ Sydney, Brain & Mind Ctr, Youth Mental Hlth Team, Camperdown, NSW, Australia.	jcro8838@uni.sydney.edu.au	Iorfino, Frank/AAD-8492-2021; Crouse, Jacob/K-2218-2019; Hickie, Ian B/K-8975-2015; Moustafa, Ahmed/AAM-2836-2021	Crouse, Jacob/0000-0002-3805-2936; Hickie, Ian B/0000-0001-8832-9895; Iorfino, Frank/0000-0003-1109-0972; Moustafa, Ahmed/0000-0001-5971-273X; Hermens, Daniel/0000-0002-8570-2663	University of Sydney; NHMRC [1122362, 1046899]; Australian Postgraduate Award; Brain Mind Centre; Brain and Mind Centre, University of Sydney; Western Sydney University; NHRMC Career Development Fellowship, The University of Sydney; Sunshine Coast Mind & Neuroscience Thompson Institute; Young Adult Mental Health Unit, St Vincent's Hospital Darlinghurst; Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, Research Affiliate	University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Brain Mind Centre; Brain and Mind Centre, University of Sydney; Western Sydney University; NHRMC Career Development Fellowship, The University of Sydney; Sunshine Coast Mind & Neuroscience Thompson Institute; Young Adult Mental Health Unit, St Vincent's Hospital Darlinghurst; Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, Research Affiliate	JC was supported by a postgraduate Research Training Program Stipend (provided by The University of Sydney, no stipend number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KC funding provided by NHMRC Early Career Fellowship Grant (number: 1122362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FI was supported by an Australian Postgraduate Award stipend (no stipend number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AN was supported by Brain & Mind Centre, Clinical Research Officer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NZ was supported as Research Officer at the Brain and Mind Centre, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DW was employed by The University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AM was supported as Senior Lecturer, Western Sydney University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AG was supported by NHRMC Career Development Fellowship, The University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DH was supported by Sunshine Coast Mind & Neuroscience Thompson Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ES was supported as Medical Director, Young Adult Mental Health Unit, St Vincent's Hospital Darlinghurst, Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, Research Affiliate, The University of Sydney and Consultant Psychiatrist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IH was supported by (2018-2022) Optimising Personalised Care, at scale, for Young People with Emerging Mood Disorders, $951,005 over 5 years (APP1136259); NHMRC Research fellowship (no. 1046899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Jimenez M, 2012, PSYCHOL MED, V42, P595, DOI 10.1017/S0033291711001504; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BALL SA, 1995, J CONSULT CLIN PSYCH, V63, P115, DOI 10.1037/0022-006X.63.1.115; BANKS MH, 1982, PSYCHOL MED, V12, P789, DOI 10.1017/S0033291700049096; Birrell L, 2016, J AFFECT DISORDERS, V200, P243, DOI 10.1016/j.jad.2016.04.032; Birrell L, 2015, J ANXIETY DISORD, V31, P108, DOI 10.1016/j.janxdis.2015.02.008; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boys A, 2003, BRIT J PSYCHIAT, V182, P509, DOI 10.1192/bjp.182.6.509; Brecht ML, 2007, ADDICT BEHAV, V32, P24, DOI 10.1016/j.addbeh.2006.03.017; BRESLAU N, 1993, DRUG ALCOHOL DEPEN, V33, P129, DOI 10.1016/0376-8716(93)90054-T; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Chen CK, 2003, PSYCHOL MED, V33, P1407, DOI 10.1017/S0033291703008353; Chen CY, 2005, DRUG ALCOHOL DEPEN, V79, P11, DOI 10.1016/j.drugalcdep.2004.11.014; Chilcoat HD, 1996, J AM ACAD CHILD PSY, V35, P91, DOI 10.1097/00004583-199601000-00017; Cotton SM, 2017, SOC PSYCH PSYCH EPID, V52, P575, DOI 10.1007/s00127-017-1358-0; Cotton SM, 2006, AUST NZ J PSYCHIAT, V40, P790, DOI 10.1111/j.1440-1614.2006.01885.x; Counotte DS, 2011, NAT NEUROSCI, V14, P417, DOI 10.1038/nn.2770; Counotte DS, 2009, NEUROPSYCHOPHARMACOL, V34, P299, DOI 10.1038/npp.2008.96; Crews FT, 2016, PHARMACOL REV, V68, P1074, DOI 10.1124/pr.115.012138; Dahne J, 2014, J STUD ALCOHOL DRUGS, V75, P929, DOI 10.15288/jsad.2014.75.929; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Egan M, 2016, SOC SCI MED, V156, P98, DOI 10.1016/j.socscimed.2016.03.013; Egan M, 2015, SOC SCI MED, V124, P11, DOI 10.1016/j.socscimed.2014.11.023; Ellickson P, 1998, J DRUG ISSUES, V28, P357, DOI 10.1177/002204269802800205; Ellickson PL, 2003, PEDIATRICS, V111, P949, DOI 10.1542/peds.111.5.949; Ellis LA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-119; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Fergusson DM, 2007, BRIT J PSYCHIAT, V191, P335, DOI 10.1192/bjp.bp.107.036079; Fergusson DM, 1997, ADDICTION, V92, P279; Fergusson DM, 1997, PSYCHOL MED, V27, P371, DOI 10.1017/S0033291796004412; Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479; Fowler D, 2018, LANCET PSYCHIAT, V5, P41, DOI 10.1016/S2215-0366(17)30476-5; Geiser C., 2012, DATA ANAL MPLUS; Georgiades K, 2007, J CHILD PSYCHOL PSYC, V48, P724, DOI 10.1111/j.1469-7610.2007.01740.x; Gibb SJ, 2010, BRIT J PSYCHIAT, V197, P122, DOI 10.1192/bjp.bp.109.076570; Goodman A, 2011, P NATL ACAD SCI USA, V108, P6032, DOI 10.1073/pnas.1016970108; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Goriounova NA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012120; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Gruber SA, 2012, PSYCHOL ADDICT BEHAV, V26, P496, DOI 10.1037/a0026269; Guo J, 2002, J ADOLESCENT HEALTH, V31, P354, DOI 10.1016/S1054-139X(02)00402-0; Hamilton BA, 2011, J AFFECT DISORDERS, V131, P84, DOI 10.1016/j.jad.2010.10.052; Hay P, 2003, PSYCHIAT SERV, V54, P1028, DOI 10.1176/appi.ps.54.7.1028; Hayatbakhsh MR, 2008, AUST NZ J PSYCHIAT, V42, P720, DOI 10.1080/00048670802206346; Hickie IB, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-303; Hilsenroth MJ, 2000, AM J PSYCHIAT, V157, P1858, DOI 10.1176/appi.ajp.157.11.1858; Hser YI, 2008, J ADDICT DIS, V27, P13, DOI 10.1080/10550880802122554; Iorfino F, 2018, J AFFECT DISORDERS, V238, P563, DOI 10.1016/j.jad.2018.06.032; Iorfino F, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020678; Jacobsen LK, 2005, BIOL PSYCHIAT, V57, P56, DOI 10.1016/j.biopsych.2004.10.022; Juckel G, 2008, CURR OPIN PSYCHIATR, V21, P630, DOI 10.1097/YCO.0b013e328314e144; Kaufman J, 2007, BIOL PSYCHIAT, V61, P1228, DOI 10.1016/j.biopsych.2006.06.039; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Killackey E, 2013, AUST NZ J PSYCHIAT, V47, P521, DOI 10.1177/0004867413476755; Kuperman S, 2005, ALCOHOL CLIN EXP RES, V29, P1869, DOI 10.1097/01.alc.0000183190.32692.c7; Lee RSC, 2017, PSYCHOL MED, V47, P2061, DOI 10.1017/S0033291717000484; Lee RSC, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.50; Lee RSC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058176; Levine A, 2017, J AM ACAD CHILD PSY, V56, P214, DOI 10.1016/j.jaac.2016.12.014; Lin A, 2013, CURR OPIN PSYCHIATR, V26, P138, DOI 10.1097/YCO.0b013e32835d82aa; Little R. J. A., 1987, STAT ANAL MISSING DA; Lubman DI, 2015, PHARMACOL THERAPEUT, V148, P1, DOI 10.1016/j.pharmthera.2014.11.009; Lundborg P, 2011, IZA DICUSSION PAPERS, V5804; Lydon DM, 2014, NEUROSCI BIOBEHAV R, V45, P323, DOI 10.1016/j.neubiorev.2014.07.003; Macleod J, 2008, ADDICTION, V103, P1731, DOI 10.1111/j.1360-0443.2008.02301.x; Mashhoon Y, 2018, DRUG ALCOHOL DEPEN, V184, P48, DOI 10.1016/j.drugalcdep.2017.11.020; Mayzer R, 2009, J AM ACAD CHILD PSY, V48, P820, DOI 10.1097/CHI.0b013e3181aa0383; McGorry PD, 2007, MED J AUSTRALIA, V187, pS68; Morgan VA, 2017, AUST NZ J PSYCHIAT, V51, P124, DOI 10.1177/0004867416679738; MORRELL S, 1994, SOC SCI MED, V38, P1553, DOI 10.1016/0277-9536(94)90117-1; Muthen L. K., 2017, MPLUS USERS GUIDE ST, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nees F, 2012, NEUROPSYCHOPHARMACOL, V37, P986, DOI 10.1038/npp.2011.282; Newcomb MD, 2002, J COUNS PSYCHOL, V49, P172, DOI 10.1037//0022-0167.49.2.172; Newton-Howes G, 2016, ADDICTION, V111, P637, DOI 10.1111/add.13230; Nguyen-Louie TT, 2017, ALCOHOL CLIN EXP RES, V41, P2082, DOI 10.1111/acer.13503; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Power E., 2015, Irish Journal of Psychological Medicine, V32, P155, DOI 10.1017/ipm.2014.85; Alameda-Bailen JR, 2018, PEERJ, V6, DOI 10.7717/peerj.5201; Rickwood DJ, 2014, MED J AUSTRALIA, V200, P108, DOI 10.5694/mja13.11235; Rodwell L, 2018, PSYCHOL MED, V48, P861, DOI 10.1017/S0033291717002434; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Scott EM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007066; Scott EM, 2013, INT J BIPOLAR DISORD, V1, DOI 10.1186/2194-7511-1-23; Scott J, 2014, BRIT J PSYCHIAT, V205, P362, DOI 10.1192/bjp.bp.113.134262; Solowij N, 2012, PSYCHOPHARMACOLOGY, V219, P575, DOI 10.1007/s00213-011-2486-y; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Squeglia LM, 2017, AM J PSYCHIAT, V174, P172, DOI 10.1176/appi.ajp.2016.15121587; Squeglia LM, 2015, AM J PSYCHIAT, V172, P531, DOI 10.1176/appi.ajp.2015.14101249; Squeglia LM, 2014, DEV COGN NEUROS-NETH, V9, P117, DOI 10.1016/j.dcn.2014.02.005; Stefanis NC, 2004, ADDICTION, V99, P1333, DOI 10.1111/j.1360-0443.2004.00806.x; Tandberg M, 2011, PSYCHIAT RES, V188, P334, DOI 10.1016/j.psychres.2011.04.021; Upadhyaya HP, 2002, J AM ACAD CHILD PSY, V41, P1294, DOI 10.1097/00004583-200211000-00010; Visser L, 2015, EUR J PUBLIC HEALTH, V25, P38, DOI 10.1093/eurpub/cku072; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; WEBB JA, 1991, J AM ACAD CHILD PSY, V30, P563, DOI 10.1097/00004583-199107000-00006; Weiss LM, 2014, J SUBST ABUSE TREAT, V47, P146, DOI 10.1016/j.jsat.2014.04.003; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820	102	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210877	10.1371/journal.pone.0210877	http://dx.doi.org/10.1371/journal.pone.0210877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653581	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500084
J	Matijevich, ES; Branscombe, LM; Scott, LR; Zelik, KE				Matijevich, Emily S.; Branscombe, Lauren M.; Scott, Leon R.; Zelik, Karl E.			Ground reaction force metrics are not strongly correlated with tibial bone load when running across speeds and slopes: Implications for science, sport and wearable tech	PLOS ONE			English	Article							STRESS-FRACTURE; STANCE PHASE; RISK-FACTORS; IN-VIVO; RUNNERS; FATIGUE; MODEL; ANKLE; ATTENUATION; KINEMATICS	Introduction Tibial stress fractures are a common overuse injury resulting from the accumulation of bone microdamage due to repeated loading. Researchers and wearable device developers have sought to understand or predict stress fracture risks, and other injury risks, by monitoring the ground reaction force (GRF, the force between the foot and ground), or GRF correlates (e.g., tibial shock) captured via wearable sensors. Increases in GRF metrics are typically assumed to reflect increases in loading on internal biological structures (e.g., bones). The purpose of this study was to evaluate this assumption for running by testing if increases in GRF metrics were strongly correlated with increases in tibial compression force over a range of speeds and slopes. Methods Ten healthy individuals performed running trials while we collected GRFs and kinematics. We assessed if commonly-used vertical GRF metrics (impact peak, loading rate, active peak, impulse) were strongly correlated with tibial load metrics (peak force, impulse). Results On average, increases in GRF metrics were not strongly correlated with increases in tibial load metrics. For instance, correlating GRF impact peak and loading rate with peak tibial load resulted in r = -0.29 +/- 0.37 and r = -0.20 +/- 0.35 (inter-subject mean and standard deviation), respectively. We observed high inter-subject variability in correlations, though most coefficients were negligible, weak or moderate. Seventy-six of the 80 subject-specific correlation coefficients computed indicated that higher GRF metrics were not strongly correlated with higher tibial forces. Conclusions These results demonstrate that commonly-used GRF metrics can mislead our understanding of loading on internal structures, such as the tibia. Increases in GRF metrics should not be assumed to be an indicator of increases in tibial bone load or overuse injury risk during running. This has important implications for sports, wearable devices, and research on running-related injuries, affecting >50 scientific publications per year from 2015-2017.	[Matijevich, Emily S.; Branscombe, Lauren M.; Zelik, Karl E.] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA; [Scott, Leon R.] Vanderbilt Univ, Dept Orthopaed, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Zelik, Karl E.] Vanderbilt Univ, Dept Phys Med & Rehabil, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Matijevich, ES (corresponding author), Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37235 USA.	emily.matijevich@vanderbilt.edu	Matijevich, Emily/AAQ-4402-2021	Zelik, Karl/0000-0002-5054-2479	National Institutes of Health [NIH K12HD073945]; NIH; Vanderbilt University School of Engineering; CTSA award from the National Center for Advancing Translational Sciences [UL1 TR002243]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD073945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University School of Engineering; CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by funding from the National Institutes of Health (NIH K12HD073945), the NIH-funded Clinical and Translational Science Award at the Vanderbilt University Medical Center, and institutional funds from the Vanderbilt University School of Engineering. This research was also supported by CTSA award No. UL1 TR002243 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	[Anonymous], FAQ, DOI [10.1115/1.3118762, DOI 10.1115/1.3118762]; Bennell K, 2004, MED SCI SPORT EXER, V36, P397, DOI 10.1249/01.MSS.0000117116.90297.E1; Bennell KL, 1996, AM J SPORT MED, V24, P810, DOI 10.1177/036354659602400617; Besier TF, 2018, CISC VIS NETW IND GL; Borelli GA, 1608, MOVEMENT ANIMALS; Bredeweg SW, 2013, J SCI MED SPORT, V16, P205, DOI 10.1016/j.jsams.2012.08.002; Brukner PD, 1996, CLIN J SPORT MED, DOI [10.1007/s00167-012-2160-x, DOI 10.1007/S00167-012-2160-X]; BURDETT RG, 1982, MED SCI SPORT EXER, V14, P308, DOI 10.1249/00005768-198204000-00010; CALER WE, 1989, J BIOMECH, V22, P625, DOI 10.1016/0021-9290(89)90013-4; CALHOUN JH, 1994, FOOT ANKLE INT, V15, P125, DOI 10.1177/107110079401500307; CARTER DR, 1985, J ORTHOPAED RES, V3, P84, DOI 10.1002/jor.1100030110; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Chen TL, 2016, CLIN BIOMECH, V33, P49, DOI 10.1016/j.clinbiomech.2016.02.013; Clark KP, 2017, J EXP BIOL, V220, P247, DOI 10.1242/jeb.138057; COLLINS JJ, 1989, CLIN BIOMECH, V4, P179, DOI 10.1016/0268-0033(89)90023-5; Corey DM, 1998, J GEN PSYCHOL, V125, P245, DOI 10.1080/00221309809595548; Cosman F, 2013, BONE, V55, P359, DOI 10.1016/j.bone.2013.04.011; Creaby MW, 2008, MED SCI SPORT EXER, V40, P1669, DOI 10.1249/MSS.0b013e31817571ae; Crossley KM, 1999, MED SCI SPORTS EXERC, P419, DOI [10.1016/j.clinbiomech.2005.11.009, DOI 10.1016/J.CLINBIOMECH.2005.11.009]; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Currey J.D., 2013, BONES STRUCTURE MECH; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; Davis IS, 2017, J SPORT HEALTH SCI, V6, P154, DOI 10.1016/j.jshs.2017.03.013; Davis IS, 2016, BRIT J SPORT MED, V50, P887, DOI 10.1136/bjsports-2015-094579; Derrick TR, 2016, J BIOMECH, V49, P429, DOI 10.1016/j.jbiomech.2016.01.003; Dixon SJ, 2006, CLIN BIOMECH, V21, P412, DOI 10.1016/j.clinbiomech.2005.11.009; Dudley RI, 2017, HUM MOVEMENT SCI, V52, P197, DOI 10.1016/j.humov.2017.02.007; Dziewiecki K, 2013, BIOL SPORT, V30, P103, DOI 10.5604/20831862.1044225; Edwards WB, 2018, EXERC SPORT SCI REV, V46, P224, DOI 10.1249/JES.0000000000000163; Edwards WB, 2010, CLIN BIOMECH, V25, P372, DOI 10.1016/j.clinbiomech.2010.01.001; Edwards WB, 2009, MED SCI SPORT EXER, V41, P2177, DOI 10.1249/MSS.0b013e3181a984c4; Edwards WB, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118762; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Ferber R., 2002, MED SCI SPORTS EXER, V34, DOI [10.1097/00005768-200205001-00025, DOI 10.1097/00005768-200205001-00025]; Gallagher S, 2017, ERGONOMICS, V60, P255, DOI 10.1080/00140139.2016.1208848; Giandolini M, 2016, J BIOMECH, V49, P1765, DOI 10.1016/j.jbiomech.2016.04.001; HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C; Hamill J, 2018, CURR ISSUES SPORT SC; Hennig E. M., 1993, USE GROUND REACTION, V9, DOI DOI 10.1123/JAB.9.4.306,10.1123/JAB.9.4.306; Honert EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163169; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; HULKKO A, 1987, INT J SPORTS MED, V8, P221, DOI 10.1055/s-2008-1025659; JOHANSSON C, 1992, Scandinavian Journal of Medicine and Science in Sports, V2, P87; Kernozek T, 2017, J SPORT SCI, V35, P2073, DOI 10.1080/02640414.2016.1255769; Kiernan D, 2018, J BIOMECH, V73, P201, DOI 10.1016/j.jbiomech.2018.04.001; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; Kuhman DJ, 2016, HUM MOVEMENT SCI, V47, P9, DOI 10.1016/j.humov.2016.01.013; LANYON LE, 1975, ACTA ORTHOP SCAND, V46, P256, DOI 10.3109/17453677508989216; Loundagin LL, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038288; Martin JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03797-6; MATHESON GO, 1987, AM J SPORT MED, V15, P46, DOI 10.1177/036354658701500107; Matijevich ES, 2018, J BIOMECH, V72, P200, DOI 10.1016/j.jbiomech.2018.03.013; McBryde A M, 1982, Orthopedics, V5, P913, DOI 10.3928/0147-7447-19820701-12; McBryde AM, 1982, ORTHOP THOROFARE, V5, P918; McBryde AM, 1982, ORTHOP THOROFARE, V5, P920; McBryde AM, 1982, ORTHOP THOROFARE, V5, P915; Meardon SA, 2015, CLIN BIOMECH, V30, P895, DOI 10.1016/j.clinbiomech.2015.07.012; Messier SP, 2018, AM J SPORT MED, V46, P2211, DOI 10.1177/0363546518773755; Miller RH, 2014, MED SCI SPORT EXER, V46, P572, DOI 10.1249/MSS.0000000000000135; Miller RH, 2009, COMPUT METHOD BIOMEC, V12, P481, DOI 10.1080/10255840802695437; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Napier C, 2018, SCAND J MED SCI SPOR, V28, P2164, DOI 10.1111/sms.13228; Neugebauer JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099023; Nigg B, 2017, CURR ISSUES SPORT SC, DOI [10.1080/10255840802695437, DOI 10.1080/10255840802695437]; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; Nigg B. M., 2010, BIOMECHANICS SPORTS; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; Paquette MR, 2018, CURR ISSUES SPORT SC; Peake JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00743; Pollard CD, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118775720; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Ritchie RO, 2005, FATIGUE FRACT ENG M, V28, P345, DOI 10.1111/j.1460-2695.2005.00878.x; Sasimontonkul S, 2007, J BIOMECH, V40, P3503, DOI 10.1016/j.jbiomech.2007.05.024; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; Schmitt S, 2011, ARCH APPL MECH, V81, P887, DOI 10.1007/s00419-010-0458-z; SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357; Sharkey NA, 1998, CLIN BIOMECH, V13, P420, DOI 10.1016/S0268-0033(98)00003-5; SIMON SR, 1972, J BIOMECH, V5, P267, DOI 10.1016/0021-9290(72)90042-5; Suresh S., 1998, FATIGUE MAT; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; VANDENBOGERT A, 1996, P 9 BIENN C CAN SOC; Wells MD, 2020, SPORT BIOMECH, V19, P333, DOI 10.1080/14763141.2018.1510538; Yagi S, 2013, KNEE SURG SPORT TR A, V21, P556, DOI 10.1007/s00167-012-2160-x; Yong JR, 2018, J BIOMECH, V76, P1, DOI 10.1016/j.jbiomech.2018.05.017; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005; Zioupos P, 2001, J THEOR BIOL, V210, P389, DOI 10.1006/jtbi.2001.2316	86	77	78	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210000	10.1371/journal.pone.0210000	http://dx.doi.org/10.1371/journal.pone.0210000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653510	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500024
J	Ohnsorge, K; Rehmann-Sutter, C; Streeck, N; Gudat, H				Ohnsorge, Kathrin; Rehmann-Sutter, Christoph; Streeck, Nina; Gudat, Heike			Wishes to die at the end of life and subjective experience of four different typical dying trajectories. A qualitative interview study	PLOS ONE			English	Article							PHYSICIAN-ASSISTED SUICIDE; ILL CANCER-PATIENTS; AMYOTROPHIC-LATERAL-SCLEROSIS; PALLIATIVE CARE; HASTENED DEATH; OLDER-PEOPLE; DESIRE; EUTHANASIA; ATTITUDES; ALS	Research aims The motivations that lead to wishes to die (WTD) in palliative care patients with cancer are relatively well studied. But little is known about WTD in other pathologies and the relation between subjective understandings of dying trajectories and a WTD. We investigated the WTD of palliative patients in four different dying trajectories: neurological diseases, organ failure, frailty due to age, and cancer. Study population 62 palliative cancer (n = 30) and non-cancer (n = 32) patients (10 neurological disease; 11 organ failure; 11 frailty), their families and health professionals in different palliative care settings (248 interviews). Study design and methods Qualitative semi-structured interviews. Data analysis through Interpretive Phenomenological Analysis and Grounded Theory. Results In addition to personal motivations, we found that people dealing with similar trajectories were often confronted with similar questions and concerns due to similar challenges. For four trajectories we show typical patterns, similarities and differences that should be considered when talking with patients about their WTD. These illness-related considerations do not explain the WTD completely, but give important information on the challenges for particular patient groups that might experience a WTD. In all patient groups, there were clear moments that triggered a WTD: for neurological patients it was experiencing breathlessness, high-dependency care, or when considering tube feeding or respiratory support; for persons with organ failure it was an acute burdensome crisis; for patients with cancer after the initial diagnosis, it was the first relapse or the move into advanced palliative care; for elderly frail persons it was the move into care facilities, or the loss of important relationships or capabilities. The feeling of being a burden to others was reported in all patient groups. Interpretation WTD can be triggered within disease trajectories by specific conditions and transitional points that affect agency and self-understanding. A better understanding of the concerns and challenges of a particular dying trajectory as well as its characteristic trigger points can facilitate early and comprehensive communication about patients' WTD, and the underlying motivations and protective factors.	[Ohnsorge, Kathrin; Gudat, Heike] Hosp Pk, Hosp Palliat Care, Arlesheim, Switzerland; [Rehmann-Sutter, Christoph] Univ Lubeck, Inst Hist Med & Sci Studies, Lubeck, Germany; [Streeck, Nina] Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland	University of Lubeck; University of Zurich	Ohnsorge, K (corresponding author), Hosp Pk, Hosp Palliat Care, Arlesheim, Switzerland.	kathrin.ohnsorge@gmx.ch	Rehmann-Sutter, Christoph/U-9760-2019	Rehmann-Sutter, Christoph/0000-0001-7642-5556; Streeck, Nina/0000-0001-9321-2392	Oncosuisse [01960-10-2006]; Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation/NFP 67 end of life [406740 145089]; Forderstiftung HOSPIZ IM PARK, Arlesheim	Oncosuisse; Gottfried und Julia Bangerter-Rhyner Stiftung; Swiss National Science Foundation/NFP 67 end of life; Forderstiftung HOSPIZ IM PARK, Arlesheim	We are grateful to Oncosuisse (grant 01960-10-2006) and to the Gottfried und Julia Bangerter-Rhyner Stiftung for funding the first part of the study (oncology,) and to the Swiss National Science Foundation/NFP 67 end of life (grant 406740 145089) and the Forderstiftung HOSPIZ IM PARK, Arlesheim, for funding the second part of the study (non-oncology). The pilot study was made possible by the Forderstiftung HOSPIZ IM PARK, Arlesheim and the Freiwillige Akademische Gesellschaft Basel (FAG).; Our greatest thanks go to those people near the end of their lives, their families and healthcare providers, who shared their experiences, thoughts and intimate stories so kindly and openly in the interviews. We also thank all the institutions that collaborated in the study and made the interviews possible. We are grateful to Oncosuisse (grant 01960-10-2006) and to the Gottfried und Julia Bangerter-Rhyner-Stiftung for funding the first part of the study (oncology,) and to the Swiss National Science Foundation/NRP 67 end of life (grant 406740 145089) and the Forderstiftung HOSPIZ IM PARK, Arlesheim, for funding the second part of the study (nononcology). The pilot study was made possible by the Forderstiftung HOSPIZ IM PARK, Arlesheim and the Freiwillige Akademische Gesellschaft Basel (FAG).	Albert SM, 2005, NEUROLOGY, V65, P68, DOI 10.1212/01.wnl.0000168161.54833.bb; [Anonymous], 2009, INTERPRETIVE PHENOME; BARCLAY S, 2011, BRIT J GEN PRACT, V61; Barnow S, 2000, Crisis, V21, P171, DOI 10.1027//0227-5910.21.4.171; Bascom PB, 2002, JAMA-J AM MED ASSOC, V288, P91, DOI 10.1001/jama.288.1.91; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bonnewyn A, 2016, INT J GERIATR PSYCH, DOI [10.1002/gps, DOI 10.1002/GPS]; Bonnewyn A, 2014, DEATH STUD, V38, P612, DOI 10.1080/07481187.2013.835753; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Charmaz K., 2006, CONSTRUCTING GROUNDE, VSecond; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Coyle N, 2004, ONCOL NURS FORUM, V31, P699, DOI 10.1188/04.ONF.699-709; Crocker L, 2006, AGING MENT HEALTH, V10, P638, DOI 10.1080/13607860600640905; Dennis M, 2007, PSYCHOL MED, V37, P795, DOI 10.1017/S0033291707000013; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161; Fanos JH, 2008, J PALLIAT MED, V11, P470, DOI 10.1089/jpm.2007.0098; Frank Arthur, 1995, BODY ILLNESS ETHICS; Gadoud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113188; Ganzini L, 2002, J PAIN SYMPTOM MANAG, V24, P312, DOI 10.1016/S0885-3924(02)00496-7; Glaser BG, 2008, DISCOVERY GROUNDED T; Gudat H, 2015, THE PATIENTS WISH TO, P217; Guell E, 2015, PALLIAT SUPPORT CARE, V13, P295, DOI 10.1017/S1478951514000121; Johansen S, 2005, PALLIATIVE MED, V19, P454, DOI 10.1191/0269216305pm1048oa; JORM AF, 1995, AGE AGEING, V24, P389, DOI 10.1093/ageing/24.5.389; Kjolseth I, 2010, INT PSYCHOGERIATR, V22, P209, DOI 10.1017/S1041610209990949; Kjolseth I, 2009, INT PSYCHOGERIATR, V21, P903, DOI 10.1017/S1041610209990342; Kolva E, 2017, PSYCHOL ASSESSMENT, V29, P349, DOI 10.1037/pas0000343; Lapierre S, 2012, INT PSYCHOGERIATR, V24, P243, DOI 10.1017/S1041610211001591; Lule D, 2014, J NEUROL, V261, P518, DOI 10.1007/s00415-013-7229-z; Maessen M, 2009, NEUROLOGY, V73, P954, DOI 10.1212/WNL.0b013e3181b87983; Maessen M, 2010, J NEUROL, V257, P1192, DOI 10.1007/s00415-010-5474-y; Marx G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011555; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; Momen N, 2012, THORAX, V67, P777, DOI 10.1136/thoraxjnl-2012-201835; Monforte-Royo C, 2010, J PSYCHOSOC ONCOL, V20, P795, DOI DOI 10.1002/P0N.1839; Morita T, 2004, SUPPORT CARE CANCER, V12, P137, DOI 10.1007/s00520-003-0561-6; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j878; Ohnsorge K, 2014, PSYCHO-ONCOLOGY, V23, P1021, DOI 10.1002/pon.3524; Ohnsorge K, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-38; Ohnsorge K, 2012, NURS ETHICS, V19, P629, DOI 10.1177/0969733011436206; Olney RK, 2005, NEUROLOGY, V65, P9, DOI 10.1212/01.wnl.0000171741.00711.b5; Oyen E, 2004, HANDBOOK OF COMPARATIVE SOCIAL POLICY, P276; Plahuta JM, 2002, SOC SCI MED, V55, P2131, DOI 10.1016/S0277-9536(01)00356-2; Rehmann-Sutter C, 2017, ETHICS ONCOLOGY NEW, P103; Robinson JA, 2005, PALLIATIVE MED, V19, P278, DOI 10.1191/0269216305pm1021oa; Rodriguez-Prat A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016659; Rosenfeld B, 2000, CANCER, V88, P2868, DOI 10.1002/1097-0142(20000615)88:12<2868::AID-CNCR30>3.0.CO;2-K; Rosenfeld B, 2014, SOC SCI MED, V111, P35, DOI 10.1016/j.socscimed.2014.03.027; Rurup ML, 2011, CRISIS, V32, P194, DOI 10.1027/0227-5910/a000079; Rurup ML, 2011, CRISIS, V32, P204, DOI 10.1027/0227-5910/a000078; Schroepfer TA, 2006, J GERONTOL B-PSYCHOL, V61, pS129, DOI 10.1093/geronb/61.3.S129; Schroepfer TA, 2009, GERONTOLOGIST, V49, P755, DOI 10.1093/geront/gnp060; Scocco P, 2002, INT J GERIATR PSYCH, V17, P842, DOI 10.1002/gps.691; SEALE C, 1994, SOC SCI MED, V39, P647, DOI 10.1016/0277-9536(94)90021-3; Stewart S, 2002, BRIT MED J, V325, P915, DOI 10.1136/bmj.325.7370.915; Stutzki R, 2014, AMYOTROPH LAT SCL FR, V15, P68, DOI 10.3109/21678421.2013.837928; Stutzki R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00443; Suarez-Almazor ME, 2002, J CLIN ONCOL, V20, P2134, DOI 10.1200/JCO.2002.08.025; van Wijngaarden E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009895; Veldink JH, 2002, NEW ENGL J MED, V346, P1638, DOI 10.1056/NEJMsa012739; Wiktorsson S, 2010, AM J GERIAT PSYCHIAT, V18, P57, DOI 10.1097/JGP.0b013e3181bd1c13; Wilson KG, 2016, BMJ SUPPORT PALLIAT, V6, P170, DOI 10.1136/bmjspcare-2013-000604	64	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210784	10.1371/journal.pone.0210784	http://dx.doi.org/10.1371/journal.pone.0210784			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653575	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000456015500070
J	Shah, S; Meganathan, K; Christianson, AL; Leonard, AC; Thakar, CV				Shah, Silvi; Meganathan, Karthikeyan; Christianson, Annette L.; Leonard, Anthony C.; Thakar, Charuhas V.			Pre-dialysis acute care hospitalizations and clinical outcomes in dialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; PRACTICE PATTERNS; ASSOCIATION; PREVALENCE; PREDICTORS; MORTALITY; SURVIVAL; VISITS; HEALTH	Background Patients with chronic kidney disease (CKD), a precursor of end stage renal disease (ESRD), face an increasing burden of hospitalizations. Although mortality on dialysis is highest during the first year, the impact of pre-dialysis acute hospitalizations on clinical outcomes in dialysis patients remains unknown. Methods We evaluated 170,897 adult patients who initiated dialysis between 1/1/2010 and 12/31/2014 with linked Medicare claims from the United States Renal Data System. Using logistic regression models, we examined the association of 2-year pre-dialysis hospitalization on the primary outcome of 1-year all-cause mortality. Secondary outcomes included 90-day mortality, type of initial dialysis modality and type of vascular access at hemodialysis initiation. Results Mean age was 72.7 +/- 11.0 years. In the study sample, 76.0% of patients had at least one pre-dialysis hospitalization. Compared to patients with no pre-dialysis hospitalization, the adjusted 1-year mortality was higher with pre-dialysis cardiovascular related hospitalization (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.57-1.68), infection related hospitalization (OR, 1.51; CI, 1.45-1.57), both cardiovascular and infection hospitalization (OR, 1.91; CI, 1.83-1.99), and neither-cardiovascular nor-infection hospitalization (OR, 1.23; CI, 1.19-1.27). Additionally, the adjusted odds of hemodialysis vs. peritoneal dialysis as the initial dialysis modality were higher, whereas adjusted odds to initiate hemodialysis with an arteriovenous access vs. central venous catheter were lower in patients with any type of hospitalization. Conclusion Pre-dialysis hospitalization is an independent predictor of 1-year mortality in dialysis patients. Reducing the risk of pre-dialysis hospitalization may provide opportunities to improve quality of care in ESRD.	[Shah, Silvi; Thakar, Charuhas V.] Univ Cincinnati, Kidney CARE Program, Div Nephrol, Cincinnati, OH 45220 USA; [Meganathan, Karthikeyan; Christianson, Annette L.] Univ Cincinnati, Dept Biomed Informat, Cincinnati, OH USA; [Leonard, Anthony C.] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Thakar, Charuhas V.] VA Med Ctr, Div Nephrol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Shah, S (corresponding author), Univ Cincinnati, Kidney CARE Program, Div Nephrol, Cincinnati, OH 45220 USA.	shah2sv@ucmail.uc.edu	shah, silvi/AAA-4368-2020		Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine	Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine	Silvi Shah is supported by a Junior Pilot Faculty Award from University of Cincinnati's Department of Internal Medicine. The study was a part of Silvi Shah's masters of clinical and translational research thesis at University of Cincinnati.	Boulware LE, 2006, AM J KIDNEY DIS, V48, P192, DOI 10.1053/j.ajkd.2006.04.073; Bowman B, 2018, AM J KIDNEY DIS, V72, P278, DOI 10.1053/j.ajkd.2018.01.035; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chan KE, 2009, KIDNEY INT, V76, P331, DOI 10.1038/ki.2009.199; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; Erickson KF, 2015, J AM SOC NEPHROL, V26, P1990, DOI 10.1681/ASN.2014050464; Erickson KF, 2014, J AM SOC NEPHROL, V25, P2079, DOI 10.1681/ASN.2013080879; Gillespie BW, 2015, CLIN KIDNEY J, V8, P772, DOI 10.1093/ckj/sfv103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Holland DC, 2000, NEPHROL DIAL TRANSPL, V15, P650, DOI 10.1093/ndt/15.5.650; Honeycutt AA, 2013, J AM SOC NEPHROL, V24, P1478, DOI 10.1681/ASN.2012040392; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Mix TCH, 2003, AM J KIDNEY DIS, V42, P972, DOI 10.1016/j.ajkd.2003.06.001; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Naqvi SB, 2006, ADV CHRONIC KIDNEY D, V13, P199, DOI 10.1053/j.ackd.2006.04.004; Nitsch D, 2011, AM J KIDNEY DIS, V57, P664, DOI 10.1053/j.ajkd.2010.09.026; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; Saran R, 2018, AM J KIDNEY DIS, V71, pS1, DOI 10.1053/j.ajkd.2018.01.002; Shah S, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0898-1; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; United States Renal Data System, 2016, USRDS ANN DAT REP EP; US Renal Data System, 2015, 2015 RES GUID USRDS; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Yang JY, 2017, AM J KIDNEY DIS, V70, P164, DOI 10.1053/j.ajkd.2016.12.018	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209578	10.1371/journal.pone.0209578	http://dx.doi.org/10.1371/journal.pone.0209578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650094	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300018
J	Fitzhugh, MC; Whitehead, PS; Johnson, L; Cai, JM; Baxter, LC; Rogalsky, C				Fitzhugh, Megan C.; Whitehead, Peter S.; Johnson, Lisa; Cai, Julia M.; Baxter, Leslie C.; Rogalsky, Corianne			A functional MRI investigation of crossmodal interference in an audiovisual Stroop task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SUPERIOR TEMPORAL SULCUS; COLOR-WORD TEST; COGNITIVE CONTROL; PREFRONTAL CORTEX; MULTISENSORY INTEGRATION; ATTENTIONAL CONTROL; TEST-PERFORMANCE; VISUAL SPEECH; BRAIN	The visual color-word Stroop task is widely used in clinical and research settings as a measure of cognitive control. Numerous neuroimaging studies have used color-word Stroop tasks to investigate the neural resources supporting cognitive control, but to our knowledge all have used unimodal (typically visual) Stroop paradigms. Thus, it is possible that this classic measure of cognitive control is not capturing the resources involved in multisensory cognitive control. The audiovisual integration and crossmodal correspondence literatures identify regions sensitive to congruency of auditory and visual stimuli, but it is unclear how these regions relate to the unimodal cognitive control literature. In this study we aimed to identify brain regions engaged by crossmodal cognitive control during an audiovisual color-word Stroop task, and how they relate to previous unimodal Stroop and audiovisual integration findings. First, we replicated previous behavioral audiovisual Stroop findings in an fMRI-adapted audiovisual Stroop paradigm: incongruent visual information increased reaction time towards an auditory stimulus and congruent visual information decreased reaction time. Second, we investigated the brain regions supporting cognitive control during an audiovisual color-word Stroop task using fMRI. Similar to unimodal cognitive control tasks, a left superior parietal region exhibited an interference effect of visual information on the auditory stimulus. This superior parietal region was also identified using a standard audiovisual integration localizing procedure, indicating that audiovisual integration resources are sensitive to cognitive control demands. Facilitation of the auditory stimulus by congruent visual information was found in posterior superior temporal cortex, including in the posterior STS which has been found to support audiovisual integration. The dorsal anterior cingulate cortex, often implicated in unimodal Stroop tasks, was not modulated by the audiovisual Stroop task. Overall the findings indicate that an audiovisual color-word Stroop task engages overlapping resources with audiovisual integration and overlapping but distinct resources compared to unimodal Stroop tasks.	[Fitzhugh, Megan C.] Arizona State Univ, Interdisciplinary Neurosci Grad Degree Program, Tempe, AZ USA; [Fitzhugh, Megan C.; Whitehead, Peter S.; Johnson, Lisa; Cai, Julia M.; Rogalsky, Corianne] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Fitzhugh, Megan C.; Baxter, Leslie C.] Barrow Neurol Inst, Keller Ctr Imaging Innovat, Phoenix, AZ 85013 USA; [Fitzhugh, Megan C.; Baxter, Leslie C.] St Josephs Hosp, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Rogalsky, C (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA.	Corianne.rogalsky@asu.edu		Rogalsky, Corianne/0000-0002-0499-9355; Whitehead, Peter/0000-0002-1966-0848; Fitzhugh, Megan/0000-0001-5275-7361; Baxter, Leslie/0000-0002-3971-863X	Arizona State University	Arizona State University	Funding was provided by Arizona State University awarded to Corianne Rogalsky. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sharmeen Maze at the Keller Center for Imaging Innovation at the Barrow Neurological Institute for her critical assistance in fMRI data acquisition. Funding was provided by Arizona State University.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amer T, 2016, TRENDS COGN SCI, V20, P905, DOI 10.1016/j.tics.2016.10.002; Baayen RH, 2010, INT J PSYCHOL RES, V3, P12; Balk MH, 2010, NEUROREPORT, V21, P822, DOI 10.1097/WNR.0b013e32833d138f; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bugg JM, 2008, MEM COGNITION, V36, P1484, DOI 10.3758/MC.36.8.1484; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Christensen TA, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00236; COHEN G, 1979, COGNITIVE PSYCHOL, V11, P412, DOI 10.1016/0010-0285(79)90019-7; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COWAN N, 1987, PERCEPT PSYCHOPHYS, V41, P393, DOI 10.3758/BF03203031; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; DALRYMPLEALFORD EC, 1972, PERCEPT PSYCHOPHYS, V11, P274, DOI 10.3758/BF03210377; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Donohue SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062802; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; GREEN EJ, 1981, PERCEPT PSYCHOPHYS, V30, P459, DOI 10.3758/BF03204842; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HAMERS JF, 1972, J VERB LEARN VERB BE, V11, P303, DOI 10.1016/S0022-5371(72)80091-4; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Herd SA, 2006, J COGNITIVE NEUROSCI, V18, P22, DOI 10.1162/089892906775250012; HINTZMAN DL, 1972, J EXP PSYCHOL, V95, P458, DOI 10.1037/h0033644; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Ikeda Y, 2011, PSYCHOL REP, V108, P577, DOI 10.2466/04.10.22.PR0.108.2.577-584; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KLEIN GS, 1964, AM J PSYCHOL, V77, P576, DOI 10.2307/1420768; Koelewijn T, 2009, J EXP PSYCHOL HUMAN, V35, P1303, DOI 10.1037/a0013901; Lachaud CM, 2011, APPL PSYCHOLINGUIST, V32, P389, DOI 10.1017/S0142716410000457; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Laurienti PJ, 2003, HUM BRAIN MAPP, V19, P213, DOI 10.1002/hbm.10112; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Manwell LA, 2004, PSYCHON B REV, V11, P458, DOI 10.3758/BF03196595; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Matthews SC, 2004, NEUROIMAGE, V22, P1151, DOI 10.1016/j.neuroimage.2004.03.005; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V33, P266, DOI 10.3758/BF03202864; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Okada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068959; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Perrachione TK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00055; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; PIETERS JM, 1981, CORTEX, V17, P369, DOI 10.1016/S0010-9452(81)80024-X; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Ramachandran VS, 2018, SYNAESTHESIA A WINDO, P33; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; REDDING GM, 1977, PERCEPT MOTOR SKILL, V45, P11, DOI 10.2466/pms.1977.45.1.11; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; SMITH LB, 1992, COGNITIVE PSYCHOL, V24, P99, DOI 10.1016/0010-0285(92)90004-L; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; Talairach J, 1988, CO PLANAR STEREOTAXI, P11078, DOI [10.1073/pnas.0704320104, DOI 10.1073/PNAS.0704320104]; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Venezia JH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00174; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	106	4	4	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210736	10.1371/journal.pone.0210736	http://dx.doi.org/10.1371/journal.pone.0210736			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645634	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200049
J	Guzman-Otazo, J; Gonzales-Siles, L; Poma, V; Bengtsson-Palme, J; Thorell, K; Flach, CF; Iniguez, V; Sjoling, A				Guzman-Otazo, Jessica; Gonzales-Siles, Lucia; Poma, Violeta; Bengtsson-Palme, Johan; Thorell, Kaisa; Flach, Carl-Fredrik; Iniguez, Volga; Sjoling, Asa			Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; BETA-LACTAMASE GENES; MULTIPLEX PCR ASSAYS; CTX-M; WATER-QUALITY; WASTE-WATER; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; MOLECULAR CHARACTERIZATION	Water borne diarrheal pathogens might accumulate in river water and cause contamination of drinking and irrigation water. The La Paz River basin, including the Choqueyapu River, flows through La Paz city in Bolivia where it is receiving sewage, and residues from inhabitants, hospitals, and industry. Using quantitative real-time PCR (qPCR), we determined the quantity and occurrence of diarrheagenic Escherichia coli (DEC), Salmonella enterica, Klebsiella pneumoniae, Shigella spp. and total enterobacteria in river water, downstream agricultural soil, and irrigated crops, during one year of sampling. The most abundant and frequently detected genes were gapA and eltB, indicating presence of enterobacteria and enterotoxigenic E. coli (ETEC) carrying the heat labile toxin, respectively. Pathogen levels in the samples were significantly positively associated with high water conductivity and low water temperature. In addition, a set of bacterial isolates from water, soil and crops were analyzed by PCR for presence of the genes bla(CTX-M), bla(KPC), bla(NDM), bla(VIM) and bla(OXA-48). Four isolates were found to be positive for bla(CTX-M) genes and whole genome sequencing identified them as E. coli and one Enterobacter cloacae. The E. coli isolates belonged to the emerging, globally disseminated, multi-resistant E. coli lineages ST648, ST410 and ST162. The results indicate not only a high potential risk of transmission of diarrheal diseases by the consumption of contaminated water and vegetables but also the possibility of antibiotic resistance transfer from the environment to the community.	[Guzman-Otazo, Jessica; Poma, Violeta; Iniguez, Volga] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia; [Guzman-Otazo, Jessica; Thorell, Kaisa; Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Gonzales-Siles, Lucia; Bengtsson-Palme, Johan; Flach, Carl-Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Bengtsson-Palme, Johan; Flach, Carl-Fredrik] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Bengtsson-Palme, Johan] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA	Universidad Mayor de San Andres; Karolinska Institutet; University of Gothenburg; University of Gothenburg; University of Wisconsin System; University of Wisconsin Madison	Guzman-Otazo, J (corresponding author), Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia.; Guzman-Otazo, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	jessica.guzman.otazo@ki.se	Flach, Carl-Fredrik/AAL-1006-2020; Gonzales Strömberg, Lucia/GYQ-8934-2022; Bengtsson-Palme, Johan/K-3871-2012	Gonzales Strömberg, Lucia/0000-0001-7441-8483; Bengtsson-Palme, Johan/0000-0002-6528-3158; Flach, Carl-Fredrik/0000-0002-4101-5095	Swedish International Development Cooperation Agency (Sida); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water [SWWA 13-102]; International Science Program (ISP); FORMAS	Swedish International Development Cooperation Agency (Sida); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water(Swedish Research Council Formas); International Science Program (ISP); FORMAS(Swedish Research Council Formas)	This work was supported by the Swedish International Development Cooperation Agency (Sida) to [VI and AS], and a Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)/Swedish Water funded project on Risk-Based Decision Support for Safe Drinking Water [SWWA 13-102] to [AS]. The project is part of a Sweden-Bolivia Sida-Universidad Mayor de San Andres (UMSA) development program. JG-O acknowledges the financial support from the International Science Program (ISP). JB-P acknowledges financial support from FORMAS. The findings and conclusions contained in the article are those of the authors and do not necessarily reflect positions or policies of funder institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelowo OO, 2018, ENVIRON SCI POLLUT R, V25, P2744, DOI 10.1007/s11356-017-0686-7; Ahmed D, 2013, J APPL MICROBIOL, V114, P1223, DOI 10.1111/jam.12109; Alvarez R, 2008, RENEW ENERG, V33, P726, DOI 10.1016/j.renene.2007.05.001; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; Anbazhagan D, 2011, BRAZ J MICROBIOL, V42, P448, DOI 10.1590/S1517-83822011000200006; Archundia D, 2017, SCI TOTAL ENVIRON, V576, P671, DOI 10.1016/j.scitotenv.2016.10.129; Bajaj P, 2015, SCI TOTAL ENVIRON, V505, P350, DOI 10.1016/j.scitotenv.2014.09.084; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Banna MH, 2014, SENSOR ACTUAT B-CHEM, V193, P434, DOI 10.1016/j.snb.2013.12.002; Bartoloni A, 2016, INT J INFECT DIS, V43, P1, DOI 10.1016/j.ijid.2015.12.008; Begum YA, 2007, CAN J MICROBIOL, V53, P19, DOI 10.1139/W06-098; Ben Said L, 2016, SCI TOTAL ENVIRON, V550, P1103, DOI 10.1016/j.scitotenv.2016.01.042; Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5; Bengtsson-Palme J, 2018, FEMS MICROBIOL REV, V42, P68, DOI 10.1093/femsre/fux053; Bengtsson-Palme J, 2017, CURR OPIN FOOD SCI, V14, P66, DOI 10.1016/j.cofs.2017.01.010; Borgogna TR, 2016, MICROB DRUG RESIST, V22, P312, DOI 10.1089/mdr.2015.0197; Burke RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-708; Cabal A, 2013, APPL ENVIRON MICROB, V79, P4170, DOI 10.1128/AEM.00537-13; Delgado DYC, 2016, BRAZ J INFECT DIS, V20, P627, DOI 10.1016/j.bjid.2016.07.001; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Celenza G, 2006, J ANTIMICROB CHEMOTH, V57, P975, DOI 10.1093/jac/dkl055; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Conte D, 2017, ECOTOX ENVIRON SAFE, V136, P62, DOI 10.1016/j.ecoenv.2016.10.031; Dropa M, 2016, ENVIRON SCI POLLUT R, V23, P4953, DOI 10.1007/s11356-016-6079-5; Escandon-Vargas K, 2017, EXPERT REV ANTI-INFE, V15, P277, DOI 10.1080/14787210.2017.1268918; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Ewers C, 2014, J ANTIMICROB CHEMOTH, V69, P1224, DOI 10.1093/jac/dkt516; Fernandes MR, 2018, INFECT GENET EVOL, V66, P48, DOI 10.1016/j.meegid.2018.09.009; Ferreira JC, 2014, DIAGN MICR INFEC DIS, V80, P304, DOI 10.1016/j.diagmicrobio.2014.09.012; Galfi H, 2016, J HYDROL, V539, P125, DOI 10.1016/j.jhydrol.2016.05.006; Garcia-Fulgueiras V, 2013, New Microbes New Infect, V1, P44, DOI 10.1002/nmi2.25; Gebreyes WA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003257; Gonzales L, 2013, J MED MICROBIOL, V62, P1697, DOI 10.1099/jmm.0.060798-0; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Hayashi M, 2004, ENVIRON MONIT ASSESS, V96, P119, DOI 10.1023/B:EMAS.0000031719.83065.68; Hoorfar J, 2000, J CLIN MICROBIOL, V38, P3429, DOI 10.1128/JCM.38.9.3429-3435.2000; INE, ENC SAL 2016; Irrgang A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02318; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; Kabayiza JC, 2014, PEDIATR INFECT DIS J, V33, P1037, DOI 10.1097/INF.0000000000000448; Kney AD, 2007, J ENVIRON MANAGE, V82, P519, DOI 10.1016/j.jenvman.2006.01.014; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Larsson DGJ, 2018, ENVIRON INT, V117, P132, DOI 10.1016/j.envint.2018.04.041; Loock MM, 2015, WATER SA, V41, P705, DOI [10.4314/wsa.v41i5.14, 10.4314/WSA.V41I5.14]; Lothigius A, 2008, J APPL MICROBIOL, V104, P1128, DOI 10.1111/j.1365-2672.2007.03628.x; Lothigius A, 2010, J APPL MICROBIOL, V108, P1441, DOI 10.1111/j.1365-2672.2009.04548.x; Lyew D, 2001, WATER RES, V35, P2081, DOI 10.1016/S0043-1354(00)00473-5; Marti E, 2014, TRENDS MICROBIOL, V22, P36, DOI 10.1016/j.tim.2013.11.001; Mokomane M, 2017, THERAPEUTIC ADV INFE; Nascimento T, 2017, SCI TOTAL ENVIRON, V598, P910, DOI 10.1016/j.scitotenv.2017.03.207; Nicklasson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035827; Nuesch-Inderbinen M, 2018, J GLOB ANTIMICROB RE, V13, P53, DOI 10.1016/j.jgar.2018.03.001; Ohno A, 1997, AM J TROP MED HYG, V57, P438, DOI 10.4269/ajtmh.1997.57.438; Ortega-Paredes D, 2018, INT J FOOD MICROBIOL, V280, P41, DOI 10.1016/j.ijfoodmicro.2018.04.037; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poma V, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2132-6; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Qin SS, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.117; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Furlan JPR, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-017-6453-x; Ruiz SJ, 2011, J CLIN MICROBIOL, V49, P1993, DOI 10.1128/JCM.00045-11; Sartori L, 2017, J GLOB ANTIMICROB RE, V11, P145, DOI 10.1016/j.jgar.2017.10.009; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sellera FP, 2018, MAR POLLUT BULL, V135, P183, DOI 10.1016/j.marpolbul.2018.07.012; Sennati S, 2016, J GLOB ANTIMICROB RE, V4, P70, DOI 10.1016/j.jgar.2015.10.007; Sevillano E, 2012, J MED MICROBIOL, V61, P80, DOI 10.1099/jmm.0.032722-0; Shaw RK, 2011, ENV MICROBIOL REP, V3, P112, DOI 10.1111/j.1758-2229.2010.00195.x; Silva KC, 2016, ANTIMICROB AGENTS CH, V60, P2505, DOI 10.1128/AAC.02788-15; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Skarbovik E, 2015, ACTA AGR SCAND B-S P, V65, P63, DOI 10.1080/09064710.2014.966751; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Wiejaczka L, 2015, WATER RESOUR+, V42, P362, DOI 10.1134/S0097807815030070; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarfel G, 2017, SCI TOTAL ENVIRON, V593, P399, DOI 10.1016/j.scitotenv.2017.03.138	82	19	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210735	10.1371/journal.pone.0210735	http://dx.doi.org/10.1371/journal.pone.0210735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640938	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000043
J	Coyle, R; Feher, M; Jones, S; Hamilton, M; de Lusignan, S				Coyle, Rachel; Feher, Michael; Jones, Simon; Hamilton, Mark; de Lusignan, Simon			Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; MYOCARDIAL-INFARCTION; UNITED-STATES; 52 COUNTRIES; PREDICTORS; PREVALENCE; AWARENESS; RISK	Background Hypertension is a major cause of preventable disability and death globally and affects more than one in four adults in England. Unwarranted variation is variation in access, quality, outcome or value which is unexplained by differences in the condition or patient characteristics and which reduces quality and efficiency. Distinguishing unwarranted from variation due to clinical, organisational or patient factors can be challenging. We carried out this study to explore inter-practice variation in the diagnosis and management of hypertension in the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network database, a large, representative surveillance database. Methods and finding We carried out a cross-sectional study using primary care data extracted from the electronic health records of 1,271,419 adults registered at RCGP RSC general practices on 31st December 2016. Logistic regression was used to indirectly standardise practice-level hypertension prevalence and control against the RCGP RSC population, adjusted for age, gender, ethnicity, deprivation, co-morbidity, NHS region and practice size. Inter-practice variation was demonstrated using funnel plots with 95% and 99.8% control limits. The prevalence of detected hypertension was 18.4% (95% CI 18.4-18.5), n = 234,165. Uncontrolled hypertension was present in 146,553 of 196,052 individuals, 25.2% (25.1-25.4), in whom blood pressure had been recorded in the previous year. Hypertension management varied markedly between practices with a three-fold difference in prevalence, 13.5-38.4%, and a four-fold difference in the proportion of uncontrolled hypertension, 11.8-47.9%. Despite adjustment for sociodemographic and practice characteristics funnel plots demonstrated marked over-dispersion. Conclusions Substantial variation in the prevalence of diagnosed hypertension and the management of hypertension was only partially explained by characteristics captured within a routine data-set. The over-dispersion suggests variation is not fully explained by these factors and that context, behaviour and processes of care delivery may contribute to variation. Routine data sources in isolation to not provide sufficient contextual data to diagnose the causes of variation.	[Coyle, Rachel; Feher, Michael; de Lusignan, Simon] Univ Surrey, Dept Clin & Expt Med, London, England; [Jones, Simon] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Hamilton, Mark] Surrey Heartlands Clin Acad, Guildford, Surrey, England	University of Surrey; New York University	Coyle, R (corresponding author), Univ Surrey, Dept Clin & Expt Med, London, England.	rachelcoyle@nhs.net	de Lusignan, Smion/S-7838-2019	de Lusignan, Smion/0000-0002-8553-2641; Jones, Simon/0000-0002-8267-5647	Public Health England	Public Health England	The patients and practices that are members of the RCGP Research and Surveillance Centre and allow their data to be shared; EMIS, In Practice Systems and TPP SystmOne who helped facilitate data extraction; Apollo Medical Systems for expertise in secure data processing; the core surveillance function of RCGP Research and Surveillance Centre, which is funded by Public Health England; and Rachel Byford and Julian Sherlock, SQL developers, for their help with database management and data extraction.	Angell SY, 2008, CIRC-CARDIOVASC QUAL, V1, P46, DOI 10.1161/CIRCOUTCOMES.108.791954; Baltaci D, 2013, EUR REV MED PHARMACO, V17, P1884; Buchan IE, 2017, J EPIDEMIOL COMMUN H, V71, P928, DOI 10.1136/jech-2017-209195; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Corsino L, 2011, J CLIN HYPERTENS, V13, P106, DOI 10.1111/j.1751-7176.2010.00385.x; Costa FF, 2018, J CLIN HYPERTENS, V20, P125, DOI 10.1111/jch.13139; Dartm. Inst. Health Policy Clin. Pract, 2018, DARTM ATL HLTH CAR; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; Djulbegovic B, 2015, J EVAL CLIN PRACT, V21, P1121, DOI 10.1111/jep.12486; Egan B., 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI DOI 10.1001/JAMA.2010.650; Filipiak KJ, 2018, KARDIOL POL, V76, P353, DOI 10.5603/KP.a2017.0211; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fuller L., 2017, ADULT HLTH TRENDS; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Glover J A, 1938, Proc R Soc Med, V31, P1219; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Health Research Authority, 2017, DEF RES; Israels A., 2013, STAT METHODS CHATPER; Kelly E., DOES GP PRACTICE SIZ, DOI [10.1186/1477-7525-11-102, DOI 10.1186/1477-7525-11-102]; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; Mercuri M, 2015, ACAD MED, V90, P191, DOI 10.1097/ACM.0000000000000542; Mercuri M, 2011, J EVAL CLIN PRACT, V17, P671, DOI 10.1111/j.1365-2753.2011.01689.x; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; National Institute for Health and Care Excellence, 2015, NG28 TYP 2 DIAB AD M; National Institute for Health and Care Excellence, 2010, CG101 CHRON OBSTR PU; National Institute for Health and Care Excellence, 2016, HYP AD DIAGN MAN GUI; National Institute for Health and Care Excellence, 2015, NG17 TYP 1 DIAB AD D; National Institute for Health and Care Excellence, 2014, CG181 CARD DIS RISK; National Institute of Health and Care Excellence, 2010, CG108 CHRON HEART FA; National Institute of Health and Care Excellence, 2015, CG182 CHRON KIDN DIS; NHS England, 2017, NHS RIGHTC SHIFT VAL; Paddison CAM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006172; Persell SD, 2010, ANN INTERN MED, V152, P225, DOI 10.7326/0003-4819-152-4-201002160-00007; Public Health England, 2018, FUNN PLOTS TECHN BRI; Public Health England, 2018, ATL VAR; Public Health England, 2014, TACKL HIGH BLOOD PRU; Public Health England, 2015, TACKL UNW VAR HEALTH; Rowan CG, 2015, PHARMACOEPIDEM DR S, V24, P1170, DOI 10.1002/pds.3849; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; The King's Fund, 2013, TIM THINK DIFF; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1; Willis TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177949; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210657	10.1371/journal.pone.0210657	http://dx.doi.org/10.1371/journal.pone.0210657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629703	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000119
J	Koni, E; Moradi, S; Arahanga-Doyle, H; Neha, T; Hayhurst, JG; Boyes, M; Cruwys, T; Hunter, JA; Scarf, D				Koni, Elizabeth; Moradi, Saleh; Arahanga-Doyle, Hitaua; Neha, Tia; Hayhurst, Jillian G.; Boyes, Mike; Cruwys, Tegan; Hunter, John A.; Scarf, Damian			Promoting resilience in adolescents: A new social identity benefits those who need it most	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSION SYMPTOMS; GROUP MEMBERSHIPS; PEER GROUPS; IDENTIFICATION; CATEGORIZATION; COMMUNITY; CURE	The Social Identity Approach to Health holds that groups provide us with a sense of meaning and belonging, and that these identity processes have a significant positive impact on our health and wellbeing. Typically, research drawing from the social identity approach with adolescents has focused on the benefits of existing group memberships. Here, using a sail-training intervention, we investigated the impact of providing adolescents with a new group (i.e., a new social identity) on psychological resilience. Across two studies, we demonstrate the benefits of a new social identity, in terms of increases in psychological resilience, flow predominantly to those adolescents who report the lowest levels of resilience at the start of the voyage. We discuss our findings in relation to the social identity approach and adolescent identity development more generally.	[Koni, Elizabeth; Moradi, Saleh; Arahanga-Doyle, Hitaua; Hayhurst, Jillian G.; Hunter, John A.; Scarf, Damian] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Neha, Tia] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Boyes, Mike] Univ Otago, Sch Phys Educ, Dunedin, New Zealand; [Cruwys, Tegan] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	University of Otago; Victoria University Wellington; University of Otago; Australian National University	Scarf, D (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	damian@psy.otago.ac.nz	Hayhurst, Jillian G/W-1503-2017; Cruwys, Tegan/G-2956-2014	Hayhurst, Jillian G/0000-0002-1739-3707; Cruwys, Tegan/0000-0001-5296-3480; Scarf, Damian/0000-0002-9486-8059				Albarello F, 2018, J YOUTH ADOLESCENCE, V47, P689, DOI 10.1007/s10964-017-0791-4; Arahanga-Doyle H, 2018, PROMOTING POSITIVE Y, DOI [10.1080/1177083X.2018.1508479, DOI 10.1080/1177083X.2018.1508479]; Becker TE, 2005, ORGAN RES METHODS, V8, P274, DOI 10.1177/1094428105278021; Benish-Weisman M, 2015, J ADOLESCENCE, V44, P21, DOI 10.1016/j.adolescence.2015.06.008; Bernerth JB, 2016, PERS PSYCHOL, V69, P229, DOI 10.1111/peps.12103; Bizumic B, 2009, APPL PSYCHOL-INT REV, V58, P171, DOI 10.1111/j.1464-0597.2008.00387.x; Bratt C, 2015, BRIT J SOC PSYCHOL, V54, P671, DOI 10.1111/bjso.12105; Cotterell J., 1996, SOCIAL NETWORKS SOCI; Crocetti E, 2008, J ADOLESCENCE, V31, P207, DOI 10.1016/j.adolescence.2007.09.002; Crocetti E, 2017, CHILD DEV PERSPECT, V11, P145, DOI 10.1111/cdep.12226; Cruwys T, 2015, SOC PSYCHOL PERS SCI, V6, P65, DOI 10.1177/1948550614543309; Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839; Cruwys T, 2014, J AFFECT DISORDERS, V159, P139, DOI 10.1016/j.jad.2014.02.019; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; Dias K. L., 2001, J ADVENTURE EDUC OUT, V1, P35, DOI [10.1080/14729670185200061, DOI 10.1080/14729670185200061]; Ellemers N, 1999, EUR J SOC PSYCHOL, V29, P371, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<371::AID-EJSP932>3.3.CO;2-L; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Gillies WM, 2017, J CHILD FAM STUD, V26, P2889, DOI 10.1007/s10826-017-0792-7; Haslam C., 2018, NEW PSYCHOL HLTH UNL, DOI DOI 10.3109/14992027.2013.839888; Haslam SA, 2018, SOC SCI MED, V198, P14, DOI 10.1016/j.socscimed.2017.12.020; Hunter JA, 2010, J CHILD ADOLESC MENT, V22, P63, DOI 10.2989/17280583.2010.496943; Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628; Jetten J, 2017, EUR J SOC PSYCHOL, V47, P789, DOI 10.1002/ejsp.2333; Jetten J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124609; Kafka S, 2016, SELF ESTEEM PERSPECT, P195; Macfarlane AH, 2008, ETHNICITIES, V8, P102, DOI 10.1177/1468796807087021; Marie D, 2008, AUST NZ J PSYCHIAT, V42, P293, DOI 10.1080/00048670701787644; Meeus W, 2011, J RES ADOLESCENCE, V21, P75, DOI 10.1111/j.1532-7795.2010.00716.x; Miller K, 2017, BRIT J CLIN PSYCHOL, V56, P357, DOI 10.1111/bjc.12143; Miller K, 2015, PSYCHIAT RES, V228, P340, DOI 10.1016/j.psychres.2015.05.088; Newman BM, 2001, J YOUTH ADOLESCENCE, V30, P515, DOI 10.1023/A:1010480003929; PALMONARI A, 1990, SOC BEHAV, V5, P33; Postmes T, 2013, BRIT J SOC PSYCHOL, V52, P597, DOI 10.1111/bjso.12006; Praharso NF, 2017, PSYCHIAT RES, V247, P265, DOI 10.1016/j.psychres.2016.11.039; Scarf D, 2017, AUSTRALAS PSYCHIATRY, V25, P154, DOI 10.1177/1039856216671668; Scarf D, 2016, BRIT J SOC PSYCHOL, V55, P588, DOI 10.1111/bjso.12151; Sheldon KM, 2002, BRIT J SOC PSYCHOL, V41, P25, DOI 10.1348/014466602165036; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tanti C, 2011, J ADOLESCENCE, V34, P555, DOI 10.1016/j.adolescence.2010.05.012; Tarrant M, 2002, SOC DEV, V11, P110, DOI 10.1111/1467-9507.00189; Turner J.C., 1987, REDISCOVERING SOCIAL; Vignoles VL, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P1, DOI 10.1007/978-1-4419-7988-9_1; Wagnild G M, 1993, J Nurs Meas, V1, P165	44	13	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210521	10.1371/journal.pone.0210521	http://dx.doi.org/10.1371/journal.pone.0210521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629716	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000100
J	Bello-Perez, M; Falco, A; Novoa, B; Perez, L; Coll, J				Bello-Perez, Melissa; Falco, Alberto; Novoa, Beatriz; Perez, Luis; Coll, Julio			Hydroxycholesterol binds and enhances the anti-viral activities of zebrafish monomeric creactive protein isoforms	PLOS ONE			English	Article							C-REACTIVE PROTEIN; VIRUS-INFECTION; SWISS-MODEL; INFLAMMATION; PENTRAXINS; MEMBRANE; CRP; CHOLESTEROL; 25-HYDROXYCHOLESTEROL; ATHEROSCLEROSIS	C-reactive proteins (CRPs) are among the faster acute-phase inflammation-responses proteins encoded by one gene (hcrp) in humans and seven genes (crp1-7) in zebrafish (Danio rerio) with importance in bacterial and viral infections. In this study, we described novel preferential bindings of 25-hydroxycholesterol (25HOCh) to CRP1-7 compared with other lipids and explored the antiviral effects of both 25HOCh and CRP1-7 against spring viremia carp virus (SVCV) infection in zebrafish. Both in silico and in vitro results confirmed the antiviral effect of 25HOCh and CRP1-7 interactions, thereby showing that the crosstalk between them differed among the zebrafish isoforms. The presence of oxidized cholesterols in human atherosclerotic plaques amplifies the importance that similar interactions may occur for vascular and/or neurodegenerative diseases during viral infections. In this context, the zebrafish model offers a genetic tool to further investigate these interactions.	[Bello-Perez, Melissa; Falco, Alberto; Perez, Luis] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain; [Novoa, Beatriz] CSIC, Inst Marine Res IIM, Vigo, Spain; [Coll, Julio] Inst Nacl Invest & Tecnol Agr & Alimentarias, INIA, Dept Biotechnol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Coll, J (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentarias, INIA, Dept Biotechnol, Madrid, Spain.	juliocoll@inia.es	Novoa, Beatriz/K-3785-2014; Coll, julio/M-6071-2019; Falco, Alberto/A-3250-2012	Coll, julio/0000-0001-8496-3493; Falco, Alberto/0000-0001-7726-6577; Novoa, Beatriz/0000-0003-4888-8419; Perez Garcia-Estan, Luis/0000-0003-4078-8763; Bello Perez, Melissa/0000-0002-9212-083X	Generalidad Valenciana, fellowship ACIF/2016; CICYT of the Ministerio de Economia, Industria y Competitividad of Spain [AGL2014-51773-C3-R, BIO2017-82851]	Generalidad Valenciana, fellowship ACIF/2016; CICYT of the Ministerio de Economia, Industria y Competitividad of Spain	Melissa Bello-Perez was financed by the Generalidad Valenciana, fellowship ACIF/2016. This work was supported by CICYT projects AGL2014-51773-C3-R and BIO2017-82851 of the Ministerio de Economia, Industria y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Paula Perez Gonzalez who helped with the experimentation. Dr. Jose Antonio Encinar and Dra. Marcela Giudici from the IBMC-UMH, revised the docking prediction data and helped to perform gel electrophoresis experiments under native conditions, respectively. Melissa Bello-Perez was supported by the Generalidad Valenciana, fellowship ACIF/2016.	Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; AGRAWAL A, 1992, J BIOL CHEM, V267, P25352; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bello-Perez M, 2017, MOL IMMUNOL, V91, P145, DOI 10.1016/j.molimm.2017.09.005; Bello-Perez M, 2017, DEV COMP IMMUNOL, V69, P33, DOI 10.1016/j.dci.2016.12.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biro A, 2007, J LIPID RES, V48, P19, DOI 10.1194/jlr.M600158-JLR200; Bottazzi B, 2016, J HEPATOL, V64, P1416, DOI 10.1016/j.jhep.2016.02.029; Braig D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14188; Caprio V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01089; Chen R, 2015, J STRUCT BIOL, V189, P259, DOI 10.1016/j.jsb.2015.01.001; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Coll JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00039; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Deng LT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159458, 10.137]; Desplanques AS, 2008, VIROLOGY, V376, P339, DOI 10.1016/j.virol.2008.03.039; Dong H, 2018, ANTIVIR THER; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Estepa A, 1996, VIROLOGY, V216, P60, DOI 10.1006/viro.1996.0034; Estepa AM, 2001, J BIOL CHEM, V276, P46268, DOI 10.1074/jbc.M108682200; Estepa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135483; Falco A, 2012, DEV COMP IMMUNOL, V37, P127, DOI 10.1016/j.dci.2011.10.005; Filjan N, 1971, Vet Arhiv, V41, P125; Fujita H, 2011, ARCH VIROL, V156, P995, DOI 10.1007/s00705-011-0938-7; Garcia-Valtanen P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00121; Glisoni RJ, 2015, J NANOSCI NANOTECHNO, V15, P4224, DOI 10.1166/jnn.2015.9613; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; ICTV, 2015, IMPL TAX WID NONL BI, V9, P430, DOI [10.1016/j.virol.2007.03.016, DOI 10.1016/J.VIROL.2007.03.016]; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Li HY, 2016, J BIOL CHEM, V291, P8795, DOI 10.1074/jbc.M115.695023; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lv JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20014-y; Magnadottir B, 2018, DEV COMP IMMUNOL, V87, P1, DOI 10.1016/j.dci.2018.05.014; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; McFadyen JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01351; McKibben RA, 2016, J INFECT DIS, V213, P257, DOI 10.1093/infdis/jiv396; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; PEPYS MB, 1981, LANCET, V1, P653; Pereiro P, 2017, ANTIVIR RES, V145, P146, DOI 10.1016/j.antiviral.2017.08.003; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; Potempa Lawrence A, 2015, Biophys Rep, V1, P18; Shah S, 2015, AIDS, V29, P1325, DOI 10.1097/QAD.0000000000000654; Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749; Shrivastava AK, 2015, EGYPT HEART J, V67, P89, DOI 10.1016/j.ehj.2014.11.005; Shrivastava-Ranjan P, 2016, MBIO, V7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TANAKA T, 1983, J IMMUNOL METHODS, V65, P333, DOI 10.1016/0022-1759(83)90128-X; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Tian ZY, 2017, EUR J MED CHEM, V134, P133, DOI 10.1016/j.ejmech.2017.03.087; Torrent F, 2016, ARCH VIROL, V161, P2653, DOI 10.1007/s00705-016-2934-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vilahur G, 2015, VASC PHARMACOL, V73, P38, DOI 10.1016/j.vph.2015.05.001; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Voulgaris Theodoros, 2016, Hepat Res Treat, V2016, P7629318, DOI 10.1155/2016/7629318; Wang JH, 2015, ATHEROSCLEROSIS, V239, P343, DOI 10.1016/j.atherosclerosis.2015.01.024; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Widziolek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36023; Wu Y, 2015, BIOL CHEM, V396, P1181, DOI 10.1515/hsz-2015-0149; Yang J, 2017, ORG BIOMOL CHEM, V15, P4644, DOI 10.1039/c7ob00684e; Yang Q, 2015, VIROLOGY, V484, P170, DOI 10.1016/j.virol.2015.06.005; Zhu XL, 2018, EUR J MED CHEM, V146, P194, DOI 10.1016/j.ejmech.2018.01.040; Zieden B, 1999, ARTERIOSCL THROM VAS, V19, P967, DOI 10.1161/01.ATV.19.4.967	68	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0201509	10.1371/journal.pone.0201509	http://dx.doi.org/10.1371/journal.pone.0201509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653529	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500002
J	Jablonowska, E; Siwak, E; Bociaga-Jasik, M; Gasiorowski, J; Kalinowska, A; Burkacka, EF; Wojcik-Cichy, K; Piatek, A; Cielniak, I; Horban, A				Jablonowska, Elzbieta; Siwak, Ewa; Bociaga-Jasik, Monika; Gasiorowski, Jacek; Kalinowska, Anna; Burkacka, Ewa Firlag; Wojcik-Cichy, Kamila; Piatek, Anna; Cielniak, Iwona; Horban, Andrzej			Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NUCLEOSIDE-SPARING REGIMEN; MYOCARDIAL-INFARCTION; PLUS RALTEGRAVIR; RENAL TOXICITY; DOUBLE-BLIND; HIV; EFFICACY; TENOFOVIR/EMTRICITABINE; SAFETY	Background Dual therapy based on dolutegravir and ritonavir-boosted darunavir (DTG/DRV/r) is a combination of well-known drugs with a high genetic barrier to HIV resistance. Method A retrospective analysis of all HIV-1 infected treatment-experienced patients who switched to DTG/DRV/r from May 2014 till March 2017 in 4 Polish centres-results of a 48-week treatment. Results The study group consisted of 59 men and 17 women. Median baseline parameters were: age-42.7 years, CD4 cells count-560.5 cells/mu l, CD4 cells nadir-150 cells/mu l, number of prior antiretroviral regimens-3. The introduction of dual therapy was primarily due to virologic failure (30 patients), adverse events on previous regimens (17 patients) and therapy simplification (27 patients). At week 48 the treatment was continued in 70/76 of patients and the median CD4 cells count increased from 560.5 to 641.0 cells/mu l. The therapy was discontinued in six patients (1 -virologic failure, 1 -decrease of estimated glomerular filtration rate (eGFR), 1 -myalgia, 3 -lost to follow-up). At week 48 six patients had detectable viremia, but only in one patient viremia was higher than 200 copies/ml. At week 48 the level of serum total cholesterol of the investigated subjects was statistically significantly higher than at the moment of dual therapy introduction (185.8 mg/dl vs. 174.8 mg/dl- p<0.05). However, in patients previously not treated with TDF, there were no changes in lipid parameters during therapy. Proteinuria was observed in 13.2% of patients before the switch to dual therapy and in 7.1% of patients at week 48. Conclusions The investigated dual therapy was effective and safe. The observed increase in lipid parameters only concerned the patients who had used a TDF-based regimen prior to analysed dual treatment.	[Jablonowska, Elzbieta; Wojcik-Cichy, Kamila] Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland; [Siwak, Ewa; Burkacka, Ewa Firlag; Cielniak, Iwona; Horban, Andrzej] HIV Out Patient Clin, Hosp Infect Dis, Warsaw, Poland; [Bociaga-Jasik, Monika; Kalinowska, Anna; Piatek, Anna] Jagiellonian Univ, Coll Med, Dept Infect Dis, Krakow, Poland; [Gasiorowski, Jacek] Wroclaw Med Univ, Dept Infect Dis Hepatol & Acquired Immune Deficie, Wroclaw, Poland; [Horban, Andrzej] Med Univ Warsaw, Hosp Infect Dis, Warsaw, Poland	Medical University Lodz; Jagiellonian University; Collegium Medicum Jagiellonian University; Wroclaw Medical University; Medical University of Warsaw	Jablonowska, E (corresponding author), Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland.	elajablonowska@gmail.com		Jablonowska, Elzbieta/0000-0002-7282-1225; Wojcik-Cichy, Kamila/0000-0003-2465-401X				[Anonymous], GUIDELINES USE ANTIR; Burgos J, 2012, J ANTIMICROB CHEMOTH, V67, P1453, DOI 10.1093/jac/dks057; Calza L, 2011, SCAND J INFECT DIS, V43, P656, DOI 10.3109/00365548.2011.572906; Capetti AF, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2755-4; Casado JL, 2016, AIDS, V30, P1423, DOI 10.1097/QAD.0000000000001067; Cottrell ML, 2013, CLIN PHARMACOKINET, V52, P981, DOI 10.1007/s40262-013-0093-2; Gallant JE, 2003, ANTIVIR THER, V8, P489; Gueler A, 2017, AIDS, V31, P427, DOI 10.1097/QAD.0000000000001335; Hoffmann C, 2017, HIV MED, V18, P56, DOI 10.1111/hiv.12468; Hughes CA, 2008, ANN PHARMACOTHER, V42, P387, DOI 10.1345/aph.1K522; Jablonowska E, 2017, J MED VIROL, V89, P2122, DOI 10.1002/jmv.24826; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lepik KJ, 2018, AIDS, V32, P903, DOI 10.1097/QAD.0000000000001781; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Margolis AM, 2014, J MED TOXICOL, V10, P26, DOI 10.1007/s13181-013-0325-8; Mitra Shubhanker, 2014, J Assoc Physicians India, V62, P580; Montessori V, 2004, CAN MED ASSOC J, V170, P229; Penafiel J, 2017, J ANTIMICROB CHEMOTH, V72, P1752, DOI 10.1093/jac/dkx053; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Santos JR, 2015, CLIN INFECT DIS, V61, P403, DOI 10.1093/cid/civ296; Sterrantino G, 2015, INFECTION, V43, P339, DOI 10.1007/s15010-015-0764-z; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tremblay Cecile L, 2008, Ther Clin Risk Manag, V4, P759; Viani RM, 2015, PEDIATR INFECT DIS J, V34, P1207, DOI 10.1097/INF.0000000000000848	28	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210476	10.1371/journal.pone.0210476	http://dx.doi.org/10.1371/journal.pone.0210476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653541	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500041
J	Levitzky, N; Smith, E; Lachman, O; Luria, N; Mizrahi, Y; Bakelman, H; Sela, N; Laskar, O; Milrot, E; Dombrovsky, A				Levitzky, Naama; Smith, Elisheva; Lachman, Oded; Luria, Neta; Mizrahi, Yaniv; Bakelman, Helen; Sela, Noa; Laskar, Orly; Milrot, Elad; Dombrovsky, Aviv			The bumblebee Bombus terrestris carries a primary inoculum of Tomato brown rugose fruit virus contributing to disease spread in tomatoes	PLOS ONE			English	Article							MOSAIC-VIRUS; POLLINATION; HYMENOPTERA; TRANSMISSION; APIDAE; CROPS	The bumblebee Bombus terrestris is a beneficial pollinator extensively used in tomato production. Our hypothesis was that bumblebee hives collected from a Tomato brown rugose fruit virus (ToBRFV) infected tomato greenhouse, preserve an infectious primary inoculum. Placing a bumblebee hive collected from a ToBRFV contaminated greenhouse, in a glass-/net-house containing only uninfected healthy tomato plants, spread ToBRFV disease. Control uninfected tomato plants grown in a glass-/net-house devoid of any beehive remained uninfected. ToBRFV-contaminated hives carried infectious viral particles as demonstrated in a biological assay on laboratory test plants of virus extracted from hive components. Viral particles isolated from a contaminated hive had a typical tobamovirus morphology observed in transmission electron microscopy. Assembly of ToBRFV genome was achieved by next generation sequencing analysis of RNA adhering to the bumblebee body. Bumblebee dissection showed that ToBRFV was mostly present in the abdomen suggesting viral disease spread via buzz pollination. These results demonstrate that bumblebee hives collected from ToBRFV-contaminated greenhouses carry a primary inoculum that reflects the status of viruses in the growing area. This new mode of ToBRFV spread by pollinators opens an avenue for detection of viruses in a growing area through analysis of the pollinators, as well as emphasizes the need to reevaluate the appropriate disease management protocols.	[Levitzky, Naama; Smith, Elisheva; Lachman, Oded; Luria, Neta; Mizrahi, Yaniv; Bakelman, Helen; Sela, Noa; Dombrovsky, Aviv] Volcani Ctr, ARO, Dept Plant Pathol, Rishon Leziyyon, Israel; [Levitzky, Naama] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Mizrahi, Yaniv] Hebrew Univ Jerusalem, Agroecol & Plant Hlth, Rehovot, Israel; [Laskar, Orly; Milrot, Elad] IIBR, Ness Ziona, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Bar Ilan University; Hebrew University of Jerusalem	Dombrovsky, A (corresponding author), Volcani Ctr, ARO, Dept Plant Pathol, Rishon Leziyyon, Israel.	aviv@volcani.agri.gov.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X	Ministry of Agriculture [20-10-0070]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This research was supported by the Israeli Chief Scientist, Ministry of Agriculture on ToBRFV grant number: 20-10-0070 to AD; https://agriscience.co.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignus Y, 2007, PLANT DIS, V91, P47, DOI 10.1094/PD-91-0047; Asada S, 1996, APPL ENTOMOL ZOOL, V31, P581, DOI 10.1303/aez.31.581; Banda H, 1990, 6 INT S POLL, V288; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Darzi E, 2017, PLANT PATHOLOGY; Dogterom MH, 1998, J ECON ENTOMOL, V91, P71, DOI 10.1093/jee/91.1.71; Dombrovsky A., 2017, ADV SEED BIOL; Galbraith DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27164-z; Genda Y, 2011, J GEN PLANT PATHOL, V77, P201, DOI 10.1007/s10327-011-0307-0; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Groen SC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005790; Kawai Y, 2009, ECOL RES, V24, P215, DOI 10.1007/s11284-008-0500-6; KOENIG R, 1981, J GEN VIROL, V55, P53, DOI 10.1099/0022-1317-55-1-53; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li RG, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00794-13; Luria N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170429; Matsuura S, 2010, EUR J PLANT PATHOL, V126, P111, DOI 10.1007/s10658-009-9515-2; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Moreira SR, CARACTERIZACAO NOVA; Okada Kiyotsugu, 2000, Journal of General Plant Pathology, V66, P71, DOI 10.1007/PL00012924; Salem N, 2016, ARCH VIROL, V161, P503, DOI 10.1007/s00705-015-2677-7; Sastry KS., 2013, SEED BORNE PLANT VIR; Schoonvaere K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168456; Shipp JL, 2008, ANN APPL BIOL, V153, P149, DOI 10.1111/j.1744-7348.2008.00245.x; Sui XL, 2017, PLANT DIS, V101, P704, DOI [10.1094/PDIS-10-16-1504-RE, 10.1094/pdis-10-16-1504-re]; TAYLOR RH, 1961, PHYTOPATHOLOGY, V51, P837; Webster CG, 2014, PLANT HLTH PROG, V15, P2; Winter K, 2006, IMPORTATION NONNATIV, P33, DOI DOI 10.1016/J.VIROL.2016.10.017; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	29	37	42	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210871	10.1371/journal.pone.0210871	http://dx.doi.org/10.1371/journal.pone.0210871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653593	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500082
J	McMillan, TM; Graham, L; Pell, JP; McConnachie, A; Mackay, DF				McMillan, T. M.; Graham, L.; Pell, J. P.; McConnachie, A.; Mackay, D. F.			The lifetime prevalence of hospitalised head injury in Scottish prisons: A population study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ASSOCIATION	Background There is mounting evidence that associates brain injury and offending behaviour, and there is a need to understand the epidemiology of head injury in prisoners in order to plan interventions to reduce associated disability and risk of reoffending. This is the first study to determine the lifetime prevalence of hospitalised head injury (HHI) in a national population of current prison inmates. In addition characteristics of prisoners with HHI and were compared to prisoners without HHI to discover whether those with HI differed demographically. Methods Whole life hospital records of everyone aged 35 years or younger and resident in a prison in Scotland on a census date in 2015 were electronically linked via their unique NHS identifier and checked for ICD-9 and 10 codes for head injury. Using a case-control design, these data were compared with a sample from the general population matched 3: 1 for age, gender and area-based social deprivation. Comparison of demographic variables was made between prisoners with and without HHI. Results HHI was found in 24.7% (1,080/4,374) of prisoners and was significantly more prevalent than found in the matched general population sample (18.2%; 2394/13122; OR 2.10; 95% CI 1.87, 2.16). The prevalence of HHI in prisoners and controls was similar with the exception of a higher risk of HHI in prisoners in lower deprivation quintiles. Having three or more HHI was more common in prisoners (OR 3.04; 95% CI 2.33, 3.97) as were HHI with ICD codes for intracranial injuries (OR 1.81; 95% CI 1.54, 2.11), suggesting that more severe HHI is more prevalent in prisoners than the general population. The distributions within demographic variables and the characteristics of HHI admissions in prisoners with and without a history of HHI were similar. Conclusion Prisoners in Scotland aged 35 years or younger have a higher lifetime prevalence of HHI than the general population and are more likely to have had repeated HI or intracranial injuries. Further work is required to elucidate the correspondence between self-report of HI and hospitalised records and to ascertain persisting effects of HI in prisoners and the need for services to reduce associated disability and risk of reoffending.	[McMillan, T. M.; Pell, J. P.; McConnachie, A.; Mackay, D. F.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Graham, L.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland	University of Glasgow; NHS National Services Scotland	McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Thomas.mcmillan@glasgow.ac.uk	McMillan, Thomas/K-2055-2015	McMillan, Thomas/0000-0002-5278-9889	NHS Scotland National Prisoner Healthcare Network	NHS Scotland National Prisoner Healthcare Network	Funded by NHS Scotland National Prisoner Healthcare Network.	Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Mental Health, 2016, TRAUM BRAIN INJ OFF; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Farrington D. P., 2006, CRIMINAL CAREERS AGE; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HIRSCHI T, 1983, AM J SOCIOL, V89, P552, DOI 10.1086/227905; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McMillan TM, 2017, NEUROBEHAVIOURAL DIS, P57; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, 10.1300/J076v27n03_01]; Moynan CR, 2018, J HEAD TRAUMA REHAB, V33, P275, DOI 10.1097/HTR.0000000000000354; National Prisoner Healthcare Network, 2016, BRAIN INJ OFF; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Roworth MA, 1998, COM MED, V10, P327; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scottish Executive, 2012, SCOTT IND MULT DEPR; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Worthington A, 2017, NEUROBEHAVIOURAL DIS, P3	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210427	10.1371/journal.pone.0210427	http://dx.doi.org/10.1371/journal.pone.0210427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653552	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000456015500038
J	Potenza, MA; Sgarra, L; Nacci, C; Leo, V; Salvia, MA; Montagnani, M				Potenza, Maria Assunta; Sgarra, Luca; Nacci, Carmela; Leo, Valentina; De Salvia, Maria Antonietta; Montagnani, Monica			Activation of AMPK/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I/R) injury in rats	PLOS ONE			English	Article							PROTEIN-KINASE; NITRIC-OXIDE; CARDIAC DYSFUNCTION; SIRT1; AMPK; INFARCTION; METABOLISM; SURVIVAL; HEART; AKT	Background Adiponectin (AD) cardioprotective activities are mediated by AMPK, a fuel-sensing molecule sharing common targets and cellular activities with SIRT-1. Whether AD preconditioning may involve SIRT-1 activity is not known; however, the protective role of SIRT-1 during ischemia and the potential interplay between AMPK and SIRT-1 suggest this possibility. Methods Isolated hearts from male Sprague-Dawley rats (n = 85) underwent ischemia/reperfusion (I/R, 30/180 min). Preconditioning with resveratrol (RSV, SIRT-1 activator) was compared to preconditioning with AD alone, or in combination with compound C (CC, AMPK inhibitor) or sirtinol (STN, SIRT-1 inhibitor). For each heart, left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (dLVP), coronary flow (CF) and left ventricular infarct mass (IM) were measured, together with the phosphorylation/activation status of AMPK, LKB1, eNOS and SIRT-1, at the beginning (15 min) and at the end (180 min) of reperfusion. Results and conclusions When compared to I/R, both RSV and AD improved cardiac function and reduced IM (p < 0.01, p < 0.05, respectively). Cardioprotective effects of AD were completely reversed in the AD+CC group, and significantly attenuated in the AD+STN group. Both RSV and AD increased eNOS, AMPK and LKB1 phosphorylation (for each parameter: p < 0.05 vs. I/R, in both RSV and AD treatment groups) at 15 min of reperfusion, and SIRT-1 activity at the end of reperfusion (p < 0.01, p < 0.05 vs. I/R, respectively). Interestingly, AD-mediated phosphorylation of AMPK and LKB1, and SIRT-1 deacetylation activity was markedly reduced in both the AD+CC and AD+STN groups (p < 0.05 vs. AD). Thus, AD-mediated cardioprotection requires both AMPK and SIRT-1 signaling pathways, that act as a component of a cycle and regulate each other's activities.	[Potenza, Maria Assunta; Nacci, Carmela; Leo, Valentina; De Salvia, Maria Antonietta; Montagnani, Monica] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Med Sch, Pharmacol Sect, Bari, Italy; [Sgarra, Luca] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Med Sch, Sect Cardiovasc Dis, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Montagnani, M (corresponding author), Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Med Sch, Pharmacol Sect, Bari, Italy.	monica.montagnani@uniba.it	Montagnani, Monica/AAV-2057-2020; Sgarra, Luca/AAC-4773-2022	Montagnani, Monica/0000-0002-5697-8185; Sgarra, Luca/0000-0001-8475-8270; De Salvia, Maria Antonietta/0000-0001-5326-792X	Italian Ministry of University (MIUR) [PRIN 2010YK7Z5K_008]; University of Bari [CUP H96J15001610005]	Italian Ministry of University (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Bari	This work was supported, in part, by the Italian Ministry of University (MIUR) research grant award (PRIN 2010YK7Z5K_008) to M.M. and, in part, by the University of Bari Research funds (CUP H96J15001610005) to M.M.	Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Aksentijevic D, 2016, EXP PHYSIOL, V101, P282, DOI 10.1113/EP085380; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carvajal K, 2007, AM J PHYSIOL-HEART C, V292, pH3136, DOI 10.1152/ajpheart.00683.2006; Cattelan A, 2015, VASC PHARMACOL, V70, P35, DOI 10.1016/j.vph.2015.02.004; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cotton JM, 2002, HEART, V88, P564, DOI 10.1136/heart.88.6.564; Debinski M, 2011, INT J MOL MED, V27, P775, DOI 10.3892/ijmm.2011.643; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; FERRARI R, 1995, AM J CARDIOL, V76, pB17; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Gu XS, 2014, GENET MOL RES, V13, P323, DOI 10.4238/2014.January.17.17; Hattori Y, 2003, DIABETOLOGIA, V46, P1543, DOI 10.1007/s00125-003-1224-3; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Hostrup A, 2012, CELL PHYSIOL BIOCHEM, V30, P642, DOI 10.1159/000341445; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jungtrakoon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026792; Kojima S, 2003, HEART, V89, P667, DOI 10.1136/heart.89.6.667; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lecour S, 2005, CIRCULATION, V112, P3911, DOI 10.1161/CIRCULATIONAHA.105.581058; Li J L, 2017, INT J AEROSPACE ENG, V2017, P1, DOI DOI 10.1155/2017/7584691; Li L, 2007, REGUL PEPTIDES, V139, P72, DOI 10.1016/j.regpep.2006.10.007; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nanayakkara G, 2012, AM J CARDIOVASC DIS, V2, P253; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nystrom T, 2006, CLIN SCI, V110, P673, DOI 10.1042/CS20050353; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rosano GMC, 2008, CURR PHARM DESIGN, V14, P2551, DOI 10.2174/138161208786071317; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sgarra L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088542; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Skyschally A, 2015, CIRC RES, V117, P279, DOI 10.1161/CIRCRESAHA.117.306878; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Wang L, 2018, CARDIOVASC RES, P781, DOI [10.3892/ijmm.2011.643, DOI 10.3892/IJMM.2011.643]; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005	65	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210654	10.1371/journal.pone.0210654	http://dx.doi.org/10.1371/journal.pone.0210654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653603	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500061
J	Bedford, JG; O'Keeffe, M; Reading, PC; Wakim, LM				Bedford, James G.; O'Keeffe, Meredith; Reading, Patrick C.; Wakim, Linda M.			Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection	PLOS ONE			English	Article							PROTEINS; RESISTANCE; BINDING; RISK	Interferon-induced transmembrane protein 3 (IFITM3) is a potent antiviral protein that enhances cellular resistance to a variety of pathogens, including influenza virus. Classically defined as an interferon-stimulated gene, expression of IFITM3 on cells is rapidly up-regulated in response to type I and II interferon. Here we found that IFITM3 is rapidly up-regulated by T cells following their activation and this occurred independently of type I and II interferon and the interferon regulatory factors 3 and 7. Up-regulation of IFITM3 on effector T cells protected these cells from virus infection and imparted a survival advantage at sites of virus infection. Our results show that IFITM3 expression on effector T cells is crucial for these cells to mediate their effector function and highlights an interferon independent pathway for the induction of IFITM3 which, if targeted, could be an effective approach to harness the activity of IFITM3 for infection prevention.	[Bedford, James G.; Reading, Patrick C.; Wakim, Linda M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [O'Keeffe, Meredith] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [O'Keeffe, Meredith] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Reading, Patrick C.] WHO, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	University of Melbourne; Monash University; Monash University; Victorian Infectious Diseases Reference Laboratory; World Health Organization	Wakim, LM (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	wakiml@unimelb.edu.au	O'Keeffe, Meredith/U-9347-2017	O'Keeffe, Meredith/0000-0002-0779-4654; Bedford, James/0000-0001-5216-1779	National Health and Medical Research Council (NHMRC) of Australia; Australian Research Council (ARC); Australian Government Department of Health	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC) (LMW). The Melbourne World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health (PR).	Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723; Everitt AR, 2012, NATURE; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Infusini G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143539; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Zhang YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2830	27	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210132	10.1371/journal.pone.0210132	http://dx.doi.org/10.1371/journal.pone.0210132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650117	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300044
J	Jiang, CJ; Meng, C; Schapaugh, A				Jiang, Changjian; Meng, Chen; Schapaugh, Adam			Comparative analysis of genetically-modified crops: Part 1. Conditional difference testing with a given genetic background	PLOS ONE			English	Article							SAFETY EVALUATION; EQUIVALENCE	The European Food Safety Authority (EFSA) mandates two sets of statistical tests in the comparative assessment of a genetically-modified (GM) crop: difference testing to demonstrate whether the GM crop is different from its appropriate non-traited control; and equivalence testing to demonstrate whether it is equivalent to conventional references with an history-of-safe-use. The equivalence testing method prescribed by EFSA confounds the so called GM trait effect with genotypic differences between the reference varieties and non-traited control. Critically, these genotypic differences, which we define as a 'control background effect', are the result of conventional plant breeding. Thus, the result of EFSA equivalence testing often has little or nothing to do with the GM trait effect, which should be the sole focus of the comparative assessment. Here, an integrated method is introduced for both difference and equivalence testing that considers the differences of the three genotype groups (GM, control, and references) as a two-dimensional random variable. A novel statistical model is proposed, called the trait model, that treats the effects of the GM and control materials as fixed for their difference, and as random for their common background. For significance testing, the covariance structure of the three genotype groups is utilized to decompose the differences into the trait effect and the control background effect. The trait difference is then derived as a conditional mean, given the background effect. The comparative assessment can then focus on the conditional mean difference, which is independent of the control background effect. Furthermore, the trait model is flexible enough to include various types of genotype-by-environment (GxE) interactions inherent to the experimental design of the trial. Numerical evaluations and simulations show that this new method is substantially more efficient than the current EFSA method in reducing both Type I and Type II errors (protecting both the consumer and producer risk) after the background effect is removed from the test statistic, and successfully addresses two major criticisms (i.e. statistical model lack of GxE, and study-specific equivalence criterion) that have been raised.	[Jiang, Changjian; Meng, Chen; Schapaugh, Adam] Monsanto Co, Global Regulatory Sci, Chesterfield, MO 63167 USA	Monsanto	Schapaugh, A (corresponding author), Monsanto Co, Global Regulatory Sci, Chesterfield, MO 63167 USA.	adam.schapaugh@monsanto.com		Schapaugh, Adam/0000-0001-8060-846X	Monsanto Company	Monsanto Company	Monsanto Company provided funding for the compilation and analysis of the data and the preparation of the manuscript. The funder provided support in the form of salaries for Changjian Jiang, Chen Meng, and Adam Schapaugh. The funder also provided final approval for publication of the manuscript.	[Anonymous], 2003, GUID COND FOOD SAF A; [Anonymous], 2009, FOODS DER MOD BIOT; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1637; Freedman D. A., 2012, STAT MODELS THEORY P; Herman RA, 2017, PLANT BIOTECHNOL J, V15, P1264, DOI 10.1111/pbi.12713; Kang Q, 2016, J AGR SCI-CAMBRIDGE, V154, P1392, DOI 10.1017/S0021859615001367; Kang Q, 2014, CROP SCI, V54, P2183, DOI 10.2135/cropsci2014.01.0011; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; OECD, 1993, SAF EV FOODS DER MOD; SAS, 2012, SOFTW REL 9 4 TS1M4; U.S. Food and Drug Administration, 2001, STAT APPR EST BIOEQ; Vahl CI, 2015, J AGR SCI, V154, P383; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Ward KJ, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-13	15	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210747	10.1371/journal.pone.0210747	http://dx.doi.org/10.1371/journal.pone.0210747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650144	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300075
J	Machnowska, P; Meixenberger, K; Schmidt, D; Jessen, H; Hillenbrand, H; Gunsenheimer-Bartmeyer, B; Hamouda, O; Kucherer, C; Bannert, N; Knechten, H; Panstruga, P; Arasteh, K; Rittweger, M; Schurmann, M; Wesselmann, H; Moll, A; Bohr, U; Jessen, AB; Schulbin, H; Schmidt, W; Karcher, H; Fischer, K; Schranz, D; Vallee, M; Claus, JA; Thomas, C; Grimm, R; Klausen, G; Cordes, C; Brockmeyer, NH; Potthoff, A; Rossler, S; Hower, M; Bachmann, C; Spornraft-Ragaller, P; Teichmann, D; Haussinger, D; Jensen, B; Arbter, PA; Haars, U; Esser, S; Schenk-Westkamp, P; Usadel, S; Muller, MC; Kreft, B; Lange, D; Polywka, S; Degen, O; Plettenbger, A; Kuhlendahl, F; Wiemer, D; Schmidt, RE; Behrens, G; Pletz, MW; Schleenvoigt, BT; Rieke, A; Schneeweiss, SM; Scholten, SHA; Grunewald, T; Weidemann, S; Claus, B; Galle, PR; Sprinzl, M; Ebert, MP; Vogelmann, R; Roider, J; Bogner, J; Todorova, A; Traidl-Hoffmann, C; Jager, H; Muck, B; Pauli, R; Spinner, CD; Schneider, J; Postel, N; Anzbock, M; Baumann, R; Schubel, N; Berning, C; Audebert, F; Trein, A; Schnaitmann, E; Ulmer, A; Muller, M; Harter, G; Gruner, B				Machnowska, Patrycja; Meixenberger, Karolin; Schmidt, Daniel; Jessen, Heiko; Hillenbrand, Heribert; Gunsenheimer-Bartmeyer, Barbara; Hamouda, Osamah; Kuecherer, Claudia; Bannert, Norbert; Knechten, H.; Panstruga, P.; Arasteh, K.; Rittweger, M.; Schuermann, M.; Wesselmann, H.; Moll, A.; Bohr, U.; Jessen, A. B.; Schulbin, H.; Schmidt, W.; Karcher, H.; Fischer, K.; Schranz, D.; Vallee, M.; Claus, J. A.; Thomas, C.; Grimm, R.; Klausen, G.; Cordes, C.; Brockmeyer, N. H.; Potthoff, A.; Roessler, S.; Hower, M.; Bachmann, C.; Spornraft-Ragaller, P.; Teichmann, D.; Haeussinger, D.; Jensen, B.; Arbter, P. A.; Haars, U.; Esser, S.; Schenk-Westkamp, P.; Usadel, S.; Mueller, M. C.; Kreft, B.; Lange, D.; Polywka, S.; Degen, O.; Plettenbger, A.; Kuhlendahl, F.; Wiemer, D.; Schmidt, R. E.; Behrens, G.; Pletz, M. W.; Schleenvoigt, B. T.; Rieke, A.; Schneeweiss, S. M.; Scholten, S. H. A.; Gruenewald, T.; Weidemann, S.; Claus, B.; Galle, P. R.; Sprinzl, M.; Ebert, M. P.; Vogelmann, R.; Roider, J.; Bogner, J.; Todorova, A.; Traidl-Hoffmann, C.; Jaeger, H.; Mueck, B.; Pauli, R.; Spinner, C. D.; Schneider, J.; Postel, N.; Anzboeck, M.; Baumann, R.; Schuebel, N.; Berning, C.; Audebert, F.; Trein, A.; Schnaitmann, E.; Ulmer, A.; Mueller, M.; Haerter, G.; Gruener, B.		German HIV-1 Seroconverter Study	Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort	PLOS ONE			English	Article							NONNUCLEOSIDE REVERSE-TRANSCRIPTASE; TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; TRANSMISSION; POPULATION; PROTEASE; FAILURE; SURVEILLANCE; INDIVIDUALS; RILPIVIRINE	The prevalence of transmitted drug resistance (TDR) in antiretroviral therapy (ART)-naive individuals remains stable in most developed countries despite a decrease in the prevalence of acquired drug resistance. This suggests that persistence and further transmission of HIV-1 that encodes transmitted drug resistance mutations (TDRMs) is occurring in ART-naive individuals. In this study, we analysed the prevalence and persistence of TDRMs in the protease and reverse transcriptase-sequences of ART-naive patients within the German HIV-1 Seroconverter Study Cohort who were infected between 1996 and 2017. The prevalence of TDRMs and baseline susceptibility to antiretroviral drugs were assessed using the Stanford HIVdb list and algorithm. Mean survival times of TDRMs were calculated by Kaplan-Meier analysis. The overall prevalence of TDR was 17.2% (95% CI 15.7-18.6, N = 466/2715). Transmitted NNRTI resistance was observed most frequently with 7.8% (95% CI 6.8-8.8), followed by NRTI resistance (5.0%, 95% CI 4.2-5.9) and PI resistance (2.8%, 95% CI 2.2-3.4). Total TDR (OR = 0.89, p = 0.034) and transmitted NRTI resistance (OR = 0.65, p = 0.000) decreased between 1996 and 2017 but has remained stable during the last decade. Viral susceptibility to NNRTIs (6.5%-6.9% for individual drugs) was mainly reduced, while <3% of the recommended NRTIs and PIs were affected. The longest mean survival times were calculated for the NNRTI mutations K103N (5.3 years, 95% CI 4.2-5.6) and E138A/G/K (8.0 years, 95% CI 5.8-10.2/7.9 years, 95% CI 5.4-10.3/6.7 years, 95% CI 6.7-6.7) and for the NRTI mutation M41L (6.4 years, 95% CI 6.0-6.7). The long persistence of single TDRMs indicates that onward transmission from ART-naive individuals is the main cause for TDR in Germany. Transmitted NNRTI resistance was the most frequent TDR, showing simultaneously the highest impact on baseline ART susceptibility and on TDRMs with prolonged persistence. These results give cause for concern regarding the use of NNRTI in first-line regimens.	[Machnowska, Patrycja; Meixenberger, Karolin; Kuecherer, Claudia; Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Schmidt, Daniel; Gunsenheimer-Bartmeyer, Barbara; Hamouda, Osamah] Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany; [Jessen, Heiko] Med Care Ctr Jessen, Berlin, Germany; [Hillenbrand, Heribert] Med Care Ctr City Ost, Berlin, Germany; [Bannert, Norbert] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Knechten, H.; Panstruga, P.] Praxis Knechten, Berlin, Germany; Robert Koch Inst, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Machnowska, P; Bannert, N (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.; Machnowska, P; Bannert, N (corresponding author), Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany.; Bannert, N (corresponding author), Charite Univ Med Berlin, Inst Virol, Berlin, Germany.	MachnowskaP@rki.de; BannertN@rki.de	Roider, Julia/ADV-9989-2022; Jessen, Heiko/P-2192-2019; Spinner, Christoph/H-7039-2019; Pletz, Mathias Wilhelm/H-9782-2019; Grünewald, Thomas G. P./O-2317-2013; Galle, Peter R/T-5292-2018; Schranz, Dietmar/AAU-3268-2021	Spinner, Christoph/0000-0002-3875-5367; Pletz, Mathias Wilhelm/0000-0001-8157-2753; Grünewald, Thomas G. P./0000-0003-0920-7377; Galle, Peter R/0000-0001-8294-0992; Klink, Patrycja/0000-0001-6139-9199	Federal Ministry of Health (BMG); Federal Ministry of Education and Research (BMBF)	Federal Ministry of Health (BMG); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The German Seroconverter Study was partially funded by the Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Initials of authors who were receiving funds is not applicable.; The German Seroconverter Study was partially funded by the Federal Ministry of Health (BMG) and the Federal Ministry of Education and Research (BMBF).	Alteri C, 2011, J ANTIMICROB CHEMOTH, V66, P2615, DOI 10.1093/jac/dkr354; AMBROSIONI J, 2015, PLOS ONE, V10, P10; ANDER H, 2017, EPID BULL, V2017; Bartmeyer B, 2010, PLOS ONE, V5, P12718; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Castro H, 2013, J INFECT DIS, V208, P1459, DOI 10.1093/infdis/jit345; Clutter DS, 2017, J INFECT DIS, V216, P387, DOI 10.1093/infdis/jix338; CONG ME, 1941, PUBMED; Cunningham E, 2017, J ANTIMICROB CHEMOTH, V72, P227, DOI 10.1093/jac/dkw404; Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0; De Luca A, 2006, ANTIRETROVIRAL RESIS; De Luca A, 2015, J INFECT DIS, V212, P5, DOI 10.1093/infdis/jiv008; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436; HAUSER A, 2018, 16TH EUROPEAN MEETIN, V2018, pP27; HAUSER A, 2018, PUBMED, V13, P8827; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; HTTPS, 1995, PUBMED; HTTPS, 2015, PUBMED, V212, P28; HTTPS, PUBMED; HTTPS, 1979, PUBMED; HTTPS, 1989, PUBMED; Hu ZX, 2014, J VIROL, V88, P9268, DOI 10.1128/JVI.00695-14; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; McCallum M, 2013, ANTIMICROB AGENTS CH, V57, P4681, DOI 10.1128/AAC.01029-13; Meixenberger K, 2014, J CLIN MICROBIOL, V52, P2977, DOI 10.1128/JCM.03289-13; Mourad R, 2015, AIDS, V29, P1917, DOI 10.1097/QAD.0000000000000768; Olson A, 2018, AIDS, V32, P161, DOI 10.1097/QAD.0000000000001689; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paraskevis D, 2017, INFECT GENET EVOL, V54, P183, DOI [10., 10.1016/j.meegid.2017.07.003]; Parczewski M, 2015, J ANTIMICROB CHEMOTH, V70, P233, DOI 10.1093/jac/dku372; Pineda-Pena AC, 2014, EUROPEAN AIDS CLINIC, V9, DOI 10.1371/journal.pone.0101738; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; PINEDAPENA AC, 2014, PUBMED, V9, P3369; Pingen M, 2013, HIV MED, V14, P176, DOI 10.1111/j.1468-1293.2012.01037.x; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; POURAN Y, 2016, J ACQ IMMUN DEF SYND, V73, P356; PROGRAMME TS, 2008, AIDS, V22, P625; Ragonnet-Cronin M, 2016, J INFECT DIS, V213, P1410, DOI 10.1093/infdis/jiv758; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Sachdeva Naresh, 2005, MedGenMed, V7, P68, DOI 10.1186/1758-2652-7-3-68; SCHMIDT D, 2017, 16TH EUROPEAN AIDS C, V16, P2017; SCHMIDT D, 2014, PUBMED, V9, P8412; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; SINGH K, 2012, J BIOL CHEM, V287, P3811; Stella-Ascariz N, 2017, J INFECT DIS, V216, pS847, DOI 10.1093/infdis/jix430; Taiwo B, 2009, INT J INFECT DIS, V13, P552, DOI 10.1016/j.ijid.2008.10.008; Toni TA, 2009, ANTIMICROB AGENTS CH, V53, P1670, DOI 10.1128/AAC.01494-08; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Violin M, 2004, AIDS, V18, P227, DOI 10.1097/00002030-200401230-00012; von Wyl V, 2009, CLIN INFECT DIS, V48, P979, DOI 10.1086/597352; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4; WHO, 2017, WHO; Xu HT, 2013, ANTIMICROB AGENTS CH, V57, P3100, DOI 10.1128/AAC.00348-13; YANG WL, MUTATIONS, P1; YANG WL, 2015, PUBMED, V11, P8934; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad; ZUKNYPHAUSEN F, 2014, PUBMED, V9, P8613	68	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209605	10.1371/journal.pone.0209605	http://dx.doi.org/10.1371/journal.pone.0209605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650082	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300020
J	Runesson, B; Qureshi, AR; Xu, H; Gasparini, A; Lindholm, B; Barany, P; Elinder, CG; Carrero, JJ				Runesson, Bjorn; Qureshi, Abdul R.; Xu, Hong; Gasparini, Alessandro; Lindholm, Bengt; Barany, Peter; Elinder, Carl G.; Carrero, Juan J.			Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; VASCULAR CALCIFICATION; RISK; MORTALITY; CKD; HEMODIALYSIS; GENDER	Introduction Reduced kidney function increases the risk of death, but there is limited information on causes of death across stages of chronic kidney disease (CKD). We aimed to identify leading causes of death in community-dwelling individuals with differing kidney function. Methods Observational analysis from SCREAM, a healthcare utilization cohort of Stockholm, Sweden. We included all individuals who died during 2006-2012 and had one serum creatinine measured in the year prior to death. Using the CKD-EPI formula, we calculated eGFR and stratified individuals according to CKD stages. Causes of death were classified as cardiovascular (CVD), cancer, infection and other, using ICD-10 codes. We compared age- and sex-adjusted differences in the proportions of deaths from each cause. Results Out of 89,117 registered deaths, 70,547 (79%) had a recent eGFR estimation and were included in this study. Individuals had a median age of 82 (IRE 62-93) years and 52% were women. The proportions of deaths from CVD increased with lower eGFR, along with the proportion of deaths from infections. Deaths due to diabetes and genito-urinary diseases increased. Deaths due to cancer decreased, but other death causes did not vary. Within CVD causes of death, the proportion of arrhythmias and heart failure increased, but ischemic heart disease and cerebrovascular disease remained stable. Conclusion In a region-representative Swedish healthcare extraction, we observe differences regarding specific causes of death across different CKD stages. Increasing patient and provider awareness of this differential pattern of risk may have benefits for patient management, prevention strategies, and health service planning.	[Runesson, Bjorn; Qureshi, Abdul R.; Lindholm, Bengt; Barany, Peter; Elinder, Carl G.] Karolinska Inst, Dept Clin Sci Technol & Intervent, Div Renal Med & Baxter Novum, Stockholm, Sweden; [Xu, Hong; Carrero, Juan J.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gasparini, Alessandro] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	Karolinska Institutet; Karolinska Institutet; University of Leicester	Runesson, B (corresponding author), Karolinska Inst, Dept Clin Sci Technol & Intervent, Div Renal Med & Baxter Novum, Stockholm, Sweden.	Bjorn.runesson@karolinska.se	Gasparini, Alessandro/S-9581-2019; Qureshi, Abdul Rashid Tony/G-1358-2010	Gasparini, Alessandro/0000-0002-8319-7624; Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Barany, Peter/0000-0001-6501-8293; Runesson, Bjorn/0000-0002-8970-0577; Xu, Hong/0000-0002-7266-3431	Swedish Heart and Lung Foundation; Stockholm County Council; Martin Rind's Foundation; Baxter Healthcare; Westman's Foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Martin Rind's Foundation; Baxter Healthcare; Westman's Foundation	Baxter Healthcare provided support for this study in the form of salary for BL. The specific roles of this author are articulated in the 'author contributions' section.; This study was supported by the Swedish Heart and Lung Foundation, the Stockholm County Council, Martin Rind's and Westman's Foundations. Baxter Novum is supported by a grant from Baxter Healthcare to Karolinska Institutet.	Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; Carrero JJ, 2017, KIDNEY INT, V91, P244, DOI 10.1016/j.kint.2016.09.037; Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; de Jager DJ, 2014, NAT REV NEPHROL, V10, P208, DOI 10.1038/nrneph.2014.8; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Eleftheriadis T, 2007, SEMIN DIALYSIS, V20, P440, DOI 10.1111/J.1525-139X.2007.00283.x; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gasparini A, 2016, NEPHROL DIAL TRANSPL, V31, P2086, DOI 10.1093/ndt/gfw354; Himmelfarb J, 2009, SEMIN DIALYSIS, V22, P636, DOI 10.1111/j.1525-139X.2009.00659.x; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Ishigami J, 2017, AM J KIDNEY DIS, V69, P752, DOI 10.1053/j.ajkd.2016.09.018; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; London GM, 2005, CURR OPIN NEPHROL HY, V14, P525, DOI 10.1097/01.mnh.0000168336.67499.c0; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsushita K, 2017, LANCET DIABETES ENDO, V5, P718, DOI 10.1016/S2213-8587(17)30183-3; McDonald HI, 2015, AM J KIDNEY DIS, V66, P60, DOI 10.1053/j.ajkd.2014.11.027; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mok Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153429; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Neovius M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004251; Ostan R, 2016, CLIN SCI, V130, P1711, DOI 10.1042/CS20160004; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Shah T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0574-5; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Xu H, 2017, CLIN J AM SOC NEPHRO, V12, P1399, DOI 10.2215/CJN.00250117	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209440	10.1371/journal.pone.0209440	http://dx.doi.org/10.1371/journal.pone.0209440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650090	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300016
J	Steven, B; Lange, L; Schulz, H; Bleich, C				Steven, Berenike; Lange, Lukas; Schulz, Holger; Bleich, Christiane			Views of psycho-oncologists, physicians, and nurses on cancer care-A qualitative study	PLOS ONE			English	Article							SHARED DECISION-MAKING; EARLY PALLIATIVE CARE; BREAKING BAD-NEWS; OF-LIFE; COMMUNICATION; DISTRESS; PATIENT; PARTICIPATION; SURGERY; SUPPORT	Background As worldwide cancer prevalence continues to increase, the challenges facing cancer care are also increasing. Various topics related to deficiencies in cancer care have been discussed repeatedly in the literature. The most frequently stated topics are the unmet psychosocial support needs of cancer patients, difficulties in multidisciplinary teamwork, difficulties in communication between physicians and patients, and issues in palliative care settings. However, there is little research regarding the views of health care providers on these topics. With the aim of gaining abundant information regarding the care of German cancer patients, this study explores the stances of psycho-oncologists, physicians, and nurses regarding the quality of cancer care. Materials and methods Semi-structured interviews were conducted at the University Medical Center Hamburg-Eppendorf (UKE) and in different oncological outpatient offices in Hamburg; twenty-five interviews in total were conducted with health care providers. Interviews were semi-structured to gain a broad range of information on cancer care. The data were analyzed using thematic analysis by Braun and Clarke with an inductive, constant comparison approach to identify themes and categorized codes. Results The following five principle themes were identified in the interviews: "psycho-oncological care", "cooperation of health care providers", "palliative care", "health care provider-patient contact", and "coordination and organization of care". Participants seemed satisfied with the overall quality of cancer care in Germany. Nevertheless, the results showed deficiencies regarding communication among different health care providers and between health care providers and patients. Important findings in conjunction with these communication problems were a lack of psycho-oncological support, shortages in the oncology work force, language and cultural barriers, and deficient education in the communication of providers. Conclusions The statements of psycho-oncologists, physicians, and nurses on cancer care provide a suitable basis to conduct further focused research on the studied deficiencies in cancer care. In particular, communication in psycho-oncological care, communication within multi-disciplinary teams, and health care provider-patient communication should be further explored with the aim of developing new ideas for improvements and thereby enhancing the quality of cancer care.	[Steven, Berenike; Lange, Lukas; Schulz, Holger; Bleich, Christiane] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Lange, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	lu.lange@uke.de		Lange-Drenth, Lukas/0000-0002-4877-2005; Steven, Berenike/0000-0002-4862-1733				Alelwani Somia M, 2014, J Educ Health Promot, V3, P51, DOI 10.4103/2277-9531.134737; Alt-Epping B, 2015, BUNDESGESUNDHEITSBLA, V58, P430, DOI 10.1007/s00103-015-2125-6; Atun R, 2009, ANAL NATL CANC CONTR; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Barnett MM, 2007, MED EDUC, V41, P947, DOI 10.1111/j.1365-2923.2007.02832.x; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bultz BD, 2011, PSYCHO-ONCOLOGY, V20, P569, DOI 10.1002/pon.1986; Burton MV, 1997, PSYCHO-ONCOL, V6, P47, DOI 10.1002/(SICI)1099-1611(199703)6:1<47::AID-PON248>3.0.CO;2-S; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Clover KA, 2015, PSYCHO-ONCOLOGY, V24, P812, DOI 10.1002/pon.3729; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Delgado-Guay M, 2009, SUPPORT CARE CANCER, V17, P573, DOI 10.1007/s00520-008-0529-7; Eakin EG, 2001, PSYCHO-ONCOL, V10, P103, DOI 10.1002/pon.500; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Friedrichsen M, 2006, J PALLIAT MED, V9, P673, DOI 10.1089/jpm.2006.9.673; Goldstein D, 2014, ANN ONCOL, V25, P1643, DOI 10.1093/annonc/mdu182; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P263, DOI 10.1016/j.zefq.2011.04.002; Hahlweg P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3768-5; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Hillen MA, 2014, ANN ONCOL, V25, P896, DOI 10.1093/annonc/mdu027; Hillen MA, 2011, PSYCHO-ONCOLOGY, V20, P227, DOI 10.1002/pon.1745; Horlait M, 2016, SUPPORT CARE CANCER, V24, P3873, DOI 10.1007/s00520-016-3211-5; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Jacobsen PB, 2009, CANCER-AM CANCER SOC, V115, P4419, DOI 10.1002/cncr.24589; Jain AK, 2016, J ONCOL PRACT, V12, P1000, DOI 10.1200/JOP.2016.013300; Jansky M, 2011, Z PALLIATMEDIZIN, V12, P164, DOI 10.1055/s-0031-1276839; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Kaatsch P, 2016, CANC GERMANY 2011 20; Kamradt M, 2015, FAM PRACT, V32, P686, DOI 10.1093/fampra/cmv069; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Kolva E, 2011, J PAIN SYMPTOM MANAG, V42, P691, DOI 10.1016/j.jpainsymman.2011.01.013; Kowalski C, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3824-1; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kullberg A, 2015, EUR J ONCOL NURS, V19, P142, DOI 10.1016/j.ejon.2014.10.005; Laidsaar-Powell R, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12470; Laidsaar-Powell R, 2016, SUPPORT CARE CANCER, V24, P4131, DOI 10.1007/s00520-016-3237-8; Lancaster G, 2015, J NURS SCHOLARSHIP, V47, P275, DOI 10.1111/jnu.12130; Lee Sunmin, 2012, J Behav Health, V1, DOI 10.5455/jbh.20120403024919; Levit L, 2010, J ONCOL PRACT, V6, P7, DOI 10.1200/JOP.091067; McDonald J, 2017, ANN ONCOL, V28, P163, DOI 10.1093/annonc/mdw438; McNair AGK, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2292-3; Mechanic D, 2000, SOC SCI MED, V51, P657, DOI 10.1016/S0277-9536(00)00014-9; Mehnert A, 2014, J CLIN ONCOL, V32, P3540, DOI 10.1200/JCO.2014.56.0086; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Owen R, 2008, EUR J CANCER, V44, P1163, DOI 10.1016/j.ejca.2008.02.029; Paap JV, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0130-z; Paika V, 2010, PSYCHO-ONCOLOGY, V19, P273, DOI 10.1002/pon.1563; Patlak M., 2009, ENSURING QUALITY CAN; Perneger TV, 2015, QUAL LIFE RES, V24, P147, DOI 10.1007/s11136-014-0752-2; Ringdal GI, 2001, J PAIN SYMPTOM MANAG, V22, P1016, DOI 10.1016/S0885-3924(01)00363-3; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schneider W, 2015, GESUNDHEITSWESEN, V77, P219, DOI 10.1055/s-0034-1382041; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Silow-Carroll Sharon, 2012, Issue Brief (Commonw Fund), V17, P1; Siminoff LA, 2006, PATIENT EDUC COUNS, V62, P355, DOI 10.1016/j.pec.2006.06.011; Sollner W, 2004, PSYCHO-ONCOL, V13, P893, DOI 10.1002/pon.897; Spinks TE, 2014, HEALTHCARE-J DEL SCI, V2, P53, DOI 10.1016/j.hjdsi.2013.11.003; Spinks TE, 2011, HEALTH AFFAIR, V30, P664, DOI 10.1377/hlthaff.2011.0089; Srivastava R, 2013, NEW ENGL J MED, V368, P302, DOI 10.1056/NEJMp1212410; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Sutton Jane, 2015, Can J Hosp Pharm, V68, P226; Taplin SH, 2015, J ONCOL PRACT, V11, P231, DOI 10.1200/JOP.2014.003376; Taylor E J, 2001, Semin Oncol Nurs, V17, P197, DOI 10.1053/sonu.2001.25949; Temel JS, 2017, J CLIN ONCOL, V35, P834, DOI 10.1200/JCO.2016.70.5046; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Voerman B, 2007, PSYCHO-ONCOL, V16, P1092, DOI 10.1002/pon.1160; Walsh J, 2011, EUR J CANCER CARE, V20, P220, DOI 10.1111/j.1365-2354.2010.01187.x; Wangmo T, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14309; Wentlandt K, 2016, J PAIN SYMPTOM MANAG, V51, P184, DOI 10.1016/j.jpainsymman.2015.10.006; Wentlandt K, 2014, SUPPORT CARE CANCER, V22, P2315, DOI 10.1007/s00520-014-2203-6; Wild C, 2013, EUR J CANCER CARE, V22, P773, DOI 10.1111/ecc.12089; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	77	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210325	10.1371/journal.pone.0210325	http://dx.doi.org/10.1371/journal.pone.0210325			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650112	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300051
J	Dodd, SAS; Cave, NJ; Adolphe, JL; Shoveller, AK; Verbrugghe, A				Dodd, Sarah A. S.; Cave, Nick J.; Adolphe, Jennifer L.; Shoveller, Anna K.; Verbrugghe, Adronie			Plant-based (vegan) diets for pets: A survey of pet owner attitudes and feeding practices	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-STYLE; CONSCIENTIOUS OMNIVORES; VEGETARIAN DIETS; MEAT-EATERS; HEALTH; FOOD; CONSUMPTION; CATS; DOGS	People who avoid eating animals tend to share their homes with animal companions, and moral dilemma may arise when they are faced with feeding animal products to their omnivorous dogs and carnivorous cats. One option to alleviate this conflict is to feed pets a diet devoid of animal ingredients-a 'plant-based' or 'vegan' diet. The number of pet owners who avoid animal products, either in their own or in their pets' diet, is not currently known. The objective of this study was to estimate the number of meat-avoiding pet owners, identify concerns regarding conventional animal- and plant-based pet food, and estimate the number of pets fed a plant-based diet. A questionnaire was disseminated online to English-speaking pet owners (n = 3,673) to collect data regarding pet owner demographics, diet, pet type, pet diet, and concerns regarding pet foods. Results found that pet owners were more likely to be vegetarian (6.2%; 229/3,673) or vegan (5.8%; 212/3,673) than previously reported for members of the general population. With the exception of one dog owned by a vegetarian, vegans were the only pet owners who fed plant-based diets to their pets (1.6%; 59/3,673). Of the pet owners who did not currently feed plant-based diets but expressed interest in doing so, a large proportion (45%; 269/599) desired more information demonstrating the nutritional adequacy of plant-based diets. Amongst all pet owners, the concern most commonly reported regarding meat-based pet foods was for the welfare of farm animals (39%; 1,275/3,231). The most common concern regarding strictly plant-based pet foods was regarding the nutritional completeness of the diet (74%; 2,439/3,318). Amongst vegans, factors which predicted the feeding of plant-based diets to their pets were concern regarding the cost of plant-based diets, a lack of concern regarding plant-based diets being unnatural, and reporting no concern at all regarding plant-based diets for pets. Given these findings, further research is warranted to investigate plant-based nutrition for domestic dogs and cats.	[Dodd, Sarah A. S.; Verbrugghe, Adronie] Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada; [Cave, Nick J.] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Adolphe, Jennifer L.] Petcurean Pet Nutr, Chilliwack, BC, Canada; [Shoveller, Anna K.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada	University of Guelph; Massey University; University of Guelph	Verbrugghe, A (corresponding author), Univ Guelph, Dept Clin Studies, Ontario Vet Coll, Guelph, ON, Canada.	averbrug@uoguelph.ca	Cave, Nick/AAQ-9789-2021	Cave, Nick/0000-0002-6037-5942; Dodd, Sarah/0000-0002-8151-5844	Petcurean Pet Nutrition; Mitacs Accelerate program; Mitacs Accelerate award [IT10206]	Petcurean Pet Nutrition; Mitacs Accelerate program; Mitacs Accelerate award	One of the authors, Dr. Jennifer Adolphe, is employed by the commercial company Petcurean Pet Nutrition. Petcurean Pet Nutrition also provided financial support for the MSc stipend for the primary author, Dr. Sarah Dodd, in association with the Mitacs Accelerate program. The funder provided support in the form of salaries for Dr. Adolphe and partial support for Dr. Dodd, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Indeed, study design, data collection and analysis had all been performed prior to Dr. Adolphe's inclusion in the project and prior to Dr. Dodd's Mitacs Accelerate award (IT10206). The specific roles of these authors are articulated in the 'author contributions' section.	Agency FS, 2006, GUID VEG VEG LAB; Allen MW, 2000, J SOC PSYCHOL, V140, P405, DOI 10.1080/00224540009600481; [Anonymous], 2017, ASS AM FEED CONTROL; [Anonymous], 2014, BOO RIPENED HUMAN DE; [Anonymous], 2017, US WORLD POP CLOCK; Appleby PN, 2016, P NUTR SOC, V75, P287, DOI 10.1017/S0029665115004334; *AVMA, 2002, US PET OWN DEM SOURC; Bates B, 2009, NATL DIET NUTR SURVE; BAUDRY J, 2017, NUTRIENTS, V9, DOI DOI 10.3390/NU9091023; Beaton L., 2018, Petfood Industry, V60, P22; Bella F, 2017, INT J FOOD SCI NUTR, V68, P402, DOI 10.1080/09637486.2016.1261087; Berschneider HM, 2002, CLIN TECH SMALL AN P, V17, P1, DOI 10.1053/svms.2002.27782; Brown W. Y., 2009, RECENT ADV ANIM NUTR, V17, P137; Brown WY, 2009, BRIT J NUTR, V102, P1318, DOI 10.1017/S0007114509389254; Case L, 2008, J ANIM SCI, V86, P3245, DOI 10.2527/jas.2008-1147; Chambers L, 2018, NUTR BULL, V43, P46, DOI 10.1111/nbu.12305; Connolly KM, 2014, JAVMA-J AM VET MED A, V245, P669, DOI 10.2460/javma.245.6.669; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; de Boer J, 2011, ECOL ECON, V70, P1259, DOI 10.1016/j.ecolecon.2011.03.001; de Fomel-Thibaud P, 2007, J AM ANIM HOSP ASSOC, V43, P52, DOI 10.5326/0430052; DEFRA, 2007, REP QUEST DAT TABL F; Deng P, 2015, J ANIM SCI, V93, P823, DOI 10.2527/jas.2014-8520; Dillitzer N, 2011, BRIT J NUTR, V106, pS53, DOI 10.1017/S0007114511002765; European Pet Food Industry Federation (FEDIAF), 2017, NUTR GUID COMPL COMP; Fardet A, 2014, NUTR REV, V72, P741, DOI 10.1111/nure.12153; Filippi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010847; Fox N, 2008, APPETITE, V50, P422, DOI 10.1016/j.appet.2007.09.007; GlobalData, 2017, TOP TRENDS PREP FOOD; Gosper EC, 2016, AUST VET J, V94, P12, DOI 10.1111/avj.12397; Graca J, 2015, APPETITE, V95, P113, DOI 10.1016/j.appet.2015.06.024; Graca J, 2015, APPETITE, V90, P80, DOI 10.1016/j.appet.2015.02.037; Gray CM, 2004, JAVMA-J AM VET MED A, V225, P1670, DOI 10.2460/javma.2004.225.1670; Health Navigator, 2017, VEG VEG; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Henderson L, 2002, NATL DIET NUTR SURVE, V1; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Hill D., 2004, PET FOOD ASS CAN FAL; Hill RC, 2009, JAVMA-J AM VET MED A, V234, P347, DOI 10.2460/javma.234.3.347; Hoek AC, 2004, APPETITE, V42, P265, DOI 10.1016/j.appet.2003.12.003; Hutchinson D, 2012, JAVMA-J AM VET MED A, V241, P477, DOI 10.2460/javma.241.4.477; Janssen M, 2016, APPETITE, V105, P643, DOI 10.1016/j.appet.2016.06.039; Kanakubo K, 2015, JAVMA-J AM VET MED A, V247, P385, DOI 10.2460/javma.247.4.385; Kerschke-Risch P., 2015, Ernahrungs Umschau, V62, P98; Kienzle E., 2001, COMPENDIUM, V23, P81; Kivimaki H., 2013, CROSS SECTIONAL STUD; Knight A, 2016, ANIMALS, V6, DOI 10.3390/ani6090057; Kosonen H, 2005, SOZ PRAVENTIV MED, V50, P142, DOI 10.1007/s00038-005-3167-6; Lauten S. D., 2005, Journal of Veterinary Internal Medicine, V19, P476; Lawton R, 2009, HEALTH PSYCHOL, V28, P56, DOI 10.1037/a0013424; Lummis D., NATURAL ORGANIC ECO; Lund TB, 2016, ANTHROZOOS, V29, P89, DOI 10.1080/08927936.2015.1083192; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; Maine IR, 2015, ACTA VET SCAND, V57, P1, DOI 10.1186/s13028-015-0097-z; Mangels AR, 2003, J AM DIET ASSOC, V103, P748, DOI 10.1053/jada.2003.50142; McDonald B, 2000, SOC ANIM, V8, P1, DOI 10.1163/156853000X00011; Meeker DL, 2015, J ANIM SCI, V93, P835, DOI 10.2527/jas.2014-8524; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Michel KE, 2006, VET CLIN N AM-SMALL, V36, P1269, DOI 10.1016/j.cvsm.2006.08.003; Michel KE, 2008, JAVMA-J AM VET MED A, V233, P1699, DOI 10.2460/javma.233.11.1699; Morgan R., 2016, SLOW STEADY RISE VEG; Morgan SK, 2017, PEERJ, V5, DOI 10.7717/peerj.3031; Morris JG, 2002, NUTR RES REV, V15, P153, DOI 10.1079/NRR200238; Nath J, 2010, HEALTH SOCIOL REV, V19, P356, DOI 10.5172/hesr.2010.19.3.356; National Research Council, 2006, NUTR REQ DOGS CATS; Newport F, 2012, US 5 CONSIDER THEMSE; Okin GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181301; Parr JM, 2014, VET CLIN N AM-SMALL, V44, P667, DOI 10.1016/j.cvsm.2014.03.006; Paul ES, 2000, ANTHROZOOS, V13, P194, DOI 10.2752/089279300786999699; PFI, 2015, PET FOOD TRENDS FOLL; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Preylo BD, 2008, ANTHROZOOS, V21, P387, DOI 10.2752/175303708X371654; Prunty J, 2013, ANTHROZOOS, V26, P265, DOI 10.2752/175303713X13636846944367; Radnitz C, 2015, APPETITE, V90, P31, DOI 10.1016/j.appet.2015.02.026; Rahaman S, 2000, COMPENDIUM CONTINUIN, V22, P70; Rajagopaul S, 2016, J SMALL ANIM PRACT, V57, P484, DOI 10.1111/jsap.12526; Remillard RL, 2008, TOP COMPANION ANIM M, V23, P137, DOI 10.1053/j.tcam.2008.04.006; Rothgerber H, 2015, APPETITE, V87, P251, DOI 10.1016/j.appet.2014.12.206; Rothgerber H, 2014, ANTHROZOOS, V27, P485, DOI 10.2752/089279314X14072268687844; Rothgerber H, 2015, APPETITE, V84, P196, DOI 10.1016/j.appet.2014.10.012; Rothgerber H, 2013, APPETITE, V68, P76, DOI 10.1016/j.appet.2013.04.012; Roudebush Philip, 1992, Vet Dermatol, V3, P23, DOI 10.1111/j.1365-3164.1992.tb00139.x; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Semp P., 2014, THESIS VET U VIENNA; Spencer EH, 2007, J AM DIET ASSOC, V107, P72, DOI 10.1016/j.jada.2006.10.034; Stockman J, 2013, JAVMA-J AM VET MED A, V242, P1500, DOI 10.2460/javma.242.11.1500; Swanson KS, 2013, ADV NUTR, V4, P141, DOI 10.3945/an.112.003335; Sydney N, 2013, SURV 1202 AUSTR WHET; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Verbrugghe A, 2011, VLAAMS DIERGEN TIJDS, V80, P61; Verbrugghe A, 2012, CRITICAL REV FOOD SC, V52, P203; Vinnari M, 2007, PUBLIC HEALTH NUTR, V12, P481; Vinnari M, 2009, PUBLIC HEALTH NUTR, V12, P481, DOI 10.1017/S1368980008002486; Wakefield LA, 2006, JAVMA-J AM VET MED A, V229, P70, DOI 10.2460/javma.229.1.70; Yeliosof O, 2018, J PEDIATR ENDOCR MET, V31, P91, DOI 10.1515/jpem-2017-0082; Yip CSC, 2013, INT J PUBLIC HEALTH, V58, P683, DOI 10.1007/s00038-013-0484-z	96	30	30	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210806	10.1371/journal.pone.0210806	http://dx.doi.org/10.1371/journal.pone.0210806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645644	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200057
J	Han, XN; Huang, J; Lv, JH; Ma, L; Peng, LR; Wang, JP; Nie, XJ; Xia, L; Zan, X				Han, Xiaonian; Huang, Jing; Lv, Jianhua; Ma, Li; Peng, Lirong; Wang, Jinping; Nie, Xiaojing; Xia, Li; Zan, Xin			The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy	PLOS ONE			English	Article							VALPROIC ACID; PHARMACOKINETICS; COMEDICATION; CHILDREN; POLYMORPHISM; TOPIRAMATE; AGE; GLUCURONIDATION; OXCARBAZEPINE; EFFICACY	Objective The aims of this study were to identify the influencing factors such as gender, age, dose and combinations of other antiepileptic drugs (AEDs), especially in triple combinations on the pharmacokinetic of Lamotrigine (LTG) in epilepsy patients of Northwest Chinese Han population. Methods Data of the LTG concentration and clinical information were analyzed retrospectively from a therapeutic drug monitoring (TDM) database at the Clinical Pharmacy Laboratory of Xi'an Central Hospital between January 1, 2016 and January 1, 2018. The independent-sample t-test, one-way ANOVA analysis and Bonferroni and Tamhane T3 post-hoc test, the stepwise multivariate regression analysis were adopted by IBM SPSS, version 22.0. Results 226 serum samples met the inclusion criteria and were evaluated. The mean LTG serum concentration was 5.48 +/- 3.83 mu g/mL. There were no gender differences (P = 0.64), and there were no significant effects by age on LTG serum concentration after age stratification (3-14 years old, 14-45 years old, 45-59 years old) (P = 0.05). Multiple regression analysis showed that the daily LTG dose and co-administration of other AEDs significantly affected LTG serum concentrations. Combination with enzyme-inducer AEDs, the mean steady-state LTG concentration could be decreased by 30.73% compared with LTG monotherapy. Among enzyme-inducer AEDs, particularly strong inducer Carbamazepine (CBZ) could decrease the mean LTG concentration by 53.65%, but weak inducer AEDs such as Oxcarbazepine (OXC) and Topiramate (TPM) had no effect, Valproic acid (VPA) could increase the mean LTG concentration by 93.95%, and the inducer only partially compensated for the inhibitory effect of VPA in triple combination. Conclusions There were no significant gender and age effects, but the LTG daily dose and co-administration of other AEDs significantly affected LTG serum concentration. Combination with enzyme-inducer AEDs, especially CBZ could significantly decrease LTG serum concentrations, VPA could significantly increase LTG serum concentrations, and the inducer only partially compensated for the inhibitory effect of VPA in triple combination. In the clinical setting, these findings can help to estimate LTG concentrations and adjust dosage and evaluate adverse drug reactions.	[Han, Xiaonian; Huang, Jing; Lv, Jianhua; Ma, Li; Peng, Lirong; Wang, Jinping; Nie, Xiaojing; Xia, Li; Zan, Xin] Xian Cent Hosp, Dept Clin Pharm, Xian, Shaanxi, Peoples R China		Han, XN (corresponding author), Xian Cent Hosp, Dept Clin Pharm, Xian, Shaanxi, Peoples R China.	xjtuhxn@126.com						Anderson GD, 1998, ANN PHARMACOTHER, V32, P554, DOI 10.1345/aph.17332; Argikar UA, 2009, XENOBIOTICA, V39, P355, DOI 10.1080/00498250902745082; Bartoli A, 1997, THER DRUG MONIT, V19, P252, DOI 10.1097/00007691-199706000-00002; Battino D, 1997, THER DRUG MONIT, V19, P620, DOI 10.1097/00007691-199712000-00003; Battino D, 2001, THER DRUG MONIT, V23, P217, DOI 10.1097/00007691-200106000-00006; Berry DJ, 2002, EPILEPSIA, V43, P818, DOI 10.1046/j.1528-1157.2002.37701.x; Chang Y, 2014, EUR J CLIN PHARMACOL, V70, P941, DOI 10.1007/s00228-014-1690-1; Doose DR, 2003, EPILEPSIA, V44, P917, DOI 10.1046/j.1528-1157.2003.64402.x; Flesch G, 2004, CLIN DRUG INVEST, V24, P185, DOI 10.2165/00044011-200424040-00001; Gidal BE, 2003, EPILEPSY RES, V57, P85, DOI 10.1016/j.eplepsyres.2003.09.008; Gulcebi MI, 2011, EPILEPSY RES, V95, P1, DOI 10.1016/j.eplepsyres.2011.01.016; Taing KD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169974; Kim HJ, 2015, CLIN CHIM ACTA, V438, P269, DOI 10.1016/j.cca.2014.09.004; Lalic M, 2009, EUR J DRUG METAB PH, V34, P93; Liu LM, 2015, EUR J CLIN PHARMACOL, V71, P1341, DOI 10.1007/s00228-015-1925-9; Ma CL, 2015, PHARMACOGENOMICS, V16, P347, DOI [10.2217/PGS.14.186, 10.2217/pgs.14.186]; MAGDALOU J, 1992, J PHARMACOL EXP THER, V260, P1166; May TW, 1996, THER DRUG MONIT, V18, P523, DOI 10.1097/00007691-199610000-00001; May TW, 1999, THER DRUG MONIT, V21, P175, DOI 10.1097/00007691-199904000-00007; Milosheska D, 2016, BRIT J CLIN PHARMACO, V82, P399, DOI 10.1111/bcp.12984; Nims RW, 1997, DRUG METAB DISPOS, V25, P750; Otoul C, 2007, EPILEPSIA, V48, P2111, DOI 10.1111/j.1528-1167.2007.01201.x; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; Reimers A, 2016, EUR J DRUG METAB PH, V41, P149, DOI 10.1007/s13318-014-0247-0; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; van Dijkman SC, 2018, CLIN PHARMACOKINET, V57, P1039, DOI 10.1007/s40262-017-0614-5; Wang QN, 2015, DRUG METAB PHARMACOK, V30, P209, DOI 10.1016/j.dmpk.2014.12.007; Weintraub D, 2005, ARCH NEUROL-CHICAGO, V62, P1432, DOI 10.1001/archneur.62.9.1432; WnukWV A, 1999, THERAPEUTIC DRUG MON, V21; Yasam VR, 2016, EXPERT REV CLIN PHAR, V9, P1533, DOI 10.1080/17512433.2016.1254041; Yuen AWC P A, 1998, BR J CLIN PHARM, V26, P242; Zhang Shen, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P105	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210600	10.1371/journal.pone.0210600	http://dx.doi.org/10.1371/journal.pone.0210600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645607	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200039
J	Panpetch, W; Somboonna, N; Palasuk, M; Hiengrach, P; Finkelman, M; Tumwasorn, S; Leelahavanichkul, A				Panpetch, Wimonrat; Somboonna, Naraporn; Palasuk, Matanee; Hiengrach, Pratsanee; Finkelman, Malcolm; Tumwasorn, Somying; Leelahavanichkul, Asada			Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium	PLOS ONE			English	Article							INTESTINAL FUNGI; GUT MICROBIOME; COLONIZATION; MICE; ANTIBIOTICS; NORVEGENSIS; INCONSPICUA; TOXIN	Gut fungi may influence the course of Clostridium difficile infection either positively or negatively for the host. Fungi are not prominent in the mouse gut, and C. albicans, the major human gastrointestinal commensal yeast, is in low abundance or absent in mice. Bifidobacterium is one of the probiotics that may attenuate the severity of C. difficile infection. Inflammatory synergy between C. albicans and C. difficile, in gut, may provide a state that more closely resembles human infection and be more suitable for testing probiotic effects. We performed fecal mycobiota analysis and administered C. albicans at 1 day prior to C. difficile dosing. Fecal eukaryotic 18S rDNA analysis demonstrated the presence of Ascomycota, specifically, Candida spp., after oral antibiotics, despite negative fecal fungal culture. C. albicans administration enhanced the severity of the C. difficile infection model as determined by mortality rate, weight loss, gut leakage (FITC-dextran assay), and serum and intestinal tissue cytokines. This occurred without increased fecal C. difficile or bacteremia, in comparison with C. difficile gavage alone. Candida lysate with C. difficile increased IL-8 production from HT-29 and Caco-2 human intestinal epithelial cell-lines. Bifidobacterium attenuated the disease severity of the C. difficile plus Candida model. The reduced severity was associated with decreased Candida burdens in feces. In conclusion, gut C. albicans worsened C. difficile infection, possibly through exacerbation of inflammation. Hence, a mouse model of Clostridium difficile infection with C. albicans present in the gut may better model the human patient condition. Gut fungal mycobiome investigation in patients with C. difficile is warranted and may suggest therapeutic targets.	[Panpetch, Wimonrat; Hiengrach, Pratsanee; Tumwasorn, Somying; Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Somboonna, Naraporn; Palasuk, Matanee] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand; [Finkelman, Malcolm] Associates Cape Cod Inc, East Falmouth, MA USA; [Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	aleelahavanit@gmail.com			Thailand Government Fund [RSA-6080023]; Thailand Research Fund [RES_61_202_30_022]; Chulalongkorn University [760001-HR]; Chulalongkorn University; Cape Cod Inc.	Thailand Government Fund; Thailand Research Fund(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); Chulalongkorn University(Chulalongkorn University); Cape Cod Inc.	This study was supported by Thailand Government Fund (RSA-6080023 to AL) and Thailand Research Fund (RES_61_202_30_022 to AL) and grant for International Research Integration, Chula Research Scholar, Ratchadaphisek Somphot Endowment Fund (2017), Chulalongkorn University (760001-HR to AL). WP was supported by Ratchadaphisek Somphot Fund for Postdoctoral Fellowship, Chulalongkorn University. MF received salary from Cape Cod Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Boonma P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-177; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Evans CT, 2015, CLIN INFECT DIS, V60, pS66, DOI 10.1093/cid/civ140; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Giraldo A, 2014, J CLIN MICROBIOL, V52, P4189, DOI 10.1128/JCM.02027-14; Guitard J, 2015, J CLIN MICROBIOL, V53, P1655, DOI 10.1128/JCM.02913-14; Guitard J, 2013, MED MYCOL, V51, P795, DOI 10.3109/13693786.2013.807444; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hutton ML, 2014, FEMS MICROBIOL LETT, V352, P140, DOI 10.1111/1574-6968.12367; Iizumi T, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0143-z; Issara-Amphorn J, 2018, J INNATE IMMUN, V10, P189, DOI 10.1159/000486321; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kikkert R, 2007, J ENDOTOXIN RES, V13, P140, DOI 10.1177/0968051907080024; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Kumamoto CA, 2011, CURR OPIN MICROBIOL, V14, P386, DOI 10.1016/j.mib.2011.07.015; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Leelahavanichkul A, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw204; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Libby DB, 2009, INT J INFECT DIS, V13, pE305, DOI 10.1016/j.ijid.2009.01.014; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Panpetch W, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00700-17; Panpetch W, 2018, SHOCK, V49, P62, DOI 10.1097/SHK.0000000000000896; Panpetch W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181439; Panpetch W, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0861-x; Qiu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10416; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yamaguchi N, 2006, GUT, V55, P954, DOI 10.1136/gut.2005.084954; Yamaguchi N, 2005, J NUTR, V135, P109, DOI 10.1093/jn/135.1.109; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	41	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210798	10.1371/journal.pone.0210798	http://dx.doi.org/10.1371/journal.pone.0210798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645630	gold, Green Submitted, Green Published			2022-12-27	WOS:000455810200056
J	Chu, KA; Chen, W; Hsu, CY; Hung, YM; Wei, JCC				Chu, Kuo-An; Chen, Weishan; Hsu, Chung Y.; Hung, Yao-Min; Wei, James Cheng-Chung			Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan	PLOS ONE			English	Article							SYNOVIAL-FLUID; AUTOIMMUNE; INFECTIONS; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; MECHANISMS; RESPONSES; DISEASE; SYSTEM	Objective An association between Mycoplasma pneumonia ( MP) and rheumatoid arthritis ( RA) had been reported in animal studies for decades. However, clinical evidence for this association is lacking. Therefore, this study aimed to provide epidemiologic evidence to clarify the relationship between MP and development of RA. Methods This 13-year nationwide, population-based, retrospective cohort study analyzed the risk of RA in a cohort of MP patients. We cross linked and compared the database of those with catastrophic illnesses to make sure the diagnoses of RA are correctly labeled. We selected 116,053 hospitalized patients diagnosed with MP between 2000 and 2012 from the Taiwan National Health Insurance Research Database and 464,212 matched controls at a 1: 4 ratio by age, gender, and index year, in relation to the risk of developing RA. The follow-up period referred to the initial diagnosis of MP until the date of RA diagnosis, censoring of RA, or 31st December 2013. The Cox proportional hazard model was used to analyze the association between MP and incidence of RA among patients with different potential risks. Results The adjusted hazard ratio (HR) for incidental RA in the MP group was 1.37 (95% confidence interval CI = 0.87-2.16), compared to non-MP controls. Stratified analysis revealed that the adjusted HR was 3.05 (95% CI = 1.16-7.99, p = 0.02) in a subgroup of patients over the age of 65. The adjusted HR of RA for the MP group among aged <= 19 years and >= 65 years was 3.19 (95% CI = 1.04.9.76) and 4.14 (95% CI = 1.27,13.4) within the first 2 years of follow-up. Conclusion This cohort study demonstrated that patients with MP had a higher risk of developing RA, especially in the first 2 years, in those aged younger than 19 and over 65 .	[Chu, Kuo-An] Kaohsiung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Kaohsiung, Taiwan; [Chu, Kuo-An] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Chu, Kuo-An; Hung, Yao-Min] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Weishan] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Weishan] China Med Univ, Coll Med, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hung, Yao-Min] Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Hung, Yao-Min] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan	Hung, YM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hung, YM (corresponding author), Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan.; Hung, YM (corresponding author), Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan.	ymhung1@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679	Ministry of Health and Welfare, Taiwan [MOHW107-TDU-B-212-123004]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; China Medical University Hospital [DMR-107-192]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; China Medical University Hospital; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW107-TDU-B-212-123004), the China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), the MOST Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), the China Medical University Hospital (DMR-107-192), the Tseng-Lien Lin Foundation, Taichung, Taiwan, and the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Autoimmune Related Diseases Association; National Coalition of Autoimmune Patient Groups, COST BURD AUT DIS LA; Ataee RA, 2015, ARCH IRAN MED, V18, P345, DOI 015186/AIM.004; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BURMESTER GR, 1995, ANNU REV IMMUNOL, V13, P229, DOI 10.1146/annurev.iy.13.040195.001305; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Chaudhry Rama, 2003, Indian J Pathol Microbiol, V46, P433; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; COLE BC, 1976, ANN RHEUM DIS, V35, P14, DOI 10.1136/ard.35.1.14; Cole BC, 1996, ASM NEWS, V62, P471; COLE BC, 1993, ARTHRITIS RHEUM-US, V36, P994, DOI 10.1002/art.1780360717; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Danzer C, 2013, ARCH IMMUNOL THER EX, V61, P175, DOI 10.1007/s00005-013-0216-3; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Guo HM, 2016, J INFECT CHEMOTHER, V22, P162, DOI 10.1016/j.jiac.2015.12.006; HAKKARAINEN K, 1992, ANN RHEUM DIS, V51, P1170, DOI 10.1136/ard.51.10.1170; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hoffman RW, 1997, ARTHRITIS RHEUM-US, V40, P1219, DOI 10.1002/art.1780400705; Jung JY, 2017, KOREAN J INTERN MED, V32, P429, DOI 10.3904/kjim.2016.234; KVIEN TK, 1994, J RHEUMATOL, V21, P115; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Li Song, 2013, J Clin Cell Immunol, V4; Luo WY, 2008, INFECT IMMUN, V76, P4989, DOI 10.1128/IAI.00667-08; Odeh AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155648; Raaschou P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i262; Rosenblum MD, 2015, J CLIN INVEST, V125, P2228, DOI 10.1172/JCI78088; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sandberg MEC, 2015, ANN RHEUM DIS, V74, P904, DOI 10.1136/annrheumdis-2014-206493; Schaeverbeke T, 1997, BRIT J RHEUMATOL, V36, P310; TaylorRobinson D, 1996, CLIN INFECT DIS, V23, P671, DOI 10.1093/clinids/23.4.671; Vesely M.C.A., 2012, J PARASITOL RES, V2012, DOI [10.1155/2012/362131, DOI 10.1155/2012/362131]	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210750	10.1371/journal.pone.0210750	http://dx.doi.org/10.1371/journal.pone.0210750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640923	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000044
J	Zhang, JH; Shi, JT; Gao, S; Huo, YZ; Cui, JJ; Shen, H; Liu, GY; He, PM				Zhang, Jianheng; Shi, Jinting; Gao, Song; Huo, Yuanzi; Cui, Jianjun; Shen, Hui; Liu, Guiyan; He, Peimin			Annual patterns of macroalgal blooms in the Yellow Sea during 2007-2017	PLOS ONE			English	Article							LARGEST GREEN-TIDE; ULVA-PROLIFERA; SEAWEED AQUACULTURE; EXPANSION; CHINA; TEMPERATURE; SALINITY; GROWTH; ALGAE; IRRADIANCE	The world's largest macroalgal blooms caused by Ulva prolifera have occurred in the Yellow Sea for 11 consecutive years. The area covered by blooms has been approximately 500 km(2) in previous years, while in 2017, the maximum area decreased significantly to 312 km(2). In this study, we concluded that species competition between Ulva and Sargassum (fast rise of the golden tides), extreme high sea surface temperature and harvest for floating Ulva macroalgae were the three critical factors influencing the sharp reduction in covered area for blooms in 2017. In addition, analysis of annual variations of Pyropia aquaculture area in the Southern Yellow Sea over the past two decades revealed that a great expansion in "Sansha" regions was mainly responsible for the initial blooms in 2007, and that this expansion supported the great biomass of the blooms in following years. Based on these findings, we suggest comprehensive utilization of the macroalgal blooms is a feasible way to control them.	[Zhang, Jianheng; Shi, Jinting; Huo, Yuanzi; Cui, Jianjun; He, Peimin] Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China; [Gao, Song; Liu, Guiyan] State Ocean Administrator, North China Sea Marine Forecasting Ctr, Qingdao, Peoples R China; [Shen, Hui] Jiangsu Inst Marine Fisheries, Nantong, Peoples R China	Shanghai Ocean University	Cui, JJ; He, PM (corresponding author), Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China.	cuijianjun29@163.com; pmhe@shou.edu.cn	Huo, Yuanzi/R-4840-2017; he, peimin/ABG-4220-2021	He, Peimin/0000-0003-3704-7905	National Natural Science Foundation of China [41576163]; National Key R&D Program of China for Blue Granary [2018YFD0901500]; Shanghai Sailing Program [17YF1407900]; Ocean Public Welfare Scientific Research Project, China [201205010]; Jiangsu marine science and technology innovation project [HY2017-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China for Blue Granary; Shanghai Sailing Program; Ocean Public Welfare Scientific Research Project, China; Jiangsu marine science and technology innovation project	This work was funded by National Natural Science Foundation of China (Grant No. 41576163), National Key R&D Program of China for Blue Granary (2018YFD0901500), Shanghai Sailing Program (17YF1407900), the Ocean Public Welfare Scientific Research Project, China (201205010), and the Jiangsu marine science and technology innovation project (HY2017-4).	Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Cai ZiHao, 2016, Acta Agriculturae Zhejiangensis, V28, P1206; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Cui JJ, 2018, MAR POLLUT BULL, V130, P223, DOI 10.1016/j.marpolbul.2018.03.036; Cui JJ, 2015, MAR POLLUT BULL, V101, P660, DOI 10.1016/j.marpolbul.2015.10.033; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; [何华春 He Huachun], 2012, [第四纪研究, Quaternary Sciences], V32, P1161; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; Huo YZ, 2013, LIMNOL OCEANOGR, V58, P2206, DOI 10.4319/lo.2013.58.6.2206; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Largo DB, 2004, HYDROBIOLOGIA, V512, P247, DOI 10.1023/B:HYDR.0000020333.33039.4b; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu F, 2018, LIMNOL OCEANOGR, V63, P1762, DOI 10.1002/lno.10806; Liu XQ, 2016, MAR ENVIRON RES, V119, P189, DOI 10.1016/j.marenvres.2016.06.004; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS, P366, DOI [10.1017/CBO9780511626210, 10.1111/jpy.12398, DOI 10.1111/JPY.12398]; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; Shimada Satoshi, 2003, Phycological Research, V51, P99, DOI 10.1046/j.1440-1835.2003.00296.x; Sousa AI, 2007, J EXP MAR BIOL ECOL, V341, P142, DOI 10.1016/j.jembe.2006.09.020; Su L, 2018, J APPL PHYCOL, V30, P1417, DOI 10.1007/s10811-017-1296-y; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; Wang ZL, 2015, LIMNOL OCEANOGR, V60, P1105, DOI 10.1002/lno.10083; Xiao J, 2016, ACTA OCEANOL SIN, V35, P114, DOI 10.1007/s13131-016-0891-0; Xing QG, 2017, IEEE GEOSCI REMOTE S, V14, P1815, DOI 10.1109/LGRS.2017.2737079; Yan YX, 1999, SCI CHINA SER D, V42, P13, DOI 10.1007/BF02878493; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang JH, 2013, MAR ENVIRON RES, V92, P35, DOI 10.1016/j.marenvres.2013.08.009; Zhang JH, 2017, ESTUAR COAST SHELF S, V189, P58, DOI 10.1016/j.ecss.2017.03.011; Zhang JH, 2016, MAR POLLUT BULL, V104, P101, DOI 10.1016/j.marpolbul.2016.01.056; Zhang JH, 2014, MAR POLLUT BULL, V89, P276, DOI 10.1016/j.marpolbul.2014.09.049; Zhang JH, 2013, J APPL PHYCOL, V25, P795, DOI 10.1007/s10811-012-9972-4; Zhang XW, 2011, LIMNOL OCEANOGR, V56, P233, DOI 10.4319/lo.2011.56.1.0233	34	40	43	9	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210460	10.1371/journal.pone.0210460	http://dx.doi.org/10.1371/journal.pone.0210460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640934	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000029
J	Stefani, MMA; Rosa, PS; Costa, MB; Schetinni, APM; Manhaes, I; Pontes, MAA; Costa, P; Fachin, LRV; Batista, IMFD; Virmond, M; Pereira, E; Penna, MLF; Penna, GO				Araujo Stefani, Mariane Martins; Rosa, Patricia Sammarco; Costa, Mauricio Barcelos; Mendes Schetinni, Antonio Pedro; Manhaes, Igor; Andrade Pontes, Maria Araci; Costa, Patricia; Vincenzi Fachin, Luciana Raquel; Foschiani Dias Batista, Ida Maria; Virmond, Marcos; Pereira, Emilia; Fernandes Penna, Maria Lucia; Penna, Gerson Oliveira			Leprosy survey among rural communities and wild armadillos from Amazonas state, Northern Brazil	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE DNA; PARACOCCIDIOIDES-BRASILIENSIS; DASYPUS-NOVEMCINCTUS; ZOONOTIC LEPROSY; INFECTION; DISEASE; MODEL; PCR	There is evidence that in southern US, leprosy is a zoonosis infecting wild Dasypus novemcinctus armadillos but the extent of this finding is unknown. This ecological study investigated leprosy in rural communities and in wild armadillos from the Brazilian Amazon. The study area was the Mamia Lake of Coari municipality, Amazonas State, Northern region, a hyper endemic leprosy area where residents live on subsistence farming, fishing and armadillo hunting and its meat intake are frequent. The leprosy survey was conducted in sixteen communities by a visiting team of specialists. Local partakers provided wild armadillos to investigate M. leprae infection. Volunteers had complete dermato-neurological examination by a dermatologist with expertise in leprosy diagnosis, suspect skin lesions were biopsied for histopathology (Hematoxylin-eosin/HE, Fite-Faraco/FF staining); slit skin smears were collected. Armadillos' tissue fragments (skins, spleens, livers, lymph nodes, adrenal glands, others) were prepared for histopathology (HE/FF) and for M. leprae repetitive element-RLEP-qPCR. Among 176 volunteers, six new indeterminate leprosy cases were identified (incidence = 3.4%). Suspect skin sections and slit skin smears were negative for bacilli. Twelve wild D. novemcinctus were investigated (48 specimens/96 slides) and histopathological features of M. leprae infection were not found, except for one skin presenting unspecific inflammatory infiltrate suggestive of indeterminate leprosy. Possible traumatic neuroma, granuloma with epithelioid and Langhans cells, foreign-body granuloma were also identified. Granulomatous/non-granulomatous dermatitides were periodic-acid-Schiff/PAS negative for fungus. M. leprae-RLEP-qPCR was negative in all armadillos' tissues; no bacillus was found in histopathology. Our survey in rural communities confirmed the high endemicity for leprosy while one armadillo was compatible with paucibacillary M. leprae infection. At least in the highly endemic rural area of Coari, in the Brazilian Amazon region where infectious sources from untreated multibacillary leprosy are abundant, M. leprae infected armadillos may not represent a major source of infection nor a significant public health concern.	[Araujo Stefani, Mariane Martins] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Rosa, Patricia Sammarco; Vincenzi Fachin, Luciana Raquel; Foschiani Dias Batista, Ida Maria; Virmond, Marcos] Inst Lauro Souza Lima Bauru, Sao Paulo, Brazil; [Costa, Mauricio Barcelos] Univ Fed Goias, Fac Med, Goiania, Go, Brazil; [Mendes Schetinni, Antonio Pedro; Pereira, Emilia] Fundacao Dermatol Trop & Venerol, Manaus, Amazonas, Brazil; [Manhaes, Igor] Univ Fed Rio de Janeiro, Dept Dermatol, Rio De Janeiro, Brazil; [Andrade Pontes, Maria Araci] Ctr Dermatol Dona Libania, Fortaleza, Ceara, Brazil; [Costa, Patricia] Secretaria Municipal Saude, Coari, Amazonas, Brazil; [Fernandes Penna, Maria Lucia] Univ Fed Fluminense, Inst Saude Colet, Niteroi, RJ, Brazil; [Penna, Gerson Oliveira] Univ Brasilia, Ctr Med Trop, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade de Brasilia	Stefani, MMA (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.; Penna, GO (corresponding author), Univ Brasilia, Ctr Med Trop, Brasilia, DF, Brazil.	mmastefani@gmail.com; gerson.penna@fiocruz.br	Fachin, Luciana R. V./N-7054-2013; Penna, Gerson/AAE-5254-2020; Visentainer, Jeane Eliete Laguila/B-3510-2009; Visentainer, Jeane/AAJ-1618-2021	Visentainer, Jeane Eliete Laguila/0000-0002-5815-7903; Penna, Gerson/0000-0001-8967-536X; Fachin, Luciana Raquel Vincenzi/0000-0002-7493-950X	Department of Science and Technology (DECIT) of Brazilian Ministry of Health; Brazilian Council for Research (CNPq) [401791/2014-9]	Department of Science and Technology (DECIT) of Brazilian Ministry of Health(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Brazilian Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Department of Science and Technology (DECIT) of Brazilian Ministry of Health and the Brazilian Council for Research (CNPq process #No 401791/2014-9 to GOP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abide JM, 2008, SOUTH MED J, V101, P635, DOI 10.1097/SMJ.0b013e31816f8610; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P461; Avanzi C, 2016, SCIENCE, V354, P744, DOI 10.1126/science.aah3783; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Pedrini SCB, 2010, BRAZ J INFECT DIS, V14, P47, DOI 10.1590/S1413-86702010000100010; Cardona-Castro N, 2009, LEPROSY REV, V80, P424; Clark BM, 2008, AM J TROP MED HYG, V78, P962, DOI 10.4269/ajtmh.2008.78.962; Deps PD, 2007, REV SOC BRAS MED TRO, V40, P86, DOI 10.1590/S0037-86822007000100019; Deps PD, 2002, INT J LEPROSY, V70, P34; Dhaliwal U, 2003, INT J LEPROSY, V71, P10, DOI 10.1489/1544-581X(2003)71&lt;10:ENLAOI&gt;2.0.CO;2; Job CK, 2000, INT J LEPROSY, V68, P18; KIRCHHEIMER W F, 1972, International Journal of Leprosy and Other Mycobacterial Diseases, V40, P229; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Kirchheimer W F, 1977, Lepr India, V49, P48; Lane JE, 2006, J AM ACAD DERMATOL, V55, P714, DOI 10.1016/j.jaad.2006.02.070; Moises B., 2018, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.0006532, DOI 10.1371/JOURNAL.PNTD.0006532]; Scollard DM, 2006, CLIN INFECT DIS, V43, pE19, DOI 10.1086/505222; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Sharma I, 2015, INDIAN J MED RES, V142, P680, DOI 10.4103/0971-5916.174554; Sharma R, 2018, INFECT GENET EVOL, V62, P20, DOI 10.1016/j.meegid.2018.04.017; Sharma R, 2015, EMERG INFECT DIS, V21, P2127, DOI 10.3201/eid2112.150501; Sharma R, 2013, DIS MODEL MECH, V6, P19, DOI 10.1242/dmm.010215; SHEPARD CC, 1960, J EXP MED, V112, P445, DOI 10.1084/jem.112.3.445; Shepard CC, 1965, INT J LEPROSY, V33, P657; Azevedo MDS, 2017, BRAZ J INFECT DIS, V21, P71, DOI 10.1016/j.bjid.2016.09.017; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Truman R, 2005, LEPROSY REV, V76, P198; Truman R, 2008, SOUTH MED J, V101, P581, DOI 10.1097/SMJ.0b013e318172dd6c; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; WALSH GP, 1975, J RETICULOENDOTH SOC, V18, P347; Wilder-Smith EP, 2008, NAT CLIN PRACT NEURO, V4, P656, DOI 10.1038/ncpneuro0941; Zumarraga MJ, 2001, INT J LEPROSY, V69, P21	35	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209491	10.1371/journal.pone.0209491	http://dx.doi.org/10.1371/journal.pone.0209491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629624	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000026
J	Heins, F; Meermeier, A; Lappe, M				Heins, Frauke; Meermeier, Annegret; Lappe, Markus			Volitional control of saccadic adaptation	PLOS ONE			English	Article							GAIN ADAPTATION; EYE-MOVEMENTS; VISUAL ERROR; PLASTICITY	Saccadic adaptation is assumed to be driven by an unconscious and automatic mechanism. We wondered if the adaptation process is accessible to volitional control, specifically whether any change in saccade gain can be inhibited. Participants were exposed to post-saccadic error by using the double-step paradigm in which a target is presented in a peripheral location and then stepped during the saccade to another location. In one condition, participants were instructed to follow the target step and look at the final target location. In the other condition they were instructed to inhibit the adjustment of saccade amplitude and look at the initial target location. We conducted two experiments, which differed in the size of the intra-saccadic target step. We found that when told to inhibit amplitude adjustment, gain change was close to zero for outward steps, but some adaptation remained for inward steps. Saccadic latency was not affected by the instruction type for inward steps, but when the target was stepped outward, latencies were longer in the inhibition than in the adaptation condition. The results show that volitional control can be exerted on saccadic adaptation. We suggest that volitional control affects the remapping of the target, thus having a larger impact on outward adaptation.	[Heins, Frauke; Meermeier, Annegret; Lappe, Markus] Univ Munster, Dept Psychol, Munster, Germany; [Meermeier, Annegret; Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	University of Munster; University of Munster	Heins, F (corresponding author), Univ Munster, Dept Psychol, Munster, Germany.	frauke.heins@uni-muenster.de		Meermeier, Annegret/0000-0002-3090-3927; Heins, Frauke/0000-0001-8093-9840	German Research Foundation [DFG La 952-6, La 952-8]; European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [734227]	German Research Foundation(German Research Foundation (DFG)); European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant	This work was supported by the German Research Foundation (DFG La 952-6 and La 952-8) and has received funding from the European Unions Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 734227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Alahyane N, 2007, BRAIN RES, V1135, P107, DOI 10.1016/j.brainres.2006.11.077; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Becker W, 1989, Rev Oculomot Res, V3, P13; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; FISCHER B, 1992, EXP BRAIN RES, V89, P415; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HENSON DB, 1978, VISION RES, V18, P63, DOI 10.1016/0042-6989(78)90078-0; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Nyffeler T, 2007, EUR J NEUROSCI, V26, P1381, DOI 10.1111/j.1460-9568.2007.05758.x; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; STRAUBE A, 1995, VISION RES, V35, P3451, DOI 10.1016/0042-6989(95)00076-Q; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Zimmermann E, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00225; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210020	10.1371/journal.pone.0210020	http://dx.doi.org/10.1371/journal.pone.0210020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629610	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000042
J	Shinomiya, Y; Hoshino, Y				Shinomiya, Yuki; Hoshino, Yukinobu			A proposal of prior probability-oriented clustering in feature encoding strategies	PLOS ONE			English	Article							IMAGE; VECTOR	Codebook-based feature encodings are a standard framework for image recognition issues. A codebook is usually constructed by clusterings, such as the k-means and the Gaussian Mixture Model (GMM). A codebook size is an important factor to decide the trade-off between recognition performance and computational complexity and a traditional framework has the disadvantage to image recognition issues when a large codebook; the number of unique clusters becomes smaller than a designated codebook size because some clusters converge to close positions. This paper focusses on the disadvantage from a perspective of the distribution of prior probabilities and presents a clustering framework including two objectives that are alternated to the k-means and the GMM. Our approach is first evaluated with synthetic clustering datasets to analyze a difference to traditional clustering. In the experiment section, although our approach alternated to the k-means generates similar results to the k-means results, our approach is able to finely tune clusters for our objective. Our approach alternated to the GMM significantly improves our objective and constructs intuitively appropriate clusters, especially for huge and complicatedly distributed samples. In the experiment on image recognition issues, two state-of-the-art encodings, the Fisher Vector (FV) using the GMM and the Vector of Locally Aggregated Descriptors (VLAD) using the k-means, are evaluated with two publicly available image datasets, the Birds and the Butterflies. For the results of the VLAD with our approach, the recognition performances tend to be worse compared to the original VLAD results. On the other hand, the FV using our approach is able to improve the performance, especially in a larger codebook size.	[Shinomiya, Yuki; Hoshino, Yukinobu] Kochi Univ Technol, Sch Syst Engn, Kochi, Japan	Kochi University Technology	Shinomiya, Y (corresponding author), Kochi Univ Technol, Sch Syst Engn, Kochi, Japan.	196005c@gs.kochi-tech.ac.jp		Shinomiya, Yuki/0000-0003-3023-2163				Arandjelovic R, 2013, PROC CVPR IEEE, P1578, DOI 10.1109/CVPR.2013.207; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Birgin EG, 2008, OPTIM METHOD SOFTW, V23, P177, DOI 10.1080/10556780701577730; Bradski G., 2000, DOBBS J SOFTWARE TOO; CONN AR, 1991, SIAM J NUMER ANAL, V28, P545, DOI 10.1137/0728030; Costa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037731; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Franti P, 2006, PATTERN RECOGN, V39, P761, DOI 10.1016/j.patcog.2005.09.012; Gosselin PH, 2014, PATTERN RECOGN LETT, V49, P92, DOI 10.1016/j.patrec.2014.06.011; Johnson S.G., NLOPT NONLINEAR OPTI; Karkkainen I., 2002, DYNAMIC LOCAL SEARCH; Ke Y, 2004, PROC CVPR IEEE, P506; Lazebnik S, 2005, IEEE I CONF COMP VIS, P832, DOI 10.1109/ICCV.2005.10; Lazebnik S., 2004, P BRIT MACH VIS C, V2, P959, DOI DOI 10.5244/C.18.98; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maji S, 2009, IEEE I CONF COMP VIS, P40, DOI 10.1109/ICCV.2009.5459203; Manning C, 1999, FDN STAT NATURAL LAN; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nishio M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192892; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Perronnin F, 2007, PROC CVPR IEEE, P2272; Polanski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134256; Powell MJD, 2006, NONCON OPTIM ITS APP, V83, P255; Raghuwanshi SS, 2012, COMP K MEANS MODIFIE; Rowan T.H., 1990, FUNCTIONAL STABILITY; Shinomiya Y, 2016, JOINT INT CONF SOFT, P103, DOI [10.1109/SCIS-ISIS.2016.0034, 10.1109/SCIS&ISIS.2016.45]; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Zhou X, 2010, LECT NOTES COMPUT SC, V6315, P141, DOI 10.1007/978-3-642-15555-0_11	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210146	10.1371/journal.pone.0210146	http://dx.doi.org/10.1371/journal.pone.0210146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629616	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000053
J	Diamond, DM; de Lorgeril, M; Kendrick, M; Ravnskov, U; Rosch, PJ				Diamond, David M.; de Lorgeril, Michel; Kendrick, Malcolm; Ravnskov, Uffe; Rosch, Paul J.			Formal comment on "Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease"	PLOS ONE			English	Review							COA REDUCTASE INHIBITORS; FAMILIAL HYPERCHOLESTEROLEMIA; AUTOIMMUNE MYOPATHY; DIABETES-MELLITUS; HERPES-ZOSTER; UCSD STATIN; RISK; ASSOCIATION; POPULATION; THERAPY	Statins have been prescribed for primary prevention of cardiovascular disease (CVD) for nearly 3 decades. Throughout this period key opinion leaders in the field have been dismayed by the high rate of non-adherence of patients to follow their statin regimen. Hope et al., [1] have addressed this issue by providing a systematic review of research on predictors of statin adherence for primary prevention of CVD. However, their review does not address the ongoing debate as to whether statin treatment is warranted for primary prevention of CVD, nor does it adequately address concerns regarding adverse effects of statins. We have therefore written a commentary which provides a broader perspective on the benefits versus harms of statin therapy. Our perspective of the literature is that non-adherence to statin treatment for primary prevention of CVD is justified because the meager benefits are more than offset by the extensive harms.	[Diamond, David M.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Diamond, David M.] Univ S Florida, Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [de Lorgeril, Michel] Univ Grenoble Alpes, Sch Med, TIMC IMAG, Lab Coeur & Nutr, Grenoble, France; [Kendrick, Malcolm] East Cheshire Trust, Macclesfield Dist Gen Hosp, Macclesfield, Cheshire, England; [Ravnskov, Uffe] Magle Stora Kyrkogata, Lund, Sweden; [Rosch, Paul J.] New York Med Coll, Valhalla, NY 10595 USA; [Rosch, Paul J.] Amer Inst Stress, Ft Worth, TX USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; New York Medical College	Diamond, DM (corresponding author), Univ S Florida, Dept Psychol, Tampa, FL 33620 USA.; Diamond, DM (corresponding author), Univ S Florida, Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ddiamond@usf.edu		Diamond, David/0000-0003-4155-8687				ABRAMSON JD, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2017.12.032; Antoniou T, 2014, CLIN INFECT DIS, V58, P350, DOI 10.1093/cid/cit745; Bang CN, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0461-4; Bjornsson ES, 2017, LIVER INT, V37, P173, DOI 10.1111/liv.13308; Braamskamp MJAM, 2015, PEDIATR DRUGS, V17, P159, DOI 10.1007/s40272-014-0116-y; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Chen HH, 2015, EUR J CLIN MICROBIOL, V34, P1451, DOI 10.1007/s10096-015-2372-3; Chung SD, 2015, OTOLARYNG HEAD NECK, V152, P319, DOI 10.1177/0194599814559382; Chung YH, 2013, PHARMACOEPIDEM DR S, V22, P583, DOI 10.1002/pds.3433; Corrao G, 2014, ATHEROSCLEROSIS, V234, P224, DOI 10.1016/j.atherosclerosis.2014.02.022; Cranney M, 1996, BRIT J GEN PRACT, V46, P661; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; de Jong HJI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041289; de Jong HJI, 2011, SEMIN ARTHRITIS RHEU, V41, P373, DOI 10.1016/j.semarthrit.2011.06.002; Demasi M, 2018, BRIT J SPORT MED, V52, P905, DOI 10.1136/bjsports-2017-098497; Diamond DM, 2015, EXPERT REV CLIN PHAR, V8, P201, DOI 10.1586/17512433.2015.1012494; Dirks Amie J, 2006, Am J Physiol Cell Physiol, V291, pC1208; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; DuBroff R, 2015, WORLD J CARDIOL, V7, P404, DOI 10.4330/wjc.v7.i7.404; Evans MA, 2009, PHARMACOTHERAPY, V29, P800, DOI 10.1592/phco.29.7.800; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; Gabb GM, 2017, HYPERTENSION, V69, pE31; Gigerenzer G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4830; Golomb BA, 2004, QJM-INT J MED, V97, P229, DOI 10.1093/qjmed/hch035; Golomb BA, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0042866, DOI 10.1371/JOURNAL.PONE.0042866]; Golomb BA, 2018, DRUG SAFETY, V41, P403, DOI 10.1007/s40264-017-0620-4; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Golomb BA, 2009, DRUG SAFETY, V32, P649, DOI 10.2165/00002018-200932080-00004; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Golomb BA, 2009, CIRCULATION, V119, pE308; Goodarzi MO, 2013, DIABETES CARE, V36, pE100, DOI 10.2337/dc13-0490; Grover HS, 2014, J FORMOS MED ASSOC, V113, P892, DOI 10.1016/j.jfma.2013.05.016; Hoffman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042866; Hope HF, 2018, PLOS ONE; Huang CY, 2015, UROL INT, V95, P227, DOI 10.1159/000431185; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Kalantzakou T, 2016, EUR J NEUROL, V23, P419; Khan S, 2018, INT J CARDIOL, V262, P25, DOI 10.1016/j.ijcard.2018.02.085; Kim MC, 2018, PLOS ONE, V13, DOI [10.1159/000431185, DOI 10.1159/000431185]; Lai CL, 2013, DRUG SAFETY, V36, P1017, DOI 10.1007/s40264-013-0076-0; Lakey WC, 2016, J CLIN LIPIDOL, V10, P870, DOI 10.1016/j.jacl.2016.03.004; Lei Q, 2014, PHARMAZIE, V69, P448, DOI 10.1691/ph.2014.3892; Leuschen J, 2013, JAMA OPHTHALMOL, V131, P1427, DOI 10.1001/jamaophthalmol.2013.4575; Liu GD, 2017, MOVEMENT DISORD, V32, P913, DOI 10.1002/mds.27006; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; Malhotra A, 2017, BRIT J SPORT MED, V51, P1111, DOI 10.1136/bjsports-2016-097285; Mammen AL, 2016, NEW ENGL J MED, V374, P664, DOI 10.1056/NEJMra1515161; Mansi I, 2015, J GEN INTERN MED, V30, P1599, DOI 10.1007/s11606-015-3335-1; Mansi I, 2013, JAMA INTERN MED, V173, P1318, DOI 10.1001/jamainternmed.2013.6184; Mansi IA, 2017, J SCI MED SPORT, V20, P627, DOI 10.1016/j.jsams.2016.12.075; McDougall JA, 2013, CANCER EPIDEM BIOMAR, V22, P1529, DOI 10.1158/1055-9965.EPI-13-0414; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Nazir S, 2017, JCR-J CLIN RHEUMATOL, V23, P149, DOI 10.1097/RHU.0000000000000497; Ng ASL, 2017, MOVEMENT DISORD, V32, P807, DOI 10.1002/mds.27053; Nissen SE, 2017, ANN INTERN MED, V167, P281, DOI 10.7326/M17-1566; Padala KP, 2007, J AM GERIATR SOC, V55, pS153; Padala KP, 2006, ANN PHARMACOTHER, V40, P1880, DOI 10.1345/aph.1H014; Padala KP, 2012, AM J GERIATR PHARMAC, V10, P296, DOI 10.1016/j.amjopharm.2012.08.002; Ravnskov U, EXPERT REV CLIN PHAR; Ravnskov U, 2015, J CLIN ONCOL, V33, P810, DOI 10.1200/JCO.2014.58.9564; Redberg RF, 2017, JAMA INTERN MED, V177, P21, DOI 10.1001/jamainternmed.2016.7585; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Rehman ZU, 2016, PATHOLOGY, V48, P747, DOI 10.1016/j.pathol.2016.08.009; Reidenberg MM, 2008, CLIN PHARMACOL THER, V83, P498, DOI 10.1038/sj.clpt.6100256; Reidenberg MM, 2005, BRIT J CLIN PHARMACO, V59, P606, DOI 10.1111/j.1365-2125.2005.02359.x; Roberts WC, 1996, AM J CARDIOL, V78, P377; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sahebzamani F.M., 2014, J PHARMACOVIGIL, V2, P4, DOI [10.4172/2329-6887.1000141, DOI 10.4172/2329-6887.1000141]; Sampson UK, 2011, CURR OPIN CARDIOL, V26, P342, DOI 10.1097/HCO.0b013e3283470359; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x; Skolbekken JA, 1998, BMJ-BRIT MED J, V316, P1956, DOI 10.1136/bmj.316.7149.1956; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Stock JK, 2018, ATHEROSCLEROSIS, V269, P260, DOI 10.1016/j.atherosclerosis.2017.12.032; Strom BL, 2015, JAMA INTERN MED, V175, P1399, DOI 10.1001/jamainternmed.2015.2092; Tatley M, 2007, DRUG SAFETY, V30, P195, DOI 10.2165/00002018-200730030-00003; Taylor BA, 2017, ATHEROSCLEROSIS, V256, P100, DOI 10.1016/j.atherosclerosis.2016.11.011; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Teive HAG, 2016, PARKINSONISM RELAT D, V25, P97, DOI 10.1016/j.parkreldis.2016.02.005; Tomlinson SS, 2005, PHYS THER, V85, P459, DOI 10.1093/ptj/85.5.459; Tuccori M, 2014, CNS DRUGS, V28, P249, DOI 10.1007/s40263-013-0135-1; Tuteja S, 2008, PHARMACOTHERAPY, V28, P1188, DOI 10.1592/phco.28.9.1188; van der Sandt N, 2016, SA PHARM J, V83, P26; Waters MJ, 2018, CLIN RHEUMATOL, V37, P543, DOI 10.1007/s10067-017-3831-2; Wisniowska B, 2011, CURR MED RES OPIN, V27, P99, DOI 10.1185/03007995.2010.536745	88	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0205138	10.1371/journal.pone.0205138	http://dx.doi.org/10.1371/journal.pone.0205138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653537	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500006
J	Hu, HP; Chan, H; Ujiie, H; Bernards, N; Fujino, K; Irish, JC; Zheng, JZ; Yasufuku, K				Hu, Hsin-pei; Chan, Harley; Ujiie, Hideki; Bernards, Nicholas; Fujino, Kosuke; Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro			Nanoparticle-based CT visualization of pulmonary vasculature for minimally-invasive thoracic surgery planning	PLOS ONE			English	Article							CELL LUNG-CANCER; ACTIVATION-RELATED PSEUDOALLERGY; BEAM COMPUTED-TOMOGRAPHY; COMPLEMENT ACTIVATION; SUBLOBAR RESECTION; IMAGE GUIDANCE; TASK WORKLOAD; LOBECTOMY; SEGMENTECTOMY; SURVIVAL	Purpose To evaluate CF800, a novel lipid-based liposomal nanoparticle that co-encapsulates indocyanine green (ICG) and iohexol, for CT imaging of pulmonary vasculature in minimally-invasive thoracic surgery planning. Methods CF800 was intravenously administered to 7 healthy rabbits. In vivo CT imaging was performed 15 min post-injection, with a subset of animals imaged at 24h, 48h, and 72h post injection. Signal-to-background ratios (SBR) were calculated at the inferior vena cava and compared across time-points. A similar protocol was applied to 2 healthy pigs to evaluate the feasibility and efficacy in a large animal model. To evaluate the feasibility of clinical application, a survey was completed by 7 surgical trainees to assess pre- and post-injection CT images of rabbits and pigs. Responses on the discernibility of pulmonary vasculature sub-branches and comfort level to use the images for pre- operative planning were collected and analyzed. Results CF800 injection improved visualization of pulmonary vessels in both rabbit and pig models. The SBR of rabbit pulmonary vasculature was significantly higher after CF800 injection (range 3.7-4.4) compared to pre- injection (range 3.3-3.8, n = 7; p<0.05). SBR remained significantly different up to 24 hours after injection (range 3.7-4.3, n = 4; p<0.05). Trainees' evaluation found the post-injection CT images had significantly higher discernibility at the second vessel branch generation in both rabbit and pig models. Trainees identified smaller vasculature branch generations in the post-injection images compared to the pre- treatment images in both rabbit (mean 6.7 +/- 1.8 vs 5.4 +/- 2.1; p<0.05) and pig (mean 6.7 +/- 1.8 vs 5.4 +/- 2.1; p<0.05). Trainees were significantly more comfortable using post-injection images for surgical planning compared to the pre-injection images (rabbit: 8.1 +/- 1.1 vs. 4.7 +/- 2.1; pig: 7.6 +/- 2.1 vs. 4.9 +/- 2.2; p<0.05). Conclusion CF800 provides SBR and contrast enhancement of pulmonary vasculature which may assist in pre-surgical CT planning of minimally invasive thoracic surgery.	[Hu, Hsin-pei; Ujiie, Hideki; Fujino, Kosuke; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Chan, Harley; Bernards, Nicholas; Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Irish, Jonathan C.; Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Yasufuku, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.; Yasufuku, K (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.; Yasufuku, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	kazuhiro.yasufuku@uhn.ca	Ujiie, Hideki/I-1939-2019	Ujiie, Hideki/0000-0001-6119-8776; Hu, Hsin-pei/0000-0001-9604-2587	Canadian Cancer Society [702900]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This research was funded by the Canadian Cancer Society (grant 702900).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adibi S, 2012, J DENT EDUC, V76, P1437; Altorki NK, 2014, J THORAC CARDIOV SUR, V147, P754, DOI 10.1016/j.jtcvs.2013.09.065; [Anonymous], 2017, CANCER; Bachar G, 2009, LARYNGOSCOPE, V119, P434, DOI 10.1002/lary.20089; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Bedetti B, 2017, J THORAC DIS, V9, P1615, DOI 10.21037/jtd.2017.05.79; BEST PV, 1961, CIRC RES, V9, P288, DOI 10.1161/01.RES.9.2.288; Cao C, 2015, LUNG CANCER, V89, P121, DOI 10.1016/j.lungcan.2015.05.010; Charloux A, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0079-2017; Dixon BJ, 2012, INT FORUM ALLERGY RH, V2, P405, DOI 10.1002/alr.21049; Dixon BJ, 2011, LARYNGOSCOPE, V121, P2060, DOI 10.1002/lary.22153; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fukuhara K, 2008, EUR J CARDIO-THORAC, V34, P875, DOI 10.1016/j.ejcts.2008.07.014; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Gossot D, 2013, J THORAC DIS, V5, pS200, DOI 10.3978/j.issn.2072-1439.2013.06.25; Imperatori Andrea, 2008, Int J Surg, V6 Suppl 1, pS78, DOI 10.1016/j.ijsu.2008.12.014; Jackman JA, 2016, NANOMED-NANOTECHNOL, V12, P933, DOI 10.1016/j.nano.2015.12.377; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Keenan RJ, 2004, ANN THORAC SURG, V78, P228, DOI 10.1016/j.athoracsur.2004.01.024; Khullar OV, 2015, J THORAC ONCOL, V10, P1625, DOI 10.1097/JTO.0000000000000664; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Landreneau RJ, 2014, J CLIN ONCOL, V32, P2449, DOI 10.1200/JCO.2013.50.8762; Lenz HJ, 2007, ONCOLOGIST, V12, P601, DOI 10.1634/theoncologist.12-5-601; Lochowski MP, 2014, VIDEOSURGERY MINIINV, V9, P495, DOI 10.5114/wiitm.2014.44250; Meacci Elisa, 2018, J Vis Surg, V4, P17, DOI 10.21037/jovs.2017.12.16; Misaki N, 2009, J THORAC CARDIOV SUR, V138, P613, DOI 10.1016/j.jtcvs.2009.01.003; Moon MH, 2018, RESPIROLOGY, V23, P695, DOI 10.1111/resp.13277; Nakamura H, 2011, THORAC CARDIOV SURG, V59, P137, DOI 10.1055/s-0030-1250377; Nishio W, 2016, ANN THORAC SURG, V102, P1702, DOI 10.1016/j.athoracsur.2016.05.071; Nomori H, 2018, EUR J CARDIO-THORAC, V53, P640, DOI 10.1093/ejcts/ezx357; Oizumi H, 2014, ANN CARDIOTHORAC SUR, V3, P170, DOI 10.3978/j.issn.2225-319X.2014.02.03; Oizumi H, 2011, J THORAC CARDIOV SUR, V141, P678, DOI 10.1016/j.jtcvs.2010.08.027; Pardolesi A, 2014, J THORAC CARDIOV SUR, V148, P737, DOI 10.1016/j.jtcvs.2014.03.001; Patel P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161991; Rotolo N, 2016, EUR RADIOL, V26, P381, DOI 10.1007/s00330-015-3861-6; Saito H, 2014, WORLD J SURG, V38, P2025, DOI 10.1007/s00268-014-2521-3; Sato Toshihiko, 2017, J Vis Surg, V3, P26, DOI 10.21037/jovs.2016.12.14; Seguin-Givelet A, 2018, J THORAC DIS, V10, pS1187, DOI 10.21037/jtd.2018.02.21; Sekine Y, 2012, J THORAC CARDIOV SUR, V143, P1330, DOI 10.1016/j.jtcvs.2012.01.079; She XW, 2018, THORAC CANCER, V9, P305, DOI 10.1111/1759-7714.12585; Sheng DL, 2018, BIOMATERIALS, V165, P1, DOI 10.1016/j.biomaterials.2018.02.041; Shimizu Kimihiro, 2017, J Vis Surg, V3, P88, DOI 10.21037/jovs.2017.05.10; Siewerdsen JH, 2009, HIGH PERFORMANCE INT, DOI [10.1117/12.813747, DOI 10.1117/12.813747]; Subotich D, 2009, CLIN ANAT, V22, P698, DOI 10.1002/ca.20834; Sugimoto S, 2011, J THORAC CARDIOV SUR, V141, P1325, DOI 10.1016/j.jtcvs.2010.09.029; Suzuki H, 2017, SURG TODAY, V47, P463, DOI 10.1007/s00595-016-1387-4; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Szebeni J, 2006, AM J PHYSIOL-HEART C, V290, pH1050, DOI 10.1152/ajpheart.00622.2005; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 2014, MOL IMMUNOL, V61, P163, DOI 10.1016/j.molimm.2014.06.038; Szebeni J, 2012, NANOMED-NANOTECHNOL, V8, P176, DOI 10.1016/j.nano.2011.06.003; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Tanvetyanon T, 2013, ANN ONCOL, V24, P889, DOI 10.1093/annonc/mds495; Wada H, 2018, ANN THORAC SURG; Watanabe S, 2003, ANN THORAC SURG, P75; Whitson BA, 2011, ANN THORAC SURG, V92, P1943, DOI 10.1016/j.athoracsur.2011.05.091; Yamashita S, 2013, ANN THORAC SURG, V95, P994, DOI 10.1016/j.athoracsur.2012.11.005; Yoshimoto K, 2010, EUR J CARDIO-THORAC, V37, P36, DOI 10.1016/j.ejcts.2009.07.002; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zaiontz C., 2018, REAL STAT USING EXCE; Zheng J, 2004, MOL IMAGING CONTRAST; Zheng JZ, 2015, BIOMATERIALS, V67, P160, DOI 10.1016/j.biomaterials.2015.07.010; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	67	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209501	10.1371/journal.pone.0209501	http://dx.doi.org/10.1371/journal.pone.0209501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653521	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500013
J	Islam, MN; Wang, AM; Pedersen, JS; Sorensen, JN; Korner, O; Edelenbos, M				Islam, Md. Nahidul; Wang, Aimei; Pedersen, Jakob Skov; Sorensen, Jorn Nygaard; Koerner, Oliver; Edelenbos, Merete			Online measurement of temperature and relative humidity as marker tools for quality changes in onion bulbs during storage	PLOS ONE			English	Article							ALLIUM-CEPA L.; RESPIRATION RATE; CHEMICAL-COMPOSITION; HARVEST; DISEASE	A long shelf life of onions (Allium cepa L.) is of high importance in the onion industry. Onions are dried and stored in large wooden boxes that are difficult to access. Monitoring temperature and relative humidity during these processes is challenging. Moreover, quality may change in storage without being noticed. Therefore, there is a need to find alternative methods for monitoring and controlling the drying and storage processes of onions and to identify early changes in quality during storage. The potential use of online measurements of temperature and relative humidity (RH) in the vicinity of onions was evaluated during drying and long-term storage of six onion batches (four cultivars and three selections of one of the cultivars) in commercial storage. The batches varied in bulb weight, dry matter content, firmness and disease incidence. The dry matter content and firmness decreased during storage, while the respiration rate and incidences of individual and total disease increased. Two of the batches had low storability with high disease incidences and high average temperatures and variations in the RH. The results showed that tracking the temperature and RH in the vicinity of the onions is a promising tool for improving the drying and storage processes in commercial storage and for identifying onion batches with reduced storability early in storage.	[Islam, Md. Nahidul; Wang, Aimei; Sorensen, Jorn Nygaard; Edelenbos, Merete] Aarhus Univ, Dept Food Sci, Aarslev, Denmark; [Pedersen, Jakob Skov] Danish Technol Inst, Taastrup, Denmark; [Koerner, Oliver] Leibniz Inst Vegetable & Ornamental Crops, Grossbeeren, Germany	Aarhus University; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Edelenbos, M (corresponding author), Aarhus Univ, Dept Food Sci, Aarslev, Denmark.	merete.edelenbos@food.au.dk	Körner, Oliver/AAG-9942-2021; Islam, Nahidul/C-3395-2012	Körner, Oliver/0000-0002-3241-481X; Islam, Nahidul/0000-0002-2797-410X; Wang, Aimei/0000-0002-6575-4028	Innovation Fund Denmark [1382-00057B]	Innovation Fund Denmark	Grant no. 1382-00057B from Innovation Fund Denmark funded this work (https://innovationsfonden.dk/en). All authors of this manuscript received funding from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkeblia N, 2004, SCI AGR, V61, P281, DOI 10.1590/S0103-90162004000300007; Benkeblia N, 2002, INT J FOOD SCI TECH, V37, P169, DOI 10.1046/j.1365-2621.2002.00554.x; Brewster J. L., 2008, Onions and other vegetable alliums, DOI 10.1079/9781845933999.0000; Chope GA, 2006, POSTHARVEST BIOL TEC, V39, P233, DOI 10.1016/j.postharvbio.2005.10.010; Coolong TW, 2008, HORTSCIENCE, V43, P465, DOI 10.21273/HORTSCI.43.2.465; Coolong TW, 2008, J SCI FOOD AGR, V88, P1277, DOI 10.1002/jsfa.3219; Eshel D, 2014, POSTHARVEST BIOL TEC, V88, P34, DOI 10.1016/j.postharvbio.2013.09.002; Galsurker O, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02031; Gashua I. B., 2014, EUR J APPL SCI, V6, P07; Harrow KM, 2012, NZ J AGR RES, V12, P592, DOI [10.1080/00288233.1969.10421244, DOI 10.1080/00288233.1969.10421244]; Hoffmann T, 2007, AGR ENG; Islam MN, 2017, ACTA HORTIC, V1154, P229, DOI [10.17660/ActaHortic.2017.1154.30, 10.17660/actahortic.2017.1154.30]; Islam MN, 2018, J FOOD SCI TECH MYS, V55, P3314, DOI 10.1007/s13197-018-3268-x; Islam MN, 2018, APPL SPECTROSC, V72, P1467, DOI 10.1177/0003702818792282; Islam MN, 2018, THESIS, DOI [10.13140/RG.2.2.27905.97124, DOI 10.13140/RG.2.2.27905.97124]; Kader AA, 2002, POSTHARVEST TECHNOLO, DOI [10.1016/s0925-5214(00)00133-2, DOI 10.1016/S0925-5214(00)00133-2]; Kays SJ, 2004, POSTHARVEST BIOL, P79, DOI DOI 10.1007/978-1-4684-8255-3_3; Ko SS, 2002, J AM SOC HORTIC SCI, V127, P848, DOI 10.21273/JASHS.127.5.848; KOLE NK, 1994, INT J REFRIG, V17, P199, DOI 10.1016/0140-7007(94)90019-1; MAUDE RB, 1977, ANN APPL BIOL, V86, P163, DOI 10.1111/j.1744-7348.1977.tb01829.x; Paull RE, 1999, POSTHARVEST BIOL TEC, V15, P263, DOI 10.1016/S0925-5214(98)00090-8; Petropoulos SA, 2016, FOOD CHEM, V201, P168, DOI 10.1016/j.foodchem.2016.01.095; Schroeder BK, 2012, PLANT DIS, V96, P1548, DOI 10.1094/PDIS-02-12-0117-RE; Schwartz HF, 2016, COMPENDIUM ONION GAR, DOI [10.1094/9780890545003, DOI 10.1094/9780890545003]; Sharma K, 2016, J FOOD SCI TECH MYS, V53, P1620, DOI 10.1007/s13197-015-2076-9; Snowden A.L., 1992, POSTHARVEST DIS DISO, V2, DOI [10.1201/b18215, DOI 10.1201/B18215]; Tanaka M, 1985, RESEARCH BULLETIN OF; Toivonen PMA, 2008, POSTHARVEST BIOL TEC, V48, P1, DOI 10.1016/j.postharvbio.2007.09.004; Vahling-Armstrong C, 2016, PLANT PATHOL, V65, P536, DOI 10.1111/ppa.12438; Vinay Kumar, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P737; Walters DR, 2015, RESPIRATION PLANTS I, P88, DOI [10.1002/9781118783054.ch4, DOI 10.1002/9781118783054.CH4]; Wang A, 2016, ACTA HORTIC, V1144, P333, DOI 10.17660/ActaHortic.2016.1144.49; WARD CM, 1979, ANN APPL BIOL, V91, P113, DOI 10.1111/j.1744-7348.1979.tb07420.x; Watkins CB, 2012, PRODUCTION GUIDE STO, P67; Yemane Kahsay, 2013, Journal of Plant Breeding and Crop Science, V5, P127	35	4	4	9	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210577	10.1371/journal.pone.0210577	http://dx.doi.org/10.1371/journal.pone.0210577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653555	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500053
J	Loosen, SH; Lurje, G; Wiltberger, G; Vucur, M; Koch, A; Kather, JN; Paffenholz, P; Tacke, F; Ulmer, FT; Trautwein, C; Luedde, T; Neumann, UP; Roderburg, C				Loosen, Sven H.; Lurje, Georg; Wiltberger, Georg; Vucur, Mihael; Koch, Alexander; Kather, Jakob N.; Paffenholz, Pia; Tacke, Frank; Ulmer, Florian T.; Trautwein, Christian; Luedde, Tom; Neumann, Ulf P.; Roderburg, Christoph			Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CIRCULATING MICRORNAS; INTRAHEPATIC CHOLANGIOCARCINOMA; POTENTIAL BIOMARKERS; CANCER; EXPRESSION; DIAGNOSIS; REGULATORS; MORTALITY; MARKERS	Objectives Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy. Despite tremendous research activities, the prognosis for the majority of patients is still poor. Only in case of early diagnosis, liver resection might potentially lead to long-term survival. However, it is still unclear which patients benefit most from extensive liver surgery, highlighting the need for new diagnostic and prognostic stratification strategies. Methods Serum concentrations of a 4 miRNA panel (miR-122, miR-192, miR-29b and miR-155) were analyzed using semi-quantitative reverse-transcriptase PCR in serum samples from 94 patients with cholangiocarcinoma undergoing tumour resection and 40 healthy controls. Results were correlated with clinical data. Results Serum concentrations of miR-122, miR-192, miR-29b and miR-155 were significantly elevated in patients with CCA compared to healthy controls or patients with primary sclerosing cholangitis without malignant transformation. Although preoperative levels of these miRNAs were unsuitable as a prognostic marker of survival, a strong postoperative decline of miR-122 serum levels was significantly associated with a favorable patients' prognosis. Conclusions Analysis of circulating miRNAs represents a promising tool for the diagnosis of even early stage CCA. A postoperative decline in miRNA serum concentrations might be indicative for a favorable patients' outcome and helpful to identify patients with a good prognosis after extended liver surgery.	[Loosen, Sven H.; Koch, Alexander; Kather, Jakob N.; Tacke, Frank; Trautwein, Christian; Luedde, Tom; Roderburg, Christoph] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Lurje, Georg; Wiltberger, Georg; Ulmer, Florian T.; Neumann, Ulf P.] Univ Hosp RWTH Aachen, Dept Visceral & Transplantat Surg, Aachen, Germany; [Vucur, Mihael; Luedde, Tom] Univ Hosp RWTH Aachen, Div Gastroenterol Hepatol & Hepatobiliary Oncol, Aachen, Germany; [Paffenholz, Pia] Univ Hosp Cologne, Dept Urol, Cologne, Germany; [Neumann, Ulf P.] MUMC, Dept Surg, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne; Maastricht University	Roderburg, C (corresponding author), Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany.; Neumann, UP (corresponding author), Univ Hosp RWTH Aachen, Dept Visceral & Transplantat Surg, Aachen, Germany.; Neumann, UP (corresponding author), MUMC, Dept Surg, Maastricht, Netherlands.	uneumann@ukaachen.de; croderburg@ukaachen.de	Roderburg, Christoph/AAR-3051-2021; Loosen, Sven/AHC-5236-2022; Kather, Jakob Nikolas/D-4279-2015; Luedde, Tom/AAE-9135-2022; Roderburg, Christoph/AHC-8101-2022; Tacke, Frank/ABF-2212-2020	Loosen, Sven/0000-0002-2799-2287; Kather, Jakob Nikolas/0000-0002-3730-5348; Luedde, Tom/0000-0002-6288-8821; Roderburg, Christoph/0000-0002-1409-7697; Lurje, Georg/0000-0001-9674-0756	German Cancer Aid (Deutsche Krebshilfe) [110043]; German Cancer Aid (Mildred-Scheel-Professorship); German-Research-Foundation [SFB-TRR57/P06, LU 1360/3-1]; Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen; German Research Foundation [DFG RO 4317/4-1]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Cancer Aid (Mildred-Scheel-Professorship); German-Research-Foundation(German Research Foundation (DFG)); Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen; German Research Foundation(German Research Foundation (DFG))	Work in the lab of TL was supported by the German Cancer Aid (Deutsche Krebshilfe 110043 and a Mildred-Scheel-Professorship), the German-Research-Foundation (SFB-TRR57/P06 and LU 1360/3-1), the Ernst-Jung-Foundation Hamburg, the IZKF (interdisciplinary centre of clinical research) Aachen and a grant from the medical faculty of the RWTH Aachen. Moreover, this work was supported by project grants from the German Research Foundation (DFG RO 4317/4-1) and a START grant from the medical faculty RWTH Aachen to CR.	Benz F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010078; Bergquist A, 2015, BEST PRACT RES CL GA, V29, P221, DOI 10.1016/j.bpg.2015.02.003; Bernuzzi F, 2016, CLIN EXP IMMUNOL, V185, P61, DOI 10.1111/cei.12776; Bjornsson E, 1999, LIVER, V19, P501, DOI 10.1111/j.1478-3231.1999.tb00083.x; Cardoso AR, 2016, BIOSENS BIOELECTRON, V80, P621, DOI 10.1016/j.bios.2016.02.035; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099431; Correa-Gallego C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163699; D'Angelo B, 2016, ANTICANCER RES, V36, P5571, DOI 10.21873/anticanres.11142; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EL-Abd NE, 2015, MOL DIAGN THER, V19, P213, DOI 10.1007/s40291-015-0148-1; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Geiger J, 2017, CELL MOL LIFE SCI, V74, P631, DOI 10.1007/s00018-016-2342-7; Gradilone SA, 2015, SEMIN LIVER DIS, V35, P26, DOI 10.1055/s-0034-1397346; Hand NJ, 2012, J PEDIATR GASTR NUTR, V54, P186, DOI 10.1097/MPG.0b013e318244148b; Huang Mindan, 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P748, DOI 10.3760/cma.j.issn.1007-3418.2015.10.008; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kishimoto T, 2013, CANCER SCI, V104, P1626, DOI 10.1111/cas.12300; KOCH A, 2011, CRIT CARE, V15; Lao GY, 2014, TUMOR BIOL, V35, P11933, DOI 10.1007/s13277-014-2479-7; Li G, 2015, CLIN TRANSL ONCOL, V17, P684, DOI 10.1007/s12094-015-1294-y; Liang B, 2015, MED SCI MONITOR, V21, P3555, DOI 10.12659/MSM.895040; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Loosen SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17175-7; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; O'Hara Steven P, 2014, Curr Pathobiol Rep, V2, P133; Otsuka M, 2017, J HUM GENET, V62, P75, DOI 10.1038/jhg.2016.53; Parpart S, 2014, HEPATOLOGY, V60, P872, DOI 10.1002/hep.27200; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Qin XL, 2004, WORLD J GASTROENTERO, V10, P427; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Roderburg C, 2017, J HEPATOL, V66, P655, DOI 10.1016/j.jhep.2016.09.015; Roderburg C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0988-4; Roderburg C, 2015, LIVER INT, V35, P1172, DOI 10.1111/liv.12627; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Skrha Pavel, 2015, Vnitr Lek, V61, P351; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SL, 2015, ONCOL REP, V33, P819, DOI 10.3892/or.2014.3641; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Wu X, 2016, TUMOUR BIOL, V2016; Xing TJ, 2014, GENET MOL RES, V13, P7912, DOI 10.4238/2014.September.29.4; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yan B, 2015, ONCOTARGETS THER, V8, P539, DOI 10.2147/OTT.S75899	53	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210944	10.1371/journal.pone.0210944	http://dx.doi.org/10.1371/journal.pone.0210944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653586	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500090
J	Smajla, D; Garcia-Ramos, A; Tomazin, K; Strojnik, V				Smajla, Darjan; Garcia-Ramos, Amador; Tomazin, Katja; Strojnik, Vojko			Selective effect of static stretching, concentric contractions, and a balance task on ankle force sense	PLOS ONE			English	Article							POSITION SENSE; MUSCLE STRENGTH; PEAK TORQUE; FATIGUE; KNEE; PREVENTION; INJURIES; KINESTHESIA; MOVEMENT; EXERCISE	Proper ankle motor control is critical for balance in the human body during functional activities such as standing, walking, and running. Different exercise modalities are often performed during the same training session where earlier activities may influence later ones. The purpose of the current study was to determine the acute effects of different exercise modalities on ankle force sense. Seventeen subjects performed four different intervention protocols (static stretching, balance task, concentric contractions, and control) in random order. Each session comprised measurements before and after the intervention protocol of the force sense of the ankle plantar flexors (PF) and dorsal flexors (DF) at 10% and 30% of maximal voluntary isometric contraction (MVC). Absolute errors (AE) were calculated separately for each force level and muscle group. An overall PF error (PF-SUM = PF at 10% MVC + PF at 30% MVC), DF error (DF-SUM = DF at 10% MVC + DF at 30% MVC) and ankle error (PF-DF-SUM = PF-SUM + DF-SUM) were also calculated. The main effect of time generally revealed that ankle force sense was significantly reduced after static stretching (PF-DF-SUM: Pre: 6.11 +/- 2.17 Nm, Post: 8.03 +/- 3.28 Nm; p < 0.05), but no significant differences were observed for the concentric contractions (PF-DF-SUM: Pre: 6.01 +/- 1.97 Nm, Post: 6.50 +/- 2.28 Nm) and the balance task (PF-DF-SUM: Pre: 5.25 +/- 1.97 Nm, Post: 5.50 +/- 1.26 Nm). The only significant interaction was observed for the PF-DF-SUM (F = 4.48, p = 0.008) due to greater error scores after stretching (+31.4%) compared to the concentric (+8.2%), balance (+4.8%), and control (-3.5%) conditions. Based on these results, static stretching should not be performed before activities that require a high ankle force sense such as balance, coordination, and precision tasks.	[Smajla, Darjan; Tomazin, Katja; Strojnik, Vojko] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Garcia-Ramos, Amador] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia-Ramos, Amador] Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile	University of Ljubljana; University of Granada; Universidad Catolica de la Santisima Concepcion	Smajla, D (corresponding author), Univ Ljubljana, Fac Sport, Ljubljana, Slovenia.	darjan.smajla@fsp.uni-lj.si	Ramos, Amador Garcia/S-6982-2016	Ramos, Amador Garcia/0000-0003-0608-8755; Smajla, Darjan/0000-0001-5441-8988	Javna Agencija za Raziskovalno Dejavnost RS (SI) [P5-0142]	Javna Agencija za Raziskovalno Dejavnost RS (SI)	This work was supported by Javna Agencija za Raziskovalno Dejavnost RS (SI) (P5-0142 to DS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako M, 2003, MIL MED, V168, P442, DOI 10.1093/milmed/168.6.442; Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2004, MED SCI SPORT EXER, V36, P1397, DOI 10.1249/01.MSS.0000135788.23012.5F; Behm DG, 2001, CAN J APPL PHYSIOL, V26, P261, DOI 10.1139/h01-017; Bernardino S, 2014, EFFECTS DYNAMIC STRE, P586, DOI [10.1249/MSS.0000000000000138, DOI 10.1249/MSS.0000000000000138]; Billot M, 2010, EUR J APPL PHYSIOL, V109, P669, DOI 10.1007/s00421-010-1397-7; Bixler B, 1992, Fam Pract Res J, V12, P131; Bjorklund M, 2006, J ATHL TRAINING, V41, P270; Brindle TJ, 2010, SCAND J MED SCI SPOR, V20, P262, DOI 10.1111/j.1600-0838.2009.00887.x; Brockett C, 1997, BRAIN RES, V771, P251, DOI 10.1016/S0006-8993(97)00808-1; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Chalmers GR, 2002, J GERONTOL A-BIOL, V57, pB321, DOI 10.1093/gerona/57.8.B321; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Costa PB, 2013, SCAND J MED SCI SPOR, V23, P38, DOI 10.1111/j.1600-0838.2011.01348.x; Costa PB, 2009, J SPORT MED PHYS FIT, V49, P401; Costa PB, 2009, INT J SPORTS MED, V30, P60, DOI 10.1055/s-2008-1038738; Costa PB, 2018, J SPORT MED PHYS FIT, V58, P957, DOI 10.23736/S0022-4707.17.07072-4; Docherty CL, 2008, J ORTHOP RES, V26, P1489, DOI 10.1002/jor.20682; EKSTRAND J, 1983, AM J SPORT MED, V11, P116, DOI 10.1177/036354658301100302; Fischer M, 2005, BRAIN RES, V1043, P163, DOI 10.1016/j.brainres.2005.02.059; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Garcia-Ramos A, 2017, EUR J SPORT SCI, V17, P690, DOI 10.1080/17461391.2017.1304999; Guissard N, 2006, EXERC SPORT SCI REV, V34, P154, DOI 10.1249/01.jes.0000240023.30373.eb; Hadala M, 2009, MED SCI SPORT EXER, V41, P1587, DOI 10.1249/MSS.0b013e31819c0de7; Hemmati L, 2016, ANN REHABIL MED-ARM, V40, P845, DOI 10.5535/arm.2016.40.5.845; Hopkins W, 2000, CALCULATIONS RELIABI; Hortobagyi T, 2004, ARTHRIT RHEUM-ARTHR, V51, P562, DOI 10.1002/art.20545; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; Lima BN, 2014, J SPORT SCI MED, V13, P564; Magnusson SP, 1996, J PHYSIOL-LONDON, V497, P291, DOI 10.1113/jphysiol.1996.sp021768; Marek SM, 2005, J ATHL TRAINING, V40, P94; Milani J, 2000, J EXERC PHYSL ONLINE, V3, P14; Okamura Y, 2004, EFFECT LOCAL GEN FAT, V20, P414, DOI [10.1016/j.arthro.2004.01.007, DOI 10.1016/J.ARTHRO.2004.01.007]; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Ribeiro F., 2011, BIOMECHANICS APPL, DOI [10.5772/20335, DOI 10.5772/20335]; Ribeiro F, 2007, EUR J APPL PHYSIOL, V99, P379, DOI 10.1007/s00421-006-0357-8; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Robbins S, 1998, SPORTS MED, V25, P63, DOI 10.2165/00007256-199825010-00005; Rosker J, 2010, SPORT SCI REV, V4, P165, DOI DOI 10.2478/V10237-011-0037-4; South M, 2007, PHYS THER SPORT, V8, P82, DOI 10.1016/j.ptsp.2006.12.001; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Torres R, 2012, J HUM KINET, V34, P33, DOI 10.2478/v10078-012-0061-1; Trimble MH, 2001, INT J NEUROSCI, V106, P1, DOI 10.3109/00207450109149734; Tripp BL, 2006, CLIN BIOMECH, V21, P466, DOI 10.1016/j.clinbiomech.2005.12.015; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; van Dieen JH, 2015, J NEUROPHYSIOL, V114, P2967, DOI 10.1152/jn.00434.2015; Vuillerme N, 2008, GAIT POSTURE, V28, P521, DOI 10.1016/j.gaitpost.2008.03.005; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Westlake KP, 2007, PHYS THER, V87, P1274, DOI 10.2522/ptj.20060263; WIKTORSSONMOLLER M, 1983, AM J SPORT MED, V11, P249, DOI 10.1177/036354658301100412	52	1	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210881	10.1371/journal.pone.0210881	http://dx.doi.org/10.1371/journal.pone.0210881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653585	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500109
J	Tat, RM; Golea, A; Vesa, SC; Ionescu, D				Tat, Raluca Mihaela; Golea, Adela; Vesa, Stefan Cristian; Ionescu, Daniela			Resistin-Can it be a new early marker for prognosis in patients who survive after a cardiac arrest? A pilot study	PLOS ONE			English	Article							RESUSCITATION COUNCIL GUIDELINES; NEURON-SPECIFIC ENOLASE; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; BIOMARKERS; SERUM; S100B; PREDICTORS; MANAGEMENT	Aim The aim of our study was to evaluate the potential role of resistin in estimating the 30 days prognosis in patients with hypoxic-ischemic organ injury who survived after a cardiac arrest (CA). Materials and methods The study included 40 patients resuscitated after a non-traumatic out-of-hospital CA admitted in Emergency Department (ED). All patients were followed for 30 days after CA or until death. Clinical data on admission were recorded. Blood samples were collected on admission in ED (0-time interval), and at 6, 12, 24, 48- and 72-hours following resuscitation. Serum concentrations of resistin, S100B and neuron specific enolase (NSE) were measured. Several predictive scores for the mortality at 30 days were created with logistic regressions. Results At each time interval, median serum levels of resistin and S100 B were significantly higher in non-survivors compared to survivors. For NSE, plasma levels were significantly lower in survivors as compared to non-survivors at 48 and 72 hours, respectively. Accurate predictive scores for 30-days mortality were the ones which included the values of resistin and S100B measured at 12 hours after admittance [AUC 0.938 (0.813-0.989), sensitivity 85.71% (67.3%-96%), specificity 91.67% (61.5%'99.8%), p<0.001], which included the values of all three markers measured at 12 hours after admittance [AUC 0.955 (0.839-0.995), sensitivity 82.14% (63.1%'93.9%), specificity 100.00% (73.5%'100.0%), p<0.001] and the that included the values of resistin and S-100B at 6 hours together with serum lactate on admission [AUC = 0.994 (0.901-1.0), sensitivity 96.4% (81.7%'99.9%), specificity 100.00% (73.5%'100.0%), p<0.001]. Conclusion In our study, serum levels of resistin or a combination of resistin with S-100B or resistin with S-100B and lactate, were highly predictive for 30 days mortality in resuscitated patients after CA. Further studies on large number of patients are needed to confirm our data.	[Tat, Raluca Mihaela; Ionescu, Daniela] Iuliu Hatieganu Univ Med & Pharm, Dept Anesthesia & Intens Care 1, Cluj Napoca, Cluj, Romania; [Golea, Adela] Iuliu Hatieganu Univ Med & Pharm, Surg Dept, Cluj Napoca, Cluj, Romania; [Vesa, Stefan Cristian] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca, Cluj, Romania; [Ionescu, Daniela] Outcome Res Consortium, Cleveland, OH USA	Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy	Vesa, SC (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca, Cluj, Romania.	stefanvesa@gmail.com	Golea, Adela/M-7834-2019; Vesa, Stefan Cristian/I-2481-2019	Vesa, Stefan Cristian/0000-0003-4549-3526	"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca [7690/42/15.04.2016]	"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca	This study was partially funded by the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, through the Doctoral Research Project-2015 (No. 7690/42/15.04.2016). The financial support allocated from the grant was used for the acquisition of biomarkers and laboratory supplies. The sponsor had no involvement in study design, collection, analysis and interpretation of data, writing of the manuscript or decision to submit the manuscript for publication. There was no additional external funding received for this study (the authors supported part of the study).; This study was partially funded by the "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, through the Doctoral Research Project-2015 (No. 7690/42/15.04.2016). The financial support allocated from the grant was used for the acquisition of biomarkers and laboratory supplies.	Calderon LM, 2014, RESUSCITATION, V85, P1025, DOI 10.1016/j.resuscitation.2014.04.020; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Daubin C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-48; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Einav S, 2013, RESUSCITATION, V84, P1083, DOI 10.1016/j.resuscitation.2013.01.031; Einav S, 2012, J AM COLL CARDIOL, V60, P304, DOI 10.1016/j.jacc.2012.04.020; Elmer J, 2016, CRIT CARE MED, V44, P111, DOI 10.1097/CCM.0000000000001357; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Jamaluddin MS, 2012, BRIT J PHARMACOL, V165, P622, DOI 10.1111/j.1476-5381.2011.01369.x; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Langeland H, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.8558; Macdonald SPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110678; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Park YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190519; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ecp.12.64, 10.1586/ECP.12.64]; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Sun BD, 2013, WORLD J EMERG MED, V4, P165, DOI [10.5847/wjem.j.issn.1920-8642.2013.03.001, 10.5847/wjem.j.1920-8642.2013.03.001]; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wiberg S, 2017, RESUSCITATION, V121, P49, DOI 10.1016/j.resuscitation.2017.10.006; Wiberg S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168894	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210666	10.1371/journal.pone.0210666	http://dx.doi.org/10.1371/journal.pone.0210666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650128	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300069
J	Chen, YT; Kuo, SC; Chao, PW; Chang, YY				Chen, Yung-Tai; Kuo, Shu-Chen; Chao, Pei-Wen; Chang, Yea-Yuan			Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study	PLOS ONE			English	Article							STATIN	Objectives Animal and ex vitro studies suggested lipid-lowering agents (LLAs) may be used as an adjunct to standard anti-tuberculosis (TB) treatment. No human study has been conducted to date. Using the Taiwan National Health Insurance Research Database (NHIRD), the current population-based cohort study sought to examine the association between use of LLAs and outcomes of patients with pulmonary TB receiving anti-TB treatment. Methods Using a NHIRD from 2003 to 2010, this population-based cohort study retrospectively examined the association between LLAs (statins or fibrates) and the outcomes of patients with pulmonary TB receiving anti-TB treatment. Results A total of 1452 adult patients newly diagnosed with pulmonary TB during the study period were identified and compared with 5808 matched patients. In the LAA cohort, 1258 received statin, and 295 received fibrate. Compared with patients who did not take LLA, patients who took oral LLAs had similar incidence of treatment completion at 9, 12, and 24 months. Conclusions Neither statins nor fibrates provide clinical benefit superior to that achieved with standard anti-tuberculosis treatment. Future clinical trials should investigate the effects of statins and fibrates on short-course standard anti-TB therapy.	[Chen, Yung-Tai] Taipei City Hosp, Heping Fuyou Branch, Dept Med, Taipei, Taiwan; [Chen, Yung-Tai; Chang, Yea-Yuan] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Kuo, Shu-Chen; Chang, Yea-Yuan] Taipei Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taipei, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Miaoli County, Taiwan; [Chao, Pei-Wen] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Chao, Pei-Wen] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chang, Yea-Yuan] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chang, Yea-Yuan] Natl Yang Ming Univ Hosp, Div Infect Dis, Dept Internal Med, Yilan, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Yang Ming Chiao Tung University	Chang, YY (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan.; Chang, YY (corresponding author), Taipei Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taipei, Taiwan.; Chang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Chang, YY (corresponding author), Natl Yang Ming Univ Hosp, Div Infect Dis, Dept Internal Med, Yilan, Taiwan.	15890@ymuh.ym.edu.tw	Kuo, Shu-Chen/U-6115-2019; chao, P/GSD-8001-2022	Kuo, Shu-Chen/0000-0002-6940-6450; 	National Health Research Institute [IV-106-PP-09]; Wan-Fang Hospital [106-swf-06]	National Health Research Institute(National Health Research Institutes - Taiwan); Wan-Fang Hospital	This work was supported by grants from the National Health Research Institute (IV-106-PP-09) (SCK) and Wan-Fang Hospital (106-swf-06) (PWC). The sponsors did not contribute to study design, the collection, analysis, or interpretation of data, writing of the report, or the decision to submit the article for publication.; The authors would like to thank the National Health Research Institute for making their database available. This work was supported by grants from the National Health Research Institute (IV-106-PP-09) (SCK) and Wan-Fang Hospital (106-swf-06) (PWC). The sponsors did not contribute to study design; the collection, analysis, or interpretation of data; writing of the report; or the decision to submit the article for publication.	Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dutta NK, 2016, J ANTIMICROB CHEMOTH, V71, P1570, DOI 10.1093/jac/dkw014; Kim SJ, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-42; Lai CC, 2016, THORAX, V71, P646, DOI 10.1136/thoraxjnl-2015-207052; Lee MY, 2015, INT J MOL SCI, V16, P11369, DOI 10.3390/ijms160511369; Liao KF, 2017, FRONT PHARMACOL, V8, P59, DOI [10.3389/fphar.2017.00059, DOI 10.3389/FPHAR.2017.00059]; Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13; Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550; Reich-Slotky R, 2009, J BACTERIOL, V191, P5262, DOI 10.1128/JB.00175-09; Shih CJ, 2014, CIRCULATION, V130, P1684, DOI 10.1161/CIRCULATIONAHA.114.012717; Skerry C, 2014, J ANTIMICROB CHEMOTH, V69, P2453, DOI 10.1093/jac/dku166; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; WHO, TUBERCULOSIS	14	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210479	10.1371/journal.pone.0210479	http://dx.doi.org/10.1371/journal.pone.0210479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633771	Green Submitted, gold, Green Published			2022-12-27	WOS:000455485100024
J	Gamboa, M; Muranyi, D; Kanmori, S; Watanabe, K				Gamboa, Maribet; Muranyi, David; Kanmori, Shota; Watanabe, Kozo			Molecular phylogeny and diversification timing of the Nemouridae family (Insecta, Plecoptera) in the Japanese Archipelago	PLOS ONE			English	Article							OHOMOPTERUS GROUND BEETLES; STONEFLIES PLECOPTERA; SPECIES GROUP; DIVERSITY; EVOLUTION; CLOCK; GENUS; TREE; AGE; PHYLOGEOGRAPHY	The generation of the high species diversity of insects in Japan was profoundly influenced by the formation of the Japanese Archipelago. We explored the species diversification and biogeographical history of the Nemouridae Billberg, 1820 family in the Japanese Archipelago using mitochondrial DNA and nuclear DNA markers. We collected 49 species among four genera: Indonemoura Baumann, 1975; Protonemura Kempny, 1898; Amphinemura, Ris 1902 and Nemoura Latreille, 1796 in Japan, China, South Korea and North America. We estimated their divergence times-based on three molecular clock node calibrations-using Bayesian phylogeography approaches. Our results suggested that Japanese Archipelago formation events resulted in diversification events in the middle of the Cretaceous (<120 Ma), speciation in the Paleogene (<50 Ma) and intra-species diversification segregated into eastern and western Japan of the Fossa Magna region at late Neogene (20 Ma). The Indonemoura samples were genetically separated into two clades-that of Mainland China and that of Japan. The Japanese clade clustered with the Nemouridae species from North America, suggesting the possibility of a colonisation event prior to the formation of the Japanese Archipelago. We believe that our results enhanced the understanding both of the origin of the species and of local species distribution in the Japanese Archipelago.	[Gamboa, Maribet; Muranyi, David; Kanmori, Shota; Watanabe, Kozo] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime, Japan; [Muranyi, David] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Zool, Budapest, Hungary	Ehime University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Gamboa, M (corresponding author), Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime, Japan.	gamboa@cee.ehime-u.ac.jp	Gamboa, Maribet/AAT-7556-2020; Watanabe, Kozo/F-7388-2010	Gamboa, Maribet/0000-0003-3744-1339; Muranyi, David/0000-0002-3907-5590; Watanabe, Kozo/0000-0002-7062-595X	Japan Society for the Promotion of Science (JSPS) [13F03366, 17F17908, 15F15065]; JSPS International Research Fellowship [P13366, PU17908, P15065]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS International Research Fellowship	The Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) supported this study under the grants: 13F03366, 17F17908, and 15F15065. The JSPS International Research Fellowship supported Maribet Gamboa (ID No. P13366, PU17908) and David Muranyi (ID No. P15065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST; Barba-Montoya J, 2017, MOL PHYLOGENET EVOL, V114, P386, DOI 10.1016/j.ympev.2017.07.005; Baumann RW, 1975, SMITHSON CONTR ZOOL, V211; Beaulieu JM, 2015, SYST BIOL, V64, P869, DOI 10.1093/sysbio/syv027; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boumans L, 2017, ECOL EVOL, V7, P1635, DOI 10.1002/ece3.2638; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Condamine FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19208; Condie K., 1997, PLATE TECTONIC CRUST; DeWalt R. E., 2018, PLECOPTERA SPECIES F; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ezard T, 2014, SPLITS SPECIES LIMIT; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Grubbs SA, 2014, ZOOKEYS, P11, DOI 10.3897/zookeys.401.7299; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafson GT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08403-1; Hague MTJ, 2016, HEREDITY, V116, P92, DOI 10.1038/hdy.2015.76; Heath TA, 2014, P NATL ACAD SCI USA, V111, pE2957, DOI 10.1073/pnas.1319091111; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Kawai T., 2005, AQUATIC INSECTS JAPA; Konstantinov Alexander S., 2009, P107, DOI 10.1002/9781444308211.ch7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WH, 2017, ZOOTAXA, V4258, P60, DOI 10.11646/zootaxa.4258.1.4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu YS, 2009, PALEONTOL J+, V43, P183, DOI 10.1134/S0031030109020099; Marin J, 2018, MOL BIOL EVOL, V35, P2077, DOI 10.1093/molbev/msy103; McCulloch GA, 2016, MOL PHYLOGENET EVOL, V96, P150, DOI 10.1016/j.ympev.2015.10.028; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Muranyi D, 2014, ZOOTAXA, V3812, P1, DOI 10.11646/zootaxa.3812.1.1; Muranyi D, 2013, ZOOTAXA, V3694, P167, DOI 10.11646/zootaxa.3694.2.6; Ninomiya T, 2014, ISL ARC, V23, P206, DOI 10.1111/iar.12072; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; OTOFUJI YI, 1985, NATURE, V317, P603, DOI 10.1038/317603a0; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2009, FIGTREE V 1 3 1; Saito R, 2016, FRESHW SCI, V35, P712, DOI 10.1086/686564; Schoville SD, 2012, ANNU REV ECOL EVOL S, V43, P23, DOI 10.1146/annurev-ecolsys-110411-160248; Sekine K, 2013, BIOL J LINN SOC, V109, P181, DOI 10.1111/bij.12033; SHIMIZU T, 1994, AQUAT INSECT, V16, P213, DOI 10.1080/01650429409361558; Shimizu T, 1997, AQUAT INSECT, V19, P193, DOI 10.1080/01650429709361656; Shimizu T, 1998, AQUAT INSECT, V20, P203, DOI 10.1076/aqin.20.4.203.4469; Shimizu T., 2001, 21 CENTURY AQUATIC E, P11; Shimizu Takao, 1998, Species Diversity, V3, P133; Shimizu Takao, 1994, Japanese Journal of Entomology, V62, P619; Shimizu Takao, 1997, Japanese Journal of Systematic Entomology, V3, P77; Shimizu Takao, 1998, Japanese Journal of Systematic Entomology, V4, P227; Shimizu Takao, 1997, Japanese Journal of Entomology, V65, P793; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Sota T, 2008, PHILOS T R SOC B, V363, P3377, DOI 10.1098/rstb.2008.0111; Su ZH, 1996, J MOL EVOL, V43, P662, DOI 10.1007/BF02202114; Suzuki T, 2014, MOL PHYLOGENET EVOL, V72, P7, DOI 10.1016/j.ympev.2013.12.008; Taira A, 2001, ANNU REV EARTH PL SC, V29, P109, DOI 10.1146/annurev.earth.29.1.109; Teslenko VA, 2009, AQUAT INSECT, V31, P693, DOI 10.1080/01650420902812230; Tojo K., 2015, WONDERFUL MARVELOUS, P105; Tojo K, 2017, ENTOMOL SCI, V20, P357, DOI 10.1111/ens.12261; Tokuda M, 2010, BIOL J LINN SOC, V99, P570, DOI 10.1111/j.1095-8312.2010.01386.x; Tominaga O, 2000, J MOL EVOL, V50, P541, DOI 10.1007/s002390010057; van Tuinen M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00203; Verdone Chris J., 2017, Illiesia, V13, P30, DOI 10.25031/2017/13.03; Vitecek S, 2017, ARTHROPOD SYST PHYLO, V75, P497; Xiang QY, 2011, MOL PHYLOGENET EVOL, V59, P123, DOI 10.1016/j.ympev.2011.01.016; Yanai S, 2010, J GEOGR-TOKYO, V119, P1079, DOI 10.5026/jgeography.119.1079; Yang D, 2015, FAUNA SINICA, V58, P1; Yushuang L, 2011, PALAENTOLOGY, V54, P923; Zessin W., 2008, DTSCH ENTOMOL Z, V34, P1; Zhiltzova L. A., 2001, Russian Entomological Journal, V10, P125; Zhiltzova L.A., 2003, FAUNA RUSSIA NEIGHBO, V145, P1	78	13	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210269	10.1371/journal.pone.0210269	http://dx.doi.org/10.1371/journal.pone.0210269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633758	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000455485100015
J	Alomaim, H; Griffin, P; Swist, E; Plouffe, LJ; Vandeloo, M; Demonty, I; Kumar, A; Bertinato, J				Alomaim, Haya; Griffin, Philip; Swist, Eleonora; Plouffe, Louise J.; Vandeloo, Michelle; Demonty, Isabelle; Kumar, Ashok; Bertinato, Jesse			Dietary calcium affects body composition and lipid metabolism in rats	PLOS ONE			English	Article							SERUM-LIPIDS; CARDIOVASCULAR-DISEASE; ENERGY RESTRICTION; DAIRY-PRODUCTS; BLOOD-PRESSURE; OBESE ADULTS; WEIGHT-LOSS; FAT-CONTENT; SUPPLEMENTATION; CHOLESTEROL	Calcium (Ca) intakes may affect cardiovascular disease risk by altering body composition (body weight and fat) and serum lipid profile, but results have been inconsistent and the underlying mechanisms are not well understood. The effects of dietary Ca on body composition and lipid metabolism were examined in rats. Male Sprague-Dawley rats were fed high-fat, high-energy diets containing (g/kg) low (0.75Ca, 0.86 +/- 0.05; 2Ca, 2.26 +/- 0.02), normal (5Ca, 5.55 +/- 0.08) or high (10Ca, 11.03 +/- 0.17; 20Ca, 21.79 +/- 0.15) Ca for 10 weeks. Rats fed the lowest Ca diet (0.75Ca) had lower (p < 0.05) body weight and fat mass compared to other groups. Rats fed the high Ca diets had lower serum total and LDL cholesterol compared to rats fed normal or low Ca. Liver total cholesterol was lower in rats fed high compared to low Ca. In general, liver mRNA expression of genes involved in cholesterol uptake from the circulation (Ldlr), cholesterol synthesis (Hmgcr and Hmgcs1), fatty acid oxidation (Cpt2) and cholesterol esterification (Acat2) were higher in rats fed higher Ca. Apparent digestibility of total trans, saturated, monounsaturated and polyunsaturated fatty acids was lower in rats fed the high compared to the low Ca diets, with the largest effects seen on trans and saturated fatty acids. Fecal excretion of cholesterol and total bile acids was highest in rats fed the highest Ca diet (20Ca). The results suggest little effect of dietary Ca on body composition unless Ca intakes are very low. Decreased bile acid reabsorption and reduced absorption of neutral sterols and saturated and trans fatty acids may contribute to the better serum lipid profile in rats fed higher Ca.	[Alomaim, Haya; Griffin, Philip; Swist, Eleonora; Plouffe, Louise J.; Vandeloo, Michelle; Demonty, Isabelle; Bertinato, Jesse] Hlth Canada, Nutr Res Div, Bur Nutr Sci, Hlth Prod & Food Branch, Ottawa, ON, Canada; [Alomaim, Haya; Kumar, Ashok; Bertinato, Jesse] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Alomaim, Haya] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia	Health Canada; University of Ottawa; King Saud Bin Abdulaziz University for Health Sciences	Bertinato, J (corresponding author), Hlth Canada, Nutr Res Div, Bur Nutr Sci, Hlth Prod & Food Branch, Ottawa, ON, Canada.; Bertinato, J (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	jesse.bertinato@canada.ca			Bureau of Nutritional Sciences, Health Canada	Bureau of Nutritional Sciences, Health Canada	This research was funded by the Bureau of Nutritional Sciences, Health Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendsen NT, 2008, INT J OBESITY, V32, P1816, DOI 10.1038/ijo.2008.173; Bertinato J, 2016, J TRACE ELEM MED BIO, V38, P194, DOI 10.1016/j.jtemb.2016.02.005; Bertinato J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050253; Bertinato J, 2014, MAGNESIUM RES, V27, P35, DOI 10.1684/mrh.2014.0360; Bertinato J, 2014, EUR J NUTR, V53, P885, DOI 10.1007/s00394-013-0592-9; Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bostick RM, 2000, ARCH FAM MED, V9, P31, DOI 10.1001/archfami.9.1.31; Brouwer IA, 2016, EFFECTS TRANSFATTY A; Canadian Community Health Survey, 2004, NUTR INT FOOD PROV R, V1; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; Chaput JP, 2009, OBESITY, V17, P1964, DOI 10.1038/oby.2009.116; Chung M, 2016, ANN INTERN MED, V165, P856, DOI 10.7326/M16-1165; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CZUBAYKO F, 1991, J LIPID RES, V32, P1861; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; DENKE MA, 1993, J NUTR, V123, P1047; DeRodas BZ, 1996, J DAIRY SCI, V79, P2121, DOI 10.3168/jds.S0022-0302(96)76586-4; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Ditscheid B, 2005, J NUTR, V135, P1678, DOI 10.1093/jn/135.7.1678; Felsenfeld AJ, 2015, CLIN KIDNEY J, V8, P180, DOI 10.1093/ckj/sfv011; GROOT PHE, 1980, EUR J PEDIATR, V135, P81, DOI 10.1007/BF00445899; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; He YH, 2011, J NUTR, V141, P1938, DOI 10.3945/jn.111.141762; Health Canada, 2012, DO CAN AD MEET THEIR, DOI [10.1016/j.jada.2011.02.014, DOI 10.1016/J.JADA.2011.02.014]; Heaney RP, 2012, ADV NUTR, V3, P763, DOI 10.3945/an.112.002899; Hsu HHT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-16; Jensen S. K., 2008, Lipid Technology, V20, P280, DOI 10.1002/lite.200800074; Jones KW, 2013, EUR J CLIN NUTR, V67, P371, DOI 10.1038/ejcn.2013.52; Kabrnova-Hlavata K, 2008, PHYSIOL RES, V57, P237, DOI 10.33549/physiolres.931057; Leong Xin-Fang, 2015, Biomed Res Int, V2015, P528757, DOI 10.1155/2015/528757; Lovejoy JC, 2001, AM J CLIN NUTR, V74, P90; Ma KY, 2011, MOL NUTR FOOD RES, V55, P247, DOI 10.1002/mnfr.201000161; Major GC, 2008, OBES REV, V9, P428, DOI 10.1111/j.1467-789X.2007.00465.x; Malekzadeh JM, 2007, PAKISTAN J NUTR, V6, P478; Mangano KM, 2011, J AM DIET ASSOC, V111, P687, DOI 10.1016/j.jada.2011.02.014; Marotte C, 2014, EUR J NUTR, V53, P769, DOI 10.1007/s00394-013-0581-z; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; Mensink RP, 2016, EFFECTS SATURATED FA, P1; Olatunji LA, 2008, CLIN HEMORHEOL MICRO, V38, P135; Onakpoya IJ, 2011, NUTR REV, V69, P335, DOI 10.1111/j.1753-4887.2011.00397.x; Palacios C, 2011, NUTRITION, V27, P520, DOI 10.1016/j.nut.2010.02.011; Papakonstantinou E, 2003, OBES RES, V11, P387, DOI 10.1038/oby.2003.52; Paradis S, 2005, PHYSIOL BEHAV, V85, P259, DOI 10.1016/j.physbeh.2005.03.026; Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353; Parikh SJ, 2003, AM J CLIN NUTR, V77, P281, DOI 10.1093/ajcn/77.2.281; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reid IR, 2010, AM J CLIN NUTR, V91, P131, DOI 10.3945/ajcn.2009.28097; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Sergeev IN, 2014, MOL NUTR FOOD RES, V58, P1342, DOI 10.1002/mnfr.201300503; Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246; Torres MRSG, 2013, NUTRITION, V29, P143, DOI 10.1016/j.nut.2012.05.012; Thomas AP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-3; Tremblay A, 2011, J AM COLL NUTR, V30, p449S, DOI 10.1080/07315724.2011.10719989; Trowman R, 2006, BRIT J NUTR, V95, P1033, DOI 10.1079/BJN20051727; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vaskonen T, 2002, BRIT J NUTR, V87, P239, DOI 10.1079/BJN2001508; Villarroel P, 2014, NUTR REV, V72, P627, DOI 10.1111/nure.12135; Vinarova L, 2016, FOOD FUNCT, V7, P151, DOI [10.1039/c5fo00856e, 10.1039/C5FO00856E]; Voznesenskaya A, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0035-0; Waldman T, 2015, AM J LIFESTYLE MED, V9, P298, DOI 10.1177/1559827613512593; Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664; Yanovski JA, 2009, ANN INTERN MED, V150, P821, DOI 10.7326/0003-4819-150-12-200906160-00005; Zemel MB, 2004, AM J CLIN NUTR, V79, P907; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zhang QM, 2004, AM J PHYSIOL-REG I, V286, pR669, DOI 10.1152/ajpregu.00655.2003	72	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210760	10.1371/journal.pone.0210760	http://dx.doi.org/10.1371/journal.pone.0210760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629707	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000126
J	Coetzer, A; Gwenhure, L; Makaya, P; Markotter, W; Nel, L				Coetzer, Andre; Gwenhure, Lambert; Makaya, Pious; Markotter, Wanda; Nel, Louis			Epidemiological aspects of the persistent transmission of rabies during an outbreak (2010-2017) in Harare, Zimbabwe	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MONGOOSE RABIES; VIRUS; AFRICA; CANID	Canine-mediated human rabies is endemic to the entire African continent, where the disease burden is often highest in rural communities of resource-limited countries. In this study, we analysed an animal rabies outbreak, which had persisted since 2010 in the predominantly metropolitan capital city of Zimbabwe, Harare. As rabies is considered to disproportionally affect rural communities, the persistence of urban rabies in this metropolitan setting is of interest. In order to gain an improved understanding of the epidemiology of the outbreak under investigation, we utilised both routine surveillance data that had been collected during the first eight years of the outbreak (2010-2017), as well as molecular epidemiological analyses relying on the Bayesian Markov Chain Monte Carlo methodology. This approach allowed us to characterize virus transmission by identifying specific suburbs within the city limits where persistent disease transmission took place, while also confirming that immunologically naive dogs were the most likely reservoir species in and around the city. In addition to gaining an improved local understanding of the outbreak, we are also able to infer that rabies was likely introduced to the city in 2010 when a rabid animal was moved from the north-east of Zimbabwe into Harare-resulting in an epizootic event. The work presented here not only showcased the value of combining conventional and molecular epidemiological data, but also highlighted the importance of maintaining rabies vaccination coverage and continued public awareness in urban areas where the risk appears to be low. By educating the general population on rabies and relying on owners to bring their companion animals to strategically placed vaccination points, the control and elimination of rabies from Harare may be feasible.	[Coetzer, Andre; Nel, Louis] Univ Pretoria, Dept Biochem Genet & Microbiol, Fac Nat & Agr Sci, Pretoria, Gauteng, South Africa; [Coetzer, Andre; Nel, Louis] Global Alliance Rabies Control SA NPC, Pretoria, Gauteng, South Africa; [Gwenhure, Lambert; Makaya, Pious] Cent Vet Res & Diagnost Lab, Dept Livestock & Vet Serv, Harare, Harare Metropol, Zimbabwe; [Markotter, Wanda] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Pretoria, Gauteng, South Africa	University of Pretoria; University of Pretoria	Nel, L (corresponding author), Univ Pretoria, Dept Biochem Genet & Microbiol, Fac Nat & Agr Sci, Pretoria, Gauteng, South Africa.; Nel, L (corresponding author), Global Alliance Rabies Control SA NPC, Pretoria, Gauteng, South Africa.	louis.nel@up.ac.za	Nel, Louis H/F-1001-2012	Nel, Louis H/0000-0001-8963-0153; Coetzer, Andre/0000-0003-0581-7207; Markotter, Wanda/0000-0002-7550-0080	World Animal Protection (WAP) [WAP/AF/IHC/GR/2016-01]; Centers for Disease Control and Prevention [1U2GGH001874-01]	World Animal Protection (WAP); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research is supported in part by grants from the World Animal Protection (WAP) (grant number: WAP/AF/IHC/GR/2016-01) and the Cooperative Agreement Number, (grant number: 1U2GGH001874-01) funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official position of the funding agencies.	Badrane H, 2001, J VIROL, V75, P3268, DOI 10.1128/JVI.75.7.3268-3276.2001; Banyard AC, 2013, ANTIVIR RES, V98, P357, DOI 10.1016/j.antiviral.2013.04.004; Bingham J, 1999, ONDERSTEPOORT J VET, V66, P1; Bingham J, 1999, ONDERSTEPOORT J VET, V66, P11; Bingham J., 1999, CONTROL RABIES JACKA; Bourhy H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005525; BROOKS R, 1990, VET REC, V127, P592; Brunker K, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev011; Butler JRA, 1998, ECOLOGY DOMESTIC DOG; Centers for Disease Control and Prevention (CDC), 2003, PROT POSTM DIAGN RAB; Chikwati E., 2016, THE HERALD; Coetzer A., 2014, CURRENT LAB TECHNIQU, V1st, P27; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis PL, 2007, ARCH VIROL, V152, P1251, DOI 10.1007/s00705-007-0962-9; Dean DJ, LAB TECHNIQUES RABIE; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Edmonds C.R., 1922, DIS ANIMALS S AFRICA; Foggin CM, 1988, RABIES RABIES RELATE; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hayman DTS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001001; Kgaladi Joe, 2013, Onderstepoort j. vet. res., V80, P1; KISSI B, 1995, VIROLOGY, V209, P526, DOI 10.1006/viro.1995.1285; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Madzima W.N., 1995, P 3 INT C SO E AFR R, P134; Mollentze N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3251; Vigilato MAN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0143; Nel L., 2009, MICROBE, V4, P61; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; Nel LH, 2005, VIRUS RES, V109, P165, DOI 10.1016/j.virusres.2004.12.003; Parliament of Zimbabwe, 2002, PUBL HLTH ACT; Parliament of Zimbabwe, 2001, AN HLTH ACT; Qiagen, 2017, CLC GEN WORKB; Rambaut A., 2007, FIGTREE; Sabeta CT, 2007, VIRUS RES, V129, P1, DOI 10.1016/j.virusres.2007.04.024; Sabeta CT, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.923; Sabeta CT, 2003, VIRUS RES, V91, P203, DOI 10.1016/S0168-1702(02)00272-1; SACRAMENTO D, 1991, MOL CELL PROBE, V5, P229, DOI 10.1016/0890-8508(91)90045-L; Salomao C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005787; Sinclair JM, 1914, REPORT DIRECTOR AGR; SWANEPOEL R, 1978, CENT AFR J MED, V24, P107; SWANEPOEL R, 1993, ONDERSTEPOORT J VET, V60, P325; Taylor LH, 2017, ACTA TROP, V165, P133, DOI 10.1016/j.actatropica.2015.12.007; The Gates Foundation, 2014, ASS RISKS DIG PAYM; TORDO N, 1993, ONDERSTEPOORT J VET, V60, P263; Van Zyl N, 2010, VIRUS RES, V150, P93, DOI 10.1016/j.virusres.2010.02.018; VONTEICHMAN BF, 1995, J GEN VIROL, V76, P73, DOI 10.1099/0022-1317-76-1-73; WHO, 2018, WHO TECH REP SER, V1012, P1; WHO, 2013, WHO TECH REP SER, V982, P1; World Health Organization, 2018, DIS OUTBR; Zimbabwe National Statistical Agency, 2012, ZIMB POP CENS 2012; Zulu GC, 2009, VIRUS RES, V140, P71, DOI 10.1016/j.virusres.2008.11.004	52	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210018	10.1371/journal.pone.0210018	http://dx.doi.org/10.1371/journal.pone.0210018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629634	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000041
J	da Silva, EF; Botsford, S; Dare-Shih, J; Hanna, MA; Porter, LA				da Silva, Elizabeth Fidalgo; Botsford, Sabrina; Dare-Shih, Jessica; Hanna, Miranda A.; Porter, Lisa A.			The Tuberin and Cyclin B1 complex functions as a novel G2/M sensor of serum conditions and Akt signaling	PLOS ONE			English	Article							GENE-PRODUCT; SCLEROSIS; PHOSPHORYLATION; TSC2; LOCALIZATION; HAMARTIN; GROWTH; IDENTIFICATION; PATHWAY; TARGET	A great deal of ground breaking work has determined that the Tuberin and Hamartin Complex function as a negative regulator of protein synthesis and cell cycle progression through G1/S. This is largely attributed to the GTPase activity of Tuberin that indirectly inhibits the mammalian target of rapamycin (mTOR). During times of ample nutrition Tuberin is inhibited by growth factor signaling, including direct phosphorylation by Akt/PKB, allowing for activation of mTOR and subsequent protein synthesis. It is well rationalized that maintaining homeostasis requires communication between cell growth (mTOR signaling) and cell division (cell cycle regulation), however how this occurs mechanistically has not been resolved. This work demonstrates that in the presence of high serum, and/or Akt signaling, direct binding between Tuberin and the G2/M cyclin, Cyclin B1, is stabilized and the rate of mitotic entry is decreased. Importantly, we show that this results in an increase in cell size. We propose that this represents a novel cell cycle checkpoint linking mitotic onset with the nutritional status of the cell to control cell growth.	[da Silva, Elizabeth Fidalgo; Botsford, Sabrina; Dare-Shih, Jessica; Hanna, Miranda A.; Porter, Lisa A.] Univ Windsor, Dept Biol Sci, Windsor, ON, Canada	University of Windsor	Porter, LA (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON, Canada.	lporter@uwindsor.ca	, Lisa/AAA-3185-2020	, Lisa/0000-0002-9234-1712; Fidalgo da Silva, Elizabeth/0000-0003-3540-9335	Natural Sciences and Engineering Council of Canada [312014-2009]; NSERC Undergraduate Student Research Assistance program (USRA); Southwestern Research Program (SWORP); Canadian Institutes of Health Research (CIHR) MSc Scholarship program	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Student Research Assistance program (USRA); Southwestern Research Program (SWORP); Canadian Institutes of Health Research (CIHR) MSc Scholarship program(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating grant from the Natural Sciences and Engineering Council of Canada (#312014-2009 to LAP). Student scholarship support was received from the NSERC Undergraduate Student Research Assistance program (USRA), the Southwestern Research Program (SWORP) and the Canadian Institutes of Health Research (CIHR) MSc Scholarship program. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Astrinidis A, 2006, HUM MOL GENET, V15, P287, DOI 10.1093/hmg/ddi444; Astrinidis A, 2003, J BIOL CHEM, V278, P51372, DOI 10.1074/jbc.M303956200; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Catania MG, 2001, J NEUROPATH EXP NEUR, V60, P711, DOI 10.1093/jnen/60.7.711; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; da Silva EF, 2011, CELL CYCLE, V10, P3129, DOI 10.4161/cc.10.18.17296; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fidalgo da Silva E, 2014, CYTOTECHNOLOGY; Govindarajan B, 2005, J BIOL CHEM, V280, P5870, DOI 10.1074/jbc.M411768200; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Pasumarthi KBS, 2000, CIRC RES, V86, P1069, DOI 10.1161/01.RES.86.10.1069; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210612	10.1371/journal.pone.0210612	http://dx.doi.org/10.1371/journal.pone.0210612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629673	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000117
J	Hashem, MM; Salama, MM; Mohammed, FF; Tohamy, AF; El Deeb, KS				Hashem, Mona M.; Salama, Maha M.; Mohammed, Faten F.; Tohamy, Adel F.; El Deeb, Kadriya S.			Metabolic profile and hepatoprotective effect of Aeschynomene elaphroxylon (Guill. & Perr.)	PLOS ONE			English	Article							CCL4-INDUCED LIVER-DAMAGE; ANTIOXIDANT ACTIVITIES; TRITERPENE SAPONINS; PHENOLIC CONTENTS; OXIDATIVE STRESS; EXTRACT; SERUM; MS; FLAVONOIDS; SEEDS	Liver diseases are life-threatening and need urgent medical treatments. Conventional treatment is expensive and toxic, so the urge for nutraceutical hepatoprotective agents is crucial. This study is considered the first metabolic profile of Aeschynomene elaphroxylon (Guill. & Perr.) extracts of; flowers, leaves & bark adopting UPLC-Orbitrap HRMS analysis to determine their bioactive metabolites, and it was designed to investigate the potential hepatoprotective activity of A. elaphroxylon flowers and bark extracts against CCl4-induced hepatic fibrosis in rats. Forty-nine compounds of various classes were detected in the three extracts, with triterpenoid saponins as the major detected metabolite. Flowers and bark extracts presented similar chemical profile while leaves extract was quite different. The antioxidant activities of the flowers, leaves & bark extracts were measured by in vitro assays as Fe+3 reducing antioxidant power and Oxygen radical absorbance capacity. It revealed that flowers and bark extracts had relatively high antioxidant activity as compared to leaves extract. Based on the metabolic profile and in vitro antioxidant activity, flowers and bark ethanolic extracts were chosen for alleviation of hepatotoxicity induced by CCl4 in rats. The hepato-protective activity was studied through measuring hepatotoxicity biomarkers in serum (ALT, AST, and Albumin). Liver tissues were examined histopathologically and their homogenates were used in determining the intracellular levels of oxidative stress biomarkers (MDA, GSH), inflammatory markers (TNF-alpha). Flowers and bark ethanolic extracts exerted a significant hepatoprotective effect through reduction in the activities of ALT, AST and Albumin, the tested extracts reduced oxidative stress by increasing GSH content and reducing the MDA level. Furthermore, the extracts decreased levels of pro-inflammatory TNF-alpha. Moreover, the present study revealed the potentiality of A. elaphroxylon in ameliorating the CCl4-induced hepatic fibrosis in rats. In this aspect, A. elaphroxylon can be used with other agents as a complementary drug.	[Hashem, Mona M.; Salama, Maha M.; El Deeb, Kadriya S.] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Giza, Egypt; [Salama, Maha M.] British Univ Egypt, Dept Pharmacognosy, Fac Pharm, El Sherouk City, Egypt; [Mohammed, Faten F.] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt; [Tohamy, Adel F.] Cairo Univ, Dept Toxicol & Forens Med, Fac Vet Med, Giza, Egypt; [Tohamy, Adel F.] Univ Vet Med Hannover, Inst Pharmacol Toxicol & Pharm, Hannover, Germany	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of Veterinary Medicine Hannover, Foundation	Hashem, MM (corresponding author), Cairo Univ, Dept Pharmacognosy, Fac Pharm, Giza, Egypt.	mona.hashem@pharma.cu.edu.eg	Mohammed, Faten/AHA-4407-2022; Afify, adel/AEY-4864-2022	Mohammed, Faten/0000-0003-0410-8118; Tohamy, Adel/0000-0001-7711-7432				Achika JI, 2016, BRIT J PHARM RES, V11, DOI 10.9734/BJPR/2016/23506; Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Alekhya C, 2013, INT J PHARM PHARM SC, V5, P386; [Anonymous], [No title captured]; Aruna C, 2012, INT J PHARM PHARM SC, V4, P1; Bharathi M. P., 2015, Journal of Pharmacy Research, V9, P21; Boll M, 2001, Z NATURFORSCH C, V56, P649; Burkill HM, 1994, USEFUL PLANTS W TROP, V2; Caamal-Fuentes E, 2013, NAT PROD COMMUN, V8, P1421; Caamal-Fuentes E, 2011, J ETHNOPHARMACOL, V135, P719, DOI 10.1016/j.jep.2011.04.004; Caamal-Fuentes EE, 2015, MOLECULES, V20, P13563, DOI 10.3390/molecules200813563; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Chiu YJ, 2018, J FOOD DRUG ANAL, V26, P369, DOI 10.1016/j.jfda.2017.04.007; Clichici S, 2015, J MED FOOD, V18, P290, DOI 10.1089/jmf.2013.0179; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI 10.1002/jms.622; Davis BD, 2004, J AM SOC MASS SPECTR, V15, P1287, DOI 10.1016/j.jasms.2004.06.003; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Dutta S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196411; ElSayed NH, 1997, ASIAN J CHEM, V9, P549; Ezejindu DN, 2013, INT J ENG SCI, V2, P54; Farag MA, 2015, ANAL BIOANAL CHEM, V407, P1937, DOI 10.1007/s00216-014-8432-1; Farag MA, 2013, PHYTOCHEMISTRY, V95, P177, DOI 10.1016/j.phytochem.2013.07.003; Ferreres F, 2004, J MASS SPECTROM, V39, P312, DOI 10.1002/jms.586; Ferreres F, 2012, FOOD CHEM, V134, P894, DOI 10.1016/j.foodchem.2012.02.201; Figueirinha A, 2008, FOOD CHEM, V110, P718, DOI 10.1016/j.foodchem.2008.02.045; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harish R, 2006, FOOD CHEM, V95, P180, DOI 10.1016/j.foodchem.2004.11.049; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hong J, 2016, J MED FOOD, V19, P549, DOI 10.1089/jmf.2015.3604; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Hua YS, 2012, J CHROMATOGR SCI, V50, P213, DOI 10.1093/chromsci/bmr049; Ignoato MC, 2012, QUIM NOVA, V35, P2241, DOI 10.1590/S0100-40422012001100028; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JIANG Z, 1992, J HEPATOL, V16, P282, DOI 10.1016/S0168-8278(05)80658-0; Jin MC, 2007, J CHROMATOGR B, V846, P169, DOI 10.1016/j.jchromb.2006.08.043; KITAGAWA I, 1985, CHEM PHARM BULL, V33, P598; Koley TK, 2017, ARABIAN J CHEM; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; Liang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105146; Maatta KR, 2003, J AGR FOOD CHEM, V51, P6736, DOI 10.1021/jf0347517; Mahmoodzadeh Y, 2017, TOXICOL REP, V4, P455, DOI 10.1016/j.toxrep.2017.08.003; Murakami T, 2001, CHEM PHARM BULL, V49, P73, DOI 10.1248/cpb.49.73; Pandae PT KaV, 2011, PHARMACOLOGYONLINE, V3, P297; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Pollier J, 2011, J NAT PROD, V74, P1462, DOI 10.1021/np200218r; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Radwan HA, 2015, RES J PHARM BIOL CHE, V6, P1061; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Rockenbach II, 2012, FOOD RES INT, V48, P848, DOI 10.1016/j.foodres.2012.07.001; Sadeghi H, 2016, AVICENNA J PHYTOMEDI, V6, P181; SHIRAIWA M, 1991, AGR BIOL CHEM TOKYO, V55, P911, DOI 10.1080/00021369.1991.10870686; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Xu Hui-Xian, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2187; Xu RA, 2012, CELL MOL IMMUNOL, V9, P296, DOI 10.1038/cmi.2011.53; Xu Y, 2018, CHIN J NAT MEDICINES, V16, P271, DOI 10.1016/S1875-5364(18)30057-8; Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253; Zhang W, 2009, MOLECULES, V14, P2959, DOI 10.3390/molecules14082959; Zhao HF, 2008, FOOD CHEM, V107, P296, DOI 10.1016/j.foodchem.2007.08.018; Zheng YF, 2015, MOLECULES, V20, P6273, DOI 10.3390/molecules20046273; Zhu LJ, 2016, PHARMACOGN MAG, V12, P302, DOI 10.4103/0973-1296.192203	65	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210576	10.1371/journal.pone.0210576	http://dx.doi.org/10.1371/journal.pone.0210576			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629685	Green Published, gold			2022-12-27	WOS:000455483000111
J	Htwe, KTZ; Dapat, C; Shobugawa, Y; Odagiri, T; Hibino, A; Kondo, H; Yagami, R; Saito, T; Takemae, N; Tamura, T; Watanabe, H; Kyaw, Y; Lin, N; Myint, YY; Tin, HH; Thein, W; Kyaw, LL; Soe, PE; Naito, M; Zaraket, H; Suzuki, H; Abe, T; Saito, R				Htwe, Khin Thu Zar; Dapat, Clyde; Shobugawa, Yugo; Odagiri, Takashi; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Saito, Takehiko; Takemae, Nobuhiro; Tamura, Tsutomu; Watanabe, Hisami; Kyaw, Yadanar; Lin, Nay; Myint, Yi Yi; Tin, Htay Htay; Thein, Win; Kyaw, Latt Latt; Soe, Pan Ei; Naito, Makoto; Zaraket, Hassan; Suzuki, Hiroshi; Abe, Takashi; Saito, Reiko			Phylogeographic analysis of human influenza A and B viruses in Myanmar, 2010-2015	PLOS ONE			English	Article							EPIDEMIOLOGIC DYNAMICS; GLOBAL CIRCULATION; INFERENCE; SOUTHERN	We investigated the circulation patterns of human influenza A and B viruses in Myanmar between 2010 and 2015 by analyzing full HA genes. Upper respiratory tract specimens were collected from patients with symptoms of influenza-like illness. A total of 2,860 respiratory samples were screened by influenza rapid diagnostic test, of which 1,577 (55.1%) and 810 (28.3%) were positive for influenza A and B, respectively. Of the 1,010 specimens that were positive for virus isolation, 370 (36.6%) were A(H1N1) pdm09, 327 (32.4%) were A(H3N2), 130 (12.9%) B(Victoria), and 183 (18.1%) were B(Yamagata) viruses. Our data showed that influenza epidemics mainly occurred during the rainy season in Myanmar. Our three study sites, Yangon, Pyinmana, and Pyin Oo Lwin had similar seasonality and circulating type and subtype of influenza in a given year. Moreover, viruses circulating in Myanmar during the study period were closely related genetically to those detected in Thailand, India, and China. Phylogeographic analysis showed that A(H1N1) pdm09 viruses in Myanmar originated from Europe and migrated to other countries via Japan. Similarly, A (H3N2) viruses in Myanmar originated from Europe, and disseminated to the various countries via Australia. In addition, Myanmar plays a key role in reseeding of influenza B viruses to Southeast Asia and East Asia as well as Europe and Africa. Thus, we concluded that influenza virus in Myanmar has a strong link to neighboring Asian countries, Europe and Oceania.	[Htwe, Khin Thu Zar; Shobugawa, Yugo; Odagiri, Takashi; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Saito, Reiko] Niigata Univ, Div Int Hlth, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi Dori, Niigata, Niigata, Japan; [Dapat, Clyde] Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi, Japan; [Saito, Takehiko; Takemae, Nobuhiro] Natl Agr & Food Res Org, Influenza & Prion Dis Res Ctr, NARO, 3-1-1 Kannondai, Tsukuba, Ibaraki, Japan; [Tamura, Tsutomu] Niigata Prefectural Inst Publ Hlth & Environm Sci, Nishi Ku, 314-1 Sowa, Niigata, Niigata, Japan; [Watanabe, Hisami] Niigata Univ, Infect Dis Res Ctr, Niigata Univ Myanmar, Grad Sch Med & Dent Sci, Niigata, Niigata, Japan; [Kyaw, Yadanar] Thingangyun Sanpya Hosp, Dept Resp Med, Yangon Div, Yangon, Myanmar; [Lin, Nay] Pyinmana Township Hosp, Clin Lab, Microbiol Sect, Pyinmana Township, Nay Pyi Taw, Myanmar; [Myint, Yi Yi] Yangon Gen Hosp, Yangon Div, Lanmadaw, Yangon, Myanmar; [Tin, Htay Htay; Thein, Win; Kyaw, Latt Latt; Soe, Pan Ei] Minist Hlth & Sports, Natl Hlth Lab, Yangon Div, Dagon, Yangon, Myanmar; [Naito, Makoto] Niigata Med Ctr Hosp, Dept Pathol, Nishi Ku, Niigata, Niigata, Japan; [Zaraket, Hassan] Amer Univ Beirut, Dept Expt Pathol Immunol & Microbiol, Fac Med, Beirut, Lebanon; [Zaraket, Hassan] Amer Univ Beirut, Ctr Infect Dis Res, Fac Med, Beirut, Lebanon; [Suzuki, Hiroshi] Niigata Seiryo Univ, Sch Nursing & Psychol, Chuo Ku, Suido Cho, Niigata, Niigata, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata, Niigata, Japan	Niigata University; Tohoku University; National Agriculture & Food Research Organization - Japan; Niigata University; American University of Beirut; American University of Beirut; Niigata University	Htwe, KTZ (corresponding author), Niigata Univ, Div Int Hlth, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi Dori, Niigata, Niigata, Japan.	ktzh@med.niigata-u.ac.jp	Dapat, Clyde/B-4196-2009; Saito, Takehiko/AFM-3038-2022	Dapat, Clyde/0000-0002-7616-4680; KONDO, HIROKI/0000-0002-8336-3995	International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization) [15fm0108009h0001]; JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan	International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the International Development Strategy Program for Infectious Diseases Research (J-GRID) of AMED (Japan Medical Research and Development Organization) (15fm0108009h0001 to RS), JSPS Core-to-core Program, B to RS. Asia-Africa Science Platforms, and Kakenhi (Grants-in-Aid for Scientific Research), sourced from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Health and Labor Sciences Research Grant, Ministry of Health, Labor and Welfare, Japan.	Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Control CfD Prevention, 1982, CONCEPTS PROCEDURES; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dapat C, 2013, INFLUENZA OTHER RESP, V7, P766, DOI 10.1111/irv.12030; Dapat C, 2010, EMERG INFECT DIS, V16, P493, DOI 10.3201/eid1603.091321; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; Oliveira TFDS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0817-z; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, ROUGH GUIDE BEAST 1, DOI [10.1093/molbev/msw082, DOI 10.1093/MOLBEV/MSW082]; Geoghegan JL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006780; Gong YN, 2019, J FORMOS MED ASSOC, V118, P116, DOI 10.1016/j.jfma.2018.01.019; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Lemey MSaGB P., PHYLOGEOGRAPHIC INFE; Le MQ, 2013, EMERG INFECT DIS, V19, P1756, DOI 10.3201/eid1911.130349; Manito ACB, 2017, VIRUS RES, V238, P69, DOI 10.1016/j.virusres.2017.06.002; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Shaw M, 2013, FIELDS VIROLOGY, V1; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmerman JM, 2004, VACCINE, V23, P182, DOI 10.1016/j.vaccine.2004.05.025; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Suzuki Y, RAPID SPECIFIC DETEC; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; who, WHO RECOMMENDATIONS; World Health Organization, 2011, MAN LAB DIAGN VIR SU	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210550	10.1371/journal.pone.0210550	http://dx.doi.org/10.1371/journal.pone.0210550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629691	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000107
J	Krishnamurthy, N; Santini, T; Wood, S; Kim, J; Zhao, TJ; Aizenstein, HJ; Ibrahim, TS				Krishnamurthy, Narayanan; Santini, Tales; Wood, Sossena; Kim, Junghwan; Zhao, Tiejun; Aizenstein, Howard J.; Ibrahim, Tamer S.			Computational and experimental evaluation of the Tic-Tac-Toe RF coil for 7 Tesla MRI	PLOS ONE			English	Article							TIME-INTERLEAVED ACQUISITION; B-1 INHOMOGENEITY; POWER DEPOSITION; TRANSMIT; FIELD; SAR; EXCITATION; REDUCTION; REPRESENTATION; HOMOGENEITY	A variety of 7 Tesla RF coil systems have been proposed to produce spin excitation (B-1(+) field) and MR image acquisition. Different groups have attempted to mitigate the challenges at high and ultra-high field MRI by proposing novel hardware and software solutions to obtain uniformly high spin excitation at acceptable RF absorption levels. In this study, we extensively compare the designs of two distributed-circuit based RF coils: the Tic-Tac-Toe (TTT) head coil and TEM head coil on multiple anatomically detailed head models and invivo. Bench measurements of s-parameters and experimental B-1(+) field distribution were obtained in volunteers and compared with numerical simulations. RF absorption, quantified by both average and peak SAR, and B-1(+) field intensity and homogeneity, calculated/measured in terms of maximum over minimum and coefficient of variation (CV) in the region of interest (ROI), are presented for both coils. A study of the RF consistency of both coils across multiple head models for different RF excitation strategies is also presented.	[Krishnamurthy, Narayanan; Santini, Tales; Wood, Sossena; Kim, Junghwan; Aizenstein, Howard J.; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Zhao, Tiejun] Siemens Med Solut, New York, NY USA; [Aizenstein, Howard J.; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Siemens AG; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	tibrahim@pitt.edu		Ibrahim, Tamer/0000-0001-6738-5855; Santini, Tales/0000-0003-4533-9190	National Institutes of Health [R01MH111265, R01EB009848]; CAPES Foundation, Ministry of Education of Brazil [13385/13-5]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work reported in this publication is supported by the National Institutes of Health under award numbers: R01MH111265 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9483825&icde=0) and R01EB009848 (https://projectreporter.nih.gov/project_info_description.cfm?aid=8100222 & both to author Tamer S. Ibrahim. Tales Santini was partially supported by the CAPES Foundation, Ministry of Education of Brazil, under the award number 13385/13-5. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Siemens Medical Solutions provided support in the form of salaries for author Tiejun Zhao, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Avdievich NI, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3680; Bitz A, 2010, P 18 ANN M ISMRM STO; CHO ZH, 1992, MAGNET RESON MED, V23, P193, DOI 10.1002/mrm.1910230120; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; de Greef M, 2013, MAGN RESON MED, V69, P1476, DOI 10.1002/mrm.24378; Ercan AE, 2015, MAGN RESON MED, V73, P2053, DOI 10.1002/mrm.25346; FSL, BRAIN EXTR TOOL FMRI; Homann H, 2012, MAGN RESON MATER PHY, V25, P193, DOI 10.1007/s10334-011-0281-8; Hue Y-K, 2008, ISMRM; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, PHYS MED BIOL, V46, P2545, DOI 10.1088/0031-9155/46/10/303; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; Ibrahim TS, 2015, 10 BIANN 2015 WORKSH; Ibrahim TS, 2012, ISMRM, V2807; Ibrahim TS, 2008, ISMRM; Ibrahim TS, 2016, ISMRM WORKSH ULTR FI; Keil B, 2010, DESIGN OPTIMIZATION, P6960; Kim J, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3664; Kim J, 2016, J MAGN RESON, V269, P55, DOI 10.1016/j.jmr.2016.04.012; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Lattanzi R, 2009, MAGN RESON MED, V61, P315, DOI 10.1002/mrm.21782; Li MY, 2015, J MAGN RESON, V252, P29, DOI 10.1016/j.jmr.2014.12.004; Luengo CL, 2003, DIP LIB IMAGE MEASUR; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; PROFFITT D, 1979, COMPUT VISION GRAPH, V10, P318, DOI 10.1016/S0146-664X(79)80041-6; Rietsch SHG, 2018, MAGN RESON MED, V79, P1116, DOI 10.1002/mrm.26704; Robitaille PML, 1998, NMR BIOMED, V11, P263, DOI 10.1002/(SICI)1099-1492(199810)11:6<263::AID-NBM549>3.0.CO;2-0; Santini T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206127; Santini T, 2018, MAGN RESON IMAGING, V45, P1, DOI 10.1016/j.mri.2017.09.005; Smagula SF, ASS HIPPOCAMPAL SUBS, DOI [10.1016/j.jagp.2018.03.003, DOI 10.1016/J.JAGP.2018.03.003]; Smagula SF, GRAY MATTER REGIONS; Sohn SM, 2014, IEEE T MICROW THEORY, V62, P1784, DOI 10.1109/TMTT.2014.2331621; STAEWEN RS, 1990, INVEST RADIOL, V25, P559, DOI 10.1097/00004424-199005000-00015; Stenger VA, 2000, MAGNET RESON MED, V44, P525, DOI 10.1002/1522-2594(200010)44:4<525::AID-MRM5>3.0.CO;2-L; Tamer S, 2017, HOMOGENEOUS 7T NEURO; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; Tannus A, 1997, NMR BIOMED, V10, P423, DOI 10.1002/(SICI)1099-1492(199712)10:8<423::AID-NBM488>3.0.CO;2-X; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Tilley AR, 2002, MEASURE MAN WOMAN HU, P27; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Umutlu L, 2014, ROFO-FORTSCHR RONTG, V186, P121, DOI 10.1055/s-0033-1350406; van Lier ALHMW, 2012, J MAGN RESON IMAGING, V35, P795, DOI 10.1002/jmri.22878; VAUGHAN JT, 1994, MAGNET RESON MED, V32, P206, DOI 10.1002/mrm.1910320209; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; VOSSEPOEL AM, 1982, COMPUT VISION GRAPH, V20, P347, DOI 10.1016/0146-664X(82)90057-0; Wang CS, 2006, J MAGN RESON IMAGING, V24, P439, DOI 10.1002/jmri.20635; Wolf S, 2013, MAGN RESON MED, V69, P1157, DOI 10.1002/mrm.24329; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 2003, MAGNET RESON MED, V49, P655, DOI 10.1002/mrm.10433; Yujuan Zhao TZ, 2014, MRM, DOI [10.1002/mrm.25424, DOI 10.1002/MRM.25424]; Zhang ZH, 2007, MAGN RESON MED, V57, P842, DOI 10.1002/mrm.21221; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	56	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209663	10.1371/journal.pone.0209663	http://dx.doi.org/10.1371/journal.pone.0209663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629618	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000031
J	MacDougall, L; Smolina, K; Otterstatter, M; Zhao, B; Chong, M; Godfrey, D; Mussavi-Rizi, A; Sutherland, J; Kuo, M; Kendall, P				MacDougall, Laura; Smolina, Kate; Otterstatter, Michael; Zhao, Bin; Chong, Mei; Godfrey, David; Mussavi-Rizi, Ali; Sutherland, Jenny; Kuo, Margot; Kendall, Perry			Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada	PLOS ONE			English	Article							OPIOID OVERDOSE; PUBLIC-HEALTH	Introduction British Columbia (BC), Canada declared a public health emergency in April 2016 for opioid overdose. Comprehensive data was needed to identify risk factors, inform interventions, and evaluate response actions. We describe the development of an overdose cohort, including linkage strategy, case definitions, and data governance model, and present the resulting characteristics, including data linkage yields and case overlap among data sources. Methods Overdose events from hospital admissions, physician visits, poison centre and ambulance calls, emergency department visits, and coroner's data were grouped into episodes if records were present in multiple sources. A minimum of five years of universal health care records (all prescription dispensations, fee-for-service physician billings, emergency department visits and hospitalizations) were appended for each individual. A 20% random sample of BC residents and a 1: 5 matched case-control set were generated. Consultation and prioritization ensured analysts worked to address questions to directly inform public health actions. Results 10,456 individuals suffered 14,292 overdoses from January 1, 2015 to Nov 30, 2016. Only 28% of overdose events were found in more than one dataset with the unique contribution of cases highest from ambulance records (32%). Compared with fatal overdoses, non-fatal events more often involved females, younger individuals (20 to 29 years) and those 60 or older. In 78% of illegal drug deaths, there was no associated ambulance response. In the year prior to first recorded overdose, 60% of individuals had at least one ED visit, 31% at least one hospital admission, 80% at least one physician visit, and 87% had filled at least one prescription in a community pharmacy. Conclusion While resource-intensive to establish, a linked cohort is useful for characterizing the full extent of the epidemic, defining sub-populations at risk, and patterns of contact with the health system. Overdose studies in other jurisdictions should consider the inclusion of multiple data sources.	[MacDougall, Laura; Smolina, Kate; Otterstatter, Michael; Zhao, Bin; Chong, Mei; Kuo, Margot] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Smolina, Kate; Otterstatter, Michael] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Godfrey, David] British Columbia Minist Hlth, Data Management & Stewardship Branch, Victoria, BC, Canada; [Mussavi-Rizi, Ali] Prov Hlth Serv Author, Performance Measurement & Reporting, Vancouver, BC, Canada; [Sutherland, Jenny; Kendall, Perry] British Columbia Minist Hlth, Off Prov Hlth Officer, Victoria, BC, Canada	University of British Columbia	MacDougall, L (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	laura.macdougall@canada.ca		Otterstatter, Michael/0000-0001-5489-014X				[Anonymous], 2018, ILL DRUG OV DEATHS B; [Anonymous], 2017, DRUG ALCOHOL REV; [Anonymous], 2017, COMMUNICATION; Bahorik AL, 2017, SUBST ABUS, V19, P1; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Canadian Institute for Health Information, 2016, DAT QUAL DOC NAT AMB; Drug Analysis Service, 2017, DRUG SIT SUMM REP CA; European Monitoring Centre for Drugs and Drug Addiction, 2018, STAT B 2018 OV DEATH; Formica SW, 2018, INT J DRUG POLICY, V54, P43, DOI 10.1016/j.drugpo.2018.01.001; Gladstone EJ, 2016, INJURY PREV, V22, P288, DOI 10.1136/injuryprev-2015-041604; Janjua NZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150176; Leamon AW, 2017, ENHANCED EMERGENCY D; Office of the Provincial Health Officer of British Columbia, 2017, PREV PHARM OP ASS MO; Rasali D, 2016, PUBL HLTH ASS BRIT C; Rizi SAM, 2013, STUD HEALTH TECHNOL, V192, P861, DOI 10.3233/978-1-61499-289-9-861; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003	17	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210129	10.1371/journal.pone.0210129	http://dx.doi.org/10.1371/journal.pone.0210129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629607	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000052
J	Sandmann, J; Sichtermann, T; Muschenich, FS; Nasri, H; Heringer, S; Mpotsaris, A; Kramer, M; Wiesmann, M; Nikoubashman, O				Sandmann, Johanna; Sichtermann, Thorsten; Mueschenich, Franziska Sonja; Nasri, Hadi; Heringer, Sarah; Mpotsaris, Anastasios; Kramer, Martin; Wiesmann, Martin; Nikoubashman, Omid			Intra-arterial pulse wave analysis during thrombectomy for the assessment of collateral status - A feasibility study	PLOS ONE			English	Article							ISCHEMIC-STROKE; PREDICTOR; PRESSURE; MODEL	Purpose Knowledge of the collateralization of an occluded vessel is important for the risk-benefit analysis of difficult revascularization maneuvers during mechanical thrombectomy. If the territory behind a clot is well perfused, one could desist from performing a risky thrombectomy maneuver. The arterial pulse pressure curve may serve as an indicator for the collateralization of an occluded target vessel. We investigated the feasibility of arterial pulse measurements with a standard microcatheter. Methods We measured the intra-arterial blood pressure proximal and distal to the clot in 40 thrombectomy maneuvers in a porcine stroke model. We used a microcatheter (Trevo Pro 18, Stryker, Kalamazoo, CA, USA), a pressure transducer (MEMSCAP SP844), an AdInstruments Powerlab 16/35 workstation, and LabChart 8 Software (AdInstruments, Dunedin, New Zealand). Results Median arterial blood pressure proximal and distal to the clot was 96.0 mmHg (IQR, 23.8 mmHg) and 47.5 mmHg (IQR, 43.5 mmHg), respectively (p <.001). The median difference between systolic maximum and diastolic minimum proximal and distal to the clot decreased significantly from 1.8 mmHg (IQR, 3.6 mmHg) to 0.0 mmHg (IQR, 0.5 mmHg) (p <.001). There was loss of the curve in 26 of 40 cases and loss of pressure in 23 of 40 cases (p =.008). There was no significant correlation between vessel diameter and either loss of the pulse pressure curve (p =.20) or overall pressure loss (p =.31). Conclusion It is possible to measure the pulse pressure proximal and distal to the clot with a standard microcatheter used during mechanical thrombectomy.	[Sandmann, Johanna; Sichtermann, Thorsten; Mueschenich, Franziska Sonja; Nasri, Hadi; Heringer, Sarah; Mpotsaris, Anastasios; Wiesmann, Martin; Nikoubashman, Omid] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Univ Hosp, Aachen, Germany; [Kramer, Martin] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Justus Liebig University Giessen	Sandmann, J (corresponding author), Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Univ Hosp, Aachen, Germany.	jsandmann@ukaachen.de	Wiesmann, Martin/GLU-1902-2022; Sichtermann, Thorsten/AAA-2045-2022; Mpotsaris, Anastasios/O-2247-2016	Sichtermann, Thorsten/0000-0002-9115-9548; Mpotsaris, Anastasios/0000-0002-1275-8164				Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; Chueh JY, 2016, J NEUROINTERV SURG, V8, P197, DOI 10.1136/neurintsurg-2014-011491; Gounis MJ, 2013, STROKE, V44, pS7, DOI 10.1161/STROKEAHA.111.000692; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Gralla J, 2006, AM J NEURORADIOL, V27, P1357; Henkes H, 1999, BRIT J RADIOL, V72, P448, DOI 10.1259/bjr.72.857.10505007; Keulers A, 2019, J NEUROINTERV SURG, V11, P653, DOI 10.1136/neurintsurg-2018-014267; Kucinski T, 2003, NEURORADIOLOGY, V45, P11, DOI 10.1007/s00234-002-0881-0; Lenis G, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/9295029; Massari F, 2016, INTERV NEURORADIOL, V22, P325, DOI 10.1177/1591019916632369; Maus V, 2018, CLIN NEURORADIOL, V28, P327, DOI 10.1007/s00062-017-0566-z; Nikoubashman O, 2015, AM J NEURORADIOL, V36, P1162, DOI 10.3174/ajnr.A4240; Othman AE, 2016, J NEURORADIOLOGY, V43, P1, DOI 10.1016/j.neurad.2015.06.003; Robbie LA, 1997, THROMB HAEMOSTASIS, V77, P510; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Sorimachi T, 2005, J NEUROSURG, V102, P870, DOI 10.3171/jns.2005.102.5.0870; Sorimachi T, 2011, J NEUROINTERV SURG, V3, P43, DOI 10.1136/jnis.2010.003061; van der Born IMJ, 2012, AM J NEURORADIOL, V33, P353, DOI 10.3174/ajnr.A2944; Wiesmann M, 2017, J NEUROINTERV SURG, V9, P253, DOI 10.1136/neurintsurg-2016-012322	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210572	10.1371/journal.pone.0210572	http://dx.doi.org/10.1371/journal.pone.0210572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629721	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000110
J	Tanaka, K; Kawano, M; Iwasaki, T; Itonaga, I; Tsumura, H				Tanaka, Kazuhiro; Kawano, Masanori; Iwasaki, Tatsuya; Itonaga, Ichiro; Tsumura, Hiroshi			A meta-analysis of randomized controlled trials that compare standard doxorubicin with other first-line chemotherapies for advanced/metastatic soft tissue sarcomas	PLOS ONE			English	Article							PHASE-III TRIAL; EUROPEAN-ORGANIZATION; OPEN-LABEL; DOSE DOXORUBICIN; COMBINATION CHEMOTHERAPY; PLUS IFOSFAMIDE; SPANISH GROUP; DOUBLE-BLIND; ADRIAMYCIN; TRABECTEDIN	Objective The standard treatment for patients with advanced/metastatic soft tissue sarcomas (ASTS) is systemic chemotherapy with doxorubicin. A previous meta-analysis of 8 randomized controlled trials (RCTs) demonstrated the superiority of single-agent doxorubicin over doxorubicin-based combination chemotherapy for ASTS. However, meta-analyses of all RCTs that compare doxorubicin to other single-agent or combination regimens as first-line treatments for ASTS are lacking. We conducted a systematic review and meta-analysis to evaluate the efficacy and toxicity of current primary treatments for ASTS. Methods Eligible studies were RCTs of first-line chemotherapies for ASTS comparing doxorubicin alone to other single agents or to combination therapies (experimental arm). Data from studies reporting hazard ratios (HR) and 95% confidence intervals (CI) for overall survival (OS) and progression-free survival (PFS) were pooled. Other time-to-event endpoints were extracted from the studies based on Kaplan-Meier estimates, and pooled odds ratios (OR) and 95% CI were calculated. Results Twenty-seven eligible RCTs comprising 6156 patients were identified. Overall, the 1-year OS (OR 0.88, 95% CI 0.79-0.99, P = 0.03) was significantly improved in the experimental arm over the doxorubicin-only arm; however, there was no significant difference in 2-year OS (OR 0.87, 95% CI 0.73-1.03, P = 0.11) or OS (HR 0.97, 95% CI 0.91-1.03, P = 0.28) between the two groups. PFS and other time-to-event endpoints were not significantly different between the two treatment arms. While incidences of overall severe adverse events were not significantly different (OR 1.20, 95% CI 0.88-1.65, P = 0.26), severe nausea/vomiting was significantly more frequent in the experimental arm (OR 1.90, 95% CI 1.27-2.83, P = 0.002). Conclusion The efficacies of doxorubicin-only and experimental arm regimens were similar, although toxicities were more frequent in the experimental arms. Hence, doxorubicin monotherapy remains suitable as a standard first-line regimen for ASTS.	[Tanaka, Kazuhiro; Kawano, Masanori; Iwasaki, Tatsuya; Itonaga, Ichiro; Tsumura, Hiroshi] Oita Univ, Dept Orthopaed Surg, Fac Med, Yufu City, Oita, Japan	Oita University	Tanaka, K (corresponding author), Oita Univ, Dept Orthopaed Surg, Fac Med, Yufu City, Oita, Japan.	ktanaka@oita-u.ac.jp	Tanaka, Kazuhiro/Q-7387-2019	Tanaka, Kazuhiro/0000-0002-5138-8952	National Cancer Center Research and Development Fund [29-A-3]; Japan Agency for Medical Research and Development [JP17ck0106336]; Japan Society for the Promotion of Science [18 K09110]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the National Cancer Center Research and Development Fund (29-A-3), by Japan Agency for Medical Research and Development under Grant Number JP17ck0106336, and by Japan Society for the Promotion of Science, grant number 18 K09110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2017, CANC FACTS FIG 2017; Blay JY, 2014, EUR J CANCER, V50, P1137, DOI 10.1016/j.ejca.2014.01.012; BORDEN EC, 1990, CANCER, V66, P862, DOI 10.1002/1097-0142(19900901)66:5<862::AID-CNCR2820660509>3.0.CO;2-R; BORDEN EC, 1987, J CLIN ONCOL, V5, P840, DOI 10.1200/JCO.1987.5.6.840; Bramwell VH, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003293; BRAMWELL VHC, 1983, EUR J CANCER CLIN ON, V19, P1097, DOI 10.1016/0277-5379(83)90034-2; Bui-Nguyen B, 2015, EUR J CANCER, V51, P1312, DOI 10.1016/j.ejca.2015.03.023; Casali P G, 2018, Ann Oncol, V29, piv268, DOI 10.1093/annonc/mdy321; CHANG P, 1976, CLIN PHARMACOL THER, V20, P605; Chawla SP, 2015, JAMA ONCOL, V1, P1272, DOI 10.1001/jamaoncol.2015.3101; CRUZ AB, 1979, J SURG ONCOL, V11, P313, DOI 10.1002/jso.2930110406; Dangoor A, 2016, CLIN SARCOMA RES, V6, DOI 10.1186/s13569-016-0060-4; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Demetri GD, 2012, EUR J CANCER, V48, P547, DOI 10.1016/j.ejca.2011.12.008; EDMONSON JH, 1993, J CLIN ONCOL, V11, P1269, DOI 10.1200/JCO.1993.11.7.1269; Gelderblom H, 2014, EUR J CANCER, V50, P388, DOI 10.1016/j.ejca.2013.10.002; Japanese Orthopaedic Association Musculoskeletal Tumor Committee, 2015, SOFT TISS TUM REG JA; Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Karch A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1434-x; Lopez-Pousa A, 2016, CLIN TRANSL ONCOL, V18, P1213, DOI 10.1007/s12094-016-1574-1; Lorigan P, 2007, J CLIN ONCOL, V25, P3144, DOI 10.1200/JCO.2006.09.7717; Martin-Broto J, 2016, J CLIN ONCOL, V34, P2294, DOI 10.1200/JCO.2015.65.3329; Maurel J, 2009, J CLIN ONCOL, V27, P1893, DOI 10.1200/JCO.2008.19.2930; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MOURIDSEN HT, 1987, EUR J CANCER CLIN ON, V23, P1477, DOI 10.1016/0277-5379(87)90089-7; MUSS HB, 1985, CANCER, V55, P1648, DOI 10.1002/1097-0142(19850415)55:8<1648::AID-CNCR2820550806>3.0.CO;2-7; Nielsen OS, 1998, BRIT J CANCER, V78, P1634, DOI 10.1038/bjc.1998.735; OMURA GA, 1983, CANCER, V52, P626, DOI 10.1002/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E; SANTORO A, 1995, J CLIN ONCOL, V13, P1537, DOI 10.1200/JCO.1995.13.7.1537; SAVLOV ED, 1981, CANCER TREAT REP, V65, P21; SCHOENFELD DA, 1982, CANCER, V50, P2757, DOI 10.1002/1097-0142(19821215)50:12<2757::AID-CNCR2820501211>3.0.CO;2-J; Schoffski P, 2016, LANCET, V387, P1629, DOI 10.1016/S0140-6736(15)01283-0; Seddon B, 2017, LANCET ONCOL, V18, P1397, DOI 10.1016/S1470-2045(17)30622-8; Tap WD, 2017, LANCET ONCOL, V18, P1089, DOI 10.1016/S1470-2045(17)30381-9; Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Verweij J, 2000, J CLIN ONCOL, V18, P2081, DOI 10.1200/JCO.2000.18.10.2081; Zer A, 2018, CANCER TREAT REV, V63, P71, DOI 10.1016/j.ctrv.2017.12.003; Zer A, 2016, J CLIN ONCOL, V34, P1469, DOI 10.1200/JCO.2015.64.3437	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210671	10.1371/journal.pone.0210671	http://dx.doi.org/10.1371/journal.pone.0210671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629708	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000123
J	Amei, A; Zhou, SL				Amei, Amei; Zhou, Shilei			Inferring the distribution of selective effects from a time inhomogeneous model	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; AMINO-ACID REPLACEMENTS; RANDOM-FIELD MODEL; NUCLEOTIDE POLYMORPHISM; DROSOPHILA-MELANOGASTER; DIRECTIONAL SELECTION; POPULATION-GENETICS; MOLECULAR EVOLUTION; POSITIVE SELECTION; DIVERGENCE	We have developed a Poisson random field model for estimating the distribution of selective effects of newly arisen nonsynonymous mutations that could be observed as polymorphism or divergence in samples of two related species under the assumption that the two species populations are not at mutation-selection-drift equilibrium. The model is applied to 91 Drosophila genes by comparing levels of polymorphism in an African population of D. melanogaster with divergence to a reference strain of D. simulans. Based on the difference of gene expression level between testes and ovaries, the 91 genes were classified as 33 male-biased, 28 female-biased, and 30 sex-unbiased genes. Under a Bayesian framework, Markov chain Monte Carlo simulations are implemented to the model in which the distribution of selective effects is assumed to be Gaussian with a mean that may differ from one gene to the other to sample key parameters. Based on our estimates, the majority of newly-arisen nonsynonymous mutations that could contribute to polymorphism or divergence in Drosophila species are mildly deleterious with a mean scaled selection coefficient of -2.81, while almost 86% of the fixed differences between species are driven by positive selection. There are only 16.6% of the nonsynonymous mutations observed in sex-unbiased genes that are under positive selection in comparison to 30% of male-biased and 46% of female-biased genes that are beneficial. We also estimated that D. melanogaster and D. simulans may have diverged 1.72 million years ago.	[Amei, Amei] Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA; [Zhou, Shilei] 54 Crescent Ave,Apt G, Dorchester, MA USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Amei, A (corresponding author), Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA.	amei.amei@unlv.edu						Abel HJ, 2009, THESIS, DOI [10.1073/pnas.1833064100, DOI 10.1073/PNAS.1833064100]; Akashi H, 1999, GENETICS, V151, P221; Amei A, 2014, G3-GENES GENOM GENET, V4, P2425, DOI 10.1534/g3.114.014969; Amei A, 2014, GENETICS, V196, P225, DOI 10.1534/genetics.113.157776; Amei A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034413; Amei A, 2010, ANN APPL PROBAB, V20, P1663, DOI 10.1214/09-AAP668; Bai Y., 2009, ADAPTIVE DIRECTIONAL; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2001, GENETICS, V159, P1779; CACCONE A, 1988, GENETICS, V118, P671; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clark AG, 2003, CURR OPIN GENET DEV, V13, P296, DOI 10.1016/S0959-437X(03)00056-X; Dongarra JJ, 1995, COMMUNICATIONS ACM; Durrett R., 2002, PROB APPL S; Eyre-Walker A, 2002, GENETICS, V162, P2017; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2001, GENETICS, V158, P1227; Gelman A., 1996, INFERENCE MONITORING; Glinka S, 2003, GENETICS, V165, P1269; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hartl :D. L, 2000, PRIMER POPULATION GE; HARTL DL, 1994, GENETICS, V138, P227; HUDSON RR, 1987, GENETICS, V116, P153; KEIGHTLEY PD, 1994, GENETICS, V138, P1315; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Lemeunier F, 1986, GENETICS BIOL DROSOP; Li W. H, 1997, MOL EVOLUTION; Loewe L, 2006, GENETICS, V172, P1079, DOI 10.1534/genetics.105.047217; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Piganeau G, 2003, P NATL ACAD SCI USA, V100, P10335, DOI 10.1073/pnas.1833064100; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roberts GO, 2007, J APPL PROBAB, V44, P458, DOI 10.1239/jap/1183667414; SAWYER SA, 1992, GENETICS, V132, P1161; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; SAWYER SA, 1987, P NATL ACAD SCI USA, V84, P6225, DOI 10.1073/pnas.84.17.6225; Sawyer SA, 1994, NONNEUTRAL EVOLUTION; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Wakeley J, 2003, GENETICS, V163, P411; Williamson S, 2004, GENETICS, V168, P463, DOI 10.1534/genetics.103.024745; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Zhu L, 2005, GENETICS, V170, P1411, DOI 10.1534/genetics.104.035097	55	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0194709	10.1371/journal.pone.0194709	http://dx.doi.org/10.1371/journal.pone.0194709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657757	Green Published, gold			2022-12-27	WOS:000456017000001
J	Jones, MG; Rice, SM; Cotton, SM				Jones, Melanie G.; Rice, Simon M.; Cotton, Susan M.			Incorporating animal-assisted therapy in mental health treatments for adolescents: A systematic review of canine assisted psychotherapy	PLOS ONE			English	Review							CHILDREN; DOGS; INTERVENTIONS; DEPRESSION; DISORDERS; EFFICACY; YOUTH; ACCEPTABILITY; SUPPORT; UPDATE	Introduction As interest in Animal-Assisted Interventions (AAI) grows, there is increasing need to differentiate informal activities from formal and professionally directed therapies, including mental health focussed Canine-Assisted Psychotherapy (CAP). There have been no reviews focusing exclusively on CAP and the distinct developmental period of adolescence. The aims of this study were to identify the characteristics of CAP interventions, their impacts and their acceptability, tolerability and feasibility for adolescents with mental health disorders. Method A systematic review identified studies incorporating canines into mental health treatments for adolescents aged 10-19 years. Studies reporting qualitative or quantitative psychological or psychosocial outcomes were included. Results Seven studies were scrutinised. Intervention characteristics varied, including a range of formats, settings, locations, doses, and facilitators. Information on the role of the canines in sessions was sparse. CAP had a positive impact on primary diagnoses and symptomatology, conferring additional benefits to standard treatments for internalising disorders, post-traumatic stress disorder, and equivalent effects for anxiety, anger and externalising disorders. CAP was associated with positive impacts on secondary factors including increased engagement and socialisation behaviours, and reductions in disruptive behaviours within treatment sessions. Global functioning also improved. There was insufficient evidence that CAP improved factors associated with self-esteem, subjective wellbeing, or coping. Good attendance and retention rates indicated high levels of acceptability. Moderate to high tolerability was also indicated. Feasibility may be limited by additional training and logistical requirements. Recommendations We recommend the development of theoretically informed, standardised (manualised) intervention protocols that may subsequently form the basis of efficacy and effectiveness testing. Such protocols should clearly describe canine-participant-facilitator interactions via a formalised nomenclature; spontaneous (animal-led), adjunctive (facilitator-led), and experiential (participant-led). Conclusions There is emerging evidence to suggest that CAP improves the efficacy of mental health treatments in self-selected adolescent populations via reductions in primary symptomatology, and via secondary factors that improve therapeutic processes and quality, such as engagement and retention.	[Jones, Melanie G.; Rice, Simon M.; Cotton, Susan M.] Orygen Natl Ctr Excellence Youth Mental Hlth, Parkville, Vic, Australia; [Jones, Melanie G.; Rice, Simon M.; Cotton, Susan M.] Univ Melbourne, Parkville, Vic, Australia; [Jones, Melanie G.] Lead Way Inst, Boronia, Vic, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Jones, MG (corresponding author), Orygen Natl Ctr Excellence Youth Mental Hlth, Parkville, Vic, Australia.; Jones, MG (corresponding author), Univ Melbourne, Parkville, Vic, Australia.; Jones, MG (corresponding author), Lead Way Inst, Boronia, Vic, Australia.	melanie.jones@orygen.org.au	Rice, Simon/J-5656-2014	Rice, Simon/0000-0003-4045-8553; Cotton, Sue/0000-0002-9386-8348; Jones, Melanie/0000-0001-9192-9605				Anestis MD, 2014, J CLIN PSYCHOL, V70, P1115, DOI 10.1002/jclp.22113; Australian Government: National Health Medical Research Council (NHMRC), 2009, NHMRC ADD LEV EV GRA; Bauer MS, 1998, J CLIN PSYCHIAT, V59, P449, DOI 10.4088/JCP.v59n0902; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; Becker JL, 2017, ANTHROZOOS, V30, P307, DOI 10.1080/08927936.2017.1311055; Beetz A, 2012, FRONT PSYCHOL, P3; Bert F, 2016, EUR J INTEGR MED, V8, P695, DOI 10.1016/j.eujim.2016.05.005; Brelsford VL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070669; Brooks S, 2011, EQ SPEC MENT HLTH LE; Calvo P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00631; Chandler CK, 2012, ANIMAL ASSISTED THERAPY IN COUNSELING, 2ND EDITION, P1; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.41596.6f; Davis TN, 2015, EDUC TRAIN AUTISM DE, V50, P316; Delta Society, 1996, STAND PRACT AN ASS A; Dietz TJ, 2012, J CHILD SEX ABUS, V21, P665, DOI 10.1080/10538712.2012.726700; [EAGALA Association EAGaL], 2012, FUND EAG MOD PRACT; Fine, 2015, HDB ANIMAL ASSISTED, P157, DOI DOI 10.3390/IJERPH16203997; Fine A., 2015, HDB ANIMAL ASSISTED; Fine A. H., 2015, HDB ANIMAL ASSISTED, V4th, P21, DOI DOI 10.1016/B978-0-12-801292-5.00003-1; Fine AH, HDB ANIMAL ASSISTED; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; FOLSE EB, 1994, ANTHROZOOS, V7, P188, DOI 10.2752/089279394787001880; Garcia JA, 2002, J CONSULT CLIN PSYCH, V70, P439, DOI 10.1037//0022-006X.70.2.439; Gee NR, 2012, ANTHROZOOS, V25, P187, DOI 10.2752/175303712X13316289505387; Gee NR, 2010, ANTHROZOOS, V23, P173, DOI 10.2752/175303710X12682332910051; Germain SM, 2018, ANTHROZOOS, V31, P141, DOI 10.1080/08927936.2018.1434044; Glenk LM, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7020007; Greenhalgh T, 1999, J ROY COLL PHYS LOND, V33, P36; Gueguen N, 2008, ANTHROZOOS, V21, P339, DOI 10.2752/175303708X371564; Hamama L, 2011, CHILD YOUTH SERV REV, V33, P1975, DOI 10.1016/j.childyouth.2011.05.021; Hanselman JL., 2001, J CHILD ADOLESC GROU, V11, P159, DOI [10.1023/A:1014802324267, DOI 10.1023/A:1014802324267]; Hart L.A., 2015, HDB ANIMAL ASSISTED, V4th ed., P53; Hartwig EK, 2017, J CREAT MENT HEALTH, V12, P468, DOI 10.1080/15401383.2017.1283281; HAVIGHURST RJ, 1956, SCHOOL REV, V64, P215, DOI 10.1086/442319; Hoagwood KE, 2017, APPL DEV SCI, V21, P1, DOI 10.1080/10888691.2015.1134267; Hunt MG, 2014, ANTHROZOOS, V27, P457, DOI 10.2752/175303714X14023922797959; IAHAIO, 2014, IAHAIO WHIT PAP; Jones MG, 2018, AUSTRALAS PSYCHIATRY, V26, P196, DOI 10.1177/1039856217749056; Julius H, INTEGRATIVE VIEW HUM; Julius H, 2013, ATTACHMENT PETS INTE, P35; Kamioka H, 2014, COMPLEMENT THER MED, V22, P371, DOI 10.1016/j.ctim.2013.12.016; Kendall E, 2015, EUR J PSYCHOTHER COU, V17, P57, DOI 10.1080/13642537.2014.996169; Kirby M., 2016, PRINCIPLES THEORY PR; Kohanov L., 2018, ABOUT EPONAQUEST; La Greca AM, 2005, J CLIN CHILD ADOLESC, V34, P49, DOI 10.1207/s15374424jccp3401_5; Lac V., 2017, HUMAN EQUINE RELATIO; Lange AM, 2007, J CREAT MENT HEALTH, V2, P17, DOI 10.1300/J456v02n02_03; Lawrence D., 2015, MENTAL HLTH CHILDREN; Lee PT, 2016, HEALTH SOC CARE COMM, V24, P225, DOI 10.1111/hsc.12201; Lentini JA, 2015, J CREAT MENT HEALTH, V10, P278, DOI 10.1080/15401383.2015.1023916; Lubbe C, 2013, S AFR J PSYCHOL, V43, P116, DOI 10.1177/0081246312474405; Maharaj N, 2016, J LOSS TRAUMA, V21, P335, DOI 10.1080/15325024.2015.1084857; Marr CA, 2000, ANTHROZOOS, V13, P43, DOI 10.2752/089279300786999950; Maujean A, 2015, ANTHROZOOS, V28, P23, DOI 10.2752/089279315X14129350721812; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Mission-Australia, 2017, YOUTH MENT HLTH REP; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Molaeb H, 2010, ADOLESCENT COMMUNITY; Nathans-Barel I, 2005, PSYCHOTHER PSYCHOSOM, V74, P31, DOI 10.1159/000082024; NHMRC, 2000, HDB SER PREP CLIN PR; NIH NHLaBI, 2018, NIH TOOL ASS QUAL PR; NIH NHLaBI, 2018, NIH TOOL ASS QUAL CO; Nimer J, 2007, ANTHROZOOS, V20, P225, DOI 10.2752/089279307X224773; Norton C., 2008, UNDERSTANDING IMPACT; Nurenberg JR, 2015, PSYCHIAT SERV, V66, P80, DOI 10.1176/appi.ps.201300524; O'Brien A, 2009, SOC PSYCH PSYCH EPID, V44, P558, DOI 10.1007/s00127-008-0476-0; O'Haire ME, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01121; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; Olfson M, 2009, PSYCHIAT SERV, V60, P898, DOI 10.1176/appi.ps.60.7.898; Parish-Plass N., 2014, CHAYOT VCHEVRA, V50, P71; Parish-Plass N., 2013, ANIMAL ASSISTED PSYC; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; Pearson A, 2005, INT J EVID-BASED HEA, V3, P207, DOI 10.1111/j.1479-6988.2005.00026.x; Pet-Partners, 2018, PET PARTN TERM 2018; Rabbitt SM, 2014, ANTHROZOOS, V27, P335, DOI 10.2752/175303714X13903827487881; Reichert E., 1994, FAMILY THERAPY, V2, P55; Reichert E., 1998, CHILD ADOLESCENT SOC, V15; Schneider MS, 2006, ANTHROZOOS, V19, P128, DOI 10.2752/089279306785593784; Schuck SEB, 2015, J ATTEN DISORD, V19, P125, DOI 10.1177/1087054713502080; Selby A, 2013, HEALTH PSYCHOL, V32, P418, DOI 10.1037/a0029188; Shambo L, 2013, MANUAL HEAL MODEL EQ; Signal T, 2017, APPL DEV SCI, V21, P81, DOI 10.1080/10888691.2016.1165098; Smith-Osborne A, 2010, CHILD ADOLESC SOC WO, V27, P291, DOI 10.1007/s10560-010-0201-1; Souter MA, 2007, ANTHROZOOS, V20, P167, DOI 10.2752/175303707X207954; Stefanini MC, 2015, COMPLEMENT THER CLIN, V21, P42, DOI 10.1016/j.ctcp.2015.01.001; Stefanini MC, 2016, EUR J INTEGR MED, V8, P81, DOI 10.1016/j.eujim.2016.03.001; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stern Cindy, 2013, Animals (Basel), V3, P127, DOI 10.3390/ani3010127; Szamoskozi, 2012, TRANSYLVANIAN J PSYH, V13, P1, DOI [DOI 10.2752/089279307X224773, 10.2752/089279307X224773]; VanFleet R., 2010, BRIT J PLAY THERAPY, V6, P4; Wesley MC, 2009, ANTHROZOOS, V22, P137, DOI 10.2752/175303709X434167; White JH, 2015, INTEGR CANCER THER, V14, P460, DOI 10.1177/1534735415580678; Wilson CC, 2003, AM BEHAV SCI, V47, P16, DOI 10.1177/0002764203255208; World Health Organization, 2014, REC AD; Zhou XY, 2015, WORLD PSYCHIATRY, V14, P207, DOI 10.1002/wps.20217; Zilcha-Mano S, 2017, CLIN CHILD PSYCHOL P, V22, P34, DOI 10.1177/1359104516671385; Zilcha-Mano S, 2011, ATTACH HUM DEV, V13, P541, DOI 10.1080/14616734.2011.608987	97	48	48	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210761	10.1371/journal.pone.0210761	http://dx.doi.org/10.1371/journal.pone.0210761			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653587	Green Published, gold			2022-12-27	WOS:000456015500068
J	Mrkvicova, A; Chmelarova, M; Peterova, E; Havelek, R; Baranova, I; Kazimirova, P; Rudolf, E; Rezacova, M				Mrkvicova, Alena; Chmelarova, Marcela; Peterova, Eva; Havelek, Radim; Baranova, Ivana; Kazimirova, Petra; Rudolf, Emil; Rezacova, Martina			The effect of sodium butyrate and cisplatin on expression of EMT markers	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITORS; OVARIAN-CARCINOMA CELLS; E-CADHERIN; MOLECULAR-MECHANISMS; GENE-EXPRESSION; VALPROIC ACID; UP-REGULATION; CANCER; METHYLATION	Histone modifications play a key role in the epigenetic regulation of gene transcription in cancer cells. Histone acetylations are regulated by two classes of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). HDACs are increased in ovarian carcinomas and they are involved in carcinogenesis and resistance to chemotherapeutic agents. In our study we investigated anticancer effect of HDAC inhibitor sodium butyrate (NaBu) on cisplatin-sensitive and cisplatin-resistant ovarian cell lines A2780 and A2780cis. A2780 and A2780cis were treated with NaBu alone or in combination with cisplatin (CP). NaBu inhibited the growth of both cell lines and enhanced cytotoxic effect of CP. Exposure to NaBu for 24 h induced cell cycle arrest. The expressions of EMT-related genes and proteins were further investigated by qPCR and western blot analysis. Loss of E-cadherin has been shown to be crucial in ovarian cancer development. We found that NaBu dramatically induce expression of E-cadherin gene (CDH1) and protein levels in A2780 and A2780cis. We investigated correlation between transcription and methylation of CDH1gene. Methylation level analysis in 32 CpG sites in CDH1 gene (promoter/exon1 regions) was performed using bisulfite NGS (Next Generation Sequencing). We found that cisplatin-resistant cell line A2780cis cells differ from their cisplatin-sensitive counterparts in the CDH1 methylation. Methylation in A2780cis cells is elevated compared to A2780. However, NaBu-induced expression of CDH1 was not accompanied by CDH1 demethylation. NaBu treatment induced changes in expression of EMT-related genes and proteins. Interestingly E-cadherin zinc finger transcriptional repressor SNAIL1 was upregulated in both cell lines. Mesenchymal marker vimentin was downregulated. Matrix metalloproteases (MMPs) are necessary for pericellular proteolysis and facilitate migration and invasion of tumour cells. NaBu induced mRNA expression of MMPs, mild changes in activities of gelatinases MMP2 and MMP9 were detected. Our data demonstrate that NaBu sensitizes cisplatin-resistant ovarian cancer cells, re-established E-cadherin expression, but it was not able to reverse the EMT phenotype completely.	[Mrkvicova, Alena; Peterova, Eva; Havelek, Radim; Kazimirova, Petra; Rezacova, Martina] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic; [Mrkvicova, Alena; Chmelarova, Marcela; Baranova, Ivana] Charles Univ Prague, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Mrkvicova, Alena; Chmelarova, Marcela; Peterova, Eva; Baranova, Ivana] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Peterova, Eva] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Gastroenterol 2, Hradec Kralove, Czech Republic; [Rudolf, Emil] Charles Univ Prague, Fac Med Hradec Kralove, Dept Biol, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove	Mrkvicova, A (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biochem, Hradec Kralove, Czech Republic.; Mrkvicova, A (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic.; Mrkvicova, A (corresponding author), Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic.	mrkvicovaa@lfhk.cuni.cz	Rudolf, Emil/B-5956-2017; Baranová, Ivana/S-5881-2016; Rezacova, Martina/A-2046-2009; Baranová, Ivana/AAH-4713-2020; Havelek, Radim/S-5723-2016; Peterova, Eva/S-5665-2016; Mrkvicova, Alena/A-4414-2017	Rudolf, Emil/0000-0002-9526-3174; Baranová, Ivana/0000-0001-8273-2595; Rezacova, Martina/0000-0001-5370-2290; Baranová, Ivana/0000-0001-8273-2595; Havelek, Radim/0000-0003-0528-1334; Peterova, Eva/0000-0001-7866-9722; Mrkvicova, Alena/0000-0001-7802-5564; /0000-0002-7891-9979	Charles University, Czech Republic [Progres/UK Q40/01]; Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO [00179906]	Charles University, Czech Republic(Czech Republic Government); Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO	This work was supported by Progres/UK Q40/01 Charles University, Czech Republic, https://www.cuni.cz/UK-7368.html, and by Ministry of Health, Czech Republic - conceptual development of research organization MH CZ-DRO 00179906 (University Hospital Hradec Kralove), https://www.mzcr.cz/obsah/institucionalni-podpora_978_3.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Boettcher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011002; Brozovic A, 2015, MOL ONCOL, V9, P1678, DOI 10.1016/j.molonc.2015.04.015; Chen CA, 2015, AM J TRANSL RES, V7, P139; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Eckstein N, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-91; Feng JT, 2015, CELL ADHES MIGR, V9, P495, DOI 10.1080/19336918.2015.1112486; Ganatra DA, 2015, EYE, V29, P828, DOI 10.1038/eye.2015.29; Gilardini Montani MS, 2017, CELL ONCOL, V40, P167, DOI 10.1007/s13402-017-0314-z; Giudice FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058672; Issa ME, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0319-5; Januchowski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365867; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jiang GM, 2013, BBA-MOL CELL RES, V1833, P663, DOI 10.1016/j.bbamcr.2012.12.002; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim MG, 2012, J GYNECOL ONCOL, V23, P182, DOI 10.3802/jgo.2012.23.3.182; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Koprinarova M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-49; Kwiecinska P, 2014, TOXICOL LETT, V224, P225, DOI 10.1016/j.toxlet.2013.10.035; Labrie M, 2013, CELL MOL LIFE SCI, V70, P3109, DOI 10.1007/s00018-012-1214-z; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lapinska K, 2016, ANTICANCER RES, V36, P5731, DOI 10.21873/anticanres.11156; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Lu HG, 2014, MOL MED REP, V10, P2595, DOI 10.3892/mmr.2014.2517; Muenyi CS, 2014, TOXICOL SCI, V139, P74, DOI 10.1093/toxsci/kfu029; Noguchi S, 2015, LUNG, V193, P691, DOI 10.1007/s00408-015-9776-9; Nural-Guvener HF, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-10; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Reid BM, 2017, CANCER BIOL MED, V14, P9, DOI 10.20892/j.issn.2095-3941.2016.0084; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sato T, 2006, INT J ONCOL, V28, P1233; Takai N, 2004, CANCER-AM CANCER SOC, V101, P2760, DOI 10.1002/cncr.20709; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Wang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.242; Wilkins DE, 1997, CANCER CHEMOTH PHARM, V40, P159, DOI 10.1007/s002800050641; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450	45	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210889	10.1371/journal.pone.0210889	http://dx.doi.org/10.1371/journal.pone.0210889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653577	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500085
J	Noles, NS; Keil, FC				Noles, Nicholaus S.; Keil, Frank C.			Exploring the first possessor bias in children	PLOS ONE			English	Article							INFER OWNERSHIP; PROPERTY; PRESCHOOL; ADULTS; RIGHTS; MINE	Even very young children are adept at linking property to owners (Gelman, Manczak, & Noles, 2012). However, some studies report that children systematically conserve property with the first possessors (Blake & Harris, 2009; Friedman & Neary, 2008). The present study seeks to integrate these two findings by testing for the presence of a first possessor bias in older children (ages 7-10) using a broader array of property transfers, and by investigating how manipulations of context-from third-person to first-person-yield ownership attributions that are more or less biased. Seven- and 8-year-olds, but not older children, exhibited a first possessor bias when property transfers were presented in a third-person context. This finding suggests that the first possessor bias persists longer in childhood than previously suspected. However, the bias was greatly attenuated or absent when property transfers were presented in a first-person context, rather than a third-person context.	[Noles, Nicholaus S.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Keil, Frank C.] Yale Univ, Dept Psychol, New Haven, CT USA	University of Louisville; Yale University	Noles, NS (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	n.noles@louisville.edu		Noles, Nicholaus/0000-0002-0419-192X				Blake PR, 2009, COGNITIVE DEV, V24, P133, DOI 10.1016/j.cogdev.2009.01.002; Constable MD, 2011, COGNITION, V119, P430, DOI 10.1016/j.cognition.2011.02.007; Fasig LG, 2000, SOC DEV, V9, P370, DOI 10.1111/1467-9507.00131; Friedman O, 2008, PSYCHON B REV, V15, P290, DOI 10.3758/PBR.15.2.290; Friedman O, 2008, COGNITION, V107, P829, DOI 10.1016/j.cognition.2007.12.002; Friedman O, 2011, NEW DIR CHILD ADOLES, V132, P79, DOI 10.1002/cd.298; Gelman SA, 2016, CHILD DEV, V87, P239, DOI 10.1111/cdev.12453; Gelman SA, 2015, J COGN DEV, V16, P97, DOI 10.1080/15248372.2013.815623; Gelman SA, 2014, TOP COGN SCI, V6, P599, DOI 10.1111/tops.12106; Gelman SA, 2012, CHILD DEV, V83, P1732, DOI 10.1111/j.1467-8624.2012.01806.x; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; Hay DF, 2006, BRIT J DEV PSYCHOL, V24, P39, DOI 10.1348/026151005X68880; HAY DF, 1982, CHILD DEV, V53, P105, DOI 10.1111/j.1467-8624.1982.tb01297.x; HOOK J, 1993, LAW HUMAN BEHAV, V17, P135, DOI 10.1007/BF01044542; Jones E. E., 1971, ACTOR OBSERVER DIVER; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Kanngiesser P, 2015, CHILD DEV, V86, P1282, DOI 10.1111/cdev.12365; Kanngiesser P, 2014, COGNITIVE DEV, V29, P30, DOI 10.1016/j.cogdev.2013.09.003; Kanngiesser P, 2010, PSYCHOL SCI, V21, P1236, DOI 10.1177/0956797610380701; Kim S, 2009, COGNITIVE DEV, V24, P322, DOI 10.1016/j.cogdev.2009.03.004; LAMB ME, 1978, CHILD DEV, V49, P51, DOI 10.2307/1128592; LEVINE LE, 1983, DEV PSYCHOL, V19, P544, DOI 10.1037/0012-1649.19.4.544; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Neary KR, 2009, DEV PSYCHOL, V45, P873, DOI 10.1037/a0014088; NELSON K, 1976, COGNITION, V4, P13, DOI 10.1016/0010-0277(76)90008-1; Noles NS, 2012, J COGN CULT, V12, P265, DOI 10.1163/15685373-12342076; Noles NS, 2011, NEW DIR CHILD ADOLES, V132, P91, DOI 10.1002/cd.299; Rochat P, 2014, COGNITION, V132, P471, DOI 10.1016/j.cognition.2014.04.014; RODGON MM, 1976, CHILD DEV, V47, P1219; Ross HS, 1996, DEV PSYCHOL, V32, P90; Rossano F, 2011, COGNITION, V121, P219, DOI 10.1016/j.cognition.2011.06.007; Scorolli C, 2018, PSYCHOL RES-PSYCH FO, V82, P929, DOI 10.1007/s00426-017-0871-9; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209422	10.1371/journal.pone.0209422	http://dx.doi.org/10.1371/journal.pone.0209422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653536	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500011
J	Price, J; Pettifor, A; Selin, A; Wagner, RG; MacPhail, C; Agyei, Y; Gomez-Olive, FX; Kahn, K				Price, Jessica; Pettifor, Audrey; Selin, Amanda; Wagner, Ryan G.; MacPhail, Catherine; Agyei, Yaw; Gomez-Olive, F. Xavier; Kahn, Kathleen			The association between perceived household educational support and HIV risk in young women in a rural South African community (HPTN 068): A cross sectional study	PLOS ONE			English	Article							CONDITIONAL CASH TRANSFER; PARENTAL INVOLVEMENT; ACADEMIC-ACHIEVEMENT; TRANSFER PROGRAM; SEXUAL-BEHAVIOR; ADOLESCENTS; HEALTH; SURVEILLANCE; PERCEPTIONS; PREVALENCE	Objective To characterise perceived household support for female education and the associations between educational support and HIV prevalence, HSV-2 prevalence and sexual risk behaviours. Methods This cross-sectional study used baseline survey data from the Swa Koteka HPTN 068 trial undertaken in Mpumalanga, South Africa. The study included 2533 young women aged 13-20, in grades 8-11 at baseline. HIV and HSV-2 status were determined at baseline. Information about patterns of sexual behaviour and household support for education was collected during the baseline survey. Linear regression and binary logistic regression were used to determine associations between household support for education and both biological and behavioural outcomes. Results High levels of educational support were reported across all measures. HIV prevalence was 3.2% and HSV-2 prevalence was 4.7%, both increasing significantly with age. Over a quarter (26.6%) of young women reported vaginal sex, with 60% reporting condom use at last sex. The median age of sexual debut was 16 years. Household educational support was not significantly associated with HIV or HSV-2; however, the odds of having had vaginal sex were significantly lower in those who reported greater homework supervision (OR 0.82, 95% CI: 0.72-0.94), those who engaged in regular discussion of school marks with a caregiver (OR 0.82, 95% CI: 0.71-0.95) and when caregivers had greater educational goals for the young woman (OR 0.82, 95% CI: 0.71-0.96). In contrast, greater caregiver disappointment at dropout was significantly associated with reported vaginal sex (OR 1.29, 95% CI: 1.14-1.46). Conclusion Young women in rural South Africa report experiencing high levels of household educational support. This study suggests that greater household educational support is associated with lower odds of having vaginal sex and engaging in risky sexual behaviour, though not with HIV or HSV-2 prevalence.	[Price, Jessica] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Price, Jessica] Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Pettifor, Audrey; Wagner, Ryan G.; MacPhail, Catherine; Gomez-Olive, F. Xavier; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pettifor, Audrey; Selin, Amanda] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Pettifor, Audrey; MacPhail, Catherine] Univ Witwatersrand, Sch Clin Med, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [Wagner, Ryan G.; Kahn, Kathleen] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [MacPhail, Catherine] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW, Australia; [Agyei, Yaw] Johns Hopkins Univ, Sch Med, Dept Pathol, HPTN Lab Ctr, Baltimore, MD 21205 USA	University of Cape Town; University of Oxford; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; Umea University; University of Wollongong; Johns Hopkins University	Price, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa.; Price, J (corresponding author), Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	jessica.price@gtc.ox.ac.uk	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Wagner, Ryan G/AFK-7323-2022; MacPhail, Catherine/N-4234-2014	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Wagner, Ryan G/0000-0003-2741-3676; Kahn, Kathleen/0000-0003-3339-3931; Price, Jessica/0000-0002-4020-6850; Pettifor, Audrey/0000-0002-3387-0817; MacPhail, Catherine/0000-0002-0614-0157	HIV Prevention Trials Network (HPTN), through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; Division of Intramural Research NIAID; Wellcome Trust [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; University of the Witwatersrand; Medical Research Council, South Africa;  [5R01MH087118-02];  [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, UM1AI068617, UM1AI069423, UM1AI068619, UM1AI068613] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN), through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH); Division of Intramural Research NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); University of the Witwatersrand; Medical Research Council, South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the HPTN 068 study was provided by the HIV Prevention Trials Network (HPTN), funded through the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The study was also funded under Award Number 5R01MH087118-02 and R24 HD050924 to the Carolina Population Center. Additional funding was provided by the Division of Intramural Research NIAID. HPTN 068 is nested within the Agincourt Health and socio-Demographic Surveillance System, with funding from the Wellcome Trust (058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z), University of the Witwatersrand, and Medical Research Council, South Africa.	[Anonymous], 2012 NAT ANT SENT HI; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9; Brook DW, 2006, AIDS EDUC PREV, V18, P259, DOI 10.1521/aeap.2006.18.3.259; Carranza FD, 2009, ADOLESCENCE, V44, P313; Desforges C., 2003, THE IMPACT OF PARENT; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Duflo E, 2006, ED HIV AIDS PREVENTI; Fan X, 2001, ED PSYCHOL REV; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Gonzalez-DeHass AR, 2005, EDUC PSYCHOL REV, V17, P95, DOI 10.1007/s10648-005-3949-7; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hoover-Dempsey KV, 2001, EDUC PSYCHOL-US, V36, P195, DOI 10.1207/S15326985EP3603_5; Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1; Jeynes WH, 2007, URBAN EDUC, V42, P82, DOI 10.1177/0042085906293818; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Li XM, 2000, J ADOLESCENT HEALTH, V27, P43, DOI 10.1016/S1054-139X(99)00077-4; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Peltzer K, 2010, ACTA PAEDIATR, V99, P1242, DOI 10.1111/j.1651-2227.2010.01874.x; Peng SS, J ED RES; Perrino T, 2000, Clin Child Fam Psychol Rev, V3, P81, DOI 10.1023/A:1009571518900; Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/S2214-109X(16)30253-4, 10.1016/s2214-109x(16)30253-4]; Pettifor A, 2016, AIDS BEHAV, V20, P1863, DOI 10.1007/s10461-015-1270-0; Ryan J., 2015, OPEN FAMILY STUDIES, V7, P7, DOI [10.2174/1874922401507010012, DOI 10.2174/1874922401507010012]; Shisana O, 2012, S AFRICAN NATL HIV P; Silverberg S, 1991, PARENTING MONITORING; Singh P, 2006, S AFRICAN J ED, P301; SMALL SA, 1993, J MARRIAGE FAM, V55, P941, DOI 10.2307/352774; Spera C, 2006, J EARLY ADOLESCENCE, V26, P456, DOI 10.1177/0272431606291940; Stephenson R, 2014, J HEALTH POPUL NUTR, V32, P161; SuiChu EH, 1996, SOCIOL EDUC, V69, P126, DOI 10.2307/2112802; [UNICEF UNICEF], 2018, PROT CAR SUPP CHILDR; van Wyk N, 2007, S AFRICAN J ED, P27; Waruru Anthony K, 2005, BMC Med Inform Decis Mak, V5, P24, DOI 10.1186/1472-6947-5-24; WHO, EST GLOB PREV INC HE; Wight D, 2006, J ADOLESCENCE, V29, P473, DOI 10.1016/j.adolescence.2005.08.007	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210632	10.1371/journal.pone.0210632	http://dx.doi.org/10.1371/journal.pone.0210632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653540	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500057
J	Mukumbang, FC; van Wyk, B; Van Belle, S; Marchal, B				Mukumbang, Ferdinand C.; van Wyk, Brian; Van Belle, Sara; Marchal, Bruno			Unravelling how and why the Antiretroviral Adherence Club Intervention works (or not) in a public health facility: A realist explanatory theory-building case study	PLOS ONE			English	Article							THERAPY PATIENTS; CAPE-TOWN; IMPLEMENTATION; CONTEXT; CARE	Background Although empirical evidence suggests that the adherence club model is more effective in retaining people living with HIV in antiretroviral treatment care and sustaining medication adherence compared to standard clinic care, it is poorly understood exactly how and why this works. In this paper, we examined and made explicit how, why and for whom the adherence club model works at a public health facility in South Africa. Methods We applied an explanatory theory-building case study approach to examine the validity of an initial programme theory developed a priori. We collected data using a retrospective cohort quantitative design to describe the suppressive adherence and retention in care behaviours of patients on ART using Kaplan-Meier methods. In conjunction, we employed an explanatory qualitative study design using non-participant observations and realist interviews to gain insights into the important mechanisms activated by the adherence club intervention and the relevant contextual conditions that trigger the different mechanisms to cause the observed behaviours. We applied the retroduction logic to configure the intervention- context-actor-mechanism-outcome map to formulate generative theories. Results A modified programme theory involving targeted care for clinically stable adult patients (18 years+) receiving antiretroviral therapy was obtained. Targeted care involved receiving quick, uninterrupted supply of antiretroviral medication (with reduced clinic visit frequencies), health talks and counselling, immediate access to a clinician when required and guided by club rules and regulations within the context of adequate resources, and convenient (size and position) space and proper preparation by the club team. When grouped for targeted care, patients feel nudged, their self-efficacy is improved and they become motivated to adhere to their medication and remain in continuous care. Conclusion This finding has implications for understanding how, why and under what health system conditions the adherence club intervention works to improve its rollout in other contexts.	[Mukumbang, Ferdinand C.; van Wyk, Brian; Marchal, Bruno] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Mukumbang, Ferdinand C.; Van Belle, Sara; Marchal, Bruno] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium	University of the Western Cape; Institute of Tropical Medicine (ITM)	Mukumbang, FC (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.; Mukumbang, FC (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	mukumbang@gmail.com	Mukumbang, Ferdinand C/J-4215-2019; Mukumbang, Ferdinand/GQB-3347-2022; Van Belle, Sara/HHN-6814-2022	Mukumbang, Ferdinand C/0000-0003-1441-2172; 	Medical Research Council of South Africa by National Department of Health; African Doctoral Dissertation Research Fellowship (ADDRF) award by Africa Population and Health Research Center (APHRC); International Development Research Centre (IDRC)	Medical Research Council of South Africa by National Department of Health; African Doctoral Dissertation Research Fellowship (ADDRF) award by Africa Population and Health Research Center (APHRC); International Development Research Centre (IDRC)	The PhD from which this study emanated was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for this purpose by the National Department of Health. This research was partially funded by an African Doctoral Dissertation Research Fellowship (ADDRF) award offered by the Africa Population and Health Research Center (APHRC) in partnership with the International Development Research Centre (IDRC).	Bango F, 2016, TROP MED INT HEALTH, V21, P1115, DOI 10.1111/tmi.12736; Bateman C, 2013, SAMJ S AFR MED J, V103, P71, DOI [10.7196/samj.6666, 10.7196/SAMJ.6666]; BECKER MH, 1977, J HEALTH SOC BEHAV, V18, P348, DOI 10.2307/2955344; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Brousselle A, 2011, EVAL PROGRAM PLANN, V34, P69, DOI 10.1016/j.evalprogplan.2010.04.001; Burnard P, 2008, BRIT DENT J, V204, P429, DOI 10.1038/sj.bdj.2008.292; Byng R, 2005, EVALUATION, V11, P69, DOI DOI 10.1177/1356389005053198; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Department of Health, 2016, REIMPL UN TEST TREAT; Easton G, 2010, IND MARKET MANAG, V39, P118, DOI 10.1016/j.indmarman.2008.06.004; Eastwood John G, 2014, Springerplus, V3, P12, DOI 10.1186/2193-1801-3-12; Edwards N, 2014, JAIDS-J ACQ IMM DEF, V67, pS157, DOI 10.1097/QAI.0000000000000322; Edwards R, 2003, WHAT IS QUALITATIVE; Elman C, 2016, SOCIOL METHOD RES, V45, P375, DOI 10.1177/0049124116644273; Grimsrud Anna, 2017, J Int AIDS Soc, V20, P22024, DOI 10.7448/IAS.20.5.22024; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; Grimsrud A, 2016, JAIDS-J ACQ IMM DEF, V71, pE16, DOI 10.1097/QAI.0000000000000863; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Hedstrom P., 1998, SOCIAL MECH; Human Sciences Research Council, 2017, S AFR NAT PREV INC B; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, 90 90 90 AMB TREATM, V40; Kaboub F, 2004, SOC SCI J, V41, P153, DOI 10.1016/j.soscij.2003.10.017; Koenig G., 2009, EVALUATION-US, V15, P9, DOI DOI 10.1177/1356389008097869; Lokke A.K., 2014, ELECT J BUSINESS RES, V12, P66; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Manzano A, 2016, EVALUATION-US, V22, P342, DOI 10.1177/1356389016638615; Marchal B, 2017, DOING REALIST RES SA; McEvoy P, 2006, J RES NURS, V11, P66, DOI 10.1177/1744987106060192; Medecins Sans Frontieres, 2014, ART ADH CLUB REP TOO; Miles M., 2013, QUALITATIVE DATA ANA; Mills AJ, 2010, ENCY CASE STUDY RES; Mukumbang FC, 2018, REALIST EVALUATION A; Mukumbang FC, 2018, QUAL HEALTH RES, V28, P1839, DOI 10.1177/1049732318784883; Mukumbang FC, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0503-0; Mukumbang FC, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3150-6; Mukumbang FC, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0638-0; Mukumbang FC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4322-8; Mukumbang FC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161790; Mukumbang FC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009977; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Patton MQ, 2005, QUALITATIVE RES EVAL; Pawson R, 1996, BRIT J SOCIOL, V47, P295, DOI 10.2307/591728; Pawson R., 2009, EVIDENCE BASED PUBLI, P43, DOI [DOI 10.1093/ACPROF:OSO/9780199563623.003.04, DOI 10.1093/ACPROF:0S0/9780199563623.001.0001]; Pawson R., 1997, REALISTIC EVALUATION; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sales A, 2006, J GEN INTERN MED, V21, pS43, DOI 10.1111/j.1525-1497.2006.00362.x; Seville, 1987, STAT SIMPLIFIED APPR; Sobh R, 2006, EUR J MARKETING, V40, P1194, DOI 10.1108/03090560610702777; Tilley N., 2000, REALISTIC EVALUATION; Tsondai PR, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21649; Van Belle S., 2014, STUDY 2 LOCAL HLTH S; Van Belle S, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000181; Western Cape Government: Health, 201415 W CAP GOV; Westhorp G, 2014, RES POLICY DEV; Westhorp G, 2016, EVALUATION-US, V22, P361, DOI 10.1177/1356389016656514; WHO, 2013, CONSOLIDATED GUIDELI; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; Wong G, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0643-1; Xyrichis A, 2008, J ADV NURS, V61, P232, DOI 10.1111/j.1365-2648.2007.04496.x; Yin Robert., 2002, CASE STUDY RES DESIG	60	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210565	10.1371/journal.pone.0210565	http://dx.doi.org/10.1371/journal.pone.0210565			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650129	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300063
J	Goncalves, LD; Franchi, M; Mathor, MB; Lugao, AB; Carvalho, VH; Medeiros, MHG; Artioli, GG; Varca, GHC				Goncalves, Livia de Souza; Franchi, Mariana; Mathor, Monica B.; Lugao, Ademar B.; Carvalho, Victor H.; Medeiros, Marisa H. G.; Artioli, Guilherme Giannini; Varca, Gustavo H. C.			The molecular structure of beta-alanine is resistant to sterilising doses of gamma radiation	PLOS ONE			English	Article							MUSCLE CARNOSINE; SKELETAL-MUSCLE; SUPPLEMENTATION; EXERCISE; PERFORMANCE; ANSERINE; CA2+	beta-alanine is the rate-limiting point for the endogenous synthesis of carnosine in skeletal muscle. Carnosine has a wide range of implications for health, normal function and exercise performance. Whilst the physiological relevance of carnosine to different tissues remains enigmatic, beta-alanine administration is a useful strategy to investigate the physiological roles of carnosine in humans. Intravenous administration of beta-alanine is an interesting approach to study carnosine metabolism. However, sterilisation is mandatory due to the nature of the administration route. We evaluated whether sterilising doses of gamma radiation damages the molecular structure and leads to the loss of functional characteristics of beta-alanine. Pure beta-alanine was sterilised by gamma radiation in sealed glass vials using a Co-60 multipurpose irradiator at a dose rate of 8.5 kGy.hour(-1) totalising 10, 20, 25 30 and 40 kGy. The molecular integrity was assessed by X-ray Diffraction and changes in content were determined by High Performance Liquid Chromatography (UV-HPLC) and Triple Quadrupole Mass Spectrometer (HPLC/MS-MS). Sterility assurance was evaluated by inoculation assay. To examine whether functional properties were preserved, beta-alanine was infused in one participant, who rated the level of paraesthesia on the skin using a 0-3 scale. Urinary beta-alanine was quantified before and 24-h following beta-alanine infusion using HPLC-ESI+-MS/MS. Irradiation resulted in no change in the crystal structure of beta-alanine, no degradation, and no new peaks were identified in the dose range assayed. The inoculation assay showed the absence of viable microorganisms in all beta-alanine samples, including those that did not undergo irradiation. Intravenous infusion of beta-alanine resulted in paraesthesia and it detected in the urine as per normal. We conclude that gamma radiation is a suitable technique for the sterilisation of beta-alanine. It does not lead to degradation, damage to the beta-alanine structure, content or loss of function within the evaluated irradiation conditions.	[Goncalves, Livia de Souza; Franchi, Mariana; Artioli, Guilherme Giannini] Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil; [Mathor, Monica B.; Lugao, Ademar B.; Varca, Gustavo H. C.] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Sao Paulo, SP, Brazil; [Carvalho, Victor H.; Medeiros, Marisa H. G.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Artioli, GG (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil.	artioli@usp.br	Gonçalves, Lívia/Q-1715-2019; Mathor, Monica B/C-3975-2012; Varca, Gustavo H. C./C-2729-2013; Medeiros, Marisa H. G./A-5212-2008; Lugao, Ademar B/B-6847-2013; Carvalho, Victor Henrique/U-8239-2018; Artioli, Guilherme Giannini/K-5925-2013	Gonçalves, Lívia/0000-0003-4859-9078; Mathor, Monica B/0000-0002-7294-9106; Varca, Gustavo H. C./0000-0002-6545-237X; Medeiros, Marisa H. G./0000-0002-5438-1174; Artioli, Guilherme Giannini/0000-0001-8463-2213	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Sao Paulo Research Foundation - FAPESP [2015/22686-7, 2014/11948-8, 2015/13979-0]; Comissao Nacional de Energia Nuclear - CNEN; CNPq; Sao Paulo Research Foundation FAPESP [2013/07937-8]; NAP-Redoxoma (PRPUSP) [2011.1.9352.1.8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Comissao Nacional de Energia Nuclear - CNEN; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-Redoxoma (PRPUSP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: LSG - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; MF - Sao Paulo Research Foundation - FAPESP (#2015/22686-7); GGA-Sao Paulo Research Foundation - FAPESP (#2014/11948-8); GHCV - Sao Paulo Research Foundation - FAPESP(#2015/13979-0) Comissao Nacional de Energia Nuclear - CNEN; VHC - CNPq; MHGM - Sao Paulo Research Foundation FAPESP (#2013/07937-8) and NAP-Redoxoma (PRPUSP: Proc. 2011.1.9352.1.8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Centro de Tecnologia das Radiacoes (CTR/IPEN vertical bar) for beta-alanine irradiation, Rene Ramos de Oliveira and Centro de Ciencia e Tecnologia de Materiais (CCTM/IPEN) for access to X-ray Diffraction, Daniel Lebre and Centro de Espectrometria de Massa Aplicada (CEMSA-Cietec/IPEN) for access to Triple Quadrupole (MS/MS). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES-Finance Code 001).	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Abirami S, 2005, J PHYS CHEM A, V109, P500, DOI 10.1021/jp047399o; Aldini G, 2004, J MASS SPECTROM, V39, P1417, DOI 10.1002/jms.696; [Anonymous], 2009, 1173722009 ISO; Artioli GG, 2010, MED SCI SPORT EXER, V42, P1162, DOI 10.1249/MSS.0b013e3181c74e38; Baguet A, 2009, J APPL PHYSIOL, V106, P837, DOI 10.1152/japplphysiol.91357.2008; Bate-Smith E., 1938, J PHYSL, V92; Baye E, 2016, AMINO ACIDS, V48, P1131, DOI 10.1007/s00726-016-2208-1; Blancquaert L, 2016, J PHYSIOL-LONDON, V594, P4849, DOI 10.1113/JP272050; BOLDYREV AA, 1993, MOL CHEM NEUROPATHOL, V19, P83, DOI 10.1007/BF03160170; BYRNE MM, 1995, AM J PHYSIOL-ENDOC M, V268, pE21, DOI 10.1152/ajpendo.1995.268.1.E21; Carvalho VH, 2018, REDOX BIOL, V18, P222, DOI 10.1016/j.redox.2018.07.009; Chmielewski AG, 2004, RADIAT PHYS CHEM, V71, P17, DOI 10.1016/j.radphyschem.2004.05.040; del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x; Dunnett M, 1999, Equine Vet J Suppl, P499; Dutka TL, 2012, J APPL PHYSIOL, V112, P728, DOI 10.1152/japplphysiol.01331.2011; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4; GOTTSCHALL WC, 1968, J PHYS CHEM-US, V72, P922, DOI 10.1021/j100849a024; Hannah R, 2015, J APPL PHYSIOL, V118, P604, DOI 10.1152/japplphysiol.00991.2014; Harris RC, 1998, J SPORT SCI, V16, P639; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Hipkiss AR, 2017, AGING DIS, V8, P334, DOI 10.14336/AD.2016.1030; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; Ishida K, 2001, RAD DEGRADATION SILK, P2001; ISO, 2012, 1113722012 ISO; Lee Y, 2002, J BIOCHEM MOL BIOL, V35, P590; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Martinho AC, 2013, CELL TISSUE BANK, V14, P117, DOI 10.1007/s10561-012-9306-4; Miller BF, 2005, J APPL PHYSIOL, V98, P856, DOI 10.1152/japplphysiol.00753.2004; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Nardi DT, 2008, INT J RADIAT BIOL, V84, P937, DOI 10.1080/09553000802460164; ODOWD JJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P241, DOI 10.1016/0304-4165(88)90015-3; PARKER CD, 1985, ANAL CHEM, V57, P698, DOI 10.1021/ac00280a028; PISANO JJ, 1961, J BIOL CHEM, V236, P499; RAHN O, 1945, BACTERIOL REV, V9, P1; Rela P., 2001, UTILIZACAO RADIACAO; Sale C, 2013, AMINO ACIDS, V44, P1477, DOI 10.1007/s00726-013-1476-2; Saunders B, 2017, MED SCI SPORT EXER, V49, P896, DOI 10.1249/MSS.0000000000001173; Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396; Schoen P, 2003, CLIN CHEM, V49, P1930, DOI 10.1373/clinchem.2003.019398; Solis MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123857; Sousa JCF, 2017, VIB SPECTROSC, V89, P69, DOI 10.1016/j.vibspec.2017.01.003; Stegen S, 2013, MED SCI SPORT EXER, V45, P1478, DOI 10.1249/MSS.0b013e31828ab073; Stephens FB, 2006, FASEB J, V20, P377, DOI 10.1096/fj.05-4985fje; Swietach P, 2013, P NATL ACAD SCI USA, V110, pE2064, DOI 10.1073/pnas.1222433110; UEMATSU T, 1988, EUR J CLIN PHARMACOL, V34, P213, DOI 10.1007/BF00614562; Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g	49	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210713	10.1371/journal.pone.0210713	http://dx.doi.org/10.1371/journal.pone.0210713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645623	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200046
J	Romero, D; Kwan, A; Suchman, L				Romero, Diana; Kwan, Amy; Suchman, Lauren			Methodologic approach to sampling and field-based data collection for a large-scale in-depth interview study: The Social Position and Family Formation (SPAFF) project	PLOS ONE			English	Article							UNITED-STATES; QUALITATIVE RESEARCH; MARRIAGE; COHABITATION; TRENDS; CHILDBEARING; TECHNOLOGY	Over the past several decades there have been dramatic shifts in demographic patterns pertaining to family formation, with declining and delayed marriage and childbearing, and increased cohabitation in the United States and other Western industrialized nations. These trends in family demography have been predominantly studied using large-scale datasets, which have identified total population and subgroup trends over time, including differences by age, gender, racial/ethnic, economic, educational, religious, and other characteristics. However, there is limited knowledge and understanding of how individuals across different levels of social position, as well as other important characteristics, make decisions around forming families. This lack of qualitative data on contemporary attitudes regarding family formation has hampered our ability to more completely understand the factors driving behaviors pertaining to the large-scale (ie, international) shifts in demographic trends. The Social Position and Family Formation (SPAFF) project is an in-depth interview study that used quantitative data to guide recruitment of a large sample for qualitative interview data collection on factors influencing different aspects of family formation among heterosexual females and males (18-35 years) in the context of individuals' social position. This methodological paper describes the use of a 'quantitatively-informed' purposive sampling approach in a large metropolitan area to collect qualitative data (through in-depth interviews) from a large sample (n = 200), utilizing web-based tools for successful community-based recruitment and project management.	[Romero, Diana; Kwan, Amy] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Community Hlth & Social Sci, New York, NY 10021 USA; [Suchman, Lauren] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA	City University of New York (CUNY) System; University of California System; University of California San Francisco	Romero, D (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Community Hlth & Social Sci, New York, NY 10021 USA.	diana.romero@sph.cuny.edu		Romero, Diana/0000-0002-4832-9564	National Institute of Child Health and Human Development (NIH) [1K01HD055263]	National Institute of Child Health and Human Development (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (NIH), Grant #1K01HD055263 to DR, URL: https://www.nichd.nih.gov/Pages/index.aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WORKSH SUMM 37 DEV R; Bramlett Matthew D, 2002, Vital Health Stat 23, P1; Carlson M, 2011, SOCIAL CLASS CHANGIN; Centers for Disease Control and Prevention, 2009, NAT CTR HLTH STAT PU; Centers for Disease Control and Prevention, 2016, NAT SURV FAM GROWTH; Cherlin AJ, 2005, FUTURE CHILD, V15, P33, DOI 10.1353/foc.2005.0015; Cherlin AJ, 2010, J MARRIAGE FAM, V72, P403, DOI 10.1111/j.1741-3737.2010.00710.x; Clampet-Lundquist S, 2011, AM J SOCIOL, V116, P1154, DOI 10.1086/657352; Cook T.C., 1979, QUASIEXPERIMENTATION; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Deakin H, 2014, QUAL RES, V14, P603, DOI 10.1177/1468794113488126; Donovan Charles A., 2011, BACKGROUNDER, V2567, P1; Edin K, 2010, J MARRIAGE FAM, V72, P460, DOI 10.1111/j.1741-3737.2010.00713.x; England P., 2007, UNMARRIED COUPLES CH; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Forste R, 2002, J FAM ISSUES, V23, P579, DOI 10.1177/0192513X02023005001; Fowler F.J., 2009, SURV RES METHODS-GER; Glaser B.G., 1965, AWARENESS DYING; Graffigna G, 2016, INT J QUAL METH, V5, P55, DOI [10.1177/160940690600500307], DOI 10.1177/160940690600500307]; Hanna P, 2012, QUAL RES, V12, P239, DOI 10.1177/1468794111426607; Hayford SR, 2014, J MARRIAGE FAM, V76, P520, DOI 10.1111/jomf.12114; Hayford SR, 2013, DEMOGRAPHY, V50, P1641, DOI 10.1007/s13524-013-0215-3; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kefalas M., 2005, CONTEXTS, V4, P16, DOI 10.1525/ctx.2005.4.2.16; Laditka SB, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp076; Land R., 2009, CHRISTIAN POST  0325; Lewis, 2006, QUALITATIVE RES PRAC; Luker K., 2008, SALSA DANCING SOCIAL; Manning WD, 2001, FAM PLANN PERSPECT, V33, P217, DOI 10.2307/2673785; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Matthews J, 2008, QUAL REP, V13, P301; McLanahan S, 2009, ANN AM ACAD POLIT SS, V621, P111, DOI 10.1177/0002716208324862; Moylan CA, 2015, QUAL SOC WORK, V14, P36, DOI 10.1177/1473325013516988; Musick K, 2007, DEMOGR RES, V16; Rector R., 2012, MARRIAGE AM GREATEST; Rhoades GK, 2009, J FAM ISSUES, V30, P233, DOI 10.1177/0192513X08324388; Ritchie J, 2003, QUALITATIVE RES PRAC, P77; Sakellariadis A, 2008, QUAL INQ, V14, P1205, DOI 10.1177/1077800408324210; Shrestha Laura B, 2006, CHANGING DEMOGRAPHIC; Small ML, 2009, ETHNOGRAPHY, V10, P5, DOI 10.1177/1466138108099586; Smock PJ, 2010, J MARRIAGE FAM, V72, P576, DOI 10.1111/j.1741-3737.2010.00719.x; Smock PJ, 2000, ANNU REV SOCIOL, V26, P1, DOI 10.1146/annurev.soc.26.1.1; Smyth JoleneD., 2008, INTERNET MAIL MIXED; Strauss A., 1998, BASICS QUALITATIVE R; Teachman JD, 2000, J MARRIAGE FAM, V62, P1234, DOI 10.1111/j.1741-3737.2000.01234.x; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Ventura S J, 2000, Natl Vital Stat Rep, V48, P1; Ventura S. J., 2009, CHANGING PATTERNS NO; Weigold A, 2013, PSYCHOL METHODS, V18, P53, DOI 10.1037/a0031607; White DE, 2012, INT J QUAL METH, V11, P244, DOI 10.1177/160940691201100305; Wiles R, 2011, QUAL RES, V11, P587, DOI 10.1177/1468794111413227	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210776	10.1371/journal.pone.0210776	http://dx.doi.org/10.1371/journal.pone.0210776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645631	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200052
J	Hagel, S; Makarewicz, O; Hartung, A; Weiss, D; Stein, C; Brandt, C; Schumacher, U; Ehricht, R; Patchev, V; Pletz, MW				Hagel, Stefan; Makarewicz, Oliwia; Hartung, Anita; Weiss, Daniel; Stein, Claudia; Brandt, Christian; Schumacher, Ulrike; Ehricht, Ralf; Patchev, Vladimir; Pletz, Mathias W.			ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; HIGH-RISK PATIENTS; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; PREVALENCE; INFECTION; DISSEMINATION; ADMISSION; DURATION	A prospective cohort study (German Clinical Trial Registry, No. 00005273) was performed to determine pre-admission colonization rates, hospital acquisition risk factors, subsequent infection rates and colonization persistence including the respective molecular epidemiology and transmission rates of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (EPE). A total of 342 EPEs were isolated from rectal swabs of 1,334 patients on admission, at discharge and 6 months after hospitalization. Inclusion criteria were patients' age > 18 years, expected length of stays > 48 hours, external referral. The EPEs were characterized by routine microbiological methods, a DNA microarray and ERIC-PCR. EPE colonization was found in 12.7% of admitted patients, with the highest rate (23.8 %) in patients from nursing homes. During hospitalization, 8.1 % of the patients were de novo EPE colonized, and invasive procedures, antibiotic and antacid therapies were independent risk factors. Only 1/169 patients colonized on admission developed a hospital-acquired EPE infection. Escherichia coli was the predominant EPE (88.9 %), and 92.1% of the ESBL phenotypes could be related to CTX-M variants with CTX-M-1/15 group being most frequent (88.9%). A corresponding beta-lactamase could not be identified in five isolates. Hospital-acquired EPE infections in patients colonized before or during hospitalization were rare. The diversity of the EPE strains was much higher than that of the underlying plasmids. In seven patients, transmission of the respective plasmid across different species could be observed indicating that the current strain-based surveillance approaches may underestimate the risk of inter-species transmission of resistance genes.	[Hagel, Stefan; Makarewicz, Oliwia; Hartung, Anita; Weiss, Daniel; Stein, Claudia; Brandt, Christian; Patchev, Vladimir; Pletz, Mathias W.] Jena Univ Hosp, Inst Infect Dis & Infect Control, Jena, Germany; [Makarewicz, Oliwia; Weiss, Daniel; Stein, Claudia; Brandt, Christian; Ehricht, Ralf; Pletz, Mathias W.] Infectognost Res Campus, Jena, Germany; [Weiss, Daniel; Ehricht, Ralf] Abbott Alere Technol GmbH, Jena, Germany; [Schumacher, Ulrike; Patchev, Vladimir] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Ehricht, Ralf] Leibniz Inst Photon Technol IPHT, Jena, Germany	Friedrich Schiller University of Jena; Alere; Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien	Makarewicz, O (corresponding author), Jena Univ Hosp, Inst Infect Dis & Infect Control, Jena, Germany.; Makarewicz, O (corresponding author), Infectognost Res Campus, Jena, Germany.	oliwia.makarewicz@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019; Hagel, Stefan/AAE-1174-2022	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Hagel, Stefan/0000-0003-2999-6131; Brandt, Christian/0000-0002-7199-3957; Makarewicz, Oliwia/0000-0002-4404-1862	German Ministry of Education and Research (BMBF) [01KI1204, 01KI1501, 13GW0096B, 13GW0096D]; Abbott (Alere Technologies GmbH)	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Abbott (Alere Technologies GmbH)	This work was supported by grants from the German Ministry of Education and Research (BMBF), grant numbers 01KI1204, 01KI1501, 13GW0096B and 13GW0096D. Abbott (Alere Technologies GmbH) provided support in the form of salaries for authors DW and RE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adler A, 2014, CLIN MICROBIOL INFEC, V20, pO516, DOI 10.1111/1469-0691.12560; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Ardakani Maryam Afkhami, 2016, Electron Physician, V8, P2291, DOI 10.19082/2291; Biehl LM, 2016, CRIT REV MICROBIOL, V42, P1, DOI 10.3109/1040841X.2013.875515; Birgand G, 2013, AM J INFECT CONTROL, V41, P443, DOI 10.1016/j.ajic.2012.05.015; Braun SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102232; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; Friedmann R, 2009, INFECT CONT HOSP EP, V30, P534, DOI 10.1086/597505; Hamprecht A, 2016, J ANTIMICROB CHEMOTH, V71, P2957, DOI 10.1093/jac/dkw216; Heudorf U, 2015, REHABILITATION, V54, P339, DOI 10.1055/s-0035-1559642; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Lartigue MF, 2004, FEMS MICROBIOL LETT, V234, P201, DOI 10.1016/j.femsle.2004.01.051; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Ludden C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0880-5; Mischnik A, 2017, J ANTIMICROB CHEMOTH, V72, P1359, DOI 10.1093/jac/dkw577; Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Shin HW, 2015, J MICROBIOL BIOTECHN, V25, P137, DOI 10.4014/jmb.1409.09041; Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Titelman E, 2014, CLIN MICROBIOL INFEC, V20, pO508, DOI 10.1111/1469-0691.12559; Tschudin-Sutter S, 2017, CLIN INFECT DIS, V65, P342, DOI 10.1093/cid/cix258; Vehreschild MJGT, 2014, J ANTIMICROB CHEMOTH, V69, P3387, DOI 10.1093/jac/dku305; Willemsen I, 2015, INFECT CONT HOSP EP, V36, P394, DOI 10.1017/ice.2014.76; Zahar JR, 2010, J HOSP INFECT, V75, P76, DOI 10.1016/j.jhin.2009.11.010; Zong Z, 2015, PLASMID, V80, P118, DOI 10.1016/j.plasmid.2015.04.007; Zong ZY, 2010, ANTIMICROB AGENTS CH, V54, P3039, DOI 10.1128/AAC.00041-10	29	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208505	10.1371/journal.pone.0208505	http://dx.doi.org/10.1371/journal.pone.0208505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640915	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000005
J	Lee, CH; Choi, SS; Lee, MK; Kim, JE; Chung, DI; Lee, M				Lee, Chung Hun; Choi, Sang Sik; Lee, Mi Kyoung; Kim, Jung Eun; Chung, Dong Ik; Lee, Mido			Electric stimulation-guided epidural analgesia for vaginal delivery: A randomized prospective study	PLOS ONE			English	Article							CONFIRMATION; ANESTHESIA; FAILURE; SPACE	Background The failure rate of epidural anesthesia using the loss of resistance technique is 13-23%. Objectives To investigate the efficacy of epidural electric stimulation-guided epidural analgesia in vaginal delivery. Study design An open label randomized prospective study. Methods Laboring women were randomized to two groups: epidural catheter insertion using only a loss of resistance technique or a loss of resistance technique with confirmation by electric stimulation. Catheters in both groups were initially tested with 3 ml of 1% lidocaine and those with any evidence of motor blockade were considered intrathecal. Sensory blockade and an 11 point numerical rating score for pain were assessed 30 minutes after administration of an epidural bolus of 10 ml of 0.22% ropivacaine with fentanyl. Successful epidural analgesia was defined as a decrease of 2 or more in the pain score and a bilateral L1-T10 sensory blockade. Results Thirty-one patients were randomized to each group. The first 20 patients in each group were enrolled in a pilot study and were also included in the final analysis. One patient in the electric stimulation group was excluded owing to dural puncture by the Tuohy needle. One patient in each group demonstrated motor blockade after test dose and were considered failures. The number (% (95% confidence interval)) of successful cases were 29 out of 30 (97% (85, 100%)) in the electric stimulation group and 24 out of 31 (77% (61, 89%)) in the loss of resistance group (P = 0.053). However, analysis of only patients with absence of motor blockade revealed that 29 out of 29 (100% (92, 100%)) patients in the electric stimulation group and 24 of 29 (80% (63, 91%)) patients in the loss of resistance group had adequate analgesia (P = 0.024). Conclusions Although limited by lack of blinding, small study size and inclusion of pilot study data, this study suggests epidural electric stimulation improves the success rate of subsequent labor analgesia.	[Lee, Chung Hun; Choi, Sang Sik; Lee, Mi Kyoung; Kim, Jung Eun; Chung, Dong Ik; Lee, Mido] Korea Univ, Med Ctr, Guro Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Choi, SS (corresponding author), Korea Univ, Med Ctr, Guro Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	clonidine@empal.com	Choi, Sangsik/HGD-4295-2022		Sewoon Medical Co., Ltd., Seoul, Korea	Sewoon Medical Co., Ltd., Seoul, Korea	The authors have no sources of funding to declare, however, the epidural catheter (RegionalStim (TM)) used in this study was provided by Sewoon Medical Co., Ltd., Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder only provided support in the form of research materials for authors [S. S. C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agaram R, 2009, INT J OBSTET ANESTH, V18, P10, DOI 10.1016/j.ijoa.2007.10.008; Eappen S, 1998, INT J OBSTET ANESTH, V7, P220, DOI 10.1016/S0959-289X(98)80042-3; Gomar C, 2000, EUR J ANAESTH, V17, P542, DOI 10.1046/j.1365-2346.2000.00733.x; Goobie SM, 2003, ANESTH ANALG, V97, P984, DOI 10.1213/01.ANE.0000080609.05942.38; Grau T, 2002, J CLIN ANESTH, V14, P169, DOI 10.1016/S0952-8180(01)00378-6; Grau T, 2001, BRIT J ANAESTH, V86, P798, DOI 10.1093/bja/86.6.798; Hermanides J, 2012, BRIT J ANAESTH, V109, P144, DOI 10.1093/bja/aes214; Hislop H, 2014, PRINCIPLES MANUAL MU, P1; Jeong JS, 2012, KOREAN J ANESTHESIOL, V63, P238, DOI 10.4097/kjae.2012.63.3.238; Kinsella SM, 2008, ANAESTHESIA, V63, P822, DOI 10.1111/j.1365-2044.2008.05499.x; MICHAEL S, 1989, ANAESTHESIA, V44, P578, DOI 10.1111/j.1365-2044.1989.tb11446.x; Pan PH, 2004, INT J OBSTET ANESTH, V13, P227, DOI 10.1016/j.ijoa.2004.04.008; Silva M, 2010, LOCAL REG ANESTH, V3, P143, DOI 10.2147/LRA.S10237; Sutherland MA, 2009, REGION ANESTH PAIN M, V34, P575, DOI 10.1097/AAP.0b013e3181bfbe1e; Thangamuthu A, 2013, INT J OBSTET ANESTH, V22, P310, DOI 10.1016/j.ijoa.2013.04.013; Toledano RD, 2014, ANESTHESIOLOGY, V121, P9, DOI 10.1097/ALN.0000000000000239; Tsui BCH, 1998, CAN J ANAESTH, V45, P640, DOI 10.1007/BF03012093; Wantman A, 2006, ANAESTHESIA, V61, P370, DOI 10.1111/j.1365-2044.2006.04534.x	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209967	10.1371/journal.pone.0209967	http://dx.doi.org/10.1371/journal.pone.0209967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633755	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100010
J	Slater, JM; Gilbert, L; Johnson, D; Karley, AJ				Slater, Jennifer M.; Gilbert, Lucy; Johnson, David; Karley, Alison J.			Limited effects of the maternal rearing environment on the behaviour and fitness of an insect herbivore and its natural enemy	PLOS ONE			English	Article							APHIDIUS-ERVI HYMENOPTERA; HOST-PLANT; POPULATION DIFFERENTIATION; GENETIC-VARIATION; PEA APHIDS; GENERALIST; PERFORMANCE; PREFERENCE; CHOICE; SPECIALIST	The maternal rearing environment can affect offspring fitness or phenotype indirectly via 'maternal effects' and can also influence a mother's behaviour and fecundity directly. However, it remains uncertain how the effects of the maternal rearing environment cascade through multiple trophic levels, such as in plant-insect herbivore-natural enemy interactions. Pea aphids (Acyrthosiphon pisum) show differential fitness on host legume species, while generalist aphid parasitoids can show variable fitness on different host aphid species, suggesting that maternal effects could operate in a plant-aphid-parasitoid system. We tested whether the maternal rearing environment affected the behaviour and fitness of aphids by rearing aphids on two plant hosts that were either the same as or different from those experienced by the mothers. A similar approach was used to test the behaviour and fitness of parasitoid wasps in response to maternal rearing environment. Here, the host environment was manipulated at the plant or plant and aphid trophic levels for parasitoid wasps. We also quantified the quality of host plants for aphids and host aphids for parasitoid wasps. In choice tests, aphids and parasitoid wasps had no preference for the plant nor plant and aphid host environment on which they were reared. Aphid offspring experienced 50.8% higher intrinsic rates of population growth, 43.4% heavier offspring and lived 14.9% longer when feeding on bean plants compared to aphids feeding on pea plants, with little effect of the maternal rearing environment. Plant tissue nitrogen concentration varied by 21.3% in response to aphid mothers' rearing environment, and these differences correlated with offspring fitness. Maternal effects in parasitoid wasps were only observed when both the plant and aphid host environment was changed: wasp offspring were heaviest by 10.9-73.5% when both they and their mothers developed in bean-reared pea aphids. Also, parasitoid wasp fecundity was highest by 38.4% when offspring were oviposited in the maternal rearing environment. These findings indicate that maternal effects have a relatively small contribution towards the outcome of plant-aphid-parasitoid interactions.	[Slater, Jennifer M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Slater, Jennifer M.; Karley, Alison J.] James Hutton Inst, Ecol Sci Grp, Dundee, Scotland; [Slater, Jennifer M.; Gilbert, Lucy] James Hutton Inst, Ecol Sci Grp, Aberdeen, Scotland; [Johnson, David] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England; [Gilbert, Lucy] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Aberdeen; James Hutton Institute; James Hutton Institute; University of Manchester; University of Glasgow	Karley, AJ (corresponding author), James Hutton Inst, Ecol Sci Grp, Dundee, Scotland.	Alison.Karley@hutton.ac.uk		Karley, Alison/0000-0002-0252-2086; Johnson, David/0000-0003-2299-2525	Scottish Food Security Alliance: Crops by the James Hutton Institute; Universities of Aberdeen and Dundee; N8 Agri-Food programme; Scottish Government's Rural and Environment Science and Analytical Services Division	Scottish Food Security Alliance: Crops by the James Hutton Institute; Universities of Aberdeen and Dundee; N8 Agri-Food programme; Scottish Government's Rural and Environment Science and Analytical Services Division	JMS was funded through The Scottish Food Security Alliance: Crops by the James Hutton Institute and the Universities of Aberdeen and Dundee. DJ received support from the N8 Agri-Food programme. LG and AJK were supported by the strategic research programme funded by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikova Z, 2014, FUNCT ECOL, V28, P375, DOI 10.1111/1365-2435.12181; Babikova Z, 2013, ECOL LETT, V16, P835, DOI 10.1111/ele.12115; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; Cao HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21954; Chesnais Q, 2016, ECOL EVOL, V6, P7882, DOI 10.1002/ece3.2404; Chesnais Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135661; CHOW A, 1992, J INSECT BEHAV, V5, P99, DOI 10.1007/BF01049161; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Donald KJ, 2016, MICROB ECOL, V71, P1, DOI 10.1007/s00248-015-0690-8; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fei MH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081263; Fei MH, 2014, J ANIM ECOL, V83, P234, DOI 10.1111/1365-2656.12122; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Fox J., 2019, R COMPANION APPL REG; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gorur G, 2007, ARTHROPOD-PLANT INTE, V1, P187, DOI 10.1007/s11829-007-9017-0; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; He X. Z., 2006, New Zealand Plant Protection, V59, P190; He XZ, 2008, BIOL CONTROL, V45, P281, DOI 10.1016/j.biocontrol.2008.03.003; He XZ, 2006, BIOL CONTROL, V36, P293, DOI 10.1016/j.biocontrol.2005.09.014; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; Hu XS, 2016, ECOL ENTOMOL, V41, P147, DOI 10.1111/een.12282; Johnson SN, 2012, AGR FOREST ENTOMOL, V14, P217, DOI 10.1111/j.1461-9563.2011.00561.x; Jones TS, 2015, ECOL EVOL, V5, P459, DOI 10.1002/ece3.1333; Kaiser MC, 2016, ENTOMOL EXP APPL, V159, P197, DOI 10.1111/eea.12431; Keiser CN, 2013, J INSECT BEHAV, V26, P603, DOI 10.1007/s10905-013-9376-6; Mackauer M, 1996, CAN ENTOMOL, V128, P959, DOI 10.4039/Ent128959-6; McLean AHC, 2009, ECOL ENTOMOL, V34, P330, DOI 10.1111/j.1365-2311.2008.01081.x; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Nespolo RF, 2015, ECOL EVOL, V5, P5601, DOI 10.1002/ece3.1763; Olivares-Donoso R, 2007, B ENTOMOL RES, V97, P61, DOI 10.1017/S0007485307004774; Orians CM, 2011, OECOLOGIA, V167, P1, DOI 10.1007/s00442-011-1968-2; Rehman A., 2010, J PLANT BREEDING CRO, V2, P299, DOI [10.5897/JPBCS.9000077, DOI 10.1016/J.BEPROC.2010.12.002]; RStudio Team, 2019, RSTUDIO INT DEV R; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; Sasso R, 2009, CHEMOECOLOGY, V19, P195, DOI 10.1007/s00049-009-0023-9; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; Tapia DH, 2015, ANIM BEHAV, V106, P1, DOI 10.1016/j.anbehav.2015.04.027; Ueno T, 2015, EUR J ENTOMOL, V112, P281, DOI 10.14411/eje.2015.048; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Winter TR, 2010, J CHEM ECOL, V36, P642, DOI 10.1007/s10886-010-9797-z; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; Wyckhuys KAG, 2008, B ENTOMOL RES, V98, P361, DOI 10.1017/S000748530800566X; Zehnder CB, 2007, ECOL ENTOMOL, V32, P172, DOI 10.1111/j.1365-2311.2007.00853.x	48	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0209965	10.1371/journal.pone.0209965	http://dx.doi.org/10.1371/journal.pone.0209965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633753	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000455485100009
J	Govorov, I; Bremme, K; Larsson, A; Holmstrom, M; Komlichenko, E; Chaireti, R; Mints, M				Govorov, Igor; Bremme, Katarina; Larsson, Anders; Holmstrom, Margareta; Komlichenko, Eduard; Chaireti, Roza; Mints, Miriam			Blood inflammatory and endothelial markers in women with von Willebrand disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SOLUBLE ADHESION MOLECULES; MENSTRUAL-CYCLE; CATHEPSIN-S; E-SELECTIN; ANGIOGENESIS; INTERLEUKIN-6; PROGESTERONE; EXPRESSION; ESTRADIOL	Introduction VWD-affected females often experience menorrhagia. Periodical fluctuations of the sex steroids during the menstrual cycle cause changes both in the coagulation and immune system. The aim of the current study was to assess the changes in selected inflammatory and endothelial markers in women with VWD during two phases of the menstrual cycle (follicular and luteal) and to compare it with corresponding data from healthy controls. Materials and methods The study group included 12 VWD-affected females with regular menstrual cycle, with none of them being prescribed hormone treatment. They were not pregnant or breastfeeding. The control group consisted of 102 healthy females, matched for age and BMI. Results Within the VWD group, endostatin was higher during the follicular phase, compared to the luteal phase, although the difference was not significant (p = 0.062). sICAM-1 and IL-6 were higher in VWD-affected females, compared to the controls, sVCAM-1, cathepsin S and sPselectin were lower (p<0.003 for all cases). The pattern was constant throughout the menstrual cycle. Conclusions Higher levels of endostatin during early follicular phase could potentially predispose women with VWD to the development of heavy menstrual bleeding, due to antiangiogenic properties and ability to suppress several coagulation factors. Lower p-selectin levels in VWD group, compared to controls, may also contribute to the bleeding tendency. Changes in other proteins, involved in angiogenesis are hypothetically related to the formation of angiodysplasia-common complication of VWF deficiency. The latter statement requires confirmation in larger studies.	[Govorov, Igor; Bremme, Katarina; Mints, Miriam] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Holmstrom, Margareta] Karolinska Univ Hosp Solna, Dept Med, Stockholm, Sweden; [Komlichenko, Eduard] Almazov Natl Med Res Ctr, Inst Pediat & Perinatol, St Petersburg, Russia; [Chaireti, Roza] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Chaireti, Roza] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Almazov National Medical Research Centre; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Govorov, I (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	igor.govorov@ki.se	Chaireti, Roza/G-7456-2014; Chaireti, Roza/AAG-7534-2020; Holmström, Margareta/AAJ-2628-2021; Govorov, Igor/P-1257-2015; Eduard, Komlichenko/N-5315-2015	Chaireti, Roza/0000-0002-9069-1903; Govorov, Igor/0000-0003-1809-0270; Eduard, Komlichenko/0000-0003-2943-0883				Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Alvergne A, 2018, TRENDS ECOL EVOL, V33, P399, DOI 10.1016/j.tree.2018.03.006; Angstwurm MWA, 1997, CYTOKINE, V9, P370, DOI 10.1006/cyto.1996.0178; Aziz KE, 1996, CELL IMMUNOL, V167, P79, DOI 10.1006/cimm.1996.0010; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Blann AD, 1998, DIABETIC MED, V15, P634, DOI 10.1002/(SICI)1096-9136(199808)15:8<634::AID-DIA636>3.0.CO;2-8; BLANN AD, 1994, THROMB HAEMOSTASIS, V72, P151; Blum CA, 2005, J CLIN ENDOCR METAB, V90, P3230, DOI 10.1210/jc.2005-0231; Bonello N, 2002, HUM REPROD, V17, P2272, DOI 10.1093/humrep/17.9.2272; Bowman M, 2010, J THROMB HAEMOST, V8, P213, DOI 10.1111/j.1538-7836.2009.03661.x; Chaireti R, 2013, HUM REPROD, V28, P1846, DOI 10.1093/humrep/det092; Chaireti R, 2016, SCAND J CLIN LAB INV, V76, P190, DOI 10.3109/00365513.2015.1129670; Chenillot O, 2000, CLIN CHEM LAB MED, V38, P1003, DOI 10.1515/CCLM.2000.149; Critchley HOD, 2001, CLIN ENDOCRINOL, V55, P701, DOI 10.1046/j.1365-2265.2001.01432.x; EECKHOUT Y, 1977, BIOCHEM J, V166, P21, DOI 10.1042/bj1660021; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Franchini M, 2013, BRIT J HAEMATOL, V161, P177, DOI 10.1111/bjh.12272; Frenette PS, 2004, BLOOD, V103, P1979; Gaskins AJ, 2012, AM J EPIDEMIOL, V175, P423, DOI 10.1093/aje/kwr343; Gho YS, 1999, CANCER RES, V59, P5128; Gopinathan G, 2015, CANC RES; Jackel S, 2017, BLOOD, V130, P542, DOI 10.1182/blood-2016-11-754416; Jilma B, 1997, J LAB CLIN MED, V130, P69, DOI 10.1016/S0022-2143(97)90060-3; Jilma B, 1996, J CLIN ENDOCR METAB, V81, P2350, DOI 10.1210/jc.81.6.2350; Jokimaa V, 2001, MOL HUM REPROD, V7, P73, DOI 10.1093/molehr/7.1.73; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; LaMonte MJ, 2002, CIRCULATION, V106, P403, DOI 10.1161/01.CIR.0000025425.20606.69; Lenting PJ, 2012, J THROMB HAEMOST, V10, P2428, DOI 10.1111/jth.12008; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Lipinski S, 2011, HAMOSTASEOLOGIE, V31, P94, DOI 10.5482/ha-1134; Lorenz TK, 2018, J SEX RES, V55, P1087, DOI 10.1080/00224499.2017.1394961; Makris M, 2006, THROMB RES, V118, pS13, DOI 10.1016/j.thromres.2006.01.022; Murphy G, 1992, Matrix Suppl, V1, P224; O'Brien SM, 2007, NEUROIMMUNOMODULAT, V14, P84, DOI 10.1159/000107423; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA486, DOI 10.1016/j.autrev.2011.11.023; Porter KM, 2016, REPROD SCI, V23, P623, DOI 10.1177/1933719115611752; Randi AM, 2017, J THROMB HAEMOST, V15, P13, DOI 10.1111/jth.13551; Reijerkerk A, 2000, EUR J CANCER, V36, P1695, DOI 10.1016/S0959-8049(00)00157-X; Rugeri L, 2007, HAEMATOLOGICA, V92, P1639, DOI 10.3324/haematol.11460; Sattar N, 2004, ARTERIOSCL THROM VAS, V24, P583, DOI 10.1161/01.ATV.0000118277.41584.63; SCHMITT M, 1991, BIOMED BIOCHIM ACTA, V50, P731; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Song GH, 2005, ENDOCRINOLOGY, V146, P4825, DOI 10.1210/en.2005-0768; Souter I, 2009, FERTIL STERIL, V91, P2012, DOI 10.1016/j.fertnstert.2008.04.039; Starke RD, 2010, BLOOD; Tchernof A, 2002, CIRCULATION, V105, P564, DOI 10.1161/hc0502.103331; Vanderslice P, 1998, Angiogenesis, V2, P265, DOI 10.1023/A:1009296700991; Wander K, 2008, AM J PHYS ANTHROPOL, V136, P138, DOI 10.1002/ajpa.20785; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Witkowska AM, 2004, EUR CYTOKINE NETW, V15, P91	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210544	10.1371/journal.pone.0210544	http://dx.doi.org/10.1371/journal.pone.0210544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629692	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000105
J	Nishiwaki, H; Hasegawa, T; Koiwa, F; Hamano, T; Masakane, I				Nishiwaki, Hiroki; Hasegawa, Takeshi; Koiwa, Fumihiko; Hamano, Takayuki; Masakane, Ikuto			The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry	PLOS ONE			English	Article							DIALYSIS OUTCOMES; ANEMIA MANAGEMENT; PRACTICE PATTERNS; IRON	Background Few clinical studies have directly examined the associations of hemoglobin (Hb) levels after hemodialysis (HD) and of the difference in Hb levels before and after HD (Delta Hb) with patient outcomes. The present study aimed to determine Delta Hb and post-HD Hb levels with nationwide data and to examine their associations with all-cause mortality in patients undergoing HD. Methods This study is based on data from 2008 and 2009 recorded in the Japanese Renal Data Registry. Study endpoints were all-cause mortality within 1-year. The Delta Hb and post-HD Hb level as categorical variables using Cox regression for 1-year mortality, adjusting for potential confounders. Results The median Delta Hb was 1.0 g/dl, and the post-HD Hb level was 11.3 g/d. The median pre-HD Hb level was 10.4 g/dl. The risk of mortality was lower with a Delta Hb of 0 to 1.0 g/dl (adjusted hazard ratio [aHR], 0.90; 95% confidence interval [CI], 0.70-1.01) or > 1.0 g/dl (aHR, 0.73; 95% CI, 0.64-0.84) than with a Delta Hb < 0 g/dl. The risk for mortality was also lower with a post-HD Hb of 10 to 11 g/dl (aHR, 0.82; 95% CI, 0.73-0.92), 11 to 12 g/dl (aHR, 0.77; 95% CI, 0.68-0.87), or > 12 g/dl (aHR, 0.77; 95% CI, 0.68-0.87) than with a post-HD Hb < 10 g/ dl. Conclusions Both a low Delta Hb and a low post-HD Hb level were associated with a higher risk of 1-year mortality.	[Nishiwaki, Hiroki; Hasegawa, Takeshi; Hamano, Takayuki; Masakane, Ikuto] Comm Renal Data Registry, Japanese Soc Dialysis Therapy, Tokyo, Japan; [Nishiwaki, Hiroki; Hasegawa, Takeshi; Koiwa, Fumihiko] Showa Univ, Div Nephrol, Fujigaoka Hosp, Dept Med,Sch Med, Yokohama, Kanagawa, Japan; [Hasegawa, Takeshi] Showa Univ, Off Promoting Med Res, Tokyo, Japan; [Hamano, Takayuki] Osaka Univ, Dept Comprehens Kidney Dis Res, Grad Sch Med, Osaka, Japan; [Masakane, Ikuto] Yabuki Hosp, Yamagata, Japan	Showa University; Showa University; Osaka University	Hasegawa, T (corresponding author), Comm Renal Data Registry, Japanese Soc Dialysis Therapy, Tokyo, Japan.; Hasegawa, T (corresponding author), Showa Univ, Div Nephrol, Fujigaoka Hosp, Dept Med,Sch Med, Yokohama, Kanagawa, Japan.; Hasegawa, T (corresponding author), Showa Univ, Off Promoting Med Res, Tokyo, Japan.	tahasegawa-npr@umin.net	Nishiwaki, Hiroki/I-5001-2019; Hamano, TAKAYUKI/AAZ-4837-2021	Nishiwaki, Hiroki/0000-0001-7365-7685; Hamano, TAKAYUKI/0000-0002-2100-9106; Hasegawa, Takeshi/0000-0003-0420-5583				Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; [Anonymous], 2017, ETH GUID MED HLTH RE; Bellizzi V, 2002, AM J KIDNEY DIS, V40, P549, DOI 10.1053/ajkd.2002.34913; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; del Castillo N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-60; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Geller AB, 2010, DIALYSIS TRANSPLANT, V39, P57, DOI 10.1002/dat.20406; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamano T, 2015, KIDNEY INT SUPPL, V5, P23, DOI 10.1038/kisup.2015.6; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Korzets A, 2002, AM J KIDNEY DIS, V40, P873, DOI 10.1053/ajkd.2002.36594; Maruyama Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143430; Minutolo R, 2003, NEPHROL DIAL TRANSPL, V18, P2606, DOI 10.1093/ndt/gfg387; Movilli E, 2002, AM J KIDNEY DIS, V39, P850, DOI 10.1053/ajkd.2002.32007; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Nishiwaki H, 2018, J VASC ACCESS, V19, P69, DOI 10.5301/jva.5000798; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Sagheb M.M., 2016, NEPHRO UROL MON, V8; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Wong MMY, 2017, AM J KIDNEY DIS, V69, P367, DOI 10.1053/j.ajkd.2016.08.030; Yamamoto H., 2017, RENAL REPLACE THER, V3, P36, DOI [10.1186/s41100-017-0114-y, DOI 10.1186/S41100-017-0114-Y]	25	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210533	10.1371/journal.pone.0210533	http://dx.doi.org/10.1371/journal.pone.0210533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629677	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000103
J	Amidu, N; Antuamwine, BB; Addai-Mensah, O; Abdul-Karim, A; Stebleson, A; Abubakari, BB; Abenyeri, J; Opoku, S; Nkukah, JE; Najibullah, AS				Amidu, Nafiu; Antuamwine, Benedict Boateng; Addai-Mensah, Otchere; Abdul-Karim, Abass; Stebleson, Azure; Abubakari, Braimah Baba; Abenyeri, John; Opoku, Serwaa; Nkukah, John Eyulaku; Najibullah, Ali Sidi			Diagnosis of bacterial meningitis in Ghana: Polymerase chain reaction versus latex agglutination methods	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PNEUMOCOCCAL MENINGITIS; MENINGOCOCCAL DISEASE; BURKINA-FASO; SEROGROUP; OUTBREAK; CHILDREN; BELT; EPIDEMIOLOGY; INFECTIONS	Bacterial meningitis is a public health crisis in the northern part of Ghana, where it contributes to very high mortality and morbidity rates. Early detection of the causative organism will lead to better management and effective treatment. Our aim was to evaluate the diagnostic accuracy of Pastorex and Wellcogen latex agglutination tests for the detection of bacterial meningitis in a resource-limited setting. CSF samples from 330 suspected meningitis patients within the northern zone of Ghana were analysed for bacterial agents at the zonal Public Health Reference Laboratory in Tamale using polymerase chain reaction (PCR) and two latex agglutination test kits; Pastorex and Wellcogen. The overall positivity rate of samples tested for bacterial meningitis was 46.4%. Streptococcus pneumoniae was the most common cause of bacterial meningitis within the sub-region, with positivity rate of 25.2%, 28.2% and 28.8% when diagnosed using Wellcogen, Pastorex and PCR respectively. The Pastorex method was 97.4% sensitive while the Wellcogen technique was 87.6% sensitive. Both techniques however produced the same specificity of 99.4%. Our study revealed that the Pastorex method has a better diagnostic value for bacterial meningitis than the Wellcogen method and should be the method of choice in the absence of PCR.	[Amidu, Nafiu; Antuamwine, Benedict Boateng; Opoku, Serwaa; Nkukah, John Eyulaku; Najibullah, Ali Sidi] Univ Dev Studies, Sch Allied Hlth Sci, Dept Biomed Lab Sci, Tamale, Ghana; [Addai-Mensah, Otchere] Kwame Nkrumah Univ Sci & Technol, Sch Allied Hlth Sci, Dept Med Lab Technol, Kumasi, Ghana; [Abdul-Karim, Abass; Stebleson, Azure] Publ Hlth Reference Lab, Tamale, Northern Region, Ghana; [Abubakari, Braimah Baba; Abenyeri, John] Ghana Hlth Serv, Northern Reg Hlth Directorate, Tamale, Ghana	University for Development Studies; Kwame Nkrumah University Science & Technology; Ghana Health Service	Amidu, N (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Biomed Lab Sci, Tamale, Ghana.	nafamidu@yahoo.com	Addai-Mensah, Otchere/AAI-6182-2021	Antuamwine, Benedict Boateng/0000-0002-0111-6991				Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; [Anonymous], PLOS ONE; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Bozio CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203205; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Bryant PA, 2004, J CLIN MICROBIOL, V42, P2919, DOI 10.1128/JCM.42.7.2919-2925.2004; Chandrakeerthy S.R.S, 1994, TRANSACTIONS, P93; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Crossley KB, 1996, CLIN INFECT DIS, V22, P209, DOI 10.1093/clinids/22.2.209; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Djibo S, 2006, T ROY SOC TROP MED H, V100, P573, DOI 10.1016/j.trstmh.2005.10.002; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Ferraro CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101129; Gagneux S, 2000, TROP MED INT HEALTH, V5, P280, DOI 10.1046/j.1365-3156.2000.00550.x; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; GHS, PRESS STAT MEN SIT G; Gold R, 1999, INFECT DIS CLIN N AM, V13, P515, DOI 10.1016/S0891-5520(05)70092-1; Goodman AL, 2014, AM J TROP MED HYG, V91, P281, DOI 10.4269/ajtmh.13-0763; Jagadevi, 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P1005; Kwambana-Adams BA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1914-3; Kwarteng A, 2017, ACTA TROP, V169, P51, DOI 10.1016/j.actatropica.2017.01.014; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lussiana C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025706; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Messmer TO, 2004, DIAGN MICR INFEC DIS, V49, P249, DOI 10.1016/j.diagmicrobio.2004.04.013; Mohammadi SF, 2013, ANN INDIAN ACAD NEUR, V16, P645, DOI 10.4103/0972-2327.120491; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Nigrovic LE, 2004, PEDIATR INFECT DIS J, V23, P786, DOI 10.1097/01.inf.0000135679.98790.14; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Rose AMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011086; Rose AMC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007326; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saha SK, 2005, PEDIATR INFECT DIS J, V24, P1093, DOI 10.1097/01.inf.0000190030.75892.78; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Stephen AA- I, ANAL BACTERIAL MENIN; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Vuong J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147765; Whittle R.S., 2020, BMC MED; WHO, 2018, WHO UNICEF EST 13 VA; World Health Organization, 2012, MEN VACC PROV HOP PE; World Health Organization, 1999, WHO REC SURV STAND; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940; Youssef FG, 2004, ANN EPIDEMIOL, V14, P44, DOI 10.1016/S1047-2797(03)00075-9	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210812	10.1371/journal.pone.0210812	http://dx.doi.org/10.1371/journal.pone.0210812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653582	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500076
J	Parikh, RV; Iribarren, C; Lee, C; Levine-Hall, T; Tan, TC; Sanchez, G; Ding, HJ; Bidgoli, FA; Molloi, S; Go, AS				Parikh, Rishi V.; Iribarren, Carlos; Lee, Catherine; Levine-Hall, Tory; Tan, Thida C.; Sanchez, Gabriela; Ding, Huanjun; Bidgoli, Fatemeh Azamian; Molloi, Sabee; Go, Alan S.			Kidney function, proteinuria and breast arterial calcification in women without clinical cardiovascular disease: The MINERVA study	PLOS ONE			English	Article							BETA-ADRENERGIC ANTAGONISTS; VASCULAR CALCIFICATION; RISK-FACTORS; MEDIA CALCIFICATION; ATRIAL-FIBRILLATION; HEART-FAILURE; ADULTS; ANTICOAGULATION; THERAPY; DEATH	Background Breast arterial calcification (BAC) may be a predictor of cardiovascular events and is highly prevalent in persons with end-stage kidney disease. However, few studies to date have examined the association between mild-to-moderate kidney function and proteinuria with BAC. Methods We prospectively enrolled women with no prior cardiovascular disease aged 60 to 79 years undergoing mammography screening at Kaiser Permanente Northern California between 10/24/2012 and 2/13/2015. Urine albumin-to-creatinine ratio (uACR), along with specific laboratory, demographic, and medical data, were measured at the baseline visit. Baseline estimated glomerular filtration rate (eGFR), medication history, and other comorbidities were identified from self-report and/or electronic medical records. BAC presence and gradation (mass) was measured by digital quantification of full-field mammograms. Results Among 3,507 participants, 24.5% were aged >= 70 years, 63.5% were white, 7.5% had eGFR <60 ml/min/1.73m(2), with 85.7% having uACR >= 30 mg/g and 3.3% having uACR >= 300 mg/g. The prevalence of any measured BAC (>0 mg) was 27.9%. Neither uACR >= 30 mg/g nor uACR >= 300 were significantly associated with BAC in crude or multivariable analyses. Reduced eGFR was associated with BAC in univariate analyses (odds ratio 1.53, 95% CI: 1.18-2.00), but the association was no longer significant after adjustment for potential confounders. Results were similar in various sensitivity analyses that used different BAC thresholds or analytic approaches. Conclusions Among women without cardiovascular disease undergoing mammography screening, reduced eGFR and albuminuria were not significantly associated with BAC.	[Parikh, Rishi V.; Iribarren, Carlos; Lee, Catherine; Levine-Hall, Tory; Tan, Thida C.; Sanchez, Gabriela; Go, Alan S.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94595 USA; [Ding, Huanjun; Bidgoli, Fatemeh Azamian; Molloi, Sabee] Univ Calif Irvine, Sch Med, Dept Radiat Sci, Irvine, CA 92717 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol Biostat & Med, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California Irvine; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94595 USA.; Go, AS (corresponding author), Univ Calif San Francisco, Dept Epidemiol Biostat & Med, San Francisco, CA 94143 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019	Parikh, Rishi/0000-0002-1115-844X; Lee, Catherine/0000-0003-0008-9052	National Heart, Lung and Blood Institute [R01 HL106043]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a research grant from the National Heart, Lung and Blood Institute (R01 HL106043). The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation and review of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou Hassan N, 2012, CLIN J AM SOC NEPHRO, V7, P275, DOI 10.2215/CJN.06490711; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Chadashvili T, 2016, EUR J RADIOL, V85, P1121, DOI 10.1016/j.ejrad.2016.03.006; Chen J, 2017, JAMA CARDIOL, V2, P635, DOI 10.1001/jamacardio.2017.0363; de Oliveira Rodrigo Bueno, 2013, J Bras Nefrol, V35, P147, DOI 10.5935/0101-2800.20130024; Duhn V, 2011, CLIN J AM SOC NEPHRO, V6, P377, DOI 10.2215/CJN.07190810; Go AS, 2007, AM J CARDIOL, V100, P690, DOI 10.1016/j.amjcard.2007.03.084; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2008, CIRC-CARDIOVASC QUAL, V1, P138, DOI 10.1161/CIRCOUTCOMES.108.801654; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Go AS, 2008, ARCH INTERN MED, V168, P2415, DOI 10.1001/archinternmed.2008.506; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Goodman WG, 2004, AM J KIDNEY DIS, V43, P572, DOI 10.1053/j.ajkd.2003.12.005; Gordon NP, 2013, CHARACTERISTICS OF A; Hendriks EJE, 2015, JACC-CARDIOVASC IMAG, V8, P984, DOI 10.1016/j.jcmg.2014.09.014; Hendriks EJE, 2015, ATHEROSCLEROSIS, V239, P11, DOI 10.1016/j.atherosclerosis.2014.12.035; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Iribarren C, 2004, J WOMENS HEALTH, V13, P381, DOI 10.1089/154099904323087060; Iribarren C SG, ANN EPIDEMIOLOGY; Iribarren C, 2007, ANN EPIDEMIOL, V17, P669, DOI 10.1016/j.annepidem.2007.02.004; Iribarren C, 2013, CURR CARDIOVASC RISK, V7, P126, DOI 10.1007/s12170-013-0290-4; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kestenbaum BR, 2009, KIDNEY INT, V76, P991, DOI 10.1038/ki.2009.298; Ketteler M, 2006, HYPERTENSION, V47, P1027, DOI 10.1161/01.HYP.0000219635.51844.da; Koleganova N, 2009, NEPHROL DIAL TRANSPL, V24, P2488, DOI 10.1093/ndt/gfp137; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lo JC, 2007, AM J KIDNEY DIS, V50, P552, DOI 10.1053/j.ajkd.2007.07.011; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manzoor S, 2018, KIDNEY INT REP, V3, P1328, DOI 10.1016/j.ekir.2018.07.011; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Molloi S, 2008, MED PHYS, V35, P1428, DOI 10.1118/1.2868756; O'Neill WC, 2014, KIDNEY INT, V85, P668, DOI 10.1038/ki.2013.351; Peters SAE, 2012, EUR J CLIN INVEST, V42, P110, DOI 10.1111/j.1365-2362.2011.02555.x; Polonsky TS, 2017, CIRCULATION, V135, P499, DOI 10.1161/CIRCULATIONAHA.116.025277; Schlieper G, 2016, NEPHROL DIAL TRANSPL, V31, P31, DOI 10.1093/ndt/gfv111; Silverberg MJ, 2009, ANN INTERN MED, V150, P301, DOI 10.7326/0003-4819-150-5-200903030-00006; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210973	10.1371/journal.pone.0210973	http://dx.doi.org/10.1371/journal.pone.0210973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653590	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500094
J	Steiner, M; Schneider, L; Yillah, J; Gerlach, K; Kuvardina, ON; Meyer, A; Maring, A; Bonig, H; Seifried, E; Zornig, M; Lausenid, J				Steiner, Marlene; Schneider, Lucas; Yillah, Jasmin; Gerlach, Katharina; Kuvardina, Olga N.; Meyer, Annekarin; Maring, Alisa; Bonig, Halvard; Seifried, Erhard; Zoernig, Martin; Lausenid, Joern			FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation	PLOS ONE			English	Article							HEMATOPOIETIC STEM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; TARGET GENES; ERYTHROPOIESIS; LACKING; SCL; MYC; ACTIVATION; CHROMATIN	During erythropoiesis, haematopoietic stem cells (HSCs) differentiate in successive steps of commitment and specification to mature erythrocytes. This differentiation process is controlled by transcription factors that establish stage-and cell type-specific gene expression. In this study, we demonstrate that FUSE binding protein 1 (FUBP1), a transcriptional regulator important for HSC self-renewal and survival, is regulated by T-cell acute lymphocytic leukaemia 1 (TAL1) in erythroid progenitor cells. TAL1 directly activates the FUBP1 promoter, leading to increased FUBP1 expression during erythroid differentiation. The binding of TAL1 to the FUBP1 promoter is highly dependent on an intact GATA sequence in a combined E-box/GATA motif. We found that FUBP1 expression is required for efficient erythropoiesis, as FUBP1-deficient progenitor cells were limited in their potential of erythroid differentiation. Thus, the finding of an interconnection between GATA1/TAL1 and FUBP1 reveals a molecular mechanism that is part of the switch from progenitor-to erythrocyte-specific gene expression. In summary, we identified a TAL1/FUBP1 transcriptional relationship, whose physiological function in haematopoiesis is connected to proper erythropoiesis.	[Steiner, Marlene; Gerlach, Katharina; Maring, Alisa; Zoernig, Martin] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany; [Schneider, Lucas; Yillah, Jasmin; Kuvardina, Olga N.; Meyer, Annekarin; Bonig, Halvard; Seifried, Erhard; Lausenid, Joern] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany; [Schneider, Lucas; Yillah, Jasmin; Kuvardina, Olga N.; Meyer, Annekarin; Bonig, Halvard; Seifried, Erhard; Lausenid, Joern] German Red Cross Blood Serv, Frankfurt, Germany; [Gerlach, Katharina] Fresenius Kabi Deutschland GmbH, Oberursel, Germany	Octapharma; Goethe University Frankfurt	Zornig, M (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany.; Lausenid, J (corresponding author), Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany.; Lausenid, J (corresponding author), German Red Cross Blood Serv, Frankfurt, Germany.	zoernig@gsh.uni-frankfurt.de; j.lausen@blutspende.de	Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Maring, Alisa/0000-0001-8904-3151				Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Chacon D, 2014, NUCLEIC ACIDS RES, V42, pD172, DOI 10.1093/nar/gkt1036; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chung HJ, 2005, MOL CELLS, V20, P157; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Dixit U, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-925; Eggold JT, 2019, BONE, V119, P36, DOI 10.1016/j.bone.2018.03.014; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Haas N, 2015, CELL DEATH DIFFER, V22, P790, DOI 10.1038/cdd.2014.172; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Han GC, 2016, MOL CELL BIOL, V36, P157, DOI 10.1128/MCB.00806-15; Herglotz J, 2013, ONCOGENE, V32, P2565, DOI 10.1038/onc.2012.274; Herkt SC, 2018, HAEMATOLOGICA, V103, P18, DOI 10.3324/haematol.2017.174516; Hewitt KJ, 2016, CURR TOP DEV BIOL, V118, P45, DOI 10.1016/bs.ctdb.2016.01.002; Higgins JM, 2015, CLIN LAB MED, V35, P43, DOI 10.1016/j.cll.2014.10.002; Hoang T, 2016, CURR TOP DEV BIOL, V118, P163, DOI 10.1016/bs.ctdb.2016.01.004; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; PEVNY L, 1995, DEVELOPMENT, V121, P163; Porcher C, 2017, BLOOD, V129, P2051, DOI 10.1182/blood-2016-12-754051; Rabenhorst U, 2015, CELL REP, V11, P1847, DOI 10.1016/j.celrep.2015.05.038; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sivertsen EA, 2006, BRIT J HAEMATOL, V135, P117, DOI 10.1111/j.1365-2141.2006.06252.x; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Wesely J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5762301; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Wu WS, 2014, GENOME RES, V24, P1945, DOI 10.1101/gr.164830.113; Zhang J, 2013, ONCOGENE, V32, P2907, DOI 10.1038/onc.2012.350; Zheng YH, 2011, INT J BIOCHEM CELL B, V43, P1641, DOI 10.1016/j.biocel.2011.08.001	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210515	10.1371/journal.pone.0210515	http://dx.doi.org/10.1371/journal.pone.0210515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653565	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500047
J	Wakayama, A; Matsumoto, C; Ayato, Y; Shimomura, Y				Wakayama, Akemi; Matsumoto, Chota; Ayato, Yoriko; Shimomura, Yoshikazu			Comparison of monocular sensitivities measured with and without occlusion using the head-mounted perimeter imo	PLOS ONE			English	Article							BINOCULAR SUMMATION; FIELD; TRANSLUCENT; ADAPTATION; BLANKOUT	Purpose Using a head-mounted perimeter imo that can measure monocular sensitivity with both eyes open, we investigated the difference between monocular sensitivities measured with and without occlusion of the fellow eye and if the difference was influenced by eccentricity. Methods Using the perimeter imo, monocular sensitivities with/without occlusion and binocular sensitivity were measured and compared. Three test conditions for monocular sensitivity without occlusion were: with/without a fusional fixation target, and a binocular random single eye test in which the target was randomly presented to either eye and the examinee was not aware of the tested eye. Within the central 25 degrees visual field (VF), 29 points located at the fovea and on the 45 degrees, 135 degrees, 225 degrees, and 315 degrees meridians with 3 degrees intervals were tested. Differences among the four monocular sensitivities with/without occlusion were further evaluated at the fovea, within and beyond the central 5 degrees VF. Results Sixteen visually normal volunteers (mean age, 28.6 +/- 4.6 years) were included in this study. Except at the fovea, monocular sensitivities measured without occlusion were significantly higher than those with occlusion (P < 0.01). No significant difference was seen among the three monocular sensitivities without occlusion (P = 0.82). Conclusions Except at the fovea, monocular sensitivities measured with and without occlusion significantly differed. This indicates that without occlusion, binocular interaction is activated and affects not only binocular sensitivity but also monocular sensitivity.	[Wakayama, Akemi; Matsumoto, Chota; Ayato, Yoriko; Shimomura, Yoshikazu] Kindai Univ, Fac Med, Dept Ophthalmol, Osakasayama City, Osaka, Japan		Wakayama, A (corresponding author), Kindai Univ, Fac Med, Dept Ophthalmol, Osakasayama City, Osaka, Japan.	akemi-wakayama@med.kindai.ac.jp			CREWT Medical Systems, Inc.; CREWT	CREWT Medical Systems, Inc.; CREWT	YS and CM received funding from CREWT Medical Systems, Inc. CREWT made a custom program for "imo" in this study. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2002, OPTOMETRY VISION SCI, V79, P88, DOI 10.1097/00006324-200202000-00009; Anderson AJ, 2007, INVEST OPHTH VIS SCI, V48, P943, DOI 10.1167/iovs.06-0685; Aydin P, 1997, NEURO-OPHTHALMOLOGY, V17, P185, DOI 10.3109/01658109709044664; BANTON T, 1991, J OPT SOC AM A, V8, P673, DOI 10.1364/JOSAA.8.000673; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BOLANOWSKI SJ, 1987, VISION RES, V27, P967, DOI 10.1016/0042-6989(87)90012-5; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; FUHR PS, 1990, ARCH OPHTHALMOL-CHIC, V108, P983, DOI 10.1001/archopht.1990.01070090085045; Goseki T, 2016, NEURO-OPHTHALMOLOGY, V40, P281, DOI 10.1080/01658107.2016.1220593; GRIGSBY SS, 1994, VISION RES, V34, P2841, DOI 10.1016/0042-6989(94)90053-1; LIU L, 1992, VISION RES, V32, P1471, DOI 10.1016/0042-6989(92)90203-U; Matsumoto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161974; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Spry PGD, 2002, OPTOMETRY VISION SCI, V79, P93, DOI 10.1097/00006324-200202000-00010; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wakayama A, 2005, INVEST OPHTH VIS SCI, V46, P2810, DOI 10.1167/iovs.04-1421; Wakayama A, 2002, GRAEF ARCH CLIN EXP, V240, P743, DOI 10.1007/s00417-002-0526-3; Wakayama A, 2012, INVEST OPHTH VIS SCI, V53, P387, DOI 10.1167/iovs.11-8022; Wakayama A, 2011, VISION RES, V51, P174, DOI 10.1016/j.visres.2010.11.002	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210691	10.1371/journal.pone.0210691	http://dx.doi.org/10.1371/journal.pone.0210691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653560	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500063
J	Aghdam, AG; Moradhaseli, S; Jafari, F; Motahari, P; Samavat, S; Mahboudi, R; Maleknia, S				Aghdam, Atefeh Ghorbani; Moradhaseli, Saeed; Jafari, Farnoush; Motahari, Paria; Samavat, Sepideh; Mahboudi, Rasoul; Maleknia, Shayan			Therapeutic Fc fusion protein misfolding: A three-phasic cultivation experimental design	PLOS ONE			English	Article							CULTURE TEMPERATURE; PRODUCTIVITY; CELLS; ERYTHROPOIETIN; CHROMATOGRAPHY; AGGREGATION; EXPRESSION; STRATEGIES; SHIFT; TOOL	Cell culture process optimization is a critical solution to most of the challenges faced by the pharmaceutical manufacturing. One of the major problems encountered in large-scale production of therapeutic proteins is misfolded protein production. The accumulation of misfolded therapeutic proteins is an immunogenic signal and a risk factor for immunogenicity of the final product. The aim of this study was the statistical optimization of three-phasic temperature shift and timing for enhanced production of correctly folded Fc-fusion protein. The effect of culture temperatures were investigated using the biphasic culture system. Box-Behnken design was then used to compute temperature and time of shifting optimum. Response surface methodology revealed that maximum production with low level of misfolded protein was achieved at two-step temperature shift from 37 degrees C to 30 degrees C during the late logarithmic phase and 30 degrees C to 28 degrees C in the mid-stationary phase. The optimized condition gave the best results of 1860 mg L-1 protein titer with 24.5% misfolding level. The validation experiments were carried out under optimal conditions with three replicates and the protein misfolding level was decreased by two times while productivity increased by similar to 1.3-fold. Large-scale production in 250 L bioreactor under the optimum conditions was also verified the effectiveness and the accuracy of the model. The results showed that by utilizing two-step temperature shift, productivity and the quality of target protein have been improved simultaneously. This model could be successfully applied to other products.	[Aghdam, Atefeh Ghorbani; Moradhaseli, Saeed; Jafari, Farnoush; Motahari, Paria; Samavat, Sepideh; Mahboudi, Rasoul; Maleknia, Shayan] Alborz Univ Med Sci, Aryogen Pharmed Inc, Biopharmaceut Res Ctr, Karaj, Iran		Maleknia, S (corresponding author), Alborz Univ Med Sci, Aryogen Pharmed Inc, Biopharmaceut Res Ctr, Karaj, Iran.	Maleknias@aryogen.com			Aryogen Pharmed Inc.	Aryogen Pharmed Inc.	Aryogen Pharmed Inc., provided all funding supports during this specific study. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We have no conflict of interest to disclose. The authors declare that the funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarabi CD, 2015, J PHARM SCI-US, V104, P1919, DOI 10.1002/jps.24420; Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Bedoya-Lopez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151529; Berger S., 2015, MABS-AUSTIN, V7, P456, DOI 10.1080/19420862.2015.1019788; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Chaturvedi SK, 2016, PROCESS BIOCHEM, V51, P1183, DOI 10.1016/j.procbio.2016.05.015; Cynthia C., 2016, PROTEIN IMPURITIES P, P30; del Monte F, 2014, PROTEOM CLIN APPL, V8, P534, DOI 10.1002/prca.201400037; Dinarvand M, 2017, BRAZ J MICROBIOL, V48, P427, DOI 10.1016/j.bjm.2016.10.026; Elkhidir, 2011, TREN APPL SCI RES, V6, P121, DOI DOI 10.3923/tasr.2011.121.129; Estes B, 2015, BIOTECHNOL PROGR, V31, P258, DOI 10.1002/btpr.2021; Fairbrass DL, 2016, THESIS; Freund NW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020385; Gilbert A, 2014, PHARM BIOPROCESS, V2, P519, DOI 10.4155/PBP.14.35; Hackl M., 2009, THESIS; Haverick M, 2014, MABS-AUSTIN, V6, P852, DOI 10.4161/mabs.28693; Howard R, 2017, G3-GENES GENOM GENET, V7, P3103, DOI 10.1534/g3.117.044453; J Masterton R, 2014, IMPACT PROCESS TEMPE, P49; Jose Manuel G, 2008, US, Patent No. 12107533; Kallberg K, 2012, BIOTECHNOL J, V7, P1485, DOI 10.1002/biot.201200074; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kaufmann H, 1999, INFLUENCE LOW TEMPER, P573; Kelly P., 2014, THESIS; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kumar N, 2007, CYTOTECHNOLOGY, V53, P33, DOI 10.1007/s10616-007-9047-6; Kumar N, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-42; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Mammar K., 2013, LEONARDO J SCI, V23, P84; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Mason M, 2014, ANTIBODIES, V3, P253, DOI 10.3390/antib3030253; MdLV Suberbie, 2013, THESIS; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Ozturk S, 2005, CELL CULTURE TECHNOL, P47, DOI [10.1023/A:1007919921991, DOI 10.1023/A:1007919921991]; Pasma SA, 2013, INT J POLYM SCI, V2013, DOI 10.1155/2013/104502; Rath T, 2015, CRIT REV BIOTECHNOL, V35, P235, DOI 10.3109/07388551.2013.834293; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Siew A., 2015, ANAL PROTEIN AGGREGA, P40; Son YJ, 2007, BIOTECHNOL BIOPROC E, V12, P556, DOI 10.1007/BF02931354; Sou SN, 2018, BIOTECHNOL BIOENG, V115, P512, DOI 10.1002/bit.26456; Strnad J, 2010, BIOTECHNOL PROGR, V26, P653, DOI 10.1002/btpr.390; Terova O, 2018, OVERCOMING DOWNSTREA, P101; Tjeldhorn L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024009; Torkashvand F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140597; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1045, DOI 10.1002/bit.20958; Vergara M, 2013, BMC P S6, V7, P108; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zhang TC, 2015, P 2 INT C APPL BIOT, VI	50	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210712	10.1371/journal.pone.0210712	http://dx.doi.org/10.1371/journal.pone.0210712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650123	gold, Green Published			2022-12-27	WOS:000455813300072
J	Charani, E; Smith, I; Skodvin, B; Perozziello, A; Lucet, JC; Lescure, FX; Birgand, G; Poda, A; Ahmad, R; Singh, S; Holmes, AH				Charani, Esmita; Smith, Ingrid; Skodvin, Brita; Perozziello, Anne; Lucet, Jean-Christophe; Lescure, Francois-Xavier; Birgand, Gabriel; Poda, Armel; Ahmad, Raheelah; Singh, Sanjeev; Holmes, Alison Helen			Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study	PLOS ONE			English	Article							PRESCRIBING PRACTICES; ANTIBIOTIC USE; RESISTANCE; INFECTIONS; HOSPITALS; NEED	Background Most of the evidence on antimicrobial stewardship programmes (ASP) to help sustain the effectiveness of antimicrobials is generated in high income countries. We report a study investigating implementation of ASP in secondary care across low-, middle- and high-income countries. The objective of this study was to map the key contextual, including cultural, drivers of the development and implementation of ASP across different resource settings. Materials and methods Healthcare professionals responsible for implementing ASP in hospitals in England, France, Norway, India, and Burkina Faso were invited to participate in face-to face interviews. Field notes from observations, documentary evidence, and interview transcripts were analysed using grounded theory approach. The key emerging categories were analysed iteratively using constant comparison, initial coding, going back the field for further data collection, and focused coding. Theoretical sampling was applied until the categories were saturated. Cross-validation and triangulation of the findings were achieved through the multiple data sources. Results 54 participants from 24 hospitals (England 9 participants/4 hospitals; Norway 13 participants/4 hospitals; France 9 participants/7 hospitals; India 13 participants/7 hospitals; Burkina Faso 8 participants/2 hospitals) were interviewed. Across Norway, France and England there was consistency in ASP structures. In India and Burkina Faso there were country level heterogeneity in ASP. State support for ASP was perceived as essential in countries where it is lacking (India, Burkina Faso), and where it was present, it was perceived as a barrier (England, France). Professional boundaries are one of the key cultural determinants dictating involvement in initiatives with doctors recognised as leaders in ASP. Nurse and pharmacist involvement was limited to England. The surgical specialty was identified as most difficult to engage with in each country. Despite challenges, one hospital in India provided the best example of interdisciplinary ASP, championed through organisational leadership. Conclusions ASP initiatives in this study were restricted by professional boundaries and hierarchies, with lack of engagement with the wider healthcare workforce. There needs to be promotion of interdisciplinary team work including pharmacists and nurses, depending on the available healthcare workforce in different countries, in ASP. The surgical pathway remains a hard to reach, but critical target for ASP globally. There is a need to develop contextually driven ASP targeting the surgical pathway in different resource settings.	[Charani, Esmita; Birgand, Gabriel; Ahmad, Raheelah; Holmes, Alison Helen] Imperial Coll London, NIHR Hlth Protect Res Unit Healthcare Associated, London, England; [Smith, Ingrid] WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland; [Skodvin, Brita] Haukeland Hosp, Norwegian Advisory Unit Antibiot Use Hosp, Bergen, Norway; [Perozziello, Anne; Lucet, Jean-Christophe; Lescure, Francois-Xavier] Bichat Claude Bernard Hosp, AP HP, Infect Control Unit, Paris, France; [Lucet, Jean-Christophe; Lescure, Francois-Xavier] Univ Paris Diderot, IAME, UMR 1137, INSERM,Sorbonne Paris Cite, Paris, France; [Poda, Armel] Univ Bobo Dioulasso, Univ Hosp Souro Sanou, Sch Med, Bobo Dioulasso, Burkina Faso; [Singh, Sanjeev] Amrita Univ, Dept Med, Amrita Inst Med Sci, Kollam, Kerala, India	Imperial College London; World Health Organization; University of Bergen; Haukeland University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Charani, E (corresponding author), Imperial Coll London, NIHR Hlth Protect Res Unit Healthcare Associated, London, England.	e.charani@imperial.ac.uk	Lescure, Xavier/AAM-5261-2020	Charani, Esmita/0000-0002-5938-1202; Holmes, Alison/0000-0001-5554-5743; Ahmad, Raheelah/0000-0002-4294-7142	Economic and Social Science Research Council (ESRC) as part of the Antimicrobial Cross Council initiative - UK research councils [ES/P008313/1]; Global Challenges Research Fund, UK Department of Health [HPRU-2012-10047]; National Institute for Health Research, UK Department of Health [HPRU-2012-10047]; Public Health England; Norwegian Advisory Unit for Antibiotic Use in Hospitals, Haukeland University Hospital; ESRC [ES/P008313/1] Funding Source: UKRI	Economic and Social Science Research Council (ESRC) as part of the Antimicrobial Cross Council initiative - UK research councils; Global Challenges Research Fund, UK Department of Health; National Institute for Health Research, UK Department of Health; Public Health England; Norwegian Advisory Unit for Antibiotic Use in Hospitals, Haukeland University Hospital; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by Economic and Social Science Research Council (ESRC) as part of the Antimicrobial Cross Council initiative [ES/P008313/1] supported by the seven UK research councils, and the Global Challenges Research Fund and the National Institute for Health Research, UK Department of Health [HPRU-2012-10047] in partnership with Public Health England; The Norwegian Advisory Unit for Antibiotic Use in Hospitals, Haukeland University Hospital. The funders were not involved in the design, analysis and writing of this study.	Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Bernabe KJ, 2017, INT J ANTIMICROB AG, V50, P629, DOI 10.1016/j.ijantimicag.2017.07.002; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Charani E, 2017, CLIN MICROBIOL INFEC, V23, P752, DOI 10.1016/j.cmi.2017.03.013; Charani E, 2017, INT J INFECT DIS, V60, P29, DOI 10.1016/j.ijid.2017.04.020; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2018, CLIN INFECT DIS; Charani E, 2013, BMJ QUAL SAF, V22, P885, DOI 10.1136/bmjqs-2013-002444; Datta P, 2010, J HOSP INFECT, V76, P184, DOI 10.1016/j.jhin.2010.06.013; Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]; Davey P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub4; Davey P, 2015, INT J ANTIMICROB AG, V45, P203, DOI 10.1016/j.ijantimicag.2014.11.014; Dixon-Woods M, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-70; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Gelband H, 2015, TRENDS MICROBIOL, V23, P524, DOI 10.1016/j.tim.2015.06.005; Glaser B.G., 1965, AWARENESS DYING; Greenhalgh T, 2018, BMC MED, V16, P4; Habibi S, 2008, TROP DOCT, V38, P233, DOI 10.1258/td.2008.070395; Hay SI, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1073-z; HOFSTEDE G, 1984, J CROSS CULT PSYCHOL, V15, P417, DOI 10.1177/0022002184015004003; Kamat Us, 2008, Indian J Community Med, V33, P89, DOI 10.4103/0970-0218.40875; Klein EY, 2018, P NATL ACAD SCI USA, P1; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435; Lorencatto F, 2018, J ANTIMICROB CHEMOTH, V73, P2613, DOI 10.1093/jac/dky222; Mehta A, 2007, J HOSP INFECT, V67, P168, DOI 10.1016/j.jhin.2007.07.008; National Health Service, 2015, COMM QUAL INN GUID 2; ONeill J., 2016, TACKLING DRUG RESIST; Perozziello A, 2018, INT J ANTIMICROB AG, V51, P829, DOI 10.1016/j.ijantimicag.2018.01.002; Pollack LA, 2014, CLIN INFECT DIS, V59, pS97, DOI 10.1093/cid/ciu542; Pope C, 2007, ANAL QUALITATIVE DAT, P63, DOI DOI 10.1002/9780470750841.CH7; Pulcini C, 2018, CLIN MICROBIOL INFEC; Ramana B, 2012, J NTR U HLTH SCI, V1, P86; Rawson TM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0751-y; Skodvin B, 2017, J ANTIMICROB CHEMOTH, V72, P2666, DOI 10.1093/jac/dkx163; Skodvin B, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0065-4; Spradley J.P., 1980, ETHNOGRAPHY WHAT PAR, P13; Taneja N, 2004, BURNS, V30, P665, DOI 10.1016/j.burns.2004.02.011; Thu TA, 2012, AM J INFECT CONTROL, V40, P840, DOI 10.1016/j.ajic.2011.10.020; Voss A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-7; Walia K, 2015, INDIAN J MED RES, V142, P130, DOI 10.4103/0971-5916.164228; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; 2013, WORLD MAL REP 2013, P1	43	65	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209847	10.1371/journal.pone.0209847	http://dx.doi.org/10.1371/journal.pone.0209847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650099	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000455813300031
J	Lewis, TW; Mellersh, CS				Lewis, T. W.; Mellersh, C. S.			Changes in mutation frequency of eight Mendelian inherited disorders in eight pedigree dog populations following introduction of a commercial DNA test	PLOS ONE			English	Article							ROD-CONE DEGENERATION	Introduction DNA testing for autosomal recessive disease mutations in many dog breeds is now relatively commonplace. There have, however, been few efforts made to determine changes in the frequency of disease causing mutations as a result of probable selection based on the results of DNA testing. This study makes use of genotype data from both DNA test results reported to the UK Kennel Club and where known from a 'hereditary status' (where a definitive genotype may be inferred and ascribed based on known parental genotypes) to do so. Results The results, using all known genotype data, show a general and sizeable decline in disease causing mutation frequency across eight diseases in eight breeds (by between 12-86% in dogs born 2-4 years after publication of the mutation, and by nearly 90% or more in those born 8-10 years after). In contrast, data from test results only, while revealing an almost complete and immediate end to the production of affected individuals, show little general decline in either the derived mutation frequency or the proportion of heterozygote carriers. It appears that the numerical size of the breed is an important determinant on the rate of uptake of a DNA test (as judged by the proportion of a breed born four years after publication of the disease-causing mutation with a known genotype). Conclusion These results show that dog breeders appear to be incorporating the results of DNA testing into their selection strategies to successfully decrease the frequency of the mutation. It is shown that use of DNA test result data alone does not reveal such trends, possibly as some breeders undertake testing to determine clear stock which can then be used to produce future disease-free generations in the knowledge they are not carrying the disease causing mutation.	[Lewis, T. W.] Kennel Club, London, England; [Lewis, T. W.] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Mellersh, C. S.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England	University of Nottingham; Animal Health Trust	Lewis, TW (corresponding author), Kennel Club, London, England.; Lewis, TW (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	tom.lewis@thekennelclub.org.uk		Lewis, Thomas/0000-0003-4166-7955				AGUIRRE G, 1982, INVEST OPHTH VIS SCI, V23, P610; Ahonen Saija, 2018, Canine Genet Epidemiol, V5, P2, DOI 10.1186/s40575-018-0058-8; [Anonymous], R LANG ENV STAT COMP; Donner J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007361; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Downs LM, 2013, ANIM GENET, V44, P169, DOI 10.1111/j.1365-2052.2012.02379.x; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; Forman OP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002462; Gill JL, 2012, NEUROBIOL DIS, V45, P130, DOI 10.1016/j.nbd.2011.07.014; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113; Mellersh CS, 2006, VET OPHTHALMOL, V9, P369, DOI 10.1111/j.1463-5224.2006.00496.x; Online Mendelian Inheritance in Animals OMIA, ONL MEND INH AN OMIA; Patterson EE, 2008, NAT GENET, V40, P1235, DOI 10.1038/ng.224; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007	16	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209864	10.1371/journal.pone.0209864	http://dx.doi.org/10.1371/journal.pone.0209864			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650096	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300032
J	van Es, DM; Knapen, T				van Es, Daniel Marten; Knapen, Tomas			Implicit and explicit learning in reactive and voluntary saccade adaptation	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; SENSORIMOTOR ADAPTATION; VISUOMOTOR ADAPTATION; VOLITIONAL SACCADES; ADAPTIVE-CONTROL; MOTOR MEMORY; AGE; ATTENTION; CORTEX; REFLEXIVE	Saccades can either be elicited automatically by salient peripheral stimuli or can additionally depend on explicit cognitive goals. Similarly, it is thought that motor adaptation is driven by the combination of a more automatic, implicit process and a more explicit, cognitive process. However, the degree to which such implicit and explicit learning contribute to the adaptation of more reactive and voluntary saccades remains elusive. To study this question, we employed a global saccadic adaptation paradigm with both increasing and decreasing saccade amplitudes. We assessed the resulting adaptation using a dual state model of motor adaptation. This model decomposes learning into a fast and slow process, which are thought to constitute explicit and implicit learning, respectively. Our results show that adaptation of reactive saccades is equally driven by fast and slow learning, while fast learning is nearly absent when adapting voluntary (i.e. scanning) saccades. This pattern of results was present both when saccade gain was increased or decreased. Our results suggest that the increased cognitive demands associated with voluntary compared to reactive saccade planning interfere specifically with explicit learning.	[van Es, Daniel Marten; Knapen, Tomas] Vrije Univ Amsterdam, Behav & Movement Sci, Amsterdam, Noord Holland, Netherlands; [Knapen, Tomas] Royal Acad Sci, Spinoza Ctr Neuroimaging, Amsterdam, Noord Holland, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW)	van Es, DM; Knapen, T (corresponding author), Vrije Univ Amsterdam, Behav & Movement Sci, Amsterdam, Noord Holland, Netherlands.; Knapen, T (corresponding author), Royal Acad Sci, Spinoza Ctr Neuroimaging, Amsterdam, Noord Holland, Netherlands.	daan.van.es@gmail.com; tknapen@gmail.com		Knapen, Tomas/0000-0001-5863-8689	Netherlands Organization for Scientific Research [464-11-030]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	DvE was supported by an Open Research Area grant (ORA; #464-11-030) issued by the Netherlands Organization for Scientific Research (www.nwo.nl) awarded to Jan Theeuwes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahyane N, 2005, ANN NY ACAD SCI, V1039, P558, DOI 10.1196/annals.1325.067; Alahyane N, 2007, BRAIN RES, V1135, P107, DOI 10.1016/j.brainres.2006.11.077; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Anguera JA, 2007, BRAIN RES, V1185, P136, DOI 10.1016/j.brainres.2007.09.088; Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Bender J, 2013, BRAIN COGNITION, V83, P1, DOI [10.1016/j.bandc.2013:06.005, 10.1016/j.bandc.2013.06.005]; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cotti J, 2007, J NEUROPHYSIOL, V98, P602, DOI 10.1152/jn.00293.2007; Cotti J, 2009, J PHYSIOL-LONDON, V587, P127, DOI 10.1113/jphysiol.2008.159459; CRAIK FI, 2000, HDB AGING COGNITION, V2; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; Deubel H, 2010, VISION RES, V50, P249, DOI 10.1016/j.visres.2009.09.020; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Eversheim U, 2001, LEARN MEMORY, V8, P183, DOI 10.1101/lm.39301; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gerardin P, 2012, NEUROIMAGE, V61, P1100, DOI 10.1016/j.neuroimage.2012.03.037; Heuer H, 2011, J NEUROPHYSIOL, V106, P2078, DOI 10.1152/jn.00043.2011; Heuer H, 2011, HUM MOVEMENT SCI, V30, P916, DOI 10.1016/j.humov.2010.07.004; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Huberdeau DM, 2015, CURR OPIN NEUROBIOL, V33, P71, DOI 10.1016/j.conb.2015.03.003; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Joosten ERM, 2018, J VISION, V18, DOI 10.1167/18.3.10; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Langan J, 2011, BEHAV BRAIN RES, V225, P160, DOI 10.1016/j.bbr.2011.07.014; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Noto CT, 1999, J NEUROPHYSIOL, V81, P2798, DOI 10.1152/jn.1999.81.6.2798; Panouilleres M, 2014, CEREB CORTEX, V24, P304, DOI 10.1093/cercor/bhs312; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Rolfs M, 2010, VISION RES, V50, P1882, DOI 10.1016/j.visres.2010.06.010; Schall JD, 2015, ANNU REV VIS SCI, V1, P469, DOI 10.1146/annurev-vision-082114-035317; Schneider WX, 1995, VISUAL SELECTIVE ATTENTION, P331, DOI 10.1080/13506289508401737; Seidler RD, 2012, J MOTOR BEHAV, V44, P445, DOI 10.1080/00222895.2012.672348; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Taylor JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002485; Zimmermann E, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00225; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	73	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0203248	10.1371/journal.pone.0203248	http://dx.doi.org/10.1371/journal.pone.0203248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650083	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300002
J	Zhou, H; Wang, AQ; Huang, XN; Guo, SF; Yang, YN; Martin, K; Tian, XB; Josephs-Spaulding, J; Ma, CY; Scherpbier, RW; Wang, Y				Zhou, Hong; Wang, Anqi; Huang, Xiaona; Guo, Sufang; Yang, Yuning; Martin, Kathryn; Tian, Xiaobo; Josephs-Spaulding, Jonathan; Ma, Chuyang; Scherpbier, Robert W.; Wang, Yan			Quality antenatal care protects against low birth weight in 42 poor counties of Western China	PLOS ONE			English	Article							PRENATAL-CARE; SUPPLEMENTATION; PREGNANCY; MOTHERS	Limited data exist related to low birth weight (LBW) incidence and risk factors in Western China. This paper aims to assess LBW and its relationship with antenatal care (ANC) in the poor counties of Western China. A community-based study in rural Western China was conducted in 2011. A kernel distribution was used to estimate the adjusted LBW incidence, and associations between LBW and socio-demographic or maternal factors were examined using multilevel logistic regression. Among 8,964 participants, 65.7% were weighed at birth. Crude LBW incidence was 6.6% and the adjusted rate was 9.3%. The study revealed that risk factors of LBW are being female, raised within a minority group, and with a family income below the national poverty line. For maternal risk factors, LBW was positively associated with not attending at least five or eight ANC visits, not receiving any ANC during the first trimester, and not having access to assess certain ANC content (weight, blood pressure, blood test, urine test, B-scan ultrasound, and folic acid supplement). There is urgent need to promote quality ANC in poor and rural areas of Western China and to prioritize vulnerable women and children who will benefit from quality ANC.	[Zhou, Hong; Wang, Anqi; Wang, Yan] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China; [Zhou, Hong; Wang, Yan] Natl Human Genet Resources Ctr, Environm & Spatial Epidemiol Res Ctr, Beijing, Peoples R China; [Wang, Anqi] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Huang, Xiaona; Yang, Yuning; Martin, Kathryn; Tian, Xiaobo; Scherpbier, Robert W.] UNICEF China, Beijing, Peoples R China; [Guo, Sufang] UNICEF Reg Off South Asia, Leknath Marg, Kathmandu, Nepal; [Josephs-Spaulding, Jonathan] Christian Albrechts Univ Kiel, Inst Expt Med, Kiel, Germany; [Ma, Chuyang] Beijing Lu He Int Acad, Beijing, Peoples R China	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Kiel	Wang, Y (corresponding author), Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing, Peoples R China.; Wang, Y (corresponding author), Natl Human Genet Resources Ctr, Environm & Spatial Epidemiol Res Ctr, Beijing, Peoples R China.; Scherpbier, RW (corresponding author), UNICEF China, Beijing, Peoples R China.	rscherpbier@unicef.org; wangyan@bjmu.edu.cn	Josephs-Spaulding, Jonathan/T-7730-2019	Josephs-Spaulding, Jonathan/0000-0001-9828-0685	UNICEF China [YH702]	UNICEF China	This work was funded by a grant from UNICEF China (YH702 to YW); https://www.unicef.org/infobycountry/china.html.The funders participated the process of study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazs P, 2013, EUR J PUBLIC HEALTH, V23, P480, DOI 10.1093/eurpub/cks089; Bener Abdulbari, 2012, ISRN Obstet Gynecol, V2012, P540495; Bian YH, 2013, J BIOMED RES, V27, P14, DOI 10.7555/JBR.27.20120046; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Borah Madhur, 2015, J Family Med Prim Care, V4, P380, DOI 10.4103/2249-4863.161326; da Fonseca CRB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-255; Charnigo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-37; Chinese Nutrition Society, 2016, CHIN DIET GUID; Cui Hao, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P161; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Department of Household Surveys National Bureau of Statistics of China, 2016, POV MON REP RUR CHIN; Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299, DOI 10.1093/ajcn/80.5.1299; Division UNP, 2017, SEX RAT BIRTH REF MA; Keen CL, 2003, J NUTR, V133, p1597S, DOI 10.1093/jn/133.5.1597S; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; Kirkham C, 2005, AM FAM PHYSICIAN, V71, P1307; Lin Liangming, 2002, Zhonghua Yufang Yixue Zazhi, V36, P149; Pinzon-Rondon AM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0541-0; Martinez-Mesa J, 2013, OSTEOPOROSIS INT, V24, P7, DOI 10.1007/s00198-012-2114-7; Matthews T J, 2013, Natl Vital Stat Rep, V62, P1; Nation Health and Family Planning Commission of the People's Republic of China, 2011, NAT BAS PUBL HLTH SE; National Bureau of Statistics, 2011, 2010 POP CENS PEOPL; National Bureau of Statistics of China, NAT DAT ANN 2010; National Health and Family Planning Commission of China, 2011, ADM HLTH CARE PREGN; Rao JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21771-6; Servan-Mori E, 2016, HEALTH POLICY PLANN, V31, P444, DOI 10.1093/heapol/czv082; Shan XY, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-105; State Council of the People's Republic of China, 2009, OP CENTR COMM COMM P; Tang L, 2013, BIRTH-ISS PERINAT C, V40, P134, DOI 10.1111/birt.12038; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Van Kerm P, 2003, STATA J, V3, P148, DOI 10.1177/1536867X0300300204; Van Kerm P, 2012, STATA J, V12, P543, DOI 10.1177/1536867X1201200313; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2004, LOW BIRTHW COUNTR RE; WHO, 2018, GUIDELINES OPTIMAL F; World Health Organization, 2015, PREGN CHILDB POSTP N; Xiao PL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0684-z; Ye F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134756; Zarrati M, 2013, ANN NUTR METAB, V63, P69, DOI 10.1159/000351869	42	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210393	10.1371/journal.pone.0210393	http://dx.doi.org/10.1371/journal.pone.0210393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650127	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300055
J	Enshaeifar, S; Zoha, A; Skillman, S; Markides, A; Acton, ST; Elsaleh, T; Kenny, M; Rostill, H; Nilforooshan, R; Barnaghi, P				Enshaeifar, Shirin; Zoha, Ahmed; Skillman, Severin; Markides, Andreas; Acton, Sahr Thomas; Elsaleh, Tarek; Kenny, Mark; Rostill, Helen; Nilforooshan, Ramin; Barnaghi, Payam			Machine learning methods for detecting urinary tract infection and analysing daily living activities in people with dementia	PLOS ONE			English	Article							EARLY WARNING SCORE; HOSPITAL ADMISSIONS; VALIDATION; ACTIGRAPHY; PREVALENCE; OUTCOMES; REASONS; EVENTS	Dementia is a neurological and cognitive condition that affects millions of people around the world. At any given time in the United Kingdom, 1 in 4 hospital beds are occupied by a person with dementia, while about 22% of these hospital admissions are due to preventable causes. In this paper we discuss using Internet of Things (IoT) technologies and in-home sensory devices in combination with machine learning techniques to monitor health and well-being of people with dementia. This will allow us to provide more effective and preventative care and reduce preventable hospital admissions. One of the unique aspects of this work is combining environmental data with physiological data collected via low cost in-home sensory devices to extract actionable information regarding the health and well-being of people with dementia in their own home environment. We have worked with clinicians to design our machine learning algorithms where we focused on developing solutions for real-world settings. In our solutions, we avoid generating too many alerts/alarms to prevent increasing the monitoring and support workload. We have designed an algorithm to detect Urinary Tract Infections (UTI) which is one of the top five reasons of hospital admissions for people with dementia (around 9% of hospital admissions for people with dementia in the UK). To develop the UTI detection algorithm, we have used a Non-negative Matrix Factorisation (NMF) technique to extract latent factors from raw observation and use them for clustering and identifying the possible UTI cases. In addition, we have designed an algorithm for detecting changes in activity patterns to identify early symptoms of cognitive decline or health decline in order to provide personalised and preventative care services. For this purpose, we have used an Isolation Forest (iForest) technique to create a holistic view of the daily activity patterns. This paper describes the algorithms and discusses the evaluation of the work using a large set of real-world data collected from a trial with people with dementia and their caregivers.	[Enshaeifar, Shirin; Zoha, Ahmed; Skillman, Severin; Markides, Andreas; Acton, Sahr Thomas; Elsaleh, Tarek; Barnaghi, Payam] Univ Surrey, CVSSP, Dept Elect & Elect Engn, Guildford, Surrey, England; [Kenny, Mark; Rostill, Helen; Nilforooshan, Ramin] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England	University of Surrey	Barnaghi, P (corresponding author), Univ Surrey, CVSSP, Dept Elect & Elect Engn, Guildford, Surrey, England.	p.barnaghi@surrey.ac.uk	Zoha, Ahmed/ABB-8933-2020; Enshaeifar, Shirin/M-7783-2016; Elsaleh, Tarek/X-1141-2019; Elsaleh, Tarek/AAK-5803-2021; Barnaghi, Payam/ABE-9236-2020	Zoha, Ahmed/0000-0001-7497-9336; Enshaeifar, Shirin/0000-0001-6216-0622; Elsaleh, Tarek/0000-0002-9134-0232; Barnaghi, Payam/0000-0001-8591-9638; Nilforooshan, Ramin/0000-0001-9801-183X	Office of Life Sciences at Department of Health UK [TS/N009894/1]	Office of Life Sciences at Department of Health UK	This project is supported by a grant from the Office of Life Sciences at Department of Health UK, grant number (TS/N009894/1) (PB). More information can be found here: (https://www.gov.uk/government/organisations/office-for-lifesciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu S, 2002, INT J GERIATR PSYCH, V17, P422, DOI 10.1002/gps.624; Bernardes C, 2018, ARCH GERONTOL GERIAT, V77, P150, DOI 10.1016/j.archger.2018.05.006; Berry B., 2012, RULES TERMINOLOGY TE, VVolume 176, P2012; Caljouw MAA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-57; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13, DOI DOI 10.1016/B0-72-160797-7/50009-4; Chernbumroong S, 2013, EXPERT SYST APPL, V40, P1662, DOI 10.1016/j.eswa.2012.09.004; Cook DJ, 2014, J INTELL INF SYST, V43, P503, DOI 10.1007/s10844-014-0341-4; Dawadi PN, 2013, TECHNOL HEALTH CARE, V21, P323, DOI 10.3233/THC-130734; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Demiris George, 2008, Technol Health Care, V16, P111; Enshaeifar S., 2018, IEEE T IND INFORM; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gehrman P, 2002, J SLEEP RES, V11, P229, DOI 10.1046/j.1365-2869.2002.00306.x; Gerry S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019268; Hayes TL, 2010, IEEE ENG MED BIO, P2147, DOI 10.1109/IEMBS.2010.5628022; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; Ibrisimovic MA, 2017, IFMBE PROC, V62, P289, DOI 10.1007/978-981-10-4166-2_43; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Kim H, 2008, SIAM J MATRIX ANAL A, V30, P713, DOI 10.1137/07069239X; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Leibovici L, 2000, IEEE T KNOWL DATA EN, V12, P517, DOI 10.1109/69.868905; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Ligeza A., 2006, LOGICAL FDN RULE BAS, V11; Lymberopoulos D, 2011, UNIVERSAL ACCESS INF, V10, P125, DOI 10.1007/s10209-010-0197-5; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; McCurry SM, 2006, AM J GERIAT PSYCHIAT, V14, P112, DOI 10.1097/01.JGP.0000192499.25940.da; Meister L, 2013, ACAD EMERG MED, V20, P632, DOI 10.1111/acem.12171; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Mukadam N, 2011, INT PSYCHOGERIATR, V23, P344, DOI 10.1017/S1041610210001717; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; Nourhashemi F, 2001, ALZ DIS ASSOC DIS, V15, P21, DOI 10.1097/00002093-200101000-00003; ORRELL M, 1995, PSYCHOL MED, V25, P373, DOI 10.1017/S0033291700036278; Rantz M. J., 2011, 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services (Healthcom 2011), P142, DOI 10.1109/HEALTH.2011.6026731; Rao A, 2016, ARCH GERONTOL GERIAT, V66, P198, DOI 10.1016/j.archger.2016.06.008; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Sampson EL, 2014, BRIT J PSYCHIAT, V205, P189, DOI 10.1192/bjp.bp.113.130948; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Samy L, 2014, IEEE SENS J, V14, P2092, DOI 10.1109/JSEN.2013.2293917; Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361; Skubic M, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2421499; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Smith L. J., 2003, MEASUREMENT SLEEP; Society A, 2018, COUNT COST CAR PEOPL; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Tamura Toshiyo, 2007, Open Med Inform J, V1, P1, DOI 10.2174/1874431100701010001; Toot S, 2013, J AM MED DIR ASSOC, V14, P463, DOI 10.1016/j.jamda.2013.01.011; Tuppin P, 2009, DEMENT GERIATR COGN, V28, P225, DOI 10.1159/000238394; Urwyler P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42084; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wang HY, 2010, IEEE INT C BIO BIO W, P405, DOI 10.1109/BIBMW.2010.5703836; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	56	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209909	10.1371/journal.pone.0209909	http://dx.doi.org/10.1371/journal.pone.0209909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645599	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000455810200015
J	de Dios, MA; Cano, MA; Vaughan, EL; Childress, SD; McNeel, MM; Harvey, LM; Niaura, RS				de Dios, Marcel A.; Cano, Miguel Angel; Vaughan, Ellen L.; Childress, Sarah D.; McNeel, Morgan M.; Harvey, Laura M.; Niaura, Raymond S.			A pilot randomized trial examining the feasibility and acceptability of a culturally tailored and adherence-enhancing intervention for Latino smokers in the US	PLOS ONE			English	Article							SMOKING-CESSATION INTERVENTION; NICOTINE REPLACEMENT THERAPY; QUIT SMOKING; RACIAL/ETHNIC DISPARITIES; ETHNIC-DIFFERENCES; CIGARETTE SMOKERS; UNITED-STATES; ABSTINENCE; SPANISH; ADVICE	Latino smokers in the United States (US) are known to experience smoking cessation treatment disparities due to their under-utilization of services, limited access to health care, and poor smoking cessation treatment outcomes. A limited number of studies have focused on developing and testing smoking cessation treatments for Latino smokers in the US. The objectives of this study were to conduct a feasibility pilot randomized trial testing three smoking cessation interventions for Latinos. Twenty-five adult Latino smokers were randomized to one of three groups: Culturally-Tailored Smoking Cessation plus Adherence Enhancement (CT+AE), Culturally-Tailored Smoking Cessation (CTSC), and a Health Education (HE) control group. All participants received three counseling sessions along with nicotine replacement therapy (NRT). Data relating to intervention acceptability and NRT adherence were collected. Self-reported 7-day point prevalence smoking was collected at 3 and 6 month follow-up and biochemically verified with expired carbon monoxide testing. Overall, the interventions demonstrated high levels of feasibility and acceptability. Days of nicotine patch use were found to be higher in the CT+AE group (mean (M) = 81.3; standard deviation (SD) = 3.32) than the CTSC (M = 68.6; SD = 13.66) and HE (M = 64; SD = 17.70) groups. At 3-month follow-up, approximately 50% of the CT+AE group were smoking abstinent, 25% of the CTSC group, and 44% of the HE group. At 6-month follow-up, 37.5% of the CT+AE group were abstinent, 25% of the CTSC group, and 44.4% of the HE group. This study is the first to target Latino smokers in the US with a culturally-tailored intervention that addresses treatment adherence. Results support the preliminary feasibility and acceptability of the CT+AE intervention.	[de Dios, Marcel A.; Childress, Sarah D.; McNeel, Morgan M.; Harvey, Laura M.] Univ Houston, Coll Educ, Dept Psychol Hlth & Learning Sci, Houston, TX 77004 USA; [de Dios, Marcel A.; Childress, Sarah D.] Univ Houston, Hlth Res Inst, Houston, TX 77004 USA; [Cano, Miguel Angel] Florida Int Univ, Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA; [Vaughan, Ellen L.] Indiana Univ, Sch Educ, Dept Counseling & Educ Psychol, Bloomington, IN 47405 USA; [Niaura, Raymond S.] NYU, Coll Global Publ Hlth, Dept Social & Behav Sci, New York, NY USA	University of Houston System; University of Houston; University of Houston System; University of Houston; State University System of Florida; Florida International University; Indiana University System; Indiana University Bloomington; New York University	de Dios, MA (corresponding author), Univ Houston, Coll Educ, Dept Psychol Hlth & Learning Sci, Houston, TX 77004 USA.; de Dios, MA (corresponding author), Univ Houston, Hlth Res Inst, Houston, TX 77004 USA.	madedios@uh.edu	Niaura, Raymond/AAE-7319-2019; Cano, Miguel Angel/V-8215-2017; Cano, Miguel/GSO-1160-2022	Niaura, Raymond/0000-0002-0856-3540; Cano, Miguel Angel/0000-0002-9847-1358; 	National Cancer Institute [K01-CA160670]; National Institute on Alcohol Abuse and Alcoholism [K01-AA025992]; NATIONAL CANCER INSTITUTE [K01CA160670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA025992] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Cancer Institute [K01-CA160670, M. de Dios, PI] and the National Institute on Alcohol Abuse and Alcoholism [K01-AA025992, M. Cano, PI].	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; [Anonymous], 2017, QUICK FACTS US CENSU; BECONA E, 1992, PSYCHOL REP, V71, P1227, DOI 10.2466/PR0.71.8.1227-1233; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Borrelli B, 2010, J CONSULT CLIN PSYCH, V78, P34, DOI 10.1037/a0016932; Bureau USC, 2017, QUICK FACTS HOUST TE; Bustamante AV, 2010, AM J PREV MED, V38, P610, DOI 10.1016/j.amepre.2010.01.029; Cabriales JA, 2012, EXP CLIN PSYCHOPHARM, V20, P410, DOI 10.1037/a0029039; Cahill K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub7; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Carrozzi Laura, 2008, Ther Adv Respir Dis, V2, P301, DOI 10.1177/1753465808096136; (CDC) CfDCaP, 2017, CDC DOHAHS; Champagne BR, 2016, J HEALTH PSYCHOL, V21, P2376, DOI 10.1177/1359105315577117; Covey LS, 2008, ETHNIC DIS, V18, P59; Cropsey KL, 2014, NICOTINE TOB RES, V16, P1348, DOI 10.1093/ntr/ntu085; de Dios MA, 2012, J SUBST ABUSE TREAT, V43, P322, DOI 10.1016/j.jsat.2012.01.004; de los Monteros KE, 2011, INT J BEHAV MED, V18, P310, DOI 10.1007/s12529-010-9119-4; Denny CH, 2003, AM J PREV MED, V24, P71, DOI 10.1016/S0749-3797(02)00568-8; Eldridge Sandra M, 2016, Pilot Feasibility Stud, V2, P64, DOI 10.1136/bmj.i5239; Fant Reginald V, 2009, Handb Exp Pharmacol, P487, DOI 10.1007/978-3-540-69248-5_17; Fiore M C, 2000, Respir Care, V45, P1196; Fiore MC, 2008, TREATING TOBACCO USE; Fu SS, 2008, CANCER EPIDEM BIOMAR, V17, P1640, DOI 10.1158/1055-9965.EPI-07-2726; Gandhi KK, 2009, INT J CLIN PRACT, V63, P360, DOI 10.1111/j.1742-1241.2008.01969.x; GlaxoSmithKline Corp, 2015, NIC CQ PATCH; Guendelman S, 2000, J HEALTH CARE POOR U, V11, P179; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hill A L, 2000, Nicotine Tob Res, V2, P247; Hollands GJ, 2013, NICOTINE TOB RES, V15, P1537, DOI 10.1093/ntr/ntt010; Houston TK, 2005, AM J PUBLIC HEALTH, V95, P1056, DOI 10.2105/AJPH.2004.039909; IBM Corp, IBM SPSS STAT WIND V; JACKSON PH, 1989, ADDICT BEHAV, V14, P335, DOI 10.1016/0306-4603(89)90064-6; Jamal A, 2018, MMWR-MORBID MORTAL W, V67, P53, DOI 10.15585/mmwr.mm6702a1; Kang-Kim M, 2008, MED CARE, V46, P507, DOI 10.1097/MLR.0b013e31816dd966; Kaplan RC, 2014, AM J PREV MED, V46, P496, DOI 10.1016/j.amepre.2014.01.014; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lancaster T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001292.pub3; Levinson AH, 2004, AM J PREV MED, V26, P105, DOI 10.1016/j.amepre.2003.10.012; Levinson AH, 2006, AM J PREV MED, V31, P167, DOI 10.1016/j.amepre.2006.03.022; Lopez G, 2015, IMPACT SLOWING IMMIG; Lopez-Quintero C, 2006, AM J PUBLIC HEALTH, V96, P2235, DOI 10.2105/AJPH.2005.071035; Marin G, 1991, RES HISPANIC POPULAT; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; McAlister A L, 1992, Am J Health Promot, V6, P274; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; Munoz RF, 1997, AM J COMMUN PSYCHOL, V25, P325, DOI 10.1023/A:1024676626955; Nevid JS, 1997, AM J HEALTH PROMOT, V11, P198, DOI 10.4278/0890-1171-11.3.198; Nicita-Mauro V, 2010, CURR PHARM DESIGN, V16, P775, DOI 10.2174/138161210790883552; ORLEANS CT, 1991, J CONSULT CLIN PSYCH, V59, P439, DOI 10.1037/0022-006X.59.3.439; PEREZSTABLE EJ, 1991, PUBLIC HEALTH REP, V106, P564; Pollak KI, 2015, CANCER EPIDEM BIOMAR, V24, P379, DOI 10.1158/1055-9965.EPI-14-0841; Rabius V, 2007, TOB CONTROL, V16, pI71, DOI 10.1136/tc.2007.019950; Reed MB, 2008, NICOTINE TOB RES, V10, P1487, DOI 10.1080/14622200802323217; Robinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992; Shiffman S, 2002, ADDICTION, V97, P505, DOI 10.1046/j.1360-0443.2002.00141.x; Silagy CA, 2001, BRIT MED J, V323, P833, DOI 10.1136/bmj.323.7317.833; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; Stanton CA, 2015, NICOTINE TOB RES, V17, P975, DOI 10.1093/ntr/ntv014; Stanton CA, 2009, AIDS EDUC PREV, V21, P65, DOI 10.1521/aeap.2009.21.3_supp.65; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; U.S. Department of Health and Human Services. Tobacco Use Among U.S. Racial/Ethnic Minority Groups-African Americans American Indiants and Alaska Natives, 1998, AM IND AL NAT AS AM; Vasthare R K S, 2018, J INT ORAL HLTH, V10, P71, DOI [10.4103/jioh.jioh_273_17, DOI 10.4103/JIOH.JIOH_273_17]; Webb MS, 2010, AM J HEALTH PROMOT, V25, P109, DOI 10.4278/ajhp.090123-LIT-25; Wetter DW, 2007, CANCER-AM CANCER SOC, V109, P406, DOI 10.1002/cncr.22360; Whitehead AL, 2016, STAT METHODS MED RES, V25, P1057, DOI 10.1177/0962280215588241; Woodruff SI, 2002, TOB CONTROL, V11, P361, DOI 10.1136/tc.11.4.361	68	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210323	10.1371/journal.pone.0210323	http://dx.doi.org/10.1371/journal.pone.0210323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633744	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100017
J	Ivanova, MM; Changsila, E; Iaonou, C; Goker-Alpan, O				Ivanova, Margarita M.; Changsila, Erk; Iaonou, Chidima; Goker-Alpan, Ozlem			Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; MAMMALIAN TARGET; GLUCOSYLCERAMIDE ACCUMULATION; RAPAMYCIN MTOR; CELLS; DEGRADATION; DYSFUNCTION; MOUSE; MANIFESTATIONS; REFORMATION	The major cellular clearance pathway for organelle and unwanted proteins is the autophagy-lysosome pathway (ALP). Lysosomes not only house proteolytic enzymes, but also traffic organelles, sense nutrients, and repair mitochondria. Mitophagy is initiated by damaged mitochondria, which is ultimately degraded by the ALP to compensate for ATP loss. While both systems are dynamic and respond to continuous cellular stressors, most studies are derived from animal models or cell based systems, which do not provide complete real time data about cellular processes involved in the progression of lysosomal storage diseases in patients. Gaucher and Fabry diseases are rare sphingolipid disorders due to the deficiency of the lysosomal enzymes; glucocerebrosidase and alpha-galactosidase A with resultant lysosomal dysfunction. Little is known about ALP pathology and mitochondrial function in patients with Gaucher and Fabry diseases, and the effects of enzyme replacement therapy (ERT). Studying blood mononuclear cells (PBMCs) from patients, we provide in vivo evidence, that regulation of ALP is defective. In PBMCs derived from Gaucher patients, we report a decreased number of autophagic vacuoles with increased cytoplasmic localization of LC3A/B, accompanied by lysosome accumulation. For both Gaucher and Fabry diseases, the level of the autophagy marker, Beclin1, was elevated and ubiquitin binding protein, SQSTM1/p62, was decreased. mTOR inhibition did not activate autophagy and led to ATP inhibition in PBMCs. Lysosomal abnormalities, independent of the type of the accumulated substrate suppress not only autophagy, but also mitochondrial function and mTOR signaling pathways. ERT partially restored ALP function, LC3-II accumulation and decreased LC3-I/LC3-II ratios. Levels of lysosomal (LAMP1), autophagy (LC3), and mitochondrial markers, (Tfam), normalized after ERT infusion. In conclusion, there is mTOR pathway dys-function in sphingolipidoses, as observed in both PBMCs derived from patients with Gaucher and Fabry diseases, which leads to impaired autophagy and mitochondrial stress. ERT partially improves ALP function.	[Ivanova, Margarita M.; Changsila, Erk; Iaonou, Chidima; Goker-Alpan, Ozlem] Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA 22030 USA		Ivanova, MM; Goker-Alpan, O (corresponding author), Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA 22030 USA.	mivanova@ldrtc.org; ogoker-alpan@ldrtc.org	Ivanova, Margarita/AAM-4510-2021	Ivanova, Margarita/0000-0002-6197-8606				Aflaki E, 2016, AGING CELL, V15, P77, DOI 10.1111/acel.12409; Awad O, 2015, HUM MOL GENET, V24, P5775, DOI 10.1093/hmg/ddv297; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Baris HN, 2014, PEDIATR ENDOCR REV P, V12, P72; Bauerly KA, 2006, BBA-GEN SUBJECTS, V1760, P1741, DOI 10.1016/j.bbagen.2006.07.009; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Charrow J, 2015, AM J HEMATOL, V90, pS19, DOI 10.1002/ajh.24056; Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Collins Lucy M, 2017, F1000Res, V6, P1751, DOI 10.12688/f1000research.12090.1; Das AM, 2009, ADV CLIN CHEM, V49, P57, DOI 10.1016/S0065-2423(09)49003-6; de la Mata Mario, 2016, Diseases, V4, DOI 10.3390/diseases4040031; de la Mata M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10903; Du TT, 2015, AUTOPHAGY, V11, P1803, DOI 10.1080/15548627.2015.1086055; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Gegg ME, 2016, NEUROBIOL DIS, V90, P43, DOI 10.1016/j.nbd.2015.09.006; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hu YW, 2016, J CELL BIOCHEM, V117, P413, DOI 10.1002/jcb.25287; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kinghorn KJ, 2016, J NEUROSCI, V36, P11654, DOI 10.1523/JNEUROSCI.4527-15.2016; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Limgala RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168135; Lucke T, 2004, MOL GENET METAB, V82, P93, DOI 10.1016/j.ymgme.2004.01.011; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Magalhaes J, 2016, HUM MOL GENET, V25, P3432, DOI 10.1093/hmg/ddw185; Marchesan D, 2012, J INHERIT METAB DIS, V35, P1107, DOI 10.1007/s10545-012-9472-3; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mehta AB, 2009, INT J CLIN PHARM TH, V47, pS66; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Nelson MP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-20; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Osellame LD, 2014, BRIT J PHARMACOL, V171, P1958, DOI 10.1111/bph.12453; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pandey MK, 2017, NATURE, V543, P108, DOI 10.1038/nature21368; Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Perrot A, 2002, HERZ, V27, P699, DOI 10.1007/s00059-002-2429-9; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Plotegher N, 2017, TRENDS MOL MED, V23, P116, DOI 10.1016/j.molmed.2016.12.003; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Radde BN, 2015, BIOCHEM J, V465, P49, DOI 10.1042/BJ20131608; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Slaats GG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29240-w; Squillaro T, 2017, J CELL PHYSIOL, V232, P3454, DOI 10.1002/jcp.25807; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tatti M, 2012, HUM MOL GENET, V21, P5159, DOI 10.1093/hmg/dds367; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Welford RWD, 2018, HUM MOL GENET, V27, P3392, DOI 10.1093/hmg/ddy248; Wu YJ, 2018, MOL MED REP, V17, P8003, DOI 10.3892/mmr.2018.8831; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	80	33	34	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210617	10.1371/journal.pone.0210617	http://dx.doi.org/10.1371/journal.pone.0210617			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633777	Green Submitted, Green Published, gold			2022-12-27	WOS:000455485100033
J	Czobor, A; Hajdinak, P; Nemeth, B; Piros, B; Nemeth, A; Szarka, A				Czobor, Adam; Hajdinak, Peter; Nemeth, Bence; Piros, Borbala; Nemeth, Aron; Szarka, Andras			Comparison of the response of alternative oxidase and uncoupling proteins to bacterial elicitor induced oxidative burst	PLOS ONE			English	Article							HYPERSENSITIVE CELL-DEATH; GENE-EXPRESSION; HYDROGEN-PEROXIDE; MITOCHONDRIAL PROTEIN; DISEASE RESISTANCE; RESPIRATORY-CHAIN; BIOTIC STRESS; ACTIVE OXYGEN; ARABIDOPSIS; DEFENSE	Plant UCPs are proved to take part in the fine-tuning of mitochondrial ROS generation. It has emerged that mitochondrion can be an important early source of intracellular ROS during plant-pathogen interaction thus plant UCPs must also play key role in this redox fine-tuning during the early phase of plant-pathogen interaction. On the contrary of this well-established assumption, the expression of plant UCPs and their activity has not been investigated in elicitor induced oxidative burst. Thus, the level of plant UCPs both at RNA and protein level and their activity was investigated and compared to AOX as a reference in Arabidopsis thaliana cells due to bacterial harpin treatments. Similar to the expression and activity of AOX, the transcript level of UCP4, UCP5 and the UCP activity increased due to harpin treatment and the consequential oxidative burst. The expression of UCP4 and UCP5 elevated 15-18-fold after 1 h of treatment, then the activity of UCP reached its maximal value at 4h of treatment. The quite rapid activation of UCP due to harpin treatment gives another possibility to fine tune the redox balance of plant cell, furthermore explains the earlier observed rapid decrease of mitochondrial membrane potential and consequent decrease of ATP synthesis after harpin treatment.	[Czobor, Adam; Hajdinak, Peter; Nemeth, Bence; Piros, Borbala; Szarka, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary; [Nemeth, Aron] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Fermentat Pilot Plant Lab, Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics	Szarka, A (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary.	szarka@mail.bme.hu	Nemeth, Aron/I-1264-2012	Nemeth, Aron/0000-0002-4092-9805; Szarka, Andras/0000-0001-6594-254X; Hajdinak, Peter/0000-0002-7705-2074	National Scientific Research Fund grant [OTKA 105416, 123752, 129593]; BME-Biotechnology FIKP grant of EMMI; MedinProt Protein Excellence foundation	National Scientific Research Fund grant; BME-Biotechnology FIKP grant of EMMI; MedinProt Protein Excellence foundation	This work was supported by the National Scientific Research Fund grant (OTKA 105416, 123752, 129593), by the BME-Biotechnology FIKP grant of EMMI and MedinProt Protein Excellence foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Amirsadeghi S, 2007, PLANTA, V226, P453, DOI 10.1007/s00425-007-0495-1; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; BAKER CJ, 1991, PHYTOPATHOLOGY, V81, P1504, DOI 10.1094/Phyto-81-1504; Balogh T, 2016, PATHOL ONCOL RES, V22, P431, DOI 10.1007/s12253-015-0020-y; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brandalise M, 2003, J BIOENERG BIOMEMBR, V35, P203, DOI 10.1023/A:1024603530043; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Castro-Concha Lizbeth A, 2006, Methods Mol Biol, V318, P71; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Considine MJ, 2003, J BIOL CHEM, V278, P22298, DOI 10.1074/jbc.M301075200; Costa ADT, 1999, J BIOENERG BIOMEMBR, V31, P527, DOI 10.1023/A:1005408809619; Cvetkovska M, 2013, PLANT CELL ENVIRON, V36, P721, DOI 10.1111/pce.12009; Cvetkovska M, 2012, PLANT CELL ENVIRON, V35, P1121, DOI 10.1111/j.1365-3040.2011.02477.x; Czobor A, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2365-1; DAY DA, 1995, J BIOENERG BIOMEMBR, V27, P379, DOI 10.1007/BF02110000; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Desikan R, 1996, BIOCHEM SOC T, V24, P199; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Escobar MA, 2004, PLANT PHYSIOL, V136, P2710, DOI 10.1104/pp.104.046698; Vercesi AE, 2006, ANNU REV PLANT BIOL, V57, P383, DOI 10.1146/annurev.arplant.57.032905.105335; Garmier M, 2007, J BIOL CHEM, V282, P37556, DOI 10.1074/jbc.M707226200; Geisler Daniela A., 2004, BMC Plant Biology, V4, P8, DOI 10.1186/1471-2229-4-8; Gonzalez-Meler MA, 1999, PLANT PHYSIOL, V120, P765, DOI 10.1104/pp.120.3.765; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Hajdinak P, 2019, PERIOD POLYTECH-CHEM, V63, P1, DOI 10.3311/PPch.11785; Hakmaoui A, 2012, J EXP BOT, V63, P5487, DOI 10.1093/jxb/ers212; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Ito-Inaba Y, 2009, PLANTA, V231, P121, DOI 10.1007/s00425-009-1034-z; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; Juszczuk IM, 2001, PHYSIOL PLANTARUM, V113, P185, DOI 10.1034/j.1399-3054.2001.1130205.x; Karpinski S, 2003, CURR OPIN PLANT BIOL, V6, P390, DOI 10.1016/S1369-5266(03)00061-X; KEPPLER LD, 1989, PHYTOPATHOLOGY, V79, P974, DOI 10.1094/Phyto-79-974; Keunen E, 2013, ENVIRON EXP BOT, V91, P63, DOI 10.1016/j.envexpbot.2013.02.008; Kornas A, 2010, ACTA BIOCHIM POL, V57, P143; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; Kuhn K, 2015, PLANT PHYSIOL, V167, P228, DOI 10.1104/pp.114.249946; Kuhn H, 2014, NEW PHYTOL, V202, P727, DOI 10.1111/nph.12804; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Lacomme C, 1999, FEBS LETT, V459, P149, DOI 10.1016/S0014-5793(99)01233-8; Lennon AM, 1997, PLANT PHYSIOL, V115, P783, DOI 10.1104/pp.115.2.783; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nantes IL, 1999, FEBS LETT, V457, P103, DOI 10.1016/S0014-5793(99)01017-0; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nogueira FTS, 2003, PLANT PHYSIOL, V132, P1811, DOI 10.1104/pp.102.017483; Ordog SH, 2002, PLANT PHYSIOL, V129, P1858, DOI 10.1104/pp.003855; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; Paventi G, 2006, BIOCHIMIE, V88, P179, DOI 10.1016/j.biochi.2005.07.009; Polidoros AN, 2009, PHYSIOL PLANTARUM, V137, P342, DOI 10.1111/j.1399-3054.2009.01284.x; PRESTON G, 1995, MOL PLANT MICROBE IN, V8, P717, DOI 10.1094/MPMI-8-0717; PURVIS AC, 1993, PHYSIOL PLANTARUM, V88, P712, DOI 10.1111/j.1399-3054.1993.tb01393.x; Reboutier D, 2007, MOL PLANT MICROBE IN, V20, P94, DOI 10.1094/MPMI-20-0094; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Simons BH, 1999, PLANT PHYSIOL, V120, P529, DOI 10.1104/pp.120.2.529; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Strodtkotter I, 2009, MOL PLANT, V2, P284, DOI 10.1093/mp/ssn089; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Szarka A, 2012, INT J MOL SCI, V13, P4458, DOI 10.3390/ijms13044458; Thirkettle-Watts D, 2003, PLANT PHYSIOL, V133, P1158, DOI 10.1104/pp.103.028183; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Trono D, 2006, BIOSCIENCE REP, V26, P251, DOI 10.1007/s10540-006-9020-1; Unger C, 2005, J PHYTOPATHOL, V153, P15, DOI 10.1111/j.1439-0434.2004.00922.x; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; VANLERBERGHE GC, 1992, PLANT PHYSIOL, V100, P115, DOI 10.1104/pp.100.1.115; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vercauteren I, 2001, MOL PLANT MICROBE IN, V14, P288, DOI 10.1094/MPMI.2001.14.3.288; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Xie ZX, 2000, MOL PLANT MICROBE IN, V13, P183, DOI 10.1094/MPMI.2000.13.2.183; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P592, DOI 10.1093/pcp/pcn031; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260; Zsigmond L, 2011, PLANT PHYSIOL BIOCH, V49, P809, DOI 10.1016/j.plaphy.2011.04.013	88	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210592	10.1371/journal.pone.0210592	http://dx.doi.org/10.1371/journal.pone.0210592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629714	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000115
J	Hu, X; Steimel, JP; Kapka-Kitzman, DM; Davis-Vogel, C; Richtman, NM; Mathis, JP; Nelson, ME; Lu, AL; Wu, GS				Hu, Xu; Steimel, Joseph P.; Kapka-Kitzman, Deirdre M.; Davis-Vogel, Courtney; Richtman, Nina M.; Mathis, John P.; Nelson, Mark E.; Lu, Albert L.; Wu, Gusui			Molecular characterization of the insecticidal activity of double-stranded RNA targeting the smooth septate junction of western corn rootworm (Diabrotica virgifera virgifera)	PLOS ONE			English	Article							COLEOPTERA; RESISTANCE	The western corn rootworm (WCR, Diabrotica virgifera virgifera) gene, dvssj1, is a putative homolog of the Drosophila melanogaster gene, snakeskin (ssk). This gene encodes a membrane protein associated with the smooth septate junction (SSJ) which is required for the proper barrier function of the epithelial lining of insect intestines. Disruption of DVSSJ integrity by RNAi technique has been shown previously to be an effective approach for corn rootworm control, by apparent suppression of production of DVSSJ1 protein leading to growth inhibition and mortality. To understand the mechanism that leads to the death of WCR larvae by dvssj1 double-stranded RNA, we examined the molecular characteristics associated with SSJ functions during larval development. Dvssj1 dsRNA diet feeding results in dose-dependent suppression of mRNA and protein; this impairs SSJ formation and barrier function of the midgut and results in larval mortality. These findings suggest that the malfunctioning of the SSJ complex in midgut triggered by dvssj1 silencing is the principal cause of WCR death. This study also illustrates that dvssj1 is a midgut-specific gene in WCR and its functions are consistent with biological functions described for ssk.	[Hu, Xu; Steimel, Joseph P.; Kapka-Kitzman, Deirdre M.; Davis-Vogel, Courtney; Richtman, Nina M.; Mathis, John P.; Nelson, Mark E.; Lu, Albert L.] DuPont Pioneer, Johnston, IA 50131 USA; [Wu, Gusui] DuPont Pioneer, Hayward, CA USA; [Wu, Gusui] Syngenta, Foster City, CA USA	DuPont; Pioneer Hi-Bred International, Inc.; Syngenta	Hu, X; Nelson, ME (corresponding author), DuPont Pioneer, Johnston, IA 50131 USA.	xu.hu@pioneer.com; MARK.E.NELSON@pioneer.com		Hu, Xu/0000-0002-1372-5399	DuPont Pioneer	DuPont Pioneer	Funding for this work was provided by DuPont Pioneer. The funder provided support in the form of salaries for XH, JPS, DMKK, NMR, CDV, JPM, MEN, ALL, and GW, as well as research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chien CH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126001; DOW JAT, 1986, ADV INSECT PHYSIOL, V19, P187; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 2017, ANN NY ACAD SCI, V1397, P17, DOI 10.1111/nyas.13366; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; GREEN LFB, 1980, TISSUE CELL, V12, P365, DOI 10.1016/0040-8166(80)90011-7; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hammack L, 2003, J ECON ENTOMOL, V96, P1153, DOI 10.1603/0022-0493-96.4.1153; HU X, 2017, International Patent Application NoWO, Patent No. [2017/218207, 2017218207]; Hu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep30542; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Izumi Y, 2016, J CELL SCI, V129, P1155, DOI 10.1242/jcs.180448; Izumi Y, 2014, SEMIN CELL DEV BIOL, V36, P186, DOI 10.1016/j.semcdb.2014.09.009; Izumi Y, 2012, J CELL SCI, V125, P4923, DOI 10.1242/jcs.112243; Katoch R, 2013, APPL BIOCHEM BIOTECH, V171, P847, DOI 10.1007/s12010-013-0399-4; King B, 2014, ARTHROPOD STRUCT DEV, V43, P605, DOI 10.1016/j.asd.2014.08.002; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Li H, 2015, J APPL ENTOMOL, V139, P432, DOI 10.1111/jen.12224; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; Niu XP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12638-3; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Yanagihashi Y, 2012, J CELL SCI, V125, P1980, DOI 10.1242/jcs.096800; Zhao JZ, 2016, J ECON ENTOMOL, V109, P1369, DOI 10.1093/jee/tow049	41	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210491	10.1371/journal.pone.0210491	http://dx.doi.org/10.1371/journal.pone.0210491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629687	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000096
J	Kim, JK; Lee, H; Oh, JJ; Lee, S; Hong, SK; Lee, SE; Byun, SS				Kim, Jung Kwon; Lee, Hakmin; Oh, Jong Jin; Lee, Sangchul; Hong, Sung Kyu; Lee, Sang Eun; Byun, Seok-Soo			Comparison of robotic and open partial nephrectomy for highly complex renal tumors (RENAL nephrometry score >= 10)	PLOS ONE			English	Article							ASSISTED PARTIAL NEPHRECTOMY; CELL CARCINOMA; SOLITARY KIDNEY; EAU GUIDELINES; OUTCOMES; CM; CLASSIFICATION; COMPLICATIONS; MULTICENTER; SURGERY	Purpose To compare the outcomes of robotic partial nephrectomy (RPN) with those of open PN (OPN) in patients with highly complex renal tumors defined as RENAL nephrometry score >= 10 Materials and methods We analyzed clinical data from a total of 149 patients who underwent OPN or RPN for a highly complex renal mass at our institution between 2003 and 2017. Perioperative data, complication profiles, functional outcomes, pathologic variables, and oncologic outcomes were evaluated in both groups. Results The median (interquartile range, IQR) patient age was 52.0 (42.0-59.0) years, and the median (IQR) follow-up period was 30.0 (7.0-54.0) months. Among the patients, 64 (43.0%) and 85 (57.0%) underwent OPN and RPN, respectively. The RPN group showed higher rates of clinical T1b and >= T2 than the OPN group (p = 0.019). There were no significant differences between the groups in terms of intraoperative outcomes such as operation time, estimated blood loss, warm ischemic time, and transfusion. Notably, the RPN group showed significantly shorter length of hospital stay than the OPN group (p < 0.001). Regarding the complication profiles and renal functional outcomes, no significant differences were reported between the groups. The estimated glomerular filtration rate decline from baseline at the last follow-up showed no significant differences between the two groups (p = 0.351). Kaplan-Meier survival analysis also showed no significant differences in survival outcomes between the groups (log-rank test, all p > 0.05). Conclusions RPN performed in patients with highly complex renal tumors offers perioperative, functional, and oncologic outcomes comparable to those associated with OPN.	[Kim, Jung Kwon; Lee, Hakmin; Oh, Jong Jin; Lee, Sangchul; Hong, Sung Kyu; Lee, Sang Eun; Byun, Seok-Soo] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea	Seoul National University (SNU)	Byun, SS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.	ssbyun@snubh.org		Kim, Jung Kwon/0000-0002-8069-6225				Arora S, 2018, BJU INT, V121, P119, DOI 10.1111/bju.13967; Becker F, 2011, EUR UROL, V59, P931, DOI 10.1016/j.eururo.2011.02.017; Bertolo R, 2018, EUR UROL, V74, P226, DOI 10.1016/j.eururo.2018.05.004; Brandao LF, 2014, UROLOGY, V84, P602, DOI 10.1016/j.urology.2014.04.015; Buse S, 2018, INT J MED ROBOT COMP, V14, DOI 10.1002/rcs.1920; Cacciamani GE, 2018, J UROLOGY, V200, P258, DOI 10.1016/j.juro.2017.12.086; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ficarra V, 2012, WORLD J UROL, V30, P665, DOI 10.1007/s00345-012-0943-9; Garisto J, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.06.012; Gupta GN, 2013, UROL ONCOL-SEMIN ORI, V31, P51, DOI 10.1016/j.urolonc.2010.10.008; Hansen J, 2012, UROLOGY, V80, P347, DOI 10.1016/j.urology.2012.04.043; Hillyer SP, 2013, UROLOGY, V81, P93, DOI 10.1016/j.urology.2012.08.055; Kang M, 2017, J ENDOUROL, V31, P1231, DOI 10.1089/end.2017.0369; Kopp RP, 2014, BJU INT, V114, P708, DOI 10.1111/bju.12580; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Long CJ, 2012, BJU INT, V109, P1450, DOI 10.1111/j.1464-410X.2011.10608.x; Long JA, 2012, EUR UROL, V61, P1257, DOI 10.1016/j.eururo.2012.03.012; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Malkoc E, 2017, WORLD J UROL, V35, P781, DOI 10.1007/s00345-016-1937-9; Masson-Lecomte A, 2013, EJSO-EUR J SURG ONC, V39, P799, DOI 10.1016/j.ejso.2013.03.007; National Comprehensive Cancer Network, 2011, NCCN CLIN PRACT GUID, V2; Patel HD, 2013, J UROLOGY, V189, P1229, DOI 10.1016/j.juro.2012.10.024; Tanagho YS, 2013, UROLOGY, V81, P573, DOI 10.1016/j.urology.2012.10.067; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Volpe A, 2015, EUR UROL, V68, P61, DOI 10.1016/j.eururo.2015.01.025; Wang YB, 2016, BJU INT, V117, P126, DOI 10.1111/bju.13214; Yu HY, 2012, J UROLOGY, V187, P1392, DOI 10.1016/j.juro.2011.11.089; Zargar H, 2014, J ENDOUROL, V28, P1224, DOI 10.1089/end.2014.0297	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210413	10.1371/journal.pone.0210413	http://dx.doi.org/10.1371/journal.pone.0210413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629644	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000085
J	Sarkheil, P; Goik, N; Ibrahim, CN; Schneider, F				Sarkheil, Pegah; Goik, Niko; Ibrahim, Camellia N.; Schneider, Frank			Effect of negative valence on assessment of self-relevance in female patients with borderline personality disorder	PLOS ONE			English	Article							ATTENTIONAL BIAS; EMOTION; METAANALYSIS; DEPRESSION; VALIDITY; VERSION; BRAIN; MODEL	Background A disturbed self-image is central to the characteristic symptoms of borderline personality disorder (BPD). Evaluations of self-relevance (SR) are highly important in cognitive and emotional processing of information and adaptive behavior. Method In the current study, we used affective statements to investigate if SR is altered in patients with higher scores on Borderline Symptom List (BSL-95). Forthyfemale adults with BPD and 20 healthy participants assessed a set of stimuli consisting of sentences in third-person for relevance to self. Results BPD patients exhibited a higher SR for negative contents as compared to healthy controls (p <.001). Furthermore, a significant positive correlation coefficient was found between the increased bias in evaluating the SR of stimuli and borderline symptom severity scores, as measured by BSL-95 questionnaire (r = 0.67, p <.001). This effect persisted after controlling for depressive symptoms by a partial correlation analysis. Conclusion Our results revealed an enhanced SR for negative statements, which was related to the severity of individuals' BPD symptoms. These findings add to the diagnostic information regarding the disturbed organization of self in this clinical population. We suggest the maladaptive evaluation of SR offers an important treatment target for therapeutic approaches to BPD.	[Sarkheil, Pegah; Goik, Niko; Ibrahim, Camellia N.; Schneider, Frank] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Sarkheil, Pegah; Schneider, Frank] Res Ctr Julich, JARA Inst Brain Struct Funct Relationship, Aachen, Germany; [Sarkheil, Pegah; Schneider, Frank] Rhein Westfal TH Aachen, Aachen, Germany; [Goik, Niko] Maastricht Univ, Dept Cognit Neurosci, Fac Psychol & Neurosci, Maastricht, Netherlands; [Schneider, Frank] Univ Hosp Dusseldorf, Dusseldorf, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich; RWTH Aachen University; Maastricht University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Sarkheil, P (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	psarkheil@ukaachen.de		Schneider, Frank/0000-0003-1557-7956; Ibrahim, Camellia/0000-0002-2953-8002				Abler B, 2009, DIAGNOSTICA, V55, P144, DOI 10.1026/0012-1924.55.3.144; Alloy LB, 1999, BEHAV RES THER, V37, P503, DOI 10.1016/S0005-7967(98)00157-0; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Auerbach Randy P, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P335, DOI 10.1016/j.bpsc.2016.04.004; Baer RA, 2012, CLIN PSYCHOL REV, V32, P359, DOI 10.1016/j.cpr.2012.03.002; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bender DS, 2007, J PERS DISORD, V21, P500, DOI 10.1521/pedi.2007.21.5.500; Bohus M, 2001, PSYCHOTHER PSYCH MED, V51, P201, DOI 10.1055/s-2001-13281; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; Chechko N, 2016, NEUROIMAGE-CLIN, V12, P517, DOI 10.1016/j.nicl.2016.08.015; Cutuli D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00175; Daros AR, 2013, PSYCHOL MED, V43, P1953, DOI 10.1017/S0033291712002607; Dyck M, 2009, PSYCHOL MED, V39, P855, DOI 10.1017/S0033291708004273; FENSKE S, 2015, BIOMED CENTRAL, V2, P50498, DOI DOI 10.1186/S40479-015-0031-Z; Gaddy MA, 2014, CLIN PSYCHOL REV, V34, P402, DOI 10.1016/j.cpr.2014.06.001; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Jorgensen CR, 2006, J PERS DISORD, V20, P618, DOI 10.1521/pedi.2006.20.6.618; Kaiser D, 2016, PSYCHOPATHOLOGY, V49, P383, DOI 10.1159/000448624; KANEY S, 1989, BRIT J MED PSYCHOL, V62, P191, DOI 10.1111/j.2044-8341.1989.tb02826.x; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Linehan M., 1993, COGNITIVE BEHAV TREA; Moritz S, 2011, J BEHAV THER EXP PSY, V42, P349, DOI 10.1016/j.jbtep.2011.02.003; Murray RJ, 2015, HUM BRAIN MAPP, V36, P1304, DOI 10.1002/hbm.22703; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2014, PSYCHOPATHOLOGY, V47, P365, DOI 10.1159/000363351; Pankow A, 2016, SCHIZOPHRENIA BULL, V42, P67, DOI 10.1093/schbul/sbv098; Sanislow CA, 2002, AM J PSYCHIAT, V159, P284, DOI 10.1176/appi.ajp.159.2.284; Sansone Randy A, 2011, Innov Clin Neurosci, V8, P16; Schilling L, 2015, J PERS DISORD, V29, P839, DOI 10.1521/pedi_2015_29_181; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Selby EA, 2009, J ABNORM PSYCHOL, V118, P375, DOI 10.1037/a0015711; Sui J, 2015, TRENDS COGN SCI, V19, P719, DOI 10.1016/j.tics.2015.08.015; Taylor SE, 2003, J PERS SOC PSYCHOL, V84, P165, DOI 10.1037//0022-3514.84.1.165; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; WEINER B, 1980, J PERS SOC PSYCHOL, V39, P186, DOI 10.1037/0022-3514.39.2.186; Winter D, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0771-0; Winter D, 2016, BORDER PERS DIS EMOT, V3, DOI 10.1186/s40479-016-0047-z; Winter D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117083; Wisco BE, 2010, BEHAV RES THER, V48, P1113, DOI 10.1016/j.brat.2010.08.004	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209989	10.1371/journal.pone.0209989	http://dx.doi.org/10.1371/journal.pone.0209989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629628	gold, Green Published			2022-12-27	WOS:000455483000039
J	Song, YJ; Kim, YW; Park, KH; Kim, YK; Choi, HJ; Jeoung, JW				Song, Yong Ju; Kim, Yong Woo; Park, Ki Ho; Kim, Young Kook; Choi, Hyuk Jin; Jeoung, Jin Wook			Comparison of glaucoma patients referred by glaucoma screening versus referral from primary eye clinic	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PREVALENCE; POPULATION; OUTCOMES; MYOPIA	Purpose To investigate whether mass glaucoma screening relative to opportunistic case finding at a primary eye clinic is helpful for early detection of glaucoma. Methods Subjects referred by glaucoma screening (by non-contact tonometry and non-mydriatic fundus photography; group A, n = 220) and from a primary eye clinic (group B, n = 327) were retrospectively recruited. The positive predictive value (PPV) for glaucoma and the rate of glaucoma awareness were compared. Also, for the newly diagnosed glaucoma ('definite glaucoma') patients, the demographics and structural and functional severities of glaucoma were compared. Results The PPV for definite glaucoma was 25.5% for group A and 52.4% for group B. The rate of false-positive for 'glaucoma referral to tertiary hospital' was significantly higher for group A than for group B (38.6 vs. 18.3%, P < 0.001). Among the definite-glaucoma patients (group A: n = 56; group B: n = 182), the proportion of glaucoma awareness was significantly higher in group B (69.2%) than in group A (8.9%, P < 0.001). The mean deviation (MD) of visual field (VF) was significantly higher in group A than in group B (-3.08 +/- 3.99 vs. -6.70 +/- 7.29 dB, P-adjusted = 0.040), and the inferior and inferotemporal ganglion cell-inner plexiform layer (GCIPL) thicknesses tended to be greater in group A than in group B, with marginal significance (P-adjusted < 0.10). Conclusions Glaucoma screening can be helpful for early detection of glaucoma. However, improvement of the screening strategy is needed in order to enhance its specificity for glaucoma.	[Song, Yong Ju] Chosun Univ, Chosun Univ Hosp, Dept Ophthalmol, Coll Med, Gwangju, South Korea; [Kim, Yong Woo; Park, Ki Ho; Kim, Young Kook; Jeoung, Jin Wook] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Choi, Hyuk Jin] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul, South Korea	Chosun University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeoung, JW (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Choi, HJ (corresponding author), Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	docchoi@hanmail.net; neuroprotect@gmail.com		Kim, Young Kook/0000-0002-6037-8449				Blumberg DM, 2014, INVEST OPHTH VIS SCI, V55, P3491, DOI 10.1167/iovs.14-14014; Cho HK, 2014, SURV OPHTHALMOL, V59, P434, DOI 10.1016/j.survophthal.2013.09.003; Detry-Morel M, 2004, EUR J OPHTHALMOL, V14, P387, DOI 10.1177/112067210401400505; EDDY DM, 1983, SURV OPHTHALMOL, V28, P194, DOI 10.1016/0039-6257(83)90097-8; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; Kim YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114058; Ladapo JA, 2012, ARCH OPHTHALMOL-CHIC, V130, P365, DOI 10.1001/archopthalmol.2011.1224; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Moyer VA, 2013, ANN INTERN MED, V159, P484, DOI 10.7326/0003-4819-159-6-201309170-00686; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Spaeth G L, 1996, Eur J Ophthalmol, V6, P101; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TUULONEN A, 1990, ACTA OPHTHALMOL, V68, P445; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	18	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210582	10.1371/journal.pone.0210582	http://dx.doi.org/10.1371/journal.pone.0210582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629694	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000113
J	Zhou, ZH; Whitney, C; Strother, L				Zhou, Zhiheng; Whitney, Carol; Strother, Lars			Embedded word priming elicits enhanced fMRI responses in the visual word form area	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; EVENT-RELATED FMRI; ORTHOGRAPHIC SIMILARITY; LEFT-HEMISPHERE; REPETITION ENHANCEMENT; FUNCTIONAL-PROPERTIES; WHOLE WORDS; RECOGNITION; CORTEX; REPRESENTATIONS	Lexical embedding is common in all languages and elicits mutual orthographic interference between an embedded word and its carrier. The neural basis of such interference remains unknown. We employed a novel fMRI prime-target embedded word paradigm to test for involvement of a visual word form area (VWFA) in left ventral occipitotemporal cortex in co-activation of embedded words and their carriers. Based on the results of related fMRI studies we predicted either enhancement or suppression of fMRI responses to embedded words initially viewed as primes, and repeated in the context of target carrier words. Our results clearly showed enhancement of fMRI responses in the VWFA to embedded-carrier word pairs as compared to unrelated prime-target pairs. In contrast to non-visual language-related areas (e.g., left inferior frontal gyrus), enhanced fMRI responses did not occur in the VWFA when embedded-carrier word pairs were restricted to the left visual hemifield. Our finding of fMRI enhancement in the VWFA is novel evidence of its involvement in representational rivalry between orthographically similar words, and the co-activation of embedded words and their carriers.	[Zhou, Zhiheng; Strother, Lars] Univ Nevada, Dept Psychol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Strother, L (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	lars@unr.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103650]; National Institute of General Medical Sciences [P20 GM103650]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103650 to LS.; We thank Gennady Erlikhman for fMRI data analyses and Matthew T. Harrison for comments on earlier version of the manuscript. This study was supported by the National Institute of General Medical Sciences (P20 GM103650).	Abel S, 2012, BRAIN BEHAV, V2, P109, DOI 10.1002/brb3.31; Andrews S, 1997, PSYCHON B REV, V4, P439, DOI 10.3758/BF03214334; Axelrod V, 2015, CEREB CORTEX, V25, P2160, DOI 10.1093/cercor/bhu022; Baeck A, 2015, NEUROIMAGE, V111, P321, DOI 10.1016/j.neuroimage.2015.01.060; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Bolger DJ, 2008, HUM BRAIN MAPP, V29, P1416, DOI 10.1002/hbm.20476; Bowers JS, 2005, J MEM LANG, V52, P131, DOI 10.1016/j.jml.2004.09.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buchsbaum BR, 2009, CEREB CORTEX, V19, P1474, DOI 10.1093/cercor/bhn186; Burgund ED, 2009, EXP BRAIN RES, V193, P591, DOI 10.1007/s00221-008-1661-9; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Gardelle V, 2013, CEREB CORTEX, V23, P2235, DOI 10.1093/cercor/bhs211; De Moor W, 2000, PSYCHOL RES-PSYCH FO, V63, P159, DOI 10.1007/PL00008174; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; DREWS E, 1995, J EXP PSYCHOL HUMAN, V21, P1098, DOI 10.1037/0096-1523.21.5.1098; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Fang F, 2005, J NEUROPHYSIOL, V94, P4188, DOI 10.1152/jn.00378.2005; Fischer-Baum S, 2017, CORTEX, V90, P88, DOI 10.1016/j.cortex.2017.02.017; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Glezer LS, 2016, NEUROIMAGE, V138, P248, DOI 10.1016/j.neuroimage.2016.05.072; Glezer LS, 2015, J NEUROSCI, V35, P4965, DOI 10.1523/JNEUROSCI.4031-14.2015; Glezer LS, 2013, J NEUROSCI, V33, P11221, DOI 10.1523/JNEUROSCI.5002-12.2013; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grose-Fifer J, 2004, NEUROPSYCHOLOGIA, V42, P1948, DOI 10.1016/j.neuropsychologia.2004.04.024; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Henderson L, 2007, BRAIN LANG, V103, P276, DOI 10.1016/j.bandl.2007.04.009; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Kravitz DJ, 2008, TRENDS COGN SCI, V12, P114, DOI 10.1016/j.tics.2007.12.006; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kronbichler M, 2009, J COGNITIVE NEUROSCI, V21, P222, DOI 10.1162/jocn.2009.21002; LUCE PA, 1986, PERCEPT PSYCHOPHYS, V39, P155, DOI 10.3758/BF03212485; Ludersdorfer P, 2016, NEUROIMAGE, V124, P834, DOI 10.1016/j.neuroimage.2015.09.039; LUPKER SJ, 1994, J EXP PSYCHOL HUMAN, V20, P437, DOI 10.1037/0096-1523.20.2.437; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; McCormick SF, 2010, J EXP PSYCHOL LEARN, V36, P1256, DOI 10.1037/a0020224; Nation K, 2009, PHILOS T R SOC B, V364, P3665, DOI 10.1098/rstb.2009.0119; Nation K, 2009, COGNITION, V110, P273, DOI 10.1016/j.cognition.2008.11.004; Natu VS, 2016, J NEUROSCI, V36, P10893, DOI 10.1523/JNEUROSCI.1886-16.2016; Pas M, 2016, NEUROIMAGE, V125, P428, DOI 10.1016/j.neuroimage.2015.10.063; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perea M, 2008, BRAIN LANG, V105, P199, DOI 10.1016/j.bandl.2007.08.005; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Purcell JJ, 2017, NEUROIMAGE, V147, P554, DOI 10.1016/j.neuroimage.2016.12.054; Rapp B, 2016, BRAIN, V139, P588, DOI 10.1093/brain/awv348; Rauschecker AM, 2012, P NATL ACAD SCI USA, V109, pE1568, DOI 10.1073/pnas.1121304109; Richards TL, 2009, J NEUROLINGUIST, V22, P327, DOI 10.1016/j.jneuroling.2008.11.002; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Saad Z. S., 2004, 2004 2 IEEE INT S BI; Schurz M, 2010, NEUROIMAGE, V49, P2649, DOI 10.1016/j.neuroimage.2009.10.082; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; SEGUI J, 1990, J EXP PSYCHOL HUMAN, V16, P65, DOI 10.1037/0096-1523.16.1.65; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Stigliani A, 2015, J NEUROSCI, V35, P12412, DOI 10.1523/JNEUROSCI.4822-14.2015; Strother L, 2017, NEUROPSYCHOLOGIA, V100, P35, DOI 10.1016/j.neuropsychologia.2017.04.003; Strother L, 2016, J COGNITIVE NEUROSCI, V28, P252, DOI 10.1162/jocn_a_00900; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Verosky SC, 2012, J COGNITIVE NEUROSCI, V24, P1006, DOI 10.1162/jocn_a_00196; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weingartner KM, 2012, J COGN PSYCHOL, V24, P179, DOI 10.1080/20445911.2011.604028; Whitney C, 2005, COGNITIVE PSYCHOL, V51, P179, DOI 10.1016/j.cogpsych.2005.07.001; Whitney C, 2004, NEUROPSYCHOLOGIA, V42, P1680, DOI 10.1016/j.neuropsychologia.2004.04.007; Whitney C, 2011, BRAIN LANG, V118, P90, DOI 10.1016/j.bandl.2011.03.001; Woodhead ZVJ, 2014, CEREB CORTEX, V24, P817, DOI 10.1093/cercor/bhs365; Zhou WB, 2017, MOL ONCOL, V11, P1459, DOI 10.1002/1878-0261.12112	87	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0208318	10.1371/journal.pone.0208318	http://dx.doi.org/10.1371/journal.pone.0208318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629612	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000012
J	Carter, EA; Sheel, AW; Milsom, WK; Koehle, MS				Carter, Eric A.; Sheel, A. William; Milsom, William K.; Koehle, Michael S.			Sildenafil does not improve performance in 16.1 km cycle exercise time-trial in acute hypoxia	PLOS ONE			English	Article							PULMONARY GAS-EXCHANGE; INDUCED ARTERIAL HYPOXEMIA; NORMOBARIC HYPOXIA; CAPACITY; VASOCONSTRICTION; REGURGITATION; HEMODYNAMICS; PREVALENCE; RESPONSES	Sildenafil is a pulmonary vasodilator that has potential to mitigate the decrement in endurance performance caused by hypoxic pulmonary vasoconstriction. The purpose of this study was to determine the effects of sildenafil on pulmonary artery pressure, cardiac output, pulse oxygen saturation, and exercise performance at moderate simulated altitude. We hypothesized that sildenafil would reduce the decline in exercise performance in hypoxia by blunting the rise in pulmonary artery pressure and causing a relative increase in cardiac output and oxygen saturation. Twelve endurance trained men performed three experimental cycling trials at sea level and simulated moderate altitude of 3,000m (FIO2 = 0.147) after ingesting either a placebo or sildenafil 50 mg capsule in a double blinded fashion. Each test consisted of a warmup period, a 15-minute steady state period at 60% of peak power output, and a 16.1 km time-trial. All subjects experienced a decline in maximal exercise capacity in hypoxia that ranged from 6% to 24%. This decline was correlated with the reduction in pulse oxygen saturation in hypoxic maximal exercise. Sildenafil had no effect on pulmonary artery pressure, cardiac output, or pulse oxygen saturation measured during steady state exercise. There was no effect of sildenafil on mean power output during the time-trial. During high intensity cycle exercise in acute, moderate hypoxia pulmonary artery pressure is unaffected by sildenafil and does not appear to influence cardiovascular function or exercise performance.	[Carter, Eric A.; Sheel, A. William; Koehle, Michael S.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Milsom, William K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Koehle, Michael S.] Univ British Columbia, Div Sports Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Koehle, MS (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.; Koehle, MS (corresponding author), Univ British Columbia, Div Sports Med, Vancouver, BC, Canada.	Michael.koehle@ubc.ca	Koehle, Michael/C-7850-2013	Koehle, Michael/0000-0001-7026-8422; Carter, Eric/0000-0002-6060-6122	NSERC [RGPIN-2017-04519]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by an NSERC Discovery Grant (#RGPIN-2017-04519) awarded to MK. The Natural Sciences and Engineering Research Council of Canada can be found at: http://www.nserc-crsng.gc.ca/index_eng.asp.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett CF, 2006, VASC HEALTH RISK MAN, V2, P411, DOI 10.2147/vhrm.2006.2.4.411; Calbet JAL, 2009, CELL MOL LIFE SCI, V66, P3601, DOI 10.1007/s00018-009-0148-6; Chapman RF, 2013, BRIT J SPORT MED, V47, P40; Conkin J, 2008, AVIAT SPACE ENVIR MD, V79, P975, DOI 10.3357/ASEM.2331.2008; Dominelli PB, 2013, J PHYSIOL-LONDON, V591, P3017, DOI 10.1113/jphysiol.2013.252767; DOUGLAS PS, 1989, AM J CARDIOL, V64, P209, DOI 10.1016/0002-9149(89)90459-1; Dunham-Snary KJ, 2017, CHEST, V151, P181, DOI 10.1016/j.chest.2016.09.001; Faiss R, 2014, INT J SPORT PHYSIOL, V9, P978, DOI 10.1123/ijspp.2013-0524; Faoro V, 2007, HIGH ALT MED BIOL, V8, P155, DOI 10.1089/ham.2007.1058; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Gillies HC, 2002, INT J CARDIOL, V86, P131, DOI 10.1016/S0167-5273(02)00421-7; Guazzi M, 2004, J AM COLL CARDIOL, V44, P2339, DOI 10.1016/j.jacc.2004.09.041; Hopkins SR, 1996, RESP PHYSIOL, V103, P67, DOI 10.1016/0034-5687(95)00028-3; Hopkins SR, 2006, ADV EXP MED BIOL, V588, P17; Hsu AR, 2006, J APPL PHYSIOL, V100, P2031, DOI 10.1152/japplphysiol.00806.2005; Jacobs KA, 2011, HIGH ALT MED BIOL, V12, P215, DOI 10.1089/ham.2011.0011; JENSEN KS, 1992, J APPL PHYSIOL, V72, P2018, DOI 10.1152/jappl.1992.72.5.2018; JOHNSON BD, 1992, J APPL PHYSIOL, V73, P874, DOI 10.1152/jappl.1992.73.3.874; Kressler J, 2011, EUR J APPL PHYSIOL, V111, P3031, DOI 10.1007/s00421-011-1930-3; LAWLER J, 1988, J APPL PHYSIOL, V64, P1486, DOI 10.1152/jappl.1988.64.4.1486; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; Macinnis MJ, 2015, MED SCI SPORT EXER, V47, P1869, DOI 10.1249/MSS.0000000000000628; POWERS SK, 1989, J APPL PHYSIOL, V66, P2491, DOI 10.1152/jappl.1989.66.6.2491; Ricart A, 2005, HIGH ALT MED BIOL, V6, P43, DOI 10.1089/ham.2005.6.43; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; Richard NA, 2012, AVIAT SPACE ENVIR MD, V83, P677, DOI 10.3357/ASEM.3182.2012; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Stickland MK, 2004, J PHYSIOL-LONDON, V561, P321, DOI 10.1113/jphysiol.2004.069302; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; West J.B., 2012, RESP PHYSL ESSENTIAL	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210841	10.1371/journal.pone.0210841	http://dx.doi.org/10.1371/journal.pone.0210841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653578	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500081
J	Forczek, W; Maslon, A; Fraczek, B; Curylo, M; Salamaga, M; Suder, A				Forczek, Wanda; Maslon, Agata; Fraczek, Barbara; Curylo, Marta; Salamaga, Marcin; Suder, Agnieszka			Does the first trimester of pregnancy induce alterations in the walking pattern?	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; PLANTAR PRESSURE; LUMBAR LORDOSIS; ARCH INDEX; FOOT ARCH; GAIT; WOMEN; PAIN; ADAPTATIONS; PARAMETERS	Introduction From among many studies observing the walking pattern throughout pregnancy, only two items monitor the influence of pregnancy on the movement system during gait considering the period before gestation. Research question Does the women's gait pattern at the end of the first trimester undergo changes in comparison to body movement pattern before pregnancy? Methods All subjects who met the inclusion criteria gave signed and informed consent before the study. Two experimental sessions were arranged according to the same protocol: (P0) before pregnancy and (P1) at the end of the first trimester of pregnancy (12th week of gestation). At first the anthropometric measures were taken. Then, walking trials at a self-selected speed along a walkway were registered with Vicon 250 (Oxford Metrics Ltd.; Oxford, UK) and FreeMED force platform (Sensor Medica, Italy). Results An analysis of anthropometric parameters in 12 th pregnancy week demonstrated significant changes in mean values of waist circumference and waist to hip ratio as well as waist to height ratio indexes compared to the results before pregnancy. No significant differences were found in the basic kinematic gait parameters between experimental conditions. Significant increase of mean inter-ankle distance during double support phase occurred during the first trimester of pregnancy. Also, the ratio of the ankle separation width to the pelvic width was noticeably higher in gestation. Then, angular changes of the pelvis in coronal and transverse planes throughout gait cycle during pregnancy demonstrated significant differences compared to those measured before pregnancy. At the same time in the first trimester of pregnancy no adaptive changes in the pattern of feet loading take place. Significance Since our study is of longitudinal character, in the course of pregnancy we expect compensatory mechanisms more clearly demonstrated. Therefore, we hope to identify a strategy of the gravid body progression in space.	[Forczek, Wanda] Univ Phys Educ, Fac Phys Educ & Sport, Sect Biomech, Krakow, Poland; [Maslon, Agata] Univ Phys Educ, Fac Motor Rehabil, Sect Rehabil Orthopaed, Dept Clin Rehabil, Krakow, Poland; [Maslon, Agata] Univ Phys Educ, Fac Motor Rehabil, Lab Pathol Musculoskeletal Syst, Krakow, Poland; [Fraczek, Barbara] Univ Phys Educ, Fac Phys Educ & Sport, Sect Human Nutr, Krakow, Poland; [Curylo, Marta] Univ Phys Educ, Fac Motor Rehabil, Dept Clin Rehabil, Sect Rehabil Internal Dis, Krakow, Poland; [Salamaga, Marcin] Cracow Univ Econ, Dept Stat, Krakow, Poland; [Suder, Agnieszka] Univ Phys Educ, Fac Motor Rehabil, Sect Anat, Dept Physiotherapy, Krakow, Poland	Cracow University of Economics	Forczek, W (corresponding author), Univ Phys Educ, Fac Phys Educ & Sport, Sect Biomech, Krakow, Poland.	wanda.forczek@awf.krakow.pl	Forczek, Wanda/AAM-8461-2020; Suder, Agnieszka/GZA-5397-2022; Salamaga, Marcin/T-3370-2018	Forczek, Wanda/0000-0002-6890-2823; Fraczek, Barbara/0000-0002-5673-6135; Salamaga, Marcin/0000-0003-0225-6651; Maslon, Agata/0000-0001-5081-2179; Suder, Agnieszka/0000-0001-6135-8274	 [99/BS/INB/2016]		Sources of financing: Research project No 99/BS/INB/2016 realised within statutory activities.	ALVAREZ R, 1988, J BONE JOINT SURG AM, V70A, P271, DOI 10.2106/00004623-198870020-00017; Bertuit J, 2015, ACTA BIOENG BIOMECH, V17, P93, DOI 10.5277/ABB-00092-2014-03; Blaszczyk JW, 2016, GAIT POSTURE, V43, P160, DOI 10.1016/j.gaitpost.2015.09.016; Branchtein L, 1997, DIABETES CARE, V20, P509, DOI 10.2337/diacare.20.4.509; Branco M, 2015, 3 DIMENSIONAL KINETI, DOI [10.1155/2015/580374, DOI 10.1155/2015/580374]; Branco Marco, 2014, ScientificWorldJournal, V2014, P527940, DOI 10.1155/2014/527940; Branco MAC, 2016, ACTA BIOENG BIOMECH, V18, P153, DOI 10.5277/ABB-00418-2015-05; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Butler EE, 2006, AM J OBSTET GYNECOL, V195, P1104, DOI 10.1016/j.ajog.2006.06.015; Carpes FP., 2008, BRAZILIAN J BIOMECH, V9, P33; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Conti MHS, 2003, FEMINA, V31, P531; Dumas GA, 1997, J ORTHOP SPORT PHYS, V26, P2, DOI 10.2519/jospt.1997.26.1.2; Dunning K, 2010, MATERN CHILD HLTH J, V14, P720, DOI 10.1007/s10995-009-0511-0; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Forczek W, 2018, GAIT POSTURE, V62, P7, DOI 10.1016/j.gaitpost.2018.02.024; Forczek W, 2012, ACTA BIOENG BIOMECH, V14, P113, DOI 10.5277/abb120413; Foti T, 2000, J BONE JOINT SURG AM, V82A, P625, DOI 10.2106/00004623-200005000-00003; Gilleard WL, 2018, L N COMPUT VIS BIOME, V29, P109, DOI 10.1007/978-3-319-71574-2_9; Gilleard WL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-71; Goldberg J, 2002, OBSTET GYNECOL, V99, P395, DOI 10.1016/S0029-7844(01)01756-2; Hagan L., 2010, J WOMENS HLTH PHYS T, V34, P46, DOI DOI 10.1097/JWH.0B013E3181E8FD4D; Jelen K, 2005, NEUROENDOCRINOL LETT, V26, P752; Karadag-Saygi E, 2010, FOOT ANKLE INT, V31, P153, DOI 10.3113/FAI.2010.0153; Krkeljas Z, 2018, HUM MOVEMENT SCI, V58, P315, DOI 10.1016/j.humov.2017.12.011; Levine D, 1996, J ORTHOP SPORT PHYS, V24, P130, DOI 10.2519/jospt.1996.24.3.130; Nyska M, 1997, ISRAEL J MED SCI, V33, P139; Ojukwu CP, 2017, MED PRIN PRACT, V26, P480, DOI 10.1159/000481622; Perry J., 1992, GAIT ANAL NORMAL PAT; Ribeiro AP, 2013, WOMENS HEALTH, V9, P99, DOI [10.2217/WHE.12.59, 10.2217/whe.12.59]; Ribeiro AP, 2011, J AM PODIATR MED ASS, V101; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Segal NA., 2015, MUSCULOSKELETAL HLTH, P1, DOI [10.1007/ 978-3-319-14319-4_1, DOI 10.1007/978-3-319-14319-4_1, 10.1007/978-3-319-14319-4_1]; Segal NA, 2013, AM J PHYS MED REHAB, V92, P232, DOI 10.1097/PHM.0b013e31827443a9; SHIRAZIADL A, 1987, J BIOMECH, V20, P601, DOI 10.1016/0021-9290(87)90281-8; Sunaga Y, 2013, APPL ERGON, V44, P792, DOI 10.1016/j.apergo.2013.01.010; Weiner J. S., 1969, IBP HDB, V9; Wendland EMDR, 2007, CAD SAUDE PUBLICA, V23, P391, DOI 10.1590/S0102-311X2007000200015; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Yoo H, 2015, J PHYS THER SCI, V27, P279, DOI 10.1589/jpts.27.279	40	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209766	10.1371/journal.pone.0209766	http://dx.doi.org/10.1371/journal.pone.0209766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650108	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300026
J	McGinnis, RS; McGinnis, EW; Hruschak, J; Lopez-Duran, NL; Fitzgerald, K; Rosenblum, KL; Muzik, M				McGinnis, Ryan S.; McGinnis, Ellen W.; Hruschak, Jessica; Lopez-Duran, Nestor L.; Fitzgerald, Kate; Rosenblum, Katherine L.; Muzik, Maria			Rapid detection of internalizing diagnosis in young children enabled by wearable sensors and machine learning	PLOS ONE			English	Article							PRESCHOOL DEPRESSION; BEHAVIOR CHECKLIST; ANXIETY DISORDERS; EMOTION REGULATION; EARLY-CHILDHOOD; MENTAL-HEALTH; AGES 3; PARENT; PSYCHOPATHOLOGY; ADOLESCENCE	There is a critical need for fast, inexpensive, objective, and accurate screening tools for childhood psychopathology. Perhaps most compelling is in the case of internalizing disorders, like anxiety and depression, where unobservable symptoms cause children to go unassessed-suffering in silence because they never exhibiting the disruptive behaviors that would lead to a referral for diagnostic assessment. If left untreated these disorders are associated with long-term negative outcomes including substance abuse and increased risk for suicide. This paper presents a new approach for identifying children with internalizing disorders using an instrumented 90-second mood induction task. Participant motion during the task is monitored using a commercially available wearable sensor. We show that machine learning can be used to differentiate children with an internalizing diagnosis from controls with 81% accuracy (67% sensitivity, 88% specificity). We provide a detailed description of the modeling methodology used to arrive at these results and explore further the predictive ability of each temporal phase of the mood induction task. Kinematical measures most discriminative of internalizing diagnosis are analyzed in detail, showing affected children exhibit significantly more avoidance of ambiguous threat. Performance of the proposed approach is compared to clinical thresholds on parent-reported child symptoms which differentiate children with an internalizing diagnosis from controls with slightly lower accuracy (.68-. 75 vs. .81), slightly higher specificity (.88-1.00 vs. .88), and lower sensitivity (.00-. 42 vs. .67) than the proposed, instrumented method. These results point toward the future use of this approach for screening children for internalizing disorders so that interventions can be deployed when they have the highest chance for long-term success.	[McGinnis, Ryan S.] Univ Vermont, Dept Elect & Biomed Engn, Burlington, VT USA; [McGinnis, Ellen W.] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA; [McGinnis, Ellen W.; Lopez-Duran, Nestor L.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Hruschak, Jessica; Fitzgerald, Kate; Rosenblum, Katherine L.; Muzik, Maria] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Vermont; University of Vermont; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McGinnis, EW (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA.; McGinnis, EW (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	ryan.mcginnis@uvm.edu	Rosenblum, Katherine/AAC-5921-2019; Fitzgerald, Kate D./AAV-7278-2020	McGinnis, Ryan/0000-0001-8396-6967; Lopez-Duran, Nestor/0000-0003-0666-496X	Michigan Institute for Clinical and Health Research [UL1TR000433]; Blue Cross Blue Shield of Michigan Foundation [1982.SAP]; Brain Behavior Research Foundation; National Institute of Mental Health [R03MH102648]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER	Michigan Institute for Clinical and Health Research; Blue Cross Blue Shield of Michigan Foundation; Brain Behavior Research Foundation(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work received support from the following sources: Michigan Institute for Clinical and Health Research (UL1TR000433, PI: Muzik; Biomedical and Social Sciences Scholar Program, University of Michigan PI: E.W. McGinnis); Blue Cross Blue Shield of Michigan Foundation Grant (1982.SAP, PI: E.W. McGinnis); Brain Behavior Research Foundation (PI: Fitzgerald); National Institute of Mental Health R03MH102648 (PI: Fitzgerald; Rosenblum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Achenbach TM, 2001, ASEBA SCHOOL AGE FOR; Adrian M, 2011, J EXP CHILD PSYCHOL, V110, P171, DOI 10.1016/j.jecp.2011.03.009; [Anonymous], JOURNALIST DC IS A F; Aschenbrand SG, 2005, J CLIN CHILD ADOLESC, V34, P735, DOI 10.1207/s15374424jccp3404_15; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Belden AC, 2012, J AM ACAD CHILD PSY, V51, P889, DOI 10.1016/j.jaac.2012.06.018; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Bufferd SJ, 2012, AM J PSYCHIAT, V169, P1157, DOI 10.1176/appi.ajp.2012.12020268; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Calkins SD, 2008, DEV PSYCHOBIOL, V50, P751, DOI 10.1002/dev.20344; Chansky TE, 1997, J ANXIETY DISORD, V11, P347, DOI 10.1016/S0887-6185(97)00015-7; Chorney JM, 2015, J PEDIATR PSYCHOL, V40, P154, DOI 10.1093/jpepsy/jsu099; Cole DA, 1998, J CONSULT CLIN PSYCH, V66, P451, DOI 10.1037/0022-006X.66.3.451; Compton SN, 2002, J CONSULT CLIN PSYCH, V70, P1240, DOI 10.1037//0022-006X.70.6.1240; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de la Osa N, 2016, EUR CHILD ADOLES PSY, V25, P17, DOI 10.1007/s00787-015-0694-4; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Durbin CE, 2007, EMOTION, V7, P388, DOI 10.1037/1528-3542.7.2.388; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Elenko E, 2015, NAT BIOTECHNOL, DOI [10.1038/nbt0715-683a, DOI 10.1038/NBT0715-683A]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaffrey MS, 2012, KIDDIE SCHEDULE FOR; Garber J, 2000, J CLIN CHILD PSYCHOL, V29, P509, DOI 10.1207/S15374424JCCP2904_5; Gould MS, 1998, J AM ACAD CHILD PSY, V37, P915, DOI 10.1097/00004583-199809000-00011; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Herjanic B, 1997, J ABNORM CHILD PSYCH, V25, P21, DOI 10.1023/A:1025703323438; Hudziak JJ, 2004, J CHILD PSYCHOL PSYC, V45, P1299, DOI 10.1111/j.1469-7610.2004.00314.x; Isaksson A, 2008, PATTERN RECOGN LETT, V29, P1960, DOI 10.1016/j.patrec.2008.06.018; KAMINER Y, 1995, ADOLESCENCE, V30, P483; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; Kendall PC, 2004, J CONSULT CLIN PSYCH, V72, P276, DOI 10.1037/0022-006X.72.2.276; KOLKO DJ, 1993, J CHILD PSYCHOL PSYC, V34, P991, DOI 10.1111/j.1469-7610.1993.tb01103.x; Konnopka A, 2009, J AFFECT DISORDERS, V114, P14, DOI 10.1016/j.jad.2008.07.014; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lopez-Duran NL, 2009, J EXP CHILD PSYCHOL, V103, P285, DOI 10.1016/j.jecp.2009.03.008; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Luby JL, 2003, J AM ACAD CHILD PSY, V42, P340, DOI 10.1097/00004583-200303000-00015; Luby JL, 2003, AM J PSYCHIAT, V160, P1169, DOI 10.1176/appi.ajp.160.6.1169; Luby JL, 2010, CURR DIR PSYCHOL SCI, V19, P91, DOI 10.1177/0963721410364493; Luby JL, 2009, ARCH GEN PSYCHIAT, V66, P897, DOI 10.1001/archgenpsychiatry.2009.97; Luby JL, 2009, J AFFECT DISORDERS, V112, P111, DOI 10.1016/j.jad.2008.03.026; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; Mash EJ, 2001, PSYCHOL ASSESSMENT, V13, P86, DOI 10.1037//1040-3590.13.1.86; MAZIADE M, 1992, AM J PSYCHIAT, V149, P1674; McGinnis EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195598; McGinnis EW, 2017, IEEE J BIOMED HEALTH, V21, P1460, DOI 10.1109/JBHI.2016.2603159; McGinnis RS, 2018, 2018 ANNUAL INTERNAT; McGinnis RS, 2018, 2018 IEEE INTERNATIO; McGinnis RS, 2014, VALIDATION COMPLEMEN, DOI [10.1115/IMECE2014-36909, DOI 10.1115/IMECE2014-36909]; McGinnis RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178366; McGinnis W., 2017, PYGEOHASH; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Mian ND, 2014, CLIN CHILD FAM PSYCH, V17, P85, DOI 10.1007/s10567-013-0152-0; Moon Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171346; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Pavuluri MN, 1996, J AM ACAD CHILD PSY, V35, P215, DOI 10.1097/00004583-199602000-00015; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Rapee RM, 2009, ANNU REV CLIN PSYCHO, V5, P311, DOI 10.1146/annurev.clinpsy.032408.153628; RENOUF AG, 1994, J AM ACAD CHILD PSY, V33, P208, DOI 10.1097/00004583-199402000-00008; Rishel CW, 2005, RES SOCIAL WORK PRAC, V15, P195, DOI 10.1177/1049731504270382; Santafe G, 2015, ARTIF INTELL REV, V44, P467, DOI 10.1007/s10462-015-9433-y; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Sun Ruopeng, 2018, Digit Biomark, V2, P1, DOI 10.1159/000485958; Tandon M, 2009, CHILD ADOL PSYCH CL, V18, P593, DOI 10.1016/j.chc.2009.03.004; Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125; Towe-Goodman NR, 2014, J AM ACAD CHILD PSY, V53, P437, DOI [10.1016/j.jaac.2013.12,017, 10.1016/j.jaac.2013.12.017]; Vasey MW, 1996, CHILD DEV, V67, P1173, DOI 10.2307/1131886; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Whalen DJ, 2017, CHILD ADOL PSYCH CL, V26, P503, DOI 10.1016/j.chc.2017.02.006; Wittchen H-U, 2000, EUROPEAN NEUROPSYCHO, V10, P119, DOI DOI 10.1016/S0924-977X(00)80014-0	73	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210267	10.1371/journal.pone.0210267	http://dx.doi.org/10.1371/journal.pone.0210267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650109	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300049
J	Engerud, H; Hope, K; Berg, HF; Fasmer, KE; Tangen, IL; Haldorsen, IS; Trovik, J; Krakstad, C				Engerud, Hilde; Hope, Kirsten; Berg, Hege Fredriksen; Fasmer, Kristine Eldevik; Tangen, Ingvild Loberg; Haldorsen, Ingfrid Salvesen; Trovik, Jone; Krakstad, Camilla			Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; LYMPH-NODE METASTASES; RISK; EXPRESSION; MIC-1; CURETTAGE; BIOMARKER; MEMBER; LEVEL	Objective Better biomarkers are needed in order to identify patients with endometrial carcinoma at risk of recurrence and who may profit from a more aggressive treatment regimen. Our objective was to explore the applicability of plasma growth differentiation factor 15 (GDF-15) as a marker for recurrent disease, as well as a marker for poor prognosis and lymph node metastases. Methods EDTA-blood samples were obtained from 235 patients with endometrial cancer before primary surgery. For 36 of these patients, matching blood samples were collected at time of recurrence. Blood samples were also collected from 78 patients with endometrial hyperplasia. Plasma GDF-15 was measured by an enzyme-linked immunosorbent assay (ELISA). Preoperative pelvic MRI scans for 141 patients were investigated in parallel for imaging variables. Results Preoperative plasma level of GDF-15 was significantly higher for patients who experienced recurrence (1780 ng/L; 95% CI; 518-9475 ng/L) than for patients who did not develop recurrent disease (1236 ng/L; 95% CI; 307-7030 ng/L) (p<0.001). Plasma levels of GDF-15 at recurrence (2818 ng/L, 95% CI 2088-3548 ng/L) were significantly higher than plasma levels of GDF-15 measured at time of primary diagnosis (1857 ng/L, 95% CI; 1317-2398 ng/L) (p = 0.001). High plasma level GDF-15 independently predicts recurrent disease (OR = 3.14; 95% CI 2.10-4.76) and lymph node metastases (OR = 2.64; 95% CI 1.52-4.61). Patients with high plasma level of GDF-15 had significantly larger tumor volume (p = 0.008). Conclusion Elevated plasma level of GDF-15 is associated with aggressive disease and lymph node metastasis in endometrial carcinoma. GDF-15 may be helpful in indicating recurrent disease.	[Engerud, Hilde; Berg, Hege Fredriksen; Tangen, Ingvild Loberg; Trovik, Jone; Krakstad, Camilla] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Engerud, Hilde; Hope, Kirsten; Berg, Hege Fredriksen; Tangen, Ingvild Loberg; Trovik, Jone; Krakstad, Camilla] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Fasmer, Kristine Eldevik; Haldorsen, Ingfrid Salvesen] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Fasmer, Kristine Eldevik; Haldorsen, Ingfrid Salvesen] Univ Bergen, Sect Radiol, Dept Clin Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Krakstad, C (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway.; Krakstad, C (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.	camilla.krakstad@med.uib.no	Berg, Hege/GWC-6893-2022; Krakstad, Camilla/AAB-5138-2020	Berg, Hege/0000-0002-1712-6609; Krakstad, Camilla/0000-0002-0174-8139	University of Bergen; Helse Vest; Norwegian Cancer Society [628837]; Research Council of Norway [239840]; Bergen Research Foundation	University of Bergen; Helse Vest; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Bergen Research Foundation	The study was supported by the University of Bergen, Helse Vest, the Norwegian Cancer Society (628837), the Research Council of Norway (239840), and Bergen Research Foundation. None of the funding sources were involved in collecting, analyzing or interpreting data, nor writing the article or deciding to submit for publication.	Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Baydar T, 2009, J CRIT CARE, V24, P318, DOI 10.1016/j.jcrc.2008.06.013; Berg A, 2017, ONCOTARGET, V8, P68530, DOI 10.18632/oncotarget.19708; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; de Wit NJW, 2005, BRIT J CANCER, V92, P2249, DOI 10.1038/sj.bjc.6602612; Haldorsen IS, 2013, EUR RADIOL, V23, P2916, DOI 10.1007/s00330-013-2901-3; Haldorsen IS, 2012, GYNECOL ONCOL, V126, P413, DOI 10.1016/j.ygyno.2012.05.009; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Knific T, 2018, J STEROID BIOCHEM, V178, P312, DOI 10.1016/j.jsbmb.2018.01.012; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Tangen IL, 2017, BRIT J CANCER, V117, P840, DOI 10.1038/bjc.2017.235; Tanner E, 2017, GYNECOL ONCOL, V147, P535, DOI 10.1016/j.ygyno.2017.10.020; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Trovik J, 2014, INT J GYNECOL CANCER, V24, P252, DOI 10.1097/IGC.0000000000000037; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210585	10.1371/journal.pone.0210585	http://dx.doi.org/10.1371/journal.pone.0210585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645608	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200037
J	Du, Y; Wolf, IK; Busch, MA; Knopf, H				Du, Yong; Wolf, Ingrid-Katharina; Busch, Markus A.; Knopf, Hildtraud			Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998	PLOS ONE			English	Article							RISK; ANTIDEPRESSANTS; DEMENTIA; OPIOIDS; MEDICATION; PEOPLE; DEATH; BENZODIAZEPINES; ANTIPSYCHOTICS; PRESCRIPTION	Background Use of psychotropic drugs is common among older adults. Population-based studies on the associations of psychotropic drug use with mortality are sparse. Objectives To investigate the associations between the use of specific psychotropic drug groups (opioids, antipsychotics, antidepressants and benzodiazepines) and all-cause mortality among community-dwelling older adults in Germany. Methods Participants of the German National Health Interview and Examination Survey 1998 were followed up for mortality from 1997 to 2011. Persons aged 60-79 years with complete data on psychotropic drug use at baseline and on mortality follow-up were considered as study population (N = 1,563). Associations between the use of opioids, antipsychotics, antidepressants and benzodiazepines and all-cause mortality were examined by Cox proportional hazards models adjusted for sociodemographics (sex, age, community size, region, socioeconomic status), life style (smoking, sports, risky alcohol drinking) and health conditions (obesity, disability, history of cardiovascular diseases, diabetes, hyperlipidemia, hypertension, any cancers, any mental disorders) at baseline. Results After a median follow-up of 11.4 years, 21, 18, 23 and 26 deaths were documented among those who used at baseline opioids (n = 39), antipsychotics (n = 30), antidepressants (n = 53) and benzodiazepines (n = 54) with an unadjusted mortality rate (MR) of 57.7, 59.1, 44.6 and 53.7 per 1000 person-years, respectively. Meanwhile, 400 deaths were documented among 1,406 nonusers of any of the above mentioned psychotropic drugs with a MR of 26.7 per 1000 person-years. The age and sex adjusted mortality rate ratios in comparison with nonusers were 2.20 (95% confidence intervals 1.42-3.41), 1.66(1.03-2.70), 1.56(1.062.28), and 1.57(1.07-2.31) for the use of opioids, antipsychotics, antidepressants and benzodiazepines, respectively. In the fully adjusted Cox models, use of opioids (hazardous ratio 2.04, 95% confidence intervals 1.07-3.89), antipsychotics (2.15, 1.11-4.15) and benzodiazepines (1.76, 1.09-2.82), but not antidepressants, were significantly associated with an increased risk of mortality. Conclusions Use of opioids, antipsychotics, benzodiazepines is significantly associated with an increased risk of all-cause mortality among community-dwelling older adults in Germany. Clinicians should be careful in prescribing these psychotropic drugs to older adults while patients already under psychotropic therapy should well balance the risks and benefits of drug use. Further studies with a larger sample size and information on specific indications for psychotropic drug use and mental comorbidities are required to confirm the findings of the present study.	[Du, Yong; Wolf, Ingrid-Katharina; Busch, Markus A.; Knopf, Hildtraud] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute	Du, Y (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	duy@rki.de		Du, Yong/0000-0001-8309-9293	Federal Ministry of Health; Robert Koch Institute	Federal Ministry of Health; Robert Koch Institute	This work was supported by the Federal Ministry of Health (https://www.bundesgesundheitsministerium.de) and the Robert Koch Institute (www.rki.de).The German Health Interview and Examination Survey for Adults 20082011 was funded by the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Coupland CAC, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15280; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Diez-Quevedo C, 2013, INT J CARDIOL, V167, P1217, DOI 10.1016/j.ijcard.2012.03.143; Du Y, 2008, PHARMACOPSYCHIATRY, V41, P242, DOI 10.1055/s-0028-1083791; Du Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182432; Du Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012182; Enache D, 2016, ACTA PSYCHIAT SCAND, V134, P430, DOI 10.1111/acps.12630; Fontanella CA, 2016, J CLIN PSYCHIAT, V77, pE661, DOI 10.4088/JCP.15m10271; Frandsen R, 2014, PARKINSONISM RELAT D, V20, P1124, DOI 10.1016/j.parkreldis.2014.07.012; Gisev N, 2011, CAN J PSYCHIAT, V56, P377, DOI 10.1177/070674371105600609; Gomes T, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3207; Hall WD, 2006, AUST NZ J PSYCHIAT, V40, P941, DOI 10.1111/j.1440-1614.2006.01917.x; Honkola J, 2012, EUR HEART J, V33, P745, DOI 10.1093/eurheartj/ehr368; Hulshof TA, 2015, J AM MED DIR ASSOC, V16, P817, DOI 10.1016/j.jamda.2015.03.015; Ilomaki J, 2013, DRUG ALCOHOL REV, V32, P218, DOI 10.1111/j.1465-3362.2012.00496.x; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Jennum P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010662; Jennum P, 2015, EUR NEUROPSYCHOPHARM, V25, P1906, DOI 10.1016/j.euroneuro.2015.08.014; Johnell K, 2017, INT J GERIATR PSYCH, V32, P414, DOI 10.1002/gps.4483; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Kripke DF, 2016, DRUG SAFETY, V39, P93, DOI 10.1007/s40264-015-0362-0; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Malekzadeh MM, 2013, AM J GASTROENTEROL, V108, P1757, DOI 10.1038/ajg.2013.336; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; Ndukwe HC, 2014, DRUG AGING, V31, P755, DOI 10.1007/s40266-014-0205-1; Neutel CI, 2015, EUR J CLIN PHARMACOL, V71, P637, DOI 10.1007/s00228-015-1841-z; Parsaik AK, 2016, AUST NZ J PSYCHIAT, V50, P520, DOI 10.1177/0004867415616695; Rahmati A, 2017, THORAX, V72, P1028, DOI 10.1136/thoraxjnl-2015-208251; Ralph SJ, 2018, J ALZHEIMERS DIS REP, V2, P1, DOI 10.3233/ADR-170042; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Rikala M, 2011, EUR J CLIN PHARMACOL, V67, P731, DOI 10.1007/s00228-011-0996-5; Ruths S, 2013, INT J GERIATR PSYCH, V28, P868, DOI 10.1002/gps.3902; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Schneider-Thoma J, 2018, LANCET PSYCHIAT, V5, P653, DOI 10.1016/S2215-0366(18)30177-9; Seth P, 2018, AM J TRANSPLANT, V18, P1556, DOI 10.1111/ajt.14905; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Tampi RR, 2016, THER ADV CHRONIC DIS, V7, P229, DOI 10.1177/2040622316658463; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Timour Q, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00076; Veien KT, 2011, INT J CARDIOL, V146, P64, DOI 10.1016/j.ijcard.2010.01.006; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Weisberg DF, 2015, JAIDS-J ACQ IMM DEF, V69, P223, DOI 10.1097/QAI.0000000000000591; Witchel HJ, 2003, J CLIN PSYCHOPHARM, V23, P58, DOI 10.1097/00004714-200302000-00010; Wolf IK, 2014, BUNDESGESUNDHEITSBLA, V57, P1331, DOI 10.1007/s00103-014-2053-x; Wolf IK, 2012, BUNDESGESUNDHEITSBLA, V55, P431, DOI 10.1007/s00103-012-1443-1; Wolf IK, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1254-x; Zhai YM, 2016, J ALZHEIMERS DIS, V52, P631, DOI 10.3233/JAD-151207; Zimmermann-Viehoff F, 2014, PSYCHOL MED, V44, P2975, DOI 10.1017/S003329171400066X; Zivin K, 2016, J CLIN PSYCHOPHARM, V36, P445, DOI 10.1097/JCP.0000000000000545	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210695	10.1371/journal.pone.0210695	http://dx.doi.org/10.1371/journal.pone.0210695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640945	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000039
J	Egea, LG; Jimenez-Ramos, R; Hernandez, I; Brun, FG				Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Brun, Fernando G.			Effect of In Situ short-term temperature increase on carbon metabolism and dissolved organic carbon (DOC) fluxes in a community dominated by the seagrass Cymodocea nodosa	PLOS ONE			English	Article							CLIMATE-CHANGE; POSIDONIA-OCEANICA; HEAT WAVES; ECOSYSTEM SERVICES; ZOSTERA-MARINA; MATTER; PRODUCTIVITY; REDUCTION; BALANCE; IMPACTS	Seagrasses form one of the most productive and threatened ecosystems worldwide because of global change and anthropogenic pressures. The frequency of extreme climatic events, such as heat waves, are expected to increase and may drive even more adverse effects than gradual warming. This study explores for the first time the effects of a sudden and temporary increase of temperature in situ on carbon metabolism and dissolved organic carbon (DOC) fluxes in a community dominated by a seagrass (Cymodocea nodosa) during two contrasting seasons (winter and summer). Results showed a positive correlation between temperature and seagrass production between seasons, while the experimental sudden and temporary increase in water temperature did not produce significant differences in carbon community metabolism and DOC fluxes in winter. In contrast, high temperature conditions in summer enhanced significantly the net community production and affected positively to DOC fluxes. Hence, this study indicates that a sudden and temporary increase in water temperature, which characterize marine heat waves, in temperate areas may enhance the autotrophic metabolism of seagrass communities and can yield an increase in the DOC released, in contrast to previous researches suggesting solely negative effects on seagrasses.	[Egea, Luis G.; Jimenez-Ramos, Rocio; Hernandez, Ignacio; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Puerto Real, Cadiz, Spain	Universidad de Cadiz	Egea, LG (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Puerto Real, Cadiz, Spain.	gonzalo.egea@uca.es	Brun, Fernando G. G/L-1346-2014; Jiménez-Ramos, Rocío/AAT-8081-2020; Hernandez, Ignacio/N-2942-2013; Egea, Luis G./AAT-7290-2020	Brun, Fernando G. G/0000-0002-6313-9531; Jiménez-Ramos, Rocío/0000-0003-1705-1149; Hernandez, Ignacio/0000-0002-8024-2813; Egea, Luis G./0000-0002-2233-3426	Junta de Andalucia Excellence Project [P12-RNM-3020]; Spanish national project [CTM2017-85365-R]; European Social Fund (ESF)	Junta de Andalucia Excellence Project(Junta de Andalucia); Spanish national project(Spanish Government); European Social Fund (ESF)(European Social Fund (ESF))	This work was supported by the Junta de Andalucia Excellence Project P12-RNM-3020 (PRODESCA) and by the Spanish national project CTM2017-85365-R (PAVAROTTI). LGE and RJ hold a contract as young researchers financed by the European Social Fund (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39930; Alcoverro T, 2000, MAR ECOL PROG SER, V194, P13, DOI 10.3354/meps194013; [Anonymous], 2013, LIMNOL OCEANOGR FLUI; [Anonymous], 2018, IPCC SR 1 5; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Arias-Ortiz A, 2018, NAT CLIM CHANGE, V8, P338, DOI 10.1038/s41558-018-0096-y; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barron C, 2004, LIMNOL OCEANOGR, V49, P1642, DOI 10.4319/lo.2004.49.5.1642; Barron C., 2014, FRONT MAR SCI, V1, P1; Barron C, 2009, MAR ECOL PROG SER, V374, P75, DOI 10.3354/meps07715; Beca-Carretero P, 2018, MAR ECOL PROG SER, V589, P59, DOI 10.3354/meps12439; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2003, MAR ECOL PROG SER, V265, P85, DOI 10.3354/meps265085; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; Carruthers TJB, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P369, DOI 10.1016/B978-044450891-1/50020-7; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Cullen-Unsworth L, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.785864; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Boeck HJ, 2016, NEW PHYTOL, V209, P531, DOI 10.1111/nph.13601; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; DUARTE CM, 1989, MAR ECOL PROG SER, V51, P269, DOI 10.3354/meps051269; Egea LG, 2018, MAR POLLUT BULL, V134, P14, DOI 10.1016/j.marpolbul.2018.02.029; Egea LG, 2017, THESIS; Egea LG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192402; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ferguson AJP, 2017, ESTUAR COAST SHELF S, V187, P216, DOI 10.1016/j.ecss.2017.01.005; Field C.B., 2012, MANAGING RISKS EXTRE, P555; Field C.B., 2014, CLIMATE CHANGE 2014, P1132; Fraser MW, 2014, J ECOL, V102, P1528, DOI 10.1111/1365-2745.12300; Frolicher TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03163-6; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garthwin RG, 2014, MAR POLLUT BULL, V83, P475, DOI 10.1016/j.marpolbul.2013.08.010; Gonzalez-Ortiz V, 2014, ESTUAR COAST SHELF S, V139, P20, DOI 10.1016/j.ecss.2013.12.015; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hegerl GC, 2011, NAT GEOSCI, V4, P142, DOI 10.1038/ngeo1090; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hopkinson CS, 1999, ESTUARIES, V22, P863, DOI 10.2307/1353067; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jimenez-Arias JL, 2016, HOLOCENE, V26, P1355, DOI 10.1177/0959683616640046; Jimenez-Ramos R, 2017, J EXP MAR BIOL ECOL, V497, P41, DOI 10.1016/j.jembe.2017.09.008; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Macreadie PI, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040115; Malinverno A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17861; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marchand FL, 2006, NEW PHYTOL, V170, P291, DOI 10.1111/j.1469-8137.2006.01659.x; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; McGregor P, 2015, 1142 WMO, V1142, P96; Mckay G, 2017, ENVIRON SCI TECHNOL, V51, P5404, DOI 10.1021/acs.est.6b06372; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moore KA, 2014, ESTUAR COAST, V37, pS20, DOI 10.1007/s12237-013-9667-3; Moreno-Marin F, 2018, LIMNOL OCEANOGR, V63, P1528, DOI 10.1002/lno.10789; Morris EP, 2009, MAR ECOL PROG SER, V390, P117, DOI 10.3354/meps08184; Navarro N, 2004, AQUAT MICROB ECOL, V37, P47, DOI 10.3354/ame037047; Olive I, 2016, ESTUAR COAST, V39, P138, DOI 10.1007/s12237-015-9973-z; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; PAI SC, 1993, MAR CHEM, V41, P343, DOI 10.1016/0304-4203(93)90266-Q; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEREZ M, 1992, AQUAT BOT, V43, P51, DOI 10.1016/0304-3770(92)90013-9; Perkins-Kirkpatrick SE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12520-2; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Robinson KIM, 1987, EFFECTS THERMAL POWE, V7, P1; Roland F, 1999, LIMNOL OCEANOGR, V44, P1148, DOI 10.4319/lo.1999.44.4.1148; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Royer PD, 2011, J ECOL, V99, P714, DOI 10.1111/j.1365-2745.2011.01804.x; Ruiz-Frau A, 2017, OCEAN COAST MANAGE, V149, P107, DOI 10.1016/j.ocecoaman.2017.10.004; Schrameyer V, 2018, MAR ENVIRON RES, V136, P38, DOI 10.1016/j.marenvres.2018.02.008; Seddon S, 2000, AQUAT BOT, V66, P297, DOI 10.1016/S0304-3770(99)00080-7; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Thomson JA, 2015, GLOBAL CHANGE BIOL, V21, P1463, DOI 10.1111/gcb.12694; Thorhaug A, 2017, SCI TOTAL ENVIRON, P605; Thorhaugh A., 1984, BIOSPHERE PROBLEM SO, P407; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vergara JJ, 2012, ESTUAR COAST SHELF S, V112, P255, DOI 10.1016/j.ecss.2012.07.031; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yuan WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep18813; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; Ziegler S, 1998, MAR ECOL PROG SER, V173, P1, DOI 10.3354/meps173001; ZIMMERMAN RC, 1989, J EXP MAR BIOL ECOL, V130, P93, DOI 10.1016/0022-0981(89)90197-4	95	18	18	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210386	10.1371/journal.pone.0210386	http://dx.doi.org/10.1371/journal.pone.0210386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640926	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000025
J	Lee, JY; Lim, KC; Kim, SY; Paik, HR; Kim, YJ; Jin, BH				Lee, Jae-Young; Lim, Kyung-Cheol; Kim, So-Yun; Paik, Hye-Ran; Kim, Young-Jae; Jin, Bo-Hyoung			Oral health status of the disabled compared with that of the non-disabled in Korea: A propensity score matching analysis	PLOS ONE			English	Article							DISABILITY; ADULTS	Background There are many types of disabilities, and each type has a variety related to socioeconomic factors. Such factors affect to many health problems of the disabled. However, surveys of the oral health status of the disabled in Korea are rare. Objective The purpose of this study was to estimate oral health disparity through comparing oral health status of the disabled to the non-disabled, adjusted for the net effect of the disability on oral health status. Methods A cross-sectional study was conducted among the disabled in urban and suburban areas in Korea from June to September 2016. People with physical, mental, and multiple disabilities took part in this survey. The clinical examinations were carried out by trained dentists. Statistical analysis was performed to quantify the association between oral health and socioeconomic status after restricting the analysis using a propensity score matching method. Results The disabled had more DMFT, DT, and MT, fewer FT, and fewer teeth than the non-disabled based on entire groups (P<0.01). No difference in the ratio of periodontitis was observed. The subjects with mental disabilities (MD) scored 3.09 (95% CI, 1.07-8.97), and those with multiple disabilities scored 4.37 (95% CI, 1.16-16.37) for edentulous status. The MD had an odds ratio of 1.34 (95% CI, 1.03-1.74), and those with multiple disabilities had an odds ratio of 1.75 (95% CI, 1.11-2.76) for the DMFT index. Conclusions These results represent poor oral health status of the disabled compared to the non-disabled. Consequentially, we can verify that not only the existence of disability but also the type of disability has a decisive effect on oral health condition. This comparison is necessary to widen our approach to evaluate the actual status condition of the disabled.	[Lee, Jae-Young; Lim, Kyung-Cheol; Jin, Bo-Hyoung] Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, Seoul, South Korea; [Lee, Jae-Young; Paik, Hye-Ran] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea; [Kim, So-Yun] Seoul Natl Univ, Dept Consumer Sci, Coll Human Ecol, Seoul, South Korea; [Kim, Young-Jae] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jin, BH (corresponding author), Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, Seoul, South Korea.; Kim, YJ (corresponding author), Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul, South Korea.	neokarma@snu.ac.kr; jjbh@snu.ac.kr	jin, bo-hyoung/AAU-8576-2021; Lee, Jae-Young/GWZ-2558-2022	Jin, Bo-Hyoung/0000-0003-3526-6805	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1503]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1503).	Abe Y, 2015, J JAP SOC DISABIL OR, V36, P4; Al-Qahtani Z, 2004, Odontostomatol Trop, V27, P37; America Dental Lifeline Network, 2017, AM DENT LIF NETW 201; Angelillo IF, 1995, COMMUNITY DENT ORAL, V23, P360, DOI 10.1111/j.1600-0528.1995.tb00263.x; [Anonymous], 2011, WORLD REP DIS; Baelum V, 2002, ACTA ODONTOL SCAND, V60, P80, DOI 10.1080/000163502753509464; Bagramian RA, 2009, AM J DENT, V22, P3; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P332, DOI 10.2105/AJPH.2004.055277; Brzuzy S, 1999, J SOCIOL SOC WELFARE, V26, P191; Couto P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193953; Dieguez-Perez Montserrat, 2016, J Clin Exp Dent, V8, pe337, DOI 10.4317/jced.52922; Hennequin M, 2000, J DENT, V28, P131, DOI 10.1016/S0300-5712(99)00052-4; Huang ST., 2006, NATL SURVEY ORAL HLT; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kebede B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039142; KENDALL NP, 1991, COMMUNITY DENT ORAL, V19, P357, DOI 10.1111/j.1600-0528.1991.tb00187.x; Kenkre A M, 2000, Indian J Dent Res, V11, P5; Khocht A, 2010, SPEC CARE DENT, V30, P118, DOI 10.1111/j.1754-4505.2010.00134.x; Korea Ministry of Health & Welfare, 2014, 2014 INV DIS PERS, V229; del Valle LML, 2007, J DENT CHILD, V74, P130; Norlin D, 2013, J INTELL DISABIL RES, V57, P552, DOI 10.1111/j.1365-2788.2012.01564.x; Oredugba Folakemi A, 2007, Downs Syndr Res Pract, V12, P72; Rey V, 2011, EUR J NEUROL, V18, P1094, DOI 10.1111/j.1468-1331.2010.03264.x; Saravane D, 2009, ENCEPHALE, V35, P330, DOI 10.1016/j.encep.2008.10.014; Sasaki Y, 2004, Int J Paediatr Dent, V14, P127, DOI 10.1111/j.1365-263X.2004.00529.x; Shyama M, 2001, Community Dent Health, V18, P181; Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3; Statistics Korea. Korea Statistical Information System (KOSIS), STAT DB REG STAT DIS; Tiller S, 2001, Community Dent Health, V18, P167; Turner S, 2008, J INTELL DISABIL RES, V52, P29, DOI 10.1111/j.1365-2788.2007.00971.x; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG, P63; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th; Yamamoto K, 2016, J JAP SOC DISABIL OR, V37, P180	33	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0208246	10.1371/journal.pone.0208246	http://dx.doi.org/10.1371/journal.pone.0208246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640962	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000003
J	Behme, D; Tsogkas, I; Colla, R; Gera, RG; Schregel, K; Hesse, AC; Maier, IL; Liman, J; Liebeskind, DS; Psychogios, MN				Behme, Daniel; Tsogkas, Ioannis; Colla, Ruben; Gera, Roland G.; Schregel, Katharina; Hesse, Amelie C.; Maier, Ilko L.; Liman, Jan; Liebeskind, David S.; Psychogios, Marios-Nikos			Validation of the extended thrombolysis in cerebral infarction score in a real world cohort	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; REPERFUSION; RECANALIZATION; THROMBECTOMY; 2B	Background A thrombolysis in cerebral infarction (TICI) score of 2b is defined as a good recanalization result although the reperfusion may only cover 50% of the affected territory. An additional mTICI2c category was introduced to further differentiate between mTICI scores. Despite the new mTICI2c category, mTICI2b still covers a range of 50-90% reperfusion which might be too imprecise to predict neurological improvement after therapy. Aim To compare the 7-point "expanded TICI" (eTICI) scale with the traditional mTICI in regard to predict functional independence at 90 days. Methods Retrospective review of 225 patients with large artery occlusion. Angiograms were graded by 2 readers according the 7-point eTICI score (0% = eTICI0; reduced clot = eTICI1; 1-49% = eTICI2a, 50-66% = eTICI2b50; 67-89% = eTICI2b67, 90-99% = eTICI2c and complete reperfusion = eTICI3) and the conventional mTICI score. The ability of e-and mTICI to predict favorable outcome at 90days was compared. Results Given the ROC analysis eTICI was the better predictor of favorable outcome (p-value 0.047). Additionally, eTICI scores 2b50, 2b67 and 2c (former mTICI2b) were significantly superior at predicting the probability of a favorable outcome at 90 days after endovascular therapy with a p-value of 0.033 (probabilities of 17% for mTICI2b50, 24% for mTICI2b67 and 54% for mTICI2c vs. 36% for mTICI2b). Conclusions The 7-point eTICI allows for a more accurate outcome prediction compared to the mTICI score because it refines the broad range of former mTICI2b results.	[Behme, Daniel; Tsogkas, Ioannis; Colla, Ruben; Schregel, Katharina; Hesse, Amelie C.; Psychogios, Marios-Nikos] Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany; [Gera, Roland G.] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Maier, Ilko L.; Liman, Jan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Liebeskind, David S.] UCLA, Dept Neurol, Neurovasc Imaging Res Core, Los Angeles, CA 90024 USA; [Liebeskind, David S.] UCLA, Dept Neurol, Stroke Ctr, Los Angeles, CA 90024 USA	University of Gottingen; University of Gottingen; University of Gottingen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Psychogios, MN (corresponding author), Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany.	m.psychogios@med.uni-goettingen.de	Behme, Daniel/H-4551-2019	Gera, Roland Gerard/0000-0001-8896-3749				Almekhlafi MA, 2014, INTERV NEURORADIOL, V20, P21, DOI 10.15274/INR-2014-10004; Behme D, 2016, J NEUROINTERV SURG, V8, P8, DOI 10.1136/neurintsurg-2014-011446; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gobin YP, 2004, STROKE, V35, P2848, DOI 10.1161/01.STR.0000147718.12954.60; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jayaraman MV, 2013, AM J NEURORADIOL, V34, P135, DOI 10.3174/ajnr.A3278; Jung C, 2016, AM J NEURORADIOL, V37, P285, DOI 10.3174/ajnr.A4529; Kaesmacher J, 2018, EUR RADIOL, V28, P274, DOI 10.1007/s00330-017-4928-3; Kleine JF, 2017, J NEUROINTERV SURG, V9, P117, DOI 10.1136/neurintsurg-2015-012218; Kowoll A, 2016, J NEUROINTERV SURG, V8, P230, DOI 10.1136/neurintsurg-2014-011520; Leyhe JR, 2017, J NEUROINTERV SURG, V9, P1253, DOI 10.1136/neurintsurg-2016-012866; Liebeskind DS, 2019, J NEUROINTERV SURG, V11, P433, DOI 10.1136/neurintsurg-2018-014127; Maus V, 2019, CLIN NEURORADIOL, V29, P669, DOI 10.1007/s00062-018-0702-4; Maus V, 2018, CLIN NEURORADIOL, V28, P327, DOI 10.1007/s00062-017-0566-z; Psychogios MN, 2017, STROKE, V48, P3152, DOI 10.1161/STROKEAHA.117.018077; Rozeman AD, 2016, J STROKE CEREBROVASC, V25, P115, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.002; Sanossian N, 2017, STROKE, V48, P1389, DOI 10.1161/STROKEAHA.117.014745; Tung EL, 2017, STROKE, V48, P2488, DOI 10.1161/STROKEAHA.117.017182; Volny O, 2017, J STROKE CEREBROVASC, V26, P992, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.008; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	20	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210334	10.1371/journal.pone.0210334	http://dx.doi.org/10.1371/journal.pone.0210334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629664	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000075
J	Goel, S; Angeli, F; Dhirar, N; Sangwan, G; Thakur, K; Ruwaard, D				Goel, Sonu; Angeli, Federica; Dhirar, Nonita; Sangwan, Garima; Thakur, Kanchan; Ruwaard, Dirk			Factors affecting medical students' interests in working in rural areas in North India-A qualitative inquiry	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; RECRUITMENT; CHALLENGES; RETENTION	Background and Objective The shortage of doctors, especially in rural areas, is a major concern in India, which in turn affects the effective delivery of health care services. To support new policies able to address this issue, a study was conducted to determine the discouraging and encouraging factors affecting medical students' interests towards working in rural areas. Methods This cross-sectional, descriptive qualitative study has been conducted in three states of North India. It comprised six focus group discussions, each consisting of 10-20 medical students of six government medical colleges. The verbatim and thematic codes have been transcribed by using a 'categorical aggregation approach'. The discussions were thematically analyzed. Results Ninety medical students participated in the study. The discouraging factors were grouped under two broad themes namely unchallenging professional environment (poor accommodation facilities and lack of necessary infrastructure; lack of drug and equipment supplies; inadequate human resource support; lesser travel and research opportunities) and gap between financial rewards and social disadvantages (lower salary and incentives, social isolation, political interference, lack of security). Similarly, the encouraging factors were congregated under three main themes namely willingness to give back to disadvantaged communities (desire to serve poor, underprivileged and home community), broader clinical exposure (preferential admission in post-graduation after working more than 2-3 years in rural areas) and higher status and respect (achieving higher social status). Conclusions This qualitative study highlights key factors affecting medical students' interest to work in rural areas. A substantial similarity was noted between the factors which emerge from the current study and those documented in other countries. These findings will help policy-makers and medical educators to design and implement a comprehensive human resource strategy that shall target specific factors to encourage medical students to choose job positions in rural areas.	[Goel, Sonu; Dhirar, Nonita; Sangwan, Garima; Thakur, Kanchan] Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India; [Goel, Sonu; Dhirar, Nonita; Sangwan, Garima; Thakur, Kanchan] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Angeli, Federica; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Hlth Serv Res, Maastricht, Netherlands	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Maastricht University; Maastricht University Medical Centre (MUMC)	Goel, S (corresponding author), Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India.; Goel, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	sonugoel007@yahoo.co.in	Goel, Sonu/F-7956-2010	Goel, Sonu/0000-0001-5231-7083; Ruwaard, Dirk/0000-0003-4887-8413; Angeli, Federica/0000-0003-4010-3103	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study is funded by Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, YB HLTH STAT; [Anonymous], 1994, QUALITATIVE DATA ANA; Chaudhury N, 2004, WORLD BANK ECON REV, V18, P423, DOI 10.1093/wber/lhh047; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cooper RS, 2006, INT J EPIDEMIOL, V35, P817, DOI 10.1093/ije/dyl175; Couper ID, 2007, SAMJ S AFR MED J, V97, P1082; Creswell JW., 2018, QUAL INQ, V4th; Curran V, 2004, MED TEACH, V26, P265, DOI 10.1080/0142159042000192055; de Vries E, 2003, SAMJ S AFR MED J, V93, P789; Deakin University, 2001, RURAL REMOTE HLTH; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; Dovlo D, BRAIN DRAIN RETENTIO; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; Easterbrook M, 1999, CAN MED ASSOC J, V160, P1159; Elam CL, 2015, MED EDUC ONLINE, V20, DOI 10.3402/meo.v20.27081; Gadi A. D., 2012, Health, V4, P824, DOI 10.4236/health.2012.410127; Garg S, 2012, NATL MED J INDIA, V25, P111; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Katrak H, 2008, INT J HEALTH PLAN M, V23, P93, DOI 10.1002/hpm.871; Kaye DK, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-47; Khan MM, 2013, INT J HEALTH PLAN M, V28, P202, DOI 10.1002/hpm.2136; Kruk ME, 2010, B WORLD HEALTH ORGAN, V88, P333, DOI 10.2471/BLT.09.072892; Laven Gillian, 2003, Aust J Rural Health, V11, P277, DOI 10.1111/j.1440-1584.2003.00534.x; Ly C, 2014, EC DEMOGRAPHIC EPIDE; Maslow A. H., 1943, CLASSICS HIST PSYCHO; Mohamed AM, 2013, HEALTHC LOW-RESOUR S, V1, P11, DOI 10.4081/hls.2013.e4; Panagariya A, 2014, ANN NEUROSCI, V21, P125, DOI 10.5214/ans.0972.7531.210401; Partners A., 2016, COMM HLTH SYST CAT C; Peach HG, 2000, MED EDUC, V34, P231; Playford Denese, 2006, Aust J Rural Health, V14, P14, DOI 10.1111/j.1440-1584.2006.00745.x; Polasek Ozren, 2006, Hum Resour Health, V4, P7, DOI 10.1186/1478-4491-4-7; RABINOWITZ HK, 1993, NEW ENGL J MED, V328, P934, DOI 10.1056/NEJM199304013281307; Rao KD, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-19; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Saini N, 1967, CAP REG INDIA RURAL, P12; Singh Zile, 2013, Indian J Community Med, V38, P70, DOI 10.4103/0970-0218.112430; Steinhaeuser J, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-112; Steven J., INTRO QUALITATIVE RE; Stilwell B., 2004, B WHO, V82; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; Syed NA, 2008, MED EDUC, V42, P61, DOI 10.1111/j.1365-2923.2007.02904.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WHO, 2011, FOR GLOB SHORT PHYS; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Wilson NW, RURAL REMOTE HLTH, V9, P1060; World Health Orgainzation, 2013, WORLD HLTH REP 2006; World Health Organization, 2018, GLOB HLTH OBS GHO DA	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210251	10.1371/journal.pone.0210251	http://dx.doi.org/10.1371/journal.pone.0210251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629641	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000066
J	Ijichi, T; Nakazawa, G; Torii, S; Nagamatsu, H; Yoshikawa, A; Souba, J; Isobe, A; Hagiwara, H; Ikari, Y				Ijichi, Takeshi; Nakazawa, Gaku; Torii, Sho; Nagamatsu, Hirofumi; Yoshikawa, Ayako; Souba, Junko; Isobe, Atsushi; Hagiwara, Hitomi; Ikari, Yuji			Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery	PLOS ONE			English	Article							BARE-METAL; EX-VIVO; SIROLIMUS; RESTENOSIS; COATINGS; THROMBOGENICITY; THROMBOSIS; PERMANENT; PATHOLOGY; RESPONSES	Current drug-eluting stents have abluminal polymer coating; however, thrombus formation in these compared with that in uniformly coated stents remains controversial. We evaluated thrombus formation and early endothelialization after using abluminal biodegradable polymer- coated sirolimus-(BP-SES), and everolimus-eluting stents (BP-EES) versus a durable polymer-coated everolimus-eluting stent (DP-EES) in an in vivo setting. BP-SES, BP-EES, and DP-EES (n = 6 each) were implanted in coronary arteries of 12 mini-pigs that were then sacrificed after 7 and 10 days. Stents were stained with hematoxylin and eosin, and a combined Verhoeff and Masson trichrome stain. Areas of fibrin deposition were digitally detected and measured with off-line morphometric software. Stents were investigated for re-endothelialization by transmission electron microscopy. At 7 days, histological analysis revealed the lowest area of fibrin deposition in BP-SES (BP-SES vs. BP-EES vs. DP-EES; 0.10 +/- 0.06 mm(2) vs. 0.15 +/- 0.07 mm(2) vs. 0.19 +/- 0.06 mm(2), p = 0.0004). At 10 days, the area of fibrin deposition was significantly greater in DP-EES (0.13 +/- 0.04 mm(2) vs. 0.14 +/- 0.05 mm(2) vs. 0.19 +/- 0.08 mm(2), p = 0.007). Endothelial cells in BP-SES demonstrated a significantly greater number of tight junctions than those in DP-EES according to by transmission electron microscopy for both days (p< 0.05). Various parameters, including an inflammatory reaction and neointimal formation, were comparable among the groups at 7 and 10 days. An abluminal biodegradable polymer-coated SES showed the least fibrin deposition and greatest endothelial cell recovery at an early stage following implantation in the coronary arteries of mini-pigs.	[Ijichi, Takeshi; Nakazawa, Gaku; Torii, Sho; Nagamatsu, Hirofumi; Yoshikawa, Ayako; Ikari, Yuji] Tokai Univ, Dept Cardiol, Sch Med, Hiratsuka, Kanagawa, Japan; [Souba, Junko; Isobe, Atsushi; Hagiwara, Hitomi] TERUMO Corp Evaluat Ctr, Nakai, Kanagawa, Japan	Tokai University; Terumo Corporation	Nakazawa, G (corresponding author), Tokai Univ, Dept Cardiol, Sch Med, Hiratsuka, Kanagawa, Japan.	gnakazawa@tokai-u.jp			TERUMO Corporation	TERUMO Corporation	This study was all supported by TERUMO Corporation. There was no additional external funding received for this study. The funder provided support in the form of salaries or research grants for authors GN, JS, AI, HH and YI.	Granada JF, 2010, CIRC-CARDIOVASC INTE, V3, P257, DOI 10.1161/CIRCINTERVENTIONS.109.919936; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Koppara T, 2016, EUROINTERVENTION, V11, P1020, DOI 10.4244/EIJY14M10_08; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Lee DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183079; Longo G, 2015, MINERVA CARDIOANGIOL, V63, P193; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Nakano M, 2014, J AM COLL CARDIOL, V63, P2510, DOI 10.1016/j.jacc.2014.02.607; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Otsuka F, 2015, JACC-CARDIOVASC INTE, V8, P1248, DOI 10.1016/j.jcin.2015.03.029; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Saito N, 2016, MED DEVICES-EVID RES, V9, P33, DOI 10.2147/MDER.S102094; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Seifert PS, 2007, CARDIOVASC REVASCULA, V8, P251, DOI 10.1016/j.carrev.2007.08.002; Steigerwald K, 2012, EUROINTERVENTION, V8, P752, DOI 10.4244/EIJV8I6A115; Stojkovic S, 2015, FUND CLIN PHARMACOL, V29, P95, DOI 10.1111/fcp.12092; Tada T, 2014, INT J CARDIOVAS IMAG, V30, P495, DOI 10.1007/s10554-014-0376-1; van Beusekom HMM, 1998, J AM COLL CARDIOL, V32, P1109, DOI 10.1016/S0735-1097(98)00348-9; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Wilson GJ, 2015, CATHETER CARDIO INTE, V86, pE247, DOI 10.1002/ccd.25993; Wilson GJ, 2012, EUROINTERVENTION, V8, P250, DOI 10.4244/EIJV8I2A39	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209841	10.1371/journal.pone.0209841	http://dx.doi.org/10.1371/journal.pone.0209841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629613	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000035
J	Curveira-Santos, G; Pedroso, NM; Barros, AL; Santos-Reis, M				Curveira-Santos, Goncalo; Pedroso, Nuno M.; Barros, Ana Luisa; Santos-Reis, Margarida			Mesocarnivore community structure under predator control: Unintended patterns in a conservation context	PLOS ONE			English	Article							CATS FELIS-SILVESTRIS; FERAL DOMESTIC CATS; FOX VULPES-VULPES; RED FOX; CARNIVORE DIVERSITY; PHOTOGRAPHIC RATES; EUROPEAN WILDCAT; GAME MANAGEMENT; TOP PREDATORS; FOREST COVER	Across the Mediterranean, conservation programmes often operate concomitantly with hunting interests within game-lands. Carnivore guilds lie at the interface between contrasting management goals, being simultaneously fundamental components of ecosystems and targets of predator control to reduce predation on game species. Here, we evaluate the composition and spatial structure of a mesocarnivore community in a protected area of Southeast Portugal, with high economic investment in conservation and significant hunting activity. Between June and August 2015, we deployed 77 camera-traps across a similar to 80 km(2) area. We report on interspecific disparities in mesocarnivore occupancy and associated environmental determinants. Contrasting occupancy states suggest an unbalanced community, biased towards the widespread occurrence of the red fox Vulpes vulpes ((psi) over cap = 0.92 +/- 0.04) compared to other species (stone marten Martes foina, European badger Meles meles, Egyptian mongoose Herpestes ichneumon, common genet Genetta genetta, and Eurasian otter Lutra lutra) exhibiting spatially-restricted occupancy patterns ((psi) over cap /naive occupancy < 0.35). The feral cat Felis silvestris catus was the exception (<(psi)over cap> = 0.48 +/- 0.11) and, together with the stone marten, exhibited a positive association with human settlements. These findings are consistent with theoretical predictions on how mesocarnivore communities are shaped by the effects of non-selective predator control, paradoxically favouring species with higher population growth rates and dispersal abilities, such as the red fox. Our results reinforce the need to understand the role of predator control as a community structuring agent with potential unintended effects, while exposing issues hindering such attempts, namely non-selective illegal killing or biased/concealed information on legal control measures.	[Curveira-Santos, Goncalo; Pedroso, Nuno M.; Barros, Ana Luisa; Santos-Reis, Margarida] Univ Lisbon, Fac Ciencias, CE3c Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Pedroso, Nuno M.] Univ Sao Paulo, CENA, Piracicaba, SP, Brazil	Universidade de Lisboa; Universidade de Sao Paulo	Curveira-Santos, G (corresponding author), Univ Lisbon, Fac Ciencias, CE3c Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal.	goncalo-cs@hotmail.com	Santos-Reis, Margarida/H-4064-2011; Pedroso, Nuno Miguel Peres Sampaio/I-6295-2013	Pedroso, Nuno Miguel Peres Sampaio/0000-0001-6486-130X; Barros, Ana Luisa/0000-0003-1363-1509; Curveira-Santos, Goncalo/0000-0002-7136-5088; Santos-Reis, Margarida/0000-0002-0337-963X	LIFE+ Nature project - Life Programme - European Commission [LIFE13 NAT/PT/001300]; Fundacao para a Ciencia e a Tecnologia (FCT) [PD/BD/114037/2015, UID/BIA/00329/2013]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP)) [2014/08601-6]; Sao Paulo Research Foundation (FAPESP) [2014/08601-6]; FCT [UID/BIA/00329/2013]; Liga para a Proteccao da Natureza [LIFE08 NAT/P/000227]; Life Programme-European Commission [LIFE13 NAT/PT/001300]	LIFE+ Nature project - Life Programme - European Commission; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP))(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Liga para a Proteccao da Natureza; Life Programme-European Commission	Funding was received from the LIFE+ Nature project LIFE13 NAT/PT/001300 (http://ec.europa.eu/environment/life/), supported 75% by the Life Programme - European Commission. We would like to thank Liga para a Proteccao da Natureza for the vegetation geographic information system coverage available for GVNP, produced under the LIFE Project "Enhancing habitat for the Iberian Lynx and Black Vulture in the Southeast of Portugal" - LIFE08 NAT/P/000227. GCS (PD/BD/114037/2015), MSR and ALB (UID/BIA/00329/2013) were supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt). NMP was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation (FAPESP)) (#2014/08601-6) (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted under the LIFE+ Nature project "Conservation of the Spanish Imperial Eagle (Aquila adalberti) in Portugal"-LIFE13 NAT/PT/001300, supported 75% by the Life Programme-European Commission. We would like to thank Liga para a Proteccao da Natureza for the vegetation geographic information system coverage available for GVNP, produced under the LIFE Project " Enhancing habitat for the Iberian Lynx and Black Vulture in the Southeast of Portugal"-LIFE08 NAT/P/000227. We would also thank Ricardo Martins for all his support in fieldwork and to Barbara Madeira for her field and photo identification work. We also thank the feedback from two anonymous reviewers which led to substantial improvements. During the writing phase of the manuscript, GCS was funded by a doctoral grant from Fundacao para a Ciencia e a Tecnologia (FCT) (PD/BD/114037/2015). NMP was supported by grant #2014/08601-6, Sao Paulo Research Foundation (FAPESP). MSR and ALB had support from FCT (UID/BIA/00329/2013).	[Anonymous], 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-2.RLTS.T12520A50655794.EN; [Anonymous], 2005, PROGRAM MARK GENTLE; Baker PJ, 2006, EUR J WILDLIFE RES, V52, P99, DOI 10.1007/s10344-005-0018-y; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Barrull J, 2014, MAMM BIOL, V79, P123, DOI 10.1016/j.mambio.2013.11.004; Barrull J, 2014, ITAL J ZOOL, V81, P271, DOI 10.1080/11250003.2014.893378; Barrull J, 2011, MAMMALIA, V75, P363, DOI 10.1515/MAMM.2011.052; Beja P, 2009, EUR J WILDLIFE RES, V55, P227, DOI 10.1007/s10344-008-0236-1; Biro Z, 2005, J ZOOL, V266, P187, DOI 10.1017/S0952836905006771; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; BRIGHT PW, 1993, MAMMAL REV, V23, P101, DOI 10.1111/j.1365-2907.1993.tb00420.x; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Casanovas JG, 2012, ECOL RES, V27, P603, DOI 10.1007/s11284-012-0931-y; Caut S, 2007, AUSTRAL ECOL, V32, P858, DOI 10.1111/j.1442-9993.2007.01770.x; Cruz J, 2015, J MAMMAL, V96, P854, DOI 10.1093/jmammal/gyv109; Curveira-Santos G, 2017, AGR ECOSYST ENVIRON, V237, P280, DOI 10.1016/j.agee.2016.12.037; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Delibes-Mateos M, 2008, BIODIVERS CONSERV, V17, P559, DOI 10.1007/s10531-007-9272-5; Delibes-Mateos M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05367-180228; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dorresteijn I, 2015, P ROY SOC B-BIOL SCI, V282, P105, DOI 10.1098/rspb.2015.1602; Duarte A, 2012, VET MICROBIOL, V158, P400, DOI 10.1016/j.vetmic.2012.02.033; Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896; Fedriani JM, 1999, OECOLOGIA, V121, P138, DOI 10.1007/s004420050915; FERREIRA JP, 2011, PLOS ONE, V6, P38426; Ferreras P, 2017, J ZOOL, V301, P23, DOI 10.1111/jzo.12386; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Galvez N, 2013, ORYX, V47, P251, DOI 10.1017/S0030605312000099; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Kauhala K, 1999, IMPACT PREDATOR REMO, P139; Kays Roland W., 2008, P110; Kilshaw K, 2010, SCOTTISH WILDCAT COM; Kuijper DPJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1625; LISZKA T, 1984, INT J NUMER METH ENG, V20, P1599, DOI 10.1002/nme.1620200905; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; LOSS SR, 2013, NAT COMMUN, V4; Lozano J, 2013, ANIM BIODIV CONSERV, V36, P37; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martinez J., 2002, SOCIOECONOMIC ASPECT; McDonald RA, 2002, J APPL ECOL, V39, P793, DOI 10.1046/j.1365-2664.2002.00757.x; Monterroso P, 2014, EUR J WILDLIFE RES, V60, P279, DOI 10.1007/s10344-013-0780-1; Newsome TM, 2014, EUR J WILDLIFE RES, V60, P749, DOI 10.1007/s10344-014-0844-x; O'Bryan CJ, 2018, NAT ECOL EVOL, V2, P229, DOI 10.1038/s41559-017-0421-2; Oldfield TEE, 2003, NATURE, V423, P531, DOI 10.1038/nature01678; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; PALOMARES F, 1993, J APPL ECOL, V30, P752, DOI 10.2307/2404253; PALOMARES F, 1995, CONSERV BIOL, V9, P295, DOI 10.1046/j.1523-1739.1995.9020295.x; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Recio MR, 2015, CURR ZOOL, V61, P793, DOI 10.1093/czoolo/61.5.793; Reynolds JC, 1996, CONTROL MAMMALIAN PR, P26; Ritchie EG, 2012, TRENDS ECOL EVOL, V27, P265, DOI 10.1016/j.tree.2012.01.001; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Rosalino LM, 2010, ANN ZOOL FENN, V47, P195, DOI 10.5735/086.047.0304; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; SANTOS MJ, 2007, WEB ECOL, V7, P53, DOI DOI 10.5194/WE-7-53-2007; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Sarmento P, 1996, ACTA THERIOL, V41, P409, DOI 10.4098/AT.arch.96-39; Sarmento P, 2009, EUR J WILDLIFE RES, V55, P247, DOI 10.1007/s10344-008-0240-5; Sarmento PB, 2011, EUR J WILDLIFE RES, V57, P119, DOI 10.1007/s10344-010-0405-x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sillero-Zubiri C., 2004, P257; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; Team QGD, 2017, QUANT GIS GEOGR INF; Team RDC, 2011, R LANG ENV STAT COMP; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; Virgos E, 2005, BIODIVERS CONSERV, V14, P3475, DOI 10.1007/s10531-004-0823-8; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Virgos E, 2001, BIODIVERS CONSERV, V10, P1039, DOI 10.1023/A:1016684428664; Virgos E, 2016, BIODIVERS CONSERV, V25, P1409, DOI 10.1007/s10531-016-1117-7; Whitfield DP, 2003, BIOL CONSERV, V114, P157, DOI 10.1016/S0006-3207(03)00019-3	87	6	6	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210661	10.1371/journal.pone.0210661	http://dx.doi.org/10.1371/journal.pone.0210661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653547	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500062
J	Hjelmgren, O; Stromberg, U; Gellerman, K; Thurin, A; Zetterberg, M; Bergstrom, G				Hjelmgren, Ola; Stromberg, Ulf; Gellerman, Karl; Thurin, Anders; Zetterberg, Madeleine; Bergstrom, Goran			Does retinopathy predict stroke recurrence in type 2 diabetes patients: A retrospective study?	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; CARDIOVASCULAR EVENTS; GENERAL-POPULATION; CAROTID STENOSIS; DISEASE; MORTALITY; MICROANGIOPATHY; ATHEROSCLEROSIS; ENDARTERECTOMY; COMPLICATIONS	Aims To study if retinopathy increases the risk of stroke recurrence in stroke patients with type 2 diabetes. Also, to study if stroke patients with type 2 diabetes have an increased risk of stroke recurrence compared to non-diabetics and if stroke patients with type 2 diabetes, regardless of retinopathy, have a higher incidence of carotid stenosis. Also, to study if stroke patients with type 2 diabetes retinopathy have increased incidence of carotid stenosis. Methods We included 445 patients with type 2 diabetes mellitus and a matched control group of 445 patients without diabetes, who had all suffered their first stroke or TIA. Information on retinopathy, risk factors and stroke recurrence were obtained from registers and medical records. Results Retinopathy did not increase the risk of stroke recurrence in diabetes patients, HR 0.89 (0.51-1.53), p = 0.67. The risk of stroke recurrence was not increased in diabetics compared to non-diabetes. Diabetes patients had an increased prevalence of carotid stenosis compared to non-diabetics, 1.69 (1.15-2.48), p = 0.008. The prevalence of carotid stenosis in diabetics with retinopathy was not increased compared to diabetics without retinopathy. Conclusion Retinopathy is not a predictor of stroke recurrence or carotid stenosis in type 2 diabetes patients.	[Hjelmgren, Ola; Gellerman, Karl; Bergstrom, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden; [Hjelmgren, Ola; Thurin, Anders; Bergstrom, Goran] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden; [Stromberg, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Hlth Metr Unit, Gothenburg, Sweden; [Zetterberg, Madeleine] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil Ophthalmol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Hjelmgren, O (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden.; Hjelmgren, O (corresponding author), Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden.	ola.hjelmgren@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722; Hjelmgren, Ola/0000-0002-8639-6928	Swedish Heart Lung Foundation [20150372]; Swedish government; ALF [ALFGBG-718851]	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish government; ALF	This work was supported by the Swedish Heart Lung Foundation (20150372) to GB and the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-718851) to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cardoso CRL, 2012, J HYPERTENS, V30, P940, DOI 10.1097/HJH.0b013e328352aba6; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; de Kreutzenberg SV, 2011, NUTR METAB CARDIOVAS, V21, P286, DOI 10.1016/j.numecd.2009.10.003; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Gerstein HC, 2013, DIABETES CARE, V36, P1266, DOI 10.2337/dc12-1311; GUO V, 2016, STROKE, V4, P14, DOI DOI 10.1016/J.JSTR0KECEREBR0VASDIS.2016.03.009; Hankey GJ, 2013, J NEUROL NEUROSUR PS, V84, P281, DOI 10.1136/jnnp-2012-303365; HELLINGS WE, CIRCULATION, P1941, DOI DOI 10.1161/CIRCULATI0NAHA.109.887497; Joakimsen O, 2000, STROKE, V31, P1871, DOI 10.1161/01.STR.31.8.1871; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P574, DOI 10.1016/j.ophtha.2012.08.029; Kawasaki R, 2011, OPHTHALMOLOGY, V118, P860, DOI 10.1016/j.ophtha.2010.08.040; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1487; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Miyamoto M, 2012, ACTA DIABETOL, V49, P63, DOI 10.1007/s00592-011-0287-8; MRCEUROPEAN C, LANCET, V70, P99; PMID, PUBMED; PMID, 2010, PUBMED, V8, P40; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Son JW, 2011, DIABETES RES CLIN PR, V91, P253, DOI 10.1016/j.diabres.2010.11.005; VISONA A, 1995, ANGIOLOGY, V46, P793, DOI 10.1177/000331979504600905; Arcidiacono MV, 2013, ATHEROSCLEROSIS, V228, P142, DOI 10.1016/j.atherosclerosis.2013.02.011; Yla-Herttuala S, 2013, EUR HEART J, V34, P3251, DOI 10.1093/eurheartj/eht301; Yun Yong Woon, 2011, J Prev Med Public Health, V44, P260, DOI 10.3961/jpmph.2011.44.6.260	35	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210832	10.1371/journal.pone.0210832	http://dx.doi.org/10.1371/journal.pone.0210832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653584	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500078
J	Maeno, T; Haruta, J; Takayashiki, A; Yoshimoto, H; Goto, R; Maeno, T				Maeno, Takami; Haruta, Junji; Takayashiki, Ayumi; Yoshimoto, Hisashi; Goto, Ryohei; Maeno, Tetsuhiro			Interprofessional education in medical schools in Japan	PLOS ONE			English	Article							LEARNING ACTIVITIES; HEALTH; COLLABORATION; STUDENTS; CARE; PERCEPTIONS; ATTITUDES	Interprofessional education (IPE) for medical students is becoming increasingly important, as reflected in the increasing number of medical schools adopting IPE. However, the current status of and barriers to pre-registration IPE implementation in Japanese medical schools remain unknown. The purpose of this study was to clarify the status and barriers of IPE implementation in medical schools in Japan. We conducted a curriculum survey from September to December 2016 of all 81 medical schools in Japan. We mailed the questionnaire and asked the schools' undergraduate education staff to respond. The survey items were the IPE implementation status and barriers to program implementation. Sixty-four of the 81 schools responded (response rate 79.0%), of which 46 (71.9%) had implemented IPE, 42 (89.1%) as compulsory programs. Half of IPE programs were implemented in the first 2 years, while less than 10% were implemented in the latter years of medical programs. As part of the IPE programs, medical students collaborated with a wide range of professional student groups. The most common learning strategy was lectures. However, one-third of IPE programs used didactic lectures without interaction between multi-professional students. The most common perceived major barrier to implementing IPE was adjustment of the academic calendar and schedule (82.8%), followed by insufficient staff numbers (73.4%). Our findings indicate that IPE is being promoted in undergraduate education at medical schools in Japan. IPE programs differed according to the circumstances of each school. Barriers to IPE may be resolved by improving learning methods, introducing group discussions between multi-professional students in lectures or introducing IPE programs using team-based learning. In summary, we demonstrated the current status and barriers of IPE implementation in Japanese medical schools. Our findings will likely lead to the promotion of IPE programs in Japan.	[Maeno, Takami; Haruta, Junji; Takayashiki, Ayumi; Yoshimoto, Hisashi; Goto, Ryohei; Maeno, Tetsuhiro] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	University of Tsukuba	Maeno, T (corresponding author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.	takami-m@md.tsukuba.ac.jp		Maeno, Takami/0000-0003-0232-9873	JSPS KAKENHI [JP26460589]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP26460589.	Abu-Rish E, 2012, J INTERPROF CARE, V26, P444, DOI 10.3109/13561820.2012.715604; Barr H., 2008, EFFECTIVE INTERPROFE; Barr H, 2013, SURVEY PREREGISTRATI; Blue AV, 2010, J INTERPROF CARE, V24, P204, DOI 10.3109/13561820903442887; Braithwaite J, 2013, INT J QUAL HEALTH C, V25, P8, DOI 10.1093/intqhc/mzs071; Chang WY, 2009, J ADV NURS, V65, P1946, DOI 10.1111/j.1365-2648.2009.05085.x; General Medical Council, 2015, OUTC GRAD TOM DOCT; Goto M, 2018, ASIA PACIFIC SCHOLAR, V3, P37; Haidet P, 2012, ACAD MED, V87, P292, DOI 10.1097/ACM.0b013e318244759e; Hammick M, 2007, MED TEACH, V29, P735, DOI 10.1080/01421590701682576; Hosny S, 2013, MED TEACH, V35, pS68, DOI 10.3109/0142159X.2013.765550; Lapkin S, 2012, J INTERPROF CARE, V26, P390, DOI 10.3109/13561820.2012.690009; Medical Education Model Core Curriculum Coordination Committee, 2016, MOD COR CURR MED ED; Michaelsen L., 2004, TEAM BASED LEARNING; Michaelsen LK, 2008, TEAMBASED LEARNING H, P128; Mishra Sundeep, 2015, Indian Heart J, V67, P187, DOI 10.1016/j.ihj.2015.05.015; Nakamura S., 2017, FUJITA MED J, V3, P33, DOI [10.20407/fmj.3.2_33, DOI 10.20407/FMJ.3.2_33]; Ogawa S., 2015, J RES INTERPROFESSIO, V5, P1; Onishi M, 2013, J INTERPROF CARE, V27, P231, DOI 10.3109/13561820.2012.736095; Pollard KC, 2008, J INTERPROF CARE, V22, P399, DOI 10.1080/13561820802190483; Reid R, 2006, MED EDUC, V40, P415, DOI 10.1111/j.1365-2929.2006.02442.x; Rice K, 2010, J INTERPROF CARE, V24, P350, DOI 10.3109/13561820903550713; Tan NCK, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-91; Thistlethwaite JE., 2017, PRACTICAL GUIDE MED, P128; Watanabe H, 2010, ADVANCED INITIATIVES IN INTERPROFESSIONAL EDUCATION IN JAPAN, P1, DOI 10.1007/978-4-431-98076-6; World Health Organization, 2010, FRAM ACT INT ED COLL; You P, 2017, J INTERPROF CARE, V31, P670, DOI 10.1080/13561820.2017.1315060	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210912	10.1371/journal.pone.0210912	http://dx.doi.org/10.1371/journal.pone.0210912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653563	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500089
J	Deng, CF; Dai, L; Yi, L; Li, XH; Deng, K; Mu, Y; Wang, K; Tao, J; Li, Q; Xu, LZ				Deng, Changfei; Dai, Li; Yi, Ling; Li, Xiaohong; Deng, Kui; Mu, Yi; Wang, Ke; Tao, Jing; Li, Qi; Xu, Liangzhi			Temporal trends in the birth rates and perinatal mortality of twins: A population-based study in China	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; TWINNING RATES; MULTIPLE BIRTHS; PRETERM BIRTH; MATERNAL AGE; INFANT-MORTALITY; STILLBIRTH; WEIGHT; EPIDEMIOLOGY; SINGLETONS	Objective Until now, little was known about the epidemiological characteristics of twins in China due to a lack of reliable national data. In this study, we aimed to analyze temporal trends and perinatal mortality of twins from China. Methods Data on twins between 2007 and 2014 were obtained from the China National Population-Based Birth Defects Surveillance System. Twin and singleton deliveries after at least 28 weeks of gestation were recruited and followed until postnatal day 42. Twinning rates were defined as the number of twin individuals per 1000 births(stillbirths and live births). The Weinberg's differential method was utilized to estimate the number of monozygotic and dizygotic twins. Results During 2007-2014, the twinning rate increased by 32.3% from 16.4 to 21.7 per 1000 total births with an average of 18.8 parts per thousand. Among twins, both the perinatal mortality rate (26.1 per 1000 total births) and neonatal death rate (15.7 per 1000 live births) presented a downward tendency but remained at a high level. Large urban-rural and geographic disparities were identified in twinning rates, in perinatal and neonatal mortality, and in their temporal trends. Conclusions The upward trend of twinning rates in China paired with the relatively high rates of perinatal and neonatal mortality among twins highlights the need for improved perinatal care in the light of socio-demographic differences.	[Deng, Changfei; Dai, Li; Yi, Ling; Li, Xiaohong; Deng, Kui; Mu, Yi; Wang, Ke; Tao, Jing; Li, Qi] Sichuan Univ, West China Second Univ Hosp, Natl Ctr Birth Defects Monitoring, Chengdu, Sichuan, Peoples R China; [Deng, Changfei; Xu, Liangzhi] Sichuan Univ, West China Second Univ Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China; [Deng, Changfei; Xu, Liangzhi] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China; [Dai, Li] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Xu, LZ (corresponding author), Sichuan Univ, West China Second Univ Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China.; Xu, LZ (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China.	xuliangzhi@scu.edu.cn		Dai, Li/0000-0001-6116-8024; Li, Xiaohong/0000-0003-0336-7302	National Health and Family Planning Commission of China; National Natural Science Foundation of China [81072375]	National Health and Family Planning Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the National Health and Family Planning Commission of China (data collection), and by Grant 81072375 from the National Natural Science Foundation of China (data analysis and interpretation).	Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; Blondel B, 2002, AM J PUBLIC HEALTH, V92, P1323, DOI 10.2105/AJPH.92.8.1323; Blondel B, 2002, SEMIN PERINATOL, V26, P239, DOI 10.1053/sper.2002.34775; Collins John, 2007, Reprod Biomed Online, V15 Suppl 3, P45; D'Addato AV, 2007, J BIOSOC SCI, V39, P147, DOI 10.1017/S0021932006001337; Dai L, 2017, ANN MED, V49, P470, DOI 10.1080/07853890.2017.1294258; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Fell DB, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-103; Fellman J, 2005, TWIN RES HUM GENET, V8, P515, DOI 10.1375/twin.8.5.515; Fellman J, 2006, HUM BIOL, V78, P253, DOI 10.1353/hub.2006.0044; Gan JP, 2007, TWIN RES HUM GENET, V10, P633, DOI 10.1375/twin.10.4.633; Getahun D, 2014, J PERINATOL, V34, P823, DOI 10.1038/jp.2014.119; Groen H, 2017, PRENATAL DIAG, V37, P1100, DOI 10.1002/pd.5148; Hehir MP, 2016, AM J PERINAT, V33, P84, DOI 10.1055/s-0035-1559807; Hesketh T, 2008, PUBLIC HEALTH REP, V123, P189, DOI 10.1177/003335490812300211; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Hur YM, 2005, TWIN RES HUM GENET, V8, P76, DOI 10.1375/twin.8.1.76; Imaizumi Y, 2001, PAEDIATR PERINAT EP, V15, P298, DOI 10.1046/j.1365-3016.2001.00361.x; Joseph KS, 2001, PEDIATRICS, V108, P1055, DOI 10.1542/peds.108.5.1055; Li Hong, 2002, Zhonghua Yi Xue Za Zhi, V82, P164; Lu Xin-pu, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P565; Lu XR, 2013, TWIN RES HUM GENET, V16, P608, DOI 10.1017/thg.2013.7; Luo ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075354; McClure EM, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S7; Oleszczuk JJ, 2001, J REPROD MED, V46, P550; Ooki S, 2011, J EPIDEMIOL, V21, P507, DOI 10.2188/jea.JE20100189; Ooki S, 2010, J EPIDEMIOL, V20, P480, DOI 10.2188/jea.JE20100022; Petit N, 2011, TWIN RES HUM GENET, V14, P88, DOI 10.1375/twin.14.1.88; Pharoah POD, 2009, HUM REPROD UPDATE, V15, P639, DOI 10.1093/humupd/dmp019; Pison G, 2015, POPUL DEV REV, V41, P629, DOI 10.1111/j.1728-4457.2015.00088.x; Russo FM, 2013, EUR J OBSTET GYN R B, V170, P131, DOI 10.1016/j.ejogrb.2013.06.014; Shek Y, 1997, J Obstet Gynaecol Res, V23, P407; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Sun B, 2013, ARCH DIS CHILD-FETAL, V98, pF440, DOI 10.1136/archdischild-2012-302524; Tandberg A, 2007, ACTA OBSTET GYN SCAN, V86, P833, DOI 10.1080/00016340701417323; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Vasak B, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.005; Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549; Wu K. B., 2012, EARLY CHILD DEV CHIN; Yang XK, 2014, FERTIL STERIL, V101, P385, DOI 10.1016/j.fertnstert.2013.10.017; Zhu J, 2016, LANCET GLOB HEALTH, V4, pE109, DOI 10.1016/S2214-109X(15)00271-5	41	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209962	10.1371/journal.pone.0209962	http://dx.doi.org/10.1371/journal.pone.0209962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650106	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300035
J	Kim, MS; Kim, Y; Lee, S; Lee, S; Golmie, N				Kim, Mun-Suk; Kim, Yena; Lee, SeungSeob; Lee, SuKyoung; Golmie, Nada			A user application-based access point selection algorithm for dense WLANs	PLOS ONE			English	Article								The current commercial access point (AP) selection schemes are mostly based on received signal strength, but perform poorly in many situations. To address this problem, a number of alternative schemes collect and analyze the actual load of every candidate AP. However, these schemes may incur significant latency and signaling overhead in dense wireless local area networks (WLANs). To mitigate such overhead, we propose a user application-based AP selection scheme that considers historical information about AP performance. Without inducing any signaling activity, our scheme monitors the amount of network traffic used by applications and estimates the achievable throughput of APs. Our scheme employs the characteristics of application traffic with the intent of accurately predicting AP performance. Using a measurement study in dense WLAN environments, we show that our scheme achieves higher throughput and lower association latency than those of existing schemes in places highly accessible to the user.	[Kim, Mun-Suk; Kim, Yena; Golmie, Nada] NIST, Gaithersburg, MD 20899 USA; [Lee, SeungSeob; Lee, SuKyoung] Yonsei Univ, Dept Comp Sci, Seoul, South Korea	National Institute of Standards & Technology (NIST) - USA; Yonsei University	Lee, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul, South Korea.	sklee@yonsei.ac.kr		Lee, Seung-seob/0000-0002-5224-8599	National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2017R1A2B4002000]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work has supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2017R1A2B4002000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld T, 2007, IEEE T NEURAL NETWOR, V18, P223, DOI 10.1109/TNN.2006.883010; Bellalta B, 2017, IEEE COMMUN LETT, V21, P592, DOI 10.1109/LCOMM.2016.2632109; Debele FG, 2015, IEEE J SEL AREA COMM, V33, P2494, DOI 10.1109/JSAC.2015.2482007; Hong K, 2016, PERVASIVE MOB COMPUT, V30, P58, DOI 10.1016/j.pmcj.2015.10.018; Im Y, 2013, IEEE INFOCOM SER, P435; Kim D. H., 2010, P 8 ACM C EMB NETW S, P43, DOI DOI 10.1145/1869983.1869989; Kim H, 2017, IEEE T MOBILE COMPUT, V16, P2366, DOI 10.1109/TMC.2016.2618790; Kim S, 2016, P 2016 IEEE INT C PE; Kim Y., 2017, P IEEE ACM INT S LOW, P1, DOI 10.1109/SMARTCOMP.2017.7946985; Kornycky J, 2017, IEEE ACM T NETWORK, V25, P56, DOI 10.1109/TNET.2016.2562259; Lee K, 2013, IEEE ACM T NETWORK, V21, P536, DOI 10.1109/TNET.2012.2218122; Lei T, 2017, IEEE ACCESS, V5, P15332, DOI 10.1109/ACCESS.2017.2733083; Michael A. K. J., 2017, NETWORK TRAFFIC CLAS; Moh S, 2007, IEEE ICC, P3636, DOI 10.1109/ICC.2007.599; Moore A. W., 2005, Performance Evaluation Review, V33, P50, DOI 10.1145/1071690.1064220; Neal R.M., 2004, SOFTWARE FLEXIBLE BA; Nguyen TTT, 2008, IEEE COMMUN SURV TUT, V10, P56, DOI 10.1109/SURV.2008.080406; Nicholson AJ, P 4 INT C MOB SYST A; Pang J, 2010, IEEE T MOBILE COMPUT, V9, P1713, DOI 10.1109/TMC.2010.151; Park JH, 2018, IEEE ACCESS, V6, P11482, DOI 10.1109/ACCESS.2018.2799384; Press W H, 1992, NUMERICAL RECIPES C; Raschella A, 2017, IEEE T NETW SERV MAN, V14, P441, DOI 10.1109/TNSM.2017.2678021; Sanchez MI, 2016, IEEE WIREL COMMUN, V23, P48, DOI 10.1109/MWC.2016.7422405; Shafigh AS, 2016, IEEE ACM T NETWORK, V24, P717, DOI 10.1109/TNET.2014.2383437; Sohn I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116592; Sun TT, 2016, IEEE T MOBILE COMPUT, V15, P1157, DOI 10.1109/TMC.2015.2442254; Wu H, 2007, IEEE INFOCOM SER, P749, DOI 10.1109/INFCOM.2007.93	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210738	10.1371/journal.pone.0210738	http://dx.doi.org/10.1371/journal.pone.0210738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650150	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300074
J	Orue, B; Lopez, J; Moreno, G; Santiago, J; Soto, M; Murua, H				Orue, Blanca; Lopez, Jon; Moreno, Gala; Santiago, Josu; Soto, Maria; Murua, Hilario			Aggregation process of drifting fish aggregating devices (DFADs) in the Western Indian Ocean: Who arrives first, tuna or non-tuna species?	PLOS ONE			English	Article							PURSE-SEINE FISHERIES; TROPICAL TUNA; THUNNUS-OBESUS; ASSOCIATIVE BEHAVIOR; FLOATING OBJECTS; YELLOWFIN TUNA; PELAGIC FISH; FADS; VARIABILITY; PRODUCTIVITY	Floating objects drifting in the surface of tropical waters, also known as drifting fish aggregating devices (DFADs), attract hundreds of marine species, including tuna and non-tuna species. Industrial tropical purse seiners have been increasingly deploying artificial man-made DFADs equipped with satellite linked echo-sounder buoys, which provide fishers with information on the accurate geo-location of the object and rough estimates of the biomass aggregated underneath, to facilitate the catch of tuna. Although several hypotheses are under consideration to explain the aggregation and retention processes of pelagic species around DFADs, the reasons driving this associative behavior are uncertain. This study uses information from 962 echo-sounder buoys attached to virgin (i.e. newly deployed) DFADs deployed in the Western Indian Ocean between 2012 and 2015 by the Spanish fleet (42,322 days observations) to determine the first detection day of tuna and non-tuna species at DFAD and to model the aggregation processes of both species group using Generalize Additive Mixed Models. Moreover, different seasons, areas and depths of the DFAD under-water structure were considered in the analysis to account for potential spatio-temporal and structure differences. Results show that tuna species arrive at DFADs before non-tuna species (13.5 +/- 8.4 and 21.7 +/- 15.1 days, respectively), and provide evidence of the significant relationship between DFAD depth and detection time for tuna, suggesting faster tuna colonization in deeper objects. For non-tuna species, this relationship appeared to be not significant. The study also reveals both seasonal and spatial differences in the aggregation patterns for different species groups, suggesting that tuna and non-tuna species may have different aggregative behaviors depending on the spatio-temporal dynamic of DFADs. This work will contribute to the understanding of the fine and mesoscale ecology and behavior of target and non-target species around DFADs and will assist managers on the sustainability of exploited resources, helping to design spatio-temporal conservation management measures for tuna and non-tuna species.	[Orue, Blanca; Lopez, Jon; Santiago, Josu; Murua, Hilario] AZTI Tecnalia, Pasaia, Gipuzkoa, Spain; [Lopez, Jon] IATTC, La Jolla, CA USA; [Moreno, Gala] ISSF, Washington, DC USA; [Soto, Maria] Inst Espanol Oceanog, Madrid, Spain	AZTI; Spanish Institute of Oceanography	Orue, B (corresponding author), AZTI Tecnalia, Pasaia, Gipuzkoa, Spain.	borue@azti.es		Lopez, Jon/0000-0002-4172-4094; Orue, Blanca/0000-0002-6823-2292	AZTI Foundation	AZTI Foundation	The study was funded by PhD grant by the AZTI Foundation. The author who receives the funds was the main author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baez JC, 2017, IOTC2017WPTT19INFO5; Bard F-X, 1985, PECHE MARITIME   OCT, P655; Baske A, 2012, ESTIMATING USE DRIFT; BLOCK BA, 2001, TUNA PHYSL ECOLOGY E; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; Capello M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36415; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Dagorn L, 1999, CAN J FISH AQUAT SCI, V56, P984, DOI 10.1139/cjfas-56-6-984; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; Dagorn L, 2012, FISH FISH, DOI [10.1111/faf.12007, DOI 10.1111/FAF.12007]; Dagorn L, 2000, AQUAT LIVING RESOUR, P13; Dagorn L, 2007, AQUAT LIVING RESOUR, V20, P307, DOI 10.1051/alr:2008001; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2012, CAN J FISH AQUAT SCI, V69, P1463, DOI 10.1139/F2012-089; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Davies TK, 2014, MAR POLICY, V45, P163, DOI 10.1016/j.marpol.2013.12.014; Dempster T, 2003, MAR ECOL PROG SER, V258, P213, DOI 10.3354/meps258213; DINNO A., 2017, PACKAGE DUNN TEST; Doray M, 2009, ICES J MAR SCI, V66, P1410, DOI 10.1093/icesjms/fsp039; Essington TE, 2002, ECOL APPL, V12, P724; Filmalter JD, 2011, B MAR SCI, V87, P325, DOI 10.5343/bms.2010.1057; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; FOOTE KG, 1980, J ACOUST SOC AM, V67, P2084, DOI 10.1121/1.384452; Forget FG, 2015, CAN J FISH AQUAT SCI, V72, P1398, DOI 10.1139/cjfas-2014-0458; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Fuller DW, 2015, FISH RES, V172, P57, DOI 10.1016/j.fishres.2015.06.024; Ghazali SM, 2013, FISH RES; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; GOODING RM, 1967, PAC SCI, V21, P486; Govinden R., 2010, IOTC2010WPTT25; Govinden R, 2013, AQUAT LIVING RESOUR, V26, P69, DOI 10.1051/alr/2012022; Hall M., 1992, P INT WORKSH EC FISH, P396; Hall M, 2016, SAC0703E IATTC; Hallier J-P, 1992, INT WORKSH EC FISH T; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Harley S, 2009, WCPFCTCC52009IP02; Hitchcock GL, 2000, DEEP-SEA RES PT II, V47, P1605, DOI 10.1016/S0967-0645(99)00156-3; HUNTER JR, 1967, US FISH WLD S FISH B, V66, P13; IATTC I-ATTC, 2008, WCPFCSC42008FTIP3; Ishibashi Y, 2009, AQUACULTURE, V293, P157, DOI 10.1016/j.aquaculture.2009.04.029; ISSF, 2017, 201702 ISSF; Itano D, 2003, 16 16 M STAND COMM T; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Josse E, 2000, AQUAT LIVING RESOUR, V13, P183, DOI 10.1016/S0990-7440(00)00051-6; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kawamura G., 1981, MEM KAGOSHIMA U RES, V1, P3; Le Gall JY, 2000, AQUAT LIVING RESOUR, V13, P181, DOI 10.1016/S0990-7440(00)01067-6; Lennert-Cody C, 2000, DEV PURSE SEINE FISH; Lennert-Cody CE, 2008, ICES J MAR SCI, V65, P970, DOI 10.1093/icesjms/fsn075; Leroy B, 2013, AQUAT LIVING RESOUR, V26, P49, DOI 10.1051/alr/2012033; Leroy B, 2009, REV-METHODS TECHNOL, V9, P161, DOI 10.1007/978-1-4020-9640-2_10; Longhurst A.R., 1987, ECOLOGY TROPICAL OCE; Lopez J, 2016, FISH B, V114; Lopez J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3075-3; Lopez J, 2014, FISH RES, V155, P127, DOI 10.1016/j.fishres.2014.02.033; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Macusi ED, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00188; Marsac F, 2008, OUTLOOK OCEAN CLIMAT; Marsac Francis, 2000, IFREMER Actes de Colloques, V28, P537; Matsumoto T, 2014, FISH RES, V157, P78, DOI 10.1016/j.fishres.2014.03.023; Maufroy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128023; Moreno G, 2016, FISH RES, V178, P122, DOI 10.1016/j.fishres.2015.09.021; Moreno G, 2015, SAC07INFC IATTC; Moreno G, 2007, AQUAT LIVING RESOUR, V20, P343, DOI 10.1051/alr:2008015; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Murua J, 2016, 201608 ISSF; Nickson A., 2015, ESTIMATING USE FADS; Parin N.V., 1999, PELAGIC FISH COMMUNI, V11, P447; Petit C, 2000, NEW SAMPLING DATA PR; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; R Development Core Team, 2017, R LANG ENV STAT COMP; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; Romanov EV, 2002, FISH B-NOAA, V100, P90; Romanov Evgeny V., 2008, Western Indian Ocean Journal of Marine Science, V7, P163; ROUNTREE RA, 1989, B MAR SCI, V44, P960; Santiago J, 2017, IOTC2017WGFAD0113; Satoh K, 2008, WCPFCSC42008FTWP120; Schaefer KM, 2013, MAR BIOL, V160, P3005, DOI 10.1007/s00227-013-2290-9; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Scott GP, 2014, IPBPECHIC2013123 EUR; Soto M, 2016, IOTC2016WPDCS12INF04; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P331, DOI 10.1051/alr:2008007; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P323, DOI 10.1051/alr:2008008; Veldhuis MJW, 1997, DEEP-SEA RES PT I, V44, P425, DOI 10.1016/S0967-0637(96)00116-1; Weng JS, 2013, J APPL ICHTHYOL, V29, P990, DOI 10.1111/jai.12265; Wiebinga CJ, 1997, DEEP-SEA RES PT I, V44, P451, DOI 10.1016/S0967-0637(96)00115-X; Wiggert JD, 2006, DEEP-SEA RES PT II, V53, P644, DOI 10.1016/j.dsr2.2006.01.027; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	91	17	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210435	10.1371/journal.pone.0210435	http://dx.doi.org/10.1371/journal.pone.0210435			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645612	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200030
J	Wang, XL; Zhang, GH				Wang, Xiaoli; Zhang, Guohong			The influence of infiltration feedback on the characteristic of banded vegetation pattern on hillsides of semiarid area	PLOS ONE			English	Article							KLAUSMEIER MODEL; SPATIAL-PATTERN; SOIL; TRANSITION; STABILITY; CLIMATE	The formation and characteristics are two important topics in the study of vegetation pattern. In this paper, we focus on the influence of infiltration feedback of surface runoff on the formation and characteristics of banded vegetation pattern on hillsides of semiarid area. Firstly, it is shown that the infiltration feedback of surface runoff is an important formation mechanics of the banded vegetation pattern in semiarid area. Then it is found that the patterns formed within the reasonable parameter space are periodic both in space and time and the wave speed of the periodic vegetation stripes become larger with the increase of the infiltration feedback strength, while the wavelength is negatively correlated with the infiltration feedback strength. At last, it is shown that the mean productivity of grass pattern is lower than that of homogeneous steady state when the infiltration feedback is weak and it is larger than that with stronger infiltration feedback.	[Wang, Xiaoli; Zhang, Guohong] Southwest Univ, Sch Math & Stat, Chongqing 400700, Peoples R China	Southwest University - China	Zhang, GH (corresponding author), Southwest Univ, Sch Math & Stat, Chongqing 400700, Peoples R China.	zgh711@swu.edu.cn			National Natural Science Foundation of China [11701472, 11671327, 11871403, 11871060]; Fundamental Research Funds for the Central Universities [XDJK2017C055]; Foundation of Southwest University [SWU116069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Southwest University(Southwest University - China)	This work is supported by the National Natural Science Foundation of China (11701472, 11671327, 11871403, 11871060) (http://www.nsfc.gov.cn/), Fundamental Research Funds for the Central Universities (XDJK2017C055) and the Ph.D. Foundation of Southwest University (SWU116069).	Adams B, 2003, NONLINEARITY, V16, P1339, DOI 10.1088/0951-7715/16/4/309; Carteni F, 2012, J THEOR BIOL, V313, P153, DOI 10.1016/j.jtbi.2012.08.008; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; D'Odorico P, 2005, P NATL ACAD SCI USA, V102, P10819, DOI 10.1073/pnas.0502884102; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Isham V, 2005, P ROY SOC A-MATH PHY, V461, P4035, DOI 10.1098/rspa.2005.1568; Kealy BJ, 2012, B MATH BIOL, V74, P803, DOI 10.1007/s11538-011-9688-7; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; Liu QX, 2008, J THEOR BIOL, V254, P350, DOI 10.1016/j.jtbi.2008.05.017; Marasco A, 2014, B MATH BIOL, V76, P2866, DOI 10.1007/s11538-014-0036-6; Marasco A, 2013, PROCEDIA ENVIRON SCI, V19, P139, DOI 10.1016/j.proenv.2013.06.016; Meron E, 2004, CHAOS SOLITON FRACT, V19, P367, DOI 10.1016/S0960-0779(03)00049-3; Murray J. D., 2001, MATH BIOL, V18; Peters DPC, 2006, J ARID ENVIRON, V65, P196, DOI 10.1016/j.jaridenv.2005.05.010; Qian Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032807; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rodriguez-Iturbe I, 1999, P ROY SOC A-MATH PHY, V455, P3789, DOI 10.1098/rspa.1999.0477; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; Sherratt JA, 2005, J MATH BIOL, V51, P183, DOI 10.1007/s00285-005-0319-5; Sherratt JA, 2013, SIAM J APPL MATH, V73, P1347, DOI 10.1137/120899510; Sherratt JA, 2013, SIAM J APPL MATH, V73, P330, DOI 10.1137/120862648; Sherratt JA, 2013, PHYSICA D, V242, P30, DOI 10.1016/j.physd.2012.08.014; Sherratt JA, 2011, P ROY SOC A-MATH PHY, V467, P3272, DOI 10.1098/rspa.2011.0194; Sherratt JA, 2010, NONLINEARITY, V23, P2657, DOI 10.1088/0951-7715/23/10/016; Shnerb NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.038101; Sun GQ, 2013, NONLINEAR DYNAM, V73, P2207, DOI 10.1007/s11071-013-0935-3; Ursino N, 2005, ADV WATER RESOUR, V28, P956, DOI 10.1016/j.advwatres.2005.02.009; von Hardenberg J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198101; Wang XL, 2017, COMMUN NONLINEAR SCI, V42, P571, DOI 10.1016/j.cnsns.2016.06.008	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0205715	10.1371/journal.pone.0205715	http://dx.doi.org/10.1371/journal.pone.0205715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645597	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200003
J	Xu, Y				Xu, Yang			Intervention on default contagion under partial information in a financial network	PLOS ONE			English	Article							SYSTEMIC RISK; LIQUIDITY PROVISION; MARKET	We study the optimal interventions of a regulator (a central bank or government) on the illiquidity default contagion process in a large, heterogeneous, unsecured interbank lending market. The regulator has only partial information on the interbank connections and aims to minimize the fraction of final defaults with minimal interventions. We derive the analytical results of the asymptotic optimal intervention policy and the asymptotic magnitude of default contagion in terms of the network characteristics. We extend the results of Amini, Cont and Minca's work to incorporate interventions and adopt the dynamics of Amini, Minca and Sulem's model to build heterogeneous networks with degree sequences and initial equity levels drawn from arbitrary distributions. Our results generate insights that the optimal intervention policy is "monotonic" in terms of the intervention cost, the closeness to invulnerability and connectivity. The regulator should prioritize interventions on banks that are systematically important or close to invulnerability. Moreover, the regulator should keep intervening on a bank once having intervened on it. Our simulation results show a good agreement with the theoretical results.	[Xu, Yang] Univ Calif Berkeley, Ind Engn & Operat Res, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Xu, Y (corresponding author), Univ Calif Berkeley, Ind Engn & Operat Res, Berkeley, CA 94720 USA.	yangxu@berkeley.edu		Xu, Yang/0000-0003-0158-9083				Acharya VV, 2008, REV FINANC STUD, V21, P2705, DOI 10.1093/rfs/hhm078; Afonso G, 2011, J FINANC, V66, P1109, DOI 10.1111/j.1540-6261.2011.01670.x; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Amini H., 2013, MATH FINANC, P1; Amini H, 2017, J FINANC STABIL, V31, P1, DOI 10.1016/j.jfs.2017.05.008; Amini H, 2015, SIAM J FINANC MATH, V6, P1195, DOI 10.1137/140981538; Bech ML, 2010, PHYSICA A, V389, P5223, DOI 10.1016/j.physa.2010.05.058; Berger AN, 2016, J FINANC INTERMED, V26, P115, DOI 10.1016/j.jfi.2016.01.001; Boss M., 2004, OESTERREICHISCHE NAT, P77; Carlson MA, 2015, WHY DO WE NEED BOTH, DOI [10.1038/nature09659, DOI 10.1038/NATURE09659]; Chachuat B. C., 2009, NONLINEAR DYNAMIC OP; Chinazzi M, 2013, SSRN ELECT J, DOI [10.2139/ssrn.2243504, DOI 10.2139/SSRN.2243504]; Cont R, 2010, NETWORK STRUCTURE SY, P327; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Eisenberg L, 2001, MANAGE SCI, V47, P236, DOI 10.1287/mnsc.47.2.236.9835; Freixas X, 2000, J MONEY CREDIT BANK, V32, P611, DOI 10.2307/2601198; Furfine C., 1999, FINANCIAL MARKETS IN, V8, P24, DOI DOI 10.1111/1468-0416.00031; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Gai P, 2011, J MONETARY ECON, V58, P453, DOI 10.1016/j.jmoneco.2011.05.005; Garcia-de-Andoain C, 2016, J FINANC INTERMED, V28, P32, DOI 10.1016/j.jfi.2016.01.003; Gorton G, 2004, AM ECON REV, V94, P455, DOI 10.1257/0002828041464650; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hurd TR., 2015, CONTAGION SPREAD SYS; Leitner Y, 2005, J FINANC, V60, P2925, DOI 10.1111/j.1540-6261.2005.00821.x; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Philippon T, 2013, J FINANC, V68, P1, DOI 10.1111/j.1540-6261.2012.01793.x; Rogers LCG, 2013, MANAGE SCI, V59, P882, DOI 10.1287/mnsc.1120.1569; Rudin W., 1976, PRINCIPLES MATH ANAL, DOI [10.1002/cbdv.200490137/abstract, DOI 10.1002/CBDV.200490137/ABSTRACT]; VAN DER HOFSTAD R, 2014, RANDOM GRAPHS COMPLE, VII; Vollmer U., 2014, LENDER LAST RESORT, P1; Wormald N.C., 1999, LECT APPROXIMATION R, P73	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209819	10.1371/journal.pone.0209819	http://dx.doi.org/10.1371/journal.pone.0209819			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645587	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200013
J	Hossain, P; Das Gupta, R; YarZar, P; Jalloh, MS; Tasnim, N; Afrin, A; Naher, N; Hossain, MT; Joarder, T; Ahmed, SM				Hossain, Puspita; Das Gupta, Rajat; YarZar, Phyoe; Jalloh, Mohamed Salieu; Tasnim, Nishat; Afrin, Ayesha; Naher, Nahitun; Hossain, Md Tarek; Joarder, Taufique; Ahmed, Syed Masud			'Feminization' of physician workforce in Bangladesh, underlying factors and implications for health system: Insights from a mixed-methods study	PLOS ONE			English	Article							CANADIAN MEDICINE; EXPECTATIONS; EDUCATION; GENDER; WOMEN	Background Bangladesh is currently faced with an emerging scenario of increased number of female physicians in the health workforce which has health system implications. For a health system to attract and retain female physicians, information is needed regarding their motivation to choose medical profession, real-life challenges encountered in home and workplaces, propensity to choose a few particular specialties, and factors leading to drop-out from the system. This exploratory mixed-methods study attempted to fill-in this knowledge gap and help the policy makers in designing a gender-sensitive health system. Methods Three-hundred and fifteen final year female medical students from four purposively selected medical colleges of Dhaka city (two each from public and private colleges) were included in a quantitative survey using self-administered questionnaire. Besides, 31 in-depth interviews with female students, their parents, and in-service trainee physicians, and two focus group discussions with female students were conducted. Gender disaggregated data of physicians and admitted students were also collected. Data were analysed using Stata version 13 and thematic analysis method, as appropriate. Results During 2006-2015, the female physicians outnumbered their male peers (52% vs. 48%), which is also supported by student admission data during 2011-2016 from the sampled medical colleges, (67% in private compared to 52% in public). Majority of the female medical graduates specialized in Obstetrics and Gynaecology (96%). Social status (66%), respect for medical profession (91%), image of a 'noble profession' (91%), and prospects of helping common people (94%) were common motivating factors for them. Gender disparity in work, career and work environment especially in rural areas, and problems of work-home balance, were a few of the challenges mentioned which forced some of them to drop-out. Also, this scenario conditioned them to crowd into a few selected specialties, thereby constraining health system from delivering needed services. Conclusions Increasing number of female physicians in health workforce, outnumbering their male peers, is a fact of life for health system of Bangladesh. It's high time that policy makers pay attention to this and take appropriate remedial measures so that women can pursue their career in an enabling environment and serve the needs and priorities of the health system.	[Hossain, Puspita; Das Gupta, Rajat; Naher, Nahitun; Ahmed, Syed Masud] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [YarZar, Phyoe] Univ Res Co LLC, Yangon, Myanmar; [Jalloh, Mohamed Salieu] EHlth Africa, Freetown, Sierra Leone; [Tasnim, Nishat] WAVE Fdn, Dhaka, Bangladesh; [Afrin, Ayesha] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Div Infect Dis, Dhaka, Bangladesh; [Hossain, Md Tarek] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Joarder, Taufique] FHI 360, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Das Gupta, R (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	rajat89.dasgupta@gmail.com	Hossain, Puspita/AAX-5430-2021; Ahmed, Syed/GSN-7305-2022; Ahmed, Syed Masud/AGQ-4786-2022; Gupta, Rajat Das/E-5545-2018; Joarder, Taufique/O-3678-2015	Hossain, Puspita/0000-0003-4042-9824; Ahmed, Syed Masud/0000-0001-5032-7181; Gupta, Rajat Das/0000-0002-7680-676X; Joarder, Taufique/0000-0002-3299-2628	MPH academic Committee of the BRAC James P Grant School of Public Health, BRAC University	MPH academic Committee of the BRAC James P Grant School of Public Health, BRAC University	This work was funded by a small grant from the MPH academic Committee of the BRAC James P Grant School of Public Health, BRAC University, usual for facilitating the student projects which is a requirement for completing the MPH course. The Committee did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This grant covered for travel, food and printing tools but not salary or remuneration, neither for the students [PH, RDG, PYZ, MSJ, NT and AA] nor for the academic supervisors [SMA and TJ] and mentors [NN and MTH]. Further, PYZ is currently working for a commercial company named University Research Co., LLC, Myanmar which had no role in designing the study, data collection and analysis, and decision to publish, or prepare the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Amin Z, 2008, MED TEACH, V30, P243, DOI 10.1080/01421590801947010; [Anonymous], 2016, BDNEWS24COM; [Anonymous], 2015, BBC; [Anonymous], 2017, NEW AGE; Anukriti S, 2017, OXFORD HDB WOMEN EC, DOI [10.1093/oxfordhb/9780190628963.013.5, DOI 10.1093/OXFORDHB/9780190628963.013.5]; Bhadra M., 2011, INDIAN ANTHR, V41, P17; Buddeberg-Fischer B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-120; BURKETT GL, 1981, HEALTH POLICY EDUC, V2, P33, DOI 10.1016/0165-2281(81)90003-5; Cacciottolo J., 2015, MALTA MED J, V27; Chatterjee P., 2010, STORY AMBIVALENT MOD; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Diwan V, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-127; Duffin J, 2012, CAN BULL MED HIST, V29, P83, DOI 10.3138/cbmh.29.1.83; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Government of India, 2016, NAT COMM SCHED CAST; Haklai Z, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-37; Han H, 2018, MED EDUC, V52, P1083, DOI 10.1111/medu.13682; Hedden L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-32; Kawnine N, 1998, EC ASPECTS HUMAN RES; Kwon E, 2017, GEND ISSUES, V34, P186, DOI 10.1007/s12147-016-9168-3; Levinson W, 2004, ANN INTERN MED, V141, P471, DOI 10.7326/0003-4819-141-6-200409210-00013; Malik AA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-201; McHarg J, 2007, MED EDUC, V41, P815, DOI 10.1111/j.1365-2923.2007.02798.x; MOHFW, 2013, SOC BEH CHANG COMM S; Nepal Health Research Council, 2019, DAT NEP STEPS 2019; Pas B, 2011, HUM RESOUR MANAG J, V21, P285, DOI 10.1111/j.1748-8583.2010.00161.x; Phillips SP, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-47; Phillips SP, 2009, JAMA-J AM MED ASSOC, V301, P863, DOI 10.1001/jama.2009.155; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Rao N, 2012, J DEV STUD, V48, P26, DOI 10.1080/00220388.2011.629648; Rawal LB, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0030-6; Reichenbach L, 2004, BMJ-BRIT MED J, V329, P792, DOI 10.1136/bmj.329.7469.792; Shah SM, 2016, INT J HEALTH POLICY, V5, P467, DOI 10.15171/ijhpm.2016.38; Smith R, 2013, J PUBLIC HEALTH-UK, V35, P164, DOI 10.1093/pubmed/fds066; Talukder MHK, 2017, POSTGRADUATE MED ED; The World Health Organization, 2016, HUM RES HLTH COUNTR; Tiwari R, 2017, INT J RES MED SCI, V4, P2649, DOI [10.18203/2320-6012.ijrms20161926, DOI 10.18203/2320-6012.IJRMS20161926]; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Weizblit N, 2009, MED EDUC, V43, P442, DOI 10.1111/j.1365-2923.2009.03309.x; World Health Organization Regional Office for the Western Pacific, 2014, HUM RES HLTH COUNTR	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210820	10.1371/journal.pone.0210820	http://dx.doi.org/10.1371/journal.pone.0210820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1MW	30633775	Green Published, Green Submitted, gold			2022-12-27	WOS:000455485100036
J	Howel, D; Moffatt, S; Haighton, C; Bryant, A; Becker, F; Steer, M; Lawson, S; Aspray, T; Milne, EMG; Vale, L; McColl, E; White, M				Howel, Denise; Moffatt, Suzanne; Haighton, Catherine; Bryant, Andrew; Becker, Frauke; Steer, Melanie; Lawson, Sarah; Aspray, Terry; Milne, Eugene M. G.; Vale, Luke; McColl, Elaine; White, Martin			Does domiciliary welfare rights advice improve health-related quality of life in independent-living, socio-economically disadvantaged people aged >= 60 years? Randomised controlled trial, economic and process evaluations in the North East of England	PLOS ONE			English	Article							EARLY OLD-AGE; INCOME; CARE; INEQUALITIES; MORTALITY; BENEFITS; EUROQOL; MODEL	Background There are major socio-economic gradients in health that could be influenced by increasing personal resources. Welfare rights advice can enhance resources but has not been rigorously evaluated for health-related impacts. Methods Randomised, wait-list controlled trial with individual allocation, stratified by general practice, of welfare rights advice and assistance with benefit entitlements, delivered in participants' homes by trained advisors. Control was usual care. Participants were volunteers sampled from among all those aged. 60 years registered with general practices in socio-economically deprived areas of north east England. Outcomes at 24 months were: CASP-19 score (primary), a measure of health-related quality of life; changes in income, social and physical function, and cost-effectiveness (secondary). Intention to treat analysis compared outcomes using multiple regression, with adjustment for stratification and key covariates. Qualitative interviews with purposive samples from both trial arms were thematically analysed. Findings Of 3912 individuals approached, 755 consented and were randomised (381 Intervention, 374 Control). Results refer to outcomes at 24 months, with data available on 562 (74.4%) participants. Intervention was received as intended by 335 (88%), with 84 (22%) awarded additional benefit entitlements; 46 did not receive any welfare rights advice, and none of these were awarded additional benefits. Mean CASP-19 scores were 42.9 (Intervention) and 42.4 (Control) (adjusted mean difference 0.3 [95% CI -0.8, 1.5]). There were no significant differences in secondary outcomes except Intervention participants reported receiving more care at home at 24m (53.7 (Intervention) vs 42.0 (Control) hours/week (adjusted mean difference 26.3 [95% CIs 0.8, 56.1]). Exploratory analyses did not support an intervention effect and economic evaluation suggested the intervention was unlikely to be cost-effective. Qualitative data from 50 interviews suggested there were improvements in quality of life among those receiving additional benefits. Conclusions We found no effects on health outcomes; fewer participants than anticipated received additional benefit entitlements, and participants were more affluent than expected. Our findings do not support delivery of domiciliary welfare rights advice to achieve the health outcomes assessed in this population. However, better intervention targeting may reveal worthwhile health impacts.	[Howel, Denise; Moffatt, Suzanne; Bryant, Andrew; Becker, Frauke; Steer, Melanie; Lawson, Sarah; Milne, Eugene M. G.; Vale, Luke; McColl, Elaine; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Haighton, Catherine] Northumbria Univ, Dept Social Work Educ & Community Wellbeing, Newcastle Upon Tyne, Tyne & Wear, England; [Becker, Frauke] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Aspray, Terry] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Milne, Eugene M. G.] Newcastle City Council, Newcastle Upon Tyne, Tyne & Wear, England; [White, Martin] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	Newcastle University - UK; Northumbria University; University of Oxford; Newcastle University - UK; University of Cambridge	White, M (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.; White, M (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	martin.white@mrc-epid.cam.ac.uk	McColl, Elaine/V-9906-2019; Becker, Frauke/Q-7738-2018; Haighton, Catherine/H-1528-2015	McColl, Elaine/0000-0001-8300-3204; Becker, Frauke/0000-0003-1175-3932; Howel, Denise/0000-0002-0033-548X; Haighton, Catherine/0000-0002-8061-0428; Aspray, Terry/0000-0001-9522-6069; White, Martin/0000-0002-1861-6757; Steer, Mel/0000-0001-8965-5625; Vale, Luke/0000-0001-8574-8429	UK National Institute of Health Research, Public Health Research Programme [09/3009/02]; North East Strategic Health Authority; MRC [MR/K023187/1] Funding Source: UKRI	UK National Institute of Health Research, Public Health Research Programme; North East Strategic Health Authority; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors received a grant of 798,884 pound from the UK National Institute of Health Research, Public Health Research Programme (No. 09/3009/02). www.nihr.ac.uk.All authors received a grant of 28,000 pound from the North East Strategic Health Authority in 2012 to cover the costs of delivering the intervention, associated training and other non-research costs of this study. North East SHA no longer exists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S, 2000, PUBLIC HEALTH, V114, P324, DOI 10.1016/S0033-3506(00)00356-5; Abbott S, 1999, 9963 HLTH COMM CAR R; Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-81; Age Concern, 2007, CONF BEN SYST KEEP P; Age Concern, FORG GOOD LUCK KNOW; Bambra C, 2014, J PUBLIC HEALTH-UK, V36, P183, DOI 10.1093/pubmed/fdu029; Banks J, 2010, FINANCIAL CIRCUMSTAN; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; CHARLTON BG, 1995, PUBLIC HEALTH, V109, P235, DOI 10.1016/S0033-3506(95)80200-2; Clayman SE, 1994, SITUATED ORDER STUDI; Connor J, 1999, J EPIDEMIOL COMMUN H, V53, P725, DOI 10.1136/jech.53.11.725; CRAIG P, 1991, J SOC POLICY, V20, P537, DOI 10.1017/S0047279400019796; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Department for Work and Pensions, 2010, INC REL BEN EST TAK; Department of Health, 2016, NHS CALD GUARD; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fiebig DG., 2001, COMPANION THEORETICA, P101; Gray A., 2011, APPL METHODS COST EF; Griffin T, 2010, J CLIN EPIDEMIOL, V63, P746, DOI 10.1016/j.jclinepi.2009.07.019; Haighton C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-382; Health Research Authority, 2016, RES ETHICS; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Howel D, 2012, AGE AGEING, V41, P612, DOI 10.1093/ageing/afs023; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Lazzarino AI, 2013, JAMA INTERN MED, V173, P22, DOI 10.1001/2013.jamainternmed.951; Lewis, 2006, QUALITATIVE RES PRAC; Loopstra R, 2016, J ROY SOC MED, V109, P109, DOI 10.1177/0141076816632215; Mackintosh J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-162; Marmot M, 2010, FAIR SOC HLTH LIVES; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McGee MA, 1998, AGE AGEING, V27, P605, DOI 10.1093/ageing/27.5.605; Ministry of Housing Communities and Local Government, ENGL IND DEPR 2015; Moffatt S, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-28; Moffatt S., 2004, CRIT PUBLIC HEALTH, V14, P295, DOI [10.1080/09581590400007959, DOI 10.1080/09581590400007959]; Moffatt S, 2008, AGEING SOC, V28, P875, DOI 10.1017/S0144686X08007253; Moffatt S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-163; Moffatt S, 2007, SOC POLICY ADMIN, V41, P449, DOI 10.1111/j.1467-9515.2007.00567.x; Moffatt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042979; National Audit Office, 2002, TACKL PENS POV ENC T; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence (NICE), 2012, METH DEV NICE PUB HL; Peyre H, 2011, QUAL LIFE RES, V20, P287, DOI 10.1007/s11136-010-9740-3; Sandell A, 1998, OXFORD HDB PATIENTS; Scholz R, 2003, MAX PLANCK I DEMOGRA; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Serwinski B, 2016, PSYCHONEUROENDOCRINO, V67, P182, DOI 10.1016/j.psyneuen.2016.02.008; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Szende A, 2007, EQ 5D VALUE SETS INV; The Department of Health, COMM EQ SERV NAT CAT; The Poverty Site, TAK UP OF BEN; Vogt T., 2014, P INT NETW TIMB ENG, P1; Wiggins RD, 2008, SOC INDIC RES, V89, P61, DOI 10.1007/s11205-007-9220-5; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209560	10.1371/journal.pone.0209560	http://dx.doi.org/10.1371/journal.pone.0209560			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629609	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000455483000028
J	Iftikhar, S; Saqib, A; Sarwar, MR; Sarfraz, M; Arafat, M; Shoaib, QUA				Iftikhar, Sadia; Saqib, Anum; Sarwar, Muhammad Rehan; Sarfraz, Muhammad; Arafat, Mosab; Shoaib, Qurat-ul-ain			Capacity and willingness to use information technology for managing chronic diseases among patients: A cross-sectional study in Lahore, Pakistan	PLOS ONE			English	Article							E-MAIL COMMUNICATION; HEALTH-CARE; INTERNET; TELEMEDICINE; DISTANCE; SERVICES; SEEKING; DIVIDE; EMAIL	Background and objectives The information technology is a pivotal source of communication between patients and healthcare providers for managing chronic diseases. The objective of this study is to assess the capacity and willingness of patients to use information technology for managing chronic diseases. Methods A descriptive, cross-sectional study design was employed. Study was conducted in six tertiary care hospitals of Lahore, Pakistan. The study population consisted of patients aged >= 18 years and diagnosed with a minimum of one chronic non-communicable disease. A structured questionnaire was administered to the study participants for data collection. SPSS was used for data analysis. Results Among the 400 respondents, hypertension (39.5%) was the leading chronic condition followed by diabetes (27.5%). Majority of the patients owned a cell phone (90.7%) and had internet access (66.2%). Almost half of the respondents (51.0%) were willing to use text messages; whereas 78.5% and 75.7% of the respondents were reluctant to use video conference and e-mail as a source of communication with healthcare providers. Reason for unwillingness to use e-mail was the patients' desire to be directly examined by the doctor; whereas unfamiliarity with the use of text message and video conference was the major reason for not using these technologies. Logistic regression analysis revealed that interest in using e-mail to interact with specialist was more among those participants who had good self-reported health (OR = 2.579, 95% CI = 1.276-5.212, p = .008), access to internet (OR = 5.416, 95% CI = 2.777-10.564, p < .001), and those who owned a cell phone (OR = 12.944, 95% CI = 1.751-95.704, p = .012). Interest in using text messages to interact with specialist was more among participants with middle-income group (OR = 2.303, 95% CI = 1.389-3.818, p < .001), residency in close proximity to healthcare professional (OR = 3.529, 95% CI = 2.333-5.339, p < .001), access to internet (OR = 3.253, 95% CI = 2.102-5.033, p < .001) and among those who owned a cell phone (OR = 46.709, 95% CI = 6.335-344.377, p < .001). Interest in using video conference to interact with specialist was more among those participants who had access to internet (OR = 5.840, 95% CI = 2.825-12.069, p < .001) and among those who owned a cell phone (OR = 11.177, 95% CI = 1.510-82.725, p = .018). Conclusion This study concluded that nearly half of the respondents were willing to use text messages; whereas, majority was reluctant in using video conference and e-mail as a source of communication with healthcare providers. Most of the respondents who were located farther from the health care provider were willing to use video conferencing in case it could save more than 60 minutes of their time.	[Iftikhar, Sadia; Sarwar, Muhammad Rehan; Shoaib, Qurat-ul-ain] Akhtar Saeed Coll Pharmaceut Sci, Dept Pharm Practice, Lahore, Punjab, Pakistan; [Saqib, Anum; Sarwar, Muhammad Rehan; Sarfraz, Muhammad] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan; [Sarfraz, Muhammad; Arafat, Mosab] Al Ain Univ Sci & Technol, Coll Pharm, Abu Dhabi, U Arab Emirates; [Shoaib, Qurat-ul-ain] Univ Punjab, Coll Pharm, Lahore, Pakistan	Islamia University of Bahawalpur; University of Punjab	Sarwar, MR (corresponding author), Akhtar Saeed Coll Pharmaceut Sci, Dept Pharm Practice, Lahore, Punjab, Pakistan.; Sarwar, MR (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.	rehansarwaralvi@gmail.com	Sarfraz, Muhammad/GLS-0139-2022; Sarfraz, Dr Muhamad/GRS-2564-2022	Sarfraz, Muhammad/0000-0002-0516-4966; Sarfraz, Dr Muhamad/0000-0002-0516-4966; Arafat, Mosab/0000-0001-9297-6745; Sarwar, Muhammad Rehan/0000-0003-4312-9157				Aday L A, 1974, Health Serv Res, V9, P208; Adler KG, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e26; Afshar Arash Ehteshami, 2014, CMAJ Open, V2, pE51, DOI 10.9778/cmajo.20130070; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Atif M., 2017, PHARM POLICY COUNTRI, P25, DOI [DOI 10.1007/978-3-319-51673-8_3, 10.1007/978-3-319-51673-8_3]; Atif M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0726-4; Attfield Simon J, 2006, Health Informatics J, V12, P165, DOI 10.1177/1460458206063811; BENTHAM G, 1985, J RURAL STUD, V1, P231, DOI 10.1016/0743-0167(85)90106-8; Brick J E, 1997, Telemed J, V3, P159, DOI 10.1089/tmj.1.1997.3.159; BRONSTEIN JM, 1990, MED CARE, V28, P853, DOI 10.1097/00005650-199009000-00013; Brooks RG, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.1.e2; Caiata-Zufferey M, 2010, QUAL HEALTH RES, V20, P1050, DOI 10.1177/1049732310368404; Car J, 2004, BMJ-BRIT MED J, V329, P435, DOI 10.1136/bmj.329.7463.435; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Echerer SJ, 2000, COMMUNICATION, DOI [10.1186/1471-2458-7-53, DOI 10.1186/1471-2458-7-53]; Eikelboom RH, 2005, J TELEMED TELECARE, V11, P22, DOI 10.1258/135763305775124920; Fox S., 2009, PEW INTERNET AM LIFE, DOI [10.1542/peds.2012-3786K, DOI 10.1542/PEDS.2012-3786K]; Fox S, 2013, PEDIATRICS, V131, pS224, DOI 10.1542/peds.2012-3786K; Fridsma DB, 1994, P ANN S COMPUTER APP; Goodyear-Smith Felicity, 2005, Inform Prim Care, V13, P195; Hou JR, 2010, J HEALTH COMMUN, V15, P186, DOI 10.1080/10810730.2010.522691; Kannisto KA, 2014, J MED INTERNET RES, V16, P100, DOI 10.2196/jmir.3442; Katz SJ, 2004, AM J MANAG CARE, V10, P593; Kelly Jessica M, 2012, ISRN Neurol, V2012, P135329, DOI 10.5402/2012/135329; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; Lee K, 2014, RES SOC ADMIN PHARM, V10, pE14, DOI 10.1016/j.sapharm.2014.07.042; Leong SL, 2005, J AM BOARD FAM PRACT, V18, P180, DOI 10.3122/jabfm.18.3.180; Moyer CA, 2002, AM J MANAG CARE, V8, P427; Murray E, 2003, ARCH INTERN MED, V163, P1727, DOI 10.1001/archinte.163.14.1727; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; Oliver A, 2004, J EPIDEMIOL COMMUN H, V58, P655, DOI 10.1136/jech.2003.017731; Pakistan Telecommunication Authority, 2018, TEL IND; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Raosoft, SAMPL SIZ CALC; Sanghara H, 2010, MENT HEALTH REV J, V15, P28, DOI 10.5042/mhrj.2010.0369; Saqib A, 2018, J PHARM HEALTH SERV, V9, P123, DOI 10.1111/jphs.12220; Shaw R, 2012, HEALTH INFORM J, V18, P235, DOI 10.1177/1460458212442422; Shi C, 2013, INT J EVID-BASED HEA, V11, P344, DOI 10.1111/1744-1609.12041; Shields Margot, 2011, Health Rep, V22, P35; Sittig DF, 2001, INT J MED INFORM, V61, P71, DOI 10.1016/S1386-5056(00)00134-9; Tustin N, 2010, J HEALTH COMMUN, V15, P3, DOI 10.1080/10810730903465491; Virji A, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-18; Werner P, 2003, J TELEMED TELECARE, V9, P264, DOI 10.1258/135763303769211274; Wikipedia, LIST HOSP LAH; Zickuhr K, 2012, PEW INTERNET AM LIFE, V6; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	47	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209654	10.1371/journal.pone.0209654	http://dx.doi.org/10.1371/journal.pone.0209654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629632	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000030
J	Richter, L; Schmid, D; Kanitz, EE; Zwazl, I; Pollabauer, E; Jasinska, J; Burgmann, H; Kundi, M; Wiedermann, U				Richter, Lukas; Schmid, Daniela; Kanitz, Elisabeth Eva; Zwazl, Ines; Poellabauer, Eva; Jasinska, Joanna; Burgmann, Heinz; Kundi, Michael; Wiedermann, Ursula			Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; IMPACT; BURDEN; PHID-CV10; INCREASE; YOUNGER; ENGLAND; QUEBEC	Background In February 2012 the ten-valent pneumococcal conjugate vaccine (PCV10) with a 2+1 doses schedule (3, 5, 12 or 14 months of age) without catch-up vaccination was introduced in Austria. We assessed direct and indirect vaccine effects on invasive pneumococcal disease (IPD) by a population-based intervention study. Methods The study period was divided into pre-(2009-2011) and post-period (2013-2017, February), regarding 2012 as transition year. Outcomes were defined as PCV10 ST-IPD, the PCV10-related ST 6A and 19A IPD and non-PCV10 excluding ST 6A-/19A-IPD (NVT-IPD). We used national surveillance data and compared average monthly incidence rate (IR) between pre- and post-period among <5, 5-49 and >= 50 years old. Additionally, for the 5-49 and >= 50 years old, and the 50-59 and >= 60 years old, we analyzed monthly incidence data of the pre-, post-period, and estimated trend and level changes by using a segmented time-series regression. Results The PCV-10 IPD was reduced by 58% (95% CI: 30%; 74%) and 67% (95% CI: 32%; 84%) among <5 and >= 50 years old; the reduction in >= 60 years was 71% (95% CI: 36%; 88%). There were no significant changes in the pre-post-rate or incidence trend of NVT-IPD in the <5 and >= 50 years old. ST-specific analyses revealed no ST 6A-and ST 19A IPD decline in any age-group, and a ST 8 IPD increase among >= 50 years old (IR ratio: 3.5; 95% CI: 1.7; 7.2). We found no vaccine effects among 5-49 years old. Conclusions Our study adds to the evidence on direct and indirect protection of a childhood PCV10 vaccine program. Elderlies seem to benefit the most. Findings did not support PCV 10 cross-protection, but indicate replacement at least for ST 8 among the >= 50 years old. Follow-up analyses of IPD surveillance data are needed to fully characterize the magnitude of serotype replacement and further vaccine-attributable IPD reduction with time.	[Richter, Lukas; Schmid, Daniela; Kanitz, Elisabeth Eva] Austrian Agcy Hlth & Food Safety, Dept Infect Dis Epidemiol, Vienna, Austria; [Zwazl, Ines; Poellabauer, Eva; Jasinska, Joanna; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Burgmann, Heinz] AKH, Gen Hosp, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Inst Environm Hlth, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Wiedermann, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at	Jasińska, Joanna/AAO-3161-2020	Jasińska, Joanna/0000-0002-0822-2084; Richter, Lukas/0000-0001-6982-6239; Wiedermann, Ursula/0000-0002-1302-3223	Pfizer AG	Pfizer AG	LR, DS, EK, MK, and HB did not receive any specific funding, their work was part of the national surveillance program of the Austrian Agency for health and Food Safety. UW, JJ, EP are employed by the medical university which received an investigator initiated grant from Pfizer AG for cooperation with children hospitals in Austria. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; [Anonymous], 2014, R LANG ENV STAT COMP; Avila-Aguero Maria L, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334555; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Camara J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175224; Cilloniz C, 2016, CURR OPIN INFECT DIS, V29, P187, DOI 10.1097/QCO.0000000000000246; Cohen O, 2017, PNEUMOCOCCAL CONJUGA; Davison AC, 2003, STAT SCI, V18, P141; De Wals P, 2014, VACCINE, V32, P1501, DOI 10.1016/j.vaccine.2013.11.028; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; European Medicines Agency, 2008, PREV 13 EPAR PROD IN; Ewald H, 2016, DTSCH ARZTEBL INT, V113, P139, DOI 10.3238/arztebl.2016.0139; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Feldman Charles, 2016, F1000Res, V5, P2320; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hanquet G, 2017, ECCMID; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hausdorff WP, 2016, HUM VACC IMMUNOTHER, V12, P358, DOI 10.1080/21645515.2015.1118593; Htar MTT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1147-x; International Vaccine Access Center JHUBSoPH, 2017, EV BAS PNEUM CONJ VA; Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Lepoutre A, 2015, VACCINE, V33, P359, DOI 10.1016/j.vaccine.2014.11.011; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Madhi Shabir A., 2008, P95; Manly BFJ, 2011, J BIOPHARM STAT, V21, P1164, DOI 10.1080/10543406.2011.607748; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; Naucler P, 2017, CLIN INFECT DIS, V65, P1780, DOI 10.1093/cid/cix685; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Palmu AA, 2014, LANCET RESP MED, V2, P717, DOI 10.1016/S2213-2600(14)70139-0; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Paulke-Korinek M, 2014, EUR J PEDIATR, V173, P469, DOI 10.1007/s00431-013-2193-2; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Principi N, 2015, EXPERT REV VACCINES, V14, P1359, DOI 10.1586/14760584.2015.1075884; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Roos R, 2015, INVASIVE PNEUMOCOCCA; Steens A, 2015, EPIDEMICS-NETH, V11, P24, DOI 10.1016/j.epidem.2015.01.001; The National Institute for Health and Welfare, 2017, INC INV PNEUM DIS FI; Tsaban G, 2017, VACCINE, V35, P2882, DOI 10.1016/j.vaccine.2017.04.032; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; van der Linden M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0941-9; Verani JR, 2015, VACCINE, V33, P6145, DOI 10.1016/j.vaccine.2015.10.007; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; World Health Organization, 2017, EX SUMM SAGE OCT 201; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	58	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210081	10.1371/journal.pone.0210081	http://dx.doi.org/10.1371/journal.pone.0210081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629620	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000048
J	Sanders, LMJ; Hortobagyi, T; la Bastide-van Gemert, S; van der Zee, EA; van Heuvelen, MJG				Sanders, Lianne M. J.; Hortobagyi, Tibor; la Bastide-van Gemert, Sacha; van der Zee, Eddy A.; van Heuvelen, Marieke J. G.			Dose-response relationship between exercise and cognitive function in older adults with and without cognitive impairment: A systematic review and meta-analysis	PLOS ONE			English	Review							AEROBIC EXERCISE; EXECUTIVE FUNCTIONS; PHYSICAL-ACTIVITY; RESISTANCE EXERCISE; HIPPOCAMPAL VOLUME; ELDERLY-PEOPLE; BRAIN VOLUME; INTENSITY; HEALTH; DURATION	This systematic review and meta-analysis examined the dose-response relationship between exercise and cognitive function in older adults with and without cognitive impairments. We included single-modality randomized controlled aerobic, anaerobic, multicomponent or psychomotor exercise trials that quantified training frequency, session and program duration and specified intensity quantitatively or qualitatively. We defined total exercise duration in minutes as the product of program duration, session duration, and frequency. For each study, we grouped test-specific Hedges' d (n = 163) and Cohen's d (n = 23) effect sizes in the domains Global cognition, Executive function and Memory. We used multilevel mixed-effects models to investigate dose-related predictors of exercise effects. In healthy older adults (n = 23 studies), there was a small positive effect of exercise on executive function (d = 0.27) and memory (d = 0.24), but dose-parameters did not predict the magnitude of effect sizes. In older adults with cognitive impairments (n = 13 studies), exercise had a moderate positive effect on global cognition (d = 0.37). For older adults with cognitive impairments, we found evidence for exercise programs with a short session duration and high frequency to predict higher effect sizes (d = 0.43-0.50). In healthy older adults, dose-parameters did not predict the magnitude of exercise effects on cognition. For older adults with cognitive impairments, exercise programs with shorter session duration and higher frequency may generate the best cognitive results. Studies are needed in which different exercise doses are directly compared among randomized subjects or conditions.	[Sanders, Lianne M. J.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [la Bastide-van Gemert, Sacha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Sanders, LMJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	l.m.j.sanders@umcg.nl	Sanders, Lianne/GVU-5268-2022; van der Zee, Eddy/AAZ-2120-2020; la Bastide-van Gemert, Sacha/C-5151-2013	Sanders, Lianne/0000-0002-9898-2860; la Bastide-van Gemert, Sacha/0000-0003-0666-6690	Deltaplan Dementia (ZonMW, Dutch Ministry of Health: Memorabel) [733050303]; University of Groningen; University Medical Center Groningen	Deltaplan Dementia (ZonMW, Dutch Ministry of Health: Memorabel); University of Groningen; University Medical Center Groningen	The current study was supported by the Deltaplan Dementia (LS, TH, EvdZ, MvH: ZonMW, Dutch Ministry of Health: Memorabel, project number 733050303, received by TH, EvdZ, MvH, url: https://www.zonmw.nl/nl/over-zonmw/ehealthen-ict-in-de-zorg/programmas/project-detail/memorabel/train-the-sedentary-brain-move-smart-to-reduce-the-risk-of-dementia/), University of Groningen (all authors, url: https://www.rug.nl/? lang=en) and the University Medical Center Groningen (LS, TH, SIBvG, MvH, url: https://www.umcg.nl/EN/corporate/Paginas/default.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SB, 2014, J AM GERIATR SOC, V62, P1380, DOI 10.1111/jgs.12916; Albinet CT, 2016, BIOL PSYCHOL, V115, P69, DOI 10.1016/j.biopsycho.2016.01.010; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; American College of Sports Medicine, 2013, ACSMS GUIDELINES EXE; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Ansai JH, 2015, GERIATR GERONTOL INT, V15, P1127, DOI 10.1111/ggi.12411; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Best JR, 2015, J INT NEUROPSYCH SOC, V21, P745, DOI 10.1017/S1355617715000673; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Borde R, 2015, SPORTS MED, V45, P1693, DOI 10.1007/s40279-015-0385-9; Borg G, 1998, BORGS PERCEIVED EXER; Bossers WJR, 2015, AM J GERIAT PSYCHIAT, V23, P1106, DOI 10.1016/j.jagp.2014.12.191; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chang YK, 2015, MED SCI SPORT EXER, V47, P159, DOI 10.1249/MSS.0000000000000383; Chang YK, 2009, J SPORT EXERCISE PSY, V31, P640, DOI 10.1123/jsep.31.5.640; Coetsee C, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0183-5; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Csukly G, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00052; Cummings J, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0207-9; Dai CT, 2013, BRAIN COGNITION, V83, P153, DOI 10.1016/j.bandc.2013.07.007; Dao E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052831; Davis JC, 2013, PLOS ONE, V8; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; de Souto Barreto P, 2017, J AM GERIATR SOC, P421, DOI [10.1055/s-2002-33735, DOI 10.1055/S-2002-33735]; Enette L, 2017, REJUVENATION RES; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Etman Astrid, 2016, BMC Geriatr, V16, P183; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Ferreira L, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S79560; Firth J, 2018, NEUROIMAGE, V166, P230, DOI 10.1016/j.neuroimage.2017.11.007; Forbes D, 2014, SAO PAULO MED J, V132, P195, DOI [10.1590/1516-3180.20141323T2, 10.1002/14651858.CD006489.pub4]; Foulds HJA, 2014, EUR J APPL PHYSIOL, V114, P1563, DOI 10.1007/s00421-014-2887-9; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hox JJ, 2003, MULT APPL BK SER, P87; Iuliano E, 2015, EXP GERONTOL, V70, P105, DOI 10.1016/j.exger.2015.07.008; Jonasson LS, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00336; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kemoun G, 2010, DEMENT GERIATR COGN, V29, P109, DOI 10.1159/000272435; Kimura K, 2010, J PHYSIOL ANTHROPOL, V29, P95, DOI 10.2114/jpa2.29.95; Krell-Roesch J, 2017, JAMA NEUROL, V74, P330, DOI 10.1001/jamaneurol.2016.3822; Kwak YS, 2008, INT J SPORTS MED, V29, P471, DOI 10.1055/s-2007-964853; Leckie RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00985; Lipsey M. W., 2001, PRACTICAL METAANALYS, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Liu-Ambrose T, 2016, NEUROLOGY, V87, P2082, DOI 10.1212/WNL.0000000000003332; Liu-Ambrose T, 2012, NEUROBIOL AGING, V33, P1690, DOI 10.1016/j.neurobiolaging.2011.05.010; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Maass A, 2015, MOL PSYCHIATR, V20, P585, DOI 10.1038/mp.2014.114; Maass A, 2016, NEUROIMAGE, V131, P142, DOI 10.1016/j.neuroimage.2015.10.084; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; MADDEN DJ, 1989, PSYCHOL AGING, V4, P307, DOI 10.1037/0882-7974.4.3.307; Merom D, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00026; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moreau D, 2015, ACTA PSYCHOL, V157, P44, DOI 10.1016/j.actpsy.2015.02.007; Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462; Nagamatsu Lindsay S, 2013, J Aging Res, V2013, P861893, DOI 10.1155/2013/861893; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nemoto K, 2007, MAYO CLIN PROC, V82, P803, DOI 10.4065/82.7.803; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Nouchi R, 2014, AGE, V36, P787, DOI 10.1007/s11357-013-9588-x; Oja P, 2018, BRIT J SPORT MED, V52, P769, DOI 10.1136/bjsports-2017-098558; Pensel MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23308-3; Powers S, 2011, EXERCISE PHYSL THEOR; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ruiz JR, 2015, INT J SPORTS MED, V36, P54, DOI 10.1055/s-0034-1375693; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Scherder E, 2014, AM J GERIAT PSYCHIAT, V22, P782, DOI 10.1016/j.jagp.2012.12.026; Schnohr P, 2012, EUR J PREV CARDIOL, V19, P73, DOI 10.1177/1741826710393196; Schulz KF, 1995, JAMA, V273; Schwarz AJ, 1996, J CLIN ENDOCR METAB, V81, P3492, DOI 10.1210/jc.81.10.3492; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Silva NL, 2014, J SCI MED SPORT, V17, P337, DOI 10.1016/j.jsams.2013.05.009; Telenius EW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0151-8; Tempest GD, 2017, BRAIN COGNITION, V113, P133, DOI 10.1016/j.bandc.2017.02.001; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tsai C, 2015, FRONT BEHAV NEUROSCI, V9; Tsai CL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00294; Tsutsumi Toshihiko, 1997, Applied Human Science, V16, P257, DOI 10.2114/jpa.16.257; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; van Rhee H., 2015, SSRN ELECT J, V2015, P1355, DOI [10.2139/ssrn.3241355, DOI 10.2139/SSRN.3241355]; Varela S, 2012, CLIN REHABIL, V26, P442, DOI 10.1177/0269215511425835; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vedovelli K, 2017, GEROSCIENCE     0713; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vincent Kevin R, 2003, Prev Cardiol, V6, P197, DOI 10.1111/j.1520-037X.2003.01723.x; Voss MW, 2014, MENT HEALTH PHYS ACT, V7, P9, DOI 10.1016/j.mhpa.2014.01.001; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wei XH, 2014, NEUROSCI LETT, V566, P98, DOI 10.1016/j.neulet.2014.02.035; Wibbelink CJM, 2015, MANUAL CONDUCTING 3, DOI [10.1007/s00421-010-1393-y, DOI 10.1007/S00421-010-1393-Y]; Wilson D. B., 2010, METAANALYSIS MACROS; Wong CN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00154; World Health Organization, 2017, DEMENTIA; World Health Organization, 2017, WHAT IS MOD INT VIG; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411	101	107	109	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210036	10.1371/journal.pone.0210036	http://dx.doi.org/10.1371/journal.pone.0210036			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629631	gold, Green Submitted, Green Published			2022-12-27	WOS:000455483000043
J	Zhang, XQ; Zheng, YQ				Zhang, Xiaoqi; Zheng, Yanqiao			Gender differences in self-view and desired salaries: A study on online recruitment website users in China	PLOS ONE			English	Article							PAY EXPECTATIONS; ESTEEM; EFFICACY; ROLES; WOMEN; MODEL	One explanation for the gender pay differences in labor markets is that women propose lower desired salaries. By using an actual job seeking resume database and applying text mining techniques, we are able to observe both the extent of gender differences in desired salaries and job-related self-view. We find gender differences in global self-view favoring females, and in some domain-specific self-view favoring males. Previous findings of disadvantaged groups having levels of self-view at least as high as those of advantaged groups lend credibility to our findings. Moreover, we argue that the differences in global self-view favoring females may be related to the theories of "belief flipping", since women in our sample of online-recruitment markets are distinct from the general population, with on average 15.2 years of education and 8.99 years of work experience, due to self-selection. In addition, we find that women do propose lower desired salary than men, after controlling for various factors such as human capital, marital status, industries. We further investigate the role of self-view and find it contributes to explain desired salaries, with modest mediator effect but little moderator effect on gender differences in desired salaries.	[Zhang, Xiaoqi; Zheng, Yanqiao] Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Finance & Economics	Zheng, YQ (corresponding author), Zhejiang Univ Finance & Econ, Sch Finance, Hangzhou, Zhejiang, Peoples R China.	yanqiaoz@buffalo.edu						Altonji J, 1999, HDB LABOR EC C, V3C, P3143, DOI DOI 10.1016/S1573-4463(99)30039-0; [Anonymous], 1997, SELF EFFICACY; [Anonymous], 2006, ADV EC ANAL POLICY; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Blau FD, 2007, J LABOR ECON, V25, P393, DOI 10.1086/513416; Booth A, 2010, ECON LETT, V107, P236, DOI 10.1016/j.econlet.2010.01.034; Bowles HR, 2005, J PERS SOC PSYCHOL, V89, P951, DOI 10.1037/0022-3514.89.6.951; Bursztyn L, 2017, AM ECON REV, V107, P3288, DOI 10.1257/aer.20170029; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Capraro V, 2017, COGN PROCESS, V18, P399, DOI 10.1007/s10339-017-0822-9; Flory JA, 2015, REV ECON STUD, V82, P122, DOI 10.1093/restud/rdu030; Fryer RG, 2007, J PUBLIC ECON, V91, P1151, DOI 10.1016/j.jpubeco.2006.05.015; Garza P, 2018, EC LETT; Gasser M, 2000, J BUS PSYCHOL, V15, P321, DOI 10.1023/A:1007876103048; Gentile B, 2009, REV GEN PSYCHOL, V13, P34, DOI 10.1037/a0013689; Heckert TM, 2002, SEX ROLES, V47, P139, DOI 10.1023/A:1021095005694; Hogue M, 2010, PSYCHOL WOMEN QUART, V34, P215, DOI 10.1111/j.1471-6402.2010.01563.x; JACKSON LA, 1992, J APPL PSYCHOL, V77, P651, DOI 10.1037/0021-9010.77.5.651; JENSEN GF, 1982, SOC PROBL, V30, P226, DOI 10.1525/sp.1982.30.2.03a00080; Kanfer R, 2001, J APPL PSYCHOL, V86, P837, DOI 10.1037//0021-9010.86.5.837; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Leibbrandt A, 2015, MANAGE SCI, V61, P2016, DOI 10.1287/mnsc.2014.1994; MAJOR B, 1984, ACAD MANAGE J, V27, P777, DOI 10.2307/255878; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; O'Shea PG, 2002, J BUS PSYCHOL, V16, P365, DOI 10.1023/A:1012868806617; Owens T., 2006, HDB SOCIAL PSYCHOL, P205; Pajares F, 1999, CONTEMP EDUC PSYCHOL, V24, P124, DOI 10.1006/ceps.1998.0991; Raiffa H., 1982, ART SCI NEGOTIATION; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Riach PA, 2002, ECON J, V112, pF480, DOI 10.1111/1468-0297.00080; Rosenberg M, 1979, CONCEIVING SELF 1979; Sarsons H., 2015, GENDER DIFFERENCES R; Schooling Mincer J., HUMAN BEHAV SOCIAL I; Smith N, 2013, ILR REV, V66, P380, DOI 10.1177/001979391306600204; Twenge JM, 2001, PERS SOC PSYCHOL REV, V5, P321, DOI 10.1207/S15327957PSPR0504_3; U. S. Bureau of Labor Statistics, 2018, HOUS SURV DAT EMPL E; Weichselbaumer D, 2005, J ECON SURV, V19, P479, DOI 10.1111/j.0950-0804.2005.00256.x; Williams MJ, 2010, PSYCHOL WOMEN QUART, V34, P7, DOI 10.1111/j.1471-6402.2009.01537.x; Wilson F, 2007, ENTREP THEORY PRACT, V31, P387, DOI 10.1111/j.1540-6520.2007.00179.x; Wylie R. C, 1979, THE SELF CONCEPT, V2	40	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210072	10.1371/journal.pone.0210072	http://dx.doi.org/10.1371/journal.pone.0210072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629623	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000045
J	Chang, TC; Wei, PL; Makondi, PT; Chen, WT; Huang, CY; Chang, YJ				Chang, Tung-Cheng; Wei, Po-Li; Makondi, Precious Takondwa; Chen, Wei-Ting; Huang, Chien-Yu; Chang, Yu-Jia			Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy	PLOS ONE			English	Article							INDUCED CYTOKINE PRODUCTION; INDUCED APOPTOSIS; OXIDATIVE STRESS; STATISTICS; PATHWAY; LC3; EXPRESSION; AIF	Advanced colorectal cancer (CRC) survival rates are still low despite advances in cytotoxic and targeted therapies. The development of new effective or alternative therapies is therefore urgently needed. Bromelain, an extract of pineapple, was shown to have anticancer effects, but its mechanisms in CRC have not been fully explored. Therefore, the roles of bromelain in CRC progression were investigated using different CRC cell lines, a zebrafish model, and a xenograft mouse model. The anticancer mechanisms were explored by assessing the role of bromelain in inducing reactive oxygen species (ROS), superoxide, autophagosomes, and lysosomes. The role of bromelain in the induction of apoptosis was also assessed. It was found that bromelain inhibited CRC cell growth in cell lines and tumor growth in the zebrafish and xenograft mouse models. It also induced high levels of ROS and superoxide, plus autophagosome and lysosome formation. High levels of apoptosis were also induced, which were associated with elevated amounts of apoptotic proteins like apoptotic induction factor, Endo G, and caspases-3, -8, and -9 according to a qPCR analysis. In a Western blot analysis, increases in levels of ATG5/12, beclin, p62, and LC3 conversion rates were found after bromelain treatment. Levels of cleaved caspase-3, caspase-8, caspase-9, and poly(ADP ribose) polymerase (PARP)-1 increased after bromelain exposure. This study explored the role of bromelain in CRC while giving insights into its mechanisms of action. This compound can offer a cheap alternative to current therapies.	[Chang, Tung-Cheng; Wei, Po-Li; Makondi, Precious Takondwa; Chen, Wei-Ting; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chang, Tung-Cheng; Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Tung-Cheng; Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, New Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, New Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw			Taipei Medical University; Shuang Ho Hospital [105TMU-SHH-19]; Shuang Ho Hospital, Taipei Medical University [105TMU-SHH-19]	Taipei Medical University; Shuang Ho Hospital; Shuang Ho Hospital, Taipei Medical University	This work was supported by a grant form Taipei Medical University and Shuang Ho Hospital (105TMU-SHH-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from Taipei Medical University and Shuang Ho Hospital, Taipei Medical University (105TMU-SHH-19).	Amini A, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0092-7; Baez R, 2007, PLANTA MED, V73, P1377, DOI 10.1055/s-2007-990221; Bhui K, 2012, MOL CARCINOGEN, V51, P231, DOI 10.1002/mc.20769; Bhui K, 2009, CANCER LETT, V282, P167, DOI 10.1016/j.canlet.2009.03.003; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Brien S, 2004, EVID-BASED COMPL ALT, V1, P251, DOI 10.1093/ecam/neh035; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Castell JV, 1997, AM J PHYSIOL-GASTR L, V273, pG139, DOI 10.1152/ajpgi.1997.273.1.G139; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Chobotova K, 2010, CANCER LETT, V290, P148, DOI 10.1016/j.canlet.2009.08.001; Davalli P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2389523; Novaes LCD, 2016, BIOTECHNOL PROGR, V32, P5, DOI 10.1002/btpr.2190; Dhandayuthapani S, 2012, J MED FOOD, V15, P344, DOI 10.1089/jmf.2011.0145; Dolman NJ, 2013, AUTOPHAGY, V9, P1653, DOI 10.4161/auto.24001; FELTON GE, 1980, MED HYPOTHESES, V6, P1123, DOI 10.1016/0306-9877(80)90134-6; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; GERARD G, 1972, AGRESSOLOGIE, V13, P261; Glaser D, 2006, PLATELETS, V17, P37, DOI 10.1080/09537100500197489; Goldstein N, 1975, Hawaii Med J, V34, P91; GUM JR, 1992, AM J RESP CELL MOL, V7, P557, DOI 10.1165/ajrcmb/7.6.557; Hou RCW, 2006, J AGR FOOD CHEM, V54, P2193, DOI 10.1021/jf052390k; Huang JR, 2008, IMMUNOL INVEST, V37, P263, DOI 10.1080/08820130802083622; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Juhasz B, 2008, AM J PHYSIOL-HEART C, V294, pH1365, DOI 10.1152/ajpheart.01005.2007; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalra N, 2008, TOXICOL APPL PHARM, V226, P30, DOI 10.1016/j.taap.2007.08.012; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuo LJ, 2013, J SURG RES, V185, P264, DOI 10.1016/j.jss.2013.05.020; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li DY, 2017, EUR REV MED PHARMACO, V21, P5548, DOI 10.26355/eurrev_201712_13991; Liang HH, 2013, TUMOR BIOL, V34, P3209, DOI 10.1007/s13277-013-0891-z; Liu KC, 2011, INT J ONCOL, V38, P787, DOI 10.3892/ijo.2010.894; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matsuda K, 2008, SCAND J GASTROENTERO, V43, P25, DOI 10.1080/00365520701579795; Maurer HR, 2001, CELL MOL LIFE SCI, V58, P1234, DOI 10.1007/PL00000936; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Mokarram P, 2017, AUTOPHAGY, V13, P781, DOI 10.1080/15548627.2017.1290751; MORITA AH, 1979, ARCH INT PHARMACOD T, V239, P340; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Pavan Rajendra, 2012, Biotechnol Res Int, V2012, P976203, DOI 10.1155/2012/976203; Qi Rong, 2006, Int J Biomed Sci, V2, P211; Rathnavelu V, 2016, BIOMED REP, V5, P283, DOI 10.3892/br.2016.720; Romano B, 2014, MOL NUTR FOOD RES, V58, P457, DOI 10.1002/mnfr.201300345; Rosenberg L, 2015, Ann Burns Fire Disasters, V28, P264; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; She C, 2014, CELL SIGNAL, V26, P1, DOI 10.1016/j.cellsig.2013.08.046; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; TAUSSIG SJ, 1985, PLANTA MED, V51, P538, DOI 10.1055/s-2007-969596; TAUSSIG SJ, 1975, HIROSHIMA J MED SCI, V24, P185; Twayana KS, 2018, LIFE SCI, V205, P73, DOI 10.1016/j.lfs.2018.05.002; Tysnes BB, 2001, NEOPLASIA, V3, P469, DOI 10.1038/sj.neo.7900196; VanKlinken BJW, 1996, GLYCOCONJUGATE J, V13, P757, DOI 10.1007/BF00702340; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Yang J, 2017, ONCOTARGET, V8, P23492, DOI 10.18632/oncotarget.15626; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	59	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210274	10.1371/journal.pone.0210274	http://dx.doi.org/10.1371/journal.pone.0210274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657763	gold, Green Submitted, Green Published			2022-12-27	WOS:000456017000008
J	Berkhout, ED; Malan, M; Kram, T				Berkhout, Ezra D.; Malan, Mandy; Kram, Tom			Better soils for healthier lives? An econometric assessment of the link between soil nutrients and malnutrition in Sub-Saharan Africa	PLOS ONE			English	Article							NUTRITION; ZINC; FOOD; UNDERNUTRITION; FORTIFICATION; EMISSIONS; MALARIA; GROWTH; POOR	Malnutrition, the suboptimal consumption of essential nutrients like zinc, severely affects human health. This burden of malnutrition falls disproportionally heavy on developing countries, directly increasing child mortality and childhood stunting, or reducing people's ability mending diseases. One option to combat malnutrition is to blend missing nutrients in crop fertilizers, thereby increasing crop yields and possibly the nutrient density in harvested crop products, thus enriching crop products destined for human consumption. But, the effectiveness of so-called agronomic fortification remains ill-understood, primarily due to a paucity of field trials. We hypothesize that, if at all this is an effective strategy, there should exist a causal link between malnutrition and natural variation in the quality of soils to begin with. Until now, data limitations prevented the establishment of such a link, but new soil micronutrient maps for Sub-Saharan Africa allow for a detailed assessment. In doing so, we find statistically significant relations between soil nutrients and child mortality, stunting, wasting and underweight. For instance, a simultaneous increase in soil densities of copper, manganese and zinc by one standard deviation reduces child mortality by 4-6 per mille points, but only when malaria pressure is modest. The effects of soil nutrients on health dissipate when malaria pressure increases. Yet, the effects are fairly small in magnitude suggesting that except for a few regions, agronomic fortification is a relatively cost ineffective means to combat malnutrition.	[Berkhout, Ezra D.; Kram, Tom] PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands; [Malan, Mandy] Int Inst Trop Agr, Kampala, Uganda; [Malan, Mandy] Wageningen Univ & Res, Dev Econ Grp, Wageningen, Netherlands	Wageningen University & Research	Berkhout, ED (corresponding author), PBL Netherlands Environm Assessment Agcy, The Hague, Netherlands.	ezra.berkhout@pbl.nl		Berkhout, Ezra/0000-0003-2536-8912; Malan, Mandy/0000-0003-1565-005X	Netherlands Ministry of Foreign Affairs; Directorate-General for International Cooperation (DGIS)	Netherlands Ministry of Foreign Affairs; Directorate-General for International Cooperation (DGIS)	PBL Netherlands Environmental Assessment Agency received funding from the Netherlands Ministry of Foreign Affairs, specifically the Directorate-General for International Cooperation (DGIS), for conducting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2017, LONDON METAL EXCHANG; Barrett CB, 2015, NAT GEOSCI, V8, P907, DOI [10.1038/ngeo2591, 10.1038/NGEO2591]; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Berkhout E, 2017, MICRONUTRIENTS AGR I; Bevis L.E.M., 2015, SPRINGER SCI REV, V3, P77, DOI [DOI 10.1007/S40362-014-0026-Y, 10.1007/S40362-014-0026-Y]; Bevis LEM, 2015, WHO SUPPLIES NUTRIEN; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Boulder CO, 2017, NIGHTT LIGHTS; Briggs RC, 2018, WORLD DEV, V103, P133, DOI 10.1016/j.worlddev.2017.10.020; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Cameron AC, 2011, J BUS ECON STAT, V29, P238, DOI 10.1198/jbes.2010.07136; CIESIN Center for International Earth Science Information Network Columbia University, 2016, GRIDD POP WORLD VERS, DOI 10.7927/H4NP22DQ; Correia S., 2014, REGHDFE STATA MODULE; Deaton A., 2013, GREAT ESCAPE HLTH WE; Deaton A., 127352006 NBER; DeVellis R. F., 2003, SCALE DEVELOPMENT TH; Diao X, 2007, MARKET OPPORTUNITIES; Dimkpa CO, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-015-0346-6; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Fiedler JL, 2013, FOOD NUTR BULL, V34, P480, DOI 10.1177/156482651303400412; Fink G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-852; Gilmore E, 2005, CONFLICT MANAG PEACE, V22, P257, DOI 10.1080/07388940500201003; Goheen MM, 2016, EBIOMEDICINE, V14, P123, DOI 10.1016/j.ebiom.2016.11.011; Gregory PJ, 2017, GLOB FOOD SECUR-AGR, V15, P1, DOI 10.1016/j.gfs.2017.03.003; Harou A., 2015, GLOB FOOD SEC C 2015; Henderson V, 2011, AM ECON REV, V101, P194, DOI 10.1257/aer.101.3.194; Hengl T, 2017, NUTR CYCL AGROECOSYS, V109, P77, DOI 10.1007/s10705-017-9870-x; Horton S, 2008, MICRONUTRIENT SUPPLE; Horton S., 2014, BENEFITS COSTS FOOD, DOI DOI 10.1017/CBO9781107415324.004; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; Joy EJM, 2017, PLANT SOIL, V411, P139, DOI 10.1007/s11104-016-2961-7; Joy EJM, 2015, PLANT SOIL, V389, P1, DOI 10.1007/s11104-015-2430-8; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kihara J, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0431-0; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lomborg B., 2014, SPEND 75 BILLION MAK; Lujala P, 2005, 37 CONFLICT MANAGEME, V24, P239; Lyons G., 2012, FERTILIZING CROPS IM; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Michalopoulos S, 2013, ECONOMETRICA, V81, P113, DOI 10.3982/ECTA9613; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Population Facts, 2018, SPEED URB WORLD POP; Poulton C, 2006, DEV POLICY REV, V24, P243, DOI 10.1111/j.1467-7679.2006.00324.x; Program TD, 2018, DEM HLTH SURV SPAT D; Pruss-Ustun A., 2003, INTRO METHODS ASSESS; Ros GH, 2016, PLANT SOIL, V404, P99, DOI 10.1007/s11104-016-2830-4; Stein AJ, 2014, GLOB FOOD SECUR-AGR, V3, P193, DOI 10.1016/j.gfs.2014.09.003; Teklic T, 2013, FOOD ENERGY SECUR, V2, P81, DOI 10.1002/fes3.24; Thomas David, 2007, Nutrition and Health (Bicester), V19, P21; Wang YH, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0382-x; Weidmann NB, 2017, J PEACE RES, V54, P125, DOI 10.1177/0022343316630359	56	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210642	10.1371/journal.pone.0210642	http://dx.doi.org/10.1371/journal.pone.0210642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653538	Green Submitted, gold, Green Published			2022-12-27	WOS:000456015500058
J	Byun, SJ; Park, W; Cho, KH; Cho, J; Chang, AR; Kang, KM; Kim, JH; Kim, JH				Byun, Sang Jun; Park, Won; Cho, Kwan Ho; Cho, Jaeho; Chang, Ah Ram; Kang, Ki Mun; Kim, Jin Ho; Kim, Jin Hee			A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)	PLOS ONE			English	Article							COMBINED-MODALITY THERAPY; LONG-TERM OUTCOMES; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; ORGAN PRESERVATION; CHEMORADIATION; COMPLICATIONS; INTENT	Background Although radical cystectomy is a standard treatment in muscle-invasive bladder cancer, bladder preservation therapy including transurethral resection of bladder tumor, radiotherapy, and concurrent chemotherapy has been widely adopted, recently. This retrospective analysis was performed to evaluate the survival rates and prognostic factors related to treatment outcomes following bladder-preserving therapy including radiotherapy (RT) in bladder cancer with a curative intent. Materials and methods We conducted a multi-institutional retrospective study of 152 patients with stage II-IV bladder cancer treated with curative RT between 2000 and 2010. There were 72 patients in stage II, 49 in stage III, and 31 in stage IV. Ninety-seven patients were treated with concurrent chemoradiotherapy and fifty-five with RT alone. Radiation was delivered to the pelvis (median 63 Gy), mainly with cisplatin. The median follow-up time was 35.5 months. Results Sixty-nine patients (45.4%) showed a complete response to RT. The 5-year overall survival (OS) rate was 45.8%, the 5-year cause-specific survival (CSS) rate was 48.9%, and the 5-year disease-free survival (DFS) rate was 20.8%. Univariate analysis revealed significant differences in the following factors according to the survival rates: patient age, initial hemoglobin level, clinical T stage, clinical N stage, clinical stage group, tumor response to RT, hydronephrosis, and concurrent chemotherapy. Multivariate analysis also revealed a significant difference in patient age (p = 0.003 in OS, p<0.017 in CSS) and tumor response to RT (p = 0.002 in OS, p<0.001 in CSS). Concurrent chemotherapy was significantly different in the DFS rates (p = 0.046). Conclusions The survival rates reported herein are comparable to those from other studies, and tumor response and concurrent chemoradiotherapy were significant prognostic factors for better survival rates. Further randomized studies are needed to elucidate the impact of RT in bladder cancer.	[Byun, Sang Jun; Kim, Jin Hee] Keimyung Univ, Sch Med, Dept Radiat Oncol, Dongsan Med Ctr, Daegu, South Korea; [Park, Won] Sungkyunkwan Univ, Sch Med, Dept Radiat Oncol, Samsung Med Ctr, Seoul, South Korea; [Cho, Kwan Ho] Natl Canc Ctr, Res Inst & Hosp, Proton Therapy Ctr, Goyang, South Korea; [Cho, Jaeho] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiat Oncol, Seoul, South Korea; [Chang, Ah Ram] Soonchunhyang Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Kang, Ki Mun] Gyeongsang Natl Univ Hosp, Dept Radiat Oncol, Jinju, South Korea; [Kim, Jin Ho] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	Keimyung University; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Soonchunhyang University; Gyeongsang National University; Gyeongsang National University Hospital; Seoul National University (SNU)	Kim, JH (corresponding author), Keimyung Univ, Sch Med, Dept Radiat Oncol, Dongsan Med Ctr, Daegu, South Korea.	jhkim@dsmc.or.kr	Song, Jin/HHS-8731-2022; Kang, Kimun/AAA-3684-2022	Byun, SangJun/0000-0002-6115-2804; Kim, Jin Ho/0000-0002-7918-1072; Cho, Jaeho/0000-0001-9966-5157	National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2014R1A5A2010008]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (MSIP). (No. 2014R1A5A2010008).	Abol-Enein H, 2003, LANCET, V361, P1927; Baumgarten AS, 2014, UROLOGY, V83, P946, DOI 10.1016/j.urology.2013.09.058; Byun SJ, 2015, RADIAT ONCOL J, V33, P294, DOI 10.3857/roj.2015.33.4.294; Chai XF, 2010, INT J RADIAT ONCOL, V77, P309, DOI 10.1016/j.ijrobp.2009.08.019; Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001; Choudhury A, 2011, J CLIN ONCOL, V29, P733, DOI 10.1200/JCO.2010.31.5721; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Ha US, 2010, INT J UROL, V17, P55, DOI 10.1111/j.1442-2042.2009.02425.x; Hafeez S, 2016, INT J RADIAT ONCOL, V94, P1022, DOI 10.1016/j.ijrobp.2015.12.379; Hagan MP, 2003, INT J RADIAT ONCOL, V57, P665, DOI 10.1016/S0360-3016(03)00718-1; James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106; Koga F, 2008, UROLOGY, V72, P384, DOI 10.1016/j.urology.2008.03.017; Koga F, 2012, INT J UROL, V19, P388, DOI 10.1111/j.1442-2042.2012.02974.x; Konety BR, 2006, UROLOGY, V68, P58, DOI 10.1016/j.urology.2006.01.051; Lagrange JL, 2011, INT J RADIAT ONCOL, V79, P172, DOI 10.1016/j.ijrobp.2009.10.038; Mak RH, 2014, J CLIN ONCOL, V32, P3801, DOI 10.1200/JCO.2014.57.5548; McHaffie DR, 2016, UROL ONCOL-SEMIN ORI, V34, P271, DOI 10.1016/j.urolonc.2016.03.011; Murthy V, 2016, INT J RADIAT ONCOL, V94, P60, DOI 10.1016/j.ijrobp.2015.09.010; Novotny V, 2007, EUR UROL, V51, P397, DOI 10.1016/j.eururo.2006.06.014; Ploussard G, 2014, EUR UROL, V66, P120, DOI 10.1016/j.eururo.2014.02.038; Rivera I, 2000, Cancer Control, V7, P340; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Rouanne M, 2018, WORLD J UROL, V36, P1727, DOI 10.1007/s00345-018-2332-5; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; Song W, 2015, KOREAN J UROL, V56, P422, DOI 10.4111/kju.2015.56.6.422; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Tunio MA, 2012, INT J RADIAT ONCOL, V82, pE457, DOI 10.1016/j.ijrobp.2011.05.051; Zapatero A, 2012, UROLOGY, V80, P1056, DOI 10.1016/j.urology.2012.07.045	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209998	10.1371/journal.pone.0209998	http://dx.doi.org/10.1371/journal.pone.0209998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653591	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500023
J	Lohsoonthorn, V; Rattananupong, T; Wynne, K; Thomas, C; Chahal, HS; Berhane, HY; Mostofsky, E; Wuttithai, N; Gelaye, B				Lohsoonthorn, Vitool; Rattananupong, Thanapoom; Wynne, Keona; Thomas, Colbren; Chahal, Harpreet S.; Berhane, Hanna Y.; Mostofsky, Elizabeth; Wuttithai, Nudsinee; Gelaye, Bizu			Immediate risk of myocardial infarction following physical exertion, tea, and coffee: A case-crossover study in Thailand	PLOS ONE			English	Article							ACUTE CARDIAC EVENTS; CARDIOVASCULAR EVENTS; SEXUAL-ACTIVITY; CONSUMPTION; CAFFEINE; TRIGGERS; ASSOCIATION; MECHANISMS; IMPACT; ONSET	Background Physical exertion and caffeine consumption are associated with acute myocardial infarction (MI). However, physical exertion and caffeine consumption have not been examined as immediate triggers of MI in low and middle-income countries. Objective Using a self-matched case-crossover design, we examined the acute risk of MI in the hour following episodes of physical exertion, caffeinated coffee, and tea consumption among MI survivors in Thailand. Methods A total of 506 Thai participants (women = 191, men = 315) were interviewed between 2014 and 2017 after sustaining an acute MI. We compared each subject's exposure to physical exertion and consumption of caffeine-containing beverages in the hour preceding the onset of MI with the subject's expected usual frequency in the prior year to calculate relative risks (RRs) and 95% confidence intervals (95% CIs). Results Of the 506 participants, 47 (9.3%) engaged in moderate or heavy physical exertion, 6 (1.2%) consumed tea, and 21 (4.2%) consumed coffee within the hour before MI. The relative risk of MI after moderate or heavy physical exertion was 3.0 (95% CI 2.2-4.2) compared to periods of no exertion, with a higher risk among more sedentary participants compared to active participants. Compared to times with no caffeinated beverage consumption, there was a higher risk of MI in the hour following consumption of caffeinated tea (RR = 3.7; 95% CI: 1.5-9.3) and coffee (RR = 2.3; 95% CI: 1.4-3.6). Conclusion Physical exertion, coffee and tea consumption were associated with a higher risk of MI in the subsequent hour compared to times when the participants were sedentary or did not consume caffeinated beverages. Our study identifies high-risk populations for targeted screening and intervention to prevent acute MI.	[Lohsoonthorn, Vitool; Rattananupong, Thanapoom] Chulalongkorn Univ, Fac Med, Bangkok, Thailand; [Wynne, Keona; Thomas, Colbren; Chahal, Harpreet S.; Mostofsky, Elizabeth; Gelaye, Bizu] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chahal, Harpreet S.] Univ Toronto Mississauga, Mississauga Acad Med, Mississauga, ON, Canada; [Berhane, Hanna Y.] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Wuttithai, Nudsinee] Chiangrai Prachanukroh Hosp, Chiangrai, Thailand	Chulalongkorn University; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Mississauga; Addis Continental Institute of Public Health	Gelaye, B (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu			National Institutes of Minority Health and Health Disparities [T37-MD001449]; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Our work is supported by an award from the National Institutes of Minority Health and Health Disparities (T37-MD001449). Ms. Keona Wynne and Mr. Colbren Thomas were research training fellows with the Multidisciplinary International Research Training (MIRT) Program of the Harvard T. H. Chan School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin A, 2007, ANN EPIDEMIOL, V17, P112, DOI 10.1016/j.annepidem.2006.05.004; Baylin A, 2006, EPIDEMIOLOGY, V17, P506, DOI 10.1097/01.ede.0000229444.55718.96; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Campa C, 2005, FOOD CHEM, V91, P633, DOI 10.1016/j.foodchem.2004.06.032; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336; de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003; Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151; Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; LANDOLFI R, 1984, BIOCHEM PHARMACOL, V33, P1525, DOI 10.1016/0006-2952(84)90423-4; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maclure M, 2007, PHARMACOEPIDEM DR S, V16, P850, DOI 10.1002/pds.1438; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; [Ministry of Public Health Bureau of Policy and Strategy Ministry of Public Health], 2017, THAIL PUBL HLTH STAT; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Mittleman MA, 2011, CIRCULATION, V124, P346, DOI 10.1161/CIRCULATIONAHA.110.968776; Mostofsky E, 2018, EPIDEMIOLOGY, V29, P804, DOI 10.1097/EDE.0000000000000904; Mostofsky E, 2016, CIRCULATION, V133, P979, DOI 10.1161/CIRCULATIONAHA.115.019743; Mukamal KJ, 2002, CIRCULATION, V105, P2476, DOI 10.1161/01.CIR.0000017201.88994.F7; Muller JE, 1997, CIRCULATION, V96, P3233, DOI 10.1161/01.CIR.96.9.3233; Nazari S, 2015, J BIOSTAT EPIDEMIOL, V1, P59; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Oliveira Gustavo B F, 2015, Front Cardiovasc Med, V2, P32, DOI 10.3389/fcvm.2015.00032; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Smyth A, 2016, CIRCULATION, V134, P1059, DOI 10.1161/CIRCULATIONAHA.116.023142; Somogyi LP, 2012, CAFFEINE INTAKE US P; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; WILLICH SN, 1991, CIRCULATION, V84, P62; Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051; Yoshida H, 1999, BIOCHEM PHARMACOL, V58, P1695, DOI 10.1016/S0006-2952(99)00256-7	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210959	10.1371/journal.pone.0210959	http://dx.doi.org/10.1371/journal.pone.0210959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653616	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500092
J	Pilch, Z; Tonecka, K; Skorzynski, M; Sas, Z; Braniewska, A; Kryczka, T; Boon, L; Golab, J; Meyaard, L; Rygiel, TP				Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Kryczka, Tomasz; Boon, Louis; Golab, Jakub; Meyaard, Linde; Rygiel, Tomasz P.			The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; PROGNOSTIC-FACTOR; DOWN-REGULATION; LIGAND; METASTASIS; RESPONSES; PROTEIN; CELLS; HOST	Tumor-infiltrating immune cells can impact tumor growth and progression. The inhibitory CD200 receptor (CD200R) suppresses the activation of myeloid cells and lack of this pathway results in a reduction of tumor growth, conversely a tumorigenic effect of CD200R triggering was also described. Here we investigated the role of CD200R activation in syngeneic mouse tumor models. We showed that agonistic CD200R antibody reached tumors, but had no significant impact on tumor growth and minor effect on infiltration of immune myeloid cells. These effects were reproduced using two different anti-CD200R clones. In contrast, we showed that CD200-deficiency did decrease melanoma tumor burden. The presence of either endogenous or tumor-expressed CD200 restored the growth of metastatic melanoma foci. On the basis of these findings, we conclude that blockade of the endogenous ligand CD200 prevented the tumorigenic effect of CD200R-expressing myeloid cells in the tumor microenvironment, whereas agonistic anti-CD200R has no effect on tumor development.	[Pilch, Zofia; Tonecka, Katarzyna; Skorzynski, Marcin; Sas, Zuzanna; Braniewska, Agata; Golab, Jakub; Rygiel, Tomasz P.] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Kryczka, Tomasz] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Golab, Jakub] Med Univ Warsaw, Ctr Preclin Res & Technol, Warsaw, Poland; [Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Meyaard, Linde] Univ Med Ctr Utrecht, Oncode Inst, Utrecht, Netherlands	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Bioceros B.V.; Medical University of Warsaw; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Rygiel, TP (corresponding author), Med Univ Warsaw, Dept Immunol, Warsaw, Poland.	trygiel@wum.edu.pl	Braniewska, Agata/AAJ-1627-2021; Golab, Jakub/K-6974-2013; Boon, Laurence/HCI-3629-2022; Kryczka, Tomasz/T-2056-2018	Braniewska, Agata/0000-0002-2525-1290; Golab, Jakub/0000-0002-2830-5100; Rygiel, Tomasz/0000-0003-4746-6505; Skorzynski, Marcin/0000-0001-6665-9041; Meyaard, Linde/0000-0003-0707-4793; Kryczka, Tomasz/0000-0003-2607-1651; Boon, Louis/0000-0002-0937-9171	Polish National Science Center (NCN) [2011/03/D/NZ6/03685]	Polish National Science Center (NCN)	This work was financed by Polish National Science Center (NCN) under grant no. 2011/03/D/NZ6/03685 (to TPR). The funding organization (NCN) did not play a role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries to ZP, KT and TPR. The commercial company (Bioceros BV) did not play a role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript and only provided research materials (antibodies).	Akkaya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063325; Cameron CM, 2005, J VIROL, V79, P6052, DOI 10.1128/JVI.79.10.6052-6067.2005; Erin N, 2015, ONCOGENE, V34, P3860, DOI 10.1038/onc.2014.317; Foster-Cuevas M, 2004, J VIROL, V78, P7667, DOI 10.1128/JVI.78.14.7667-7676.2004; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Gorczynski RM, 2013, BREAST CANCER RES TR, V142, P271, DOI 10.1007/s10549-013-2735-3; Hatherley D, 2005, J IMMUNOL, V175, P2469, DOI 10.4049/jimmunol.175.4.2469; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Pilch Z, 2018, CANCER IMMUNOL RES, V6, P930, DOI 10.1158/2326-6066.CIR-17-0454; Pingwara R, 2017, J PHYSIOL PHARMACOL, V68, P573; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rygiel TP, 2012, ONCOGENE, V31, P2979, DOI 10.1038/onc.2011.477; Rygiel TF, 2012, CURR OPIN IMMUNOL, V24, P233, DOI 10.1016/j.coi.2012.01.002; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; Talebian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031442; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Vaine CA, 2014, ADV IMMUNOL, V121, P191, DOI 10.1016/B978-0-12-800100-4.00005-2	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210796	10.1371/journal.pone.0210796	http://dx.doi.org/10.1371/journal.pone.0210796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653571	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500071
J	Sudarski, S; Haubenreisser, H; Henzler, T; Reischauer, C; Kolokythas, O; Matoori, S; Herzog, BA; Schonberg, SO; Gutzeit, A				Sudarski, Sonja; Haubenreisser, Holger; Henzler, Thomas; Reischauer, Carolin; Kolokythas, Orpheus; Matoori, Simon; Herzog, Bernhard A.; Schoenberg, Stefan O.; Gutzeit, Andreas			Incidence of transient interruption of contrast (TIC) - A retrospective single-centre analysis in CT pulmonary angiography exams acquired during inspiratory breath-hold with the breathing command: "Please inspire gently!"	PLOS ONE			English	Article							REDUCE INSPIRATION; DEEP-INSPIRATION; BLOOD-FLOW; DYNAMICS; EMBOLISM; IMPROVE; ENHANCEMENT; RESISTANCE; ARTERY	Objectives To assess the occurrence of transient interruption of contrast (TIC) phenomenon in pulmonary computed tomography angiography (CTPA) exams performed in inspiratory breath-hold after patients were told to inspire gently. Methods In this retrospective single-centre study, CTPA exams of 225 consecutive patients scanned on a 16-slice CT scanner system were analysed. A-priori to measurements, exams were screened for inadequate pulmonary artery contrast due to incorrect bolus tracking or failure of i.v. contrast administration. Those exams were excluded. Attenuation values in the thoracic aorta and in the pulmonary trunk were assessed in duplicate measurements (M1 and M2) and the aorto-pulmonary density ratio was calculated. An aorto-pulmonary ratio > 1 with still contrast inflow being visible within the superior vena cava was defined as TIC. Results 3 patients were excluded due to incorrect bolus tracking. Final analysis was performed in 222 patients (mean age 65 +/- 19 years, range 18 to 99 years). Mean density in the pulmonary trunk was 275 +/- 17 HU, in the aorta 208 +/- 15 HU. Mean aorto-pulmonary ratio was 0.81 +/- 0.29. 48 patients (21.6%) had an aorto-pulmonary ratio > 1. Correlation of mean aorto-pulmonary ratio and age was: -0.213 (p = 0.001). Age was not significantly different for an aorto-pulmonary ratio > 1 vs. <= 1 (p = 0.122). Both in M1 and M2, 33/222 patients presented with absolute HU values of < 200 HU within the pulmonary artery. In M1 measurements, 24 of these 33 patients (72%) fulfilled TIC criteria (M2: 25/33 patients (75%)). Conclusions TIC is a common phenomenon in CTPA studies with inspiratory breath-hold commands after patients were told to inspire gently with an incidence of 22% in our retrospective cohort. Occurrence of TIC shows a significant negative correlation with increasing age and disproportionately often occurs in patients with lower absolute contrast density values within their pulmonary arteries.	[Sudarski, Sonja; Haubenreisser, Holger; Henzler, Thomas; Schoenberg, Stefan O.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Reischauer, Carolin; Matoori, Simon; Gutzeit, Andreas] Hirslanden Hosp St Anna, Clin Res Unit, Inst Radiol & Nucl Med, Luzern, Switzerland; [Kolokythas, Orpheus] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Matoori, Simon; Gutzeit, Andreas] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Herzog, Bernhard A.] HerzClin Luzern, Luzern, Switzerland; [Gutzeit, Andreas] Paracelsus Med Univ, Dept Radiol, Salzburg, Austria	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paracelsus Private Medical University	Sudarski, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany.	sonja.sudarski@medma.uni-heidelberg.de		Matoori, Simon/0000-0002-1559-0950; Reischauer, Carolin/0000-0002-6624-6615				Bernabe-Garcia JM, 2012, INSIGHTS IMAGING, V3, P505, DOI 10.1007/s13244-012-0182-z; Chen YH, 2008, EMERG RADIOL, V15, P161, DOI 10.1007/s10140-007-0695-9; Estrada-Y-Martin RM, 2011, INT J COMPUT ASS RAD, V6, P557, DOI 10.1007/s11548-010-0526-4; Gosselin MV, 2004, J THORAC IMAG, V19, P1, DOI 10.1097/00005382-200401000-00001; Gossner J, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.100999; Gutzeit A, 2015, EUR RADIOL, V25, P3133, DOI 10.1007/s00330-015-3735-y; Gutzeit A, 2014, EUR RADIOL, V24, P3034, DOI 10.1007/s00330-014-3328-1; Hamilton MCK, 2013, CLIN RADIOL, V68, pE99, DOI 10.1016/j.crad.2012.10.015; Henk CB, 2003, RADIOLOGY, V226, P749, DOI 10.1148/radiol.2263012200; Kuzo RS, 2007, AM J ROENTGENOL, V188, P839, DOI 10.2214/AJR.06.5035; Mortimer AM, 2011, CLIN RADIOL, V66, P1159, DOI 10.1016/j.crad.2011.06.012; Renne J, 2014, ACTA RADIOL, V55, P932, DOI 10.1177/0284185113507712; Ridge CA, 2009, AM J ROENTGENOL, V193, P1223, DOI 10.2214/AJR.09.2360; Wang M, 2015, EUR RADIOL, V25, P2541, DOI 10.1007/s00330-015-3664-9; Wittram C, 2007, J THORAC IMAG, V22, P125, DOI 10.1097/01.rti.0000213566.78785.26	15	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210473	10.1371/journal.pone.0210473	http://dx.doi.org/10.1371/journal.pone.0210473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653548	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500040
J	Schirmer, A; Feng, YJ; Sen, A; Penney, TB				Schirmer, Annett; Feng, Yenju; Sen, Antarika; Penney, Trevor B.			Angry, old, male - and trustworthy? How expressive and person voice characteristics shape listener trust	PLOS ONE			English	Article							1ST IMPRESSIONS; JUDGING PERSONALITY; PITCH; ATTRACTIVENESS; PERCEPTION; JUDGMENTS; EMOTION; BIAS; MEN	This study examined how trustworthiness impressions depend on vocal expressive and person characteristics and how their dependence may be explained by acoustical profiles. Sentences spoken in a range of emotional and conversational expressions by 20 speakers differing in age and sex were presented to 80 age and sex matched listeners who rated speaker trustworthiness. Positive speaker valence but not arousal consistently predicted greater perceived trustworthiness. Additionally, voices from younger as compared with older and female as compared with male speakers were judged more trustworthy. Acoustic analysis highlighted several parameters as relevant for differentiating trustworthiness ratings and showed that effects largely overlapped with those for speaker valence and age, but not sex. Specifically, a fast speech rate, a low harmonic-to-noise ratio, and a low fundamental frequency mean and standard deviation differentiated trustworthy from untrustworthy, positive from negative, and younger from older voices. Male and female voices differed in other ways. Together, these results show that a speaker's expressive as well as person characteristics shape trustworthiness impressions and that their effect likely results from a combination of low-level perceptual and higher-order conceptual processes.	[Schirmer, Annett; Penney, Trevor B.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Schirmer, Annett; Penney, Trevor B.] Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China; [Feng, Yenju; Sen, Antarika] Natl Univ Singapore, Grad Sch Integrated Sci & Engn, Singapore, Singapore	Chinese University of Hong Kong; Chinese University of Hong Kong; National University of Singapore	Schirmer, A (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.; Schirmer, A (corresponding author), Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China.	schirmer@cuhk.edu.hk		Schirmer, Annett/0000-0003-1474-2788	Singapore MOE grant [R-581-000-190-112]	Singapore MOE grant(Ministry of Education, Singapore)	This research was supported by Singapore MOE grant R-581-000-190-112 awarded to Annett Schirmer. The funder had no role in this research.	Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Bailey PE, 2015, PSYCHOL AGING, V30, P977, DOI 10.1037/a0039736; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Banziger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136675; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; Belin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185651; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Boersma P, 2013, PRAAT DOING PHONETIC; Bonnefon JF, 2015, TRENDS COGN SCI, V19, P421, DOI 10.1016/j.tics.2015.05.002; Bonnefon JF, 2013, J EXP PSYCHOL GEN, V142, P143, DOI 10.1037/a0028930; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Christensen R. H. B., 2018, ORDINAL REGRESSION M, V2018, P8; Ciardo F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04746; Costa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172739; Dehqan A, 2012, FOLIA PHONIATR LOGO, V64, P265, DOI 10.1159/000343998; Fant G., 1960, ACOUSTIC THEORY SPEE; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Gamer M., 2012, PACKAGE IRR VARIOUS; Gill D, 2014, PSYCHOL SCI, V25, P1079, DOI 10.1177/0956797614522274; Gonzalez J, 2004, MED SCI MONITOR, V10, pCR649; Gordon RA, 2004, J APPL SOC PSYCHOL, V34, P468, DOI 10.1111/j.1559-1816.2004.tb02557.x; Hall JA, 2017, J PERS, V85, P583, DOI 10.1111/jopy.12262; Jack RE, 2017, ANNU REV PSYCHOL, V68, P269, DOI 10.1146/annurev-psych-010416-044242; Kiiski HSM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00437; Klofstad CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133779; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Kovacs-Balint Z, 2013, BRIT J PSYCHOL, V104, P563, DOI 10.1111/bjop.12007; KRAMER E, 1964, J SOC PSYCHOL, V62, P247, DOI 10.1080/00224545.1964.9919523; Levine EE, 2018, J PERS SOC PSYCHOL, V115, P468, DOI 10.1037/pspi0000136; Lortie CL, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.02.015; Mattarozzi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135529; Mileva M, 2018, J EXP PSYCHOL HUMAN, V44, P128, DOI 10.1037/xhp0000439; Montano KJ, 2017, EVOL HUM BEHAV, V38, P293, DOI 10.1016/j.evolhumbehav.2016.10.010; O'Connor JJM, 2017, EVOL HUM BEHAV, V38, P506, DOI 10.1016/j.evolhumbehav.2017.03.001; O'Connor JJM, 2011, EVOL PSYCHOL-US, V9, P64, DOI 10.1177/147470491100900109; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Olszanowski M, 2017, COGNITION EMOTION, P1, DOI [DOI 10.1080/02699931.2017.1386622, 10.1080/02699931.2017.1386622]; Over H, 2018, COGNITION, V170, P190, DOI 10.1016/j.cognition.2017.10.002; Palumbo R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01704; Pear T. H., 1931, VOICE PERSONALITY AP; Ponsot E, 2018, P NATL ACAD SCI USA, V115, P3972, DOI 10.1073/pnas.1716090115; Powlishta KK, 2004, DEVELOPMENT OF THE SOCIAL SELF, P103, DOI 10.4324/9780203391099_chapter_4; R Development Core Team, 2009, R LANG ENV STAT COMP; Re DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032719; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schroeder J, 2017, PSYCHOL SCI, V28, P1745, DOI 10.1177/0956797617713798; SECORD PF, 1960, J SOC PSYCHOL, V52, P329, DOI 10.1080/00224545.1960.9922088; Secord PF., 1958, PERSON PERCEPTION IN, P300; Sen A, 2018, COGNITION EMOTION, V32, P1189, DOI 10.1080/02699931.2017.1393399; Sutherland CAM, 2017, BRIT J PSYCHOL, V108, P397, DOI 10.1111/bjop.12206; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Tognetti A, 2013, EVOL HUM BEHAV, V34, P427, DOI 10.1016/j.evolhumbehav.2013.08.002; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; Tsantani MS, 2016, PERCEPTION, V45, P946, DOI 10.1177/0301006616643675; Walker M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181306; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01; Zebrowitz LA, 2013, PSYCHOL AGING, V28, P202, DOI 10.1037/a0030927; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049	64	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210555	10.1371/journal.pone.0210555	http://dx.doi.org/10.1371/journal.pone.0210555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650135	Green Published, gold			2022-12-27	WOS:000455813300062
J	Goes, ESD; Goes, MD; de Castro, PL; de Lara, JAF; Vital, ACP; Ribeiro, RP				dos Reis Goes, Elenice Souza; Goes, Marcio Douglas; de Castro, Pedro Luiz; Ferreira de lara, Jorge Antonio; Pelaes Vital, Ana Carolina; Ribeiro, Ricardo Pereira			Imbalance of the redox system and quality of tilapia fillets subjected to pre-slaughter stress	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MEAT TENDERNESS; FLESH QUALITY; IN-VITRO; MUSCLE; EXPRESSION; OXIDATION; TRANSPORTATION; INDICATORS; CONSUMERS	The objective of this study was to evaluate the effect of oxidative stress on the instrumental and sensory quality of Nile tilapia fillets. The experiment was conducted in a 2x2 factorial arrangement, evaluating densities (60 and 300 kg m(-3)) and depuration times (1 and 24 hours) in a total of four treatments. The serum levels of cortisol and gene expression levels of catalase (CAT), glutathione peroxidase (GPx) and 70 kDa heat shock protein (HSP70) as well as the pH, color, tenderness, water-holding capacity and sensory analysis of the fillets were evaluated. High density (300 kg m(-3)) resulted in higher mean cortisol levels, lower expression of CAT and GPx enzymes as well as higher expression of HSP70. Fish under this treatment also exhibited fillets with greater tenderness, higher lightness, lower redness and lower sensory acceptance. The longer depuration time (24 hours) resulted in lower expression of the CAT and GPx enzymes and fillets with higher lightness. The water-holding capacity was not affected by the different treatments. Therefore, low density and longer depuration times are recommended for decreased stress and improved quality of fillets.	[dos Reis Goes, Elenice Souza] Fed Univ Grande Dourados, Sch Agr Sci, Dourados, MG, Brazil; [Goes, Marcio Douglas] State Univ Western Parana, Anim Sci Postgrad Program, Marechal Candido Rodondo, Parana, Brazil; [de Castro, Pedro Luiz] Univ Estadual Maringa, Anim Sci Postgrad Program, Maringa, Parana, Brazil; [Ferreira de lara, Jorge Antonio] EMBRAPA Pantanal, Brazilian Agr Res Corp, Corumba, MG, Brazil; [Pelaes Vital, Ana Carolina] Univ Estadual Maringa, Food Sci Postgrad Program, Maringa, Parana, Brazil; [Ribeiro, Ricardo Pereira] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Maringa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Maringa; Universidade Estadual de Maringa	Goes, ESD (corresponding author), Fed Univ Grande Dourados, Sch Agr Sci, Dourados, MG, Brazil.	elenicesreis@yahoo.com.br	Vital, Ana Carolina/AAE-1715-2022; Souza dos Reis Goes, Elenice/HHS-6947-2022; de Castro, Pedro Luiz/AAM-2517-2020	Souza dos Reis Goes, Elenice/0000-0003-2437-4800; de Castro, Pedro Luiz/0000-0001-7351-6938; Vital, Ana Carolina/0000-0002-6033-6898	CNPq National Research Council [150657/2015-3]; Federal University of Grande Dourados	CNPq National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Grande Dourados	This work was supported and financed by the CNPq National Research Council (150657/2015-3) and the Federal University of Grande Dourados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2009, GEN COMP ENDOCR, V164, P142, DOI 10.1016/j.ygcen.2009.03.020; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bernard C, 2007, J AGR FOOD CHEM, V55, P5229, DOI 10.1021/jf063372l; Bjarnadottir SG, 2012, J ANIM SCI, V90, P2035, DOI 10.2527/jas.2011-4721; Carvalho ME, 2014, MEAT SCI, V96, P1318, DOI 10.1016/j.meatsci.2013.11.014; Carvalho RH, 2017, FOOD CHEM, V215, P129, DOI 10.1016/j.foodchem.2016.07.182; Chen T, 2010, MEAT SCI, V84, P143, DOI 10.1016/j.meatsci.2009.08.039; Coble DJ, 2011, POULTRY SCI, V90, P1659, DOI 10.3382/ps.2010-01279; Contreras-Guzman E., 1994, BIOQUIMICA PESCADOS; D'Alessandro A, 2013, J PROTEOMICS, V78, P558, DOI 10.1016/j.jprot.2012.10.023; D'Alessandro A, 2012, J PROTEOMICS, V75, P4360, DOI 10.1016/j.jprot.2012.02.013; Daun C, 2004, FOOD CHEM, V85, P295, DOI 10.1016/j.foodchem.2003.07.009; Delles RM, 2014, POULTRY SCI, V93, P1561, DOI 10.3382/ps.2013-03682; Digre H, 2010, AQUAC RES, V41, P1190, DOI 10.1111/j.1365-2109.2009.02406.x; Goes ESD, 2018, SCI AGR, V75, P321, DOI [10.1590/1678-992X-2016-0387, 10.1590/1678-992x-2016-0387]; Erikson U, 2011, J FOOD SCI, V76, pS251, DOI 10.1111/j.1750-3841.2011.02141.x; Estevez M, 2015, POULTRY SCI, V94, P1368, DOI 10.3382/ps/pev094; Furnols MFI, 2008, MEAT SCI, V80, P1013, DOI 10.1016/j.meatsci.2008.04.018; Guillemin N. P., 2012, International Journal of Biology, V4, P26, DOI 10.5539/ijb.v4n2p26; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Iwama George K., 2006, P319; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kristoffersen S, 2006, INT J FOOD SCI TECH, V41, P861, DOI 10.1111/j.1365-2621.2005.01149.x; Lakshmanan R, 2007, LWT-FOOD SCI TECHNOL, V40, P544, DOI 10.1016/j.lwt.2005.12.003; Lefevre F, 2016, AQUACULTURE, V464, P654, DOI 10.1016/j.aquaculture.2016.07.039; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; LOWE TE, 1993, J FOOD SCI, V58, P770, DOI 10.1111/j.1365-2621.1993.tb09355.x; MACFIE HJH, 1990, NUTR REV, V48, P87, DOI [10.1111/j.1745-459X.1989.tb00463.x, 10.1111/j.1753-4887.1990.tb02910.x]; Mercier Y, 2004, MEAT SCI, V66, P467, DOI 10.1016/S0309-1740(03)00135-9; Ouali A, 2006, MEAT SCI, V74, P44, DOI 10.1016/j.meatsci.2006.05.010; Picard B., 2012, Animal Frontiers, V2, P18, DOI 10.2527/af.2012-0058; Poli BM, 2009, ITAL J ANIM SCI, V8, P139; Rahmanifarah K., 2011, J FISH AQUAT SCI, V11, P139, DOI [10.4194/trjfas.20110118, DOI 10.4194/TRJFAS.2011.0118]; Robb DHF, 2000, AQUACULTURE, V182, P261, DOI 10.1016/S0044-8486(99)00273-2; Santos GA, 2010, AQUACULTURE, V299, P73, DOI 10.1016/j.aquaculture.2009.11.018; Sentandreu MA, 2002, TRENDS FOOD SCI TECH, V13, P400, DOI 10.1016/S0924-2244(02)00188-7; Skjervold PO, 2001, AQUACULTURE, V192, P265, DOI 10.1016/S0044-8486(00)00447-6; Stien LH, 2005, AQUAC RES, V36, P1197, DOI 10.1111/j.1365-2109.2005.01339.x; Sveinsdottir K, 2010, J SENS STUD, V25, P280, DOI 10.1111/j.1745-459X.2009.00257.x; Terevinto A, 2010, MEAT SCI, V84, P706, DOI 10.1016/j.meatsci.2009.11.007; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yu JM, 2009, MEAT SCI, V83, P474, DOI 10.1016/j.meatsci.2009.06.028	45	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210742	10.1371/journal.pone.0210742	http://dx.doi.org/10.1371/journal.pone.0210742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645627	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200050
J	Guhn, A; Steinacher, B; Merkl, A; Sterzer, P; Kohler, S				Guhn, Anne; Steinacher, Bruno; Merkl, Angela; Sterzer, Philipp; Koehler, Stephan			Negative mood induction: Affective reactivity in recurrent, but not persistent depression	PLOS ONE			English	Article							CHILDHOOD MALTREATMENT; EMOTIONAL REACTIVITY; EPISODIC DEPRESSION; MAJOR DEPRESSION; GERMAN VERSION; VALIDATION; DISORDER; EVENTS; TRAUMA; WOMEN	Background Despite the high clinical and epidemiological relevance of persistent depression, little is known about its specific psychopathology and whether it is distinct from recurrent depression. Depression in general has been associated with blunted affective reactivity but the evidence from previous studies is inconsistent. Here, we asked whether affective reactivity might differ between persistent and recurrent depression. Methods Twenty patients with persistent depression, 20 patients with recurrent depression and 20 healthy controls (HC) were recruited. Both patient groups showed moderate symptom severity. All participants underwent a sad mood induction procedure. Affective reactivity was assessed with the Positive and Negative Affect Schedule (PANAS) before and after mood induction. Results We found a striking difference in affective reactivity between patient groups. While the persistent group showed blunted reactivity to mood induction, the recurrent group demonstrated an affective response that was comparable to HC, with an increase in negative and a decrease in positive affect. Blunted affective reactivity was thus specifically associated with persistent in contrast to recurrent depression. Conclusions These results highlight affective reactivity as an important psychopathological feature that differs between the two patient groups. Preserved affective reactivity to emotional stimuli in the recurrent group might reflect a resilience factor against persistence of depression.	[Guhn, Anne; Merkl, Angela; Sterzer, Philipp; Koehler, Stephan] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany; [Steinacher, Bruno] Vivantes GmbH Wenckebach Hosp, Dept Psychiat & Psychotherapy, Berlin, Germany; [Merkl, Angela] Fliedner Clin Berlin, Outpatient Clin Psychiat Psychotherapy & Psychoso, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Guhn, A (corresponding author), Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany.	anne.guhn@charite.de		Guhn, Anne/0000-0003-1481-0269	German Research Foundation (DFG) [KO 5231/2-1]; Charite- Universitatsmedizin Berlin; Berlin Institute of Health	German Research Foundation (DFG)(German Research Foundation (DFG)); Charite- Universitatsmedizin Berlin; Berlin Institute of Health	This work was funded by the German Research Foundation (DFG, KO 5231/2-1 to S.K.: "Empathiedefizit chronisch depressiver Patienten nach emotionaler Aktivierung"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the German Research Foundation (DFG, KO 5231/2-1 to S.K.: "Empathiedefizit chronisch depressiver Patienten nach emotionaler Aktivierung"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stephan Kohler is a participant in the Charite Clinical Scientist Program funded by the Charite- Universitatsmedizin Berlin and the Berlin Institute of Health. We would like to thank Tom Bschor and Mazda Adli for their support in patient recruitment.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angst J, 2009, J AFFECT DISORDERS, V115, P112, DOI 10.1016/j.jad.2008.09.023; [Anonymous], 2016, BER EFF; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Brakemeier EL, 2018, PSYCHOTHER PSYCHOSOM, V87, P49, DOI 10.1159/000484481; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Canli T, 2005, NEUROREPORT, V16, P1267, DOI 10.1097/01.wnr.0000174407.09515.cc; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Constantino MJ, 2012, J CONSULT CLIN PSYCH, V80, P354, DOI 10.1037/a0028351; Cuijpers P, 2011, NORD J PSYCHIAT, V65, P354, DOI 10.3109/08039488.2011.596570; Domes G, 2016, J AFFECT DISORDERS, V195, P144, DOI 10.1016/j.jad.2016.02.006; Dunn BD, 2004, J ABNORM PSYCHOL, V113, P654, DOI 10.1037/0021-843X.113.4.654; Guhn A, 2018, J AFFECT DISORDERS, V229, P275, DOI 10.1016/j.jad.2017.12.090; Gustafson GE, 2019, INFANT BEHAV DEV, V56, DOI 10.1016/j.infbeh.2017.08.004; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Klein DN, 2006, AM J PSYCHIAT, V163, P872, DOI 10.1176/appi.ajp.163.5.872; Kohler S, 2018, DEPRESSION ANXIETY; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lang P.J., 2008, INT AFFECTIVE PICTUR; LIZARDI H, 1995, J ABNORM PSYCHOL, V104, P132, DOI 10.1037/0021-843X.104.1.132; Mattern M, 2015, PSYCHOPATHOLOGY, V48, P240, DOI 10.1159/000430450; McCullough JP, 2000, TREATMENT CHRONIC DE; Miranda J, 1998, COGNITIVE THER RES, V22, P363; Murphy JA, 2012, J AFFECT DISORDERS, V139, P172, DOI 10.1016/j.jad.2012.01.033; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nelson J, 2017, BRIT J PSYCHIAT, V210, P96, DOI 10.1192/bjp.bp.115.180752; Nemeroff CB, 2003, P NATL ACAD SCI USA, V100, P14293, DOI 10.1073/pnas.2336126100; Peeters F, 2010, BEHAV RES THER, V48, P754, DOI 10.1016/j.brat.2010.04.008; Qiao-Tasserit E, 2018, NEUROPSYCHOLOGIA, V116, P99, DOI 10.1016/j.neuropsychologia.2017.12.027; Riise T, 2001, J AFFECT DISORDERS, V65, P297, DOI 10.1016/S0165-0327(00)00260-3; Rojas R, 2015, DIAGNOSTICA, V61, P173, DOI 10.1026/0012-1924/a000123; Rottenberg J, 2003, CLIN PSYCHOL-SCI PR, V10, P227, DOI 10.1093/clipsy/bpg012; Rottenberg J, 2017, COGNITION EMOTION, P1, DOI [10.1080/02699931.2017.1246685, DOI 10.1080/02699931.2017.1246685]; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SIGMON ST, 1992, J PSYCHOPATHOL BEHAV, V14, P225, DOI 10.1007/BF00962630; van Randenborgh A, 2012, J AFFECT DISORDERS, V141, P177, DOI 10.1016/j.jad.2012.02.039; Vanderhasselt MA, 2016, J AFFECT DISORDERS, V190, P443, DOI 10.1016/j.jad.2015.10.022; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; Wilbertz G, 2010, J AFFECT DISORDERS, V124, P262, DOI 10.1016/j.jad.2009.11.021; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0208616	10.1371/journal.pone.0208616	http://dx.doi.org/10.1371/journal.pone.0208616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645583	gold, Green Submitted, Green Published			2022-12-27	WOS:000455810200006
J	Hynninen, Y; Linna, M; Vilkkumaa, E				Hynninen, Yrjana; Linna, Miika; Vilkkumaa, Eeva			Value of genetic testing in the prevention of coronary heart disease events	PLOS ONE			English	Article							COST-EFFECTIVENESS; CARDIOVASCULAR-DISEASE; RISK SCORE; PREDICTION	Background The health economic evidence about the value and optimal targeting of genetic testing in the prevention of coronary heart disease (CHD) events has remained limited and ambiguous. The objective of this study is to optimize the population-level use and targeting of genetic testing alongside traditional risk factors in the prevention of CHD events and, thereby, to assess the cost-benefit of genetic testing. Methods and findings We compare several strategies for using traditional and genetic testing in the prevention of CHD through statin therapy. The targeting of tests to different patient segments within these strategies is optimized by using a decision-analytic model, in which a patient's estimated risk of CHD is updated based on test results using Bayesian methods. We adopt the perspective of healthcare sector. The data for the model is exceptionally wide and combined from national healthcare registers, the Finnish Institute for Molecular Medicine, and published literature. Our results suggest that targeting genetic testing in an optimal way to those patients about which traditional risk factors do not provide sufficiently accurate information results in the highest expected net benefit. In particular, compared to the use of traditional risk factors only, the optimal use of genetic testing would decrease the expected costs of an average patient aged 45 years or more by 2.54(sic) in a 10-year follow-up period while maintaining the level of the expected health outcome. Thus, genetic testing is found to be a part of a cost-beneficial testing strategy alongside traditional risk factors. This conclusion is robust to reasonable changes in model inputs. Conclusions If targeted optimally, the use of genetic testing alongside traditional risk factors is cost-beneficial in the prevention of CHD.	[Hynninen, Yrjana] Aalto Univ, Sch Sci, Dept Math & Syst Anal, Espoo, Finland; [Linna, Miika] Aalto Univ, Inst Healthcare Engn Management & Architecture, Sch Sci, Dept Ind Engn & Management, Espoo, Finland; [Vilkkumaa, Eeva] Aalto Univ, Sch Business, Dept Informat & Serv Management, Helsinki, Finland	Aalto University; Aalto University; Aalto University	Hynninen, Y (corresponding author), Aalto Univ, Sch Sci, Dept Math & Syst Anal, Espoo, Finland.	yrjana.hynninen@gmail.com		Hynninen, Yrjana/0000-0001-9224-7171; Vilkkumaa, Eeva/0000-0002-4217-8697	Aalto University; SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation) [534/14]; Academy of Finland; PVN project of the Strategic Research Council of the Academy of Finland [293446]	Aalto University; SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation); Academy of Finland(Academy of Finland); PVN project of the Strategic Research Council of the Academy of Finland	Financial support for this study was provided in part by a contract with Aalto University (YH, ML, EV), in part by a grant from the SalWe Research Program for GET IT DONE (Tekes - the Finnish Funding Agency for Technology and Innovation grant 534/14; https://www.tekes.fi/) (ML), and in part by a grant from the Academy of Finland's IMPRO project (https://www.stnimpro.fi/) (ML). This research has been partly supported by the PVN project, funding decision 293446 of the Strategic Research Council of the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio E, 2015, ATHEROSCLEROSIS, V239, P240, DOI 10.1016/j.atherosclerosis.2014.12.059; Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Borodulin K, 2013, STATISTICS; BORODULIN K, 2016, KANSALLINEN FINRISKI, V1, P2013; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Casas JP, 2006, ANN HUM GENET, V70, P145, DOI 10.1111/j.1469-1809.2005.00241.x; Drummond MF, 2005, JOHN; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GENERISK R, 2016, AUG, V10; Gold MR, 1996, COST EFFECTIVENESS I; *GOV COMM DEP, GOVERNMENT AGREES GE, P2017; Grosse SD, 2008, GENET MED, V10, P648, DOI 10.1097GIM.0b013e3181837217; Hujanen T, 2008, DD; HUJANEN T, 2008, TERVEYDENHUOLLON YKS, P2006; Hutchins R, 2015, CIRC-CARDIOVASC QUAL, V8, P155, DOI 10.1161/CIRCOUTCOMES.114.001240; Ingles J, 2014, TRENDS CARDIOVAS MED, V24, P217, DOI 10.1016/j.tcm.2014.05.009; INOUYE M, 2018, MJ, V500; Inouye M, 2018, HEALTH CARE PRICE IN; Jarmul J, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004171; KAPIAINEN S, 2016, TERVEYDEN JA HYVINVO, V1, P1; Kattainen E, 2005, INT J TECHNOL ASSESS, V21, P172, DOI 10.1017/S0266462305050233; KATTAINEN E, 2004, A LONGITUDINAL RESEA; Kattainen E, 2005, THL RAPORTTI 68 2012, V2, P172; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kiviniemi V, 2011, EUR J CLIN PHARMACOL, V67, P971, DOI 10.1007/s00228-011-1037-0; Mushlin AI, 2001, LANCET, V358, P1353, DOI 10.1016/S0140-6736(01)06417-0; *NAT I HLTH WELF, 2016, NATIONAL CARDIOVASCU, V3; National Institute for Health and Welfare, FFF; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Palomaki GE, 2010, GENET MED, V12, P772, DOI 10.1097/GIM.0b013e3181f8728d; Peura P, 2008, CURR MED RES OPIN, V24, P1823, DOI 10.1185/03007990802144705; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Ruas J., 2018, DD; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Statistics Finland, 2017, PRESS; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Thanassoulis G, 2012, CIRC-CARDIOVASC GENE, V5, P113, DOI 10.1161/CIRCGENETICS.111.961342; Tikkanen E, 2013, ARTERIOSCL THROM VAS, V33, P2261, DOI 10.1161/ATVBAHA.112.301120; Vartiainen E., 2007, FIN MED J, V48, P4507; WHO, 2013, ORGANIZATION; WHO, 2016, CARDIOVASCULAR DISEA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wordsworth S, 2010, EUR HEART J, V31, P926, DOI 10.1093/eurheartj/ehq067; *WORK SET FINN MED, 2016, CURRENT CARE GUIDELI, V2, P2014	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210010	10.1371/journal.pone.0210010	http://dx.doi.org/10.1371/journal.pone.0210010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645616	Green Published, gold			2022-12-27	WOS:000455810200016
J	Sartor, ITS; Recamonde-Mendoza, M; Ashton-Prolla, P				Sauthier Sartor, Ivaine Tais; Recamonde-Mendoza, Mariana; Ashton-Prolla, Patricia			TULP3: A potential biomarker in colorectal cancer?	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPHATIC INVASION; CARCINOMA; COLON; POLYPS; CELLS; WNT	Colorectal cancer (CRC) is the second most common cancer in women and the third most common cancer in men globally. The identification of differentially expressed genes associated to patient's clinical data may represent a useful approach to find important genes in CRC carcinogenesis. Previously, the TULP3 transcription factor was identified as a possible prognostic biomarker in pancreatic ductal adenocarcinoma. Considering that pancreatic and colorectal tissues have the same embryonic origin, we investigated the profile of TULP3 expression in CRC hypothesizing that it may have a role in its development. We comparatively analysed TULP3 gene expression in CRC and normal adjacent colonic tissue and assessed association of expression profiles with survival and clinicopathological information, using publicly available datasets. TULP3 expression levels were increased in CRC when compared to the adjacent non-tumoral tissue. In addition, higher TULP3 gene expression was associated to lymphatic and vascular invasion in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ), respectively. In summary, our results point to a possible role of TULP3 as a diagnostic and prognostic biomarker in CRC. Additional studies are necessary to confirm these preliminary findings.	[Sauthier Sartor, Ivaine Tais; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, PPGBM, Porto Alegre, RS, Brazil; [Sauthier Sartor, Ivaine Tais; Ashton-Prolla, Patricia] HCPA, SPE, LMG, Porto Alegre, RS, Brazil; [Recamonde-Mendoza, Mariana] Univ Fed Rio Grande do Sul, INF, Inst Informat, Dept Informat Aplicada, Porto Alegre, RS, Brazil; [Recamonde-Mendoza, Mariana] Hosp Clin Porto Alegre, Serv Pesquisa Expt, Nucleo Bioinformat, Porto Alegre, RS, Brazil; [Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, DEGEN, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Sartor, ITS (corresponding author), Univ Fed Rio Grande do Sul, PPGBM, Porto Alegre, RS, Brazil.; Sartor, ITS (corresponding author), HCPA, SPE, LMG, Porto Alegre, RS, Brazil.	ivaine.sauthier@gmail.com	Sartor, Ivaine/AAR-1856-2021; Ashton-Prolla, Patricia/T-3515-2019; Recamonde Mendoza, Mariana/F-6818-2015; Ashton-Prolla, Patricia/H-2927-2012	Sartor, Ivaine/0000-0002-8775-6622; Recamonde Mendoza, Mariana/0000-0003-2800-1032; 	Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre [FIPE-HCPA 16-0032]; FAPERGS [16/2551-0000520-6]; I. T.S.S scholarship [140045/2015-5, 307826/2017-1]; P.A-P CNPq scholarship [140045/2015-5, 307826/2017-1]	Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre; FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); I. T.S.S scholarship; P.A-P CNPq scholarship	This study was supported in part by grants from Fundo de Incentivo a Pesquisa, Hospital de Clinicas de Porto Alegre (FIPE-HCPA 16-0032), FAPERGS (16/2551-0000520-6), and I. T.S.S. and P.A-P CNPq scholarships (140045/2015-5 and 307826/2017-1).	Alhopuro P, 2012, INT J CANCER, V130, P1558, DOI 10.1002/ijc.26167; Aran D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01027-z; Assumpcao PP, 2016, GASTRIC CANCER, V19, P1024, DOI [10.1007/s10120-015-0539-3, DOI 10.1007/S10120-015-0539-3]; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Cameron DA, 2009, DEV DYNAM, V238, P1140, DOI 10.1002/dvdy.21926; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Costa NR, 2018, LIFE SCI, V199, P188, DOI 10.1016/j.lfs.2018.02.025; COVERLIZZA S, 1989, CANCER-AM CANCER SOC, V64, P1937, DOI 10.1002/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>3.0.CO;2-X; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fausett SR, 2012, WIRES DEV BIOL, V1, P184, DOI 10.1002/wdev.12; Fujii T, 2014, ANTICANCER RES, V34, P3147; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GLOBOCAN, 2018, EST CANC INC MORT PR; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Han T, 2018, BIOMED PHARMACOTHER, V103, P1369, DOI 10.1016/j.biopha.2018.04.190; Harris EI, 2008, AM J SURG PATHOL, V32, P1816, DOI 10.1097/PAS.0b013e3181816083; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Kim TH, 2016, DEVELOPMENT, V143, P554, DOI 10.1242/dev.124891; Koumarianou A, 2014, ANTICANCER RES, V34, P4949; Li CS, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0158-7; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; MULLER S, 1989, GUT, V30, P1385, DOI 10.1136/gut.30.10.1385; Nakagawa N, 2017, GENE DEV, V31, P1679, DOI 10.1101/gad.302679.117; NIVATVONGS S, 1991, DIS COLON RECTUM, V34, P323, DOI 10.1007/BF02050592; Norman RX, 2009, HUM MOL GENET, V18, P1740, DOI 10.1093/hmg/ddp113; Ouchi K, 1996, CANCER, V78, P2313, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2313::AID-CNCR7>3.0.CO;2-N; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Qian XH, 2016, ONCOTARGET, V7, P55377, DOI 10.18632/oncotarget.10553; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Sanz-Pamplona R, 2011, CLIN CANCER RES, V17, P7303, DOI 10.1158/1078-0432.CCR-11-1570; Sartor ITS, 2014, MOL BIOSYST, V10, P1461, DOI 10.1039/c3mb70590k; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Therneau T, 2013, MODELING SURVIVAL DA; Tsukamoto S, 2011, CLIN CANCER RES, V17, P2444, DOI 10.1158/1078-0432.CCR-10-2884; Umbreit C, 2014, ANTICANCER RES, V34, P7061; Xing YW, 2018, ONCOL REP, V39, P2365, DOI 10.3892/or.2018.6324; Yoshida N, 2015, ANTICANCER RES, V35, P4403	40	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210762	10.1371/journal.pone.0210762	http://dx.doi.org/10.1371/journal.pone.0210762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640939	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000046
J	MacCormick, IJC; Williams, BM; Zheng, Y; Li, K; Al-Bander, B; Czanner, S; Cheeseman, R; Willoughby, CE; Brown, EN; Spaeth, GL; Czanner, G				MacCormick, Ian J. C.; Williams, Bryan M.; Zheng, Yalin; Li, Kun; Al-Bander, Baidaa; Czanner, Silvester; Cheeseman, Rob; Willoughby, Colin E.; Brown, Emery N.; Spaeth, George L.; Czanner, Gabriela			Accurate, fast, data efficient and interpretable glaucoma diagnosis with automated spatial analysis of the whole cup to disc profile	PLOS ONE			English	Article							PROSTATE-CANCER	Background Glaucoma is the leading cause of irreversible blindness worldwide. It is a heterogeneous group of conditions with a common optic neuropathy and associated loss of peripheral vision. Both over and under-diagnosis carry high costs in terms of healthcare spending and preventable blindness. The characteristic clinical feature of glaucoma is asymmetrical optic nerve rim narrowing, which is difficult for humans to quantify reliably. Strategies to improve and automate optic disc assessment are therefore needed to prevent sight loss. Methods We developed a novel glaucoma detection algorithm that segments and analyses colour photographs to quantify optic nerve rim consistency around the whole disc at 15-degree intervals. This provides a profile of the cup/disc ratio, in contrast to the vertical cup/disc ratio in common use. We introduce a spatial probabilistic model, to account for the optic nerve shape, we then use this model to derive a disc deformation index and a decision rule for glaucoma. We tested our algorithm on two separate image datasets (ORIGA and RIMONE). Results The spatial algorithm accurately distinguished glaucomatous and healthy discs on internal and external validation (AUROC 99.6% and 91.0% respectively). It achieves this using a dataset 100-times smaller than that required for deep learning algorithms, is flexible to the type of cup and disc segmentation (automated or semi-automated), utilises images with missing data, and is correlated with the disc size (p = 0.02) and the rim-to-disc at the narro-west rim (p<0.001, in external validation). Discussion The spatial probabilistic algorithm is highly accurate, highly data efficient and it extends to any imaging hardware in which the boundaries of cup and disc can be segmented, thus making the algorithm particularly applicable to research into disease mechanisms, and also glaucoma screening in low resource settings.	[MacCormick, Ian J. C.; Williams, Bryan M.; Zheng, Yalin; Czanner, Gabriela] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [MacCormick, Ian J. C.] Univ Edinburgh, Ctr Clin Brain Sci, Chancellors Bldg, Edinburgh, Midlothian, Scotland; [Zheng, Yalin; Cheeseman, Rob; Czanner, Gabriela] Royal Liverpool Univ Hosp NHS Trust, St Pauls Eye Unit, Liverpool, Merseyside, England; [Li, Kun] Taishan Med Sch, Med Informat Engn Dept, Tai An, Shandong, Peoples R China; [Al-Bander, Baidaa] Univ Liverpool, Dept Elect Engn & Elect, Brownlow Hill, Liverpool, Merseyside, England; [Czanner, Silvester] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Fac Sci & Engn, Manchester, Lancs, England; [Willoughby, Colin E.] Ulster Univ, Biomed Sci Res Inst, Fac Life & Hlth Sci, Coleraine, Londonderry, North Ireland; [Willoughby, Colin E.] Royal Victoria Hosp, Dept Ophthalmol, Belfast, Antrim, North Ireland; [Brown, Emery N.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Brown, Emery N.] Harvard Med Sch, Massachusetts Gen Hosp, Anesthesia Crit Care & Pain Med, Boston, MA USA; [Spaeth, George L.] Wills Eye Hosp & Res Inst, Glaucoma Res Ctr, Philadelphia, PA USA; [Czanner, Gabriela] Liverpool John Moores Univ, Fac Engn & Technol, Dept Appl Math, Liverpool, Merseyside, England	University of Liverpool; University of Edinburgh; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Liverpool; Manchester Metropolitan University; Ulster University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Jefferson University; Liverpool John Moores University	Czanner, G (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England.; Czanner, G (corresponding author), Royal Liverpool Univ Hosp NHS Trust, St Pauls Eye Unit, Liverpool, Merseyside, England.; Czanner, G (corresponding author), Liverpool John Moores Univ, Fac Engn & Technol, Dept Appl Math, Liverpool, Merseyside, England.	g.czanner@ljmu.ac.uk	MacCormick, Ian/GPW-8622-2022; Al-Bander, Baidaa/F-3116-2019; MacCormick, Ian JC/AFW-1885-2022; Williams, Bryan/ABE-7633-2021; Czanner, Gabriela/ABC-7569-2021	MacCormick, Ian/0000-0002-8171-0332; Al-Bander, Baidaa/0000-0002-2518-7364; MacCormick, Ian JC/0000-0002-8171-0332; Williams, Bryan/0000-0001-5930-287X; Czanner, Gabriela/0000-0002-1157-2093; Willoughby, Colin/0000-0002-1246-4166	 [EP/N014499/1]; EPSRC [EP/N014499/1] Funding Source: UKRI	; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	GC received funding from: Grant EP/N014499/1 (https://epsrc.ukri.org/research/ourportfolio/themes/healthcaretechnologies/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bander B, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10040087; [Anonymous], 2016, OPHTHALMIC SERVICES; Barrett C., 2018, OPHTHALMIC PHYSL OPT; Bayer A, 2002, AM J OPHTHALMOL, V133, P758, DOI 10.1016/S0002-9394(02)01422-8; Brant LJ, 2003, J R STAT SOC A STAT, V166, P51, DOI 10.1111/1467-985X.00258; Cheng J, 2017, BIOMED OPT EXPRESS, V8, P3763, DOI 10.1364/BOE.8.003763; Efron B., 2016, COMPUTER AGE STAT IN, V5; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fumero F., 2015, WSCG C COMP GRAPH VI; Fumero F., 2011, P IEEE S COMP BAS ME; George D, 2017, SCIENCE, V358, DOI 10.1126/science.aag2612; Harizman N., 2016, ARCH OPHTHALMOL-CHIC, V124, P1579; Hildebrand GD, 2010, ARCH OPHTHALMOL-CHIC, V128, P1625, DOI 10.1001/archophthalmol.2010.291; Huang G., DENSELY CONNECTED CO; Hughes D., 2016, STAT METHODS MED RES, V27, P2060; Li Z., 2018, OPHTHALMOL; Lindquist MA, 2008, STAT SCI, V23, P439, DOI 10.1214/09-STS282; MacCormick IJC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16620-x; Mahalanobis P. C., 1927, J ASIATIC SOC BENGAL, V23, P301; Medeiros FA, 2015, BRIT J OPHTHALMOL, V99, P599, DOI 10.1136/bjophthalmol-2014-305550; Miller SE, 2017, AM J OPHTHALMOL, V182, P99, DOI 10.1016/j.ajo.2017.07.010; Morrell CH, 2012, J APPL STAT, V39, P1151, DOI 10.1080/02664763.2011.644523; Oleskiw TD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02438-8; Shelhamer E., 2017, IEEE T PATTERN ANAL; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Spaeth George L, 2002, Trans Am Ophthalmol Soc, V100, P181; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tuulonen A, 2011, CURR OPIN OPHTHALMOL, V22, P102, DOI 10.1097/ICU.0b013e3283437bf0; Vernon SA, 2001, EYE, V15, P458, DOI 10.1038/eye.2001.155; Zhang Z., 2010, C P ANN INT C IEEE E	30	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209409	10.1371/journal.pone.0209409	http://dx.doi.org/10.1371/journal.pone.0209409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629635	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000455483000024
J	Perslev, K; Msemo, OA; Minja, DTR; Moller, SL; Theander, TG; Lusingu, JPA; Bygbjerg, IC; Nielsen, BB; Schmiegelow, C				Perslev, K.; Msemo, O. A.; Minja, D. T. R.; Moller, S. L.; Theander, T. G.; Lusingu, J. P. A.; Bygbjerg, I. C.; Nielsen, B. B.; Schmiegelow, C.			Marked reduction in fertility among African women with urogenital infections: A prospective cohort study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INFERTILITY CARE; REPRODUCTIVE TECHNOLOGIES; ASSOCIATION; ACCESS; AGE; CONSEQUENCES; PREVALENCE; MANAGEMENT; PREGNANCY	Background There is paucity of data on risk factors for reduced fertility in low-income countries. Objective To investigate factors associated with fertility among women in rural north eastern Tanzania. Subjects and methods A cohort of 1248 non-pregnant women was followed with urine pregnancy testing every third month or more regularly if they reported a missed menstrual period. Pregnancy was confirmed with trans-abdominal ultrasound. Information regarding general health, socioeconomic status and obstetric-gynaecological history was collected. Factors associated with conceiving within 180 days were identified using multivariate logistic regression analyses. Results Among the 1248 women, 736 were followed for 180 days and 209 of these had an ultra-sound confirmed pregnancy. During the follow-up period, 169/736 women were diagnosed with urogenital infections, including suspected sexually transmitted or reproductive tract infections, urinary tract infection, and vaginal candidiasis. Urogenital infections were significantly associated with reduced odds of conceiving within 180 days (adjusted OR (AOR) 00.21, 95% CI 0.11-0.36). Being above 30 years of age was also negatively associated with odds of conceiving (AOR 0.45, 95% CI 0.26-0.77). In contrast, women who recently stopped using hormonal contraceptives (AOR 2.86, 95% CI 1.45-5.70) and women with low socioeconomic status (AOR 1.56, 95% CI 1.04-2.33) were significantly more likely to become pregnant within 180 days. Conclusion Urogenital infection seems to be a major health factor associated with reduced chances of conceiving. Considering the availability of effective treatment options for these diseases, public health authorities should increase awareness of diagnostic tools in settings with limited resources in order to improve fertility.	[Perslev, K.; Theander, T. G.; Lusingu, J. P. A.; Schmiegelow, C.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Msemo, O. A.; Minja, D. T. R.; Lusingu, J. P. A.] Natl Inst Med Res, Korogwe, Tanga, Tanzania; [Moller, S. L.; Bygbjerg, I. C.] Univ Copenhagen, Dept Publ Hlth, Div Global Hlth, Copenhagen, Denmark; [Nielsen, B. B.] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Perslev, K (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	kperslev@hotmail.com	Lusingu, John P. A./GSJ-3228-2022; Theander, Thor G./F-6714-2015	Lusingu, John P. A./0000-0002-9407-0602; perslev, kathrine/0000-0001-5201-8171; shmiegelow, christentze/0000-0002-9360-9741; Theander, Thor G./0000-0002-3509-7514; ABDUL, OMARI/0000-0002-7728-0149; Bygbjerg, Ib/0000-0001-9100-2754	Danish Council for Strategic Research [1309-00003B]; Lundbeck Foundation [R209-2015-3580]; Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden; NIMR-Tanga Center, Joint Malaria Programme	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden; NIMR-Tanga Center, Joint Malaria Programme	This study received funding from the Danish Council for Strategic Research (http://ufm.dk/en/research-and-innovation/councils-andcommissions/formercouncilsandcommissions/the-danish-council-for-strategicresearch) with grant number 1309-00003B received by ICB. The funders had no role in study design, data collection and analysis or preparation of this manuscript. Christentze Schmiegelow was also funded by the Lundbeck Foundation [R209-2015-3580] and Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Fonden.; Locally this project was made possible by the help and support from the NIMR-Tanga Center, Joint Malaria Programme, and the administration at Korogwe District hospital. We are grateful to all study participants and the project team in Tanzania including all nurses, fieldworkers, drivers, clinicians, laboratory technicians, data entry clerks, administration, and research assistants, for the hard work and unprecedented commitment on this study.	Adegbola O, 2013, NIGERIA AFR HLTH SCI, V13, P1126, DOI DOI 10.4314/AHS.V13I4.37; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012; Asemota OA, 2015, SEMIN REPROD MED, V33, P17, DOI 10.1055/s-0034-1395274; Augood C, 1998, HUM REPROD, V13, P1532, DOI 10.1093/humrep/13.6.1532; Ayele DG, 2015, AFR HEALTH SCI, V15, P546, DOI 10.4314/ahs.v15i2.29; Bahamondes L, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-87; Basso O, 1997, HUM REPROD, V12, P1448, DOI 10.1093/humrep/12.7.1448; Best D, 2015, HORM MOL BIOL CLIN I, V24, P5, DOI 10.1515/hmbci-2015-0023; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Borghtb MV WC, 2018, CLIN BIOCH; Bygbjerg I, FOETAL EXPOSURE EPID; CATES W, 1985, LANCET, V2, P596; Crawford NM, 2015, OBSTET GYN CLIN N AM, V42, P15, DOI 10.1016/j.ogc.2014.09.005; Darwish O A, 1979, Egypt Popul Fam Plann Rev, V13, P1; Department of Reproductive Health and Research World Health Organization, 2011, UNS AB GLOB REG EST; Ericksen K, 1996, SOC SCI MED, V42, P209, DOI 10.1016/0277-9536(95)00087-9; Famurewa O, 2013, AFR HEALTH SCI, V13, P441, DOI 10.4314/ahs.v13i2.34; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P570, DOI 10.1097/OLQ.0b013e3181a866b8; Gottlieb SL, 2013, INT J GYNECOL OBSTET, V123, P183, DOI 10.1016/j.ijgo.2013.09.013; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hollos M, 2014, HUM FERTIL, V17, P188, DOI 10.3109/14647273.2014.936052; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Kucera R, 2016, GYNECOL ENDOCRINOL, V32, P383, DOI 10.3109/09513590.2015.1121981; Li YQ, 2014, GYNECOL OBSTET INVES, V77, P19, DOI 10.1159/000355112; Manoni F, 2012, CLIN CHEM LAB MED, V50, P679, DOI [10.1515/cclm.2011.823, 10.1515/CCLM.2011.823]; Mascarenhas MN, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-17; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Mikkelsen EM, 2016, BMJ-BRIT MED J, V354, pi4262; Msuya S E, 2002, East Afr Med J, V79, P16; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; Ombelet W, 2011, FACTS VIEWS VIS OBGY, V3, P257; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Polis CB, 2017, HUM REPROD, V32, P1064, DOI 10.1093/humrep/dex025; Rouchou B, 2013, PERSPECT PUBLIC HEAL, V133, P174, DOI 10.1177/1757913912472415; Tann CJ, 2006, SEX TRANSM INFECT, V82, P285, DOI 10.1136/sti.2005.014845; Van Balen F, 2008, HUM REPROD, P25, DOI 10.1093/humrep/den141; Vitale SG, 2015, CURR OPIN OBSTET GYN, V27, P432, DOI 10.1097/GCO.0000000000000220; WHO, POINT CAR DIAGN TEST; World Health Organization, INF DEF TERM; World Health Organization, REPR HLTH; World Health Organization (WHO), 2004, DEM HLTH SURV DHS CO, V9	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210421	10.1371/journal.pone.0210421	http://dx.doi.org/10.1371/journal.pone.0210421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629655	Green Published, gold			2022-12-27	WOS:000455483000086
J	Severnini, E				Severnini, Edson			The unintended impact of ecosystem preservation on greenhouse gas emissions: Evidence from environmental constraints on hydropower development in the United States	PLOS ONE			English	Article							HYDROELECTRIC RESERVOIRS; POWER; IDENTIFICATION; ECONOMICS; RIVER; COST; COAL	Many countries have passed environmental laws aiming at preserving natural ecosystems, such as the Endangered Species Act of 1973 in the United States. Although those regulations seem to have improved preservation, they may have had unintended consequences in energy production. Here we show that while environmental constraints on hydropower may have preserved the wilderness and wildlife by restricting the development of hydroelectric projects, they led to more greenhouse gas emissions. Environmental regulations gave rise to a replacement of hydropower, which is a renewable, relatively low-emitting source of energy, with conventional fossil-fuel power, which is highly polluting. Our estimates indicate that, on average, each megawatt of fossil fuel power-generating capacity added to the grid because of environmental constraints on hydropower development led to an increase in annual carbon dioxide emissions of about 1,400 tons. Environmental regulations focusing only on the preservation of ecosystems appear to have encouraged electric utilities to substitute dirtier fuels for hydropower in electricity generation.	[Severnini, Edson] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Severnini, Edson] IZA, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Severnini, E (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.; Severnini, E (corresponding author), IZA, Pittsburgh, PA 15213 USA.	edsons@andrew.cmu.edu		Severnini, Edson/0000-0002-0166-4250				[Anonymous], 2003, 9844 NBER; Atack J., 2016, HIST GEOGRAPHIC INFO; Banzhaf S, 2008, AM ECON REV, V98, P843, DOI 10.1257/aer.98.3.843; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Baum-Snow N, 2007, Q J ECON, V122, P775, DOI 10.1162/qjec.122.2.775; Borenstein S, 2012, J ECON PERSPECT, V26, P67, DOI 10.1257/jep.26.1.67; Brown GM, 1998, J ECON PERSPECT, V12, P3, DOI 10.1257/jep.12.3.3; CALZONETTI FJ, 1980, ENERG POLICY, V8, P138, DOI 10.1016/0301-4215(80)90006-3; Casey JA, 2018, AM J EPIDEMIOL, V187, P1586, DOI 10.1093/aje/kwy110; Casey JA, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0388-8; Cirillo R.R., 1977, EVALUATION REGIONAL; Conner A.M., 1998, US HYDROPOWER RESOUR; Davis LW, 2011, REV ECON STAT, V93, P1391, DOI 10.1162/REST_a_00119; de Faria FAM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124019; Deemer BR, 2016, BIOSCIENCE, V66, P949, DOI 10.1093/biosci/biw117; Demarty M, ENERGY POLICY, V39, P4197; Diamond R, 2016, AM ECON REV, V106, P479, DOI 10.1257/aer.20131706; Edwards BK, 1999, LAND ECON, V75, P267, DOI 10.2307/3147010; Emissions and Generation Resource Integrated Database (eGRID), 2014, EGRID2014; Fairley P, 2017, NATURE, V551, pS150, DOI 10.1038/d41586-017-07511-2; Fearnside PM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/1/011002; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Fowlie ML, 2009, AM ECON J-ECON POLIC, V1, P72, DOI 10.1257/pol.1.2.72; Giles J, 2006, NATURE, V444, P524, DOI 10.1038/444524a; Greenstone M, 2010, J POLIT ECON, V118, P536, DOI 10.1086/653714; HAMILTON MS, 1979, NAT RESOUR J, V19, P75; Harpman DA, 1999, LAND ECON, V75, P390, DOI 10.2307/3147185; Hu YA, 2013, NAT CLIM CHANGE, V3, P708, DOI 10.1038/NCLIMATE1831; Huppert DD, 1999, CONTEMP ECON POLICY, V17, P476, DOI 10.1111/j.1465-7287.1999.tb00698.x; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; INL, 1998, US HYDR RES ASS; Kosnik L, 2010, LAND ECON, V86, P444, DOI 10.3368/le.86.3.444; Kotchen MJ, 2006, LAND ECON, V82, P384, DOI 10.3368/le.82.3.384; Mas-Colell A., 1995, MICROECONOMIC THEORY; Mendelsohn R, 2009, ANNU REV ENV RESOUR, V34, P325, DOI [10.1146/annurev-environ-011509-135201, 10.1146/annurev.environ.011509-135201]; Michaels G, 2008, REV ECON STAT, V90, P683, DOI 10.1162/rest.90.4.683; Pociask S, 2011, PROGR DENIED STUDY P; Rasanen TA, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa817; Rhodes JD, 2017, ENERG POLICY, V102, P491, DOI 10.1016/j.enpol.2016.12.025; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Severnini E, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.51; Shilling F, 1997, SCIENCE, V276, P1662, DOI 10.1126/science.276.5319.1662; Sovacool BK, 2009, ENERG POLICY, V37, P2241, DOI 10.1016/j.enpol.2009.02.011; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Stokstad E, 2005, SCIENCE, V309, P2150, DOI 10.1126/science.309.5744.2150; Sutton A, 2004, GEOGRAPHY, V89, P111; Tarlock AD, 1972, SOUTH CALIF LAW REV, V45, P502; The Energy Policy Staff, 1968, CONS AFF STEAM POW P; U. S. Department of Energy, 1995, DOEEIS0170 BONN POW; U. S. Department of the Interior, 1995, OP GLEN CAN DAM FIN; U. S. Environmental Protection Agency (EPA), 430R18003 US EPA; Ulibarri N, 2018, J ENVIRON PLANN MAN, V61, P617, DOI 10.1080/09640568.2017.1327845; Union of Concerned Scientists (UCS), ENV IMP WIND POW; Upton J., 2014, SOLAR FARMS THREATEN; Wehrli B, 2011, NAT GEOSCI, V4, P585, DOI 10.1038/ngeo1226; Willis CKR, 2010, ENERG POLICY, V38, P2067, DOI 10.1016/j.enpol.2009.08.034; Yang MZ, 2018, J ENVIRON ECON MANAG, V90, P269, DOI 10.1016/j.jeem.2018.05.005	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210483	10.1371/journal.pone.0210483	http://dx.doi.org/10.1371/journal.pone.0210483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629678	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000095
J	Valenza, F; Cittaro, D; Stupka, E; Biancolini, D; Patricelli, MG; Bonanomi, D; Lazarevic, D				Valenza, Fabiola; Cittaro, Davide; Stupka, Elia; Biancolini, Donatella; Patricelli, Maria Grazia; Bonanomi, Dario; Lazarevic, Dejan			A novel truncating variant of GLI2 associated with Culler-Jones syndrome impairs Hedgehog signalling	PLOS ONE			English	Article							PITUITARY ANOMALIES; MUTATIONS; HYPOPITUITARISM; PHENOTYPE; FRAMEWORK; PROTEINS; GENOME; DOMAIN; GENE	Background GLI2 encodes for a transcription factor that controls the expression of several genes in the Hedgehog pathway. Mutations in GLI2 have been described as causative of a spectrum of clinical phenotypes, notably holoprosencephaly, hypopituitarism and postaxial polydactyl. Methods In order to identify causative genetic variant, we performed exome sequencing of a trio from an Italian family with multiple affected individuals presenting clinical phenotypes in the Culler-Jones syndrome spectrum. We performed a series of cell-based assays to test the functional properties of mutant GLI2. Results Here we report a novel deletion c.3493delC (p.P1167LfsX52) in the C-terminal activation domain of GLI2. Functional assays confirmed the pathogenicity of the identified variant and revealed a dominant-negative effect of mutant GLI2 on Hedgehog signalling. Conclusions Our results highlight the variable clinical manifestation of GLI2 mutations and emphasize the value of functional characterisation of novel gene variants to assist genetic counselling and diagnosis.	[Valenza, Fabiola; Bonanomi, Dario] IRCSS San Raffaele Sci Inst, Div Neurosci, Mol Neurobiol Lab, Milan, Italy; [Cittaro, Davide; Stupka, Elia; Biancolini, Donatella; Lazarevic, Dejan] IRCSS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy; [Stupka, Elia] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Patricelli, Maria Grazia] IRCSS San Raffaele Sci Inst, Mol Biol & Citogenet, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Lazarevic, D (corresponding author), IRCSS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy.	lazarevic.dejan@hsr.it	Lazarevic, Dejan/AAN-1861-2020; Bonanomi, Dario/K-3450-2016; Cittaro, Davide/K-2405-2018; Biancolini, Donatella/AAN-4924-2020	Bonanomi, Dario/0000-0003-4517-1244; Cittaro, Davide/0000-0003-0384-3700; lazarevic, dejan/0000-0003-4527-290X	European Research Council under the European Union's Seventh Framework Programme [(FP7/2007-2013)/ERC-StG 335590 NEVAI]; Career Development Award of the Giovanni Armenise-Harvard Foundation; Italian Ministry of Health	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Career Development Award of the Giovanni Armenise-Harvard Foundation; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC-StG 335590 NEVAI (https://cordis.europa.eu/project/rcn/192565_en.html); Career Development Award of the Giovanni Armenise-Harvard Foundation (http://www.armeniseharvard.org/portfolio-articoli/dario-bonanomi/) and 5x1000 from Italian Ministry of Health (http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=4227&area=Ricerca%20sanitaria&menu=vuoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Arnhold IJP, 2015, J MOL ENDOCRINOL, V54, pR141, DOI 10.1530/JME-15-0009; Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Bear KA, 2015, AM J MED GENET A, V167, P2491, DOI 10.1002/ajmg.a.37160; Bear KA, 2014, J MED GENET, V51, P413, DOI 10.1136/jmedgenet-2013-102249; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Flemming GMC, 2013, J CLIN ENDOCR METAB, V98, pE567, DOI 10.1210/jc.2012-3224; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heavner W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008391; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Kordass U, 2015, AM J MED GENET A, V167, P1121, DOI 10.1002/ajmg.a.36972; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Park HL, 2000, DEVELOPMENT, V127, P1593; Paulo SS, 2015, CLIN ENDOCRINOL, V82, P562, DOI 10.1111/cen.12565; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Rahimov F, 2006, AM J MED GENET A, V140A, P2571, DOI 10.1002/ajmg.a.31370; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Treier M, 2001, DEVELOPMENT, V128, P377; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xavier GM, 2016, DEV BIOL, V415, P198, DOI 10.1016/j.ydbio.2016.02.009; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/NMETH.3484, 10.1038/nmeth.3484]	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210097	10.1371/journal.pone.0210097	http://dx.doi.org/10.1371/journal.pone.0210097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629636	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000049
J	Xu, CY; Huang, Q; Ge, XH; Li, ZY				Xu, Chuanyuan; Huang, Qian; Ge, Xianhong; Li, Zaiyun			Phenotypic, cytogenetic, and molecular marker analysis of Brassica napus introgressants derived from an intergeneric hybridization with Orychophragmus	PLOS ONE			English	Article							INTERTRIBAL PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; DOSAGE COMPENSATION; HEXAPLOID OAT; C-GENOME; GENE; WHEAT; RAPA; CROSSES; VIOLACEUS	Aneuploids of a single species that have lost or gained different chromosomes are useful for genomic analysis. The polyploid nature of many crops including oilseed rape (Brassica napus) allows these plants to tolerate the loss of individual chromosomes from homologous pairs, thus facilitating the development of aneuploid lines. Here, we selected 39 lines from advanced generations of an intergeneric hybridization between Brassica rapa and Orychophragmus violaceus with accidental pollination by B. napus. The lines showed a wide spectrum of phenotypic variations, with some traits specific to O. violaceus. Most lines had the same chromosome number (2n = 38) as B. napus. However, we also identified B. napus nulli-tetrasomics with 22 A-genome and 16 C-genome chromosomes and lines with the typical B. napus complement of 20 A-genome and 18 C-genome chromosomes, as revealed by FISH analysis using a C-genome specific probe. Other lines had 2n = 37 or 39 chromosomes, with variable numbers of A- or C-genome chromosomes. The formation of quadrivalents by four A-genome chromosomes with similar shapes suggests that they were derived from the same chromosome. The frequent homoeologous pairing between chromosomes of the A and C genomes points to their non-diploidized meiotic behavior. Sequence-related amplified polymorphism (SRAP) analysis revealed substantial genomic changes of the lines compared to B. rapa associated with O. violaceus specific DNA bands, but only a few genes were identified in these bands by DNA sequencing. These novel B. napus aneuploids and introgressants represent unique tools for studies of Brassica genetics and for Brassica breeding projects.	[Xu, Chuanyuan; Huang, Qian; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Xu, Chuanyuan] North China Univ Sci & Technol, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Huang, Qian] CAAS, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crops Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; North China University of Science & Technology; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	gexianhong@mail.hzau.edu.cn			National Key Research and Development Program of China [2016YFD0100202]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China to XH (grant no. 2016YFD0100202, http://service.most.gov.cn/2015tztg_all/20160622/1104.html).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAGONCILLO C, 1978, P NATL ACAD SCI USA, V75, P1446, DOI 10.1073/pnas.75.3.1446; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Boyd LA, 2006, PLANT PATHOL, V55, P475, DOI 10.1111/j.1365-3059.2006.01402.x; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2001, GENOME, V44, P738, DOI 10.1139/gen-44-4-738; CHENG BF, 1994, GENOME, V37, P584, DOI 10.1139/g94-083; Cheng DW, 2002, GENOME, V45, P100, DOI 10.1139/g01-135; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; FAN ZG, 1985, CAN J GENET CYTOL, V27, P683, DOI 10.1139/g85-102; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; GALILI G, 1986, P NATL ACAD SCI USA, V83, P6524, DOI 10.1073/pnas.83.17.6524; Garg M, 2007, THEOR APPL GENET, V114, P1141, DOI 10.1007/s00122-007-0506-4; Grant G, 2010, LEARNING DISABILITY, P43; Heneen WK, 2012, ANN BOT-LONDON, V109, P1227, DOI 10.1093/aob/mcs052; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; Hua YW, 2006, PLANT BREEDING, V125, P144, DOI 10.1111/j.1439-0523.2006.01200.x; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Khush G, 1973, CYTOGENETICS ANEUPLO; Kianian SF, 1997, GENOME, V40, P386, DOI 10.1139/g97-052; Leflon M, 2010, PLANT CELL, V22, P2253, DOI 10.1105/tpc.110.075986; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li Z, 1999, THEOR APPL GENET, V99, P694, DOI 10.1007/s001220051286; Li Z, 1998, THEOR APPL GENET, V96, P251, DOI 10.1007/s001220050734; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Makarevitch I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-7; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Schwarzacher T, 2000, PRACTICAL SITU HYBRI, P35; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Thorneycroft D, 2003, PLANT BIOTECHNOL J, V1, P259, DOI 10.1046/j.1467-7652.2003.00025.x; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; WILLS AB, 1966, CARYOLOGIA, V19, P103, DOI 10.1080/00087114.1966.10796209; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Xu CY, 2007, J GENET, V86, P249, DOI 10.1007/s12041-007-0032-9; Zhang A, 2010, PLANT PHYSIOL, V175, P828; Zhu B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00377; Zhu B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00763; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	50	3	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210518	10.1371/journal.pone.0210518	http://dx.doi.org/10.1371/journal.pone.0210518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629679	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000099
J	Yang, ZG; Zhou, JY; Wei, BH; Cheng, YX; Zhang, L; Zhen, XM				Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin			Comparative transcriptome analysis reveals osmotic-regulated genes in the gill of Chinese mitten crab (Eriocheir sinensis)	PLOS ONE			English	Article							LONG-TERM EXPOSURE; POSTERIOR GILLS; H+-ATPASE; SALINITY; OSMOREGULATION; DOPAMINE; DECAPODA; NA+,K+-ATPASE; TEMPERATURE; AMERICANUS	Salinity is one of the most important abiotic factors directly affecting the reproduction, molting, growth, immune, physiological and metabolic activities of Chinese mitten crab (Eriocheir sinensis). This species has strong osmoregulatory capacity and can maintain stringent internal homeostasis. However, the mechanisms conferring tolerance to salinity fluctuations are not well understood. To reveal the genes and pathways involved in osmoregulation, adult male crabs (body weight = 110 +/- 5 g) were acclimated for 144 h in freshwater (FW, 0 ppt) or seawater (SW, 25 ppt). Changes in the transcriptome of crab gills were then analysed by RNA-Seq, and 174,903 unigenes were obtained. Comparison of genes between FW-SW-acclimated groups identified 932 genes that were significantly differentially expressed in the gill, comprising 433 and 499 up- and downregulated transcripts. Gene Ontology functional enrichment analysis revealed that important biological processes related to salt stress were significantly enriched, including energy metabolism, ion transport, signal transduction and antioxidant activity. Kyoto Encyclopaedia of Genes and Genomes enrichment analysis mapped the differentially expressed genes to 241 specific metabolic pathways, and pathways related to energy metabolism, oxidative phosphorylation and the tricarboxylic acid (TCA)/citrate cycle were significantly enriched. Salinity stress altered the expression of many enzymes involved in energy metabolism, ion transport, signal transduction and antioxidant pathways, including citrate synthase (CS), Na+/K+-ATPase (NKA), Na+-K+-2Cl cotran-sporter-1 (NKCC1), dopamine receptor D1 (DRD1), synaptic binding protein 1 (STXBP1), Cu2+/Zn2+ superoxide dismutase (SOD1) and glutathione S-transferase (GST). Additionally, the obtained transcriptomic sequencing data provided a useful resource for identification of novel genes, and further physiological analysis of Chinese mitten crab.	[Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Minist Agr, CREEFN, Shanghai, Peoples R China; [Yang, Zhigang; Zhou, Junyu; Wei, Banghong; Cheng, Yongxu; Zhang, Long; Zhen, Xiaomin] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.; Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Minist Agr, CREEFN, Shanghai, Peoples R China.; Yang, ZG; Cheng, YX (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.	zgyang@shou.edu.cn; chengyongxucrablab6@hotmail.com	Wei, Banghong/AAT-5451-2020		National Natural Science Foundation of China [31472287]; China Agriculture Research System-48	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-48	National Natural Science Foundation of China [grant number 31472287] and the China Agriculture Research System-48 are all the funding of support received during this study; there is no additional external funding received for this study.	Mejia SA, 2018, EUR J PHARMACOL, V818, P499, DOI 10.1016/j.ejphar.2017.10.048; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; BARRA JA, 1983, TISSUE CELL, V15, P583, DOI 10.1016/0040-8166(83)90009-5; Belli NM, 2009, COMP BIOCHEM PHYS A, V152, P431, DOI 10.1016/j.cbpa.2008.11.017; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Castilho PC, 2001, J EXP MAR BIOL ECOL, V256, P215, DOI 10.1016/S0022-0981(00)00315-4; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Chen GH, 2007, NEUROBIOL AGING, V28, P611, DOI 10.1016/j.neurobiolaging.2006.03.001; Chen JC, 1997, COMP BIOCHEM PHYS A, V117, P239, DOI 10.1016/S0300-9629(96)00237-X; Cheng YX, 2008, REV FISH SCI, V16, P377, DOI 10.1080/10641260701681698; Cutler CP, 2002, BBA-BIOMEMBRANES, V1566, P92, DOI 10.1016/S0005-2736(02)00596-5; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; DALLA VIA GJ, 1987, COMP BIOCHEM PHYS A, V88, P299; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; Evans David H., 2010, J EXPT ZOOLOGY A, V293, P336, DOI [10.1002/jez.1857, DOI 10.1002/JEZ.1857]; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; GILLES R, 1988, COMP BIOCHEM PHYS A, V90, P201, DOI 10.1016/0300-9629(88)91028-6; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Jia XiaoYan, 2012, Journal of Fisheries of China, V36, P91; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kultz D, 2007, J EXP BIOL, V210, P1593, DOI 10.1242/jeb.000141; KUTTY MN, 1971, MAR BIOL, V11, P125; LA H, 2008, J BIOL CHEM, V283, P36441; Leguen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139938; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Liu SS, 2017, FISH SHELLFISH IMMUN, V60, P545, DOI 10.1016/j.fsi.2016.07.033; Liu Y, 2007, AQUACULTURE, V265, P351, DOI 10.1016/j.aquaculture.2007.02.010; Long XW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179036; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; Mendonca NN, 2007, COMP BIOCHEM PHYS A, V146, P534, DOI 10.1016/j.cbpa.2006.01.019; Mo JL, 2003, J CRUSTACEAN BIOL, V23, P505; Onken H, 1999, COMP BIOCHEM PHYS A, V123, P377, DOI 10.1016/S1095-6433(99)00078-1; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; PEQUEUX A, 1984, MAR BIOL LETT, V5, P35; Rathmayer M, 2001, J COMP PHYSIOL B, V171, P271, DOI 10.1007/s003600100173; RIESTENPATT S, 1995, COMP BIOCHEM PHYS A, V110, P235, DOI 10.1016/0300-9629(94)00169-T; Roast SD, 2002, MAR ENVIRON RES, V53, P453, DOI 10.1016/S0141-1136(02)00090-9; Rudneva II, 1997, COMP BIOCHEM PHYS C, V118, P255, DOI 10.1016/S0742-8413(97)00111-4; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Schnarrenberger C, 2010, FEBS J, V269, P868, DOI [10.1046/j.0014-2956.2001, DOI 10.1046/J.0014-2956.2001]; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; STRANGE PG, 1991, TRENDS PHARMACOL SCI, V12, P48, DOI 10.1016/0165-6147(91)90494-D; Sui LY, 2009, MAR BIOL, V156, P1573, DOI 10.1007/s00227-009-1193-2; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Wang RF, 2012, CRUSTACEANA, V85, P1431, DOI 10.1163/15685403-00003125; Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yip YY, 2014, J BIOL CHEM, V289, P2157, DOI 10.1074/jbc.M113.470682; Zhang DZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203280; Zhang TL, 2001, J FRESHWATER ECOL, V16, P633, DOI 10.1080/02705060.2001.9663855; Zhang XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173238	57	21	22	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210469	10.1371/journal.pone.0210469	http://dx.doi.org/10.1371/journal.pone.0210469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629688	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000094
J	Zhu, LY; Fu, CZ; Liu, H; Zhao, DD; Su, L; Rehman, H; Ji, SC				Zhu, Lingyu; Fu, Chenzhao; Liu, Hao; Zhao, Dandan; Su, Lei; Rehman, Habibur; Ji, Shengchang			A decoupled circuital model methodology for calculating DC currents in AC grids induced by HVDC grounding current	PLOS ONE			English	Article							POWER-SYSTEM; TRANSFORMER; SIMULATION; SOIL	Large currents are injected into the earth from grounding poles of HVDC systems under monopole ground return mode. The currents change the earth surface potential and result in DC currents in AC systems. This paper proposes a computationally efficient decoupled circuital calculation method for assessing the unwanted DC currents in AC grids. Firstly, the earth resistive network is acquired by simulating the DC grounding current distribution using Finite Element Method (FEM). Secondly, the earth resistive network and AC grid are combined to develop a decoupled circuital model of the overall system. The acquired model is used to calculate the DC currents in AC grids by solving a set of linear equations. The proposed method is computationally more efficient as compared to field-circuit coupled methods. In addition, its accuracy is proved by showing a close agreement between our results and field-circuit coupled model as well as the actual measurements. Finally, in Shanghai area power grid the DC currents are calculated using the proposed technique. Based on these calculations, remedial measures for reducing the DC currents in AC grid are suggested. Our research results indicate that DC currents in AC systems can be reduced by operating the two HVDC projects with opposite polarities.	[Zhu, Lingyu; Ji, Shengchang] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China; [Fu, Chenzhao; Zhao, Dandan; Su, Lei] Shanghai Elect Power Co, Elect Power Res Inst, Shanghai, Peoples R China; [Liu, Hao] State Grid Chengdu Power Supply Co, Chengdu, Sichuan, Peoples R China; [Rehman, Habibur] Amer Univ Sharjah, Sharjah, U Arab Emirates	Xi'an Jiaotong University; Shanghai Electric; American University of Sharjah	Zhu, LY (corresponding author), Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China.	zhuly1026@xjtu.edu.cn	Zhu, Lingyu/AAE-6230-2019; Zhu, Lingyu/A-8077-2013; Rehman, Habibur/AAJ-6402-2021	Zhu, Lingyu/0000-0002-0379-4059; Zhu, Lingyu/0000-0002-0379-4059; Rehman, Habibur/0000-0002-8251-654X				Chou CJ, 2012, IEEE T IND APPL, V48, P1639, DOI 10.1109/TIA.2012.2209622; Etemadi AH, 2014, IEEE T POWER SYST, V29, P2753, DOI 10.1109/TPWRS.2014.2309004; Guihua Mei, 2010, Journal of Electromagnetic Analysis and Applications, V2, P418, DOI 10.4236/jemaa.2010.27054; Hao Z, 2009, ELECT POWER AUTOMATI, P610; He J.-H., 2017, NONLINEAR SCI LETT A, V8, P121; He JL, 2012, IEEE T POWER DELIVER, V27, P1835, DOI 10.1109/TPWRD.2012.2205409; KOVARSKY D, 1988, IEEE T POWER DELIVER, V3, P1204, DOI 10.1109/61.193904; LAGACE PJ, 1988, IEEE T POWER DELIVER, V3, P1573, DOI 10.1109/61.193957; Li XP, 2010, IEEE T POWER DELIVER, V25, P2504, DOI 10.1109/TPWRD.2010.2052837; Liu Qu, 2007, Proceedings of the CSEE, V27, P8; Lu Jiming, 2006, High Voltage Engineering, V32, P55; Marti L, 2014, IEEE T POWER DELIVER, V29, P1886, DOI 10.1109/TPWRD.2014.2317851; Marti L, 2013, IEEE T POWER DELIVER, V28, P1280, DOI 10.1109/TPWRD.2012.2219885; Overbye TJ, 2013, IEEE T POWER SYST, V28, P4821, DOI 10.1109/TPWRS.2013.2274624; Pan ZH, 2016, IEEE T POWER DELIVER, V31, P103, DOI 10.1109/TPWRD.2015.2438853; Pan ZH, 2016, IEEE T POWER DELIVER, V31, P165, DOI 10.1109/TPWRD.2015.2445913; Pan Zhuohong, 2011, Automation of Electric Power Systems, V35, P110; Rezaei-Zare A, 2015, IEEE T POWER DELIVER, V30, P316, DOI 10.1109/TPWRD.2014.2347934; Villas JET, 2003, IEEE T POWER DELIVER, V18, P867, DOI 10.1109/TPWRD.2003.809741; Wang Faming, 2012, High Voltage Engineering, V38, P3054, DOI 10.3969/j.issn.1003-6520.2012.11.038; Zeng R, 2011, IEEE T POWER DELIVER, V26, P2785, DOI 10.1109/TPWRD.2011.2161345; Zhang B, 2006, IEEE T MAGN, V42, P703, DOI 10.1109/TMAG.2006.871460; Zhang B, 2008, IEEE T POWER DELIVER, V23, P960, DOI 10.1109/TPWRD.2007.908748; Zhao Wanjun, 2004, HIGH VOLTAGE DIRECT; Zheng K, 2013, IEEE T POWER DELIVER, V28, P442, DOI 10.1109/TPWRD.2012.2226248; Zhu H, 2015, IEEE T POWER SYST, V30, P2081, DOI 10.1109/TPWRS.2014.2357213	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209548	10.1371/journal.pone.0209548	http://dx.doi.org/10.1371/journal.pone.0209548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629629	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000027
J	Huang, GC; Kaufman, AJ; Ryan, RJH; Romin, Y; Huryn, L; Bains, S; Manova-Todorova, K; Morris, PL; Hunnicutt, GR; Adelman, CA; Petrini, JHJ; Ramanathan, Y; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Ryan, Russell J. H.; Romin, Yevgeniy; Huryn, Laryssa; Bains, Sarina; Manova-Todorova, Katia; Morris, Patricia L.; Hunnicutt, Gary R.; Adelman, Carrie A.; Petrini, John H. J.; Ramanathan, Y.; Singh, Bhuvanesh			Mouse DCUN1D1 (SCCRO) is required for spermatogenetic individualization	PLOS ONE			English	Article							EARLY EMBRYONIC LETHALITY; INTERCELLULAR BRIDGES; CULLIN; PROTEIN; NEDD8; PROLIFERATION; ACTIVATION; COMPLEX; TEX14	Squamous cell carcinoma-related oncogene (SCCRO, also known as DCUN1D1) is a component of the E3 for neddylation. As such, DCUN1D1 regulates the neddylation of cullin family members. Targeted inactivation of DCUN1D1 in mice results in male-specific infertility. Infertility in DCUN1D1(-/-) mice is secondary to primary defects in spermatogenesis. Time-dam experiments mapped the onset of the defect in spermatogenesis to 5.5 to 6 weeks of age, which temporally corresponds to defects in spermiogenesis. Although the first round of spermatogenesis progressed normally, the number of spermatozoa released into the seminiferous lumen and epididymis of DCUN1D1(-/-) mice was significantly reduced. Spermatozoa in DCUN1D1(-/-) mice had multiple abnormalities, including globozoospermia, macrocephaly, and multiple flagella. Many of the malformed spermatozoa in DCUN1D1(-/-) mice were multinucleated, with supernumerary and malpositioned centrioles, suggesting a defect in the resolution of intercellular bridges. The onset of the defect in spermatogenesis in DCUN1D1(-/-) mice corresponds to an increase in DCUN1D1 expression observed during normal spermatogenesis. Moreover, consistent with its known function as a component of the E3 in neddylation, the pattern of DCUN1D1 expression temporally correlates with an increase in the neddylated cullin fraction and stage-specific increases in the total ubiquitinated protein pool in wild-type mice. Levels of neddylated Cul3 were decreased in DCUN1D1(-/-) mice, and ubiquitinated proteins did not accumulate during the stages in which DCUN1D1 expression peaks during spermatogenesis in wild-type mice. Combined, these findings suggest that DCUN1D1(-/-) mice fail to release mature spermatozoa into the seminiferous lumen, possibly due to unresolved intercellular bridges. Furthermore, the effects of DCUN1D1 on spermatogenesis likely involve its regulation of cullin-RING-ligase (CRL)-type ubiquitin E3 activity during spermiogenesis through its role in promoting Cul3 neddylation. The specific CRLs required for spermiogenesis and their protein targets require identification.	[Huang, Guochang; Kaufman, Andrew J.; Ryan, Russell J. H.; Huryn, Laryssa; Bains, Sarina; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10021 USA; [Romin, Yevgeniy; Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, 1275 York Ave, New York, NY 10021 USA; [Morris, Patricia L.; Hunnicutt, Gary R.] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Morris, Patricia L.; Hunnicutt, Gary R.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Adelman, Carrie A.; Petrini, John H. J.] Mem Sloan Kettering Canc Ctr, Dept Mol Biol, 1275 York Ave, New York, NY 10021 USA; [Kaufman, Andrew J.; Ramanathan, Y.] Mt Sinai Med Ctr, Dept Cardiothorac Surg, New York, NY 10029 USA; [Ryan, Russell J. H.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Huryn, Laryssa] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Bains, Sarina] St Barnabas Hosp, Livingston, NJ USA; [Hunnicutt, Gary R.] NIH, Cellular Mol & Integrat Reprod, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA; [Adelman, Carrie A.] AstraZeneca, Cambridge, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Population Council; Rockefeller University; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10021 USA.	singhb@mskcc.org			American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award); Hackers for Hope; National Institutes of Health [R01HD038807, P30 CA008748]; Matheson Fellowship; NATIONAL CANCER INSTITUTE [K08CA208013, P30CA008748] Funding Source: NIH RePORTER	American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award); Hackers for Hope; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Matheson Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the American College of Surgeons (George H.A. Clowes Memorial Research Career Development Award to B.S.); Hackers for Hope (to B.S.); the Matheson Fellowship (to Y.R.); and the National Institutes of Health (R01HD038807 to G.H. and P30 CA008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman CA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000042; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brill JA, 2000, DEVELOPMENT, V127, P3855; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Fu WM, 2016, J BIOL CHEM, V291, P6200, DOI 10.1074/jbc.M115.692756; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang GC, 2017, J BIOL CHEM, V292, P15254, DOI 10.1074/jbc.M117.778530; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jenab S, 1998, ENDOCRINOLOGY, V139, P1883, DOI 10.1210/en.139.4.1883; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Russell LD, 1990, HISTOLOGICAL HISTOPA, pxiv; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209995	10.1371/journal.pone.0209995	http://dx.doi.org/10.1371/journal.pone.0209995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653527	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500022
J	Linnemann, J; Poll, G; Jakob, S; Ferreira-Cerca, S; Griesenbeck, J; Tschochner, H; Milkereit, P				Linnemann, Jan; Poell, Gisela; Jakob, Steffen; Ferreira-Cerca, Sebastien; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Impact of two neighbouring ribosomal protein clusters on biogenesis factor binding and assembly of yeast late small ribosomal subunit precursors	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; EUKARYOTIC RIBOSOME; RNA; LTV1; PROCESSOME; EXPRESSION; MARKERS; 3'-END	Many of the small ribosomal subunit proteins are required for the stabilisation of late small ribosomal subunit (SSU) precursors and for final SSU rRNA processing in S. cerevisiae. Among them are ribosomal proteins (r-proteins) which form a protein cluster around rpS0 (uS2) at the "neck" of the SSU (S0-cluster) and others forming a nearby protein cluster around rpS3 (uS3) at the SSU "beak". Here we applied semi-quantitative proteomics together with complementary biochemical approaches to study how incomplete assembly of these two r-protein clusters affects binding and release of SSU maturation factors and assembly of other r-proteins in late SSU precursors in S. cerevisiae. For each of the two clusters specific impairment of the local r-protein assembly state was observed in Rio2 associated SSU precursors. Besides, cluster-specific effects on the association of biogenesis factors were detected. These suggested a role of S0-cluster formation for the efficient release of the two nuclear export factors Rrp12 and Slx9 from SSU precursors and for the correct incorporation of the late acting biogenesis factor Rio2. Based on our and on previous results we propose the existence of at least two different r-protein assembly checkpoints during late SSU maturation in S. cerevisiae. We discuss in the light of recent SSU precursor structure models how r-protein assembly states might be sensed by biogenesis factors at the S0-cluster checkpoint.	[Linnemann, Jan; Poell, Gisela; Jakob, Steffen; Ferreira-Cerca, Sebastien; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany; [Linnemann, Jan] Evotec Munchen GmbH, Martinsried, Germany; [Poell, Gisela] Sandoz GmbH, Langkampfen, Austria	University of Regensburg; Evotec; Novartis; Sandoz	Griesenbeck, J; Tschochner, H; Milkereit, P (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	joachim.griesenbeck@vkl.uni-regensburg.de; herbert.tschochner@vkl.uni-regensburg.de; philipp.milkereit@vkl.uni-regensburg.de	Ferreira-Cerca, Sébastien/P-2065-2019	Ferreira-Cerca, Sébastien/0000-0002-0522-843X	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameismeier M, 2018, NATURE, V558, P249, DOI 10.1038/s41586-018-0193-0; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Barandun J, 2018, CURR OPIN STRUC BIOL, V49, P85, DOI 10.1016/j.sbi.2018.01.008; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Belhabich-Baumas K, 2017, NUCLEIC ACIDS RES, V45, P10824, DOI 10.1093/nar/gkx734; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Chaker-Margot M, 2018, RNA, V24, P881, DOI 10.1261/rna.066985.118; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Espinar-Marchena FJ, 2017, MICROB CELL, V4, P144, DOI 10.15698/mic2017.05.572; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ferreira-Cerca S, 2014, NUCLEIC ACIDS RES, V42, P8635, DOI 10.1093/nar/gku542; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Fischer U, 2015, ELIFE, V4, DOI 10.7554/eLife.05745; Ford CL, 1999, CANCER RES, V59, P704; Garcia-Gomez JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004205; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Ghalei H, 2017, MOL CELL, V68, P1155, DOI 10.1016/j.molcel.2017.12.001; Ghalei H, 2015, J CELL BIOL, V208, P745, DOI 10.1083/jcb.201409056; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hector RD, 2014, NUCLEIC ACIDS RES, V42, P12138, DOI 10.1093/nar/gku815; Heuer A, 2017, ELIFE, V6, DOI 10.7554/eLife.30189; Jakob S., 2011, ANAL RELATIONSHIP RI; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson MC, 2017, STRUCTURE, V25, P329, DOI 10.1016/j.str.2016.12.011; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Knuppel R, 2018, NUCLEIC ACIDS RES, V46, P1441, DOI 10.1093/nar/gkx1236; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Mitterer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10336; Moriggi G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004836; MORITZ M, 1990, J CELL BIOL, V111, P2261, DOI 10.1083/jcb.111.6.2261; Neueder A., 2011, CHARACTERIZATION R P; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Pena C, 2016, ELIFE, V5, DOI 10.7554/eLife.21755; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sambrook J, 1989, MOL CLONING LAB MANU, DOI [10.1002/jcc.20084, DOI 10.1002/JCC.20084]; Scaiola A, 2018, EMBO J, V37, DOI 10.15252/embj.201798499; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Smith JS, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sturm M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02199-4; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tabb-Massey A, 2003, NUCLEIC ACIDS RES, V31, P6798, DOI 10.1093/nar/gkg899; Turowski TW, 2014, NUCLEIC ACIDS RES, V42, P12189, DOI 10.1093/nar/gku878; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyler E, 2011, RNA, V17, P189, DOI 10.1261/rna.2325911; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115	70	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0203415	10.1371/journal.pone.0203415	http://dx.doi.org/10.1371/journal.pone.0203415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653518	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500004
J	Blume, C; Ost, J; Muhlenbruch, M; Peterhansel, C; Laxa, M				Blume, Christian; Ost, Julia; Muehlenbruch, Marco; Peterhaensel, Christoph; Laxa, Miriam			Low CO2 induces urea cycle intermediate accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; PROLINE DEHYDROGENASE GENES; TRANSCRIPTIONAL REGULATION; SALT STRESS; WILD WATERMELON; DROUGHT STRESS; AMINO-ACIDS; METABOLISM; LEAVES; PLANTS	The non-proteinogenic amino acid ornithine links several stress response pathways. From a previous study we know that ornithine accumulates in response to low CO2. To investigate ornithine accumulation in plants, we shifted plants to either low CO2 or low light. Both conditions increased carbon limitation, but only low CO2 also increased the rate of photorespiration. Changes in metabolite profiles of light- and CO2-limited plants were quite similar. Several amino acids that are known markers of senescence accumulated strongly under both conditions. However, urea cycle intermediates respond differently between the two treatments. While the levels of both ornithine and citrulline were much higher in plants shifted to 100 ppm CO2 compared to those kept in 400 ppm CO2, their metabolite abundance did not significantly change in response to a light limitation. Furthermore, both ornithine and citrulline accumulation is independent from sugar starvation. Exogenous supplied sugar did not significantly change the accumulation of the two metabolites in low CO2-stressed plants, while the accumulation of other amino acids was reduced by about 50%. Gene expression measurements showed a reduction of the entire arginine biosynthetic pathway in response to low CO2. Genes in both proline biosynthesis and degradation were induced. Hence, proline did not accumulate in response to low CO2 like observed for many other stresses. We propose that excess of nitrogen re-fixed during photorespiration can be alternatively stored in ornithine and citrulline under low CO2 conditions. Furthermore, ornithine is converted to pyrroline-5-carboxylate by the action of delta OAT.	[Blume, Christian; Ost, Julia; Muehlenbruch, Marco; Peterhaensel, Christoph; Laxa, Miriam] Leibniz Univ Hannover, Inst Bot, Hannover, Germany; [Laxa, Miriam] Univ Bielefeld, Plant Biochem & Physiol Plants, Bielefeld, Germany	Leibniz University Hannover; University of Bielefeld	Laxa, M (corresponding author), Leibniz Univ Hannover, Inst Bot, Hannover, Germany.; Laxa, M (corresponding author), Univ Bielefeld, Plant Biochem & Physiol Plants, Bielefeld, Germany.	miriam.laxa@uni-bielefeld.de			Open Access Fund of the Leibniz Universitat Hannover	Open Access Fund of the Leibniz Universitat Hannover	The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; An YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077897, 10.1371/journal.pone.0069942]; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bourrellier ABF, 2009, BIOCHEM BIOPH RES CO, V387, P700, DOI 10.1016/j.bbrc.2009.07.088; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Brownfield DL, 2008, PLANT MOL BIOL, V67, P429, DOI 10.1007/s11103-008-9336-2; BUCCI LR, 1991, J NUTR BIOCHEM, V2, P363, DOI 10.1016/0955-2863(91)90092-J; Bundig C, 2016, PLANT CELL TISS ORG, V127, P195, DOI 10.1007/s11240-016-1042-1; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Crawford NM, 2006, J EXP BOT, V57, P471, DOI 10.1093/jxb/erj050; DELAUNEY AJ, 1993, J BIOL CHEM, V268, P18673; Dellero Y, 2015, PLANT J, V83, P1005, DOI 10.1111/tpj.12945; Eisenhut M, 2017, MOL PLANT, V10, P47, DOI 10.1016/j.molp.2016.09.011; Engineer CB, 2016, TRENDS PLANT SCI, V21, P16, DOI 10.1016/j.tplants.2015.08.014; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Florez-Sarasa I, 2012, NEW PHYTOL, V195, P136, DOI 10.1111/j.1469-8137.2012.04153.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Girousse C, 1996, PLANT PHYSIOL, V111, P109, DOI 10.1104/pp.111.1.109; Halket JM, 2005, J EXP BOT, V56, P219, DOI 10.1093/jxb/eri069; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hayashi F, 2000, PLANT CELL PHYSIOL, V41, P1096, DOI 10.1093/pcp/pcd036; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Igarashi D, 2006, PLANT PHYSIOL, V142, P901, DOI 10.1104/pp.106.085514; Kalamaki MS, 2009, J EXP BOT, V60, P1859, DOI 10.1093/jxb/erp072; Kawasaki S, 2000, PLANT CELL PHYSIOL, V41, P864, DOI 10.1093/pcp/pcd005; Kusvuran S, 2013, SCI WORLD J, DOI 10.1155/2013/253414; Laxa M, 2018, CURR PLANT BIOL, V14, P2, DOI 10.1016/j.cpb.2018.09.001; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Matt P, 2001, PLANT CELL ENVIRON, V24, P177, DOI 10.1111/j.1365-3040.2001.00676.x; Miller G, 2005, PLANTA, V222, P70, DOI 10.1007/s00425-005-1518-4; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Niessen M, 2012, J EXP BOT, V63, P2705, DOI 10.1093/jxb/err453; Novitskaya L, 2002, PLANT CELL ENVIRON, V25, P821, DOI 10.1046/j.1365-3040.2002.00866.x; Peng Z, 1996, MOL GEN GENET, V253, P334, DOI 10.1007/s004380050329; Peterhansel Christoph, 2010, Arabidopsis Book, V8, pe0130, DOI 10.1199/tab.0130; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Raymond MJ, 2002, ANN BOT-LONDON, V89, P813, DOI 10.1093/aob/mcf082; REHFELD DW, 1972, J BIOL CHEM, V247, P4803; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; Saha J, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00021; Schertl P, 2014, FEBS J, V281, P2794, DOI 10.1111/febs.12821; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; SHARGOOL PD, 1988, PHYTOCHEMISTRY, V27, P1571, DOI 10.1016/0031-9422(88)80404-7; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Stranska J, 2008, PLANT SIGNAL BEHAV, V3, P929, DOI 10.4161/psb.6771; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; Vankova R, 2012, PLANT SIGNAL BEHAV, V7, P19, DOI 10.4161/psb.7.1.18375; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verma S, 2005, J PLANT PHYSIOL, V162, P669, DOI 10.1016/j.jplph.2004.08.008; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yang CW, 1999, PLANT GROWTH REGUL, V27, P189; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; You J, 2012, PLANT SCI, V197, P59, DOI 10.1016/j.plantsci.2012.09.002; Zarattini M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00927	77	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210342	10.1371/journal.pone.0210342	http://dx.doi.org/10.1371/journal.pone.0210342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650113	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300052
J	Guell, X; Goncalves, M; Kaczmarzyk, JR; Gabrieli, JDE; Schmahmann, JD; Ghosh, SS				Guell, Xavier; Goncalves, Mathias; Kaczmarzyk, Jakub R.; Gabrieli, John D. E.; Schmahmann, Jeremy D.; Ghosh, Satrajit S.			LittleBrain: A gradient-based tool for the topographical interpretation of cerebellar neuroimaging findings	PLOS ONE			English	Article							FUNCTIONAL TOPOGRAPHY; ORGANIZATION; THOUGHT; CONNECTIVITY; OPTIMIZATION; REGISTRATION; PARCELLATION; PROJECTIONS; DYSFUNCTION; DYSMETRIA	Gradient-based approaches to brain function have recently unmasked fundamental properties of brain organization. Diffusion map embedding analysis of resting-state fMRI data revealed a primary-to-transmodal axis of cerebral cortical macroscale functional organization. The same method was recently used to analyze resting-state data within the cerebellum, revealing for the first time a sensorimotor-fugal macroscale organization principle of cerebellar function. Cerebellar gradient 1 extended from motor to non-motor task-unfocused (default-mode network) areas, and cerebellar gradient 2 isolated task-focused processing regions. Here we present a freely available and easily accessible tool that applies this new knowledge to the topographical interpretation of cerebellar neuroimaging findings. Little-Brain illustrates the relationship between cerebellar data (e.g., volumetric patient study clusters, task activation maps, etc.) and cerebellar gradients 1 and 2. Specifically, LittleBrain plots all voxels of the cerebellum in a two-dimensional scatterplot, with each axis corresponding to one of the two principal functional gradients of the cerebellum, and indicates the position of cerebellar neuroimaging data within these two dimensions. This novel method of data mapping provides alternative, gradual visualizations that complement discrete parcellation maps of cerebellar functional neuroanatomy. We present application examples to show that LittleBrain can also capture subtle, progressive aspects of cerebellar functional neuroanatomy that would be difficult to visualize using conventional mapping techniques. Download and use instructions can be found at https://xaviergp.github.io/littlebrain.	[Guell, Xavier; Goncalves, Mathias; Kaczmarzyk, Jakub R.; Gabrieli, John D. E.; Ghosh, Satrajit S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Guell, Xavier; Schmahmann, Jeremy D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab Neuroanat & Cerebellar Neurobiol, Boston, MA 02115 USA; [Schmahmann, Jeremy D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ataxia Unit,Cognit Behav Neurol Unit, Boston, MA USA; [Ghosh, Satrajit S.] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Guell, X (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Guell, X (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab Neuroanat & Cerebellar Neurobiol, Boston, MA 02115 USA.	xaviergp@mit.edu	Schmahmann, Jeremy/ABF-1215-2021; Gabrieli, John/AAJ-2869-2020	Schmahmann, Jeremy/0000-0003-0706-5125; Ghosh, Satrajit/0000-0002-5312-6729; Guell, Xavier/0000-0002-0684-0954	La Caixa Banking Foundation; MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award; MINDLink foundation; National Institutes of Health [R01 EB020740, P41 EB019936]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020740, P41EB019936] Funding Source: NIH RePORTER	La Caixa Banking Foundation(La Caixa Foundation); MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award; MINDLink foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by La Caixa Banking Foundation (XG), the MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award (XG), the MINDLink foundation (JDS), and National Institutes of Health R01 EB020740 (SSG) and P41 EB019936 (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arnold Anteraper S, 2018, BRAIN CONNECT; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bajada CJ, 2017, NEUROIMAGE, V155, P503, DOI 10.1016/j.neuroimage.2017.04.016; Baldassano C, 2017, NEURON, V95, P709, DOI 10.1016/j.neuron.2017.06.041; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cerliani L, 2012, HUM BRAIN MAPP, V33, P2005, DOI 10.1002/hbm.21338; Chirigati F, 2016, P 2016 INT C MAN DAT; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gorgolewski KJ, 2016, NEUROIMAGE, V124, P1242, DOI 10.1016/j.neuroimage.2015.04.016; Guell X, 2018, XAVIERGP LITTLEBRAIN; Guell X, 2018, ELIFE, V7, DOI 10.7554/eLife.36652; Guell X, 2018, CORTEX, V100, P140, DOI 10.1016/j.cortex.2017.07.005; Guell X, 2018, NEUROIMAGE, V172, P437, DOI 10.1016/j.neuroimage.2018.01.082; Guell X, 2015, CEREBELLUM, V14, P50, DOI 10.1007/s12311-014-0630-z; Guo CC, 2016, BRAIN, V139, P1527, DOI 10.1093/brain/aww003; Haak KV, 2018, NEUROIMAGE, V170, P83, DOI 10.1016/j.neuroimage.2017.06.075; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hoche F, 2018, BRAIN, V141, P248, DOI 10.1093/brain/awx317; Huntenburg JM, 2018, TRENDS COGN SCI, V22, P21, DOI 10.1016/j.tics.2017.11.002; Huntenburg JM, 2017, CEREB CORTEX, V27, P981, DOI 10.1093/cercor/bhx030; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Jackson RL, 2018, NEUROIMAGE, V170, P385, DOI 10.1016/j.neuroimage.2017.04.024; Jbabdi S, 2013, CURR OPIN NEUROBIOL, V23, P207, DOI 10.1016/j.conb.2012.12.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kaczmarzyk J, 2018, KACZMARJ NEURO DOCKE; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kim H, 2015, NEUROIMAGE-CLIN, V7, P667, DOI 10.1016/j.nicl.2015.02.022; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Leite AJB, 2006, STROKE, V37, P105, DOI 10.1161/01.STR.0000196984.90718.8a; Lesage E, 2017, J NEUROSCI, V37, P6231, DOI 10.1523/JNEUROSCI.3203-16.2017; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Marcus Daniel S, 2011, Front Neuroinform, V5, P4, DOI 10.3389/fninf.2011.00004; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Marquand AF, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0146; Merkel Dirk, 2014, LINUX J, V239, P2, DOI DOI 10.5555/2600239.2600241; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Phillips JR, 2015, FRONT PUBLIC HEALTH, P3; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; SCHMAHMANN JD, 1991, J COMP NEUROL, V308, P224, DOI 10.1002/cne.903080209; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schroder TN, 2015, ELIFE, V4, DOI 10.7554/eLife.06738; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Wang T, 2016, SCI REP, P6; Wilkins A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00312; Wolf RC, 2015, J NEUROL, V262, P859, DOI 10.1007/s00415-015-7642-6; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	62	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210028	10.1371/journal.pone.0210028	http://dx.doi.org/10.1371/journal.pone.0210028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650101	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300038
J	van der Cruijsen, R; Murphy, J; Bird, G				van der Cruijsen, Renske; Murphy, Jennifer; Bird, Geoffrey			Alexithymic traits can explain the association between puberty and symptoms of depression and anxiety in adolescent females	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; UNITED-STATES; PREVALENCE; PSYCHOPATHOLOGY; GIRLS; AGE; INTEROCEPTION	Symptoms of internalizing disorders such as depression and anxiety increase in adolescence, especially in females. However, gender differences in depression and anxiety symptoms emerge only after puberty onset. Levels of alexithymia, characterized by difficulties identifying and describing one's emotions, are elevated in depression and anxiety, and fluctuate across adolescence in a gender-specific manner. This study investigated changes in alexithymia across adolescence, and explored the potential role of alexithymia in the development of depression and anxiety, separately for females and males. Accordingly, 140 adolescents aged 11 to 21 years (77 female) completed self-report measures of alexithymia, depression and anxiety, and pubertal development. For females alone, pubertal maturation was associated with alexithymic traits (specifically difficulties identifying and describing feelings), as well as symptoms of depression and anxiety. After accounting for alexithymia, the relationship between puberty and depression and anxiety was absent or reduced in females. Thus, alexithymic traits may have differential consequences for males and females, and possibly contribute towards increased depression and anxiety symptoms in females during adolescence. We propose that developmental changes in alexithymia should be considered when studying the onset and development of internalizing psychological disorders during adolescence.	[van der Cruijsen, Renske] Leiden Univ, Dept Dev Psychol, Leiden, Netherlands; [Murphy, Jennifer; Bird, Geoffrey] Kings Coll London, Inst Psychiat Psychol & Neurosci, Genet & Dev Psychiat Ctr, MRC Social, London, England; [Bird, Geoffrey] Univ Oxford, Dept Expt Psychol, Oxford, England	Leiden University; Leiden University - Excl LUMC; University of London; King's College London; University of Oxford	van der Cruijsen, R (corresponding author), Leiden Univ, Dept Dev Psychol, Leiden, Netherlands.	l.w.p.van.der.cruijsen@fsw.leidenuniv.nl	Bird, Geoff/AAA-3652-2020	Bird, Geoffrey/0000-0002-2310-0202	Netherlands Organization for Scientific Research (NWO-VICI) [453-14-001]; Economic and Social Research Council [1599941, ES/J500057/1]; Baily Thomas Trust	Netherlands Organization for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Baily Thomas Trust	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VICI 453-14-001 E.A.C.). Additionally, JM was supported by a doctoral studentship from the Economic and Social Research Council [1599941; ES/J500057/1] and GB by the Baily Thomas Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloy LB, 2016, CLIN PSYCHOL SCI, V4, P867, DOI 10.1177/2167702616643008; Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; COLE DA, 1990, J ABNORM PSYCHOL, V99, P422, DOI 10.1037/0021-843X.99.4.422; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Conley CS, 2009, DEV PSYCHOPATHOL, V21, P593, DOI 10.1017/S0954579409000327; Copeland WE, 2014, J AM ACAD CHILD PSY, V53, P21, DOI 10.1016/j.jaac.2013.09.017; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; Craig A.D., 2002, DO YOU FEEL INTEROCE, V3; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Dorn LD, 2003, J YOUTH ADOLESCENCE, V32, P157, DOI 10.1023/A:1022590818839; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Field AP, 2017, BEHAV RES THER, V98, P19, DOI 10.1016/j.brat.2017.05.013; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Gatta M, 2014, NEUROSCIENCE MED, V5, P60, DOI DOI 10.4236/NM.2014.51009; Gohm CL, 2000, PERS SOC PSYCHOL B, V26, P679, DOI 10.1177/0146167200268004; Grabauskaite A, 2017, CONSCIOUS COGN, V48, P129, DOI 10.1016/j.concog.2016.11.002; Graber JA, 2004, J AM ACAD CHILD PSY, V43, P718, DOI 10.1097/01.chi.0000120022.14101.11; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1351, DOI 10.4088/JCP.v66n1102; Griffin C, 2016, AUTISM RES, V9, P773, DOI 10.1002/aur.1569; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hankin BL, 2015, J ABNORM PSYCHOL, V73, P389; Harter S., 2012, CONSTRUCTION SELF, DOI 10.1017/CBO9781107415324.004; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; HENDRYX MS, 1991, J PERS ASSESS, V56, P227, DOI 10.1207/s15327752jpa5602_4; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Honkalampi K, 2009, COMPR PSYCHIAT, V50, P263, DOI 10.1016/j.comppsych.2008.08.007; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Kajanoja J, 2017, J PSYCHOSOM RES, V97, P111, DOI 10.1016/j.jpsychores.2017.04.010; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Karukivi M, 2010, J AFFECT DISORDERS, V125, P383, DOI 10.1016/j.jad.2010.02.126; Karukivi Max, 2010, Eat Disord, V18, P226, DOI 10.1080/10640261003719518; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khalsa SS, 2018, BIOL PSYCHIAT-COGN N, V3, P501, DOI 10.1016/j.bpsc.2017.12.004; Khalsa SS, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00121; Klabunde M, 2013, EAT BEHAV, V14, P488, DOI 10.1016/j.eatbeh.2013.08.002; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Marchesi C, 2000, J PSYCHOSOM RES, V49, P43, DOI 10.1016/S0022-3999(00)00084-2; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; McLaughlin KA, 2015, J ABNORM CHILD PSYCH, V43, P311, DOI 10.1007/s10802-014-9898-1; Mendle J, 2007, DEV REV, V27, P151, DOI 10.1016/j.dr.2006.11.001; Mendle J, 2014, CHILD DEV PERSPECT, V8, P218, DOI 10.1111/cdep.12092; Murphy J, 2017, J EXP PSYCHOL GEN, V44, P1; Murphy J, 2018, BIOL PSYCHOL, V136, P189, DOI 10.1016/j.biopsycho.2018.05.010; Murphy J, 2017, DEV COGN NEUROS-NETH, V23, P45, DOI 10.1016/j.dcn.2016.12.006; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Quattrocki E, 2014, NEUROSCI BIOBEHAV R, V47, P410, DOI 10.1016/j.neubiorev.2014.09.012; Reardon LE, 2009, CLIN PSYCHOL REV, V29, P1, DOI 10.1016/j.cpr.2008.09.005; Rieffe C, 2006, PERS INDIV DIFFER, V40, P123, DOI 10.1016/j.paid.2005.05.013; Robins RW, 2005, CURR DIR PSYCHOL SCI, V14, P158, DOI 10.1111/j.0963-7214.2005.00353.x; Sakkinen P, 2007, PSYCHOSOMATICS, V48, P154, DOI 10.1176/appi.psy.48.2.154; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Schuch JJJ, 2014, J AFFECT DISORDERS, V156, P156, DOI 10.1016/j.jad.2013.12.011; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Spilt JL, 2014, CHILD DEV, V85, P1248, DOI 10.1111/cdev.12181; Taylor GJ, 2016, NEUROSCI BIOBEHAV R, V68, P1006, DOI 10.1016/j.neubiorev.2016.05.025; Tondo L, 2017, EUR PSYCHIAT, V39, P80, DOI 10.1016/j.eurpsy.2016.08.001; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; Van Oort FVA, 2009, J CHILD PSYCHOL PSYC, V50, P1209, DOI 10.1111/j.1469-7610.2009.02092.x; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Wasserman RM, 2012, J PEDIATR PSYCHOL, V37, P755, DOI 10.1093/jpepsy/jsr121; Werner NS, 2010, BIOL PSYCHOL, V85, P370, DOI 10.1016/j.biopsycho.2010.08.008; Werner NS, 2009, J PSYCHOPHYSIOL, V23, P35, DOI 10.1027/0269-8803.23.1.35; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	77	13	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210519	10.1371/journal.pone.0210519	http://dx.doi.org/10.1371/journal.pone.0210519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650139	Green Published, gold			2022-12-27	WOS:000455813300058
J	Wu, CY; Yu, SL; Chen, YT; Chen, YH; Hsiao, PW; Chow, YH; Chen, JR				Wu, Chia-Ying; Yu, Shu-Ling; Chen, Yung-Tsung; Chen, Yi-Hsuan; Hsiao, Pei-Wen; Chow, Yen-Hung; Chen, Juine-Ruey			The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus	PLOS ONE			English	Article							ENTEROVIRUS 71 VACCINE; MECHANISM; CLEAVAGE; DISEASE	Enterovirus 71 (EV71) has emerged as a neurological virus causing life-threatening diseases in young children and infants. Although EV71 vaccines in development have presented promising results in several clinical trials, the identified key antigen for improving the broad protective efficacy of EV71 vaccines has not been well investigated. In this report, we show that different multiplicities of infection (MOIs) of the B4(E59) virus significantly affect EV71 vaccine production in a serum-free microcarrier bioreactor system. The antigens produced from high MOIs of 10(-1) and 10(-2) exhibited higher yield and more infectious full particle (FP) contents in the EV71 vaccines than those produced with low MOIs of 10(-4) and 10(-6), leading to better cross-neutralizing efficacy. The C4(E36) neutralization results showed that only antisera raised from EV71 FPs provided substantial neutralizing titers against C4(E36), whereas empty particles (EPs) of EV71 conferred no efficacy. Competitive ELISA showed that anti-FP mainly binds to FPs and that 20% of antibodies bind to EPs, whereas most anti-EP binds EPs, with only 10% antibodies binding to FPs. VP1-adsorbed anti-FP lost most of the virus neutralization efficiency, suggesting that the VP1 subunit of FP is the major immunogenic antigen determining the ability of the EV71 vaccine to elicit cross-neutralizing antibodies against EV71 virus subtypes. These findings demonstrate that the high-MOI production approach is significantly correlated with FP productivity, thereby improving the cross-neutralization efficacy of an EV71 vaccine and providing the basis for a better vaccine design against widespread EV71 viruses.	[Wu, Chia-Ying; Chen, Yung-Tsung; Chen, Yi-Hsuan; Chen, Juine-Ruey] Adimmune Corp, Taichung, Taiwan; [Yu, Shu-Ling; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Chow, Yen-Hung] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chen, JR (corresponding author), Adimmune Corp, Taichung, Taiwan.; Chow, YH (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.; Chow, YH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	choeyenh@nhri.org.tw; juinerueychen@gmail.com		Chen, Juine Ruey/0000-0002-4751-1217	Adimmune Corporation; Ministry of Economic Affairs [101-EC-17-A-20-I1-0054]	Adimmune Corporation; Ministry of Economic Affairs	This study was supported by funds from Adimmune Corporation (http://www.adimmune.com.tw/index.php) and a Ministry of Economic Affairs grant (101-EC-17-A-20-I1-0054). Coauthors C.Y.W., Y.T.C., Y.H. Chen., and J.R.C. are all employees of Adimmune Corporation. The parties provided the financial support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; BASAVAPPA R, 1994, PROTEIN SCI, V3, P1651, DOI 10.1002/pro.5560031005; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chong P, 2015, CLIN INFECT DIS, V60, P797, DOI 10.1093/cid/ciu852; Chong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049973; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831282; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; CHOW M, 1982, P NATL ACAD SCI-BIOL, V79, P7518, DOI 10.1073/pnas.79.23.7518; Chu SC, 2013, J FORMOS MED ASSOC, V112, P508, DOI 10.1016/j.jfma.2012.12.001; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; Dai DX, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121231; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Liu CC, 2011, J VIROL METHODS, V176, P60, DOI 10.1016/j.jviromet.2011.06.001; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136420; Wu YY, 2005, ACTA CRYSTALLOGR F, V61, P902, DOI 10.1107/S1744309105027132; Yi EJ, 2017, CLIN EXP VACCINE RES, V6, P4, DOI [10.7774/cevr.2017.6.1.4, 10.7774/cevr.2017.6.1.4.]; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	27	5	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210553	10.1371/journal.pone.0210553	http://dx.doi.org/10.1371/journal.pone.0210553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650163	gold, Green Published			2022-12-27	WOS:000455813300061
J	Agnetta, D; Badalamenti, F; Colloca, F; D'Anna, G; Di Lorenzo, M; Fiorentino, F; Garofalo, G; Gristina, M; Labanchi, L; Patti, B; Pipitone, C; Solidoro, C; Libralato, S				Agnetta, Davide; Badalamenti, Fabio; Colloca, Francesco; D'Anna, Giovanni; Di Lorenzo, Manfredi; Fiorentino, Fabio; Garofalo, Germana; Gristina, Michele; Labanchi, Lucio; Patti, Bernardo; Pipitone, Carlo; Solidoro, Cosimo; Libralato, Simone			Benthic-pelagic coupling mediates interactions in Mediterranean mixed fisheries: An ecosystem modeling approach	PLOS ONE			English	Article							CENTRAL ADRIATIC SEA; WATER ROSE SHRIMP; PARAPENAEUS-LONGIROSTRIS; ENGRAULIS-ENCRASICOLUS; PHYSICAL FORCINGS; MARINE ECOSYSTEM; SICILIAN CHANNEL; GLOBAL ANALYSIS; STRAIT; NORTHERN	Benthic-pelagic coupling plays a pivotal role in aquatic ecosystems but the effects of fishery driven interactions on its functioning has been largely overlooked. Disentangling the benthic-pelagic links including effects of mixed fisheries, however, needs sketching a whole description of ecosystem interactions using quantitative tools. A holistic food web model has been here developed in order to understand the interplay between the benthic-pelagic coupling and mixed fisheries in a Mediterranean system such as the Strait of Sicily. The reconstruction of the food web required review and integration of a vast set of local and regional biological information from bacteria to large pelagic species that were aggregated into 72 functional groups. Fisheries were described by 18 fleet segments resulting from combination of fishing gears and fishing vessel size. The input-output analysis on the food web of energy pathways allowed identifying effects of biological and fishery components. Results showed that the structure of the Strait of Sicily food web is complex. Similarly to other Mediterranean areas, the food web of the Strait of Sicily encompasses 4.5 trophic levels (TLs) with the highest TLs reached by bluefin tuna, swordfish and large hake and largely impacted by bottom trawling and large longline. Importantly, benthic-pelagic coupling is affected by direct and indirect impacts among groups of species, fleets and fleets-species through the whole trophic spectrum of the food web. Moreover, functional groups able to move on large spatial scales or life history of which is spent between shelf and slope domains play a key role in linking subsystems together and mediate interactions in the Mediterranean mixed fisheries.	[Agnetta, Davide; Solidoro, Cosimo; Libralato, Simone] OGS OCE, Trieste, Italy; [Badalamenti, Fabio; D'Anna, Giovanni; Pipitone, Carlo] CNR, IAS, Castellammare Del Golfo, TP, Italy; [Badalamenti, Fabio] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Badalamenti, Fabio] SZN, Naples, Italy; [Colloca, Francesco; Di Lorenzo, Manfredi; Fiorentino, Fabio; Garofalo, Germana; Gristina, Michele] CNR, IRBIM, Mazara Del Vallo, TP, Italy; [Labanchi, Lucio] Mably Soc Cooperat, Salerno, Italy; [Patti, Bernardo] CNR, IAS, Campobello Di Mazara, TP, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Impatti Antropici Sostenibilita in Ambiente Marino (IAS-CNR); University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Risorse Biologiche Biotecnologie Marine (IRBIM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Impatti Antropici Sostenibilita in Ambiente Marino (IAS-CNR)	Agnetta, D (corresponding author), OGS OCE, Trieste, Italy.	dagnetta@inogs.it	Libralato, Simone/AAR-2198-2020; Fiorentino, Fabio/AAX-2883-2020; Patti, Bernardo/ABG-7214-2020; Pipitone, Carlo/B-7562-2015; BADALAMENTI, FABIO/B-8508-2015; D'ANNA, GIOVANNI/B-7995-2015	Libralato, Simone/0000-0001-8112-1274; Fiorentino, Fabio/0000-0002-6302-649X; Agnetta, Davide\\/0000-0002-3019-9095; Pipitone, Carlo/0000-0002-7632-1228; BADALAMENTI, FABIO/0000-0002-2395-454X; D'ANNA, GIOVANNI/0000-0002-8644-8222; solidoro, cosimo/0000-0003-2354-4302	Flagship Project RITMARE - The Italian Research for the Sea; Italian Ministry of Education, University and Research; Flagship Project RITMARE-The Italian Research for the Sea	Flagship Project RITMARE - The Italian Research for the Sea; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Flagship Project RITMARE-The Italian Research for the Sea	This work has been funded by the Flagship Project RITMARE - The Italian Research for the Sea -coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013 to DA.; This work has been funded by the Flagship Project RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013. Many thanks to Valentina Mosetti for precious help in drawing the pictogram.	Abid N, 2018, J MAR BIOL ASSOC UK, V98, P895, DOI 10.1017/S002531541700011X; Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Baustian M., 2014, ECO DAS X S P, P25, DOI DOI 10.4319/ECODAS.2014.978-0-9845591-4-5.38; Beranger K, 2004, DEEP-SEA RES PT II, V51, P411, DOI 10.1016/j.dsr2.2003.08.004; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOLLENS SM, 1992, HYDROBIOLOGIA, V234, P33, DOI 10.1007/BF00010777; Castriota L, 2001, SCI COUNC M NAFO SCR, V9; Celic I, 2018, ICES J MAR SCI; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Civile D, 2015, GLOBAL PLANET CHANGE, V125, P36, DOI 10.1016/j.gloplacha.2014.12.003; Coll M, 2007, J MARINE SYST, V67, P119, DOI 10.1016/j.jmarsys.2006.10.002; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll M, 2009, MAR ECOL PROG SER, V381, P17, DOI 10.3354/meps07944; Consoli P, 2017, MAR BIOL RES, V13, P1084, DOI 10.1080/17451000.2017.1348010; Damalas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119330; de Juan S, 2007, MAR ECOL PROG SER, V334, P117; Di Lorenzo M, 2018, HYDROBIOLOGIA, V821, P235, DOI 10.1007/s10750-017-3389-7; Dunton KH, 2005, DEEP-SEA RES PT II, V52, P3462, DOI 10.1016/j.dsr2.2005.09.007; Eddy TD, 2017, FISH FISH, V18, P40, DOI 10.1111/faf.12165; Eigaard OR, 2017, ICES J MAR SCI, V74, P847, DOI 10.1093/icesjms/fsw194; FAO, 2016, STAT MED BLACK SEA F; Fiorentino F, 2013, MEDSUDMED TECH DOC, V32; Fiorentino F, 2013, FISH RES, V147, P290, DOI 10.1016/j.fishres.2013.06.001; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; Garofalo G., 2007, BIOL MAR MEDITERR, V14, P250; Graf G, 1997, J MARINE SYST, V11, P269, DOI 10.1016/S0924-7963(96)00126-1; Griffiths JR, 2017, GLOBAL CHANGE BIOL, V23, P2179, DOI 10.1111/gcb.13642; Hiddink JG, 2017, P NATL ACAD SCI USA, V114, P8301, DOI 10.1073/pnas.1618858114; Howarth LM, 2018, MAR ECOL PROG SER, V602, P31, DOI 10.3354/meps12690; ICCAT, 2010, COLLECTIVE VOLUME SC; Jul-Larsen E., 2003, 4261 FAO; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Knittweiss L, 2013, MEDSUDMED TECH DOC, V28; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; Lauria V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08386-z; Lauzon-Guay JS, 2007, MAR ECOL PROG SER, V329, P191, DOI 10.3354/meps329191; Lazzari P, 2012, BIOGEOSCIENCES, V9, P217, DOI 10.5194/bg-9-217-2012; Lee JY, 2002, J SEA RES, V48, P287, DOI 10.1016/S1385-1101(02)00182-X; Levi D, 1997, ANAL TRAWIS DISCARD; Libralato S, 2016, VIE MILIEU, V66, P315; Libralato S., 2008, ENCY ECOLOGY, P3473; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lopez S.D., 2013, THESIS; Madigan DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00654; Mangano MC, 2013, MAR ECOL PROG SER, V475, P101, DOI 10.3354/meps10115; Mannini A., 2015, Biologia Marina Mediterranea, V22, P1; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Mazzola S, 2006, AMECO SCI MARINE APP; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCormick MI, 1998, MAR BIOL, V132, P9, DOI 10.1007/s002270050367; Milisenda G, 2017, MEDITERR MAR SCI, V18, P53, DOI 10.12681/mms.1787; Milisenda G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094600; Moutopoulos DK, 2013, J MARINE SYST, V113, P13, DOI 10.1016/j.jmarsys.2012.12.002; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Petihakis G, 2007, ICES J MAR SCI, V64, P1627, DOI 10.1093/icesjms/fsm161; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinnegar JK, 2007, J EXP MAR BIOL ECOL, V352, P378, DOI 10.1016/j.jembe.2007.08.016; Piroddi C, 2015, MAR ECOL PROG SER, V533, P47, DOI 10.3354/meps11387; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Raffaelli D, 2003, J EXP MAR BIOL ECOL, V285, P191, DOI 10.1016/S0022-0981(02)00527-0; Romano C, 2016, MAR ENVIRON RES, V122, P113, DOI 10.1016/j.marenvres.2016.10.002; Rossi S, 2013, OCEAN COAST MANAGE, V84, P77, DOI 10.1016/j.ocecoaman.2013.07.004; Sanchez-Hernandez J, 2017, ECOL EVOL, V7, P358, DOI 10.1002/ece3.2600; Sara G, 2007, J APPL ICHTHYOL, V23, P122, DOI 10.1111/j.1439-0426.2006.00829.x; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Sciberras M, 2018, FISH FISH, V19, P698, DOI 10.1111/faf.12283; Shannon L, 2014, MAR ECOL PROG SER, V512, P115, DOI 10.3354/meps10821; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Sinopoli M, 2012, SCI MAR, V76, P677, DOI 10.3989/scimar.03564.29A; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Tecchio S, 2015, PROG OCEANOGR, V135, P156, DOI 10.1016/j.pocean.2015.05.018; Tecchio S, 2013, DEEP-SEA RES PT I, V75, P1, DOI 10.1016/j.dsr.2013.01.003; Tilves U, 2018, MAR ECOL PROG SER, V591, P101, DOI 10.3354/meps12332; Torri M, 2018, PROG OCEANOGR, V162, P25, DOI 10.1016/j.pocean.2018.02.009; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Tsagarakis K, 2010, ESTUAR COAST SHELF S, V88, P233, DOI 10.1016/j.ecss.2010.04.007; ULANOWICZ R E, 1990, Coenoses, V5, P7; Walters C, 2007, ECOL MODEL, V209, P342, DOI 10.1016/j.ecolmodel.2007.06.025	93	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210659	10.1371/journal.pone.0210659	http://dx.doi.org/10.1371/journal.pone.0210659			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645620	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200042
J	He, H; Fu, JT; Li, X; Guo, R				He, Hao; Fu, Jingtao; Li, Xi; Guo, Rui			The interplay between endorser social status and normative appeals on the endorsement effectiveness of pro-environmental behaviors	PLOS ONE			English	Article							CELEBRITY ENDORSER; CONSUMER; SPOKESPERSON; CONSERVATION; CONGRUENCE; SELF; HYPOTHESIS; BELIEFS; IMPACT; GREEN	Employing message endorser is a popular strategy in encouraging consumers to protect the environment. This research explores how the social status of endorsers and the forms of normative messages can influence the effectiveness of endorsement for pro-environmental behaviors. Drawing on the focus theory of normative conduct and the match-up hypothesis, the authors propose that the effects of endorser social status on consumers' responses to green advertising are contingent on whether the normative messages is framed as injunctive norms or descriptive norms. In three experiments, the results indicate that participants show more positive attitudes toward the advertisement and higher intentions to act environmentally friendly when endorsers with high social status are presented in combination with injunctive norm appeals. In contrast, ordinary consumer endorsers produce stronger impact on attitudes and behavioral intentions when descriptive norm appeals are used. These findings show that marketers using endorsers to promote pro-environmental behaviors should develop normative message accordingly.	[He, Hao] Changsha Univ Sci & Technol, Sch Econ & Management, Changsha, Hunan, Peoples R China; [Fu, Jingtao] Hainan Univ, Sch Econ & Management, Haikou, Hainan, Peoples R China; [Li, Xi] Hong Kong Baptist Univ, United Int Coll, Beijing Normal Univ, Div Business & Management, Zhuhai, Guangdong, Peoples R China; [Guo, Rui] China Univ Geosci, Sch Econ & Management, Wuhan, Hubei, Peoples R China	Changsha University of Science & Technology; Hainan University; Beijing Normal University; Beijing Normal University - Hong Kong Baptist University United International College; Hong Kong Baptist University; China University of Geosciences	Fu, JT (corresponding author), Hainan Univ, Sch Econ & Management, Haikou, Hainan, Peoples R China.	fjthainan@163.com			National Nature Science Foundation of China [71402010]; Scientific Research Fund of Hunan Provincial Education Department of China [17B019]; Research Fund of Hunan Modern Enterprise Management Research Center of China [17qgzd07]; National Social Science Foundation of China [15BGL164]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department of China(Hunan Provincial Education Department); Research Fund of Hunan Modern Enterprise Management Research Center of China; National Social Science Foundation of China	The study was support by the National Nature Science Foundation of China (Grant No. 71402010), the Scientific Research Fund of Hunan Provincial Education Department of China (Grant No. 17B019), and the Research Fund of Hunan Modern Enterprise Management Research Center of China (Grant No. 17qgzd07) credited to the first author, and was supported by the National Social Science Foundation of China (Grant No. 15BGL164) credited to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170216; Biswas D, 2006, J ADVERTISING, V35, P17, DOI 10.1080/00913367.2006.10639231; Bohner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104086; Brough AR, 2016, J CONSUM RES, V43, P567, DOI 10.1093/jcr/ucw044; Choi SM, 2012, PSYCHOL MARKET, V29, P639, DOI 10.1002/mar.20550; Cialdini Robert B, 1990, J PERS SOC PSYCHOL, V58; Erdogan, 1999, J MARK MANAG, V15, P291, DOI [DOI 10.1362/026725799784870379, 10.1362/026725799784870379]; Escalas JE, 2003, J CONSUM PSYCHOL, V13, P339, DOI 10.1207/S15327663JCP1303_14; Giesler M, 2014, J CONSUM RES, V41, P840, DOI 10.1086/677842; Gockeritz S, 2010, EUR J SOC PSYCHOL, V40, P514, DOI 10.1002/ejsp.643; Goffman E, 1951, BRIT J SOCIOL, V2, P294, DOI 10.2307/588083; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Griskevicius V, 2010, J PERS SOC PSYCHOL, V98, P392, DOI 10.1037/a0017346; Grunert SC, 1993, EUROPEAN ADV CONSUME, V48, P367; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hovland C.I., 1953, COMMUN PERSUATION; Jacobson RP, 2011, J PERS SOC PSYCHOL, V100, P433, DOI 10.1037/a0021470; KAHLE LR, 1985, J CONSUM RES, V11, P954, DOI 10.1086/209029; KAMINS MA, 1990, J ADVERTISING, V19, P4, DOI 10.1080/00913367.1990.10673175; KAMINS MA, 1994, PSYCHOL MARKET, V11, P569, DOI 10.1002/mar.4220110605; KAMINS MA, 1989, J ADVERTISING RES, V29, P34; Keel A, 2012, PSYCHOL MARKET, V29, P690, DOI 10.1002/mar.20555; Li JX, 2017, J BUS ETHICS, V143, P589, DOI 10.1007/s10551-015-2807-x; Lindenberg S, 2011, SOC PSYCHOL QUART, V74, P98, DOI 10.1177/0190272511398208; Malar L, 2011, J MARKETING, V75, P35, DOI 10.1509/jmkg.75.4.35; MCCRACKEN G, 1989, J CONSUM RES, V16, P310, DOI 10.1086/209217; Milner M, 2010, SOCIETY, V47, P379, DOI 10.1007/s12115-010-9347-x; MISRA S, 1990, J BUS RES, V21, P159, DOI 10.1016/0148-2963(90)90050-N; Newton JD, 2015, J ADVERTISING, V44, P151, DOI 10.1080/00913367.2015.1018464; Packard, 2007, HIDDEN PERSUADERS; Phua J, 2016, J HEALTH PSYCHOL, V21, P699, DOI 10.1177/1359105314536452; Smith JR, 2012, J ENVIRON PSYCHOL, V32, P353, DOI 10.1016/j.jenvp.2012.06.001; Stafford MR, 2002, J ADVERTISING, V31, P17, DOI 10.1080/00913367.2002.10673664; Wang SW, 2018, J ADVERTISING RES, V58, P16, DOI 10.2501/JAR-2017-042; Wen FH, 2018, APPL ECON, V50, P319, DOI 10.1080/00036846.2017.1321838; Wen FH, 2016, ENERG ECON, V59, P400, DOI 10.1016/j.eneco.2016.07.014; White K, 2013, J MARKETING, V77, P78, DOI 10.1509/jm.11.0278; White K, 2011, J MARKETING RES, V48, P472, DOI 10.1509/jmkr.48.3.472; Winterich KP, 2018, J MARKETING, V82, P70, DOI 10.1509/jm.16.0169	39	5	5	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210699	10.1371/journal.pone.0210699	http://dx.doi.org/10.1371/journal.pone.0210699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645643	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200043
J	Park, J; Choi, EK; Han, KD; Choi, YJ; Lee, E; Choe, W; Lee, SR; Cha, MJ; Lim, WH; Kang, J; Park, KW; Oh, S; Lip, GYH				Park, Jiesuck; Choi, Eue-Keun; Han, Kyung-Do; Choi, You-jung; Lee, Euijae; Choe, Wonseok; Lee, So-Ryoung; Cha, Myung-Jin; Lim, Woo-Hyun; Kang, Jeehoon; Park, Kyung Woo; Oh, Seil; Lip, Gregory Y. H.			Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study	PLOS ONE			English	Article							ANTAGONIST ORAL ANTICOAGULANTS; VITAMIN-K ANTAGONIST; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; SYNDROME AND/OR; ARTERY-DISEASE; RISK-FACTOR; MANAGEMENT; WARFARIN; STROKE	Background We investigated the recent 10-year trends in the number of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in relation to prescription patterns of antithrombotic therapy. Methods We analyzed the annual prevalence of PCI and patterns of antithrombotic therapy after PCI, including antiplatelets and oral anticoagulants (vitamin K antagonists and non-vitamin K antagonist oral anticoagulants [NOACs]), in patients with AF between 2006 and 2015 by using the Korean National Health Insurance Service database. Independent factors associated with triple therapy (oral anticoagulant plus dual antiplatelet) prescription were assessed using multivariable logistic regression analysis. Results The number of patients with AF undergoing PCI increased gradually from 2006 (n = 2,140) to 2015 (n = 3,631) (p(trend)<0.001). In 2006, only 22.7% of patients received triple therapy after PCI although 96.2% of them were indicated for anticoagulation (CHA(2)DS(2)-VASc score >= 2). The prescription rate of triple therapy increased to 38.3% in 2015 (p(trend)<0.001), which was mainly attributed to a recent increment of NOAC-based triple therapy from 2013 (17.5% in 2015). Previous ischemic stroke or systemic embolism, old age, hypertension, and congestive heart failure were significantly associated with a higher triple therapy prescription rate, whereas previous myocardial infarction, PCI, and peripheral arterial disease were associated with triple therapy underuse. Conclusions From 2006 to 2015, the number of patients with AF undergoing PCI and the prescription rate of triple therapy increased gradually with a recent increment of NOAC-based antithrombotic therapy from 2013. Previous myocardial infarction, peripheral artery disease, and PCI were associated with underuse of triple therapy.	[Park, Jiesuck; Choi, Eue-Keun; Choi, You-jung; Lee, Euijae; Choe, Wonseok; Cha, Myung-Jin; Kang, Jeehoon; Park, Kyung Woo; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, So-Ryoung] Soon Chun Hyang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lim, Woo-Hyun] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Thrombosis Res Unit, Aalborg, Denmark	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Soonchunhyang University; Seoul National University (SNU); Seoul National University Hospital; University of Birmingham; Aalborg University	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Park, Kyung Woo/AAX-3046-2020; Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014	Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lim, Woo-Hyun/0000-0001-9298-8500	Seoul National University Hospital Research Fund [620172540]; Korea National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2014R1A1A2A16055218]; Korean Healthcare Technology R&D project - Ministry of Health Welfare [HI15C1200]; Biosense Webster [IIS368, IIS457]; Daiichi-Sankyo [06-2017-1370]; BMS/Pfizer [CV185-704]	Seoul National University Hospital Research Fund; Korea National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Korean Healthcare Technology R&D project - Ministry of Health Welfare; Biosense Webster; Daiichi-Sankyo(Daiichi Sankyo Company Limited); BMS/Pfizer(Pfizer)	This study was supported by a grant from the Seoul National University Hospital Research Fund (620172540) and the Korea National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2014R1A1A2A16055218). EKC specifically received grants from the Korean Healthcare Technology R&D project funded by the Ministry of Health & Welfare (HI15C1200), Biosense Webster (IIS368, IIS457), Daiichi-Sankyo (06-2017-1370), and BMS/Pfizer (CV185-704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angiolillo DJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004395; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Choi HI, 2017, JACC-CARDIOVASC INTE, V10, pE107, DOI 10.1016/j.jcin.2017.02.028; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; Fosbol EL, 2013, AM HEART J, V166, P864, DOI 10.1016/j.ahj.2013.08.005; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gong XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186449; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; January C.T., 2014, J AM COLL CARDIOL, V64, pE1, DOI [DOI 10.1523/JNEUROSCI.2810-14.2015, DOI 10.1016/j.jacc.2014.03.022]; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lam DH, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0703-4; Lamberts M, 2013, J AM COLL CARDIOL, V62, P981, DOI 10.1016/j.jacc.2013.05.029; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495; Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lopes RD, 2018, AM HEART J, V200, P17, DOI 10.1016/j.ahj.2018.03.001; Ntaios G, 2017, INT J STROKE, V12, P589, DOI 10.1177/1747493017700663; Pastori D, 2018, INT J CARDIOL, V255, P69, DOI 10.1016/j.ijcard.2017.12.076; Rossini R, 2008, AM J CARDIOL, V102, P1618, DOI 10.1016/j.amjcard.2008.08.021; Rubboli A, 2009, J INTERV CARDIOL, V22, P390, DOI 10.1111/j.1540-8183.2009.00468.x; Schomig A, 2009, HEART, V95, P1280, DOI 10.1136/hrt.2008.160457; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Sutton NR, 2016, J AM COLL CARDIOL, V68, P895, DOI 10.1016/j.jacc.2016.05.085; Vranckx P, 2018, AM HEART J, V196, P105, DOI 10.1016/j.ahj.2017.10.009; Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947; Zulkifly H, 2017, AM J CARDIOL, V120, P1139, DOI 10.1016/j.amjcard.2017.06.058	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209593	10.1371/journal.pone.0209593	http://dx.doi.org/10.1371/journal.pone.0209593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645601	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200011
J	Blondeau, JM; Fitch, SD				Blondeau, Joseph M.; Fitch, Shantelle D.			Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; SELECTION WINDOW HYPOTHESIS; LUNG-TISSUE CONCENTRATIONS; PROTEIN-BINDING; ANTIMICROBIAL SUSCEPTIBILITY; CEREBROSPINAL-FLUID; TRACT-INFECTION; UNITED-STATES; PHARMACOKINETICS; FLUOROQUINOLONES	Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis are prevalent bacterial causes of swine infections. Morbidity, mortality and positively impacting the financial burden of infection occurs with appropriate antimicrobial therapy. Increasing antimicrobial resistance complicates drug therapy and resistance prevention is now a necessity to optimize therapy and prolong drug life. Mutant bacterial cells are said to arise spontaneously in bacterial densities of 10(7)-10(9) or greater colony forming units/ml. Antibiotic drug concentration inhibiting growth of the least susceptible cell in these high density populations has been termed the mutant prevention concentration (MPC). In this study MPC and minimum inhibitory concentration (MIC) values of ceftiofur, enrofloxacin, florfenicol, tilmicosin and tulathromycin were determined against the swine pathogens A. pleuropneumoniae, P. multocida and S. suis. The following MIC90/MPC90 values (mg/L) for 67 A. pleuropneumoniae and 73 P. multocida strains respectively were as follows: A. pleuropneumoniae 0.031/0.5, <= 0.016/0.5, 0.5/2, 4/32, 2/32; P. multocida 0.004/0.25, 0.016/0.125, 0.5/0.5, 8/16, 0.5/1. For 33 S. suis strains, MIC90 values (mg/L) respectively were as follows: 1, 0.25, 4, >= 8 and >= 8. A total of 16 S. suis strains with MIC values of 0.063-0.5 mg/L to ceftiofur and 0.25-0.5 mg/L to enrofloxacin were tested by MPC; MPC values respectively were 0.5 and 1 mg/L respectively. MPC concentrations provide a dosing target which may serve to reduce amplification of bacterial subpopulations with reduced antimicrobial susceptibility. Drug potency based on MIC90 values was ceftiofur > enrofloxacin > florfenicol = tulathromycin > tilmicosin; based on MPC90 values was enrofloxacin > ceftiofur > tulathromycin > florfenicol >= tilmicosin.	[Blondeau, Joseph M.; Fitch, Shantelle D.] Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK, Canada; [Blondeau, Joseph M.; Fitch, Shantelle D.] Saskatchewan Hlth Author, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada; [Blondeau, Joseph M.] Univ Saskatchewan, Dept Ophthalmol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Blondeau, JM (corresponding author), Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Saskatchewan Hlth Author, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada.; Blondeau, JM (corresponding author), Univ Saskatchewan, Dept Ophthalmol, Saskatoon, SK, Canada.	joseph.blondeau@saskhealthauthority.ca			Bayer Animal Health	Bayer Animal Health(Bayer AG)	This study was funded, in part, by an investigator initialized unrestricted research grant from Bayer Animal Health to JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Deb Hills for excellent clerical assistance. This study was funded, in part, by an investigator initialized unrestricted research grant from Bayer Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Benchaoui HA, 2004, J VET PHARMACOL THER, V27, P203, DOI 10.1111/j.1365-2885.2004.00586.x; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Blondeau JM, 2012, VET MICROBIOL, V160, P85, DOI 10.1016/j.vetmic.2012.05.006; Blondeau J M, 2004, J Chemother, V16 Suppl 3, P1; Blondeau JM, 2001, ANTIMICROB AGENTS CH, V45, P433, DOI 10.1128/AAC.45.2.433-438.2001; Blondeau JM, 2009, VET DERMATOL, V20, P383, DOI 10.1111/j.1365-3164.2009.00856.x; Bochev I., 2007, Bulgarian Journal of Veterinary Medicine, V10, P131; Burch DGS, 2010, THE PIG J, V63, P34; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT DISK; Croisier DE, 2004, ANTIMICROB AGENTS CH, V48, P1699, DOI 10.1128/AAC.48.5.1699-1707.2004; Cui JC, 2010, J ANTIBIOT, V63, P29, DOI 10.1038/ja.2009.111; Dagan R, 2001, J ANTIMICROB CHEMOTH, V47, P129, DOI 10.1093/jac/47.2.129; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Dorey L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177568; Dosen R., 2007, Biotechnology in Animal Husbandry, V23, P237; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Evans NA, 2005, VET THER, V6, P83; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; FELDMAN WE, 1976, J PEDIATR-US, V88, P549, DOI 10.1016/S0022-3476(76)80003-0; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; Firsov AA, 2014, INT J ANTIMICROB AG, V44, P301, DOI 10.1016/j.ijantimicag.2014.06.013; Firsov AA, 2006, J ANTIMICROB CHEMOTH, V58, P1185, DOI 10.1093/jac/dkl387; Frisch AW, 1942, J EXP MED, V76, P505, DOI 10.1084/jem.76.6.505; Hansen GT, 2005, J CHEMOTHERAPY, V17, P484, DOI 10.1179/joc.2005.17.5.484; Hedlin Peter, 2007, Eye Contact Lens, V33, P161, DOI 10.1097/01.icl.0000246872.73559.43; Hesje C, 2007, DETERMINATION MINIMU; Hesje CK, 2015, J ANTIMICROB CHEMOTH, V70, P494, DOI 10.1093/jac/dku389; Kamp EM, 1996, J VET DIAGN INVEST, V8, P304, DOI 10.1177/104063879600800305; Lei Z, 2018, FRONT PHARMACOL, V9, P1, DOI [10.3389/fphar.2018.00001, DOI 10.3389/FPHAR.2018.00001]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McVey DS, 2010, BACTERIAL ISOLATES L; Metzler K, 2013, J ANTIMICROB CHEMOTH, V68, P631, DOI 10.1093/jac/dks461; Nicolau David P., 2003, Journal of Infection and Chemotherapy, V9, P292, DOI 10.1007/s10156-003-0279-x; Nowakowski MA, 2004, VET THER, V5, P60; Portis E, 2013, J SWINE HEALTH PROD, V21, P30; Rapp RP, 1998, ANN PHARMACOTHER, V32, P785, DOI 10.1345/aph.17299; SALMON SA, 1995, J CLIN MICROBIOL, V33, P2435, DOI 10.1128/JCM.33.9.2435-2444.1995; SEBUNYA TNK, 1983, J AM VET MED ASSOC, V182, P1331; Shin SJ, 2005, VET MICROBIOL, V106, P73, DOI 10.1016/j.vetmic.2004.11.015; SINGHVI SM, 1978, CHEMOTHERAPY, V24, P121, DOI 10.1159/000237771; Smith HJ, 2003, J ANTIMICROB CHEMOTH, V51, P1323, DOI 10.1093/jac/dkg255; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Wetzstein HG, 2005, ANTIMICROB AGENTS CH, V49, P4166, DOI 10.1128/AAC.49.10.4166-4173.2005; Zbinden R., 2015, MANUAL CLIN MICROBIO, P652; Zeitlinger MA, 2004, J ANTIMICROB CHEMOTH, V54, P876, DOI 10.1093/jac/dkh443; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10; Zhou Q, 2017, FORESTS, V8, DOI 10.3390/f8080266; Zinner SH, 2003, J ANTIMICROB CHEMOTH, V52, P616, DOI 10.1093/jac/dkg401	49	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210154	10.1371/journal.pone.0210154	http://dx.doi.org/10.1371/journal.pone.0210154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629633	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000054
J	Galak, J; Chow, RM				Galak, Jeff; Chow, Rosalind M.			Compensate a little, but punish a lot: Asymmetric routes to restoring justice	PLOS ONE			English	Article							REWARD; PERPETRATOR; DETERRENCE; SYMPATHY; MOTIVES; IMPACT; WORLD	Most people have a desire to live in a just world, a place where good things happen to good people and bad things happen to bad people. And yet, injustices do occur: good things happen to bad people and bad things happen to good people. Across four experiments, we show that people respond quite differently to correct these two types of injustices. When bad things happen to good people, individuals are eager to compensate a good person's losses, but only do so to a small degree. In contrast, when a good thing happens to a bad person, because the only perceived appropriate act of punishment is to fully strip the bad actor of all his or her illegitimate gains, few people choose to punish in this costly way. However, when they do, they do so to very large degrees. Moreover, we demonstrate that differential psychological mechanisms drive this asymmetry.	[Galak, Jeff; Chow, Rosalind M.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Galak, J (corresponding author), Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.	jgalak@cmu.edu		Galak, Jeff/0000-0003-1166-8842				Adams GS, 2015, SOC PSYCHOL PERS SCI, V6, P31, DOI 10.1177/1948550614542346; [Anonymous], 2013, PSYCHOL INTERPERSONA; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Becker G.S., 1968, EC DIMENSIONS CRIME, P13; Bentham Jeremy, 1830, RATIONALE PUNISHMENT; Branas-Garza P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06025; Bryan JH, 1968, ETS RES B SERIES, V1968; Callan MJ, 2006, PERS SOC PSYCHOL B, V32, P1646, DOI 10.1177/0146167206292236; Carlsmith KM, 2006, J EXP SOC PSYCHOL, V42, P437, DOI 10.1016/j.jesp.2005.06.007; Carlsmith KM, 2002, J PERS SOC PSYCHOL, V83, P284, DOI 10.1037//0022-3514.83.2.284; CHAIKIN AL, 1973, J PERS SOC PSYCHOL, V25, P268, DOI 10.1037/h0033948; Corgnet B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00287; Crockett MJ, 2014, J EXP PSYCHOL GEN, V143, P2279, DOI 10.1037/xge0000018; Cropanzano R, 2003, J ORGAN BEHAV, V24, P1019, DOI 10.1002/job.228; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Eckel CC, 1996, RELATIVE PRICE FAIRN; Edele A, 2013, LEARN INDIVID DIFFER, V24, P96, DOI 10.1016/j.lindif.2012.12.020; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Feather N T, 1999, Pers Soc Psychol Rev, V3, P86, DOI 10.1207/s15327957pspr0302_1; Feather NT, 2002, PERS SOC PSYCHOL B, V28, P953, DOI 10.1177/01467202028007008; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Folger R., 2001, ADV ORG JUSTICE, P1; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Garza P, 2012, P R SOC B; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goldin G., 2013, TURKGATE VERSION 0 4; Hafer CL, 2005, PSYCHOL BULL, V131, P128, DOI 10.1037/0033-2909.131.1.128; Handy F, 2010, NONPROF VOLUNT SEC Q, V39, P498, DOI 10.1177/0899764009344353; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hogan R., 1981, JUSTICE MOTIVE SOCIA, P125; Hu Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00024; Janoff-Bulman R, 2013, PERS SOC PSYCHOL REV, V17, P219, DOI 10.1177/1088868313480274; Lerner M. J., 1976, ADV EXP SOC PSYCHOL, V9, P133, DOI DOI 10.1016/S0065-2601(08)60060-X; Lerner MJ, 1980, BELIEF JUST WORLD FU, P9, DOI [10. 1007/978-1-4899-0448-5_2, DOI 10.1007/978-1-4899-0448-5]; MCFATTER RM, 1978, J PERS SOC PSYCHOL, V36, P1490, DOI 10.1037/0022-3514.36.12.1490; Mulder LB, 2009, PSYCHOLOGICAL PERSPECTIVES ON ETHICAL BEHAVIOR AND DECISION MAKING, P169; Nagin DS, 1998, CRIME JUSTICE, V23, P1, DOI 10.1086/449268; Okimoto TG, 2011, SOC PSYCHOL PERS SCI, V2, P373, DOI 10.1177/1948550610393032; Raman L, 2004, BRIT J DEV PSYCHOL, V22, P255, DOI 10.1348/026151004323044609; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Shampanier K, 2007, MARKET SCI, V26, P742, DOI 10.1287/mksc.1060.0254; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Sober E., 1999, OTHERS EVOLUTION PSY; Sutter M, 2010, REV ECON STUD, V77, P1540, DOI 10.1111/j.1467-937X.2010.00608.x; Sutton RI, 2007, NO ASSHOLE RULE BUIL; Tenbrunsel AE, 1999, ADMIN SCI QUART, V44, P684, DOI 10.2307/2667052; Tetlock P.E., 1996, REVISING VALUE PLURA; Tetlock PE, 2007, J EXP SOC PSYCHOL, V43, P195, DOI 10.1016/j.jesp.2006.02.009; Turillo CJ, 2002, ORGAN BEHAV HUM DEC, V89, P839, DOI 10.1016/S0749-5978(02)00032-8; Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07; van Prooijen JW, 2010, EUR J SOC PSYCHOL, V40, P72, DOI 10.1002/ejsp.611; Whitson JA, 2015, ORGAN BEHAV HUM DEC, V128, P84, DOI 10.1016/j.obhdp.2015.03.006	56	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210676	10.1371/journal.pone.0210676	http://dx.doi.org/10.1371/journal.pone.0210676			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629720	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000124
J	Show, KL; Le Win, L; Saw, S; Myint, CK; Than, KM; Oo, YTN; Wai, KT				Show, Kyaw Lwin; Le Win, Le; Saw, Saw; Myint, Chomar Kaung; Than, Kyi Maw; Oo, Yin Thet Nu; Wai, Khin Thet			Knowledge of potential risk of blood-borne viral infections and tattooing practice among adults in Mandalay Region, Myanmar	PLOS ONE			English	Article							BODY PIERCINGS; PREVALENCE	Introduction Tattooing especially gains popularity among both men and women in adulthood from the wide range of socioeconomic groups and is noted as a risk taking behaviour in adults. Especially when tattooing does not perform to the highest standards, it can potentially be the hazardous practice. Myanmar has a paucity of evidence-based information on the estimated prevalence of tattoos and awareness of potential disease transmission from tattooing under insanitary conditions as well as the infection risk. The present research was undertaken to help identify the self-reported prevalence of tattooing among adults (18-35 years) and their knowledge of transmission risk of blood-borne infections and its determinants. Methods A community-based cross-sectional study focused on residents aged 18-35 years was carried out in two urban and two rural areas in Mandalay district, Mandalay Region during 2015. Trained interviewers used a pre-tested structured questionnaire for face-to-face interviews with one eligible participant per selected household (n = 401). Bivariate analysis and multivariable analysis using binary logistic regression were done to ascertain the relevant explanatory variables. Results The overall self-reported prevalence of tattooing was 19.5% (78/401) (95% CI = 16-24). Nearly 80% of participants (318/401) knew at least one blood-borne viral infection that could be transmitted from tattooing. The persons who had high formal education, manual laborers and those who lived with their families were significantly more likely to cite at least one blood-borne viral infection. Their perceived possibility to remove tattoo independently influenced the practice of tattooing (aOR = 1.91, 95% CI = 1.06-3.45; p = 0.03) compared with participants who reported no perceived possibility. Tattooing was more common in male (aOR = 13.07, 95% CI = 6.25- 27.33; p<0.001) compared to female which was independently significant. Conclusions This study ascertained the tattoo prevalence as two in ten adults of working age especially among male in central part of Myanmar in the context of lack of registration system for tattoo parlours and the issuance of safety guidelines. Findings have suggested the target groups and risk factors to be included in future health promotion programs. Future research directions should focus on perspectives of tattooists to create and sustain the sanitary practices to reduce the chance of transmission of blood- borne viral infections.	[Show, Kyaw Lwin; Le Win, Le; Saw, Saw; Than, Kyi Maw; Oo, Yin Thet Nu; Wai, Khin Thet] Minist Hlth & Sports, Dept Med Res, Yangon, Myanmar; [Myint, Chomar Kaung] Univ Publ Hlth, Yangon, Myanmar		Show, KL (corresponding author), Minist Hlth & Sports, Dept Med Res, Yangon, Myanmar.	kyawlwins@gmail.com	Show, Kyaw Lwin/ABD-8457-2020	Saw, Saw/0000-0002-7778-6086; Show, Kyaw Lwin/0000-0001-9349-5134	World Health Organization (WHO) [2014/455422-0]	World Health Organization (WHO)(World Health Organization)	Funding was provided by the World Health Organization (WHO Registration 2014/455422-0) to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyedun V., LIT REV EPIDEMIOLOGY; [Anonymous], 2016, 2014 MYANMAR POPULAT; Bai JR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-50; Bone A, 2008, BRIT MED J, V336, P1426, DOI 10.1136/bmj.39580.497176.25; Carroll ST, 2002, PEDIATRICS, V109, P1021, DOI 10.1542/peds.109.6.1021; Cegolon L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-73; Deschesnes M., CANADIAN J PUBLIC HL, V97, P325; Dey A, 2017, SOCIOL INT J, V1; Forbes GB, 2001, PSYCHOL REP, V89, P774, DOI 10.2466/pr0.2001.89.3.774; Galle F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-625; Heywood W, 2012, ANN EPIDEMIOL, V22, P51, DOI 10.1016/j.annepidem.2011.10.005; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Lipscomb T. J., 2008, SERVICES MARKETING Q, V29, P42, DOI [10.1080/15332960802218745, DOI 10.1080/15332960802218745]; Mayers LB, 2002, MAYO CLIN PROC, V77, P29, DOI 10.4065/77.1.29; Mayers L, 2007, ARCH PEDIAT ADOL MED, V161, P1219, DOI 10.1001/archpedi.161.12.1219-b; Mayers LB, 2008, J ADOLESCENT HEALTH, V42, P201, DOI 10.1016/j.jadohealth.2007.09.014; Rapid Response Service, 2012, RAP RESP HIV RISKS A; Schorzman CM, 2007, J AM OSTEOPATH ASSOC, V107, P432; SPERRY K, 1991, AM J FOREN MED PATH, V12, P313, DOI 10.1097/00000433-199112000-00008; Stieger S, 2010, PERCEPT MOTOR SKILL, V110, P1065, DOI 10.2466/07.13.17.PMS.110.C.1065-1074; Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820; Wohlrab S, 2007, BODY IMAGE, V4, P87, DOI 10.1016/j.bodyim.2006.12.001	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0209853	10.1371/journal.pone.0209853	http://dx.doi.org/10.1371/journal.pone.0209853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629615	Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000038
J	Silvestrini, A; Bruno, C; Vergani, E; Venuti, A; Favuzzi, AMR; Guidi, F; Nicolotti, N; Meucci, E; Mordente, A; Mancini, A				Silvestrini, Andrea; Bruno, Carmine; Vergani, Edoardo; Venuti, Angela; Favuzzi, Angela Maria Rita; Guidi, Francesco; Nicolotti, Nicola; Meucci, Elisabetta; Mordente, Alvaro; Mancini, Antonio			Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study	PLOS ONE			English	Article							ASSOCIATION; PLASMA; SERUM	Irisin, a recently discovered myokine, has been considered a prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin in patients with heart failure (HF), both with preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evaluated the circulating irisin levels in HFpEF and HFrEF patients, correlating them with metabolic parameters and total antioxidant capacity (TAC), as index of oxidative stress. Irisin was significantly higher in HFpEF than in HFrEF patients (7.72 +/- 0.76 vs 2.77 +/- 0.77 ng/ml, respectively). An inverse correlation between irisin and TAC was found in HFpEF, but not in HFrEF. Conversely, no correlation was present with HOMA index. These data support the hypothesis that a different pathophysiological mechanism is involved in the two HF subtypes, and oxidative stress modulates irisin secretion.	[Silvestrini, Andrea; Meucci, Elisabetta; Mordente, Alvaro] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Biochem & Clin Biochem, Rome, Italy; [Bruno, Carmine; Vergani, Edoardo; Mancini, Antonio] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Endocrinol, Internal Med Dept, Rome, Italy; [Venuti, Angela; Favuzzi, Angela Maria Rita] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Internal Med & Cardiovasc Dis, Internal Med Dept, Rome, Italy; [Guidi, Francesco] Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Gen Pathol, Rome, Italy; [Nicolotti, Nicola] Roma Univ Cattolica Sacro Cuore, Hosp Med Direct, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Silvestrini, A (corresponding author), Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Inst Biochem & Clin Biochem, Rome, Italy.; Mancini, A (corresponding author), Roma Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Div Endocrinol, Internal Med Dept, Rome, Italy.	andrea.silvestrini@unicatt.it; mancini.giac@mclink.it	Guidi, Francesco/AAS-9209-2021; Nicolotti, Nicola/K-1846-2018; Mordente, Alvaro/AAB-7290-2019; Vergani, Edoardo/GLT-3879-2022; Nicolotti, Nicola/P-9895-2019; Silvestrini, Andrea/B-3410-2009	Nicolotti, Nicola/0000-0002-3096-6397; Vergani, Edoardo/0000-0002-8444-0091; Nicolotti, Nicola/0000-0002-3096-6397; Silvestrini, Andrea/0000-0002-2005-3746; Bruno, Carmine/0000-0002-3489-0238				Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Borlaug BA, 2011, CARDIOL CLIN, V29, P447, DOI 10.1016/j.ccl.2011.06.004; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Han F, 2015, AM J PHYSIOL-HEART C, V309, pH1501, DOI 10.1152/ajpheart.00443.2015; Hosmer DW, 1997, STAT MED, V16, P965; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Mancini A, 2008, METABOLISM, V57, P1384, DOI 10.1016/j.metabol.2008.05.007; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1; Polyzos SA, 2015, METABOLISM, V64, P937, DOI 10.1016/j.metabol.2015.06.005; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reddy YNV, 2016, CURR PROB CARDIOLOGY, V41, P145, DOI 10.1016/j.cpcardiol.2015.12.002; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; Tromp J, 2017, JACC-HEART FAIL, V5, P507, DOI 10.1016/j.jchf.2017.04.007; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	20	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210320	10.1371/journal.pone.0210320	http://dx.doi.org/10.1371/journal.pone.0210320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657767	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000009
J	Peretti, DE; Garcia, DV; Reesink, FE; van der Goot, T; De Deyn, PP; de Jong, BM; Dierckx, RAJO; Boellaard, R				Peretti, Debora E.; Garcia, David Vallez; Reesink, Fransje E.; van der Goot, Tim; De Deyn, Peter P.; de Jong, Bauke M.; Dierckx, Rudi A. J. O.; Boellaard, Ronald			Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies	PLOS ONE			English	Article							REFERENCE TISSUE MODEL; BLOOD-FLOW; SENILE PLAQUES; EARLY-PHASE; BRAIN; DIAGNOSIS; IMAGES; F-18-FDG-PET; CEREBELLUM; METABOLISM	In Alzheimer's Disease (AD) dual-tracer positron emission tomography (PET) studies with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) and C-11-labelled Pittsburgh Compound B (PIB) are used to assess metabolism and cerebral amyloid-beta deposition, respectively. Regional cerebral metabolism and blood flow (rCBF) are closely coupled, both providing an index for neuronal function. The present study compared PIB-derived rCBF, estimated by the ratio of tracer influx in target regions relative to reference region (R-1) and early-stage PIB uptake (ePIB), to FDG scans. Fifteen PIB positive (+) patients and fifteen PIB negative (-) subjects underwent both FDG and PIB PET scans to assess the use of R-1 and ePIB as a surrogate for FDG. First, subjects were classified based on visual inspection of the PIB PET images. Then, discriminative performance (PIB+ versus PIB-) of rCBF methods were compared to normalized regional FDG uptake. Strong positive correlations were found between analyses, suggesting that PIB-derived rCBF provides information that is closely related to what can be seen on FDG scans. Yet group related differences between method's distributions were seen as well. Also, a better correlation with FDG was found for R-1 than for ePIB. Further studies are needed to validate the use of R-1 as an alternative for FDG studies in clinical applications.	[Peretti, Debora E.; Garcia, David Vallez; van der Goot, Tim; Dierckx, Rudi A. J. O.; Boellaard, Ronald] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Reesink, Fransje E.; De Deyn, Peter P.; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Alzheimer Res Ctr, Dept Neurol, Groningen, Netherlands; [De Deyn, Peter P.] Univ Antwerp, Lab Neurochem & Behav, Inst Born Bunge, Antwerp, Belgium	University of Groningen; University of Groningen; University of Antwerp	Garcia, DV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	d.vallez-garcia@umcg.nl	García, David Vállez/N-2348-2015	García, David Vállez/0000-0003-3308-3167; Peretti, Debora Elisa/0000-0002-3033-8817; De Deyn, Peter Paul/0000-0002-2228-2964; de Jong, Bauke M./0000-0002-6568-5739				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Blomquist Gunnar, 2008, Open Neuroimag J, V2, P114, DOI 10.2174/1874440000802010114; Chen YJ, 2015, J NUCL MED, V56, P1199, DOI 10.2967/jnumed.114.152405; Daerr S, 2017, NEUROIMAGE-CLIN, V14, P77, DOI 10.1016/j.nicl.2016.10.005; Forsberg A, 2012, BBA-MOL BASIS DIS, V1822, P380, DOI 10.1016/j.bbadis.2011.11.006; Gjedde A, 2013, FRONT AGING NEUROSCI, V5, P1, DOI DOI 10.3389/FNAGI.2013.00001; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Greve DN, 2016, NEUROIMAGE, V132, P334, DOI 10.1016/j.neuroimage.2016.02.042; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Grimmer T, 2009, NEUROBIOL AGING, V30, P1902, DOI 10.1016/j.neurobiolaging.2008.01.016; Gur RC, 2009, CEREB CORTEX, V19, P375, DOI 10.1093/cercor/bhn087; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hsiao IT, 2013, EUR J NUCL MED MOL I, V40, P908, DOI 10.1007/s00259-013-2350-x; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust W, 2007, NEUROLOGY, V69, P871, DOI 10.1212/01.wnl.0000269790.05105.16; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lopresti BJ, 2005, J NUCL MED, V46, P1959; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meyer PT, 2011, J NUCL MED, V52, P393, DOI 10.2967/jnumed.110.083683; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Morbelli S, 2015, J ALZHEIMERS DIS, V44, P815, DOI 10.3233/JAD-142229; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; R Development Core Team, 2017, R A LANGUAGE AND ENV; Rodriguez-Vieitez E, 2017, J CEREBR BLOOD F MET, V37, P740, DOI 10.1177/0271678X16645593; Rodriguez-Vieitez E, 2016, J NUCL MED, V57, P1071, DOI 10.2967/jnumed.115.168732; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Rousset OG, 1998, J NUCL MED, V39, P904; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Teipel S, 2015, LANCET NEUROL, V14, P1037, DOI 10.1016/S1474-4422(15)00093-9; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Tiepolt S, 2016, EUR J NUCL MED MOL I, V43, P1700, DOI 10.1007/s00259-016-3353-1; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; YAMAGUCHI H, 1989, ACTA NEUROPATHOL, V77, P314, DOI 10.1007/BF00687584; Yaqub M, 2008, NEUROIMAGE, V42, P76, DOI 10.1016/j.neuroimage.2008.04.251; Zhou Y, 2007, NEUROIMAGE, V36, P298, DOI 10.1016/j.neuroimage.2007.03.004	46	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211000	10.1371/journal.pone.0211000	http://dx.doi.org/10.1371/journal.pone.0211000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653612	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500096
J	Simonsen, C; Thorsteinsson, K; Mortensen, RN; Torp-Pedersen, C; Kjaergaard, B; Andreasen, JJ				Simonsen, Carsten; Thorsteinsson, Kristinn; Mortensen, Rikke Normark; Torp-Pedersen, Christian; Kjaergaard, Benedict; Andreasen, Jan Jesper			Carbon monoxide poisoning in Denmark with focus on mortality and factors contributing to mortality	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; LONG-TERM MORTALITY; SUICIDE	Introduction Carbon monoxide (CO) poisoning is frequent worldwide but knowledge regarding the epidemiology is insufficient. The aim of this study was to clarify the extent of this intoxication, its mortality and factors associated with mortality. Materials and methods National databases from Statistics Denmark were used to identify individuals who suffered from CO-poisoning during 1995-2015, as well as information regarding co-morbidities, mortality and manner of death. Results During the period from 1995 to 2015, 22,930 patients suffered from CO-poisoning in Denmark, and 21,138 of these patients (92%) were hospitalized. A total of 2,102 patients died within the first 30 days after poisoning (9.2%). Among these, 1,792 (85% of 2,102) were declared dead at the scene and 310 (15% of 2,102) died during hospitalization. Deaths due to CO-poisoning from smoke were intentional in 6.3% of cases, whereas deaths due to CO containing gases were intentional in 98.0% of cases. Among patients who survived > 30 days, there was no significant difference in survival when comparing hyperbaric oxygen therapy (HBO) treatment with no HBO treatment after adjustment for age and co-morbidities such as drug abuse, psychiatric disease, stroke, alcohol abuse, arterial embolism, chronic obstructive pulmonary disease, cerebrovascular disease and atrial fibrillation. Several co-morbidities predicted poorer outcomes for patients who survived the initial 30 days. Conclusions Poisoning from smoke and/or CO is a frequent incident in Denmark accounting for numerous contacts with hospitals and deaths. Both intoxication and mortality are highly associated with co-morbidities interfering with cognitive and physical function. Treatment with HBO was not seen to have an effect on survival.	[Simonsen, Carsten; Thorsteinsson, Kristinn; Kjaergaard, Benedict; Andreasen, Jan Jesper] Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark; [Simonsen, Carsten; Andreasen, Jan Jesper] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Mortensen, Rikke Normark; Torp-Pedersen, Christian] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark; [Kjaergaard, Benedict] Biomed Res Lab, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Simonsen, C (corresponding author), Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark.; Simonsen, C (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	carsten.simonsen@rn.dk	Kjaergaard, Benedict/HHD-1772-2022	Kjaergaard, Benedict/0000-0001-5797-7638	Brodrene Hartmanns Fond [A31510]	Brodrene Hartmanns Fond	This research received funding from "Brodrene Hartmanns Fond," application number A31510 to CS; www.hartmannfonden.dk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelborg K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012817; Al-Moamary MS, 2000, SAUDI MED J, V21, P361; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Braubach M, 2013, INDOOR AIR, V23, P115, DOI 10.1111/ina.12007; Buckley NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002041.pub3; Dalgaard Jorgen B., 1961, ACTA JUTL, V33; Graversen Rie, 2017, COFORGIFTNING VISITA; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Hampson NB, 2016, ANN AM THORAC SOC, V13, P1768, DOI 10.1513/AnnalsATS.201604-318OC; Hampson NB, 2015, UNDERSEA HYPERBAR M, V42, P159; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Huang CC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100349; Huang CC, 2017, CHEST, V152, P943, DOI 10.1016/j.chest.2017.03.049; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lee FY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000624; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen T, 2013, J CLIN PSYCHIAT, V74, pE1190, DOI 10.4088/JCP.13m08656; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Mutluoglu M, 2016, UNDERSEA HYPERBAR M, V43, P49; Neuman TS., 2008, PHYSL MED HYPERBARIC; Nordentoft M, 2007, DAN MED BULL, V54, P306; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Rose JJ, 2018, CRIT CARE MED, V46, pE649, DOI 10.1097/CCM.0000000000003135; Rose JJ, 2017, AM J RESP CRIT CARE, V195, P596, DOI 10.1164/rccm.201606-1275CI; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sundhedsstyrelsen, 2003, VISITATION OVERFLYTN; Tapeantong Toungrat, 2009, Journal of the Medical Association of Thailand, V92, P1374; Thomsen AH, 2006, FORENSIC SCI INT, V161, P41, DOI 10.1016/j.forsciint.2005.10.022; Thomsen Asser Hedegard, 2007, Ugeskr Laeger, V169, P2020; Van Sickle D, 2006, CLIN CHEM, V52, P338, DOI 10.1373/clinchem.2005.061911; Vest-Hansen Betina, 2013, Clin Epidemiol, V5, P129, DOI 10.2147/CLEP.S41905	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210767	10.1371/journal.pone.0210767	http://dx.doi.org/10.1371/journal.pone.0210767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653615	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500069
J	Tonn, B; Porath, I; Lattanzi, FA; Isselstein, J				Tonn, Bettina; Porath, Ina; Lattanzi, Fernando A.; Isselstein, Johannes			Urine effects on grass and legume nitrogen isotopic composition: Pronounced short-term dynamics of delta N-15	PLOS ONE			English	Article							NATURAL N-15 ABUNDANCE; AMMONIA VOLATILIZATION; OXIDE EMISSIONS; GRAZED PASTURE; SOIL; VEGETATION; PLANTS; FATE; PHOSPHORUS; PARAMETERS	Nitrogen stable isotope (N-15) natural abundance is widely used to study nitrogen cycling. In grazed ecosystems, urine patches are hot-spots of nitrogen inputs, losses, and changes in delta N-15. Understanding delta N-15 dynamics in urine-affected vegetation is therefore crucial for accurate inferences from N-15 natural abundance in grasslands. We hypothesized that leaf delta N-15 following urine deposition varies with time and plant functional group. Specifically, we expected (i) short-term decreases in delta N-15 due to foliar absorption of N-15-depleted volatilized ammonia, (ii) followed by increases in delta N-15 due to uptake of N-15-enriched soil inorganic nitrogen, and (iii) that the magnitude of these changes is less in legumes than in grasses. The latter should be expected because ammonia absorption depends on leaf nitrogen concentration, which is higher in legumes than grasses, and because biological nitrogen fixation will modify the influence of urine-derived nitrogen on delta N-15 in legumes. We applied cattle urine to a mixture of Lolium perenne and Trifolium repens in a pot experiment. Nitrogen concentration and delta N-15 were determined for successive leaf cohorts and bulk biomass either 17 (early) or 32 (late) days after urine application. Early after urine application, leaves of L. perenne were N-15-depleted compared to control plants (delta N-15 0.1 vs. 5.8 parts per thousand, respectively), but leaves of T. repens were not (-1.1 vs. -1.1 parts per thousand, respectively). Later, both species increased their delta N-15, but T. repens (4.5 parts per thousand) less so than L. perenne (5.9 parts per thousand). Vegetation sampled within and outside urine patches in the field further supported these results. Our findings confirm that foliar ammonia uptake can substantially decrease grass foliar delta N-15, and that in both grass and legume the direction of the delta N-15 response to urine changes over time. Temporal dynamics of plant delta N-15 at urine patches therefore need to be explicitly addressed when N-15 natural abundance is used to study nitrogen cycling in grazed grasslands.	[Tonn, Bettina; Porath, Ina; Isselstein, Johannes] Univ Goettingen, Dept Crop Sci, Grassland Sci, Gottingen, Germany; [Lattanzi, Fernando A.] Tech Univ Munich, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany; [Lattanzi, Fernando A.] Inst Nacl Invest Agr INIA Uruguay, INIA La Estanzuela, Colonia, Uruguay; [Isselstein, Johannes] Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; Technical University of Munich; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA)	Tonn, B (corresponding author), Univ Goettingen, Dept Crop Sci, Grassland Sci, Gottingen, Germany.	btonn@gwdg.de	Lattanzi, Fernando/A-5609-2009; Tonn, Bettina/AAH-5302-2019	Lattanzi, Fernando/0000-0002-2682-3692; Tonn, Bettina/0000-0003-1086-1990				[Anonymous], 2014, AGR ECOSYST ENVIRON, V184, P158, DOI [10.1016/j.agee.2013.11.028, DOI 10.1016/J.AGEE.2013.11.028]; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Barton K., 2020, MUMIN MULTIMODEL INF; Cameron KC, 2014, NEW ZEAL J AGR RES, V57, P251, DOI 10.1080/00288233.2013.797914; CARLSON GE, 1966, CROP SCI, V6, P293, DOI 10.2135/cropsci1966.0011183X000600030024x; Craine JM, 2015, PLANT SOIL, V396, P1, DOI 10.1007/s11104-015-2542-1; Craine JM, 2012, PLANT SOIL, V356, P395, DOI 10.1007/s11104-012-1141-7; Decau ML, 2003, J ENVIRON QUAL, V32, P1405, DOI 10.2134/jeq2003.1405; Dennis SJ, 2013, GRASS FORAGE SCI, V68, P378, DOI 10.1111/gfs.12000; Eriksen J, 1998, PLANT SOIL, V205, P67, DOI 10.1023/A:1004353229409; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; FARQUHAR GD, 1980, PLANT PHYSIOL, V66, P710, DOI 10.1104/pp.66.4.710; Frank DA, 2004, BIOGEOCHEMISTRY, V68, P169, DOI 10.1023/B:BIOG.0000025736.19381.91; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Kriszan M, 2014, AGR ECOSYST ENVIRON, V184, P158, DOI 10.1016/j.agee.2013.11.028; LEDGARD SF, 1982, NEW ZEAL J AGR RES, V25, P541, DOI 10.1080/00288233.1982.10425219; Li CL, 2010, J PLANT NUTR SOIL SC, V173, P946, DOI 10.1002/jpln.200900243; Massad RS, 2010, ATMOS CHEM PHYS, V10, P10359, DOI 10.5194/acp-10-10359-2010; Moir JL, 2011, J AGR SCI-CAMBRIDGE, V149, P473, DOI 10.1017/S0021859610001012; PARSONS AJ, 1991, J AGR SCI, V116, P47, DOI 10.1017/S0021859600076139; Pinheiro J, R PACKAGE VERSION; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Schjoerring JK, 1998, ATMOS ENVIRON, V32, P491, DOI 10.1016/S1352-2310(97)00006-X; Schnyder H, 2006, GLOBAL CHANGE BIOL, V12, P1315, DOI 10.1111/j.1365-2486.2006.01169.x; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Team RC., 2013, R LANG ENV STAT COMP; THOMAS RJ, 1988, PLANT SOIL, V107, P173, DOI 10.1007/BF02370544; Wachendorf C, 2008, J PLANT NUTR SOIL SC, V171, P171, DOI 10.1002/jpln.200625217; Watzka M, 2006, SOIL BIOL BIOCHEM, V38, P1564, DOI 10.1016/j.soilbio.2005.11.007; Wells NS, 2015, AGR ECOSYST ENVIRON, V199, P290, DOI 10.1016/j.agee.2014.10.001; Whitehead CD, 2000, NUTR ELEMENTS GRASSL; WHITEHEAD DC, 1991, BIOL FERT SOILS, V11, P279, DOI 10.1007/BF00335848; Wittmer MHOM, 2011, PLANT SOIL, V340, P25, DOI 10.1007/s11104-010-0411-5; Wrage N, 2011, NUTR CYCL AGROECOSYS, V90, P189, DOI 10.1007/s10705-011-9421-9; Xu YQ, 2010, J PLANT ECOL-UK, V3, P201, DOI 10.1093/jpe/rtq023	40	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210623	10.1371/journal.pone.0210623	http://dx.doi.org/10.1371/journal.pone.0210623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650124	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300064
J	Brekke, IJ; Puntervoll, LH; Pedersen, PB; Kellett, J; Brabrand, M				Brekke, Idar Johan; Puntervoll, Lars Haland; Pedersen, Peter Bank; Kellett, John; Brabrand, Mikkel			The value of vital sign trends in predicting and monitoring clinical deterioration: A systematic review	PLOS ONE			English	Review							IN-HOSPITAL MORTALITY; EARLY WARNING SCORE; PROGNOSTIC IMPLICATIONS; CARE; ADMISSION; ASSOCIATION; ANTECEDENTS; FREQUENCY; QUALITY; IMPACT	Background Vital signs, i.e. respiratory rate, oxygen saturation, pulse, blood pressure and temperature, are regarded as an essential part of monitoring hospitalized patients. Changes in vital signs prior to clinical deterioration are well documented and early detection of preventable outcomes is key to timely intervention. Despite their role in clinical practice, how to best monitor and interpret them is still unclear. Objective To evaluate the ability of vital sign trends to predict clinical deterioration in patients hospitalized with acute illness. Data Sources PubMed, Embase, Cochrane Library and CINAHL were searched in December 2017. Study Selection Studies examining intermittently monitored vital sign trends in acutely ill adult patients on hospital wards and in emergency departments. Outcomes representing clinical deterioration were of interest. Data Extraction Performed separately by two authors using a preformed extraction sheet. Results Of 7,366 references screened, only two were eligible for inclusion. Both were retrospective cohort studies without controls. One examined the accuracy of different vital sign trend models using discrete-time survival analysis in 269,999 admissions. One included 44,531 medical admissions examining trend in Vitalpac Early Warning Score weighted vital signs. They stated that vital sign trends increased detection of clinical deterioration. Critical appraisal was performed using evaluation tools. The studies had moderate risk of bias, and a low certainty of evidence. Additionally, four studies examining trends in early warning scores, otherwise eligible for inclusion, were evaluated. Conclusions This review illustrates a lack of research in intermittently monitored vital sign trends. The included studies, although heterogeneous and imprecise, indicates an added value of trend analysis. This highlights the need for well-controlled trials to thoroughly assess the research question.	[Brekke, Idar Johan; Puntervoll, Lars Haland; Pedersen, Peter Bank] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Pedersen, Peter Bank; Brabrand, Mikkel] Odense Univ Hosp, Dept Emergency Med, Odense, Denmark; [Kellett, John; Brabrand, Mikkel] Hosp South West Jutland, Dept Emergency Med, Esbjerg, Denmark; [Kellett, John; Brabrand, Mikkel] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Brekke, IJ (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	idar.j.brekke@gmail.com	Brekke, Idar Johan/AAI-3585-2021; Brabrand, Mikkel/F-7276-2011	Brekke, Idar Johan/0000-0002-1022-2227; Brabrand, Mikkel/0000-0002-3340-8251; Bank Pedersen, Peter/0000-0002-2831-674X				Baker T, 2017, EUR J INTERN MED, V45, P37, DOI 10.1016/j.ejim.2017.09.012; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-28; Bruera S, 2014, J PAIN SYMPTOM MANAG, V48, P510, DOI 10.1016/j.jpainsymman.2013.10.019; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Cardona-Morrell M, 2016, INT J CLIN PRACT, V70, P806, DOI 10.1111/ijcp.12846; Cardona-Morrell M, 2016, INT J NURS STUD, V56, P9, DOI 10.1016/j.ijnurstu.2015.12.007; Cardona-Morrell M, 2017, TXB RAPID RESPONSE S, P277; Chua WL, 2013, INT NURS REV, V60, P501, DOI 10.1111/inr.12061; Churpek MM, 2016, RESUSCITATION, V102, P1, DOI 10.1016/j.resuscitation.2016.02.005; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Downey CL, 2018, INT J NURS STUD, V84, P19, DOI 10.1016/j.ijnurstu.2018.04.013; Farrohknia N, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-42; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Goldstein BA, 2015, J BIOMED INFORM, V57, P219, DOI 10.1016/j.jbi.2015.08.010; Groarke JD, 2008, EMERG MED J, V25, P803, DOI 10.1136/emj.2007.051425; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Henriksen DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094649; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Hogan Jacqueline, 2006, Br J Nurs, V15, P489; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; Kellett J, 2015, Acute Med, V14, P3; Kellett J., 2017, TXB RAPID RESPONSE S, P63, DOI DOI 10.1007/978-3-319-39391-9_8; Kellett J, 2017, EUR J INTERN MED, V45, P13, DOI 10.1016/j.ejim.2017.09.018; Kellett J, 2013, RESUSCITATION, V84, P471, DOI 10.1016/j.resuscitation.2012.12.002; Kellett J, 2013, RESUSCITATION, V84, P13, DOI 10.1016/j.resuscitation.2012.08.331; Kellett J, 2011, EUR J INTERN MED, V22, P394, DOI 10.1016/j.ejim.2011.01.013; Kellett J, 2011, EUR J INTERN MED, V22, P375, DOI 10.1016/j.ejim.2011.03.005; Kim WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130523; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; Ljunggren M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0213-8; Mao Y, 2011, 2011 IEEE 11 INT C D; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Pedersen NE, 2016, ACTA ANAESTH SCAND, V60, P616, DOI 10.1111/aas.12668; Puskarich MA, 2017, CLIN EXP EMERG MED, V4, P2, DOI 10.15441/ceem.16.144; Quarterman CPJ, 2005, J EVAL CLIN PRACT, V11, P133, DOI 10.1111/j.1365-2753.2005.00513.x; Sankey CB, 2016, J GEN INTERN MED, V31, P895, DOI 10.1007/s11606-016-3654-x; Schmidt PE, 2015, BMJ QUAL SAF, V24, P10, DOI 10.1136/bmjqs-2014-003073; Smith GB, 2017, INT J NURS STUD, V74, pA1, DOI 10.1016/j.ijnurstu.2017.07.001; Smith GB, 2002, POSTGRAD MED J, V78, P335, DOI 10.1136/pmj.78.920.335; Smith LB, 2009, CIN-COMPUT INFORM NU, V27, P318, DOI 10.1097/NCN.0b013e3181b21d65; Still M, 2017, J NURS CARE QUAL; van Loon K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144626; Wang J, 2017, INT J GEN MED, V10, P329, DOI 10.2147/IJGM.S145933; Wheatley Iain, 2006, Intensive Crit Care Nurs, V22, P115, DOI 10.1016/j.iccn.2005.08.003; Wong J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-171; Yoder JC, 2013, JAMA INTERN MED, V173, P1554, DOI 10.1001/jamainternmed.2013.7791; Zimlichman E, 2012, J HOSP MED, V7, P628, DOI 10.1002/jhm.1963	48	65	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210875	10.1371/journal.pone.0210875	http://dx.doi.org/10.1371/journal.pone.0210875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645637	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200060
J	Celi, LA; Citi, L; Ghassemi, M; Pollard, TJ				Celi, Leo A.; Citi, Luca; Ghassemi, Marzyeh; Pollard, Tom J.			The PLOS ONE collection on machine learning in health and biomedicine: Towards open code and open data	PLOS ONE			English	Article							COMPUTER CODE; BIG DATA; GENETICS	Recent years have seen a surge of studies in machine learning in health and biomedicine, driven by digitalization of healthcare environments and increasingly accessible computer systems for conducting analyses. Many of us believe that these developments will lead to significant improvements in patient care. Like many academic disciplines, however, progress is hampered by lack of code and data sharing. In bringing together this PLOS ONE collection on machine learning in health and biomedicine, we sought to focus on the importance of reproducibility, making it a requirement, as far as possible, for authors to share data and code alongside their papers.	[Celi, Leo A.; Pollard, Tom J.] MIT, MIT Lab Computat Physiol, Cambridge, MA 02139 USA; [Citi, Luca] Univ Essex, Sch Comp Sci & Elect Engn, Colchester, Essex, England; [Ghassemi, Marzyeh] Univ Toronto, Comp Sci & Med, Toronto, ON, Canada; [Ghassemi, Marzyeh] Vector Inst, Toronto, ON, Canada	Massachusetts Institute of Technology (MIT); University of Essex; University of Toronto	Pollard, TJ (corresponding author), MIT, MIT Lab Computat Physiol, Cambridge, MA 02139 USA.	tpollard@mit.edu	Citi, Luca/AAE-3192-2022	Citi, Luca/0000-0001-8702-5654; Pollard, Tom/0000-0002-5676-7898	National Institutes of Health [NIH-R01-EB017205, NIH-R01-EB001659, NIH-R01-GM104987]; Philips Healthcare; NSERC; European Union [689691, 687905]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips Healthcare; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	"LAC and TP receive funding from the National Institutes of Health (NIH-R01-EB017205, NIH-R01-EB001659, and NIH-R01-GM104987) and Philips Healthcare. MG is partially supported by an NSERC Discovery Grant. LC is partially funded through the European Union's Horizon 2020 research and innovation programme under grant agreements No 689691 (NEVERMIND) and No 687905 (DeTOP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlNoamany Y, 2018, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.163; Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Auffray C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0323-y; Baker M, 2016, NATURE, DOI [10.1038/nature.2016.20504, DOI 10.1038/NATURE.2016.20504]; Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Buckheit JB., 1995, WAVELETS STAT, P55, DOI [10.1007/978-1-4612-2544-7_5, DOI 10.1007/978-1-4612-2544-7_5]; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860; Economist, 2013, ECONOMIST; Eglen SJ, 2017, NAT NEUROSCI, V20, P770, DOI 10.1038/nn.4550; European Commission, RES INN PART PORT H2; Guinchard A, 2018, EUR LAW J, V24, P434, DOI 10.1111/eulj.12273; Ioannidis JPA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002576; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Kohane I S, 1996, Proc AMIA Annu Fall Symp, P608; Koitka S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207496; Kucur SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206081; LeVeque R. J., TOP 10 REASONS NOT S; Maggio V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208924; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; McLennan S, 2018, CHALLENGE LOCAL CONS, DOI [10.1007/s00134-018-5257-y, DOI 10.1007/S00134-018-5257-Y]; Mello MM, 2018, NEW ENGL J MED, V378, P2202, DOI 10.1056/NEJMsa1713258; Oudeyer P. -Y., 2016, CDS NEWSLETTER TECHN, V13; Piccolo SR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0135-4; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; PLOS, 2018, CALL PAP; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Stodden V, 2014, J OPEN RES SOFTWARE, V2, pe21, DOI DOI 10.5334/J0RS.AY; Stodden V, 2018, P NATL ACAD SCI USA, V115, P2584, DOI 10.1073/pnas.1708290115; Torvalds L., 2010, GIT FAST VERSION CON; UKRI, COMM PRINC DAT POL; Varoquaux G., 2016, NEWSLETTER IEEE TECH, V13; Vogeli C, 2006, ACAD MED, V81, P128, DOI 10.1097/00001888-200602000-00007; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wittek P., PLOS BLOGS STOP HIDI	37	17	17	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210232	10.1371/journal.pone.0210232	http://dx.doi.org/10.1371/journal.pone.0210232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645625	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000455810200021
J	Hollnagel, JO; Elzoheiry, S; Gorgas, K; Kins, S; Beretta, CA; Kirsch, J; Kuhse, J; Kann, O; Kiss, E				Hollnagel, Jan-Oliver; Elzoheiry, Shehabeldin; Gorgas, Karin; Kins, Stefan; Beretta, Carlo Antonio; Kirsch, Joachim; Kuhse, Jochen; Kann, Oliver; Kiss, Eva			Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis	PLOS ONE			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; GAMMA-OSCILLATIONS; SYNAPTIC PLASTICITY; PRESYNAPTIC BOUTONS; ENTORHINAL CORTEX; PROTEIN GEPHYRIN; DENTATE GYRUS; CALRETININ; BETA; INTERNEURONS	Several lines of evidence imply changes in inhibitory interneuron connectivity and subsequent alterations in oscillatory network activities in the pathogenesis of Alzheimer's Disease (AD). Recently, we provided evidence for an increased immunoreactivity of both the postsynaptic scaffold protein gephyrin and the GABA(A) receptor gamma 2-subunit in the hippocampus of young (1 and 3 months of age), APPPS1 mice. These mice represent a well-established model of cerebral amyloidosis, which is a hallmark of human AD. In this study, we demonstrate a robust increase of parvalbumin immunoreactivity and accentuated projections of parvalbumin positive (PV+) interneurons, which target perisomatic regions of pyramidal cells within the hippocampal subregions CA1 and CA3 of 3-month-old APPPS1 mice. Colocalisation studies confirmed a significant increase in the density of PV+ projections labeled with antibodies against a presynaptic (vesicular GABA transporter) and a postsynaptic marker (gephyrin) of inhibitory synapses within the pyramidal cell layer of CA1 and CA3. As perisomatic inhibition by PV+-interneurons is crucial for the generation of hippocampal network oscillations involved in spatial processing, learning and memory formation we investigated the impact of the putative enhanced perisomatic inhibition on two types of fast neuronal network oscillations in acute hippocampal slices: 1. spontaneously occurring sharp wave-ripple complexes (SPW-R), and 2. cholinergic gamma-oscillations. Interestingly, both network patterns were generally preserved in APPPS1 mice similar to WT mice. However, the comparison of simultaneous CA3 and CA1 recordings revealed that the incidence and amplitude of SPW-Rs were significantly lower in CA1 vs CA3 in APPPS1 slices, whereas the power of gamma-oscillations was significantly higher in CA3 vs CA1 in WT-slices indicating an impaired communication between the CA3 and CA1 network activities in APPPS1 mice. Taken together, our data demonstrate an increased GABAergic synaptic output of PV+ interneurons impinging on pyramidal cells of CA1 and CA3, which might limit the coordinated cross-talk between these two hippocampal areas in young APPPS1 mice and mediate long-term changes in synaptic inhibition during progression of amyloidosis.	[Hollnagel, Jan-Oliver; Elzoheiry, Shehabeldin; Kann, Oliver] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Gorgas, Karin; Kirsch, Joachim; Kuhse, Jochen; Kiss, Eva] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Kins, Stefan] Univ Kaiserslautern, Dept Human Biol & Human Genet, Kaiserslautern, Germany; [Beretta, Carlo Antonio] Heidelberg Univ, CellNetworks Math Clin Core Facil, Heidelberg, Germany; [Kiss, Eva] Univ Med & Pharm Targu Mures, Dept Cellular & Mol Biol, Targu Mures, Romania	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Kaiserslautern; Ruprecht Karls University Heidelberg; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Kuhse, J; Kiss, E (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany.; Kiss, E (corresponding author), Univ Med & Pharm Targu Mures, Dept Cellular & Mol Biol, Targu Mures, Romania.	jochen.kuhse@urz.uni-heidelberg.de; kiss@ana.uni-heidelberg.de	Kann, Oliver/M-4302-2019; Kuhse, Jochen/T-3864-2019	Kann, Oliver/0000-0003-4365-8067; , Eva/0000-0003-4052-2797; hollnagel, jan-oliver/0000-0002-4060-0022	Romanian Ministry of Research and Innovation CNCS- UEFISCDI within PNCDI III [PN-III-P4-ID-PCE-2016-0052]; Alzheimer Forschung Initiative e.V. (AFI) [17024]	Romanian Ministry of Research and Innovation CNCS- UEFISCDI within PNCDI III; Alzheimer Forschung Initiative e.V. (AFI)	This work was supported by a grant of Romanian Ministry of Research and Innovation CNCS- UEFISCDI (PN-III-P4-ID-PCE-2016-0052, within PNCDI III) to E.K. and was supported by a grant of the Alzheimer Forschung Initiative e.V. (AFI) (Project number: 17024) to J. Kuhse; E.K; S.K. URLs of funders: http://uefiscdi.gov.ro, https:// www.alzheimer-forschung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant of Romanian Ministry of Research and Innovation CNCS- UEFISCDI (PN-III-P4-ID-PCE-2016-0052, within PNCDI III) to E.K and a grant of the Alzheimer Forschung Initiative e.V. (AFI) (Project number: 17024) to J. Kuhse, E. K. and S.K.	Albuquerque MS, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/Thagi.2015.00030, 10.3389/fnagi.2015.00030]; Arendt T, 1997, J NEUROSCI, V17, P516; Auffret A, 2009, J NEUROSCI, V29, P10144, DOI 10.1523/JNEUROSCI.1856-09.2009; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Battaglia S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0203-17.2017; Bell KFS, 2003, NEUROSCI LETT, V353, P143, DOI 10.1016/j.neulet.2003.09.027; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Brady DR, 1997, NEUROSCIENCE, V80, P1113, DOI 10.1016/S0306-4522(97)00068-7; BRION JP, 1994, ACTA NEUROPATHOL, V88, P33, DOI 10.1007/BF00294357; Brown JA, 2015, MOL PSYCHIATR, V20, P1499, DOI 10.1038/mp.2014.192; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, ANNU REV NEUROSCI, V35, P203; Caliskan G, 2016, CEREB CORTEX, V26, P2325, DOI 10.1093/cercor/bhw001; Canas PM, 2014, NEUROPHARMACOLOGY, V76, P51, DOI 10.1016/j.neuropharm.2013.08.026; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; Chevaleyre V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00093; Chong SA, 2011, NEUROBIOL DIS, V44, P284, DOI 10.1016/j.nbd.2011.07.006; da Silva SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11915; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Driver JE, 2007, EUR J NEUROSCI, V26, P1280, DOI 10.1111/j.1460-9568.2007.05705.x; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; FLOOD DG, 1990, PROG BRAIN RES, V83, P435; Flores CE, 2015, P NATL ACAD SCI USA, V112, pE65, DOI 10.1073/pnas.1411170112; FONSECA M, 1993, NEUROSCIENCE, V55, P1107, DOI 10.1016/0306-4522(93)90324-9; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Hengen KB, 2016, CELL, V165, P180, DOI 10.1016/j.cell.2016.01.046; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; HOF PR, 1991, J NEUROPATH EXP NEUR, V50, P451, DOI 10.1097/00005072-199107000-00006; HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E; Hollnagel JO, 2015, NEUROSCIENCE, V284, P459, DOI 10.1016/j.neuroscience.2014.10.016; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hu L, 2003, NEUROSCIENCE, V121, P421, DOI 10.1016/S0306-4522(03)00394-4; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; Kiss E, 2016, AM J PATHOL, V186, P2279, DOI 10.1016/j.ajpath.2016.05.013; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klein AS, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00083; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; LEUNG LWS, 1982, ELECTROEN CLIN NEURO, V54, P203, DOI 10.1016/0013-4694(82)90162-6; Li YF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00031; Lietzau G, 2017, PSYCHONEUROENDOCRINO, V82, P46, DOI 10.1016/j.psyneuen.2017.04.012; Machado NJ, 2017, MOL NEUROBIOL, V54, P1552, DOI 10.1007/s12035-016-9774-9; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Mikkonen M, 1999, NEUROSCIENCE, V92, P515, DOI 10.1016/S0306-4522(99)00047-0; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roumis DK, 2015, CURR OPIN NEUROBIOL, V35, P6, DOI 10.1016/j.conb.2015.05.001; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Simburger E, 2000, CEREB CORTEX, V10, P422, DOI 10.1093/cercor/10.4.422; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Solodkin A, 1996, J NEUROSCI, V16, P3311; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; SU JH, 1993, BRAIN RES, V625, P228, DOI 10.1016/0006-8993(93)91063-X; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Teter B, 2002, J NEUROSCI RES, V70, P402, DOI 10.1002/jnr.10441; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Verdaguer E, 2015, EXP GERONTOL, V69, P176, DOI 10.1016/j.exger.2015.06.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang Y., 2017, J ALZHEIMERS DIS PAR, V7; Witton J, 2016, J PHYSIOL-LONDON, V594, P4615, DOI 10.1113/jphysiol.2014.282889; Zott B, 2018, ANNU REV NEUROSCI, V41, P277, DOI 10.1146/annurev-neuro-080317-061725	89	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209228	10.1371/journal.pone.0209228	http://dx.doi.org/10.1371/journal.pone.0209228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645585	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200008
J	Kalembo, FW; Kendall, GE; Ali, M; Chimwaza, AF				Kalembo, Fatch Welcome; Kendall, Garth E.; Ali, Mohammed; Chimwaza, Angela F.			Socio-demographic, clinical, and psychosocial factors associated with primary caregivers' decisions regarding HIV disclosure to their child aged between 6 and 12 years living with HIV in Malawi	PLOS ONE			English	Article							INFECTED CHILDREN; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; LIFE EXPECTANCY; SOCIAL SUPPORT; FAMILY SCALE; DIAGNOSIS; IMPACT; ADOLESCENTS; FOUNDATION	The World Health Organisation (WHO) recommends that children living with HIV should be informed about their HIV status within the ages of 6 to 12 years using age-appropriate resources. The aim of this study was to assess the socio-demographic, clinical and psycho-social factors associated with primary caregivers' decisions to disclose HIV to children living with HIV aged 6 to 12 years in Malawi. A cross-sectional study of 429 primary caregivers of children living with HIV were systematically recruited from all regions of the country. Information on HIV disclosure, family and child socio-demographic characteristics, child clinical characteristics, and child and family psychosocial characteristics was collected using validated instruments. Logistic regression was used to analyse data. The prevalence of non-disclosure of HIV status to children was 64 per cent. Concerns about the child's inability to cope with the news (29%), a lack of knowledge on how to disclose HIV status (19%), and fear of stigma and discrimination (17%) were the main reasons for non-disclosure. On multivariate analysis, the odds of non-disclosure were higher among primary caregivers who were farmers (aOR 3.0; 95% CI: 1.1-8.4), in younger children (6-8 years) (aOR 4.1; 95% CI: 2.3-7.4), in children who were in WHO HIV clinical stage one (aOR 3.8; 95% CI: 1.4-10.2), and in children who were not asking why they were taking ARVs (aOR 2.9; 95% CI: 1.8-4.8). On the other hand, nondisclosure of HIV status was less likely in underweight children (aOR 0.6; 95% CI: 0.3-0.9). Many children living with HIV in Malawi are unaware of their HIV status. Non-disclosure is associated with a number of clinical and demographic characteristics. The findings highlight the need to provide guidance and support to primary caregivers to help them to effectively disclose HIV status to their children.	[Kalembo, Fatch Welcome; Kendall, Garth E.; Ali, Mohammed] Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Kalembo, Fatch Welcome] Mzuzu Univ, Fac Hlth Sci, Mzuzu, Malawi; [Chimwaza, Angela F.] Univ Malawi, Kamuzu Coll Nursing, Blantyre, Malawi	Curtin University; University of Malawi	Kalembo, FW (corresponding author), Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.; Kalembo, FW (corresponding author), Mzuzu Univ, Fac Hlth Sci, Mzuzu, Malawi.	kalembofatch@yahoo.com		Kalembo, Fatch W./0000-0003-3032-3495				Amare Alemu, 2013, Journal of AIDS and Clinical Research, V4, P253; American Academy Paediatrics, 1999, J AM ACAD PEDIAT, V103, P164; Anderson M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-22; [Anonymous], 2011, MAL DEM HLTH SURV; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Binagwaho A., 2012, RWANDA MED J, V69, P9; Brewer Devon D, 2012, F1000Res, V1, P1, DOI 10.12688/f1000research.1-1.v1; Demmer C, 2011, AIDS CARE, V23, P873, DOI 10.1080/09540121.2010.542123; Doku Paul Narh, 2009, Int J Ment Health Syst, V3, P26, DOI 10.1186/1752-4458-3-26; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Dunst C., 1988, ENABLING EMPOWERING; DUNST CJ, 1986, AM J MENT DEF, V90, P403; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Fry K., 2014, MEASURING EQUITY NAT; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R., SCORING STRENGTHS DI; Government of Malawi, 2016, MAL POP BAS HIV IMP; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Kajubi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147119; Kajubi P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19012; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kuczmarski RJ, 2000, HEALTH, V11, P1; Madiba S., 2016, NURSING RES PRACTICE, V2016; Madiba S, 2016, NURS RES PRACT, V2016, DOI 10.1155/2016/9637587; Madiba S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/402403; Madiba S, 2015, PEERJ, V3, DOI 10.7717/peerj.893; Mahloko JM, 2012, AFR J ODI DISTR S AF, V4, P1, DOI [10.4102/phcfm.v4i1.345, DOI 10.4102/PHCFM.V4I1.345]; Malawi National Statistical Office Integrated Household Survey, 2010, HOUS SOC CHAR REP; Mandalazi P, 2014, MALAWI MED J, V26, P101; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Mccleary-Sills J, 2013, J HIV-AIDS SOC SERV, V12, P49, DOI 10.1080/15381501.2012.749818; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Mutevedzi PC, 2014, TROP MED INT HEALTH, V19, P1015, DOI 10.1111/tmi.12344; Namasopo-Oleja MS, 2015, AFR HEALTH SCI, V15, P344, DOI 10.4314/ahs.v15i2.6; Namukwaya S, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00343; Nsanzimana S, 2015, LANCET GLOB HEALTH, V3, pE169, DOI 10.1016/S2214-109X(14)70364-X; Nyando MC, 2014, EXPERIENCES CAREGIVE; Nzota MS, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0399-3; O'Malley G, 2014, J ACQ IMMUN DEF SYND, V68, pe1, DOI DOI 10.1097/QAI; Oddy WH, 2010, J PEDIATR-US, V156, P568, DOI 10.1016/j.jpeds.2009.10.020; Odiachi A, 2017, VULNERABLE CHILD YOU, V12, P58, DOI 10.1080/17450128.2016.1247220; Odiachi A, 2016, AIDS CARE, V28, P1046, DOI 10.1080/09540121.2016.1147018; Pindani M, 2014, WORLD J AIDS, V2014, DOI [10.4236/wja.2014.43039, DOI 10.4236/WJA.2014.43039]; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Sharer M, 2016, AIDS CARE, V28, P110, DOI 10.1080/09540121.2016.1178942; Sheeran T, 1997, J PEDIATR PSYCHOL, V22, P197; Sirikum C, 2014, AIDS CARE, V26, P1144, DOI 10.1080/09540121.2014.894614; Skeen S, 2014, CHILD YOUTH SERV REV, V45, P90, DOI 10.1016/j.childyouth.2014.03.041; SPINETTA JJ, 1975, PEDIATRICS, V56, P1034; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; TENNANT C, 1976, AUST NZ J PSYCHIAT, V10, P27, DOI 10.3109/00048677609159482; TENNANT C, 1979, PSYCHOL MED, V9, P525, DOI 10.1017/S0033291700032086; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Turissini ML, 2013, J PEDIATR INFECT DIS, V2, P136, DOI 10.1093/jpids/pit024; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2014, BEG END AIDS EP; United Nations programme for HIV/ AIDS Malawi, 2016, HIV EST; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LME, 2011, J DEV BEHAV PEDIATR, V32, P307, DOI 10.1097/DBP.0b013e31820f7a47; Vreeman RC, 2015, AIDS CARE, V27, P6, DOI 10.1080/09540121.2015.1026307; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2014, PROC TRANSL AD INSTR	76	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210781	10.1371/journal.pone.0210781	http://dx.doi.org/10.1371/journal.pone.0210781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645639	gold, Green Published, Green Submitted			2022-12-27	WOS:000455810200053
J	Jansen, P; Scheer, C; Zayed, K				Jansen, Petra; Scheer, Clara; Zayed, Kashef			Motor ability and working memory in Omani and German primary school-aged children	PLOS ONE			English	Article							6-YEAR-OLD CHILDREN; GENDER-DIFFERENCES; COORDINATION; PERFORMANCE; ATTENTION; CULTURE; FITNESS; EXPERT	This study investigated the motor ability and working memory performance of Omani and German primary school-aged children. One hundred eighty-five children from public schools participated in a gross motor test that integrated whole body coordination, three different ball tasks, and a 20-meter run. Furthermore, they completed four working memory tests (the Digit-Span Test forward and backwards and the Corsi Block-Tapping Test forward and backwards). Two MANOVAS with the different motor and working memory tests and one univariate analysis of the general motor ability with the between-subject factors group and gender were conducted. Additionally, correlations between motor ability and working memory scores were executed. German children outperformed Omani children in the overall measurement of motor ability, (p = .01) and all aspects of working memory, (all p<.015). There were no correlations between motor and cognitive variables, when analyzing the results for the Omani and German children separately. These findings may be a result of different educational styles or socioeconomic status and must be investigated in more detail.	[Jansen, Petra; Scheer, Clara] Univ Regensburg, Fac Psychol Pedag & Sport Sci, Regensburg, Germany; [Zayed, Kashef] Sultan Qaboos Univ, Dept Phys Educ, Muscat, Oman	University of Regensburg; Sultan Qaboos University	Jansen, P (corresponding author), Univ Regensburg, Fac Psychol Pedag & Sport Sci, Regensburg, Germany.	petra.jansen@ur.de		Jansen, Petra/0000-0002-0973-2158; Zayed, Kashef/0000-0001-6440-4643	Deanship of Research at Sultan Qaboos University [IG/EDU/PHED/17/02]	Deanship of Research at Sultan Qaboos University	The study was approved and funded by the Deanship of Research at Sultan Qaboos University, IG/EDU/PHED/17/02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2008, J LEARN DISABIL-US, V41, P251, DOI 10.1177/0022219408315815; Amer T, 2017, BRIT J PSYCHOL, V108, P244, DOI 10.1111/bjop.12194; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bardid F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00964; Bos K, 2002, GESUNDHEITSWESEN, V64, pS80; Castelli DM, 2014, MONOGR SOC RES CHILD, V79, P119, DOI 10.1111/mono.12133; Chow SMK, 2001, AM J OCCUP THER, V55, P55, DOI 10.5014/ajot.55.1.55; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Corsi P., 1972, THESIS; de Abreu PMJE, 2014, MEMORY, V22, P323, DOI 10.1080/09658211.2013.781186; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Guida A, 2018, COGNITION, V175, P96, DOI 10.1016/j.cognition.2018.02.013; Hill AC, 2014, BIOL PSYCHOL, V102, P18, DOI 10.1016/j.biopsycho.2014.06.008; Hsieh SS, 2017, MED SCI SPORT EXER, V49, P2537, DOI 10.1249/MSS.0000000000001399; Huttermann S, 2014, PHYSIOL BEHAV, V131, P87, DOI 10.1016/j.physbeh.2014.04.020; Islam M Mazharul, 2015, Oman Med J, V30, P241, DOI 10.5001/omj.2015.50; Jansen P, 2018, J GENET PSYCHOL, P1; Jansen P, 2016, LEARN INDIVID DIFFER, V51, P284, DOI 10.1016/j.lindif.2016.08.033; Kahan D, 2015, CLIN OBES, V5, P87, DOI 10.1111/cob.12089; Kahan David, 2015, Prev Med Rep, V2, P71, DOI 10.1016/j.pmedr.2014.12.007; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kokstejn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176556; Lehmann J, 2014, EUR J DEV PSYCHOL, V11, P560, DOI 10.1080/17405629.2014.888995; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Petermann F., 2010, HAWIK 4 HAMBURG WECH; Piek JP, 2004, ARCH CLIN NEUROPSYCH, V19, P1063, DOI 10.1016/j.acn.2003.12.007; R?thlisberger M., 2013, J ED DEV PSYCHOL, V3, P153, DOI [DOI 10.5539/JEDP.V3N2P153, 10.5539/jedp.v3n2p153]; Raine LB, 2018, J COGNITIVE ENHANCEM, P1; Rigoli D, 2012, ARCH CLIN NEUROPSYCH, V27, P766, DOI 10.1093/arclin/acs061; Roth A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7231818; Samuel RD, 2017, J HUM KINET, V57, P85, DOI 10.1515/hukin-2017-0050; Sjowall D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01342; van der Fels IMJ, 2015, J SCI MED SPORT, V18, P697, DOI 10.1016/j.jsams.2014.09.007; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Voyer D, 2017, PSYCHON B REV, V24, P307, DOI 10.3758/s13423-016-1085-7; Wassenberg R, 2005, CHILD DEV, V76, P1092, DOI 10.1111/j.1467-8624.2005.00899.x; Zayed K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02477	41	2	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209848	10.1371/journal.pone.0209848	http://dx.doi.org/10.1371/journal.pone.0209848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640912	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000015
J	Flores, RMO; Distel, JS; Aguilera, MO; Beron, W				Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Beron, Walter			The role of microtubules and the dynein/dynactin motor complex of host cells in the biogenesis of the Coxiella burnetii-containing vacuole	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; EFFECTOR PROTEIN; ALPHA-TUBULIN; RAB7 EFFECTOR; DYNEIN; ACETYLATION; TRANSPORT; TRAFFICKING; RECRUITMENT; INHIBITION	Microtubules (Mts) are dynamic cytoskeleton structures that play a key role in vesicular transport. The Mts-mediated transport depends on motor proteins named kinesins and the dynein/dynactin motor complex. The Rab7 adapter protein FYCO1 controls the anterograde transport of the endocytic compartments through the interaction with the kinesin KIF5. Rab7 and its partner RILP induce the recruitment of dynein/dynactin to late endosomes regulating its retrograde transport to the perinuclear area to fuse with lysosomes. The late endosomal-lysosomal fusion is regulated by the HOPS complex through its interaction with RILP and the GTPase Arl8. Coxiella burnetii (Cb), the causative agent of Q fever, is an obligate intracellular pathogen, which generates a large compartment with autophagolysosomal characteristics named Cb-containing vacuole (CCV). The CCV forms through homotypic fusion between small non-replicative CCVs (nrCCV) and through heterotypic fusion with other compartments, such as endosomes and lysosomes. In this work, we characterise the role of Mts, motor proteins, RILP/Rab7 and Arl8 on the CCV biogenesis. The formation of the CCV was affected when either the dynamics and/or the acetylation state of Mts were modified. Similarly, the overexpression of the dynactin subunit non-functional mutants p150(Glued) and RILP led to the formation of small nrCCVs. This phenomenon is not observed in cells overexpressing WT proteins, the motor KIF5 or its interacting protein FYCO1. The formation of the CCV was normal in infected cells that overexpressed Arl8 alone or together with hVps41 (a HOPS subunit) or in cells co-overexpressing hVps41 and RILP. The dominant negative mutant of Arl8 and the non-functional hVps41 inhibited the formation of the CCV. When the formation of CCV was affected, the bacterial multiplication diminished. Our results suggest that nrCCVs recruit the molecular machinery that regulate the Mts-dependent retrograde transport, Rab7/RILP and the dynein/dynactin system, as well as the tethering processes such as HOPS complex and Arl8 to finally originate the CCV where C. burnetii multiplies.	[Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Beron, Walter] Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Beron, W (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, CONICET, Inst Histol & Embriol, Mendoza, Argentina.	wberon@fcm.uncu.edu.ar	Ortiz Flores, Rodolfo Matias/ABA-5380-2021	Ortiz Flores, Rodolfo Matias/0000-0003-4509-0161; Beron, Walter/0000-0001-9654-5467; Distel, Jesus Sebastian/0000-0003-4589-5314	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) [PICT-2012-2425]; SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo	This work was supported by grants from ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) (PICT-2012-2425) and SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2016-2017), Universidad Nacional de Cuyo, to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bhuwania R, 2014, EUR J CELL BIOL, V93, P424, DOI 10.1016/j.ejcb.2014.07.006; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Bouwman LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054759; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Clausen JD, 1997, MOL MICROBIOL, V25, P441, DOI 10.1046/j.1365-2958.1997.4591832.x; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dumont A, 2010, TRAFFIC, V11, P899, DOI 10.1111/j.1600-0854.2010.01069.x; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Guardia CM, 2016, CELL REP, V17, P1950, DOI 10.1016/j.celrep.2016.10.062; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; HECHEMY KE, 1993, INFECT IMMUN, V61, P4485, DOI 10.1128/IAI.61.10.4485-4488.1993; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huynh KK, 2010, J INNATE IMMUN, V2, P522, DOI 10.1159/000319864; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kaniuk NA, 2011, CELL MICROBIOL, V13, P1812, DOI 10.1111/j.1462-5822.2011.01663.x; Khatter Divya, 2015, Cell Logist, V5, pe1086501; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Magiera MM, 2014, CURR BIOL, V24, pR351, DOI 10.1016/j.cub.2014.03.032; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Meyer DH, 1999, INFECT IMMUN, V67, P6518; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Personnic N, 2016, TRENDS MICROBIOL, V24, P450, DOI 10.1016/j.tim.2016.02.003; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; PRESTON RA, 1992, GENETICS, V131, P551; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Rajashekar R, 2011, EUR J CELL BIOL, V90, P897, DOI 10.1016/j.ejcb.2011.05.008; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Richards TS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-185; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadoul K, 2016, BIOCHEM J, V473, P1859, DOI 10.1042/BCJ20160172; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shaaban KA, 2014, J ANTIBIOT, V67, P223, DOI 10.1038/ja.2013.113; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Taylor P, 2014, PATIENTS ACTIVE TUBE, P37, DOI [10.4161/15548627.2014.981791, DOI 10.4161/15548627.2014.981791]; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van der Kant R, 2015, J BIOL CHEM, V290, P30280, DOI 10.1074/jbc.M115.688440; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; VERAS PST, 1995, INFECT IMMUN, V63, P3502, DOI 10.1128/IAI.63.9.3502-3506.1995; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wang JA, 2008, INT J MED MICROBIOL, V298, P209, DOI 10.1016/j.ijmm.2007.05.004; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	104	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209820	10.1371/journal.pone.0209820	http://dx.doi.org/10.1371/journal.pone.0209820			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640917	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000013
J	Rando, A; de la Torre, M; Martinez-Muriana, A; Zaragoza, P; Musaro, A; Hernandez, S; Navarro, X; Toivonen, JM; Osta, R				Rando, Amaya; de la Torre, Miriam; Martinez-Muriana, Anna; Zaragoza, Pilar; Musaro, Antonio; Hernandez, Sara; Navarro, Xavier; Toivonen, Janne M.; Osta, Rosario			Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION; STEM-CELLS; MICE; PROLIFERATION; LEVEL	Amyotrophic lateral sclerosis (ALS) is a lethal motor neuron disease with no cure. Currently there are only two ALS drugs approved by the FDA, both with a limited therapeutic effect. In the search for drug candidates for ALS, we studied the effect of known stem cell mobilizing agents (treatment) and antimetabolite 5-fluorouracil (5-FU) (anti-treatment) in SOD1G93A model of ALS. Surprisingly, we found that anti-cancer drug 5-FU increases lifespan, delays the disease onset and improves motor performance in ALS mice. Although we were not able to demonstrate the mechanistic basis of the beneficial 5-FU action in ALS mice, our findings suggest that 5-FU or similar drugs are possible drug candidates for the treatment of motor neuron diseases through drug repurposing.	[Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] Univ Zaragoza, Fac Vet, Dept Anat Embriol & Genet Anim, LAGENBIO, Zaragoza, Spain; [Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] Univ Zaragoza CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain; [Rando, Amaya; de la Torre, Miriam; Zaragoza, Pilar; Toivonen, Janne M.; Osta, Rosario] CIBA, Inst Invest Sanitaria Aragon, Zaragoza, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Univ Autonoma Barcelona, Inst Neurosci, Bellaterra, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain; [Martinez-Muriana, Anna; Navarro, Xavier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain; [Musaro, Antonio] Sapienza Univ Rome, Ist Pasteur Italia, Fdn Cenci Bolognetti, DAHFMO Unit Histol & Med Embryol, Rome, Italy; [Musaro, Antonio] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Hernandez, Sara] Univ Lleida IRBLLEIDA, Fac Med, Grp Patol Neuromuscular Expt, Dept Med Expt, Lleida, Catalonia, Spain	University of Zaragoza; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Universitat de Lleida	Toivonen, JM; Osta, R (corresponding author), Univ Zaragoza, Fac Vet, Dept Anat Embriol & Genet Anim, LAGENBIO, Zaragoza, Spain.; Toivonen, JM; Osta, R (corresponding author), Univ Zaragoza CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain.; Toivonen, JM; Osta, R (corresponding author), CIBA, Inst Invest Sanitaria Aragon, Zaragoza, Spain.	toivonen@unizar.es; osta@unizar.es	Osta, Rosario/R-5410-2019; Musarò, Antonio/K-9598-2016; Hernandez, Sara/N-4017-2014; zaragoza, pilar/AAN-9479-2021; Toivonen, Janne M./E-5691-2011; Hernández, Sara/HHN-5230-2022; Musaro, Antonio/P-2953-2019; Navarro, Xavier/C-9577-2011	Musarò, Antonio/0000-0002-2944-9739; Hernandez, Sara/0000-0002-6451-724X; Toivonen, Janne M./0000-0002-7243-1737; Musaro, Antonio/0000-0002-2944-9739; Navarro, Xavier/0000-0001-9849-902X; Osta, Rosario/0000-0001-5687-6704	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI14/00947, PI17/00949]; Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza; Instituto de Salud Carlos III of Spain [RD12/0019/0011, RD16/0011/0035, CB06/05/1105]; Fondazione Roma; Agenzia Spaziale Italiana	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza; Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); Fondazione Roma(Fondazione RomaEuropean Commission); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union (Grants PI14/00947 and PI17/00949), Asociacion Adelante de La Roda, Plataforma Afectados por la ELA, Asociacion Juntos Venceremos ELA, AVPA Zaragoza (RO), TERCEL (RD12/0019/0011 and RD16/0011/0035) and CIBERNED (CB06/05/1105) funds from the Instituto de Salud Carlos III of Spain (XN), and Fondazione Roma and Agenzia Spaziale Italiana (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey D, 2014, AMYOTROPHIC LATERAL, V14, P1; Amante DJ, 2010, AMYOTROPH LATERAL SC, V11, P520, DOI 10.3109/17482968.2010.491867; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bucchia M, 2015, CLIN THER, V37, P668, DOI 10.1016/j.clinthera.2014.12.020; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; CHENAILLE PJ, 1990, BLOOD, V76, P508; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Hardiman O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.71; Henriques A, 2011, MOL THER, V19, P284, DOI 10.1038/mt.2010.271; Leitner M, GUIDELINES PRECLINIC; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mancuso R, 2012, NEUROTHERAPEUTICS, V9, P814, DOI 10.1007/s13311-012-0140-y; Manzano R, 2011, BIOCHEM BIOPH RES CO, V407, P758, DOI 10.1016/j.bbrc.2011.03.096; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Mojardin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078172; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Numazawa S, 2011, BASIC CLIN PHARMACOL, V108, P40, DOI 10.1111/j.1742-7843.2010.00621.x; Olivan S, 2014, EXP ANIM; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Petrov D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00068; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Pokrishevsky E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184384; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Pollari E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00131; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; QUESNIAUX VFJ, 1993, BLOOD, V81, P1497; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rando A, 2017, NEURODEGENER DIS, V17, P1, DOI 10.1159/000446113; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Udelnow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020143	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210752	10.1371/journal.pone.0210752	http://dx.doi.org/10.1371/journal.pone.0210752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640943	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000045
J	Zimmermann, KM; Stratil, AS; Thome, I; Sommer, J; Jansen, A				Zimmermann, Kristin M.; Stratil, Ann-Sophie; Thome, Ina; Sommer, Jens; Jansen, Andreas			Illusory face detection in pure noise images: The role of interindividual variability in fMRI activation patterns	PLOS ONE			English	Article							NEURAL SYSTEMS; PERCEPTION; LATERALIZATION; RECOGNITION; FAMILIAR	Illusory face detection tasks can be used to study the neural correlates of top-down influences on face perception. In a typical functional magnetic resonance imaging (fMRI) study design, subjects are presented with pure noise images, but are told that half of the stimuli contain a face. The illusory face perception network is assessed by comparing blood oxygenation level dependent (BOLD) responses to images in which a face has been detected against BOLD activity related to images in which no face has been detected. In the present study, we highlight the existence of strong interindividual differences of BOLD activation patterns associated with illusory face perception. In the core system of face perception, 4 of 9 subjects had highly significant (p<0.05, corrected for multiple comparisons) activity in the bilateral occipital face area (OFA) and fusiform face area (FFA). In contrast, 5 of 9 subjects did not show any activity in these regions, even at statistical thresholds as liberal as p = 0.05, uncorrected. At the group level, this variability is reflected by non-significant activity in all regions of the core system. We argue that these differences might be related to individual differences in task execution: only some participants really detected faces in the noise images, while the other subjects simply responded in the desired way. This has several implications for future studies on illusory face detection. First, future studies should not only analyze results at the group level, but also for single subjects. Second, subjects should be explicitly queried after the fMRI experiment about whether they really detected faces or not. Third, if possible, not only the overt response of the subject, but also additional parameters that might indicate the perception of a noise stimulus as face should be collected (e.g., behavioral classification images).	[Zimmermann, Kristin M.; Stratil, Ann-Sophie; Thome, Ina; Jansen, Andreas] Univ Marburg, Dept Psychiat, Marburg, Germany; [Zimmermann, Kristin M.; Thome, Ina; Sommer, Jens; Jansen, Andreas] Univ Marburg, CMBB, Marburg, Germany; [Sommer, Jens; Jansen, Andreas] Univ Marburg, Fac Med, Core Unit Brainimaging, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Zimmermann, KM; Jansen, A (corresponding author), Univ Marburg, Dept Psychiat, Marburg, Germany.; Zimmermann, KM; Jansen, A (corresponding author), Univ Marburg, CMBB, Marburg, Germany.; Jansen, A (corresponding author), Univ Marburg, Fac Med, Core Unit Brainimaging, Marburg, Germany.	kzimmerm@med.uni-marburg.de; andreas.jansen@staff.uni-marburg.de	Thome, Ina/AAH-6374-2020; Stratil, Ann-Sophie/AAV-5806-2020; Jansen, Andreas/AAL-5264-2020	Thome, Ina/0000-0002-1285-3348; Stratil, Ann-Sophie/0000-0002-8977-6731; Jansen, Andreas/0000-0002-3140-8207	Else Kroner-Fresenius-Stiftung [2012_A219]; German Research Foundation (DFG) [JA 1890/11-1]; CRC/Transregio [135]	Else Kroner-Fresenius-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); CRC/Transregio	This work was supported by research grants from the Else Kroner-Fresenius-Stiftung (2012_A219), the German Research Foundation (DFG, grant JA 1890/11-1) and the CRC/Transregio 135 (Cardinal mechanisms of perception: prediction, valuation, categorization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research grants from the Else Kroner-Fresenius-Stiftung (2012_A219), the German Research Foundation (DFG, grant JA 1890/11-1) and the CRC/Transregio 135 (Cardinal mechanisms of perception: prediction, valuation, categorization). We thank Hannes Rusch for helpful comments.	Bernstein M, 2015, NEUROSCI BIOBEHAV R, V55, P536, DOI 10.1016/j.neubiorev.2015.06.010; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Frassle S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27153; Frassle S, 2016, HUM BRAIN MAPP, V37, P730, DOI 10.1002/hbm.23061; Frassle S, 2016, NEUROIMAGE, V124, P977, DOI 10.1016/j.neuroimage.2015.09.055; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Hasse J Michael, 2017, Vis Neurosci, V34, DOI 10.1017/S095252381700013X; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Li J, 2010, BRAIN RES, V1340, P40, DOI 10.1016/j.brainres.2010.04.044; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Meng M, 2012, P ROY SOC B-BIOL SCI, V279, P2052, DOI 10.1098/rspb.2011.1784; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rossion Bruno, 2014, Front Biosci (Elite Ed), V6, P258; Smith ML, 2012, CURR BIOL, V22, P191, DOI 10.1016/j.cub.2011.11.061; Summerfield C, 2006, CEREB CORTEX, V16, P500, DOI 10.1093/cercor/bhi129; Zhang HC, 2008, NEUROREPORT, V19, P229, DOI 10.1097/WNR.0b013e3282f49083	25	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209310	10.1371/journal.pone.0209310	http://dx.doi.org/10.1371/journal.pone.0209310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640899	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000012
J	Montano-Campaz, ML; Gomes-Dias, L; Restrepo, BET; Garcia-Merchan, CH				Leoncio Montano-Campaz, Milton; Gomes-Dias, Lucimar; Toro Restrepo, Beatriz Edilma; Hugo Garcia-Merchan, Victor			Incidence of deformities and variation in shape of mentum and wing of Chironomus columbiensis (Diptera, Chironomidae) as tools to assess aquatic contamination	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; LARVAE DIPTERA; MORPHOLOGICAL DEFORMITIES; GEOMETRIC MORPHOMETRICS; MOUTHPART DEFORMITIES; EVOLUTION; TOXICITY; PATTERNS; EXPOSURE; STREAMS	Constantly, aquatic ecosystems are under pressure by complex mixtures of contaminants whose effects are not always easy to evaluate. Due to this, organisms are sought in which early warning signs may be detected upon the presence of potentially toxic xenobiotic substances. Thereby, the study evaluated the incidence of deformities and other morphometric variations in the mentum and wing of Chironomus columbiensis exposed to water from some of the Colombian Andes affected by mining, agriculture, and cattle raising. Populations of C. columbiensis were subjected throughout their life cycle (24 days) for two generations (F-1 and F-2). Five treatments were carried out in controlled laboratory conditions (water from the site without impact, site of mining mercury, mining mercury + cyanide, cattle raising, and agriculture) and the respective control (reconstituted water). Thereafter, the percentage of deformities in the mentum was calculated, and for the morphometric analysis 29 landmarks were digitized for the mentum and 12 for the wing. As a result, four types of deformities were registered in the C. columbiensis mentum, like absence of teeth, increased number of teeth, fusion and space between teeth, none of them detected in the individuals from the control. Additionally, the highest incidence of deformity in F-1 occurred in the treatment of mining mercury, while for F-2 this took place in the treatments of mining mercury + cyanide, cattle raising and agriculture. Differences were also found with respect to the morphometric variations of the mentum and wing of C. columbiensis among the control and the treatments with water from the creeks intervened. The treatments of mining mercury + cyanide and agriculture had the highest morphological variation in the mentum and wing of C. columbiensis. The results suggest that the anthropogenic impacts evaluated generate alterations in the oral apparatus of the larval state of C. columbiensis and in the adult state provoke alterations in the wing shape (increased width and reduced basal area). These deformities may be related to multiple stress factors, among them the xeno-biotics metabolized by the organisms under conditions of environmental contamination.	[Leoncio Montano-Campaz, Milton; Gomes-Dias, Lucimar; Toro Restrepo, Beatriz Edilma] Univ Caldas, Grp Invest BIONAT Biodiversidad & Recursos Nat, Fac Ciencias Exactas & Nat, Dept Ciencias Biol, Manizales, Colombia; [Hugo Garcia-Merchan, Victor] Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Quindio, Colombia	Universidad de Caldas; Universidad del Quindio	Garcia-Merchan, CH (corresponding author), Univ Quindio, Programa Biol, Grp Invest Evoluc Ecol & Conservac EECO, Quindio, Colombia.	victorhgarcia@uniquindio.edu.co		Montano Campaz, Milton Leoncio/0000-0002-9470-9840	University of Caldas	University of Caldas	The University of Caldas financed the research and the University of Quindio the translation of the document.	Adams CA, 2004, J BIOL CHEM, V279, P1376, DOI 10.1074/jbc.M307867200; [Anonymous], PRINCIPLES SERVICES; Arambourou H, 2014, SCI TOTAL ENVIRON, V484, P92, DOI 10.1016/j.scitotenv.2014.03.010; Arambourou H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048844; Benitez HA, 2013, NEOTROP ENTOMOL, V42, P164, DOI 10.1007/s13744-012-0107-z; Bispo P. C., 2006, Braz. J. Biol., V66, P611, DOI 10.1590/S1519-69842006000400005; Bonada N, 2007, HYDROBIOLOGIA, V589, P91, DOI 10.1007/s10750-007-0723-5; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Campero M, 2008, FUNCT ECOL, V22, P271, DOI 10.1111/j.1365-2435.2007.01381.x; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Chara J., 2003, MANUAL EVALUACION BI; Chara-Serna AM, 2015, FRESHW SCI, V34, P727, DOI 10.1086/681094; Clarke GM, 1998, HEREDITY, V80, P562, DOI 10.1046/j.1365-2540.1998.00294.x; Conroy PT, 1996, ENVIRON TOXICOL CHEM, V15, P1245, DOI 10.1002/etc.5620150733; de Bisthoven LJ, 1998, FRESHWATER BIOL, V39, P179, DOI 10.1046/j.1365-2427.1998.00265.x; Di Veroli A, 2012, ENVIRON POLLUT, V166, P212, DOI 10.1016/j.envpol.2012.03.029; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; GARCIABELLIDO A, 1992, ANNU REV GENET, V26, P277, DOI 10.1146/annurev.ge.26.120192.001425; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Groenendijk D, 1998, ENVIRON TOXICOL CHEM, V17, P1999, DOI [10.1002/etc.5620171016, 10.1897/1551-5028(1998)017&lt;1999:FAAMGI&gt;2.3.CO;2]; HARE L, 1976, CAN J ZOOL, V54, P2129, DOI 10.1139/z76-246; Hoffman DJ., 2002, HDB ECOTOXICOLOGY; Hoffmann AA, 2005, AUST J ENTOMOL, V44, P233, DOI 10.1111/j.1440-6055.2005.00469.x; Hudson LA, 1996, CAN J FISH AQUAT SCI, V53, P297, DOI 10.1139/cjfas-53-2-297; Iannacone J, 2007, AGR TEC, V67, P126; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1255, DOI 10.1098/rspb.1998.0427; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; Lal R., 1998, AGR ECOSYST ENVIRON, V24, P101; Leah Zelditch Miriam, 2012, GEOMETRIC MORPHOMETR; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P265, DOI 10.2307/1467461; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; Marin E., 2005, TERRA LATINOAM, V25, P297; Martinez EA, 2004, ARCH ENVIRON CON TOX, V47, P193, DOI 10.1007/s00244-004-3116-z; Martinez S, 2002, NUTR HOSP, V17; MAYER FL, 1988, AMBIO, V17, P367; Meregalli V, 2001, APPL PHYS A-MATER, V72, P143, DOI 10.1007/s003390100789; Miserendino ML, 2012, SCI TOTAL ENVIRON, V424, P202, DOI 10.1016/j.scitotenv.2012.02.054; Moore M, 1987, PHILOS T R SOC B, V316, P209; Mozeto A, 2008, ECOTOXICOLOGIA AQUAT, V2, P15; Odume ON, 2016, ECOL INDIC, V67, P391, DOI 10.1016/j.ecolind.2016.03.001; OECD, 2004, SED WAT CHIR TOX TES; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; Piggott JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049873; PINDER LCV, 1983, ENTOMOL SCAND, P7; Pither J, 2000, CAN J ZOOL, V78, P1740, DOI 10.1139/cjz-78-10-1740; Pitt RE, 2002, HDB ECOTOXICOLOGY, P575; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Salmelin J, 2015, ENVIRON TOXICOL CHEM, V34, P1891, DOI 10.1002/etc.3010; Sanin D, 2008, REV ACAD COLOMBIANA, V32, P331; WARWICK WF, 1988, CAN J FISH AQUAT SCI, V45, P1123, DOI 10.1139/f88-136; WIEDERHOLM T, 1984, HYDROBIOLOGIA, V109, P243, DOI 10.1007/BF00007742; Zelditch ML, 2004, EVOL DEV, V6, P194, DOI 10.1111/j.1525-142X.2004.04025.x; Zorrilla Domenichi M., 2012, THESIS	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210348	10.1371/journal.pone.0210348	http://dx.doi.org/10.1371/journal.pone.0210348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629652	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000077
J	Rajasingham, R; Meya, DB; Greene, GS; Jordan, A; Nakawuka, M; Chiller, TM; Boulware, DR; Larson, BA				Rajasingham, Radha; Meya, David B.; Greene, Gregory S.; Jordan, Alexander; Nakawuka, Mina; Chiller, Tom M.; Boulware, David R.; Larson, Bruce A.			Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MENINGITIS; IMMUNODEFICIENCY; START	Background Cryptococcal meningitis accounts for 15% of AIDS-related mortality. Cryptococcal antigen (CrAg) is detected in blood weeks before onset of meningitis, and CrAg positivity is an independent predictor of meningitis and death. CrAg screening for patients with advanced HIV and preemptive treatment is recommended by the World Health Organization, though implementation remains limited. Our objective was to evaluate costs and mortality reduction (lives saved) from a national CrAg screening program across Uganda. Methods We created a decision analytic model to evaluate CrAg screening. CrAg screening was considered for those with a CD4<100 cells/mu L per national and international guidelines, and in the context of a national HIV test-and-treat program where CD4 testing was not available. Costs (2016 USD) were estimated for screening, preemptive therapy, hospitalization, and maintenance therapy. Parameter assumptions were based on large prospective CrAg screening studies in Uganda, and clinical trials from sub Saharan Africa. CrAg positive (CrAg+) persons could be: (a) asymptomatic and thus eligible for preemptive treatment with fluconazole; or (b) symptomatic with meningitis with hospitalization. Results In the base case model for 1 million persons with a CD4 test annually, 128,000 with a CD4<100 cells/mu L were screened, and 8,233 were asymptomatic CrAg+ and received preemptive therapy. Compared to no screening and treatment, CrAg screening and treatment in the base case cost $3,356,724 compared to doing nothing, and saved 7,320 lives, for a cost of $ 459 per life saved, with the $ 3.3 million in cost savings derived from fewer patients developing fulminant meningitis. In the scenario of a national HIV test-and-treat program, of 1 million HIV-infected persons, 800,000 persons were screened, of whom 640,000 returned to clinic, and 8,233 were incident CrAg positive (CrAg prevalence 1.4%). The total cost of a CrAg screening and treatment program was $4.16 million dollars, with 2,180 known deaths. Conversely, without CrAg screening, the cost of treating meningitis was $3.09 million dollars with 3,806 deaths. Thus, despite the very low CrAg prevalence of 1.4% in the general HIV-infected population, and inadequate retention-in-care, CrAg screening averted 43% of deaths from cryptococcal meningitis at a cost of $662 per death averted. Conclusion CrAg screening and treatment programs are cost-saving and lifesaving, assuming preemptive treatment is 77% effective in preventing death, and could be adopted and implemented by ministries of health to reduce mortality in those with advanced HIV disease. Even within HIV test-and-treat programs where CD4 testing is not performed, and CrAg prevalence is only 1.4%, CrAg screening is cost-effective.	[Rajasingham, Radha; Boulware, David R.] Univ Minnesota, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA; [Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Greene, Gregory S.; Jordan, Alexander; Chiller, Tom M.] CDC, Mycot Dis Branch, Atlanta, GA 30333 USA; [Nakawuka, Mina] Minist Hlth, AIDS Control Program, Kampala, Uganda; [Larson, Bruce A.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Centers for Disease Control & Prevention - USA; Boston University	Rajasingham, R (corresponding author), Univ Minnesota, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA.	radha@umn.edu	Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Meya, David/AAO-2796-2020	Boulware, David R/0000-0002-4715-0060; Jordan, Alexander/0000-0002-7834-866X; , David/0000-0002-8854-0321; Larson, Bruce/0000-0002-9322-2387	National Institute of Allergy and Infectious diseases [K23AI138851]; CDC foundation; Pfizer Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI138851] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer Inc(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RR is supported by the National Institute of Allergy and Infectious diseases (K23AI138851). BL is supported by the CDC foundation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The source of this information is the Global Cryptococcal Antigen Screening Initiative, a project of the CDC Foundation funded by a grant from Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Beyene T, 2017, CLIN INFECT DIS, V65, P2126, DOI 10.1093/cid/cix613; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Larson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158986; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Merry M, 2016, CLIN INFECT DIS, V62, P1564, DOI 10.1093/cid/ciw151; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mfinanga S, 2015, LANCET; Morawski B, 2016, PRE ART CRYPTOCOCCAL; Nalintya E MD, 2018, PROSPECTIVE EVALUATI; Nalintya E, 2018, JAIDS-J ACQ IMM DEF, V78, P231, DOI 10.1097/QAI.0000000000001669; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Rhein J, 2018, HIGH MORTALITY ASS U; Siedner MJ, 2014, TRENDS CD4 COUNT PRE; Wake RM, 2018, CLIN INFECT DIS, V66, P686, DOI 10.1093/cid/cix872; World Health Organization, 2018, GUID DIAGN PREV MAN; World Health Organization (WHO), 2017, GUIDELINES MANAGING	21	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210105	10.1371/journal.pone.0210105	http://dx.doi.org/10.1371/journal.pone.0210105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629619	Green Published, gold, Green Submitted			2022-12-27	WOS:000455483000050
J	Koushyar, H; Bieryla, KA; Nussbaum, MA; Madigan, ML				Koushyar, Hoda; Bieryla, Kathleen A.; Nussbaum, Maury A.; Madigan, Michael L.			Age-related strength loss affects non-stepping balance recovery	PLOS ONE			English	Article							JOINT ANGLE; ANKLE; MECHANISMS; STRATEGIES; TORQUE	Aging is associated with a higher risk of falls, and an impaired ability to recover balance after a postural perturbation is an important contributing factor. In turn, this impaired recovery ability likely stems from age-related decrements in lower limb strength. The purpose of this study was to investigate the effects of age-related strength loss on non-stepping balance recovery capability after a perturbation while standing, without constraining movements to the ankle as in prior reports. Two experiments were conducted. In the first, five young adults (ages 20-30) and six community-dwelling older adults (ages 70-80) recovered their balance, without stepping, from a backward displacement of a support surface. Balance recovery capability was quantified as the maximal backward platform displacement that a subject could withstand without stepping. The maximal platform displacement was 27% smaller among the older group (11.8 +/- 2.1 cm) vs. the young group (16.2 +/- 2.6 cm). In the second experiment, forward dynamic simulations of a two-segment, rigid-body model were used to investigate the effects of manipulating strength in the hip extensors/flexors and ankle plantar flexors/dorsiflexors. In these, typical age-related reductions in strength were included. The model predicted lower maximal platform displacements with age-related reductions only in plantar flexion and hip flexion strength. These findings support the previously reported age-related loss of balance recovery ability, and an important role for plantar flexor strength in this ability.	[Koushyar, Hoda] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Bieryla, Kathleen A.] Univ Portland, Dept Mech & Biomed Engn, Portland, OR 97203 USA; [Nussbaum, Maury A.; Madigan, Michael L.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; University of Portland; Virginia Polytechnic Institute & State University	Madigan, ML (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	mlm@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431	Centers for Disease Control and Prevention (CDC) [R01OH009880]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by award R01OH009880 from the Centers for Disease Control and Prevention (CDC). The contents of this paper are solely the responsibility of the authors, and do not necessarily represent the official views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Ashby BM, 2006, J BIOMECH, V39, P1726, DOI 10.1016/j.jbiomech.2005.04.017; Barrett RS, 2008, J THEOR BIOL, V254, P546, DOI 10.1016/j.jtbi.2008.06.018; Cheng KYB, 2008, J BIOMECH, V41, P1847, DOI 10.1016/j.jbiomech.2008.04.004; de Leva P, 1996, J BIOMECH, V29, P1231, DOI 10.1016/0021-9290(96)00021-8; Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horlings CGC, 2009, NEUROSCIENCE, V164, P1876, DOI 10.1016/j.neuroscience.2009.09.063; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Liu W, 2003, NEUROSCI LETT, V336, P1, DOI 10.1016/S0304-3940(02)01215-6; Mackey DC, 2006, GAIT POSTURE, V23, P59, DOI 10.1016/j.gaitpost.2004.11.009; MANCHESTER D, 1989, J GERONTOL, V44, pM118; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Matrangola SL, 2011, HUM MOVEMENT SCI, V30, P584, DOI 10.1016/j.humov.2010.11.007; Matrangola SL, 2009, MED SCI SPORT EXER, V41, P1488, DOI 10.1249/MSS.0b013e31819bd4bd; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Robinovitch SN, 2002, J NEUROPHYSIOL, V88, P613, DOI 10.1152/jn.2002.88.2.613; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Selbie WS, 1996, J BIOMECH, V29, P1137, DOI 10.1016/0021-9290(96)00030-9; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Vincent G, 2010, NEXT 4 DECADES OLDER, P25; WOOLLACOTT MH, 1993, J GERONTOL, V48, P56, DOI 10.1093/geronj/48.Special_Issue.56; Yang F, 2008, J BIOMECH, V41, P1823, DOI 10.1016/j.jbiomech.2008.04.005; Yeadon MR, 2002, J APPL BIOMECHANICS, V18	25	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210049	10.1371/journal.pone.0210049	http://dx.doi.org/10.1371/journal.pone.0210049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657760	gold, Green Submitted, Green Published			2022-12-27	WOS:000456017000006
J	Yogalingam, G; Luu, AR; Prill, H; Lo, MJ; Yip, B; Holtzinger, J; Christianson, T; Aoyagi-Scharber, M; Lawrence, R; Crawford, BE; LeBowitz, JH				Yogalingam, Gouri; Luu, Amanda R.; Prill, Heather; Lo, Melanie J.; Yip, Bryan; Holtzinger, John; Christianson, Terri; Aoyagi-Scharber, Mika; Lawrence, Roger; Crawford, Brett E.; LeBowitz, Jonathan H.			BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE VI; HEPARAN-SULFATE; CLEARANCE; DELIVERY; STORAGE; MODEL; IIIB	Sanfilippo syndrome type B (Sanfilippo B; Mucopolysaccharidosis type IIIB) occurs due to genetic deficiency of lysosomal alpha-N-acetylglucosaminidase (NAGLU) and subsequent lysosomal accumulation of heparan sulfate (HS), which coincides with devastating neurodegenerative disease. Because NAGLU expressed in Chinese hamster ovary cells is not mannose-6-phosphorylated, we developed an insulin-like growth factor 2 (IGF2)-tagged NAGLU molecule (BMN 250; tralesinidase alfa) that binds avidly to the IGF2 / cation-independent mannose 6-phosphate receptor (CI-MPR) for glycosylation independent lysosomal targeting. BMN 250 is currently being developed as an investigational enzyme replacement therapy for Sanfilippo B. Here we distinguish two cellular uptake mechanisms by which BMN 250 is targeted to lysosomes. In normal rodent-derived neurons and astrocytes, the majority of BMN250 uptake over 24 hours reaches saturation, which can be competitively inhibited with IGF2, suggestive of CI-MPR-mediated uptake. K-uptake, defined as the concentration of enzyme at half-maximal uptake, is 5 nM and 3 nM in neurons and astrocytes, with a maximal uptake capacity (V-max) corresponding to 764 nmol/hr/mg and 5380 nmol/hr/mg, respectively. Similar to neurons and astrocytes, BMN 250 uptake in Sanfilippo B patient fibroblasts is predominantly CI-MPR-mediated, resulting in augmentation of NAGLU activity with doses of enzyme that fall well below the K-uptake (5 nM), which are sufficient to prevent HS accumulation. In contrast, uptake of the untagged recombinant human NAGLU (rhNAGLU) enzyme in neurons, astrocytes and fibroblasts is negligible at the same doses tested. In microglia, receptor-independent uptake, defined as enzyme uptake resistant to competition with excess IGF2, results in appreciable lysosomal delivery of BMN 250 and rhNAGLU (V-max = 12,336 nmol/hr/mg and 5469 nmol/hr/mg, respectively). These results suggest that while receptor-independent mechanisms exist for lysosomal targeting of rhNAGLU in microglia, BMN 250, by its IGF2 tag moiety, confers increased CI-MPR-mediated lysosomal targeting to neurons and astrocytes, two additional critical cell types of Sanfilippo B disease pathogenesis.	[Yogalingam, Gouri; Luu, Amanda R.; Prill, Heather; Lo, Melanie J.; Yip, Bryan; Holtzinger, John; Christianson, Terri; Aoyagi-Scharber, Mika; Lawrence, Roger; Crawford, Brett E.; LeBowitz, Jonathan H.] BioMarin Pharmaceut Inc, Res, Novato, CA 94949 USA	BioMarin Pharmaceutical Inc.	Yogalingam, G (corresponding author), BioMarin Pharmaceut Inc, Res, Novato, CA 94949 USA.	gyogalingam@bmrn.com		Crawford, Brett/0000-0002-7811-4564				Andrade F, 2015, PEDIATR INT, V57, P331, DOI 10.1111/ped.12636; Aoyagi-Scharber M, 2017, MOL THER-METH CLIN D, V6, P43, DOI 10.1016/j.omtm.2017.05.009; Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Clark WT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200008; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Crawley AC, 1998, J CLIN INVEST, V101, P109, DOI 10.1172/JCI935; Ellinwood NM, 2018, MOL GENET METAB, V123, pS42, DOI 10.1016/j.ymgme.2017.12.091; Kan S, 2014, P NATL ACAD SCI USA, V111, P14870, DOI 10.1073/pnas.1416660111; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Poswar F, 2017, EXPERT OPIN INV DRUG, V26, P1331, DOI 10.1080/13543784.2017.1397130; Prill H., RAPID EFFICIEN UNPUB; Yogalingam G, 1998, J BIOL CHEM, V273, P13421, DOI 10.1074/jbc.273.22.13421; Yogalingam G, 2000, BBA-MOL BASIS DIS, V1502, P415, DOI 10.1016/S0925-4439(00)00066-1; Yogalingam G, 2001, HUM MUTAT, V18, P264, DOI 10.1002/humu.1189; Zhao KW, 2000, PROTEIN EXPRES PURIF, V19, P202, DOI 10.1006/prep.2000.1230	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0207836	10.1371/journal.pone.0207836	http://dx.doi.org/10.1371/journal.pone.0207836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657762	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000004
J	Garcia-Heras, MS; Arroyo, B; Mougeot, F; Bildstein, K; Therrien, JF; Simmons, RE				Garcia-Heras, Marie-Sophie; Arroyo, Beatriz; Mougeot, Francois; Bildstein, Keith; Therrien, Jean-Francois; Simmons, Robert E.			Migratory patterns and settlement areas revealed by remote sensing in an endangered intra-African migrant, the Black Harrier (Circus maurus)	PLOS ONE			English	Article							SOUTH-AFRICA; HOME-RANGE; SATELLITE-TRACKING; BREEDING DISPERSAL; PRAIRIE FALCONS; HABITAT; MOVEMENTS; SURVIVAL; FLEXIBILITY; POPULATION	Annual movements have been widely described for birds migrating across the Americas and between Eurasia and Africa, yet relatively little information exists for intra-African migrants. Identifying the areas used throughout a species annual cycle by understanding migratory patterns and settlement areas during breeding and non-breeding seasons is essential for conservation initiatives. Here, we describe for the first time, the migratory patterns and settlement areas of an endangered raptor endemic to Southern Africa, the Black Harrier (Circus maurus). From 2008 to 2015, thirteen breeding adult Black Harriers were trapped in south-western South Africa and fitted either with a GPS-GSM or with a PTT tracker device. Adults were monitored for 365 +/- 198 days (range: 56-819 days) revealing great individual variability in annual movements. Most Black Harriers performed an unusual West-East migration from their breeding areas, but routes of all migrating individuals covered the entire southern land area of South Africa and Lesotho. The distance travelled averaged 814 +/- 324 km, but unlike many other species, migrants travelled faster during post-breeding (i.e. austral summer) (207.8 +/- 113.2 km.day(-1)) than during pre-breeding (i.e. austral winter/spring) migrations (143.8 +/- 32.2 km.day(-1)). Although most marked individuals displayed movements similar to those that bred following pre-breeding migrations, only two of thirteen were confirmed as breeders the year after being tagged. This suggests that individuals may sometimes take a sabbatical year in reproduction, although this requires confirmation. Most tagged birds died on migration or during the non-breeding season. Adults frequently returned to the same non-breeding settlement areas, and often used up to 3 different locations an average of about 200 km apart. On the other hand, there was wide variation in distance between subsequent reproductive events. We discuss the implications of our study for the conservation of Black Harriers and more broadly for intra-African bird migrants.	[Garcia-Heras, Marie-Sophie] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Garcia-Heras, Marie-Sophie; Simmons, Robert E.] Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa; [Arroyo, Beatriz; Mougeot, Francois] UCLM, CSIC, JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Bildstein, Keith; Therrien, Jean-Francois] Acopian Ctr Conservat Learning, Hawk Mt Sanctuary, Orwigsburg, PA USA	Oregon State University; National Research Foundation - South Africa; University of Cape Town; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Garcia-Heras, MS (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.; Garcia-Heras, MS (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, FitzPatrick Inst African Ornithol, Cape Town, South Africa.	ms.garciaheras@oregonstate.edu	Mougeot, Francois/Y-9569-2019; Arroyo, Beatriz/A-3504-2013; Simmons, Robert E/AAE-3915-2020	Mougeot, Francois/0000-0002-5819-6275; Arroyo, Beatriz/0000-0002-4657-6609; Garcia-Heras, Marie-Sophie/0000-0002-3460-5484; Simmons, Robert/0000-0003-4964-8126	National Research Foundation of South Africa [90582]; DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town); Consejo Superior de Investigaciones Cientificas [PIE 201330E106]; Hawk Mountain Sanctuary (USA); BirdLife South Africa, Inkwazi and Wits Bird Club; Jakkalsfontein Private Nature Reserve; Two Oceans Slope Soarers (TOSS); Natural Research UK; Peregrine Fund; UCT	National Research Foundation of South Africa(National Research Foundation - South Africa); DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town)(Department of Science & Technology (India)); Consejo Superior de Investigaciones Cientificas; Hawk Mountain Sanctuary (USA); BirdLife South Africa, Inkwazi and Wits Bird Club; Jakkalsfontein Private Nature Reserve; Two Oceans Slope Soarers (TOSS); Natural Research UK; Peregrine Fund; UCT	This study was supported financially by the National Research Foundation of South Africa (Grant no. 90582 to RES), the DST-NRF Centre of Excellence at the Percy FitzPatrick Institute (University of Cape Town), CoE 2014 PhD bursary to M.S.G.H. through G. Cummings, the Consejo Superior de Investigaciones Cientificas (PIE 201330E106 to BA), and private landowners and organizations. Particular thanks for economic support are due to Hawk Mountain Sanctuary (USA), to "Golden Fleece Merino", BirdLife South Africa, Inkwazi and Wits Bird Club, Jakkalsfontein Private Nature Reserve, the Two Oceans Slope Soarers (TOSS), Natural Research UK, the Peregrine Fund, Sven Carlsson-Smith, Nial Perrins, Chris Cory, Gisela Ortner and James Smith. FM and BA thank UCT for financial support (2015 Science Faculty Distinguished Visitor award to FM; and Foreign Research Fellowship to BA).	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Arroyo B, 2014, BIRD STUDY, V61, P48, DOI 10.1080/00063657.2013.874976; Arroyo BE, 2007, IBIS, V149, P806, DOI 10.1111/j.1474-919X.2007.00716.x; Bates D., 2012, IME4 LINEAR MIXED EF; Berthold P., 2001, OXFORD ORNITHOLOGY S, V12; Bildstein K. L., 2006, MIGRATING RAPTORS WO; Bivand R, 2014, RDAL BINDINGS GEOSPA; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Curtis O, 2004, BIRD CONSERV INT, V14, P233, DOI 10.1017/S0959270904000310; Curtis O, 2005, THESIS; del Hoyo J., 1992, P1; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; DOLMAN PM, 1995, IBIS, V137, pS38, DOI 10.1111/j.1474-919X.1995.tb08456.x; Fuchs J, 2014, IBIS, V156, P227, DOI 10.1111/ibi.12103; Garbett R, 2018, SCI TOTAL ENVIRON, V630, P1654, DOI 10.1016/j.scitotenv.2018.02.220; Garcia-Heras M- S, 2017, THESIS; Garcia-Heras MS, 2018, ENVIRON POLLUT, V232, P440, DOI 10.1016/j.envpol.2017.09.059; Garcia-Heras MS, 2017, SCI TOTAL ENVIRON, V603, P299, DOI 10.1016/j.scitotenv.2017.06.048; Garcia-Heras MS, 2017, IBIS, V159, P567, DOI 10.1111/ibi.12478; Garcia-Heras MS, 2017, OSTRICH, V88, P1, DOI 10.2989/00306525.2016.1257515; Garcia-Heras MS, 2016, NAT CONSERV-BULGARIA, P23, DOI 10.3897/natureconservation.15.9800; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Klaassen RHG, 2011, P ROY SOC B-BIOL SCI, V278, P1339, DOI 10.1098/rspb.2010.2106; Kruger AC, 2010, STRONG WIND CLIMATIC, V13; Liminana R, 2007, J ORNITHOL, V148, P517, DOI 10.1007/s10336-007-0182-9; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McGrady MJ, 2002, CONDOR, V104, P39, DOI 10.1650/0010-5422(2002)104[0039:MAROPF]2.0.CO;2; Mellone U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039833; Meyburg Bernd-U., 2007, P242; Meyburg BU, 1995, OSTRICH, V66, P135, DOI 10.1080/00306525.1995.9632720; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Mokotjomela T, 2010, AFR ZOOL, V45, P225, DOI 10.3377/004.045.0201; Monti F, 2018, MIGRATION WINTERING, V4, P554; Mucina L, 2006, VEGETATION MAP S AFR; Nater CR, 2016, OIKOS, V125, P1838, DOI 10.1111/oik.03384; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1979, POPULATION ECOLOGY R; Newton I, 2006, ARDEA, V94, P433; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Paijmans DM, 2017, OSTRICH, V88, P163, DOI 10.2989/00306525.2017.1337051; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Peery MZ, 2000, AUK, V117, P511, DOI 10.1642/0004-8038(2000)117[0511:FAIVIH]2.0.CO;2; PERRIN MR, 1981, S AFR J ZOOL, V16, P248; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Reid T, 2015, J APPL ECOL, V52, P881, DOI 10.1111/1365-2664.12468; Robillard A, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01707; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodriguez-Riuz J, 2018, BIRD CONSERVATION IN; Rymer TL, 2013, SUSTAINABILITY-BASEL, V5, P163, DOI 10.3390/su5010163; Schlaich AE, 2016, J ANIM ECOL, V85, P1491, DOI 10.1111/1365-2656.12583; Schradin C, 2004, J COMP PSYCHOL, V118, P37, DOI 10.1037/0735-7036.118.1.37; Simmons R. E., 2000, HARRIERS WORLD THEIR; Simmons R. E., 2015, BIRDS WATCH NAMIBIA; Simmons RE, 1997, BEHAV ECOL, V8, P544, DOI 10.1093/beheco/8.5.544; Steenhof K, 2005, CONDOR, V107, P481, DOI 10.1650/0010-5422(2005)107[0481:LMABDO]2.0.CO;2; Steenhof K, 2006, WILDLIFE SOC B, V34, P116, DOI 10.2193/0091-7648(2006)34[116:EOROPF]2.0.CO;2; Szep T, 2006, J ORNITHOL, V147, P245, DOI 10.1007/s10336-006-0060-x; Tarboton WR, 1984, STATUS CONSERVATION; Taylor M., 2015, 2015 ESKOM RED DATA, P125; Terraube J, 2012, BIODIVERS CONSERV, V21, P1835, DOI 10.1007/s10531-012-0282-6; Terraube J, 2012, DIVERS DISTRIB, V18, P401, DOI 10.1111/j.1472-4642.2011.00830.x; Terraube J., 2011, THESIS; The R foundation for statistical computing, 2015, R FDN STAT COMP WOOD; Therrien JF, 2014, J AVIAN BIOL, V45, P536, DOI 10.1111/jav.00426; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Trierweiler C, 2010, THESIS; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Underhill L.G., 2016, BIODIVERS OBS, V7, P1, DOI DOI 10.1080/09766901.2016.11884754; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	78	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210756	10.1371/journal.pone.0210756	http://dx.doi.org/10.1371/journal.pone.0210756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653592	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500066
J	Maniragaba, F; Nzabona, A; Asiimwe, JB; Bizimungu, E; Mushomi, J; Ntozi, J; Kwagala, B				Maniragaba, Fred; Nzabona, Abel; Asiimwe, John Bosco; Bizimungu, Emmanuel; Mushomi, John; Ntozi, James; Kwagala, Betty			Factors associated with older persons' physical health in rural Uganda	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL SUPPORT; ADULTS; DISABILITY; IMPACT; PEOPLE	Introduction The proportion of older persons in developing countries is increasing with no clear evidence of improvement in physical health. The aim of this paper was to examine the factors associated with older persons' physical health in rural Uganda. Methods This paper is based on a cross-sectional study of 912 older persons age 60 years and older across four major regions of Uganda. The study was conceptualized basing on World Health Organization quality of life BREF (WHOQOL-BREF). Analysis was done at three levels, that is, frequency distributions were generated to describe background characteristics of respondents and cross-tabulations were done to determine associations between dependent and each of the independent variables. Ordinal logistic regression was used to determine the predictors of physical health. Results The likelihood of good physical health is high among older persons (Ops) who controlled their household assets (OR = 3.64; CI = 1.81-7.30) or the household assets controlled by their spouses (OR = 4.44; CI = 1.91-10.32) relative to those whose household assets were controlled by their children. There is high likelihood of good physical health among those who engage in physical activities (OR = 2.28; CI = 1.52-3.43) compared to those who do not. Conclusion The findings have various policy implications, including creating an enabling environment and building capacities of older persons to remain in control of their household assets. Interventions focusing on deepening sensitization of older persons about importance of physical exercises could be a viable strategy for improving physical health of older persons.	[Maniragaba, Fred; Nzabona, Abel; Mushomi, John; Ntozi, James; Kwagala, Betty] Makerere Univ, Dept Populat Studies, Kampala, Uganda; [Asiimwe, John Bosco] Makerere Univ, Dept Planning & Appl Stat, Kampala, Uganda; [Bizimungu, Emmanuel] Int Food Policy Res Inst, Kampala, Uganda	Makerere University; Makerere University; CGIAR; International Food Policy Research Institute (IFPRI)	Maniragaba, F (corresponding author), Makerere Univ, Dept Populat Studies, Kampala, Uganda.	fmaniragaba@gmail.com		Maniragaba, Fred/0000-0001-5977-1924; Kwagala, Betty/0000-0002-1095-0072	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government; College of Business and Management Sciences, Makerere University	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government; College of Business and Management Sciences, Makerere University	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The authors also thank the College of Business and Management Sciences, Makerere University (http://bams.mak.ac.ug/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA (http://cartafrica.org/) is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The authors also thank the College of Business and Management Sciences, Makerere University (http://bams.mak.ac.ug/) for financial support. We also appreciate the Centre for Population and Applied Statistics (CPAS), Makerere University for providing space while writing this paper. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	AAPOR, 2016, ENCY SURVEY RES METH; Aboderin IAG, 2015, LANCET, V385, pE9, DOI 10.1016/S0140-6736(14)61602-0; Azevedo J.P., 2006, FACTORTEST STATA MOD; Bigombe B, 2003, MAJOR TRENDS AFFECTI; Bilgili N, 2014, ARCH GERONTOL GERIAT, V59, P415, DOI 10.1016/j.archger.2014.07.005; Brown J.D., 2009, EVAL SIG NEWSL, V13, P20, DOI DOI 10.1016/0147-1767(92)90031-0; Chaudhuri S, 2013, CIN-COMPUT INFORM NU, V31, P547, DOI 10.1097/01.NCN.0000432131.92020.42; Chen Y, 2015, HEALTH EDUC J, V74, P156, DOI 10.1177/0017896914523943; Crasto CL, 2012, REJUV RES, V15, P295, DOI 10.1089/rej.2011.1268; Dai H, 2015, PUBLIC HEALTH, V129, P667, DOI 10.1016/j.puhe.2015.02.022; Feng ZX, 2015, SOC SCI MED, V130, P181, DOI 10.1016/j.socscimed.2015.02.020; Fillenbaum GG, 2010, J AGING HEALTH, V22, P362, DOI 10.1177/0898264309359307; Finch WH, 2011, J MODERN APPL STAT M, V10, P14; Gabriel Z, 2004, AGEING SOC, V24, P675, DOI 10.1017/S0144686X03001582; Golaz V., 2015, AGEING SOC, P1; Golaz V, 2011, AFRICAN POPULATION S, V25, P2; Gomez-Olive FX, 2014, INT J EPIDEMIOL, V43, P1531, DOI 10.1093/ije/dyu093; HAI, 2003, AU POL FRAM PLAN ACT; Hamer M, 2014, BRIT J SPORT MED, V48, P239, DOI 10.1136/bjsports-2013-092993; Han L, 2013, ANN EPIDEMIOL, V23, P87, DOI 10.1016/j.annepidem.2012.11.010; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hui EKH, 2006, J AM MED DIR ASSOC, V7, P310, DOI 10.1016/j.jamda.2006.03.006; Kabunga NS, 2014, FOOD POLICY, V45, P25, DOI 10.1016/j.foodpol.2013.12.009; Kikafunda JK, 2005, NUTRITION, V21, P59, DOI 10.1016/j.nut.2004.09.009; Kim BJ, 2013, J APPL GERONTOL, V32, P997, DOI 10.1177/0733464812448528; Kwag KH, 2011, INT J AGING HUM DEV, V72, P137, DOI 10.2190/AG.72.2.c; Liang J, 2014, FAM PRACT, V31, P164, DOI 10.1093/fampra/cmt073; Melchiorre MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054856; Ministry of Gender Labour and Social Development (MoGLSD), 2009, NAT POL OLD PERS AG; MoGLSD, 2013, NAT ACT PLAN OLD PER; Mwanyangala MA, 2010, GLOBAL HEALTH ACTION, V3, P36, DOI 10.3402/gha.v3i0.2142; Najjumba-Mulindwa I, 2003, STAYING POOR CHRON P; Nzabona A, 2016, AGEING SOC, V36, P860, DOI 10.1017/S0144686X15000112; Paskulin LMG, 2007, WESTERN J NURS RES, V29, P10, DOI 10.1177/0193945906292550; Phillips SP, 2015, WOMENS RELATIVE IMMU, P8, DOI [10.3402/gha.v8.27259, DOI 10.3402/GHA.V8.27259]; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; PRB (Population Reference Bureau), 2017, WORLD POP DAT SHEET; Rajan KB, 2013, J GERONTOL A-BIOL, V68, P624, DOI 10.1093/gerona/gls208; Roe Brenda, 2011, Prim Health Care Res Dev, V12, P200, DOI 10.1017/S1463423611000053; Schatz E, 2012, SOC SCI MED, V75, P1864, DOI 10.1016/j.socscimed.2012.07.004; Stenhagen M, 2014, CLIN INTERV AGING, V9, P1839, DOI 10.2147/CIA.S70075; Thompson WW, 2012, AM J PUBLIC HEALTH, V102, P496, DOI 10.2105/AJPH.2011.300500; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Uganda Bureau of Statistics (UBOS), 2021, UG NAT HOUS SURV 201; UN, 2013, POP AG DEV DEP EC SO; Unalan D, 2015, EUR GERIATR MED, V6, P319, DOI 10.1016/j.eurger.2015.02.009; UNDESA, 2014, CONC REP WORLD POP S; UNECA, 2007, STAT OLD PEOPL AFR 2; UNFPA (United Nations Population Fund) and HelpAge International, 2012, AG 21 CENT CEL CHALL; United Nation, 2017, DEP EC SOC AFF POP D; Van Minh H, 2010, GLOBAL HLTH ACTION, P3, DOI [10.3402/gha.v3i0, DOI 10.3402/GHA.V3I0]; Wandera SO, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0157-z; World Health Organization, 1996, WHOQOL BREF INTR ADM; Yamamoto, 2014, J INT HLTH, V29, P11, DOI DOI 10.11197/JAIH.29.11; Yuan SC, 2011, ARCH GERONTOL GERIAT, V53, P274, DOI 10.1016/j.archger.2010.11.029	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209262	10.1371/journal.pone.0209262	http://dx.doi.org/10.1371/journal.pone.0209262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650092	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300010
J	Tomiyama, T; Goto, K; Tanaka, Y; Maruta, T; Ogawa, T; Sawa, Y; Ito, T; Ishikawa, T				Tomiyama, Takuya; Goto, Kyo; Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Sawa, Yoshihiro; Ito, Takuro; Ishikawa, Takahiro			A major isoform of mitochondrial trans-2-enoyl-CoA reductase is dispensable for wax ester production in Euglena gracilis under anaerobic conditions	PLOS ONE			English	Article							FATTY-ACID SYNTHETASES; FERMENTATION; PURIFICATION	Under anaerobic conditions, Euglena gracilis produces a large amount of wax ester through mitochondrial fatty acid synthesis from storage polysaccharides termed paramylon, to generate ATP. Trans-2-enoyl-CoA reductases (TERs) in mitochondria have been considered to play a key role in this process, because the enzymes catalyze the reduction of short chain length CoA-substrates (such as crotonyl-CoA). A TER enzyme (EgTER1) has been previously identified and enzymologically characterized; however, its physiological significance remained to be evaluated by genetic analysis. We herein generated EgTER1-knockdown Euglena cells, in which total crotonyl-CoA reductase activity was decreased to 10% of control value. Notably, the knockdown cells showed a severe bleaching phenotype with deficiencies in chlorophylls and glycolipids, but grew normally under heterotrophic conditions (with glucose supplementation). Moreover, the knockdown cells accumulated much greater quantities of wax ester than control cells before and after transfer to anaerobic conditions, which was accompanied by a large metabolomic change. Furthermore, we failed to find any contribution of other potential TER genes in wax ester production. Our findings propose a novel role of EgTER1 in the greening process and demonstrate that this enzyme is dispensable for wax ester production under anaerobic conditions.	[Tomiyama, Takuya; Goto, Kyo; Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Sawa, Yoshihiro; Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Tanaka, Yuji; Maruta, Takanori; Ogawa, Takahisa; Ishikawa, Takahiro] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Ito, Takuro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Ito, Takuro] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan	Shimane University; Japan Science & Technology Agency (JST); Keio University; Keio University	Ishikawa, T (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.; Ishikawa, T (corresponding author), Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan.	ishikawa@life.shimane-u.ac.jp	Ishikawa, Takahiro/AAX-5792-2021; Sawa, Yoshihiro/F-8295-2017	Sawa, Yoshihiro/0000-0002-2379-470X; Maruta, Takanori/0000-0003-4144-7821; Ito, Takuro/0000-0001-5043-1886; Ishikawa, Takahiro/0000-0002-5834-2922	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) (YT, TM, TO, TI), http://www.jst.go.jp/presto/bioenergy/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barras D. R., 1968, P149; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; DELO J, 1971, ARCH BIOCHEM BIOPHYS, V143, P384, DOI 10.1016/0003-9861(71)90225-6; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; ERNSTFONBERG ML, 1971, ARCH BIOCHEM BIOPHYS, V143, P392, DOI 10.1016/0003-9861(71)90226-8; HENDREN RW, 1980, J BIOL CHEM, V255, P1504; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x; INUI H, 1986, J BIOCHEM, V100, P995, DOI 10.1093/oxfordjournals.jbchem.a121813; INUI H, 1983, AGR BIOL CHEM TOKYO, V47, P2669, DOI 10.1080/00021369.1983.10866013; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Inui H, 2017, ADV EXP MED BIOL, V979, P269, DOI 10.1007/978-3-319-54910-1_13; Ito T, 2013, METABOLOMICS, V9, pS178, DOI 10.1007/s11306-012-0463-z; KISS JZ, 1988, PROTOPLASMA, V146, P150, DOI 10.1007/BF01405924; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; Kuda T, 2009, J FUNCT FOODS, V1, P399, DOI 10.1016/j.jff.2009.08.003; Nakazawa M, 2018, FEBS LETT, V592, P4020, DOI 10.1002/1873-3468.13276; ODA Y, 1982, J GEN MICROBIOL, V128, P853; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sugimoto M, 2010, J AGR FOOD CHEM, V58, P374, DOI 10.1021/jf903680d; Tanaka Y, 2017, FEBS LETT, V591, P1360, DOI 10.1002/1873-3468.12659; Tomiyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14077-6; Winkler U, 2003, PLANT PHYSIOL, V131, P753, DOI 10.1104/pp.013151; Yoshida Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2540-6	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210755	10.1371/journal.pone.0210755	http://dx.doi.org/10.1371/journal.pone.0210755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650145	Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300076
J	Kotil, S; Jakobsson, E				Kotil, Seyfullah; Jakobsson, Eric			Rationally designing antisense therapy to keep up with evolving bacterial resistance	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS; ESCHERICHIA-COLI; PEPTIDE; MUTATIONS; OLIGOMERS; SYSTEMS; VALIDATION; CONJUGATE	Antisense molecules used as antibiotics offer the potential to keep up with acquired resistance, by redesigning the sequence of an antisense. Once bacteria acquire resistance by mutating the targeted sequence, new antisense can readily be designed by using sequence information of a target gene. However, antisense molecules require additional delivery vehicles to get into bacteria and be protected from degradation. Based on progress in the last few years it appears that, while redesigning or finding new delivery vehicle will be more difficult than redesigning the antisense cargo, it will perhaps be less difficult than finding new conventional small molecule antibiotics. In this study we propose a protocol that maximizes the combined advantages of engineered delivery vehicle and antisense cargo by decreasing the immediate growth advantage to the pathogen of mutating the entry mechanisms and increasing the advantage to the pathogen of antisense target mutations. Using this protocol, we show by computer simulation an appropriately designed antisense therapy can potentially be effective many times longer than conventional antibiotics before succumbing to resistance. While the simulations describe an in-vitro situation, based on comparison with other in-vitro studies on acquired resistance we believe the advantages of the combination antisense strategy have the potential to provide much more sustainability in vivo than conventional antibiotic therapy.	[Kotil, Seyfullah; Jakobsson, Eric] Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA; [Kotil, Seyfullah; Jakobsson, Eric] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jakobsson, Eric] Univ Illlinois Urbana Champaign, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Kotil, Seyfullah] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison	Jakobsson, E (corresponding author), Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA.; Jakobsson, E (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.; Jakobsson, E (corresponding author), Univ Illlinois Urbana Champaign, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jake@illinois.edu			National Institute of General Medical Sciences [R01GM098736]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant #R01GM098736 from the National Institute of General Medical Sciences nigms.nih.gov to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11660; Bergmann R, 2014, ANTIMICROBIAL AGENTS; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Crooke ST, 1999, BBA-GENE STRUCT EXPR, V1489, P31, DOI 10.1016/S0167-4781(99)00148-7; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Figliuzzi M, 2016, MOL BIOL EVOL, V33, P268, DOI 10.1093/molbev/msv211; Geller BL, 2014, THER DELIV, V5, P243, DOI [10.4155/tde.13.145, 10.4155/TDE.13.145]; Geller BL, 2013, J INFECT DIS, V208, P1553, DOI 10.1093/infdis/jit460; Gerth ML, 2012, ENVIRON MICROBIOL, V14, P1929, DOI 10.1111/j.1462-2920.2011.02691.x; Ghosal A, 2013, ACS CHEM BIOL, V8, P360, DOI 10.1021/cb300434e; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663; Hoynes-O'Connor A, 2017, BIOTECHNOL BIOENG, V114, P1626, DOI 10.1002/bit.26279; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Kalhapure RS, 2015, J PHARM SCI-US, V104, P872, DOI 10.1002/jps.24298; Kieldsen KR, 2009, BIOTECHNOL BIOENG, V102, P583, DOI 10.1002/bit.22067; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Mann JK, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003776; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Meng J, 2015, J ANTIBIOT, V68, P158, DOI 10.1038/ja.2014.132; Morse TO, 2010, ENVIRON SCI TECHNOL, V44, P3293, DOI 10.1021/es901404a; Nayak DD, 2016, CURR BIOL, V26, P1416, DOI 10.1016/j.cub.2016.04.029; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Nurjadi D, 2014, J ANTIMICROB CHEMOTH, V69, P2361, DOI 10.1093/jac/dku174; Okumus B, 2014, CURR OPIN BIOTECH, V25, P30, DOI 10.1016/j.copbio.2013.08.016; Podnecky NL, 2013, ANTIMICROBIAL AGENTS; Puckett SE, 2012, ANTIMICROBIAL AGENTS; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Sawyer AJ, 2013, INT J PHARMACEUT, V453, P651, DOI 10.1016/j.ijpharm.2013.05.041; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Stoer J., 2013, INTRO NUMERICAL ANAL; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Ventola C Lee, 2015, P T, V40, P344; Wesolowski D, 2011, P NATL ACAD SCI; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	57	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0209894	10.1371/journal.pone.0209894	http://dx.doi.org/10.1371/journal.pone.0209894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645595	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200014
J	Lee, JLC; Amorim, FE; Cassini, LF; Amaral, OB				Lee, Jonathan L. C.; Amorim, Felippe E.; Cassini, Lindsey F.; Amaral, Olavo B.			Different temporal windows for CB1 receptor involvement in contextual fear memory destabilisation in the amygdala and hippocampus	PLOS ONE			English	Article							CONDITIONED FEAR; NMDA RECEPTOR; RECONSOLIDATION; EXTINCTION; RETRIEVAL; PHOSPHORYLATION	Reconsolidation is a process in which re-exposure to a reminder causes a previously acquired memory to undergo a process of destabilisation followed by subsequent restabilisation. Different molecular mechanisms have been postulated for destabilisation in the amygdala and hippocampus, including CB1 receptor activation, protein degradation and AMPA receptor exchange; however, most of the amygdala studies have used pre-reexposure interventions, while those in the hippocampus have usually performed them after reexposure. To test whether the temporal window for destabilisation is similar across both structures, we trained Lister Hooded rats in a contextual fear conditioning task, and 1 day later performed memory reexposure followed by injection of either the NMDA antagonist MK-801 (0.1 mg/kg) or saline in order to block reconsolidation. In parallel, we also performed local injections of either the CB1 antagonist SR141716A or its vehicle in the hippocampus or in the amygdala, either immediately before or immediately after reactivation. Infusion of SR141716A in the hippocampus prevented the reconsolidation-blocking effect of MK-801 when performed after reexposure, but not before it. In the amygdala, meanwhile, pre-reexposure infusions of SR141716A impaired reconsolidation blockade by MK-801, although the time-dependency of this effect was not as clear as in the hippocampus. Our results suggest the temporal windows for CB1-receptor-mediated memory destabilisation during reconsolidation vary between brain structures. Whether this reflects different time windows for engagement of these structures or different roles played by CB1 receptors in destabilisation across structures remains an open question for future studies.	[Lee, Jonathan L. C.; Cassini, Lindsey F.] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Amorim, Felippe E.; Amaral, Olavo B.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil	University of Birmingham; Universidade Federal do Rio de Janeiro	Lee, JLC (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	j.l.c.lee@bham.ac.uk	Lee, Jonathan LC/A-9629-2008; Amaral, Olavo/B-2874-2009	Lee, Jonathan LC/0000-0002-2284-2482; E. Amorim, Felippe/0000-0002-1922-8211; Amaral, Olavo/0000-0002-4299-8978	UK Biotechnology and Biological Sciences Research Council [BB/J014982/1]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/010.002674/2014]; University of Birmingham; BBSRC [BB/J014982/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); University of Birmingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was conducted with funding from the UK Biotechnology and Biological Sciences Research Council (grant number BB/J014982/1 to JLCL), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to OBA (grant number E-26/010.002674/2014 to OBA) and the University of Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Correa S, 2014, J PHYSIOL-PARIS, V108, P292, DOI 10.1016/j.jphysparis.2014.08.006; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904; Carneiro CFD, 2018, PUBMED, V13, DOI 10.1371/journal.pone.0196258; Carneiro CFD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196258; Cassini LF, 2017, LEARN MEMORY, V24, P392, DOI 10.1101/lm.045724.117; Crestani AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13633; Da Silva WC, 2013, P NATL ACAD SCI USA, V110, P6566, DOI 10.1073/pnas.1302356110; Delorenzi A, 2014, J PHYSIOL-PARIS, V108, P307, DOI 10.1016/j.jphysparis.2014.07.002; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; EPUB H, 1951, PUBMED; EPUB H, 2016, PUBMED, V1, P19; EPUB H, PUBMED, P3082; EPUB H, 1927, PUBMED; EPUB H, PUBMED; EPUB H, 1950, PUBMED; Exton-McGuinness MTJ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0009-15.2015; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Flavell CR, 2013, NEUROBIOL LEARN MEM, V104, P25, DOI 10.1016/j.nlm.2013.04.009; Fukushima H, 2014, ELIFE, V3, DOI 10.7554/eLife.02736; Gisquet-Verrier P, 2015, J NEUROSCI, V35, P11623, DOI 10.1523/JNEUROSCI.1386-15.2015; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; Itzhak Y, 2008, ANN NY ACAD SCI, V1139, P350, DOI 10.1196/annals.1432.051; Jarome TJ, 2016, NEUROBIOL LEARN MEM, V128, P103, DOI 10.1016/j.nlm.2016.01.001; JAROME TJ, 2011, PUBMED, V10, P1; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; KAMPRATH K, 2006, J NEUROSCI, V6, P24; KIM R, 1956, MOL BRAIN, V15, P4; KIM S, 2014, PLOS BIOL, V7, P2; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; LEE JLC, HIPPOCAMPUS, P233; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2017, TRENDS COGN SCI, V21, P531, DOI 10.1016/j.tics.2017.04.006; Lee JLC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00144; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lin HC, 2006, LEARN MEMORY, V13, P316, DOI 10.1101/lm.217006; MAREN S, NAT REV NEUROSCI, P417; MARSICANO G, 2002, NATURE, V8, P2; Merlo E, 2015, AMYGDALA DOPAMINE RE, V2, DOI 10.1523/ENEURO.0024-14.2015; MILTON AL, 2013, J NEUROSCI, V1, P18; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nakayama D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21007; ONISHI BK, 2009, NEUROBIOL LEARN MEM, V9, P22; Pertwee R. G., 2004, Current Neuropharmacology, V2, P9, DOI 10.2174/1570159043476927; PERTWEE RG, 2005, LIFE SCI, V1, P27; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PLENDL W, J NEUROSCI, P4990; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Ratano P, 2014, NEUROPSYCHOPHARMACOL, V39, P2529, DOI 10.1038/npp.2014.103; Reichelt AC, 2013, PUBMED, V7, P118; Reichelt AC, 2013, J NEUROSCI, V33, P14205, DOI 10.1523/JNEUROSCI.1614-13.2013; Roche M, 2007, EUR J NEUROSCI, V26, P2643, DOI 10.1111/j.1460-9568.2007.05861.x; Rodriguez-Ortiz CJ, 2017, NEUROBIOL LEARN MEM, V142, P4, DOI 10.1016/j.nlm.2016.12.005; Rodriguez-Ortiz CJ, 2012, NEUROBIOL LEARN MEM, V98, P215, DOI 10.1016/j.nlm.2012.08.002; Rossato JI, 2015, BEHAV BRAIN RES, V285, P194, DOI 10.1016/j.bbr.2014.09.009; Sachser RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22771; SADLER R, 2007, BEHAV PHARMACOL, V10, P4; SHEHATA M, 2018, J NEUROSCI, V3, P21; SOLFUSTINANA M, 2014, PUBMED, V21, P478; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Suzuki A, 2008, LEARN MEMORY, V15, P426, DOI 10.1101/lm.888808; von der Goltz C, 2009, PSYCHOPHARMACOLOGY, V205, P389, DOI 10.1007/s00213-009-1544-1; Yu YJ, 2016, LEARN MEMORY, V23, P486, DOI 10.1101/lm.039941.115	66	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0205781	10.1371/journal.pone.0205781	http://dx.doi.org/10.1371/journal.pone.0205781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6AH	30645588	Green Published, gold, Green Submitted			2022-12-27	WOS:000455810200004
J	Oyetunde, T; Liu, D; Martin, HG; Tang, YJJ				Oyetunde, Tolutola; Liu, Di; Garcia Martin, Hector; Tang, Yinjie J.			Machine learning framework for assessment of microbial factory performance	PLOS ONE			English	Article							SYNTHETIC BIOLOGY	Metabolic models can estimate intrinsic product yields for microbial factories, but such frameworks struggle to predict cell performance (including product titer or rate) under suboptimal metabolism and complex bioprocess conditions. On the other hand, machine learning, complementary to metabolic modeling necessitates large amounts of data. Building such a database for metabolic engineering designs requires significant manpower and is prone to human errors and bias. We propose an approach to integrate data-driven methods with genome scale metabolic model for assessment of microbial bio-production (yield, titer and rate). Using engineered E. coli as an example, we manually extracted and curated a data set comprising about 1200 experimentally realized cell factories from similar to 100 papers. We furthermore augmented the key design features (e.g., genetic modifications and bioprocess variables) extracted from literature with additional features derived from running the genome-scale metabolic model iML1515 simulations with constraints that match the experimental data. Then, data augmentation and ensemble learning (e.g., support vector machines, gradient boosted trees, and neural networks in a stacked regressor model) are employed to alleviate the challenges of sparse, non-standardized, and incomplete data sets, while multiple correspondence analysis/principal component analysis are used to rank influential factors on bio-production. The hybrid framework demonstrates a reasonably high cross-validation accuracy for prediction of E. coli factory performance metrics under presumed bioprocess and pathway conditions (Pearson correlation coefficients between 0.8 and 0.93 on new data not seen by the model).	[Oyetunde, Tolutola; Liu, Di; Tang, Yinjie J.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Garcia Martin, Hector] DOE Joint BioEnergy Inst, Emeryville, CA USA; [Garcia Martin, Hector] DOE Agile BioFoundry, Emeryville, CA USA; [Garcia Martin, Hector] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Garcia Martin, Hector] Basque Ctr Appl Math, Bilbao, Spain; [Liu, Di] Sandia Natl Labs, Livermore, CA USA	Washington University (WUSTL); United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Basque Center for Applied Mathematics (BCAM); United States Department of Energy (DOE); Sandia National Laboratories	Tang, YJJ (corresponding author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.	yinjie.tang@seas.wustl.edu	Tang, Yinjie/AAI-5584-2020; Garcia Martin, Hector/B-5357-2009	Garcia Martin, Hector/0000-0002-4556-9685; Oyetunde, Tolutola/0000-0002-3875-8613	Department of Energy [DESC0018324]; National Science Foundation [MCB 1616619]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a Department of Energy grant (DESC0018324) and a National Science Foundation grant (MCB 1616619) to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by an NSF grant (MCB 1616619) and a DOE grant (DESC0018324) to YT. Authors thank Jeffery Czajka for useful discussions.	Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Arkin AP, 2018, NAT BIOTECHNOL, V36, P566, DOI 10.1038/nbt.4163; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chollet F., 2015, KERAS DEEP LEARNING; Chuang KV, 2018, SCIENCE, V362, DOI 10.1126/science.aat8603; Colletti PF, 2011, BIOTECHNOL BIOENG, V108, P893, DOI 10.1002/bit.22996; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Krizhevsky A., P 25 INT C NEUR INF, P1097; Long MR, 2015, CURR OPIN BIOTECH, V34, P135, DOI 10.1016/j.copbio.2014.12.019; Maarleveld TR, 2014, PLANT PHYSIOL, P113; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003989; Monk JM, 2017, NAT BIOTECHNOL, V35, P904, DOI 10.1038/nbt.3956; Morell WC, 2017, ACS SYNTH BIOL, V6, P2248, DOI 10.1021/acssynbio.7b00204; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Smith L. I., 2002, TUTORIAL PRINCIPAL C; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Winkler James D, 2015, Metab Eng Commun, V2, P30, DOI 10.1016/j.meteno.2015.06.003; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Wu SG, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0219-3; Wu SG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004838; Wu SG, 2016, CHEMBIOENG REV, V3, P45, DOI 10.1002/cben.201500024; Zhang ZD, 2015, NUCLEIC ACIDS RES, V43, pD549, DOI 10.1093/nar/gku1137	26	20	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210558	10.1371/journal.pone.0210558	http://dx.doi.org/10.1371/journal.pone.0210558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645629	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000455810200034
J	Cava, JA; Perlut, NG; Travis, SE				Cava, Jenna A.; Perlut, Noah G.; Travis, Steven E.			Heritability and evolvability of morphological traits of Savannah sparrows (Passerculus sandwichensis) breeding in agricultural grasslands	PLOS ONE			English	Article							NATURAL-POPULATIONS; MICROSATELLITE LOCI; NATAL PHILOPATRY; PATERNITY; SELECTION; BIRD; CONSERVATION; SONGBIRDS	Heritability and evolvability estimates of adult traits from free-living bird populations can be used to gauge the ability of populations to respond to selection, but are rare due to difficulties in gathering detailed pedigree information. The capacity to respond to selection is particularly important for species occupying managed habitats such as agricultural grasslands because of the potential for humans to accidentally influence traits. We calculated heritability and evolvability of six morphological traits in a population of Savannah Sparrows (Passerculus sandwichensis) breeding in a large agricultural landscape. We used microsatellite analysis to determine a genetic pedigree, revealing a high level of extra-pair paternity (63%) within a relatively philopatric population. For the entire population, heritabilities varied from low to high (bill width: 0.160 +/- 0.182 to tarsus length: 0.651 +/- 0.155), while evolvabilities were low across all traits (wing length: 0.035 +/- 0.013 to body mass: 0.066 +/- 0.106). Our results indicate that any directional selection from agricultural management practices will produce negligible changes in basic morphometrics of Savannah sparrow populations occupying the Champlain Valley of Vermont, USA.	[Cava, Jenna A.] Univ New England, Dept Biol, Biddeford, ME USA; [Perlut, Noah G.; Travis, Steven E.] Univ New England, Dept Environm Studies, Biddeford, ME 04005 USA	University of New England - Maine; University of New England - Maine	Perlut, NG (corresponding author), Univ New England, Dept Environm Studies, Biddeford, ME 04005 USA.	nperlut@une.edu			Toyota TogetherGreen, Toyota; National Audubon; Nuttall Ornithological Club; 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award [0841361]	Toyota TogetherGreen, Toyota; National Audubon; Nuttall Ornithological Club; 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award	This work was supported by D. Galipeau, private donation (NGP); Toyota TogetherGreen, Toyota and National Audubon, https://www.toyotaglobal.com/sustainability/social_contribution/environment/overseas/togethergreen/ (NGP); Nuttall Ornithological Club, https://www.nuttallclub.org/ (JC); 'Interface: a Systemic PARTnership Aimed at Connecting University and School (SPARTACUS)' National Science Foundation DGE Award (number 0841361) (JC).	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; Cava JA, 2016, ANIM BEHAV, V118, P39, DOI 10.1016/j.anbehav.2016.05.006; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Fajardo N, 2009, AUK, V126, P310, DOI 10.1525/auk.2009.07097; Falconer DS, 1996, INTRO QUANTITATIVE G; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; HANOTTE O, 1994, MOL ECOL, V3, P529, DOI 10.1111/j.1365-294X.1994.tb00133.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; HOULE D, 1992, GENETICS, V130, P195; Jeffery KJ, 2001, MOL ECOL NOTES, V1, P11, DOI 10.1046/j.1471-8278.2000.00005.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kim SY, 2013, HEREDITY, V111, P139, DOI 10.1038/hdy.2013.29; Kinnard TB, 2009, AUK, V126, P884, DOI 10.1525/auk.2009.08119; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Meyer K., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Morrissey MB, 2007, J EVOLUTION BIOL, V20, P2309, DOI 10.1111/j.1420-9101.2007.01412.x; [NASS] National Agricultural Statistics Service, 2010, CENS AGR; Perlut NG, 2008, ECOLOGY, V89, P1941, DOI 10.1890/07-0900.1; Perlut NG, 2008, MOL ECOL, V17, P1248, DOI 10.1111/j.1365-294X.2008.03695.x; Perlut NG, 2006, ECOL APPL, V16, P2235, DOI 10.1890/1051-0761(2006)016[2235:GSIADM]2.0.CO;2; Perlut NG, 2011, J WILDLIFE MANAGE, V75, P1657, DOI 10.1002/jwmg.199; Perlut NG, 2008, BIOL CONSERV, V141, P3139, DOI 10.1016/j.biocon.2008.09.011; Postma E, 2014, QUANTITATIVE GENETICS IN THE WILD, P16; Rodewald P. G., 2008, BIRDS N AM; Saunders SP, 2014, BIOL CONSERV, V177, P26, DOI 10.1016/j.biocon.2014.06.005; Temple M, 2000, THESIS; Teplitsky C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090444; Teplitsky C, 2009, EVOLUTION, V63, P716, DOI 10.1111/j.1558-5646.2008.00581.x; Urlich SC, 2015, NEW ZEAL J ECOL, V39, P133; WEATHERHEAD PJ, 1994, BEHAV ECOL, V5, P426, DOI 10.1093/beheco/5.4.426; Wheelwright NT, 2014, EVOLUTION, V68, P3325, DOI 10.1111/evo.12499; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	40	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210472	10.1371/journal.pone.0210472	http://dx.doi.org/10.1371/journal.pone.0210472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640933	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000032
J	Rivera-Espinosa, L; Toledo-Lopez, A; Chavez-Pacheco, JL; Alemon-Medina, R; Gomez-Garduno, J; Lugo-Goytia, G; Garcia-Alvarez, R; Juarez-Olguin, H; Torres-Espindola, LM; Perez-Guille, MG				Rivera-Espinosa, Liliana; Toledo-Lopez, Alejandra; Luis Chavez-Pacheco, Juan; Alemon-Medina, Radames; Gomez-Garduno, Josefina; Lugo-Goytia, Gustavo; Garcia-Alvarez, Raquel; Juarez-Olguin, Hugo; Maria Torres-Espindola, Luz; Perez-Guille, Maria-Gabriela			Determination of blood dexmedetomidine in dried blood spots by LC-MS/MS to screen therapeutic levels in paediatric patients	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PHARMACOKINETICS; PLASMA; QUANTIFICATION; QUANTITATION; CHILDREN; SAMPLES	Dexmedetomidine is an imidazole derivative, with high affinity for alpha(2) adrenergic receptors, used for sedation, analgesia and adjuvant anaesthesia. In this study, an analytical method for the quantification of dexmedetomidine in dried blood spots was developed, validated and applied. The drug was extracted from dried blood spot by liquid extraction; the separation was carried out by ultra high-resolution liquid chromatography in reverse phase coupled to tandem mass spectrometry method. An X Select cyano 5 mu m HSS column (2.1 X 150 mm, Waters) and a mobile phase composed of 0.1% formic acid: acetonitrile [50: 50 v/v], were used. The test was linear over the concentration range of 50 to 2000 pg/mL. The coefficients of variation for the intra and interday trials were less than 15%. The drug was stable under the conditions tested. The method was successfully applied for the quantification of 6 patients, aged 0 to 2 years, with classification ASA I, who underwent ambulatory surgeries, receiving a dose of 1 mu g/Kg dexmedetomidine IV. The drug concentrations in the different sampling times were in the range of 76 to 868 pg/mL.	[Rivera-Espinosa, Liliana; Toledo-Lopez, Alejandra; Luis Chavez-Pacheco, Juan; Alemon-Medina, Radames; Gomez-Garduno, Josefina; Garcia-Alvarez, Raquel; Juarez-Olguin, Hugo; Maria Torres-Espindola, Luz; Perez-Guille, Maria-Gabriela] Natl Inst Paediat, Pharmacol Lab, Mexico City, DF, Mexico; [Lugo-Goytia, Gustavo] Natl Inst Med Sci & Nutr, Anaesthesiol & Crit Med Dept, Mexico City, DF, Mexico; [Lugo-Goytia, Gustavo] Natl Inst Resp Dis, Intens Care Unit, Mexico City, DF, Mexico		Perez-Guille, MG (corresponding author), Natl Inst Paediat, Pharmacol Lab, Mexico City, DF, Mexico.	reparo_gaby@hotmail.com	Perez, Maria/S-3085-2019	RIVERA ESPINOSA, LILIANA/0000-0002-1334-0026; CHAVEZ PACHECO, JUAN LUIS/0000-0001-6919-4497; Perez-Guille, Maria-Gabriela/0000-0003-2448-7952; Torres-Espindola, Luz-Maria/0000-0001-9929-9361	Instituto Nacional de Pediatria (INP) [INP-062/2014]	Instituto Nacional de Pediatria (INP)	The internal govermental budget of the Instituto Nacional de Pediatria (INP) supported the study, INP-062/2014. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becan-McBride K, 2010, SUCCESS PHLEBOTOMY; Biccard BM, 2008, ANAESTHESIA, V63, P4, DOI 10.1111/j.1365-2044.2007.05306.x; Bioanalytical method validation-guidance for industry, BIOAN METH VAL GUID; Buck Marcia L, 2010, J Pediatr Pharmacol Ther, V15, P17; Carrillo-Torres O, 2014, REV MEX ANEST, V37, P27, DOI 10.2165/11207190-000000000-00000; Committee for Medicinal Products for Human Use (CHMP), GUID BIOAN METH VAL; Cui Z, 2014, J CHROMATOGR B, V961, P13, DOI 10.1016/j.jchromb.2014.04.037; Del Angel Garcia R, 2006, Gac Med Mex, V142, P9; Diaz SM, 2007, PEDIATR CRIT CARE ME, V8, P419, DOI 10.1097/01.PCC.0000282046.66773.39; Enderle Y, 2016, J PHARMACEUT BIOMED, V130, P231, DOI 10.1016/j.jpba.2016.06.026; Perez-Guille MG, 2016, INDIAN J PHARM EDUC, V50, pS153, DOI 10.5530/ijper.50.2.31; Garza D, 2010, PHLEBOTOMY HDB; Hoy SM, 2011, DRUGS, V71, P1481, DOI 10.2165/11207190-000000000-00000; Inoue K, 2013, BIOMED CHROMATOGR, V27, P853, DOI 10.1002/bmc.2870; Ji QC, 2004, RAPID COMMUN MASS SP, V18, P1753, DOI 10.1002/rcm.1548; Lee JI, 2007, J CHROMATOGR B, V852, P195, DOI 10.1016/j.jchromb.2007.01.013; Li WJ, 2009, J PHARMACEUT BIOMED, V50, P897, DOI 10.1016/j.jpba.2009.06.012; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Liu HC, 2016, J CHROMATOGR B, V1023, P30, DOI 10.1016/j.jchromb.2016.04.051; Lopez-Santiago N, 2016, ACTA PEDIATR MEX, V37, P246, DOI 10.18233/APM37No4pp246-249; Malva H, 2004, BANCO SANGRE MED TRA; Mani V, 2010, PEDIATR ANESTH, V20, P211, DOI 10.1111/j.1460-9592.2009.03112.x; Mato M, 2002, Rev Esp Anestesiol Reanim, V49, P407; McPherson R A, 2001, Clin Leadersh Manag Rev, V15, P3; Moosavi SM, 2018, J CHROMATOGR B, V1073, P118, DOI 10.1016/j.jchromb.2017.12.006; Nakanishi R, 2017, J CHROMATOGR B, V1040, P208, DOI 10.1016/j.jchromb.2016.11.015; Pandya HC, 2011, BIOANALYSIS, V3, P779, DOI 10.4155/BIO.11.19; Perez-Guille MG, 2018, ANESTH ANALG, V127, P716, DOI 10.1213/ANE.0000000000003413; Petroz GC, 2006, ANESTHESIOLOGY, V105, P1098, DOI 10.1097/00000542-200612000-00009; Potts AL, 2008, PEDIATR ANESTH, V18, P722, DOI 10.1111/j.1460-9592.2008.02653.x; Ramsay MAE, 2004, ANESTHESIOLOGY, V101, P787; Su F, 2010, ANESTH ANALG, V110, P1383, DOI 10.1213/ANE.0b013e3181d783c8; Szerkus O, 2017, BIOANALYSIS, V9, P395, DOI 10.4155/bio-2016-0242; Timmerman P, 2011, BIOANALYSIS, V3, P1567, DOI [10.4155/BIO.11.132, 10.4155/bio.11.132]; Tobias JD, 2011, PEDIATR CARDIOL, V32, P1075, DOI 10.1007/s00246-011-0092-8; Vilo S, 2008, BRIT J ANAESTH, V100, P697, DOI 10.1093/bja/aen070	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210391	10.1371/journal.pone.0210391	http://dx.doi.org/10.1371/journal.pone.0210391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640937	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000026
J	Szamado, S; Czegel, D; Zachar, I				Szamado, Szabolcs; Czegel, Daniel; Zachar, Istvan			One problem, too many solutions: How costly is honest signalling of need?	PLOS ONE			English	Article							NESTLING TREE SWALLOWS; EMPIRICAL-EVIDENCE; ENERGETIC COST; GROWTH; RELATIVES; PREDATION; INCREASES; CONFLICT; RISK	The "cost of begging" is a prominent prediction of costly signalling theory, suggesting that offspring begging has to be costly in order to be honest. Seminal signalling models predict that there is a unique equilibrium cost function for the offspring that results in honest signalling and this cost function must be proportional to parent's fitness loss. This prediction is only valid if signal cost and offspring condition is assumed to be independent. Here we generalize these models by allowing signal cost to depend on offspring condition. We demonstrate in the generalized model that any signal cost proportional to the fitness gain of the offspring also results in honest signalling. Moreover, we show that any linear combination of the two cost functions (one proportional to parent's fitness loss, as in previous models, the other to offspring's fitness gain) also leads to honest signalling in equilibrium, yielding infinitely many solutions. Furthermore, we demonstrate that there exist linear combinations such that the equilibrium cost of signals is negative and the signal is honest. Our results show that costly signalling theory cannot predict a unique equilibrium cost in signalling games of parent-offspring conflicts if signal cost depends on offspring condition. It follows, contrary to previous claims, that the existence of parent-offspring conflict does not imply costly equilibrium signals. As an important consequence, it is meaningless to measure the "cost of begging" as long as the dependence of signal cost on offspring condition is unknown. Any measured equilibrium cost in case of condition-dependent signal cost has to be compared both to the parent's fitness loss and to the offspring's fitness gain in order to provide meaningful interpretation.	[Szamado, Szabolcs] MTA Ctr Social Sci, CSS RECENS, Toth Kalman U 4, Budapest, Hungary; [Szamado, Szabolcs; Czegel, Daniel; Zachar, Istvan] Hungarian Acad Sci, Ctr Ecol Res, MTA, Evolutionary Syst Res Grp, Tihany, Hungary; [Czegel, Daniel] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Czegel, Daniel] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Czegel, Daniel; Zachar, Istvan] Parmenides Fdn, Ctr Conceptual Fdn Sci, Munich, Germany; [Zachar, Istvan] Eotvos Lorand Univ, MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Dept Plant Taxon & Ecol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University; Massachusetts Institute of Technology (MIT); Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand University	Szamado, S (corresponding author), MTA Ctr Social Sci, CSS RECENS, Toth Kalman U 4, Budapest, Hungary.; Szamado, S (corresponding author), Hungarian Acad Sci, Ctr Ecol Res, MTA, Evolutionary Syst Res Grp, Tihany, Hungary.	szamszab@ludens.elte.hu	Számadó, Szabolcs/A-9804-2013; Zachar, István/P-5101-2015	Számadó, Szabolcs/0000-0003-2204-9705; Zachar, István/0000-0002-3505-0628	OTKA grant [K 108974]; European Research Council (ERC) [648693]; National Research, Development and Innovation Office [GINOP-2.3.2-15-2016-00057]; Volkswagen Stiftung initiative "Leben?- Ein neuer Blick der Naturwissenschaften auf die grundlegenden Prinzipien des Lebens"	OTKA grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Research Council (ERC)(European Research Council (ERC)European Commission); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Volkswagen Stiftung initiative "Leben?- Ein neuer Blick der Naturwissenschaften auf die grundlegenden Prinzipien des Lebens"	S.S. was supported by OTKA grant K 108974 and by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 648693). S.S., I.Z. and D.C. acknowledge support from the National Research, Development and Innovation Office under grant number GINOP-2.3.2-15-2016-00057; I.Z. was supported by the Volkswagen Stiftung initiative "Leben? - Ein neuer Blick der Naturwissenschaften auf die grundlegenden Prinzipien des Lebens" under project name "A unified model of recombination in life." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman GC, 1998, ANIM BEHAV, V55, P1607, DOI 10.1006/anbe.1997.0719; Bebbington K, 2017, EVOL LETT, V1, P132, DOI 10.1002/evl3.18; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; Caro SM, 2016, P NATL ACAD SCI USA, V113, P13803, DOI 10.1073/pnas.1606378113; Caro SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10985; Dugas M. B., 2016, P NATL ACAD SCI USA; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Helfenstein F, 2008, BEHAV ECOL, V19, P108, DOI 10.1093/beheco/arm103; Hurd PL, 1997, J THEOR BIOL, V184, P83, DOI 10.1006/jtbi.1996.0246; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; JOHNSTONE RA, 1992, J THEOR BIOL, V156, P215, DOI 10.1016/S0022-5193(05)80674-5; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Lachmann M, 1998, THEOR POPUL BIOL, V54, P146, DOI 10.1006/tpbi.1997.1372; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; Leech SM, 1996, P ROY SOC B-BIOL SCI, V263, P983, DOI 10.1098/rspb.1996.0145; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; Maronde L., 2018, J EVOLUTIONARY BIOL; Maronde L, 2015, BEHAV ECOL, V26, P465, DOI 10.1093/beheco/aru215; McCarty JP, 1996, AUK, V113, P178, DOI 10.2307/4088944; McDonald PG, 2009, BEHAV ECOL, V20, P821, DOI 10.1093/beheco/arp066; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044647; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040367; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Noldeke G, 1999, J THEOR BIOL, V197, P527, DOI 10.1006/jtbi.1998.0893; Redondo T, 2016, BEHAV ECOL, V27, P1376, DOI 10.1093/beheco/arw045; Rodriguez-Girones MA, 1998, P NATL ACAD SCI USA, V95, P4453, DOI 10.1073/pnas.95.8.4453; Soler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111929; Stynoski JL, 2018, ZOOL ANZ, V273, P203, DOI 10.1016/j.jcz.2018.01.012; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; TRIVERS RL, 1974, AM ZOOL, V14, P249	41	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0208443	10.1371/journal.pone.0208443	http://dx.doi.org/10.1371/journal.pone.0208443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633748	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000455485100003
J	Domizi, P; Malizia, F; Chazarreta-Cifre, L; Diacovich, L; Banchio, C				Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia			KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells	PLOS ONE			English	Article							PHOSPHOLIPID BIOSYNTHESIS; CPG ISLANDS; PHOSPHATIDYLCHOLINE; PROLIFERATION; MECHANISMS; PATHWAY; COMPLEX; ASSAY	The process of neuronal differentiation is associated with neurite elongation and membrane biogenesis, and phosphatidylcholine (PtdCho) is the major membrane phospholipid in mammalian cells. During neuroblast differentiation, the transcription of two genes involved in PtdCho biosynthesis are stimulated: Chka gene for choline kinase (CK) alpha isoform and Pcyt1a gene for CTP:phosphocholine cytidylyltransferase (CCT) alpha isoform. Here we show that CK alpha is essential for neuronal differentiation. In addition, we demonstrated that KDM2B regulates CK alpha expression and, as a consequence, neuronal differentiation. This factor is up-regulated in the course of the neuroblasts proliferative and undifferentiated state and down-regulated during differentiation induced by retinoic acid (RA). During proliferation, KDM2B binds to the Box2 located in the Chka promoter repressing its transcription. Interestingly, KDM2B knockdown enhances the levels of CK alpha expression in neuroblast cells and induces neuronal differentiation even in the absence of RA. These results suggest that KDM2B is required for the appropriate regulation of CK alpha during neuronal differentiation and to the maintaining of the undifferentiated stage of neuroblast cells.	[Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia] Univ Nacl Rosario, Predio CONICET, Inst Biol Mol & Celular Rosario, IBR,CONICET,Ocampo & Esmeralda, Rosario, Santa Fe, Argentina; [Domizi, Pablo; Malizia, Florencia; Chazarreta-Cifre, Lorena; Diacovich, Lautaro; Banchio, Claudia] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	Banchio, C (corresponding author), Univ Nacl Rosario, Predio CONICET, Inst Biol Mol & Celular Rosario, IBR,CONICET,Ocampo & Esmeralda, Rosario, Santa Fe, Argentina.	banchio@ibr-conicet.gov.ar		Banchio, Claudia/0000-0002-5234-7212; Diacovich, Lautaro/0000-0002-3339-0100; Domizi, Pablo/0000-0003-2903-0337	Fondo para la Investigacion Cientifica y Tecnologica [PICT2013]	Fondo para la Investigacion Cientifica y Tecnologica	This study was supported by Fondo para la Investigacion Cientifica y Tecnologica, grant number PICT2013 to CB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Domizi P, 2014, BBA-MOL CELL BIOL L, V1841, P544, DOI 10.1016/j.bbalip.2014.01.007; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Galbiati A, 2017, ONCOTARGET, V8, P37091, DOI 10.18632/oncotarget.16181; Guimier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101990; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Inagaki T, 2015, J BIOL CHEM, V290, P4163, DOI 10.1074/jbc.M114.626929; INFANTE JP, 1977, BIOCHEM J, V167, P847, DOI 10.1042/bj1670847; Jansen SM, 2001, J BIOL CHEM, V276, P18722, DOI 10.1074/jbc.M101817200; KNIPPER M, 1989, NEUROCHEM INT, V14, P211, DOI 10.1016/0197-0186(89)90124-1; Kuang Y, 2017, ONCOTARGETS THER, V10, P3131, DOI 10.2147/OTT.S134784; Lochmann TL, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4680; Marcucci H, 2010, J BIOL CHEM, V285, P25382, DOI 10.1074/jbc.M110.139477; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paoletti L, 2016, MOL NEUROBIOL, V53, P6316, DOI 10.1007/s12035-015-9528-0; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Sugimoto H, 2008, PROG LIPID RES, V47, P204, DOI 10.1016/j.plipres.2008.01.002; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zhao ER, 2017, CELL SIGNAL, V36, P222, DOI 10.1016/j.cellsig.2017.05.011; Zhao XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0066-8	29	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210207	10.1371/journal.pone.0210207	http://dx.doi.org/10.1371/journal.pone.0210207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629659	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000061
J	Mitsuya, K; Nakasu, Y; Hayashi, N; Deguchi, S; Takahashi, T; Murakami, H; Naito, T; Kenmotsu, H; Ono, A; Wakuda, K; Harada, H				Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Deguchi, Shoichi; Takahashi, Toshiaki; Murakami, Haruyasu; Naito, Tateaki; Kenmotsu, Hirotsugu; Ono, Akira; Wakuda, Kazushige; Harada, Hideyuki			Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study	PLOS ONE			English	Article							NEOPLASTIC MENINGITIS; INTRATHECAL CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; LUMBOPERITONEAL SHUNT; CANCER PATIENTS; CARCINOMATOSIS; SURVIVAL; DISEASE; BRAIN; METHOTREXATE	Purpose Management of leptomeningeal metastasis-related hydrocephalus (LM-H) is particularly challenging regarding the control of severe headache, nausea, and vomiting due to intracranial hypertension. To investigate the improvements of performance status and outcome with cerebrospinal fluid (CSF) shunt surgery for LM-H in patients with lung adenocarcinoma. Methods Data on patients with leptomeningeal metastasis-related hydrocephalus from lung adenocarcinoma diagnosed by MR imaging and/or cytological examination were retrospectively analyzed. Between August 2008 and July 2017, the authors reviewed 31 patients requiring CSF shunt, who underwent ventriculo-peritoneal or lumbo-peritoneal shunt. Results The patients consisted of 11 men and 20 women with a median age of 59 years. Twenty-six patients received EGFR-tyrosine kinase inhibitors (TKIs). CSF shunt surgery yielded rapid improvement in the performance status of 90.3% of patients. Median overall survival from the diagnosis of LM in patients with ECOG performance status less than 2 was 7.7 months, and this was significantly longer than those in patients with PS 3 or 4 (4.4 or 1.5 months; p<0.001). Multivariate analysis by Cox regression revealed survival differences according to PS at diagnosis of LM [PS 1-3 vs. PS4, hazard ratio (HR) 0.201, p = 0.034], controlled extra-cranial disease (HR 0.248, p = 0.005), and post-shunt EGFR-TKI for LM treatment (HR 0.193, p = 0.008). Postoperative symptomatic peritoneal carcinomatosis was observed in one patient (3.2%). Conclusion CSF shunting may be a safe and effective strategy in patients with LM-H from lung adenocarcinoma. A prospective study is needed to establish the effectiveness and safety of palliative CSF shunt for LM-H.	[Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Deguchi, Shoichi] Shizuoka Canc Ctr, Div Neurosurg, Shizuoka, Japan; [Takahashi, Toshiaki; Murakami, Haruyasu; Naito, Tateaki; Kenmotsu, Hirotsugu; Ono, Akira; Wakuda, Kazushige] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Harada, Hideyuki] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka, Japan	Shizuoka Cancer Center; Shizuoka Cancer Center; Shizuoka Cancer Center	Mitsuya, K (corresponding author), Shizuoka Canc Ctr, Div Neurosurg, Shizuoka, Japan.	k.mitsuya@scchr.jp	Naito, Tateaki/K-4703-2019	Naito, Tateaki/0000-0003-4047-2929; Mitsuya, Koichi/0000-0001-8956-5427				Aparicio A, 2002, CURR NEUROL NEUROSCI, V2, P325; BERGER MS, 1991, J NEUROSURG, V74, P872, DOI 10.3171/jns.1991.74.6.0872; Bruna J, 2009, CANCER-AM CANCER SOC, V115, P381, DOI 10.1002/cncr.24041; Chamberlain MC, 2009, SEMIN ONCOL, V36, pS35, DOI 10.1053/j.seminoncol.2009.05.005; Chamberlain MC, 1997, ARCH NEUROL-CHICAGO, V54, P1364, DOI 10.1001/archneur.1997.00550230037013; Chamberlain MC, 1998, ARCH NEUROL-CHICAGO, V55, P506, DOI 10.1001/archneur.55.4.506; Chuang TY, 2008, J FORMOS MED ASSOC, V107, P851, DOI 10.1016/S0929-6646(08)60201-6; DeAngelis LM, 2005, CANCER INVEST, V23, P145, DOI 10.1081/CNV-200050458; Demopoulos Alexis, 2004, Curr Neurol Neurosci Rep, V4, P196, DOI 10.1007/s11910-004-0039-z; Glantz MJ, 1999, CLIN CANCER RES, V5, P3394; Gong L, 2015, LUNG CANCER, V89, P268, DOI 10.1016/j.lungcan.2015.06.001; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Herrlinger U, 2004, J NEUROL SCI, V223, P167, DOI 10.1016/j.jns.2004.05.008; Jung TY, 2014, CLIN NEUROL NEUROSUR, V119, P80, DOI 10.1016/j.clineuro.2014.01.023; Kim DY, 2003, JPN J CLIN ONCOL, V33, P608, DOI 10.1093/jjco/hyg118; Le Rhun Emilie, 2013, Surg Neurol Int, V4, pS265, DOI 10.4103/2152-7806.111304; Lee SJ, 2013, J THORAC ONCOL, V8, P185, DOI 10.1097/JTO.0b013e3182773f21; Li YS, 2016, J THORAC ONCOL, V11, P1962, DOI 10.1016/j.jtho.2016.06.029; Lin N, 2011, J NEUROSURG, V115, P730, DOI 10.3171/2011.5.JNS101768; Masuda T, 2011, CANCER CHEMOTH PHARM, V67, P1465, DOI 10.1007/s00280-011-1555-6; Melisko ME, 2009, NAT CLIN PRACT ONCOL, V6, P25, DOI 10.1038/ncponc1243; Morris PG, 2012, J THORAC ONCOL, V7, P382, DOI 10.1097/JTO.0b013e3182398e4f; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Omuro AMP, 2005, NEUROLOGY, V64, P1625, DOI 10.1212/01.WNL.0000160396.69050.DC; Palma JA, 2013, CLIN NEUROL NEUROSUR, V115, P19, DOI 10.1016/j.clineuro.2012.03.048; Park JH, 2012, LUNG CANCER, V76, P387, DOI 10.1016/j.lungcan.2011.11.022; Tailliberta S, 2006, CURR OPIN ONCOL, V18, P637, DOI 10.1097/01.cco.0000245323.19411.d7; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7; Yamashiro S, 2017, PALLIATIVE MED, V31, P93, DOI 10.1177/0269216316649128; Yi HG, 2009, LUNG CANCER, V65, P80, DOI 10.1016/j.lungcan.2008.10.016; Zhang XH, 2015, MED HYPOTHESES, V84, P506, DOI 10.1016/j.mehy.2015.02.009	31	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210074	10.1371/journal.pone.0210074	http://dx.doi.org/10.1371/journal.pone.0210074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629621	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000047
J	Ruffman, T; Then, R; Cheng, C; Imuta, K				Ruffman, Ted; Then, Rebecca; Cheng, Christie; Imuta, Kana			Lifespan differences in emotional contagion while watching emotion-eliciting videos	PLOS ONE			English	Article							EARLY PROSOCIAL BEHAVIOR; YOUNG-CHILDREN; SEE OTHERS; 1ST YEAR; DISTRESS; EMPATHY; AGE; SYMPATHY; INFANTS; MIND	Previous research has examined empathic concern by presenting toddlers with a sad stimulus and examining their emotional response, with the conclusion that toddlers display empathy. Yet, such research has failed to include basic control conditions involving some other aversive stimulus such as white noise. Nor has it compared toddlers to adults to examine potential development in empathy. In the present study, we showed toddlers and adults four video types: infant crying, infant laughing, infant babbling, and a neutral infant accompanied by white noise. We then coded happiness and sadness while viewing the videos, and created a difference score (happiness minus sadness), testing 52 toddlers and 61 adults. Whereas adults showed more sadness towards infant crying than any other stimulus, toddlers' response to crying and white noise was similar. Thus, the toddler response to crying was comparable to previous studies (slight sadness), but was no different to white noise and was significantly reduced relative to adults. As such, toddlers' response seemed to be better characterized as a reaction to an aversive stimulus rather than empathy.	[Ruffman, Ted; Then, Rebecca; Cheng, Christie] Univ OtagoDunedin, Dept Psychol, Dunedin, New Zealand; [Imuta, Kana] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Ruffman, T (corresponding author), Univ OtagoDunedin, Dept Psychol, Dunedin, New Zealand.	tedr@psy.otago.ac.nz		Ruffman, Ted/0000-0001-8790-6451	Royal Marsden NHS Foundation Trust [15-UOO-185]	Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Royal Marsden NHS Foundation Trust grant 15-UOO-185 to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2007, SOC COGN AFFECT NEUR, V2, P71, DOI 10.1093/scan/nsm022; Bailey PE, 2009, PSYCHOL AGING, V24, P224, DOI 10.1037/a0014112; Bischof-Kohler D, 2012, EMOT REV, V4, P40, DOI 10.1177/1754073911421377; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brownell CA, 2013, INFANCY, V18, P91, DOI 10.1111/j.1532-7078.2012.00125.x; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Davidov M, 2013, CHILD DEV PERSPECT, V7, P126, DOI 10.1111/cdep.12028; Dienes Z., 2017, MAKING MOST YOUR DAT; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; Gilbert HR, 1996, INT J PEDIATR OTORHI, V34, P237, DOI 10.1016/0165-5876(95)01273-7; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Hepach R, 2016, CHILD DEV, V87, P1703, DOI 10.1111/cdev.12633; Hepach R, 2012, PSYCHOL SCI, V23, P967, DOI 10.1177/0956797612440571; Huhnel I, 2014, J EXP SOC PSYCHOL, V50, P136, DOI 10.1016/j.jesp.2013.09.011; Imuta K, 2016, DEV PSYCHOL, V52, P1192, DOI 10.1037/dev0000140; Kartner J, 2010, DEV PSYCHOL, V46, P905, DOI 10.1037/a0019718; Krevans J, 1996, CHILD DEV, V67, P3263, DOI 10.1111/j.1467-8624.1996.tb01913.x; Kumar S, 2008, J ACOUST SOC AM, V124, P3810, DOI 10.1121/1.3006380; MARTIN GB, 1982, DEV PSYCHOL, V18, P3, DOI 10.1037/0012-1649.18.1.3; Nichols SR, 2015, INFANCY, V20, P70, DOI 10.1111/infa.12066; Nichols Sara R, 2009, Cogn Brain Behav, V13, P449; Parsons CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01440; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; PROVINE RR, 1992, B PSYCHONOMIC SOC, V30, P1; Reuter C, 2011, J ACOUST SOC AM, V130; Richter D, 2011, PSYCHOL AGING, V26, P60, DOI 10.1037/a0021138; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Rothganger H, 2003, EARLY HUM DEV, V75, P55, DOI 10.1016/j.earlhumdev.2003.09.003; Ruffman T, 2006, BRIT J DEV PSYCHOL, V24, P105, DOI 10.1348/026151005X82848; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Ruffman T, 2017, CHILD DEV PERSPECT, V11, P270, DOI 10.1111/cdep.12244; Ruffman T, 2014, DEV REV, V34, P265, DOI 10.1016/j.dr.2014.04.001; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; SHERMAN LW, 1975, CHILD DEV, V46, P53; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; Staff RT, 2014, INTELLIGENCE, V47, P194, DOI 10.1016/j.intell.2014.09.013; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Trommsdorff G, 2007, INT J BEHAV DEV, V31, P284, DOI 10.1177/0165025407076441; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Volbrecht MM, 2007, J GENET PSYCHOL, V168, P105, DOI 10.3200/GNTP.168.2.105-130; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Waugh WE, 2017, INFANCY, V22, P665, DOI 10.1111/infa.12189; Young SK, 1999, DEV PSYCHOL, V35, P1189, DOI 10.1037/0012-1649.35.5.1189; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0209253	10.1371/journal.pone.0209253	http://dx.doi.org/10.1371/journal.pone.0209253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657754	gold, Green Published, Green Submitted			2022-12-27	WOS:000456017000005
J	Kechavarzi, BD; Wu, HM; Doman, TN				Kechavarzi, Bobak D.; Wu, Huanmei; Doman, Thompson N.			Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA	PLOS ONE			English	Article								The massive genomic data from The Cancer Genome Atlas (TCGA), including proteomics data from Clinical Proteomic Tumor Analysis Consortium (CPTAC), provides a unique opportunity to study cancer systematically. While most observations are made from a single type of genomics data, we apply big data analytics and systems biology approaches by simultaneously analyzing DNA amplification, mRNA and protein abundance. Using multiple genomic profiles, we have discovered widespread dosage compensation for the extensive aneuploidy observed in TCGA breast cancer samples. We do identify 11 genes that show strong correlation across all features (DNA/mRNA/protein) analogous to that of the well-known oncogene HER2 (ERBB2). These genes are generally less well-characterized regarding their role in cancer and we advocate their further study. We also discover that shRNA knockdown of these genes has an impact on cancer cell growth, suggesting a vulnerability that could be used for cancer therapy. Our study shows the advantages of systematic big data methodologies and also provides future research directions.	[Kechavarzi, Bobak D.; Wu, Huanmei; Doman, Thompson N.] Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA; [Kechavarzi, Bobak D.; Doman, Thompson N.] Eli Lilly, Indianapolis, IN 46241 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly	Kechavarzi, BD (corresponding author), Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA.; Kechavarzi, BD (corresponding author), Eli Lilly, Indianapolis, IN 46241 USA.	bkechava@indiana.edu		Wu, Huanmei/0000-0003-0346-6044	Eli Lilly	Eli Lilly(Eli Lilly)	The authors received no specific funding for this work. Eli Lilly provided support in the form of salaries for authors BDK and TND. The funder provided tuition reimbursement for BDK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bloomfield M, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0297-x; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dumaual CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072977; Edwards NJ, 2016, PROTEIN REPORTS CPTA; Ellis MJ, 2013, CANCER DISCOV, V3, P1108, DOI 10.1158/2159-8290.CD-13-0219; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Laddha SV, 2014, MOL CANCER RES, V12, P485, DOI 10.1158/1541-7786.MCR-13-0614; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; National Cancer Institute National Human Genome Research Institute, 2010, CANC GEN ATL; OConnor C, 2008, NATURE ED, V1, P172; Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8; Rasool N, 2010, CLIN CANCER RES, V16, P600, DOI 10.1158/1078-0432.CCR-09-1979; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Slattery ML, 2011, MUTAT RES-FUND MOL M, V706, P13, DOI 10.1016/j.mrfmmm.2010.10.005; Society AC, 2015, CANC FACTS FIGURES 2; Tabach Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014632; Tanaka S, 1997, CANCER RES, V57, P28; Technologies N, 2009, REF GEN NORM EXPR DA; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torres EM, 2016, ELIFE, V5, DOI 10.7554/eLife.10996; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210910	10.1371/journal.pone.0210910	http://dx.doi.org/10.1371/journal.pone.0210910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653567	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500087
J	Paul, P; Ziegler, J; Chalmers, E; Snedeker, J				Paul, Pooja; Ziegler, Jayden; Chalmers, Elizabeth; Snedeker, Jesse			Children and adults successfully comprehend subject-only sentences online	PLOS ONE			English	Article							FOCUS PARTICLES; INFORMATION; ENGLISH; TIME	In many offline studies, children show selectively better comprehension of sentences with the focus particle only when it modifies the object argument (Jane only ate an apple) than they do when it modifies the subject argument (Only Jane ate an apple). Here we explore the nature of this asymmetry by examining performance in a different kind of task: the moment-to-moment comprehension of unambiguous sentences. If past errors reflect a fundamental difference in representation or complexity of computation, we would expect the same asymmetry in this task. We observed that adults were able to successfully predict the target referent for both types of only-sentences, as indicated by anticipatory looks, while 6- to 8-year-old children could do so only for subject-modifying only-sentences. These findings suggest that much of the asymmetry in past work may be due to task demands. We discuss the implications of these results for children's syntactic and pragmatic development.	[Paul, Pooja; Ziegler, Jayden; Chalmers, Elizabeth; Snedeker, Jesse] Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA; [Paul, Pooja] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA	Harvard University; Harvard University	Paul, P (corresponding author), Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA.; Paul, P (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	poojapaul@g.harvard.edu		Ziegler, Jayden/0000-0002-3861-5145				Ambridge B, 2013, WIRES COGN SCI, V4, P149, DOI 10.1002/wcs.1215; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bergsma W., PROCESS LANGUAGE ACQ; Chierchia G., 2012, SEMANTICS INT HDB NA, V33, P2297, DOI DOI 10.1515/9783110253382.2297; CRAIN S, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P443; Endo M, 2004, PROC ANN BUCLD, P141; Fernald A, 2008, DEV PSYCHOLINGUISTIC, P98; Gualmini Andrea, 2003, P 25 ANN PENN LING C, P87; Gundel J.K., 1988, STUDIES SYNTACTIC TY, V17, P209, DOI DOI 10.1075/TSL.17.16GUN; Hakes D.T., 1980, DEV METALINGUISTIC A; Hohle B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149870; Hohle B, 2009, LANG ACQUIS, V16, P36, DOI 10.1080/10489220802584550; Huang YT, 2009, DEV PSYCHOL, V45, P1723, DOI 10.1037/a0016704; Hughes C, 2011, INFANT CHILD DEV, V20, P251, DOI 10.1002/icd.736; Ito K, 2014, J CHILD LANG, V41, P84, DOI 10.1017/S0305000912000554; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kim CS, 2015, COGNITION, V139, P28, DOI 10.1016/j.cognition.2015.02.009; Kim CS, 2008, P SINN BEDEUTUNG, V13; Kim S.-W., 2011, THESIS; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; Muller A., 2011, P GALANA 4, P163; Muller A, 2015, LANG ACQUIS, P330; Muller Anja, 2011, EXPT PRAGMATICS SEMA, P79; Notley A, 2009, LANG ACQUIS, V16, P240, DOI 10.1080/10489220903266669; Paterson K, 2006, LANG ACQUIS, V13, P253, DOI DOI 10.1207/S15327817LA1303_4; Paterson KB, 2003, COGNITION, V89, P263, DOI 10.1016/S0010-0277(03)00126-4; Paul P, 2016, 29 ANN M CUNY C HUM; Paul P. P., 2017, THESIS; Philip W, 2000, PROC ANN BUCLD, P583; Romoli J, 2015, STUD THEOR PSYCHOLIN, V45, P67, DOI 10.1007/978-3-319-07980-6_3; ROOTH Mats, 1992, NAT LANG SEMANT, V1, P75, DOI [DOI 10.1007/BF02342617, 10.1007/bf02342617, DOI 10.1007/BF02342617A]; Santos AL, LANGUAGE ACQUISITION; Schwarz F, 2015, STUD THEOR PSYCHOLIN, V45, P89, DOI 10.1007/978-3-319-07980-6_4; Sugawara A., 2016, THESIS; Wells B, 2004, J CHILD LANG, V31, P749, DOI 10.1017/S030500090400652X; Zhou P, P 3 C GEN APPR LANG; Zhou P, 2012, J CHILD LANG, V39, P687, DOI 10.1017/S0305000911000249	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209670	10.1371/journal.pone.0209670	http://dx.doi.org/10.1371/journal.pone.0209670			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653524	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500014
J	Wagner, AO; Friedrich, V; Barthels, C; Marconi, P; Blutke, A; Brombacher, F; Brocker, T				Wagner, Ana Ogrinc; Friedrich, Verena; Barthels, Christian; Marconi, Peggy; Blutke, Andreas; Brombacher, Frank; Brocker, Thomas			Strain specific maturation of Dendritic cells and production of IL-1 beta controls CD40-driven colitis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; SOLUBLE CD40 LIGAND; TRANSCRIPTION-FACTOR; TGF-BETA; INTESTINAL INFLAMMATION; SIGNALING CONTROLS; CD103(+) DCS; TH1 CELLS; REG-CELLS	Intestinal integrity is maintained by balanced numbers of CD103(+) Dendritic cells (DCs), which generate peripherally induced regulatory T cells (iTregs). We have developed a mouse model where DC-specific constitutive CD40 signals caused a strong reduction of CD103(+) DCs in the lamina propria (LP) and intestinal lymph nodes (LN). As a consequence, also iTregs were strongly reduced and transgenic mice on the C57Bl/6-background (B6) developed fatal colitis. Here we describe that transgenic mice on a pure Balb/c-background (B/c) do not show any pathologies, while transgenic C57Bl/6 x Balb/c (F1) mice develop weak colon inflammation, without fatal colitis. This graded pathology correlated with the effects of CD40-signalling on DCs in each background, with striking loss of CD103(+) DCs in B6, but reduced in F1 and diminished in B/c background. We further show direct correlation of CD103(+) DC-numbers with numbers of iTregs, the frequencies of which behave correspondingly. Striking effects on B6-DCs reflected robust loss of surface MHCII, known to be crucial for iTreg induction. Furthermore, elevated levels of IL-23 together with IL-1, found only in B6 mice, support generation of intestinal IFN-gamma(+) IL-17(+) Th17 cells and IFN-gamma(+) Th1 cells, responsible for onset of disease. Together, this demonstrates a novel aspect of colitis-control, depending on genetic background. Moreover, strain-specific environmental sensing might alter the CD103(+) DC/iTreg-axis to tip intestinal homeostatic balance to pathology.	[Wagner, Ana Ogrinc; Friedrich, Verena; Barthels, Christian; Brocker, Thomas] Ludwig Maximilians Univ Munchen, Fac Med, Inst Immunol, Planegg Martinsried, Germany; [Marconi, Peggy] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy; [Blutke, Andreas] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany; [Brombacher, Frank] Univ Cape Town, Div Immunol, Cape Town, South Africa; [Brombacher, Frank] South African Med Res Council, Cape Town, South Africa; [Brombacher, Frank] Cape Town Component, Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa	University of Munich; University of Ferrara; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cape Town; South African Medical Research Council; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town	Brocker, T (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Inst Immunol, Planegg Martinsried, Germany.	brocker@lmu.de		Marconi, Peggy C. R./0000-0003-3488-0491; Brocker, Thomas/0000-0001-7060-5433	Deutsche Forschungsgemeinschaft [SFB1054 B03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB1054 B03 to T.B.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Ai TL, 2014, IMMUNOL REV, V259, P60, DOI 10.1111/imr.12171; Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Barthels C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14715; Boeglin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025542; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gonsky R, 2014, INFLAMM BOWEL DIS, V20, P1794, DOI 10.1097/MIB.0000000000000172; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Hurdayal R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003699; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasran A, 2005, ALIMENT PHARM THER, V22, P111, DOI 10.1111/j.1365-2036.2005.02526.x; Kishi Y, 2016, J EXP MED, V213, P2489, DOI 10.1084/jem.20151118; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Liu ZJ, 1999, J IMMUNOL, V163, P4049; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Ludwiczek O, 2003, INT J COLORECTAL DIS, V18, P142, DOI 10.1007/s00384-002-0425-4; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	67	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210998	10.1371/journal.pone.0210998	http://dx.doi.org/10.1371/journal.pone.0210998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653608	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500095
J	Geissmann, Q; Rodriguez, LG; Beckwith, EJ; Gilestro, GF				Geissmann, Quentin; Rodriguez, Luis Garcia; Beckwith, Esteban J.; Gilestro, Giorgio F.			Rethomics: An R framework to analyse high-throughput behavioural data	PLOS ONE			English	Article							BIG DATA; DROSOPHILA; PERIODOGRAM; ETHOMICS	The recent development of automatised methods to score various behaviours on a large number of animals provides biologists with an unprecedented set of tools to decipher these complex phenotypes. Analysing such data comes with several challenges that are largely shared across acquisition platform and paradigms. Here, we present rethomics, a set of R packages that unifies the analysis of behavioural datasets in an efficient and flexible manner. rethomics offers a computational solution to storing, manipulating and visualising large amounts of behavioural data. We propose it as a tool to bridge the gap between behavioural biology and data sciences, thus connecting computational and behavioural scientists. rethomics comes with a extensive documentation as well as a set of both practical and theoretical tutorials.	[Geissmann, Quentin; Beckwith, Esteban J.; Gilestro, Giorgio F.] Imperial Coll London, Dept Life Sci, London, England; [Rodriguez, Luis Garcia] Westfalische Wilhelms Univ, Inst Neuro & Behav Biol, D-48149 Munster, Germany	Imperial College London; University of Munster	Geissmann, Q; Gilestro, GF (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	qgeissmann@gmail.com; giorgio@gilest.ro	Gilestro, Giorgio/A-8721-2010; Geissmann, Quentin/J-3120-2019	Gilestro, Giorgio/0000-0001-7512-8541; Geissmann, Quentin/0000-0001-6546-4306; Beckwith, Esteban/0000-0002-3373-1833; Garcia Rodriguez, Luis/0000-0003-1659-2306	BBSRC [BB/J014575/1]; Gas Safety Trust;  [H2020/705930]; BBSRC [BB/M003930/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gas Safety Trust; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC http://www.bbsrc.ac.uk/ (grant number BB/J014575/1, received by GFG and QG); Marie Curie https://ec.europa.eu (grant number H2020/705930, received by EJB and GFG); The Gas Safety Trust received by GFG, QG and Robert Dickinson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar-Conraria L, 2011, J MACROECON, V33, P477, DOI 10.1016/j.jmacro.2011.02.005; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; [Anonymous], 2017, QDOAS VERSION 32 SO; Berman GJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0494-7; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brown AEX, 2018, NAT PHYS, V14, P653, DOI 10.1038/s41567-018-0093-0; Buhl E, 2016, P NATL ACAD SCI USA, V113, P13486, DOI 10.1073/pnas.1606547113; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Dowle M, 2017, TABLE EXTENSION DATA; Dubowy C, 2017, GENETICS, V205, P1373, DOI 10.1534/genetics.115.185157; Faville R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08454; Geissmann Q, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003026; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Hashem IAT, 2015, INFORM SYST, V47, P98, DOI 10.1016/j.is.2014.07.006; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Itskov PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5560; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; Leipzig J, 2017, BRIEF BIOINFORM, V18, P530, DOI 10.1093/bib/bbw020; Leise Tanya L, 2013, J Circadian Rhythms, V11, P5, DOI 10.1186/1740-3391-11-5; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Ogueta M, 2018, BEHAVIOUR OF TIM; Pelkowski SD, 2011, BEHAV BRAIN RES, V223, P135, DOI 10.1016/j.bbr.2011.04.033; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; R Core Team, 2017, R A LANGUAGE AND ENV; Reiser M, 2009, NAT METHODS, V6, P413, DOI 10.1038/nmeth0609-413; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Roumpeka DD, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00023; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Schatz MC, 2015, GENOME RES, V25, P1417, DOI 10.1101/gr.191684.115; Schmidbauer AR, 2018, WAVELETCOMP COMPUTAT; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Stodden V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067111; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	42	30	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209331	10.1371/journal.pone.0209331	http://dx.doi.org/10.1371/journal.pone.0209331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650089	Green Submitted, gold, Green Published			2022-12-27	WOS:000455813300012
J	Jones, HS; Towse, JN; Race, N; Harrison, T				Jones, Helen S.; Towse, John N.; Race, Nicholas; Harrison, Timothy			Email fraud: The search for psychological predictors of susceptibility	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; SELF-CONTROL	Decisions that we make about email legitimacy can result in a pernicious threat to security of both individuals and organisations. Yet user response to phishing emails is far from uniform; some respond while others do not. What is the source of this diversity in decision-making? From a psychological perspective, we consider cognitive and situational influences that might explain why certain users are more susceptible than others. Alongside an email judgment task employed as a proxy for fraud susceptibility, 224 participants completed a range of cognitive tasks. In addition, we manipulated time pressure for email legitimacy judgments. We identify cognitive reflection and sensation seeking as significant, albeit modest, predictors of susceptibility. Further to this, participants asked to make quicker responses made more judgment errors. We conclude there are cognitive signatures that partially contribute to email fraud susceptibility, with implications for efforts to limit online security breaches and train secure behaviors.	[Jones, Helen S.; Towse, John N.] Univ Lancaster, Dept Psychol, Lancaster, England; [Race, Nicholas] Univ Lancaster, Sch Comp & Commun, Lancaster, England; [Harrison, Timothy] Def Sci & Technol Lab, Salisbury, Wilts, England; [Jones, Helen S.] Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England	Lancaster University; Lancaster University; Defence Science & Technology Laboratory; University of Central Lancashire	Jones, HS (corresponding author), Univ Lancaster, Dept Psychol, Lancaster, England.; Jones, HS (corresponding author), Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England.	hsjones1@uclan.ac.uk	Towse, John/E-9269-2010	Towse, John/0000-0003-1183-5508; Race, Nicholas/0000-0002-6870-8078; Jones, Helen/0000-0002-2716-051X	Ministry of Defence through the Defence Science and Technology Laboratory	Ministry of Defence through the Defence Science and Technology Laboratory	This work was funded by the Ministry of Defence through the Defence Science and Technology Laboratory (https://www.gov.uk/government/organisations/defence-science-and-technology-laboratory) as part of their National PhD Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ACM P 16 INT C WORLD, DOI DOI 10.1145/1242572.1242660; Bergholz A, 2010, J COMPUT SECUR, V18, P7, DOI 10.3233/JCS-2010-0371; Borwell J., 2018, PSYCHOL BEHAV EXAMIN, P26; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Curtis SR, 2018, COMPUT HUM BEHAV, V87, P174, DOI 10.1016/j.chb.2018.05.037; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Eng J., 2014, ROC ANAL WEB BASED C; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Fischer P, 2013, J APPL SOC PSYCHOL, V43, P2060, DOI 10.1111/jasp.12158; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Goldberg LR., 1999, PERSONALITY PSYCHOL, V7, P7; Gow AJ, 2005, PERS INDIV DIFFER, V39, P317, DOI 10.1016/j.paid.2005.01.011; Hamby T, 2016, J PSYCHOL, V150, P422, DOI 10.1080/00223980.2015.1060186; Harrison B, 2016, P ANN HICSS, P5628, DOI 10.1109/HICSS.2016.696; Holtfreter K, 2010, CRIM JUSTICE BEHAV, V37, P188, DOI 10.1177/0093854809354977; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Islam R, 2013, J NETW COMPUT APPL, V36, P324, DOI 10.1016/j.jnca.2012.05.009; Jagatic T., 2005, COMMUN ACM, V50, P94; Jones Helen S., 2015, International Journal of Cyber Behavior, Psychology and Learning, V5, P13, DOI 10.4018/ijcbpl.2015070102; Jones HS, 2018, PSYCHOL BEHAV EXAMIN, P80; Kahneman D, 2000, BEHAV BRAIN SCI, V23, P681, DOI 10.1017/S0140525X00403432; Kruglanski A. W., 1990, HDB MOTIVATION COGNI, V2, P333; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Lea S.E.G., 2013, SCAM COMPLIANCE PSYC; Macmillan N. A., 1993, HDB DATA ANAL BEHAV, P21; Markovits H., 2002, THINK REASONING, V8, P97, DOI DOI 10.1080/13546780143000143; Modic D, 2011, 2011 C INT CONF ADV; Modic D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194119; Moreno-Fernandez MM, 2017, COMPUT HUM BEHAV, V69, P421, DOI 10.1016/j.chb.2016.12.044; Parsons K, 2013, IFIP ADV INF COMM TE, V405, P366; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Pennycook G, 2018, COGNITION; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Simmons JP, 2012, 21 WORD SOLUTION SOC; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stanovich K. E., 1999, WHO IS RATIONAL STUD; Stanovich K. E., 2002, HEURISTICS BIASES PS, P421, DOI DOI 10.1017/CBO9780511808098.026; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tversky A, 1975, UTILITY PROBABILITY, P141, DOI DOI 10.1007/978-94-010-1834-0_8; van de Weijer SGA, 2017, CYBERPSYCH BEH SOC N, V20, P407, DOI 10.1089/cyber.2017.0028; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Williams EJ, 2018, INT J HUM-COMPUT ST, V120, P1, DOI 10.1016/j.ijhcs.2018.06.004; Williams EJ, 2017, COMPUT HUM BEHAV, V72, P412, DOI 10.1016/j.chb.2017.03.002; Wood S, 2018, J EXP PSYCHOL-APPL, V24, P196, DOI 10.1037/xap0000167; Yan Z, 2018, COMPUT HUM BEHAV, V84, P375, DOI 10.1016/j.chb.2018.02.019; Yan ZQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00309; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	50	19	19	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209684	10.1371/journal.pone.0209684	http://dx.doi.org/10.1371/journal.pone.0209684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650114	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000455813300024
J	Alpizar, P; Rodriguez-Herrera, B; Jung, K				Alpizar, Priscilla; Rodriguez-Herrera, Bernal; Jung, Kirsten			The effect of local land use on aerial insectivorous bats (Chiroptera) within the two dominating crop types in the Northern-Caribbean lowlands of Costa Rica	PLOS ONE			English	Article							SHADE CACAO PLANTATIONS; SOUTHERN BAHIA; BIODIVERSITY; HABITAT; FOREST; IDENTIFICATION; ECHOLOCATION; INTENSIFICATION; CONSERVATION; DIVERSITY	Land transformation into agricultural areas and the intensification of management practices represent two of the most devastating threats to biodiversity worldwide. Within this study, we investigated the effect of intensively managed agroecosystems on bat activity and species composition within two focal areas differing in landscape structure. We sampled bats via acoustic monitoring and insects with flight interception traps in banana and pineapple monoculture plantations and two nearby protected forested areas within the area of Sarapiqui, Costa Rica. Our results revealed that general occurrence and feeding activity of bats was higher above plantations compared to forested areas. We also recorded higher species richness at recording sites in plantations. This trend was especially strong within a fragmented landscape, with only four species recorded in forests, but 12 above pineapple plantations. Several bat species, however, occurred only once or twice above plantations, and forest specialist species such as Centronycteris centralis, Myotis riparius and Pteronotus mesoamericanus were only recorded at forest sites. Our results indicated, that mostly mobile open space and edge foraging bat species can use plantations as potential foraging habitat and might even take advantage of temporal insect outbreaks. However, forests are vital refugia for several species, including slower flying forest specialists, and thus a prerequisite to safeguard bat diversity within agricultural dominated landscapes.	[Alpizar, Priscilla; Rodriguez-Herrera, Bernal] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Alpizar, Priscilla; Jung, Kirsten] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Baden Wurttemberg, Germany	Universidad Costa Rica; Ulm University	Alpizar, P (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.; Alpizar, P (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Baden Wurttemberg, Germany.	priscilla.alpizar-alpizar@uni-ulm.de			Bat Conservation International; University of Costa Rica; German Academic Exchange Program (DAAD); Spanish Agency of International Cooperation and Development [D/027406/09, D/033858/10, A1/039089/11]	Bat Conservation International; University of Costa Rica; German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Agency of International Cooperation and Development	This work was supported by Bat Conservation International (BCI Student Research Scholarship 2012), University of Costa Rica, the German Academic Exchange Program (DAAD), and the Spanish Agency of International Cooperation and Development (funding projects D/027406/09, D/033858/10, and A1/039089/11 for the Universidad de Las Palmas de Gran Canaria and Universidad de Costa Rica).	Alpizar Priscilla, 2012, Revista Biodiversidad Neotropical, V2, P138; Bader E, 2015, BIOL CONSERV, V186, P97, DOI 10.1016/j.biocon.2015.02.028; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellamy AS, 2013, AMBIO, V42, P334, DOI 10.1007/s13280-012-0341-y; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brose U, 2004, OIKOS, V105, P292, DOI 10.1111/j.0030-1299.2004.12884.x; CEBALLOS G, 1988, Mammalian Species, P1, DOI 10.2307/3504140; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Estrada-Villegas S, 2012, ECOLOGY, V93, P1183, DOI 10.1890/11-0275.1; Estrada-Villegas S, 2010, BIOL CONSERV, V143, P597, DOI 10.1016/j.biocon.2009.11.009; FAO, 2011, STAT WORLDS LAND WAT, DOI DOI 10.1007/978-3-319-92049-8_31; Faria D, 2006, BIODIVERS CONSERV, V15, P587, DOI 10.1007/s10531-005-2089-1; Faria D, 2007, BIODIVERS CONSERV, V16, P291, DOI 10.1007/s10531-005-8346-5; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Freudmann A, 2015, BIODIVERS CONSERV, V24, P3583, DOI 10.1007/s10531-015-1021-6; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gotelli NJ, 2006, ECOSIM NULL MODELS S; Heer K, 2015, J MAMMAL, V96, P720, DOI 10.1093/jmammal/gyv068; Heim O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134443; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085279; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kerr JT, 2002, BIODIVERS CONSERV, V11, P695, DOI 10.1023/A:1015500513603; Kingston T, 2010, BIODIVERS CONSERV, V19, P471, DOI 10.1007/s10531-008-9458-5; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; LaVal RK, 2002, MURCIELAGOS COSTA RI; Lentini PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048201; McDade Lucinda A., 1994, P6; Meynard CN, 2014, BIODIVERS CONSERV, V23, P1949, DOI 10.1007/s10531-014-0697-3; Mone Shamika, 2014, Journal of Threatened Taxa, V6, P6186, DOI 10.11609/JoTT.o3778.6186-94; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Ruiz AT, 2017, 8 INT C PATT REC SUS, DOI [10.1049/cp.2017.0130, DOI 10.1049/CP.2017.0130]; Ruiz AT, 23 IB C PATT REC MAD; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SEPSA, 2012, B EST AGR; SINAC (Sistema Nacional de areas de Conservacion), 2012, SINAC NUM INF AN EST; Solano J., 1996, ASPECTOS FISIOGRAFIC; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Treitler JT, 2016, ECOL EVOL, V6, P4289, DOI 10.1002/ece3.2160; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Williams-Guillen Kimberly, 2016, P151	59	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210364	10.1371/journal.pone.0210364	http://dx.doi.org/10.1371/journal.pone.0210364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645621	Green Submitted, gold, Green Published			2022-12-27	WOS:000455810200026
J	Spackman, E; Clement, F; Allan, GM; Bell, CM; Bjerre, LM; Blackburn, DF; Blais, R; Hazlewood, G; Klarenbach, S; Nicolle, LE; Persaud, N; Alessi-Severini, S; Tierney, M; Wijeysundera, HC; Manns, B				Spackman, Eldon; Clement, Fiona; Allan, G. Michael; Bell, Chaim M.; Bjerre, Lise M.; Blackburn, Dave F.; Blais, Regis; Hazlewood, Glen; Klarenbach, Scott; Nicolle, Lindsay E.; Persaud, Nav; Alessi-Severini, Silvia; Tierney, Mike; Wijeysundera, Harindra C.; Manns, Braden			Developing key performance indicators for prescription medication systems	PLOS ONE			English	Article							QUALITY; CARE	Objective To develop key performance indicators that evaluate the effectiveness of a prescription medication system. Methods A modified RAND/UCLA appropriateness method was used to develop key performance indicators (KPIs) for a prescription medication system. A broad list of potential KPIs was compiled. A multidisciplinary group composed of 21 experts rated the potential KPIs. A face-to-face meeting was held following the first rating exercise to discuss each potential KPI individually. The expert panel undertook a final rating of KPIs. The final set of KPIs were those indicators where at least 80 percent of experts rated the indicator highly i.e. rating of >= 7 on a scale from 1 to 9. Results 292 KPIs were identified from the published literature. After removing duplicates and combining similar indicators 71 KPIs were included. The final ranking resulted in six indicators being ranked 7 or higher by 80% of the respondents and an additional seven indicators being ranked 7 or higher by >= 70 but <= 80% of respondents. The six selected indicators include four specific disease areas, measure structural and process aspects of health service delivery, and assessed three of the domains of healthcare quality: efficiency, effectiveness, and safety. Conclusions These indicators are recommended as a starting point to assess the current performance of prescription medication systems. Consideration should be given to developing indicators in additional disease areas as well as indicators that measure the domains of timeliness and patient-centeredness. Future work should focus on the feasibility of measuring these indicators.	[Spackman, Eldon; Clement, Fiona; Hazlewood, Glen; Manns, Braden] Dept Community Hlth Sci, Calgary, AB, Canada; [Spackman, Eldon; Clement, Fiona; Hazlewood, Glen; Manns, Braden] OBrien Inst Publ Hlth, Calgary, AB, Canada; [Allan, G. Michael] Univ Alberta, Dept Family Med, Edmonton, AB, Canada; [Bell, Chaim M.] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Bjerre, Lise M.] Univ Ottawa, Dept Family Med, Bruyere Res Inst, Ottawa, ON, Canada; [Bjerre, Lise M.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Blackburn, Dave F.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Blais, Regis] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Hazlewood, Glen; Manns, Braden] Univ Calgary, Dept Med, Calgary, AB, Canada; [Klarenbach, Scott] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Nicolle, Lindsay E.] Univ Manitoba, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Persaud, Nav] St Michaels Hosp, Toronto, ON, Canada; [Persaud, Nav] Univ Toronto, Toronto, ON, Canada; [Alessi-Severini, Silvia] Univ Manitoba, Rady Fac Hlth Sci, Coll Pharm, Winnipeg, MB, Canada; [Alessi-Severini, Silvia] Univ Manitoba, Rady Fac Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Wijeysundera, Harindra C.] CADTH, Ottawa, ON, Canada; [Wijeysundera, Harindra C.] Univ Toronto, Schulich Heart Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Ottawa; University of Ottawa; University of Saskatchewan; Universite de Montreal; University of Calgary; University of Alberta; University of Manitoba; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Manitoba; University of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Spackman, E (corresponding author), Dept Community Hlth Sci, Calgary, AB, Canada.; Spackman, E (corresponding author), OBrien Inst Publ Hlth, Calgary, AB, Canada.	eldon.spackman@ucalgary.ca	Hazlewood, Glen S/N-2233-2019; Wijeysundera, Harindra/AAA-6058-2020	Hazlewood, Glen S/0000-0001-7709-3741; Bjerre, Lise M./0000-0003-3634-3585; Alessi-Severini, Silvia/0000-0002-6543-7719; Wijeysundera, Harindra/0000-0001-8464-1080; Spackman, David Eldon/0000-0001-8558-5973	Alberta Health; Ontario Ministry of Health and Long-Term Care	Alberta Health; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Funding was provided by Alberta Health and the Ontario Ministry of Health and Long-Term Care. Provincial Drug Plan Managers from Alberta Health and the Ontario Ministry of Health and Long-Term Care participated in the survey and discussions with the other experts.	*AG HEALTHC RES QU, NAT QUAL MEAS CLEAR; Agency for Healthcare Research and Quality, 2017, 6 DOM HLTH CAR QUAL; [Anonymous], QUAL OUTC FRAM; Bigdeli M, 2014, MED HLTH SYSTEMS ADV; Canadian Institute for Health Information, IND LIB; Canadian Medical Association, 2011, PRESCR OPT PRESCR; Clement FM, 2016, CANADIAN PUBLICLY FU; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fitch K., 2001, RAND UCLA APPROPRIAT; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; National Committee for Quality Assurance, HEDIS MEAS; National Prescribing Service (Australia), 2006, IND QUAL PRESCR AUST; OECD, DAT MEAS HLTH CAR QU; Roland M., 2004, NEW ENGL J MED N ENG, P35114; Shekelle PG, 1998, INT J TECHNOL ASSESS, V14, P707, DOI 10.1017/S0266462300012022; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Sheldon T, 1998, QUAL HEALTH CARE, V7, pS45; Stelfox HT, STAKEHOLDER ENGAGEME; The World Bank, SERV DEL IND; World Health Organization, GLOB HLTH OBS IND VI	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210794	10.1371/journal.pone.0210794	http://dx.doi.org/10.1371/journal.pone.0210794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645647	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200055
J	Ke, CJ; Guan, WX; Bu, SH; Li, XX; Deng, Y; Wei, ZN; Wu, WR; Zheng, Y				Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Li, Xiaoxu; Deng, Yun; Wei, Zhinan; Wu, Weiren; Zheng, Yan			Determination of absorption dose in chemical mutagenesis in plants	PLOS ONE			English	Article							EFFICIENCY; SULFONATE	Chemical mutagenesis is a useful tool for inducing mutations in plants. Seeds are often used as the material for chemical mutagenesis. The biological effect of a chemical mutagen on seeds is determined by absorption dose (the product of mutagen concentration and acting time, which starts after the mutagen is absorbed by the seeds). In practice, however, the concept of exposure dose (the product of mutagen concentration and treating time) is usually used instead because the time for absorbing mutagen is unknown. In this study, we conducted an experiment using ethyl methane sulphonate (EMS) to treat cauliflower seeds, in which five EMS concentrations (0%, 0.5%, 1.0%, 1.5% and 2.0%), three treating time lengths (4 h, 6 h and 8 h) and two pretreatments (non-presoaking and presoaking of seeds for 2 h) were set. We obtained a well-fitted nonlinear regression model for the relationship between seedling survival rate and the EMS treatment, and its marginal models for the two pretreatments. Based on the models, we determined the EMS absorption doses under the two different pretreatments and identified their 50% lethality dose (LD50). We found that presoaking could delay EMS absorption and therefore reduce the injury caused by EMS within a given treating time, but could hardly change the biological effect of EMS after it is absorbed. The conclusions about absorption dose and presoaking effect obtained in this study might be generally applicable to plant chemical mutagenesis in principle.	[Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Wu, Weiren; Zheng, Yan] Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China; [Ke, Changjiao; Guan, Wenxiang; Bu, Suhong; Wu, Weiren; Zheng, Yan] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China; [Li, Xiaoxu; Deng, Yun; Wei, Zhinan; Zheng, Yan] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wu, WR; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China.; Wu, WR; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Fujian Prov Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China.; Zheng, Y (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wuwr@fafu.edu.cn; swallow1318@126.com			Natural Science Foundation of Fujian Province (CN) [2017J01424]	Natural Science Foundation of Fujian Province (CN)	Funding was provided by the Natural Science Foundation of Fujian Province (CN), grant #2017J01424, to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Dhanavel D, 2008, AFR J BIOTECHNOL, V7, P4116; Feng HY, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P107, DOI 10.1079/9781780640853.0107; Hohmann U, 2005, PLANT BREEDING, V124, P317, DOI 10.1111/j.1439-0523.2005.01126.x; Jander G, 2003, PLANT PHYSIOL, V131, P139, DOI 10.1104/pp.102.010397; Khan S, 2009, ENV WE INT J SCI TEC, V4, P1; Kodym A, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P169, DOI 10.1079/9781780640853.0169; Lee DK, 2017, APPL BIOL CHEM, V60, P241, DOI 10.1007/s13765-017-0273-0; Leitao JM, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P135, DOI 10.1079/9781780640853.0135; Rajarajeswari P., 2017, INT J FUZZY LOGIC SY, V7, P1; Rajib Roychowdhury, 2011, Current Botany, V2, P19; Talebi A. B., 2012, American Journal of Plant Sciences, V3, P1661, DOI 10.4236/ajps.2012.312202; Wani Aijaz A., 2009, Asian Journal of Plant Sciences, V8, P318	13	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210596	10.1371/journal.pone.0210596	http://dx.doi.org/10.1371/journal.pone.0210596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640941	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000034
J	Mayday, MY; Khan, LM; Chow, ED; Zinter, MS; DeRisi, JL				Mayday, Madeline Y.; Khan, Lillian M.; Chow, Eric D.; Zinter, Matt S.; DeRisi, Joseph L.			Miniaturization and optimization of 384-well compatible RNA sequencing library preparation	PLOS ONE			English	Article							TECHNOLOGIES	Preparation of high-quality sequencing libraries is a costly and time-consuming component of metagenomic next generation sequencing (mNGS). While the overall cost of sequencing has dropped significantly over recent years, the reagents needed to prepare sequencing samples are likely to become the dominant expense in the process. Furthermore, libraries prepared by hand are subject to human variability and needless waste due to limitations of manual pipetting volumes. Reduction of reaction volumes, combined with sub-microliter automated dispensing of reagents without consumable pipette tips, has the potential to provide significant advantages. Here, we describe the integration of several instruments, including the Labcyte Echo 525 acoustic liquid handler and the iSeq and NovaSeq Illumina sequencing platforms, to miniaturize and automate mNGS library preparation, significantly reducing the cost and the time required to prepare samples. Through the use of External RNA Controls Consortium (ERCC) spike-in RNAs, we demonstrated the fidelity of the miniaturized preparation to be equivalent to full volume reactions. Furthermore, detection of viral and microbial species from cell culture and patient samples was also maintained in the mini-aturized libraries. For 384-well mNGS library preparations, we achieved cost savings of over 80% in materials and reagents alone, and reduced preparation time by 90% compared to manual approaches, without compromising quality or representation within the library.	[Mayday, Madeline Y.; Zinter, Matt S.] UCSF Sch Med, Benioff Childrens Hosp, Div Crit Care, Dept Pediat, San Francisco, CA USA; [Khan, Lillian M.; Chow, Eric D.; DeRisi, Joseph L.] UCSF Sch Med, Dept Biochem & Biophys, San Francisco, CA 94115 USA; [DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeRisi, JL (corresponding author), UCSF Sch Med, Dept Biochem & Biophys, San Francisco, CA 94115 USA.; DeRisi, JL (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	joe@derisilab.ucsf.edu		Mayday, Madeline/0000-0002-7209-0434; DeRisi, Joseph/0000-0002-4611-9205; Zinter, Matt/0000-0003-3351-3278	Chan Zuckerberg Biohub;  [K12HD000850/HD/NICHD NIH]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER	Chan Zuckerberg Biohub; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	MYM and MSZ were funded by K12HD000850/HD/NICHD NIH. LMK and JLD received funding from the Chan Zuckerberg Biohub. EDC received no specific funding for this work.	Agrawal S, 2016, JALA-J LAB AUTOM, V21, P57, DOI 10.1177/2211068215609315; Badal S, 2004, VIROLOGY, V324, P483, DOI 10.1016/j.virol.2004.04.002; Callejas S, 2014, BIOTECHNIQUES, V56, P28, DOI 10.2144/000114124; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kanigowska P, 2016, JALA-J LAB AUTOM, V21, P49, DOI 10.1177/2211068215593754; Langelier C, 2018, AM J RESP CRIT CARE, V197, P524, DOI 10.1164/rccm.201706-1097LE; Lee Hangnoh, 2016, J Genomics, V4, P19, DOI [10.7150/jgen.16082, 10.14190/JRCR.2016.4.1.019]; Mora-Castilla S, 2016, JALA-J LAB AUTOM, V21, P557, DOI 10.1177/2211068216630741; MS Zinter, 2018, CLIN INFECT DIS; Pine PS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0281-x; Reid LH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-150; Roberts K, 2016, JALA-J LAB AUTOM, V21, P76, DOI 10.1177/2211068215595212; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Schiebelhut LM, 2017, MOL ECOL RESOUR, V17, P721, DOI 10.1111/1755-0998.12620; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Shapland EB, 2015, ACS SYNTH BIOL, V4, P860, DOI 10.1021/sb500362n; Sinclair I, 2016, JALA-J LAB AUTOM, V21, P19, DOI 10.1177/2211068215619124; Thomas A.W., 1998, JALA-J ASSOC LAB AUT, V3, P62; Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0344-6; Ware J L, 2000, J Biomol Tech, V11, P151; Wilson MR, 2018, JAMA NEUROL, V75, P947, DOI 10.1001/jamaneurol.2018.0463; Wilson MR, 2017, ANN NEUROL, V82, P105, DOI 10.1002/ana.24982; Yin XY, 2014, ACTA CRYSTALLOGR D, V70, P1177, DOI 10.1107/S1399004713034603	24	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0206194	10.1371/journal.pone.0206194	http://dx.doi.org/10.1371/journal.pone.0206194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629604	Green Published, Green Submitted, gold			2022-12-27	WOS:000455483000008
J	Spiteri, J; James, J; Belot, M				Spiteri, Jonathan; James, Jonathan; Belot, Michele			A computer-based incentivized food basket choice tool: Presentation and evaluation	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY-INTAKE; FREQUENCY QUESTIONNAIRES; PHYSICAL-ACTIVITY; RANDOMIZED-RESPONSE; NATIONAL-HEALTH; ENERGY-INTAKE; NUTRITION; RECALL; VALIDITY	Objective To develop and evaluate a low-cost computer-based tool to elicit dietary choices in an incentive compatible manner, which can be used on-line or as part of a laboratory study. Methods The study was conducted with around 255 adults. Respondents were asked to allocate a fixed monetary budget across a choice of around a hundred grocery items with the prospect of receiving these items with some probability delivered to their home by a real supermarket. The tool covers a broad range of food items, allows inference of macro-nutrients and calories, and allows the researcher to fix the choice set participants can choose from. We compare the information derived from our incentivized tool, and compare it to alternative low-cost ways of measuring dietary intake, namely the food frequency questionnaire and a one-shot version of the 24-hour dietary recall, which are both based on self-reports. We compare the calorie intake indicators derived from each tool with a number of biometric measures for each subject, namely weight, body-mass-index (BMI) and waist size. Results The results show that the dietary information collected is only weakly correlated across the three methods. We find that only the calorie intake measure from our incentivized tool is positively and significantly related to each of the biometric indicators. Specifically, a 10% increase in calorie intake is associated with a 1.5% increase in BMI. By contrast, we find no significant correlations for either of the two measures based on self-reports. Conclusion The computer-based tool is a promising new, low-cost measure of dietary choices, particularly in one-shot situations where such behaviours are only observed once, whereas other tools like 24-hour dietary recalls and food frequency questionnaires may be more suited when they are administered repeatedly. The tool may be useful for research conducted with limited time and budget.	[Spiteri, Jonathan] Univ Malta, Fac Econ Management & Accountancy, Msida, Malta; [James, Jonathan] Univ Bath, Dept Econ, Bath, Avon, England; [Belot, Michele] European Univ Inst, Dept Econ, Florence, Italy	University of Malta; University of Bath; European University Institute	James, J (corresponding author), Univ Bath, Dept Econ, Bath, Avon, England.	J.James@bath.ac.uk		James, Jonathan/0000-0002-8206-1637	NUDGE-IT [607310]	NUDGE-IT	This work was supported by NUDGE-IT, Project ID: 607310, Funded under: FP7-KBBE (https://cordis.europa.eu/project/rcn/111139_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz W, 1998, AM J AGR ECON, V80, P64, DOI 10.2307/3180269; Alfnes F, 2006, AM J AGR ECON, V88, P1050, DOI 10.1111/j.1467-8276.2006.00915.x; Arab L, 2011, AM J EPIDEMIOL, V174, P1256, DOI 10.1093/aje/kwr224; Atkin LM, 2000, AM J CLIN NUTR, V72, P15; Baranowski T, 2012, J ACAD NUTR DIET, V112, P527, DOI 10.1016/j.jada.2011.10.002; Barrios P, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0150-2; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Belot M, WHAT YOU DONT UNPUB; Berg JE, 2010, GAME ECON BEHAV, V68, P443, DOI 10.1016/j.geb.2009.07.008; Bertrand M, 2001, AM ECON REV, V91, P67, DOI 10.1257/aer.91.2.67; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2002, PUBLIC HEALTH NUTR, V5, P821, DOI 10.1079/PHN2002368; Bingham SA, 2001, AM J CLIN NUTR, V74, P188; BLOCK G, 1982, AM J EPIDEMIOL, V115, P492, DOI 10.1093/oxfordjournals.aje.a113331; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Burger R, 2010, WORLD DEV, V38, P1263, DOI 10.1016/j.worlddev.2009.12.018; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Carlsson F, 2007, AM J AGR ECON, V89, P152, DOI 10.1111/j.1467-8276.2007.00969.x; Chang JB, 2009, AM J AGR ECON, V91, P518, DOI 10.1111/j.1467-8276.2008.01242.x; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI 10.1079/PHN2004666; Cubitt R. P., 1998, Experimental Economics, V1, P115, DOI 10.1023/A:1026435508449; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Daniel Z, 131 CHE; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Demarque C, 2015, J ENVIRON PSYCHOL, V43, P166, DOI 10.1016/j.jenvp.2015.06.008; Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.3.CO;2-2; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; George SM, 2012, PUBLIC HEALTH NUTR, V15, P1000, DOI 10.1017/S1368980011003272; Graham DJ, 2011, J AM DIET ASSOC, V111, P1704, DOI 10.1016/j.jada.2011.08.005; Griffith R, 2015, OXFORD REV ECON POL, V31, P116, DOI 10.1093/oxrep/grv004; Griffith R, 2010, FISC STUD, V31, P481, DOI 10.1111/j.1475-5890.2010.00122.x; Griffith R, 2009, FISC STUD, V30, P339, DOI 10.1111/j.1475-5890.2009.00099.x; Guo X, 2004, EUR J CLIN NUTR, V58, P1580, DOI 10.1038/sj.ejcn.1601989; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Harper H, 2016, COUNTING CALORIES RE; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Johnson RK, 2002, OBES RES, V10, p63S, DOI 10.1038/oby.2002.192; KOLLAT DT, 1967, J MARKETING RES, V4, P21, DOI 10.2307/3150160; Kozup JC, 2003, J MARKETING, V67, P19, DOI 10.1509/jmkg.67.2.19.18608; Kristal AK, 1992, P 17 NAT NUTR DAT C, P110; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Loomis J.B., 2009, J AGRIC APPL ECON, V41, P698, DOI DOI 10.1017/S1074070800003163; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Lynch JG, 2006, J PUBLIC POLICY MARK, V25, P67, DOI 10.1509/jppm.25.1.67; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; McFerran B, 2010, J CONSUM RES, V36, P915, DOI 10.1086/644611; Mulligan AA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004503; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2007, J LAW MED ETHICS, V35, P35, DOI 10.1111/j.1748-720X.2007.00112.x; Newby PK, 2003, ARCH PEDIAT ADOL MED, V157, P759, DOI 10.1001/archpedi.157.8.759; Office of National Statistics, 2018, FAM SPEND UK FIN YEA; Panzone LA, J ENV EC MANAGEMENT; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; RAGHAVARAO D, 1979, J ROY STAT SOC B MET, V41, P40; Resnicow K, 2000, AM J EPIDEMIOL, V152, P1072, DOI 10.1093/aje/152.11.1072; Romieu I, 2004, PEDIATR PULM, V38, P31, DOI 10.1002/ppul.20042; Shang Lei, 2015, Prev Med Rep, V2, P265, DOI 10.1016/j.pmedr.2015.04.003; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Smith C, 2006, AM J HUM BIOL, V18, P706, DOI 10.1002/ajhb.20475; STARMER C, 1991, AM ECON REV, V81, P971; STERN H, 1962, J MARKETING, V26, P59, DOI 10.2307/1248439; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Thomas M, 2011, J CONSUM RES, V38, P126, DOI 10.1086/657331; Thompson FE, 2005, J AM DIET ASSOC, V105, P352, DOI 10.1016/j.jada.2004.12.032; Thompson FE, 2004, PUBLIC HEALTH NUTR, V7, P1097, DOI 10.1079/PHN2004642; Trost SG, 2003, INT J OBESITY, V27, P834, DOI 10.1038/sj.ijo.0802311; Umbach P., 2005, NEW DIRECTIONS I RES, V127, P73, DOI DOI 10.1002/ir.156; Wansink B, 2009, AM ECON REV, V99, P165, DOI 10.1257/aer.99.2.165; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Wisdom J, 2010, AM ECON J-APPL ECON, V2, P164, DOI 10.1257/app.2.2.164; Zhou X, 2015, NUTRIENTS, V7, P5396, DOI 10.3390/nu7075228	77	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210061	10.1371/journal.pone.0210061	http://dx.doi.org/10.1371/journal.pone.0210061			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629643	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000044
J	Sultana, M; Sarker, AR; Sheikh, N; Akram, R; Ali, N; Mahumud, RA; Alam, NH				Sultana, Marufa; Sarker, Abdur Razzaque; Sheikh, Nurnabi; Akram, Raisul; Ali, Nausad; Mahumud, Rashidul Alam; Alam, Nur Haque			Prevalence, determinants and health care-seeking behavior of childhood acute respiratory tract infections in Bangladesh	PLOS ONE			English	Article							CHILDREN; PNEUMONIA; EPIDEMIOLOGY; ILLNESS; URBAN	Background Acute respiratory infections (ARIs) are one of the leading causes of child mortality worldwide and contribute significant health burden for developing nations such as Bangladesh. Seeking care and prompt management is crucial to reduce disease severity and to prevent associated morbidity and mortality. Objective This study investigated the prevalence and care-seeking behaviors among under-five children in Bangladesh and identified factors associated with ARI prevalence and subsequent care-seeking behaviors. Method The present study analyzed cross-sectional data from the 2014 Bangladesh Demographic Health Survey. Bivariate analysis was performed to estimate the prevalence of ARIs and associated care-seeking. Logistic regression analysis was used to determine the influencing socio-economic and demographic predictors. A p-value of <0.05 was considered as the level of significance. Result Among 6,566 under-five children, 5.42% had experienced ARI symptoms, care being sought for 90% of affected children. Prevalence was significantly higher among children < 2 years old, and among males. Children from poorer and the poorest quintiles of households were 2.40 (95% CI = 1.12, 5.15) and 2.36 (95% CI = 1.06, 5.24) times more likely to suffer from ARIs compared to the wealthiest group. Seeking care was significantly higher among female children (AOR = 2.19, 95% CI = 0.94, 5.12). The likelihood of seeking care was less for children belonging to the poorest quintile compared to the richest (AOR = 0.03, 95% CI = 0.01, 0.55). Seeking care from untrained providers was 3.74 more likely among rural residents compared to urban (RRR = 3.74, 95% CI = 1.10, 12.77). Conclusion ARIs continue to contribute high disease burden among under-five children in Bangladesh lacking of appropriate care-seeking behavior. Various factors, such as age and sex of the children, wealth index, the education of the mother, and household lifestyle factors were significantly associated with ARI prevalence and care-seeking behaviors. In addition to publicprivate actions to increase service accessibility for poorer households, equitable and efficient service distribution and interventions targeting households with low socio-economic status and lower education level, are recommended.	[Sultana, Marufa; Alam, Nur Haque] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sultana, Marufa] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Sarker, Abdur Razzaque; Sheikh, Nurnabi; Akram, Raisul; Ali, Nausad] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Sarker, Abdur Razzaque] Univ Strathclyde, Glasgow, Lanark, Scotland; [Mahumud, Rashidul Alam] Univ Southern Queensland, Toowoomba, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Deakin University; International Centre for Diarrhoeal Disease Research (ICDDR); University of Strathclyde; University of Southern Queensland	Sultana, M (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Sultana, M (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia.	marufa@icddrb.org	Mahumud, Rashidul Alam/O-2477-2018	Mahumud, Rashidul Alam/0000-0001-9788-1868; Sheikh, Nurnabi/0000-0002-5185-9996				Abdulkadir MB, 2016, S AFR J CHILD HEALTH, V10, P92, DOI [10.7196/sajch.2016.v10i1.1076, 10.7196/SAJCH.2016.v10i1.1076]; Abdulkadir Mohammed B, 2015, Oman Med J, V30, P331, DOI 10.5001/omj.2015.68; Adesanya OA, 2016, BMC PUBLIC HEALTH, V16, P1, DOI [10.1186/s12889-015-2639-8, DOI 10.1186/S12889-015-2639-8]; Akram R, 2018, FOOD NUTR BULL, V39, P521, DOI 10.1177/0379572118794770; Althouse BM, 2018, INT J INFECT DIS, V75, P18, DOI 10.1016/j.ijid.2018.08.001; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2013, MEAS DHS ICF INT DEM; Astale T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142553; Azad K., 2009, J SCI RES, V1, P72, DOI 10.3329/jsr.v1i1.1055; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; BBS, 2013, HLTH MORB STAT SURV; Erling V, 1999, J PUBLIC HEALTH MED, V21, P331, DOI 10.1093/pubmed/21.3.331; Goldman N, 2000, TROP MED INT HEALTH, V5, P145, DOI 10.1046/j.1365-3156.2000.00527.x; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Hamed A, 2017, WORLD J UROL, V35, P459, DOI 10.1007/s00345-016-1879-2; Hemila H, 2008, RESP MED, V102, P625, DOI 10.1016/j.rmed.2007.12.011; International Vaccine Access Center (IVAC), 2015, JOHNS HOPKINS BLOOMB, P1; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam F, 2013, J GLOB INFECT DIS, V5, P8, DOI 10.4103/0974-777X.107167; Kabir AL, 2016, J RESP MED RES TREAT, V11, DOI [10.5171/2016.183615, DOI 10.5171/2016.183615]; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kante AM, 2015, BMC PUBLIC HLTH, V15, P1, DOI [10.1186/1471-2458-15-1, DOI 10.1186/1471-2458-15-1]; Kanungo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125865; Khera R, 2014, ARCH DIS CHILD, V99, P369, DOI 10.1136/archdischild-2013-303889; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kilabuko James H, 2007, Int J Environ Res Public Health, V4, P283, DOI 10.3390/ijerph200704040003; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P91, DOI 10.3961/jpmph.16.089; Pinzon-Rondon AM, 2016, PAEDIATR INT CHILD H, V36, P84, DOI 10.1179/2046905515Y.0000000021; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Ndugwa RP, 2008, J CHILD HEALTH CARE, V12, P314, DOI 10.1177/1367493508096206; NIPORT, 2015, BANGL URB HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Pal Ranabir, 2009, Indian J Community Med, V34, P310, DOI 10.4103/0970-0218.58389; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Rutstein S. O., 2004, DHS WEALTH INDEX; Sadruddin S, 2012, AM J TROP MED HYG, V87, P137, DOI 10.4269/ajtmh.2012.12-0242; Sahoo AK, 2014, J HEALTH MANAG, V16, P397, DOI 10.1177/0972063414539614; Sanbata H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1122; Sarker AR, 2018, PUBLIC HEALTH, V157, P94, DOI 10.1016/j.puhe.2018.01.010; Sarker Abdur Razzaque, 2016, Glob Pediatr Health, V3, p2333794X16680901, DOI 10.1177/2333794X16680901; Sarker AR, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000052; Scott JAG, 2008, B WORLD HEALTH ORGAN, V86, P494, DOI 10.2471/BLT.08.052753; Seam MOR, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6010006; Selvaraj Kalaiselvi, 2014, J Nat Sci Biol Med, V5, P15, DOI 10.4103/0976-9668.127275; Shibata T, 2014, INT J ENV RES PUB HE, V11, P12190, DOI 10.3390/ijerph111212190; Sreeramareddy CT., 2006, BMC INT HEALTH HUM R, V6, P1; Sultana NK, 2013, J PEDIATR-US, V163, pS73, DOI 10.1016/j.jpeds.2013.03.033; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; UNICEF, 2022, DEM WSPOLCZ DZIETN; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; Walke Sneha P, 2014, Int Sch Res Notices, V2014, P165152, DOI 10.1155/2014/165152; Walke SP, 2014, INT SCH RES NOTICES, V2014, P6; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization (WHO), 2013, PNEUM FACTSH	59	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210433	10.1371/journal.pone.0210433	http://dx.doi.org/10.1371/journal.pone.0210433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629689	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000455483000090
J	Leynaud-Kieffer, LMC; Curran, SC; Kim, I; Magnuson, JK; Gladden, JM; Baker, SE; Simmons, BA				Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Kim, Irene; Magnuson, Jon K.; Gladden, John M.; Baker, Scott E.; Simmons, Blake A.			A new approach to Cas9-based genome editing in Aspergillus niger that is precise, efficient and selectable	PLOS ONE			English	Article							FILAMENTOUS FUNGI; HOMOLOGOUS RECOMBINATION; GENE; TRANSFORMATION; ENDONUCLEASE; EXPRESSION; SELECTION; ENZYMES	Aspergillus niger and other filamentous fungi are widely used in industry, but efficient genetic engineering of these hosts remains nascent. For example, while molecular genetic tools have been developed, including CRISPR/Cas9, facile genome engineering of A. niger remains challenging. To address these challenges, we have developed a simple Cas9-based gene targeting method that provides selectable, iterative, and ultimately marker-free generation of genomic deletions and insertions. This method leverages locus-specific "popout" recombination to suppress off-target integrations. We demonstrated the effectiveness of this method by targeting the phenotypic marker albA and validated it by targeting the glaA and mstC loci. After two selection steps, we observed 100% gene editing efficiency across all three loci. This method greatly reduces the effort required to engineer the A. niger genome and overcomes low Cas9 transformations efficiency by eliminating the need for extensive screening. This method represents a significant addition to the A. niger genome engineering toolbox and could be adapted for use in other organisms. It is expected that this method will impact several areas of industrial biotechnology, such as the development of new strains for the secretion of heterologous enzymes and the discovery and optimization of metabolic pathways.	[Leynaud-Kieffer, Laure M. C.] Swiss Fed Inst Technol Lausanne, Lausanne, Vaud, Switzerland; [Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Magnuson, Jon K.; Gladden, John M.; Baker, Scott E.; Simmons, Blake A.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Leynaud-Kieffer, Laure M. C.; Curran, Samuel C.; Simmons, Blake A.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Curran, Samuel C.] Univ Calif Berkeley, Comparat Biochem Grad Grp, Berkeley, CA 94720 USA; [Kim, Irene] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Magnuson, Jon K.] Pacific Northwest Natl Lab, Chem & Biol Proc Dev Grp, Richland, WA USA; [Gladden, John M.] Sandia Natl Labs, Dept Biomass Sci & Convers Technol, Livermore, CA USA; [Baker, Scott E.] Pacific Northwest Natl Lab, Environm Mol Sci Div, Biosyst Design & Simulat Grp, Richland, WA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Simmons, BA (corresponding author), Joint Bioenergy Inst, Emeryville, CA 94608 USA.; Simmons, BA (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	basimmons@lbl.gov	Simmons, Blake/N-6022-2016; Baker, Scott E./ABB-1635-2020	Simmons, Blake/0000-0002-1332-1810; Baker, Scott E./0000-0001-5085-3106; Leynaud Kieffer, Laure/0000-0002-2074-9903	DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies Office; U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Vehicle Technologies Office	DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies Office(United States Department of Energy (DOE)); U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Vehicle Technologies Office(United States Department of Energy (DOE))	This work was supported by the DOE Joint BioEnergy Institute (http://www.jbei.org) and by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. This research was also conducted as part of the Co-Optimization of Fuels & Engines (Co-Optima) project sponsored by the U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies and Vehicle Technologies Offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chiang YM, 2011, FUNGAL GENET BIOL, V48, P430, DOI 10.1016/j.fgb.2010.12.001; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; Deng HX, 2017, GENE, V627, P212, DOI 10.1016/j.gene.2017.06.019; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J; Gladden JM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-15; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haq I, 2012, BIOTECHNOL LETT, V34, P1703, DOI 10.1007/s10529-012-0953-0; Horlbeck M. A., 2016, ELIFE, P5; Imran M, 2010, PAKISTAN J BOT; Jensen KT, 2017, FEBS LETT, V591, P1892, DOI 10.1002/1873-3468.12707; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Krappmann Sven, 2007, Fungal Biology Reviews, V21, P25, DOI 10.1016/j.fbr.2007.02.004; Li DD, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0785-7; Ling SOS, 2013, SCI WORLD J, DOI 10.1155/2013/634317; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Martinez AT, 2005, INT MICROBIOL, V8, P195; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Nodvig CS, 2018, FUNGAL GENET BIOL, V115, P78, DOI 10.1016/j.fgb.2018.01.004; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Olempska-Beer ZS, 2006, REGUL TOXICOL PHARM, V45, P144, DOI 10.1016/j.yrtph.2006.05.001; Patyshakuliyeva A, 2016, BIOTECHNOL LETT, V38, P969, DOI 10.1007/s10529-016-2060-0; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Reilly MC, 2018, APPL MICROBIOL BIOT, V102, P1797, DOI 10.1007/s00253-017-8717-3; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Ruiz-Diez B, 2002, J APPL MICROBIOL, V92, P189, DOI 10.1046/j.1365-2672.2002.01516.x; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Shi TQ, 2017, APPL MICROBIOL BIOT, V101, P7435, DOI 10.1007/s00253-017-8497-9; Song L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202868; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Zhang JX, 2011, CURR MICROBIOL, V62, P1342, DOI 10.1007/s00284-010-9853-5; Zheng YR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17658-7; Zhu XG, 2004, SCI CHINA SER C, V47, P139, DOI 10.1360/03yc0097; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	43	30	33	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210243	10.1371/journal.pone.0210243	http://dx.doi.org/10.1371/journal.pone.0210243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653574	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500029
J	Marcinkowska, UM; Hahn, AC; Little, AC; DeBruine, LM; Jones, BC				Marcinkowska, Urszula M.; Hahn, Amanda C.; Little, Anthony C.; DeBruine, Lisa M.; Jones, Benedict C.			No evidence that women using oral contraceptives have weaker preferences for masculine characteristics in men's faces	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SEXUAL-DIMORPHISM; MENSTRUAL-CYCLE	Previous research has suggested that women using oral contraceptives show weaker preferences for masculine men than do women not using oral contraceptives. Such research would be consistent with the hypothesis that steroid hormones influence women's preferences for masculine men. Recent large-scale longitudinal studies, however, have found limited evidence linking steroid hormones to masculinity preferences. Given the relatively small samples used in previous studies investigating putative associations between masculinity preferences and oral contraceptive use, we compared the facial masculinity preferences of women using oral contraceptives and women not using oral contraceptives in a large online sample of 6482 heterosexual women. We found no evidence that women using oral contraceptives had weaker preferences for male facial masculinity than did women not using oral contraceptives. These findings add to a growing literature suggesting that links between reproductive hormones and preferences are more limited than previously proposed.	[Marcinkowska, Urszula M.] Jagiellonian Univ, Coll Med, Dept Hlth Sci, Fac Publ Hlth, Krakow, Poland; [Hahn, Amanda C.] Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA; [Little, Anthony C.] Univ Bath, Dept Psychol, Bath, Avon, England; [DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Jagiellonian University; Collegium Medicum Jagiellonian University; California State University System; California State Polytechnic University, Humboldt; University of Bath; University of Glasgow	Marcinkowska, UM (corresponding author), Jagiellonian Univ, Coll Med, Dept Hlth Sci, Fac Publ Hlth, Krakow, Poland.	ummarcinkowska@gmail.com	Little, Anthony/W-2732-2019; Marcinkowska, Urszula/R-9738-2019; Hahn, Amanda C/AAH-1106-2021; DeBruine, Lisa M/A-6990-2008; Jones, Benedict/A-7850-2008	Little, Anthony/0000-0001-9100-1903; Marcinkowska, Urszula/0000-0002-6851-4513; Hahn, Amanda C/0000-0002-4555-7924; DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220	Polish National Science Centre [2014/12/S/NZ8/00722]; ERC	Polish National Science Centre; ERC(European Research Council (ERC)European Commission)	This work has been supported by Polish National Science Centre Grant no. 2014/12/S/NZ8/00722 (https://www.ncn.gov.pl/?language=en) to UMM and ERC grants OCMATE (https://cordis.europa.eu/project/rcn/101375_en.html) and KINSHIP awarded to BCJ and LMD, respectively.	Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blake KR, 2016, HORM BEHAV, V81, P74, DOI 10.1016/j.yhbeh.2016.03.004; Cobey KD, 2015, BIOL PSYCHOL, V104, P35, DOI 10.1016/j.biopsycho.2014.11.002; Feinberg DR, 2008, EVOL HUM BEHAV, V29, P233, DOI 10.1016/j.evolhumbehav.2007.12.008; Gangestad SW, 2016, EVOL HUM BEHAV, V37, P85, DOI 10.1016/j.evolhumbehav.2015.09.001; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Jern P, 2018, EVOL HUM BEHAV, V39, P373, DOI 10.1016/j.evolhumbehav.2018.02.008; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Jones BC, 2017, PSYCHOL SCI, DOI [10.1101/136549, DOI 10.1101/136549]; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lisa D, 2017, YOUNG ADULT WHITE FA; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2013, PSYCHONEUROENDOCRINO, V38, P1777, DOI 10.1016/j.psyneuen.2013.02.014; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Little AC, 2010, PSYCHONEUROENDOCRINO, V35, P912, DOI 10.1016/j.psyneuen.2009.12.006; Marcinkowska UM, 2018, PSYCHONEUROENDOCRINO, V88, P47, DOI 10.1016/j.psyneuen.2017.11.007; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; Welling LLM, 2012, HORM BEHAV, V61, P114, DOI 10.1016/j.yhbeh.2011.10.011	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210162	10.1371/journal.pone.0210162	http://dx.doi.org/10.1371/journal.pone.0210162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629658	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000455483000055
J	Levin, AM; Francis, JH; McFadden, M; Brodie, S; Gobin, YP; Abramson, DH				Levin, Ariana M.; Francis, Jasmine H.; McFadden, Molly; Brodie, Scott; Gobin, Y. Pierre; Abramson, David H.			Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes	PLOS ONE			English	Article							BILATERAL RETINOBLASTOMA; CHEMOREDUCTION; CHEMOTHERAPY	Importance Predictions of visual outcomes are useful in clinical and family decisions regarding treatment for retinoblastoma. Very little has been published on the association of post-treatment visual acuity with pre-treatment electroretinography (ERG), which can be performed on infants too young to reliably quantify visual acuity. Objective To report associations of pre-treatment ERG with post-treatment visual acuity in eyes with advanced retinoblastoma treated with ophthalmic artery chemosurgery (OAC). Design Retrospective case-control study of eyes treated from 2006 through 2017, with mean followup of 51 months (range 2.3-150 months). Setting Single large academic center. Participants Group D and E eyes treated with OAC at Memorial Sloan Kettering Cancer Center with recorded visual acuity and ERG (30Hz flicker). Main outcome and measure Snellen visual acuity (uncorrected) compared to initial 30Hz flicker ERG. Results This study included 157 Group D and E eyes. Results of the Jonckheere-Terpstra test for trend were statistically significant and indicated that eyes with lower pre-treatment ERG readings tended to have more visual impairment post-treatment. Among eyes with initial ERG 75+ mu V, 11 of 32 eyes (34%) had visual acuity 20/40 or better. Among eyes with ERG 0 mu V, 44 of 46 (96%) had visual acuity of 20/200 or worse. Conclusions and relevance Eyes with advanced intraocular retinoblastoma treated with OAC can achieve excellent visual acuity, but poor ERG at initial visit is associated with poor visual acuity after treatment in the majority of eyes. Expectations regarding visual potential may influence decisions about treatment.	[Levin, Ariana M.; Francis, Jasmine H.; Brodie, Scott; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Levin, Ariana M.; McFadden, Molly] Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Francis, Jasmine H.; Gobin, Y. Pierre; Abramson, David H.] Weill Cornell Med Ctr, New York, NY USA; [Brodie, Scott] NYU, Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Utah System of Higher Education; University of Utah; Cornell University; New York University	Levin, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.; Levin, AM (corresponding author), Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84112 USA.	ariana.levin@hsc.utah.edu		Brodie, Scott/0000-0002-3303-4552; Francis, Jasmine/0000-0002-7637-3108	Fund For Ophthalmic Knowledge, Inc.; Achievement Rewards for College Scientists Foundation	Fund For Ophthalmic Knowledge, Inc.; Achievement Rewards for College Scientists Foundation(General Electric)	This work was supported by The Fund For Ophthalmic Knowledge, Inc. (N.Y.) and the Achievement Rewards for College Scientists Foundation.	Berry JL, 2014, BRIT J OPHTHALMOL, V98, P1061, DOI 10.1136/bjophthalmol-2013-304411; Berry JL, 2013, PEDIATR BLOOD CANCER, V60, P688, DOI 10.1002/pbc.24303; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Chen QY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4406-6; Choi SY, 2010, J KOREAN MED SCI, V25, P546, DOI 10.3346/jkms.2010.25.4.546; Fabian ID, 2017, AM J OPHTHALMOL, V179, P137, DOI 10.1016/j.ajo.2017.05.003; Francis JH, 2018, NEOPLASIA, V20, P757, DOI 10.1016/j.neo.2018.05.007; Francis JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197081; Jung EH, 2018, J PEDIAT HEMATOL ONC, P763, DOI [10.1016/j.neo.2018.05.007, DOI 10.1016/J.NEO.2018.05.007]; Kim Jae Min, 2010, Korean J Ophthalmol, V24, P347, DOI 10.3341/kjo.2010.24.6.347; Rao R, 2018, BRIT J OPHTHALMOL, V102, P490, DOI 10.1136/bjophthalmol-2017-310641; Schefler AC, 2007, OPHTHALMOLOGY, V114, P162, DOI 10.1016/j.ophtha.2006.06.042; Shields CL, 2009, OPHTHALMOLOGY, V116, P544, DOI 10.1016/j.ophtha.2008.10.014; Tsimpida M, 2013, BRIT J OPHTHALMOL, V97, P1464, DOI 10.1136/bjophthalmol-2013-303694	14	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210647	10.1371/journal.pone.0210647	http://dx.doi.org/10.1371/journal.pone.0210647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650131	gold, Green Published, Green Submitted			2022-12-27	WOS:000455813300067
J	Hugdahl, E; Bachmann, IM; Schuster, C; Ladstein, RG; Akslen, LA				Hugdahl, Emilia; Bachmann, Ingeborg M.; Schuster, Cornelia; Ladstein, Rita G.; Akslen, Lars A.			Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AGGRESSIVE TUMOR FEATURES; VASCULAR PROLIFERATION; NECROSIS; HYPOXIA; CANCER; UROKINASE; INVASION; INHIBITION; LYMPHANGIOGENESIS	Angiogenesis is important for the progression of cutaneous melanoma. Here, we analyzed the prognostic impact of the angiogenic factor urokinase plasminogen activator resecptor (uPAR), vascular proliferation index (VPI) and tumor necrosis as a measure of hypoxia in a patient series of nodular melanomas (n = 255) and matched loco-regional metastases (n = 78). Expression of uPAR was determined by immunohistochemistry and VPI was assessed by dual immunohistochemistry using Factor-VIII/Ki67 staining. Necrosis was recorded based on HE-slides. As novel findings, high uPAR expression and high VPI were associated with each other, and with increased tumor thickness, presence of tumor necrosis, tumor ulceration, increased mitotic count and reduced cancer specific survival in primary melanoma. In matched cases, VPI was decreased in metastases, whereas the frequency of necrosis was increased. Our findings demonstrate for the first time the impact on melanoma specific survival of uPAR expression and VPI in primary tumors, and of increased necrosis as an indicator of tumor hypoxia in loco-regional metastases. These findings support the importance of tumor angiogenesis in melanoma aggressiveness, and suggest uPAR as an indicator of vascular proliferation and a potential biomarker in melanoma.	[Hugdahl, Emilia; Bachmann, Ingeborg M.; Ladstein, Rita G.; Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Hugdahl, Emilia; Bachmann, Ingeborg M.; Ladstein, Rita G.] Haukeland Hosp, Dept Dermatol, Bergen, Norway; [Schuster, Cornelia] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Schuster, Cornelia] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, Bergen, Norway.; Akslen, LA (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	Lars.Akslen@k1.uib.no	Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017; Schuster, Cornelia/AAX-9719-2021	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543; Schuster, Cornelia/0000-0003-2665-9527	Research Council of Norway through its Centres of Excellence funding scheme [223250]; University of Bergen; Research Council of Norway [802630]; Norwegian Cancer Society [803149]; Helse Vest Research Fund [911873]	Research Council of Norway through its Centres of Excellence funding scheme; University of Bergen; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest Research Fund	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223250. Other funding sources were University of Bergen, Research Council of Norway (grant #802630), Norwegian Cancer Society (grant #803149) and Helse Vest Research Fund (grant #911873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gerd Lillian Hallseth, Bendik Nordanger and Randi Hope Lavik for excellent technical assistance. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, Project Number 223250.	Alexander RA, 2012, CARDIOVASC RES, V94, P125, DOI 10.1093/cvr/cvs017; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Arnes JB, 2012, BREAST CANCER RES TR, V133, P501, DOI 10.1007/s10549-011-1785-7; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bredholt G, 2015, ONCOTARGET, V6, P39676, DOI 10.18632/oncotarget.5344; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Breuss JM, 2012, CELL ADHES MIGR, V6, P535, DOI 10.4161/cam.22243; CLARK WH, 1969, CANCER RES, V29, P705; de Geus SWL, 2017, BIOMARK INSIGHTS, V12, P1, DOI 10.1177/1177271917715443; DEVRIES TJ, 1994, AM J PATHOL, V144, P70; Dohn L.H., 2015, UROL ONCOL, V33, pe15, DOI DOI 10.1016/J.UR0L0NC.2014.12.001; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Edwards JG, 2003, CHEST, V124, P1916, DOI 10.1378/chest.124.5.1916; Erhard H, 1997, MELANOMA RES, V7, pS19; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hillen F, 2006, MELANOMA RES, V16, P453, DOI 10.1097/01.cmr.0000232291.68666.4c; Hoyer-Hansen G, 2012, J CLIN ONCOL S, V30, P35; Hugdahl E, 2017, BR J CANC; Hugdahl E, 2016, BRIT J CANCER, V114, P801, DOI 10.1038/bjc.2016.44; Kashani-Sabet M, 2002, J CLIN ONCOL, V20, P1826, DOI 10.1200/JCO.2002.07.082; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kriegbaum MC, 2015, J HISTOCHEM CYTOCHEM, V63, P142, DOI 10.1369/0022155414563107; Ladstein RG, 2012, J INVEST DERMATOL, V132, P1247, DOI 10.1038/jid.2011.464; Ladstein RG, 2012, AM J SURG PATHOL, V36, P1477, DOI 10.1097/PAS.0b013e31825a5b45; Laerum OD, 2012, INT J CANCER, V131, P558, DOI 10.1002/ijc.26382; Laurenzana A, 2015, J MOL MED, V93, P783, DOI 10.1007/s00109-015-1266-2; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Li YL, 2014, INT J CLIN EXP PATHO, V7, P3771; Marconi C, 2008, CLIN EXP METASTAS, V25, P225, DOI 10.1007/s10585-007-9136-0; Matheis F, 2016, J INVEST DERMATOL, V136, P2475, DOI 10.1016/j.jid.2016.07.026; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Pastushenko I, 2016, AM J DERMATOPATH, V38, P338, DOI 10.1097/DAD.0000000000000488; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Ramnefjell M, 2017, J PATHOL CLIN RES, V3, P249, DOI 10.1002/cjp2.78; Ria R, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/185687; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Schuster C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155242; Shi H, 2015, MELANOMA RES, V25, P15, DOI 10.1097/CMR.0000000000000124; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; STAHL A, 1994, CANCER RES, V54, P3066; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Stefansson IM, 2004, HISTOPATHOLOGY, V44, P472, DOI 10.1111/j.1365-2559.2004.01882.x; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Straume O, 1999, INT J ONCOL, V15, P595; Straume O, 1997, INT J CANCER, V74, P535, DOI 10.1002/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5; Straume O, 2002, AM J PATHOL, V160, P1009, DOI 10.1016/S0002-9440(10)64922-X; Streit M, 2003, ONCOGENE, V22, P3172, DOI 10.1038/sj.onc.1206457; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vinay K., 2007, ROBBINS BASIC PATHOL; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	57	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210399	10.1371/journal.pone.0210399	http://dx.doi.org/10.1371/journal.pone.0210399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640942	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000027
J	Feltrin, AS; Tahira, AC; Simoes, SN; Brentani, H; Martins, DC				Feltrin, Arthur Sant'Anna; Tahira, Ana Carolina; Simoes, Sergio Nery; Brentani, Helena; Martins, David Correa, Jr.			Assessment of complementarity of WGCNA and NERI results for identification of modules associated to schizophrenia spectrum disorders	PLOS ONE			English	Article							NETWORK BIOLOGY; GENE NETWORKS; NEUROGENESIS; PATHWAYS; SLC6A3; EEF2	Psychiatric disorders involve both changes in multiple genes as well different types of variations. As such, gene co-expression networks allowed the comparison of different stages and parts of the brain contributing to an integrated view of genetic variation. Two methods based on co-expression networks presents appealing results: Weighted Gene Correlation Network Analysis (WGCNA) and Network-Medicine Relative Importance (NERI). By selecting two different gene expression databases related to schizophrenia, we evaluated the biological modules selected by both WGCNA and NERI along these databases as well combining both WGCNA and NERI results (WGCNA-NERI). Also we conducted a enrichment analysis for the identification of partial biological function of each result (as well a replication analysis). To appraise the accuracy of whether both algorithms (as well our approach, WGCNA-NERI) were pointing to genes related to schizophrenia and its complex genetic architecture we conducted the MSET analysis, based on a reference gene list of schizophrenia database (SZDB) related to DNA Methylation, Exome, GWAS as well as copy number variation mutation studies. The WGCNA results were more associated with inflammatory pathways and immune system response; NERI obtained genes related with cellular regulation, embryological pathways e cellular growth factors. Only NERI were able to provide a statistical meaningful results to the MSET analysis (for Methylation and de novo mutations data). However, combining WGCNA and NERI provided a much more larger overlap in these two categories and additionally on Transcriptome database. Our study suggests that using both methods in combination is better for establishing a group of modules and pathways related to a complex disease than using each method individually. NERI is available at: https://bitbucket.org/sergionery/neri.	[Feltrin, Arthur Sant'Anna; Martins, David Correa, Jr.] Fed Univ ABC UFABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil; [Tahira, Ana Carolina; Brentani, Helena] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, LIM23,Inst Psiquiatria, Sao Paulo, SP, Brazil; [Simoes, Sergio Nery] Fed Inst Educ Sci & Technol Espirito Santo, Serra, ES, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo, SP, Brazil; [Brentani, Helena] Natl Inst Dev Psychiat Children & Adolescents INP, Sao Paulo, SP, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Instituto Federal do Espirito Santo (IFES); Universidade de Sao Paulo	Feltrin, AS; Martins, DC (corresponding author), Fed Univ ABC UFABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil.	s.feltrin@ufabc.edu.br; david.martins@ufabc.edu.br	Brentani, Helena/G-6839-2011; Feltrin, Arthur/GON-5818-2022; Tahira, Ana/AAD-4196-2020; TAHIRA, ANA C/H-7936-2016; Martins-Jr, David/G-2271-2012	Brentani, Helena/0000-0001-5192-4682; Feltrin, Arthur/0000-0002-1810-2203; Tahira, Ana/0000-0002-7036-7305; TAHIRA, ANA C/0000-0002-7036-7305; Martins-Jr, David/0000-0003-0398-8328	FAPESP - Sao Paulo Research Foundation [2014/10488-3, 2011/50761-2, 2015/01587-0, 2014/00041-1, 2011/04956-6]; CNPq - National Council for Scientific and Technological Development [304955/2014-0]; CAPES - Coordination for the Improvement of Higher Education Personnel [1750212, 88881.187975/2018-01]; NAP eScience -PRP- USP; UFABC - Federal University of ABC	FAPESP - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NAP eScience -PRP- USP; UFABC - Federal University of ABC	This work was supported by FAPESP - Sao Paulo Research Foundation (http://www.fapesp.br/en/): grant numbers 2014/10488-3 (received by ASF); 2011/50761-2 (received by DCMJ); 2015/01587-0 (received by DCMJ); 2014/00041-1 (received by ACT); 2011/04956-6 received by HB); CNPq - National Council for Scientific and Technological Development (http://www.cnpq.br/): grant 304955/2014-0 (received by DCMJ); CAPES - Coordination for the Improvement of Higher Education Personnel (http://www.capes.gov.br/) grant numbers 1750212 and 88881.187975/2018-01 (received by ASF); NAP eScience -PRP- USP and UFABC - Federal University of ABC. The funders had no other role in the project.	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arpon A, 2018, EPIGENOMICS-UK, V10, P91, DOI 10.2217/epi-2017-0082; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Carroll LS, 2010, MOL PSYCHIATR, V15, P1101, DOI 10.1038/mp.2009.96; Chaste P, 2015, BIOL PSYCHIAT, V77, P775, DOI 10.1016/j.biopsych.2014.09.017; Chinese Marketing, 2019, P 3 INT ICWSM C; Damiani D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13509; Dresler T, 2010, NEUROPSYCHOPHARMACOL, V35, P2193, DOI 10.1038/npp.2010.91; Eisinger BE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-147; Fillman SG, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.8; Flint J, 2014, NATURE, V511, P412, DOI 10.1038/nature13645; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hirt L., 2018, CLIN TRANSLATIONAL N, P1, DOI [10.1177/2514183X17752902, DOI 10.1177/2514183X17752902]; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2014, BIOL PSYCHIAT, V75, P316, DOI 10.1016/j.biopsych.2013.06.010; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iancu OD, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00174; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kelley RL, 2017, CLIN EXP REPROD MED, V44, P119, DOI 10.5653/cerm.2017.44.3.119; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Malki K, 2013, PHARMACOGENOMICS, V14, P1979, DOI [10.2217/PGS.13.154, 10.2217/pgs.13.154]; Maschietto M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0098-9; McCamphill PK, 2015, J NEUROSCI, V35, P4403, DOI 10.1523/JNEUROSCI.2376-14.2015; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Pinheiro J., 2018, NLME LINEAR NONLINEA; Popescu BFG, 2014, ACTA NEUROPATHOLOGIC; Querol-Vilaseca M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0893-7; Rieckmann A, 2018, P NATL ACAD SCI USA, V115, P10160, DOI 10.1073/pnas.1804641115; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sanfilippo C, 2017, MOL CELL NEUROSCI, V85, P162, DOI 10.1016/j.mcn.2017.10.001; Saxena Ashwini, 2017, Mol Neuropsychiatry, V3, P108, DOI 10.1159/000480349; Simats A, 2016, BBA-MOL BASIS DIS, V1862, P411, DOI 10.1016/j.bbadis.2015.10.025; Simoes SN, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S19-S9; Simoes SN, 2015, ABORDAGEM INTEGRACAO; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tan MC, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00124; Tiberi L, 2014, CANCER CELL, V26, P797, DOI 10.1016/j.ccell.2014.10.021; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158; Wu Y, 2017, SCHIZOPHRENIA BULL, V43, P459, DOI 10.1093/schbul/sbw102; Xu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05846-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zuo LJ, 2016, PSYCHIAT GENET, V26, P109, DOI 10.1097/YPG.0000000000000129	58	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210431	10.1371/journal.pone.0210431	http://dx.doi.org/10.1371/journal.pone.0210431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645614	Green Submitted, gold, Green Published			2022-12-27	WOS:000455810200029
J	Lof, A; Konig, G; Schneppenheim, S; Schneppenheim, R; Benoit, M; Budde, U; Muller, JP; Brehm, MA				Loef, Achim; Koenig, Gesa; Schneppenheim, Sonja; Schneppenheim, Reinhard; Benoit, Martin; Budde, Ulrich; Mueller, Jochen P.; Brehm, Maria A.			Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; DISEASE; SECRETION; DOMAIN; DIMERIZATION; STORAGE; PH; MUTATIONS; ADHESION	The formation of hemostatic plugs at sites of vascular injury crucially involves the multimeric glycoprotein von Willebrand factor (VWF). VWF multimers are linear chains of N-terminally linked dimers. The latter are formed from monomers via formation of the C-terminal disulfide bonds Cys2771-Cys2773', Cys2773-Cys2771', and Cys2811-Cys2811'. Mutations in VWF that impair multimerization can lead to subtype 2A of the bleeding disorder von Willebrand Disease (VWD). Commonly, the multimer size distribution of VWF is assessed by electrophoretic multimer analysis. Here, we present atomic force microscopy (AFM) imaging as a method to determine the size distribution of VWF variants by direct visualization at the single-molecule level. We first validated our approach by investigating recombinant wildtype VWF and a previously studied mutant (p. Cys1099Tyr) that impairs N-terminal multimerization. We obtained excellent quantitative agreement with results from earlier studies and with electrophoretic multimer analysis. We then imaged specific mutants that are known to exhibit disturbed C-terminal dimerization. For the mutants p. Cys2771Arg and p. Cys2773Arg, we found the majority of monomers (87 +/- 5% and 73 +/- 4%, respectively) not to be C-terminally dimerized. While these results confirm that Cys2771 and Cys2773 are crucial for dimerization, they additionally provide quantitative information on the mutants' different abilities to form alternative C-terminal disulfides for residual dimerization. We further mutated Cys2811 to Ala and found that only 23 +/- 3% of monomers are not C-terminally dimerized, indicating that Cys2811 is structurally less important for dimerization. Furthermore, for mutants p. Cys2771Arg, p. Cys2773Arg, and p. Cys2811Ala we found 'even-numbered' non-native multimers, i.e. multimers with monomers attached on both termini; a multimer species that cannot be distinguished from native multimers by conventional multimer analysis. Summarizing, we demonstrate that AFM imaging can provide unique insights into VWF processing defects at the single-molecule level that cannot be gained from established methods of multimer analysis.	[Loef, Achim; Benoit, Martin; Mueller, Jochen P.] Ludwig Maximilians Univ Munchen, Dept Phys, Munich, Germany; [Koenig, Gesa; Schneppenheim, Reinhard; Brehm, Maria A.] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Schneppenheim, Sonja; Budde, Ulrich] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany	University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brehm, MA (corresponding author), Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany.	m.brehm@uke.de		Brehm, Maria Alexandra/0000-0003-0416-8233; Lof, Achim/0000-0002-4301-2402	German Research foundation (DFG) [386143268]	German Research foundation (DFG)(German Research Foundation (DFG))	Funding was provided by the German Research foundation (DFG; www.dfg.de) to Research group FOR1543 (RS, MB) and to project 386143268 (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm MA, 2014, THROMB HAEMOSTASIS, V112, P96, DOI 10.1160/TH13-11-0902; Budde U, 2008, J THROMB HAEMOST, V6, P762, DOI 10.1111/j.1538-7836.2008.02945.x; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; Castaman G, 2012, J THROMB HAEMOST, V10, P951, DOI 10.1111/j.1538-7836.2012.04702.x; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Groeneveld DJ, 2014, BRIT J HAEMATOL, V167, P529, DOI 10.1111/bjh.13074; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Lippok S, 2016, BLOOD, V127, P1183, DOI 10.1182/blood-2015-04-641902; Lippok S, 2013, BIOPHYS J, V105, P1208, DOI 10.1016/j.bpj.2013.07.037; Lof A, 2018, J CELL PHYSIOL, V233, P799, DOI 10.1002/jcp.25887; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2003, BLOOD, V102, P2452, DOI 10.1182/blood-2003-02-0599; Muller JP, 2016, BIOPHYS J, V111, P312, DOI 10.1016/j.bpj.2016.06.022; Muller JP, 2016, P NATL ACAD SCI USA, V113, P1208, DOI 10.1073/pnas.1516214113; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schmidt TGM, 2013, PROTEIN EXPRES PURIF, V92, P54, DOI 10.1016/j.pep.2013.08.021; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; SCHNEPPENHEIM R, 1988, THROMB HAEMOSTASIS, V60, P133; Schneppenheim R, 1996, P NATL ACAD SCI USA, V93, P3581, DOI 10.1073/pnas.93.8.3581; Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; SPORN LA, 1989, J CELL BIOL, V108, P1283, DOI 10.1083/jcb.108.4.1283; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; White-Adams TC, 2016, THROMB RES, V145, P112, DOI 10.1016/j.thromres.2016.08.009; Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210963	10.1371/journal.pone.0210963	http://dx.doi.org/10.1371/journal.pone.0210963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645640	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200062
J	Ingelse, SA; Juschten, J; Maas, MAW; Matute-Bello, G; Juffermans, NP; van Woensel, JBM; Bem, RA				Ingelse, Sarah A.; Juschten, Jenny; Maas, Martinus A. W.; Matute-Bello, Gustavo; Juffermans, Nicole P.; van Woensel, Job B. M.; Bem, Reinout A.			Fluid restriction reduces pulmonary edema in a model of acute lung injury in mechanically ventilated rats	PLOS ONE			English	Article							CRITICALLY-ILL CHILDREN; BALANCE; WATER; INFLAMMATION; MANAGEMENT; RESPONSES; OVERLOAD; REMOVAL	Experimental acute lung injury models are often used to increase our knowledge on the acute respiratory distress syndrome (ARDS), however, existing animal models often do not take into account the impact of specific fluid strategies on the development of lung injury. In contrast, the current literature strongly suggests that fluid management strategies have a significant impact on clinical outcome of patients with ARDS. Thus, it is important to characterize the role of fluid management strategies in experimental models of lung injury. In this study we investigated the effect of two different fluid strategies on commonly used outcome variables in a short-term model of acute lung injury, in relation to age. Infant (2-3 weeks) and adult (3-4 months) Wistar rats received intratracheal instillations of lipopolysaccharide and 24 hours later were mechanically ventilated for 6 hours. During mechanical ventilation, rats from both age groups were randomized to either a standard or conservative intravenous fluid strategy. We found that the hemodynamic response in infant and adult rats was similar in both fluid strategies. Lung wet-to-dry ratios were lower in adult, but not in infant rats receiving the conservative fluid strategy as compared to the standard fluid strategy. There were age-related differences in markers of alveolar capillary barrier disruption and alveolar fluid clearance, yet these were unaffected by fluid strategy. Finally, we found significantly higher IL-1 beta and TNF-alpha concentrations in the adult rats treated with the conservative as compared to the standard fluid regimen. In conclusion, the choice of fluid strategy in mechanically ventilated rats with experimental LPS-induced acute lung injury has a significant effect on pulmonary extravascular water, an important and well-recognized lung injury marker, and on the local pro-inflammatory cytokine profiles. We advocate the use of a more uniform, conservative, fluid strategy regimen in experimental models of acute lung injury.	[Ingelse, Sarah A.; van Woensel, Job B. M.; Bem, Reinout A.] Acad Med Ctr, Emma Childrens Hosp, Pediat Intens Care Unit, Amsterdam, Netherlands; [Ingelse, Sarah A.; Juschten, Jenny; Maas, Martinus A. W.; Juffermans, Nicole P.] Acad Med Ctr, LEICA, Amsterdam, Netherlands; [Juschten, Jenny; Juffermans, Nicole P.] Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Juschten, Jenny] Vrije Univ Amsterdam Med Ctr, Dept Intens Care & Res VUmc Intens Care REVIVE, Amsterdam, Netherlands; [Matute-Bello, Gustavo] Univ Washington, Ctr Lung Biol, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Matute-Bello, Gustavo] VA Puget Sound Healthcare Syst, Med Res Serv, Seattle, WA USA	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Ingelse, SA (corresponding author), Acad Med Ctr, Emma Childrens Hosp, Pediat Intens Care Unit, Amsterdam, Netherlands.; Ingelse, SA (corresponding author), Acad Med Ctr, LEICA, Amsterdam, Netherlands.	s.a.ingelse@amc.uva.nl	A., Reinout/AAN-1411-2021	Bem, Reinout Alexander/0000-0002-9454-5321	Ammodo Foundation; Foundation of Pediatric Intensive Care (SKIC) in the Netherlands; NIH	Ammodo Foundation; Foundation of Pediatric Intensive Care (SKIC) in the Netherlands(Netherlands Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Ammodo Foundation and the Foundation of Pediatric Intensive Care (SKIC) in the Netherlands. This publication was also funded in part by the NIH. The sponsors had no role in the design and execution of the research, the writing of the report or the decision to submit the manuscript for publication.	Alobaidi R, 2018, JAMA PEDIATR, V172, P257, DOI 10.1001/jamapediatrics.2017.4540; Aloia JF, 1998, J LAB CLIN MED, V132, P483, DOI 10.1016/S0022-2143(98)90126-3; Avila-Diaz M, 2006, PERITON DIALYSIS INT, V26, P574; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; CHAPPELL D, 2014, CRIT CARE, V18; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Flori HR, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/854142; Ingelse SA, 2017, PEDIATR CRIT CARE ME, V18, pE106, DOI 10.1097/PCC.0000000000001060; Ingelse SA, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00021; Ito Y, 2007, EXP LUNG RES, V33, P375, DOI 10.1080/01902140701634843; Katira BH, 2017, AM J RESP CRIT CARE, V196, P1411, DOI 10.1164/rccm.201611-2268OC; Kneyber MCJ, 2014, AM J RESP CRIT CARE, V190, P258, DOI 10.1164/rccm.201401-0168CP; Knoferl MW, 1999, J TRAUMA, V46, P23, DOI 10.1097/00005373-199901000-00005; Kornecki A, 2005, AM J RESP CRIT CARE, V171, P743, DOI 10.1164/rccm.200408-1053OC; Kuebler WM, 1999, J CLIN INVEST, V104, P495, DOI 10.1172/JCI6872; Mafia LDA, 2017, ANESTH ANALG, V125, P1364, DOI 10.1213/ANE.0000000000002348; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Milos S, 2017, AM J PHYSIOL-LUNG C, V313, pL524, DOI 10.1152/ajplung.00055.2017; Nusmeier A, 2015, PEDIATR CRIT CARE ME, V16, pE28, DOI 10.1097/PCC.0000000000000312; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenberg Andrew L, 2009, J Intensive Care Med, V24, P35, DOI 10.1177/0885066608329850; Sakr Y, 2017, CRIT CARE MED, V45, P386, DOI 10.1097/CCM.0000000000002189; Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI [10.1097/CCM.0000000000001388, 10.1097/CCM.0000000000002008]; Schouten LR, 2016, CRIT CARE MED; Setzer F, 2013, CRIT CARE, V17, DOI 10.1186/cc12744; Sinitsky L, 2015, PEDIATR CRIT CARE ME, V16, P205, DOI 10.1097/PCC.0000000000000318; Valentine SL, 2012, CRIT CARE MED, V40, P2883, DOI 10.1097/CCM.0b013e31825bc54d; Weisberg JFS, 2011, R COMPANION APPL REG; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Willson DF, 2013, PEDIATR CRIT CARE ME, V14, P666, DOI 10.1097/PCC.0b013e3182917cb5	32	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210172	10.1371/journal.pone.0210172	http://dx.doi.org/10.1371/journal.pone.0210172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653512	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500027
J	Lavallee, KL; Parker, JG				Lavallee, Kristen L.; Parker, Jeffrey G.			Beliefs about the controllability of social characteristics and children's jealous responses to outsiders' interference in friendship	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; GENDER-DIFFERENCES; YOUNG ADOLESCENTS; IMPLICIT THEORIES; SELF-ESTEEM; ATTRIBUTIONS; AGGRESSION; PREDICTORS; ALTRUISM; SUCCESS	Although some jealous children respond to outsider interference in friendships with problem solving and discussion, others withdraw from the relationship or retaliate against the friends or others. Beliefs about the nature of social characteristics are proposed as an explanation for behavioral heterogeneity in response to jealous provocation. Based on learned helplessness theory and research on children's implicit personality theories, children who subscribed strongly to the belief that social characteristics are fixed and that social outcomes are uncontrollable (high entity beliefs), were expected to more strongly endorse asocial and antisocial responses and less strongly endorse prosocial responses to outsider interference than children who did not have strong entity beliefs, depending on their internal versus external attributions of blame. Two hundred eighty-six children in sixth through eighth grades (primarily Caucasian) participated in an experimental test of this hypothesis. Although hypothesized interactions between beliefs and locus of blame were not supported, results indicated that children who believe social characteristics are changeable also believed they had more control in the internal condition than children who believe social characteristics are immutable. Further, pessimistic children were more likely to tend to endorse asocial and antisocial behavior and less likely to endorse prosocial behavior than optimistic children.	[Lavallee, Kristen L.] Ruhr Univ Bochum, Bochum, Germany; [Parker, Jeffrey G.] Univ Alabama, Tuscaloosa, AL USA	Ruhr University Bochum; University of Alabama System; University of Alabama Tuscaloosa	Lavallee, KL (corresponding author), Ruhr Univ Bochum, Bochum, Germany.	Kllavallee@gmail.com						ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Anderman EM, 2001, CONTEMP EDUC PSYCHOL, V26, P76, DOI 10.1006/ceps.1999.1043; Beer JS, 2002, J PERS SOC PSYCHOL, V83, P1009, DOI 10.1037//0022-3514.83.4.1009; BRADBURY TN, 1990, PSYCHOL BULL, V107, P3, DOI 10.1037/0033-2909.107.1.3; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Burnette JL, 2013, PSYCHOL BULL, V139, P655, DOI 10.1037/a0029531; CAIN KM, 1995, MERRILL PALMER QUART, V41, P25; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Casper DM, 2010, J ADOLESCENT RES, V25, P499, DOI 10.1177/0743558410366596; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; CRICK NR, 1995, CHILD DEV, V66, P710, DOI 10.1111/j.1467-8624.1995.tb00900.x; Culotta CM, 2008, J GENET PSYCHOL, V169, P21, DOI 10.3200/GNTP.169.1.21-33; Dweck C.S., 1996, PSYCHOL ACTION LINKI, P69; Dweck C. S., 2000, MOTIVATIONAL SCI SOC, P394; EARN BM, 1990, PSYCHOL REC, V40, P173, DOI 10.1007/BF03399556; ERDLEY CA, 1993, CHILD DEV, V64, P863, DOI 10.2307/1131223; Erdley CA, 1997, DEV PSYCHOL, V33, P263, DOI 10.1037/0012-1649.33.2.263; Graham S, 1998, DEV PSYCHOL, V34, P587, DOI 10.1037/0012-1649.34.3.587; Graham S, PEER HARASSMENT SCH; Heyman GD, 2008, DEV PSYCHOL, V44, P908, DOI 10.1037/0012-1649.44.4.908; Hong YY, 1999, J PERS SOC PSYCHOL, V77, P588, DOI 10.1037/0022-3514.77.3.588; Howell AJ, 2017, J SOC CLIN PSYCHOL, V36, P437; KASLOW N, 1978, KASTAN CHILDRENS ATT; Kim H, 2017, J APPL DEV PSYCHOL, V52, P170, DOI 10.1016/j.appdev.2017.06.007; Kim-Spoon J, 2012, CHILD PSYCHIAT HUM D, V43, P612, DOI 10.1007/s10578-012-0287-0; Lavallee KL, 2009, J ABNORM CHILD PSYCH, V37, P873, DOI 10.1007/s10802-009-9317-1; LEPORE SJ, 1989, CHILD STUDY J, V19, P259; NOLENHOEKSEMA S, 1992, J ABNORM PSYCHOL, V101, P405, DOI 10.1037/0021-843X.101.3.405; Park JH, 2018, J BUS ETHICS, V147, P919, DOI 10.1007/s10551-015-2997-2; Parker J. G., 2010, HDB JEALOUSY THEORY, P516, DOI DOI 10.1002/9781444323542.CH22; Parker JG, 2005, DEV PSYCHOL, V41, P235, DOI 10.1037/0012-1649.41.1.235; Pomerantz EM, 2001, CHILD DEV, V72, P152, DOI 10.1111/1467-8624.00271; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Roth MA, 2001, J ADOLESCENCE, V24, P281, DOI 10.1006/jado.2001.0408; Sobol M.P., 1985, CHILDRENS PEER RELAT, P93, DOI 10.1007/978-1-4684-6325-5_6; Tamir M, 2007, J PERS SOC PSYCHOL, V92, P731, DOI 10.1037/0022-3514.92.4.731; Weiner B, 1985, EMOTIONS COGNITION B, P167	38	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209845	10.1371/journal.pone.0209845	http://dx.doi.org/10.1371/journal.pone.0209845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650115	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300030
J	Zhu, YB; Liu, S; Chen, W; Liu, B; Zhang, F; Lv, HZ; Ji, CN; Zhang, XL; Zhang, YZ				Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Xiaolin; Zhang, Yingze			Epidemiology of low-energy lower extremity fracture in Chinese populations aged 50 years and above	PLOS ONE			English	Article							DISTAL RADIUS FRACTURE; HIP FRACTURE; OSTEOPOROTIC FRACTURES; ULTRAVIOLET-RADIATION; RISK; METAANALYSIS; ASSOCIATION; WOMEN; INDEX; OLDER	This study aimed to investigate the epidemiology of low-energy lower-extremity fracture in Chinese men and women aged 50 years and above. This study was a part of Chinese National Fracture Survey (CNFS), which used the stratified multistage cluster random sampling method to recruit subjects between January and May 2015. A total of 512187 individuals participated in the CNFS and of them there were 154099 men and women aged 50 years and above included in this study for data analysis. Low-energy fracture was defined as a fracture caused by slip, trip or fall from standing height. Univariate analyses and gender-based multivariate logistic regression models were constructed to identify the independent risk factors. A total of 215 patients had sustained low-energy lower extremity fractures in 2014, indicating the overall incidence was 139.5 (120.9 to 158.2) per 100000 persons, with 127.8 (102.5 to 153.1) and 151.1 (123.8 to 178.5) per 100000 person-year in men and women. Over 80% of fractures occurred at home and on the common road. In men, alcohol consumption (OR, 2.00; 95% CI, 1.29 to 3.08), sleep duration <7h/d (OR, 2.60; 95% CI, 1.68 to 4.03) and history of past fracture (OR, 2.57; 95% CI, 1.33 to 4.95) were identified as significant risk factors associated with low-energy fractures. In women, advanced age (80+ years) (OR, 3.22; 95% CI, 1.80 to 5.75), alcohol consumption(OR, 1.72; 95% CI, 1.00 to 2.98), sleep duration <7h/d (OR, 2.11; 95% CI, 1.40 to 3.18), and history of past fracture (OR, 3.46; 95% CI, 1.97 to 6.09) were identified as significant risk factors and living in western region (OR, 0.60; 95% CI, 0.38 to 0.94) and current weight of 50 to 59.9 kg (OR, 0.17; 95% CI, 0.04 to 0.73) were identified as protective factors for fractures. Accordingly, awareness on the importance of sleep and alcohol consumption on fragility fracture should be improved, and health policies that focus on decreasing alcohol consumption and encouraging individuals to improve their sleep quality and duration should be considered. Maintaining a healthy bodyweight for women should be specifically emphasized to prevent low-energy fractures.	[Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China; [Zhu, Yanbin; Liu, Song; Chen, Wei; Liu, Bo; Zhang, Fei; Lv, Hongzhi; Ji, Chenni; Zhang, Yingze] Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Zhang, Xiaolin] Hebei Med Univ, Dept Stat & Epidemiol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingze] Chinese Acad Engn, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Chinese Acad Engn, Beijing, Peoples R China.	drzhang2013@126.com	Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105; Zhu, Yanbin/0000-0002-7822-9329	Hebei Province Medical Science Special Major Projects Research Fund	Hebei Province Medical Science Special Major Projects Research Fund	This study was funded by the Hebei Province Medical Science Special Major Projects Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2003, OSTEOPOROSIS INT, V14, P895, DOI 10.1007/s00198-003-1483-3; Adams AL, 2013, OSTEOPOROSIS INT, V24, P373, DOI 10.1007/s00198-012-1938-5; Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; Arakaki H, 2011, J BONE MINER METAB, V29, P309, DOI 10.1007/s00774-010-0218-8; Chen CW, 2013, J TRAUMA ACUTE CARE, V74, P317, DOI 10.1097/TA.0b013e31824bb325; Chen W, 2017, LANCET GLOB HEALTH, V5, pE807, DOI 10.1016/S2214-109X(17)30222-X; Chevalley T, 2007, BONE, V40, P1284, DOI 10.1016/j.bone.2006.12.063; Clark MK, 2003, OSTEOPOROSIS INT, V14, P396, DOI 10.1007/s00198-003-1387-2; Cooper C, 2005, RHEUMATOLOGY, V44, P36, DOI 10.1093/rheumatology/kei060; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Durvasula S, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0197-9; Foote JE, 2012, J HAND SURG-AM, V37A, P165, DOI 10.1016/j.jhsa.2011.09.025; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Horii M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-304; Ikpeze TC, 2016, GERIATR ORTHOP SURG, V7, P202, DOI 10.1177/2151458516669202; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnell O, 2006, HORM RES, V16, P1; Jpw B, 2016, OSTEOPOROSIS INT, V27, P1; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kannus P, 2002, BONE, V31, P430, DOI 10.1016/S8756-3282(02)00832-3; Kaye JA, 2004, INJURY PREV, V10, P368, DOI 10.1136/ip.2004.005843; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Koski AM, 2014, SCAND J SURG, V103, P215, DOI 10.1177/1457496914525554; Ling X, 1996, AM J EPIDEMIOL, V144, P901; Lofman O, 2002, OSTEOPOROSIS INT, V13, P18; Lonnroos E, 2006, BONE, V39, P623, DOI 10.1016/j.bone.2006.03.001; Lubbeke A, 2005, AGING CLIN EXP RES, V17, P276; Maharlouei N, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-013-0165-9; Mann Eva, 2008, BMC Geriatr, V8, P35, DOI 10.1186/1471-2318-8-35; Piirtola M, 2007, AGING CLIN EXP RES, V19, P269; Rice SA, 2015, BRIT J DERMATOL, V172, P652, DOI 10.1111/bjd.13575; Saraiva GL, 2005, OSTEOPOROSIS INT, V16, P1649, DOI 10.1007/s00198-005-1895-3; Scholes S, 2014, AGE AGEING, V43, P234, DOI 10.1093/ageing/aft167; Shen RG, 2004, MATERNAL CHILD HLTH; Statement NC, 2001, J A M A., V17, P1; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Weiss RJ, 2009, INJURY, V40, P304, DOI 10.1016/j.injury.2008.07.017; Yoon BH, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0157-9; Zhu YB, 2017, INT WOUND J, V14, P982, DOI 10.1111/iwj.12743	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209203	10.1371/journal.pone.0209203	http://dx.doi.org/10.1371/journal.pone.0209203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640907	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000011
J	Park, B; Cho, HN; Choi, E; Seo, DH; Kim, S; Park, YR; Choi, KS; Rhee, Y				Park, Boyoung; Cho, Ha Na; Choi, Eunji; Seo, Da Hea; Kim, Sue; Park, Yeong-Ran; Choi, Kui Son; Rhee, Yumie			Self-perceptions of body weight status according to age-groups among Korean women: A nationwide population-based survey	PLOS ONE			English	Article							MASS INDEX; CONTROL BEHAVIORS; OBESITY STIGMA; OVERWEIGHT; YOUNG; IMAGE; PREVALENCE; ADULTS; MISPERCEPTION; ASSOCIATION	While numerous studies have investigated body image, including body weight perception, most of which have focused on adolescents or young women, few studies have attempted to evaluate body weight perceptions in adult women according to age groups. This study was conducted to investigate the accuracy of self-perceived weight and actual body mass index (BMI) values among adult Korean women according to age. We used data from the 2016 Korean Study of Women's Health Related Issues, a population-based, nationwide, cross-sectional survey. BMI was calculated from self-reported weight and height. Participants were asked to describe their body image by choosing one of the following descriptions: very underweight, underweight, about right, overweight, or obese. The proportions of women aged 20-29, 30-39, 40-49, 50-59, 60-69, and 70-79 years who underestimated their body weight relative to their actual BMI category were 12.6%, 15.1%, 22.2%, 34.0%, 45.6%, and 50.7%, respectively; those who overestimated their body weight comprised 18.7%, 17.8%, 14.3%, 10.8%, and 7.4%. In all BMI categories, the proportion of those who overestimated their weight status increased as age decreased, while those who underestimated their weight status increased as age increased. After adjusting for possible covariates, age was strongly associated with both underestimation and overestimation. The odds ratio for underestimating one's weight status among women aged 70-79 yeas was 2.96 (95% CI: 2.10-4.18), and that for overestimation was 0.52 (95% CI: 0.35-0.79), compared to women aged 20-29 years. Age is the most important factor associated with weight perceptions among Korean women, affecting both underestimation and overestimation of weight status.	[Park, Boyoung] Hanyang Univ, Coll Med, Dept Med, Seoul, South Korea; [Park, Boyoung; Cho, Ha Na; Choi, Eunji; Choi, Kui Son] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Seo, Da Hea] Inha Univ, Sch Med, Dept Endocrinol & Metab, Incheon, South Korea; [Kim, Sue] Yonsei Univ, Coll Nursing, Seoul, South Korea; [Park, Yeong-Ran] Kangnam Univ, Dept Silver Ind, Yongin, South Korea; [Rhee, Yumie] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Endocrine Res Inst, Seoul, South Korea	Hanyang University; National Cancer Center - Korea (NCC); Inha University; Yonsei University; Yonsei University Health System; Kangnam University; Yonsei University; Yonsei University Health System	Choi, KS (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.; Rhee, Y (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Endocrine Res Inst, Seoul, South Korea.	kschoi@ncc.re.kr; yumie@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Sue/AAB-4253-2021	Rhee, Yumie/0000-0003-4227-5638; Kim, Sue/0000-0003-3785-2445; Choi, Kui Son/0000-0001-5336-3874	Center for Disease Control and Prevention, Korea [2015ER630300]; National Cancer Center of Korea [1610401]	Center for Disease Control and Prevention, Korea; National Cancer Center of Korea	The study was funded from the Center for Disease Control and Prevention, Korea (http://www.cdc.go.kr/CDC/main.jsp) (2015ER630300), and the National Cancer Center of Korea (http://www.ncc.re.kr) (#1610401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern Amy L, 2008, Eat Disord, V16, P294, DOI 10.1080/10640260802115852; Alwan H, 2011, J OBES, V2011, DOI 10.1155/2011/817242; Bhanji S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-363; Brewis AA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22972; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Chisuwa-Hayami N, 2017, HEALTH PROMOT PERSPE, V7, P80, DOI 10.15171/hpp.2017.15; Cho HN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4531-1; Choi Y, 2015, J KOREAN MED SCI, V30, P1558, DOI 10.3346/jkms.2015.30.11.1558; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Committee S, 2000, AS PAC PERSP RED OB, P11; Craig BM, 2009, MATERN CHILD HLTH J, V13, P489, DOI 10.1007/s10995-008-0384-7; Daniels Judi, 2005, J Pediatr Health Care, V19, P33; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Fruh SM, 2016, JNP-J NURSE PRACT, V12, P425, DOI 10.1016/j.nurpra.2016.05.013; Gutierrez-Fisac JL, 2002, EUR J CLIN NUTR, V56, P866, DOI 10.1038/sj.ejcn.1601404; Ikeda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148297; Jeong JS, 2007, KOREAN J PREV MED PU, V40, P197, DOI DOI 10.3961/JPMPH.2007.40.3.197; Joh HK, 2013, OBESITY FACTS, V6, P17, DOI 10.1159/000346805; Johnson C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-005561, 10.1136/bmjopen-2014-006629]; Johnson F, 2008, BMJ-BRIT MED J, V337, pa494, DOI DOI 10.1136/BMJ.A494; Jung J, 2007, PSYCHOL WOMEN QUART, V31, P381, DOI 10.1111/j.1471-6402.2007.00387.x; Kang HT, 2014, J EPIDEMIOL, V24, P109, DOI 10.2188/jea.JE20130017; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim Dong-Sik, 2008, J Prev Med Public Health, V41, P323, DOI 10.3961/jpmph.2008.41.5.323; KIM JH, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-010183; Kim S, 2016, OBES RES CLIN PRACT, V14, P30030; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198841; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543; Monteagudo C, 2015, J NUTR HEALTH AGING, V19, P612, DOI 10.1007/s12603-015-0486-z; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Noh JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183881; Park B, 2011, J KOREAN MED SCI, V26, P711, DOI 10.3346/jkms.2011.26.6.711; Perloff RM, 2014, SEX ROLES, V71, P363, DOI 10.1007/s11199-014-0384-6; Pruis TA, 2010, J GEN PSYCHOL, V137, P225, DOI 10.1080/00221309.2010.484446; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Rahman M, 2010, OBSTET GYNECOL, V116, P1274, DOI 10.1097/AOG.0b013e3181fdfc47; Robertson A, 2014, APPETITE, V75, P157, DOI 10.1016/j.appet.2014.01.006; Rochelle TL, 2017, PSYCHOL HEALTH MED, V22, P310, DOI 10.1080/13548506.2016.1226507; RODIN M, 1989, PERS SOC PSYCHOL B, V15, P439, DOI 10.1177/0146167289153013; Shin Jaeyong, 2015, J Prev Med Public Health, V48, P94, DOI 10.3961/jpmph.14.055; Skeie G, 2015, CLIN EPIDEMIOL, V7, P313, DOI 10.2147/CLEP.S83839; Suh M, 2016, CANCER RES TREAT, V48, P1, DOI 10.4143/crt.2014.204; Talamayan KS, 2006, THESCIENTIFICWORLDJO, V6, P365, DOI 10.1100/tsw.2006.70; Tang Wesley, 2016, BMC Obes, V3, P11, DOI 10.1186/s40608-016-0088-2; Viner RM, 2006, INT J OBESITY, V30, P1514, DOI 10.1038/sj.ijo.0803352; Wang A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150070; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; World Health Organization, OB OV, DOI [10.3945/an.112.002063, DOI 10.3945/AN.112.002063]; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Yost J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-465	57	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210486	10.1371/journal.pone.0210486	http://dx.doi.org/10.1371/journal.pone.0210486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653596	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500042
J	He, J; Tang, F; Chen, DW; Yu, B; Luo, YH; Zheng, P; Mao, XB; Yu, J; Yu, F				He, Jun; Tang, Feng; Chen, Daiwen; Yu, Bing; Luo, Yuheng; Zheng, Ping; Mao, Xiangbing; Yu, Jie; Yu, Feng			Design, expression and functional characterization of a thermostable xylanase from Trichoderma reesei	PLOS ONE			English	Article							BACILLUS-CIRCULANS XYLANASE; MICROBIAL XYLANASES; THERMOTOGA-MARITIMA; DISULFIDE BRIDGE; RESIDUES; YEAST; GLYCOSYLATION; THERMOSTABILIZATION; IDENTIFICATION; OPTIMIZATION	Xylanases isolated from microorganisms such as the Trichoderma reesei have attracted considerable research interest because of their potential in various industrial applications. However, naturally isolated xylanases cannot withstand harsh conditions such as high temperature and basic pH. In this study, we performed structural analysis of the major T. reesei xylanase (Xyn2), and novel flexible regions of the enzyme were identified based on B-factor, a molecular dynamics (MD) parameter. To improve thermostability of the Xyn2, disulfide bonds were introduced into the unstable flexible region by using site-directed mutagenesis and two recombinant xylanases, XM1 (Xyn2(Cys12-52)) and XM2 (Xyn2(Cys59-149)) were successfully expressed in Pichia pastoris. Secreted recombinant Xyn2 was estimated by SDS-PAGE to be 24 kDa. Interestingly, the half-lives of XM1 and XM2 at 60 degrees C were 2.5- and 1.8-fold higher, respectively than those of native Xyn2. The XM1 also exhibited improved pH stability and maintained more than 60% activity over pH values ranging from 2.0 to 10.0. However, the specific activity and catalytic efficiency of XM1 was decreased as compared to those of XM2 and native Xyn2. Our results will assist not only in elucidating of the interactions between protein structure and function, but also in rational target selection for improving the thermostability of enzymes.	[He, Jun; Tang, Feng; Chen, Daiwen; Yu, Bing; Luo, Yuheng; Zheng, Ping; Mao, Xiangbing; Yu, Jie; Yu, Feng] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	He, J (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	hejun8067@163.com			Key Research and Development Program of Sichuan Province [2018NZDZX0005]; Fok Ying Tung Education Foundation [141027]; Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm	Key Research and Development Program of Sichuan Province; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm	JH: the Key Research and Development Program of Sichuan Province [2018NZDZX0005], and the Fok Ying Tung Education Foundation [no. 141027] to HJ.; This work was supported by the Key Research and Development Program of Sichuan Province [2018NZDZX0005], and the Fok Ying Tung Education Foundation [no. 141027], and Opening Grant of Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm.	Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Basu M, 2018, CURR PROTEIN PEPT SC, V19, P87, DOI 10.2174/1389203718666161122110200; Baweja M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00965; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bhardwaj A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011347; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BUCKHOLZ RG, 1991, BIO-TECHNOL, V9, P1067, DOI 10.1038/nbt1191-1067; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hamilton SR, 2015, METHODS MOL BIOL, V1321, P73, DOI 10.1007/978-1-4939-2760-9_6; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jiang ZQ, 2004, J BIOTECHNOL, V114, P125, DOI 10.1016/j.jbiotec.2004.05.007; Jiang ZQ, 2004, J MOL CATAL B-ENZYM, V27, P207, DOI 10.1016/j.molcatb.2003.11.012; Joo JC, 2011, J BIOTECHNOL, V151, P56, DOI 10.1016/j.jbiotec.2010.10.002; JUN H., 2010, BRIT J NUTR, V103, P1507, DOI [10.1016/j.jbiotec.2006.04.031, DOI 10.1016/J.JBIOTEC.2006.04.031]; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kumar V, 2018, MOL BIOTECHNOL, V60, P226, DOI 10.1007/s12033-018-0059-6; Kumar V, 2017, BIORESOURCE TECHNOL, V243, P1009, DOI 10.1016/j.biortech.2017.07.094; Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; MIAO SC, 1994, BIOCHEMISTRY-US, V33, P7027, DOI 10.1021/bi00189a002; Muta K, 2014, BIOCHEM PHARMACOL, V87, P352, DOI 10.1016/j.bcp.2013.10.001; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; PULS J, 1993, PORT PR R M, V4, P1; Roberge M, 1999, PROTEIN ENG, V12, P251, DOI 10.1093/protein/12.3.251; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Satyanarayana DVT, 2013, J IND MICROBIOL BIOT, V40, P1373, DOI 10.1007/s10295-013-1347-6; Seelhorst K, 2013, GLYCOBIOLOGY, V23, P559, DOI 10.1093/glycob/cws219; Sriprang R, 2006, J BIOTECHNOL, V126, P454, DOI 10.1016/j.jbiotec.2006.04.031; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; TORRONEN A, 1992, BIO-TECHNOL, V10, P1461, DOI 10.1038/nbt1192-1461; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yang HM, 2007, J IND MICROBIOL BIOT, V34, P213, DOI 10.1007/s10295-006-0188-y; Yang Hao-Meng, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P26, DOI 10.1016/S1872-2075(06)60003-4; Zhang HM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-3; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159	39	11	13	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210548	10.1371/journal.pone.0210548	http://dx.doi.org/10.1371/journal.pone.0210548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650138	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300060
J	Nash, M; Nielsen, HEF; Shaw, J; King, M; Lea, MA; Bax, N				Nash, Meredith; Nielsen, Hanne E. F.; Shaw, Justine; King, Matt; Lea, Mary-Anne; Bax, Narissa			"Antarctica just has this hero factor ... ": Gendered barriers to Australian Antarctic research and remote fieldwork	PLOS ONE			English	Article							SEXUAL-HARASSMENT; WOMEN; SCIENCE; EXPERIENCES; CONSTRUCTION; WORKING; FEMALE; QUEER	Antarctica is often associated with images of masculine figures battling against the blizzard. The pervasiveness of heroic white masculine leadership and exploration in Antarctica and, more broadly, in Science, Technology, Engineering, Mathematics, and Medicine (STEMM) research cultures, has meant women have had lesser access to Antarctic research and fieldwork opportunities, with a marked increase since the 1980s. This article presents findings from an exploratory online survey examining how 95 women experienced research and remote Antarctic fieldwork with the Australian Antarctic Program. Although women are entering polar science in greater numbers, a key theme of the qualitative findings of this survey is that gendered barriers to participation in research and fieldwork persist. We discuss five key gendered barriers including: 1) Physical barriers, 2) Caring responsibilities/unpaid work, 3) Cultural sexism/gender bias, 4) Lack of opportunities/recognition, and 5) Unwanted male attention/sexual harassment. We argue that the lack of attention paid to gender and sexuality in polar fieldwork contributes to the invisibility and exclusion of women and other marginalized identities broadly. To conclude, we point to the importance of targeted inclusivity, diversity and equity initiatives through Antarctic research globally and specifically by National Antarctic Programs.	[Nash, Meredith] Univ Tasmania, Sch Social Sci, Hobart, Tas, Australia; [Nielsen, Hanne E. F.] Univ Tasmania, Sch Humanities, Hobart, Tas, Australia; [Nielsen, Hanne E. F.; Lea, Mary-Anne; Bax, Narissa] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Shaw, Justine] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, St Lucia, Qld, Australia; [King, Matt] Univ Tasmania, Sch Technol Environm & Design, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Tasmania; University of Queensland; University of Tasmania	Nash, M (corresponding author), Univ Tasmania, Sch Social Sci, Hobart, Tas, Australia.	Meredith.Nash@utas.edu.au	Bax, Narissa/L-5771-2019; Nash, Meredith/O-6178-2019; Nash, Meredith/D-8217-2014; King, Matt/B-4622-2008; Lea, Mary-Anne/E-9054-2013; Nielsen, Hanne E F/I-4472-2014	Bax, Narissa/0000-0002-4338-1080; Nash, Meredith/0000-0002-7429-4924; Nash, Meredith/0000-0002-7429-4924; King, Matt/0000-0001-5611-9498; Lea, Mary-Anne/0000-0001-8318-9299; Nielsen, Hanne E F/0000-0002-2761-7727; Shaw, Justine/0000-0002-9603-2271	University of Tasmania, Antarctic and Maritime Research Theme grant; University of Tasmania Marine, Antarctic and Maritime Research Theme grant	University of Tasmania, Antarctic and Maritime Research Theme grant; University of Tasmania Marine, Antarctic and Maritime Research Theme grant	This research was funded by a University of Tasmania, Antarctic and Maritime Research Theme grant to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank our survey respondents for generously sharing their experiences. This work was supported by a University of Tasmania Marine, Antarctic and Maritime Research Theme grant.	Acker S, 2010, INT STUD SOCIOL EDUC, V20, P129, DOI 10.1080/09620214.2010.503062; [Anonymous], 1998, SPECTATOR, P7; Australian Antarctic Division, 2018, AUSTR ANT MED REC; Australian Antarctic Division, WOM IC FRONT; Australian Antarctic Division, 2015, ANT SERV COD PERS BE; Australian Antarctic Division, 2018, SCI PROJ; Australian Bureau of Statistics, 2013, 4125 0 GEND IND; Bell R.E., 2003, EOS T AM GEOPHYS UN, V84, P292, DOI [10.1029/2003EO310005, DOI 10.1029/2003EO310005]; Bell RE, 2017, SCIENCE, V358, P1223, DOI 10.1126/science.aar6134; Bloom Lisa, 1993, GENDER ICE AM IDEOLO; Boyle P, 2015, NATURE, V525, P181, DOI 10.1038/525181a; Bracken L, 2004, AREA, V36, P280, DOI 10.1111/j.0004-0894.2004.00225.x; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burns R., 2000, WOMENS STUDIES Q, V28, P104; Cannady MA, 2014, SCI EDUC, V98, P443, DOI 10.1002/sce.21108; Carey M, 2016, PROG HUM GEOG, V40, P770, DOI 10.1177/0309132515623368; Chipman E, 1986, WOMEN ICE HIST WOMEN; Clancy KBH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102172; Collis C, 2009, SIGNS, V34, P514, DOI 10.1086/593379; Cross Michael., 1991, NEW SCI; de Vries JA, 2015, EQUAL DIVERS INCL, V34, P21, DOI 10.1108/EDI-05-2013-0031; Ecklund EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036240; Edwards K, 1994, GENDER ON ICE, P6; Equality Challenge Unit, 2018, ATH SWAN CHART; Farley Rebecca, 2005, INT J CULTURAL STUD, V8, P231, DOI DOI 10.1177/1367877905052419; Flood M, 2008, MEN MASC, V10, P339, DOI 10.1177/1097184X06287761; Freund P., 1993, ECOLOGY AUTOMOBILE; Glasberg Elena, 2012, ANTARCTICA CULTURAL; Glick P, 2001, AM PSYCHOL, V56, P109, DOI 10.1037//0003-066X.56.2.109; Hanson R, 2017, SOCIOL FORUM, V32, P587, DOI 10.1111/socf.12350; Hare J., 2012, AUSTRALIAN; Holgersson C, 2013, GENDER WORK ORGAN, V20, P454, DOI 10.1111/j.1468-0432.2012.00595.x; Howkins A., 2010, ENV HIST, V12, P518; Howkins A, 2010, ENVIRON HIST-US, V15, P514, DOI 10.1093/envhis/emq060; Hunter LA, 2010, SOC STUD SCI, V40, P433, DOI 10.1177/0306312709358472; Inspiring Australia, 2018, INSP AUSTR STRAT; Jagsi R, 2018, NEW ENGL J MED, V378, P209, DOI 10.1056/NEJMp1715962; Kahn B., 2015, CAN SCI MAKE DIFFERE; Koren Marina, 2017, ATLANTIC; Land B., 1981, NEW EXPLORERS WOMEN; Lewander L, 2009, COLD MATTERS CULTURA, P89; Metcalf H., 2010, INTERACTIONS UCLA J, V6; Meyerson DE, 2000, HARVARD BUS REV, V78, P126; Mills JE., 2014, CHALLENGING KNOWLEDG; Morley L, 2016, J EDUC POLICY, V31, P28, DOI 10.1080/02680939.2015.1062919; Morley L, 2013, GENDER EDUC, V25, P116, DOI 10.1080/09540253.2012.740888; Nash M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185727; Nelson RG, 2017, AM ANTHROPOL, V119, P710, DOI 10.1111/aman.12929; O'Reilly J., 2017, TECHNOCRATIC ANTARCT; O'Reilly J., 2017, POLAR J, V7, P9, DOI DOI 10.1080/2154896X.2017.1325593; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Rosner Victoria, 1999, A B AUTO BIOGRAPHY S, V14, P5, DOI DOI 10.1080/08989575.1999.10846753; SAGE, 2018, GEDN EQ STEMM; Sarris A, 2017, ACTA ASTRONAUT, V131, P50, DOI 10.1016/j.actaastro.2016.11.020; Savigny H, 2014, GENDER EDUC, V26, P794, DOI 10.1080/09540253.2014.970977; Seag M., 2017, POLAR J, V7, P319, DOI DOI 10.1080/2154896X.2017.1373915; Silverschanz P, 2008, SEX ROLES, V58, P179, DOI 10.1007/s11199-007-9329-7; St John K., 2016, J GEOSCIENCE ED, V64, P255, DOI [10.5408/1089-9995-64.4.255, DOI 10.5408/1089-9995-64.4.255]; Strauss, 2015, BASICS QUALITATIVE R; Strugnell J, 2016, NATURE, V536, P148, DOI 10.1038/536148b; van der Lee R, 2015, P NATL ACAD SCI USA, V112, P12349, DOI 10.1073/pnas.1510159112; Waldo CR, 1999, J COUNS PSYCHOL, V46, P218, DOI 10.1037/0022-0167.46.2.218; Watts JH, 2007, WORK EMPLOY SOC, V21, P299, DOI 10.1177/0950017007076641; Wheeler S., 1997, TERRA INCOGNITA TRAV; White Kate., 2015, KEEPING WOMEN SCI; Yoder JB, 2016, J HOMOSEXUAL, V63, P1, DOI 10.1080/00918369.2015.1078632	66	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0209983	10.1371/journal.pone.0209983	http://dx.doi.org/10.1371/journal.pone.0209983			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH6BK	30650104	Green Published, gold, Green Accepted			2022-12-27	WOS:000455813300037
J	Liu, XM; Wiersma, RD				Liu, Xinmin; Wiersma, Rodney D.			Optimization based trajectory planning for real-time 6DoF robotic patient motion compensation systems	PLOS ONE			English	Article							VOLUMETRIC MODULATED ARC; ORGAN MOTION; QUALITY-ASSURANCE; TRACKING SYSTEM; TREATMENT COUCH; TUMOR TRACKING; RADIOTHERAPY; THERAPY; CANCER; HEAD	Purpose Robotic stabilization of a therapeutic radiation beam with respect to a dynamically moving tumor target can be accomplished either by moving the radiation source, the patient, or both. As the treatment beam is on during this process, the primary goal is to minimize exposure of normal tissue to radiation as much as possible when moving the target back to the desired position. Due to the complex mechanical structure of 6 degree-of-freedom (6DoF) robots, it is not intuitive as to what 6 dimensional (6D) correction trajectory is optimal in achieving such a goal. With proportional-integrative-derivative (PID) and other controls, the potential exists that the controller may generate a trajectory that is highly curved, slow, or suboptimal in that it leads to unnecessary exposure of healthy tissue to radiation. This work investigates a novel feedback planning method that takes into account a robot's mechanical joint structure, patient safety tolerances, and other system constraints, and performs real-time optimization to search the entire 6D trajectory space in each time cycle so it can respond with an optimal 6D correction trajectory. Methods Computer simulations were created for two 6DoF robotic patient support systems: a Stewart-Gough platform for moving a patient's head in frameless maskless stereotactic radiosurgery, and a linear accelerator treatment table for moving a patient in prostate cancer radiation therapy. Motion planning was formulated as an optimization problem and solved at real-time speeds using the L-BFGS algorithm. Three planning methods were investigated, moving the platform as fast as possible (platform-D), moving the target along a straight-line (target-S), and moving the target based on the fastest descent of position error (target-D). Both synthetic motion and prior recorded human motion were used as input data and output results were analyzed. Results For randomly generated 6D step-like and sinusoidal synthetic input motion, target-D planning demonstrated the smallest net trajectory error in all cases. On average, optimal planning was found to have a 45% smaller target trajectory error than platform-D control, and a 44% smaller target trajectory error than target-S planning. For patient head motion compensation, only target-D planning was able to maintain a <= 0.5mm and <= 0.5deg clinical tolerance objective for 100% of the treatment time. For prostate motion, both target-S planning and target-D planning outperformed platform-D control. Conclusions A general 6D target trajectory optimization framework for robotic patient motion compensation systems was investigated. The method was found to be flexible as it allows control over various performance requirements such as mechanical limits, velocities, acceleration, or other system control objectives.	[Liu, Xinmin; Wiersma, Rodney D.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	University of Chicago	Wiersma, RD (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	rwiersma@uchicago.edu		Wiersma, Rodney/0000-0002-7279-5813	American Cancer Society [RSG-13-313-01-CCE]; National Cancer Institute [1R01CA227124]; NATIONAL CANCER INSTITUTE [R01CA227124] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society (RSG-13-313-01-CCE) and the National Cancer Institute (1R01CA227124). There was no additional external funding received for this study.	Alnaghy S, 2018, MED PHYS, V45, pE682; Belcher A., 2017, THESIS; Belcher AH, 2016, MED PHYS, V43, P2785, DOI 10.1118/1.4948506; Belcher AH, 2014, MED PHYS, V41, DOI 10.1118/1.4900828; Buzurovic I, 2011, PHYS MED BIOL, V56, P1299, DOI 10.1088/0031-9155/56/5/005; Buzurovic I. M., 2012, Proceedings of the 2012 IEEE 16th International Conference on Intelligent Engineering Systems (INES), P45, DOI 10.1109/INES.2012.6249877; D'Souza WD, 2005, PHYS MED BIOL, V50, P4021, DOI 10.1088/0031-9155/50/17/007; DAVIES SC, 1994, BRIT J RADIOL, V67, P1096, DOI 10.1259/0007-1285-67-803-1096; Deodato F, 2014, CLIN ONCOL-UK, V26, P748, DOI 10.1016/j.clon.2014.08.005; Fougner C, 2015, PARAMETER SELECTION; Guckenberger M, 2011, INT J RADIAT ONCOL, V79, P901, DOI 10.1016/j.ijrobp.2010.04.050; Haas OCL, 2012, PHYS MED BIOL, V57, P5787, DOI 10.1088/0031-9155/57/18/5787; Herrmann C, 2011, 18 IFAC WORLD C, V44, P5968, DOI [DOI 10.3182/20110828-6-IT-1002.00342, 10.3182/20110828-6-IT-1002.00342]; Kim DJW, 2001, INT J RADIAT ONCOL, V49, P43, DOI 10.1016/S0360-3016(00)01372-9; Kubo HD, 1996, PHYS MED BIOL, V41, P83, DOI 10.1088/0031-9155/41/1/007; Kuo YC, 2006, AM J CLIN ONCOL-CANC, V29, P600, DOI 10.1097/01.coc.0000239093.95769.b3; Lang S, 2014, MED PHYS, V41, DOI 10.1118/1.4862077; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Liu X, 2015 AM CONTR C ACC; Liu XM, 2017, MED PHYS, V44, P1246, DOI 10.1002/mp.12165; Liu XM, 2016, P AMER CONTR CONF, P5599, DOI 10.1109/ACC.2016.7526548; Liu XM, 2015, MED PHYS, V42, P2757, DOI 10.1118/1.4919279; Lohr F, 1999, INT J RADIAT ONCOL, V45, P521, DOI 10.1016/S0360-3016(99)00190-X; Morales JL, 2011, ACM T MATH SOFTWARE, V38, DOI 10.1145/2049662.2049669; Mancosu P, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150468; Men CH, 2010, PHYS MED BIOL, V55, P4309, DOI 10.1088/0031-9155/55/15/008; Menten MJ, 2012, MED PHYS, V39, P7032, DOI 10.1118/1.4761868; Murphy MJ, 2004, SEMIN RADIAT ONCOL, V14, P91, DOI 10.1053/j.semradonc.2003.10.005; Nguyen DT, 2017, RADIOTHER ONCOL, V123, P37, DOI 10.1016/j.radonc.2017.02.013; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Parikh N, 2014, MATH PROGRAM COMPUT, V6, P77, DOI 10.1007/s12532-013-0061-8; Redpath AT, 2008, ACTA ONCOL, V47, P1367, DOI 10.1080/02841860802263232; Riaz N, 2009, PHYS MED BIOL, V54, P5735, DOI 10.1088/0031-9155/54/19/005; Roper J, 2015, INT J RADIAT ONCOL, V93, P540, DOI 10.1016/j.ijrobp.2015.07.2262; ROSS CS, 1990, INT J RADIAT ONCOL, V18, P671, DOI 10.1016/0360-3016(90)90076-V; Schmidhalter D, 2013, MED PHYS, V40, DOI 10.1118/1.4823789; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; van de Bunt L, 2006, INT J RADIAT ONCOL, V64, P189, DOI 10.1016/j.ijrobp.2005.04.025; Wang H, 2008, INT J RADIAT ONCOL, V71, P1261, DOI 10.1016/j.ijrobp.2008.02.074; Wiersma RD, 2008, MED PHYS, V35, P1191, DOI 10.1118/1.2842072; Wiersma RD, 2009, PHYS MED BIOL, V54, P89, DOI 10.1088/0031-9155/54/1/006; Wiersma RD, 2016, MED PHYS, V43, P2802, DOI 10.1118/1.4948500; Wiersma RD, 2013, MED PHYS, V40, DOI 10.1118/1.4823757; Wilbert J, 2008, MED PHYS, V35, P3911, DOI 10.1118/1.2964090; Winey B, 2014, J APPL CLIN MED PHYS, V15, P122, DOI 10.1120/jacmp.v15i3.4668; Yan D, 2008, INT J RADIAT ONCOL, V71, pS28, DOI 10.1016/j.ijrobp.2007.08.082	46	10	11	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210385	10.1371/journal.pone.0210385	http://dx.doi.org/10.1371/journal.pone.0210385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633766	Green Published, gold, Green Submitted			2022-12-27	WOS:000455485100022
J	Sturesson, L; Ohlander, M; Nilsson, G; Stenfors, T				Sturesson, Linda; Ohlander, Magnus; Nilsson, Gunnar; Stenfors, Terese			Migrant physicians' conceptions of working in rural and remote areas in Sweden: A qualitative study	PLOS ONE			English	Article							REPRESENTATIONS; COUNTRYSIDE; CARE	Objective To explore migrant physicians' conceptions about working in rural and remote areas in Sweden to understand what influences their motivation to work in these areas. Method and material The study employed a qualitative approach with semi-structured interviews with 24 migrant physicians. Transcripts were thematically analysed. Results Conceptions were identified about foremost work content and tasks, and about living in rural and remote areas. Work content and tasks related to the health care systems, type of health care facility, duties, specialty, resources, patient population, colleagues, and professional development. Conceptions about living concerned geographical characteristics, people living in rural and remote areas, opportunities for travelling, family, leisure activities, social life, and language skills. Conceptions seemed to be influenced by individual, professional and societal aspects from both previous countries and Sweden. Conceptions and biographical aspects both appeared to affect motivation. Discussion Motivation regarding working in rural and remote areas appeared to be influenced by conceptions of these areas. A specific type of place could be understood as being able to provide (or not) the external conditions needed for fulfilling needs and reaching goals, whether professional or personal, and as a tool for reaching or facilitating the achievement of these. Conceptions of an area can hence affect motivation and choices for where to work and live. However, biographical aspects also impact motivation. Our results indicate that positive rural experience in the recipient country might be a predictor for motivation. Conclusion Professional and personal life and are intertwined. Conceptions about an area influence willingness to work there. Willingness is also affected by, and intertwined with, other aspects such as previous experiences, age, marital status and family circumstances.	[Sturesson, Linda; Stenfors, Terese] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Ohlander, Magnus] Stockholm Univ, Dept Ethnol Hist Relig & Gender Studies, Stockholm, Sweden; [Nilsson, Gunnar] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Sturesson, L (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden.	linda.sturesson@ki.se	Stabel, Linda Sturesson/AAL-7569-2021; Stenfors, Terese/D-7307-2016	Stabel, Linda Sturesson/0000-0001-9683-3485; Stenfors, Terese/0000-0002-0854-8631; Ohlander, Magnus/0000-0002-0712-0123	Kamprad Family Foundation for Entrepreneurship, Research Charity [20170068]	Kamprad Family Foundation for Entrepreneurship, Research Charity	This work was supported by The Kamprad Family Foundation for Entrepreneurship, Research & Charity, grant number 20170068 to TS and LS, http://familjenkampradsstiftelse.se/.The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, Lakartidningen, V63, P10; [Anonymous], 2017, FOLKM RIK LAN OCH KO; Asghari S, 2017, CAN J RURAL MED, V22, P92; Baylina M, 2010, EUR URBAN REG STUD, V17, P277, DOI 10.1177/0969776409356215; Bell MM, 2010, SOCIOL RURALIS, V50, P199, DOI 10.1111/j.1467-9523.2010.00518.x; Bosco C, 2016, REV FAMILY MED RURAL; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Chuenkongkaew WL, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0719-9; Covell CL, 2016, HUM RESOUR HEALTH, V14, P12, DOI [10.1186/s12960-016-0108-9, DOI 10.1186/S12960-016-0108-9]; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Egnell A, 2014, STAFETTLAKARE RADDAR; Gheasi M, 2017, ECONOMIES, V5, DOI 10.3390/economies5030031; Halfacree KH, 2012, SOCIOL RURALIS, V52, P92, DOI 10.1111/j.1467-9523.2011.00556.x; HALFACREE KH, 1995, J RURAL STUD, V11, P1, DOI 10.1016/0743-0167(94)00039-C; Hall S., 1997, REPRESENTATION CULTU; Hansson G, 2011, ARBETSKRAFTSFORSORJN; Henrik Tynelius UB, 2008, LANDSBYGDSDEFINITION; ?hlander, 2018, HOGUTBILDADE MIGRANT; Lineberry M, 2015, MED EDUC, V49, P863, DOI 10.1111/medu.12766; MacQueen IT, 2018, J GEN INTERN MED, V33, P191, DOI 10.1007/s11606-017-4210-z; Malau-Aduli BS, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-40; Michalski K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181330; Mick SS, 1999, J RURAL HEALTH, V15, P26, DOI 10.1111/j.1748-0361.1999.tb00596.x; Morrow G, 2013, MED TEACH, V35, pE1537, DOI 10.3109/0142159X.2013.802298; Parlier AB, 2018, ACAD MED, V93, P130, DOI 10.1097/ACM.0000000000001839; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Povrzanovic-Frykman M., 2018, HOGUTBILDADE MIGRANT, P171; Ritchie J, 2007, CARRYING OUT QUALITA; Ruiz J.R., 2009, FORUM QUALITATIVE SO, V10; Skjeggestad E, 2017, PATIENT EDUC COUNS, V100, P1466, DOI 10.1016/j.pec.2017.03.007; Svanstrom S, 2015, URBANISERING LAND ST; Terry DR, 2021, AUST J RURAL HEALTH, V29, P549, DOI 10.1111/ajr.12128; The College of Family Physicians of Canada, 2017, SUMM IMPR HLTH CAR A; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wenghofer EF, 2011, RURAL REMOTE HEALTH, V11, P11; Wolanik Bostrom KO.W M, 2012, 1102012 COMCAD; Wright A, 2012, RURAL REMOTE HEALTH, V12	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210598	10.1371/journal.pone.0210598	http://dx.doi.org/10.1371/journal.pone.0210598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640965	Green Published, Green Submitted, gold			2022-12-27	WOS:000455808000035
J	Blennow, K; Persson, E; Persson, J				Blennow, Kristina; Persson, Erik; Persson, Johannes			Are values related to culture, identity, community cohesion and sense of place the values most vulnerable to climate change?	PLOS ONE			English	Article							SEA-LEVEL RISE; ECOSYSTEM SERVICES; LOCAL VALUES; R PACKAGE; PERCEPTIONS; ADAPTATION; VALUATION; RESPONSES; SCIENCE; MODELS	Values related to culture, identity, community cohesion and sense of place have sometimes been downplayed in the climate change discourse. However, they have been suggested to be not only important to citizens but the values most vulnerable to climate change. Here we test four empirical consequences of the suggestion: (i) at least 50% of the locations citizens' consider to be the most important locations in their municipality are chosen because they represent these values, (ii) locations representing these values have a high probability of being damaged by climate change induced sea level rise, (iii) citizens for which these values are particularly strongly held less strongly believe in the local effects of climate change, and (iv) citizens for which these values are particularly strongly held less strongly believe that they have experienced the effects of climate change. The tests were made using survey data collected in 2014 from 326 citizens owning property in Hoganas municipality, Sweden, and included values elicited using a new methodology separating instrumental values from end values, and using the former (which strictly speaking should be seen as estimates of usefulness rather than as aims in themselves) as stepping stones to pinpoint the latter, that represent the true interests of the respondents. The results provide the first evidence that, albeit frequent, values related to culture, identity, community cohesion and sense of place are not the values most vulnerable to climate change. This in turn indicates a need to further investigate the vulnerability of these values to climate change, using a methodology that clearly distinguishes between instrumental and end values.	[Blennow, Kristina; Persson, Erik] Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden; [Persson, Johannes] Lund Univ, Dept Philosophy, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Blennow, K (corresponding author), Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden.	Kristina.Blennow@slu.se	Blennow, Kristina/D-7388-2016	Blennow, Kristina/0000-0002-7602-5322; Persson, Erik/0000-0002-5000-948X; Persson, Johannes/0000-0003-4568-1850	Myndigheten for Samhallsskydd och Beredskap [2011-243]; Riksbankens Jubileumsfond [M14-0138:1]; Svenska Forskningsradet Formas	Myndigheten for Samhallsskydd och Beredskap; Riksbankens Jubileumsfond; Svenska Forskningsradet Formas(Swedish Research Council Formas)	This work was supported by Myndigheten for Samhallsskydd och Beredskap, grant 2011-243, https://www.msb.se/; Riksbankens Jubileumsfond, M14-0138: 1, http://www.rj.se/; Svenska Forskningsradet Formas, http://www.formas.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2013, NAT CLIM CHANGE, V3, P112, DOI [10.1038/NCLIMATE1666, 10.1038/nclimate1666]; Adger WN, 2010, CLIMATE CHANGE SCI P; Blennow K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155137; Blennow K, 2014, FORESTRY, V87, P219, DOI 10.1093/forestry/cpt032; Blennow K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050182; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; BRUUN P, 1988, J COASTAL RES, V4, P627; Carlsson-Kanyama A, 2012, FOIR3441SE SWED DEF; Chee YE, 2004, BIOL CONSERV, V120, P549, DOI 10.1016/j.biocon.2004.03.028; DAVIDSON D, 1963, J PHILOS, V60, P685, DOI 10.2307/2023177; de Bruin Waendi Bruine, 2014, Environment Systems & Decisions, V34, P591, DOI 10.1007/s10669-014-9513-6; de Leeuw J, 2006, STAT SOC BEHAV SCI, P107; DHI, 2013, OV KLIM HOG KOMM AVS; Garrod G., 1999, EC VALATION ENV; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Graham S, 2018, WORLD DEV, V108, P332, DOI 10.1016/j.worlddev.2017.12.008; Graham S, 2014, GLOBAL ENVIRON CHANG, V29, P41, DOI 10.1016/j.gloenvcha.2014.07.013; Harvatt J, 2011, J RISK RES, V14, P63, DOI 10.1080/13669877.2010.503935; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hothorn T, LAB RECURSIVE PARTYT; Hume D., 1777, ENQUIRIES HUMAN UNDE, V3rd; IPBES, 2015, PREL GUID REG DIV CO; Janitza S, 2016, COMPUT STAT DATA AN, V96, P57, DOI 10.1016/j.csda.2015.10.005; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; LimeSurvey Project Team, 2015, LIMESURVEY OP SOURC; Mair P, 2010, J STAT SOFTW, V32, P1; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Meyer D, 2006, J STAT SOFTW, V17, P1, DOI [DOI 10.18637/JSS.V017.I03, 10.18637/jss.v017.i03]; Midgley PM, MANAGING RISKS EXTRE; Mortreux C, 2009, GLOBAL ENVIRON CHANG, V19, P105, DOI 10.1016/j.gloenvcha.2008.09.006; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; O'Brien KL, 2010, WIRES CLIM CHANGE, V1, P232, DOI 10.1002/wcc.30; O'Brien KL, 2009, ADAPTING TO CLIMATE CHANGE: THRESHOLDS, VALUES, GOVERNANCE, P164; ONeil R, 1997, ENVIRON ETHICS, V19, P45, DOI 10.5840/enviroethics199719138; ONEILL J, 1992, MONIST, V75, P119, DOI 10.5840/monist19927527; Persson E., 2008, THESIS; POULTON EC, 1968, PSYCHOL BULL, V69, P1, DOI 10.1037/h0025267; R CORE TEAM, 2016, R LANG ENV STAT COMP; Rabinowicz Wlodek, 1999, P AR SOC, V20, P20; Raymond CM, 2011, CLIMATIC CHANGE, V104, P653, DOI 10.1007/s10584-010-9806-9; Rulleau B, 2015, J ENVIRON PLANN MAN, V58, P482, DOI 10.1080/09640568.2013.862492; Sagiv L, 2017, NAT HUM BEHAV, V1, P630, DOI 10.1038/s41562-017-0185-3; SGU, SKAN ER GEOL MAP TOO; Sieber R, 2006, ANN ASSOC AM GEOGR, V96, P491, DOI 10.1111/j.1467-8306.2006.00702.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Thomas M, 2015, GLOBAL ENVIRON CHANG, V33, P71, DOI 10.1016/j.gloenvcha.2015.04.009; Wallace KJ, 2007, BIOL CONSERV, V139, P235, DOI 10.1016/j.biocon.2007.07.015; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Wilson MA, 2002, ECOL ECON, V41, P431, DOI 10.1016/S0921-8009(02)00092-7	55	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210426	10.1371/journal.pone.0210426	http://dx.doi.org/10.1371/journal.pone.0210426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629690	Green Published, gold			2022-12-27	WOS:000455483000088
J	Lee, RT; Perez, AD; Boykin, CM; Mendoza-Denton, R				Lee, Randy T.; Perez, Amanda D.; Boykin, C. Malik; Mendoza-Denton, Rodolfo			On the prevalence of racial discrimination in the United States	PLOS ONE			English	Article							PERCEIVED DISCRIMINATION; HEALTH; RACE; EXPERIENCES; DISPARITIES	Boutwell, Nedelec, Winegard, Shackelford, Beaver, Vaughn, Barnes, & Wright (2017) published an article in this journal that interprets data from the Add Health dataset as showing that only one-quarter of individuals in the United States experience discrimination. In Study 1, we attempted to replicate Boutwell et al.'s findings using a more direct measure of discrimination. Using data from the Pew Research Center, we examined a large sample of American respondents (N = 3,716) and explored the prevalence of discrimination experiences among various racial groups. Our findings stand in contrast to Boutwell et al.'s estimates, revealing that between 50% and 75% of Black, Hispanic, and Asian respondents (depending on the group and analytic approach) reported discriminatory treatment. In Study 2, we explored whether question framing affected how participants responded to Boutwell's question about experiencing less respect and courtesy. Regardless of question framing, non-White participants reported more experiences than White participants. Further, there was an interaction of participant race and question framing such that when participants were asked about experiences of less respect or courtesy broadly, there were no differences between non-White participants and White participants, but when they were asked about experiences that were specifically race-based, non-White participants reported more experiences than White participants. The current research provides a counterweight to the claim that discrimination is not a prevalent feature of the lives of minority groups and the serious implications this claim poses for research and public policy.	[Lee, Randy T.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Perez, Amanda D.; Mendoza-Denton, Rodolfo] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Boykin, C. Malik] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Cornell University; University of California System; University of California Berkeley; Brown University	Lee, RT (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	TL729@cornell.edu		Lee, Randy/0000-0003-3396-858X	National Science Foundation [1647273]; National Science Foundation Graduate Research Fellowship; Ford Foundation Fellowship	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ford Foundation Fellowship	This research is supported by the National Science Foundation (nsf.gov) under Award Number 1647273. Amanda D. Perez was supported by a National Science Foundation Graduate Research Fellowship and C. Malik Boykin was supported by a Ford Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the Ford Foundation.	Airaksinen Toni, 2017, CAMPUS REFORM; Allen AM, 2019, PSYCHONEUROENDOCRINO, V99, P225, DOI 10.1016/j.psyneuen.2018.09.001; [Anonymous], 2016, PEW RES CTR SOCIAL D; Bandler A., 2017, DAILY WIRE; Bartlett R, 2017, SSRN ELECT J; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Boutwell BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183356; Brown TN, 2001, SOCIOL SPECTRUM, V21, P377, DOI 10.1080/027321701300202046; Casey L., 2018, DISCRIMINATION AM EX; Chae DH, 2008, AM J PUBLIC HEALTH, V98, P485, DOI 10.2105/AJPH.2006.102012; Chou T, 2012, CULT DIVERS ETHN MIN, V18, P74, DOI 10.1037/a0025432; Christakis N. A., 2017, AM ALL RACES REPORT; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; CROSBY F, 1984, AM BEHAV SCI, V27, P371, DOI 10.1177/000276484027003008; Darity WA, 1998, J ECON PERSPECT, V12, P63, DOI 10.1257/jep.12.2.63; Dolezsar CM, 2014, HEALTH PSYCHOL, V33, P20, DOI 10.1037/a0033718; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Einstein KL, 2017, AM J POLIT SCI, V61, P100, DOI 10.1111/ajps.12252; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Everett BG, 2016, POPUL RES POLICY REV, V35, P445, DOI 10.1007/s11113-016-9391-3; Gallatin T., 2017, THE PATRIOT POST; Harris KM, 2006, TWIN RES HUM GENET, V9, P988, DOI 10.1375/183242706779462787; Kaiser CR, 2006, LAW SOCIAL INQUIRY, V31, P801, DOI 10.1111/j.1747-4469.2006.00036.x; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krueger A., 2006, AM LAW ECON REV, V8, P282, DOI [10.1093/aler/ahl004, DOI 10.1093/ALER/AHL004]; Kutateladze BL, 2014, CRIMINOLOGY, V52, P514, DOI 10.1111/1745-9125.12047; Landale NS, 2017, SOC SCI RES, V67, P34, DOI 10.1016/j.ssresearch.2017.05.003; Lee Jussim, 2017, MAYBE LESS OFTEN ARG; Leitner JB, 2016, PSYCHOL SCI, V27, P1299, DOI 10.1177/0956797616658450; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Lippi-Green Rosina, 2012, ENGLISH ACCENT; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; National Public Radio Robert Wood Johnson Foundation Harvard T. H. Chan School of Public Health, 2017, DISCR AM EXP VIEWS A; Quillian L, 2017, P NATL ACAD SCI USA, DOI [10.1177/0956797616658450, DOI 10.1177/0956797616658450]; Reskin B, 2012, ANNU REV SOCIOL, V38, P17, DOI 10.1146/annurev-soc-071811-145508; Saguy T, 2009, PSYCHOL SCI, V20, P114, DOI 10.1111/j.1467-9280.2008.02261.x; Shermer M., 2017, NEW PLOS STUDY N 14; TAYLOR DM, 1990, PERS SOC PSYCHOL B, V16, P254, DOI 10.1177/0146167290162006; Thrasher AD, 2012, J AGING HEALTH, V24, P1018, DOI 10.1177/0898264312440322; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002; Yoo HC, 2009, SOC SCI MED, V68, P726, DOI 10.1016/j.socscimed.2008.11.013	45	103	103	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210698	10.1371/journal.pone.0210698	http://dx.doi.org/10.1371/journal.pone.0210698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629706	Green Published, gold			2022-12-27	WOS:000455483000125
J	Kwon, JS; Lee, MJ; Kim, JY; Kim, D; Ryu, JH; Jang, S; Kim, KM; Hwang, CJ; Choi, SH				Kwon, Jae-Sung; Lee, Myung-Jin; Kim, Ji-Young; Kim, Dohyun; Ryu, Jeong-Hyun; Jang, Sungil; Kim, Kwang-Mahn; Hwang, Chung-Ju; Choi, Sung-Hwan			Novel anti-biofouling bioactive calcium silicate-based cement containing 2-methacryloyloxyethyl phosphorylcholine	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; ENTEROCOCCUS-FAECALIS; ENDODONTIC CEMENTS; PROTEIN-REPELLENT; FORMING ABILITY; ADHESIVE; BIOFILMS; CARIES; MTA	Calcium silicate-based cements (CSCs) are commonly used for endodontic procedures; however, their antibacterial effects are limited. The objective of this study was to develop a 2-methacryloyloxyethyl phosphorylcholine (MPC)-incorporated CSC with improved antibacterial properties, while maintaining the original advantageous features of CSC. MPC was incorporated into a commercial CSC (Endocem MTA) at 0 wt% (control), 1.5%, 3.0 wt%, 5.0 wt%, 7.5 wt%, and 10 wt%. The setting time, compressive strength, water sorption, and glycerol contact angle were measured. Protein absorption was measured and bacterial adhesion on the surface was evaluated using Enterococcus faecalis. The bactericidal effect was examined by the disc diffusion test. Mineralization ability was assessed based on calcium ion deposition, as assessed by alizarin red staining, after immersion into Hank's balanced salt solution for 7 days. High concentrations of MPC in CSC (7.5 wt% and 10 wt%) increased the setting time, reduced compressive strength, and reduced wettability. MPC (3 wt%) had greater protein repellent and anti-biofouling effects than those of control and test materials (P < 0.001). However, no bactericidal effect was observed for any control or test materials. There was greater calcium ion deposition on the surface of MPC-supplemented CSC than on the control (P < 0.001). The addition of 3 wt% MPC polymer to CSC confers protein-repellent properties and reduced bacterial attachment, with the potential for improved mineralization.	[Kwon, Jae-Sung; Lee, Myung-Jin; Ryu, Jeong-Hyun; Kim, Kwang-Mahn] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul, South Korea; [Kim, Ji-Young; Hwang, Chung-Ju; Choi, Sung-Hwan] Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea; [Kim, Dohyun] Yonsei Univ, Coll Dent, Dept Conservat Dent, Seoul, South Korea; [Ryu, Jeong-Hyun; Jang, Sungil] Yonsei Univ, Coll Dent, BK21 PLUS Project, Seoul, South Korea; [Jang, Sungil] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, SH (corresponding author), Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea.	selfexam@yuhs.ac	Kim, Dohyun/ABG-2808-2020; Choi, Sung-Hwan/T-6925-2019; Kwon, Jae-Sung/M-5430-2018	Kim, Dohyun/0000-0002-0772-6985; Choi, Sung-Hwan/0000-0002-1150-0268; Kim, Ji-Yeong/0000-0002-8920-5170; KIM, KWANG-MAHN/0000-0002-5235-0294; Kwon, Jae-Sung/0000-0001-9803-7730; Hwang, Chung-Ju/0000-0003-3024-4551; Jang, Sungil/0000-0001-6144-6899	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2018R1C1B6000989]; Yonsei University College of Dentistry [6-2018-0021]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Yonsei University College of Dentistry	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT & Future Planning (NRF-2018R1C1B6000989) and Yonsei University College of Dentistry (6-2018-0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 99171 ISO; Biocanin V, 2018, J ENDODONT, V44, P816, DOI 10.1016/j.joen.2017.09.022; Bjorndal L, 2010, EUR J ORAL SCI, V118, P290, DOI 10.1111/j.1600-0722.2010.00731.x; Choi Y, 2013, J ENDODONT, V39, P467, DOI 10.1016/j.joen.2012.11.023; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x; Gandolfi MG, 2013, J BIOMED MATER RES B, V101, P1107, DOI 10.1002/jbm.b.32920; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; Hubble TS, 2003, ORAL MICROBIOL IMMUN, V18, P121, DOI 10.1034/j.1399-302X.2003.00059.x; Hung CJ, 2014, J DENT SCI, V9, P158, DOI 10.1016/j.jds.2013.08.002; International Organization for Standardization, 2012, 68762020 ISO; Jang Ga-Yeon, 2013, Restor Dent Endod, V38, P248, DOI 10.5395/rde.2013.38.4.248; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Kim RJY, 2015, ARCH ORAL BIOL, V60, P1497, DOI 10.1016/j.archoralbio.2015.07.014; Lai WY, 2015, MATERIALS, V8, P4491, DOI 10.3390/ma8074491; LEE SJ, 1993, J ENDODONT, V19, P541, DOI 10.1016/S0099-2399(06)81282-3; Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6; Loison-Robert LS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190014; Moro T, 2009, BIOMATERIALS, V30, P2995, DOI 10.1016/j.biomaterials.2009.02.020; Parirokh M, 2018, INT ENDOD J, V51, P177, DOI 10.1111/iej.12841; Shin M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2071247; Shinohara MS, 2009, DENT MATER, V25, P1383, DOI 10.1016/j.dental.2009.06.011; Siboni F, 2017, INT ENDOD J, V50, pE83, DOI 10.1111/iej.12787; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Torabinejad M, 2018, INT ENDOD J, V51, P284, DOI 10.1111/iej.12843; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2; Tran XV, 2012, J DENT RES, V91, P1166, DOI 10.1177/0022034512460833; Turkcan I, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6116-7; Weng YM, 2012, J MATER SCI-MATER M, V23, P1553, DOI 10.1007/s10856-012-4629-z; Yang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112549; Yassen GH, 2015, J ENDODONT, V41, P956, DOI 10.1016/j.joen.2015.02.023; Yildirim T, 2005, ORAL SURG ORAL MED O, V100, P120, DOI 10.1016/j.tripleo.2004.09.017; Zhang N, 2015, DENT MATER, V31, P1119, DOI 10.1016/j.dental.2015.06.010; Zhang N, 2015, J DENT, V43, P225, DOI 10.1016/j.jdent.2014.11.008; Zhang N, 2014, J DENT, V42, P1284, DOI 10.1016/j.jdent.2014.07.016	35	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0211007	10.1371/journal.pone.0211007	http://dx.doi.org/10.1371/journal.pone.0211007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653611	gold, Green Submitted, Green Published			2022-12-27	WOS:000456015500097
J	Balde, A; Lang, S; Wagner, A; Ferrieres, J; Montaye, M; Tattevin, P; Cotte, L; Aslangul, E; Bidegain, F; Cheret, A; Mary-Krause, M; Meynard, JL; Molina, JM; Partisani, M; Roger, PM; Boccara, F; Costagliola, D				Balde, Aliou; Lang, Sylvie; Wagner, Aline; Ferrieres, Jean; Montaye, Michele; Tattevin, Pierre; Cotte, Laurent; Aslangul, Elisabeth; Bidegain, Frederic; Cheret, Antoine; Mary-Krause, Murielle; Meynard, Jean-Luc; Molina, Jean-Michel; Partisani, Marialuisa; Roger, Pierre-Marie; Boccara, Franck; Costagliola, Dominique			Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status	PLOS ONE			English	Article							FRENCH-HOSPITAL-DATABASE; CORONARY-HEART-DISEASE; HIV-INFECTION; ANTIRETROVIRAL DRUGS; IMMUNODEFICIENCY; AIDS; AGE; DIAGNOSIS; CANCER; ACCESS	We examined trends in the MI incidence and age at MI diagnosis among adults living with HIV-1 between 2000 and 2009, by comparison with the French MI registries, by gender. Age standardized incidence rates and standardized incidence-ratios (SIRs) were estimated for individuals included in the French hospital database on HIV (n = 71 204, MI = 663) during three periods: 2000-2002, 2003-2005 and 2006-2009. Median ages at MI diagnosis were compared using the Brown-Mood test. Over the study periods, the absolute rate difference and relative risks were higher in women than in men in 2000- 2002 and 2006-2009, with respective SIRs 1.99 (1.39-2.75) and 1.12 (0.99-1.27) in 2006-2009. The trends were different for men and women with a decreasing trend in SIRs in men and no change in women. In both sexes, among individuals with CD4 >= 500/mu L and controlled viral-load on cART, the risk was no longer elevated. Age at MI diagnosis was significantly younger than in the general population, especially among women (-6.2 years, p<0.001; men: -2.1 years, p = 0.02). In HIV-1-positive adults, absolute rate difference and relative risks and trends of MI were different between men and women and there was no additional risk among individuals on effective cART.	[Balde, Aliou; Lang, Sylvie; Mary-Krause, Murielle; Costagliola, Dominique] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, Paris, France; [Wagner, Aline] Univ Strasbourg, Lab Epidemiol & Sante Publ, Strasbourg, France; [Ferrieres, Jean] Univ Toulouse, CHU Rangueil, Serv Cardiol B, Toulouse, France; [Montaye, Michele] Univ Lille, CHU Lille, Inst Pasteur Lille, INSERM, Lille, France; [Tattevin, Pierre] Hop Univ Pontchaillou, Serv Malad Infect, Rennes, France; [Tattevin, Pierre] USI, Rennes, France; [Cotte, Laurent] Hosp Civils Lyon, Hop Croix Rousse, INSERM, U1052,Serv Malad Infect & Trop, Lyon, France; [Aslangul, Elisabeth] Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, AP HP,Serv Med Interne, Paris, France; [Bidegain, Frederic] Hop Avicenne, AP HP, Serv Malad Infect, Bobigny, France; [Cheret, Antoine] Univ Paris 05, Sorbonne Paris Cite, Ctr Hosp Tourcoing, Serv Malad Infect, Tourcoing, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, Paris, France; [Molina, Jean-Michel] Univ Paris Diderot Paris, Sorbonne Paris Cite, Hop St Louis, INSERM,AP HP,Serv Malad Infect & Trop,UMRS 941, Paris, France; [Partisani, Marialuisa] Hop Univ Strasbourg, Le Trait Union, Ctr Soins Infect VIH, Strasbourg, France; [Roger, Pierre-Marie] Univ Nice Sophia Antipolis, CHU Nice, Grp Hosp Archet, Serv Infect, Nice, France; [Boccara, Franck] Sorbonne Univ, Hop St Antoine, AP HP, INSERM,Serv Cardiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; CHU Rennes; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Balde, A (corresponding author), Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, IPLESP, Paris, France.	aliou.balde@iplesp.upmc.fr	Costagliola, Dominique/H-5849-2011	Costagliola, Dominique/0000-0003-0765-0869; Balde, Aliou/0000-0001-5956-698X	Sorbonne Universites UPMC Paris Univ 06; Boehringer-Ingelheim; ViiV Healthcare; BMS; Amgen; Merck; Sanofi; Pfizer; Bristol-Myers-Squibb; Janssen; Merck and Gilead Sciences; AstraZeneca; Boehringer Ingelheim; Gilead Sciences, Glaxo-Smith-Kline; Roche; Agence Nationale de Recherches sur le Sida (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministry of Health; FOGARTY INTERNATIONAL CENTER [D43TW010350] Funding Source: NIH RePORTER	Sorbonne Universites UPMC Paris Univ 06; Boehringer-Ingelheim(Boehringer Ingelheim); ViiV Healthcare; BMS(Bristol-Myers Squibb); Amgen(Amgen); Merck(Merck & Company); Sanofi; Pfizer(Pfizer); Bristol-Myers-Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck and Gilead Sciences; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Gilead Sciences, Glaxo-Smith-Kline(Gilead SciencesGlaxoSmithKline); Roche(Roche Holding); Agence Nationale de Recherches sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Aliou BALDE is supported by a doctoral contract from Sorbonne Universites UPMC Paris Univ 06. All authors declare no conflict of interest, although several members of the group have, at some stage in the past, received funding from a variety of pharmaceutical companies for research, travel grants, speaking engagements or consultancy fees. Sylvie Lang has received travel grants from Boehringer-Ingelheim. Laurent Cotte has received study grants from ViiV Healthcare and MSD; personal fees from BMS, Gilead Sciences, Janssen, MSD and ViiV healthcare. Jean Ferrieres has received grants and lecture fees from Amgen, Merck, and Sanofi. Elisabeth Aslangul has received travel grants from Sanofi, Pfizer and Bristol-Myers-Squibb. Antoine Cheret has received study grants from Merck and personal fees from Gilead, ViiV Healthcare, and Janssen. Jean-Luc Meynard has received honoraria from Gilead, Abbott, ViiV Healthcare and BMS. Jean-Michel Molina has received study grants from Merck and Gilead Sciences; advisory board member for Merck, Gilead Sciences, Janssen, ViiV Healthcare, BMS, and Teva, and a speakers' bureau for Gilead. Franck Boccara has received study grant from Amgen, speaker fees from AstraZeneca, Merck; advisory board member for Amgen, Sanofi, Gilead, and ViiV Healthcare. Dominique Costagliola has received travel grants, consultancy fees, honoraria or study grants from Abbott, Boehringer Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck and Roche. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; FHDH is supported by Agence Nationale de Recherches sur le Sida (ANRS), Institut National de la Sante et de la Recherche Medicale (INSERM) and the French Ministry of Health.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Arveiler D, 2005, EUR J CARDIOV PREV R, V12, P209, DOI 10.1097/00149831-200506000-00004; Badejo OA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/246870; Breslow NE, 1987, STAT METHODS CANC RE; Brown G.W., 1951, P 2 BERK S MATH STAT, P159; Chaturvedi AK, 2008, ANN EPIDEMIOL, V18, P230, DOI 10.1016/j.annepidem.2007.10.005; De Francesco D, 2018, AIDS; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Klein DB, 2015, CLIN INFECT DIS, V60, P1278, DOI 10.1093/cid/civ014; Lang S, 2012, CLIN INFECT DIS, V55, P600, DOI 10.1093/cid/cis489; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Mary-Krause M, 2014, INT J EPIDEMIOL, V43, P1425, DOI 10.1093/ije/dyu002; Monforte AD, 2013, AIDS, V27, P407, DOI 10.1097/QAD.0b013e32835b2ef1; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Rosenblatt L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1827-1; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ryom L, 2017, CROI; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tygesen K, 2007, CIRCULATION, V116, P2634; WHO, 2019, INT STAT CLASS DIS R, V10th; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210253	10.1371/journal.pone.0210253	http://dx.doi.org/10.1371/journal.pone.0210253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650119	Green Published, gold, Green Submitted			2022-12-27	WOS:000455813300047
J	Suh, MJ; Park, JA; Chang, SW; Kim, JH; Lee, KH; Hong, SC; Lee, HS; Kang, JW				Suh, Michelle J.; Park, Jin A.; Chang, Suk Won; Kim, Jeong Hong; Lee, Keun-Hwa; Hong, Seong-Chul; Lee, Hye-Sook; Kang, Ju Wan			Chronological changes in rhinitis symptoms present in school-aged children with allergic sensitization	PLOS ONE			English	Article							PREVALENCE; SKIN; INFLAMMATION; SENSITIVITY; ASSOCIATION; POPULATION; ADULTS; ASTHMA; RISK; IGE	Introduction It is difficult to accurately predict the natural course of allergic rhinitis (AR), because it is affected by a wide variety of environmental influences, as well as genetic predisposition. Considering the high prevalence of allergic rhinitis in children and adolescents, caregivers should be given appropriate information regarding the disease course. This study aimed to understand the prognosis of allergic rhinitis by examining the relationship between allergic sensitization and rhinitis symptoms during this developmental period. Methods This cross-sectional study included 1069 children aged 9-16 years from the Korean International Study of Asthma and Allergies in Childhood Survey database who had completed health questionnaires, and for whom skin prick test results were available. Data were collected during May 2016. The distribution of sensitization and allergic symptoms was compared by age groups (elementary, middle, and high school). Data were analyzed using linear-by-linear analysis. Results Sensitization to at least one tested allergen differed by age (59.2%, 58.3%, 68.2%, in elementary, middle, and high school students, respectively; p = 0.025), and seasonal allergen sensitization (35.0%, 37.1%, 53.9%, respectively) increased with age (p < 0.001). Conversely, the proportion of rhinitis symptoms among sensitized children decreased as age increased (58.80%, 52.90%, 49.70%, respectively; p = 0.047). However, the rate of non-allergic rhinitis was age-independent. Conclusion With increasing age during childhood and adolescence, symptomatic allergic rhinitis decreases; thus, subclinical allergic rhinitis increases. This suggests that the symptoms of later-sensitized children are less clearly manifested, or that the symptoms reduce as previously sensitized children mature. This should be clarified further in a longitudinal study.	[Suh, Michelle J.; Park, Jin A.; Chang, Suk Won; Kim, Jeong Hong; Kang, Ju Wan] Jeju Natl Univ, Sch Med, Dept Otorhinolaryngol, Jeju, South Korea; [Kim, Jeong Hong; Lee, Keun-Hwa; Hong, Seong-Chul; Lee, Hye-Sook; Kang, Ju Wan] Jeju Natl Univ, Environm Hlth Ctr Atop Dermatitis & Allerg Rhinit, Jeju, South Korea	Jeju National University; Jeju National University	Kang, JW (corresponding author), Jeju Natl Univ, Sch Med, Dept Otorhinolaryngol, Jeju, South Korea.; Kang, JW (corresponding author), Jeju Natl Univ, Environm Hlth Ctr Atop Dermatitis & Allerg Rhinit, Jeju, South Korea.	juwankangmd@gmail.com	suh, michelle j./AAD-4055-2019	Kang, Ju Wan/0000-0002-6260-0680; suh, michellej/0000-0001-6345-7671	Environmental Health Center (Atopic dermatitis & Allergic rhinitis); Jeju National University - Ministry of Environment, Republic of Korea	Environmental Health Center (Atopic dermatitis & Allergic rhinitis); Jeju National University - Ministry of Environment, Republic of Korea	This study was supported by grants from the Environmental Health Center (Atopic dermatitis & Allergic rhinitis), Jeju National University funded by the Ministry of Environment, Republic of Korea (http://eng.me.go.kr/eng/web/main.do).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. And there were no authors who received salary or other funding from commercial companies. There was no additional external funding received for this study.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P15, DOI 10.1016/0091-6749(81)90117-2; Blomme K, 2013, INT ARCH ALLERGY IMM, V160, P200, DOI 10.1159/000339853; Bodtger U, 2003, J ALLERGY CLIN IMMUN, V111, P149, DOI 10.1067/mai.2003.37; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Eriksson J, 2011, INT ARCH ALLERGY IMM, V154, P155, DOI 10.1159/000320230; Fineman SM, 2002, ANN ALLERG ASTHMA IM, V88, P2, DOI 10.1016/S1081-1206(10)62022-4; FREIDHOFF LR, 1984, J ALLERGY CLIN IMMUN, V73, P490, DOI 10.1016/0091-6749(84)90360-9; Govaere E, 2007, PEDIAT ALLERG IMM-UK, V18, P671, DOI 10.1111/j.1399-3038.2007.00570.x; Grimshaw KEC, 2005, CURR PAEDIAT, V15, P221; Haanpaa L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019281; Hoffmann-Petersen B, 2013, PEDIAT ALLERG IMM-UK, V24, P727, DOI 10.1111/pai.12133; Kim BK, 2016, ALLERGOL INT, V65, P186, DOI 10.1016/j.alit.2015.11.002; Kim Hyeong Yun, 2013, Korean J Pediatr, V56, P338, DOI 10.3345/kjp.2013.56.8.338; Kim SH, 2002, CLIN EXP ALLERGY, V32, P1054, DOI 10.1046/j.1365-2222.2002.01431.x; Mediaty Anja, 2005, Immun Ageing, V2, P9, DOI 10.1186/1742-4933-2-9; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Park SC, 2016, INT J PEDIATR OTORHI, V86, P167, DOI 10.1016/j.ijporl.2016.05.005; Passalacqua G, 2001, RESP RES, V2, P320, DOI 10.1186/rr80; Plaschke P, 1999, J ALLERGY CLIN IMMUN, V104, P58, DOI 10.1016/S0091-6749(99)70114-4; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Ricca V, 2000, J ALLERGY CLIN IMMUN, V105, P54, DOI 10.1016/S0091-6749(00)90177-5; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; Simola M, 1999, ANN ALLERG ASTHMA IM, V82, P152, DOI 10.1016/S1081-1206(10)62589-6	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210840	10.1371/journal.pone.0210840	http://dx.doi.org/10.1371/journal.pone.0210840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653594	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500080
J	Rodriguez, MZ; Comin, CH; Casanova, D; Bruno, OM; Amancio, DR; Costa, LD; Rodrigues, FA				Rodriguez, Mayra Z.; Comin, Cesar H.; Casanova, Dalcimar; Bruno, Odemir M.; Amancio, Diego R.; Costa, Luciano da F.; Rodrigues, Francisco A.			Clustering algorithms: A comparative approach	PLOS ONE			English	Article							SOM NEURAL-NETWORK; K-MEANS ALGORITHM; DISCRIMINANT-ANALYSIS; SPECTRAL METHODS; R-PACKAGE; MODEL; SELECTION; KERNEL	Many real-world systems can be studied in terms of pattern recognition tasks, so that proper use (and understanding) of machine learning methods in practical applications becomes essential. While many classification methods have been proposed, there is no consensus on which methods are more suitable for a given dataset. As a consequence, it is important to comprehensively compare methods in many possible scenarios. In this context, we performed a systematic comparison of 9 well-known clustering methods available in the R language assuming normally distributed data. In order to account for the many possible variations of data, we considered artificial datasets with several tunable properties (number of classes, separation between classes, etc). In addition, we also evaluated the sensitivity of the clustering methods with regard to their parameters configuration. The results revealed that, when considering the default configurations of the adopted methods, the spectral approach tended to present particularly good performance. We also found that the default configuration of the adopted implementations was not always accurate. In these cases, a simple approach based on random selection of parameters values proved to be a good alternative to improve the performance. All in all, the reported approach provides subsidies guiding the choice of clustering algorithms.	[Rodriguez, Mayra Z.; Amancio, Diego R.; Rodrigues, Francisco A.] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil; [Comin, Cesar H.] Univ Fed Sao Carlos, Dept Comp Sci, Sao Carlos, SP, Brazil; [Casanova, Dalcimar] Fed Univ Technol, Curitiba, Parana, Brazil; [Bruno, Odemir M.; Costa, Luciano da F.] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Tecnologica Federal do Parana; Universidade de Sao Paulo	Comin, CH (corresponding author), Univ Fed Sao Carlos, Dept Comp Sci, Sao Carlos, SP, Brazil.	chcomin@gmail.com	Amancio, Diego Raphael/I-1071-2012; Comin, Cesar H/G-2229-2012; Rodrigues, Francisco A./E-4418-2011; da F. Costa, Luciano/H-5475-2011; Bruno, Odemir M/A-5279-2009; Casanova, Dalcimar/J-1588-2012; Bruno, Odemir/AAU-7209-2020	Comin, Cesar H/0000-0003-1207-4982; Rodrigues, Francisco A./0000-0002-0145-5571; da F. Costa, Luciano/0000-0001-5203-4366; Bruno, Odemir M/0000-0002-2945-1556; Bruno, Odemir/0000-0002-2945-1556; Casanova, Dalcimar/0000-0002-1905-4602	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [15/18942-8, 18/09125-4, 14/20830-0, 16/19069-9, 14/08026-1, 11/50761-2, 15/22308-2]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307797/2014-7, 307333/2013-2]; Nucleo de Apoio a Pesquisa (LdFC); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nucleo de Apoio a Pesquisa (LdFC); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant nos. 15/18942-8 and 18/09125-4 for CHC, 14/20830-0 and 16/19069-9 for DRA, 14/08026-1 for OMB and 11/50761-2 and 15/22308-2 for LdFC), CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant nos. 307797/2014-7 for OMB and 307333/2013-2 for LdFC), Nucleo de Apoio a Pesquisa (LdFC) and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Finance Code 001).	Abdullah Z, 2011, PROCD SOC BEHV, V28, DOI 10.1016/j.sbspro.2011.11.022; Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Aggarwal CC, 2013, DATA CLUSTERING ALGO, V2; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amancio DR, 2012, J INFORMETR, V6, P427, DOI 10.1016/j.joi.2012.02.005; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; BENAIM M, 1992, EUROPHYS LETT, V19, P241, DOI 10.1209/0295-5075/19/3/015; Berge L, 2012, J STAT SOFTW, V46, P1; BERKHIN P, 2006, SURVEY CLUSTERING DA, P25, DOI DOI 10.1007/3-540-28349-8_2; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Bouveyron C, 2007, COMPUT STAT DATA AN, V52, P502, DOI 10.1016/j.csda.2007.02.009; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brun M, 2007, PATTERN RECOGN, V40, P807, DOI 10.1016/j.patcog.2006.06.026; Burdick D, 2001, PROC INT CONF DATA, P443, DOI 10.1109/ICDE.2001.914857; Camastra F, 2005, IEEE T PATTERN ANAL, V27, P801, DOI 10.1109/TPAMI.2005.88; Colavizza G, 2016, J INFORMETR, V10, P1037, DOI 10.1016/j.joi.2016.07.009; Costa IG, 2004, GENET MOL BIOL, V27, P623, DOI 10.1590/S1415-47572004000400025; Cover TM, 2012, ELEMENTS INFORM THEO, V2; de Arruda GF, 2012, PHYSICA A, V391, P6174, DOI 10.1016/j.physa.2012.07.007; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dhillon I. S., 2004, CITESEER; Dougherty ER, 2002, J COMPUT BIOL, V9, P105, DOI 10.1089/10665270252833217; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Erman J., 2006, P 2006 SIGCOMM WORKS, DOI 10.1145/11 62678.1162679; Ester M., 1996, DENSITY BASED ALGORI, V96, P226; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Fraley C, 1998, SIAM J SCI COMPUT, V20, P270, DOI 10.1137/S1064827596311451; Garcia C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156576; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guha S, 2003, IEEE T KNOWL DATA EN, V15, P515, DOI 10.1109/TKDE.2003.1198387; Guha S, 2001, INFORM SYST, V26, P35, DOI 10.1016/S0306-4379(01)00008-4; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Han J, 2006, DATA MINING CONCEPTS, V2; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Hirschberger M, 2007, EUR J OPER RES, V177, P1610, DOI 10.1016/j.ejor.2005.10.014; Horn, 2012, MATRIX ANAL, DOI [DOI 10.1017/CBO9780511810817, 10.1017/CBO9780511810817]; Huang JB, 2013, KNOWL-BASED SYST, V40, P111, DOI 10.1016/j.knosys.2012.11.015; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hwang C.R., 1988, ACTA APPL MATH, V12, P108; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK, 2004, ICPR 2004 P 17 INT C, V1; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jing L, 2007, IEEE T KNOWL DATA EN, V19, P1026, DOI 10.1109/TKDE.2007.1048; Joachims T., 1998, PROC 10 EUROPEAN C M, P137, DOI DOI 10.1007/BFB0026683; Jung YG, 2014, BIOTECHNOL BIOTEC EQ, V28, pS44, DOI 10.1080/13102818.2014.949045; Karypis G, 1999, COMPUTER, V32, P68, DOI 10.1109/2.781637; Kaufman L, 2009, SERIES PROBABILITY M; Kaufman L., 1990, FINDING GROUPS DATA; Khashei M, 2010, EXPERT SYST APPL, V37, P479, DOI 10.1016/j.eswa.2009.05.044; Kinnunen T, 2011, PATTERN RECOGN LETT, V32, P1604, DOI 10.1016/j.patrec.2011.06.023; Kou G, 2014, INFORM SCIENCES, V275, P1, DOI 10.1016/j.ins.2014.02.137; Kriegel HP, 2012, WIRES DATA MIN KNOWL, V2, P351, DOI 10.1002/widm.1057; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; Lei Y, 2017, PATTERN RECOGN, V65, P58, DOI 10.1016/j.patcog.2016.12.003; Liu Y, 2010, 2010 IEEE INT C DATA, P911, DOI [10.1109/ICDM.2010.35, DOI 10.1109/ICDM.2010.35]; Luczak M, 2018, J INTELL FUZZY SYST, V34, P373, DOI 10.3233/JIFS-171393; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mangiameli P, 1996, EUR J OPER RES, V93, P402, DOI 10.1016/0377-2217(96)00038-0; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; McKight P.E, 2010, CORSINI ENCYCLO PSYC, P1, DOI [DOI 10.1002/9780470479216.CORPSY0491, 10.1002/9780470479216.corpsy0491]; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mingoti SA, 2006, EUR J OPER RES, V174, P1742, DOI 10.1016/j.ejor.2005.03.039; Naeni LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157988; Nascimento MCV, 2011, EUR J OPER RES, V211, P221, DOI 10.1016/j.ejor.2010.08.012; Parsons L, 2004, WORKSH CLUST HIGH DI, P48; Parsons L., 2004, ACM SIGKDD EXPLORATI, V6, P90, DOI 10.1145/1007730.1007731; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; R Development Core Team, 2006, R LANG ENV STAT COMP; Raykov YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162259; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Ridgeway G, 2003, DATA MIN KNOWL DISC, V7, P301, DOI 10.1023/A:1024084221803; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sequeira K., 2002, P 8 ACM SIGKDD INT C, P386, DOI DOI 10.1145/775047.775103; Silva JA, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2522968.2522981; Sim K, 2013, DATA MIN KNOWL DISC, V26, P332, DOI 10.1007/s10618-012-0258-x; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; UCI, BREAST CANC WISC; Ultsch A, 2005, P WORKSHOP SELF ORG, P75; Verma Deepak, 2003, U OFWASHINGTON TECH, V1, P1; Viana MP, 2013, J INFORMETR, V7, P371, DOI 10.1016/j.joi.2012.12.005; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Williams G, 1997, ADV TOPICS ARTIFICIA, V1342, P340; Witten I.H., 2005, DATA MINING PRACTICA; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	106	176	175	12	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210236	10.1371/journal.pone.0210236	http://dx.doi.org/10.1371/journal.pone.0210236			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645617	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200022
J	Szymanska-Czerwinska, M; Jodelko, A; Zareba-Marchewka, K; Niemczuk, K				Szymanska-Czerwinska, Monika; Jodelko, Agnieszka; Zareba-Marchewka, Kinga; Niemczuk, Krzysztof			Shedding and genetic diversity of Coxiella burnetii in Polish dairy cattle	PLOS ONE			English	Article							Q-FEVER OUTBREAK; GENOTYPIC DIVERSITY; BULK MILK; RAW-MILK; PREVALENCE; COWS; HERD; GOATS; MLVA	Q fever is a worldwide zoonotic disease reported in humans and many animal species including cattle. The aims of this study were to evaluate the prevalence of Coxiella (C.) burnetii shedding in Polish dairy cattle herds and to identify the pathogen's genotypes and sequence types (STs) using multiple-locus variable number tandem repeat analysis (MLVA) and multispacer sequence typing (MST) methods. The presence of C. burnetii DNA was detected using a commercial real-time PCR kit, targeting the IS1111 element. Overall, 1,439 samples from 279 herds were tested including: 897 individual milk specimens, 101 bulk tank milk samples, 409 genital tract swabs and 32 placentas. Furthermore, 30 consumer milk samples, including 10 from vending machines and 77 dairy products were also analyzed. C. burnetii shedding was confirmed in 31.54% of tested cattle herds as well as in 69.16% of consumer milk and dairy products. Among real-time PCR-positive samples, 49 specimens obtained from 49 cattle herds and 8 samples of purchased dairy products were selected for genotyping. Overall, five previously known MLVA genotypes (I, J, BG, BE, and NM) and three new ones (proposed as PL1, PL2, and PL3) were identified. Two MST sequence types were recorded: ST16 and a novel sequence (ST61). The new genotypes and sequence types need further research particularly into their pathogenicity to humans.	[Szymanska-Czerwinska, Monika; Jodelko, Agnieszka; Zareba-Marchewka, Kinga; Niemczuk, Krzysztof] Natl Vet Res Inst, Dept Cattle & Sheep Dis, Pulawy, Poland; [Szymanska-Czerwinska, Monika] Natl Vet Res Inst, Lab Serol Diag, Pulawy, Poland	National Veterinary Institute - National Research Institute; National Veterinary Institute - National Research Institute	Jodelko, A (corresponding author), Natl Vet Res Inst, Dept Cattle & Sheep Dis, Pulawy, Poland.	agnieszka.jodelko@piwet.pulawy.pl	Niemczuk, Krzysztof/AAV-7798-2021; Jodełko, Agnieszka/ABI-7256-2020; Zaręba-Marchewka, Kinga/AAX-3839-2020; Szymańska-Czerwińska, Monika/ABI-7174-2020	Niemczuk, Krzysztof/0000-0003-1611-9770; Jodełko, Agnieszka/0000-0002-4821-4847; Zaręba-Marchewka, Kinga/0000-0003-0657-4171; Szymańska-Czerwińska, Monika/0000-0001-8974-0870	National Science Centre, Poland [2015/17/D/NZ7/00816]	National Science Centre, Poland(National Science Centre, Poland)	This scientific work was funded by the National Science Centre, Poland (Grant No. 2015/17/D/NZ7/00816, SONATA 9) https://ncn.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Anastacio S, 2016, TRANSBOUND EMERG DIS, V63, pE293, DOI 10.1111/tbed.12275; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Astobiza I, 2012, J DAIRY SCI, V95, P1632, DOI 10.3168/jds.2011-4721; Astobiza I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-241; Bauer AE, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0517-3; Ceglie L, 2015, MICROBES INFECT, V17, P776, DOI 10.1016/j.micinf.2015.09.029; Chmielewski T, 2009, POL J MICROBIOL, V58, P9; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; Cooper A, 2013, VECTOR-BORNE ZOONOT, V13, P12, DOI 10.1089/vbz.2011.0853; Di Domenico M, 2014, VECTOR-BORNE ZOONOT, V14, P710, DOI 10.1089/vbz.2014.1587; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Galiero A, 2016, INT J FOOD MICROBIOL, V237, P47, DOI 10.1016/j.ijfoodmicro.2016.08.008; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gonzalez-Barrio D, 2016, MICROB ECOL, V72, P890, DOI 10.1007/s00248-016-0786-9; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; Jodelko A, 2015, B VET I PULAWY, V59, P479, DOI 10.1515/bvip-2015-0071; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Loftis AD, 2010, FOODBORNE PATHOG DIS, V7, P1453, DOI 10.1089/fpd.2010.0579; Magnino S, 2009, LARGE ANIM REV, V15, P3; Pearson T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-41; Pexara A, 2018, TRENDS FOOD SCI TECH, V71, P65, DOI 10.1016/j.tifs.2017.11.004; Pinero A, 2015, INFECT GENET EVOL, V31, P231, DOI 10.1016/j.meegid.2015.02.006; Public Health England, V DIC DIV CALC TOOL; Reichel R, 2012, RES VET SCI, V93, P1217, DOI 10.1016/j.rvsc.2012.04.007; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Santos AS, 2012, INT J MED MICROBIOL, V302, P253, DOI 10.1016/j.ijmm.2012.08.003; Signs KA, 2012, CLIN INFECT DIS, V55, P1387, DOI 10.1093/cid/cis690; Stein A, 1999, CLIN INFECT DIS, V29, P617, DOI 10.1086/598643; Sulyok KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-107; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P2156, DOI 10.1128/JCM.06831-11; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Tilburg JJHC, 2013, THESIS; Valla G, 2014, LARGE ANIM REV, V20, P51; Van den Brom R, 2015, VET MICROBIOL, V181, P119, DOI 10.1016/j.vetmic.2015.07.011; Velasova M, 2017, J DAIRY SCI, V100, P9215, DOI 10.3168/jds.2016-11863	38	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210244	10.1371/journal.pone.0210244	http://dx.doi.org/10.1371/journal.pone.0210244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629637	gold, Green Published, Green Submitted			2022-12-27	WOS:000455483000065
J	Beasley, I; Cherel, Y; Robinson, S; Betty, E; Hagihara, R; Gales, R				Beasley, Isabel; Cherel, Yves; Robinson, Sue; Betty, Emma; Hagihara, Rie; Gales, Rosemary			Stomach contents of long-finned pilot whales, Globicephala melas mass-stranded in Tasmania	PLOS ONE			English	Article							ACID SIGNATURE ANALYSIS; MARINE MAMMALS; SPERM-WHALES; NEW-ZEALAND; PHYSETER-MACROCEPHALUS; FORAGING ECOLOGY; CLIMATE-CHANGE; FATTY-ACIDS; DIET; CEPHALOPODS	New data are reported from analyses of stomach contents from 114 long-finned pilot whales mass-stranded at four locations around Tasmania, Australia from 1992-2006. Identifiable prey remains were recovered from 84 (74%) individuals, with 30 (26%) individuals (17 females and 13 males) having empty stomachs. Prey remains comprised 966 identifiable lower beaks and 1244 upper beaks, belonging to 17 families (26 species) of cephalopods. Ommastrephidae spp. were the most important cephalopod prey accounting for 16.9% by number and 45.6% by reconstructed mass. Lycoteuthis lorigera was the next most important, followed by Ancistrocheirus lesueurii. Multivariate statistics identified significant differences in diet among the four stranding locations. Long-finned pilot whales foraging off Southern Australia appear to be targeting a diverse assemblage of prey (>= 10 species dominated by cephalopods). This is compared to other similar studies from New Zealand and some locations in the Northern Hemisphere, where the diet has been reported to be primarily restricted to <= 3 species dominated by cephalopods. This study emphasises the importance of cephalopods as primary prey for Southern long-finned pilot whales and other marine vertebrates, and has increased our understanding of long-finned pilot whale diet in Southern Ocean waters.	[Beasley, Isabel] Snubfin Dolphin Project, Colebrook, Tas, Australia; [Beasley, Isabel; Hagihara, Rie] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Cherel, Yves] Univ La Rochelle, CNRS, UMR 7372, CEBC, Villiers En Bois, France; [Robinson, Sue] Biosecur Tasmania, Invas Species Branch, Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia; [Betty, Emma] Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Betty, Emma] Massey Univ, Coll Sci, Inst Nat & Math Sci, Palmerston North, New Zealand; [Gales, Rosemary] Dept Primary Ind Pk Water & Environm, Nat Values Conservat Branch, Hobart, Tas, Australia	James Cook University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Auckland University of Technology; Massey University	Beasley, I (corresponding author), Snubfin Dolphin Project, Colebrook, Tas, Australia.; Beasley, I (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	beasleyisabel@gmail.com	Betty, Emma L./P-9625-2019	Betty, Emma L./0000-0002-9187-1957	Princess Melikoff Trust	Princess Melikoff Trust	This work was funded by the Princess Melikoff Trust. The Princess Melikoff Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; Aoki K, 2013, BEHAV PROCESS, V99, P12, DOI 10.1016/j.beproc.2013.06.002; Baird RW, 2002, MAR ECOL PROG SER, V237, P301, DOI 10.3354/meps237301; Baker A., 2009, MOL METHODS ECOLOGY; Beatson E, 2007, NEW ZEAL J ZOOL, V34, P359, DOI 10.1080/03014220709510095; Beatson E, 2007, NEW ZEAL J ZOOL, V34, P51, DOI 10.1080/03014220709510063; Beatson EL, 2009, NEW ZEAL J ZOOL, V36, P47, DOI 10.1080/03014220909510139; Beatson E, 2007, REV FISH BIOL FISHER, V17, P295, DOI 10.1007/s11160-007-9039-9; Santos MB, 2014, MAR MAMMAL SCI, V30, P1, DOI 10.1111/mms.12015; Betty E, 2013, 20 BIENN C BIOL MAR; Bigg MA, 1985, MARINE MAMMALS FISHE; Bloch D, 1995, DEV MAR BIO, V4, P499; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; BRABYN MW, 1992, J MAMMAL, V73, P469, DOI 10.2307/1382012; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; Cherel Y, 2005, P ROY SOC B-BIOL SCI, V272, P1601, DOI 10.1098/rspb.2005.3115; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2017, MAR ECOL PROG SER, V565, P197, DOI 10.3354/meps11994; CLARKE M, 1994, ANTARCT SCI, V6, P149, DOI 10.1017/S0954102094000234; Clarke M.R, 1986, HDB IDENTIFICATION C; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; COCKCROFT VG, 1993, Z SAUGETIERKD, V58, P286; Committee on Taxonomy, 2021, LIST MAR MAMM SPEC S; DAILEY M, 1978, J WILDLIFE DIS, V14, P503, DOI 10.7589/0090-3558-14.4.503; De Pierrepont JF, 2005, J MAR BIOL ASSOC UK, V85, P1539, DOI 10.1017/S0025315405012762; de Stephanis R, 2008, MAR BIOL, V154, P603, DOI 10.1007/s00227-008-0953-8; Desportes G., 1988, DIET PILOT WHALE GLO; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Desportes Genevieve, 1993, V14, P233; dos Santos RA, 2001, FISH RES, V52, P99; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Evans K, 2002, MAR MAMMAL SCI, V18, P622, DOI 10.1111/j.1748-7692.2002.tb01063.x; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Fontaine M, 2015, MAR BIOL, V162, P207, DOI 10.1007/s00227-014-2587-3; Furlani D., 2007, OTOLITHS COMMON AUST; GALES R, 1992, MAR MAMMAL SCI, V8, P405, DOI 10.1111/j.1748-7692.1992.tb00055.x; Gales R, 2012, WILDLIFE RES, V39, P520, DOI 10.1071/WR12023; Gannon D, 1997, OCEANOGRAPHIC LIT RE, V9, P1011; Gannon DP, 1997, MAR MAMMAL SCI, V13, P405, DOI 10.1111/j.1748-7692.1997.tb00648.x; Geraci J, 1993, MARINE MAMMALS ASHOR, P175; GERACI JR, 1987, INT J PARASITOL, V17, P407, DOI 10.1016/0020-7519(87)90116-0; Goodall R.N.P., 1985, P566; Guiler ER, 1978, PAPERS P ROYAL SOC T; Horstkottee J, 2008, SYSTEMATICS ECOLOGIC; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Jefferson T.A., 2015, MARINE MAMMALS WORLD; JOBLING M, 1986, SARSIA, V71, P265, DOI 10.1080/00364827.1986.10419696; Lefkaditou E, 2008, HYDROBIOLOGIA, V612, P71, DOI 10.1007/s10750-008-9490-1; Lu CC., 2002, CEPHALOPOD BEAK IDEN; MacLeod CD, 2006, MAR ECOL PROG SER, V326, P295, DOI 10.3354/meps326295; Malcom CR., 1986, HDB IDENTIFICATION C; Mansilla L, 2012, POLAR BIOL, V35, P1929, DOI 10.1007/s00300-012-1222-3; Martin A.R., 1993, Reports of the International Whaling Commission Special Issue, V14, P263; MARTIN AR, 1987, J ZOOL, V211, P11, DOI 10.1111/j.1469-7998.1987.tb07449.x; McManus T, 1984, PAPERS P ROYAL SOC T; MEADOR JP, 1993, CAN J FISH AQUAT SCI, V50, P2698, DOI 10.1139/f93-294; MERCER MC, 1967, J FISH RES BOARD CAN, V24, P2481, DOI 10.1139/f67-195; Meynier L, 2010, J MAMMAL, V91, P1484, DOI 10.1644/09-MAMM-A-299.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nicol D.J., 1988, Australian Zoologist, V24, P59; Olsen E, 2003, MAR BIOL, V142, P13, DOI 10.1007/s00227-002-0934-2; Olson P., 2002, ENCY MARINE MAMMALS, V2 nd, P898; Olson PA, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P701; Oremus M, 2009, BIOL J LINN SOC, V98, P729, DOI 10.1111/j.1095-8312.2009.01325.x; OVERHOLTZ WJ, 1991, FISH B-NOAA, V89, P723; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Perrin WF, 1980, P INT C DETERMINING; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Pinkas L., 1971, Fish Bull California, VNo. 152, P5; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Quick NJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45765; Reid A., 2016, CEPHALOPODS AUSTR SU; Rodhouse P, 1889, REDESCRIPTION MARTIA; Santos MB, 2001, FISH RES, V52, P121, DOI 10.1016/S0165-7836(01)00236-3; SEKIGUCHI K, 1992, S AFR J MARINE SCI, V12, P843; Sergeant DE, 1962, FISHERIES RES BOARD; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Spitz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050096; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Therneau TM., 2015, INTRO RECURSIVE PART; Thiemann GW, 2009, MAR MAMMAL SCI, V25, P243, DOI 10.1111/j.1748-7692.2008.00258.x; Visser F, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2397-y; Visser F, 2014, BEHAVIOUR, V151, P1453, DOI 10.1163/1568539X-00003195; Walters A, 2005, LONG FINNED PILOT WH; WARING GT, 1990, FISH B-NOAA, V88, P347; Wursig B., 2017, ENCY MARINE MAMMALS; Xavier J. C, 2009, CEPHALOPOD BEAK GUID	90	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0206747	10.1371/journal.pone.0206747	http://dx.doi.org/10.1371/journal.pone.0206747			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640963	Green Published, gold, Green Accepted			2022-12-27	WOS:000455808000002
J	Pinguet, CE; Ryll, E; Steinschulte, AA; Hoffmann, JM; Brugnoni, M; Sybachin, A; Woll, D; Yaroslavov, A; Richtering, W; Plamper, FA				Pinguet, Camille E.; Ryll, Esther; Steinschulte, Alexander A.; Hoffmann, Jon M.; Brugnoni, Monia; Sybachin, Andrey; Woell, Dominik; Yaroslavov, Alexander; Richtering, Walter; Plamper, Felix A.			PEO-b-PPO star-shaped polymers enhance the structural stability of electrostatically coupled liposome/polyelectrolyte complexes	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; TRIBLOCK COPOLYMERS; SENSITIVE LIPOSOMES; ANIONIC LIPOSOMES; BLOCK-COPOLYMERS; DRUG; RELEASE; MEMBRANES; VESICLES; POLYELECTROLYTE	We propose a strategy to counteract the salt-driven disassembly of multiliposomal complexes made by electrostatic co-assembly of anionic small unilamellar liposomes and cationic star-shaped polyelectrolytes (made of quaternized poly(dimethylaminoethyl methacrylate) (qPDMAEMA(100))(3.1)). The combined action of (qPDMAEMA(100))(3.1) and a nonionic star-shaped polymer (PEO12-b-PPO45)(4), which comprises diblock copolymer arms uniting a poly(ethylene oxide) PEO inner block and a poly(propylene oxide) PPO terminal block, leads to a stabilization of these complexes against disintegration in saline solutions. Hereby, the anchoring of the PPO terminal blocks to the lipid bilayer and the bridging between several liposomes are at the origin of the promoted structural stability. Two-focus fluorescence correlation spectroscopy verifies the formation of multiliposomal complexes with (PEO12-b-PPO45)(4). The polyelectrolyte and the amphiphilic polymer work synergistically, as the joint action still assures some membrane integrity, which is not seen for the mere (PEO12-b-PPO45)(4)-liposome interaction alone.	[Pinguet, Camille E.; Ryll, Esther; Steinschulte, Alexander A.; Hoffmann, Jon M.; Brugnoni, Monia; Woell, Dominik; Richtering, Walter; Plamper, Felix A.] Rhein Westfal TH Aachen, Inst Phys Chem, Aachen, Germany; [Sybachin, Andrey; Yaroslavov, Alexander] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Plamper, Felix A.] TU Bergakad Freiberg, Inst Phys Chem, Freiberg, Germany	RWTH Aachen University; Lomonosov Moscow State University; Technical University Freiberg	Plamper, FA (corresponding author), Rhein Westfal TH Aachen, Inst Phys Chem, Aachen, Germany.; Plamper, FA (corresponding author), TU Bergakad Freiberg, Inst Phys Chem, Freiberg, Germany.	felix.plamper@chemie.tu-freiberg.de	Wöll, Dominik/F-9768-2012; Sybachin, Andrey/AAN-4279-2021; Richtering, Walter/E-4130-2012; Yaroslavov, Alexander/V-2496-2019; Sybachin, Andrey/L-1613-2013	Wöll, Dominik/0000-0001-5700-4182; Richtering, Walter/0000-0003-4592-8171; Sybachin, Andrey/0000-0002-4860-5565; Brugnoni, Monia/0000-0003-2220-3645; Shoba, Sergei/0000-0001-9889-5831	German Research Foundation (DFG) [RI 560/22-1]; Russian Science Foundation (RSF) [19-43-04104]	German Research Foundation (DFG)(German Research Foundation (DFG)); Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	The work of C.P., W.R. (project RI 560/22-1) and F.P. was funded by the German Research Foundation (DFG; www.dfg.de). The work of A.S. and A.Y. (project 19-43-04104) was funded by the Russian Science Foundation (RSF; http://rscf.ru/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Amaro M, 2016, PHYS CHEM CHEM PHYS, V18, P7042, DOI 10.1039/c5cp05238f; BURCHARD W, 1989, PROG COLL POL SCI S, V80, P151; Cheng CY, 2012, BIOMACROMOLECULES, V13, P2624, DOI 10.1021/bm300848c; Deng NN, 2016, J AM CHEM SOC, V138, P7584, DOI 10.1021/jacs.6b02107; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; Duzgunes N, 2003, METHOD ENZYMOL, V367, P23; Enderlein J, 2005, CHEMPHYSCHEM, V6, P2324, DOI 10.1002/cphc.200500414; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; Firestone MA, 2003, BIOMACROMOLECULES, V4, P1539, DOI 10.1021/bm034134r; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Gibbs BF, 1999, INT J FOOD SCI NUTR, V50, P213, DOI 10.1080/096374899101256; Godoy-Gallardo M, 2017, ACS APPL MATER INTER, V9, P15907, DOI 10.1021/acsami.6b16275; Hashizaki K, 2003, CHEM PHARM BULL, V51, P815; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hebbeker P, 2017, LANGMUIR, V33, P4091, DOI 10.1021/acs.langmuir.6b04602; Hezaveh S, 2012, J PHYS CHEM B, V116, P14333, DOI 10.1021/jp306565e; Johnsson M, 2001, LANGMUIR, V17, P3902, DOI 10.1021/la0101245; Lasic DD, 1998, TRENDS BIOTECHNOL, V16, P307, DOI 10.1016/S0167-7799(98)01220-7; Lee BK, 2015, CHEM ENG SCI, V125, P158, DOI 10.1016/j.ces.2014.06.042; Lopes NA, 2017, FOOD HYDROCOLLOID, V70, P1, DOI 10.1016/j.foodhyd.2017.03.016; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Mergel O, 2019, CHEM SCI, V10, P1844, DOI 10.1039/c8sc04369h; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Ogawa K, 2015, ADV COLLOID INTERFAC, V226, P115, DOI 10.1016/j.cis.2015.09.005; Paleos CM, 2013, J CONTROL RELEASE, V170, P141, DOI 10.1016/j.jconrel.2013.05.011; Pasut G, 2015, J CONTROL RELEASE, V199, P106, DOI 10.1016/j.jconrel.2014.12.008; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pinguet CE, 2017, POLYMER, V121, P320, DOI 10.1016/j.polymer.2017.05.041; Plamper FA, 2007, MACROMOLECULES, V40, P5689, DOI 10.1021/ma070452x; Ramezanzade L, 2017, FOOD CHEM, V234, P220, DOI 10.1016/j.foodchem.2017.04.177; Shum HC, 2011, ANGEW CHEM INT EDIT, V50, P1648, DOI 10.1002/anie.201006023; Steinschulte AA, 2014, PHYS CHEM CHEM PHYS, V16, P4917, DOI 10.1039/c3cp54707h; Sybachin AV, 2016, MENDELEEV COMMUN, V26, P276, DOI 10.1016/j.mencom.2016.07.002; Sybachin AV, 2016, POLYMER, V93, P198, DOI 10.1016/j.polymer.2016.04.025; Sybachin AV, 2012, LANGMUIR, V28, P16108, DOI 10.1021/la3024265; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Tavano L, 2016, COLLOID SURFACE B, V147, P161, DOI 10.1016/j.colsurfb.2016.07.060; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van Elk M, 2015, EUR POLYM J, V72, P620, DOI 10.1016/j.eurpolymj.2015.03.013; Wang JY, 2012, BIOMACROMOLECULES, V13, P2616, DOI 10.1021/bm300847x; Wang JH, 2018, ANGEW CHEM INT EDIT, V57, P12680, DOI 10.1002/anie.201805707; Woll D, 2014, RSC ADV, V4, P2447, DOI 10.1039/c3ra44909b; Yaroslavov A, 2017, NANOMED-NANOTECHNOL, V13, P1491, DOI 10.1016/j.nano.2017.02.001; Yaroslavov AA, 2014, MACROMOL BIOSCI, V14, P491, DOI 10.1002/mabi.201300436; Yaroslavov AA, 2010, J AM CHEM SOC, V132, P5948, DOI 10.1021/ja1012323; Zhang R, 2017, BIOMATERIALS, V138, P13, DOI 10.1016/j.biomaterials.2017.05.025; Zhang WJ, 2017, LANGMUIR, V33, P12624, DOI 10.1021/acs.langmuir.7b02279	49	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210898	10.1371/journal.pone.0210898	http://dx.doi.org/10.1371/journal.pone.0210898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653618	Green Published, gold, Green Submitted			2022-12-27	WOS:000456015500086
J	Ayre, J; Bonner, C; Cvejic, E; McCaffery, K				Ayre, Julie; Bonner, Carissa; Cvejic, Erin; McCaffery, Kirsten			Randomized trial of planning tools to reduce unhealthy snacking: Implications for health literacy	PLOS ONE			English	Article							BRIEF PSYCHOLOGICAL INTERVENTION; PHYSICAL-ACTIVITY INTERVENTIONS; VOLITIONAL HELP SHEET; IMPLEMENTATION INTENTIONS; COGNITIVE IMPAIRMENT; SELF-EFFICACY; WEIGHT-LOSS; BEHAVIOR; CARE; IF	Objective Guidance to address health literacy often focuses on health education rather than tools to facilitate action, despite action being important for self-management. This study evaluated an online intervention informed by health literate design principles and behavior change theory to reduce unhealthy snacking. Methods 440 participants were recruited online and randomized to an intervention: 1) Health-literate action plan (guided implementation intention); 2) Standard action plan (self-guided implementation intention); 3) Education (healthy snacking fact-sheet). The primary outcome was self-reported unhealthy snacking. Follow-up was at 1 month. Results 373 participants (84.8%) completed follow-up. Half the sample had adequate health literacy (52%), and the other half had low (24%) or possibly low (25%) health literacy, as measured by Newest Vital Sign (NVS). At follow-up, lower health literacy was associated with more unhealthy snacks and there was no overall difference between intervention groups. However, participants with lower health literacy who used the health-literate action plan reported less unhealthy snacking compared to the standard action plan; the reverse was true for those with higher health literacy scores (b = 1.7, p = 0.03). People scoring 2 points below the mean NVS (M = 3.4, SD = 2.0) using the health-literate action plan reported eating 8 fewer serves of unhealthy snacks, whereas people scoring 2 points above the mean NVS reported eating 6 more serves of unhealthy snacks using the same tool. Conclusions These findings suggest that the universal precautions approach currently recommended for health information may be less effective for facilitating action than tailoring to health literacy level.	[Ayre, Julie; Bonner, Carissa; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney Hlth Literacy Lab, Sydney, NSW, Australia; [Cvejic, Erin] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney	McCaffery, K (corresponding author), Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney Hlth Literacy Lab, Sydney, NSW, Australia.	Kirsten.mccaffery@sydney.edu.au	Ayre, Julie/ABA-5914-2020; Cvejic, Erin/P-2665-2016; McCaffery, Kirsten/K-7945-2019	Ayre, Julie/0000-0002-5279-5189; Cvejic, Erin/0000-0002-6043-6071; McCaffery, Kirsten/0000-0003-2696-5006	Australian Government Research Training Program (RTP) Scholarship	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research is supported by an Australian Government Research Training Program (RTP) Scholarship; We would like to thank Tessa Copp, University of Sydney, for her contribution to the content analysis of standard action plans. We would also like to acknowledge the CSIRO for their permission to use items from the discretionary foods components of the CSIRO diet score. This research is supported by an Australian Government Research Training Program (RTP) Scholarship	Adriaanse MA, 2011, APPETITE, V56, P183, DOI 10.1016/j.appet.2010.10.012; Al Sayah F, 2013, J GEN INTERN MED, V28, P444, DOI 10.1007/s11606-012-2241-z; Armitage CJ, 2008, HEALTH PSYCHOL, V27, P557, DOI 10.1037/0278-6133.27.5.557; Armitage CJ, 2017, PREV SCI, V18, P976, DOI 10.1007/s11121-017-0807-z; Armitage CJ, 2015, J PUBLIC HEALTH-UK, V37, P438, DOI 10.1093/pubmed/fdv054; Armitage CJ, 2015, J BEHAV MED, V38, P599, DOI 10.1007/s10865-015-9634-5; Armitage CJ, 2014, BEHAV THER, V45, P700, DOI 10.1016/j.beth.2014.04.001; Armitage CJ, 2010, PSYCHOL HEALTH, V25, P1129, DOI 10.1080/08870440903121638; Bailey SC, 2014, DIABETES EDUCATOR, V40, P581, DOI 10.1177/0145721714540220; Barry MM, 2013, J HEALTH COMMUN, V18, P1507, DOI 10.1080/10810730.2013.840699; Belanger-Gravel A, 2013, HEALTH PSYCHOL REV, V7, P23, DOI 10.1080/17437199.2011.560095; Berger I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0745-9; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Brega A.G., 2015, AHRQ HLTH LITERACY U, V2nd Edn; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; de Vries H, 2005, PATIENT EDUC COUNS, V56, P154, DOI 10.1016/j.pec.2004.01.002; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Gawrilow C, 2011, J SOC CLIN PSYCHOL, V30, P616, DOI 10.1521/jscp.2011.30.6.616; Gollwitzer P. M., 1990, HDB MOTIVATION COGNI, V2, P53; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Hagger MS, 2014, EXERC SPORT SCI REV, V42, P62, DOI 10.1249/JES.0000000000000008; Hall PA, 2012, J EXP SOC PSYCHOL, V48, P432, DOI 10.1016/j.jesp.2011.09.004; Hayes A.F., 2013, INTRO MEDIATION MODE; Healthdirect, 2018, SMART GOALS 2018; HECKHAUSEN H, 1987, MOTIV EMOTION, V11, P101, DOI 10.1007/BF00992338; Hendrie GA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010047; Kelly J.R., 2010, THEN MIRACLE OCCURS, P137, DOI DOI 10.1093/ACPROF:OSO/9780195377798.003.0008; Kim SH, 2016, WORLDV EVID-BASED NU, V13, P324, DOI 10.1111/wvn.12157; Lara J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0177-3; Latham GP, 2013, NEW DEV GOAL SETTING, DOI [10.1111/j.1445-5994.2012.02758.x, DOI 10.1111/J.1445-5994.2012.02758.X]; McEwan D, 2016, HEALTH PSYCHOL REV, V10, P67, DOI 10.1080/17437199.2015.1104258; Meppelink CS, 2016, J HEALTH COMMUN, V21, P109, DOI 10.1080/10810730.2016.1193920; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; National Diabetes Services Scheme, 2016, HLTH SNACKS NAT DIAB; O'Brien N, 2015, HEALTH PSYCHOL REV, V9, P417, DOI 10.1080/17437199.2015.1012177; Office of Disease Prevention and Health Promotion, 2015, HLTH LIT ONL GUID SI; Olander Ellinor K, 2013, Int J Behav Nutr Phys Act, V10, P29, DOI 10.1186/1479-5868-10-29; Plain Language Action and Information Network, 2011, FED PLAIN LANG GUID; Prestwich A, 2005, PREDICTING HLTH BEHA; Schaffler J, 2018, J GEN INTERN MED, V33, P510, DOI 10.1007/s11606-017-4265-x; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Soureti A, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1773; Verhoeven AAC, 2014, PSYCHOL HEALTH, V29, P1476, DOI 10.1080/08870446.2014.950658; Verhoeven AAC, 2013, EUR J SOC PSYCHOL, V43, P344, DOI 10.1002/ejsp.1963; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Vila I, 2017, BRIT J HEALTH PSYCH, V22, P281, DOI 10.1111/bjhp.12230; Webb TL, 2008, BRIT J SOC PSYCHOL, V47, P373, DOI 10.1348/014466607X267010; Webb TL, 2004, EUR J SOC PSYCHOL, V34, P407, DOI 10.1002/ejsp.205; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Wilson EAH, 2009, PATIENT EDUC COUNS, V74, P318, DOI 10.1016/j.pec.2008.11.005	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0209863	10.1371/journal.pone.0209863	http://dx.doi.org/10.1371/journal.pone.0209863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653531	gold, Green Published, Green Submitted			2022-12-27	WOS:000456015500015
J	Huet, S; Deffuant, G; Nugier, A; Streith, M; Guimond, S				Huet, Sylvie; Deffuant, Guillaume; Nugier, Armelle; Streith, Michel; Guimond, Serge			Resisting hostility generated by terror: An agent-based study	PLOS ONE			English	Article							LOCAL CONVERGENCE; MANAGEMENT THEORY; MODEL	We propose an agent-based model leading to a decrease or an increase of hostility between agents after a major cultural threat such as a terrorist attack. The model is inspired from the Terror Management Theory and the Social Judgement Theory. An agent has a cultural identity defined through its acceptance segments about each of three different cultural worldviews (i.e., Atheist, Muslim, Christian) of the considered society. An agent's acceptance segment is composed from its acceptable positions toward a cultural worldview, including its most acceptable position. An agent forms an attitude about another agent depending on the similarity between their cultural identities. When a terrorist attack is perpetrated in the name of an extreme cultural identity, the negatively perceived agents from this extreme cultural identity point of view tend to decrease the width of their acceptance segments in order to differentiate themselves more from the threatening cultural identity. We generated a set of populations with cultural identities compatible with data from a survey on attitudes among a large sample representative of the population of France; we then simulated the reaction of these agents facing a terrorist attack from Muslim extremists. For most populations, the average attitude toward Muslims becomes more negative. However, for some specific populations, we noticed the opposite effect as the average attitude of the population toward Muslims becomes less negative. In these populations, the Muslim agents strongly differentiate themselves from the terrorists' extreme cultural identity, and the other agents are aware of these changes. These reactions are due to particular properties of their cultural identities that are identified in this paper.	[Huet, Sylvie; Deffuant, Guillaume] Irstea, Lab Engn Complex Syst LISC, Aubiere, France; [Nugier, Armelle; Streith, Michel; Guimond, Serge] UCA, Lab Social & Cognit Psychol LAPSCO, Clermont Ferrand, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Huet, S (corresponding author), Irstea, Lab Engn Complex Syst LISC, Aubiere, France.	sylvie.huet@irstea.fr	Huet, Sylvie/AAV-5505-2020; Deffuant, Guillaume/GRF-3580-2022	Huet, Sylvie/0000-0003-2973-7738; Deffuant, Guillaume/0000-0001-6265-9300	CNRS; Mission Interdisciplinarity [Defi S2C3]; Agence Nationale de la Recherche [ANR 11-FRQU-004-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Mission Interdisciplinarity; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by CNRS, Mission Interdisciplinarity (Defi S2C3), http://www.cnrs.fr/mi/and Agence Nationale de la Recherche (ANR 11-FRQU-004-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Deffuant G, 2011, INTERACTIONS 2011 MA; EAGLY AH, 1972, J PERS SOC PSYCHOL, V23, P388, DOI 10.1037/h0033161; Flache A, 2017, JASSS-J ARTIF SOC S, V20, P31, DOI [10.18564/jasss.3521, DOI 10.18564/JASSS.3521]; Flache A, 2011, J CONFLICT RESOLUT, V55, P970, DOI 10.1177/0022002711414371; FRIEDKIN NE, 1990, J MATH SOCIOL, V15, P193, DOI 10.1080/0022250X.1990.9990069; Greenberg J., 2013, HDB THEORIES SOCIAL, V1, P398; Greenberg J, 1986, SPRINGER SERIES SOCI; Greenberg J, 2008, SOC PERSONAL PSYCHOL, V2, P1881, DOI 10.1111/j.1751-9004.2008.00144.x; Guimond S., 2016, EFFECTS INTEGRATION; Kennedy J, 1995, PARTICLE SWARM OPTIM; Motyl M, 2011, J EXP SOC PSYCHOL, V47, P1179, DOI 10.1016/j.jesp.2011.04.010; Nugier A, 2016, INT REV SOC PSYCHOL, V29, P77, DOI 10.5334/irsp.61; Petty R, 1992, SOCIAL JUDGMENT INTE, P147; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2015, ADV EXP SOC PSYCHOL, V52, P1, DOI 10.1016/bs.aesp.2015.03.001; Radillo-Diaz A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066107; Schaller M, 2004, PSYCHOL FDN CULTURE; Sherif M., 1961, SOCIAL JUDGMENT ASSI; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Turner JC, 2013, HDB THEORIES SOCIAL, V2, P399; Van de Vyver J, 2016, PSYCHOL SCI, V27, P169, DOI 10.1177/0956797615615584	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0209907	10.1371/journal.pone.0209907	http://dx.doi.org/10.1371/journal.pone.0209907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640904	Green Submitted, Green Published, gold			2022-12-27	WOS:000455808000016
J	Negiloni, K; Ramani, KK; Sudhir, RR				Negiloni, Kalpa; Ramani, Krishna Kumar; Sudhir, Rachapalle Reddi			Environmental factors in school classrooms: How they influence visual task demand on children	PLOS ONE			English	Article							LIGHT LEVELS; IMPACT; MYOPIA	Background The key visual factors in a classroom environment include the legibility, angle subtended at the eye, illumination, contrast, and colour of the visual task. The study evaluated the visual environmental factors in the school classrooms. Materials and methods The distance Visual Acuity (VA) demand was evaluated based on the size of visual task i.e. the smallest size of chalkboard writing and its viewing distance. The environmental factors which can have an effect on the visibility in classrooms such as illuminance on the chalkboard and at student's desk, chalkboard contrast, light sources and the student's perception of their classroom visual environment were measured. To quantify the distance VA demand and to compare with a standard high contrast VA chart measure, a validation of the measurements was performed by chalkboard simulation experiment. The "acuity reserve" to be included to the measured distance VA demand was evaluated. Results We included twenty-nine classrooms of eight schools. The median distance VA threshold demand was 0.28 logMAR(0.25,0.45). The median illuminance on front desk position and chalkboard contrast was 130 lux(92,208) and 40(36,50) respectively with 62% classrooms having low illumination (<150lux). The acuity reserve evaluated to be included to the distance VA demand was 0.13logMAR and 0.29 logMAR in classrooms with optimal and low chalkboard illumination respectively which was based on the results of the simulation experiment. The median distance VA demand including the acuity reserve was 0.09 logMAR (-0.03,0.23) [Snellen Equivalent: 20/25(20/19,20/34)]. Conclusion The study findings highlight the increased visual task demand in school classrooms and the need for appropriate seating arrangements in classrooms based on the visual acuity of children. The study emphasises regular audit of the classroom environment along with the school eye screening.	[Negiloni, Kalpa; Sudhir, Rachapalle Reddi] SankaraNethralaya, Unit Med Res Fdn, Madras, Tamil Nadu, India; [Negiloni, Kalpa] Shanmugha Arts Sci Technol & Res Acad SASTRA Univ, Thanjavur, India; [Negiloni, Kalpa; Ramani, Krishna Kumar] Elite Sch Optometry, Madras, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Sudhir, RR (corresponding author), SankaraNethralaya, Unit Med Res Fdn, Madras, Tamil Nadu, India.	rrsudhir@gmail.com	Ramani, Krishna/AAF-6269-2019					[Anonymous], 2009, BRIGHT SCH LIGHT SUS; [Anonymous], 2004, 79421976 IS; Barrett P, 2015, BUILD ENVIRON, V89, P118, DOI 10.1016/j.buildenv.2015.02.013; Bureau of Indian Standards, 2010, NAT LIGHT COD 2010; Department of Education and Employment, BUILD B, V90; Gilavand A, 2016, INT J PEDIATR-MASSHA, V4, P1819; Hua WJ, 2015, OPHTHAL PHYSL OPT, V35, P252, DOI 10.1111/opo.12207; Meenakshi J., 2015, Asian Journal of Home Science, V10, P221, DOI 10.15740/HAS/AJHS/10.1/221-226; Mott MS, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012445585; Narayanasamy S, 2016, CLIN EXP OPTOM, V99, P233, DOI 10.1111/cxo.12365; Negiloni K, 2018, INDIAN J OPHTHALMOL, V66, P285, DOI [10.4103/ijo.IJO_772_17, 10.4103/ijo.IJO_1165_17]; Negiloni K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174983; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Ramamurthy D, 2015, CLIN EXP OPTOM, V98, P497, DOI 10.1111/cxo.12346; Samani S.A., 2012, INT J BUSINESS SOCIA, V3, P127; Zhou ZQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181772	16	2	2	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210299	10.1371/journal.pone.0210299	http://dx.doi.org/10.1371/journal.pone.0210299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1ME	30629656	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000071
J	Gehrig, S; Schluter, A; Hammerstein, P				Gehrig, Stefan; Schlueter, Achim; Hammerstein, Peter			Sociocultural heterogeneity in a common pool resource dilemma	PLOS ONE			English	Article							ARTIFACTUAL FIELD EXPERIMENTS; COLLECTIVE ACTION; PUBLIC-GOODS; COOPERATION; EVOLUTION; FISHERIES; TRAGEDY; TRUST; GAME; SUSTAINABILITY	Collective action of resource users is essential for sustainability. Yet, often user groups are socioculturally heterogeneous, which requires cooperation to be established across salient group boundaries. We explore the effect of this type of heterogeneity on resource extraction in lab-in-the-field Common Pool Resource (CPR) experiments in Zanzibar, Tanzania. We create heterogeneous groups by mixing fishers from two neighbouring fishing villages which have distinct social identities, a history of conflict and diverging resource use practices and institutions. Additionally, we analyse between-village differences in extraction behaviour in the heterogeneous setting to assess if out-group cooperation in a CPR dilemma is associated with a community's institutional scope in the economic realm (e.g., degree of market integration). We find no aggregate effect of heterogeneity on extraction. However, this is because fishers from the two villages behave differently in the heterogeneity treatment. We find support for the hypothesis that cooperation under sociocultural heterogeneity is higher for fishers from the village with larger institutional scope. In line with this explanation, cooperation under heterogeneity also correlates with a survey measure of individual fishers' radius of trust. We discuss implications for resource governance and collective action research.	[Gehrig, Stefan; Schlueter, Achim] Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany; [Schlueter, Achim] Jacobs Univ, Dept Econ & Business, Bremen, Germany; [Hammerstein, Peter] Humboldt Univ, Inst Theoret Biol, Berlin, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Jacobs University; Humboldt University of Berlin	Gehrig, S (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany.	stefan-gehrig@t-online.de	Gehrig, Stefan/L-7990-2019	Gehrig, Stefan/0000-0002-5270-9578	Leibniz Association [SAW-2013-ZMT-4 234]; Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS)	Leibniz Association; Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS)	The work was funded by the Leibniz Association (SAW-2013-ZMT-4 234) and the Leibniz Center for Tropical Marine Research (ZMT) within the project Sustainable Use of Tropical Aquatic Systems (SUTAS).	Adger WN, 2003, ECON GEOGR, V79, P387; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Alvard MS, 2004, ULTIMATUM GAME FAIRN, P413; Anderies JM, 2011, ECOL ECON, V70, P1571, DOI 10.1016/j.ecolecon.2011.01.011; Andrews J, 2018, SUSTAIN SCI, P1; [Anonymous], R LANG ENV STAT COMP; Apesteguia J, 2006, J CONFLICT RESOLUT, V50, P646, DOI 10.1177/0022002706290433; Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; Bardhan Pranab K., 2002, DRAMA COMMONS, P87; Basurto X, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501220; Beckenkamp M., 2006, CENTRAL EUROPEAN J O, V14, P337, DOI DOI 10.1007/S10100-006-0008-5; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.2307/2641280; Bowles S., 2004, ROUNDTABLE SER BEHAV; Burns J, 2015, J ECON BEHAV ORGAN, V118, P110, DOI 10.1016/j.jebo.2015.02.018; Carballo DM, 2014, J ARCHAEOL METHOD TH, V21, P98, DOI 10.1007/s10816-012-9147-2; Cardenas JC, 2004, AGR SYST, V82, P307, DOI 10.1016/j.agsy.2004.07.008; Carpenter J, 2011, ECON INQ, V49, P612, DOI 10.1111/j.1465-7295.2009.00268.x; Castillo D, 2011, ECOL ECON, V70, P1609, DOI 10.1016/j.ecolecon.2011.05.011; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Christensen RHB., 2015, ORDINAL REGRESSION M; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Croissant Y, 2008, J STAT SOFTW, V27, P1; Cumming GS, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12376; de la Torre-Castro M., 2012, PEOPLE NATURE RES CH; de la Torre- Castro M, 2012, MANAGEMENT CHALLENGE, P279; de la Torre-Castro M, 2006, ECOL SOC, V11; de la Torre-Castro M, 2014, MAR POLLUT BULL, V83, P398, DOI 10.1016/j.marpolbul.2014.03.034; de la Torre-Castro M, 2010, MAR POLICY, V34, P77, DOI 10.1016/j.marpol.2009.04.012; de Melo G, 2015, ECOL ECON, V120, P376, DOI 10.1016/j.ecolecon.2015.05.011; Elsner W, 2014, J I ECON, V10, P107, DOI 10.1017/S1744137413000179; Eriksson K, 2014, JUDGM DECIS MAK, V9, P360; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Gehrig S, 2018, MAR POLICY, V96, P100, DOI 10.1016/j.marpol.2018.06.017; Gelcich S, 2013, ECOL SOC, V18, DOI 10.5751/ES-05598-180302; Gneezy U, 2016, ECON J, V126, P1856, DOI 10.1111/ecoj.12209; Gowdy J, 2013, ECOL ECON, V95, P137, DOI 10.1016/j.ecolecon.2013.08.006; Guerrero AM, 2015, CONSERV LETT, V8, P107, DOI 10.1111/conl.12112; Gurven MD, 2018, P NATL ACAD SCI USA, V115, P11420, DOI 10.1073/pnas.1720433115; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hakansson E, 2012, PEOPLE NATURE RES CH, P234; Handberg ON, 2015, J ECON BEHAV ORGAN, V118, P346, DOI 10.1016/j.jebo.2015.03.007; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henningsen A., 2017, CENSREG CENSORED REG; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; HIRSCHMAN AO, 1982, J ECON LIT, V20, P1463; Hruschka DJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00559; Jiddawi N., 2012, PEOPLE NATURE RES CH, P23; Jiddawi N. S., 2012, PEOPLE NATURE RES CH, P193; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Kasper C, 2015, CURR ANTHROPOL, V56, P701, DOI 10.1086/683024; Khadjavi M, 2017, SOCIAL CAPITAL LARGE; Kinship Enke B., Q J EC; Kline MA, 2018, SUSTAIN SCI, V13, P9, DOI 10.1007/s11625-017-0509-2; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Lindstrom L, 2015, PROMOTING GOVERNABIL, P671; Lindstrom L, 2015, MARE PUBL SER, V13, P671, DOI 10.1007/978-3-319-17034-3_34; Mulder M.B., 2005, CONSERVATION LINKING; Myers GA, 2002, AREA, V34, P149, DOI 10.1111/1475-4762.00067; Nee V, 2018, ORGAN SCI, V29, P969, DOI 10.1287/orsc.2018.1213; Ortmann A., 2005, FIELD EXPT EC, P51; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E, 1994, GAMES COMMON POOL RE; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Paciotti B, 2003, CURR ANTHROPOL, V44, P427, DOI 10.1086/374903; Pakenham R. H. W., 1947, LAND TENURE WAHADIMU; Pisor AC, 2018, PEERJ PREPR; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Rehren J., 2017, THESIS U BREMEN U BR; Richerson P.J., 1996, PRINCIPLES HUMAN ECO; Romano A, 2017, P NATL ACAD SCI USA, V114, P12702, DOI 10.1073/pnas.1712921114; Rommel J, 2015, ENVIRON SCI POLICY, V53, P96, DOI 10.1016/j.envsci.2014.05.006; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Ruttan LM, 2006, CURR ANTHROPOL, V47, P843, DOI 10.1086/507185; Schaub Max, 2017, Proc Biol Sci, V284, DOI 10.1098/rspb.2017.1560; Schroeder KB, 2014, PEERJ, V2, DOI 10.7717/peerj.450; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Torres-Guevara LE, 2016, ECOL ECON, V128, P187, DOI 10.1016/j.ecolecon.2016.04.022; Varughese G, 2001, WORLD DEV, V29, P747, DOI 10.1016/S0305-750X(01)00012-2; Voors M, 2011, AM ECON REV, V101, P329, DOI 10.1257/aer.101.3.329; Wallner-Hahn S, 2016, MAR POLICY, V72, P199, DOI 10.1016/j.marpol.2016.07.001; Waring TM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07634-200234; Welzel C, 2015, J CROSS CULT PSYCHOL, V46, P875, DOI 10.1177/0022022115588366; Wible B, 2018, SCIENCE, V362, P1236, DOI 10.1126/science.aaw0911	86	7	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210561	10.1371/journal.pone.0210561	http://dx.doi.org/10.1371/journal.pone.0210561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8WT	30653546	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500051
J	Yang, ZC; Yang, CC; Wang, ZY; Yang, Z; Chen, DY; Wu, YJ				Yang, Zhenchao; Yang, Chengcheng; Wang, Zhengyan; Yang, Zhao; Chen, Danyan; Wu, Yongjun			LncRNA expression profile and ceRNA analysis in tomato during flowering	PLOS ONE			English	Article							LONG NONCODING RNAS; NATURAL ANTISENSE TRANSCRIPTS; GENOME-WIDE ANALYSIS; FUNCTIONAL PREDICTION; GENE; IDENTIFICATION; ROLES; PROTEIN; COOLAIR; FLC	Long non-coding RNAs (lncRNAs) are a class of non-coding RNAs that play essential regulatory roles in various developmental processes and stress responses. However, the functions of lncRNAs during the flowering period of tomato are largely unknown. To explore the lncRNA profiles and functions during flowering in tomato, we performed strand-specific paired-end RNA sequencing of tomato leaves, flowers and roots, with three biological replicates. We identified 10919 lncRNAs including 248 novel lncRNAs, of which 65 novel lncRNAs were significantly differentially expressed (DE) in the flowers, leaves, and roots. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were carried out to identify the cis target gene of DE lncRNAs. The results showed that the lncRNAs might play an important role in the growth, development, and apoptosis of flowering tomato plant by regulating the formation of intima in flower tissues, binding to various molecules, influencing metabolic pathways, and inducing apoptosis. Moreover, we identified the interaction between 32, 78, and 397 kinds of miRNAs, lncRNAs, and mRNAs. The results suggest that the lncRNAs can regulate the expression of mRNA during flowering period in tomato by forming competitive endogenous RNA, and further regulate various biological metabolism pathways in tomato.	[Yang, Zhenchao; Yang, Chengcheng; Wang, Zhengyan; Yang, Zhao; Chen, Danyan; Wu, Yongjun] Northwest A&F Univ, Coll Life Sci, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, YJ (corresponding author), Northwest A&F Univ, Coll Life Sci, Coll Hort, Yangling, Shaanxi, Peoples R China.	yjwu669@163.com			National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables" [2018YFD0201200]; Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture [NYKJ-2018-YL22, 2017-TS-2]	National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables"; Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture	This work was supported by the National Key R&D Program, "Integrated Research and Demonstration of Fertilizer and Pesticide Reduction Technology in Open Field Vegetables" (2018YFD0201200), Agricultural Science and Technology Innovation Integration Promotion Project of Shaanxi Provincial Department of Agriculture (NYKJ-2018-YL22 and 2017-TS-2) (ZY) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bhatia Garima, 2017, Non-Coding RNA, V3, P16, DOI 10.3390/ncrna3020016; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Celton JM, 2014, NEW PHYTOL, V203, P287, DOI 10.1111/nph.12787; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Deng FN, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1238-0; Deng PC, 2018, SCI CHINA LIFE SCI, V61, P190, DOI 10.1007/s11427-017-9174-9; Di C, 2014, PLANT J, V80, P848, DOI 10.1111/tpj.12679; Fernandez MV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007045; He L, 2018, EPIGENOMICS-UK, V10, P661, DOI 10.2217/epi-2017-0176; Heo JB, 2013, CHROMOSOME RES, V21, P685, DOI 10.1007/s10577-013-9392-6; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hotto AM, 2011, G3-GENES GENOM GENET, V1, P559, DOI 10.1534/g3.111.000752; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; LI L, 2014, GENOME BIOL, V15; Li R, 2018, PLANT J, V94, P513, DOI 10.1111/tpj.13872; Li S, 2013, GENOME RES, V23, P1730, DOI 10.1101/gr.149310.112; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Chang, 2017, Yichuan, V39, P1054, DOI 10.16288/j.yczz.17-120; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Marquardt S, 2014, MOL CELL, V54, P156, DOI 10.1016/j.molcel.2014.03.026; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nejat N, 2018, CRIT REV BIOTECHNOL, V38, P93, DOI 10.1080/07388551.2017.1312270; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Riffo-Campos AL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121987; Rubio-Somoza I, 2011, CELL, V147, P1431, DOI 10.1016/j.cell.2011.12.003; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shafiq S, 2016, BBA-GENE REGUL MECH, V1859, P155, DOI 10.1016/j.bbagrm.2015.06.009; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Signal B, 2016, TRENDS GENET, V32, P620, DOI 10.1016/j.tig.2016.08.004; Song DD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S36; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16946; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang RH, 2018, ECOL EVOL, V8, P6034, DOI 10.1002/ece3.4152; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wang YQ, 2014, MOL PLANT, V7, P514, DOI 10.1093/mp/sst177; Wang Z, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0671-2; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xu XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20715; YOUNG MD, 2010, GENOME BIOL, V11; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhang YC, 2013, BIOCHEM BIOPH RES CO, V436, P111, DOI 10.1016/j.bbrc.2013.05.086; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203; Zhu M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100274	66	17	17	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210650	10.1371/journal.pone.0210650	http://dx.doi.org/10.1371/journal.pone.0210650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653557	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500059
J	Akami, M; Andongma, AA; Chen, ZZ; Nan, J; Khaeso, K; Jurkevitch, E; Niu, CY; Yuval, B				Akami, Mazarin; Andongma, Awawing A.; Chen Zhengzhong; Nan, Jiang; Khaeso, Kanjana; Jurkevitch, Edouard; Niu, Chang-Ying; Yuval, Boaz			Intestinal bacteria modulate the foraging behavior of the oriental fruit fly Bactrocera dorsalis (Diptera: Tephritidae)	PLOS ONE			English	Article							GUT MICROBIOTA; CULTIVABLE BACTERIA; FLIES; STATE; HOST; COMMUNITIES; POPULATIONS; DROSOPHILA; DIVERSITY; MANIPULATION	The gut microbiome of insects directly or indirectly affects the metabolism, immune status, sensory perception and feeding behavior of its host. Here, we examine the hypothesis that in the oriental fruit fly (Bactrocera dorsalis, Diptera: Tephritidae), the presence or absence of gut symbionts affects foraging behavior and nutrient ingestion. We offered protein-starved flies, symbiotic or aposymbiotic, a choice between diets containing all amino acids or only the non-essential ones. The different diets were presented in a foraging arena as drops that varied in their size and density, creating an imbalanced foraging environment. Suppressing the microbiome resulted in significant changes of the foraging behavior of both male and female flies. Aposymbiotic flies responded faster to the diets offered in experimental arenas, spent more time feeding, ingested more drops of food, and were constrained to feed on time-consuming patches (containing small drops of food), when these offered the full complement of amino acids. We discuss these results in the context of previous studies on the effect of the gut microbiome on host behavior, and suggest that these be extended to the life history dimension.	[Akami, Mazarin; Andongma, Awawing A.; Chen Zhengzhong; Nan, Jiang; Khaeso, Kanjana; Niu, Chang-Ying] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Protect, Wuhan, Hubei, Peoples R China; [Akami, Mazarin] Univ Ngaoundere, Fac Sci, Dept Biol Sci, Ngaoundere, Cameroon; [Jurkevitch, Edouard] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, Rehovot, Israel; [Yuval, Boaz] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Entomol, Rehovot, Israel	Huazhong Agricultural University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Niu, CY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Protect, Wuhan, Hubei, Peoples R China.; Yuval, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Entomol, Rehovot, Israel.	niuchangying88@163.com; boaz.yuval@mail.huji.ac.il	Andongma, Awawing/AAN-3813-2020; Yuval, Boaz/C-3447-2009	Yuval, Boaz/0000-0002-6864-3825	Israel Science Foundation [2482/16]; Science Foundation of China [2482/16]; National Natural Science Foundation of China [31661143045]; International Atomic Energy Agency (CRP) [17153, 18269]; Agricultural public welfare industry research - Ministry of Agriculture of People's Republic of China [201503137]; Fundamental Research Funds for the Central Universities [2662015PY148]	Israel Science Foundation(Israel Science Foundation); Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Atomic Energy Agency (CRP)(International Atomic Energy Agency); Agricultural public welfare industry research - Ministry of Agriculture of People's Republic of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the Joint programme of the Israel Science Foundation and the Science Foundation of China (2482/16), National Natural Science Foundation of China (31661143045), International Atomic Energy Agency (CRP No. 17153 and No. 18269), Agricultural public welfare industry research supported by Ministry of Agriculture of People's Republic of China (201503137) and the Fundamental Research Funds for the Central Universities (2662015PY148).	Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Barton Browne L., 1975, Advances Insect Physiol, V11, P1; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behar Adi, 2009, P251; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2014, J EVOLUTION BIOL, V27, P2695, DOI 10.1111/jeb.12527; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Ben-Yosef M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150170; Ben-Yosef M, 2010, P ROY SOC B-BIOL SCI, V277, P1545, DOI 10.1098/rspb.2009.2102; Berasategui A, 2017, MOL ECOL, V26, P4099, DOI 10.1111/mec.14186; Catalan TP, 2011, EVOL ECOL RES, V13, P711; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chapman RF., 1995, REGULATORY MECH INSE, Vvol. 1995; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Eisthen HL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0052; Gadenne C, 2016, ANNU REV ENTOMOL, V61, P317, DOI 10.1146/annurev-ento-010715-023523; Gujjar NR, 2017, PHYTOPARASITICA, V45, P453, DOI 10.1007/s12600-017-0604-z; Guo ZJ, 2017, APPL MICROBIOL BIOT, V101, P8543, DOI 10.1007/s00253-017-8551-7; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Jin S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00672; Khaeso K, 2018, SYMBIOSIS, V74, P97, DOI 10.1007/s13199-017-0493-4; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Liu LJ, 2016, B ENTOMOL RES, V106, P718, DOI 10.1017/S0007485316000390; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mazzon L, 2010, MOL PHYLOGENET EVOL, V56, P312, DOI 10.1016/j.ympev.2010.02.016; Nash WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086029; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Pramanik M. K., 2014, Research Journal of Microbiology, V9, P278; PROKOPY RJ, 1991, OECOLOGIA, V87, P394, DOI 10.1007/BF00634597; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reyes H, 2017, PHYSIOL ENTOMOL, V42, P17, DOI 10.1111/phen.12157; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Roeder KA, 2014, FUNCT ECOL, V28, P1135, DOI 10.1111/1365-2435.12262; Sengupta L, 2013, CURR OPIN NEUROBIOL, V23, P68, DOI 10.1016/j.conb.2012.08.001; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Slansky Frank Jr., 1993, P29; Stephens D.W., 1986, pi; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wang HX, 2014, PEST MANAG SCI, V70, P80, DOI 10.1002/ps.3528; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wong ACN, 2017, CURR BIOL, V27, P2397, DOI 10.1016/j.cub.2017.07.022; Yuval B, 2017, CURR BIOL, V27, pR746, DOI 10.1016/j.cub.2017.06.050	51	43	43	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2019	14	1							e0210109	10.1371/journal.pone.0210109	http://dx.doi.org/10.1371/journal.pone.0210109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6BK	30650116	Green Published, Green Submitted, gold			2022-12-27	WOS:000455813300043
J	Meiners, JM; Griswold, TL; Carril, OM				Meiners, Joan M.; Griswold, Terry L.; Carril, Olivia Messinger			Decades of native bee biodiversity surveys at Pinnacles National Park highlight the importance of monitoring natural areas over time	PLOS ONE			English	Article							HYMENOPTERA APOIDEA; WILD BEES; COMMUNITIES; POLLINATION; RESPONSES; FAUNA; CHRONOSEQUENCE; POPULATIONS; GRASSLANDS; DIVERSITY	Thousands of species of bees are in global decline, yet research addressing the ecology and status of these wild pollinators lags far behind work being done to address similar impacts on the managed honey bee. This knowledge gap is especially glaring in natural areas, despite knowledge that protected habitats harbor and export diverse bee communities into nearby croplands where their pollination services have been valued at over $3 billion per year. Surrounded by ranches and farmlands, Pinnacles National Park in the Inner South Coast Range of California contains intact Mediterranean chaparral shrubland. This habitat type is among the most valuable for bee biodiversity worldwide, as well as one of the most vulnerable to agricultural conversion, urbanization and climate change. Pinnacles National Park is also one of a very few locations where extensive native bee inventory efforts have been repeated over time. This park thus presents a valuable and rare opportunity to monitor long-term trends and baseline variability of native bees in natural habitats. Fifteen years after a species inventory marked Pinnacles as a biodiversity hotspot for native bees, we resurveyed these native bee communities over two flowering seasons using a systematic, plot-based design. Combining results, we report a total of 450 bee species within this 109km(2) natural area of California, including 48 new species records as of 2012 and 95 species not seen since 1999. As far as we are aware, this species richness marks Pinnacles National Park as one of the most densely diverse places known for native bees. We explore patterns of bee diversity across this protected landscape, compare results to other surveyed natural areas, and highlight the need for additional repeated inventories in protected areas over time amid widespread concerns of bee declines.	[Meiners, Joan M.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Griswold, Terry L.] Utah State Univ, USDA ARS, Pollinating Insects Res Unit, Logan, UT 84322 USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Meiners, JM (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	joan.meiners@gmail.com		Meiners, Joan/0000-0001-9369-9313	Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit [P10AC00577]; University of Florida Biodiversity Institute Graduate Fellowship; Utah State University Ecology Center	Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit; University of Florida Biodiversity Institute Graduate Fellowship; Utah State University Ecology Center	This project was funded by Pinnacles National Park through the Great Basin Cooperative Ecosystem Studies Unit (Task Agreement number P10AC00577 awarded to TLG). (http://www.cesu.psu.edu/unit_portals/unit_materials/cooperative_agreements/GRBA/GRBA_CESU_2016_AMD01. pdf). JMM was supported by a University of Florida Biodiversity Institute Graduate Fellowship, and by the Utah State University Ecology Center. (https://biodiversity.institute.ufl.edu/; https://ecology.usu.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bohart G, 1973, P UT AC SCI ARTS LET; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Brown John W., 2008, Bulletin of the Biological Society of Washington, V15, P54, DOI 10.2988/0097-0298(2008)15[54:TIIFOP]2.0.CO;2; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Debano SJ, 2006, BIODIVERS CONSERV, V15, P2547, DOI 10.1007/s10531-005-2786-9; Deyrup M, DIVERSITY FLORAL HOS; Donovan B.J., 1980, New Zealand Journal of Ecology, V3, P104; Drons DJ, 2012, INVENTORY NATIVE BEE; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Frankie GW, 2009, CALIF AGR, V63, P113, DOI 10.3733/ca.v063n03p113; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giles V, 2006, J HYMENOPT RES, V15, P208; Gonzalez VH, 2013, SYST ENTOMOL, V38, P645, DOI 10.1111/syen.12029; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Griffin SR, 2017, RESTOR ECOL, V25, P650, DOI 10.1111/rec.12481; Griswold TL, 1999, SURVEY RARE BEES CLA; Grundel R, 2011, J KANSAS ENTOMOL SOC, V84, P105, DOI 10.2317/JKES101027.1; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Iles DT, 2018, J APPL ECOL, V55, P2802, DOI 10.1111/1365-2664.13175; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kuhlman M, BIODIVERS DATA J; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; LeBuhn G., 2003, STANDARDIZED METHOD; LINSLEY E. GORTON, 1958, HILGARDIA, V27, P543; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Marlin JC, 2007, ECOL SOC; MATTHEWS V, 1976, AAPG BULL, V60, P2128; Meiners J., 2018, NATIVE BEE BIODIVERS; Meiners JM, 2015, NATIVE BEES PINNACLE, P76; Meiners JM, 2016, BIODIVERSITY COMMUNI; Meiners JM, 2017, AM NAT, V190, P281, DOI 10.1086/692437; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Messinger O., 2006, SURVEY BEES GRAND ST; Messinger O, 2003, FREMONTIA, V30, P32; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; MICHENER CD, 1947, AM MIDL NAT, V38, P443, DOI 10.2307/2421575; Minckley R, 2008, APIDOLOGIE, V39, P176, DOI 10.1051/apido:2007062; Minckley RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2703; MOLDENKE A R, 1976, Phytologia, V34, P305; Moldenke AR, 1976, WASMANN J BIOL, V34, P147; Morandin LA, 2013, ECOL APPL, V23, P829, DOI 10.1890/12-1051.1; Morse R, 2001, BEE CULT, V128; NPS, 2015, NAT PINN NAT PARK; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R-Core-Team, 2015, LANG ENV STAT COMP; Rhoades Paul, 2017, Journal of Melittology, V66, P1; Romero GQ, 2018, NAT CLIM CHANGE, V8, P1087, DOI 10.1038/s41558-018-0347-y; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roubik DW, 2001, UPS DOWNS POLLINATOR; Rust R, 1985, ENTOMOLOGY OF THE CA, P22; SAWYER J.O., 2012, JEPSON MANUAL VASCUL, P1152; Smith BA, 2012, J KANSAS ENTOMOL SOC, V85, P32, DOI 10.2317/JKES111025.1; Tepedino V.J., 1979, Great Basin Naturalist Memoirs, P139; Tepedino V.J., 1998, NATL MONUMENT SCI S, P175; TEPEDINO VJ, 1981, OIKOS, V36, P35, DOI 10.2307/3544376; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tucker S, 2006, B CALIF LICHEN SOC, V13, P8; Vilela AA, 2018, ARTHROPOD-PLANT INTE, V12, P215, DOI 10.1007/s11829-017-9572-y; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams NM, 2001, CONSERV ECOL, V5; Wilson JS, 2009, J ARID ENVIRON, V73, P666, DOI 10.1016/j.jaridenv.2009.01.004; Wilson JS, 2010, WEST N AM NATURALIST, V70, P198, DOI 10.3398/064.070.0206; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wolf Amy T., 2008, Great Lakes Entomologist, V41, P129	90	18	18	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0207566	10.1371/journal.pone.0207566	http://dx.doi.org/10.1371/journal.pone.0207566			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653514	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500008
J	Wei, PL; Huang, CY; Chang, YJ				Wei, Po-Li; Huang, Chien-Yu; Chang, Yu-Jia			Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; OXIDATIVE STRESS; HELA-CELLS; APOPTOSIS; CYTOTOXICITY; TOXICITY; CURCUMIN	The poor prognosis of hepatocellular carcinoma (HCC) has been attributed to a high frequency of tumor metastasis and recurrence even after successful surgical resection. With less than 30% of patients benefiting from curative treatment, alternative treatment regimens for patients with advanced HCC are needed. Propyl gallate (PG), a synthetic antioxidant used in preserving food and medicinal preparations, has been shown to induce cancer cell death, but the anticancer effects of PG in HCC are unclear. In the present study, we demonstrated that PG inhibited HCC cell proliferation in vitro and in zebrafish models in vivo in a dose-and time-dependent manner. PG also induced cell apoptosis and increased the number of necrotic cells in a time-and dose-dependent manner as determined using a high-content analysis system. We found that PG also increased the intracellular levels of superoxide and reactive oxidative stress as well as the formation of autophagosomes and lysosomes. Regarding the molecular mechanism, PG did not alter the levels of autophagy-related 5 (ATG5), ATG5/12 or Beclin-1 but increased the rate of the LC3-I to LC3-II conversion, suggesting autophagy induction. PG exposure increased the levels of the pro-apoptotic proteins cleaved caspase-3, cleaved PARP, Bax, and Bad and a decreased level of the anti-apoptotic protein Bcl-2. In conclusion, we demonstrate that PG inhibits HCC cell proliferation through enhanced ROS production and autophagy activation. Finally, PG-treated cells induced cell apoptosis and may be a new candidate for HCC therapy.	[Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Div Colorectal Surg, Dept Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Huang, CY (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw			Taipei Medical University; Taipei Medical University Hospital [106TMU-TMUH-07]	Taipei Medical University; Taipei Medical University Hospital	This work was supported by a grant from Taipei Medical University and Taipei Medical University Hospital (106TMU-TMUH-07) to PLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2009, PROSTAG LEUKOTR ESS, V81, P391, DOI 10.1016/j.plefa.2009.08.003; Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bao W, 2010, J ETHNOPHARMACOL, V128, P549, DOI 10.1016/j.jep.2010.01.029; Bi Q, 2015, CLIN EXP METASTAS, V32, P301, DOI 10.1007/s10585-015-9706-5; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Che XH, 2012, ARCH PHARM RES, V35, P2205, DOI 10.1007/s12272-012-1219-z; Chen C, 2017, NITRIC OXIDE-BIOL CH, V70, P31, DOI 10.1016/j.niox.2017.07.005; Chen CH, 2011, FOOD CHEM TOXICOL, V49, P494, DOI 10.1016/j.fct.2010.11.031; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng P, 2013, CELL DEATH DIS, V4; Eler GJ, 2009, CHEM-BIOL INTERACT, V181, P390, DOI 10.1016/j.cbi.2009.07.006; Farrell GC, 2010, J GASTROEN HEPATOL, V25, P657, DOI 10.1111/j.1440-1746.2009.06167.x; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Hamishehkar H, 2014, DRUG CHEM TOXICOL, V37, P241, DOI 10.3109/01480545.2013.838776; Han LL, 2014, WORLD J GASTROENTERO, V20, P10249, DOI 10.3748/wjg.v20.i30.10249; Han YH, 2009, FOOD CHEM TOXICOL, V47, P2531, DOI 10.1016/j.fct.2009.07.013; Han YH, 2009, ARCH TOXICOL, V83, P825, DOI 10.1007/s00204-009-0430-2; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Jacobi H, 1998, FREE RADICAL BIO MED, V24, P972, DOI 10.1016/S0891-5849(97)00400-0; Jung HJ, 2011, INFLAMMATION, V34, P352, DOI 10.1007/s10753-010-9241-0; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Kuczynski EA, 2015, CANCER RES, V75, P2510, DOI 10.1158/0008-5472.CAN-14-3687; Li YJ, 2017, CHIN J CANCER, V52, DOI 10.1186/s40880-017-0219-2; Liang HH, 2018, LIFE SCI, V209, P43, DOI 10.1016/j.lfs.2018.07.047; Liang HH, 2013, TUMOR BIOL, V34, P3209, DOI 10.1007/s13277-013-0891-z; Liu ZK, 2017, CELL PHYSIOL BIOCHEM, V44, P1856, DOI 10.1159/000485821; Luo KW, 2011, CHEMOTHERAPY, V57, P449, DOI 10.1159/000331641; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Makhov P, 2014, BRIT J CANCER, V110, P899, DOI 10.1038/bjc.2013.810; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moniruzzaman M, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0168-5; NAKAGAWA Y, 1995, MOL PHARMACOL, V47, P1021; Nakagawa Y, 1996, TOXICOLOGY, V114, P135, DOI 10.1016/S0300-483X(96)03479-8; Panchenko L. E., 2013, Biomeditsinskaya Khimiya, V59, P452; Park EJ, 2000, J PHARM PHARMACOL, V52, P437, DOI 10.1211/0022357001774048; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reddan JR, 2003, EXP EYE RES, V76, P49, DOI 10.1016/S0014-4835(02)00256-7; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; ROSIN MP, 1980, J ENVIRON PATHOL TOX, V4, P159; Severi T, 2006, MOL CELL BIOCHEM, V290, P79, DOI 10.1007/s11010-006-9167-x; Shaker E, 2010, FOOD CHEM TOXICOL, V48, P803, DOI 10.1016/j.fct.2009.12.011; Shingai Y, 2011, J AGR FOOD CHEM, V59, P8180, DOI 10.1021/jf202561p; SUGIOKA A, 1993, SURGERY, V113, P612; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wang RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139232; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Wang YB, 2017, EBIOMEDICINE, V17, P45, DOI 10.1016/j.ebiom.2017.02.019; Wang ZP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7891574; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xu J, 2008, ANTIVIR RES, V78, P242, DOI 10.1016/j.antiviral.2007.11.011; Xu Yan, 2006, Zhonghua Yan Ke Za Zhi, V42, P309; Yang JT, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9489383; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; You BR, 2011, ONCOL REP, V25, P871, DOI 10.3892/or.2010.1121; Zaidi S M Kashif R, 2005, Drugs R D, V6, P157, DOI 10.2165/00126839-200506030-00004	66	25	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210513	10.1371/journal.pone.0210513	http://dx.doi.org/10.1371/journal.pone.0210513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653551	Green Submitted, Green Published, gold			2022-12-27	WOS:000456015500046
J	Agerso, Y; Bjerre, K; Brockmann, E; Johansen, E; Nielsen, B; Siezen, R; Stuer-Lauridsen, B; Wels, M; Zeidan, AA				Agerso, Yvonne; Bjerre, Karin; Brockmann, Elke; Johansen, Eric; Nielsen, Bea; Siezen, Roland; Stuer-Lauridsen, Birgitte; Wels, Michiel; Zeidan, Ahmad A.			Putative antibiotic resistance genes present in extant Bacillus licheniformis and Bacillus paralicheniformis strains are probably intrinsic and part of the ancient resistome	PLOS ONE			English	Article							ERYTHROMYCIN ESTERASE; BACTERIAL-RESISTANCE; NUCLEOTIDE-SEQUENCE; SP NOV.; MACROLIDE; CHLORAMPHENICOL; AMINOGLYCOSIDES; IDENTIFICATION; DETERMINANT; MECHANISMS	Whole-genome sequencing and phenotypic testing of 104 strains of Bacillus licheniformis and Bacillus paralicheniformis from a variety of sources and time periods was used to characterize the genetic background and evolution of (putative) antimicrobial resistance mechanisms. Core proteins were identified in draft genomes and a phylogenetic analysis based on single amino acid polymorphisms allowed the species to be separated into two phylogenetically distinct clades with one outlier. Putative antimicrobial resistance genes were identified and mapped. A chromosomal ermD gene was found at the same location in all B. paralichenformis and in 27% of B. licheniformis genomes. Erythromycin resistance correlated very well with the presence of ermD. The putative streptomycin resistance genes, aph and aadK, were found in the chromosome of all strains as adjacent loci. Variations in amino acid sequence did not correlate with streptomycin susceptibility although the species were less susceptible than other Bacillus species. A putative chloramphenicol resistance gene (cat), encoding a novel chloramphenicol acetyltransferase protein was also found in the chromosome of all strains. Strains encoding a truncated CAT protein were sensitive to chloramphenicol. For all four resistance genes, the diversity and genetic context followed the overall phylogenetic relationship. No potentially mobile genetic elements were detected in their vicinity. Moreover, the genes were only distantly related to previously-described cat, aph, aad and erm genes present on mobile genetic elements or in other species. Thus, these genes are suggested to be intrinsic to B. licheniformis and B. paralicheniformis and part of their ancient resistomes. Since there is no evidence supporting horizontal transmission, these genes are not expected to add to the pool of antibiotic resistance elements considered to pose a risk to human or animal health. Whole-genome based phylogenetic and sequence analysis, combined with phenotypic testing, is proposed to be suitable for determining intrinsic resistance and evolutionary relationships.	[Agerso, Yvonne; Bjerre, Karin; Brockmann, Elke; Johansen, Eric; Nielsen, Bea; Stuer-Lauridsen, Birgitte; Zeidan, Ahmad A.] Chr Hansen AS, Horsholm, Denmark; [Siezen, Roland] Microbial Bioinformat, Ede, Netherlands; [Wels, Michiel] NIZO, Ede, Netherlands	Chr Hansen; NIZO Food Research	Agerso, Y (corresponding author), Chr Hansen AS, Horsholm, Denmark.	dkyvag@chr-hansen.com	Zeidan, Ahmad A./ABG-3139-2020; Zeidan, Ahmad Adel/A-7845-2012	Zeidan, Ahmad A./0000-0001-9984-5625; Zeidan, Ahmad Adel/0000-0001-9984-5625; Johansen, Eric/0000-0003-2155-8866; Agerso, Yvonne/0000-0002-5560-8158; Bjerre, Karin/0000-0001-6439-7877	Chr. Hansen A/S	Chr. Hansen A/S	This research was supported exclusively by internal funds at Chr. Hansen A/S.	Adimpong DB, 2012, APPL ENVIRON MICROB, V78, P7903, DOI 10.1128/AEM.00730-12; Agerso Y, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01108-18; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; [Anonymous], GEN REC SAF GRAS NOT; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; ARTHUR M, 1986, NUCLEIC ACIDS RES, V14, P4987, DOI 10.1093/nar/14.12.4987; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Devirgiliis C, 2011, GENES NUTR, V6, P275, DOI 10.1007/s12263-011-0226-x; Duc LH, 2003, VACCINE, V21, P4215, DOI 10.1016/S0264-410X(03)00492-4; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P3487, DOI 10.1099/ijsem.0.000441; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; European Commission, 2002, OP SCI COMM AN NUTR; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; GRYCZAN T, 1984, MOL GEN GENET, V194, P349, DOI 10.1007/BF00425543; GRYCZAN TJ, 1984, MOL GEN GENET, V194, P357, DOI 10.1007/BF00425544; HUE KK, 1992, J BACTERIOL, V174, P5860, DOI 10.1128/jb.174.18.5860-5868.1992; Ishihara H, 2002, CURR MICROBIOL, V45, P18, DOI 10.1007/s00284-001-0041-5; Johansen E, 2015, WOODHEAD PUBL FOOD S, V265, P227, DOI 10.1016/B978-1-78242-015-6.00010-4; KIM HS, 1993, J GEN MICROBIOL, V139, P601, DOI 10.1099/00221287-139-3-601; Kim SJ, 2015, INT J SYST EVOL MICR, V65, P3586, DOI 10.1099/ijsem.0.000462; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Krause KM, 2016, COLD SPRING HARB PER, V6; KWAK JH, 1991, J BACTERIOL, V173, P4725, DOI 10.1128/jb.173.15.4725-4735.1991; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; Lopes R, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2479-7; Madslien EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-230; Martinez JL, 2017, ANN NY ACAD SCI, V1388, P26, DOI 10.1111/nyas.13282; Mulder Nicola, 2007, V396, P59; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; OUNISSI H, 1985, GENE, V35, P271, DOI 10.1016/0378-1119(85)90005-8; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rachinger M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00525-13; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts MC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00040; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; RYCHEN G, 2018, EFSA J, V16, DOI [DOI 10.2903/J.EFSA.2018.5206, 10.2903/j.efsa.2018.5206]; Santiago-Rodriguez T.M., 2018, HUMAN MICROBIOME J, V10, P21, DOI [10.1016/j.humic.2018.07.001, DOI 10.1016/J.HUMIC.2018.07.001]; Santiago-Rodriguez TM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110310; Santiago-Rodriguez TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138135; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; van Reenen CA, 2011, ARCH MICROBIOL, V193, P157, DOI 10.1007/s00203-010-0668-3; Vestergaard M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02018; Wilson DN, 2011, ANN NY ACAD SCI, V1241, P1, DOI 10.1111/j.1749-6632.2011.06192.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Wuitschick JD, 1999, J EUKARYOT MICROBIOL, V46, P239, DOI 10.1111/j.1550-7408.1999.tb05120.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhu QY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-717	63	20	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210363	10.1371/journal.pone.0210363	http://dx.doi.org/10.1371/journal.pone.0210363			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645638	Green Submitted, Green Published, gold			2022-12-27	WOS:000455810200025
J	Li, Y; Wu, HD; Wang, JZ; Cui, LJ; Tian, DS; Wang, JS; Zhang, XD; Yan, L; Yan, ZP; Zhang, KR; Kang, XM; Song, B				Li, Yong; Wu, Haidong; Wang, Jinzhi; Cui, Lijuan; Tian, Dashuan; Wang, Jinsong; Zhang, Xiaodong; Yan, Liang; Yan, Zhongqing; Zhang, Kerou; Kang, Xiaoming; Song, Bing			Plant biomass and soil organic carbon are main factors influencing dry-season ecosystem carbon rates in the coastal zone of the Yellow River Delta	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; METHANE EMISSIONS; SALT-MARSH; POLYGONAL TUNDRA; CH4 EMISSIONS; RESPIRATION; WETLANDS; FLUXES; VEGETATION; SALINITY	Coastal wetlands are considered as a significant sink of global carbon due to their tremendous organic carbon storage. Coastal CO2 and CH4 flux rates play an important role in regulating atmospheric CO2 and CH4 concentrations. However, the relative contributions of vegetation, soil properties, and spatial structure on dry-season ecosystem carbon (C) rates (net ecosystem CO2 exchange, NEE; ecosystem respiration, ER; gross ecosystem productivity, GEP; and CH4) remain unclear at a regional scale. Here, we compared dry-season ecosystem C rates, plant, and soil properties across three vegetation types from 13 locations at a regional scale in the Yellow River Delta (YRD). The results showed that the Phragmites australis stand had the greatest NEE (-1365.4 mu mol m(-2) s(-1)), ER (660.2 mu mol m(-2) s(-1)), GEP (-2025.5 mu mol m(-2) s(-1)) and acted as a CH4 source (0.27 mu mol m(-2) s(-1)), whereas the Suaeda heteroptera and Tamarix chinensis stands uptook CH4 (-0.02 to -0.12 mu mol m(-2) s(-1)). Stepwise multiple regression analysis demonstrated that plant biomass was the main factor explaining all of the investigated carbon rates (GEP, ER, NEE, and CH4); while soil organic carbon was shown to be the most important for explaining the variability in the processes of carbon release to the atmosphere, i.e., ER and CH4. Variation partitioning results showed that vegetation and soil properties played equally important roles in shaping the pattern of C rates in the YRD. These results provide a better understanding of the link between ecosystem C rates and environmental drivers, and provide a framework to predict regional-scale ecosystem C fluxes under future climate change.	[Li, Yong; Wu, Haidong; Wang, Jinzhi; Cui, Lijuan; Zhang, Xiaodong; Yan, Liang; Yan, Zhongqing; Zhang, Kerou; Kang, Xiaoming] Chinese Acad Forestry, Inst Wetland Res, Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Tian, Dashuan; Wang, Jinsong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Song, Bing] Ludong Univ, Sch Resources & Environm Engn, Yantai, Peoples R China	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Ludong University	Kang, XM (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China.; Song, B (corresponding author), Ludong Univ, Sch Resources & Environm Engn, Yantai, Peoples R China.	xmkang@ucas.ac.cn; songbing@ldu.edu.cn	Wang, Jinsong/AAO-3115-2021; Li, Yong/A-4000-2013; Kang, Xiaoming/GLU-1610-2022	Wang, Jinsong/0000-0002-3425-7387; Li, Yong/0000-0001-9146-8044; Kang, Xiaoming/0000-0002-0528-1396; Yan, Liang/0000-0001-7315-5415	National Key Research and Development Program of China [2017YFC0506203]; National Natural Science Foundation of China [41403073, 31770511, 41701113, 41403102]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Key Research and Development Program of China (2017YFC0506203 to XK) and National Natural Science Foundation of China (41403073 to YL, 31770511 to XZ, 41701113 to LY, 41403102 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen CG, 2017, GLOBAL CHANGE BIOL, V23, P1128, DOI 10.1111/gcb.13469; Ardon M, 2018, BIOGEOCHEMISTRY, V140, P217, DOI 10.1007/s10533-018-0486-2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chang TC, 2003, ATMOS ENVIRON, V37, P4551, DOI 10.1016/S1352-2310(03)00588-0; Chen GC, 2010, SCI TOTAL ENVIRON, V408, P2761, DOI 10.1016/j.scitotenv.2010.03.007; Chen QF, 2018, ENVIRON POLLUT, V239, P289, DOI 10.1016/j.envpol.2018.04.043; Choi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111879; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Han GX, 2018, AGR FOREST METEOROL, V256, P292, DOI 10.1016/j.agrformet.2018.03.018; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacotot A, 2018, SCI TOTAL ENVIRON, V631-632, P334, DOI 10.1016/j.scitotenv.2018.03.006; Jin ZW, 2019, SCI TOTAL ENVIRON, V649, P1467, DOI 10.1016/j.scitotenv.2018.08.412; Jones SF, 2018, J GEOPHYS RES-BIOGEO, V123, P1976, DOI 10.1029/2017JG004369; Kang XM, 2018, REMOTE SENSING, V10, P20; Kelsey KC, 2016, J GEOPHYS RES-BIOGEO, V121, P2960, DOI 10.1002/2016JG003546; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Knoblauch C, 2015, J GEOPHYS RES-BIOGEO, V120, P2525, DOI 10.1002/2015JG003053; Kutzbach L, 2004, BIOGEOCHEMISTRY, V69, P341, DOI 10.1023/B:BIOG.0000031053.81520.db; Leps J, 2003, MULTIVARIATE ANAL EC; Li F, 2017, ECOLOGY, V98, P2851, DOI 10.1002/ecy.1975; Li H, 2018, BIOGEOCHEMISTRY, V137, P163, DOI 10.1007/s10533-017-0413-y; Li YJ, 2018, ESTUAR COAST SHELF S, V204, P202, DOI 10.1016/j.ecss.2018.03.008; Lu WZ, 2017, GLOBAL CHANGE BIOL, V23, P1180, DOI 10.1111/gcb.13424; Lu XL, 2018, J GEOPHYS RES-BIOGEO, V123, P1756, DOI [10.1029/2017jg004273, 10.1029/2017JG004273]; Martin RM, 2017, HYDROBIOLOGIA, V802, P71, DOI 10.1007/s10750-017-3240-1; Miao GF, 2017, AGR FOREST METEOROL, V247, P343, DOI 10.1016/j.agrformet.2017.08.022; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Nobrega S, 2008, ECOSYSTEMS, V11, P377, DOI 10.1007/s10021-008-9128-1; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Peng YF, 2017, GLOBAL CHANGE BIOL, V23, P5249, DOI 10.1111/gcb.13789; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Purvaja R, 2001, ENVIRON MANAGE, V27, P547, DOI 10.1007/s002670010169; R Core Team, 2018, R LANG ENV STAT COMP; Rey A, 2017, GEODERMA, V287, P135, DOI 10.1016/j.geoderma.2016.06.025; Riveros-Iregui DA, 2012, GLOBAL CHANGE BIOL, V18, P749, DOI 10.1111/j.1365-2486.2011.02556.x; Sachs T, 2010, GLOBAL CHANGE BIOL, V16, P3096, DOI 10.1111/j.1365-2486.2010.02232.x; Shao XX, 2017, PLOS ONE, V12, P13; Sho XX, 2017, ENVIRON PROG SUSTAIN, V36, P1301, DOI 10.1002/ep.12675; Singh R, 2017, ECOL ENG, V100, P291, DOI 10.1016/j.ecoleng.2017.01.002; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Song HL, 2016, WETLANDS, V36, pS113, DOI 10.1007/s13157-014-0587-1; Tang YS, 2011, SOIL BIOL BIOCHEM, V43, P638, DOI 10.1016/j.soilbio.2010.11.035; von Fischer JC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001283; Wang JX, 2017, ATMOS ENVIRON, V167, P346, DOI 10.1016/j.atmosenv.2017.08.041; Welti N, 2017, BIOGEOCHEMISTRY, V132, P55, DOI 10.1007/s10533-016-0287-4; Wu HN, 2017, ENVIRON SCI POLLUT R, V24, P19795, DOI 10.1007/s11356-017-9602-4; Xiao LL, 2017, SCI TOTAL ENVIRON, V595, P337, DOI 10.1016/j.scitotenv.2017.03.279; Xu XW, 2014, ECOL ENG, V73, P469, DOI 10.1016/j.ecoleng.2014.09.087; Yang P, 2018, GEODERMA, V327, P138, DOI 10.1016/j.geoderma.2018.05.005	52	12	12	12	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210768	10.1371/journal.pone.0210768	http://dx.doi.org/10.1371/journal.pone.0210768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH5ZP	30640931	Green Published, gold, Green Submitted			2022-12-27	WOS:000455808000047
J	Meng, L; Childs, C; Buis, A				Meng, Lin; Childs, Craig; Buis, Arjan			Evaluation of functional methods of joint centre determination for quasi-planar movement	PLOS ONE			English	Article							TISSUE ARTIFACT MODEL; CENTER LOCALIZATION; GAIT ANALYSIS; CENTER LOCATION; FORMAL METHODS; ROTATION; ACCURACY	Functional methods identify joint centres as the centre of rotation (CoR) of two adjacent movements during an ad-hoc movement. The methods have been used for functionally determining hip joint centre in gait analysis and have revealed advantages compared to predictive regression techniques. However, the current implementation of functional methods hinders its application in clinical use when subjects have difficulties performing multi-plane movements over the required range. In this study, we systematically investigated whether functional methods can be used to localise the CoR during a quasi-planar movement. The effects of the following factors were analysed: the algorithms, the range and speed of the movement, marker cluster location, marker cluster size and distance to the joint centre. A mechanical linkage was used in our study to isolate the factors of interest and give insight to variation in implementation of functional methods. Our results showed the algorithms and cluster locations significantly affected the estimate results. For all algorithms, a significantly positive relationship between CoR errors and the distance of proximal cluster coordinate location to the joint centre along the medial-lateral direction was observed while the distal marker clusters were best located as close as possible to the joint centre. By optimising the analytical and experimental factors, the transformation algorithms achieved a root mean square error (RMSE) of 5.3 mm while the sphere fitting methods yielded the best estimation with an RMSE of 2.6 mm. The transformation algorithms performed better in presence of random noise and simulated soft tissue artefacts.	[Meng, Lin; Childs, Craig; Buis, Arjan] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Meng, Lin] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Int Joint Res Ctr Neural Engn, Tianjin, Peoples R China	University of Strathclyde; Tianjin University	Meng, L; Buis, A (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.; Meng, L (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Int Joint Res Ctr Neural Engn, Tianjin, Peoples R China.	menglynn@hotmail.com; arjan.buis@strath.ac.uk	Meng, Lin/C-9628-2017	Meng, Lin/0000-0001-9787-9936; Buis, Arjan/0000-0003-3947-293X; Childs, Craig/0000-0003-1318-0007	Engineering and Physical Sciences Research Council (EPSRC) [EP/M026388/1]; Scottish Government; EPSRC [EP/M026388/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Scottish Government; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was funded by the Engineering and Physical Sciences Research Council (EPSRC) grant "Wearable Soft Robotics for Independent Living" EP/M026388/1, and Scottish Government Health Directories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MS, 2012, GAIT POSTURE, V35, P606, DOI 10.1016/j.gaitpost.2011.11.032; Assi A, 2016, GAIT POSTURE, V48, P30, DOI 10.1016/j.gaitpost.2016.04.028; Begon M, 2007, GAIT POSTURE, V25, P353, DOI 10.1016/j.gaitpost.2006.04.010; Bonci T, 2014, J BIOMECH, V47, P2354, DOI 10.1016/j.jbiomech.2014.04.029; Camomilla V, 2006, J BIOMECH, V39, P1096, DOI 10.1016/j.jbiomech.2005.02.008; Camomilla V, 2015, J BIOMECH, V48, P1752, DOI 10.1016/j.jbiomech.2015.05.007; CAPPOZZO A, 1984, HUM MOVEMENT SCI, V3, P27, DOI 10.1016/0167-9457(84)90004-6; Cappozzo A, 1997, IEEE T BIO-MED ENG, V44, P1165, DOI 10.1109/10.649988; Carman AB, 2006, J BIOMECH, V39, P1778, DOI 10.1016/j.jbiomech.2005.05.028; Cereatti A, 2017, J BIOMECH, V62, P5, DOI 10.1016/j.jbiomech.2017.02.004; Cereatti A, 2009, J BIOMECH, V42, P818, DOI 10.1016/j.jbiomech.2009.01.031; Ehrig RM, 2007, J BIOMECH, V40, P2150, DOI 10.1016/j.jbiomech.2006.10.026; Ehrig RM, 2006, J BIOMECH, V39, P2798, DOI 10.1016/j.jbiomech.2005.10.002; Fiorentino NM, 2016, ANN BIOMED ENG, V44, P2168, DOI 10.1007/s10439-015-1522-1; Gamage SSHU, 2002, J BIOMECH, V35, P87, DOI 10.1016/S0021-9290(01)00160-9; Halvorsen K, 2003, J BIOMECH, V36, P999, DOI 10.1016/S0021-9290(03)00070-8; Kratzenstein S, 2012, GAIT POSTURE, V36, P482, DOI 10.1016/j.gaitpost.2012.04.011; Lopomo N, 2010, CLIN BIOMECH, V25, P206, DOI 10.1016/j.clinbiomech.2009.11.008; Peters A, 2012, GAIT POSTURE, V36, P282, DOI 10.1016/j.gaitpost.2012.03.011; Peters A, 2010, GAIT POSTURE, V31, P1, DOI 10.1016/j.gaitpost.2009.09.004; Piazza SJ, 2004, J BIOMECH, V37, P349, DOI 10.1016/S0021-9290(03)00288-4; Sangeux M, 2014, GAIT POSTURE, V40, P20, DOI 10.1016/j.gaitpost.2014.01.024; Sangeux M, 2011, GAIT POSTURE, V34, P324, DOI 10.1016/j.gaitpost.2011.05.019; Siston RA, 2006, J BIOMECH, V39, P125, DOI 10.1016/j.jbiomech.2004.10.032; Stagni R, 2000, J BIOMECH, V33, P1479, DOI 10.1016/S0021-9290(00)00093-2; Zuk M, 2014, ADV INTELL SYST, V284, P57, DOI 10.1007/978-3-319-06596-0_6	27	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210807	10.1371/journal.pone.0210807	http://dx.doi.org/10.1371/journal.pone.0210807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653613	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000456015500074
J	Speich, B; Schur, N; Gryaznov, D; von Niederhausern, B; Hemkens, LG; Schandelmaier, S; Amstutz, A; Kasenda, B; Pauli-Magnus, C; Ojeda-Ruiz, E; Tomonaga, Y; McCord, K; Nordmann, A; von Elm, E; Briel, M; Schwenkglenks, M; Blumle, A; Bischoff, K; Kunzweiler, K; Rehner, L; Busse, JW; Mertz, D; Wong, J; Chow, N; Hong, PJH; Sricharoenchai, S; Klatte, K				Speich, Benjamin; Schur, Nadine; Gryaznov, Dmitry; Niederhausern, Belinda von; Hemkens, Lars G.; Schandelmaier, Stefan; Amstutz, Alain; Kasenda, Benjamin; Pauli-Magnus, Christiane; Ojeda-Ruiz, Elena; Tomonaga, Yuki; McCord, Kimberly; Nordmann, Alain; von Elm, Erik; Briel, Matthias; Schwenkglenks, Matthias; Bluemle, Anette; Bischoff, Karin; Kunzweiler, Katharina; Rehner, Laura; Busse, Jason W.; Mertz, Dominik; Wong, Jaqueline; Chow, Ngai; Hong, Patrick Ji Ho; Sricharoenchai, Sirintip; Klatte, Katharina		MARTA MAking Randomized Trials; ASPIRE Adherence Stand Protocol	Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation	PLOS ONE			English	Article							DRUG DEVELOPMENT; INNOVATION	Background The preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic. Methods We surveyed investigators of RCTs which were approved by RECs in 2012 or in 2016 and asked for RCT preparation costs using a pre-specified item list. Additionally, we collected approval times from RECs and Swissmedic. Results The response rates of the investigator survey were 8.3% (19/228) for 2012 and 16.5% (47/285) in 2016. The median preparation cost of an RCT was USD 72,400 (interquartile range [IQR]: USD 59,500-87,700; n = 18) in 2012 and USD 72,600 (IQR: USD 42,800-169,600; n = 35) in 2016. For single centre RCTs a median REC approval time of 82 (IQR: 49-107; n = 38) days in 2012 and 92 (IQR: 65-131; n = 63) days in 2016 was observed. The median Swissmedic approval time for any clinical trial was 27 (IQR: 19-51; n = 213) days in 2012 and 49 (IQR: 36-67; n = 179) days in 2016. The total duration for achieving RCT approval from both authorities (REC and Swissmedic) in the parallel submission procedure applied in 2016 could not be assessed. Conclusion Based on limited data the costs to plan and prepare RCTs in Switzerland were approximately USD 72,000 in 2012 and 2016. For effective and valid research on costs and approval times of RCTs a greater willingness to share cost information among investigators and more collaboration between stakeholders with data linkage is necessary.	[Speich, Benjamin; Gryaznov, Dmitry; Hemkens, Lars G.; Schandelmaier, Stefan; Kasenda, Benjamin; McCord, Kimberly; Nordmann, Alain; Briel, Matthias; Sricharoenchai, Sirintip] Univ Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland; [Speich, Benjamin; Gryaznov, Dmitry; Niederhausern, Belinda von; Hemkens, Lars G.; Schandelmaier, Stefan; Amstutz, Alain; Kasenda, Benjamin; Pauli-Magnus, Christiane; McCord, Kimberly; Nordmann, Alain; Briel, Matthias; Sricharoenchai, Sirintip; Klatte, Katharina] Univ Hosp Basel, Basel, Switzerland; [Schur, Nadine; Schwenkglenks, Matthias] Univ Basel, Inst Pharmaceut Med, Basel, Switzerland; [Niederhausern, Belinda von; Pauli-Magnus, Christiane; Klatte, Katharina] Univ Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland; [Schandelmaier, Stefan; Briel, Matthias; Busse, Jason W.; Mertz, Dominik; Wong, Jaqueline; Chow, Ngai; Hong, Patrick Ji Ho] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Amstutz, Alain] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Amstutz, Alain] Univ Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Kasenda, Benjamin] Univ Basel, Dept Med Oncol, Basel, Switzerland; [Ojeda-Ruiz, Elena] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain; [Tomonaga, Yuki; Schwenkglenks, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [von Elm, Erik] Lausanne Univ Hosp, Cochrane Switzerland, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Speich, Benjamin] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Bluemle, Anette; Bischoff, Karin; Kunzweiler, Katharina; Rehner, Laura] Univ Freiburg, German Cochrane Ctr, Freiburg, Germany	University of Basel; University of Basel; University of Basel; University of Basel; McMaster University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; Instituto de Salud Carlos III; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Oxford; University of Freiburg	Briel, M (corresponding author), Univ Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland.; Briel, M (corresponding author), Univ Hosp Basel, Basel, Switzerland.; Briel, M (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	matthias.briel@usb.ch	Gryaznov, Dmitry/AAM-8095-2020; Ojeda-Ruiz, Elena/ABH-5998-2020; Kasenda, Benjamin/AAF-4184-2019; Amstutz, Alain/Y-7039-2019; Amstutz, Alain/P-7810-2018; Hemkens, Lars G./AAB-2653-2020; Busse, Jason/CAH-3696-2022; Schandelmaier, Stefan/GLV-3722-2022; Briel, Matthias/AAT-9284-2021	Gryaznov, Dmitry/0000-0002-2361-6794; Ojeda-Ruiz, Elena/0000-0002-4620-7010; Kasenda, Benjamin/0000-0003-0110-8585; Amstutz, Alain/0000-0003-1716-993X; Amstutz, Alain/0000-0003-1716-993X; Hemkens, Lars G./0000-0002-3444-1432; Busse, Jason/0000-0002-0178-8712; Schandelmaier, Stefan/0000-0002-8429-0337; Schwenkglenks, Matthias/0000-0001-7217-1173; Speich, Benjamin/0000-0002-3301-8085; Briel, Matthias/0000-0002-2070-5230; von Elm, Erik/0000-0002-7412-0406	Swiss Federal Office of Public Health; Research Foundation of the University of Basel	Swiss Federal Office of Public Health; Research Foundation of the University of Basel	This project was funded by the Swiss Federal Office of Public Health. The Swiss Federal Office of Public Health was involved in the protocol development for this study; however was not involved in the data collection and analysis, decision to publish, or preparation of the manuscript. Benjamin Speich was supported by the Research Foundation of the University of Basel.; We thank all Swiss RECs, Swissmedic, Interpharma for giving us access or providing us access to the relevant data presented in this study. Furthermore, we are grateful for all the data on working efforts and costs which was provided from researchers of conducted RCTs and for all the support from the Swiss Federal Office of Public Health.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Bosch X, 2005, NAT MED, V11, P1260, DOI 10.1038/nm1205-1260b; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Collier R, 2009, CAN MED ASSOC J, V180, P277, DOI 10.1503/cmaj.082041; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Eisenstein EL, 2008, CLIN TRIALS, V5, P75, DOI 10.1177/1740774507087551; Geldenhuys H, 2013, SAMJ S AFR MED J, V103, P85, DOI [10.7196/SAMJ.6390, 10.7196/samj.6390]; Kenyon GM, 2011, BRIT J NEUROSURG, V25, P352, DOI 10.3109/02688697.2010.551675; Lambers Heerspink HJ, 2008, BRIT J CLIN PHARMACO, V66, P546, DOI 10.1111/j.1365-2125.2008.03246.x; Light DW, 2011, BIOSCIENCE, p[1745, 1]; Lutz K, 2012, J CRIT CARE, V27, P225, DOI 10.1016/j.jcrc.2011.12.012; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Sinha G, 2006, JNCI-J NATL CANCER I, V98, P1100, DOI 10.1093/jnci/djj349; Speich B, 2018, J CLIN EPIDEMIOL, V96, P1, DOI 10.1016/j.jclinepi.2017.12.018; Speich B, 2018, J CLIN EPIDEMIOL, V96, P73, DOI 10.1016/j.jclinepi.2017.12.022	19	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2019	14	1							e0210669	10.1371/journal.pone.0210669	http://dx.doi.org/10.1371/journal.pone.0210669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH1MW	30633776	Green Published, gold, Green Accepted			2022-12-27	WOS:000455485100035
J	Batres, C; Kramer, SS; DeAngelis, CG; Russell, R				Batres, Carlota; Kramer, Sarah S.; DeAngelis, Caroline G.; Russell, Richard			Examining the 'cosmetics placebo effect'	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; BEAUTY; MAKEUP	Previous studies have found a positive effect of cosmetics on certain behavioral measures, such as the tip given to waitresses by male patrons. These studies have employed confederates who usually wear cosmetics. We therefore sought to examine whether the positive effect found in these studies could, in part, be explained by a change in behavior. In order to test the possibility of a 'cosmetics placebo effect', we employed a confederate to solicit donations from passersby. On some days our confederate would not have any cosmetics applied to her face (i.e., no cosmetics condition), on some days cosmetics were pretended to be applied to her face (i.e., placebo cosmetics condition), and on other days cosmetics were actually applied to her face (i.e., cosmetics condition). In line with previous research, we found that across conditions men donated significantly more than women to our female solicitor, providing support for the 'showoff hypothesis', in which male generosity serves as a mating tactic. When investigating men's donations in more detail, we found that the highest percentage of donations came in the cosmetics condition, followed by the placebo cosmetics condition, and then by no cosmetics condition. The effect of condition on donation rates, however, was not statistically significant. Our study was limited to one solicitor and one dependent variable (i.e., percentage of people approached who donated) and therefore future research would benefit from using more confederates as well as examining other behavioral measures. Given the influence of cosmetics use on so many real-world outcomes, we believe that further exploration into a possible 'cosmetics placebo effect' would be valuable.	[Batres, Carlota; Kramer, Sarah S.; DeAngelis, Caroline G.; Russell, Richard] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Batres, Carlota] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA	Gettysburg College; Franklin & Marshall College	Batres, C (corresponding author), Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA.; Batres, C (corresponding author), Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA.	cbatres@fandm.edu	Batres, Carlota/J-2294-2015	Batres, Carlota/0000-0002-3833-7667; Russell, Richard/0000-0002-4007-8596				[Anonymous], 1980, ADV CONSUMER RES; Batres C, 2018, PERS INDIV DIFFER, V122, P148, DOI 10.1016/j.paid.2017.10.023; BROCKNER J, 1984, J CONSUM RES, V11, P611, DOI 10.1086/208997; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; CASH TF, 1982, INT J COSMETIC SCI, V4, P1, DOI 10.1111/j.1467-2494.1982.tb00295.x; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; DERMER M, 1975, J PERS SOC PSYCHOL, V31, P1168, DOI 10.1037/h0077085; FRASER C, 1988, J CONSUM RES, V15, P284, DOI 10.1086/209166; GRAHAM JA, 1981, INT J COSMETIC SCI, V3, P199, DOI 10.1111/j.1467-2494.1981.tb00283.x; Gueguen N, 2008, N AM J PSYCHOL, V10, P221; Gueguen N, 2011, J COSMET SCI, V62, P283; HAMID PN, 1972, J SOC PSYCHOL, V86, P279, DOI 10.1080/00224545.1972.9918629; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Iredale W, 2008, EVOL PSYCHOL-US, V6, P386, DOI 10.1177/147470490800600302; Jacob C, 2010, INT J HOSP MANAG, V29, P188, DOI 10.1016/j.ijhm.2009.04.003; Jones AL, 2015, EVOL PSYCHOL-US, V13, P210, DOI 10.1177/147470491501300113; Jonesu AL, 2015, PERCEPTION, V44, P79, DOI 10.1068/p7904; Landry CE, 2006, Q J ECON, V121, P747, DOI 10.1162/qjec.2006.121.2.747; Mileva VR, 2016, PERCEPTION, V45, P1166, DOI 10.1177/0301006616652053; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Osborn DR, 1996, J APPL SOC PSYCHOL, V26, P31, DOI 10.1111/j.1559-1816.1996.tb01837.x; Panesar P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154202	23	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2019	14	1							e0210238	10.1371/journal.pone.0210238	http://dx.doi.org/10.1371/journal.pone.0210238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH1ME	30629657	Green Submitted, Green Published, gold			2022-12-27	WOS:000455483000064
J	Benazzo, A; Schwarz, S; Muckenhuber, M; Schweiger, T; Murakozy, G; Moser, B; Siguenza, JM; Lang, G; Taghavi, S; Klepetko, W; Hoetzenecker, K; Jaksch, P; Lambers, C				Benazzo, Alberto; Schwarz, Stefan; Muckenhuber, Moritz; Schweiger, Thomas; Murakoezy, Gabriela; Moser, Bernhard; Sigueenza, Jose Matilla; Lang, Gyoergy; Taghavi, Shahrokh; Klepetko, Walter; Hoetzenecker, Konrad; Jaksch, Peter; Lambers, Cristopher			Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience	PLOS ONE			English	Article							ANTI-THYMOCYTE GLOBULIN; RECIPIENTS RECEIVING ALEMTUZUMAB; BRONCHIOLITIS-OBLITERANS; ACUTE REJECTION; CAMPATH-1H; BASILIXIMAB; INFECTIONS; DACLIZUMAB; SURVIVAL	Question addressed by the study The value of induction therapy in lung transplantation is controversial. According to the ISHLT, only about 50% of patients transplanted within the last 10 years received induction therapy. We reviewed our institutional experience to investigate the impact of induction therapy on short-and long-term outcomes. Materials/Patients and methods Between 2007 and 2015, 446 patients with a complete follow-up were included in this retrospective analysis. Analysis comprised long-term kidney function, infectious complications, incidence of rejection and overall survival. Results A total of 231 patients received alemtuzumab, 50 patients antithymocyte globulin (ATG) and 165 patients did not receive induction therapy (NI). The alemtuzumab group revealed the lowest rate of chronic kidney insufficiency (NI: 52.2%; ATG: 60%; alemtuzumab: 36.6%; p = 0.001). Both, the NI group (p<0.001) and the ATG group (p = 0.010) showed a significant increase of serum creatinine during follow-up compared to alemtuzumab patients. Furthermore, alemtuzumab group experienced the lowest rate of infection in the first year after transplantation. Finally, improved survival, low rates of acute cellular rejection (ACR), lymphocytic bronchiolitis (LB) and chronic lung allograft dysfunction (CLAD) were found in patients treated either with alemtuzumab or ATG. Conclusion Alemtuzumab induction therapy followed by reduced maintenance immunosuppression is associated with a better kidney function compared to no induction and ATG. Survival rate as well as freedom from ACR and CLAD were comparable between alemtuzumab and ATG.	[Benazzo, Alberto; Schwarz, Stefan; Muckenhuber, Moritz; Schweiger, Thomas; Murakoezy, Gabriela; Moser, Bernhard; Sigueenza, Jose Matilla; Lang, Gyoergy; Taghavi, Shahrokh; Klepetko, Walter; Hoetzenecker, Konrad; Jaksch, Peter; Lambers, Cristopher] Med Univ Vienna, Div Thorac Surg, Dept Surg, Vienna, Austria	Medical University of Vienna	Jaksch, P (corresponding author), Med Univ Vienna, Div Thorac Surg, Dept Surg, Vienna, Austria.	peter.jaksch@meduniwien.ac.at	Moser, Bernhard/ABA-9436-2020; Benazzo, Alberto/AAU-2742-2021; Lang, György/O-5256-2017	Moser, Bernhard/0000-0002-6037-5475; Benazzo, Alberto/0000-0002-3549-4720; Lang, György/0000-0002-8839-6649; jaksch, peter/0000-0003-4635-3242				Ailawadi G, 2008, J THORAC CARDIOV SUR, V135, P594, DOI 10.1016/j.jtcvs.2007.10.044; Borro JM, 2005, TRANSPL P, V37, P3996, DOI 10.1016/j.transproceed.2005.09.192; Burton CM, 2006, J HEART LUNG TRANSPL, V25, P638, DOI 10.1016/j.healun.2006.01.011; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Floreth T, 2010, SEMIN RESP CRIT CARE, V31, P172, DOI 10.1055/s-0030-1249112; Furuya Y, 2016, AM J TRANSPLANT; Garrity ER, 2001, TRANSPLANTATION, V71, P773, DOI 10.1097/00007890-200103270-00015; Hachem RR, 2005, J HEART LUNG TRANSPL, V24, P1320, DOI 10.1016/j.healun.2004.09.002; Hartwig MG, 2008, J HEART LUNG TRANSPL, V27, P547, DOI 10.1016/j.healun.2008.01.022; Heidt S, 2012, AM J TRANSPLANT, V12, P1784, DOI 10.1111/j.1600-6143.2012.04012.x; Hopkins PM, 2008, CURR OPIN ORGAN TRAN, V13, P477, DOI 10.1097/MOT.0b013e32831040bf; Jaksch P, 2014, AM J TRANSPLANT, V14, P1839, DOI 10.1111/ajt.12824; Kaufman DB, 2006, AM J TRANSPLANT, V6, P331, DOI 10.1111/j.1600-6143.2005.01166.x; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Knechtle SJ, 2004, SURGERY, V136, P754, DOI 10.1016/j.surg.2004.06.015; Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668; Malek SK, 2006, TRANSPLANTATION, V81, P17, DOI 10.1097/01.tp.0000189713.14993.db; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Morris PJ, 2006, TRANSPLANTATION, V81, P1361, DOI 10.1097/01.tp.0000219235.97036.9c; Mullen JC, 2007, J HEART LUNG TRANSPL, V26, P504, DOI 10.1016/j.healun.2007.01.032; Nath DS, 2005, TRANSPL P, V37, P934, DOI 10.1016/j.transproceed.2005.01.054; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Palmer SM, 1999, CHEST, V116, P127, DOI 10.1378/chest.116.1.127; Peleg AY, 2007, CLIN INFECT DIS, V44, P204, DOI 10.1086/510388; Scheffert JL, 2014, J THORAC DIS, V6, P1039, DOI 10.3978/j.issn.2072-1439.2014.04.23; Sharples LD, 2002, J HEART LUNG TRANSPL; Shyu S, 2011, J HEART LUNG TRANSPL, V30, P743, DOI 10.1016/j.healun.2011.01.714; Silveira FP, 2006, J INFECTION, V53, P241, DOI 10.1016/j.jinf.2005.11.017; Tzakis AG, 2003, TRANSPLANTATION, V75, P1512, DOI 10.1097/01.TP.0000060250.50591.39; van Loenhout KCJ, 2010, INTERACT CARDIOV TH, V10, P190, DOI 10.1510/icvts.2009.213892; Whited LK, 2015, TRANSPLANTATION, V99, P2190, DOI 10.1097/TP.0000000000000687; Yusen RD, 2016, J HEART LUNG TRANSPL, V35, P1170, DOI 10.1016/j.healun.2016.09.001	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0210443	10.1371/journal.pone.0210443	http://dx.doi.org/10.1371/journal.pone.0210443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645645	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200031
J	Tissier, ML; Bousquet, CAH; Fleitz, J; Habold, C; Petit, O; Handrich, Y				Tissier, Mathilde L.; Bousquet, Christophe A. H.; Fleitz, Julie; Habold, Caroline; Petit, Odile; Handrich, Yves			Captive-reared European hamsters follow an offensive strategy during risk-assessment	PLOS ONE			English	Article							ANTI-PREDATION DEVICE; CRICETUS-CRICETUS; SMALL MAMMALS; BEHAVIOR; ODORS; FACILITATE; DEFENSE; SECURE; TESTS	Understanding whether captive-reared animals destined to reintroduction are still able to discriminate predators has important implications for conservation biology. The endangered European hamster benefits from conservation programs throughout Europe, in which several thousand individuals are released into the wild every year. Despite this, the anti-predator strategy of hamsters and their ability to maintain predator discrimination in captivity remain to be investigated. Here, we explore the predator discrimination behaviour of captive-reared European hamsters and their response to different predation cues. When first exposed to the urine of cats and goats in a Y-maze test, hamsters spent more time close to the cat scent rather than to the goat scent. In a second experiment, during which hamsters were exposed to a non-mobile European ferret (inside a cage), hamsters significantly increased the time spent close to the ferret's cage and displayed aggressive behaviour towards the ferret. Furthermore, they did not take refuge inside an anti-predation tube (APT), a device designed to upgrade wildlife underpasses and reconnect wild hamster populations. Finally, when exposed to a mobile ferret (but without physical contact), hamsters displayed mobbing and aggressive behaviours towards the ferret, before taking refuge inside the APT. Taken together, our results show that captive-reared hamsters are still able to detect and react to predation cues, but that they initially adopt an offensive strategy (grunting, spitting, mobbing) during the risk-assessment phase. After risk assessment, however, hamsters used the APT as a refuge. Our study provides important insights into the anti-predator behaviour of hamsters. Testing the efficacy of the APT, a device that will allow upgrading wildlife underpasses for the hamster and other rodents, is also of great importance and is instrumental in conservation efforts for these species.	[Tissier, Mathilde L.; Bousquet, Christophe A. H.; Fleitz, Julie; Habold, Caroline; Petit, Odile; Handrich, Yves] Univ Strasbourg, CNRS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tissier, ML; Bousquet, CAH (corresponding author), Univ Strasbourg, CNRS, Strasbourg, France.	mathilde.tissier@hotmail.com; chr_bousquet@protonmail.com	Bousquet, Christophe Alexandre Henri/AAP-4891-2020; Handrich, Yves/AAD-6472-2022	Bousquet, Christophe Alexandre Henri/0000-0003-1650-8004; 	European Commission [LIFE12 BIO/FR/000979]; LIFE + Biodiversity grant [LIFE12 BIO/FR/000979]; Ministere de l'Ecologie, du Developpement Durable et de l'Energie	European Commission(European CommissionEuropean Commission Joint Research Centre); LIFE + Biodiversity grant; Ministere de l'Ecologie, du Developpement Durable et de l'Energie	This work was supported by the European Commission (http://ec.europa.eu/environment/life/themes/biodiversity.htm), grant number: LIFE12 BIO/FR/000979. The funders did not participate in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.; We are grateful to Pierre Uhlrich for building the Y-maze. We are also grateful to the veterinarians that collected cat urine, namely Dr. Vigneron and Dr. Capber. Many thanks to Andre Gross for giving us access to his goats to collect urine used in the Y-maze test, and to Stephanie Cornejo and Caroline Croguennec that helped with data collection during the first experiment. We are also thankful to Christopher Turbill and Manfred Enstipp for their advice on this manuscript. Finally, we would like to thank anonymous reviewers that helped improving the quality of this paper. Authors have no competing interest to declare. This work was supported by the LIFE + Biodiversity grant No LIFE12 BIO/FR/000979 and the Ministere de l'Ecologie, du Developpement Durable et de l'Energie. The funders did not participate in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; APFELBACH R, BEHAV; Banks Peter B., 2003, Australian Zoologist, V32, P406; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLANCHARD RJ, 1990, NEUROSCI BIOBEHAV R, V14, P463, DOI 10.1016/S0149-7634(05)80069-7; Blumstein DT, 2006, ANIM CONSERV, V9, P274, DOI 10.1111/j.1469-1795.2006.00033.x; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Carlson NV, 2017, ANIM BEHAV, V128, P79, DOI 10.1016/j.anbehav.2017.04.006; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; De Franceschi G, 2016, CURR BIOL, V26, P2150, DOI 10.1016/j.cub.2016.06.006; DEMEYRIER V, 2016, HABITATS URBANISES D; Eibl-Eibesfeldt I., 1954, Zeitschrift fuer Tierpsychologie, V10, P204; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Fenyk-Melody J, 2012, AM COLL LAB, P923, DOI 10.1016/B978-0-12-380920-9.00036-5; Franceschini C, 2007, GEN COMP ENDOCR, V152, P14, DOI 10.1016/j.ygcen.2007.02.008; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; Graw B, 2007, ANIM BEHAV, V74, P507, DOI 10.1016/j.anbehav.2006.11.021; Haye M. J. J. la, 2010, Aspects of Applied Biology, P117; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; J CUB, DD; J CUB, 2016, SD, V6, P6; J CUB, 2015, SD, V146, P57; JUMEAU J, ANALYSE EXPERIMENTAL; Kayser A, 2003, ACTA THERIOL, V48, P47, DOI 10.1007/BF03194265; KLEIMAN DG, 1973, BEHAVIOUR, P48; Kramer DL, 1997, ANIM BEHAV, V54, P289, DOI 10.1006/anbe.1996.0360; La Haye M.J.J., 2010, ACTA THERIOL WARSZ, V100, P117; Lenth R, 2018, SF; LENTH R, 2018, R PACKAGE VERSION 1, V2, P1; McPhee ME, 2010, ETHOLOGY, V116, P517, DOI 10.1111/j.1439-0310.2010.01766.x; McPhee ME, 2009, J ETHOL, V27, P137, DOI 10.1007/s10164-008-0099-7; Monclus R, 2005, ANIM BEHAV, V70, P753, DOI 10.1016/j.anbehav.2004.12.019; Nechay G., 1977, EPPO Bulletin, V7, P255, DOI 10.1111/j.1365-2338.1977.tb02727.x; RE P, 2007, BIOL REV, V82, P291; REZNIKSCHULLER H, 1974, Z VERSUCHSTIERKD, V16, P48; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; SINGMANN H, INTERNET, P20; SIUTZ C, 2005, 13 M INT HAMST WORKG, P13; Siutz C, 2005, SF; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Spencer R.-J., 2005, Austral Ecology, V30, P868, DOI 10.1111/j.1442-9993.2005.01530.x; Surov A, 2016, ENDANGER SPECIES RES, V31, P119, DOI 10.3354/esr00749; Tissier ML, 2018, ECOL ENG, V125, P106, DOI 10.1016/j.ecoleng.2018.10.013; Tissier ML, 2016, ECOL ENG, V95, P738, DOI 10.1016/j.ecoleng.2016.07.012; Tissier ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep25531; VOHRALIK V, 1974, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V38, P228; Vohralik V, 1974, DER ZOOL GARTEN, V38, P228; Ward JF, 1996, PHYSIOL BEHAV, V60, P1469, DOI 10.1016/S0031-9384(96)00245-4; WEINHOLD U, 2008, CONVENTION ON THE CO, P1758; WICKHAM H, 2009, NEW YORK, P2; Williams JL, 1999, PSYCHOL REC, V49, P493; Zhang JX, 2008, J ETHOL, V26, P279, DOI 10.1007/s10164-007-0060-1	56	1	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210158	10.1371/journal.pone.0210158	http://dx.doi.org/10.1371/journal.pone.0210158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640936	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000020
J	Tai, Y; Guo, S; An, BF; Ju, F				Tai, Yang; Guo, Shuai; An, Baifu; Ju, Feng			Analysis of the nonlinear dynamic response of guide rails for a suspended buffer	PLOS ONE			English	Article							BACKFILL; VALIDATION; VIBRATION; GANGUE; FLOWS; MODEL	Guide rails' nonlinear dynamic response to the collision process between gangues and the suspended buffer is the basis for its intensity examination and fatigue prediction. This paper established a numerical model for simulating the dynamic response of buffer's guide rails using Pro/E and Femap based on an analysis of the basic structural components of the suspended buffer. The effects of the gangues diameter and feeding rate on the guide rails' dynamic response were investigated, which were mainly revealed by a tension in guide rails. Simulation results showed that the tension in guide rails rapidly increased to a peak value after the suspended buffer was impacted by gangues, followed by a periodic vibration. The peak tension, maximum and minimum tensions within the periodic vibration were exponential functions of the gangues diameter. And they depended linearly on the feeding rate. The vibration frequency of the tension in guide rails was an exponential function of the gangues diameter but did not depend on the feeding rate. Based on the backfilling workface parameters used in D.Ping coal miner's 15601 working panel, the feeding rate of 500 t/h was selected. The diameter of the crushed gangues was selected to be 50 mm based on the strength of guide rails. Their expected service life is 54.2 years. Finally, an industrial test was performed in D.Ping coal miner's 15601 working panel and the guide rails operated steadily. The measured vibration parameters of the tension in guide rails agree well with that of numerical predictions, which verified the reliability of the numerical model to some extent.	[Tai, Yang; An, Baifu] China Univ Min & Technol, Sch Mines, Xuzhou, Jiangsu, Peoples R China; [Tai, Yang; An, Baifu] China Univ Min & Technol, Key Lab Deep Coal Resource Min, Xuzhou, Jiangsu, Peoples R China; [Guo, Shuai; Ju, Feng] China Univ Min & Technol, State Key Lab GeoMech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Guo, S (corresponding author), China Univ Min & Technol, State Key Lab GeoMech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China.	cumtcct402@163.com		guo, shuai/0000-0003-2529-5792	State Key Laboratory of Coal Resources and Safe Mining, China University of Mining and Technology [SKLCRSM18KF08]; State Key Research Development Program of China [2016YFC0600701]; National Natural Science Foundation of China [51574055, 51504127]	State Key Laboratory of Coal Resources and Safe Mining, China University of Mining and Technology; State Key Research Development Program of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Special Funding Projects were funded by the Research Fund of the State Key Laboratory of Coal Resources and Safe Mining, China University of Mining and Technology, SKLCRSM18KF08 to SG; and the State Key Research Development Program of China grant 2016YFC0600701 to SG. The work was also funded by National Natural Science Foundation of China grant 51574055 and National Natural Science Foundation of China grant 51504127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathna PAMMB, 2014, INT C CIRC, V115, P1; Ahn K, 2013, KEY ENG MATER, V535-536, P365, DOI 10.4028/www.scientific.net/KEM.535-536.365; Barry OR, 2014, NONLINEAR DYNAM, V77, P1597, DOI 10.1007/s11071-014-1402-5; Consoli NC, 2015, GEOTECHNIQUE, V65, P866, DOI 10.1680/geot.15.D.001; El-Behery SM, 2012, INT J HEAT FLUID FL, V33, P118, DOI 10.1016/j.ijheatfluidflow.2011.09.011; Emad MZ, 2018, INT J ROCK MECH MIN, V107, P48, DOI 10.1016/j.ijrmms.2018.04.047; Galindo RA, 2017, INT J ROCK MECH MIN, V93, P215, DOI 10.1016/j.ijrmms.2016.12.017; Huang CX, 2014, BIORESOURCES, V9, P5940; Ju F, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-6194-0; Kartushinskii AI, 2004, FLUID DYNAM+, V39, P748, DOI 10.1007/s10697-005-0008-5; Liu Z., 2014, J MIN SAF ENG, V31, P310; LU Z, 2017, APPL SCI BASEL, V7; Lv Y, 2008, PROCEEDINGS OF FIRST INTERNATIONAL CONFERENCE OF MODELLING AND SIMULATION, VOL III, P50; Madzivire G, 2018, J ENVIRON SCI HEAL A, V53, P467, DOI 10.1080/10934529.2017.1410420; Oanta EM, 2016, ADV TOPICS OPTOELECT, V10, P10; Shan GK, 2011, ADV MATER RES-SWITZ, V308-310, P1961, DOI 10.4028/www.scientific.net/AMR.308-310.1961; Tian ZF, 2007, COMPUT CHEM ENG, V31, P1064, DOI 10.1016/j.compchemeng.2006.09.008; Uddin MS, 2017, MAT SCI ENG C SERIES, V84, P15; Vargas T, 2017, J S AFR I MIN METALL, V117, P727, DOI 10.17159/2411-9717/2017/v117n8a1; Wang HW, 2013, APPL MECH MATER, V401, P844, DOI 10.4028/www.scientific.net/AMM.401-403.844; Wang ZG, 2016, MECH ADV MATER STRUC, V23, P503, DOI 10.1080/15376494.2014.994150; Wen WC, 2013, STUD IMP EN ABS PERF, V415, P105; Yi XW, 2018, GEOTEXT GEOMEMBRANES, V46, P396, DOI 10.1016/j.geotexmem.2018.03.004; Yilmaz T, 2018, J ENVIRON MANAGE, V222, P250, DOI 10.1016/j.jenvman.2018.05.075; Zeng H, 2011, ADV MATER RES-SWITZ, V299-300, P1083, DOI 10.4028/www.scientific.net/AMR.299-300.1083; ZHANG Ji-xiong, 2012, J MINING SAFETY ENG, V29, P312; Zhang JX, 2017, POWDER TECHNOL, V305, P12, DOI 10.1016/j.powtec.2016.09.049; Zhao WT, 2014, APPL MECH MATER, V614, P16, DOI 10.4028/www.scientific.net/AMM.614.16; Zhao X, 2012, ADV MATER RES-SWITZ, V538-541, P1488, DOI 10.4028/www.scientific.net/AMR.538-541.1488; Zhu WB, 2017, INT J ROCK MECH MIN, V96, P58, DOI 10.1016/j.ijrmms.2017.04.014	30	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2019	14	1							e0210185	10.1371/journal.pone.0210185	http://dx.doi.org/10.1371/journal.pone.0210185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8WT	30653513	Green Published, Green Submitted, gold			2022-12-27	WOS:000456015500028
J	Rezaei, N; Asadi-Lari, M; Sheidaei, A; Khademi, S; Gohari, K; Delavari, F; Delavari, A; Abdolhamidi, E; Chegini, M; Rezaei, N; Jamshidi, H; Taghanaki, PB; Hasan, M; Yoosefi, M; FarzadFar, F				Rezaei, Negar; Asadi-Lari, Mohsen; Sheidaei, Ali; Khademi, Sara; Gohari, Kimiya; Delavari, Farnaz; Delavari, Alireza; Abdolhamidi, Elham; Chegini, Maryam; Rezaei, Nazila; Jamshidi, Hamidreza; Taghanaki, Pegah Bahrami; Hasan, Milad; Yoosefi, Moein; FarzadFar, Farshad			Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis	PLOS ONE			English	Article							HEPATITIS-C; DEATH; EPIDEMIOLOGY; PATTERNS	Background Liver cirrhosis mortality number has increased over the last decades. We aimed to estimate the liver cirrhosis mortality rate and its trends for the first time by sex, age, geographical distribution, and cause in Iran. Method Iranian Death Registration System, along with demographic (Complete and Summary Birth History, Maternal Age Cohort and Period methods) and statistical methods (Spatio-temporal and Gaussian process regression models) were used to address the incompleteness and misclassification and uncertainty of death registration system to estimate annual cirrhosis mortality rate. Percentages of deaths were proportionally redistributed into cirrhosis due to hepatitis B, C and alcohol use based on the data from the Global Burden of Disease (GBD) 2010 study. Results Liver cirrhosis mortality in elder patients was 12 times higher than that in younger patients at national level in 2015. Over the 26 years, liver cirrhosis mortality in males has increased more than that in females. Plus, the percentage of change in age adjusted mortality rate at provincial levels varied between decreases of 64.53% to nearly 17% increase. Mortality rate has increased until 2002 and then decreased until 2015. The province with highest mortality rate in 2015 has nearly two times greater rate compare to the lowest. More than 60% of livercirrhosis mortality cases at national level are caused by hepatitis B and C infection. The rate of hepatitis B mortality is four times more than that from hepatitis C. Conclusion This study demonstrated an increasing and then decreasing pattern in cirrhosis mortality that could be due to national vaccination of hepatitis B program. However monitoring, early detection and treatment of risk factors of cirrhosis, mainly in high risk age groups and regions are essential. Cirrhosis mortality could be diminished by using new non-invasive methods of cirrhosis screening, hepatitis B vaccination, definite treatment of hepatitis C.	[Rezaei, Negar; Asadi-Lari, Mohsen] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Sheidaei, Ali; Khademi, Sara; Gohari, Kimiya; Delavari, Farnaz; Abdolhamidi, Elham; Chegini, Maryam; Rezaei, Nazila; Hasan, Milad; FarzadFar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran; [Sheidaei, Ali; Gohari, Kimiya] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Biostat, Tehran, Iran; [Delavari, Alireza] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Jamshidi, Hamidreza] Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Taghanaki, Pegah Bahrami] Mashhad Univ Med Sci, Fac Med, Mashhad, Iran; [Yoosefi, Moein; FarzadFar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran	Iran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Mashhad University Medical Science; Tehran University of Medical Sciences	FarzadFar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran.; FarzadFar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	farzadfar3@yahoo.com	Gohari, Kimiya/AAD-9042-2019; Sheidaei, Ali/AAU-2165-2020; Rezaei, Negar/AAS-8147-2020; gohari, kimiya/GLU-7941-2022; Delavari, Farnaz/ABA-8007-2021	Gohari, Kimiya/0000-0001-5792-7956; Sheidaei, Ali/0000-0002-0480-5768; Rezaei, Negar/0000-0001-7047-7638; gohari, kimiya/0000-0001-5792-7956; Farzadfar, Farshad/0000-0001-8288-4046; Bahrami-Taqanaki, Pegah/0000-0001-5917-2083	Ministry of Health and Medical Education of Iran [1391-01-101-1500]	Ministry of Health and Medical Education of Iran	This work received support from the Ministry of Health and Medical Education of Iran grant number: 1391-01-101-1500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian S. M., 2017, 7 INT TEHR HEP C SEP, P17; Alavian SM, 2007, J GASTROINTEST LIVER, V16, P403; [Anonymous], 2017, HOUSEHOLD EXPENDITUR; [Anonymous], 2017, POPULATION; [Anonymous], LANCET; [Anonymous], 2015, GBD COMPARE; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Corrao G, 2004, EUR J EPIDEMIOL, V19, P861, DOI 10.1023/B:EJEP.0000040534.89451.d2; Djalalinia S, 2012, IRAN J PUBLIC HEALTH, V41, P55; Farzadfar F, 2014, ARCH IRAN MED, V17, P7, DOI 0141701/AIM.004; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Ganji A, 2009, MIDDLE E J DIG DIS, V1, P56, DOI DOI 10.15171/MIDDLE%20EAST%20J%20DI.V1I2.427; HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063; Ichikawa S, 2015, J MAGN RESON IMAGING, V42, P204, DOI 10.1002/jmri.24760; Kasaeian A., 2014, ARCH IRANIAN MED AIM, V17; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lee YR, 2016, J KOREAN MED SCI, V31, pS121, DOI 10.3346/jkms.2016.31.S2.S121; Lionis C, 2000, EUR J EPIDEMIOL, V16, P1081, DOI 10.1023/A:1010899328260; Mehdipour Parinaz, 2014, Arch Iran Med, V17, P189, DOI 0141703/AIM.009; Merat S, 2000, ARCH IRAN MED, V3, P192; Mohammadi Y, 2017, LANCET GLOB HEALTH, V5, pE537, DOI [10.1016/S2214-109X(17)30105-5, 10.1016/s2214-109x(17)30105-5]; Mohammadi Y, 2014, ARCH IRAN MED, V17, P176, DOI 0141703/AIM.007; Mohammadi Zahra, 2016, Middle East J Dig Dis, V8, P5, DOI 10.15171/mejdd.2016.01; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Parsaeian M., 2014, ARCH IRANIAN MED AIM, V17; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rezaei N., 2016, TRANSFUSION; Salehi-Vaziri M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.35577; Sari AA, 2015, IRAN J PUBLIC HEALTH, V44, P512; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Setiawan V. W., 2016, HEPATOLOGY; Sheidaei A, 2017, ARCH IRAN MED, V20, P2, DOI 0172001/AIM.003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simpura J, 1997, ADDICTION, V92, pS33, DOI 10.1111/j.1360-0443.1997.tb03393.x; Sohrabpour Aa, 2010, Middle East J Dig Dis, V2, P14; Szpakowski JL, 2013, HEPATOLOGY, V58, P21, DOI 10.1002/hep.26110; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Torres-Poveda K, 2011, ANN HEPATOL, V10, P556, DOI 10.1016/S1665-2681(19)31525-X; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; Zali M., 2005, RATE HEPATITIS B SER; Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248	44	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2019	14	1							e0198449	10.1371/journal.pone.0198449	http://dx.doi.org/10.1371/journal.pone.0198449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH6AH	30645598	Green Published, Green Submitted, gold			2022-12-27	WOS:000455810200002
J	Nikitina, L; Paidi, R; Furuoka, F				Nikitina, Larisa; Paidi, Rohayati; Furuoka, Fumitaka			Using bootstrapped quantile regression analysis for small sample research in applied linguistics: Some methodological considerations	PLOS ONE			English	Article							HELP DESK; STUDENTS; ERROR	Quantitative applied linguistics research often takes place in restricted settings of an intact language classroom, workplace, phonetics laboratory or longitudinal sample. In such settings the samples tend to be small, which raises several methodological problems. The main aim of the current paper is to give a detailed explanation of methodological and practical implications inherent in a robust statistical method called bootstrapped quantile regression (BQR) analysis. Importantly for applied linguistics research, the BQR method could help to deal with methodological difficulties inherent in small sample studies. The current study employed a moderately small sample (N = 27) of students learning the Japanese language in a Malaysian public university. It examined the relationships between the students' language learning motivation (specifically, integrative orientation), the students' images or stereotypes about Japan and their global attitudes toward the target language country and its people. The findings indicated that there was a statistically significant relationship between the students' attitudes toward the target language country and their integrative orientation. In addition, these attitudes were found to be the most constant determinant of the integrative orientation. Besides the applied linguistics research, the BQR method can be used in a variety of the human sciences research where a sample size is small.	[Nikitina, Larisa] Univ Malaya, Fac Languages & Linguist, Kuala Lumpur, Malaysia; [Paidi, Rohayati] Univ Malaya, Fac Arts & Social Sci, Kuala Lumpur, Malaysia; [Furuoka, Fumitaka] Univ Malaya, Asia Europe Inst, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Nikitina, L (corresponding author), Univ Malaya, Fac Languages & Linguist, Kuala Lumpur, Malaysia.	larisa@um.edu.my	PAIDI, ROHAYATI/AAF-9469-2019; Nikitina, Larisa/H-4481-2012; Furuoka, Fumitaka/C-4197-2012	Nikitina, Larisa/0000-0002-6061-5360; Furuoka, Fumitaka/0000-0003-1863-387X; Paidi, Rohayati/0000-0003-2819-0531	University of Malaya through the Small-Scale Research Scheme [BKS039-2017]; University of Malaya	University of Malaya through the Small-Scale Research Scheme; University of Malaya(Universiti Malaya)	This research was supported by University of Malaya through the Small-Scale Research Scheme (BKS039-2017); University of Malaya URL: https://www.um.edu.my/.The funding was given to LN as the Principle Investigator (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Takeshi, 1994, INTRO STAT ECONOMETR; Bai HY, 2016, INT J RES METHOD EDU, V39, P194, DOI 10.1080/1743727X.2015.1056135; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Brown JD., 1988, UNDERSTANDING RES SE; Chen F, 2014, LANG TEST, V31, P63, DOI 10.1177/0265532213493623; Chernozhukov V, 2009, J ECONOMETRICS, V152, P93, DOI 10.1016/j.jeconom.2009.01.004; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Gallagher HC, 2013, APPL LINGUIST, V34, P53, DOI 10.1093/applin/ams023; Gardner R.C., 1985, SOCIAL PSYCHOL 2 LAN; Gardner R.C., 1972, ATTITUDES MOTIVATION; GARDNER RC, 1959, CAN J PSYCHOLOGY, V13, P266, DOI 10.1037/h0083787; Godfrey L., 1978, J ECONOMETRICS, V8, P227, DOI [10.1016/0304-4076(78)90031-3, DOI 10.1016/0304-4076(78)90031-3]; GODFREY LG, 1978, ECONOMETRICA, V46, P1293, DOI 10.2307/1913829; Goldstein H., 2015, LONGITUD LIFE COURSE, V6, P447, DOI DOI 10.14301/LLCS.V6I4.345; Gorjian B, 2013, PROCD SOC BEHV, V84, P34, DOI 10.1016/j.sbspro.2013.06.505; Gu M, 2016, SYSTEM, V57, P14, DOI 10.1016/j.system.2016.01.001; Guan WH, 2003, STATA J, V3, P71, DOI 10.1177/1536867X0300300105; Gujarati D., 2003, BASIC ECONOMETRICS, V4th ed.; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Harvey A. C., 1981, ECONOMETRIC ANAL TIM; Hayashi Fumio, 2000, ECONOMETRICS; Hessel G, 2015, SYSTEM, V52, P103, DOI 10.1016/j.system.2015.05.008; Huber P. H., 1981, ROBUST STAT; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; Keuzenkamp H. A., 2000, PROBABILITY ECONOMET; Kline RB, 2004, SIGNIFICANCE TESTING, DOI [DOI 10.1037/10693-000, 10.1037/10693-000]; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Larson-Hall J., 2016, GUIDE DOING STAT SEC; Larson-Hall J, 2012, LANG TEACHING, V45, P460, DOI 10.1017/S0261444811000127; Larson-Hall J, 2010, APPL LINGUIST, V31, P368, DOI 10.1093/applin/amp038; Maddala GS, 1998, UNIT ROOTS COINTEGRA, DOI 10.1017/CBO9780511751974; Matthews RAJ, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171047; Mizumoto A, 2016, APPL LINGUIST, V37, P284, DOI 10.1093/applin/amv025; Murphy KR., 2004, STAT POWER ANAL, V2; Nikitina L, 2018, APPL LINGUIST, V39, P422, DOI 10.1093/applin/amx026; Nikitina L, 2016, ZB INST PEDAGOG ISTR, V48, P284, DOI 10.2298/ZIPI1602284N; Papi M, 2010, SYSTEM, V38, P467, DOI 10.1016/j.system.2010.06.011; Plonsky L, 2015, APPL LINGUIST, V36, P591, DOI 10.1093/applin/amu001; Poi BP, 2004, STATA J, V4, P312, DOI 10.1177/1536867X0400400308; Rasinger Sebastian M., 2013, QUANTITATIVE RES LIN; Salibian-Barrera M, 2002, ANN STAT, V30, P556, DOI 10.1214/aos/1021379865; Skidmore ST, 2010, EDUC PSYCHOL MEAS, V70, P777, DOI 10.1177/0013164410379320; Spencer-Rodgers J, 2001, INT J INTERCULT REL, V25, P639, DOI 10.1016/S0147-1767(01)00029-3; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Zhang DB, 2017, APPL LINGUIST, V38, P871, DOI 10.1093/applin/amv072; ZIZEK, 2014, EVENT	50	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2019	14	1							e0210668	10.1371/journal.pone.0210668	http://dx.doi.org/10.1371/journal.pone.0210668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH5ZP	30640925	gold, Green Published, Green Submitted			2022-12-27	WOS:000455808000038
